data_2d3j_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2d3j _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.2 m . . . . . 0 CA--C 1.539 0.537 0 CA-C-O 121.574 0.702 . . . . 0.0 112.066 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.7 tt -45.69 133.38 8.1 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.928 2.891 . . . . 0.0 113.45 -175.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -119.84 138.66 53.25 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.391 1.876 . . . . 0.0 108.618 173.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.27 119.39 6.75 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.921 1.688 . . . . 0.0 106.78 -178.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 17.6 p90 -136.95 157.76 45.99 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 119.607 1.094 . . . . 0.0 110.083 176.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.3 mp -91.83 116.52 33.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 103.119 -2.919 . . . . 0.0 103.119 173.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -79.33 140.07 37.62 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 123.648 1.689 . . . . 0.0 113.762 -173.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.84 -23.85 65.43 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 126.945 2.098 . . . . 0.0 116.006 -173.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 10.9 m80 -56.82 -39.03 73.44 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 43.8 tp60 -66.55 -43.81 84.05 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 123.485 0.714 . . . . 0.0 111.33 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.76 -36.3 71.92 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.704 0.802 . . . . 0.0 111.431 174.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 52.3 ttm-85 . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 173.619 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 . . . . . 0 CA--C 1.536 0.414 0 CA-C-O 118.782 -0.628 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -141.38 113.54 8.01 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.962 1.705 . . . . 0.0 109.458 -175.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -90.3 161.83 15.46 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 173.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.0 mp -140.74 113.53 4.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 173.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.55 119.82 23.05 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.5 mt -91.95 -65.83 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.914 0.886 . . . . 0.0 109.445 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.6 t -115.48 120.37 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 105.809 -1.922 . . . . 0.0 105.809 -173.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.4 p -120.25 120.29 35.66 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 103.844 -2.65 . . . . 0.0 103.844 173.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 45.69 38.95 4.55 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.376 1.471 . . . . 0.0 112.872 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.67 -10.91 1.34 Allowed Glycine 0 CA--C 1.543 1.803 0 O-C-N 120.656 -1.277 . . . . 0.0 114.586 -177.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -80.32 37.53 0.39 Allowed 'General case' 0 C--N 1.324 -0.501 1 C-N-CA 133.915 4.886 . . . . 0.0 110.381 -175.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 45.5 mtm -37.78 129.12 1.16 Allowed 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.426 1.891 . . . . 0.0 113.135 -172.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.429 ' C ' ' H ' ' A' ' 42' ' ' PHE . . . -65.35 165.68 16.93 Favored Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 113.92 -1.491 . . . . 0.0 108.456 173.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.52 33.23 0.32 Allowed 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 123.965 3.11 . . . . 0.0 111.259 173.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.429 ' H ' ' C ' ' A' ' 40' ' ' ALA . 13.5 p90 -54.01 -26.7 27.57 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 127.659 2.383 . . . . 0.0 113.121 -173.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 m -65.38 -32.38 73.98 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.949 1.299 . . . . 0.0 111.565 -173.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -58.81 -60.93 3.06 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -56.88 -40.4 76.14 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 177.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -56.65 -52.07 66.28 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.611 1.165 . . . . 0.0 110.428 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? . . . . . 0 N--CA 1.467 0.387 0 CA-C-N 117.757 0.253 . . . . 0.0 111.652 -175.5 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 78.9 mmm . . . . . 0 N--CA 1.47 0.53 0 N-CA-C 117.601 2.445 . . . . 0.0 117.601 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.9 -69.83 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.754 0 CA-C-N 121.152 1.447 . . . . 0.0 114.039 -173.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.47 114.12 8.28 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.404 1.082 . . . . 0.0 111.74 -173.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 72.5 mt -118.58 133.05 23.59 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 127.731 2.412 . . . . 0.0 106.248 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -83.34 160.22 15.03 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 122.746 2.297 . . . . 0.0 112.076 178.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.5 p -46.47 -41.29 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 125.833 1.653 . . . . 0.0 111.734 173.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -55.87 -36.97 68.18 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 126.224 1.81 . . . . 0.0 112.674 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 mm -78.4 112.86 16.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 103.663 -2.717 . . . . 0.0 103.663 173.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -78.64 -42.08 29.73 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 173.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.1 m -139.71 152.75 46.92 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.198 0.599 . . . . 0.0 111.485 -173.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 15.0 mmm -104.51 171.68 7.2 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 126.43 1.892 . . . . 0.0 106.851 173.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.261 90.2 m-20 -126.51 150.75 48.58 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 173.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -137.02 155.87 49.14 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 102.664 -3.087 . . . . 0.0 102.664 172.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.4 m -140.89 133.97 29.35 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 -175.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -146.99 166.02 28.09 Favored 'General case' 0 C--O 1.24 0.587 0 O-C-N 121.785 -0.572 . . . . 0.0 111.049 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -171.7 161.73 6.11 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 122.223 1.011 . . . . 0.0 112.788 176.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -95.34 -173.74 3.0 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 103.058 -2.942 . . . . 0.0 103.058 172.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.05 144.65 46.45 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 101.476 -3.527 . . . . 0.0 101.476 173.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 12.24 -62.82 0.0 OUTLIER Glycine 0 CA--C 1.542 1.757 1 C-N-CA 134.884 5.992 . . . . 0.0 120.78 -173.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -116.44 -6.69 11.73 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 121.978 2.889 . . . . 0.0 114.22 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.82 37.05 0.41 Allowed 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 119.329 3.085 . . . . 0.0 119.329 -173.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -53.73 114.82 1.69 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 122.826 2.557 . . . . 0.0 110.088 -177.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -83.61 155.52 23.19 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 175.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -104.95 145.45 30.4 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 104.281 -2.489 . . . . 0.0 104.281 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -128.94 162.42 27.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 120.169 1.35 . . . . 0.0 110.675 176.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -155.16 134.7 12.6 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 173.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -84.68 103.87 14.16 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.35 1.06 . . . . 0.0 109.762 -175.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.8 tt -69.27 -47.99 63.03 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.132 1.373 . . . . 0.0 109.001 176.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.7 m -130.34 138.22 50.32 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 125.453 1.501 . . . . 0.0 110.837 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -170.29 92.75 0.21 Allowed 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 102.354 -3.202 . . . . 0.0 102.354 172.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -165.27 154.8 12.75 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 119.998 1.272 . . . . 0.0 110.765 -174.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.3 t -77.39 165.57 24.24 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-O 121.878 0.847 . . . . 0.0 110.201 173.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.5 mt -126.34 -5.16 6.62 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 126.005 1.722 . . . . 0.0 112.158 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.631 ' CG ' ' H ' ' A' ' 87' ' ' LYS 0.396 14.1 t70 -89.85 176.2 6.92 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 120.067 1.303 . . . . 0.0 111.701 -176.43 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.631 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 9.0 mtmm -122.62 -48.81 2.03 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 129.37 3.068 . . . . 0.0 111.699 -173.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 90' ' ' MET . . . -94.16 -54.08 1.66 Allowed Glycine 0 CA--C 1.526 0.729 0 C-N-CA 125.026 1.298 . . . . 0.0 111.562 178.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.3 mp -79.37 15.0 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 C-N-CA 126.225 1.81 . . . . 0.0 109.437 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.44 ' H ' ' C ' ' A' ' 88' ' ' GLY . 19.8 ttp -43.5 141.74 1.33 Allowed 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 130.579 3.552 . . . . 0.0 110.584 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -159.83 175.56 12.95 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 130.293 3.437 . . . . 0.0 105.417 -173.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -139.99 113.89 7.68 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 173.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -70.94 146.82 53.86 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 121.734 1.622 . . . . 0.0 109.691 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 23.4 p -132.45 162.4 31.27 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 125.436 1.494 . . . . 0.0 108.833 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.3 m -125.89 154.34 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 C-N-CA 123.882 0.873 . . . . 0.0 110.446 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -84.17 10.57 9.92 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.812 1.645 . . . . 0.0 112.738 -177.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.9 m -141.33 166.26 23.39 Favored Pre-proline 0 C--N 1.326 -0.446 0 C-N-CA 126.43 1.892 . . . . 0.0 108.396 -173.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -66.41 163.04 33.83 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 121.013 1.142 . . . . 0.0 109.756 173.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -64.01 -10.13 19.96 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.337 1.055 . . . . 0.0 112.466 177.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -142.96 163.27 33.24 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.45 1.5 . . . . 0.0 107.657 173.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 166.83 -161.74 35.53 Favored Glycine 0 N--CA 1.461 0.324 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 82.1 p -119.6 154.39 34.01 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 117.944 0.872 . . . . 0.0 110.307 174.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.0 t -95.01 113.35 61.16 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 104.308 -2.479 . . . . 0.0 104.308 173.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -91.01 157.99 3.92 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.819 2.346 . . . . 0.0 114.355 -173.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -64.56 -19.76 65.83 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 123.087 1.423 . . . . 0.0 110.469 -176.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -79.55 113.78 17.96 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 129.367 3.067 . . . . 0.0 106.485 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.92 109.26 0.3 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.558 1.072 . . . . 0.0 108.295 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.8 m -124.42 138.19 54.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -174.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.5 t -91.29 141.66 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 88.9 t -125.14 103.83 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 127.423 2.289 . . . . 0.0 105.493 176.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -69.65 151.12 46.27 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 173.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.9 t -129.46 113.51 28.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 173.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -96.49 147.14 18.56 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 119.76 1.164 . . . . 0.0 110.701 -174.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.478 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 10.1 m-85 -131.29 73.37 80.3 Favored Pre-proline 0 C--O 1.245 0.853 0 CA-C-N 118.457 1.129 . . . . 0.0 111.048 -174.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.76 119.74 6.71 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.582 2.188 . . . . 0.0 106.887 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 5.6 t -99.45 145.62 27.23 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.3 mt -77.56 -6.76 54.82 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 118.787 -0.625 . . . . 0.0 111.986 -175.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.19 49.14 78.48 Favored Glycine 0 C--N 1.341 0.821 0 C-N-CA 126.379 1.942 . . . . 0.0 113.529 173.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -112.34 -68.53 0.92 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.17 0.985 . . . . 0.0 111.544 -174.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 46.4 tp60 -95.73 153.11 17.9 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 173.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -93.42 146.97 23.36 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 177.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 141.32 -151.84 22.89 Favored Glycine 0 C--N 1.332 0.31 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.0 t -127.62 114.02 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -177.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -85.31 168.73 14.42 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 173.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -122.99 159.37 28.48 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.826 0.851 . . . . 0.0 109.12 173.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.478 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 10.4 p90 -147.13 146.4 29.91 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 173.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -101.32 149.68 23.78 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 126.707 2.003 . . . . 0.0 110.349 -177.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 72.2 t -144.63 138.66 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 125.901 1.681 . . . . 0.0 107.31 173.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -160.58 129.69 4.87 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 173.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 41.1 t -134.31 138.77 49.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 -173.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -105.07 165.27 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.2 t -143.47 136.93 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -174.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.21 167.16 22.1 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 124.686 1.194 . . . . 0.0 109.195 -177.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.413 ' C ' HD21 ' A' ' 134' ' ' ASN . 0.1 OUTLIER -83.76 168.79 15.86 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 103.882 -2.636 . . . . 0.0 103.882 172.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.2 t -58.57 -21.19 52.15 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 120.333 1.424 . . . . 0.0 113.876 -174.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -75.01 -9.8 58.88 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.335 -1.478 . . . . 0.0 113.404 174.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 97.72 -2.63 60.47 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.868 1.223 . . . . 0.0 114.576 -175.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -68.8 118.2 11.47 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 120.183 1.991 . . . . 0.0 108.644 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.5 m -67.23 142.14 57.03 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.3 pt -140.64 -38.25 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 124.702 1.201 . . . . 0.0 113.861 -174.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -128.77 143.66 50.98 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 177.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -146.62 130.48 17.14 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 61.8 m -62.73 140.3 97.13 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -81.78 145.23 14.24 Favored 'Trans proline' 0 N--CA 1.443 -1.458 0 CA-C-N 120.258 1.128 . . . . 0.0 109.463 174.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -80.69 112.78 18.38 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -173.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.373 24.0 m-80 172.8 -16.19 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.695 1 C-N-CA 134.006 4.923 . . . . 0.0 112.463 173.663 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.83 97.62 0.08 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 122.166 0.984 . . . . 0.0 110.035 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.1 mm -130.98 138.02 54.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 -176.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.425 ' HB2' ' CE2' ' A' ' 126' ' ' PHE . 0.6 OUTLIER -117.98 170.0 9.19 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 173.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -136.21 113.51 10.69 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.29 1.036 . . . . 0.0 108.347 -173.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.36 122.55 48.05 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -174.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 18.6 m -84.02 118.68 24.21 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 7.7 m -119.26 166.37 13.08 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 123.834 0.854 . . . . 0.0 109.735 174.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.7 pp -131.27 161.77 31.52 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 126.408 1.883 . . . . 0.0 106.359 173.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.7 tm0? -63.85 136.66 57.57 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 174.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -165.32 113.08 0.98 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.194 1.398 . . . . 0.0 107.41 173.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 . . . . . 0 C--O 1.247 0.95 0 C-N-CA 130.284 3.434 . . . . 0.0 104.585 173.846 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 CA--C 1.533 0.313 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.4 tt -43.4 124.06 3.27 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 126.136 1.774 . . . . 0.0 112.36 -176.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -112.25 135.38 53.0 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.295 1.438 . . . . 0.0 108.13 173.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.51 120.67 10.15 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.057 1.743 . . . . 0.0 106.638 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 20.4 p90 -135.62 168.49 19.16 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 118.656 0.662 . . . . 0.0 109.884 175.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.3 mt -102.74 113.83 40.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 103.278 -2.86 . . . . 0.0 103.278 174.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -80.42 149.75 30.03 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.947 1.356 . . . . 0.0 110.567 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.99 -11.55 29.87 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -173.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 45.3 m80 -53.42 -44.74 69.02 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.909 1.232 . . . . 0.0 113.63 -173.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 49.7 tp60 -70.28 -39.96 74.59 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 118.867 -1.133 . . . . 0.0 111.159 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.1 -36.72 78.05 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.065 0.546 . . . . 0.0 111.637 176.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.413 HH21 ' CD ' ' A' ' 28' ' ' GLU . 27.5 ttm180 . . . . . 0 N--CA 1.444 -0.768 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 174.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.413 ' CD ' HH21 ' A' ' 22' ' ' ARG . 7.9 tp10 . . . . . 0 CA--C 1.531 0.226 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -157.38 113.95 2.96 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.688 1.195 . . . . 0.0 111.259 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -95.18 167.7 11.2 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 173.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.4 mp -137.08 113.27 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 104.912 -2.255 . . . . 0.0 104.912 173.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.0 113.96 19.56 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 177.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.4 mt -90.09 -54.41 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.9 t -125.61 113.73 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 -173.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.6 p -110.59 113.81 26.71 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 103.399 -2.815 . . . . 0.0 103.399 173.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.346 1.5 pp20? 46.26 34.13 2.08 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -178.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.73 -6.88 76.29 Favored Glycine 0 CA--C 1.536 1.385 0 O-C-N 120.751 -1.218 . . . . 0.0 114.705 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.3 37.23 0.09 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 130.621 3.568 . . . . 0.0 112.64 -174.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 40.9 mtt -38.09 117.66 0.62 Allowed 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 -173.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.94 164.8 58.04 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 113.885 -1.507 . . . . 0.0 107.851 173.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.72 36.59 0.43 Allowed 'Trans proline' 0 CA--C 1.548 1.206 0 C-N-CA 124.236 3.291 . . . . 0.0 112.024 174.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -53.93 -26.51 25.67 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 127.059 2.144 . . . . 0.0 113.756 -173.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 m -60.06 -33.42 72.04 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.922 1.689 . . . . 0.0 112.218 -173.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -60.72 -53.62 55.25 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.279 0.9 OUTLIER -76.13 -29.97 58.03 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -176.609 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -55.37 -47.45 75.77 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.2 -0.938 . . . . 0.0 108.762 173.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 . . . . . 0 CA--C 1.544 0.723 0 CA-C-O 118.562 -0.732 . . . . 0.0 111.762 175.51 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.468 0.438 0 CA-C-O 116.796 -1.573 . . . . 0.0 114.833 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.22 -70.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.729 1.619 . . . . 0.0 112.644 -173.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.26 113.15 20.49 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -174.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 55.7 mt -104.37 119.48 53.79 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 -175.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -74.21 154.22 46.45 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.319 1.346 . . . . 0.0 109.694 -177.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.0 p -41.68 -42.66 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 126.6 1.96 . . . . 0.0 113.008 177.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -59.2 -40.57 86.2 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 126.084 1.754 . . . . 0.0 112.734 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.1 mm -77.54 112.77 15.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 101.762 -3.422 . . . . 0.0 101.762 173.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -84.18 -28.95 27.01 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.568 -177.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.4 m -147.96 170.72 17.1 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.842 1.257 . . . . 0.0 110.941 -173.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.4 mmm -126.69 162.32 26.05 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 126.418 1.887 . . . . 0.0 106.937 172.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -109.34 146.32 34.57 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 173.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -135.84 153.06 51.61 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 103.082 -2.933 . . . . 0.0 103.082 172.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.1 m -140.36 133.65 29.76 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -176.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -146.07 165.05 30.21 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 121.824 -0.547 . . . . 0.0 111.0 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -167.14 144.72 4.73 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 175.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.24 -179.31 6.15 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 172.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -107.42 85.46 2.13 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.396 1.478 . . . . 0.0 111.582 -174.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.04 -59.5 0.01 OUTLIER Glycine 0 CA--C 1.537 1.426 0 C-N-CA 128.462 2.934 . . . . 0.0 119.322 173.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -116.91 -13.02 10.67 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.926 1.863 . . . . 0.0 112.95 173.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.77 37.24 0.09 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 130.755 3.622 . . . . 0.0 118.984 -173.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -44.79 113.77 0.61 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 122.397 2.362 . . . . 0.0 111.511 -174.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -96.2 120.38 36.38 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 174.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -80.01 149.09 30.86 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -134.38 160.78 36.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 119.735 1.152 . . . . 0.0 111.044 176.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -151.61 136.8 17.48 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 173.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -80.09 104.0 10.35 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.104 0.961 . . . . 0.0 110.434 -178.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.8 tt -63.14 -46.71 85.97 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.148 1.379 . . . . 0.0 108.658 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.3 m -130.2 138.97 50.85 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.716 1.206 . . . . 0.0 110.768 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.2 tt -170.28 92.66 0.21 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 103.305 -2.85 . . . . 0.0 103.305 173.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -166.82 153.89 9.02 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.485 0.584 . . . . 0.0 111.544 -174.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.2 t -72.69 163.27 28.35 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 173.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.4 mt -125.96 -20.18 4.64 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 116.661 -1.638 . . . . 0.0 112.691 174.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.473 ' CG ' ' H ' ' A' ' 87' ' ' LYS . 26.5 t0 -84.26 171.14 13.0 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 121.587 1.994 . . . . 0.0 111.526 174.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.473 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER -109.33 -47.57 3.38 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 129.192 2.997 . . . . 0.0 112.711 174.486 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 90' ' ' MET . . . -70.08 -72.52 0.86 Allowed Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 176.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mp -76.85 19.52 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 128.41 2.684 . . . . 0.0 110.228 -175.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.448 ' H ' ' C ' ' A' ' 88' ' ' GLY . 15.3 ttp -43.75 131.21 5.46 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 127.753 2.421 . . . . 0.0 108.968 -177.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -158.21 114.01 2.72 Favored 'General case' 0 CA--C 1.508 -0.673 0 C-N-CA 126.54 1.936 . . . . 0.0 106.906 -173.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -97.49 134.39 22.61 Favored Pre-proline 0 C--N 1.323 -0.567 0 O-C-N 124.209 0.943 . . . . 0.0 109.726 -173.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.42 154.25 65.25 Favored 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 121.294 1.329 . . . . 0.0 109.054 173.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 21.5 p -139.28 157.07 46.55 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 126.648 1.979 . . . . 0.0 106.736 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.8 m -126.39 153.84 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-N 119.302 0.955 . . . . 0.0 112.861 178.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -72.54 7.73 1.73 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 127.004 2.122 . . . . 0.0 113.521 174.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.8 m -141.08 165.8 26.82 Favored Pre-proline 0 C--N 1.326 -0.414 0 C-N-CA 126.03 1.732 . . . . 0.0 108.295 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -67.57 168.09 19.13 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.377 1.384 . . . . 0.0 111.082 174.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -64.09 -10.98 25.62 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.733 1.213 . . . . 0.0 112.512 175.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -145.37 164.41 31.58 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.539 1.536 . . . . 0.0 107.355 173.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 160.99 -161.68 33.05 Favored Glycine 0 C--O 1.226 -0.37 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 56.5 p -118.59 151.56 37.68 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 173.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 46.5 t -88.17 113.39 54.84 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 175.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -73.79 158.23 46.94 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.093 2.529 . . . . 0.0 112.881 -173.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -65.27 -19.62 66.05 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 -173.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . 0.266 0.0 OUTLIER -116.81 143.69 45.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 118.563 0.62 . . . . 0.0 112.36 174.159 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -43.04 108.19 0.1 Allowed 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 127.052 2.141 . . . . 0.0 110.951 -174.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.2 m -116.41 143.49 45.49 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 175.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.4 t -97.18 119.39 45.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 C-N-CA 124.403 1.081 . . . . 0.0 111.11 -173.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 72.3 t -95.56 103.58 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 173.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.4 120.55 25.12 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 173.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.5 t -93.23 113.55 28.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 103.872 -2.64 . . . . 0.0 103.872 173.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -92.99 151.12 20.28 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.411 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 11.1 m-85 -132.33 73.81 76.78 Favored Pre-proline 0 C--O 1.244 0.792 0 CA-C-N 118.81 1.305 . . . . 0.0 110.821 -176.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -63.05 114.77 2.59 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.707 2.271 . . . . 0.0 109.679 173.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 9.6 t -91.29 151.15 21.01 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 173.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.1 mt -72.11 -11.19 60.63 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 117.862 0.301 . . . . 0.0 111.545 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 54.44 30.4 49.49 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 127.413 2.435 . . . . 0.0 116.506 173.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 43.1 mttt -120.15 -32.05 4.26 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.388 1.594 . . . . 0.0 113.915 176.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 45.7 tp60 -96.65 146.67 24.64 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 173.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -95.4 148.39 22.5 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 174.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.44 -153.8 23.19 Favored Glycine 0 C--N 1.336 0.537 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 176.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.7 t -131.45 118.45 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.761 0.825 . . . . 0.0 108.864 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -93.54 175.27 6.81 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.67 1.188 . . . . 0.0 109.746 173.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -126.15 155.77 41.17 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.538 1.935 . . . . 0.0 106.997 173.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.411 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 48.9 p90 -150.63 155.49 39.48 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.322 1.049 . . . . 0.0 108.913 174.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -113.93 143.71 44.27 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 125.62 1.568 . . . . 0.0 111.131 -174.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 59.0 t -144.65 119.76 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 173.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -146.42 143.03 28.74 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.209 1.404 . . . . 0.0 108.092 177.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.0 t -139.16 141.06 36.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 119.392 0.996 . . . . 0.0 109.939 -173.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -107.3 163.57 5.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 173.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.6 t -141.85 138.3 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -173.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.66 173.37 11.78 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.625 1.57 . . . . 0.0 107.786 -177.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 44.5 p-10 -88.12 176.07 7.44 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 172.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.1 t -67.0 -6.59 17.54 Favored 'General case' 0 CA--C 1.553 1.081 0 O-C-N 120.439 -1.413 . . . . 0.0 112.318 -176.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -84.54 -15.94 44.04 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 120.435 -1.416 . . . . 0.0 110.663 173.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.99 4.62 61.38 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.735 1.159 . . . . 0.0 112.547 -173.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -77.08 117.43 18.64 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.827 1.814 . . . . 0.0 108.937 175.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.7 m -64.32 141.87 58.62 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 126.48 1.912 . . . . 0.0 108.88 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -140.01 -39.03 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 124.931 1.293 . . . . 0.0 113.769 -174.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -130.94 142.35 50.35 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 -177.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -148.59 124.5 10.62 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -176.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 25.1 m -64.1 140.48 97.91 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 174.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.47 141.28 13.97 Favored 'Trans proline' 0 N--CA 1.441 -1.585 0 CA-C-N 119.997 1.035 . . . . 0.0 109.993 177.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 28.2 mp0 -80.4 112.63 17.92 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 -173.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.343 38.5 m-80 172.65 -16.53 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 1 C-N-CA 132.201 4.201 . . . . 0.0 111.311 173.405 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -56.22 98.2 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.024 1.73 . . . . 0.0 110.13 177.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 2.8 mt -135.69 147.22 28.68 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 -174.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -129.08 175.56 8.6 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 173.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -133.23 139.58 47.05 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 -175.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -124.1 122.35 37.61 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 177.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 34.5 m -83.64 118.45 23.85 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 174.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 4.9 m -117.78 166.12 12.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.442 0.639 . . . . 0.0 110.08 173.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.4 pp -138.6 159.7 41.45 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.96 1.704 . . . . 0.0 106.893 173.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.63 127.63 33.45 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.751 0.82 . . . . 0.0 110.302 175.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -147.95 114.32 5.92 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.026 0.93 . . . . 0.0 111.057 176.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 . . . . . 0 C--O 1.256 1.442 0 C-N-CA 129.324 3.049 . . . . 0.0 105.406 173.53 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 CA--C 1.536 0.422 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.1 tt -42.96 129.14 4.41 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 128.066 2.546 . . . . 0.0 113.758 -173.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -117.55 144.6 44.96 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.174 1.79 . . . . 0.0 108.63 173.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.27 123.2 7.51 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.325 1.85 . . . . 0.0 106.615 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 25.7 p90 -141.27 160.93 39.09 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.737 1.153 . . . . 0.0 110.188 178.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -96.13 144.73 9.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 104.509 -2.404 . . . . 0.0 104.509 173.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -97.61 162.74 13.15 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -173.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.9 -18.13 54.39 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 126.114 1.766 . . . . 0.0 114.367 174.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -59.47 -41.13 89.04 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 119.747 1.158 . . . . 0.0 108.978 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 -66.68 -43.49 84.32 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.49 -31.82 73.08 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 121.965 -0.459 . . . . 0.0 111.83 174.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.4 ttm105 . . . . . 0 N--CA 1.445 -0.724 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 173.438 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 . . . . . 0 CA--C 1.533 0.321 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.261 98.7 mt-10 -159.77 112.72 2.16 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.877 1.217 . . . . 0.0 112.994 173.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -97.01 162.6 13.31 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 172.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.9 mp -141.39 113.43 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 173.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.03 119.87 23.43 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.8 mt -96.14 -58.44 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 119.024 0.829 . . . . 0.0 109.789 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.0 t -126.48 142.95 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 126.396 1.878 . . . . 0.0 109.069 -173.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.9 p -153.02 135.2 14.89 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 102.318 -3.215 . . . . 0.0 102.318 173.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 44.46 33.91 0.98 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.882 1.273 . . . . 0.0 113.167 -174.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.33 -2.99 8.57 Favored Glycine 0 CA--C 1.541 1.718 0 O-C-N 120.246 -1.534 . . . . 0.0 115.399 -177.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -64.86 37.63 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.512 1 C-N-CA 132.204 4.202 . . . . 0.0 115.076 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.5 mmt -37.82 113.75 0.3 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.376 1.471 . . . . 0.0 110.397 -173.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.402 ' C ' ' H ' ' A' ' 42' ' ' PHE . . . -68.32 168.1 15.38 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 125.764 1.626 . . . . 0.0 111.54 -174.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.77 16.73 0.5 Allowed 'Trans proline' 0 CA--C 1.548 1.216 0 C-N-CA 123.474 2.782 . . . . 0.0 111.558 173.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.402 ' H ' ' C ' ' A' ' 40' ' ' ALA . 25.6 p90 -53.43 -26.48 20.16 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 127.031 2.133 . . . . 0.0 112.158 -175.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 m -57.2 -30.95 64.98 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 126.889 2.075 . . . . 0.0 111.293 -173.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 64.8 t60 -63.02 -54.72 33.84 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.294 0.497 . . . . 0.0 110.482 178.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.305 0.9 OUTLIER -76.16 -24.63 54.83 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -178.579 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -61.12 -44.16 97.76 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 173.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 . . . . . 0 C--N 1.343 0.295 0 C-N-CA 123.387 0.675 . . . . 0.0 111.135 174.607 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.47 0 CA-C-O 117.292 -1.337 . . . . 0.0 113.394 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -74.4 -68.31 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 CA-C-N 121.11 1.432 . . . . 0.0 110.732 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.64 119.72 15.2 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.164 0.985 . . . . 0.0 110.187 -174.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.9 mt -124.81 129.93 24.42 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 127.494 2.318 . . . . 0.0 106.312 -177.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -77.76 156.82 31.47 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.124 1.882 . . . . 0.0 111.506 176.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.1 p -41.16 -43.91 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 127.697 2.399 . . . . 0.0 112.932 176.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -59.69 -34.05 72.38 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 126.328 1.851 . . . . 0.0 113.44 -175.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.9 mm -70.02 113.05 5.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 178.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -81.32 -29.07 34.3 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.184 0.594 . . . . 0.0 110.43 178.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.4 m -159.47 165.41 33.12 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.068 0.947 . . . . 0.0 109.08 -175.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 68.8 mtp -125.64 160.27 30.1 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 173.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 -111.21 134.33 52.88 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 124.564 1.145 . . . . 0.0 108.898 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -120.5 165.62 14.72 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 103.189 -2.893 . . . . 0.0 103.189 172.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.1 m -149.17 137.55 20.89 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 120.318 -1.489 . . . . 0.0 108.109 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -148.32 165.6 30.54 Favored 'General case' 0 C--O 1.24 0.597 0 O-C-N 121.801 -0.562 . . . . 0.0 111.167 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -162.2 145.35 11.66 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 174.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -91.8 140.46 29.66 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 173.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.43 78.26 0.17 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 -173.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.87 -73.14 0.12 Allowed Glycine 0 CA--C 1.53 1.025 0 C-N-CA 126.876 2.179 . . . . 0.0 117.517 173.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.97 26.34 9.87 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.473 1.636 . . . . 0.0 112.276 173.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -102.38 37.09 1.97 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.41 2.284 . . . . 0.0 111.168 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -38.81 113.36 0.3 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.98 1.312 . . . . 0.0 112.203 -173.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -114.22 119.97 38.86 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 175.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -84.38 152.5 24.02 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -134.56 160.71 37.22 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.809 1.186 . . . . 0.0 110.675 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -154.11 135.07 13.83 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 173.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -80.6 103.63 10.58 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.3 tt -61.43 -40.85 95.96 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 173.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 m -155.89 145.44 21.01 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 120.896 -1.128 . . . . 0.0 112.502 177.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.445 ' H ' ' HD3' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -153.25 93.53 1.72 Allowed 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 173.339 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.445 ' HD3' ' H ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -156.41 161.57 40.09 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 121.081 1.764 . . . . 0.0 111.52 -177.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 27.4 t -81.57 162.9 22.96 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.419 0.628 . . . . 0.0 109.375 173.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 74.7 mt -116.38 -14.96 10.99 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.054 1.741 . . . . 0.0 110.864 174.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -96.32 164.27 12.72 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 175.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.9 mmtm -138.55 -32.38 0.7 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.259 1.824 . . . . 0.0 113.263 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -64.36 -63.67 4.15 Favored Glycine 0 CA--C 1.54 1.648 0 N-CA-C 106.787 -2.525 . . . . 0.0 106.787 172.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.8 mp -76.81 21.77 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 129.473 3.109 . . . . 0.0 110.219 175.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 3.5 ttp -43.2 132.85 4.16 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 125.579 2.609 . . . . 0.0 113.56 -173.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -149.01 150.87 33.55 Favored 'General case' 0 N--CA 1.421 -1.91 2 C-N-CA 135.317 5.447 . . . . 0.0 100.939 173.583 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -139.74 113.85 7.85 Favored Pre-proline 0 C--N 1.315 -0.899 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 173.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -67.68 157.4 61.94 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.962 2.441 . . . . 0.0 113.096 -173.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 39.1 p -136.94 170.11 16.65 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.464 1.506 . . . . 0.0 109.395 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.2 m -126.26 155.65 36.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 124.612 1.165 . . . . 0.0 108.322 173.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -101.6 35.32 2.34 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.024 1.329 . . . . 0.0 110.24 174.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.9 m -139.91 162.11 52.37 Favored Pre-proline 0 C--O 1.236 0.39 0 C-N-CA 127.057 2.143 . . . . 0.0 106.14 173.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -68.74 159.0 55.52 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 N-CA-C 109.213 -1.11 . . . . 0.0 109.213 173.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.38 -11.09 29.22 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 124.194 0.998 . . . . 0.0 112.014 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -141.64 163.68 32.26 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.376 1.47 . . . . 0.0 107.79 173.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 166.61 -161.74 35.47 Favored Glycine 0 C--O 1.226 -0.385 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -177.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.2 p -125.28 144.67 50.36 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.5 t -74.25 117.3 60.59 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 105.0 -2.222 . . . . 0.0 105.0 175.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -74.51 160.53 41.41 Favored 'Trans proline' 0 C--O 1.213 -0.751 0 C-N-CA 121.974 1.782 . . . . 0.0 115.231 -173.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . 0.304 93.0 m-70 -75.05 -14.65 60.62 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 118.114 2.635 . . . . 0.0 118.114 -172.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.96 151.68 36.18 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 173.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -49.05 108.7 0.2 Allowed 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 125.438 1.495 . . . . 0.0 109.025 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 21.1 m -123.89 138.89 54.41 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.8 t -80.05 152.34 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -174.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 86.8 t -129.9 109.85 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 174.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -82.16 135.26 35.31 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 174.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.5 t -116.41 116.58 52.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 173.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -94.43 149.78 19.52 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 125.665 1.603 . . . . 0.0 111.236 -178.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.466 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 4.8 m-85 -133.79 73.8 70.92 Favored Pre-proline 0 C--O 1.242 0.672 0 CA-C-N 118.037 0.919 . . . . 0.0 110.785 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.29 123.06 9.57 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.747 1.631 . . . . 0.0 108.068 173.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 5.7 t -105.27 152.53 22.77 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 173.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.7 mt -79.25 -10.48 59.82 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.558 0.617 . . . . 0.0 112.118 -174.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.03 32.47 66.85 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 125.534 1.54 . . . . 0.0 115.499 173.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.6 mttt -122.92 -29.38 3.95 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.546 1.673 . . . . 0.0 113.857 176.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.433 ' NE2' ' H ' ' A' ' 121' ' ' ASP . 59.3 tp60 -96.71 160.08 14.57 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 173.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.433 ' H ' ' NE2' ' A' ' 120' ' ' GLN . 11.7 m-20 -114.56 148.03 38.59 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 176.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 141.19 -155.97 25.37 Favored Glycine 0 C--N 1.333 0.404 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 176.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.3 t -125.33 113.68 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.75 164.43 15.97 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 173.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -121.93 158.13 29.72 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 121.422 -0.799 . . . . 0.0 110.459 174.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.466 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 24.0 p90 -153.2 161.47 42.39 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 124.21 1.004 . . . . 0.0 109.274 173.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -140.35 159.81 41.37 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 124.543 1.137 . . . . 0.0 111.839 -173.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 77.6 t -133.05 136.35 55.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 127.702 2.401 . . . . 0.0 107.575 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -145.18 122.54 11.61 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 173.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.4 t -135.52 131.56 51.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -97.83 164.86 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 173.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.8 t -144.03 134.49 21.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 -175.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.48 173.9 11.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.282 -1.326 . . . . 0.0 108.55 -175.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -86.32 176.11 8.08 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 105.142 -2.169 . . . . 0.0 105.142 172.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.2 t -58.75 -31.38 68.29 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.846 -1.158 . . . . 0.0 112.216 -173.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -81.22 -4.15 54.59 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.39 -0.819 . . . . 0.0 112.581 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.81 7.0 57.92 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.218 0.914 . . . . 0.0 113.976 175.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -70.32 114.97 8.97 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.762 1.781 . . . . 0.0 108.688 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -69.52 141.89 53.78 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.641 0.776 . . . . 0.0 108.953 -176.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.08 -38.39 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 124.687 1.195 . . . . 0.0 113.475 -174.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -134.02 146.86 50.78 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 16.2 tm0? -148.42 153.98 39.27 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.278 1.031 . . . . 0.0 108.758 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 36.3 m -83.52 114.18 51.76 Favored Pre-proline 0 CA--C 1.529 0.162 0 C-N-CA 125.044 1.338 . . . . 0.0 108.535 -176.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -61.95 143.53 95.48 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 CA-C-N 120.294 1.141 . . . . 0.0 110.08 -173.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -81.49 112.52 18.81 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.913 -173.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.624 30.0 m-80 172.4 -11.48 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 1 C-N-CA 135.992 5.717 . . . . 0.0 112.694 173.169 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.38 75.08 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.021 2.128 . . . . 0.0 110.7 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -118.8 145.47 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 128.061 2.545 . . . . 0.0 105.434 178.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -126.91 169.34 13.38 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 174.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -136.93 113.42 10.09 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.524 1.13 . . . . 0.0 108.197 -173.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 49.0 tttt -99.29 123.3 43.45 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 31.1 m -83.47 116.7 22.65 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 173.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 25.5 m -114.49 164.99 13.22 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.5 pp -142.82 160.05 41.06 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.975 1.31 . . . . 0.0 108.191 174.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.12 127.32 32.42 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.528 1.131 . . . . 0.0 110.433 175.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -155.55 116.44 3.88 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.673 1.189 . . . . 0.0 110.807 175.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 . . . . . 0 C--O 1.247 0.974 0 C-N-CA 128.963 2.905 . . . . 0.0 105.445 173.55 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 CA--C 1.541 0.617 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.7 tt -42.85 129.32 4.31 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 128.328 2.651 . . . . 0.0 113.876 -173.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -117.17 142.14 47.4 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.187 2.195 . . . . 0.0 109.243 173.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.75 117.59 5.85 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.424 1.89 . . . . 0.0 106.652 -177.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 18.4 p90 -138.13 143.31 40.28 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.734 1.152 . . . . 0.0 109.337 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.9 mp -83.91 113.7 23.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 104.856 -2.276 . . . . 0.0 104.856 176.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -78.66 151.23 32.35 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 122.707 1.241 . . . . 0.0 111.118 -176.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.15 -9.76 49.07 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 127.216 2.206 . . . . 0.0 115.619 -173.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -54.48 -38.62 66.62 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 119.7 1.136 . . . . 0.0 112.952 -173.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 49.5 tp60 -73.84 -40.3 63.39 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.809 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.35 -39.08 78.56 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.516 1.126 . . . . 0.0 110.885 173.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 . . . . . 0 N--CA 1.448 -0.575 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 175.852 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -148.9 113.22 5.25 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 174.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -95.43 154.89 16.98 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 102.706 -3.072 . . . . 0.0 102.706 172.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.3 mm -135.31 113.31 15.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 104.535 -2.394 . . . . 0.0 104.535 173.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.03 114.28 19.79 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 -176.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.9 mt -87.49 -61.53 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.1 t -125.72 142.11 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 125.533 1.533 . . . . 0.0 108.974 -173.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.0 p -149.81 124.29 9.66 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 102.921 -2.992 . . . . 0.0 102.921 173.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 44.34 33.95 0.96 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.697 1.599 . . . . 0.0 113.582 -174.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.96 -5.95 4.26 Favored Glycine 0 CA--C 1.544 1.852 0 O-C-N 120.663 -1.273 . . . . 0.0 114.932 -176.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -75.73 37.61 0.15 Allowed 'General case' 0 N--CA 1.468 0.442 1 C-N-CA 133.248 4.619 . . . . 0.0 111.114 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 30.7 mtp -37.84 131.92 0.98 Allowed 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.886 1.674 . . . . 0.0 114.531 -172.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.03 162.26 69.94 Favored Pre-proline 0 N--CA 1.448 -0.552 0 CA-C-N 113.746 -1.57 . . . . 0.0 107.945 173.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.79 39.6 0.58 Allowed 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 124.172 3.248 . . . . 0.0 111.421 174.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -55.07 -26.55 38.49 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.695 1.998 . . . . 0.0 112.142 -173.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.6 m -60.73 -27.92 68.29 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.89 1.676 . . . . 0.0 110.786 -174.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -57.23 -65.74 0.57 Allowed 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.663 1.185 . . . . 0.0 109.713 174.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.91 -24.36 62.45 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -178.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -65.82 -50.12 65.75 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.611 0.641 . . . . 0.0 110.338 174.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? . . . . . 0 CA--C 1.541 0.601 0 O-C-N 121.453 -0.78 . . . . 0.0 109.393 -176.332 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.537 0 CA-C-O 116.98 -1.486 . . . . 0.0 115.008 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -83.68 -65.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.805 0 CA-C-N 122.0 1.75 . . . . 0.0 112.023 -174.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.26 120.5 16.03 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.094 1.358 . . . . 0.0 110.593 -173.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.3 mt -129.4 129.6 23.26 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 126.461 1.904 . . . . 0.0 106.215 -175.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -78.89 158.5 27.54 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.271 1.981 . . . . 0.0 111.393 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.4 p -41.64 -49.1 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 126.408 1.883 . . . . 0.0 112.068 174.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -59.17 -40.26 85.09 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 126.638 1.975 . . . . 0.0 113.024 -176.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.4 mm -73.18 112.76 9.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 102.256 -3.239 . . . . 0.0 102.256 174.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -81.22 -36.78 29.62 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 114.664 -1.153 . . . . 0.0 108.922 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.8 m -141.84 168.62 19.33 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 123.883 0.739 . . . . 0.0 111.968 -173.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 70.8 mtp -126.81 155.57 42.65 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 172.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 46.6 m-20 -107.22 149.29 27.89 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 174.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -135.15 155.07 51.32 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 129.788 3.235 . . . . 0.0 103.015 172.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.5 m -140.71 134.2 29.99 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 -177.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -146.82 165.03 30.94 Favored 'General case' 0 C--O 1.239 0.528 0 O-C-N 121.803 -0.561 . . . . 0.0 110.952 176.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.22 163.43 5.81 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.736 1.215 . . . . 0.0 111.169 174.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.45 ' C ' ' HD1' ' A' ' 105' ' ' HIS . . . -106.1 170.63 7.8 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 173.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.08 101.84 13.43 Favored 'General case' 0 N--CA 1.445 -0.708 0 O-C-N 119.966 -1.709 . . . . 0.0 109.099 -174.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 44.58 -48.73 0.0 OUTLIER Glycine 0 CA--C 1.54 1.637 1 C-N-CA 133.14 5.162 . . . . 0.0 121.032 174.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -116.92 -18.99 10.01 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 121.85 2.825 . . . . 0.0 115.78 174.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.48 37.1 0.56 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 128.185 2.594 . . . . 0.0 117.908 -173.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -48.99 114.11 0.93 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 122.53 2.423 . . . . 0.0 110.283 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -83.65 153.14 24.41 Favored 'General case' 0 C--N 1.335 -0.029 0 C-N-CA 125.376 1.47 . . . . 0.0 107.857 174.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -97.46 151.02 20.41 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -133.98 159.88 39.42 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.905 1.229 . . . . 0.0 110.616 174.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -156.16 141.55 17.6 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 173.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -91.75 103.66 16.2 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.309 1.043 . . . . 0.0 108.899 -174.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.7 tt -73.26 -44.09 59.94 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.154 1.382 . . . . 0.0 108.104 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.2 m -136.83 137.35 39.65 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.237 1.415 . . . . 0.0 110.218 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -170.3 92.94 0.21 Allowed 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 102.022 -3.325 . . . . 0.0 102.022 173.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -162.29 152.44 16.66 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 118.647 -0.692 . . . . 0.0 111.41 -174.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.5 t -69.85 167.71 16.72 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 122.326 1.06 . . . . 0.0 112.511 173.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.9 mt -126.51 -9.61 6.27 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 126.593 1.957 . . . . 0.0 113.37 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.576 ' CG ' ' H ' ' A' ' 87' ' ' LYS 0.348 14.4 t70 -101.53 162.22 13.06 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 121.625 2.011 . . . . 0.0 113.665 -175.489 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.576 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 0.7 OUTLIER -106.32 -48.76 3.5 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 129.476 3.11 . . . . 0.0 112.293 -173.286 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 90' ' ' MET . . . -94.05 -49.7 2.4 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 124.865 1.222 . . . . 0.0 111.754 -177.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 mt -81.31 17.56 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 126.052 1.741 . . . . 0.0 109.179 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.43 ' H ' ' C ' ' A' ' 88' ' ' GLY . 14.4 ttp -43.49 130.64 5.12 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 130.215 3.406 . . . . 0.0 109.77 -177.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.255 . . -162.47 166.67 24.63 Favored 'General case' 0 N--CA 1.441 -0.908 1 C-N-CA 133.179 4.591 . . . . 0.0 104.351 -173.578 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -141.88 145.54 36.98 Favored Pre-proline 0 N--CA 1.473 0.678 0 CA-C-N 118.923 0.783 . . . . 0.0 110.453 173.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -77.61 145.74 23.51 Favored 'Trans proline' 0 N--CA 1.443 -1.454 0 C-N-CA 121.532 1.488 . . . . 0.0 109.352 173.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 23.8 p -129.14 153.93 47.21 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 126.047 1.739 . . . . 0.0 107.353 176.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.2 m -126.06 150.37 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 119.382 0.992 . . . . 0.0 111.579 -174.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -80.52 9.08 6.46 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.432 1.893 . . . . 0.0 113.552 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.6 m -143.38 163.45 36.93 Favored Pre-proline 0 C--N 1.327 -0.381 0 C-N-CA 124.97 1.308 . . . . 0.0 109.06 -177.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -66.2 162.16 37.1 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.334 1.356 . . . . 0.0 109.339 173.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -66.44 -12.0 54.91 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.119 0.968 . . . . 0.0 112.035 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -140.81 163.49 32.78 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.155 1.382 . . . . 0.0 107.796 173.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.24 -160.83 33.46 Favored Glycine 0 C--O 1.227 -0.341 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 72.1 p -119.14 147.93 43.64 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 174.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.1 t -81.31 113.4 41.23 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 100.983 -3.71 . . . . 0.0 100.983 173.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -92.29 167.4 2.91 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.28 1.986 . . . . 0.0 116.837 -172.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.45 ' HD1' ' C ' ' A' ' 69' ' ' ALA . 76.0 m-70 -75.94 10.46 1.86 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.688 1.195 . . . . 0.0 114.167 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.93 122.49 45.46 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 176.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.26 105.25 0.14 Allowed 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 174.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.0 m -114.27 136.56 52.83 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -174.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 26.6 t -95.13 114.97 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -174.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 78.7 t -93.69 103.36 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 N-CA-C 103.514 -2.772 . . . . 0.0 103.514 173.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -85.19 140.85 30.58 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 173.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.5 t -115.61 113.83 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 104.108 -2.553 . . . . 0.0 104.108 174.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -95.76 150.4 19.64 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 125.525 1.536 . . . . 0.0 109.919 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.468 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 7.9 m-85 -130.0 73.5 81.34 Favored Pre-proline 0 C--O 1.243 0.721 0 CA-C-N 118.478 1.139 . . . . 0.0 110.366 -173.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.16 121.96 9.78 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.351 2.034 . . . . 0.0 107.898 173.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 8.7 t -103.67 149.85 24.57 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 175.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.1 mt -81.58 -8.02 59.66 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 118.752 -0.642 . . . . 0.0 111.332 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.2 49.19 78.04 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 126.312 1.91 . . . . 0.0 113.323 173.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -112.47 -75.69 0.6 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.116 0.958 . . . . 0.0 111.152 -173.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 51.2 tp60 -83.08 152.19 25.45 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 173.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -93.47 142.6 27.15 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 178.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.52 -154.68 25.94 Favored Glycine 0 C--N 1.331 0.294 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -177.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.3 t -128.14 113.78 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -86.63 169.57 12.61 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 173.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -132.19 162.22 31.46 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.14 0.576 . . . . 0.0 109.818 175.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.468 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 20.2 p90 -144.91 147.15 32.42 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 173.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -104.21 144.75 31.18 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 127.437 2.295 . . . . 0.0 109.474 -174.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 43.7 t -137.43 143.43 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 123.605 0.762 . . . . 0.0 110.02 173.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -157.5 119.4 3.74 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 128.454 2.702 . . . . 0.0 105.616 174.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.444 ' H ' ' HB ' ' A' ' 143' ' ' THR . 61.6 t -130.33 121.81 52.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.413 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -85.77 167.18 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-O 123.018 1.389 . . . . 0.0 107.501 173.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.1 t -143.24 132.64 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 C-N-CA 127.448 2.299 . . . . 0.0 105.829 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.15 174.84 10.1 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.448 1.099 . . . . 0.0 108.596 -176.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -88.98 176.09 7.15 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 172.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.7 t -67.55 -3.57 9.15 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 120.499 -1.376 . . . . 0.0 113.58 -176.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -91.36 -12.76 33.97 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 120.364 1.438 . . . . 0.0 110.581 173.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 93.26 -0.77 69.02 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.557 1.075 . . . . 0.0 111.926 -173.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 59.9 m-20 -67.73 115.42 7.27 Favored 'General case' 0 C--N 1.343 0.306 0 CA-C-N 119.427 1.613 . . . . 0.0 108.005 174.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -71.5 147.3 47.89 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.415 1.486 . . . . 0.0 109.386 -174.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.48 -33.87 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -136.83 147.45 46.56 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -173.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.2 tm0? -148.81 150.12 32.5 Favored 'General case' 0 N--CA 1.462 0.129 0 O-C-N 121.378 -0.826 . . . . 0.0 109.309 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.444 ' HB ' ' H ' ' A' ' 130' ' ' VAL . 24.1 m -82.29 113.75 46.23 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 175.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -64.86 146.43 88.03 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 121.62 1.547 . . . . 0.0 112.21 -173.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -77.72 112.55 14.68 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.303 19.5 m-80 172.71 -17.2 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 1 C-N-CA 137.773 6.429 . . . . 0.0 109.553 173.936 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.6 82.57 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.062 1.745 . . . . 0.0 109.627 174.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.2 mm -121.72 136.03 59.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 176.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.412 ' HB2' ' CE2' ' A' ' 126' ' ' PHE . 6.5 m-85 -112.85 163.51 14.53 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 174.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -138.32 113.4 9.28 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.022 1.329 . . . . 0.0 108.395 -173.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.33 121.43 44.37 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -174.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 23.1 m -84.53 115.59 22.67 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 126.042 1.737 . . . . 0.0 106.726 -175.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 4.2 m -113.98 166.35 11.69 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.185 0.902 . . . . 0.0 109.425 173.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.9 pp -134.22 162.31 32.5 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.626 1.57 . . . . 0.0 106.914 173.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.5 120.34 11.51 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 123.982 0.913 . . . . 0.0 109.907 175.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -163.93 114.17 1.28 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.063 1.345 . . . . 0.0 109.841 176.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 . . . . . 0 C--O 1.256 1.431 0 C-N-CA 128.936 2.894 . . . . 0.0 105.546 173.786 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . 0.295 4.5 m . . . . . 0 CA--C 1.541 0.606 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.9 tt -65.26 137.69 57.73 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 130.302 3.441 . . . . 0.0 112.018 -176.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -126.91 138.38 53.29 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.257 2.223 . . . . 0.0 108.342 173.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.11 118.72 6.53 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 -175.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 14.2 p90 -135.6 175.45 9.58 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.707 1.203 . . . . 0.0 110.574 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.6 mp -114.22 141.19 31.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 103.52 -2.77 . . . . 0.0 103.52 173.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -93.11 158.73 15.62 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -173.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.34 -15.13 59.03 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 113.122 -1.854 . . . . 0.0 113.497 177.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -61.02 -43.31 99.08 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 119.795 1.18 . . . . 0.0 108.428 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -66.55 -49.56 66.04 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 122.83 0.452 . . . . 0.0 111.143 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.17 -35.31 67.07 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.468 0.707 . . . . 0.0 111.785 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.438 HH21 ' CD ' ' A' ' 28' ' ' GLU . 26.9 ttm105 . . . . . 0 N--CA 1.443 -0.819 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 175.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.438 ' CD ' HH21 ' A' ' 22' ' ' ARG . 16.6 tp10 . . . . . 0 CA--C 1.532 0.263 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -155.91 113.49 3.29 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.737 0.815 . . . . 0.0 112.344 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -96.04 159.34 15.01 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 103.002 -2.962 . . . . 0.0 103.002 172.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 84.2 mt -134.39 113.4 17.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 174.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.05 114.25 23.5 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -174.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.6 mt -89.05 -62.84 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.614 0.766 . . . . 0.0 109.355 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.7 t -116.0 128.87 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 126.147 1.779 . . . . 0.0 107.725 -173.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 54.5 p -132.02 124.51 29.43 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 102.643 -3.095 . . . . 0.0 102.643 173.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.475 ' C ' ' H ' ' A' ' 38' ' ' LYS 0.265 1.7 pm0 44.07 40.77 3.64 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.417 1.487 . . . . 0.0 112.863 -175.001 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.01 -31.76 1.08 Allowed Glycine 0 CA--C 1.542 1.724 0 C-N-CA 126.268 1.89 . . . . 0.0 114.916 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.475 ' H ' ' C ' ' A' ' 36' ' ' GLU 0.462 8.8 tmtt? -54.31 37.66 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.835 1 C-N-CA 137.85 6.46 . . . . 0.0 116.126 174.966 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 42.5 mtt -38.01 142.73 0.15 Allowed 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.215 1.806 . . . . 0.0 115.418 -173.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.84 160.29 83.06 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 173.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -74.81 37.69 0.48 Allowed 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 124.217 3.278 . . . . 0.0 111.994 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -55.76 -26.66 46.84 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 126.6 1.96 . . . . 0.0 113.196 -173.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.7 m -54.77 -39.32 68.26 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.451 2.3 . . . . 0.0 112.672 -173.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 -58.0 -65.94 0.56 Allowed 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.811 1.644 . . . . 0.0 109.724 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -70.91 -27.19 63.6 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-O 118.076 -0.964 . . . . 0.0 111.689 -173.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -69.79 -49.17 55.45 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.812 1.245 . . . . 0.0 111.557 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 . . . . . 0 N--CA 1.469 0.505 0 CA-C-N 119.31 0.959 . . . . 0.0 109.566 178.2 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 91.0 mmm . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 118.164 2.654 . . . . 0.0 118.164 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -68.76 -70.0 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.697 0 CA-C-N 121.67 1.632 . . . . 0.0 113.698 -173.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.59 114.08 8.33 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.721 0.808 . . . . 0.0 110.504 -173.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 62.4 mt -119.45 127.26 26.54 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 127.097 2.159 . . . . 0.0 106.335 -177.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -77.31 156.58 33.08 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.125 1.883 . . . . 0.0 110.752 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.7 p -42.58 -43.77 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 127.136 2.174 . . . . 0.0 113.1 177.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -62.21 -41.35 98.29 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 126.181 1.792 . . . . 0.0 112.831 -174.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.6 mm -67.64 112.93 3.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 102.912 -2.995 . . . . 0.0 102.912 174.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -81.65 -27.11 34.26 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 118.716 -0.659 . . . . 0.0 109.512 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.4 m -155.27 168.96 25.34 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.383 1.073 . . . . 0.0 110.59 -173.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.1 mtm -126.26 151.02 48.01 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 172.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -104.92 113.29 26.79 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 122.882 0.473 . . . . 0.0 110.422 -176.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -100.76 153.02 19.8 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 103.06 -2.941 . . . . 0.0 103.06 172.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.3 m -138.17 133.71 33.64 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 -177.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -143.81 163.56 33.02 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.42 175.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -172.74 157.03 3.65 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.173 173.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.55 -173.6 4.59 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 172.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -123.49 134.51 53.88 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 101.478 -3.527 . . . . 0.0 101.478 173.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 16.49 -55.86 0.0 OUTLIER Glycine 0 CA--C 1.534 1.227 1 C-N-CA 135.274 6.178 . . . . 0.0 120.671 -176.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -116.61 -14.97 10.85 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 120.721 2.261 . . . . 0.0 113.999 -177.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.84 37.16 0.35 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 129.303 3.041 . . . . 0.0 118.859 -173.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -56.95 113.81 1.84 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 123.239 2.745 . . . . 0.0 110.307 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -85.81 155.72 20.88 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 125.38 1.472 . . . . 0.0 108.288 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -102.82 150.09 23.84 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 177.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -136.21 160.88 37.34 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.949 1.25 . . . . 0.0 110.905 176.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -153.53 140.13 18.86 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 172.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -87.1 103.44 15.39 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.9 tt -74.27 -40.79 62.09 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 175.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.4 m -138.34 135.97 35.9 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.328 1.051 . . . . 0.0 111.591 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -165.63 93.18 0.56 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 102.188 -3.264 . . . . 0.0 102.188 173.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.12 154.42 23.56 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 121.001 -1.062 . . . . 0.0 110.053 -174.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.4 t -73.89 169.05 18.22 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.716 0.77 . . . . 0.0 110.477 173.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.0 mt -122.34 -21.54 5.79 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 116.179 -1.867 . . . . 0.0 110.849 174.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -106.11 152.29 23.61 Favored 'General case' 0 C--N 1.353 0.741 0 CA-C-N 121.528 1.967 . . . . 0.0 110.773 173.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.481 ' HE3' ' HA ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -120.33 -23.85 6.07 Favored 'General case' 0 N--CA 1.445 -0.718 1 C-N-CA 135.67 5.588 . . . . 0.0 113.982 179.879 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 90' ' ' MET . . . -72.92 -71.57 1.07 Allowed Glycine 0 CA--C 1.533 1.214 0 N-CA-C 107.118 -2.393 . . . . 0.0 107.118 173.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 mp -77.12 26.52 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 130.052 3.341 . . . . 0.0 110.358 174.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.483 ' H ' ' C ' ' A' ' 88' ' ' GLY . 4.7 ttp -42.95 127.76 4.17 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 129.04 2.936 . . . . 0.0 113.487 -173.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -146.99 152.17 38.18 Favored 'General case' 0 N--CA 1.431 -1.42 1 C-N-CA 133.556 4.742 . . . . 0.0 102.216 173.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -139.81 114.19 7.85 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 173.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -70.0 160.76 48.48 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.114 2.543 . . . . 0.0 114.919 -173.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.1 p -137.03 167.11 22.15 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.532 1.933 . . . . 0.0 109.76 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.9 m -126.54 154.76 36.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.038 0.935 . . . . 0.0 111.432 173.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -78.94 9.58 4.16 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.592 2.357 . . . . 0.0 113.574 178.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.7 m -140.84 164.19 37.86 Favored Pre-proline 0 C--N 1.327 -0.4 0 C-N-CA 124.593 1.157 . . . . 0.0 109.557 -175.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -65.58 163.09 31.38 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.418 1.412 . . . . 0.0 109.699 173.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -62.9 -12.98 28.74 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 124.151 0.981 . . . . 0.0 112.423 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -143.66 164.85 29.27 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 120.334 1.425 . . . . 0.0 108.308 173.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.59 -161.96 35.39 Favored Glycine 0 C--O 1.228 -0.231 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 73.6 p -120.76 159.05 26.2 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 117.485 0.642 . . . . 0.0 109.784 174.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.9 t -94.05 113.18 59.96 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 173.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -93.32 163.75 2.45 Favored 'Trans proline' 0 C--O 1.218 -0.485 0 C-N-CA 122.861 2.374 . . . . 0.0 114.114 -173.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -73.26 2.11 8.07 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 120.303 -1.498 . . . . 0.0 113.887 -173.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.41 126.95 55.0 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-O 115.525 -2.179 . . . . 0.0 107.864 177.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -42.29 111.95 0.29 Allowed 'General case' 0 N--CA 1.462 0.155 0 O-C-N 125.299 1.624 . . . . 0.0 109.023 173.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.5 m -117.82 138.25 52.21 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 176.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.4 t -97.5 114.98 36.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 123.796 0.838 . . . . 0.0 110.035 -173.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 77.1 t -93.9 103.21 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 102.689 -3.078 . . . . 0.0 102.689 173.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -85.53 121.44 28.23 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 173.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.5 t -90.02 113.57 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 103.535 -2.765 . . . . 0.0 103.535 173.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -85.77 149.79 23.65 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.488 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 5.4 m-85 -135.62 73.56 61.38 Favored Pre-proline 0 C--O 1.244 0.779 0 CA-C-N 117.772 0.786 . . . . 0.0 109.229 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.3 114.42 3.44 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 N-CA-C 107.575 -1.741 . . . . 0.0 107.575 173.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 5.6 t -95.85 141.55 29.16 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 173.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.9 mt -81.92 -11.02 59.1 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 123.276 0.36 . . . . 0.0 110.716 -178.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 56.99 57.91 17.3 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 126.517 2.008 . . . . 0.0 111.871 173.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . 0.321 41.6 mmtm -113.05 -75.72 0.6 Allowed 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 117.589 -1.196 . . . . 0.0 111.065 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 49.0 tp60 -77.51 150.58 34.84 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 173.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -93.66 143.31 26.43 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 177.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.86 -152.93 24.88 Favored Glycine 0 C--N 1.334 0.442 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 19.3 t -128.34 113.71 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.96 167.41 13.75 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 173.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -127.97 163.26 24.89 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.431 0.692 . . . . 0.0 109.981 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.488 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 16.0 p90 -146.09 154.44 41.83 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.024 0.93 . . . . 0.0 108.899 173.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -114.39 149.24 36.46 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 127.55 2.34 . . . . 0.0 110.32 -174.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 63.2 t -140.16 143.49 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 125.043 1.337 . . . . 0.0 109.958 175.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -156.97 116.78 3.47 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 128.1 2.56 . . . . 0.0 105.488 173.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.485 ' H ' ' HB ' ' A' ' 143' ' ' THR . 46.3 t -126.41 121.76 59.65 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.826 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 176.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -91.13 162.62 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 O-C-N 124.543 1.152 . . . . 0.0 107.942 174.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.3 t -136.91 134.86 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 C-N-CA 125.442 1.497 . . . . 0.0 107.041 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.22 174.41 10.58 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.593 1.157 . . . . 0.0 108.854 -175.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -90.2 176.31 6.8 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 104.694 -2.335 . . . . 0.0 104.694 172.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.9 t -65.47 -4.24 5.53 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 120.4 -1.437 . . . . 0.0 113.871 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -90.3 -14.55 32.98 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 120.725 1.602 . . . . 0.0 110.833 173.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.16 1.08 65.11 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.402 1.001 . . . . 0.0 111.915 -173.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 -69.93 116.03 9.84 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 119.524 1.662 . . . . 0.0 108.209 174.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -69.74 143.63 52.98 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 125.702 1.601 . . . . 0.0 108.776 -175.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -141.4 -37.68 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 124.667 1.187 . . . . 0.0 113.915 -173.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -130.19 150.84 51.26 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.5 tm0? -150.0 148.25 28.83 Favored 'General case' 0 CA--C 1.517 -0.307 0 O-C-N 121.054 -1.029 . . . . 0.0 109.469 176.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.485 ' HB ' ' H ' ' A' ' 130' ' ' VAL . 28.7 m -79.17 113.51 36.82 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 103.541 -2.763 . . . . 0.0 103.541 173.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.56 144.74 80.1 Favored 'Trans proline' 0 N--CA 1.445 -1.37 0 CA-C-N 120.369 1.167 . . . . 0.0 110.072 -173.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -75.81 112.39 12.15 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 -174.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 172.91 -31.93 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 129.38 3.072 . . . . 0.0 109.484 -173.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.14 92.9 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.125 1.77 . . . . 0.0 109.381 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.1 mm -125.65 141.19 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.43 ' HB2' ' CE2' ' A' ' 126' ' ' PHE . 0.2 OUTLIER -124.32 166.45 15.9 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 174.151 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -133.7 113.45 12.36 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.359 1.064 . . . . 0.0 108.392 -173.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.4 tttt -100.85 122.65 43.81 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 32.7 m -83.45 117.82 23.33 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 174.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 10.0 m -118.74 166.09 13.2 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.852 0.751 . . . . 0.0 109.431 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.3 pp -138.61 161.81 36.18 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.2 1.4 . . . . 0.0 108.022 176.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.1 126.84 28.7 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.649 1.18 . . . . 0.0 110.345 176.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -158.34 166.96 31.02 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.314 1.846 . . . . 0.0 108.36 174.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 . . . . . 0 C--O 1.258 1.527 0 C-N-CA 128.591 2.757 . . . . 0.0 104.258 173.621 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.9 m . . . . . 0 CA--C 1.549 0.932 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.6 tt -47.17 124.67 6.82 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 120.903 1.683 . . . . 0.0 111.955 -174.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -116.32 145.02 43.51 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.914 0.885 . . . . 0.0 110.137 174.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.98 118.56 4.52 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 9.9 p90 -130.78 176.34 8.29 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.446 1.499 . . . . 0.0 110.534 176.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 5.9 mt -112.62 113.97 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 102.714 -3.069 . . . . 0.0 102.714 173.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -73.59 149.69 41.92 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 122.795 1.283 . . . . 0.0 109.85 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.21 -18.4 3.83 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -173.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -56.61 -34.45 67.23 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 119.515 1.052 . . . . 0.0 111.038 175.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.417 HE21 ' HA ' ' A' ' 20' ' ' GLN . 0.9 OUTLIER -61.2 -56.14 24.07 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 119.338 0.972 . . . . 0.0 110.633 174.525 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.85 -39.13 62.31 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.66 0.784 . . . . 0.0 111.799 174.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.9 ttm-85 . . . . . 0 N--CA 1.443 -0.788 0 O-C-N 121.019 -1.051 . . . . 0.0 108.86 175.493 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.534 0.346 0 CA-C-O 119.261 -0.399 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -157.63 113.97 2.89 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.209 1.803 . . . . 0.0 109.827 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -82.89 168.06 17.44 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 173.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.3 mp -137.56 113.09 10.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 173.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.73 114.15 22.47 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 -178.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.4 mt -88.75 -55.76 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -175.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.4 t -125.57 113.62 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 -174.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 94.6 p -111.89 126.88 55.59 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 102.432 -3.174 . . . . 0.0 102.432 173.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.263 0.7 OUTLIER 46.39 34.06 2.15 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.81 1.244 . . . . 0.0 114.251 175.352 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.26 -4.29 26.39 Favored Glycine 0 CA--C 1.544 1.861 0 C-N-CA 126.545 2.022 . . . . 0.0 115.561 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -76.97 37.16 0.18 Allowed 'General case' 0 N--CA 1.474 0.739 1 C-N-CA 133.98 4.912 . . . . 0.0 111.037 -173.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 35.0 mtt -38.04 118.6 0.7 Allowed 'General case' 0 C--O 1.232 0.183 0 C-N-CA 126.864 2.066 . . . . 0.0 114.568 -173.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.16 164.29 43.73 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 113.835 -1.529 . . . . 0.0 108.722 173.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -73.39 26.85 0.31 Allowed 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 123.931 3.087 . . . . 0.0 112.779 174.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -55.26 -26.61 40.99 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 125.891 1.676 . . . . 0.0 112.876 -174.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 m -65.05 -30.16 71.1 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.248 1.019 . . . . 0.0 110.77 -173.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.426 ' CE1' HH22 ' A' ' 47' ' ' ARG . 3.0 t60 -69.78 -57.31 5.25 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -58.95 -23.75 61.84 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.9 -64.96 0.8 Allowed 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 173.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.426 HH22 ' CE1' ' A' ' 44' ' ' HIS . 2.8 tmm_? . . . . . 0 CA--C 1.546 0.81 0 C-N-CA 127.132 2.173 . . . . 0.0 114.561 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.503 ' H ' ' CD ' ' A' ' 54' ' ' PRO . 85.1 mtp . . . . . 0 CA--C 1.538 0.514 0 N-CA-C 116.819 2.155 . . . . 0.0 116.819 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.503 ' CD ' ' H ' ' A' ' 53' ' ' MET . 37.8 Cg_endo -72.5 -80.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.74 0 CA-C-N 123.035 2.12 . . . . 0.0 110.073 -173.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.27 113.99 7.97 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 96.3 mt -115.14 117.08 41.8 Favored Pre-proline 0 C--N 1.326 -0.435 0 C-N-CA 128.097 2.559 . . . . 0.0 105.32 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -73.61 157.85 48.11 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.537 1.491 . . . . 0.0 110.519 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.3 p -41.05 -42.58 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 126.225 1.81 . . . . 0.0 112.403 173.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -46.88 -42.45 17.47 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 127.338 2.255 . . . . 0.0 113.047 177.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.1 mm -75.64 112.97 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 177.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -79.95 -34.13 39.05 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 173.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.5 m -160.0 155.94 26.22 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.346 0.658 . . . . 0.0 111.135 -173.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 33.1 mtt -101.76 158.36 16.17 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 103.781 -2.674 . . . . 0.0 103.781 172.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -118.59 113.73 21.71 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 173.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 16' ' ' ILE . 29.6 m-85 -101.49 157.3 16.91 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 173.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.2 m -137.07 135.48 37.53 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 177.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -143.75 166.24 25.42 Favored 'General case' 0 CA--C 1.511 -0.538 0 O-C-N 121.729 -0.607 . . . . 0.0 110.058 177.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -163.61 148.42 10.82 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.965 174.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.45 -173.84 3.52 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 122.916 1.341 . . . . 0.0 107.785 172.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -115.18 95.74 5.34 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 127.934 2.494 . . . . 0.0 110.13 -173.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 37.06 -56.6 0.0 OUTLIER Glycine 0 CA--C 1.543 1.835 1 C-N-CA 132.713 4.959 . . . . 0.0 120.795 -176.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -116.89 -16.88 10.54 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 121.643 2.722 . . . . 0.0 114.458 173.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.27 37.28 0.1 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 129.255 3.022 . . . . 0.0 115.673 -174.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -38.75 113.59 0.31 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 121.552 1.978 . . . . 0.0 110.367 -174.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -89.24 114.11 25.42 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -74.97 147.11 41.12 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 104.897 -2.261 . . . . 0.0 104.897 174.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -133.17 160.24 37.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 119.585 1.084 . . . . 0.0 110.078 176.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -152.38 135.07 15.39 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 173.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -82.92 103.7 12.58 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.062 0.945 . . . . 0.0 108.838 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.7 tt -67.04 -42.25 85.14 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.191 1.397 . . . . 0.0 108.19 174.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.3 m -135.06 139.71 44.98 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.488 1.115 . . . . 0.0 110.966 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.1 tt -170.36 92.96 0.21 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 173.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -161.72 156.3 22.75 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 118.721 0.691 . . . . 0.0 111.269 -174.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.4 t -72.0 163.78 27.26 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.1 mt -125.85 -17.02 5.5 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 116.734 -1.603 . . . . 0.0 112.379 174.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.546 ' CG ' ' H ' ' A' ' 87' ' ' LYS . 20.8 t0 -87.21 175.61 7.97 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 121.66 2.027 . . . . 0.0 112.248 177.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.546 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -115.27 -49.0 2.78 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 129.702 3.201 . . . . 0.0 112.841 177.304 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.428 ' C ' ' H ' ' A' ' 90' ' ' MET . . . -78.88 -66.44 1.71 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 178.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.5 mp -76.78 16.41 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 128.285 2.634 . . . . 0.0 109.81 -176.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.428 ' H ' ' C ' ' A' ' 88' ' ' GLY . 13.1 ttp -43.54 133.07 4.58 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 128.643 2.777 . . . . 0.0 109.838 -173.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -157.6 115.62 3.11 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 125.962 1.705 . . . . 0.0 107.908 -173.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -98.27 135.23 21.35 Favored Pre-proline 0 C--N 1.324 -0.522 0 O-C-N 123.973 0.795 . . . . 0.0 109.547 -174.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.46 154.71 55.58 Favored 'Trans proline' 0 N--CA 1.447 -1.26 0 C-N-CA 121.548 1.499 . . . . 0.0 109.25 173.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 17.9 p -140.4 157.8 44.97 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.556 1.543 . . . . 0.0 108.09 174.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.9 m -126.53 153.72 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 119.143 0.883 . . . . 0.0 113.011 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -74.94 7.11 3.42 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.498 2.319 . . . . 0.0 113.584 174.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.2 m -141.34 165.16 30.65 Favored Pre-proline 0 C--N 1.326 -0.443 0 C-N-CA 125.311 1.444 . . . . 0.0 108.632 -176.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -66.63 166.72 21.13 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 121.077 1.185 . . . . 0.0 110.398 173.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.97 -9.08 18.72 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.61 1.164 . . . . 0.0 112.03 176.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -145.63 164.35 32.01 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.446 1.498 . . . . 0.0 107.84 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 160.24 -161.25 32.38 Favored Glycine 0 C--O 1.227 -0.295 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 27.2 p -120.69 151.46 39.48 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 173.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.1 t -88.64 113.6 56.3 Favored Pre-proline 0 N--CA 1.447 -0.583 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 174.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.4 158.67 47.87 Favored 'Trans proline' 0 CA--C 1.512 -0.613 0 C-N-CA 122.245 1.963 . . . . 0.0 112.736 -174.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -64.39 -26.25 68.38 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 116.692 2.108 . . . . 0.0 116.692 -172.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . 0.566 1.0 OUTLIER -116.94 151.54 36.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 119.406 1.003 . . . . 0.0 113.102 173.134 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -38.61 110.96 0.15 Allowed 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 128.175 2.59 . . . . 0.0 113.292 -173.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.9 m -124.89 143.28 50.93 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 173.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.8 t -93.57 128.73 44.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 124.739 1.216 . . . . 0.0 112.022 -173.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 70.3 t -111.49 103.21 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 173.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -80.38 127.7 32.71 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 173.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.6 t -101.26 113.36 37.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 N-CA-C 103.549 -2.76 . . . . 0.0 103.549 173.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -92.45 148.68 19.24 Favored Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -129.54 73.75 81.34 Favored Pre-proline 0 C--O 1.243 0.762 0 CA-C-N 118.238 1.019 . . . . 0.0 110.66 -175.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.32 114.64 2.76 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.789 2.326 . . . . 0.0 109.553 173.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 8.0 t -91.15 145.29 24.8 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 173.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.3 mt -72.43 -16.39 61.83 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 117.793 0.269 . . . . 0.0 110.613 176.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 59.26 22.15 55.21 Favored Glycine 0 C--O 1.221 -0.679 0 C-N-CA 126.785 2.136 . . . . 0.0 115.456 173.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt -93.86 -46.75 7.05 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 120.2 2.0 . . . . 0.0 111.405 -174.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -96.52 151.3 19.71 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -93.69 151.59 19.54 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 174.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.79 -152.6 22.7 Favored Glycine 0 C--N 1.333 0.387 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 176.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.8 t -128.2 114.29 33.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -86.8 175.21 8.33 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.468 1.107 . . . . 0.0 108.907 173.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -128.32 156.49 42.97 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.776 1.63 . . . . 0.0 107.835 173.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.447 ' CE1' ' CD1' ' A' ' 149' ' ' PHE . 42.3 p90 -150.13 152.91 35.46 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.89 1.276 . . . . 0.0 107.904 173.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -116.28 145.9 42.81 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.736 1.615 . . . . 0.0 112.322 -173.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 92.8 t -141.63 138.28 32.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 173.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -154.3 130.21 10.18 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.854 1.661 . . . . 0.0 106.962 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.0 t -136.23 130.88 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 -174.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -98.35 163.65 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 173.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.1 t -141.91 134.06 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 -174.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.82 175.78 9.15 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 126.178 1.791 . . . . 0.0 107.067 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -93.17 176.01 6.56 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 103.76 -2.681 . . . . 0.0 103.76 172.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.4 t -65.37 -4.23 5.26 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 120.077 -1.639 . . . . 0.0 113.539 -178.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -85.54 -15.47 42.6 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 120.826 1.648 . . . . 0.0 110.374 173.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.4 0.1 65.39 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.837 1.208 . . . . 0.0 112.03 -173.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -70.8 115.63 10.17 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 119.494 1.647 . . . . 0.0 108.42 175.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -64.79 142.23 58.5 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.896 1.678 . . . . 0.0 108.253 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -140.28 -36.38 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 124.517 1.127 . . . . 0.0 113.559 -174.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -135.35 149.05 49.62 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.601 1.16 . . . . 0.0 107.929 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -142.63 138.89 31.02 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 85.8 m -65.97 131.3 94.52 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 174.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.8 143.61 41.85 Favored 'Trans proline' 0 N--CA 1.443 -1.486 0 N-CA-C 108.796 -1.271 . . . . 0.0 108.796 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -85.3 112.83 21.15 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -173.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.297 0.9 OUTLIER 173.06 -10.44 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.725 1 C-N-CA 136.395 5.878 . . . . 0.0 110.457 174.015 . . . . . . . . 4 3 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.74 83.55 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.575 1.95 . . . . 0.0 112.069 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 3.9 mm -125.04 122.97 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 -178.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.447 ' CD1' ' CE1' ' A' ' 126' ' ' PHE . 1.0 OUTLIER -103.89 164.4 11.72 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 173.62 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -134.11 113.51 12.15 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -173.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 60.4 tttt -103.9 123.94 48.06 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.815 1.189 . . . . 0.0 109.453 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 25.0 m -83.55 114.57 21.6 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 174.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 5.5 m -116.96 166.63 11.96 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 124.487 1.115 . . . . 0.0 110.301 174.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.2 159.44 41.91 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 126.61 1.964 . . . . 0.0 107.881 -177.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -69.99 117.6 11.76 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.272 1.429 . . . . 0.0 111.283 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -140.38 165.77 26.52 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.881 2.073 . . . . 0.0 108.495 174.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 . . . . . 0 C--O 1.25 1.099 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 173.67 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.6 m . . . . . 0 CA--C 1.537 0.455 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.0 tt -43.14 130.89 4.56 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.849 2.46 . . . . 0.0 112.99 -176.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -115.77 140.83 48.84 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.679 2.391 . . . . 0.0 108.235 173.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.22 118.03 6.65 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -136.63 176.11 9.0 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.759 0.79 . . . . 0.0 109.264 177.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 12.6 mt -114.47 113.53 44.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 1 N-CA-C 99.573 -4.232 . . . . 0.0 99.573 173.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -78.59 144.88 35.11 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 122.674 1.226 . . . . 0.0 110.999 -173.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.7 -26.49 68.69 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.193 -1.367 . . . . 0.0 112.898 -173.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -67.14 -38.99 86.47 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -174.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -57.54 11.09 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 117.649 -1.167 . . . . 0.0 108.49 173.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.14 -41.42 48.82 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 119.567 1.076 . . . . 0.0 111.751 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 173.629 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 . . . . . 0 CA--C 1.533 0.307 0 CA-C-O 119.548 -0.263 . . . . 0.0 110.549 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -153.19 139.24 18.24 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 128.313 2.645 . . . . 0.0 106.014 173.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -87.03 166.2 15.23 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 173.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.98 113.2 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 104.434 -2.432 . . . . 0.0 104.434 173.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.79 113.93 23.92 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -177.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.3 mt -93.09 -56.25 5.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -176.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.3 t -126.27 133.72 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 125.904 1.682 . . . . 0.0 106.767 -174.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.9 p -140.13 126.84 20.48 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 102.164 -3.272 . . . . 0.0 102.164 173.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.269 6.2 pt-20 46.05 34.0 1.88 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.177 1.391 . . . . 0.0 113.514 -177.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 64.46 -3.53 1.81 Allowed Glycine 0 CA--C 1.544 1.865 0 O-C-N 120.273 -1.517 . . . . 0.0 114.173 -174.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.5 ttpt -79.72 37.12 0.34 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 131.055 3.742 . . . . 0.0 111.436 -173.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 38.0 mtt -37.82 122.88 1.02 Allowed 'General case' 0 C--O 1.24 0.585 0 C-N-CA 125.478 1.511 . . . . 0.0 112.825 -173.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.403 ' C ' ' H ' ' A' ' 42' ' ' PHE . . . -64.1 167.83 7.29 Favored Pre-proline 0 N--CA 1.449 -0.495 0 O-C-N 125.798 1.936 . . . . 0.0 108.052 173.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.57 29.26 0.24 Allowed 'Trans proline' 0 CA--C 1.548 1.19 0 C-N-CA 123.939 3.093 . . . . 0.0 112.365 174.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.403 ' H ' ' C ' ' A' ' 40' ' ' ALA . 14.6 p90 -53.86 -26.61 25.43 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 126.784 2.033 . . . . 0.0 113.022 -173.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 m -62.17 -29.88 70.66 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.243 1.417 . . . . 0.0 111.46 -173.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -55.3 -65.83 0.52 Allowed 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.098 1.359 . . . . 0.0 109.362 175.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.253 44.1 m-20 -76.44 -23.75 53.93 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.055 0.455 . . . . 0.0 111.571 -175.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -60.31 -44.64 95.24 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 120.099 -1.626 . . . . 0.0 108.331 173.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.4 0 O-C-N 121.639 -0.663 . . . . 0.0 109.277 176.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.393 0 CA-C-O 117.379 -1.295 . . . . 0.0 114.097 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -78.84 -64.41 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 CA-C-N 121.443 1.551 . . . . 0.0 110.646 -176.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.47 118.06 13.81 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.743 1.217 . . . . 0.0 110.842 -173.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.9 mt -126.14 116.25 23.76 Favored Pre-proline 0 N--CA 1.448 -0.543 0 C-N-CA 126.555 1.942 . . . . 0.0 106.612 -174.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -72.23 155.9 55.77 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.018 1.812 . . . . 0.0 110.353 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.9 p -40.32 -43.66 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 127.715 2.406 . . . . 0.0 112.854 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -59.89 -33.97 72.55 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 126.954 2.101 . . . . 0.0 114.076 -177.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.3 mm -68.47 112.93 3.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 104.098 -2.556 . . . . 0.0 104.098 175.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -81.86 -33.48 30.6 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.669 174.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.3 m -158.39 157.88 33.15 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.32 0.648 . . . . 0.0 109.301 -174.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 33.7 mtm -126.28 166.78 16.48 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 173.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -134.63 130.92 37.16 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -107.95 162.24 14.2 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 173.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.4 m -135.86 133.43 37.76 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -175.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -144.56 165.56 27.65 Favored 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 121.332 -0.855 . . . . 0.0 111.312 179.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.09 158.37 4.6 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 124.238 1.015 . . . . 0.0 110.898 174.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.549 ' C ' ' HD1' ' A' ' 105' ' ' HIS . . . -93.27 177.42 6.05 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 173.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.15 101.79 12.93 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 120.212 -1.555 . . . . 0.0 108.996 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 44.36 -53.82 0.0 OUTLIER Glycine 0 CA--C 1.541 1.669 1 C-N-CA 132.814 5.007 . . . . 0.0 120.363 175.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -116.9 -19.83 9.67 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 121.628 2.714 . . . . 0.0 115.396 174.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.71 37.17 0.14 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 128.56 2.744 . . . . 0.0 116.082 -173.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -44.36 113.49 0.54 Allowed 'General case' 0 CA--C 1.557 1.224 0 CA-C-N 121.891 2.132 . . . . 0.0 109.147 -174.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -84.35 162.55 20.0 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.346 1.459 . . . . 0.0 111.595 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -111.77 149.53 31.57 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -135.52 161.82 34.41 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 120.226 1.375 . . . . 0.0 111.142 175.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -155.49 139.11 16.01 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 173.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -88.78 103.84 16.35 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.959 1.303 . . . . 0.0 109.71 -175.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.9 tt -72.34 -47.66 47.95 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.289 1.435 . . . . 0.0 108.981 175.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 38.1 m -131.61 138.2 48.71 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.493 1.517 . . . . 0.0 111.161 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -168.83 92.69 0.29 Allowed 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 101.936 -3.357 . . . . 0.0 101.936 173.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -165.0 154.44 12.94 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 120.037 1.289 . . . . 0.0 112.486 -174.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.1 t -67.96 161.43 26.57 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 119.6 1.091 . . . . 0.0 110.243 173.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.9 mt -126.43 -2.61 6.83 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 125.772 1.629 . . . . 0.0 112.385 174.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.547 ' CG ' ' H ' ' A' ' 87' ' ' LYS 0.337 11.2 t70 -99.07 169.11 9.64 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.819 1.645 . . . . 0.0 112.169 -175.514 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.547 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 1.4 mppt? -109.2 -49.02 3.17 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 129.557 3.143 . . . . 0.0 111.631 -173.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.415 ' C ' ' H ' ' A' ' 90' ' ' MET . . . -105.95 -47.66 1.07 Allowed Glycine 0 CA--C 1.524 0.636 0 C-N-CA 125.247 1.403 . . . . 0.0 112.095 -177.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.2 mp -80.73 14.97 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 125.571 1.548 . . . . 0.0 108.884 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.415 ' H ' ' C ' ' A' ' 88' ' ' GLY . 12.9 ttm -43.27 130.72 4.78 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 129.453 3.101 . . . . 0.0 109.199 -173.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -156.94 114.62 3.17 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 126.09 1.756 . . . . 0.0 106.62 -173.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.288 3.9 m-20 -96.36 129.14 34.21 Favored Pre-proline 0 CA--C 1.51 -0.58 0 O-C-N 124.493 1.121 . . . . 0.0 110.995 -174.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -75.64 149.68 34.5 Favored 'Trans proline' 0 N--CA 1.441 -1.561 0 C-N-CA 121.91 1.74 . . . . 0.0 109.685 175.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 20.8 p -131.88 155.44 47.86 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 125.109 1.364 . . . . 0.0 107.912 174.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.6 m -125.23 153.06 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 C-N-CA 124.193 0.997 . . . . 0.0 109.977 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -86.12 11.41 11.88 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.345 1.458 . . . . 0.0 113.367 -177.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.3 m -137.53 164.1 43.86 Favored Pre-proline 0 C--N 1.326 -0.432 0 C-N-CA 124.414 1.086 . . . . 0.0 109.798 -173.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -65.78 162.2 35.74 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.375 1.383 . . . . 0.0 109.803 173.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -65.69 -11.39 44.76 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 124.213 1.005 . . . . 0.0 112.251 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -143.02 164.37 30.28 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.138 1.375 . . . . 0.0 107.807 173.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.64 -160.67 34.13 Favored Glycine 0 C--O 1.226 -0.352 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.0 p -123.48 152.16 42.0 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.261 0.531 . . . . 0.0 109.958 176.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.5 t -94.93 113.09 60.5 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 102.736 -3.061 . . . . 0.0 102.736 173.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -97.17 161.53 1.0 Allowed 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.825 2.35 . . . . 0.0 112.514 -173.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.549 ' HD1' ' C ' ' A' ' 69' ' ' ALA . 80.8 m-70 -66.72 -19.65 65.8 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 119.971 -1.706 . . . . 0.0 114.88 -174.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.05 114.08 24.32 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 -174.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -47.3 111.43 0.41 Allowed 'General case' 0 N--CA 1.463 0.219 0 O-C-N 124.438 1.086 . . . . 0.0 109.249 -175.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 66.3 m -116.84 143.97 45.05 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -174.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.4 t -105.79 139.0 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -173.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.5 t -121.9 103.7 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -73.73 147.0 43.97 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 173.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.4 t -130.96 113.91 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 104.443 -2.429 . . . . 0.0 104.443 177.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -100.61 146.61 17.65 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 125.249 1.404 . . . . 0.0 110.517 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -129.99 73.6 81.26 Favored Pre-proline 0 CA--C 1.546 0.813 0 CA-C-N 118.88 1.34 . . . . 0.0 111.704 -174.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -64.54 117.14 4.23 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.443 2.095 . . . . 0.0 109.056 173.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 8.5 t -94.01 144.29 25.6 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 173.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.6 mt -79.59 -10.87 59.87 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 122.966 0.506 . . . . 0.0 111.15 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 55.19 33.57 57.99 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 125.817 1.675 . . . . 0.0 114.22 173.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -93.74 -63.42 1.2 Allowed 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 118.471 1.136 . . . . 0.0 110.271 -177.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 38.6 tp60 -96.05 154.66 17.12 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 174.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -93.51 152.28 19.16 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.46 1.504 . . . . 0.0 107.407 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.15 -152.07 22.12 Favored Glycine 0 C--N 1.331 0.305 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.8 t -127.47 113.86 33.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -84.35 173.34 11.01 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 173.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -133.85 159.78 39.62 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.533 1.133 . . . . 0.0 109.554 174.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -146.15 140.73 26.87 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 173.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -94.43 148.0 22.67 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 125.242 1.417 . . . . 0.0 111.25 -175.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.8 t -139.19 135.65 41.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 125.396 1.479 . . . . 0.0 108.997 173.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -155.8 120.46 4.68 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 173.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.458 ' H ' ' HB ' ' A' ' 143' ' ' THR . 43.8 t -130.44 123.83 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -88.76 166.58 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 173.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.6 t -146.1 134.59 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 -174.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.34 174.9 10.06 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.977 -175.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -86.83 175.96 7.94 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 172.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.3 t -65.65 -13.93 60.17 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 120.756 -1.215 . . . . 0.0 113.754 -173.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -94.78 -4.19 47.72 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.433 1.093 . . . . 0.0 111.423 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.86 9.44 57.35 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 118.958 -0.912 . . . . 0.0 113.703 176.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -74.28 116.49 15.01 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 119.786 1.793 . . . . 0.0 108.592 175.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.8 m -70.19 143.83 52.12 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 123.815 0.846 . . . . 0.0 109.186 -177.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.57 -36.0 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 124.523 1.129 . . . . 0.0 113.394 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -131.68 145.4 51.63 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -175.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -146.13 147.32 31.41 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.458 ' HB ' ' H ' ' A' ' 130' ' ' VAL . 58.5 m -78.48 113.49 34.84 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.26 144.28 85.87 Favored 'Trans proline' 0 N--CA 1.446 -1.31 0 CA-C-N 119.944 1.016 . . . . 0.0 110.796 -173.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -80.56 112.53 18.0 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 -173.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.444 14.0 m-80 172.55 -13.83 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 1 C-N-CA 138.555 6.742 . . . . 0.0 110.252 173.722 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.55 77.31 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.81 2.044 . . . . 0.0 109.861 173.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 37.0 mm -115.64 125.5 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -93.97 154.75 17.5 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 173.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -131.05 113.51 14.04 Favored 'General case' 0 CA--C 1.521 -0.156 0 O-C-N 121.366 -0.834 . . . . 0.0 108.755 -173.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -106.71 122.23 45.93 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 118.838 0.745 . . . . 0.0 109.204 -177.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 27.7 m -83.37 117.09 22.79 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 105.68 -1.971 . . . . 0.0 105.68 174.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 6.7 m -118.14 166.41 12.61 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.488 0.715 . . . . 0.0 109.615 173.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.4 pp -131.62 160.44 35.36 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.362 1.465 . . . . 0.0 107.627 175.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -68.41 125.22 25.77 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.457 1.503 . . . . 0.0 109.701 176.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -146.7 127.9 14.75 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.851 1.26 . . . . 0.0 107.809 174.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 . . . . . 0 C--O 1.255 1.361 0 C-N-CA 127.505 2.322 . . . . 0.0 105.42 174.162 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.9 m . . . . . 0 C--O 1.222 -0.375 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tt -43.04 126.14 3.81 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 129.011 2.925 . . . . 0.0 112.934 -173.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -114.3 141.44 47.59 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 128.281 2.632 . . . . 0.0 108.17 174.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.86 120.76 8.17 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 18.0 p90 -135.94 168.76 18.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 119.159 0.89 . . . . 0.0 109.842 175.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.9 mt -99.78 114.36 37.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 102.073 -3.306 . . . . 0.0 102.073 173.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -79.32 136.08 36.91 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 123.903 1.811 . . . . 0.0 113.068 -173.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.62 -20.37 46.9 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 127.375 2.27 . . . . 0.0 116.213 -173.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -56.47 -40.83 75.54 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 118.886 0.766 . . . . 0.0 109.55 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 42.6 tp60 -65.38 -44.24 88.18 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.681 178.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.66 -32.03 73.38 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 118.854 -0.593 . . . . 0.0 112.235 176.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 173.149 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 . . . . . 0 CA--C 1.536 0.434 0 CA-C-O 118.621 -0.704 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -137.13 113.47 10.02 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.967 1.707 . . . . 0.0 109.251 -174.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -92.14 163.31 13.99 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.144 1.338 . . . . 0.0 107.492 173.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.3 mp -136.71 113.17 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 173.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.86 116.58 23.39 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -176.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 27.4 mt -95.05 -63.76 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.034 0.934 . . . . 0.0 109.335 -177.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.9 t -118.41 133.97 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -173.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.9 p -137.59 124.55 21.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 104.216 -2.513 . . . . 0.0 104.216 173.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 43.95 33.26 0.73 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.19 2.196 . . . . 0.0 114.091 -174.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.38 -6.87 5.32 Favored Glycine 0 CA--C 1.544 1.873 0 O-C-N 120.713 -1.242 . . . . 0.0 114.73 -174.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -79.19 37.29 0.31 Allowed 'General case' 0 CA--C 1.537 0.466 1 C-N-CA 131.706 4.002 . . . . 0.0 111.215 -178.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 42.6 mtm -38.22 134.73 0.8 Allowed 'General case' 0 C--O 1.233 0.195 0 C-N-CA 126.207 1.803 . . . . 0.0 114.362 -173.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.1 165.38 48.36 Favored Pre-proline 0 N--CA 1.45 -0.446 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 173.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.28 38.2 0.53 Allowed 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 123.911 3.074 . . . . 0.0 110.6 173.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -53.72 -26.7 24.35 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 127.25 2.22 . . . . 0.0 114.095 -173.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.5 m -60.27 -32.08 70.83 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.624 1.169 . . . . 0.0 111.621 -173.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -58.36 -64.13 1.03 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.252 1.021 . . . . 0.0 109.852 176.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -76.37 -29.35 57.14 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -174.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -57.1 -55.99 27.63 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.18 0.992 . . . . 0.0 108.584 173.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.287 0 CA-C-O 118.537 -0.744 . . . . 0.0 111.102 -174.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 69.2 mmm . . . . . 0 N--CA 1.468 0.467 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -69.35 -77.39 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.042 0 CA-C-N 120.837 1.335 . . . . 0.0 110.361 173.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.21 113.32 20.59 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.39 0.614 . . . . 0.0 111.055 -173.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.89 131.5 21.92 Favored Pre-proline 0 C--N 1.327 -0.373 0 C-N-CA 128.489 2.716 . . . . 0.0 106.228 -177.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -79.31 157.6 26.0 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.731 1.621 . . . . 0.0 110.743 177.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.4 p -41.95 -41.17 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 126.97 2.108 . . . . 0.0 112.088 173.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.51 -39.47 83.97 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 127.519 2.328 . . . . 0.0 112.825 -176.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 mm -74.28 112.85 11.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 101.548 -3.501 . . . . 0.0 101.548 173.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -78.14 -38.25 44.16 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.0 m -149.83 161.3 42.53 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.362 1.065 . . . . 0.0 109.585 -173.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 24.3 mtm -126.33 152.38 46.3 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 172.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -94.59 150.29 20.39 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -136.51 152.48 50.57 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 102.376 -3.194 . . . . 0.0 102.376 172.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.0 m -139.95 135.53 32.89 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -176.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -145.84 165.69 28.13 Favored 'General case' 0 C--O 1.24 0.566 0 O-C-N 121.916 -0.49 . . . . 0.0 110.635 177.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.83 157.55 3.06 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.927 0.87 . . . . 0.0 112.438 177.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.6 -174.02 4.17 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 173.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.87 111.83 18.9 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 126.047 1.739 . . . . 0.0 107.101 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 43.4 -57.9 0.0 OUTLIER Glycine 0 CA--C 1.537 1.418 1 C-N-CA 132.74 4.971 . . . . 0.0 119.372 173.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -116.57 -25.79 7.28 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.724 1.762 . . . . 0.0 113.548 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.73 37.1 0.08 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 130.993 3.717 . . . . 0.0 119.068 -173.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -54.37 113.96 1.47 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 123.234 2.743 . . . . 0.0 111.013 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -84.1 142.93 30.04 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 125.322 1.449 . . . . 0.0 107.348 173.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -90.35 149.27 22.37 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -131.95 161.0 34.16 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 120.302 1.41 . . . . 0.0 110.905 175.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.11 134.95 13.73 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 173.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -87.28 103.13 15.16 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.098 0.559 . . . . 0.0 110.03 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.0 tt -73.38 -42.07 62.6 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.3 m -138.58 132.72 31.52 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.356 1.062 . . . . 0.0 111.486 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -162.76 93.01 0.8 Allowed 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 101.309 -3.589 . . . . 0.0 101.309 173.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -161.4 155.55 22.51 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 119.75 1.159 . . . . 0.0 111.284 -173.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.0 t -82.85 153.79 24.97 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 173.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 70.8 mt -107.31 -9.27 16.1 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.253 1.421 . . . . 0.0 111.679 176.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -104.97 162.76 13.07 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 173.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.7 mmtm -138.16 -33.24 0.7 Allowed 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.412 1.885 . . . . 0.0 112.297 -177.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -62.1 -54.26 36.21 Favored Glycine 0 CA--C 1.545 1.912 0 N-CA-C 106.808 -2.517 . . . . 0.0 106.808 172.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.7 mt -90.45 25.28 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 129.281 3.032 . . . . 0.0 110.518 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 4.1 ttp -43.17 133.82 3.82 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 125.458 2.551 . . . . 0.0 112.712 -173.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -149.68 155.38 40.11 Favored 'General case' 0 N--CA 1.422 -1.842 2 C-N-CA 135.994 5.718 . . . . 0.0 101.302 173.785 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -144.86 114.22 5.03 Favored Pre-proline 0 C--N 1.316 -0.855 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 173.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -67.44 157.93 59.44 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 122.816 2.344 . . . . 0.0 113.652 -173.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.3 p -133.17 165.65 24.28 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.513 1.525 . . . . 0.0 109.773 176.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.4 m -126.34 155.58 36.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.174 0.989 . . . . 0.0 110.677 173.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -78.21 9.47 3.77 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.209 2.204 . . . . 0.0 113.485 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.5 m -139.3 163.71 43.82 Favored Pre-proline 0 C--N 1.327 -0.372 0 C-N-CA 124.443 1.097 . . . . 0.0 109.976 -176.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -65.41 162.07 35.31 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.705 1.603 . . . . 0.0 110.071 173.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -64.34 -10.59 25.35 Favored 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 124.634 1.174 . . . . 0.0 112.586 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -145.77 164.06 33.04 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 120.151 1.341 . . . . 0.0 107.857 173.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.37 -161.65 34.22 Favored Glycine 0 C--O 1.227 -0.335 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 77.8 p -117.25 150.94 37.94 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 173.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.2 t -87.16 113.23 52.72 Favored Pre-proline 0 N--CA 1.448 -0.547 0 N-CA-C 102.276 -3.231 . . . . 0.0 102.276 173.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -92.34 155.51 3.09 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.414 2.076 . . . . 0.0 111.98 -173.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 18.0 m-70 -65.51 -16.88 64.11 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 120.164 -1.585 . . . . 0.0 112.179 -174.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -85.88 113.77 22.27 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 -174.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.65 110.58 0.48 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 119.098 0.863 . . . . 0.0 109.37 -176.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 45.3 m -117.04 139.86 50.18 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -175.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.6 t -98.37 114.16 35.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 C-N-CA 124.402 1.081 . . . . 0.0 109.425 -173.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 85.1 t -93.98 103.41 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 N-CA-C 103.875 -2.639 . . . . 0.0 103.875 173.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -84.49 126.09 32.97 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 104.921 -2.251 . . . . 0.0 104.921 173.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.7 t -94.14 113.84 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 104.462 -2.422 . . . . 0.0 104.462 174.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -87.71 148.32 21.01 Favored Glycine 0 N--CA 1.44 -1.057 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 176.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.454 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 3.8 m-85 -132.19 73.45 77.67 Favored Pre-proline 0 C--O 1.242 0.68 0 C-N-CA 124.125 0.97 . . . . 0.0 108.924 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.98 121.76 8.16 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 121.652 1.568 . . . . 0.0 108.082 174.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 5.9 t -101.99 149.69 23.98 Favored 'General case' 0 C--N 1.34 0.191 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 173.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mt -79.42 -18.0 53.14 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 118.068 0.394 . . . . 0.0 110.697 176.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.54 17.52 53.74 Favored Glycine 0 C--O 1.215 -1.082 0 C-N-CA 127.632 2.539 . . . . 0.0 115.719 173.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 24.6 mttt -93.19 -29.38 15.75 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 121.576 2.688 . . . . 0.0 111.449 -173.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.449 ' NE2' ' H ' ' A' ' 121' ' ' ASP . 53.4 tp60 -96.66 154.88 17.03 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 172.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.449 ' H ' ' NE2' ' A' ' 120' ' ' GLN . 21.4 m-20 -102.24 144.58 30.59 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 174.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 151.21 -157.71 27.34 Favored Glycine 0 C--N 1.332 0.319 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 175.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 18.8 t -127.18 113.57 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 175.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -89.32 164.16 15.03 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 173.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -122.96 163.84 19.65 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 121.227 -0.92 . . . . 0.0 110.104 176.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.454 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 9.1 p90 -149.61 150.53 32.34 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 118.4 0.545 . . . . 0.0 109.65 173.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -111.53 150.58 29.77 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 127.638 2.375 . . . . 0.0 110.33 -174.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 85.6 t -138.83 137.47 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 125.698 1.599 . . . . 0.0 109.083 174.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -156.32 124.47 5.69 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 126.809 2.043 . . . . 0.0 106.357 173.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 42.7 t -135.01 128.39 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.424 HD12 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -95.22 164.57 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 174.383 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.1 t -143.27 135.26 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -173.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.52 175.46 9.58 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.866 1.266 . . . . 0.0 108.642 -174.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 37.9 p-10 -89.99 176.32 6.84 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 172.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.6 t -65.49 -4.81 6.4 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 120.28 -1.512 . . . . 0.0 113.949 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -88.63 -16.73 31.7 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 120.714 1.597 . . . . 0.0 110.696 173.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.57 1.16 60.54 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.555 1.074 . . . . 0.0 111.808 -173.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 60.6 m-20 -70.84 116.56 11.29 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 119.535 1.668 . . . . 0.0 108.384 174.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.5 m -68.03 143.87 55.35 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.842 1.657 . . . . 0.0 109.024 -174.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -140.99 -36.34 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.628 1.171 . . . . 0.0 113.999 -174.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -130.55 144.11 51.2 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 178.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -144.79 131.37 19.91 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 177.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 77.5 m -63.57 131.35 94.82 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 174.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -72.17 144.5 42.09 Favored 'Trans proline' 0 N--CA 1.444 -1.408 0 N-CA-C 108.401 -1.423 . . . . 0.0 108.401 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -82.76 112.52 19.68 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 -175.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.599 38.9 m-80 172.31 -13.19 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 1 C-N-CA 132.739 4.415 . . . . 0.0 114.295 173.28 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.86 96.6 0.09 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.056 1.342 . . . . 0.0 108.612 177.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.1 mt -133.58 148.8 30.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.416 ' CD1' ' CZ ' ' A' ' 126' ' ' PHE . 0.4 OUTLIER -130.87 170.08 14.89 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.274 1.429 . . . . 0.0 107.624 175.648 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -135.3 113.48 11.31 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.865 1.266 . . . . 0.0 108.023 -173.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -101.31 123.55 45.58 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 23.9 m -83.48 117.81 23.34 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 175.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 30.9 m -112.25 158.17 20.05 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 174.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.8 pp -146.24 159.59 43.12 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 176.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.44 121.25 2.89 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.73 2.412 . . . . 0.0 115.223 -173.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -139.74 164.14 30.73 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 130.131 3.372 . . . . 0.0 106.646 173.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 . . . . . 0 C--O 1.252 1.188 0 C-N-CA 127.515 2.326 . . . . 0.0 105.957 175.708 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.472 0.632 0 CA-C-O 119.085 -0.484 . . . . 0.0 109.978 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.2 tt -43.41 129.23 5.05 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 127.15 2.18 . . . . 0.0 112.236 -174.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -116.18 132.88 56.54 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.041 1.736 . . . . 0.0 109.062 174.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.07 120.56 11.02 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -178.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.5 p90 -134.25 175.32 9.61 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.71 0.804 . . . . 0.0 110.088 176.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.3 mt -111.81 116.17 51.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 102.213 -3.254 . . . . 0.0 102.213 174.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -83.18 148.56 27.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 123.501 1.619 . . . . 0.0 114.639 -173.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.81 -14.33 32.15 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 126.863 2.065 . . . . 0.0 114.666 -174.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -58.26 -35.1 71.25 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 119.185 0.902 . . . . 0.0 109.876 174.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 47.2 tp60 -67.37 -43.05 82.39 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 118.376 0.535 . . . . 0.0 111.104 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.71 -37.8 82.89 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.881 0.872 . . . . 0.0 111.044 173.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 . . . . . 0 N--CA 1.445 -0.72 0 O-C-N 121.002 -1.061 . . . . 0.0 108.198 173.762 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 . . . . . 0 CA--C 1.531 0.229 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -160.0 115.46 2.37 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.449 0.7 . . . . 0.0 110.598 -178.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -89.55 175.73 7.17 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.369 1.468 . . . . 0.0 109.633 173.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 21.6 mt -143.91 113.27 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 172.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.72 114.23 24.14 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -177.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.2 mt -91.3 -61.54 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 118.944 0.793 . . . . 0.0 109.198 -177.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.6 t -116.6 122.89 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 -173.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.9 p -126.11 119.36 27.36 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 102.966 -2.976 . . . . 0.0 102.966 173.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.451 ' C ' ' H ' ' A' ' 38' ' ' LYS 0.32 17.6 pm0 45.91 42.16 8.8 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.914 1.686 . . . . 0.0 112.884 -176.333 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.99 -24.22 1.3 Allowed Glycine 0 CA--C 1.543 1.829 0 C-N-CA 125.965 1.745 . . . . 0.0 115.136 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.451 ' H ' ' C ' ' A' ' 36' ' ' GLU 0.437 7.0 tmtt? -53.94 37.32 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.686 1 C-N-CA 137.609 6.364 . . . . 0.0 117.085 174.373 . . . . . . . . 4 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 42.6 mtt -38.17 130.03 1.24 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.408 ' C ' ' H ' ' A' ' 42' ' ' PHE . . . -73.11 167.63 32.52 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 173.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.48 34.17 0.34 Allowed 'Trans proline' 0 CA--C 1.55 1.313 0 C-N-CA 124.069 3.179 . . . . 0.0 111.728 173.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.408 ' H ' ' C ' ' A' ' 40' ' ' ALA . 15.3 p90 -54.7 -26.57 34.5 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 127.899 2.48 . . . . 0.0 114.4 -173.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 m -62.9 -32.38 73.64 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.5 1.12 . . . . 0.0 112.185 -172.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 61.3 t60 -59.96 -51.42 69.74 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.328 0.9 OUTLIER -76.09 -28.69 57.65 Favored 'General case' 0 C--O 1.224 -0.237 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.294 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -55.88 -46.53 78.29 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.066 -1.021 . . . . 0.0 108.274 173.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.9 ttt85 . . . . . 0 CA--C 1.54 0.586 0 CA-C-O 118.506 -0.759 . . . . 0.0 112.302 178.775 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.535 0 CA-C-O 116.497 -1.716 . . . . 0.0 114.564 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -75.83 -71.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.593 0 CA-C-N 122.586 1.959 . . . . 0.0 113.14 -173.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.01 113.62 14.91 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.622 0.769 . . . . 0.0 110.04 -173.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 94.3 mt -109.4 119.37 48.45 Favored Pre-proline 0 C--N 1.325 -0.498 0 C-N-CA 127.122 2.169 . . . . 0.0 105.903 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -74.33 155.91 46.15 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 121.782 1.655 . . . . 0.0 109.486 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.3 p -41.54 -41.77 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 126.66 1.984 . . . . 0.0 112.598 174.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -56.25 -42.4 77.32 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 126.896 2.078 . . . . 0.0 113.099 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.2 mm -74.53 112.86 12.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 101.642 -3.466 . . . . 0.0 101.642 173.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -76.55 -36.11 57.83 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . 0.253 4.2 m -148.99 161.83 41.12 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.195 1.398 . . . . 0.0 109.933 -173.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -117.7 145.65 44.27 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 172.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 44.9 m-20 -94.12 146.82 23.7 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 174.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -136.09 153.77 51.21 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 102.528 -3.138 . . . . 0.0 102.528 172.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.1 m -139.5 133.66 31.18 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -177.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -145.02 166.76 24.41 Favored 'General case' 0 C--O 1.238 0.496 0 O-C-N 122.056 -0.403 . . . . 0.0 111.158 177.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.24 158.22 13.94 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 124.866 1.266 . . . . 0.0 110.349 174.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.476 ' C ' ' HD1' ' A' ' 105' ' ' HIS . . . -97.73 168.44 10.33 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 173.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.21 96.15 10.53 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 120.157 -1.589 . . . . 0.0 110.526 -174.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 48.74 -58.54 0.0 OUTLIER Glycine 0 CA--C 1.536 1.363 1 C-N-CA 131.783 4.516 . . . . 0.0 119.544 173.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -117.08 -15.66 10.52 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.446 2.123 . . . . 0.0 115.783 173.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.33 37.18 0.2 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 129.231 3.012 . . . . 0.0 115.998 -173.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -39.02 113.43 0.31 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 121.621 2.009 . . . . 0.0 110.031 -173.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -89.91 130.16 36.17 Favored 'General case' 0 CA--C 1.522 -0.106 0 C-N-CA 125.147 1.379 . . . . 0.0 107.62 175.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -84.6 150.95 24.84 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -137.76 160.87 38.05 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 119.913 1.233 . . . . 0.0 110.815 174.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -153.56 138.75 17.43 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 173.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -86.12 103.45 14.79 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tt -70.81 -41.99 70.84 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.627 1.171 . . . . 0.0 108.123 174.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.2 m -138.61 135.7 35.21 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.634 1.174 . . . . 0.0 111.397 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -164.97 93.13 0.61 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 102.169 -3.271 . . . . 0.0 102.169 173.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -161.43 154.14 20.52 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 120.821 -1.175 . . . . 0.0 110.76 -174.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.3 t -73.14 165.31 25.29 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.36 0.6 . . . . 0.0 109.628 173.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.5 mt -120.49 -21.87 6.65 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 116.505 -1.712 . . . . 0.0 110.764 173.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -99.35 164.89 11.93 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-O 123.935 1.826 . . . . 0.0 108.407 173.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.4 mmtm -136.71 -27.24 1.03 Allowed 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 129.255 3.022 . . . . 0.0 112.315 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.31 -63.85 3.86 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 106.67 -2.572 . . . . 0.0 106.67 172.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.7 mp -81.87 26.7 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 128.934 2.894 . . . . 0.0 110.855 174.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 2.8 ttp -43.06 128.24 4.39 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 125.107 2.385 . . . . 0.0 112.734 -173.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -150.65 146.98 26.84 Favored 'General case' 0 N--CA 1.427 -1.606 1 C-N-CA 135.435 5.494 . . . . 0.0 101.263 174.091 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -136.73 117.0 10.87 Favored Pre-proline 0 C--N 1.318 -0.802 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 177.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -68.31 159.81 51.68 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.977 2.451 . . . . 0.0 113.932 -173.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 21.7 p -138.58 161.86 36.02 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.89 2.076 . . . . 0.0 109.031 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.5 m -126.37 154.73 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.195 0.998 . . . . 0.0 111.784 174.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -80.17 10.11 4.82 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 127.522 2.329 . . . . 0.0 113.468 177.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.9 m -140.49 163.18 45.12 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 124.54 1.136 . . . . 0.0 109.72 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -66.67 161.91 39.55 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 121.454 1.436 . . . . 0.0 109.567 173.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -64.58 -12.25 43.22 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 124.232 1.013 . . . . 0.0 112.644 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -145.16 165.1 29.29 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.974 1.31 . . . . 0.0 108.023 173.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 161.08 -161.12 32.68 Favored Glycine 0 C--O 1.227 -0.286 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 68.5 p -119.06 148.21 43.28 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 173.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.0 t -80.12 113.41 38.29 Favored Pre-proline 0 N--CA 1.447 -0.608 0 N-CA-C 102.15 -3.278 . . . . 0.0 102.15 173.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -84.33 165.64 12.61 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.585 1.523 . . . . 0.0 114.647 -173.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.476 ' HD1' ' C ' ' A' ' 69' ' ' ALA . 94.1 m-70 -77.43 3.68 12.75 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 120.687 -1.258 . . . . 0.0 114.341 -173.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.67 134.09 55.23 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 173.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.86 110.84 0.46 Allowed 'General case' 0 C--O 1.231 0.13 0 C-N-CA 124.785 1.234 . . . . 0.0 108.664 176.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.2 m -118.78 140.29 50.19 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.3 t -94.98 114.81 32.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 124.156 0.983 . . . . 0.0 109.941 -173.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 77.7 t -93.84 103.48 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 103.342 -2.836 . . . . 0.0 103.342 173.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -89.26 125.37 35.07 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 173.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.5 t -95.39 113.68 30.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 103.939 -2.615 . . . . 0.0 103.939 173.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -94.17 144.77 17.32 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.477 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 6.2 m-85 -129.22 73.89 81.39 Favored Pre-proline 0 C--O 1.243 0.724 0 CA-C-N 117.903 0.851 . . . . 0.0 110.495 -174.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.09 122.47 9.78 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 N-CA-C 107.928 -1.605 . . . . 0.0 107.928 173.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 5.9 t -105.75 153.13 22.3 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 124.703 1.201 . . . . 0.0 107.97 173.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.7 mt -81.42 -10.27 59.55 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.371 0.532 . . . . 0.0 112.011 -175.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 54.21 42.73 73.63 Favored Glycine 0 C--O 1.222 -0.643 0 C-N-CA 126.78 2.133 . . . . 0.0 114.759 173.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -126.89 -29.99 2.78 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.592 1.696 . . . . 0.0 113.307 173.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -96.31 153.55 17.75 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 104.764 -2.31 . . . . 0.0 104.764 172.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -108.73 143.44 37.85 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 177.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 141.83 -154.86 25.1 Favored Glycine 0 C--N 1.334 0.435 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.0 t -130.38 113.91 27.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 123.398 0.679 . . . . 0.0 109.36 -177.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -88.88 168.82 12.1 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 173.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -127.22 160.53 31.01 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.729 0.812 . . . . 0.0 109.827 173.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.477 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 12.7 p90 -146.93 152.31 38.46 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.792 0.837 . . . . 0.0 109.51 173.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -112.23 150.23 31.18 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 127.102 2.161 . . . . 0.0 112.144 -173.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 95.3 t -139.17 141.33 36.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 124.815 1.246 . . . . 0.0 109.619 173.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -155.78 119.25 4.38 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 127.654 2.382 . . . . 0.0 105.436 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.437 ' H ' ' HB ' ' A' ' 143' ' ' THR . 45.1 t -129.45 125.28 61.45 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 179.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -92.56 161.52 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 173.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.9 t -137.52 135.12 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 -177.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.81 174.44 10.57 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 124.821 1.249 . . . . 0.0 108.355 -176.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -89.97 176.18 6.9 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 172.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.3 t -66.04 -3.68 5.85 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 120.233 -1.542 . . . . 0.0 113.765 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -89.71 -14.61 34.34 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 120.625 1.557 . . . . 0.0 110.612 173.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.62 0.46 64.59 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.581 1.086 . . . . 0.0 112.107 -173.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -69.74 115.77 9.36 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.507 1.653 . . . . 0.0 108.302 174.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -68.9 143.69 54.41 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.684 1.594 . . . . 0.0 108.821 -175.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -140.02 -37.73 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.667 1.187 . . . . 0.0 113.761 -174.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -132.78 149.14 52.31 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 10.0 tm0? -147.85 148.69 31.14 Favored 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 120.99 -1.069 . . . . 0.0 108.649 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.437 ' HB ' ' H ' ' A' ' 130' ' ' VAL . 27.1 m -80.2 113.29 37.58 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 175.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.33 146.09 79.67 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 CA-C-N 120.071 1.061 . . . . 0.0 110.856 -173.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -78.61 112.63 15.88 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 -173.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.488 28.2 m-80 172.49 -21.07 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 1 C-N-CA 136.276 5.831 . . . . 0.0 111.376 173.543 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -56.66 91.85 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.346 2.258 . . . . 0.0 110.355 176.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.6 mt -136.4 149.79 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.415 ' CD1' ' CZ ' ' A' ' 126' ' ' PHE . 0.8 OUTLIER -128.22 169.48 14.11 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 174.195 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -133.9 113.76 12.56 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.177 1.391 . . . . 0.0 107.523 -173.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 51.6 tttt -101.05 122.4 43.49 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 120.097 1.317 . . . . 0.0 109.173 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.6 m -83.52 118.39 23.75 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 173.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 20.3 m -114.55 165.22 12.99 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 173.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.4 pp -141.14 161.67 37.3 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.525 1.13 . . . . 0.0 108.666 174.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -74.67 126.82 31.66 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 128.447 2.699 . . . . 0.0 111.307 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -139.77 168.45 19.79 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 126.517 1.927 . . . . 0.0 108.989 173.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 . . . . . 0 C--O 1.247 0.921 0 C-N-CA 131.035 3.734 . . . . 0.0 104.629 174.116 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.467 0.412 0 N-CA-C 110.822 -0.066 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.0 tt -43.52 128.6 5.11 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 127.816 2.446 . . . . 0.0 112.435 -174.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -115.28 133.83 55.68 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.739 1.615 . . . . 0.0 108.822 173.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.56 120.85 10.22 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.2 p90 -135.15 170.88 15.24 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 119.201 0.91 . . . . 0.0 109.32 175.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mt -106.39 113.79 43.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 101.798 -3.408 . . . . 0.0 101.798 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -76.28 148.29 37.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 123.299 1.523 . . . . 0.0 113.373 -173.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.37 -22.4 66.09 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 113.388 -1.733 . . . . 0.0 114.84 -173.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -57.62 -38.67 75.35 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 119.448 1.022 . . . . 0.0 109.859 -177.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -69.3 -44.93 70.77 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 122.36 -0.212 . . . . 0.0 111.156 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.08 -31.28 69.87 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 119.118 -0.468 . . . . 0.0 112.006 173.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 38.2 ttm-85 . . . . . 0 N--CA 1.442 -0.865 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 173.55 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.534 0.337 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -161.17 124.85 3.34 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.183 1.793 . . . . 0.0 109.787 175.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -92.7 174.38 7.29 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.777 1.631 . . . . 0.0 106.964 173.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.2 mt -140.77 113.49 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 172.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.66 117.53 20.66 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -177.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.6 mt -89.96 -66.32 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 119.178 0.899 . . . . 0.0 108.825 177.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -111.92 116.47 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.541 1.536 . . . . 0.0 107.447 -173.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.5 p -112.47 116.08 29.7 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 173.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.493 ' C ' ' H ' ' A' ' 38' ' ' LYS 0.287 2.8 pm0 45.29 40.2 4.99 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.813 1.645 . . . . 0.0 112.813 -179.471 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.44 -30.7 1.42 Allowed Glycine 0 CA--C 1.544 1.906 0 C-N-CA 125.652 1.596 . . . . 0.0 114.101 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.493 ' H ' ' C ' ' A' ' 36' ' ' GLU 0.434 7.3 tmtt? -61.94 38.02 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.768 1 C-N-CA 138.838 6.855 . . . . 0.0 112.708 173.761 . . . . . . . . 4 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 33.0 mtm -37.51 139.23 0.29 Allowed 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 126.69 1.996 . . . . 0.0 115.527 -172.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.42 164.49 43.52 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 112.673 -2.058 . . . . 0.0 108.964 173.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.27 32.69 0.31 Allowed 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 124.039 3.16 . . . . 0.0 112.395 174.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -52.91 -26.15 14.01 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.816 2.047 . . . . 0.0 111.843 -174.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.6 m -57.65 -30.31 65.31 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.038 1.735 . . . . 0.0 109.974 -174.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -56.44 -62.83 1.45 Allowed 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.501 1.121 . . . . 0.0 108.968 173.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -68.31 -25.41 65.11 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.397 1.079 . . . . 0.0 111.989 -174.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -72.37 -49.12 36.37 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.036 0.534 . . . . 0.0 110.026 174.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.456 ' CZ ' ' HA ' ' A' ' 47' ' ' ARG . 0.2 OUTLIER . . . . . 0 CA--C 1.553 1.068 0 C-N-CA 124.811 1.244 . . . . 0.0 111.883 -174.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.415 ' H ' ' CD ' ' A' ' 54' ' ' PRO . 63.7 mmm . . . . . 0 CA--C 1.536 0.412 0 CA-C-O 117.355 -1.307 . . . . 0.0 113.688 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.415 ' CD ' ' H ' ' A' ' 53' ' ' MET . 79.0 Cg_endo -78.12 -98.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.881 1.721 . . . . 0.0 110.118 -173.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.24 124.79 24.09 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.213 -0.93 . . . . 0.0 109.748 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.5 mt -130.94 138.03 32.08 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 128.81 2.844 . . . . 0.0 106.842 -174.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -81.34 157.43 19.63 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.702 2.268 . . . . 0.0 111.655 174.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.3 p -42.94 -41.47 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 127.257 2.223 . . . . 0.0 112.908 174.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -58.25 -34.36 70.38 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 126.65 1.98 . . . . 0.0 113.077 -175.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.7 mm -71.62 112.89 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 102.863 -3.014 . . . . 0.0 102.863 174.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -95.48 -23.42 17.12 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 -177.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.6 m -149.8 166.03 30.69 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 125.118 1.367 . . . . 0.0 107.548 173.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 13.9 mmm -123.13 163.29 20.86 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 173.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -117.96 150.5 39.15 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 173.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -139.52 153.5 47.48 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 102.101 -3.296 . . . . 0.0 102.101 172.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.3 m -138.63 132.91 31.69 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -176.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -145.1 161.56 39.17 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.184 177.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -165.89 145.14 6.18 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 123.937 0.895 . . . . 0.0 110.689 173.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.436 ' C ' ' HD1' ' A' ' 105' ' ' HIS . . . -85.71 177.2 7.76 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 173.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.19 99.81 10.55 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 125.281 1.432 . . . . 0.0 110.136 -173.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 47.3 -56.27 0.0 OUTLIER Glycine 0 CA--C 1.536 1.386 1 C-N-CA 132.613 4.911 . . . . 0.0 119.396 174.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -117.01 -16.53 10.5 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.518 2.159 . . . . 0.0 115.706 173.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.31 37.11 0.38 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 128.56 2.744 . . . . 0.0 116.92 -173.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -46.36 113.87 0.71 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 122.01 2.187 . . . . 0.0 110.549 -177.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -83.83 145.95 28.38 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 125.341 1.456 . . . . 0.0 107.51 174.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -94.05 150.89 19.93 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -133.8 160.18 38.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 119.869 1.213 . . . . 0.0 111.165 175.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -154.13 138.4 16.62 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 173.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -86.43 103.68 15.21 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.896 1.279 . . . . 0.0 109.025 -177.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.9 tt -68.3 -41.78 80.44 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.792 1.237 . . . . 0.0 107.862 175.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.4 m -136.88 141.34 42.76 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.096 0.958 . . . . 0.0 111.847 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.4 tt -171.27 92.99 0.16 Allowed 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 128.755 2.822 . . . . 0.0 104.579 173.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -162.32 149.86 14.03 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 118.501 -0.761 . . . . 0.0 109.994 -174.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.8 t -91.98 134.12 35.09 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 119.593 1.088 . . . . 0.0 109.843 173.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 71.2 mt -82.26 -26.32 33.29 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 116.314 -1.803 . . . . 0.0 110.788 177.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -93.94 144.96 24.98 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 121.155 1.798 . . . . 0.0 109.485 174.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.453 ' HE3' ' HA ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -113.94 -24.53 9.03 Favored 'General case' 0 N--CA 1.443 -0.796 1 C-N-CA 133.653 4.781 . . . . 0.0 113.822 178.35 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 90' ' ' MET . . . -71.14 -69.93 1.3 Allowed Glycine 0 CA--C 1.533 1.211 0 N-CA-C 107.12 -2.392 . . . . 0.0 107.12 173.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.3 mp -78.48 26.3 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 128.579 2.752 . . . . 0.0 110.994 175.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.444 ' SD ' ' HE3' ' A' ' 87' ' ' LYS . 6.7 ttp -43.16 125.18 3.57 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.79 2.436 . . . . 0.0 111.247 -173.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -161.35 113.48 1.83 Allowed 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 101.272 -3.603 . . . . 0.0 101.272 -175.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.313 1.6 m-20 -112.97 127.45 26.82 Favored Pre-proline 0 C--N 1.319 -0.721 0 O-C-N 124.372 1.045 . . . . 0.0 110.913 -173.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.09 154.02 71.05 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 121.733 1.622 . . . . 0.0 110.318 -174.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 18.4 p -139.16 162.93 33.75 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.453 1.501 . . . . 0.0 108.482 174.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.0 m -126.5 150.39 32.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 123.829 0.852 . . . . 0.0 110.696 173.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -86.03 17.85 3.33 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.501 1.52 . . . . 0.0 111.463 173.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.6 m -132.49 163.03 53.45 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 125.651 1.58 . . . . 0.0 107.011 173.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -67.33 162.41 38.84 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 120.754 0.969 . . . . 0.0 109.767 173.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -64.38 -12.89 47.35 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.361 1.065 . . . . 0.0 111.774 176.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -140.78 164.39 30.34 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.239 1.415 . . . . 0.0 107.89 173.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.17 -161.26 33.82 Favored Glycine 0 C--O 1.227 -0.332 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 75.4 p -119.0 155.1 31.98 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 173.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 24.5 t -90.43 113.27 56.96 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 103.414 -2.809 . . . . 0.0 103.414 173.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -88.95 171.76 4.66 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.541 2.16 . . . . 0.0 114.491 -173.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.436 ' HD1' ' C ' ' A' ' 69' ' ' ALA . 88.2 m-70 -81.98 3.04 28.03 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 -173.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.5 133.84 55.55 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 114.869 -2.491 . . . . 0.0 106.834 173.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -44.95 111.06 0.28 Allowed 'General case' 0 C--O 1.232 0.171 0 O-C-N 125.808 1.942 . . . . 0.0 107.757 173.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.3 m -116.72 137.41 52.21 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.4 t -93.87 120.88 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 O-C-N 124.692 1.245 . . . . 0.0 108.794 -173.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.3 t -93.91 103.72 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 N-CA-C 103.094 -2.928 . . . . 0.0 103.094 173.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -84.2 119.24 24.79 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 173.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.4 t -95.0 113.5 29.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 104.249 -2.5 . . . . 0.0 104.249 174.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -86.34 143.14 19.26 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.407 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 14.6 m-85 -128.34 73.5 80.07 Favored Pre-proline 0 C--O 1.245 0.844 0 CA-C-N 118.333 1.066 . . . . 0.0 110.814 -178.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.55 120.33 7.28 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.332 2.021 . . . . 0.0 109.282 173.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 12.8 t -98.95 148.66 23.75 Favored 'General case' 0 C--N 1.342 0.276 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 173.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.3 mt -76.77 -13.52 60.01 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 117.88 0.309 . . . . 0.0 111.043 178.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 51.31 40.56 45.79 Favored Glycine 0 C--O 1.22 -0.765 0 C-N-CA 127.868 2.651 . . . . 0.0 115.137 173.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . 0.262 42.1 mttm -123.09 -29.67 3.86 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.847 1.824 . . . . 0.0 112.71 173.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -96.46 149.41 21.76 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 172.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -102.12 149.45 24.26 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 176.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.4 -154.56 23.59 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.7 t -128.78 113.83 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.01 166.04 15.37 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 173.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -123.81 145.02 49.36 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.715 1.206 . . . . 0.0 108.538 174.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.407 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 37.5 p90 -140.66 142.78 34.92 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 119.321 0.964 . . . . 0.0 110.317 174.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -104.07 144.79 31.09 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 126.768 2.027 . . . . 0.0 111.36 -173.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.0 t -140.05 139.12 37.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 173.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -155.15 130.6 9.75 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.906 1.682 . . . . 0.0 106.987 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.4 t -135.94 129.5 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -175.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -97.9 165.75 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 173.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.7 t -143.31 134.7 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 -174.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.01 174.35 10.66 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.876 1.27 . . . . 0.0 108.286 -175.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -89.95 176.13 6.92 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 104.667 -2.346 . . . . 0.0 104.667 172.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.1 t -66.2 -4.02 6.84 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 120.356 -1.465 . . . . 0.0 113.685 -177.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -89.34 -14.88 34.66 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 120.572 1.533 . . . . 0.0 110.657 173.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.04 0.42 63.67 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.591 1.091 . . . . 0.0 112.039 -173.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -69.57 115.51 8.9 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 119.494 1.647 . . . . 0.0 108.357 174.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -69.09 143.51 54.18 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.786 1.634 . . . . 0.0 108.81 -175.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -140.61 -37.29 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.62 1.168 . . . . 0.0 113.598 -174.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -130.5 145.43 51.85 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -143.98 136.06 26.49 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 91.7 m -66.87 128.03 93.71 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 174.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.41 143.4 43.02 Favored 'Trans proline' 0 N--CA 1.444 -1.436 0 CA-C-N 120.606 1.252 . . . . 0.0 109.122 -177.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -81.75 112.97 19.39 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 -174.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 173.17 -19.59 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.572 1 C-N-CA 135.116 5.366 . . . . 0.0 110.942 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.39 83.95 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.837 1.655 . . . . 0.0 111.4 -175.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.4 mt -125.21 135.57 63.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 175.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -106.32 161.94 14.11 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 125.911 1.684 . . . . 0.0 106.722 177.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -136.41 113.3 10.35 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 55.0 tttt -99.3 122.43 42.44 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 21.4 m -83.61 115.13 21.99 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 105.299 -2.112 . . . . 0.0 105.299 173.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 36.9 m -111.21 165.92 11.52 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 119.196 0.907 . . . . 0.0 109.192 173.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.5 pp -141.35 160.14 40.75 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.178 1.391 . . . . 0.0 107.694 173.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.99 131.11 43.87 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.795 1.238 . . . . 0.0 111.669 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -144.33 169.92 16.99 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 128.008 2.523 . . . . 0.0 107.693 173.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 . . . . . 0 C--O 1.255 1.385 0 C-N-CA 128.925 2.89 . . . . 0.0 106.057 173.857 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.6 m . . . . . 0 CA--C 1.538 0.488 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.9 tt -43.32 129.85 4.89 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 129.335 3.054 . . . . 0.0 113.285 -175.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -115.1 139.6 49.75 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.18 2.192 . . . . 0.0 108.441 173.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.25 117.97 6.19 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 126.05 1.74 . . . . 0.0 106.693 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 13.7 p90 -131.02 176.06 8.57 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.296 1.039 . . . . 0.0 110.083 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.5 mt -113.06 113.91 45.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 102.418 -3.179 . . . . 0.0 102.418 174.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -76.89 139.21 40.15 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 123.069 1.414 . . . . 0.0 111.967 -173.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.19 -25.54 61.7 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.276 1.83 . . . . 0.0 114.367 -173.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 13.6 m80 -56.53 -37.3 70.29 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 118.978 0.808 . . . . 0.0 110.018 -174.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 49.1 tp60 -66.83 -41.31 87.66 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 121.992 -0.443 . . . . 0.0 111.067 178.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.4 -35.4 80.77 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 121.683 -0.636 . . . . 0.0 110.904 173.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.512 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 173.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 . . . . . 0 CA--C 1.537 0.462 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -165.85 136.49 3.62 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 130.681 3.592 . . . . 0.0 107.507 174.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -86.45 176.21 7.98 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.093 1.757 . . . . 0.0 107.823 173.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.0 mp -137.54 113.1 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 173.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.52 115.23 26.79 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -176.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.5 mt -94.66 -53.94 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 118.635 0.652 . . . . 0.0 110.065 -176.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.2 t -126.15 129.99 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 125.68 1.592 . . . . 0.0 107.703 -173.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.0 p -138.4 132.94 32.22 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 103.165 -2.902 . . . . 0.0 103.165 173.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.31 18.0 pm0 44.33 33.73 0.91 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.151 1.38 . . . . 0.0 113.796 -174.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.54 -4.17 14.87 Favored Glycine 0 CA--C 1.543 1.813 0 O-C-N 120.652 -1.28 . . . . 0.0 115.135 -176.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -66.4 37.41 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.596 1 C-N-CA 132.467 4.307 . . . . 0.0 114.222 -176.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 31.4 mtt -38.07 114.33 0.35 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 120.183 1.356 . . . . 0.0 113.742 -173.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.56 164.79 29.19 Favored Pre-proline 0 N--CA 1.447 -0.599 0 CA-C-N 113.777 -1.556 . . . . 0.0 107.977 173.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.84 40.9 0.59 Allowed 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 124.215 3.276 . . . . 0.0 111.002 173.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -52.27 -26.26 11.46 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 127.913 2.485 . . . . 0.0 112.603 -173.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.9 m -44.01 -43.72 6.87 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.152 1.781 . . . . 0.0 111.619 177.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -60.81 -66.05 0.59 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.427 0.691 . . . . 0.0 110.191 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -73.98 -23.01 59.4 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.155 1.782 . . . . 0.0 114.062 -173.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -77.89 -56.81 4.19 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 124.669 1.187 . . . . 0.0 110.229 173.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 18.5 ttp180 . . . . . 0 C--N 1.345 0.386 0 O-C-N 121.657 -0.652 . . . . 0.0 109.873 -173.461 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 61.1 mmm . . . . . 0 N--CA 1.468 0.467 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.24 -74.21 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.195 1.93 . . . . 0.0 111.82 -173.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.73 113.42 14.36 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -174.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 62.9 mt -113.16 126.75 27.74 Favored Pre-proline 0 C--N 1.324 -0.536 0 C-N-CA 127.734 2.413 . . . . 0.0 105.803 -174.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -78.46 157.29 28.94 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 121.691 1.594 . . . . 0.0 110.356 176.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.4 p -45.7 -38.74 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 125.849 1.66 . . . . 0.0 111.975 173.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -55.91 -40.08 72.56 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 126.677 1.991 . . . . 0.0 112.832 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mm -77.11 112.73 15.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 101.914 -3.365 . . . . 0.0 101.914 173.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -79.92 -40.67 27.7 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 174.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.8 m -141.51 161.75 37.16 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.609 1.164 . . . . 0.0 110.053 -173.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 52.8 mtp -123.68 167.47 13.94 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.426 1.49 . . . . 0.0 107.092 173.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -114.03 155.85 25.17 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 174.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -140.75 151.54 44.54 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 130.489 3.516 . . . . 0.0 102.268 172.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.3 m -137.97 133.85 34.19 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -145.42 162.38 37.44 Favored 'General case' 0 C--O 1.238 0.473 0 O-C-N 121.857 -0.527 . . . . 0.0 111.198 178.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -167.36 153.36 7.78 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.969 0.89 . . . . 0.0 112.484 173.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.3 -173.65 4.83 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.333 1.453 . . . . 0.0 109.174 173.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.85 100.11 7.04 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.789 1.635 . . . . 0.0 108.324 -174.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.07 -63.29 0.0 OUTLIER Glycine 0 CA--C 1.538 1.522 0 C-N-CA 130.184 3.754 . . . . 0.0 119.016 173.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -116.88 -13.78 10.69 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 120.583 2.191 . . . . 0.0 114.113 173.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.59 37.1 0.17 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 129.136 2.975 . . . . 0.0 118.021 -173.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -53.58 113.68 1.26 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 122.873 2.579 . . . . 0.0 109.672 -177.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -84.06 129.95 34.89 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 126.187 1.795 . . . . 0.0 107.935 174.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -79.85 147.67 31.65 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -132.56 161.26 34.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 120.127 1.33 . . . . 0.0 111.182 176.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -152.71 137.24 16.8 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 173.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -81.68 104.08 11.83 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.635 1.174 . . . . 0.0 109.91 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.7 tt -67.36 -41.72 84.65 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.43 1.092 . . . . 0.0 108.114 174.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.8 m -133.87 141.29 47.33 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.881 0.872 . . . . 0.0 111.202 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.3 tt -171.95 93.07 0.14 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 104.15 -2.537 . . . . 0.0 104.15 173.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -162.18 156.73 22.17 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.024 0.829 . . . . 0.0 111.416 -173.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.6 t -75.99 161.95 28.48 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 173.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.6 mt -122.1 -26.33 4.75 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 116.99 -1.481 . . . . 0.0 112.045 174.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.444 ' CG ' ' H ' ' A' ' 87' ' ' LYS . 23.2 t0 -83.3 168.11 16.98 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 121.34 1.882 . . . . 0.0 111.604 177.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.444 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -111.3 -49.32 3.02 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 128.533 2.733 . . . . 0.0 112.501 179.099 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.84 -70.19 1.16 Allowed Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 174.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mp -79.75 18.63 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 128.786 2.834 . . . . 0.0 110.048 -174.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -43.93 134.11 4.68 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 127.061 2.144 . . . . 0.0 110.239 -175.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -157.51 113.76 2.89 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 126.118 1.767 . . . . 0.0 106.916 -173.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -97.34 132.43 25.46 Favored Pre-proline 0 C--N 1.324 -0.541 0 O-C-N 124.142 0.901 . . . . 0.0 109.876 -173.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.01 153.81 67.42 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 C-N-CA 121.409 1.406 . . . . 0.0 109.347 174.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 21.1 p -140.11 157.09 46.17 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 126.682 1.993 . . . . 0.0 107.439 174.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.9 m -126.33 153.66 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 119.648 1.113 . . . . 0.0 113.145 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -73.83 7.94 2.26 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 127.567 2.347 . . . . 0.0 113.647 174.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.6 m -140.75 164.89 33.44 Favored Pre-proline 0 C--N 1.326 -0.452 0 C-N-CA 125.648 1.579 . . . . 0.0 108.286 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -67.18 167.61 19.71 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 121.347 1.365 . . . . 0.0 110.937 174.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -63.22 -11.37 20.63 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.786 1.235 . . . . 0.0 112.119 175.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -145.07 164.3 31.64 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.22 1.408 . . . . 0.0 107.884 173.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.33 -161.74 34.28 Favored Glycine 0 C--O 1.227 -0.342 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 71.4 p -117.86 151.19 37.86 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.5 t -88.69 113.37 55.44 Favored Pre-proline 0 N--CA 1.448 -0.542 0 N-CA-C 102.84 -3.022 . . . . 0.0 102.84 173.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -90.09 160.02 4.83 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.803 2.336 . . . . 0.0 111.424 -173.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -74.18 4.44 5.65 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 119.753 -1.842 . . . . 0.0 113.3 -173.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -115.54 116.85 28.87 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 126.259 1.824 . . . . 0.0 106.736 -173.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -43.06 105.37 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 125.039 1.336 . . . . 0.0 109.755 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.3 m -112.02 136.0 51.94 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.0 t -95.68 116.09 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.05 -173.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 82.5 t -93.76 103.27 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 N-CA-C 103.476 -2.787 . . . . 0.0 103.476 173.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.58 120.11 25.11 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 103.324 -2.843 . . . . 0.0 103.324 173.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.4 t -94.7 113.64 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 104.23 -2.507 . . . . 0.0 104.23 173.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -92.36 149.42 19.62 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 175.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.458 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 9.8 m-85 -131.13 73.64 80.42 Favored Pre-proline 0 C--O 1.242 0.7 0 CA-C-N 118.544 1.172 . . . . 0.0 110.422 -176.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -62.94 116.14 3.38 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.479 2.119 . . . . 0.0 109.309 173.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 9.2 t -93.67 147.67 22.81 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 173.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.4 mt -74.16 -13.48 60.81 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.134 0.425 . . . . 0.0 111.822 -176.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.8 34.3 89.57 Favored Glycine 0 C--N 1.34 0.804 0 C-N-CA 125.757 1.646 . . . . 0.0 114.352 173.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.7 mttm -114.9 -50.64 2.76 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.349 1.575 . . . . 0.0 112.442 -173.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 48.6 tp60 -96.06 147.49 23.66 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 173.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -93.93 142.12 27.74 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 175.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.72 -154.83 26.09 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-N 118.781 0.719 . . . . 0.0 111.649 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.6 t -129.96 116.73 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 123.846 0.858 . . . . 0.0 108.789 -179.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -92.42 175.3 6.89 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.15 1.38 . . . . 0.0 109.297 173.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -128.6 155.03 45.59 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.767 1.627 . . . . 0.0 107.386 173.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.458 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 40.3 p90 -147.05 157.84 43.74 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.576 1.15 . . . . 0.0 108.035 173.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -123.36 150.52 43.57 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.542 1.537 . . . . 0.0 111.909 -173.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 62.5 t -141.45 143.2 27.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 173.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -160.81 136.13 7.85 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.023 1.329 . . . . 0.0 107.687 174.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.7 t -136.79 139.26 45.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-N 119.51 1.05 . . . . 0.0 109.265 -173.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.9 163.64 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 173.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.6 t -141.74 137.81 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -173.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.31 174.12 10.89 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.542 1.537 . . . . 0.0 108.416 -176.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -88.84 175.8 7.32 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 172.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 6.1 t -65.1 -14.86 61.55 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 120.212 -1.555 . . . . 0.0 112.112 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -80.12 -3.3 48.25 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.73 1.612 . . . . 0.0 110.65 176.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.22 5.66 89.9 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 125.123 1.345 . . . . 0.0 112.996 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -80.92 118.19 22.2 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.5 m -64.71 143.07 58.19 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.434 1.493 . . . . 0.0 108.748 -178.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -140.07 -37.26 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.774 1.23 . . . . 0.0 113.626 -175.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -130.56 141.08 50.47 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -146.6 126.35 13.46 Favored 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 121.422 -0.799 . . . . 0.0 109.081 -176.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 30.3 m -67.52 142.68 96.47 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 173.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -83.59 147.55 12.4 Favored 'Trans proline' 0 N--CA 1.443 -1.477 0 N-CA-C 108.731 -1.296 . . . . 0.0 108.731 174.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -75.46 112.63 11.99 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 103.505 -2.776 . . . . 0.0 103.505 -178.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 173.73 -23.81 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 128.17 2.588 . . . . 0.0 112.17 -173.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.89 87.34 0.14 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 122.208 1.004 . . . . 0.0 108.428 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.9 mt -127.84 147.91 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -174.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 126' ' ' PHE . 0.5 OUTLIER -134.28 167.89 19.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 113.971 -1.468 . . . . 0.0 107.298 -176.783 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -135.33 113.5 11.3 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.175 0.99 . . . . 0.0 109.456 -173.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -104.22 122.43 45.36 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 119.435 1.016 . . . . 0.0 109.431 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 25.6 m -83.68 115.44 22.17 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 174.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 5.0 m -116.78 166.3 12.3 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.496 0.665 . . . . 0.0 110.163 174.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.3 pp -134.12 162.45 32.07 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.109 1.364 . . . . 0.0 107.539 173.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -73.57 114.72 12.13 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 127.738 2.415 . . . . 0.0 109.463 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -163.5 118.54 1.64 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.335 1.454 . . . . 0.0 109.79 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 . . . . . 0 C--O 1.256 1.416 0 C-N-CA 128.667 2.787 . . . . 0.0 105.914 173.743 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 m . . . . . 0 CA--C 1.545 0.755 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.5 tt -46.57 136.8 7.32 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.165 1.786 . . . . 0.0 112.788 -174.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -122.07 137.03 54.96 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.317 1.447 . . . . 0.0 110.249 175.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.79 119.12 6.38 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.57 1.548 . . . . 0.0 107.803 -178.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 30.9 p90 -142.84 148.08 36.47 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.641 1.109 . . . . 0.0 109.541 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.0 mp -84.12 118.53 31.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 102.893 -3.003 . . . . 0.0 102.893 173.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.03 143.81 29.51 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 123.691 1.71 . . . . 0.0 114.313 -173.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.75 -26.11 61.44 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 112.774 -2.012 . . . . 0.0 113.636 -173.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.9 m80 -62.63 -38.25 89.52 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 122.926 0.49 . . . . 0.0 110.519 -173.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -71.54 -49.3 42.14 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.149 174.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.61 -43.06 56.74 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-O 118.404 -0.807 . . . . 0.0 111.218 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.0 ttp-105 . . . . . 0 C--O 1.225 -0.217 0 CA-C-N 119.797 1.181 . . . . 0.0 108.452 173.526 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 . . . . . 0 CA--C 1.535 0.368 0 CA-C-O 119.904 -0.093 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -150.7 144.98 25.52 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.437 2.695 . . . . 0.0 106.383 173.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -96.03 164.83 12.54 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 173.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.2 mp -135.27 113.38 15.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 103.858 -2.645 . . . . 0.0 103.858 173.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.4 tt -94.62 114.07 25.97 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -173.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.6 mt -83.86 -61.75 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 124.349 1.06 . . . . 0.0 108.281 -174.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.1 t -117.1 113.66 43.46 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -173.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.4 p -111.92 125.93 54.58 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 102.616 -3.105 . . . . 0.0 102.616 173.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 46.08 38.2 4.56 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.148 1.379 . . . . 0.0 112.508 174.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 54.98 19.84 16.96 Favored Glycine 0 CA--C 1.539 1.58 0 C-N-CA 124.992 1.282 . . . . 0.0 113.824 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -122.97 37.97 4.29 Favored 'General case' 0 CA--C 1.536 0.434 1 C-N-CA 131.861 4.064 . . . . 0.0 108.051 -172.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . 0.272 20.2 mtp -37.29 146.71 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 130.762 3.625 . . . . 0.0 115.696 -172.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.72 162.07 75.12 Favored Pre-proline 0 N--CA 1.452 -0.368 0 CA-C-N 113.141 -1.845 . . . . 0.0 109.314 173.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.09 42.36 0.98 Allowed 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 124.552 3.501 . . . . 0.0 111.609 174.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -53.86 -26.58 25.32 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.647 1.979 . . . . 0.0 113.197 -174.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.5 m -58.25 -29.35 65.69 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 126.501 1.92 . . . . 0.0 111.434 -173.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 62.8 t60 -62.86 -66.48 0.54 Allowed 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 118.64 0.655 . . . . 0.0 109.346 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.63 -23.82 65.4 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -175.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -67.96 -47.62 68.14 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.68 1.192 . . . . 0.0 111.223 174.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.517 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -173.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.44 ' H ' ' CD ' ' A' ' 54' ' ' PRO . 88.2 mtp . . . . . 0 CA--C 1.539 0.532 0 CA-C-O 115.587 -2.149 . . . . 0.0 115.661 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.44 ' CD ' ' H ' ' A' ' 53' ' ' MET . 54.2 Cg_exo -51.34 -68.45 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.949 0 CA-C-N 123.08 2.136 . . . . 0.0 114.641 -173.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.27 113.9 22.65 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 177.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.9 mt -103.85 118.84 56.27 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 127.008 2.123 . . . . 0.0 105.761 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -74.48 153.95 44.88 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 121.355 1.37 . . . . 0.0 110.164 176.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.3 p -39.93 -44.28 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 127.483 2.313 . . . . 0.0 113.321 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -58.71 -34.43 71.3 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 126.706 2.002 . . . . 0.0 113.567 -176.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.0 mm -71.36 113.08 7.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 104.362 -2.458 . . . . 0.0 104.362 175.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -79.85 -39.34 30.86 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 173.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.2 m -153.06 162.29 41.49 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -173.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 54.5 mtm -126.69 162.4 25.87 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 172.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 39.1 m-20 -120.47 114.09 21.28 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 118.509 0.595 . . . . 0.0 109.725 -175.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -94.32 150.69 20.05 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 102.3 -3.222 . . . . 0.0 102.3 172.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.9 m -139.5 135.68 33.75 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 -175.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -148.96 165.81 30.48 Favored 'General case' 0 CA--C 1.509 -0.611 0 O-C-N 121.572 -0.705 . . . . 0.0 110.525 -178.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -165.37 149.7 8.66 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.587 173.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.02 177.52 4.29 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 172.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.91 143.57 26.78 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 100.998 -3.705 . . . . 0.0 100.998 173.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -1.25 -73.99 0.0 OUTLIER Glycine 0 C--N 1.302 -1.324 1 C-N-CA 133.88 5.514 . . . . 0.0 117.721 -173.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . 0.273 21.4 mm100 -117.35 23.95 11.46 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 173.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -108.99 37.47 2.55 Favored 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 130.859 3.664 . . . . 0.0 120.693 -173.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -39.61 116.2 0.6 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 122.34 2.337 . . . . 0.0 113.785 -173.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -84.4 132.68 34.56 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 174.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -83.82 149.08 26.63 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 175.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -134.05 159.76 39.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 119.473 1.033 . . . . 0.0 111.133 175.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -152.83 137.93 17.33 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 173.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -85.86 104.02 15.14 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.592 1.157 . . . . 0.0 110.041 -176.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.2 tt -61.34 -43.88 98.12 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.69 1.596 . . . . 0.0 108.687 173.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.6 m -134.25 143.73 47.97 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.558 1.143 . . . . 0.0 111.723 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.2 tt -172.36 92.79 0.12 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 103.477 -2.786 . . . . 0.0 103.477 173.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -168.89 152.79 5.45 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 118.833 0.742 . . . . 0.0 111.025 -174.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.7 t -79.43 127.75 32.5 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.0 mt -87.01 -26.57 23.69 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 116.67 -1.633 . . . . 0.0 110.857 174.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -86.79 152.42 22.51 Favored 'General case' 0 C--N 1.348 0.508 0 CA-C-N 120.9 1.682 . . . . 0.0 109.377 173.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.4 ' HE3' ' SD ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -108.26 -36.54 6.25 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 128.892 2.877 . . . . 0.0 112.678 -179.599 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.455 ' C ' ' H ' ' A' ' 90' ' ' MET . . . -68.71 -75.95 0.48 Allowed Glycine 0 CA--C 1.53 1.025 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 173.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.1 mp -74.21 20.03 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 129.951 3.3 . . . . 0.0 110.441 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.455 ' H ' ' C ' ' A' ' 88' ' ' GLY . 14.0 ttp -43.42 130.81 5.01 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 127.402 2.281 . . . . 0.0 111.255 -173.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -153.65 113.37 3.85 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 -175.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -99.58 132.81 22.5 Favored Pre-proline 0 C--N 1.322 -0.615 0 O-C-N 124.286 0.991 . . . . 0.0 109.239 -173.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.9 153.67 72.28 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 C-N-CA 121.084 1.19 . . . . 0.0 109.338 174.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 17.1 p -137.57 152.57 49.56 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 126.244 1.817 . . . . 0.0 106.436 173.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.8 m -126.37 153.98 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 CA-C-N 118.966 0.803 . . . . 0.0 112.268 177.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -75.94 8.46 3.12 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.38 1.872 . . . . 0.0 113.822 174.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.67 165.1 32.13 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 124.777 1.231 . . . . 0.0 109.481 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -66.87 166.01 24.03 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.536 1.49 . . . . 0.0 110.478 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -66.97 -10.32 48.11 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.579 1.152 . . . . 0.0 112.256 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -144.28 164.1 31.76 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.564 1.545 . . . . 0.0 107.398 173.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 160.3 -161.42 32.54 Favored Glycine 0 C--O 1.228 -0.24 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 73.1 p -118.0 151.44 37.47 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.5 t -88.92 113.59 56.62 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 175.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.4 154.85 40.93 Favored 'Trans proline' 0 CA--C 1.512 -0.598 0 C-N-CA 121.839 1.692 . . . . 0.0 111.161 -176.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -74.4 -7.07 51.67 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 120.353 -1.467 . . . . 0.0 113.687 -172.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.6 mptt -116.51 122.69 45.45 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 -174.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -38.73 111.39 0.17 Allowed 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 127.123 2.169 . . . . 0.0 111.76 -173.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 57.6 m -118.62 144.54 46.07 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 176.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.0 t -100.63 117.42 45.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 124.835 1.254 . . . . 0.0 111.303 -173.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.2 t -98.47 103.06 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 104.501 -2.407 . . . . 0.0 104.501 173.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -78.55 131.12 36.66 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 104.859 -2.275 . . . . 0.0 104.859 173.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.4 t -103.11 113.45 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 101.634 -3.469 . . . . 0.0 101.634 173.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -97.06 150.26 19.51 Favored Glycine 0 N--CA 1.439 -1.123 0 N-CA-C 108.621 -1.791 . . . . 0.0 108.621 176.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -133.3 73.54 73.83 Favored Pre-proline 0 C--O 1.242 0.7 0 CA-C-N 118.199 1.0 . . . . 0.0 109.402 -174.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -63.8 116.97 3.99 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.649 2.233 . . . . 0.0 109.885 173.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 7.1 t -90.75 146.43 23.99 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 173.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.9 mt -74.27 -12.34 60.52 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 117.856 0.298 . . . . 0.0 111.371 -177.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.61 21.76 43.75 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 127.123 2.297 . . . . 0.0 116.527 173.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . 0.339 4.6 mptp? -102.16 -40.9 6.59 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.984 1.892 . . . . 0.0 114.451 174.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 38.8 tp60 -96.49 146.1 25.09 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.469 1.032 . . . . 0.0 108.467 173.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -94.38 152.06 18.91 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.446 1.498 . . . . 0.0 107.869 174.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 138.06 -152.77 21.97 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.9 t -127.67 114.12 34.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.16 173.36 9.28 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.59 1.156 . . . . 0.0 109.307 173.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -128.24 150.27 50.11 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.338 1.855 . . . . 0.0 106.58 173.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -147.74 154.35 40.42 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 173.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -113.54 141.26 47.36 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.776 1.63 . . . . 0.0 110.291 -173.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 61.1 t -146.71 113.53 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 N-CA-C 104.258 -2.497 . . . . 0.0 104.258 173.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -144.19 137.77 27.62 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -174.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.0 t -136.62 148.9 26.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 121.794 0.807 . . . . 0.0 110.071 -173.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.74 162.64 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 173.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.7 t -139.08 136.08 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 -173.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.33 175.53 9.5 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 125.495 1.518 . . . . 0.0 107.371 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -92.95 176.12 6.54 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 172.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.2 t -65.89 -3.92 5.98 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 120.03 -1.669 . . . . 0.0 113.442 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -86.02 -15.24 42.05 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 120.697 1.59 . . . . 0.0 110.41 173.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.08 -0.63 66.81 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.73 1.157 . . . . 0.0 111.964 -173.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -70.15 116.04 10.05 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 119.456 1.628 . . . . 0.0 108.346 174.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -64.66 141.95 58.59 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.915 1.686 . . . . 0.0 107.951 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.8 pt -140.07 -37.25 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 124.481 1.113 . . . . 0.0 113.71 -174.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -133.97 145.42 49.51 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -147.45 136.99 22.73 Favored 'General case' 0 CA--C 1.516 -0.354 0 O-C-N 121.339 -0.851 . . . . 0.0 109.269 -176.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 35.5 m -72.33 129.84 86.9 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 173.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.4 143.94 35.72 Favored 'Trans proline' 0 N--CA 1.444 -1.415 0 N-CA-C 108.302 -1.461 . . . . 0.0 108.302 175.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 28.3 mp0 -79.37 112.38 16.55 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -173.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.547 25.6 m-80 172.48 -4.52 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.513 1 C-N-CA 136.115 5.766 . . . . 0.0 112.121 173.472 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.66 86.45 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 123.428 1.585 . . . . 0.0 108.836 174.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.9 mm -133.98 139.39 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 127.747 2.419 . . . . 0.0 105.522 -173.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -122.98 167.13 13.99 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 173.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -129.85 113.55 14.79 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 -173.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 57.7 tttt -102.16 121.74 42.8 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 119.748 1.158 . . . . 0.0 108.715 -176.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 30.1 m -83.61 116.86 22.81 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 104.84 -2.281 . . . . 0.0 104.84 173.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 13.2 m -117.85 166.12 12.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.304 0.573 . . . . 0.0 110.315 174.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.5 pp -137.12 159.27 42.39 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.636 1.574 . . . . 0.0 107.359 173.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.61 132.59 45.69 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.236 1.014 . . . . 0.0 110.463 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -153.35 161.75 42.01 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.177 1.791 . . . . 0.0 108.68 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 . . . . . 0 C--O 1.255 1.357 0 C-N-CA 129.898 3.279 . . . . 0.0 105.109 173.723 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.6 m . . . . . 0 CA--C 1.544 0.728 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.1 tt -44.71 127.32 6.14 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.764 2.026 . . . . 0.0 113.487 -176.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -115.64 128.35 55.86 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.261 1.825 . . . . 0.0 109.185 174.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.93 118.07 11.27 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 127.135 2.174 . . . . 0.0 107.388 -178.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 9.0 p90 -133.81 170.89 14.92 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.184 0.994 . . . . 0.0 110.229 176.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.0 mp -108.02 115.15 48.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 102.187 -3.264 . . . . 0.0 102.187 173.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -82.2 142.52 32.11 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 123.32 1.533 . . . . 0.0 112.967 -173.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.62 -16.83 51.88 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.884 1.674 . . . . 0.0 115.32 -173.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 27.7 m80 -58.03 -35.34 71.16 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.51 1.05 . . . . 0.0 110.458 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -70.52 -46.64 63.26 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 122.313 -0.242 . . . . 0.0 111.052 177.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.97 -31.57 65.17 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 118.907 -0.568 . . . . 0.0 112.136 174.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.439 HH21 ' CD ' ' A' ' 28' ' ' GLU . 8.7 tpp85 . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 173.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.439 ' CD ' HH21 ' A' ' 22' ' ' ARG . 1.4 tp10 . . . . . 0 CA--C 1.528 0.132 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -153.02 113.28 3.99 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.693 1.197 . . . . 0.0 109.752 174.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -96.4 161.19 14.03 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 172.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.1 mm -138.65 113.39 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 173.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.31 113.89 20.41 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.4 mt -86.04 -65.6 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 32.0 t -114.73 114.23 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 -173.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.8 p -113.05 115.17 27.92 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 103.8 -2.667 . . . . 0.0 103.8 173.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.258 6.4 pt-20 44.43 45.97 7.74 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.689 1.195 . . . . 0.0 113.013 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 67.53 -7.28 2.09 Favored Glycine 0 CA--C 1.541 1.672 0 C-N-CA 125.804 1.669 . . . . 0.0 114.817 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -83.22 37.43 0.55 Allowed 'General case' 0 CA--C 1.539 0.533 1 C-N-CA 133.323 4.649 . . . . 0.0 109.022 -173.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 52.1 mtm -37.98 132.09 1.01 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 127.166 2.186 . . . . 0.0 114.54 -172.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.48 160.62 78.56 Favored Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.347 173.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.36 35.33 0.43 Allowed 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 124.215 3.277 . . . . 0.0 112.039 175.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -54.71 -26.59 34.82 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.481 1.913 . . . . 0.0 112.793 -173.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.7 m -48.82 -47.05 42.68 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 129.219 3.007 . . . . 0.0 112.861 -173.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -59.17 -59.08 6.04 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.258 1.023 . . . . 0.0 109.944 -175.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.298 47.0 m-20 -76.74 -27.93 55.58 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.289 -175.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -61.21 -50.52 72.78 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 120.91 -1.119 . . . . 0.0 108.767 173.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 . . . . . 0 C--N 1.346 0.426 0 CA-C-O 118.576 -0.726 . . . . 0.0 110.651 178.275 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 78.6 mmm . . . . . 0 CA--C 1.533 0.31 0 CA-C-O 117.549 -1.215 . . . . 0.0 113.936 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.52 -66.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 121.93 1.753 . . . . 0.0 113.482 -173.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.7 113.82 8.18 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.461 0.704 . . . . 0.0 110.238 -174.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 38.6 mt -124.35 132.15 24.27 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 126.421 1.888 . . . . 0.0 108.187 -173.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -80.04 157.83 23.68 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.854 2.369 . . . . 0.0 111.559 174.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.6 p -42.77 -43.49 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 127.058 2.143 . . . . 0.0 112.791 175.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -60.09 -34.19 73.13 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 126.29 1.836 . . . . 0.0 113.106 -174.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 mm -71.8 112.95 7.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 103.107 -2.923 . . . . 0.0 103.107 174.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 -94.75 -23.46 17.53 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.2 m -152.12 161.42 42.66 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.308 1.043 . . . . 0.0 108.59 173.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 16.8 mtm -126.19 156.96 39.37 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 173.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.252 59.8 m-20 -96.46 150.42 20.63 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 174.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -138.09 151.34 47.72 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 130.985 3.714 . . . . 0.0 101.799 172.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.4 m -137.35 130.65 31.0 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 -177.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -144.1 165.05 28.9 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.72 175.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -167.01 154.87 9.42 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.493 173.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.24 -174.51 2.37 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 123.403 1.573 . . . . 0.0 107.031 172.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.11 135.56 45.38 Favored 'General case' 0 N--CA 1.411 -2.375 0 C-N-CA 130.812 3.645 . . . . 0.0 101.873 173.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -7.45 -56.42 0.01 OUTLIER Glycine 0 CA--C 1.54 1.615 1 C-N-CA 133.801 5.477 . . . . 0.0 120.022 -173.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -116.93 9.89 13.9 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 121.207 2.504 . . . . 0.0 114.862 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -107.43 37.44 2.4 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 120.759 3.615 . . . . 0.0 120.759 -172.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -44.81 113.63 0.59 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 123.559 2.89 . . . . 0.0 110.601 -175.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -84.99 121.32 27.6 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -174.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -73.98 144.51 45.18 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 178.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -130.28 161.02 32.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 119.358 0.981 . . . . 0.0 110.781 176.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.57 133.94 14.4 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 173.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -84.01 103.23 13.09 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -176.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.5 tt -64.72 -40.46 95.38 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 125.566 1.546 . . . . 0.0 108.32 176.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.0 m -148.83 142.86 25.88 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 120.499 -1.376 . . . . 0.0 110.358 177.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.9 tt -164.94 93.02 0.61 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 101.658 -3.46 . . . . 0.0 101.658 173.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 42.1 mmm-85 -166.01 163.32 18.31 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.09 0.956 . . . . 0.0 110.646 -177.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.8 t -91.47 158.25 16.59 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.99 1.316 . . . . 0.0 113.792 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.0 mt -110.13 -26.46 9.66 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.256 -1.338 . . . . 0.0 111.261 177.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.428 ' CG ' ' H ' ' A' ' 87' ' ' LYS . 6.3 t70 -76.74 169.73 17.75 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 120.495 1.498 . . . . 0.0 109.349 -174.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.428 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 19.7 mmtm -131.1 -46.3 1.01 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.602 1.961 . . . . 0.0 111.307 -173.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.441 ' C ' ' H ' ' A' ' 90' ' ' MET . . . -70.38 -71.29 1.03 Allowed Glycine 0 CA--C 1.533 1.208 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 173.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.7 mp -70.04 12.19 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 129.805 3.242 . . . . 0.0 111.07 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.441 ' H ' ' C ' ' A' ' 88' ' ' GLY . 28.5 ttp -43.69 142.31 1.28 Allowed 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 128.304 2.642 . . . . 0.0 112.193 -174.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.252 . . -161.95 174.98 12.32 Favored 'General case' 0 N--CA 1.439 -0.976 1 C-N-CA 131.851 4.06 . . . . 0.0 104.492 -173.572 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -151.32 137.4 11.19 Favored Pre-proline 0 C--N 1.321 -0.661 0 C-N-CA 124.359 1.064 . . . . 0.0 110.014 172.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -71.7 157.86 54.65 Favored 'Trans proline' 0 N--CA 1.443 -1.496 0 C-N-CA 121.396 1.397 . . . . 0.0 109.081 173.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 20.2 p -142.75 161.94 36.76 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 126.916 2.087 . . . . 0.0 107.28 174.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.9 m -126.44 150.97 32.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 123.532 0.733 . . . . 0.0 110.738 174.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -82.86 15.73 2.57 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.441 1.497 . . . . 0.0 111.482 173.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.2 m -129.6 163.24 48.09 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 173.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -67.47 162.75 37.59 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 CA-C-N 119.659 0.914 . . . . 0.0 109.91 173.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.52 -6.73 8.03 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.811 1.244 . . . . 0.0 111.693 175.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -145.9 163.22 35.78 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.621 1.569 . . . . 0.0 107.249 173.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 162.13 -160.2 32.3 Favored Glycine 0 C--O 1.227 -0.294 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 80.7 p -120.82 146.41 46.57 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 173.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.0 t -87.45 113.68 55.23 Favored Pre-proline 0 N--CA 1.448 -0.549 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 173.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.42 ' C ' ' H ' ' A' ' 106' ' ' LYS . 89.6 Cg_endo -84.41 156.35 12.51 Favored 'Trans proline' 0 C--O 1.213 -0.736 0 C-N-CA 122.546 2.164 . . . . 0.0 112.402 -174.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -71.11 1.13 6.24 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 120.248 -1.532 . . . . 0.0 111.714 -174.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.42 ' H ' ' C ' ' A' ' 104' ' ' PRO . 1.8 mppt? -114.03 115.6 27.86 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 128.102 2.561 . . . . 0.0 108.125 -173.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -41.56 108.74 0.1 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.096 1.358 . . . . 0.0 110.056 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.7 m -119.25 139.34 52.05 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.61 118.9 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 114.447 -1.252 . . . . 0.0 108.621 -173.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 75.9 t -93.88 104.21 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 173.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -82.34 115.04 21.21 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 104.532 -2.396 . . . . 0.0 104.532 173.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.3 t -93.33 113.82 28.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 104.111 -2.551 . . . . 0.0 104.111 174.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -89.19 144.86 18.21 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 124.891 1.234 . . . . 0.0 110.33 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -129.63 73.6 81.41 Favored Pre-proline 0 C--O 1.244 0.769 0 CA-C-N 118.754 1.277 . . . . 0.0 111.052 -175.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.3 129.06 19.53 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.397 2.064 . . . . 0.0 109.117 173.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 5.7 t -105.82 154.61 20.28 Favored 'General case' 0 C--N 1.338 0.1 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 174.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.8 mt -71.96 -17.01 62.1 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.568 0.622 . . . . 0.0 111.593 177.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 50.65 39.19 37.7 Favored Glycine 0 C--O 1.219 -0.793 0 C-N-CA 127.336 2.398 . . . . 0.0 114.809 173.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 42.9 mttm -124.4 -28.0 3.69 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.724 1.762 . . . . 0.0 112.032 173.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.419 ' NE2' ' H ' ' A' ' 121' ' ' ASP . 53.4 tp60 -96.53 155.66 16.67 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 172.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.419 ' H ' ' NE2' ' A' ' 120' ' ' GLN . 15.0 m-20 -109.42 150.75 27.61 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 138.59 -154.23 22.97 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 174.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 19.0 t -124.77 114.19 39.46 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -88.6 168.47 12.53 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 173.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -131.6 142.38 49.88 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.561 1.145 . . . . 0.0 108.715 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -143.34 150.44 39.17 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 125.829 1.651 . . . . 0.0 108.194 174.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -129.95 164.64 23.79 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 119.671 1.123 . . . . 0.0 113.285 177.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 57.3 t -131.62 148.56 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 125.613 1.565 . . . . 0.0 108.512 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -155.66 132.96 10.88 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 125.978 1.711 . . . . 0.0 108.078 173.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 36.5 t -137.15 143.46 34.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -174.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.25 163.46 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 173.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.9 t -140.3 137.59 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 CA-C-N 114.185 -1.37 . . . . 0.0 107.337 -173.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.79 174.71 10.33 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 125.957 1.703 . . . . 0.0 107.619 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 45.0 p-10 -89.68 176.01 7.03 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 172.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.8 t -66.1 -3.6 5.82 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 120.098 -1.626 . . . . 0.0 113.484 -177.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -86.69 -17.7 33.09 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 120.613 1.551 . . . . 0.0 110.452 173.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 97.6 1.13 59.02 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.783 1.182 . . . . 0.0 112.251 -173.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 65.4 m-20 -72.29 115.14 11.18 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 119.608 1.704 . . . . 0.0 108.701 174.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.5 m -64.8 143.0 58.24 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.498 1.919 . . . . 0.0 108.624 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -141.29 -36.82 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 124.708 1.203 . . . . 0.0 113.973 -175.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -131.91 144.18 50.67 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -144.13 130.2 19.55 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 35.6 m -68.79 149.07 98.01 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 173.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -89.17 144.92 5.08 Favored 'Trans proline' 0 N--CA 1.444 -1.386 0 CA-C-N 120.84 1.336 . . . . 0.0 109.646 173.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -78.84 112.58 16.13 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 -174.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 172.99 -18.4 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 128.12 2.568 . . . . 0.0 114.331 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.9 79.06 0.12 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.999 0.92 . . . . 0.0 112.08 -173.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 3.3 mm -86.83 148.03 4.92 Favored 'Isoleucine or valine' 0 C--N 1.345 0.38 0 C-N-CA 127.341 2.256 . . . . 0.0 109.361 174.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -125.88 128.41 47.55 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 129.484 3.114 . . . . 0.0 103.12 173.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -102.49 113.26 26.46 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 178.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 56.1 tttt -103.1 121.58 42.9 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 28.9 m -83.38 114.65 21.58 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 174.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 21.8 m -113.09 165.5 12.31 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 119.01 0.823 . . . . 0.0 109.459 174.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.4 pp -141.75 161.61 37.52 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.067 1.347 . . . . 0.0 108.098 174.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.91 130.2 42.24 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.621 1.168 . . . . 0.0 111.843 178.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -144.06 170.34 16.12 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 128.239 2.616 . . . . 0.0 107.606 173.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 . . . . . 0 C--O 1.254 1.314 0 C-N-CA 128.881 2.872 . . . . 0.0 106.075 173.812 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.6 m . . . . . 0 CA--C 1.537 0.443 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.2 tt -42.99 121.91 2.26 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 127.132 2.173 . . . . 0.0 113.469 -173.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -111.76 139.84 46.9 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.265 2.226 . . . . 0.0 108.435 174.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.07 118.28 6.81 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 21.2 p90 -139.42 152.24 46.91 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 119.205 0.912 . . . . 0.0 109.58 177.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.8 mt -83.91 127.86 39.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 102.579 -3.119 . . . . 0.0 102.579 173.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -104.69 136.9 43.35 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 122.9 1.333 . . . . 0.0 111.856 -173.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.2 -22.38 66.88 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.206 -1.361 . . . . 0.0 113.891 -174.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -58.36 -37.9 76.15 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 119.564 1.075 . . . . 0.0 111.422 -173.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -71.19 -51.12 26.57 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 117.816 -1.088 . . . . 0.0 110.151 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.71 -41.73 61.72 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.034 0.834 . . . . 0.0 111.009 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 173.943 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.456 -0.168 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -162.16 126.45 3.21 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.067 2.147 . . . . 0.0 107.506 176.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -96.24 159.08 15.14 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 172.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.2 mp -135.56 113.17 14.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 173.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.67 114.13 18.35 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.8 mt -94.09 -57.06 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.1 t -125.95 141.27 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 C-N-CA 125.003 1.321 . . . . 0.0 108.901 -173.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.0 p -152.43 123.01 7.32 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 102.87 -3.011 . . . . 0.0 102.87 173.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 44.48 33.84 0.97 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.67 1.588 . . . . 0.0 113.818 -174.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.26 -8.82 6.25 Favored Glycine 0 CA--C 1.539 1.566 0 O-C-N 120.814 -1.179 . . . . 0.0 114.694 -177.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.2 ttmt -69.25 37.47 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.461 1 C-N-CA 132.941 4.496 . . . . 0.0 112.812 -177.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 43.0 mtt -38.1 133.04 0.95 Allowed 'General case' 0 C--O 1.233 0.229 0 C-N-CA 126.164 1.786 . . . . 0.0 114.767 -173.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.79 157.64 66.05 Favored Pre-proline 0 N--CA 1.448 -0.559 0 CA-C-N 113.512 -1.676 . . . . 0.0 107.859 173.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -74.27 37.69 0.45 Allowed 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 124.455 3.437 . . . . 0.0 112.192 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -52.61 -26.11 12.58 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 127.266 2.226 . . . . 0.0 113.493 -173.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.8 m -43.52 -51.95 6.46 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.757 2.023 . . . . 0.0 112.388 -174.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -58.28 -62.48 1.8 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.612 0.765 . . . . 0.0 110.569 -174.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.33 52.4 m-20 -76.84 -30.78 56.47 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -173.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.1 -51.7 68.02 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 120.659 -1.276 . . . . 0.0 107.971 173.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.3 ttt180 . . . . . 0 CA--C 1.537 0.468 0 CA-C-O 118.796 -0.621 . . . . 0.0 109.72 -177.842 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.438 0 CA-C-O 117.635 -1.174 . . . . 0.0 111.721 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -77.01 -73.92 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.835 0 CA-C-N 120.86 1.343 . . . . 0.0 113.313 -174.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.22 118.11 6.44 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.183 1.393 . . . . 0.0 114.034 -173.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.6 mt -132.09 120.77 17.4 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 127.154 2.181 . . . . 0.0 106.831 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -77.06 156.25 33.9 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.243 1.962 . . . . 0.0 111.124 -178.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.6 p -40.25 -46.84 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 127.834 2.454 . . . . 0.0 113.607 -178.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -63.23 -36.19 82.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 126.066 1.746 . . . . 0.0 113.091 -175.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.5 mm -69.06 113.05 4.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 103.454 -2.795 . . . . 0.0 103.454 174.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -79.57 -32.81 42.08 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.246 176.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.5 m -154.24 162.71 41.0 Favored 'General case' 0 C--N 1.335 -0.031 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -173.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 24.4 mtm -126.55 163.53 23.2 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 172.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -120.17 149.19 42.64 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 118.99 0.814 . . . . 0.0 108.857 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -125.58 156.55 38.95 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 102.898 -3.001 . . . . 0.0 102.898 173.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 m -138.31 135.91 35.9 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -176.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -145.72 159.97 42.4 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 121.593 -0.692 . . . . 0.0 111.053 178.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -165.74 151.99 9.53 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 121.966 0.889 . . . . 0.0 112.688 173.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -82.13 -173.53 4.57 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.504 1.122 . . . . 0.0 108.786 173.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.19 99.73 6.89 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 126.469 1.908 . . . . 0.0 109.368 -174.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 48.14 -60.17 0.0 OUTLIER Glycine 0 CA--C 1.539 1.536 0 C-N-CA 130.646 3.974 . . . . 0.0 119.619 173.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -116.77 -12.99 10.76 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 120.298 2.049 . . . . 0.0 114.354 175.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.7 37.28 0.58 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 130.015 3.326 . . . . 0.0 118.869 -173.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -52.38 113.66 1.12 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 123.058 2.663 . . . . 0.0 109.776 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -84.05 138.46 33.06 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.686 1.595 . . . . 0.0 106.885 174.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -85.61 149.37 25.38 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -133.52 160.1 38.44 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.905 1.23 . . . . 0.0 110.566 174.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -154.58 133.9 12.57 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 173.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -81.97 103.55 11.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.9 tt -64.47 -40.83 96.43 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 173.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 m -154.99 145.99 22.64 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 122.657 1.217 . . . . 0.0 111.739 174.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.54 92.81 2.05 Favored 'General case' 0 N--CA 1.451 -0.389 1 N-CA-C 97.606 -4.961 . . . . 0.0 97.606 173.191 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.01 150.78 27.7 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 120.452 -1.405 . . . . 0.0 114.559 -172.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.1 t -68.74 158.92 33.27 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.762 1.225 . . . . 0.0 111.464 173.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.3 mt -123.38 -26.25 4.29 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.983 1.713 . . . . 0.0 110.925 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.492 ' CG ' ' H ' ' A' ' 87' ' ' LYS . 7.9 t70 -79.09 176.09 9.98 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.791 1.178 . . . . 0.0 109.521 -174.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.492 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 23.4 mmtm -131.62 -50.54 0.98 Allowed 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 127.073 2.149 . . . . 0.0 110.928 -173.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' A' ' 90' ' ' MET . . . -69.48 -65.02 2.72 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 173.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.3 mp -76.63 25.59 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 C-N-CA 129.357 3.063 . . . . 0.0 110.395 -175.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.469 ' H ' ' C ' ' A' ' 88' ' ' GLY . 26.5 ttm -43.33 139.74 1.86 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 129.261 3.025 . . . . 0.0 111.803 -173.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.253 . . -168.14 173.62 7.8 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 130.177 3.391 . . . . 0.0 105.563 -173.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.412 10.4 m-20 -147.51 130.23 7.86 Favored Pre-proline 0 CA--C 1.509 -0.622 0 C-N-CA 127.435 2.294 . . . . 0.0 111.975 172.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.32 156.36 41.59 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 121.953 1.768 . . . . 0.0 109.649 173.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 23.4 p -136.59 158.6 44.07 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 126.524 1.93 . . . . 0.0 108.139 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.6 m -126.34 157.23 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 123.729 0.812 . . . . 0.0 111.222 176.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -79.99 9.77 5.05 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 127.325 2.25 . . . . 0.0 113.68 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.8 m -140.84 163.44 42.72 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 124.527 1.131 . . . . 0.0 109.914 -175.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -66.11 164.56 27.26 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.853 1.702 . . . . 0.0 110.277 173.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -63.16 -14.37 47.98 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 124.503 1.121 . . . . 0.0 112.7 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -143.33 164.78 29.3 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 120.133 1.333 . . . . 0.0 108.65 173.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 164.42 -162.92 35.79 Favored Glycine 0 C--O 1.228 -0.258 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 76.1 p -116.96 149.15 40.68 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 173.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 37.5 t -83.13 113.52 46.57 Favored Pre-proline 0 N--CA 1.448 -0.528 0 N-CA-C 103.635 -2.728 . . . . 0.0 103.635 173.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.414 ' C ' ' H ' ' A' ' 106' ' ' LYS . 45.8 Cg_endo -85.82 156.07 10.2 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.404 2.069 . . . . 0.0 112.176 -173.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -70.55 0.55 6.57 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 120.197 -1.564 . . . . 0.0 113.063 -175.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.414 ' H ' ' C ' ' A' ' 104' ' ' PRO . 0.0 OUTLIER -115.3 114.84 25.71 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 126.598 1.959 . . . . 0.0 106.951 -173.839 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -41.62 106.84 0.06 Allowed 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.693 1.597 . . . . 0.0 109.639 -178.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.4 m -112.21 137.46 50.28 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 178.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.5 t -96.75 114.18 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 114.099 -1.409 . . . . 0.0 108.703 -173.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 98.5 t -94.09 103.33 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 173.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -77.04 140.42 40.33 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 172.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.4 t -115.16 113.62 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 174.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -99.48 149.44 18.93 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 125.927 1.727 . . . . 0.0 109.603 -178.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.415 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 4.4 m-85 -132.3 73.89 76.74 Favored Pre-proline 0 C--O 1.244 0.788 0 CA-C-N 118.965 1.383 . . . . 0.0 112.479 -173.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -66.88 126.83 15.91 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.098 1.865 . . . . 0.0 109.135 173.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 5.7 t -104.82 153.37 21.42 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 124.565 1.146 . . . . 0.0 108.131 174.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.6 mt -74.5 -9.98 59.12 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.369 0.531 . . . . 0.0 111.867 178.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.7 5.93 3.16 Favored Glycine 0 C--O 1.22 -0.723 0 C-N-CA 128.458 2.933 . . . . 0.0 116.408 173.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 27.7 mmtm -93.61 -32.26 14.17 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.737 1.768 . . . . 0.0 113.114 -173.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.431 ' NE2' ' H ' ' A' ' 121' ' ' ASP . 59.4 tp60 -96.63 159.1 15.11 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 173.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.431 ' H ' ' NE2' ' A' ' 120' ' ' GLN . 13.1 m-20 -107.89 148.01 30.18 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.405 1.482 . . . . 0.0 107.197 176.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 140.21 -152.71 22.98 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 174.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.8 t -128.07 113.99 32.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -90.64 167.96 12.14 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 173.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -129.65 156.99 43.35 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 123.719 0.808 . . . . 0.0 109.464 173.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.415 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 3.8 p90 -147.95 151.0 35.07 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 126.801 2.04 . . . . 0.0 105.896 173.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -137.71 173.2 11.9 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 175.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 97.0 t -128.95 147.3 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 124.789 1.236 . . . . 0.0 111.276 -173.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -146.67 120.02 8.99 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 127.666 2.387 . . . . 0.0 106.44 173.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 23.3 t -138.2 124.2 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -177.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.411 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -90.43 164.83 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 106.635 -1.616 . . . . 0.0 106.635 173.695 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.4 t -144.71 132.34 16.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -176.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.73 174.02 11.03 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.475 1.11 . . . . 0.0 108.581 -174.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 32.1 p-10 -88.28 176.06 7.39 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 172.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.1 t -68.09 -6.78 24.69 Favored 'General case' 0 CA--C 1.551 1.015 0 O-C-N 120.659 -1.276 . . . . 0.0 112.286 -175.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -86.32 -14.69 42.87 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 120.59 -1.319 . . . . 0.0 110.606 173.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.42 4.16 62.62 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.736 1.16 . . . . 0.0 112.386 -173.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -75.9 117.55 17.75 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 119.811 1.805 . . . . 0.0 108.952 175.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.4 m -66.98 146.82 53.97 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.96 1.704 . . . . 0.0 110.021 -176.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.84 -35.68 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.868 1.267 . . . . 0.0 113.616 178.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -133.08 148.74 52.17 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -176.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -146.52 150.01 34.72 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 174.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.6 m -102.79 113.81 65.67 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -73.91 154.13 47.96 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.16 1.907 . . . . 0.0 113.105 -173.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -69.49 112.52 6.06 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 102.122 -3.288 . . . . 0.0 102.122 173.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 44.7 m-20 173.35 -30.79 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 130.821 3.649 . . . . 0.0 107.138 -173.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.58 66.6 0.08 Allowed 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 126.842 2.057 . . . . 0.0 109.157 174.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.4 mt -95.62 147.72 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 C-N-CA 126.074 1.75 . . . . 0.0 108.141 176.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.4 ' HB2' ' CE2' ' A' ' 126' ' ' PHE . 20.1 m-85 -130.88 150.61 51.96 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 173.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -127.21 113.36 16.24 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 -173.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 46.5 tttt -101.8 123.22 45.39 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.48 -0.934 . . . . 0.0 108.48 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 39.0 m -83.34 119.93 25.23 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 173.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 11.1 m -114.69 159.66 20.26 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 173.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.2 pp -143.44 160.58 40.32 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 174.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -56.56 114.11 1.9 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 127.999 2.52 . . . . 0.0 111.795 -174.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -133.89 174.83 10.04 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 127.833 2.453 . . . . 0.0 108.6 175.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 . . . . . 0 C--O 1.252 1.191 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 173.458 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.5 m . . . . . 0 CA--C 1.542 0.667 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.1 tt -47.06 132.71 11.97 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.994 1.27 . . . . 0.0 112.22 -173.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -121.26 129.94 53.41 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.073 1.349 . . . . 0.0 109.58 176.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.4 117.91 8.55 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 5.5 p90 -131.19 175.38 9.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.174 0.99 . . . . 0.0 110.257 174.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.0 mp -115.41 118.28 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 102.997 -2.964 . . . . 0.0 102.997 173.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -89.59 144.6 25.88 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 123.312 1.53 . . . . 0.0 112.487 -173.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.416 ' CB ' ' H ' ' A' ' 29' ' ' GLU . . . -59.53 -6.8 1.19 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 128.341 2.656 . . . . 0.0 115.491 -175.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 62.2 m80 -61.8 -34.06 75.24 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 120.584 1.538 . . . . 0.0 111.638 -177.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -67.35 -41.16 85.62 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.231 176.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.78 -36.32 83.49 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.545 1.138 . . . . 0.0 111.075 173.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.0 ttm-85 . . . . . 0 N--CA 1.447 -0.615 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 173.865 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.416 ' H ' ' CB ' ' A' ' 18' ' ' ALA . 30.9 mt-10 -149.29 112.64 4.97 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.446 0.566 . . . . 0.0 110.017 173.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -97.1 163.11 13.07 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 172.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.3 mp -141.1 113.15 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 103.855 -2.646 . . . . 0.0 103.855 172.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.63 114.11 23.07 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.9 mt -85.45 -58.45 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 118.543 0.61 . . . . 0.0 109.495 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.1 t -123.96 114.1 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 126.757 2.023 . . . . 0.0 106.9 -173.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.6 p -117.48 118.22 31.58 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 173.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.308 1.2 pm0 44.31 52.4 7.24 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.329 1.052 . . . . 0.0 111.121 -173.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.75 -12.95 4.42 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 126.78 2.133 . . . . 0.0 115.935 175.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -67.83 37.79 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.484 1 C-N-CA 132.963 4.505 . . . . 0.0 114.487 -174.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 30.9 mtm -37.83 116.56 0.51 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.876 1.216 . . . . 0.0 112.835 -172.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.67 161.07 22.46 Favored Pre-proline 0 N--CA 1.447 -0.612 0 CA-C-N 113.746 -1.57 . . . . 0.0 109.491 177.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -73.98 27.54 0.33 Allowed 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.699 2.933 . . . . 0.0 111.994 174.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -56.11 -26.68 50.85 Favored 'General case' 0 C--N 1.345 0.409 0 C-N-CA 124.862 1.265 . . . . 0.0 110.616 -174.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 m -45.54 -43.77 12.18 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 129.29 3.036 . . . . 0.0 110.725 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 53.0 t60 -63.65 -55.34 24.31 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.0 0.52 . . . . 0.0 110.707 -177.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -76.1 -26.76 56.75 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -175.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -68.13 -40.36 82.49 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.122 0.969 . . . . 0.0 109.634 173.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.548 0.894 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 175.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 1.1 mtp . . . . . 0 CA--C 1.534 0.362 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -75.2 -75.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.021 0 CA-C-N 121.13 1.439 . . . . 0.0 111.366 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.28 113.63 14.05 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.761 0.824 . . . . 0.0 111.829 -173.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 89.4 mt -120.35 130.43 24.85 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 128.464 2.706 . . . . 0.0 105.988 -174.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -83.05 159.32 15.56 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.491 2.127 . . . . 0.0 110.593 174.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.0 p -46.99 -34.61 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 125.715 1.606 . . . . 0.0 112.744 174.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.41 -34.19 72.17 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.509 1.524 . . . . 0.0 111.763 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.6 mm -92.15 112.83 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 102.985 -2.968 . . . . 0.0 102.985 174.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -82.86 -31.26 28.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.354 178.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.3 m -148.05 164.26 34.38 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.339 1.056 . . . . 0.0 110.422 -173.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 36.4 mtm -126.78 149.56 49.59 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 172.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -94.12 149.09 21.55 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 174.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -134.11 158.06 44.57 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 102.567 -3.123 . . . . 0.0 102.567 172.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.3 m -142.82 134.38 26.46 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 -178.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -144.53 169.02 18.76 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.248 0.546 . . . . 0.0 110.092 174.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -166.73 145.75 5.44 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.763 173.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.42 -173.3 1.36 Allowed 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 124.16 1.933 . . . . 0.0 105.864 172.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . 0.264 . . -112.42 121.26 44.34 Favored 'General case' 0 N--CA 1.408 -2.535 1 C-N-CA 131.922 4.089 . . . . 0.0 105.767 -179.084 . . . . . . . . 3 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 20.22 -73.65 0.0 OUTLIER Glycine 0 CA--C 1.536 1.358 1 C-N-CA 133.654 5.407 . . . . 0.0 119.079 178.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -116.25 -14.73 11.07 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 120.415 2.108 . . . . 0.0 112.41 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.81 37.48 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 131.339 3.856 . . . . 0.0 116.641 -173.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -38.17 114.16 0.34 Allowed 'General case' 0 C--O 1.237 0.446 0 CA-C-N 121.684 2.038 . . . . 0.0 114.719 -173.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -94.53 116.33 28.65 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 104.682 -2.34 . . . . 0.0 104.682 173.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -79.67 148.68 31.51 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 175.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -129.94 158.27 40.02 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 119.645 1.111 . . . . 0.0 109.861 174.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.49 134.26 12.91 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 173.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -89.16 102.99 15.65 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -175.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.6 tt -68.07 -41.38 82.02 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.518 1.527 . . . . 0.0 107.829 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 m -154.24 135.08 13.71 Favored 'General case' 0 N--CA 1.444 -0.734 0 O-C-N 120.645 -1.285 . . . . 0.0 110.829 179.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.463 ' H ' ' HD3' ' A' ' 83' ' ' ARG . 0.3 OUTLIER -151.99 93.15 1.8 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 101.428 -3.545 . . . . 0.0 101.428 173.508 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.463 ' HD3' ' H ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -156.94 157.17 34.31 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 120.863 1.665 . . . . 0.0 111.352 -178.319 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -78.87 152.99 30.92 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-O 121.549 0.69 . . . . 0.0 109.826 173.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.9 mt -106.91 -17.59 14.15 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.437 1.495 . . . . 0.0 110.721 174.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -90.29 163.23 14.83 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 174.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -139.8 -31.32 0.67 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.164 1.786 . . . . 0.0 112.998 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -64.12 -63.88 4.04 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 106.654 -2.579 . . . . 0.0 106.654 172.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.8 mp -75.78 22.0 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 129.993 3.317 . . . . 0.0 110.23 175.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.4 ttp -43.11 130.79 4.52 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 125.923 2.773 . . . . 0.0 113.26 -173.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -150.55 147.87 27.98 Favored 'General case' 0 N--CA 1.419 -2.014 2 C-N-CA 135.108 5.363 . . . . 0.0 100.86 173.95 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.276 5.4 m-20 -136.74 117.36 10.99 Favored Pre-proline 0 C--N 1.315 -0.931 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 173.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -67.63 158.16 58.43 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 123.033 2.489 . . . . 0.0 114.133 -173.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 32.8 p -136.11 164.52 27.84 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.248 1.819 . . . . 0.0 109.006 177.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.6 m -126.41 159.98 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 123.855 0.862 . . . . 0.0 111.295 175.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -80.1 10.46 4.35 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 127.171 2.188 . . . . 0.0 113.346 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.4 m -140.91 163.76 40.51 Favored Pre-proline 0 C--N 1.328 -0.341 0 C-N-CA 124.168 0.987 . . . . 0.0 110.288 -174.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -65.43 160.12 44.3 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 121.626 1.551 . . . . 0.0 108.836 173.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -67.19 -10.11 47.05 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 123.558 0.743 . . . . 0.0 112.264 -178.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -146.83 163.91 34.54 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 120.543 1.52 . . . . 0.0 108.338 173.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 159.19 -163.15 33.2 Favored Glycine 0 C--O 1.227 -0.298 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 177.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 70.1 p -114.9 146.03 41.56 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 173.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.3 t -77.56 122.42 85.83 Favored Pre-proline 0 CA--C 1.541 0.622 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 177.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.81 148.54 46.4 Favored 'Trans proline' 0 C--O 1.216 -0.577 0 C-N-CA 121.797 1.665 . . . . 0.0 111.749 -175.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 72.9 m-70 -63.82 -24.35 67.72 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 -172.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . 0.515 1.0 OUTLIER -116.71 150.68 37.8 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.781 1.173 . . . . 0.0 111.914 173.141 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -38.49 115.49 0.46 Allowed 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 128.387 2.675 . . . . 0.0 114.404 -172.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 44.6 m -128.69 141.49 51.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 173.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 17.1 t -94.02 122.32 45.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 124.701 1.2 . . . . 0.0 110.196 -173.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.8 t -103.72 103.5 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 173.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -81.03 141.25 34.57 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 173.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.2 t -110.27 113.86 45.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 103.525 -2.768 . . . . 0.0 103.525 174.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -95.67 151.34 19.96 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 125.091 1.329 . . . . 0.0 109.925 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -131.4 72.96 80.47 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.14 125.93 14.31 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.634 1.556 . . . . 0.0 108.471 176.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 5.3 t -105.47 156.99 17.68 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.2 mt -81.16 -8.87 59.84 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.167 0.44 . . . . 0.0 111.713 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.39 28.13 61.6 Favored Glycine 0 C--N 1.339 0.702 0 C-N-CA 126.06 1.791 . . . . 0.0 116.149 173.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 51.4 mttt -122.34 -30.72 3.93 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.938 1.869 . . . . 0.0 114.128 177.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.432 ' NE2' ' H ' ' A' ' 121' ' ' ASP . 57.5 tp60 -96.34 154.88 17.01 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 173.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.432 ' H ' ' NE2' ' A' ' 120' ' ' GLN . 7.3 m-20 -111.17 148.95 31.65 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 138.1 -156.33 23.82 Favored Glycine 0 C--N 1.332 0.361 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 176.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.4 t -122.52 113.7 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -89.45 156.98 18.31 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 173.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -117.62 158.56 24.42 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.805 0.842 . . . . 0.0 110.504 177.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.416 ' CE2' ' HB2' ' A' ' 149' ' ' PHE . 5.7 p90 -150.01 150.78 32.28 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 119.024 0.829 . . . . 0.0 109.2 173.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -123.15 156.4 35.11 Favored 'General case' 0 C--O 1.25 1.116 0 C-N-CA 125.126 1.37 . . . . 0.0 110.678 -174.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 26.6 t -137.79 140.26 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 O-C-N 125.437 1.711 . . . . 0.0 110.862 -177.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -150.61 120.59 7.16 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.931 2.493 . . . . 0.0 105.619 173.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 47.3 t -136.7 119.9 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.467 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -84.55 166.21 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 174.155 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.9 t -141.37 133.33 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 179.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.85 175.98 8.6 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 177.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -96.95 154.16 17.47 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 102.705 -3.072 . . . . 0.0 102.705 172.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.7 t -62.89 -15.86 56.6 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 120.72 -1.238 . . . . 0.0 110.573 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -69.51 -6.36 30.16 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 127.113 2.165 . . . . 0.0 111.914 173.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 99.45 20.25 18.11 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 118.192 2.037 . . . . 0.0 118.192 173.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -124.19 124.46 42.51 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 120.642 2.221 . . . . 0.0 110.071 -173.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.0 m -64.66 142.04 58.56 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 174.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.7 pt -140.51 -37.3 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 124.422 1.089 . . . . 0.0 113.813 -173.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -139.49 154.04 47.63 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 -174.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -154.83 144.52 21.49 Favored 'General case' 0 C--N 1.334 -0.102 0 O-C-N 121.025 -1.047 . . . . 0.0 108.9 174.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 26.8 m -67.77 114.56 20.71 Favored Pre-proline 0 N--CA 1.454 -0.264 0 N-CA-C 104.017 -2.586 . . . . 0.0 104.017 173.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -66.29 146.17 80.17 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 CA-C-N 120.251 1.125 . . . . 0.0 113.167 -173.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -73.45 112.95 10.0 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 173.0 -26.96 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.398 1 C-N-CA 134.792 5.237 . . . . 0.0 109.234 173.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.06 87.12 0.01 OUTLIER 'General case' 0 C--O 1.238 0.475 0 C-N-CA 126.251 1.821 . . . . 0.0 111.384 -174.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.9 mt -123.56 136.75 59.06 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.709 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 173.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.416 ' HB2' ' CE2' ' A' ' 126' ' ' PHE . 0.2 OUTLIER -116.06 164.58 14.25 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 126.263 2.227 . . . . 0.0 107.08 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -140.63 113.56 8.32 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.684 1.194 . . . . 0.0 108.349 -173.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -104.43 128.52 52.33 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 119.427 1.012 . . . . 0.0 108.638 174.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 24.4 m -83.51 114.18 21.32 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 174.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 56.2 m -108.41 165.83 11.22 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 173.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.3 pp -142.9 161.5 37.94 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.054 1.342 . . . . 0.0 108.423 174.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -68.04 122.37 18.1 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.404 1.882 . . . . 0.0 110.289 174.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -153.83 123.08 6.52 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.724 1.21 . . . . 0.0 110.218 174.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 . . . . . 0 C--O 1.255 1.371 0 C-N-CA 128.877 2.871 . . . . 0.0 105.806 173.68 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 CA--C 1.533 0.309 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.7 tt -43.33 128.21 4.74 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.945 2.098 . . . . 0.0 111.929 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -113.04 137.58 51.2 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.917 1.687 . . . . 0.0 107.94 173.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.67 116.25 7.63 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 9.8 p90 -129.85 175.83 8.53 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.937 0.895 . . . . 0.0 109.429 175.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -114.07 120.11 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 103.006 -2.961 . . . . 0.0 103.006 174.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -83.43 144.81 29.35 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 123.355 1.55 . . . . 0.0 114.746 -173.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.52 -16.48 60.85 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.521 1.928 . . . . 0.0 114.985 -174.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -55.89 -35.02 66.07 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.455 0.57 . . . . 0.0 109.488 174.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -75.74 -44.94 39.22 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.06 -33.94 63.15 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.523 0.729 . . . . 0.0 111.019 174.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 25.8 ttm105 . . . . . 0 N--CA 1.447 -0.587 0 O-C-N 121.2 -0.938 . . . . 0.0 108.841 173.544 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 . . . . . 0 CA--C 1.534 0.361 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -153.93 113.55 3.81 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.311 1.445 . . . . 0.0 109.585 -178.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -94.74 165.76 12.33 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 173.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.1 mp -141.07 113.39 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 174.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.59 122.54 29.18 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -177.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.2 mt -94.97 -65.3 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 119.027 0.831 . . . . 0.0 109.019 177.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.4 t -113.15 113.6 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 -173.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.5 p -109.22 113.58 26.55 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 103.613 -2.736 . . . . 0.0 103.613 173.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.284 18.1 pm0 44.43 40.87 4.14 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.77 1.628 . . . . 0.0 113.235 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.91 -6.76 8.74 Favored Glycine 0 CA--C 1.543 1.785 0 C-N-CA 124.768 1.175 . . . . 0.0 114.466 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -86.39 37.63 0.74 Allowed 'General case' 0 CA--C 1.539 0.554 1 C-N-CA 134.387 5.075 . . . . 0.0 108.114 -174.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 62.6 mtp -37.66 131.74 0.94 Allowed 'General case' 0 C--O 1.234 0.253 0 C-N-CA 128.427 2.691 . . . . 0.0 115.301 -172.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.6 159.39 85.21 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-N 113.464 -1.698 . . . . 0.0 109.056 173.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -76.46 41.28 0.86 Allowed 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 124.53 3.486 . . . . 0.0 111.783 175.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -54.89 -26.29 34.82 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.443 1.897 . . . . 0.0 112.802 -174.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.5 m -53.14 -33.09 50.9 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 127.201 2.2 . . . . 0.0 112.074 -173.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -62.9 -66.25 0.57 Allowed 'General case' 0 C--N 1.344 0.368 0 CA-C-N 119.201 0.91 . . . . 0.0 109.748 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.9 -35.37 74.72 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -177.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -63.87 -44.56 92.71 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 125.081 1.488 . . . . 0.0 110.092 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 48.7 tpt85 . . . . . 0 C--O 1.238 0.452 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -176.003 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 98.1 mmm . . . . . 0 CA--C 1.534 0.365 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -61.33 -71.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.687 0 CA-C-N 121.457 1.556 . . . . 0.0 114.048 -173.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.39 119.81 19.99 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.495 0.718 . . . . 0.0 110.357 -174.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 96.0 mt -123.92 127.92 25.27 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 128.226 2.61 . . . . 0.0 106.134 -175.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -84.59 161.22 12.55 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 122.755 2.304 . . . . 0.0 111.565 174.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.5 p -47.11 -37.0 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 125.281 1.432 . . . . 0.0 112.667 173.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -53.25 -37.7 62.34 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.612 1.565 . . . . 0.0 111.968 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.2 mm -83.23 112.81 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 102.992 -2.966 . . . . 0.0 102.992 173.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -79.39 -40.6 29.7 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 173.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.2 m -141.81 157.89 44.46 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.989 1.716 . . . . 0.0 109.572 -173.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 2.8 mmm -117.75 147.91 42.54 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 173.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -94.49 156.42 16.47 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 173.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -141.23 155.18 46.06 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 129.506 3.122 . . . . 0.0 102.701 172.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.2 m -139.05 133.35 31.51 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -177.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -145.93 162.59 37.43 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.404 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -163.24 146.17 10.37 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 173.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.04 -177.16 5.46 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 173.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -115.09 95.98 5.46 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.989 1.316 . . . . 0.0 109.206 -173.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.67 -89.69 0.03 OUTLIER Glycine 0 CA--C 1.534 1.254 0 C-N-CA 126.128 1.823 . . . . 0.0 115.979 173.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . 0.263 5.5 mm-40 -117.12 26.14 9.99 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.542 1.937 . . . . 0.0 114.462 174.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -94.91 37.25 1.15 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.839 2.456 . . . . 0.0 112.215 177.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -38.9 113.4 0.3 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.802 1.641 . . . . 0.0 112.515 -173.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -106.36 129.98 54.27 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.157 1.783 . . . . 0.0 107.695 175.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -91.53 150.58 21.14 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 176.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -131.93 160.22 36.39 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 119.726 1.148 . . . . 0.0 110.236 174.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -155.37 135.49 13.02 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 173.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -84.14 103.55 13.45 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.9 tt -65.24 -37.55 87.59 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 174.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.7 m -155.01 144.92 21.62 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 120.687 -1.258 . . . . 0.0 111.816 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.441 ' H ' ' HD3' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -156.24 93.52 1.42 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 102.678 -3.082 . . . . 0.0 102.678 173.573 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.441 ' HD3' ' H ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -154.21 158.64 40.6 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 121.206 1.821 . . . . 0.0 111.779 -178.184 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.1 t -71.72 167.65 19.43 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.915 0.886 . . . . 0.0 112.982 173.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.9 mt -126.69 -9.45 6.16 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 126.603 1.961 . . . . 0.0 114.308 174.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.564 ' CG ' ' H ' ' A' ' 87' ' ' LYS 0.309 13.3 t70 -96.43 170.67 9.07 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 122.01 2.186 . . . . 0.0 112.095 -173.721 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.564 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 1.3 mppt? -114.65 -53.01 2.68 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 129.16 2.984 . . . . 0.0 110.223 -173.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.495 ' C ' ' H ' ' A' ' 90' ' ' MET . . . -82.1 -58.62 2.44 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 125.052 1.31 . . . . 0.0 110.643 178.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mp -79.19 25.5 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 126.164 1.786 . . . . 0.0 110.376 -175.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.495 ' H ' ' C ' ' A' ' 88' ' ' GLY . 27.3 ttm -43.4 131.41 4.85 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 130.144 3.377 . . . . 0.0 109.292 -178.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -165.19 160.23 18.34 Favored 'General case' 0 N--CA 1.438 -1.028 1 C-N-CA 131.916 4.086 . . . . 0.0 103.785 -173.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.269 5.7 m-20 -138.16 124.84 13.17 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 118.618 0.644 . . . . 0.0 111.359 173.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -70.08 142.42 46.45 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 122.035 1.824 . . . . 0.0 110.273 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.8 p -131.87 162.09 31.43 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.938 1.695 . . . . 0.0 108.726 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.4 m -126.14 153.37 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 119.176 0.898 . . . . 0.0 112.353 -174.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -79.27 9.67 4.41 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 127.335 2.254 . . . . 0.0 113.337 177.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.5 m -144.24 164.21 30.32 Favored Pre-proline 0 C--N 1.327 -0.376 0 C-N-CA 124.725 1.21 . . . . 0.0 109.603 -174.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -66.9 161.76 40.88 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 121.25 1.3 . . . . 0.0 109.348 173.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -65.57 -7.68 16.0 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.237 1.015 . . . . 0.0 112.192 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -144.47 164.12 31.81 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.372 1.469 . . . . 0.0 108.335 173.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.66 -161.37 34.12 Favored Glycine 0 C--O 1.226 -0.357 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.5 p -125.89 139.17 53.68 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.8 t -74.3 114.34 32.54 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -78.84 150.15 23.62 Favored 'Trans proline' 0 C--O 1.211 -0.845 0 C-N-CA 121.969 1.779 . . . . 0.0 111.583 -174.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.408 ' H ' ' CD2' ' A' ' 105' ' ' HIS . 6.2 m-70 -78.29 4.09 13.76 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 119.726 -1.859 . . . . 0.0 113.98 -173.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.83 127.24 54.11 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 173.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -43.94 110.68 0.22 Allowed 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 126.501 1.921 . . . . 0.0 109.806 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.3 m -119.21 140.45 50.19 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.7 t -94.87 117.52 38.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 C-N-CA 124.953 1.301 . . . . 0.0 108.97 -173.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.6 t -100.09 104.44 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 173.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -82.11 149.01 28.23 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 173.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.5 t -122.49 113.56 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 104.035 -2.579 . . . . 0.0 104.035 175.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -89.37 147.84 19.75 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.506 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 7.0 m-85 -127.73 73.53 78.52 Favored Pre-proline 0 C--O 1.242 0.706 0 CA-C-N 118.156 0.978 . . . . 0.0 109.472 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.28 123.5 10.95 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.681 2.254 . . . . 0.0 107.55 173.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 7.3 t -105.95 152.82 22.83 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.253 1.021 . . . . 0.0 108.717 178.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mt -72.02 -14.95 62.02 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 117.953 0.342 . . . . 0.0 111.409 176.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 54.21 42.91 74.1 Favored Glycine 0 C--O 1.22 -0.77 0 C-N-CA 126.479 1.99 . . . . 0.0 113.827 173.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . 0.282 27.4 mttp -125.39 -34.05 2.75 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.733 1.766 . . . . 0.0 113.551 176.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 50.2 tp60 -96.04 142.06 28.7 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 104.043 -2.576 . . . . 0.0 104.043 172.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -93.97 141.01 29.01 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 142.64 -154.73 25.39 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.7 t -129.2 114.11 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -175.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.73 168.82 12.63 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 173.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -125.6 157.75 36.37 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 123.963 0.905 . . . . 0.0 108.888 173.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.506 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 12.4 p90 -149.89 160.87 43.25 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 173.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -140.42 160.22 40.48 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 124.454 1.102 . . . . 0.0 111.444 -173.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 83.0 t -139.46 146.94 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 126.205 1.802 . . . . 0.0 109.51 -174.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -150.63 122.85 8.33 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 127.892 2.477 . . . . 0.0 105.784 173.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.8 t -135.87 123.74 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.413 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -91.02 165.38 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 173.552 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.8 t -144.99 134.31 18.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 -176.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.77 164.7 29.25 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.605 -174.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.408 ' C ' HD21 ' A' ' 134' ' ' ASN . 0.1 OUTLIER -79.31 166.77 21.76 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 104.104 -2.554 . . . . 0.0 104.104 172.746 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.3 t -60.69 -12.66 11.08 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 120.96 1.709 . . . . 0.0 115.612 -173.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -80.46 -12.08 59.6 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 121.113 1.779 . . . . 0.0 112.303 173.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.23 -3.54 54.85 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.824 1.202 . . . . 0.0 114.117 -174.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -66.91 117.17 8.63 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 120.037 1.919 . . . . 0.0 108.648 177.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -71.81 143.83 49.35 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.681 0.792 . . . . 0.0 108.932 -176.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -138.74 -37.88 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.504 1.122 . . . . 0.0 113.516 -175.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -133.81 147.83 51.27 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 -177.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 10.3 tm0? -147.87 147.03 29.33 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.927 0.891 . . . . 0.0 108.959 174.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 23.5 m -80.67 113.74 42.38 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 176.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.17 147.5 91.31 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 121.202 1.268 . . . . 0.0 110.904 -173.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -79.54 112.24 16.61 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 -174.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.625 37.3 m-80 172.12 -8.13 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.524 1 C-N-CA 134.876 5.271 . . . . 0.0 112.214 172.991 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.74 79.93 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.362 1.465 . . . . 0.0 108.687 174.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.3 mt -117.03 148.72 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 C-N-CA 127.189 2.196 . . . . 0.0 106.316 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -133.88 164.84 26.37 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.015 -1.448 . . . . 0.0 107.182 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -137.4 113.53 9.91 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.017 1.327 . . . . 0.0 107.602 -173.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.12 120.4 41.17 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 119.313 0.96 . . . . 0.0 108.765 -175.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.9 m -84.14 116.59 22.98 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 -177.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 6.9 m -113.09 166.17 11.68 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.832 0.853 . . . . 0.0 109.261 173.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.3 pp -136.88 163.5 30.53 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.845 1.258 . . . . 0.0 108.198 173.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -72.42 121.33 19.38 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 128.258 2.623 . . . . 0.0 110.817 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -146.17 170.35 16.9 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 127.304 2.242 . . . . 0.0 109.387 177.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 . . . . . 0 C--O 1.257 1.489 0 C-N-CA 131.162 3.785 . . . . 0.0 104.339 173.822 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.5 m . . . . . 0 CA--C 1.537 0.448 0 CA-C-O 121.624 0.726 . . . . 0.0 111.296 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.7 tt -86.39 136.56 33.08 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 128.81 2.844 . . . . 0.0 109.775 178.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -127.72 138.97 52.95 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.857 1.663 . . . . 0.0 108.412 173.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.39 117.6 7.33 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 -176.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 14.1 p90 -130.78 171.18 13.42 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.683 0.793 . . . . 0.0 110.518 177.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.1 mt -108.75 135.18 48.37 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 N-CA-C 103.591 -2.744 . . . . 0.0 103.591 174.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -91.79 159.96 15.55 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 122.577 1.18 . . . . 0.0 113.164 -173.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.423 ' CB ' ' H ' ' A' ' 29' ' ' GLU . . . -76.89 -13.79 59.95 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.119 1.767 . . . . 0.0 113.99 175.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 31.6 m80 -59.4 -38.74 81.34 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 120.615 1.552 . . . . 0.0 109.058 175.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -64.08 -46.02 86.15 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.925 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.46 -31.85 73.15 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 123.244 0.618 . . . . 0.0 112.261 175.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.407 HH21 ' CD ' ' A' ' 28' ' ' GLU . 26.5 ttm180 . . . . . 0 N--CA 1.447 -0.619 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 174.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.407 ' CD ' HH21 ' A' ' 22' ' ' ARG . 16.2 tp10 . . . . . 0 N--CA 1.454 -0.225 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.423 ' H ' ' CB ' ' A' ' 18' ' ' ALA . 80.5 mt-10 -155.14 113.31 3.46 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 118.419 -0.8 . . . . 0.0 112.275 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -96.25 165.12 12.37 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 122.35 2.341 . . . . 0.0 105.765 172.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 79.2 mt -140.26 113.17 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 173.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.81 114.22 24.22 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 -177.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.4 mt -92.44 -53.16 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 118.825 0.738 . . . . 0.0 109.661 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -123.44 113.81 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 -173.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.9 p -112.96 122.66 48.3 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 173.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 44.32 44.39 6.68 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.093 1.357 . . . . 0.0 112.602 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.32 4.72 1.32 Allowed Glycine 0 CA--C 1.536 1.371 0 C-N-CA 127.121 2.296 . . . . 0.0 114.743 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.97 37.28 0.48 Allowed 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 129.875 3.27 . . . . 0.0 111.426 -172.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 34.3 mtt -38.12 116.46 0.52 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 126.339 1.855 . . . . 0.0 114.381 -173.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.34 160.55 75.19 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 173.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.7 65.67 5.77 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 124.134 3.223 . . . . 0.0 109.685 175.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -62.17 -12.33 19.28 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 126.999 2.119 . . . . 0.0 114.77 -173.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 56.8 m -43.69 -48.51 7.88 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 126.049 1.739 . . . . 0.0 113.185 -173.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -59.63 -59.51 5.33 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 118.379 0.536 . . . . 0.0 110.325 -176.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.321 49.0 m-20 -76.04 -23.26 55.13 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -173.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -75.57 -58.04 3.52 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.714 1.143 . . . . 0.0 108.645 173.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 . . . . . 0 CA--C 1.539 0.522 0 O-C-N 121.291 -0.88 . . . . 0.0 110.983 -173.65 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.37 0 CA-C-O 116.85 -1.548 . . . . 0.0 113.411 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.01 -79.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.875 0 CA-C-N 122.152 1.804 . . . . 0.0 111.462 -174.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.09 113.47 20.64 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.612 0.765 . . . . 0.0 109.062 -174.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.5 mt -110.64 126.22 29.24 Favored Pre-proline 0 C--N 1.323 -0.566 0 C-N-CA 127.158 2.183 . . . . 0.0 105.437 -175.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.3 156.36 37.27 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.562 1.508 . . . . 0.0 110.216 178.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.0 p -42.11 -44.79 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 126.354 1.862 . . . . 0.0 112.194 174.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -61.43 -36.04 79.24 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 126.354 1.861 . . . . 0.0 113.159 -176.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 mm -75.63 112.65 13.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 101.309 -3.589 . . . . 0.0 101.309 173.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -79.25 -36.6 39.65 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.997 178.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.6 m -144.78 170.69 15.62 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 124.125 0.891 . . . . 0.0 111.953 -173.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 62.9 mtp -125.87 156.85 38.98 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 172.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -121.81 113.56 19.84 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -174.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -99.95 162.68 12.84 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 173.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.8 m -141.59 136.34 30.94 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 176.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -143.71 162.93 34.7 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 120.604 -0.439 . . . . 0.0 110.582 174.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -172.8 156.59 3.49 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.265 -0.88 . . . . 0.0 112.04 173.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.44 -173.41 4.7 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 172.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.27 134.15 55.28 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 102.767 -3.049 . . . . 0.0 102.767 173.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 19.28 -60.02 0.0 OUTLIER Glycine 0 CA--C 1.534 1.26 1 C-N-CA 135.634 6.35 . . . . 0.0 120.808 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -116.58 -13.06 10.89 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 121.139 2.47 . . . . 0.0 113.672 -177.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.96 37.4 0.6 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 130.037 3.335 . . . . 0.0 119.503 -173.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -51.39 116.25 1.98 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 123.388 2.813 . . . . 0.0 110.247 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -83.72 150.41 25.85 Favored 'General case' 0 C--N 1.334 -0.089 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 174.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -100.79 146.82 26.78 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 176.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -132.49 160.69 35.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 120.239 1.381 . . . . 0.0 110.983 176.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -152.6 133.74 14.23 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 173.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -81.32 111.22 17.5 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.714 1.206 . . . . 0.0 109.34 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.8 tt -74.28 -48.61 27.43 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.656 1.183 . . . . 0.0 107.857 174.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 m -128.66 148.08 50.78 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.04 1.336 . . . . 0.0 111.839 176.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -175.6 92.62 0.06 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 130.155 3.382 . . . . 0.0 103.913 173.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -162.16 153.46 18.13 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.348 -1.47 . . . . 0.0 111.279 -173.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.8 t -85.74 165.44 16.92 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 121.72 0.771 . . . . 0.0 109.174 173.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 98.8 mt -125.85 0.65 7.36 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 126.035 1.734 . . . . 0.0 112.163 -174.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.543 ' CG ' ' H ' ' A' ' 87' ' ' LYS 0.358 11.3 t70 -98.48 166.14 11.5 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.303 0.956 . . . . 0.0 112.391 178.247 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.543 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 1.4 mppt? -104.67 -46.86 4.22 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 129.401 3.081 . . . . 0.0 112.222 -173.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.403 ' C ' ' H ' ' A' ' 90' ' ' MET . . . -105.0 -44.6 1.48 Allowed Glycine 0 CA--C 1.525 0.711 0 C-N-CA 125.075 1.321 . . . . 0.0 111.792 -178.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mt -84.41 13.93 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 C-N-CA 125.274 1.43 . . . . 0.0 108.614 176.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.403 ' H ' ' C ' ' A' ' 88' ' ' GLY . 23.5 ttp -43.62 148.71 0.33 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 131.175 3.79 . . . . 0.0 110.548 177.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -162.7 176.28 10.48 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 127.724 2.41 . . . . 0.0 107.113 -173.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -137.51 113.92 9.48 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 172.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.91 154.31 75.0 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 N-CA-C 106.602 -2.115 . . . . 0.0 106.602 173.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.0 p -141.55 162.73 34.76 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 125.112 1.365 . . . . 0.0 108.435 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.0 m -126.47 155.43 36.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 123.742 0.817 . . . . 0.0 111.915 175.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -73.24 9.06 1.38 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.712 2.405 . . . . 0.0 113.212 174.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.1 m -140.73 165.52 29.17 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 125.903 1.681 . . . . 0.0 108.594 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -67.37 168.64 17.35 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.621 1.547 . . . . 0.0 111.293 174.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -62.63 -12.53 23.8 Favored 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 124.986 1.315 . . . . 0.0 111.914 174.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -143.17 163.83 31.81 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 120.314 1.416 . . . . 0.0 108.129 173.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.61 -161.7 34.37 Favored Glycine 0 C--O 1.228 -0.277 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 82.3 p -117.81 155.33 30.27 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 117.808 0.804 . . . . 0.0 109.404 173.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.6 t -93.69 113.12 59.54 Favored Pre-proline 0 N--CA 1.448 -0.541 0 N-CA-C 101.77 -3.419 . . . . 0.0 101.77 173.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.408 ' C ' ' H ' ' A' ' 106' ' ' LYS . 11.1 Cg_endo -92.4 161.57 3.02 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.431 2.088 . . . . 0.0 111.998 -173.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -72.62 3.17 5.28 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 120.116 -1.615 . . . . 0.0 112.382 -173.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.408 ' H ' ' C ' ' A' ' 104' ' ' PRO . 2.2 mptt -114.11 116.0 28.42 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 127.654 2.382 . . . . 0.0 107.672 -173.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -44.68 105.87 0.06 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.563 1.145 . . . . 0.0 109.942 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 26.8 m -111.75 135.16 52.72 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.4 t -90.28 114.09 27.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -173.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 70.8 t -94.0 103.21 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 103.536 -2.764 . . . . 0.0 103.536 173.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -84.05 119.08 24.52 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 173.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.5 t -90.56 113.47 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 103.13 -2.915 . . . . 0.0 103.13 173.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -93.9 149.11 19.29 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.435 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 7.8 m-85 -132.3 73.45 77.35 Favored Pre-proline 0 C--O 1.244 0.784 0 CA-C-N 118.258 1.029 . . . . 0.0 110.766 -176.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -68.04 114.27 3.33 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 N-CA-C 106.844 -2.022 . . . . 0.0 106.844 173.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 5.6 t -91.88 143.58 26.36 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 175.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.0 mt -74.26 -11.41 60.27 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 119.32 -0.371 . . . . 0.0 111.5 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 53.17 39.61 58.34 Favored Glycine 0 C--N 1.339 0.744 0 C-N-CA 125.768 1.652 . . . . 0.0 113.69 173.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -93.48 -65.25 1.01 Allowed 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 118.219 1.01 . . . . 0.0 109.299 -177.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 48.6 tp60 -96.07 155.26 16.83 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 174.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -93.44 147.72 22.7 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.383 1.473 . . . . 0.0 107.72 178.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.5 -155.5 26.38 Favored Glycine 0 C--N 1.332 0.34 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.9 t -126.63 114.01 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -88.26 170.58 10.88 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 173.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -124.06 158.19 32.76 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 173.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.435 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 50.1 p90 -148.71 153.55 38.39 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 173.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.55 154.59 37.7 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 126.231 1.813 . . . . 0.0 110.199 -173.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 87.7 t -143.09 144.64 23.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 173.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -157.38 132.53 8.91 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 125.078 1.351 . . . . 0.0 107.894 173.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.3 t -137.26 135.26 47.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -174.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -103.2 164.07 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 173.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.2 t -142.66 138.21 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -173.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.81 175.65 9.42 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 125.565 1.546 . . . . 0.0 107.97 -176.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 39.3 p-10 -90.92 176.22 6.69 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 172.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.1 t -66.17 -7.13 16.14 Favored 'General case' 0 CA--C 1.553 1.059 0 O-C-N 120.552 -1.342 . . . . 0.0 112.549 -176.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -86.13 -14.85 42.93 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.455 -1.403 . . . . 0.0 110.933 173.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.5 1.44 64.15 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.659 1.123 . . . . 0.0 112.465 -173.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 63.2 m-20 -71.75 116.29 11.95 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 119.68 1.74 . . . . 0.0 108.504 174.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -64.76 142.36 58.46 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.063 1.745 . . . . 0.0 108.461 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.3 pt -140.58 -38.69 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.758 1.223 . . . . 0.0 113.841 -174.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -130.91 141.54 50.3 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 -177.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -149.07 124.95 10.57 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -176.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 41.3 m -61.67 143.72 93.57 Favored Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 174.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.49 141.95 23.01 Favored 'Trans proline' 0 N--CA 1.441 -1.613 0 N-CA-C 107.587 -1.736 . . . . 0.0 107.587 173.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -77.0 112.64 13.84 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 102.225 -3.25 . . . . 0.0 102.225 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 4.1 m120 174.45 -30.24 0.0 OUTLIER 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.17 1.788 . . . . 0.0 111.419 -173.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.75 103.91 0.39 Allowed 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.443 1.497 . . . . 0.0 110.219 -174.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 2.0 mt -134.29 148.74 29.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -176.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 126' ' ' PHE . 0.9 OUTLIER -132.19 169.98 15.66 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.198 1.799 . . . . 0.0 107.479 179.078 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -136.4 113.74 10.76 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.281 1.032 . . . . 0.0 109.073 -173.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -103.13 124.95 49.53 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.677 1.126 . . . . 0.0 109.136 179.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 25.7 m -83.67 116.69 22.76 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 174.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 4.5 m -119.27 166.21 13.28 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.494 0.718 . . . . 0.0 109.84 174.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.2 pp -133.27 161.16 35.22 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.459 1.504 . . . . 0.0 107.89 176.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.16 131.95 46.82 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.926 1.29 . . . . 0.0 109.927 177.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -146.91 133.49 19.83 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.814 1.646 . . . . 0.0 107.509 174.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 . . . . . 0 C--O 1.257 1.464 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 177.485 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 CA--C 1.537 0.462 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.1 tt -43.55 138.13 2.62 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.96 2.504 . . . . 0.0 113.075 177.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -122.12 135.57 54.81 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.51 1.924 . . . . 0.0 108.467 173.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.99 121.06 10.08 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 127.231 2.212 . . . . 0.0 107.115 -176.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 12.8 p90 -139.63 175.07 9.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 118.933 0.788 . . . . 0.0 109.946 176.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.2 mp -112.77 113.72 44.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 100.226 -3.99 . . . . 0.0 100.226 173.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -79.58 152.9 29.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 122.861 1.315 . . . . 0.0 111.832 -173.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.2 -19.18 61.32 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -173.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -61.09 -34.06 74.32 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 119.564 1.075 . . . . 0.0 109.396 174.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 48.1 tp60 -69.16 -48.44 62.25 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 118.103 0.41 . . . . 0.0 111.6 177.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.95 -29.58 68.5 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 119.131 -0.461 . . . . 0.0 111.617 174.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 27.0 ttm105 . . . . . 0 N--CA 1.447 -0.592 0 CA-C-N 119.658 1.117 . . . . 0.0 108.038 173.435 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 . . . . . 0 CA--C 1.536 0.427 0 CA-C-O 118.987 -0.53 . . . . 0.0 109.589 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -160.21 114.07 2.18 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.186 1.795 . . . . 0.0 110.569 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -94.55 165.49 12.5 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 172.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.7 mm -137.98 113.35 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 173.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.35 114.63 22.01 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -177.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.2 mt -87.42 -58.41 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -126.04 122.55 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 126.375 1.87 . . . . 0.0 107.683 -173.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 81.0 p -123.56 127.96 49.05 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 101.07 -3.678 . . . . 0.0 101.07 172.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.292 0.4 OUTLIER 44.08 36.66 1.53 Allowed 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 119.893 1.224 . . . . 0.0 114.025 178.55 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.5 -8.4 2.24 Favored Glycine 0 CA--C 1.546 2.024 0 O-C-N 120.461 -1.399 . . . . 0.0 115.443 -175.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.83 37.56 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.573 1 C-N-CA 134.524 5.13 . . . . 0.0 111.987 175.528 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 53.9 mtp -37.6 119.38 0.72 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.262 1.425 . . . . 0.0 112.826 -172.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.407 ' C ' ' H ' ' A' ' 42' ' ' PHE . . . -62.07 163.35 13.81 Favored Pre-proline 0 N--CA 1.447 -0.62 0 CA-C-N 113.442 -1.708 . . . . 0.0 109.696 177.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.97 30.57 0.29 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 123.994 3.129 . . . . 0.0 111.911 173.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.407 ' H ' ' C ' ' A' ' 40' ' ' ALA . 12.9 p90 -55.16 -26.76 40.91 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 126.363 1.865 . . . . 0.0 111.427 -174.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.9 m -56.29 -37.74 70.27 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 127.428 2.291 . . . . 0.0 111.605 -173.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -60.84 -65.51 0.68 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 177.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -65.11 -23.7 67.22 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.637 0.775 . . . . 0.0 112.997 -174.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -70.01 -47.05 63.7 Favored 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 124.002 0.921 . . . . 0.0 109.821 173.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.9 ttp180 . . . . . 0 CA--C 1.545 0.781 0 C-N-CA 124.932 1.293 . . . . 0.0 112.468 -177.026 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.555 ' H ' ' HD2' ' A' ' 54' ' ' PRO . 90.0 mmm . . . . . 0 CA--C 1.535 0.387 0 CA-C-O 116.278 -1.82 . . . . 0.0 114.635 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.555 ' HD2' ' H ' ' A' ' 53' ' ' MET . 5.6 Cg_endo -59.68 -72.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.791 0 CA-C-N 121.877 1.706 . . . . 0.0 113.252 -173.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.19 125.65 29.66 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -176.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 58.4 mt -124.86 131.18 24.07 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 128.14 2.576 . . . . 0.0 106.207 -173.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -81.07 158.44 20.53 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.11 1.873 . . . . 0.0 111.198 174.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.7 p -46.7 -37.31 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 126.058 1.743 . . . . 0.0 112.313 173.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -53.37 -40.1 64.71 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 126.492 1.917 . . . . 0.0 112.582 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 mm -76.6 112.77 14.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 103.394 -2.817 . . . . 0.0 103.394 174.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -83.09 -35.03 25.99 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 173.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.8 m -147.71 152.86 38.5 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.866 1.266 . . . . 0.0 108.271 -174.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 22.3 mtp -113.36 164.03 14.1 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 172.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -133.88 114.47 13.35 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 -173.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -98.97 168.56 10.03 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 173.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.9 m -141.34 135.24 30.3 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -143.66 164.55 30.11 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 121.856 -0.528 . . . . 0.0 111.046 176.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.51 161.56 18.68 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.525 1.13 . . . . 0.0 111.647 174.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.34 160.15 15.59 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.843 0.857 . . . . 0.0 108.759 173.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.55 84.54 7.2 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.871 1.268 . . . . 0.0 110.924 -174.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 50.88 -46.93 0.01 OUTLIER Glycine 0 CA--C 1.542 1.752 1 C-N-CA 131.51 4.386 . . . . 0.0 121.58 173.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -117.14 2.16 12.59 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 120.471 2.135 . . . . 0.0 116.017 -173.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -126.01 37.24 4.38 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 120.903 3.668 . . . . 0.0 120.903 -172.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -38.29 114.21 0.35 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 123.203 2.728 . . . . 0.0 112.882 -173.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -83.86 123.2 29.68 Favored 'General case' 0 C--N 1.338 0.068 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 -174.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -76.69 148.26 36.92 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 -176.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -132.51 160.27 37.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 119.989 1.268 . . . . 0.0 111.106 176.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -152.76 137.86 17.32 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 173.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -87.27 104.09 16.07 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 125.288 1.435 . . . . 0.0 109.764 -176.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.4 tt -70.7 -39.28 73.56 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.922 1.289 . . . . 0.0 108.449 176.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.7 m -135.56 144.25 46.13 Favored 'General case' 0 C--N 1.34 0.187 0 O-C-N 121.177 -0.952 . . . . 0.0 112.063 178.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 tt -174.13 93.04 0.08 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 128.977 2.911 . . . . 0.0 105.524 173.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -159.97 153.35 22.23 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 119.753 1.16 . . . . 0.0 111.393 -173.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.1 t -78.37 129.02 34.48 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 119.633 1.106 . . . . 0.0 110.798 174.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 68.2 mt -93.16 -27.03 17.15 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 116.874 -1.536 . . . . 0.0 111.164 174.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -77.04 165.72 24.25 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.719 1.6 . . . . 0.0 107.134 175.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.35 -41.98 1.53 Allowed 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.728 1.611 . . . . 0.0 110.855 -173.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.407 ' C ' ' H ' ' A' ' 90' ' ' MET . . . -72.39 -69.57 1.37 Allowed Glycine 0 CA--C 1.533 1.192 0 N-CA-C 108.386 -1.885 . . . . 0.0 108.386 173.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.5 mp -73.44 14.39 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 C-N-CA 128.812 2.845 . . . . 0.0 110.476 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.407 ' H ' ' C ' ' A' ' 88' ' ' GLY . 22.1 ttp -43.2 136.75 2.83 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 128.167 2.587 . . . . 0.0 112.331 -173.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -156.69 113.58 3.1 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 -174.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -97.99 122.53 54.23 Favored Pre-proline 0 CA--C 1.509 -0.629 0 O-C-N 124.364 1.04 . . . . 0.0 109.285 -173.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -65.88 152.37 81.65 Favored 'Trans proline' 0 N--CA 1.443 -1.466 0 C-N-CA 120.83 1.02 . . . . 0.0 109.5 178.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 42.0 p -135.77 161.96 34.11 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.323 1.449 . . . . 0.0 107.137 173.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.9 m -126.47 149.71 31.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 O-C-N 121.241 -0.912 . . . . 0.0 111.679 174.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -86.81 13.77 8.31 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.772 1.629 . . . . 0.0 111.174 173.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.0 m -130.99 163.13 51.21 Favored Pre-proline 0 N--CA 1.454 -0.273 0 C-N-CA 125.829 1.652 . . . . 0.0 106.587 173.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -67.51 163.32 35.32 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 120.72 0.946 . . . . 0.0 109.864 173.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -62.72 -13.36 31.69 Favored 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 124.459 1.104 . . . . 0.0 111.583 175.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -139.53 163.58 32.17 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.205 1.402 . . . . 0.0 107.894 173.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 164.54 -159.67 32.67 Favored Glycine 0 C--O 1.226 -0.349 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -178.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 68.8 p -123.03 151.36 41.99 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 117.548 0.674 . . . . 0.0 109.506 174.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 48.2 t -89.62 113.45 56.78 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 101.925 -3.361 . . . . 0.0 101.925 173.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -91.95 171.68 2.66 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 N-CA-C 117.591 2.112 . . . . 0.0 117.591 -172.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -75.9 -0.59 21.9 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 -173.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.5 138.92 51.01 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 116.319 -1.8 . . . . 0.0 106.724 173.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.54 112.15 0.7 Allowed 'General case' 0 C--O 1.231 0.129 0 O-C-N 125.407 1.692 . . . . 0.0 106.466 173.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.5 m -123.23 136.72 54.85 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -176.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.8 t -85.1 135.89 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 O-C-N 124.737 1.273 . . . . 0.0 108.673 -173.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 74.7 t -112.8 103.66 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 104.355 -2.461 . . . . 0.0 104.355 173.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -83.77 125.63 32.11 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 173.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.5 t -102.94 113.55 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 102.712 -3.07 . . . . 0.0 102.712 173.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -82.86 151.49 29.0 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 174.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.45 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 8.7 m-85 -133.42 73.35 73.57 Favored Pre-proline 0 C--O 1.244 0.784 0 CA-C-N 118.279 1.039 . . . . 0.0 109.994 177.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -67.34 114.08 3.12 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.295 1.997 . . . . 0.0 108.634 173.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 5.9 t -89.45 151.43 22.02 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 173.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.1 mt -71.22 -10.95 60.6 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.102 0.41 . . . . 0.0 111.862 -176.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.77 23.01 49.19 Favored Glycine 0 C--N 1.339 0.713 0 C-N-CA 126.74 2.114 . . . . 0.0 116.786 173.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 50.7 mttt -120.98 -27.38 4.98 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.583 1.691 . . . . 0.0 113.375 177.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -96.62 156.59 16.28 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 173.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -112.03 151.54 29.22 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 175.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 140.41 -155.94 24.92 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 118.673 0.67 . . . . 0.0 111.56 174.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 20.7 t -122.99 114.14 40.91 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 175.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.3 172.89 9.53 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.553 1.141 . . . . 0.0 109.648 173.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -131.64 148.58 52.61 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.154 1.782 . . . . 0.0 107.684 173.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.453 ' CZ ' ' HB2' ' A' ' 149' ' ' PHE . 43.5 p90 -145.69 151.66 38.39 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 173.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -111.22 148.16 33.43 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 125.152 1.381 . . . . 0.0 111.498 -173.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 31.9 t -141.45 145.35 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 173.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -159.9 135.2 8.16 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 125.168 1.387 . . . . 0.0 108.252 174.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 37.4 t -139.74 131.42 33.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -174.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -100.93 165.38 2.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 173.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.2 t -142.06 138.07 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -173.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.8 175.19 9.81 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.667 1.587 . . . . 0.0 108.113 -176.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 36.9 p-10 -89.82 176.13 6.95 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 172.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.2 t -65.91 -3.51 5.31 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 120.24 -1.538 . . . . 0.0 113.678 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -89.62 -15.25 33.15 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 120.655 1.571 . . . . 0.0 110.595 173.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.72 1.12 62.01 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.62 1.105 . . . . 0.0 112.254 -173.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -71.53 115.9 11.25 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 119.606 1.703 . . . . 0.0 108.403 174.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -64.71 142.76 58.32 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 126.203 1.801 . . . . 0.0 108.632 -177.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.7 pt -139.67 -37.97 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 124.773 1.229 . . . . 0.0 113.884 -174.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -132.72 145.12 50.76 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -148.81 126.95 12.06 Favored 'General case' 0 CA--C 1.52 -0.187 0 O-C-N 121.009 -1.057 . . . . 0.0 108.615 -177.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 63.1 m -64.92 143.46 98.85 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 176.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.55 143.36 21.54 Favored 'Trans proline' 0 N--CA 1.445 -1.372 0 N-CA-C 108.989 -1.197 . . . . 0.0 108.989 174.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -80.46 112.68 18.03 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 176.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 173.11 -19.03 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 130.182 3.393 . . . . 0.0 110.434 -174.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.8 78.58 0.86 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.185 1.394 . . . . 0.0 109.879 -175.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 27.9 mm -101.99 130.01 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 105.002 -2.222 . . . . 0.0 105.002 173.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.453 ' HB2' ' CZ ' ' A' ' 126' ' ' PHE . 0.2 OUTLIER -105.0 155.71 18.71 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 173.768 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -130.84 113.47 14.11 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -174.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -110.29 123.9 50.65 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 119.128 0.876 . . . . 0.0 109.617 -174.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 22.5 m -83.48 114.26 21.36 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 175.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 25.5 m -114.6 166.08 12.1 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 123.881 0.872 . . . . 0.0 110.099 174.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.4 pp -141.59 159.08 42.95 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.766 1.627 . . . . 0.0 107.206 173.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.56 128.12 35.25 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.182 0.993 . . . . 0.0 110.318 175.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -157.62 119.44 3.7 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.123 1.369 . . . . 0.0 110.376 176.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 . . . . . 0 C--O 1.256 1.404 0 C-N-CA 129.158 2.983 . . . . 0.0 105.271 173.583 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 CA--C 1.534 0.331 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.0 tt -43.91 128.0 5.44 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.776 1.63 . . . . 0.0 111.3 -176.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -115.98 128.48 55.77 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.503 1.521 . . . . 0.0 107.995 174.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.51 120.07 13.24 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 -179.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 14.1 p90 -140.48 174.88 10.08 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.776 0.716 . . . . 0.0 109.878 176.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.7 mp -113.74 113.72 44.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 1 N-CA-C 99.844 -4.132 . . . . 0.0 99.844 173.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -75.95 149.9 37.58 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.971 1.367 . . . . 0.0 111.417 -173.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.19 -26.46 63.9 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 113.75 -1.568 . . . . 0.0 113.304 -173.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -67.16 -44.55 79.48 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -174.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.6 -56.3 23.13 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 118.047 -0.978 . . . . 0.0 108.441 174.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.0 -41.05 61.88 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 117.228 -1.368 . . . . 0.0 111.987 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 51.9 ttm-85 . . . . . 0 N--CA 1.454 -0.228 0 CA-C-N 120.802 1.637 . . . . 0.0 108.925 174.168 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 . . . . . 0 C--O 1.225 -0.185 0 CA-C-O 118.607 -0.711 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -151.83 141.21 21.52 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 128.687 2.795 . . . . 0.0 104.25 173.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.01 166.47 13.87 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 173.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 82.3 mt -136.86 113.15 12.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 104.44 -2.429 . . . . 0.0 104.44 173.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.42 114.35 23.95 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 -177.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.2 mt -88.47 -61.99 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -116.74 114.34 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 125.648 1.579 . . . . 0.0 107.049 -173.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.9 p -109.92 114.76 28.57 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 173.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.455 ' C ' ' H ' ' A' ' 38' ' ' LYS . 11.5 pt-20 46.41 36.86 3.72 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.491 1.516 . . . . 0.0 112.777 -178.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.19 -22.31 1.28 Allowed Glycine 0 CA--C 1.544 1.891 0 O-C-N 120.15 -1.594 . . . . 0.0 114.191 -175.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.455 ' H ' ' C ' ' A' ' 36' ' ' GLU . 15.9 ttpt -67.39 37.88 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.583 1 C-N-CA 137.471 6.309 . . . . 0.0 110.985 177.024 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . 0.284 34.7 mtt -37.38 136.22 0.49 Allowed 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.882 2.073 . . . . 0.0 114.372 -172.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.31 163.04 56.21 Favored Pre-proline 0 N--CA 1.448 -0.563 0 CA-C-N 112.844 -1.98 . . . . 0.0 107.778 173.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.24 34.37 0.33 Allowed 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 124.04 3.16 . . . . 0.0 112.095 174.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -55.52 -26.75 44.7 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 126.247 1.819 . . . . 0.0 112.257 -173.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.6 m -60.4 -34.68 74.28 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 126.428 1.891 . . . . 0.0 111.585 -173.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -57.92 -65.74 0.59 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.098 0.959 . . . . 0.0 108.676 178.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -61.79 -41.43 97.73 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 117.327 -1.32 . . . . 0.0 113.563 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -55.84 -49.62 72.81 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.301 1.041 . . . . 0.0 111.069 -178.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.9 ttp180 . . . . . 0 CA--C 1.537 0.477 0 CA-C-N 118.509 0.595 . . . . 0.0 111.062 -178.768 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.7 mtp . . . . . 0 N--CA 1.471 0.623 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -65.93 -66.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 121.942 1.762 . . . . 0.0 112.401 -174.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.89 114.22 9.75 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.579 1.152 . . . . 0.0 109.863 -174.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 98.0 mt -119.43 119.91 31.26 Favored Pre-proline 0 N--CA 1.449 -0.476 0 C-N-CA 126.5 1.92 . . . . 0.0 106.379 -175.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.42 156.66 41.17 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.064 1.843 . . . . 0.0 110.174 175.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.2 p -40.61 -42.54 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 127.194 2.198 . . . . 0.0 112.91 175.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -57.45 -36.03 70.89 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 126.455 1.902 . . . . 0.0 113.23 -177.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.0 mm -72.12 112.86 8.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 102.649 -3.093 . . . . 0.0 102.649 173.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -82.42 -40.14 21.64 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 173.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.4 m -146.09 165.95 27.56 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.682 0.793 . . . . 0.0 110.141 -173.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 46.4 mtp -126.11 171.87 10.48 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 127.926 2.49 . . . . 0.0 104.889 173.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -140.23 137.48 34.32 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 173.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -111.26 169.15 8.98 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 173.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.4 m -137.37 130.91 31.33 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -144.41 165.52 27.7 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 121.726 -0.609 . . . . 0.0 110.454 174.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -168.31 155.98 8.16 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.081 173.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.99 -174.04 2.54 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 123.536 1.636 . . . . 0.0 107.55 173.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . 0.257 . . -106.37 131.36 53.67 Favored 'General case' 0 N--CA 1.411 -2.389 1 C-N-CA 131.985 4.114 . . . . 0.0 102.99 174.546 . . . . . . . . 3 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -8.63 -55.66 0.01 OUTLIER Glycine 0 CA--C 1.536 1.348 1 C-N-CA 133.883 5.516 . . . . 0.0 119.429 -173.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -116.95 12.03 14.53 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 121.045 2.423 . . . . 0.0 114.664 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.79 37.52 3.42 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 120.251 3.426 . . . . 0.0 120.251 -172.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -45.13 113.71 0.61 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 123.446 2.839 . . . . 0.0 110.448 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -83.83 134.34 34.71 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.412 1.485 . . . . 0.0 106.992 177.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -83.71 146.32 28.27 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -129.8 160.91 32.02 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 120.212 1.369 . . . . 0.0 110.714 175.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -154.48 135.03 13.47 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 173.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -85.69 104.06 15.05 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.951 1.3 . . . . 0.0 108.51 -178.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.9 tt -69.24 -54.54 14.24 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 173.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 m -131.1 141.72 50.18 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 123.342 1.544 . . . . 0.0 111.692 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -163.72 92.61 0.7 Allowed 'General case' 0 N--CA 1.448 -0.536 1 N-CA-C 96.011 -5.552 . . . . 0.0 96.011 172.82 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -158.11 146.54 18.88 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.503 -1.373 . . . . 0.0 112.339 -173.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.1 t -78.5 156.92 29.03 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.956 0.502 . . . . 0.0 110.821 174.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.4 mt -121.04 -26.34 5.16 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 116.908 -1.52 . . . . 0.0 112.461 -176.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -81.32 160.18 24.23 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 121.591 1.996 . . . . 0.0 112.038 -177.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.457 ' HE3' ' HA ' ' A' ' 87' ' ' LYS . 0.5 OUTLIER -105.39 -42.57 5.2 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 131.126 3.77 . . . . 0.0 112.556 176.02 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.465 ' C ' ' H ' ' A' ' 90' ' ' MET . . . -67.75 -74.16 0.6 Allowed Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 174.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.5 mp -77.35 26.03 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 129.996 3.319 . . . . 0.0 110.301 -177.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.465 ' H ' ' C ' ' A' ' 88' ' ' GLY . 10.7 ttm -43.55 140.52 1.72 Allowed 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 128.143 2.577 . . . . 0.0 110.031 -178.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -164.69 175.61 9.58 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 130.017 3.327 . . . . 0.0 105.286 -173.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.273 8.2 m-20 -145.46 115.03 4.86 Favored Pre-proline 0 C--N 1.324 -0.526 0 C-N-CA 124.527 1.131 . . . . 0.0 110.07 173.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -69.58 149.77 68.46 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 N-CA-C 108.322 -1.453 . . . . 0.0 108.322 173.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 21.8 p -137.13 160.63 38.42 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 125.62 1.568 . . . . 0.0 108.072 -175.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.5 m -126.01 153.82 34.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 C-N-CA 124.014 0.925 . . . . 0.0 109.637 174.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -93.2 25.63 3.23 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.613 1.565 . . . . 0.0 111.702 176.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.8 m -134.93 163.3 52.18 Favored Pre-proline 0 C--O 1.235 0.29 0 C-N-CA 124.85 1.26 . . . . 0.0 108.142 174.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -66.66 162.2 38.24 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 121.087 1.191 . . . . 0.0 109.418 173.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.01 -12.72 40.72 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 124.056 0.942 . . . . 0.0 111.902 178.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -143.29 165.71 26.72 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 120.325 1.421 . . . . 0.0 108.641 173.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 164.53 -162.73 35.69 Favored Glycine 0 C--O 1.228 -0.27 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 178.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 82.0 p -117.97 146.66 43.83 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 173.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 28.2 t -82.44 113.74 46.52 Favored Pre-proline 0 N--CA 1.447 -0.594 0 N-CA-C 102.996 -2.964 . . . . 0.0 102.996 173.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.402 ' C ' ' H ' ' A' ' 106' ' ' LYS . 36.5 Cg_endo -84.42 153.63 12.18 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.347 2.031 . . . . 0.0 111.626 -173.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -69.73 1.81 3.91 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 120.113 -1.617 . . . . 0.0 113.369 -173.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 104' ' ' PRO . 1.2 mptt -115.28 119.18 35.44 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 127.086 2.154 . . . . 0.0 107.585 -173.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -43.02 107.84 0.09 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.732 1.213 . . . . 0.0 109.91 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.1 m -118.13 139.18 51.63 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.5 t -96.75 135.25 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 114.301 -1.318 . . . . 0.0 107.834 -173.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 78.5 t -119.86 103.93 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -71.82 143.24 49.54 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 173.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.7 t -124.86 113.91 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 103.707 -2.701 . . . . 0.0 103.707 173.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -100.77 147.91 18.06 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 125.134 1.349 . . . . 0.0 110.145 -178.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.41 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 9.0 m-85 -131.16 73.54 80.47 Favored Pre-proline 0 C--O 1.242 0.706 0 CA-C-N 118.325 1.063 . . . . 0.0 111.596 -174.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -69.18 129.88 19.03 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.326 2.017 . . . . 0.0 108.239 173.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 5.7 t -105.44 154.2 20.65 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 175.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 7.6 mt -70.95 -12.78 61.73 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.559 0.618 . . . . 0.0 111.363 174.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.53 5.01 5.91 Favored Glycine 0 C--O 1.215 -1.037 0 C-N-CA 128.513 2.959 . . . . 0.0 116.169 173.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -94.64 -31.51 13.81 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 120.695 2.247 . . . . 0.0 114.418 -173.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 51.4 tp60 -96.57 146.9 24.41 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 173.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -94.25 143.07 26.71 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 174.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 141.48 -154.44 24.67 Favored Glycine 0 C--N 1.334 0.465 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 178.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.4 t -131.6 114.12 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 C-N-CA 123.288 0.635 . . . . 0.0 109.358 -177.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -89.97 168.34 12.1 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 173.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -124.08 156.87 35.8 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.119 0.968 . . . . 0.0 109.651 174.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.41 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 3.9 p90 -145.14 148.53 33.71 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.334 1.053 . . . . 0.0 108.518 173.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -111.78 157.78 20.14 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 126.456 1.902 . . . . 0.0 110.876 -174.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 89.6 t -141.67 138.32 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.403 1.081 . . . . 0.0 109.311 174.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -150.66 118.53 6.22 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 126.97 2.108 . . . . 0.0 105.889 173.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.434 ' H ' ' HB ' ' A' ' 143' ' ' THR . 31.4 t -127.72 123.96 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 177.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -89.88 164.96 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 173.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.9 t -144.37 135.35 21.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 -176.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.36 173.99 11.08 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.979 1.312 . . . . 0.0 108.832 -176.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -89.06 175.85 7.23 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 172.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 6.7 t -65.02 -15.13 61.98 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 120.11 -1.619 . . . . 0.0 112.175 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -79.86 -3.22 46.97 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.698 1.599 . . . . 0.0 110.913 175.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 80.54 6.54 89.25 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.073 1.32 . . . . 0.0 112.973 178.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -81.72 119.38 23.78 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 178.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -65.98 143.68 57.23 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.359 1.464 . . . . 0.0 109.241 -176.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -140.32 -37.62 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 125.126 1.371 . . . . 0.0 113.576 -174.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -131.01 149.82 52.44 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 178.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.3 tm0? -148.67 150.02 32.49 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.434 ' HB ' ' H ' ' A' ' 130' ' ' VAL . 57.4 m -80.11 113.56 39.52 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 178.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -61.39 140.15 86.4 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 CA-C-N 120.685 1.28 . . . . 0.0 110.59 -173.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -75.57 112.53 12.02 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 -173.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 173.07 -34.49 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 129.874 3.27 . . . . 0.0 108.501 -173.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.44 90.72 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 126.656 1.982 . . . . 0.0 110.521 -174.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.3 mt -126.24 148.58 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 176.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -126.69 164.32 21.57 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 175.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -132.83 113.53 13.02 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.223 1.009 . . . . 0.0 108.309 -173.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -101.03 120.33 40.04 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 28.6 m -83.78 116.33 22.65 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 173.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 9.3 m -111.67 163.44 14.11 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 173.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.2 pp -139.35 159.76 41.41 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 174.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -63.67 114.09 3.76 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 127.813 2.445 . . . . 0.0 111.557 -174.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -153.43 157.7 40.32 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 126.054 1.742 . . . . 0.0 109.549 176.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 . . . . . 0 C--O 1.248 0.985 0 C-N-CA 131.612 3.965 . . . . 0.0 105.557 173.661 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.2 m . . . . . 0 C--O 1.224 -0.28 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.8 tt -43.22 123.64 2.99 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.363 2.665 . . . . 0.0 113.458 -173.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -113.75 141.45 47.26 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 128.414 2.686 . . . . 0.0 108.656 173.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.01 121.94 7.07 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.759 1.623 . . . . 0.0 106.996 -178.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 26.9 p90 -137.89 175.43 9.59 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.595 1.089 . . . . 0.0 110.675 176.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -111.84 134.34 54.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 103.228 -2.879 . . . . 0.0 103.228 173.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -78.96 162.49 25.93 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 123.016 1.389 . . . . 0.0 112.846 -173.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.87 -26.41 43.95 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 113.775 -1.557 . . . . 0.0 112.137 -176.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 10.2 m80 -63.98 -41.96 97.37 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.094 0.957 . . . . 0.0 108.73 -175.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -62.26 -43.99 97.56 Favored 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 123.909 0.884 . . . . 0.0 110.616 177.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.75 -35.47 76.48 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 118.401 -0.809 . . . . 0.0 111.005 176.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 173.507 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 . . . . . 0 CA--C 1.533 0.306 0 CA-C-O 119.754 -0.165 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -155.87 137.53 14.21 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 127.809 2.443 . . . . 0.0 105.942 173.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -72.64 175.77 6.09 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.976 2.11 . . . . 0.0 109.644 173.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 66.9 mt -140.81 113.62 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 173.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.55 127.07 34.33 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -176.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.4 mt -102.39 -56.33 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 119.313 0.961 . . . . 0.0 110.665 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.2 t -125.34 131.7 71.97 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -173.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.8 p -134.49 120.3 19.56 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 174.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.433 1.0 OUTLIER 43.63 47.83 6.43 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 122.72 1.248 . . . . 0.0 112.397 -176.377 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.24 11.68 20.97 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 126.165 1.841 . . . . 0.0 114.959 177.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.469 ' HZ2' ' HB2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -74.23 37.31 0.1 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.633 2.373 . . . . 0.0 113.762 -173.308 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 9.4 mmt -38.22 113.49 0.29 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 122.746 1.26 . . . . 0.0 111.981 -173.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.409 ' C ' ' H ' ' A' ' 42' ' ' PHE . . . -95.78 170.09 8.19 Favored Pre-proline 0 N--CA 1.448 -0.535 0 C-N-CA 127.734 2.413 . . . . 0.0 109.079 -176.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.0 26.19 0.25 Allowed 'Trans proline' 0 CA--C 1.548 1.212 0 C-N-CA 123.678 2.918 . . . . 0.0 112.09 173.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.409 ' H ' ' C ' ' A' ' 40' ' ' ALA . 18.7 p90 -53.57 -26.43 21.47 Favored 'General case' 0 C--N 1.345 0.402 0 C-N-CA 126.437 1.895 . . . . 0.0 111.625 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 m -60.49 -29.81 69.31 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 126.099 1.76 . . . . 0.0 110.696 -173.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -60.76 -63.38 1.32 Allowed 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 174.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.382 1.0 OUTLIER -65.59 -22.89 66.72 Favored 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 124.835 1.254 . . . . 0.0 113.086 -177.775 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -67.95 -52.99 29.71 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.095 -1.628 . . . . 0.0 107.054 173.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.468 0 C-N-CA 124.928 1.291 . . . . 0.0 112.993 -173.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 7.2 mtp . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -61.6 -70.55 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.765 2.31 . . . . 0.0 112.9 -173.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.0 113.56 16.03 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -176.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 94.2 mt -114.31 114.07 45.67 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 126.59 1.956 . . . . 0.0 106.227 -174.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -74.14 158.67 45.21 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 121.86 1.707 . . . . 0.0 110.853 -175.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.6 p -45.45 -38.38 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.428 1.491 . . . . 0.0 112.18 173.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -53.75 -43.1 68.87 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.963 1.705 . . . . 0.0 112.563 176.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.4 mm -81.0 112.93 19.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 103.065 -2.939 . . . . 0.0 103.065 173.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -81.11 -38.45 27.23 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 173.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.3 m -142.74 162.53 35.21 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.891 1.276 . . . . 0.0 111.037 -173.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.9 mmm -116.6 159.22 22.48 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 173.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -109.48 113.16 25.72 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 174.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -100.41 160.21 14.52 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 102.696 -3.075 . . . . 0.0 102.696 172.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.4 m -147.22 136.36 22.45 Favored 'General case' 0 C--N 1.317 -0.84 0 O-C-N 120.086 -1.634 . . . . 0.0 106.976 -177.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -147.62 168.31 22.34 Favored 'General case' 0 C--O 1.246 0.885 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.53 178.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -173.56 149.28 1.64 Allowed 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 113.813 -1.54 . . . . 0.0 114.167 175.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -82.71 -173.9 4.91 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 101.977 -3.342 . . . . 0.0 101.977 172.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -110.78 131.26 55.2 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 103.384 -2.821 . . . . 0.0 103.384 173.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 38.15 -93.79 0.01 OUTLIER Glycine 0 CA--C 1.533 1.204 1 C-N-CA 131.196 4.236 . . . . 0.0 116.008 174.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -116.97 25.08 10.76 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.998 2.119 . . . . 0.0 116.079 174.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.8 37.32 0.53 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 128.855 2.862 . . . . 0.0 114.379 174.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.6 mp0 -38.43 113.56 0.3 Allowed 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 121.5 1.955 . . . . 0.0 116.052 -173.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -103.05 137.36 41.33 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 127.096 2.159 . . . . 0.0 106.446 173.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -99.45 151.31 21.26 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -135.69 159.97 39.98 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 119.918 1.235 . . . . 0.0 110.409 174.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -153.56 134.98 14.24 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 173.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -80.71 103.91 10.88 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.3 tt -64.36 -43.35 94.84 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.058 1.343 . . . . 0.0 107.579 174.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 75.4 m -148.34 149.52 31.94 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.437 1.095 . . . . 0.0 109.335 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.7 tt -169.36 93.21 0.27 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 128.933 2.893 . . . . 0.0 103.289 177.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 44.5 mmm-85 -161.95 162.07 28.9 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.495 1.043 . . . . 0.0 111.669 -174.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.2 t -84.86 161.71 19.79 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 122.271 1.034 . . . . 0.0 111.898 174.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.7 mt -126.43 -0.7 6.92 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 126.108 1.763 . . . . 0.0 113.111 -174.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.585 ' CG ' ' H ' ' A' ' 87' ' ' LYS 0.315 14.6 t70 -98.45 161.82 13.48 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 120.601 1.546 . . . . 0.0 114.591 -175.367 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.585 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER -91.0 -59.24 2.22 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 128.936 2.894 . . . . 0.0 110.2 -177.263 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.49 ' C ' ' H ' ' A' ' 90' ' ' MET . . . -97.09 -45.01 2.69 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 124.977 1.275 . . . . 0.0 112.648 -173.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.7 mp -81.0 24.47 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 CA-C-O 123.323 1.535 . . . . 0.0 109.566 -178.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.49 ' H ' ' C ' ' A' ' 88' ' ' GLY . 24.4 ttm -43.47 133.27 4.4 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 130.808 3.643 . . . . 0.0 109.479 -179.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.261 . . -167.3 176.03 6.96 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 131.382 3.873 . . . . 0.0 105.114 -173.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.283 8.2 m-20 -150.0 136.13 10.52 Favored Pre-proline 0 C--N 1.324 -0.531 0 C-N-CA 124.789 1.236 . . . . 0.0 111.746 172.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -72.99 154.4 52.88 Favored 'Trans proline' 0 N--CA 1.444 -1.394 0 C-N-CA 121.702 1.601 . . . . 0.0 108.476 173.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.2 p -143.88 162.56 35.79 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.626 1.571 . . . . 0.0 108.667 174.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.3 m -126.39 156.25 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 123.73 0.812 . . . . 0.0 112.317 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -74.38 9.23 1.79 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 127.848 2.459 . . . . 0.0 113.584 174.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.4 m -140.68 165.23 31.22 Favored Pre-proline 0 C--N 1.326 -0.421 0 C-N-CA 125.318 1.447 . . . . 0.0 108.84 -178.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -66.57 166.12 23.01 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 121.405 1.403 . . . . 0.0 110.454 173.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.35 -8.99 10.09 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.94 1.296 . . . . 0.0 111.88 175.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -144.56 163.67 33.2 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 120.505 1.502 . . . . 0.0 108.425 173.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.8 -161.28 34.11 Favored Glycine 0 C--O 1.227 -0.342 0 N-CA-C 110.544 -1.023 . . . . 0.0 110.544 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 27.1 p -120.79 148.1 44.45 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.0 t -76.47 113.61 30.61 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -79.86 121.35 4.52 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 121.835 1.69 . . . . 0.0 113.463 -173.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.693 ' H ' ' CD2' ' A' ' 105' ' ' HIS . 1.1 m-70 -63.41 -20.6 65.69 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.329 1.452 . . . . 0.0 111.974 -173.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . 0.274 4.5 mptt -91.88 112.82 24.9 Favored 'General case' 0 N--CA 1.418 -2.046 1 N-CA-C 99.062 -4.422 . . . . 0.0 99.062 176.581 . . . . . . . . 3 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -42.19 117.33 0.96 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.716 1.606 . . . . 0.0 113.003 -173.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 37.4 m -127.33 142.86 51.34 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 123.722 0.639 . . . . 0.0 110.843 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 24.3 t -94.32 116.39 35.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 C-N-CA 125.355 1.462 . . . . 0.0 109.069 -174.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 84.2 t -94.26 103.15 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 103.879 -2.637 . . . . 0.0 103.879 173.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.63 122.59 24.87 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 173.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.5 t -97.63 113.65 32.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 104.307 -2.479 . . . . 0.0 104.307 174.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -100.13 146.37 17.71 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 119.755 1.162 . . . . 0.0 110.377 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.483 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 8.1 m-85 -129.48 73.5 81.54 Favored Pre-proline 0 C--O 1.243 0.74 0 CA-C-N 118.253 1.027 . . . . 0.0 110.097 -174.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.87 127.85 19.53 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.589 2.193 . . . . 0.0 108.802 173.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 6.9 t -105.89 148.47 27.57 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 123.958 0.903 . . . . 0.0 108.908 176.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.6 mt -76.43 -15.7 59.87 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 117.751 0.25 . . . . 0.0 111.31 177.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.1 51.6 57.42 Favored Glycine 0 C--N 1.337 0.605 0 C-N-CA 125.719 1.628 . . . . 0.0 112.092 174.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . 0.297 40.5 mmtm -111.66 -55.44 2.5 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.438 1.119 . . . . 0.0 112.477 -179.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 50.4 tp60 -95.68 149.7 21.18 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 173.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -93.48 139.62 30.52 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 176.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.5 -153.55 25.2 Favored Glycine 0 C--N 1.331 0.278 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -176.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.7 t -130.41 114.14 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -175.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -85.94 170.34 12.42 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 173.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -123.95 151.63 43.4 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 173.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.483 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 32.9 p90 -145.55 156.49 43.73 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 174.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -128.14 160.71 31.18 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 126.281 1.832 . . . . 0.0 111.229 -173.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 67.5 t -141.76 139.28 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 O-C-N 125.307 1.629 . . . . 0.0 108.141 173.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -143.22 121.7 12.43 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 128.043 2.537 . . . . 0.0 106.589 174.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.8 t -133.5 124.2 47.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -177.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.412 ' H ' HD11 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -90.52 164.37 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 173.374 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.0 t -145.15 134.45 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 -175.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.13 174.82 10.2 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 124.821 1.249 . . . . 0.0 107.934 -175.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -89.63 176.06 7.02 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 104.535 -2.394 . . . . 0.0 104.535 172.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.2 t -66.67 -4.14 8.16 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 120.239 -1.538 . . . . 0.0 113.709 -177.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -88.27 -15.38 35.95 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 120.608 1.549 . . . . 0.0 110.513 173.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.75 1.18 61.93 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.705 1.145 . . . . 0.0 112.114 -173.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -70.1 115.96 9.91 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 119.564 1.682 . . . . 0.0 108.403 174.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -67.54 143.79 55.95 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.439 1.496 . . . . 0.0 108.883 -176.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -139.3 -36.58 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 124.486 1.114 . . . . 0.0 113.569 -175.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -136.88 146.97 46.18 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.723 1.609 . . . . 0.0 106.817 -174.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 13.3 tm0? -147.84 150.84 34.92 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 121.105 -0.997 . . . . 0.0 108.671 174.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.4 m -88.05 113.62 55.7 Favored Pre-proline 0 CA--C 1.532 0.253 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -66.72 148.88 83.57 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 121.55 1.5 . . . . 0.0 112.346 -173.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -81.16 112.6 18.66 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.488 -173.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.595 7.1 m-80 172.37 -13.96 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.445 1 C-N-CA 138.022 6.529 . . . . 0.0 111.128 173.279 . . . . . . . . 3 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.69 81.44 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.309 1.844 . . . . 0.0 109.158 174.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.5 mt -133.9 147.78 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 127.606 2.362 . . . . 0.0 106.182 -174.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.427 ' CD1' ' CE1' ' A' ' 126' ' ' PHE . 0.9 OUTLIER -132.18 171.03 14.18 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.363 -1.29 . . . . 0.0 107.718 178.128 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -134.25 113.64 12.2 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 -173.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.57 126.51 53.66 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 -173.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 34.1 m -93.6 115.8 28.29 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 -175.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 4.3 m -115.39 166.43 11.88 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 123.818 0.847 . . . . 0.0 110.294 174.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.1 pp -131.92 161.46 33.0 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.862 1.665 . . . . 0.0 107.129 173.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.37 130.34 42.76 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.19 0.996 . . . . 0.0 109.971 177.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -157.93 163.06 38.24 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.193 1.797 . . . . 0.0 108.739 175.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 . . . . . 0 C--O 1.246 0.885 0 C-N-CA 129.527 3.131 . . . . 0.0 104.28 173.64 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.26 0 N-CA-C 107.078 -2.409 . . . . 0.0 107.078 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.9 m -164.27 176.84 8.79 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 118.694 -1.202 . . . . 0.0 113.281 -125.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.11 177.66 2.15 Favored 'General case' 0 CA--C 1.545 0.757 1 C-N-CA 133.262 4.625 . . . . 0.0 104.975 172.546 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 65.2 mtt -44.47 164.53 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.988 0 O-C-N 120.015 -1.678 . . . . 0.0 108.371 172.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 11.1 mp -42.87 114.8 0.64 Allowed 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -172.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -66.67 176.1 2.1 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 129.125 2.97 . . . . 0.0 110.28 -178.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -126.41 114.15 17.81 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -133.86 176.65 8.37 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 129.561 3.144 . . . . 0.0 107.29 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -53.6 160.56 1.26 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.462 1.505 . . . . 0.0 112.256 -175.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -72.97 176.03 6.1 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 123.321 1.534 . . . . 0.0 113.099 -173.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.2 m -92.76 175.93 6.63 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.066 177.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.7 tt -45.69 133.38 8.1 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.928 2.891 . . . . 0.0 113.45 -175.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -119.84 138.66 53.25 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.391 1.876 . . . . 0.0 108.618 173.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.27 119.39 6.75 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.921 1.688 . . . . 0.0 106.78 -178.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 17.6 p90 -136.95 157.76 45.99 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 119.607 1.094 . . . . 0.0 110.083 176.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.3 mp -91.83 116.52 33.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 103.119 -2.919 . . . . 0.0 103.119 173.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -79.33 140.07 37.62 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 123.648 1.689 . . . . 0.0 113.762 -173.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.84 -23.85 65.43 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 126.945 2.098 . . . . 0.0 116.006 -173.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 10.9 m80 -56.82 -39.03 73.44 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 43.8 tp60 -66.55 -43.81 84.05 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 123.485 0.714 . . . . 0.0 111.33 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.76 -36.3 71.92 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.704 0.802 . . . . 0.0 111.431 174.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 52.3 ttm-85 -54.62 -54.61 39.24 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 173.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.4 t -54.4 -26.32 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 119.334 0.97 . . . . 0.0 111.618 178.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mt -70.67 -44.69 66.5 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 173.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.4 pt -150.88 15.73 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 116.253 1.946 . . . . 0.0 116.253 -173.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.98 -1.2 8.65 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 128.363 2.887 . . . . 0.0 114.881 -174.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -101.8 149.0 24.63 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 129.777 3.231 . . . . 0.0 107.549 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -112.22 123.11 49.57 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.402 1.001 . . . . 0.0 109.328 -173.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -141.38 113.54 8.01 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.962 1.705 . . . . 0.0 109.458 -175.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -90.3 161.83 15.46 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 173.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.0 mp -140.74 113.53 4.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 173.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.55 119.82 23.05 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.5 mt -91.95 -65.83 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.914 0.886 . . . . 0.0 109.445 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.6 t -115.48 120.37 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 105.809 -1.922 . . . . 0.0 105.809 -173.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.4 p -120.25 120.29 35.66 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 103.844 -2.65 . . . . 0.0 103.844 173.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 45.69 38.95 4.55 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.376 1.471 . . . . 0.0 112.872 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.67 -10.91 1.34 Allowed Glycine 0 CA--C 1.543 1.803 0 O-C-N 120.656 -1.277 . . . . 0.0 114.586 -177.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -80.32 37.53 0.39 Allowed 'General case' 0 C--N 1.324 -0.501 1 C-N-CA 133.915 4.886 . . . . 0.0 110.381 -175.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 45.5 mtm -37.78 129.12 1.16 Allowed 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.426 1.891 . . . . 0.0 113.135 -172.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.429 ' C ' ' H ' ' A' ' 42' ' ' PHE . . . -65.35 165.68 16.93 Favored Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 113.92 -1.491 . . . . 0.0 108.456 173.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.52 33.23 0.32 Allowed 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 123.965 3.11 . . . . 0.0 111.259 173.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.429 ' H ' ' C ' ' A' ' 40' ' ' ALA . 13.5 p90 -54.01 -26.7 27.57 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 127.659 2.383 . . . . 0.0 113.121 -173.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 m -65.38 -32.38 73.98 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.949 1.299 . . . . 0.0 111.565 -173.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -58.81 -60.93 3.06 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.418 ' CG ' ' HZ2' ' A' ' 48' ' ' LYS . 11.2 m-20 -56.88 -40.4 76.14 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 177.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -56.65 -52.07 66.28 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.611 1.165 . . . . 0.0 110.428 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -85.67 -23.86 27.27 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 117.757 0.253 . . . . 0.0 111.652 -175.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.418 ' HZ2' ' CG ' ' A' ' 45' ' ' ASP . 25.0 ttpt -67.48 162.54 22.97 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 173.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.05 112.71 7.42 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 173.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -97.07 166.56 11.53 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.986 1.314 . . . . 0.0 108.48 173.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.6 tp60 -61.81 -28.7 69.65 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 117.756 -1.116 . . . . 0.0 110.87 173.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.425 ' CZ ' ' HA ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -139.42 -16.8 1.03 Allowed 'General case' 0 C--N 1.351 0.639 0 N-CA-C 120.479 3.511 . . . . 0.0 120.479 -173.326 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 78.9 mmm -84.51 -53.41 0.5 Allowed Pre-proline 0 N--CA 1.47 0.53 0 N-CA-C 117.601 2.445 . . . . 0.0 117.601 -173.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.9 -69.83 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.754 0 CA-C-N 121.152 1.447 . . . . 0.0 114.039 -173.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.47 114.12 8.28 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.404 1.082 . . . . 0.0 111.74 -173.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 72.5 mt -118.58 133.05 23.59 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 127.731 2.412 . . . . 0.0 106.248 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -83.34 160.22 15.03 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 122.746 2.297 . . . . 0.0 112.076 178.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.5 p -46.47 -41.29 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 125.833 1.653 . . . . 0.0 111.734 173.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -55.87 -36.97 68.18 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 126.224 1.81 . . . . 0.0 112.674 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 mm -78.4 112.86 16.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 103.663 -2.717 . . . . 0.0 103.663 173.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -78.64 -42.08 29.73 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 173.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.1 m -139.71 152.75 46.92 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.198 0.599 . . . . 0.0 111.485 -173.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 15.0 mmm -104.51 171.68 7.2 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 126.43 1.892 . . . . 0.0 106.851 173.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.261 90.2 m-20 -126.51 150.75 48.58 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 173.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -137.02 155.87 49.14 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 102.664 -3.087 . . . . 0.0 102.664 172.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.4 m -140.89 133.97 29.35 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 -175.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -146.99 166.02 28.09 Favored 'General case' 0 C--O 1.24 0.587 0 O-C-N 121.785 -0.572 . . . . 0.0 111.049 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -171.7 161.73 6.11 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 122.223 1.011 . . . . 0.0 112.788 176.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -95.34 -173.74 3.0 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 103.058 -2.942 . . . . 0.0 103.058 172.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.05 144.65 46.45 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 101.476 -3.527 . . . . 0.0 101.476 173.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 12.24 -62.82 0.0 OUTLIER Glycine 0 CA--C 1.542 1.757 1 C-N-CA 134.884 5.992 . . . . 0.0 120.78 -173.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -116.44 -6.69 11.73 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 121.978 2.889 . . . . 0.0 114.22 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.82 37.05 0.41 Allowed 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 119.329 3.085 . . . . 0.0 119.329 -173.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -53.73 114.82 1.69 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 122.826 2.557 . . . . 0.0 110.088 -177.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -83.61 155.52 23.19 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 175.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -104.95 145.45 30.4 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 104.281 -2.489 . . . . 0.0 104.281 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -128.94 162.42 27.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 120.169 1.35 . . . . 0.0 110.675 176.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -155.16 134.7 12.6 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 173.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -84.68 103.87 14.16 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.35 1.06 . . . . 0.0 109.762 -175.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.8 tt -69.27 -47.99 63.03 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.132 1.373 . . . . 0.0 109.001 176.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.7 m -130.34 138.22 50.32 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 125.453 1.501 . . . . 0.0 110.837 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -170.29 92.75 0.21 Allowed 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 102.354 -3.202 . . . . 0.0 102.354 172.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -165.27 154.8 12.75 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 119.998 1.272 . . . . 0.0 110.765 -174.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.3 t -77.39 165.57 24.24 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-O 121.878 0.847 . . . . 0.0 110.201 173.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.5 mt -126.34 -5.16 6.62 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 126.005 1.722 . . . . 0.0 112.158 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.631 ' CG ' ' H ' ' A' ' 87' ' ' LYS 0.396 14.1 t70 -89.85 176.2 6.92 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 120.067 1.303 . . . . 0.0 111.701 -176.43 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.631 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 9.0 mtmm -122.62 -48.81 2.03 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 129.37 3.068 . . . . 0.0 111.699 -173.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 90' ' ' MET . . . -94.16 -54.08 1.66 Allowed Glycine 0 CA--C 1.526 0.729 0 C-N-CA 125.026 1.298 . . . . 0.0 111.562 178.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.3 mp -79.37 15.0 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 C-N-CA 126.225 1.81 . . . . 0.0 109.437 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.44 ' H ' ' C ' ' A' ' 88' ' ' GLY . 19.8 ttp -43.5 141.74 1.33 Allowed 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 130.579 3.552 . . . . 0.0 110.584 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -159.83 175.56 12.95 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 130.293 3.437 . . . . 0.0 105.417 -173.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -139.99 113.89 7.68 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 173.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -70.94 146.82 53.86 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 121.734 1.622 . . . . 0.0 109.691 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 23.4 p -132.45 162.4 31.27 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 125.436 1.494 . . . . 0.0 108.833 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.3 m -125.89 154.34 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 C-N-CA 123.882 0.873 . . . . 0.0 110.446 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -84.17 10.57 9.92 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.812 1.645 . . . . 0.0 112.738 -177.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.9 m -141.33 166.26 23.39 Favored Pre-proline 0 C--N 1.326 -0.446 0 C-N-CA 126.43 1.892 . . . . 0.0 108.396 -173.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -66.41 163.04 33.83 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 121.013 1.142 . . . . 0.0 109.756 173.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -64.01 -10.13 19.96 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.337 1.055 . . . . 0.0 112.466 177.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -142.96 163.27 33.24 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.45 1.5 . . . . 0.0 107.657 173.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 166.83 -161.74 35.53 Favored Glycine 0 N--CA 1.461 0.324 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 82.1 p -119.6 154.39 34.01 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 117.944 0.872 . . . . 0.0 110.307 174.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.0 t -95.01 113.35 61.16 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 104.308 -2.479 . . . . 0.0 104.308 173.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -91.01 157.99 3.92 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.819 2.346 . . . . 0.0 114.355 -173.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -64.56 -19.76 65.83 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 123.087 1.423 . . . . 0.0 110.469 -176.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -79.55 113.78 17.96 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 129.367 3.067 . . . . 0.0 106.485 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.92 109.26 0.3 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.558 1.072 . . . . 0.0 108.295 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.8 m -124.42 138.19 54.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -174.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.5 t -91.29 141.66 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 88.9 t -125.14 103.83 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 127.423 2.289 . . . . 0.0 105.493 176.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -69.65 151.12 46.27 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 173.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.9 t -129.46 113.51 28.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 173.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -96.49 147.14 18.56 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 119.76 1.164 . . . . 0.0 110.701 -174.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.478 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 10.1 m-85 -131.29 73.37 80.3 Favored Pre-proline 0 C--O 1.245 0.853 0 CA-C-N 118.457 1.129 . . . . 0.0 111.048 -174.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.76 119.74 6.71 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.582 2.188 . . . . 0.0 106.887 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 5.6 t -99.45 145.62 27.23 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.3 mt -77.56 -6.76 54.82 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 118.787 -0.625 . . . . 0.0 111.986 -175.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.19 49.14 78.48 Favored Glycine 0 C--N 1.341 0.821 0 C-N-CA 126.379 1.942 . . . . 0.0 113.529 173.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -112.34 -68.53 0.92 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.17 0.985 . . . . 0.0 111.544 -174.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 46.4 tp60 -95.73 153.11 17.9 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 173.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -93.42 146.97 23.36 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 177.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 141.32 -151.84 22.89 Favored Glycine 0 C--N 1.332 0.31 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.0 t -127.62 114.02 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -177.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -85.31 168.73 14.42 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 173.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -122.99 159.37 28.48 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.826 0.851 . . . . 0.0 109.12 173.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.478 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 10.4 p90 -147.13 146.4 29.91 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 173.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -101.32 149.68 23.78 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 126.707 2.003 . . . . 0.0 110.349 -177.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 72.2 t -144.63 138.66 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 125.901 1.681 . . . . 0.0 107.31 173.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -160.58 129.69 4.87 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 173.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 41.1 t -134.31 138.77 49.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 -173.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -105.07 165.27 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.2 t -143.47 136.93 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -174.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.21 167.16 22.1 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 124.686 1.194 . . . . 0.0 109.195 -177.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.413 ' C ' HD21 ' A' ' 134' ' ' ASN . 0.1 OUTLIER -83.76 168.79 15.86 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 103.882 -2.636 . . . . 0.0 103.882 172.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.2 t -58.57 -21.19 52.15 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 120.333 1.424 . . . . 0.0 113.876 -174.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -75.01 -9.8 58.88 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.335 -1.478 . . . . 0.0 113.404 174.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 97.72 -2.63 60.47 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.868 1.223 . . . . 0.0 114.576 -175.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -68.8 118.2 11.47 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 120.183 1.991 . . . . 0.0 108.644 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.5 m -67.23 142.14 57.03 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.3 pt -140.64 -38.25 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 124.702 1.201 . . . . 0.0 113.861 -174.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -128.77 143.66 50.98 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 177.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -146.62 130.48 17.14 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 61.8 m -62.73 140.3 97.13 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -81.78 145.23 14.24 Favored 'Trans proline' 0 N--CA 1.443 -1.458 0 CA-C-N 120.258 1.128 . . . . 0.0 109.463 174.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -80.69 112.78 18.38 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -173.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.373 24.0 m-80 172.8 -16.19 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.695 1 C-N-CA 134.006 4.923 . . . . 0.0 112.463 173.663 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.83 97.62 0.08 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 122.166 0.984 . . . . 0.0 110.035 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.1 mm -130.98 138.02 54.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 -176.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.425 ' HB2' ' CE2' ' A' ' 126' ' ' PHE . 0.6 OUTLIER -117.98 170.0 9.19 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 173.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -136.21 113.51 10.69 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.29 1.036 . . . . 0.0 108.347 -173.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.36 122.55 48.05 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -174.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 18.6 m -84.02 118.68 24.21 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 7.7 m -119.26 166.37 13.08 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 123.834 0.854 . . . . 0.0 109.735 174.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.7 pp -131.27 161.77 31.52 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 126.408 1.883 . . . . 0.0 106.359 173.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.7 tm0? -63.85 136.66 57.57 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 174.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -165.32 113.08 0.98 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.194 1.398 . . . . 0.0 107.41 173.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 . . . . . 0 C--O 1.247 0.95 0 C-N-CA 130.284 3.434 . . . . 0.0 104.585 173.846 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.795 0 N-CA-C 107.553 -2.219 . . . . 0.0 107.553 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.3 m -60.88 176.06 0.44 Allowed 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 143.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -63.16 113.21 3.02 Favored 'General case' 0 C--N 1.343 0.323 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 173.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 75.9 mtp -161.86 176.54 10.74 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 129.676 3.19 . . . . 0.0 105.09 -173.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -104.8 113.56 27.23 Favored 'General case' 0 N--CA 1.451 -0.412 1 N-CA-C 99.209 -4.367 . . . . 0.0 99.209 172.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -83.66 154.59 23.61 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -174.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -150.54 151.26 32.37 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 102.946 -2.983 . . . . 0.0 102.946 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -73.37 175.62 6.76 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.075 -1.421 . . . . 0.0 109.907 173.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -55.99 158.02 4.14 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 129.185 2.994 . . . . 0.0 112.331 -174.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -139.83 167.97 20.88 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.21 1.404 . . . . 0.0 107.546 173.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m -176.35 177.11 1.54 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 130.427 3.491 . . . . 0.0 108.501 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.4 tt -43.4 124.06 3.27 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 126.136 1.774 . . . . 0.0 112.36 -176.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -112.25 135.38 53.0 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.295 1.438 . . . . 0.0 108.13 173.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.51 120.67 10.15 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.057 1.743 . . . . 0.0 106.638 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 20.4 p90 -135.62 168.49 19.16 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 118.656 0.662 . . . . 0.0 109.884 175.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.3 mt -102.74 113.83 40.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 103.278 -2.86 . . . . 0.0 103.278 174.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -80.42 149.75 30.03 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.947 1.356 . . . . 0.0 110.567 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.99 -11.55 29.87 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -173.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 45.3 m80 -53.42 -44.74 69.02 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.909 1.232 . . . . 0.0 113.63 -173.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 49.7 tp60 -70.28 -39.96 74.59 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 118.867 -1.133 . . . . 0.0 111.159 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.1 -36.72 78.05 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.065 0.546 . . . . 0.0 111.637 176.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.413 HH21 ' CD ' ' A' ' 28' ' ' GLU . 27.5 ttm180 -55.16 -56.93 14.32 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 174.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 60.3 t -54.18 -24.28 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 124.183 0.993 . . . . 0.0 111.835 177.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.8 mt -77.83 -41.55 36.67 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 173.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.1 pt -146.85 14.9 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 117.212 2.301 . . . . 0.0 117.212 -172.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.4 10.3 21.84 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 127.503 2.477 . . . . 0.0 114.724 -174.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -101.25 174.03 6.18 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.32 2.248 . . . . 0.0 109.86 -174.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.413 ' CD ' HH21 ' A' ' 22' ' ' ARG . 7.9 tp10 -125.82 124.1 40.18 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.673 0.789 . . . . 0.0 109.253 -177.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -157.38 113.95 2.96 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.688 1.195 . . . . 0.0 111.259 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -95.18 167.7 11.2 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 173.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.4 mp -137.08 113.27 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 104.912 -2.255 . . . . 0.0 104.912 173.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.0 113.96 19.56 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 177.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.4 mt -90.09 -54.41 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.9 t -125.61 113.73 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 -173.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.6 p -110.59 113.81 26.71 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 103.399 -2.815 . . . . 0.0 103.399 173.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.346 1.5 pp20? 46.26 34.13 2.08 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -178.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.73 -6.88 76.29 Favored Glycine 0 CA--C 1.536 1.385 0 O-C-N 120.751 -1.218 . . . . 0.0 114.705 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.3 37.23 0.09 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 130.621 3.568 . . . . 0.0 112.64 -174.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 40.9 mtt -38.09 117.66 0.62 Allowed 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 -173.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.94 164.8 58.04 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 113.885 -1.507 . . . . 0.0 107.851 173.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.72 36.59 0.43 Allowed 'Trans proline' 0 CA--C 1.548 1.206 0 C-N-CA 124.236 3.291 . . . . 0.0 112.024 174.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -53.93 -26.51 25.67 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 127.059 2.144 . . . . 0.0 113.756 -173.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 m -60.06 -33.42 72.04 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.922 1.689 . . . . 0.0 112.218 -173.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.457 ' CD2' ' HZ1' ' A' ' 48' ' ' LYS . 58.9 t60 -60.72 -53.62 55.25 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.279 0.9 OUTLIER -76.13 -29.97 58.03 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -176.609 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -55.37 -47.45 75.77 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.2 -0.938 . . . . 0.0 108.762 173.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -73.08 -37.4 66.77 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 118.562 -0.732 . . . . 0.0 111.762 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.457 ' HZ1' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -126.33 112.99 16.33 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 120.324 1.42 . . . . 0.0 109.54 -176.466 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -172.73 176.86 3.05 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 120.008 1.276 . . . . 0.0 108.407 -178.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -44.29 140.72 2.1 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 173.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? -43.62 -33.78 1.27 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.085 1.754 . . . . 0.0 113.649 -173.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.44 -11.07 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 129.307 3.043 . . . . 0.0 115.601 173.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -117.54 -66.03 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.438 0 C-N-CA 126.534 1.934 . . . . 0.0 114.833 173.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.22 -70.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.729 1.619 . . . . 0.0 112.644 -173.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.26 113.15 20.49 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -174.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 55.7 mt -104.37 119.48 53.79 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 -175.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -74.21 154.22 46.45 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.319 1.346 . . . . 0.0 109.694 -177.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.0 p -41.68 -42.66 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 126.6 1.96 . . . . 0.0 113.008 177.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -59.2 -40.57 86.2 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 126.084 1.754 . . . . 0.0 112.734 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.1 mm -77.54 112.77 15.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 101.762 -3.422 . . . . 0.0 101.762 173.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -84.18 -28.95 27.01 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.568 -177.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.4 m -147.96 170.72 17.1 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.842 1.257 . . . . 0.0 110.941 -173.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.4 mmm -126.69 162.32 26.05 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 126.418 1.887 . . . . 0.0 106.937 172.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -109.34 146.32 34.57 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 173.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -135.84 153.06 51.61 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 103.082 -2.933 . . . . 0.0 103.082 172.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.1 m -140.36 133.65 29.76 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -176.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -146.07 165.05 30.21 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 121.824 -0.547 . . . . 0.0 111.0 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -167.14 144.72 4.73 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 175.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.24 -179.31 6.15 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 172.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -107.42 85.46 2.13 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.396 1.478 . . . . 0.0 111.582 -174.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.04 -59.5 0.01 OUTLIER Glycine 0 CA--C 1.537 1.426 0 C-N-CA 128.462 2.934 . . . . 0.0 119.322 173.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -116.91 -13.02 10.67 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.926 1.863 . . . . 0.0 112.95 173.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.77 37.24 0.09 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 130.755 3.622 . . . . 0.0 118.984 -173.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -44.79 113.77 0.61 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 122.397 2.362 . . . . 0.0 111.511 -174.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -96.2 120.38 36.38 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 174.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -80.01 149.09 30.86 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -134.38 160.78 36.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 119.735 1.152 . . . . 0.0 111.044 176.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -151.61 136.8 17.48 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 173.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -80.09 104.0 10.35 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.104 0.961 . . . . 0.0 110.434 -178.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.8 tt -63.14 -46.71 85.97 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.148 1.379 . . . . 0.0 108.658 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.3 m -130.2 138.97 50.85 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.716 1.206 . . . . 0.0 110.768 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.2 tt -170.28 92.66 0.21 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 103.305 -2.85 . . . . 0.0 103.305 173.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -166.82 153.89 9.02 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.485 0.584 . . . . 0.0 111.544 -174.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.2 t -72.69 163.27 28.35 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 173.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.4 mt -125.96 -20.18 4.64 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 116.661 -1.638 . . . . 0.0 112.691 174.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.473 ' CG ' ' H ' ' A' ' 87' ' ' LYS . 26.5 t0 -84.26 171.14 13.0 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 121.587 1.994 . . . . 0.0 111.526 174.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.473 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER -109.33 -47.57 3.38 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 129.192 2.997 . . . . 0.0 112.711 174.486 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 90' ' ' MET . . . -70.08 -72.52 0.86 Allowed Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 176.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mp -76.85 19.52 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 128.41 2.684 . . . . 0.0 110.228 -175.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.448 ' H ' ' C ' ' A' ' 88' ' ' GLY . 15.3 ttp -43.75 131.21 5.46 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 127.753 2.421 . . . . 0.0 108.968 -177.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -158.21 114.01 2.72 Favored 'General case' 0 CA--C 1.508 -0.673 0 C-N-CA 126.54 1.936 . . . . 0.0 106.906 -173.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -97.49 134.39 22.61 Favored Pre-proline 0 C--N 1.323 -0.567 0 O-C-N 124.209 0.943 . . . . 0.0 109.726 -173.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.42 154.25 65.25 Favored 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 121.294 1.329 . . . . 0.0 109.054 173.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 21.5 p -139.28 157.07 46.55 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 126.648 1.979 . . . . 0.0 106.736 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.8 m -126.39 153.84 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-N 119.302 0.955 . . . . 0.0 112.861 178.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -72.54 7.73 1.73 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 127.004 2.122 . . . . 0.0 113.521 174.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.8 m -141.08 165.8 26.82 Favored Pre-proline 0 C--N 1.326 -0.414 0 C-N-CA 126.03 1.732 . . . . 0.0 108.295 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -67.57 168.09 19.13 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.377 1.384 . . . . 0.0 111.082 174.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -64.09 -10.98 25.62 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.733 1.213 . . . . 0.0 112.512 175.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -145.37 164.41 31.58 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.539 1.536 . . . . 0.0 107.355 173.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 160.99 -161.68 33.05 Favored Glycine 0 C--O 1.226 -0.37 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 56.5 p -118.59 151.56 37.68 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 173.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 46.5 t -88.17 113.39 54.84 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 175.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -73.79 158.23 46.94 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.093 2.529 . . . . 0.0 112.881 -173.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -65.27 -19.62 66.05 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 -173.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . 0.266 0.0 OUTLIER -116.81 143.69 45.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 118.563 0.62 . . . . 0.0 112.36 174.159 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -43.04 108.19 0.1 Allowed 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 127.052 2.141 . . . . 0.0 110.951 -174.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.2 m -116.41 143.49 45.49 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 175.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.4 t -97.18 119.39 45.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 C-N-CA 124.403 1.081 . . . . 0.0 111.11 -173.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 72.3 t -95.56 103.58 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 173.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.4 120.55 25.12 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 173.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.5 t -93.23 113.55 28.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 103.872 -2.64 . . . . 0.0 103.872 173.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -92.99 151.12 20.28 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.411 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 11.1 m-85 -132.33 73.81 76.78 Favored Pre-proline 0 C--O 1.244 0.792 0 CA-C-N 118.81 1.305 . . . . 0.0 110.821 -176.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -63.05 114.77 2.59 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.707 2.271 . . . . 0.0 109.679 173.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 9.6 t -91.29 151.15 21.01 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 173.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.1 mt -72.11 -11.19 60.63 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 117.862 0.301 . . . . 0.0 111.545 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 54.44 30.4 49.49 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 127.413 2.435 . . . . 0.0 116.506 173.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 43.1 mttt -120.15 -32.05 4.26 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.388 1.594 . . . . 0.0 113.915 176.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 45.7 tp60 -96.65 146.67 24.64 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 173.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -95.4 148.39 22.5 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 174.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.44 -153.8 23.19 Favored Glycine 0 C--N 1.336 0.537 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 176.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.7 t -131.45 118.45 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.761 0.825 . . . . 0.0 108.864 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -93.54 175.27 6.81 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.67 1.188 . . . . 0.0 109.746 173.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -126.15 155.77 41.17 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.538 1.935 . . . . 0.0 106.997 173.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.411 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 48.9 p90 -150.63 155.49 39.48 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.322 1.049 . . . . 0.0 108.913 174.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -113.93 143.71 44.27 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 125.62 1.568 . . . . 0.0 111.131 -174.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 59.0 t -144.65 119.76 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 173.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -146.42 143.03 28.74 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.209 1.404 . . . . 0.0 108.092 177.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.0 t -139.16 141.06 36.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 119.392 0.996 . . . . 0.0 109.939 -173.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -107.3 163.57 5.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 173.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.6 t -141.85 138.3 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -173.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.66 173.37 11.78 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.625 1.57 . . . . 0.0 107.786 -177.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 44.5 p-10 -88.12 176.07 7.44 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 172.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.1 t -67.0 -6.59 17.54 Favored 'General case' 0 CA--C 1.553 1.081 0 O-C-N 120.439 -1.413 . . . . 0.0 112.318 -176.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -84.54 -15.94 44.04 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 120.435 -1.416 . . . . 0.0 110.663 173.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.99 4.62 61.38 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.735 1.159 . . . . 0.0 112.547 -173.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -77.08 117.43 18.64 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.827 1.814 . . . . 0.0 108.937 175.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.7 m -64.32 141.87 58.62 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 126.48 1.912 . . . . 0.0 108.88 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -140.01 -39.03 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 124.931 1.293 . . . . 0.0 113.769 -174.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -130.94 142.35 50.35 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 -177.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -148.59 124.5 10.62 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -176.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 25.1 m -64.1 140.48 97.91 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 174.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.47 141.28 13.97 Favored 'Trans proline' 0 N--CA 1.441 -1.585 0 CA-C-N 119.997 1.035 . . . . 0.0 109.993 177.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 28.2 mp0 -80.4 112.63 17.92 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 -173.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.343 38.5 m-80 172.65 -16.53 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 1 C-N-CA 132.201 4.201 . . . . 0.0 111.311 173.405 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -56.22 98.2 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.024 1.73 . . . . 0.0 110.13 177.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 2.8 mt -135.69 147.22 28.68 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 -174.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -129.08 175.56 8.6 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 173.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -133.23 139.58 47.05 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 -175.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -124.1 122.35 37.61 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 177.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 34.5 m -83.64 118.45 23.85 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 174.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 4.9 m -117.78 166.12 12.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.442 0.639 . . . . 0.0 110.08 173.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.4 pp -138.6 159.7 41.45 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.96 1.704 . . . . 0.0 106.893 173.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.63 127.63 33.45 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.751 0.82 . . . . 0.0 110.302 175.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -147.95 114.32 5.92 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.026 0.93 . . . . 0.0 111.057 176.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 . . . . . 0 C--O 1.256 1.442 0 C-N-CA 129.324 3.049 . . . . 0.0 105.406 173.53 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.617 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.3 p -80.51 112.53 17.95 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 120.549 2.175 . . . . 0.0 106.274 167.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -177.23 176.47 1.35 Allowed 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 130.963 3.705 . . . . 0.0 104.562 173.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.07 112.54 18.83 Favored 'General case' 0 N--CA 1.45 -0.444 1 N-CA-C 99.403 -4.295 . . . . 0.0 99.403 172.44 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 28.4 tp -177.0 113.37 0.09 Allowed 'General case' 0 CA--C 1.513 -0.465 1 N-CA-C 99.978 -4.082 . . . . 0.0 99.978 173.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -140.95 114.0 8.49 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 -173.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.6 113.83 0.44 Allowed 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 127.216 2.206 . . . . 0.0 105.46 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.9 tp60 -158.44 176.37 12.52 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 176.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.2 160.0 11.12 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.822 1.249 . . . . 0.0 108.98 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -68.11 168.38 12.22 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 122.88 1.324 . . . . 0.0 111.569 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m -171.75 176.97 3.5 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 129.117 2.967 . . . . 0.0 108.895 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.1 tt -42.96 129.14 4.41 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 128.066 2.546 . . . . 0.0 113.758 -173.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -117.55 144.6 44.96 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.174 1.79 . . . . 0.0 108.63 173.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.27 123.2 7.51 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.325 1.85 . . . . 0.0 106.615 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 25.7 p90 -141.27 160.93 39.09 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.737 1.153 . . . . 0.0 110.188 178.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -96.13 144.73 9.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 104.509 -2.404 . . . . 0.0 104.509 173.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -97.61 162.74 13.15 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -173.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.9 -18.13 54.39 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 126.114 1.766 . . . . 0.0 114.367 174.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -59.47 -41.13 89.04 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 119.747 1.158 . . . . 0.0 108.978 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 -66.68 -43.49 84.32 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.49 -31.82 73.08 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 121.965 -0.459 . . . . 0.0 111.83 174.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.4 ttm105 -57.71 -55.61 32.58 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 173.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 89.4 t -52.67 -23.85 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.632 1.173 . . . . 0.0 111.766 175.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.3 mt -75.12 -48.31 24.35 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 117.676 -1.154 . . . . 0.0 113.685 173.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.1 pt -155.71 20.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 -172.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.08 -1.65 54.64 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 126.55 2.024 . . . . 0.0 114.811 -176.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -79.92 176.47 9.71 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 129.2 3.0 . . . . 0.0 111.154 -173.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -125.47 126.97 45.75 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.516 1.526 . . . . 0.0 107.416 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.261 98.7 mt-10 -159.77 112.72 2.16 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.877 1.217 . . . . 0.0 112.994 173.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -97.01 162.6 13.31 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 172.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.9 mp -141.39 113.43 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 173.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.03 119.87 23.43 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.8 mt -96.14 -58.44 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 119.024 0.829 . . . . 0.0 109.789 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.0 t -126.48 142.95 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 126.396 1.878 . . . . 0.0 109.069 -173.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.9 p -153.02 135.2 14.89 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 102.318 -3.215 . . . . 0.0 102.318 173.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 44.46 33.91 0.98 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.882 1.273 . . . . 0.0 113.167 -174.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.33 -2.99 8.57 Favored Glycine 0 CA--C 1.541 1.718 0 O-C-N 120.246 -1.534 . . . . 0.0 115.399 -177.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -64.86 37.63 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.512 1 C-N-CA 132.204 4.202 . . . . 0.0 115.076 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.5 mmt -37.82 113.75 0.3 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.376 1.471 . . . . 0.0 110.397 -173.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.402 ' C ' ' H ' ' A' ' 42' ' ' PHE . . . -68.32 168.1 15.38 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 125.764 1.626 . . . . 0.0 111.54 -174.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.77 16.73 0.5 Allowed 'Trans proline' 0 CA--C 1.548 1.216 0 C-N-CA 123.474 2.782 . . . . 0.0 111.558 173.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.402 ' H ' ' C ' ' A' ' 40' ' ' ALA . 25.6 p90 -53.43 -26.48 20.16 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 127.031 2.133 . . . . 0.0 112.158 -175.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 m -57.2 -30.95 64.98 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 126.889 2.075 . . . . 0.0 111.293 -173.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 64.8 t60 -63.02 -54.72 33.84 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.294 0.497 . . . . 0.0 110.482 178.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.305 0.9 OUTLIER -76.16 -24.63 54.83 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -178.579 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -61.12 -44.16 97.76 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 173.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -68.7 -45.19 72.29 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.387 0.675 . . . . 0.0 111.135 174.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.42 112.79 16.03 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.019 -176.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -176.62 113.88 0.1 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 173.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.48 112.61 20.54 Favored 'General case' 0 CA--C 1.527 0.07 0 N-CA-C 103.556 -2.757 . . . . 0.0 103.556 173.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -176.48 -66.62 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.944 1.698 . . . . 0.0 108.205 173.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.42 -16.49 0.07 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -173.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.0 -66.36 0.23 Allowed Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 120.675 1.58 . . . . 0.0 113.394 -173.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -74.4 -68.31 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 CA-C-N 121.11 1.432 . . . . 0.0 110.732 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.64 119.72 15.2 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.164 0.985 . . . . 0.0 110.187 -174.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.9 mt -124.81 129.93 24.42 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 127.494 2.318 . . . . 0.0 106.312 -177.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -77.76 156.82 31.47 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.124 1.882 . . . . 0.0 111.506 176.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.1 p -41.16 -43.91 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 127.697 2.399 . . . . 0.0 112.932 176.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -59.69 -34.05 72.38 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 126.328 1.851 . . . . 0.0 113.44 -175.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.9 mm -70.02 113.05 5.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 178.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -81.32 -29.07 34.3 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.184 0.594 . . . . 0.0 110.43 178.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.4 m -159.47 165.41 33.12 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.068 0.947 . . . . 0.0 109.08 -175.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 68.8 mtp -125.64 160.27 30.1 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 173.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 -111.21 134.33 52.88 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 124.564 1.145 . . . . 0.0 108.898 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -120.5 165.62 14.72 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 103.189 -2.893 . . . . 0.0 103.189 172.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.1 m -149.17 137.55 20.89 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 120.318 -1.489 . . . . 0.0 108.109 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -148.32 165.6 30.54 Favored 'General case' 0 C--O 1.24 0.597 0 O-C-N 121.801 -0.562 . . . . 0.0 111.167 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -162.2 145.35 11.66 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 174.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -91.8 140.46 29.66 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 173.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.43 78.26 0.17 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 -173.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.87 -73.14 0.12 Allowed Glycine 0 CA--C 1.53 1.025 0 C-N-CA 126.876 2.179 . . . . 0.0 117.517 173.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.97 26.34 9.87 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.473 1.636 . . . . 0.0 112.276 173.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -102.38 37.09 1.97 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.41 2.284 . . . . 0.0 111.168 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -38.81 113.36 0.3 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.98 1.312 . . . . 0.0 112.203 -173.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -114.22 119.97 38.86 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 175.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -84.38 152.5 24.02 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -134.56 160.71 37.22 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.809 1.186 . . . . 0.0 110.675 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -154.11 135.07 13.83 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 173.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -80.6 103.63 10.58 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.3 tt -61.43 -40.85 95.96 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 173.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 m -155.89 145.44 21.01 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 120.896 -1.128 . . . . 0.0 112.502 177.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.445 ' H ' ' HD3' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -153.25 93.53 1.72 Allowed 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 173.339 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.445 ' HD3' ' H ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -156.41 161.57 40.09 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 121.081 1.764 . . . . 0.0 111.52 -177.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 27.4 t -81.57 162.9 22.96 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.419 0.628 . . . . 0.0 109.375 173.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 74.7 mt -116.38 -14.96 10.99 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.054 1.741 . . . . 0.0 110.864 174.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -96.32 164.27 12.72 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 175.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.9 mmtm -138.55 -32.38 0.7 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.259 1.824 . . . . 0.0 113.263 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -64.36 -63.67 4.15 Favored Glycine 0 CA--C 1.54 1.648 0 N-CA-C 106.787 -2.525 . . . . 0.0 106.787 172.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.8 mp -76.81 21.77 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 129.473 3.109 . . . . 0.0 110.219 175.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 3.5 ttp -43.2 132.85 4.16 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 125.579 2.609 . . . . 0.0 113.56 -173.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -149.01 150.87 33.55 Favored 'General case' 0 N--CA 1.421 -1.91 2 C-N-CA 135.317 5.447 . . . . 0.0 100.939 173.583 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -139.74 113.85 7.85 Favored Pre-proline 0 C--N 1.315 -0.899 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 173.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -67.68 157.4 61.94 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.962 2.441 . . . . 0.0 113.096 -173.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 39.1 p -136.94 170.11 16.65 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.464 1.506 . . . . 0.0 109.395 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.2 m -126.26 155.65 36.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 124.612 1.165 . . . . 0.0 108.322 173.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -101.6 35.32 2.34 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.024 1.329 . . . . 0.0 110.24 174.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.9 m -139.91 162.11 52.37 Favored Pre-proline 0 C--O 1.236 0.39 0 C-N-CA 127.057 2.143 . . . . 0.0 106.14 173.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -68.74 159.0 55.52 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 N-CA-C 109.213 -1.11 . . . . 0.0 109.213 173.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.38 -11.09 29.22 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 124.194 0.998 . . . . 0.0 112.014 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -141.64 163.68 32.26 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.376 1.47 . . . . 0.0 107.79 173.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 166.61 -161.74 35.47 Favored Glycine 0 C--O 1.226 -0.385 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -177.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.2 p -125.28 144.67 50.36 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.5 t -74.25 117.3 60.59 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 105.0 -2.222 . . . . 0.0 105.0 175.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -74.51 160.53 41.41 Favored 'Trans proline' 0 C--O 1.213 -0.751 0 C-N-CA 121.974 1.782 . . . . 0.0 115.231 -173.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . 0.304 93.0 m-70 -75.05 -14.65 60.62 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 118.114 2.635 . . . . 0.0 118.114 -172.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.96 151.68 36.18 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 173.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -49.05 108.7 0.2 Allowed 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 125.438 1.495 . . . . 0.0 109.025 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 21.1 m -123.89 138.89 54.41 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.8 t -80.05 152.34 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -174.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 86.8 t -129.9 109.85 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 174.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -82.16 135.26 35.31 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 174.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.5 t -116.41 116.58 52.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 173.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -94.43 149.78 19.52 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 125.665 1.603 . . . . 0.0 111.236 -178.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.466 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 4.8 m-85 -133.79 73.8 70.92 Favored Pre-proline 0 C--O 1.242 0.672 0 CA-C-N 118.037 0.919 . . . . 0.0 110.785 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.29 123.06 9.57 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.747 1.631 . . . . 0.0 108.068 173.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 5.7 t -105.27 152.53 22.77 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 173.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.7 mt -79.25 -10.48 59.82 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.558 0.617 . . . . 0.0 112.118 -174.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.03 32.47 66.85 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 125.534 1.54 . . . . 0.0 115.499 173.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.6 mttt -122.92 -29.38 3.95 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.546 1.673 . . . . 0.0 113.857 176.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.433 ' NE2' ' H ' ' A' ' 121' ' ' ASP . 59.3 tp60 -96.71 160.08 14.57 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 173.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.433 ' H ' ' NE2' ' A' ' 120' ' ' GLN . 11.7 m-20 -114.56 148.03 38.59 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 176.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 141.19 -155.97 25.37 Favored Glycine 0 C--N 1.333 0.404 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 176.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.3 t -125.33 113.68 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.75 164.43 15.97 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 173.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -121.93 158.13 29.72 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 121.422 -0.799 . . . . 0.0 110.459 174.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.466 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 24.0 p90 -153.2 161.47 42.39 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 124.21 1.004 . . . . 0.0 109.274 173.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -140.35 159.81 41.37 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 124.543 1.137 . . . . 0.0 111.839 -173.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 77.6 t -133.05 136.35 55.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 127.702 2.401 . . . . 0.0 107.575 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -145.18 122.54 11.61 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 173.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.4 t -135.52 131.56 51.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -97.83 164.86 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 173.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.8 t -144.03 134.49 21.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 -175.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.48 173.9 11.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.282 -1.326 . . . . 0.0 108.55 -175.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -86.32 176.11 8.08 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 105.142 -2.169 . . . . 0.0 105.142 172.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.2 t -58.75 -31.38 68.29 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.846 -1.158 . . . . 0.0 112.216 -173.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -81.22 -4.15 54.59 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.39 -0.819 . . . . 0.0 112.581 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.81 7.0 57.92 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.218 0.914 . . . . 0.0 113.976 175.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -70.32 114.97 8.97 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.762 1.781 . . . . 0.0 108.688 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -69.52 141.89 53.78 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.641 0.776 . . . . 0.0 108.953 -176.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.08 -38.39 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 124.687 1.195 . . . . 0.0 113.475 -174.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -134.02 146.86 50.78 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 16.2 tm0? -148.42 153.98 39.27 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.278 1.031 . . . . 0.0 108.758 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 36.3 m -83.52 114.18 51.76 Favored Pre-proline 0 CA--C 1.529 0.162 0 C-N-CA 125.044 1.338 . . . . 0.0 108.535 -176.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -61.95 143.53 95.48 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 CA-C-N 120.294 1.141 . . . . 0.0 110.08 -173.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -81.49 112.52 18.81 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.913 -173.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.624 30.0 m-80 172.4 -11.48 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 1 C-N-CA 135.992 5.717 . . . . 0.0 112.694 173.169 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.38 75.08 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.021 2.128 . . . . 0.0 110.7 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -118.8 145.47 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 128.061 2.545 . . . . 0.0 105.434 178.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -126.91 169.34 13.38 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 174.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -136.93 113.42 10.09 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.524 1.13 . . . . 0.0 108.197 -173.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 49.0 tttt -99.29 123.3 43.45 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 31.1 m -83.47 116.7 22.65 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 173.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 25.5 m -114.49 164.99 13.22 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.5 pp -142.82 160.05 41.06 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.975 1.31 . . . . 0.0 108.191 174.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.12 127.32 32.42 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.528 1.131 . . . . 0.0 110.433 175.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -155.55 116.44 3.88 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.673 1.189 . . . . 0.0 110.807 175.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 . . . . . 0 C--O 1.247 0.974 0 C-N-CA 128.963 2.905 . . . . 0.0 105.445 173.55 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.829 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.9 m -92.18 112.9 25.01 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 165.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -176.89 176.12 1.5 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.737 2.415 . . . . 0.0 106.766 -178.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 52.8 ttm -136.63 112.69 9.7 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 102.074 -3.306 . . . . 0.0 102.074 172.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -177.01 176.08 1.47 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 129.453 3.101 . . . . 0.0 105.91 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -114.3 113.24 24.32 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 103.552 -2.759 . . . . 0.0 103.552 173.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -162.72 176.49 10.24 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 130.826 3.65 . . . . 0.0 103.361 -177.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -125.06 173.34 8.77 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 129.354 3.062 . . . . 0.0 106.329 173.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -132.31 163.78 27.9 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 176.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -93.31 176.1 6.52 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.7 1.2 . . . . 0.0 113.932 -173.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.7 m -168.17 177.07 5.68 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 129.003 2.921 . . . . 0.0 109.531 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.7 tt -42.85 129.32 4.31 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 128.328 2.651 . . . . 0.0 113.876 -173.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -117.17 142.14 47.4 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.187 2.195 . . . . 0.0 109.243 173.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.75 117.59 5.85 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.424 1.89 . . . . 0.0 106.652 -177.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 18.4 p90 -138.13 143.31 40.28 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.734 1.152 . . . . 0.0 109.337 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.9 mp -83.91 113.7 23.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 104.856 -2.276 . . . . 0.0 104.856 176.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -78.66 151.23 32.35 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 122.707 1.241 . . . . 0.0 111.118 -176.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.15 -9.76 49.07 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 127.216 2.206 . . . . 0.0 115.619 -173.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -54.48 -38.62 66.62 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 119.7 1.136 . . . . 0.0 112.952 -173.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 49.5 tp60 -73.84 -40.3 63.39 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.809 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.35 -39.08 78.56 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.516 1.126 . . . . 0.0 110.885 173.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -55.46 -58.69 6.72 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 88.5 t -54.1 -24.35 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.664 1.186 . . . . 0.0 112.08 177.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.5 mt -73.12 -46.01 53.69 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 174.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.8 pt -154.51 18.39 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 -172.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.75 14.56 63.08 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.7 1.619 . . . . 0.0 113.218 -174.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -100.67 159.83 14.85 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 126.239 1.815 . . . . 0.0 109.236 -175.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -118.83 128.83 54.82 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -174.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -148.9 113.22 5.25 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 174.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -95.43 154.89 16.98 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 102.706 -3.072 . . . . 0.0 102.706 172.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.3 mm -135.31 113.31 15.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 104.535 -2.394 . . . . 0.0 104.535 173.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.03 114.28 19.79 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 -176.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.9 mt -87.49 -61.53 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.1 t -125.72 142.11 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 125.533 1.533 . . . . 0.0 108.974 -173.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.0 p -149.81 124.29 9.66 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 102.921 -2.992 . . . . 0.0 102.921 173.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 44.34 33.95 0.96 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.697 1.599 . . . . 0.0 113.582 -174.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.96 -5.95 4.26 Favored Glycine 0 CA--C 1.544 1.852 0 O-C-N 120.663 -1.273 . . . . 0.0 114.932 -176.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -75.73 37.61 0.15 Allowed 'General case' 0 N--CA 1.468 0.442 1 C-N-CA 133.248 4.619 . . . . 0.0 111.114 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 30.7 mtp -37.84 131.92 0.98 Allowed 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.886 1.674 . . . . 0.0 114.531 -172.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.03 162.26 69.94 Favored Pre-proline 0 N--CA 1.448 -0.552 0 CA-C-N 113.746 -1.57 . . . . 0.0 107.945 173.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.79 39.6 0.58 Allowed 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 124.172 3.248 . . . . 0.0 111.421 174.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -55.07 -26.55 38.49 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.695 1.998 . . . . 0.0 112.142 -173.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.6 m -60.73 -27.92 68.29 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.89 1.676 . . . . 0.0 110.786 -174.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -57.23 -65.74 0.57 Allowed 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.663 1.185 . . . . 0.0 109.713 174.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.91 -24.36 62.45 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -178.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -65.82 -50.12 65.75 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.611 0.641 . . . . 0.0 110.338 174.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -77.11 -40.66 45.02 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.453 -0.78 . . . . 0.0 109.393 -176.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.4 ttmt -63.97 160.91 16.79 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 175.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -79.04 112.67 16.48 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 117.947 -1.501 . . . . 0.0 110.154 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -97.24 172.02 8.07 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 172.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -65.95 -26.29 67.51 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.287 -0.883 . . . . 0.0 110.96 173.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.77 -16.18 2.98 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 -173.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.99 -66.52 0.43 Allowed Pre-proline 0 N--CA 1.47 0.537 0 CA-C-N 121.473 1.942 . . . . 0.0 115.008 -173.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -83.68 -65.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.805 0 CA-C-N 122.0 1.75 . . . . 0.0 112.023 -174.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.26 120.5 16.03 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.094 1.358 . . . . 0.0 110.593 -173.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.3 mt -129.4 129.6 23.26 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 126.461 1.904 . . . . 0.0 106.215 -175.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -78.89 158.5 27.54 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.271 1.981 . . . . 0.0 111.393 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.4 p -41.64 -49.1 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 126.408 1.883 . . . . 0.0 112.068 174.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -59.17 -40.26 85.09 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 126.638 1.975 . . . . 0.0 113.024 -176.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.4 mm -73.18 112.76 9.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 102.256 -3.239 . . . . 0.0 102.256 174.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -81.22 -36.78 29.62 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 114.664 -1.153 . . . . 0.0 108.922 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.8 m -141.84 168.62 19.33 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 123.883 0.739 . . . . 0.0 111.968 -173.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 70.8 mtp -126.81 155.57 42.65 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 172.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 46.6 m-20 -107.22 149.29 27.89 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 174.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -135.15 155.07 51.32 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 129.788 3.235 . . . . 0.0 103.015 172.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.5 m -140.71 134.2 29.99 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 -177.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -146.82 165.03 30.94 Favored 'General case' 0 C--O 1.239 0.528 0 O-C-N 121.803 -0.561 . . . . 0.0 110.952 176.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.22 163.43 5.81 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.736 1.215 . . . . 0.0 111.169 174.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.45 ' C ' ' HD1' ' A' ' 105' ' ' HIS . . . -106.1 170.63 7.8 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 173.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.08 101.84 13.43 Favored 'General case' 0 N--CA 1.445 -0.708 0 O-C-N 119.966 -1.709 . . . . 0.0 109.099 -174.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 44.58 -48.73 0.0 OUTLIER Glycine 0 CA--C 1.54 1.637 1 C-N-CA 133.14 5.162 . . . . 0.0 121.032 174.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -116.92 -18.99 10.01 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 121.85 2.825 . . . . 0.0 115.78 174.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.48 37.1 0.56 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 128.185 2.594 . . . . 0.0 117.908 -173.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -48.99 114.11 0.93 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 122.53 2.423 . . . . 0.0 110.283 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -83.65 153.14 24.41 Favored 'General case' 0 C--N 1.335 -0.029 0 C-N-CA 125.376 1.47 . . . . 0.0 107.857 174.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -97.46 151.02 20.41 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -133.98 159.88 39.42 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.905 1.229 . . . . 0.0 110.616 174.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -156.16 141.55 17.6 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 173.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -91.75 103.66 16.2 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.309 1.043 . . . . 0.0 108.899 -174.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.7 tt -73.26 -44.09 59.94 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.154 1.382 . . . . 0.0 108.104 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.2 m -136.83 137.35 39.65 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.237 1.415 . . . . 0.0 110.218 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -170.3 92.94 0.21 Allowed 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 102.022 -3.325 . . . . 0.0 102.022 173.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -162.29 152.44 16.66 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 118.647 -0.692 . . . . 0.0 111.41 -174.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.5 t -69.85 167.71 16.72 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 122.326 1.06 . . . . 0.0 112.511 173.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.9 mt -126.51 -9.61 6.27 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 126.593 1.957 . . . . 0.0 113.37 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.576 ' CG ' ' H ' ' A' ' 87' ' ' LYS 0.348 14.4 t70 -101.53 162.22 13.06 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 121.625 2.011 . . . . 0.0 113.665 -175.489 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.576 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 0.7 OUTLIER -106.32 -48.76 3.5 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 129.476 3.11 . . . . 0.0 112.293 -173.286 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 90' ' ' MET . . . -94.05 -49.7 2.4 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 124.865 1.222 . . . . 0.0 111.754 -177.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 mt -81.31 17.56 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 126.052 1.741 . . . . 0.0 109.179 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.43 ' H ' ' C ' ' A' ' 88' ' ' GLY . 14.4 ttp -43.49 130.64 5.12 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 130.215 3.406 . . . . 0.0 109.77 -177.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.255 . . -162.47 166.67 24.63 Favored 'General case' 0 N--CA 1.441 -0.908 1 C-N-CA 133.179 4.591 . . . . 0.0 104.351 -173.578 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -141.88 145.54 36.98 Favored Pre-proline 0 N--CA 1.473 0.678 0 CA-C-N 118.923 0.783 . . . . 0.0 110.453 173.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -77.61 145.74 23.51 Favored 'Trans proline' 0 N--CA 1.443 -1.454 0 C-N-CA 121.532 1.488 . . . . 0.0 109.352 173.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 23.8 p -129.14 153.93 47.21 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 126.047 1.739 . . . . 0.0 107.353 176.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.2 m -126.06 150.37 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 119.382 0.992 . . . . 0.0 111.579 -174.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -80.52 9.08 6.46 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.432 1.893 . . . . 0.0 113.552 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.6 m -143.38 163.45 36.93 Favored Pre-proline 0 C--N 1.327 -0.381 0 C-N-CA 124.97 1.308 . . . . 0.0 109.06 -177.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -66.2 162.16 37.1 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.334 1.356 . . . . 0.0 109.339 173.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -66.44 -12.0 54.91 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.119 0.968 . . . . 0.0 112.035 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -140.81 163.49 32.78 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.155 1.382 . . . . 0.0 107.796 173.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.24 -160.83 33.46 Favored Glycine 0 C--O 1.227 -0.341 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 72.1 p -119.14 147.93 43.64 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 174.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.1 t -81.31 113.4 41.23 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 100.983 -3.71 . . . . 0.0 100.983 173.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -92.29 167.4 2.91 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.28 1.986 . . . . 0.0 116.837 -172.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.45 ' HD1' ' C ' ' A' ' 69' ' ' ALA . 76.0 m-70 -75.94 10.46 1.86 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.688 1.195 . . . . 0.0 114.167 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.93 122.49 45.46 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 176.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.26 105.25 0.14 Allowed 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 174.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.0 m -114.27 136.56 52.83 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -174.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 26.6 t -95.13 114.97 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -174.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 78.7 t -93.69 103.36 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 N-CA-C 103.514 -2.772 . . . . 0.0 103.514 173.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -85.19 140.85 30.58 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 173.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.5 t -115.61 113.83 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 104.108 -2.553 . . . . 0.0 104.108 174.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -95.76 150.4 19.64 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 125.525 1.536 . . . . 0.0 109.919 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.468 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 7.9 m-85 -130.0 73.5 81.34 Favored Pre-proline 0 C--O 1.243 0.721 0 CA-C-N 118.478 1.139 . . . . 0.0 110.366 -173.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.16 121.96 9.78 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.351 2.034 . . . . 0.0 107.898 173.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 8.7 t -103.67 149.85 24.57 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 175.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.1 mt -81.58 -8.02 59.66 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 118.752 -0.642 . . . . 0.0 111.332 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.2 49.19 78.04 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 126.312 1.91 . . . . 0.0 113.323 173.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -112.47 -75.69 0.6 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.116 0.958 . . . . 0.0 111.152 -173.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 51.2 tp60 -83.08 152.19 25.45 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 173.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -93.47 142.6 27.15 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 178.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.52 -154.68 25.94 Favored Glycine 0 C--N 1.331 0.294 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -177.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.3 t -128.14 113.78 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -86.63 169.57 12.61 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 173.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -132.19 162.22 31.46 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.14 0.576 . . . . 0.0 109.818 175.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.468 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 20.2 p90 -144.91 147.15 32.42 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 173.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -104.21 144.75 31.18 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 127.437 2.295 . . . . 0.0 109.474 -174.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 43.7 t -137.43 143.43 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 123.605 0.762 . . . . 0.0 110.02 173.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -157.5 119.4 3.74 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 128.454 2.702 . . . . 0.0 105.616 174.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.444 ' H ' ' HB ' ' A' ' 143' ' ' THR . 61.6 t -130.33 121.81 52.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.413 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -85.77 167.18 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-O 123.018 1.389 . . . . 0.0 107.501 173.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.1 t -143.24 132.64 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 C-N-CA 127.448 2.299 . . . . 0.0 105.829 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.15 174.84 10.1 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.448 1.099 . . . . 0.0 108.596 -176.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -88.98 176.09 7.15 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 172.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.7 t -67.55 -3.57 9.15 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 120.499 -1.376 . . . . 0.0 113.58 -176.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -91.36 -12.76 33.97 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 120.364 1.438 . . . . 0.0 110.581 173.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 93.26 -0.77 69.02 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.557 1.075 . . . . 0.0 111.926 -173.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 59.9 m-20 -67.73 115.42 7.27 Favored 'General case' 0 C--N 1.343 0.306 0 CA-C-N 119.427 1.613 . . . . 0.0 108.005 174.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -71.5 147.3 47.89 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.415 1.486 . . . . 0.0 109.386 -174.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.48 -33.87 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -136.83 147.45 46.56 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -173.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.2 tm0? -148.81 150.12 32.5 Favored 'General case' 0 N--CA 1.462 0.129 0 O-C-N 121.378 -0.826 . . . . 0.0 109.309 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.444 ' HB ' ' H ' ' A' ' 130' ' ' VAL . 24.1 m -82.29 113.75 46.23 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 175.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -64.86 146.43 88.03 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 121.62 1.547 . . . . 0.0 112.21 -173.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -77.72 112.55 14.68 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.303 19.5 m-80 172.71 -17.2 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 1 C-N-CA 137.773 6.429 . . . . 0.0 109.553 173.936 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.6 82.57 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.062 1.745 . . . . 0.0 109.627 174.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.2 mm -121.72 136.03 59.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 176.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.412 ' HB2' ' CE2' ' A' ' 126' ' ' PHE . 6.5 m-85 -112.85 163.51 14.53 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 174.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -138.32 113.4 9.28 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.022 1.329 . . . . 0.0 108.395 -173.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.33 121.43 44.37 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -174.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 23.1 m -84.53 115.59 22.67 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 126.042 1.737 . . . . 0.0 106.726 -175.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 4.2 m -113.98 166.35 11.69 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.185 0.902 . . . . 0.0 109.425 173.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.9 pp -134.22 162.31 32.5 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.626 1.57 . . . . 0.0 106.914 173.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.5 120.34 11.51 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 123.982 0.913 . . . . 0.0 109.907 175.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -163.93 114.17 1.28 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.063 1.345 . . . . 0.0 109.841 176.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 . . . . . 0 C--O 1.256 1.431 0 C-N-CA 128.936 2.894 . . . . 0.0 105.546 173.786 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.977 0 N-CA-C 108.407 -1.877 . . . . 0.0 108.407 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.2 t -61.16 177.05 0.38 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 144.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.1 m80 -44.72 131.51 6.84 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 102.717 -3.068 . . . . 0.0 102.717 172.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.0 ptm -43.62 112.46 0.39 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 116.586 2.069 . . . . 0.0 116.586 -172.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.4 mt -177.0 113.34 0.09 Allowed 'General case' 0 N--CA 1.45 -0.432 2 C-N-CA 137.999 6.52 . . . . 0.0 95.855 173.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -148.81 176.04 10.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 120.252 1.387 . . . . 0.0 110.152 -173.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -136.19 172.99 12.21 Favored 'General case' 0 N--CA 1.428 -1.551 0 C-N-CA 130.018 3.327 . . . . 0.0 102.191 173.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -140.25 175.18 9.81 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 128.822 2.849 . . . . 0.0 109.43 -175.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.4 mp0 -69.1 165.01 21.22 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.035 1.734 . . . . 0.0 110.531 174.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -96.99 173.8 7.09 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.152 1.781 . . . . 0.0 110.458 -177.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . 0.295 4.5 m -175.87 176.57 1.8 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.49 2.316 . . . . 0.0 114.811 173.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.9 tt -65.26 137.69 57.73 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 130.302 3.441 . . . . 0.0 112.018 -176.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -126.91 138.38 53.29 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.257 2.223 . . . . 0.0 108.342 173.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.11 118.72 6.53 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 -175.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 14.2 p90 -135.6 175.45 9.58 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.707 1.203 . . . . 0.0 110.574 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.6 mp -114.22 141.19 31.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 103.52 -2.77 . . . . 0.0 103.52 173.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -93.11 158.73 15.62 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -173.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.34 -15.13 59.03 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 113.122 -1.854 . . . . 0.0 113.497 177.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -61.02 -43.31 99.08 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 119.795 1.18 . . . . 0.0 108.428 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -66.55 -49.56 66.04 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 122.83 0.452 . . . . 0.0 111.143 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.17 -35.31 67.07 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.468 0.707 . . . . 0.0 111.785 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.438 HH21 ' CD ' ' A' ' 28' ' ' GLU . 26.9 ttm105 -56.23 -56.73 17.34 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 175.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.4 t -53.78 -25.58 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 118.738 0.699 . . . . 0.0 111.513 177.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.8 mt -72.45 -43.8 63.26 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 173.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.0 pt -149.93 16.01 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 116.555 2.058 . . . . 0.0 116.555 -173.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.24 9.78 44.1 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 127.398 2.428 . . . . 0.0 114.683 -175.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -101.43 175.9 5.42 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 127.273 2.229 . . . . 0.0 109.709 -174.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.438 ' CD ' HH21 ' A' ' 22' ' ' ARG . 16.6 tp10 -120.68 122.18 39.91 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -155.91 113.49 3.29 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.737 0.815 . . . . 0.0 112.344 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -96.04 159.34 15.01 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 103.002 -2.962 . . . . 0.0 103.002 172.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 84.2 mt -134.39 113.4 17.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 174.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.05 114.25 23.5 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -174.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.6 mt -89.05 -62.84 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.614 0.766 . . . . 0.0 109.355 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.7 t -116.0 128.87 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 126.147 1.779 . . . . 0.0 107.725 -173.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 54.5 p -132.02 124.51 29.43 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 102.643 -3.095 . . . . 0.0 102.643 173.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.475 ' C ' ' H ' ' A' ' 38' ' ' LYS 0.265 1.7 pm0 44.07 40.77 3.64 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.417 1.487 . . . . 0.0 112.863 -175.001 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.01 -31.76 1.08 Allowed Glycine 0 CA--C 1.542 1.724 0 C-N-CA 126.268 1.89 . . . . 0.0 114.916 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.475 ' H ' ' C ' ' A' ' 36' ' ' GLU 0.462 8.8 tmtt? -54.31 37.66 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.835 1 C-N-CA 137.85 6.46 . . . . 0.0 116.126 174.966 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 42.5 mtt -38.01 142.73 0.15 Allowed 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.215 1.806 . . . . 0.0 115.418 -173.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.84 160.29 83.06 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 173.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -74.81 37.69 0.48 Allowed 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 124.217 3.278 . . . . 0.0 111.994 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -55.76 -26.66 46.84 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 126.6 1.96 . . . . 0.0 113.196 -173.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.7 m -54.77 -39.32 68.26 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.451 2.3 . . . . 0.0 112.672 -173.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.614 ' CE1' ' HZ3' ' A' ' 48' ' ' LYS . 5.4 t-80 -58.0 -65.94 0.56 Allowed 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.811 1.644 . . . . 0.0 109.724 178.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -70.91 -27.19 63.6 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-O 118.076 -0.964 . . . . 0.0 111.689 -173.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -69.79 -49.17 55.45 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.812 1.245 . . . . 0.0 111.557 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -71.94 -32.1 66.98 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.31 0.959 . . . . 0.0 109.566 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.614 ' HZ3' ' CE1' ' A' ' 44' ' ' HIS . 34.7 ttmt -65.2 165.7 10.99 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 172.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.88 112.96 5.22 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 173.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.404 ' H ' ' HG3' ' A' ' 54' ' ' PRO . 4.7 tt0 -96.56 172.41 7.94 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.53 -30.49 63.12 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 117.51 -1.233 . . . . 0.0 112.651 177.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.79 -16.76 2.55 Favored 'General case' 0 C--N 1.348 0.503 0 N-CA-C 118.027 2.603 . . . . 0.0 118.027 -173.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 91.0 mmm -92.13 -52.83 0.27 Allowed Pre-proline 0 N--CA 1.469 0.524 0 N-CA-C 118.164 2.654 . . . . 0.0 118.164 -173.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.404 ' HG3' ' H ' ' A' ' 50' ' ' GLN . 36.6 Cg_endo -68.76 -70.0 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.697 0 CA-C-N 121.67 1.632 . . . . 0.0 113.698 -173.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.59 114.08 8.33 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.721 0.808 . . . . 0.0 110.504 -173.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 62.4 mt -119.45 127.26 26.54 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 127.097 2.159 . . . . 0.0 106.335 -177.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -77.31 156.58 33.08 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.125 1.883 . . . . 0.0 110.752 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.7 p -42.58 -43.77 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 127.136 2.174 . . . . 0.0 113.1 177.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -62.21 -41.35 98.29 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 126.181 1.792 . . . . 0.0 112.831 -174.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.6 mm -67.64 112.93 3.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 102.912 -2.995 . . . . 0.0 102.912 174.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -81.65 -27.11 34.26 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 118.716 -0.659 . . . . 0.0 109.512 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.4 m -155.27 168.96 25.34 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.383 1.073 . . . . 0.0 110.59 -173.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.1 mtm -126.26 151.02 48.01 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 172.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -104.92 113.29 26.79 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 122.882 0.473 . . . . 0.0 110.422 -176.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -100.76 153.02 19.8 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 103.06 -2.941 . . . . 0.0 103.06 172.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.3 m -138.17 133.71 33.64 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 -177.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -143.81 163.56 33.02 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.42 175.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -172.74 157.03 3.65 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.173 173.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.55 -173.6 4.59 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 172.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -123.49 134.51 53.88 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 101.478 -3.527 . . . . 0.0 101.478 173.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 16.49 -55.86 0.0 OUTLIER Glycine 0 CA--C 1.534 1.227 1 C-N-CA 135.274 6.178 . . . . 0.0 120.671 -176.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -116.61 -14.97 10.85 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 120.721 2.261 . . . . 0.0 113.999 -177.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.84 37.16 0.35 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 129.303 3.041 . . . . 0.0 118.859 -173.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -56.95 113.81 1.84 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 123.239 2.745 . . . . 0.0 110.307 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -85.81 155.72 20.88 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 125.38 1.472 . . . . 0.0 108.288 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -102.82 150.09 23.84 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 177.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -136.21 160.88 37.34 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.949 1.25 . . . . 0.0 110.905 176.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -153.53 140.13 18.86 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 172.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -87.1 103.44 15.39 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.9 tt -74.27 -40.79 62.09 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 175.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.4 m -138.34 135.97 35.9 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.328 1.051 . . . . 0.0 111.591 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -165.63 93.18 0.56 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 102.188 -3.264 . . . . 0.0 102.188 173.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.12 154.42 23.56 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 121.001 -1.062 . . . . 0.0 110.053 -174.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.4 t -73.89 169.05 18.22 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.716 0.77 . . . . 0.0 110.477 173.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.0 mt -122.34 -21.54 5.79 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 116.179 -1.867 . . . . 0.0 110.849 174.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -106.11 152.29 23.61 Favored 'General case' 0 C--N 1.353 0.741 0 CA-C-N 121.528 1.967 . . . . 0.0 110.773 173.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.481 ' HE3' ' HA ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -120.33 -23.85 6.07 Favored 'General case' 0 N--CA 1.445 -0.718 1 C-N-CA 135.67 5.588 . . . . 0.0 113.982 179.879 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 90' ' ' MET . . . -72.92 -71.57 1.07 Allowed Glycine 0 CA--C 1.533 1.214 0 N-CA-C 107.118 -2.393 . . . . 0.0 107.118 173.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 mp -77.12 26.52 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 130.052 3.341 . . . . 0.0 110.358 174.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.483 ' H ' ' C ' ' A' ' 88' ' ' GLY . 4.7 ttp -42.95 127.76 4.17 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 129.04 2.936 . . . . 0.0 113.487 -173.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -146.99 152.17 38.18 Favored 'General case' 0 N--CA 1.431 -1.42 1 C-N-CA 133.556 4.742 . . . . 0.0 102.216 173.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -139.81 114.19 7.85 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 173.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -70.0 160.76 48.48 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.114 2.543 . . . . 0.0 114.919 -173.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.1 p -137.03 167.11 22.15 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.532 1.933 . . . . 0.0 109.76 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.9 m -126.54 154.76 36.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.038 0.935 . . . . 0.0 111.432 173.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -78.94 9.58 4.16 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.592 2.357 . . . . 0.0 113.574 178.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.7 m -140.84 164.19 37.86 Favored Pre-proline 0 C--N 1.327 -0.4 0 C-N-CA 124.593 1.157 . . . . 0.0 109.557 -175.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -65.58 163.09 31.38 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.418 1.412 . . . . 0.0 109.699 173.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -62.9 -12.98 28.74 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 124.151 0.981 . . . . 0.0 112.423 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -143.66 164.85 29.27 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 120.334 1.425 . . . . 0.0 108.308 173.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.59 -161.96 35.39 Favored Glycine 0 C--O 1.228 -0.231 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 73.6 p -120.76 159.05 26.2 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 117.485 0.642 . . . . 0.0 109.784 174.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.9 t -94.05 113.18 59.96 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 173.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -93.32 163.75 2.45 Favored 'Trans proline' 0 C--O 1.218 -0.485 0 C-N-CA 122.861 2.374 . . . . 0.0 114.114 -173.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -73.26 2.11 8.07 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 120.303 -1.498 . . . . 0.0 113.887 -173.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.41 126.95 55.0 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-O 115.525 -2.179 . . . . 0.0 107.864 177.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -42.29 111.95 0.29 Allowed 'General case' 0 N--CA 1.462 0.155 0 O-C-N 125.299 1.624 . . . . 0.0 109.023 173.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.5 m -117.82 138.25 52.21 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 176.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.4 t -97.5 114.98 36.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 123.796 0.838 . . . . 0.0 110.035 -173.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 77.1 t -93.9 103.21 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 102.689 -3.078 . . . . 0.0 102.689 173.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -85.53 121.44 28.23 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 173.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.5 t -90.02 113.57 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 103.535 -2.765 . . . . 0.0 103.535 173.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -85.77 149.79 23.65 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.488 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 5.4 m-85 -135.62 73.56 61.38 Favored Pre-proline 0 C--O 1.244 0.779 0 CA-C-N 117.772 0.786 . . . . 0.0 109.229 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.3 114.42 3.44 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 N-CA-C 107.575 -1.741 . . . . 0.0 107.575 173.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 5.6 t -95.85 141.55 29.16 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 173.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.9 mt -81.92 -11.02 59.1 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 123.276 0.36 . . . . 0.0 110.716 -178.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 56.99 57.91 17.3 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 126.517 2.008 . . . . 0.0 111.871 173.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . 0.321 41.6 mmtm -113.05 -75.72 0.6 Allowed 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 117.589 -1.196 . . . . 0.0 111.065 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 49.0 tp60 -77.51 150.58 34.84 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 173.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -93.66 143.31 26.43 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 177.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.86 -152.93 24.88 Favored Glycine 0 C--N 1.334 0.442 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 19.3 t -128.34 113.71 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.96 167.41 13.75 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 173.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -127.97 163.26 24.89 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.431 0.692 . . . . 0.0 109.981 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.488 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 16.0 p90 -146.09 154.44 41.83 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.024 0.93 . . . . 0.0 108.899 173.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -114.39 149.24 36.46 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 127.55 2.34 . . . . 0.0 110.32 -174.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 63.2 t -140.16 143.49 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 125.043 1.337 . . . . 0.0 109.958 175.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -156.97 116.78 3.47 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 128.1 2.56 . . . . 0.0 105.488 173.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.485 ' H ' ' HB ' ' A' ' 143' ' ' THR . 46.3 t -126.41 121.76 59.65 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.826 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 176.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -91.13 162.62 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 O-C-N 124.543 1.152 . . . . 0.0 107.942 174.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.3 t -136.91 134.86 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 C-N-CA 125.442 1.497 . . . . 0.0 107.041 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.22 174.41 10.58 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.593 1.157 . . . . 0.0 108.854 -175.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -90.2 176.31 6.8 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 104.694 -2.335 . . . . 0.0 104.694 172.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.9 t -65.47 -4.24 5.53 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 120.4 -1.437 . . . . 0.0 113.871 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -90.3 -14.55 32.98 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 120.725 1.602 . . . . 0.0 110.833 173.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.16 1.08 65.11 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.402 1.001 . . . . 0.0 111.915 -173.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 -69.93 116.03 9.84 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 119.524 1.662 . . . . 0.0 108.209 174.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -69.74 143.63 52.98 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 125.702 1.601 . . . . 0.0 108.776 -175.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -141.4 -37.68 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 124.667 1.187 . . . . 0.0 113.915 -173.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -130.19 150.84 51.26 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.5 tm0? -150.0 148.25 28.83 Favored 'General case' 0 CA--C 1.517 -0.307 0 O-C-N 121.054 -1.029 . . . . 0.0 109.469 176.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.485 ' HB ' ' H ' ' A' ' 130' ' ' VAL . 28.7 m -79.17 113.51 36.82 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 103.541 -2.763 . . . . 0.0 103.541 173.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.56 144.74 80.1 Favored 'Trans proline' 0 N--CA 1.445 -1.37 0 CA-C-N 120.369 1.167 . . . . 0.0 110.072 -173.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -75.81 112.39 12.15 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 -174.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 172.91 -31.93 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 129.38 3.072 . . . . 0.0 109.484 -173.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.14 92.9 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.125 1.77 . . . . 0.0 109.381 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.1 mm -125.65 141.19 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.43 ' HB2' ' CE2' ' A' ' 126' ' ' PHE . 0.2 OUTLIER -124.32 166.45 15.9 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 174.151 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -133.7 113.45 12.36 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.359 1.064 . . . . 0.0 108.392 -173.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.4 tttt -100.85 122.65 43.81 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 32.7 m -83.45 117.82 23.33 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 174.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 10.0 m -118.74 166.09 13.2 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.852 0.751 . . . . 0.0 109.431 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.3 pp -138.61 161.81 36.18 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.2 1.4 . . . . 0.0 108.022 176.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.1 126.84 28.7 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.649 1.18 . . . . 0.0 110.345 176.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -158.34 166.96 31.02 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.314 1.846 . . . . 0.0 108.36 174.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 . . . . . 0 C--O 1.258 1.527 0 C-N-CA 128.591 2.757 . . . . 0.0 104.258 173.621 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.715 0 N-CA-C 106.577 -2.609 . . . . 0.0 106.577 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.3 m -58.69 169.56 0.94 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 140.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -70.43 112.85 7.03 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 173.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 33.8 tpp -176.41 174.56 1.92 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 127.663 2.385 . . . . 0.0 106.171 -175.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -87.65 114.0 23.86 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 101.991 -3.337 . . . . 0.0 101.991 173.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -75.61 157.27 34.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.313 0.577 . . . . 0.0 110.549 -174.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.23 147.19 6.5 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 130.76 3.624 . . . . 0.0 101.413 173.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -150.86 152.46 33.73 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 123.876 0.87 . . . . 0.0 108.727 173.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -111.77 176.15 5.14 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 126.078 1.751 . . . . 0.0 108.465 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -67.55 166.91 13.91 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-O 121.842 0.83 . . . . 0.0 109.807 173.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.9 m -166.77 176.13 7.34 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 130.291 3.436 . . . . 0.0 106.453 173.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.6 tt -47.17 124.67 6.82 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 120.903 1.683 . . . . 0.0 111.955 -174.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -116.32 145.02 43.51 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.914 0.885 . . . . 0.0 110.137 174.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.98 118.56 4.52 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 9.9 p90 -130.78 176.34 8.29 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.446 1.499 . . . . 0.0 110.534 176.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 5.9 mt -112.62 113.97 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 102.714 -3.069 . . . . 0.0 102.714 173.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -73.59 149.69 41.92 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 122.795 1.283 . . . . 0.0 109.85 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.21 -18.4 3.83 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -173.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -56.61 -34.45 67.23 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 119.515 1.052 . . . . 0.0 111.038 175.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.417 HE21 ' HA ' ' A' ' 20' ' ' GLN . 0.9 OUTLIER -61.2 -56.14 24.07 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 119.338 0.972 . . . . 0.0 110.633 174.525 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.85 -39.13 62.31 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.66 0.784 . . . . 0.0 111.799 174.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.9 ttm-85 -56.24 -59.25 5.21 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 121.019 -1.051 . . . . 0.0 108.86 175.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.5 t -52.94 -23.81 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 CA-C-N 119.322 0.965 . . . . 0.0 111.49 176.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.4 mt -78.59 -42.56 28.71 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 117.845 -1.074 . . . . 0.0 113.55 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.1 pt -150.42 16.79 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 116.826 2.158 . . . . 0.0 116.826 -172.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.84 7.1 27.58 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 127.952 2.691 . . . . 0.0 115.166 -176.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -100.96 176.31 5.31 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 128.953 2.901 . . . . 0.0 110.148 -173.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -123.18 115.44 21.78 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.882 0.873 . . . . 0.0 110.149 -175.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -157.63 113.97 2.89 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.209 1.803 . . . . 0.0 109.827 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -82.89 168.06 17.44 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 173.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.3 mp -137.56 113.09 10.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 173.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.73 114.15 22.47 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 -178.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.4 mt -88.75 -55.76 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -175.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.4 t -125.57 113.62 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 -174.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 94.6 p -111.89 126.88 55.59 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 102.432 -3.174 . . . . 0.0 102.432 173.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.263 0.7 OUTLIER 46.39 34.06 2.15 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.81 1.244 . . . . 0.0 114.251 175.352 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.26 -4.29 26.39 Favored Glycine 0 CA--C 1.544 1.861 0 C-N-CA 126.545 2.022 . . . . 0.0 115.561 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -76.97 37.16 0.18 Allowed 'General case' 0 N--CA 1.474 0.739 1 C-N-CA 133.98 4.912 . . . . 0.0 111.037 -173.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 35.0 mtt -38.04 118.6 0.7 Allowed 'General case' 0 C--O 1.232 0.183 0 C-N-CA 126.864 2.066 . . . . 0.0 114.568 -173.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.16 164.29 43.73 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 113.835 -1.529 . . . . 0.0 108.722 173.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -73.39 26.85 0.31 Allowed 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 123.931 3.087 . . . . 0.0 112.779 174.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -55.26 -26.61 40.99 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 125.891 1.676 . . . . 0.0 112.876 -174.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 m -65.05 -30.16 71.1 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.248 1.019 . . . . 0.0 110.77 -173.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.426 ' CE1' HH22 ' A' ' 47' ' ' ARG . 3.0 t60 -69.78 -57.31 5.25 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -58.95 -23.75 61.84 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.9 -64.96 0.8 Allowed 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 173.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.426 HH22 ' CE1' ' A' ' 44' ' ' HIS . 2.8 tmm_? -56.59 -22.88 36.75 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 127.132 2.173 . . . . 0.0 114.561 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -63.1 176.96 0.66 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 129.595 3.158 . . . . 0.0 110.675 -176.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.43 172.15 0.93 Allowed 'General case' 0 CA--C 1.544 0.713 0 O-C-N 120.425 -1.422 . . . . 0.0 109.874 173.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 5.1 tm0? -44.42 114.34 0.67 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.675 1.59 . . . . 0.0 111.517 -174.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -142.61 -66.29 0.39 Allowed 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.339 0.655 . . . . 0.0 109.366 174.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.7 tpp180 -145.38 -16.19 0.49 Allowed 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.503 ' H ' ' CD ' ' A' ' 54' ' ' PRO . 85.1 mtp -138.43 -24.08 0.01 OUTLIER Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 116.819 2.155 . . . . 0.0 116.819 -176.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.503 ' CD ' ' H ' ' A' ' 53' ' ' MET . 37.8 Cg_endo -72.5 -80.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.74 0 CA-C-N 123.035 2.12 . . . . 0.0 110.073 -173.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.27 113.99 7.97 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 96.3 mt -115.14 117.08 41.8 Favored Pre-proline 0 C--N 1.326 -0.435 0 C-N-CA 128.097 2.559 . . . . 0.0 105.32 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -73.61 157.85 48.11 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.537 1.491 . . . . 0.0 110.519 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.3 p -41.05 -42.58 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 126.225 1.81 . . . . 0.0 112.403 173.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -46.88 -42.45 17.47 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 127.338 2.255 . . . . 0.0 113.047 177.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.1 mm -75.64 112.97 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 177.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -79.95 -34.13 39.05 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 173.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.5 m -160.0 155.94 26.22 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.346 0.658 . . . . 0.0 111.135 -173.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 33.1 mtt -101.76 158.36 16.17 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 103.781 -2.674 . . . . 0.0 103.781 172.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -118.59 113.73 21.71 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 173.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 16' ' ' ILE . 29.6 m-85 -101.49 157.3 16.91 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 173.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.2 m -137.07 135.48 37.53 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 177.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -143.75 166.24 25.42 Favored 'General case' 0 CA--C 1.511 -0.538 0 O-C-N 121.729 -0.607 . . . . 0.0 110.058 177.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -163.61 148.42 10.82 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.965 174.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.45 -173.84 3.52 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 122.916 1.341 . . . . 0.0 107.785 172.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -115.18 95.74 5.34 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 127.934 2.494 . . . . 0.0 110.13 -173.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 37.06 -56.6 0.0 OUTLIER Glycine 0 CA--C 1.543 1.835 1 C-N-CA 132.713 4.959 . . . . 0.0 120.795 -176.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -116.89 -16.88 10.54 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 121.643 2.722 . . . . 0.0 114.458 173.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.27 37.28 0.1 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 129.255 3.022 . . . . 0.0 115.673 -174.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -38.75 113.59 0.31 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 121.552 1.978 . . . . 0.0 110.367 -174.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -89.24 114.11 25.42 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -74.97 147.11 41.12 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 104.897 -2.261 . . . . 0.0 104.897 174.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -133.17 160.24 37.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 119.585 1.084 . . . . 0.0 110.078 176.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -152.38 135.07 15.39 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 173.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -82.92 103.7 12.58 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.062 0.945 . . . . 0.0 108.838 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.7 tt -67.04 -42.25 85.14 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.191 1.397 . . . . 0.0 108.19 174.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.3 m -135.06 139.71 44.98 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.488 1.115 . . . . 0.0 110.966 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.1 tt -170.36 92.96 0.21 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 173.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -161.72 156.3 22.75 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 118.721 0.691 . . . . 0.0 111.269 -174.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.4 t -72.0 163.78 27.26 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.1 mt -125.85 -17.02 5.5 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 116.734 -1.603 . . . . 0.0 112.379 174.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.546 ' CG ' ' H ' ' A' ' 87' ' ' LYS . 20.8 t0 -87.21 175.61 7.97 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 121.66 2.027 . . . . 0.0 112.248 177.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.546 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -115.27 -49.0 2.78 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 129.702 3.201 . . . . 0.0 112.841 177.304 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.428 ' C ' ' H ' ' A' ' 90' ' ' MET . . . -78.88 -66.44 1.71 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 178.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.5 mp -76.78 16.41 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 128.285 2.634 . . . . 0.0 109.81 -176.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.428 ' H ' ' C ' ' A' ' 88' ' ' GLY . 13.1 ttp -43.54 133.07 4.58 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 128.643 2.777 . . . . 0.0 109.838 -173.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -157.6 115.62 3.11 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 125.962 1.705 . . . . 0.0 107.908 -173.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -98.27 135.23 21.35 Favored Pre-proline 0 C--N 1.324 -0.522 0 O-C-N 123.973 0.795 . . . . 0.0 109.547 -174.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.46 154.71 55.58 Favored 'Trans proline' 0 N--CA 1.447 -1.26 0 C-N-CA 121.548 1.499 . . . . 0.0 109.25 173.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 17.9 p -140.4 157.8 44.97 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.556 1.543 . . . . 0.0 108.09 174.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.9 m -126.53 153.72 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 119.143 0.883 . . . . 0.0 113.011 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -74.94 7.11 3.42 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.498 2.319 . . . . 0.0 113.584 174.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.2 m -141.34 165.16 30.65 Favored Pre-proline 0 C--N 1.326 -0.443 0 C-N-CA 125.311 1.444 . . . . 0.0 108.632 -176.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -66.63 166.72 21.13 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 121.077 1.185 . . . . 0.0 110.398 173.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.97 -9.08 18.72 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.61 1.164 . . . . 0.0 112.03 176.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -145.63 164.35 32.01 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.446 1.498 . . . . 0.0 107.84 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 160.24 -161.25 32.38 Favored Glycine 0 C--O 1.227 -0.295 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 27.2 p -120.69 151.46 39.48 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 173.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.1 t -88.64 113.6 56.3 Favored Pre-proline 0 N--CA 1.447 -0.583 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 174.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.4 158.67 47.87 Favored 'Trans proline' 0 CA--C 1.512 -0.613 0 C-N-CA 122.245 1.963 . . . . 0.0 112.736 -174.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -64.39 -26.25 68.38 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 116.692 2.108 . . . . 0.0 116.692 -172.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . 0.566 1.0 OUTLIER -116.94 151.54 36.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 119.406 1.003 . . . . 0.0 113.102 173.134 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -38.61 110.96 0.15 Allowed 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 128.175 2.59 . . . . 0.0 113.292 -173.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.9 m -124.89 143.28 50.93 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 173.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.8 t -93.57 128.73 44.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 124.739 1.216 . . . . 0.0 112.022 -173.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 70.3 t -111.49 103.21 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 173.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -80.38 127.7 32.71 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 173.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.6 t -101.26 113.36 37.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 N-CA-C 103.549 -2.76 . . . . 0.0 103.549 173.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -92.45 148.68 19.24 Favored Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -129.54 73.75 81.34 Favored Pre-proline 0 C--O 1.243 0.762 0 CA-C-N 118.238 1.019 . . . . 0.0 110.66 -175.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.32 114.64 2.76 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.789 2.326 . . . . 0.0 109.553 173.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 8.0 t -91.15 145.29 24.8 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 173.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.3 mt -72.43 -16.39 61.83 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 117.793 0.269 . . . . 0.0 110.613 176.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 59.26 22.15 55.21 Favored Glycine 0 C--O 1.221 -0.679 0 C-N-CA 126.785 2.136 . . . . 0.0 115.456 173.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt -93.86 -46.75 7.05 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 120.2 2.0 . . . . 0.0 111.405 -174.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -96.52 151.3 19.71 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -93.69 151.59 19.54 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 174.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.79 -152.6 22.7 Favored Glycine 0 C--N 1.333 0.387 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 176.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.8 t -128.2 114.29 33.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -86.8 175.21 8.33 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.468 1.107 . . . . 0.0 108.907 173.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -128.32 156.49 42.97 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.776 1.63 . . . . 0.0 107.835 173.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.447 ' CE1' ' CD1' ' A' ' 149' ' ' PHE . 42.3 p90 -150.13 152.91 35.46 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.89 1.276 . . . . 0.0 107.904 173.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -116.28 145.9 42.81 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.736 1.615 . . . . 0.0 112.322 -173.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 92.8 t -141.63 138.28 32.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 173.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -154.3 130.21 10.18 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.854 1.661 . . . . 0.0 106.962 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.0 t -136.23 130.88 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 -174.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -98.35 163.65 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 173.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.1 t -141.91 134.06 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 -174.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.82 175.78 9.15 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 126.178 1.791 . . . . 0.0 107.067 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -93.17 176.01 6.56 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 103.76 -2.681 . . . . 0.0 103.76 172.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.4 t -65.37 -4.23 5.26 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 120.077 -1.639 . . . . 0.0 113.539 -178.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -85.54 -15.47 42.6 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 120.826 1.648 . . . . 0.0 110.374 173.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.4 0.1 65.39 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.837 1.208 . . . . 0.0 112.03 -173.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -70.8 115.63 10.17 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 119.494 1.647 . . . . 0.0 108.42 175.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -64.79 142.23 58.5 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.896 1.678 . . . . 0.0 108.253 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -140.28 -36.38 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 124.517 1.127 . . . . 0.0 113.559 -174.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -135.35 149.05 49.62 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.601 1.16 . . . . 0.0 107.929 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -142.63 138.89 31.02 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 85.8 m -65.97 131.3 94.52 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 174.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.8 143.61 41.85 Favored 'Trans proline' 0 N--CA 1.443 -1.486 0 N-CA-C 108.796 -1.271 . . . . 0.0 108.796 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -85.3 112.83 21.15 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -173.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.297 0.9 OUTLIER 173.06 -10.44 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.725 1 C-N-CA 136.395 5.878 . . . . 0.0 110.457 174.015 . . . . . . . . 4 3 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.74 83.55 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.575 1.95 . . . . 0.0 112.069 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 3.9 mm -125.04 122.97 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 -178.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.447 ' CD1' ' CE1' ' A' ' 126' ' ' PHE . 1.0 OUTLIER -103.89 164.4 11.72 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 173.62 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -134.11 113.51 12.15 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -173.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 60.4 tttt -103.9 123.94 48.06 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.815 1.189 . . . . 0.0 109.453 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 25.0 m -83.55 114.57 21.6 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 174.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 5.5 m -116.96 166.63 11.96 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 124.487 1.115 . . . . 0.0 110.301 174.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.2 159.44 41.91 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 126.61 1.964 . . . . 0.0 107.881 -177.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -69.99 117.6 11.76 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.272 1.429 . . . . 0.0 111.283 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -140.38 165.77 26.52 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.881 2.073 . . . . 0.0 108.495 174.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 . . . . . 0 C--O 1.25 1.099 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 173.67 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.081 0 N-CA-C 108.412 -1.875 . . . . 0.0 108.412 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.0 m -143.03 176.06 9.37 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.691 1.597 . . . . 0.0 106.73 165.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 30.5 t-80 -119.99 139.8 51.94 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -175.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -76.81 175.53 9.36 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.007 1.723 . . . . 0.0 108.263 173.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -74.09 121.31 20.92 Favored 'General case' 0 C--N 1.335 -0.045 0 N-CA-C 102.01 -3.33 . . . . 0.0 102.01 173.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -44.12 113.15 0.49 Allowed 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.519 1.127 . . . . 0.0 112.159 -173.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 -164.69 176.48 8.81 Favored 'General case' 0 N--CA 1.437 -1.093 1 C-N-CA 133.388 4.675 . . . . 0.0 102.77 -174.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.99 113.75 25.81 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 125.234 1.414 . . . . 0.0 107.582 173.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -141.36 167.53 21.94 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 126.849 2.06 . . . . 0.0 106.817 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -142.47 169.72 17.04 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.165 0.986 . . . . 0.0 109.105 173.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.6 m -176.31 177.24 1.54 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 128.862 2.865 . . . . 0.0 109.405 -175.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.0 tt -43.14 130.89 4.56 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.849 2.46 . . . . 0.0 112.99 -176.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -115.77 140.83 48.84 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.679 2.391 . . . . 0.0 108.235 173.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.22 118.03 6.65 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -136.63 176.11 9.0 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.759 0.79 . . . . 0.0 109.264 177.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 12.6 mt -114.47 113.53 44.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 1 N-CA-C 99.573 -4.232 . . . . 0.0 99.573 173.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -78.59 144.88 35.11 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 122.674 1.226 . . . . 0.0 110.999 -173.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.7 -26.49 68.69 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.193 -1.367 . . . . 0.0 112.898 -173.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -67.14 -38.99 86.47 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -174.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -57.54 11.09 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 117.649 -1.167 . . . . 0.0 108.49 173.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.14 -41.42 48.82 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 119.567 1.076 . . . . 0.0 111.751 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -51.59 -65.07 0.62 Allowed 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 173.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 84.5 t -50.46 -24.1 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 125.089 1.355 . . . . 0.0 111.659 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.1 mt -84.35 -38.28 20.53 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.2 pt -145.33 14.06 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 117.275 2.324 . . . . 0.0 117.275 -173.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.83 0.24 2.03 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 128.826 3.107 . . . . 0.0 114.913 -174.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -101.94 134.53 45.0 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 129.36 3.064 . . . . 0.0 106.416 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -124.08 113.46 18.41 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.505 1.048 . . . . 0.0 110.549 -173.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -153.19 139.24 18.24 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 128.313 2.645 . . . . 0.0 106.014 173.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -87.03 166.2 15.23 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 173.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.98 113.2 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 104.434 -2.432 . . . . 0.0 104.434 173.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.79 113.93 23.92 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -177.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.3 mt -93.09 -56.25 5.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -176.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.3 t -126.27 133.72 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 125.904 1.682 . . . . 0.0 106.767 -174.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.9 p -140.13 126.84 20.48 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 102.164 -3.272 . . . . 0.0 102.164 173.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.269 6.2 pt-20 46.05 34.0 1.88 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.177 1.391 . . . . 0.0 113.514 -177.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 64.46 -3.53 1.81 Allowed Glycine 0 CA--C 1.544 1.865 0 O-C-N 120.273 -1.517 . . . . 0.0 114.173 -174.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.5 ttpt -79.72 37.12 0.34 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 131.055 3.742 . . . . 0.0 111.436 -173.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 38.0 mtt -37.82 122.88 1.02 Allowed 'General case' 0 C--O 1.24 0.585 0 C-N-CA 125.478 1.511 . . . . 0.0 112.825 -173.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.403 ' C ' ' H ' ' A' ' 42' ' ' PHE . . . -64.1 167.83 7.29 Favored Pre-proline 0 N--CA 1.449 -0.495 0 O-C-N 125.798 1.936 . . . . 0.0 108.052 173.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.57 29.26 0.24 Allowed 'Trans proline' 0 CA--C 1.548 1.19 0 C-N-CA 123.939 3.093 . . . . 0.0 112.365 174.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.403 ' H ' ' C ' ' A' ' 40' ' ' ALA . 14.6 p90 -53.86 -26.61 25.43 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 126.784 2.033 . . . . 0.0 113.022 -173.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 m -62.17 -29.88 70.66 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.243 1.417 . . . . 0.0 111.46 -173.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.564 ' CE1' ' HZ2' ' A' ' 48' ' ' LYS . 9.7 t-80 -55.3 -65.83 0.52 Allowed 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.098 1.359 . . . . 0.0 109.362 175.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.253 44.1 m-20 -76.44 -23.75 53.93 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.055 0.455 . . . . 0.0 111.571 -175.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -60.31 -44.64 95.24 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 120.099 -1.626 . . . . 0.0 108.331 173.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -40.22 74.6 Favored 'General case' 0 C--O 1.237 0.4 0 O-C-N 121.639 -0.663 . . . . 0.0 109.277 176.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.564 ' HZ2' ' CE1' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -125.68 112.56 16.25 Favored 'General case' 0 C--O 1.215 -0.722 0 O-C-N 120.562 -1.336 . . . . 0.0 110.517 -175.917 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -177.01 113.85 0.09 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-O 116.915 -1.517 . . . . 0.0 107.245 173.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -87.35 112.43 22.09 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 100.554 -3.869 . . . . 0.0 100.554 172.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -176.76 -67.01 0.01 OUTLIER 'General case' 0 C--O 1.232 0.159 0 C-N-CA 125.784 1.634 . . . . 0.0 107.101 174.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.49 ' CZ ' ' HA ' ' A' ' 52' ' ' ARG . 0.1 OUTLIER -155.72 -16.54 0.11 Allowed 'General case' 0 C--N 1.347 0.496 0 N-CA-C 117.049 2.241 . . . . 0.0 117.049 178.569 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.92 -66.74 0.29 Allowed Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 121.173 1.806 . . . . 0.0 114.097 -174.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -78.84 -64.41 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 CA-C-N 121.443 1.551 . . . . 0.0 110.646 -176.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.47 118.06 13.81 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.743 1.217 . . . . 0.0 110.842 -173.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.9 mt -126.14 116.25 23.76 Favored Pre-proline 0 N--CA 1.448 -0.543 0 C-N-CA 126.555 1.942 . . . . 0.0 106.612 -174.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -72.23 155.9 55.77 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.018 1.812 . . . . 0.0 110.353 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.9 p -40.32 -43.66 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 127.715 2.406 . . . . 0.0 112.854 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -59.89 -33.97 72.55 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 126.954 2.101 . . . . 0.0 114.076 -177.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.3 mm -68.47 112.93 3.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 104.098 -2.556 . . . . 0.0 104.098 175.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -81.86 -33.48 30.6 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.669 174.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.3 m -158.39 157.88 33.15 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.32 0.648 . . . . 0.0 109.301 -174.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 33.7 mtm -126.28 166.78 16.48 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 173.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -134.63 130.92 37.16 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -107.95 162.24 14.2 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 173.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.4 m -135.86 133.43 37.76 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -175.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -144.56 165.56 27.65 Favored 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 121.332 -0.855 . . . . 0.0 111.312 179.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.09 158.37 4.6 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 124.238 1.015 . . . . 0.0 110.898 174.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.549 ' C ' ' HD1' ' A' ' 105' ' ' HIS . . . -93.27 177.42 6.05 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 173.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.15 101.79 12.93 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 120.212 -1.555 . . . . 0.0 108.996 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 44.36 -53.82 0.0 OUTLIER Glycine 0 CA--C 1.541 1.669 1 C-N-CA 132.814 5.007 . . . . 0.0 120.363 175.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -116.9 -19.83 9.67 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 121.628 2.714 . . . . 0.0 115.396 174.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.71 37.17 0.14 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 128.56 2.744 . . . . 0.0 116.082 -173.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -44.36 113.49 0.54 Allowed 'General case' 0 CA--C 1.557 1.224 0 CA-C-N 121.891 2.132 . . . . 0.0 109.147 -174.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -84.35 162.55 20.0 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.346 1.459 . . . . 0.0 111.595 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -111.77 149.53 31.57 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -135.52 161.82 34.41 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 120.226 1.375 . . . . 0.0 111.142 175.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -155.49 139.11 16.01 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 173.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -88.78 103.84 16.35 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.959 1.303 . . . . 0.0 109.71 -175.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.9 tt -72.34 -47.66 47.95 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.289 1.435 . . . . 0.0 108.981 175.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 38.1 m -131.61 138.2 48.71 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.493 1.517 . . . . 0.0 111.161 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -168.83 92.69 0.29 Allowed 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 101.936 -3.357 . . . . 0.0 101.936 173.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -165.0 154.44 12.94 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 120.037 1.289 . . . . 0.0 112.486 -174.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.1 t -67.96 161.43 26.57 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 119.6 1.091 . . . . 0.0 110.243 173.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.9 mt -126.43 -2.61 6.83 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 125.772 1.629 . . . . 0.0 112.385 174.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.547 ' CG ' ' H ' ' A' ' 87' ' ' LYS 0.337 11.2 t70 -99.07 169.11 9.64 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.819 1.645 . . . . 0.0 112.169 -175.514 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.547 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 1.4 mppt? -109.2 -49.02 3.17 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 129.557 3.143 . . . . 0.0 111.631 -173.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.415 ' C ' ' H ' ' A' ' 90' ' ' MET . . . -105.95 -47.66 1.07 Allowed Glycine 0 CA--C 1.524 0.636 0 C-N-CA 125.247 1.403 . . . . 0.0 112.095 -177.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.2 mp -80.73 14.97 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 125.571 1.548 . . . . 0.0 108.884 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.415 ' H ' ' C ' ' A' ' 88' ' ' GLY . 12.9 ttm -43.27 130.72 4.78 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 129.453 3.101 . . . . 0.0 109.199 -173.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -156.94 114.62 3.17 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 126.09 1.756 . . . . 0.0 106.62 -173.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.288 3.9 m-20 -96.36 129.14 34.21 Favored Pre-proline 0 CA--C 1.51 -0.58 0 O-C-N 124.493 1.121 . . . . 0.0 110.995 -174.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -75.64 149.68 34.5 Favored 'Trans proline' 0 N--CA 1.441 -1.561 0 C-N-CA 121.91 1.74 . . . . 0.0 109.685 175.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 20.8 p -131.88 155.44 47.86 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 125.109 1.364 . . . . 0.0 107.912 174.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.6 m -125.23 153.06 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 C-N-CA 124.193 0.997 . . . . 0.0 109.977 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -86.12 11.41 11.88 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.345 1.458 . . . . 0.0 113.367 -177.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.3 m -137.53 164.1 43.86 Favored Pre-proline 0 C--N 1.326 -0.432 0 C-N-CA 124.414 1.086 . . . . 0.0 109.798 -173.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -65.78 162.2 35.74 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.375 1.383 . . . . 0.0 109.803 173.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -65.69 -11.39 44.76 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 124.213 1.005 . . . . 0.0 112.251 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -143.02 164.37 30.28 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.138 1.375 . . . . 0.0 107.807 173.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.64 -160.67 34.13 Favored Glycine 0 C--O 1.226 -0.352 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.0 p -123.48 152.16 42.0 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.261 0.531 . . . . 0.0 109.958 176.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.5 t -94.93 113.09 60.5 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 102.736 -3.061 . . . . 0.0 102.736 173.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -97.17 161.53 1.0 Allowed 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.825 2.35 . . . . 0.0 112.514 -173.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.549 ' HD1' ' C ' ' A' ' 69' ' ' ALA . 80.8 m-70 -66.72 -19.65 65.8 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 119.971 -1.706 . . . . 0.0 114.88 -174.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.05 114.08 24.32 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 -174.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -47.3 111.43 0.41 Allowed 'General case' 0 N--CA 1.463 0.219 0 O-C-N 124.438 1.086 . . . . 0.0 109.249 -175.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 66.3 m -116.84 143.97 45.05 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -174.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.4 t -105.79 139.0 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -173.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.5 t -121.9 103.7 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -73.73 147.0 43.97 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 173.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.4 t -130.96 113.91 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 104.443 -2.429 . . . . 0.0 104.443 177.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -100.61 146.61 17.65 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 125.249 1.404 . . . . 0.0 110.517 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -129.99 73.6 81.26 Favored Pre-proline 0 CA--C 1.546 0.813 0 CA-C-N 118.88 1.34 . . . . 0.0 111.704 -174.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -64.54 117.14 4.23 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.443 2.095 . . . . 0.0 109.056 173.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 8.5 t -94.01 144.29 25.6 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 173.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.6 mt -79.59 -10.87 59.87 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 122.966 0.506 . . . . 0.0 111.15 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 55.19 33.57 57.99 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 125.817 1.675 . . . . 0.0 114.22 173.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -93.74 -63.42 1.2 Allowed 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 118.471 1.136 . . . . 0.0 110.271 -177.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 38.6 tp60 -96.05 154.66 17.12 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 174.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -93.51 152.28 19.16 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.46 1.504 . . . . 0.0 107.407 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.15 -152.07 22.12 Favored Glycine 0 C--N 1.331 0.305 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.8 t -127.47 113.86 33.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -84.35 173.34 11.01 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 173.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -133.85 159.78 39.62 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.533 1.133 . . . . 0.0 109.554 174.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -146.15 140.73 26.87 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 173.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -94.43 148.0 22.67 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 125.242 1.417 . . . . 0.0 111.25 -175.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.8 t -139.19 135.65 41.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 125.396 1.479 . . . . 0.0 108.997 173.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -155.8 120.46 4.68 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 173.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.458 ' H ' ' HB ' ' A' ' 143' ' ' THR . 43.8 t -130.44 123.83 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -88.76 166.58 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 173.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.6 t -146.1 134.59 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 -174.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.34 174.9 10.06 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.977 -175.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -86.83 175.96 7.94 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 172.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.3 t -65.65 -13.93 60.17 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 120.756 -1.215 . . . . 0.0 113.754 -173.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -94.78 -4.19 47.72 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.433 1.093 . . . . 0.0 111.423 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.86 9.44 57.35 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 118.958 -0.912 . . . . 0.0 113.703 176.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -74.28 116.49 15.01 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 119.786 1.793 . . . . 0.0 108.592 175.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.8 m -70.19 143.83 52.12 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 123.815 0.846 . . . . 0.0 109.186 -177.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.57 -36.0 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 124.523 1.129 . . . . 0.0 113.394 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -131.68 145.4 51.63 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -175.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -146.13 147.32 31.41 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.458 ' HB ' ' H ' ' A' ' 130' ' ' VAL . 58.5 m -78.48 113.49 34.84 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.26 144.28 85.87 Favored 'Trans proline' 0 N--CA 1.446 -1.31 0 CA-C-N 119.944 1.016 . . . . 0.0 110.796 -173.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -80.56 112.53 18.0 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 -173.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.444 14.0 m-80 172.55 -13.83 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 1 C-N-CA 138.555 6.742 . . . . 0.0 110.252 173.722 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.55 77.31 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.81 2.044 . . . . 0.0 109.861 173.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 37.0 mm -115.64 125.5 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -93.97 154.75 17.5 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 173.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -131.05 113.51 14.04 Favored 'General case' 0 CA--C 1.521 -0.156 0 O-C-N 121.366 -0.834 . . . . 0.0 108.755 -173.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -106.71 122.23 45.93 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 118.838 0.745 . . . . 0.0 109.204 -177.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 27.7 m -83.37 117.09 22.79 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 105.68 -1.971 . . . . 0.0 105.68 174.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 6.7 m -118.14 166.41 12.61 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.488 0.715 . . . . 0.0 109.615 173.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.4 pp -131.62 160.44 35.36 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.362 1.465 . . . . 0.0 107.627 175.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -68.41 125.22 25.77 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.457 1.503 . . . . 0.0 109.701 176.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -146.7 127.9 14.75 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.851 1.26 . . . . 0.0 107.809 174.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 . . . . . 0 C--O 1.255 1.361 0 C-N-CA 127.505 2.322 . . . . 0.0 105.42 174.162 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.71 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.2 m -63.78 127.56 31.9 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 163.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -144.41 175.23 10.27 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 122.028 0.918 . . . . 0.0 110.307 -175.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 8.8 tpt -142.87 176.28 9.19 Favored 'General case' 0 CA--C 1.544 0.734 1 C-N-CA 133.351 4.661 . . . . 0.0 103.174 173.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.7 tt -69.72 112.7 6.36 Favored 'General case' 0 C--N 1.344 0.341 1 N-CA-C 100.018 -4.067 . . . . 0.0 100.018 173.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -176.29 176.96 1.59 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.55 2.34 . . . . 0.0 106.306 -172.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -128.04 113.75 16.2 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 120.462 1.483 . . . . 0.0 110.302 176.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -123.59 175.9 6.53 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 128.601 2.761 . . . . 0.0 107.985 173.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -67.95 163.56 21.85 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.852 1.261 . . . . 0.0 109.391 173.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -67.46 176.69 2.23 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 123.462 1.601 . . . . 0.0 109.642 173.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.9 m -146.3 177.1 9.27 Favored 'General case' 0 C--O 1.222 -0.375 0 O-C-N 119.036 -2.29 . . . . 0.0 112.613 -173.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tt -43.04 126.14 3.81 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 129.011 2.925 . . . . 0.0 112.934 -173.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -114.3 141.44 47.59 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 128.281 2.632 . . . . 0.0 108.17 174.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.86 120.76 8.17 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 18.0 p90 -135.94 168.76 18.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 119.159 0.89 . . . . 0.0 109.842 175.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.9 mt -99.78 114.36 37.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 102.073 -3.306 . . . . 0.0 102.073 173.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -79.32 136.08 36.91 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 123.903 1.811 . . . . 0.0 113.068 -173.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.62 -20.37 46.9 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 127.375 2.27 . . . . 0.0 116.213 -173.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -56.47 -40.83 75.54 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 118.886 0.766 . . . . 0.0 109.55 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 42.6 tp60 -65.38 -44.24 88.18 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.681 178.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.66 -32.03 73.38 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 118.854 -0.593 . . . . 0.0 112.235 176.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -58.48 -54.32 48.31 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 173.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 80.0 t -53.66 -23.96 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 O-C-N 121.39 -0.819 . . . . 0.0 111.927 175.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.8 mt -76.61 -40.61 48.87 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 174.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.7 pt -148.83 14.08 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 116.808 2.151 . . . . 0.0 116.808 -172.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.27 -4.4 1.91 Allowed Glycine 0 CA--C 1.533 1.189 0 C-N-CA 128.988 3.185 . . . . 0.0 114.506 -173.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -101.99 139.8 37.13 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 130.674 3.59 . . . . 0.0 105.725 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -101.59 124.05 46.61 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.092 0.957 . . . . 0.0 109.407 -173.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -137.13 113.47 10.02 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.967 1.707 . . . . 0.0 109.251 -174.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -92.14 163.31 13.99 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.144 1.338 . . . . 0.0 107.492 173.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.3 mp -136.71 113.17 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 173.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.86 116.58 23.39 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -176.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 27.4 mt -95.05 -63.76 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.034 0.934 . . . . 0.0 109.335 -177.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.9 t -118.41 133.97 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -173.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.9 p -137.59 124.55 21.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 104.216 -2.513 . . . . 0.0 104.216 173.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 43.95 33.26 0.73 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.19 2.196 . . . . 0.0 114.091 -174.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.38 -6.87 5.32 Favored Glycine 0 CA--C 1.544 1.873 0 O-C-N 120.713 -1.242 . . . . 0.0 114.73 -174.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -79.19 37.29 0.31 Allowed 'General case' 0 CA--C 1.537 0.466 1 C-N-CA 131.706 4.002 . . . . 0.0 111.215 -178.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 42.6 mtm -38.22 134.73 0.8 Allowed 'General case' 0 C--O 1.233 0.195 0 C-N-CA 126.207 1.803 . . . . 0.0 114.362 -173.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.1 165.38 48.36 Favored Pre-proline 0 N--CA 1.45 -0.446 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 173.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.28 38.2 0.53 Allowed 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 123.911 3.074 . . . . 0.0 110.6 173.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -53.72 -26.7 24.35 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 127.25 2.22 . . . . 0.0 114.095 -173.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.5 m -60.27 -32.08 70.83 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.624 1.169 . . . . 0.0 111.621 -173.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.425 ' CE1' ' HZ2' ' A' ' 48' ' ' LYS . 23.4 t-80 -58.36 -64.13 1.03 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.252 1.021 . . . . 0.0 109.852 176.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -76.37 -29.35 57.14 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -174.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -57.1 -55.99 27.63 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.18 0.992 . . . . 0.0 108.584 173.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.6 -24.46 42.0 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 118.537 -0.744 . . . . 0.0 111.102 -174.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.425 ' HZ2' ' CE1' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -126.71 112.92 15.99 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 120.259 1.39 . . . . 0.0 109.689 173.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -172.68 151.11 2.27 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 120.379 1.445 . . . . 0.0 108.507 173.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.48 112.9 24.48 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 173.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -175.73 -67.35 0.01 OUTLIER 'General case' 0 C--O 1.235 0.342 0 N-CA-C 102.752 -3.055 . . . . 0.0 102.752 173.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.09 -17.03 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 117.819 -1.086 . . . . 0.0 110.843 172.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 69.2 mmm -44.8 -52.22 19.4 Favored Pre-proline 0 N--CA 1.468 0.467 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -173.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -69.35 -77.39 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.042 0 CA-C-N 120.837 1.335 . . . . 0.0 110.361 173.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.21 113.32 20.59 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.39 0.614 . . . . 0.0 111.055 -173.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.89 131.5 21.92 Favored Pre-proline 0 C--N 1.327 -0.373 0 C-N-CA 128.489 2.716 . . . . 0.0 106.228 -177.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -79.31 157.6 26.0 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.731 1.621 . . . . 0.0 110.743 177.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.4 p -41.95 -41.17 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 126.97 2.108 . . . . 0.0 112.088 173.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.51 -39.47 83.97 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 127.519 2.328 . . . . 0.0 112.825 -176.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 mm -74.28 112.85 11.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 101.548 -3.501 . . . . 0.0 101.548 173.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -78.14 -38.25 44.16 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.0 m -149.83 161.3 42.53 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.362 1.065 . . . . 0.0 109.585 -173.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 24.3 mtm -126.33 152.38 46.3 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 172.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -94.59 150.29 20.39 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -136.51 152.48 50.57 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 102.376 -3.194 . . . . 0.0 102.376 172.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.0 m -139.95 135.53 32.89 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -176.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -145.84 165.69 28.13 Favored 'General case' 0 C--O 1.24 0.566 0 O-C-N 121.916 -0.49 . . . . 0.0 110.635 177.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.83 157.55 3.06 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.927 0.87 . . . . 0.0 112.438 177.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.6 -174.02 4.17 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 173.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.87 111.83 18.9 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 126.047 1.739 . . . . 0.0 107.101 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 43.4 -57.9 0.0 OUTLIER Glycine 0 CA--C 1.537 1.418 1 C-N-CA 132.74 4.971 . . . . 0.0 119.372 173.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -116.57 -25.79 7.28 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.724 1.762 . . . . 0.0 113.548 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.73 37.1 0.08 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 130.993 3.717 . . . . 0.0 119.068 -173.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -54.37 113.96 1.47 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 123.234 2.743 . . . . 0.0 111.013 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -84.1 142.93 30.04 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 125.322 1.449 . . . . 0.0 107.348 173.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -90.35 149.27 22.37 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -131.95 161.0 34.16 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 120.302 1.41 . . . . 0.0 110.905 175.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.11 134.95 13.73 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 173.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -87.28 103.13 15.16 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.098 0.559 . . . . 0.0 110.03 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.0 tt -73.38 -42.07 62.6 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.3 m -138.58 132.72 31.52 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.356 1.062 . . . . 0.0 111.486 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -162.76 93.01 0.8 Allowed 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 101.309 -3.589 . . . . 0.0 101.309 173.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -161.4 155.55 22.51 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 119.75 1.159 . . . . 0.0 111.284 -173.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.0 t -82.85 153.79 24.97 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 173.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 70.8 mt -107.31 -9.27 16.1 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.253 1.421 . . . . 0.0 111.679 176.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -104.97 162.76 13.07 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 173.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.7 mmtm -138.16 -33.24 0.7 Allowed 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.412 1.885 . . . . 0.0 112.297 -177.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -62.1 -54.26 36.21 Favored Glycine 0 CA--C 1.545 1.912 0 N-CA-C 106.808 -2.517 . . . . 0.0 106.808 172.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.7 mt -90.45 25.28 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 129.281 3.032 . . . . 0.0 110.518 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 4.1 ttp -43.17 133.82 3.82 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 125.458 2.551 . . . . 0.0 112.712 -173.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -149.68 155.38 40.11 Favored 'General case' 0 N--CA 1.422 -1.842 2 C-N-CA 135.994 5.718 . . . . 0.0 101.302 173.785 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -144.86 114.22 5.03 Favored Pre-proline 0 C--N 1.316 -0.855 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 173.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -67.44 157.93 59.44 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 122.816 2.344 . . . . 0.0 113.652 -173.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.3 p -133.17 165.65 24.28 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.513 1.525 . . . . 0.0 109.773 176.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.4 m -126.34 155.58 36.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.174 0.989 . . . . 0.0 110.677 173.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -78.21 9.47 3.77 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.209 2.204 . . . . 0.0 113.485 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.5 m -139.3 163.71 43.82 Favored Pre-proline 0 C--N 1.327 -0.372 0 C-N-CA 124.443 1.097 . . . . 0.0 109.976 -176.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -65.41 162.07 35.31 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.705 1.603 . . . . 0.0 110.071 173.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -64.34 -10.59 25.35 Favored 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 124.634 1.174 . . . . 0.0 112.586 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -145.77 164.06 33.04 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 120.151 1.341 . . . . 0.0 107.857 173.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.37 -161.65 34.22 Favored Glycine 0 C--O 1.227 -0.335 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 77.8 p -117.25 150.94 37.94 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 173.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.2 t -87.16 113.23 52.72 Favored Pre-proline 0 N--CA 1.448 -0.547 0 N-CA-C 102.276 -3.231 . . . . 0.0 102.276 173.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -92.34 155.51 3.09 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.414 2.076 . . . . 0.0 111.98 -173.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 18.0 m-70 -65.51 -16.88 64.11 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 120.164 -1.585 . . . . 0.0 112.179 -174.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -85.88 113.77 22.27 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 -174.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.65 110.58 0.48 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 119.098 0.863 . . . . 0.0 109.37 -176.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 45.3 m -117.04 139.86 50.18 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -175.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.6 t -98.37 114.16 35.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 C-N-CA 124.402 1.081 . . . . 0.0 109.425 -173.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 85.1 t -93.98 103.41 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 N-CA-C 103.875 -2.639 . . . . 0.0 103.875 173.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -84.49 126.09 32.97 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 104.921 -2.251 . . . . 0.0 104.921 173.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.7 t -94.14 113.84 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 104.462 -2.422 . . . . 0.0 104.462 174.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -87.71 148.32 21.01 Favored Glycine 0 N--CA 1.44 -1.057 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 176.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.454 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 3.8 m-85 -132.19 73.45 77.67 Favored Pre-proline 0 C--O 1.242 0.68 0 C-N-CA 124.125 0.97 . . . . 0.0 108.924 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.98 121.76 8.16 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 121.652 1.568 . . . . 0.0 108.082 174.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 5.9 t -101.99 149.69 23.98 Favored 'General case' 0 C--N 1.34 0.191 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 173.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mt -79.42 -18.0 53.14 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 118.068 0.394 . . . . 0.0 110.697 176.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.54 17.52 53.74 Favored Glycine 0 C--O 1.215 -1.082 0 C-N-CA 127.632 2.539 . . . . 0.0 115.719 173.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 24.6 mttt -93.19 -29.38 15.75 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 121.576 2.688 . . . . 0.0 111.449 -173.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.449 ' NE2' ' H ' ' A' ' 121' ' ' ASP . 53.4 tp60 -96.66 154.88 17.03 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 172.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.449 ' H ' ' NE2' ' A' ' 120' ' ' GLN . 21.4 m-20 -102.24 144.58 30.59 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 174.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 151.21 -157.71 27.34 Favored Glycine 0 C--N 1.332 0.319 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 175.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 18.8 t -127.18 113.57 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 175.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -89.32 164.16 15.03 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 173.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -122.96 163.84 19.65 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 121.227 -0.92 . . . . 0.0 110.104 176.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.454 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 9.1 p90 -149.61 150.53 32.34 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 118.4 0.545 . . . . 0.0 109.65 173.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -111.53 150.58 29.77 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 127.638 2.375 . . . . 0.0 110.33 -174.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 85.6 t -138.83 137.47 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 125.698 1.599 . . . . 0.0 109.083 174.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -156.32 124.47 5.69 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 126.809 2.043 . . . . 0.0 106.357 173.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 42.7 t -135.01 128.39 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.424 HD12 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -95.22 164.57 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 174.383 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.1 t -143.27 135.26 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -173.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.52 175.46 9.58 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.866 1.266 . . . . 0.0 108.642 -174.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 37.9 p-10 -89.99 176.32 6.84 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 172.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.6 t -65.49 -4.81 6.4 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 120.28 -1.512 . . . . 0.0 113.949 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -88.63 -16.73 31.7 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 120.714 1.597 . . . . 0.0 110.696 173.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.57 1.16 60.54 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.555 1.074 . . . . 0.0 111.808 -173.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 60.6 m-20 -70.84 116.56 11.29 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 119.535 1.668 . . . . 0.0 108.384 174.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.5 m -68.03 143.87 55.35 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.842 1.657 . . . . 0.0 109.024 -174.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -140.99 -36.34 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.628 1.171 . . . . 0.0 113.999 -174.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -130.55 144.11 51.2 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 178.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -144.79 131.37 19.91 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 177.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 77.5 m -63.57 131.35 94.82 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 174.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -72.17 144.5 42.09 Favored 'Trans proline' 0 N--CA 1.444 -1.408 0 N-CA-C 108.401 -1.423 . . . . 0.0 108.401 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -82.76 112.52 19.68 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 -175.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.599 38.9 m-80 172.31 -13.19 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 1 C-N-CA 132.739 4.415 . . . . 0.0 114.295 173.28 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.86 96.6 0.09 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.056 1.342 . . . . 0.0 108.612 177.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.1 mt -133.58 148.8 30.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.416 ' CD1' ' CZ ' ' A' ' 126' ' ' PHE . 0.4 OUTLIER -130.87 170.08 14.89 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.274 1.429 . . . . 0.0 107.624 175.648 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -135.3 113.48 11.31 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.865 1.266 . . . . 0.0 108.023 -173.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -101.31 123.55 45.58 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 23.9 m -83.48 117.81 23.34 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 175.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 30.9 m -112.25 158.17 20.05 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 174.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.8 pp -146.24 159.59 43.12 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 176.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.44 121.25 2.89 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.73 2.412 . . . . 0.0 115.223 -173.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -139.74 164.14 30.73 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 130.131 3.372 . . . . 0.0 106.646 173.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 . . . . . 0 C--O 1.252 1.188 0 C-N-CA 127.515 2.326 . . . . 0.0 105.957 175.708 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.04 0 N-CA-C 107.263 -2.335 . . . . 0.0 107.263 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 p -53.04 176.56 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.415 0.686 . . . . 0.0 110.597 136.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -58.21 170.29 0.71 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 173.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -61.9 155.71 22.73 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 122.699 0.4 . . . . 0.0 109.967 175.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.7 mp -131.8 164.28 26.36 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 128.272 2.629 . . . . 0.0 104.161 173.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -80.25 148.45 30.78 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.222 1.409 . . . . 0.0 110.333 174.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.482 ' HG2' ' H ' ' A' ' 8' ' ' GLN . 4.2 tt0 -169.36 176.2 5.22 Favored 'General case' 0 N--CA 1.439 -1.009 1 C-N-CA 131.711 4.004 . . . . 0.0 102.5 173.771 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.482 ' H ' ' HG2' ' A' ' 7' ' ' GLN . 27.2 tp60 -127.62 166.03 18.84 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 128.476 2.711 . . . . 0.0 106.266 173.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 58.2 mp0 -65.47 167.29 8.95 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.529 1.532 . . . . 0.0 110.823 175.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -137.7 172.54 12.8 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.504 1.522 . . . . 0.0 109.037 -174.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m -175.79 176.99 1.76 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 129.237 3.015 . . . . 0.0 109.978 178.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.2 tt -43.41 129.23 5.05 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 127.15 2.18 . . . . 0.0 112.236 -174.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -116.18 132.88 56.54 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.041 1.736 . . . . 0.0 109.062 174.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.07 120.56 11.02 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -178.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.5 p90 -134.25 175.32 9.61 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.71 0.804 . . . . 0.0 110.088 176.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.3 mt -111.81 116.17 51.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 102.213 -3.254 . . . . 0.0 102.213 174.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -83.18 148.56 27.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 123.501 1.619 . . . . 0.0 114.639 -173.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.81 -14.33 32.15 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 126.863 2.065 . . . . 0.0 114.666 -174.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -58.26 -35.1 71.25 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 119.185 0.902 . . . . 0.0 109.876 174.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 47.2 tp60 -67.37 -43.05 82.39 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 118.376 0.535 . . . . 0.0 111.104 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.71 -37.8 82.89 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.881 0.872 . . . . 0.0 111.044 173.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -56.21 -58.22 8.89 Favored 'General case' 0 N--CA 1.445 -0.72 0 O-C-N 121.002 -1.061 . . . . 0.0 108.198 173.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 72.6 t -52.24 -23.64 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 124.563 1.145 . . . . 0.0 111.822 175.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 14.2 mt -73.87 -51.17 17.1 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 117.93 -1.034 . . . . 0.0 112.456 175.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.6 pt -156.13 21.53 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -172.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.63 -0.64 60.48 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 126.694 2.092 . . . . 0.0 114.656 -174.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -80.02 176.39 9.79 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 128.285 2.634 . . . . 0.0 110.035 -173.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -138.04 113.4 9.43 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -173.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -160.0 115.46 2.37 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.449 0.7 . . . . 0.0 110.598 -178.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -89.55 175.73 7.17 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.369 1.468 . . . . 0.0 109.633 173.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 21.6 mt -143.91 113.27 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 172.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.72 114.23 24.14 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -177.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.2 mt -91.3 -61.54 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 118.944 0.793 . . . . 0.0 109.198 -177.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.6 t -116.6 122.89 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 -173.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.9 p -126.11 119.36 27.36 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 102.966 -2.976 . . . . 0.0 102.966 173.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.451 ' C ' ' H ' ' A' ' 38' ' ' LYS 0.32 17.6 pm0 45.91 42.16 8.8 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.914 1.686 . . . . 0.0 112.884 -176.333 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.99 -24.22 1.3 Allowed Glycine 0 CA--C 1.543 1.829 0 C-N-CA 125.965 1.745 . . . . 0.0 115.136 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.451 ' H ' ' C ' ' A' ' 36' ' ' GLU 0.437 7.0 tmtt? -53.94 37.32 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.686 1 C-N-CA 137.609 6.364 . . . . 0.0 117.085 174.373 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 42.6 mtt -38.17 130.03 1.24 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.408 ' C ' ' H ' ' A' ' 42' ' ' PHE . . . -73.11 167.63 32.52 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 173.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.48 34.17 0.34 Allowed 'Trans proline' 0 CA--C 1.55 1.313 0 C-N-CA 124.069 3.179 . . . . 0.0 111.728 173.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.408 ' H ' ' C ' ' A' ' 40' ' ' ALA . 15.3 p90 -54.7 -26.57 34.5 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 127.899 2.48 . . . . 0.0 114.4 -173.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 m -62.9 -32.38 73.64 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.5 1.12 . . . . 0.0 112.185 -172.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 61.3 t60 -59.96 -51.42 69.74 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.328 0.9 OUTLIER -76.09 -28.69 57.65 Favored 'General case' 0 C--O 1.224 -0.237 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.294 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -55.88 -46.53 78.29 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.066 -1.021 . . . . 0.0 108.274 173.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.9 ttt85 -76.8 -35.46 57.61 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 118.506 -0.759 . . . . 0.0 112.302 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.56 113.0 16.19 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 116.897 -1.525 . . . . 0.0 109.171 178.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -176.03 176.91 1.69 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 121.375 1.898 . . . . 0.0 109.117 178.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -50.99 158.36 0.71 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.957 1.303 . . . . 0.0 107.668 173.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -43.73 -32.93 1.12 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.722 2.409 . . . . 0.0 113.735 -173.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 47.8 ttp85 -57.98 -11.23 2.26 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 116.754 -1.593 . . . . 0.0 115.274 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.67 -66.85 0.02 OUTLIER Pre-proline 0 N--CA 1.47 0.535 0 CA-C-N 121.732 2.06 . . . . 0.0 114.564 174.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -75.83 -71.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.593 0 CA-C-N 122.586 1.959 . . . . 0.0 113.14 -173.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.01 113.62 14.91 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.622 0.769 . . . . 0.0 110.04 -173.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 94.3 mt -109.4 119.37 48.45 Favored Pre-proline 0 C--N 1.325 -0.498 0 C-N-CA 127.122 2.169 . . . . 0.0 105.903 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -74.33 155.91 46.15 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 121.782 1.655 . . . . 0.0 109.486 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.3 p -41.54 -41.77 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 126.66 1.984 . . . . 0.0 112.598 174.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -56.25 -42.4 77.32 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 126.896 2.078 . . . . 0.0 113.099 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.2 mm -74.53 112.86 12.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 101.642 -3.466 . . . . 0.0 101.642 173.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -76.55 -36.11 57.83 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . 0.253 4.2 m -148.99 161.83 41.12 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.195 1.398 . . . . 0.0 109.933 -173.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -117.7 145.65 44.27 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 172.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 44.9 m-20 -94.12 146.82 23.7 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 174.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -136.09 153.77 51.21 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 102.528 -3.138 . . . . 0.0 102.528 172.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.1 m -139.5 133.66 31.18 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -177.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -145.02 166.76 24.41 Favored 'General case' 0 C--O 1.238 0.496 0 O-C-N 122.056 -0.403 . . . . 0.0 111.158 177.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.24 158.22 13.94 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 124.866 1.266 . . . . 0.0 110.349 174.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.476 ' C ' ' HD1' ' A' ' 105' ' ' HIS . . . -97.73 168.44 10.33 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 173.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.21 96.15 10.53 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 120.157 -1.589 . . . . 0.0 110.526 -174.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 48.74 -58.54 0.0 OUTLIER Glycine 0 CA--C 1.536 1.363 1 C-N-CA 131.783 4.516 . . . . 0.0 119.544 173.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -117.08 -15.66 10.52 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.446 2.123 . . . . 0.0 115.783 173.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.33 37.18 0.2 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 129.231 3.012 . . . . 0.0 115.998 -173.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -39.02 113.43 0.31 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 121.621 2.009 . . . . 0.0 110.031 -173.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -89.91 130.16 36.17 Favored 'General case' 0 CA--C 1.522 -0.106 0 C-N-CA 125.147 1.379 . . . . 0.0 107.62 175.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -84.6 150.95 24.84 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -137.76 160.87 38.05 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 119.913 1.233 . . . . 0.0 110.815 174.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -153.56 138.75 17.43 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 173.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -86.12 103.45 14.79 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tt -70.81 -41.99 70.84 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.627 1.171 . . . . 0.0 108.123 174.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.2 m -138.61 135.7 35.21 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.634 1.174 . . . . 0.0 111.397 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -164.97 93.13 0.61 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 102.169 -3.271 . . . . 0.0 102.169 173.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -161.43 154.14 20.52 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 120.821 -1.175 . . . . 0.0 110.76 -174.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.3 t -73.14 165.31 25.29 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.36 0.6 . . . . 0.0 109.628 173.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.5 mt -120.49 -21.87 6.65 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 116.505 -1.712 . . . . 0.0 110.764 173.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -99.35 164.89 11.93 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-O 123.935 1.826 . . . . 0.0 108.407 173.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.4 mmtm -136.71 -27.24 1.03 Allowed 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 129.255 3.022 . . . . 0.0 112.315 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.31 -63.85 3.86 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 106.67 -2.572 . . . . 0.0 106.67 172.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.7 mp -81.87 26.7 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 128.934 2.894 . . . . 0.0 110.855 174.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 2.8 ttp -43.06 128.24 4.39 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 125.107 2.385 . . . . 0.0 112.734 -173.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -150.65 146.98 26.84 Favored 'General case' 0 N--CA 1.427 -1.606 1 C-N-CA 135.435 5.494 . . . . 0.0 101.263 174.091 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -136.73 117.0 10.87 Favored Pre-proline 0 C--N 1.318 -0.802 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 177.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -68.31 159.81 51.68 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.977 2.451 . . . . 0.0 113.932 -173.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 21.7 p -138.58 161.86 36.02 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.89 2.076 . . . . 0.0 109.031 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.5 m -126.37 154.73 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.195 0.998 . . . . 0.0 111.784 174.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -80.17 10.11 4.82 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 127.522 2.329 . . . . 0.0 113.468 177.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.9 m -140.49 163.18 45.12 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 124.54 1.136 . . . . 0.0 109.72 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -66.67 161.91 39.55 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 121.454 1.436 . . . . 0.0 109.567 173.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -64.58 -12.25 43.22 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 124.232 1.013 . . . . 0.0 112.644 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -145.16 165.1 29.29 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.974 1.31 . . . . 0.0 108.023 173.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 161.08 -161.12 32.68 Favored Glycine 0 C--O 1.227 -0.286 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 68.5 p -119.06 148.21 43.28 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 173.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.0 t -80.12 113.41 38.29 Favored Pre-proline 0 N--CA 1.447 -0.608 0 N-CA-C 102.15 -3.278 . . . . 0.0 102.15 173.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -84.33 165.64 12.61 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.585 1.523 . . . . 0.0 114.647 -173.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.476 ' HD1' ' C ' ' A' ' 69' ' ' ALA . 94.1 m-70 -77.43 3.68 12.75 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 120.687 -1.258 . . . . 0.0 114.341 -173.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.67 134.09 55.23 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 173.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.86 110.84 0.46 Allowed 'General case' 0 C--O 1.231 0.13 0 C-N-CA 124.785 1.234 . . . . 0.0 108.664 176.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.2 m -118.78 140.29 50.19 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.3 t -94.98 114.81 32.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 124.156 0.983 . . . . 0.0 109.941 -173.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 77.7 t -93.84 103.48 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 103.342 -2.836 . . . . 0.0 103.342 173.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -89.26 125.37 35.07 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 173.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.5 t -95.39 113.68 30.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 103.939 -2.615 . . . . 0.0 103.939 173.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -94.17 144.77 17.32 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.477 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 6.2 m-85 -129.22 73.89 81.39 Favored Pre-proline 0 C--O 1.243 0.724 0 CA-C-N 117.903 0.851 . . . . 0.0 110.495 -174.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.09 122.47 9.78 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 N-CA-C 107.928 -1.605 . . . . 0.0 107.928 173.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 5.9 t -105.75 153.13 22.3 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 124.703 1.201 . . . . 0.0 107.97 173.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.7 mt -81.42 -10.27 59.55 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.371 0.532 . . . . 0.0 112.011 -175.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 54.21 42.73 73.63 Favored Glycine 0 C--O 1.222 -0.643 0 C-N-CA 126.78 2.133 . . . . 0.0 114.759 173.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -126.89 -29.99 2.78 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.592 1.696 . . . . 0.0 113.307 173.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -96.31 153.55 17.75 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 104.764 -2.31 . . . . 0.0 104.764 172.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -108.73 143.44 37.85 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 177.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 141.83 -154.86 25.1 Favored Glycine 0 C--N 1.334 0.435 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.0 t -130.38 113.91 27.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 123.398 0.679 . . . . 0.0 109.36 -177.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -88.88 168.82 12.1 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 173.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -127.22 160.53 31.01 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.729 0.812 . . . . 0.0 109.827 173.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.477 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 12.7 p90 -146.93 152.31 38.46 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.792 0.837 . . . . 0.0 109.51 173.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -112.23 150.23 31.18 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 127.102 2.161 . . . . 0.0 112.144 -173.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 95.3 t -139.17 141.33 36.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 124.815 1.246 . . . . 0.0 109.619 173.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -155.78 119.25 4.38 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 127.654 2.382 . . . . 0.0 105.436 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.437 ' H ' ' HB ' ' A' ' 143' ' ' THR . 45.1 t -129.45 125.28 61.45 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 179.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -92.56 161.52 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 173.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.9 t -137.52 135.12 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 -177.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.81 174.44 10.57 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 124.821 1.249 . . . . 0.0 108.355 -176.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -89.97 176.18 6.9 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 172.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.3 t -66.04 -3.68 5.85 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 120.233 -1.542 . . . . 0.0 113.765 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -89.71 -14.61 34.34 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 120.625 1.557 . . . . 0.0 110.612 173.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.62 0.46 64.59 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.581 1.086 . . . . 0.0 112.107 -173.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -69.74 115.77 9.36 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.507 1.653 . . . . 0.0 108.302 174.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -68.9 143.69 54.41 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.684 1.594 . . . . 0.0 108.821 -175.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -140.02 -37.73 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.667 1.187 . . . . 0.0 113.761 -174.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -132.78 149.14 52.31 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 10.0 tm0? -147.85 148.69 31.14 Favored 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 120.99 -1.069 . . . . 0.0 108.649 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.437 ' HB ' ' H ' ' A' ' 130' ' ' VAL . 27.1 m -80.2 113.29 37.58 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 175.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.33 146.09 79.67 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 CA-C-N 120.071 1.061 . . . . 0.0 110.856 -173.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -78.61 112.63 15.88 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 -173.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.488 28.2 m-80 172.49 -21.07 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 1 C-N-CA 136.276 5.831 . . . . 0.0 111.376 173.543 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -56.66 91.85 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.346 2.258 . . . . 0.0 110.355 176.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.6 mt -136.4 149.79 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.415 ' CD1' ' CZ ' ' A' ' 126' ' ' PHE . 0.8 OUTLIER -128.22 169.48 14.11 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 174.195 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -133.9 113.76 12.56 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.177 1.391 . . . . 0.0 107.523 -173.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 51.6 tttt -101.05 122.4 43.49 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 120.097 1.317 . . . . 0.0 109.173 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.6 m -83.52 118.39 23.75 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 173.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 20.3 m -114.55 165.22 12.99 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 173.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.4 pp -141.14 161.67 37.3 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.525 1.13 . . . . 0.0 108.666 174.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -74.67 126.82 31.66 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 128.447 2.699 . . . . 0.0 111.307 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -139.77 168.45 19.79 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 126.517 1.927 . . . . 0.0 108.989 173.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 . . . . . 0 C--O 1.247 0.921 0 C-N-CA 131.035 3.734 . . . . 0.0 104.629 174.116 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.137 0 N-CA-C 106.823 -2.511 . . . . 0.0 106.823 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 m -52.86 176.69 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 122.813 0.445 . . . . 0.0 110.42 136.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -55.75 171.06 0.24 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.534 0.734 . . . . 0.0 109.512 173.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 8.6 ttm -58.68 152.52 18.53 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 174.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.11 176.58 8.58 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 129.569 3.147 . . . . 0.0 105.992 176.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -44.15 113.49 0.54 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.976 2.11 . . . . 0.0 110.376 -173.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -164.26 145.76 8.57 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 129.375 3.07 . . . . 0.0 103.363 -174.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -147.24 175.8 10.47 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 127.57 2.348 . . . . 0.0 108.755 173.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 27.7 mp0 -74.82 168.35 20.05 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 129.223 3.009 . . . . 0.0 112.509 -173.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -82.14 175.49 10.27 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.053 1.341 . . . . 0.0 109.725 173.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m -170.73 177.02 4.02 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 127.604 2.361 . . . . 0.0 110.822 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.0 tt -43.52 128.6 5.11 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 127.816 2.446 . . . . 0.0 112.435 -174.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -115.28 133.83 55.68 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.739 1.615 . . . . 0.0 108.822 173.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.56 120.85 10.22 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.2 p90 -135.15 170.88 15.24 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 119.201 0.91 . . . . 0.0 109.32 175.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mt -106.39 113.79 43.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 101.798 -3.408 . . . . 0.0 101.798 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -76.28 148.29 37.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 123.299 1.523 . . . . 0.0 113.373 -173.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.37 -22.4 66.09 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 113.388 -1.733 . . . . 0.0 114.84 -173.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -57.62 -38.67 75.35 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 119.448 1.022 . . . . 0.0 109.859 -177.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -69.3 -44.93 70.77 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 122.36 -0.212 . . . . 0.0 111.156 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.08 -31.28 69.87 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 119.118 -0.468 . . . . 0.0 112.006 173.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 38.2 ttm-85 -58.39 -54.96 41.13 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 173.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.6 t -52.99 -23.79 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.095 0.958 . . . . 0.0 111.914 175.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.5 mt -78.46 -42.21 30.52 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 174.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.7 pt -146.81 16.07 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 117.247 2.314 . . . . 0.0 117.247 -172.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.22 6.29 10.0 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 128.522 2.963 . . . . 0.0 115.339 -175.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -101.25 176.25 5.31 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 128.532 2.733 . . . . 0.0 109.594 -173.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -125.56 116.51 21.86 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 123.166 0.586 . . . . 0.0 109.452 -178.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.408 ' CD ' HH22 ' A' ' 52' ' ' ARG . 32.6 mt-10 -161.17 124.85 3.34 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.183 1.793 . . . . 0.0 109.787 175.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -92.7 174.38 7.29 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.777 1.631 . . . . 0.0 106.964 173.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.2 mt -140.77 113.49 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 172.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.66 117.53 20.66 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -177.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.6 mt -89.96 -66.32 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 119.178 0.899 . . . . 0.0 108.825 177.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -111.92 116.47 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.541 1.536 . . . . 0.0 107.447 -173.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.5 p -112.47 116.08 29.7 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 173.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.493 ' C ' ' H ' ' A' ' 38' ' ' LYS 0.287 2.8 pm0 45.29 40.2 4.99 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.813 1.645 . . . . 0.0 112.813 -179.471 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.44 -30.7 1.42 Allowed Glycine 0 CA--C 1.544 1.906 0 C-N-CA 125.652 1.596 . . . . 0.0 114.101 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.493 ' H ' ' C ' ' A' ' 36' ' ' GLU 0.434 7.3 tmtt? -61.94 38.02 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.768 1 C-N-CA 138.838 6.855 . . . . 0.0 112.708 173.761 . . . . . . . . 4 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 33.0 mtm -37.51 139.23 0.29 Allowed 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 126.69 1.996 . . . . 0.0 115.527 -172.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.42 164.49 43.52 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 112.673 -2.058 . . . . 0.0 108.964 173.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.27 32.69 0.31 Allowed 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 124.039 3.16 . . . . 0.0 112.395 174.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -52.91 -26.15 14.01 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.816 2.047 . . . . 0.0 111.843 -174.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.6 m -57.65 -30.31 65.31 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.038 1.735 . . . . 0.0 109.974 -174.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -56.44 -62.83 1.45 Allowed 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.501 1.121 . . . . 0.0 108.968 173.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -68.31 -25.41 65.11 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.397 1.079 . . . . 0.0 111.989 -174.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -72.37 -49.12 36.37 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.036 0.534 . . . . 0.0 110.026 174.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.456 ' CZ ' ' HA ' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -76.77 -23.21 52.93 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 124.811 1.244 . . . . 0.0 111.883 -174.06 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.455 ' CG ' ' H ' ' A' ' 49' ' ' ALA . 4.7 ttpm? -63.45 177.14 0.71 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.032 1.733 . . . . 0.0 111.806 -174.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.455 ' H ' ' CG ' ' A' ' 48' ' ' LYS . . . -60.03 176.66 0.3 Allowed 'General case' 0 CA--C 1.546 0.806 0 O-C-N 120.119 -1.613 . . . . 0.0 109.635 173.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -43.61 121.51 2.34 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.645 1.578 . . . . 0.0 109.767 -174.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -152.87 -66.69 0.16 Allowed 'General case' 0 CA--C 1.533 0.292 0 O-C-N 123.797 0.686 . . . . 0.0 109.353 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.408 HH22 ' CD ' ' A' ' 29' ' ' GLU . 32.4 ttm180 -154.4 -16.87 0.13 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 177.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.415 ' H ' ' CD ' ' A' ' 54' ' ' PRO . 63.7 mmm -123.31 -35.82 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 125.402 1.481 . . . . 0.0 113.688 -177.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.415 ' CD ' ' H ' ' A' ' 53' ' ' MET . 79.0 Cg_endo -78.12 -98.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.881 1.721 . . . . 0.0 110.118 -173.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.24 124.79 24.09 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.213 -0.93 . . . . 0.0 109.748 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.5 mt -130.94 138.03 32.08 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 128.81 2.844 . . . . 0.0 106.842 -174.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -81.34 157.43 19.63 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.702 2.268 . . . . 0.0 111.655 174.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.3 p -42.94 -41.47 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 127.257 2.223 . . . . 0.0 112.908 174.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -58.25 -34.36 70.38 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 126.65 1.98 . . . . 0.0 113.077 -175.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.7 mm -71.62 112.89 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 102.863 -3.014 . . . . 0.0 102.863 174.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -95.48 -23.42 17.12 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 -177.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.6 m -149.8 166.03 30.69 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 125.118 1.367 . . . . 0.0 107.548 173.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 13.9 mmm -123.13 163.29 20.86 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 173.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -117.96 150.5 39.15 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 173.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -139.52 153.5 47.48 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 102.101 -3.296 . . . . 0.0 102.101 172.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.3 m -138.63 132.91 31.69 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -176.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -145.1 161.56 39.17 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.184 177.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -165.89 145.14 6.18 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 123.937 0.895 . . . . 0.0 110.689 173.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.436 ' C ' ' HD1' ' A' ' 105' ' ' HIS . . . -85.71 177.2 7.76 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 173.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.19 99.81 10.55 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 125.281 1.432 . . . . 0.0 110.136 -173.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 47.3 -56.27 0.0 OUTLIER Glycine 0 CA--C 1.536 1.386 1 C-N-CA 132.613 4.911 . . . . 0.0 119.396 174.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -117.01 -16.53 10.5 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.518 2.159 . . . . 0.0 115.706 173.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.31 37.11 0.38 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 128.56 2.744 . . . . 0.0 116.92 -173.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -46.36 113.87 0.71 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 122.01 2.187 . . . . 0.0 110.549 -177.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -83.83 145.95 28.38 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 125.341 1.456 . . . . 0.0 107.51 174.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -94.05 150.89 19.93 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -133.8 160.18 38.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 119.869 1.213 . . . . 0.0 111.165 175.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -154.13 138.4 16.62 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 173.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -86.43 103.68 15.21 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.896 1.279 . . . . 0.0 109.025 -177.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.9 tt -68.3 -41.78 80.44 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.792 1.237 . . . . 0.0 107.862 175.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.4 m -136.88 141.34 42.76 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.096 0.958 . . . . 0.0 111.847 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.4 tt -171.27 92.99 0.16 Allowed 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 128.755 2.822 . . . . 0.0 104.579 173.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -162.32 149.86 14.03 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 118.501 -0.761 . . . . 0.0 109.994 -174.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.8 t -91.98 134.12 35.09 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 119.593 1.088 . . . . 0.0 109.843 173.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 71.2 mt -82.26 -26.32 33.29 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 116.314 -1.803 . . . . 0.0 110.788 177.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -93.94 144.96 24.98 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 121.155 1.798 . . . . 0.0 109.485 174.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.453 ' HE3' ' HA ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -113.94 -24.53 9.03 Favored 'General case' 0 N--CA 1.443 -0.796 1 C-N-CA 133.653 4.781 . . . . 0.0 113.822 178.35 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 90' ' ' MET . . . -71.14 -69.93 1.3 Allowed Glycine 0 CA--C 1.533 1.211 0 N-CA-C 107.12 -2.392 . . . . 0.0 107.12 173.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.3 mp -78.48 26.3 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 128.579 2.752 . . . . 0.0 110.994 175.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.444 ' SD ' ' HE3' ' A' ' 87' ' ' LYS . 6.7 ttp -43.16 125.18 3.57 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.79 2.436 . . . . 0.0 111.247 -173.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -161.35 113.48 1.83 Allowed 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 101.272 -3.603 . . . . 0.0 101.272 -175.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.313 1.6 m-20 -112.97 127.45 26.82 Favored Pre-proline 0 C--N 1.319 -0.721 0 O-C-N 124.372 1.045 . . . . 0.0 110.913 -173.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.09 154.02 71.05 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 121.733 1.622 . . . . 0.0 110.318 -174.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 18.4 p -139.16 162.93 33.75 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.453 1.501 . . . . 0.0 108.482 174.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.0 m -126.5 150.39 32.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 123.829 0.852 . . . . 0.0 110.696 173.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -86.03 17.85 3.33 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.501 1.52 . . . . 0.0 111.463 173.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.6 m -132.49 163.03 53.45 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 125.651 1.58 . . . . 0.0 107.011 173.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -67.33 162.41 38.84 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 120.754 0.969 . . . . 0.0 109.767 173.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -64.38 -12.89 47.35 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.361 1.065 . . . . 0.0 111.774 176.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -140.78 164.39 30.34 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.239 1.415 . . . . 0.0 107.89 173.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.17 -161.26 33.82 Favored Glycine 0 C--O 1.227 -0.332 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 75.4 p -119.0 155.1 31.98 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 173.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 24.5 t -90.43 113.27 56.96 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 103.414 -2.809 . . . . 0.0 103.414 173.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -88.95 171.76 4.66 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.541 2.16 . . . . 0.0 114.491 -173.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.436 ' HD1' ' C ' ' A' ' 69' ' ' ALA . 88.2 m-70 -81.98 3.04 28.03 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 -173.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.5 133.84 55.55 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 114.869 -2.491 . . . . 0.0 106.834 173.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -44.95 111.06 0.28 Allowed 'General case' 0 C--O 1.232 0.171 0 O-C-N 125.808 1.942 . . . . 0.0 107.757 173.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.3 m -116.72 137.41 52.21 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.4 t -93.87 120.88 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 O-C-N 124.692 1.245 . . . . 0.0 108.794 -173.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.3 t -93.91 103.72 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 N-CA-C 103.094 -2.928 . . . . 0.0 103.094 173.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -84.2 119.24 24.79 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 173.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.4 t -95.0 113.5 29.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 104.249 -2.5 . . . . 0.0 104.249 174.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -86.34 143.14 19.26 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.407 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 14.6 m-85 -128.34 73.5 80.07 Favored Pre-proline 0 C--O 1.245 0.844 0 CA-C-N 118.333 1.066 . . . . 0.0 110.814 -178.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.55 120.33 7.28 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.332 2.021 . . . . 0.0 109.282 173.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 12.8 t -98.95 148.66 23.75 Favored 'General case' 0 C--N 1.342 0.276 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 173.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.3 mt -76.77 -13.52 60.01 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 117.88 0.309 . . . . 0.0 111.043 178.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 51.31 40.56 45.79 Favored Glycine 0 C--O 1.22 -0.765 0 C-N-CA 127.868 2.651 . . . . 0.0 115.137 173.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . 0.262 42.1 mttm -123.09 -29.67 3.86 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.847 1.824 . . . . 0.0 112.71 173.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -96.46 149.41 21.76 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 172.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -102.12 149.45 24.26 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 176.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.4 -154.56 23.59 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.7 t -128.78 113.83 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.01 166.04 15.37 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 173.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -123.81 145.02 49.36 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.715 1.206 . . . . 0.0 108.538 174.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.407 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 37.5 p90 -140.66 142.78 34.92 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 119.321 0.964 . . . . 0.0 110.317 174.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -104.07 144.79 31.09 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 126.768 2.027 . . . . 0.0 111.36 -173.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.0 t -140.05 139.12 37.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 173.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -155.15 130.6 9.75 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.906 1.682 . . . . 0.0 106.987 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.4 t -135.94 129.5 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -175.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -97.9 165.75 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 173.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.7 t -143.31 134.7 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 -174.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.01 174.35 10.66 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.876 1.27 . . . . 0.0 108.286 -175.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -89.95 176.13 6.92 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 104.667 -2.346 . . . . 0.0 104.667 172.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.1 t -66.2 -4.02 6.84 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 120.356 -1.465 . . . . 0.0 113.685 -177.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -89.34 -14.88 34.66 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 120.572 1.533 . . . . 0.0 110.657 173.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.04 0.42 63.67 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.591 1.091 . . . . 0.0 112.039 -173.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -69.57 115.51 8.9 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 119.494 1.647 . . . . 0.0 108.357 174.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -69.09 143.51 54.18 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.786 1.634 . . . . 0.0 108.81 -175.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -140.61 -37.29 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.62 1.168 . . . . 0.0 113.598 -174.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -130.5 145.43 51.85 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -143.98 136.06 26.49 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 91.7 m -66.87 128.03 93.71 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 174.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.41 143.4 43.02 Favored 'Trans proline' 0 N--CA 1.444 -1.436 0 CA-C-N 120.606 1.252 . . . . 0.0 109.122 -177.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -81.75 112.97 19.39 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 -174.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 173.17 -19.59 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.572 1 C-N-CA 135.116 5.366 . . . . 0.0 110.942 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.39 83.95 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.837 1.655 . . . . 0.0 111.4 -175.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.4 mt -125.21 135.57 63.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 175.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -106.32 161.94 14.11 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 125.911 1.684 . . . . 0.0 106.722 177.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -136.41 113.3 10.35 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 55.0 tttt -99.3 122.43 42.44 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 21.4 m -83.61 115.13 21.99 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 105.299 -2.112 . . . . 0.0 105.299 173.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 36.9 m -111.21 165.92 11.52 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 119.196 0.907 . . . . 0.0 109.192 173.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.5 pp -141.35 160.14 40.75 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.178 1.391 . . . . 0.0 107.694 173.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.99 131.11 43.87 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.795 1.238 . . . . 0.0 111.669 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -144.33 169.92 16.99 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 128.008 2.523 . . . . 0.0 107.693 173.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 . . . . . 0 C--O 1.255 1.385 0 C-N-CA 128.925 2.89 . . . . 0.0 106.057 173.857 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.628 0 N-CA-C 106.088 -2.805 . . . . 0.0 106.088 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.5 m -65.69 166.89 10.04 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 150.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -80.28 114.1 18.94 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 173.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -99.45 176.69 5.42 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.176 0.99 . . . . 0.0 111.282 -174.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -129.56 176.42 8.0 Favored 'General case' 0 CA--C 1.545 0.784 1 C-N-CA 134.889 5.275 . . . . 0.0 101.805 172.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -59.39 112.55 1.79 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 121.296 1.862 . . . . 0.0 108.467 -173.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.14 176.27 1.4 Allowed 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 131.153 3.781 . . . . 0.0 102.689 -174.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -114.81 176.07 5.22 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 127.054 2.141 . . . . 0.0 109.391 173.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -134.28 175.17 9.74 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 127.106 2.162 . . . . 0.0 105.944 173.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -141.74 174.39 10.62 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.882 1.673 . . . . 0.0 108.105 173.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.6 m -175.86 177.0 1.74 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.508 2.723 . . . . 0.0 109.863 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.9 tt -43.32 129.85 4.89 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 129.335 3.054 . . . . 0.0 113.285 -175.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -115.1 139.6 49.75 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.18 2.192 . . . . 0.0 108.441 173.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.25 117.97 6.19 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 126.05 1.74 . . . . 0.0 106.693 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 13.7 p90 -131.02 176.06 8.57 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.296 1.039 . . . . 0.0 110.083 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.5 mt -113.06 113.91 45.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 102.418 -3.179 . . . . 0.0 102.418 174.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -76.89 139.21 40.15 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 123.069 1.414 . . . . 0.0 111.967 -173.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.19 -25.54 61.7 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.276 1.83 . . . . 0.0 114.367 -173.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 13.6 m80 -56.53 -37.3 70.29 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 118.978 0.808 . . . . 0.0 110.018 -174.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 49.1 tp60 -66.83 -41.31 87.66 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 121.992 -0.443 . . . . 0.0 111.067 178.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.4 -35.4 80.77 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 121.683 -0.636 . . . . 0.0 110.904 173.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.3 -57.26 13.02 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 173.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.0 t -51.51 -27.72 7.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.712 1.205 . . . . 0.0 111.424 177.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.2 mt -71.16 -47.6 56.75 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 117.729 -1.129 . . . . 0.0 113.404 175.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.4 pt -154.56 14.66 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 -172.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.95 13.25 75.68 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 125.338 1.447 . . . . 0.0 113.314 -174.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -101.37 143.27 31.61 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 126.822 2.049 . . . . 0.0 106.849 -176.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -128.64 117.6 21.49 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.696 1.134 . . . . 0.0 109.673 -173.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -165.85 136.49 3.62 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 130.681 3.592 . . . . 0.0 107.507 174.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -86.45 176.21 7.98 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.093 1.757 . . . . 0.0 107.823 173.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.0 mp -137.54 113.1 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 173.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.52 115.23 26.79 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -176.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.5 mt -94.66 -53.94 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 118.635 0.652 . . . . 0.0 110.065 -176.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.2 t -126.15 129.99 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 125.68 1.592 . . . . 0.0 107.703 -173.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.0 p -138.4 132.94 32.22 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 103.165 -2.902 . . . . 0.0 103.165 173.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.31 18.0 pm0 44.33 33.73 0.91 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.151 1.38 . . . . 0.0 113.796 -174.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.54 -4.17 14.87 Favored Glycine 0 CA--C 1.543 1.813 0 O-C-N 120.652 -1.28 . . . . 0.0 115.135 -176.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -66.4 37.41 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.596 1 C-N-CA 132.467 4.307 . . . . 0.0 114.222 -176.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 31.4 mtt -38.07 114.33 0.35 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 120.183 1.356 . . . . 0.0 113.742 -173.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.56 164.79 29.19 Favored Pre-proline 0 N--CA 1.447 -0.599 0 CA-C-N 113.777 -1.556 . . . . 0.0 107.977 173.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.84 40.9 0.59 Allowed 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 124.215 3.276 . . . . 0.0 111.002 173.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -52.27 -26.26 11.46 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 127.913 2.485 . . . . 0.0 112.603 -173.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.9 m -44.01 -43.72 6.87 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.152 1.781 . . . . 0.0 111.619 177.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.544 ' CE1' ' HZ1' ' A' ' 48' ' ' LYS . 15.4 t-80 -60.81 -66.05 0.59 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.427 0.691 . . . . 0.0 110.191 -177.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -73.98 -23.01 59.4 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.155 1.782 . . . . 0.0 114.062 -173.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -77.89 -56.81 4.19 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 124.669 1.187 . . . . 0.0 110.229 173.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 18.5 ttp180 -69.71 -32.57 71.23 Favored 'General case' 0 C--N 1.345 0.386 0 O-C-N 121.657 -0.652 . . . . 0.0 109.873 -173.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.544 ' HZ1' ' CE1' ' A' ' 44' ' ' HIS . 0.7 OUTLIER -114.02 113.53 24.9 Favored 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 103.101 -2.926 . . . . 0.0 103.101 173.388 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -158.83 176.07 12.8 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 120.015 1.279 . . . . 0.0 111.286 -174.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -66.93 164.37 17.7 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 172.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.3 tm0? -48.4 -25.46 1.64 Allowed 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -174.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -52.19 -16.31 0.78 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.068 1.747 . . . . 0.0 114.97 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 61.1 mmm -130.69 -66.12 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.467 0 CA-C-N 121.132 1.787 . . . . 0.0 115.079 -175.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.24 -74.21 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.195 1.93 . . . . 0.0 111.82 -173.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.73 113.42 14.36 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -174.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 62.9 mt -113.16 126.75 27.74 Favored Pre-proline 0 C--N 1.324 -0.536 0 C-N-CA 127.734 2.413 . . . . 0.0 105.803 -174.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -78.46 157.29 28.94 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 121.691 1.594 . . . . 0.0 110.356 176.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.4 p -45.7 -38.74 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 125.849 1.66 . . . . 0.0 111.975 173.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -55.91 -40.08 72.56 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 126.677 1.991 . . . . 0.0 112.832 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mm -77.11 112.73 15.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 101.914 -3.365 . . . . 0.0 101.914 173.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -79.92 -40.67 27.7 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 174.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.8 m -141.51 161.75 37.16 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.609 1.164 . . . . 0.0 110.053 -173.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 52.8 mtp -123.68 167.47 13.94 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.426 1.49 . . . . 0.0 107.092 173.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -114.03 155.85 25.17 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 174.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -140.75 151.54 44.54 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 130.489 3.516 . . . . 0.0 102.268 172.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.3 m -137.97 133.85 34.19 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -145.42 162.38 37.44 Favored 'General case' 0 C--O 1.238 0.473 0 O-C-N 121.857 -0.527 . . . . 0.0 111.198 178.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -167.36 153.36 7.78 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.969 0.89 . . . . 0.0 112.484 173.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.3 -173.65 4.83 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.333 1.453 . . . . 0.0 109.174 173.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.85 100.11 7.04 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.789 1.635 . . . . 0.0 108.324 -174.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.07 -63.29 0.0 OUTLIER Glycine 0 CA--C 1.538 1.522 0 C-N-CA 130.184 3.754 . . . . 0.0 119.016 173.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -116.88 -13.78 10.69 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 120.583 2.191 . . . . 0.0 114.113 173.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.59 37.1 0.17 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 129.136 2.975 . . . . 0.0 118.021 -173.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -53.58 113.68 1.26 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 122.873 2.579 . . . . 0.0 109.672 -177.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -84.06 129.95 34.89 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 126.187 1.795 . . . . 0.0 107.935 174.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -79.85 147.67 31.65 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -132.56 161.26 34.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 120.127 1.33 . . . . 0.0 111.182 176.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -152.71 137.24 16.8 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 173.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -81.68 104.08 11.83 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.635 1.174 . . . . 0.0 109.91 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.7 tt -67.36 -41.72 84.65 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.43 1.092 . . . . 0.0 108.114 174.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.8 m -133.87 141.29 47.33 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.881 0.872 . . . . 0.0 111.202 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.3 tt -171.95 93.07 0.14 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 104.15 -2.537 . . . . 0.0 104.15 173.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -162.18 156.73 22.17 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.024 0.829 . . . . 0.0 111.416 -173.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.6 t -75.99 161.95 28.48 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 173.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.6 mt -122.1 -26.33 4.75 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 116.99 -1.481 . . . . 0.0 112.045 174.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.444 ' CG ' ' H ' ' A' ' 87' ' ' LYS . 23.2 t0 -83.3 168.11 16.98 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 121.34 1.882 . . . . 0.0 111.604 177.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.444 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -111.3 -49.32 3.02 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 128.533 2.733 . . . . 0.0 112.501 179.099 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.84 -70.19 1.16 Allowed Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 174.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mp -79.75 18.63 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 128.786 2.834 . . . . 0.0 110.048 -174.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -43.93 134.11 4.68 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 127.061 2.144 . . . . 0.0 110.239 -175.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -157.51 113.76 2.89 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 126.118 1.767 . . . . 0.0 106.916 -173.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -97.34 132.43 25.46 Favored Pre-proline 0 C--N 1.324 -0.541 0 O-C-N 124.142 0.901 . . . . 0.0 109.876 -173.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.01 153.81 67.42 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 C-N-CA 121.409 1.406 . . . . 0.0 109.347 174.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 21.1 p -140.11 157.09 46.17 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 126.682 1.993 . . . . 0.0 107.439 174.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.9 m -126.33 153.66 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 119.648 1.113 . . . . 0.0 113.145 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -73.83 7.94 2.26 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 127.567 2.347 . . . . 0.0 113.647 174.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.6 m -140.75 164.89 33.44 Favored Pre-proline 0 C--N 1.326 -0.452 0 C-N-CA 125.648 1.579 . . . . 0.0 108.286 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -67.18 167.61 19.71 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 121.347 1.365 . . . . 0.0 110.937 174.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -63.22 -11.37 20.63 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.786 1.235 . . . . 0.0 112.119 175.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -145.07 164.3 31.64 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.22 1.408 . . . . 0.0 107.884 173.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.33 -161.74 34.28 Favored Glycine 0 C--O 1.227 -0.342 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 71.4 p -117.86 151.19 37.86 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.5 t -88.69 113.37 55.44 Favored Pre-proline 0 N--CA 1.448 -0.542 0 N-CA-C 102.84 -3.022 . . . . 0.0 102.84 173.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -90.09 160.02 4.83 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.803 2.336 . . . . 0.0 111.424 -173.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -74.18 4.44 5.65 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 119.753 -1.842 . . . . 0.0 113.3 -173.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -115.54 116.85 28.87 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 126.259 1.824 . . . . 0.0 106.736 -173.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -43.06 105.37 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 125.039 1.336 . . . . 0.0 109.755 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.3 m -112.02 136.0 51.94 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.0 t -95.68 116.09 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.05 -173.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 82.5 t -93.76 103.27 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 N-CA-C 103.476 -2.787 . . . . 0.0 103.476 173.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.58 120.11 25.11 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 103.324 -2.843 . . . . 0.0 103.324 173.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.4 t -94.7 113.64 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 104.23 -2.507 . . . . 0.0 104.23 173.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -92.36 149.42 19.62 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 175.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.458 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 9.8 m-85 -131.13 73.64 80.42 Favored Pre-proline 0 C--O 1.242 0.7 0 CA-C-N 118.544 1.172 . . . . 0.0 110.422 -176.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -62.94 116.14 3.38 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.479 2.119 . . . . 0.0 109.309 173.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 9.2 t -93.67 147.67 22.81 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 173.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.4 mt -74.16 -13.48 60.81 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.134 0.425 . . . . 0.0 111.822 -176.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.8 34.3 89.57 Favored Glycine 0 C--N 1.34 0.804 0 C-N-CA 125.757 1.646 . . . . 0.0 114.352 173.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.7 mttm -114.9 -50.64 2.76 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.349 1.575 . . . . 0.0 112.442 -173.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 48.6 tp60 -96.06 147.49 23.66 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 173.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -93.93 142.12 27.74 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 175.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.72 -154.83 26.09 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-N 118.781 0.719 . . . . 0.0 111.649 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.6 t -129.96 116.73 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 123.846 0.858 . . . . 0.0 108.789 -179.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -92.42 175.3 6.89 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.15 1.38 . . . . 0.0 109.297 173.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -128.6 155.03 45.59 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.767 1.627 . . . . 0.0 107.386 173.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.458 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 40.3 p90 -147.05 157.84 43.74 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.576 1.15 . . . . 0.0 108.035 173.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -123.36 150.52 43.57 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.542 1.537 . . . . 0.0 111.909 -173.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 62.5 t -141.45 143.2 27.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 173.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -160.81 136.13 7.85 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.023 1.329 . . . . 0.0 107.687 174.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.7 t -136.79 139.26 45.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-N 119.51 1.05 . . . . 0.0 109.265 -173.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.9 163.64 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 173.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.6 t -141.74 137.81 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -173.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.31 174.12 10.89 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.542 1.537 . . . . 0.0 108.416 -176.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -88.84 175.8 7.32 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 172.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 6.1 t -65.1 -14.86 61.55 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 120.212 -1.555 . . . . 0.0 112.112 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -80.12 -3.3 48.25 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.73 1.612 . . . . 0.0 110.65 176.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.22 5.66 89.9 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 125.123 1.345 . . . . 0.0 112.996 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -80.92 118.19 22.2 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.5 m -64.71 143.07 58.19 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.434 1.493 . . . . 0.0 108.748 -178.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -140.07 -37.26 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.774 1.23 . . . . 0.0 113.626 -175.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -130.56 141.08 50.47 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -146.6 126.35 13.46 Favored 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 121.422 -0.799 . . . . 0.0 109.081 -176.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 30.3 m -67.52 142.68 96.47 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 173.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -83.59 147.55 12.4 Favored 'Trans proline' 0 N--CA 1.443 -1.477 0 N-CA-C 108.731 -1.296 . . . . 0.0 108.731 174.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -75.46 112.63 11.99 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 103.505 -2.776 . . . . 0.0 103.505 -178.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 173.73 -23.81 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 128.17 2.588 . . . . 0.0 112.17 -173.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.89 87.34 0.14 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 122.208 1.004 . . . . 0.0 108.428 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.9 mt -127.84 147.91 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -174.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 126' ' ' PHE . 0.5 OUTLIER -134.28 167.89 19.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 113.971 -1.468 . . . . 0.0 107.298 -176.783 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -135.33 113.5 11.3 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.175 0.99 . . . . 0.0 109.456 -173.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -104.22 122.43 45.36 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 119.435 1.016 . . . . 0.0 109.431 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 25.6 m -83.68 115.44 22.17 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 174.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 5.0 m -116.78 166.3 12.3 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.496 0.665 . . . . 0.0 110.163 174.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.3 pp -134.12 162.45 32.07 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.109 1.364 . . . . 0.0 107.539 173.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -73.57 114.72 12.13 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 127.738 2.415 . . . . 0.0 109.463 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -163.5 118.54 1.64 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.335 1.454 . . . . 0.0 109.79 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 . . . . . 0 C--O 1.256 1.416 0 C-N-CA 128.667 2.787 . . . . 0.0 105.914 173.743 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.131 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.7 t -60.85 176.16 0.42 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 117.985 0.892 . . . . 0.0 110.302 162.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -50.63 127.3 17.66 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.823 1.249 . . . . 0.0 111.296 -174.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 45.5 mtp -145.98 176.64 9.55 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 128.122 2.569 . . . . 0.0 107.651 -174.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.8 mt -113.24 127.48 56.18 Favored 'General case' 0 C--N 1.328 -0.343 1 N-CA-C 97.386 -5.042 . . . . 0.0 97.386 172.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -44.19 113.22 0.5 Allowed 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 -172.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.52 113.26 0.1 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 131.234 3.813 . . . . 0.0 101.373 173.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -120.55 114.09 21.23 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -173.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -126.44 159.52 33.08 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 126.796 2.038 . . . . 0.0 106.097 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -75.07 170.72 15.46 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 122.1 0.952 . . . . 0.0 111.396 176.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 m -175.53 175.72 2.07 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 129.925 3.29 . . . . 0.0 106.937 173.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.5 tt -46.57 136.8 7.32 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.165 1.786 . . . . 0.0 112.788 -174.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -122.07 137.03 54.96 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.317 1.447 . . . . 0.0 110.249 175.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.79 119.12 6.38 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.57 1.548 . . . . 0.0 107.803 -178.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 30.9 p90 -142.84 148.08 36.47 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.641 1.109 . . . . 0.0 109.541 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.0 mp -84.12 118.53 31.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 102.893 -3.003 . . . . 0.0 102.893 173.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.03 143.81 29.51 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 123.691 1.71 . . . . 0.0 114.313 -173.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.75 -26.11 61.44 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 112.774 -2.012 . . . . 0.0 113.636 -173.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.9 m80 -62.63 -38.25 89.52 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 122.926 0.49 . . . . 0.0 110.519 -173.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -71.54 -49.3 42.14 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.149 174.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.61 -43.06 56.74 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-O 118.404 -0.807 . . . . 0.0 111.218 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.0 ttp-105 -50.51 -64.91 0.66 Allowed 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 119.797 1.181 . . . . 0.0 108.452 173.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.2 t -51.27 -23.72 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.727 1.211 . . . . 0.0 111.679 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 75.6 mt -85.15 -37.49 20.13 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.3 pt -143.57 14.05 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 117.001 2.223 . . . . 0.0 117.001 -173.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.41 -1.75 0.62 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 129.761 3.553 . . . . 0.0 115.55 -174.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -101.97 143.04 32.33 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 129.192 2.997 . . . . 0.0 108.043 -177.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -132.88 114.49 14.11 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.706 1.139 . . . . 0.0 111.039 -173.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -150.7 144.98 25.52 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.437 2.695 . . . . 0.0 106.383 173.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -96.03 164.83 12.54 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 173.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.2 mp -135.27 113.38 15.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 103.858 -2.645 . . . . 0.0 103.858 173.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.4 tt -94.62 114.07 25.97 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -173.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.6 mt -83.86 -61.75 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 124.349 1.06 . . . . 0.0 108.281 -174.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.1 t -117.1 113.66 43.46 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -173.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.4 p -111.92 125.93 54.58 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 102.616 -3.105 . . . . 0.0 102.616 173.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 46.08 38.2 4.56 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.148 1.379 . . . . 0.0 112.508 174.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 54.98 19.84 16.96 Favored Glycine 0 CA--C 1.539 1.58 0 C-N-CA 124.992 1.282 . . . . 0.0 113.824 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -122.97 37.97 4.29 Favored 'General case' 0 CA--C 1.536 0.434 1 C-N-CA 131.861 4.064 . . . . 0.0 108.051 -172.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . 0.272 20.2 mtp -37.29 146.71 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 130.762 3.625 . . . . 0.0 115.696 -172.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.72 162.07 75.12 Favored Pre-proline 0 N--CA 1.452 -0.368 0 CA-C-N 113.141 -1.845 . . . . 0.0 109.314 173.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.09 42.36 0.98 Allowed 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 124.552 3.501 . . . . 0.0 111.609 174.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -53.86 -26.58 25.32 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.647 1.979 . . . . 0.0 113.197 -174.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.5 m -58.25 -29.35 65.69 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 126.501 1.92 . . . . 0.0 111.434 -173.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 62.8 t60 -62.86 -66.48 0.54 Allowed 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 118.64 0.655 . . . . 0.0 109.346 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.63 -23.82 65.4 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -175.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -67.96 -47.62 68.14 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.68 1.192 . . . . 0.0 111.223 174.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.23 -25.59 15.75 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -173.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.6 176.55 1.89 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.129 1.771 . . . . 0.0 109.285 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -51.33 160.97 0.49 Allowed 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.561 -0.712 . . . . 0.0 109.508 173.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 5.3 tm0? -43.53 134.4 4.07 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.82 1.648 . . . . 0.0 113.706 -173.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -136.31 -66.85 0.53 Allowed 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 173.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -146.94 -16.23 0.41 Allowed 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 120.546 -0.461 . . . . 0.0 111.97 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.44 ' H ' ' CD ' ' A' ' 54' ' ' PRO . 88.2 mtp -135.05 -28.66 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.532 0 CA-C-O 115.587 -2.149 . . . . 0.0 115.661 -174.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.44 ' CD ' ' H ' ' A' ' 53' ' ' MET . 54.2 Cg_exo -51.34 -68.45 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.949 0 CA-C-N 123.08 2.136 . . . . 0.0 114.641 -173.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.27 113.9 22.65 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 177.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.9 mt -103.85 118.84 56.27 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 127.008 2.123 . . . . 0.0 105.761 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -74.48 153.95 44.88 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 121.355 1.37 . . . . 0.0 110.164 176.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.3 p -39.93 -44.28 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 127.483 2.313 . . . . 0.0 113.321 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -58.71 -34.43 71.3 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 126.706 2.002 . . . . 0.0 113.567 -176.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.0 mm -71.36 113.08 7.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 104.362 -2.458 . . . . 0.0 104.362 175.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -79.85 -39.34 30.86 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 173.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.2 m -153.06 162.29 41.49 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -173.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 54.5 mtm -126.69 162.4 25.87 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 172.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 39.1 m-20 -120.47 114.09 21.28 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 118.509 0.595 . . . . 0.0 109.725 -175.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -94.32 150.69 20.05 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 102.3 -3.222 . . . . 0.0 102.3 172.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.9 m -139.5 135.68 33.75 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 -175.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -148.96 165.81 30.48 Favored 'General case' 0 CA--C 1.509 -0.611 0 O-C-N 121.572 -0.705 . . . . 0.0 110.525 -178.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -165.37 149.7 8.66 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.587 173.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.02 177.52 4.29 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 172.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.91 143.57 26.78 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 100.998 -3.705 . . . . 0.0 100.998 173.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -1.25 -73.99 0.0 OUTLIER Glycine 0 C--N 1.302 -1.324 1 C-N-CA 133.88 5.514 . . . . 0.0 117.721 -173.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . 0.273 21.4 mm100 -117.35 23.95 11.46 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 173.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -108.99 37.47 2.55 Favored 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 130.859 3.664 . . . . 0.0 120.693 -173.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -39.61 116.2 0.6 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 122.34 2.337 . . . . 0.0 113.785 -173.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -84.4 132.68 34.56 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 174.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -83.82 149.08 26.63 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 175.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -134.05 159.76 39.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 119.473 1.033 . . . . 0.0 111.133 175.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -152.83 137.93 17.33 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 173.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -85.86 104.02 15.14 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.592 1.157 . . . . 0.0 110.041 -176.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.2 tt -61.34 -43.88 98.12 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.69 1.596 . . . . 0.0 108.687 173.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.6 m -134.25 143.73 47.97 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.558 1.143 . . . . 0.0 111.723 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.2 tt -172.36 92.79 0.12 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 103.477 -2.786 . . . . 0.0 103.477 173.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -168.89 152.79 5.45 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 118.833 0.742 . . . . 0.0 111.025 -174.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.7 t -79.43 127.75 32.5 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.0 mt -87.01 -26.57 23.69 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 116.67 -1.633 . . . . 0.0 110.857 174.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -86.79 152.42 22.51 Favored 'General case' 0 C--N 1.348 0.508 0 CA-C-N 120.9 1.682 . . . . 0.0 109.377 173.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.4 ' HE3' ' SD ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -108.26 -36.54 6.25 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 128.892 2.877 . . . . 0.0 112.678 -179.599 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.455 ' C ' ' H ' ' A' ' 90' ' ' MET . . . -68.71 -75.95 0.48 Allowed Glycine 0 CA--C 1.53 1.025 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 173.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.1 mp -74.21 20.03 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 129.951 3.3 . . . . 0.0 110.441 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.455 ' H ' ' C ' ' A' ' 88' ' ' GLY . 14.0 ttp -43.42 130.81 5.01 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 127.402 2.281 . . . . 0.0 111.255 -173.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -153.65 113.37 3.85 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 -175.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -99.58 132.81 22.5 Favored Pre-proline 0 C--N 1.322 -0.615 0 O-C-N 124.286 0.991 . . . . 0.0 109.239 -173.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.9 153.67 72.28 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 C-N-CA 121.084 1.19 . . . . 0.0 109.338 174.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 17.1 p -137.57 152.57 49.56 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 126.244 1.817 . . . . 0.0 106.436 173.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.8 m -126.37 153.98 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 CA-C-N 118.966 0.803 . . . . 0.0 112.268 177.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -75.94 8.46 3.12 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.38 1.872 . . . . 0.0 113.822 174.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.67 165.1 32.13 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 124.777 1.231 . . . . 0.0 109.481 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -66.87 166.01 24.03 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.536 1.49 . . . . 0.0 110.478 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -66.97 -10.32 48.11 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.579 1.152 . . . . 0.0 112.256 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -144.28 164.1 31.76 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.564 1.545 . . . . 0.0 107.398 173.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 160.3 -161.42 32.54 Favored Glycine 0 C--O 1.228 -0.24 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 73.1 p -118.0 151.44 37.47 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.5 t -88.92 113.59 56.62 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 175.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.4 154.85 40.93 Favored 'Trans proline' 0 CA--C 1.512 -0.598 0 C-N-CA 121.839 1.692 . . . . 0.0 111.161 -176.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -74.4 -7.07 51.67 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 120.353 -1.467 . . . . 0.0 113.687 -172.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.6 mptt -116.51 122.69 45.45 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 -174.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -38.73 111.39 0.17 Allowed 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 127.123 2.169 . . . . 0.0 111.76 -173.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 57.6 m -118.62 144.54 46.07 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 176.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.0 t -100.63 117.42 45.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 124.835 1.254 . . . . 0.0 111.303 -173.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.2 t -98.47 103.06 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 104.501 -2.407 . . . . 0.0 104.501 173.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -78.55 131.12 36.66 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 104.859 -2.275 . . . . 0.0 104.859 173.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.4 t -103.11 113.45 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 101.634 -3.469 . . . . 0.0 101.634 173.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -97.06 150.26 19.51 Favored Glycine 0 N--CA 1.439 -1.123 0 N-CA-C 108.621 -1.791 . . . . 0.0 108.621 176.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -133.3 73.54 73.83 Favored Pre-proline 0 C--O 1.242 0.7 0 CA-C-N 118.199 1.0 . . . . 0.0 109.402 -174.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -63.8 116.97 3.99 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.649 2.233 . . . . 0.0 109.885 173.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 7.1 t -90.75 146.43 23.99 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 173.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.9 mt -74.27 -12.34 60.52 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 117.856 0.298 . . . . 0.0 111.371 -177.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.61 21.76 43.75 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 127.123 2.297 . . . . 0.0 116.527 173.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . 0.339 4.6 mptp? -102.16 -40.9 6.59 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.984 1.892 . . . . 0.0 114.451 174.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 38.8 tp60 -96.49 146.1 25.09 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.469 1.032 . . . . 0.0 108.467 173.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -94.38 152.06 18.91 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.446 1.498 . . . . 0.0 107.869 174.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 138.06 -152.77 21.97 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.9 t -127.67 114.12 34.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.16 173.36 9.28 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.59 1.156 . . . . 0.0 109.307 173.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -128.24 150.27 50.11 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.338 1.855 . . . . 0.0 106.58 173.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -147.74 154.35 40.42 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 173.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -113.54 141.26 47.36 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.776 1.63 . . . . 0.0 110.291 -173.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 61.1 t -146.71 113.53 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 N-CA-C 104.258 -2.497 . . . . 0.0 104.258 173.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -144.19 137.77 27.62 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -174.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.0 t -136.62 148.9 26.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 121.794 0.807 . . . . 0.0 110.071 -173.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.74 162.64 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 173.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.7 t -139.08 136.08 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 -173.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.33 175.53 9.5 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 125.495 1.518 . . . . 0.0 107.371 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -92.95 176.12 6.54 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 172.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.2 t -65.89 -3.92 5.98 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 120.03 -1.669 . . . . 0.0 113.442 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -86.02 -15.24 42.05 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 120.697 1.59 . . . . 0.0 110.41 173.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.08 -0.63 66.81 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.73 1.157 . . . . 0.0 111.964 -173.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -70.15 116.04 10.05 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 119.456 1.628 . . . . 0.0 108.346 174.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -64.66 141.95 58.59 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.915 1.686 . . . . 0.0 107.951 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.8 pt -140.07 -37.25 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 124.481 1.113 . . . . 0.0 113.71 -174.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -133.97 145.42 49.51 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -147.45 136.99 22.73 Favored 'General case' 0 CA--C 1.516 -0.354 0 O-C-N 121.339 -0.851 . . . . 0.0 109.269 -176.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 35.5 m -72.33 129.84 86.9 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 173.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.4 143.94 35.72 Favored 'Trans proline' 0 N--CA 1.444 -1.415 0 N-CA-C 108.302 -1.461 . . . . 0.0 108.302 175.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 28.3 mp0 -79.37 112.38 16.55 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -173.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.547 25.6 m-80 172.48 -4.52 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.513 1 C-N-CA 136.115 5.766 . . . . 0.0 112.121 173.472 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.66 86.45 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 123.428 1.585 . . . . 0.0 108.836 174.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.9 mm -133.98 139.39 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 127.747 2.419 . . . . 0.0 105.522 -173.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -122.98 167.13 13.99 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 173.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -129.85 113.55 14.79 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 -173.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 57.7 tttt -102.16 121.74 42.8 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 119.748 1.158 . . . . 0.0 108.715 -176.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 30.1 m -83.61 116.86 22.81 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 104.84 -2.281 . . . . 0.0 104.84 173.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 13.2 m -117.85 166.12 12.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.304 0.573 . . . . 0.0 110.315 174.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.5 pp -137.12 159.27 42.39 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.636 1.574 . . . . 0.0 107.359 173.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.61 132.59 45.69 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.236 1.014 . . . . 0.0 110.463 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -153.35 161.75 42.01 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.177 1.791 . . . . 0.0 108.68 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 . . . . . 0 C--O 1.255 1.357 0 C-N-CA 129.898 3.279 . . . . 0.0 105.109 173.723 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.14 0 N-CA-C 106.507 -2.637 . . . . 0.0 106.507 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.4 t -63.3 176.24 0.83 Allowed 'General case' 0 C--O 1.242 0.687 0 C-N-CA 118.892 -1.123 . . . . 0.0 108.166 135.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -112.82 172.14 7.11 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 173.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 28.0 ptm -144.0 176.2 9.47 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 127.217 2.207 . . . . 0.0 106.782 174.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.57 169.85 17.58 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 173.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -63.22 120.87 12.37 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 173.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.06 158.5 16.87 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 103.899 -2.63 . . . . 0.0 103.899 -173.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -123.15 113.36 18.86 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 173.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -75.0 176.28 7.35 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.082 0.953 . . . . 0.0 109.045 174.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -58.25 169.93 0.77 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.549 1.14 . . . . 0.0 110.298 173.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.6 m -159.23 176.32 12.34 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.235 1.814 . . . . 0.0 109.166 173.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.1 tt -44.71 127.32 6.14 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.764 2.026 . . . . 0.0 113.487 -176.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -115.64 128.35 55.86 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.261 1.825 . . . . 0.0 109.185 174.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.93 118.07 11.27 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 127.135 2.174 . . . . 0.0 107.388 -178.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 9.0 p90 -133.81 170.89 14.92 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.184 0.994 . . . . 0.0 110.229 176.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.0 mp -108.02 115.15 48.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 102.187 -3.264 . . . . 0.0 102.187 173.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -82.2 142.52 32.11 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 123.32 1.533 . . . . 0.0 112.967 -173.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.62 -16.83 51.88 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.884 1.674 . . . . 0.0 115.32 -173.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 27.7 m80 -58.03 -35.34 71.16 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.51 1.05 . . . . 0.0 110.458 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -70.52 -46.64 63.26 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 122.313 -0.242 . . . . 0.0 111.052 177.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.97 -31.57 65.17 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 118.907 -0.568 . . . . 0.0 112.136 174.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.439 HH21 ' CD ' ' A' ' 28' ' ' GLU . 8.7 tpp85 -55.72 -59.64 4.57 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 173.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 60.8 t -53.78 -23.81 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 124.796 1.238 . . . . 0.0 111.71 177.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.0 mt -73.05 -46.06 53.96 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 117.504 -1.236 . . . . 0.0 113.622 174.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.5 pt -152.46 17.97 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 116.247 1.944 . . . . 0.0 116.247 -173.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.76 10.17 54.3 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 127.817 2.627 . . . . 0.0 114.547 -174.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -101.39 175.71 5.48 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 126.864 2.066 . . . . 0.0 111.034 -173.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.439 ' CD ' HH21 ' A' ' 22' ' ' ARG . 1.4 tp10 -122.39 121.34 36.43 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.159 0.984 . . . . 0.0 109.129 -178.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -153.02 113.28 3.99 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.693 1.197 . . . . 0.0 109.752 174.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -96.4 161.19 14.03 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 172.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.1 mm -138.65 113.39 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 173.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.31 113.89 20.41 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.4 mt -86.04 -65.6 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 32.0 t -114.73 114.23 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 -173.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.8 p -113.05 115.17 27.92 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 103.8 -2.667 . . . . 0.0 103.8 173.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.258 6.4 pt-20 44.43 45.97 7.74 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.689 1.195 . . . . 0.0 113.013 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 67.53 -7.28 2.09 Favored Glycine 0 CA--C 1.541 1.672 0 C-N-CA 125.804 1.669 . . . . 0.0 114.817 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -83.22 37.43 0.55 Allowed 'General case' 0 CA--C 1.539 0.533 1 C-N-CA 133.323 4.649 . . . . 0.0 109.022 -173.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 52.1 mtm -37.98 132.09 1.01 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 127.166 2.186 . . . . 0.0 114.54 -172.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.48 160.62 78.56 Favored Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.347 173.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.36 35.33 0.43 Allowed 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 124.215 3.277 . . . . 0.0 112.039 175.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -54.71 -26.59 34.82 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.481 1.913 . . . . 0.0 112.793 -173.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.7 m -48.82 -47.05 42.68 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 129.219 3.007 . . . . 0.0 112.861 -173.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.526 ' CE1' ' HZ3' ' A' ' 48' ' ' LYS . 19.9 t-80 -59.17 -59.08 6.04 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.258 1.023 . . . . 0.0 109.944 -175.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.298 47.0 m-20 -76.74 -27.93 55.58 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.289 -175.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -61.21 -50.52 72.78 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 120.91 -1.119 . . . . 0.0 108.767 173.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -65.84 -42.16 90.85 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-O 118.576 -0.726 . . . . 0.0 110.651 178.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.526 ' HZ3' ' CE1' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -126.69 112.79 15.85 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-O 116.832 -1.556 . . . . 0.0 111.801 178.556 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -176.77 142.43 0.4 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 121.39 1.905 . . . . 0.0 110.463 172.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -96.74 112.91 24.47 Favored 'General case' 0 N--CA 1.452 -0.353 1 N-CA-C 100.114 -4.032 . . . . 0.0 100.114 172.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -163.87 -67.33 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 120.426 1.466 . . . . 0.0 111.046 174.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.76 -17.11 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.895 1.225 . . . . 0.0 113.075 -174.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 78.6 mmm -93.87 -65.48 0.12 Allowed Pre-proline 0 CA--C 1.533 0.31 0 CA-C-O 117.549 -1.215 . . . . 0.0 113.936 -173.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.52 -66.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 121.93 1.753 . . . . 0.0 113.482 -173.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.7 113.82 8.18 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.461 0.704 . . . . 0.0 110.238 -174.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 38.6 mt -124.35 132.15 24.27 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 126.421 1.888 . . . . 0.0 108.187 -173.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -80.04 157.83 23.68 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.854 2.369 . . . . 0.0 111.559 174.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.6 p -42.77 -43.49 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 127.058 2.143 . . . . 0.0 112.791 175.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -60.09 -34.19 73.13 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 126.29 1.836 . . . . 0.0 113.106 -174.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 mm -71.8 112.95 7.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 103.107 -2.923 . . . . 0.0 103.107 174.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 -94.75 -23.46 17.53 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.2 m -152.12 161.42 42.66 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.308 1.043 . . . . 0.0 108.59 173.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 16.8 mtm -126.19 156.96 39.37 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 173.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.252 59.8 m-20 -96.46 150.42 20.63 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 174.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -138.09 151.34 47.72 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 130.985 3.714 . . . . 0.0 101.799 172.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.4 m -137.35 130.65 31.0 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 -177.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -144.1 165.05 28.9 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.72 175.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -167.01 154.87 9.42 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.493 173.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.24 -174.51 2.37 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 123.403 1.573 . . . . 0.0 107.031 172.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.11 135.56 45.38 Favored 'General case' 0 N--CA 1.411 -2.375 0 C-N-CA 130.812 3.645 . . . . 0.0 101.873 173.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -7.45 -56.42 0.01 OUTLIER Glycine 0 CA--C 1.54 1.615 1 C-N-CA 133.801 5.477 . . . . 0.0 120.022 -173.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -116.93 9.89 13.9 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 121.207 2.504 . . . . 0.0 114.862 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -107.43 37.44 2.4 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 120.759 3.615 . . . . 0.0 120.759 -172.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -44.81 113.63 0.59 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 123.559 2.89 . . . . 0.0 110.601 -175.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -84.99 121.32 27.6 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -174.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -73.98 144.51 45.18 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 178.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -130.28 161.02 32.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 119.358 0.981 . . . . 0.0 110.781 176.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.57 133.94 14.4 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 173.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -84.01 103.23 13.09 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -176.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.5 tt -64.72 -40.46 95.38 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 125.566 1.546 . . . . 0.0 108.32 176.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.0 m -148.83 142.86 25.88 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 120.499 -1.376 . . . . 0.0 110.358 177.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.9 tt -164.94 93.02 0.61 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 101.658 -3.46 . . . . 0.0 101.658 173.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 42.1 mmm-85 -166.01 163.32 18.31 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.09 0.956 . . . . 0.0 110.646 -177.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.8 t -91.47 158.25 16.59 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.99 1.316 . . . . 0.0 113.792 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.0 mt -110.13 -26.46 9.66 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.256 -1.338 . . . . 0.0 111.261 177.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.428 ' CG ' ' H ' ' A' ' 87' ' ' LYS . 6.3 t70 -76.74 169.73 17.75 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 120.495 1.498 . . . . 0.0 109.349 -174.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.428 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 19.7 mmtm -131.1 -46.3 1.01 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.602 1.961 . . . . 0.0 111.307 -173.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.441 ' C ' ' H ' ' A' ' 90' ' ' MET . . . -70.38 -71.29 1.03 Allowed Glycine 0 CA--C 1.533 1.208 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 173.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.7 mp -70.04 12.19 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 129.805 3.242 . . . . 0.0 111.07 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.441 ' H ' ' C ' ' A' ' 88' ' ' GLY . 28.5 ttp -43.69 142.31 1.28 Allowed 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 128.304 2.642 . . . . 0.0 112.193 -174.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.252 . . -161.95 174.98 12.32 Favored 'General case' 0 N--CA 1.439 -0.976 1 C-N-CA 131.851 4.06 . . . . 0.0 104.492 -173.572 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -151.32 137.4 11.19 Favored Pre-proline 0 C--N 1.321 -0.661 0 C-N-CA 124.359 1.064 . . . . 0.0 110.014 172.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -71.7 157.86 54.65 Favored 'Trans proline' 0 N--CA 1.443 -1.496 0 C-N-CA 121.396 1.397 . . . . 0.0 109.081 173.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 20.2 p -142.75 161.94 36.76 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 126.916 2.087 . . . . 0.0 107.28 174.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.9 m -126.44 150.97 32.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 123.532 0.733 . . . . 0.0 110.738 174.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -82.86 15.73 2.57 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.441 1.497 . . . . 0.0 111.482 173.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.2 m -129.6 163.24 48.09 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 173.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -67.47 162.75 37.59 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 CA-C-N 119.659 0.914 . . . . 0.0 109.91 173.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.52 -6.73 8.03 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.811 1.244 . . . . 0.0 111.693 175.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -145.9 163.22 35.78 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.621 1.569 . . . . 0.0 107.249 173.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 162.13 -160.2 32.3 Favored Glycine 0 C--O 1.227 -0.294 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 80.7 p -120.82 146.41 46.57 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 173.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.0 t -87.45 113.68 55.23 Favored Pre-proline 0 N--CA 1.448 -0.549 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 173.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.42 ' C ' ' H ' ' A' ' 106' ' ' LYS . 89.6 Cg_endo -84.41 156.35 12.51 Favored 'Trans proline' 0 C--O 1.213 -0.736 0 C-N-CA 122.546 2.164 . . . . 0.0 112.402 -174.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -71.11 1.13 6.24 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 120.248 -1.532 . . . . 0.0 111.714 -174.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.42 ' H ' ' C ' ' A' ' 104' ' ' PRO . 1.8 mppt? -114.03 115.6 27.86 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 128.102 2.561 . . . . 0.0 108.125 -173.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -41.56 108.74 0.1 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.096 1.358 . . . . 0.0 110.056 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.7 m -119.25 139.34 52.05 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.61 118.9 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 114.447 -1.252 . . . . 0.0 108.621 -173.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 75.9 t -93.88 104.21 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 173.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -82.34 115.04 21.21 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 104.532 -2.396 . . . . 0.0 104.532 173.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.3 t -93.33 113.82 28.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 104.111 -2.551 . . . . 0.0 104.111 174.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -89.19 144.86 18.21 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 124.891 1.234 . . . . 0.0 110.33 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -129.63 73.6 81.41 Favored Pre-proline 0 C--O 1.244 0.769 0 CA-C-N 118.754 1.277 . . . . 0.0 111.052 -175.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.3 129.06 19.53 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.397 2.064 . . . . 0.0 109.117 173.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 5.7 t -105.82 154.61 20.28 Favored 'General case' 0 C--N 1.338 0.1 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 174.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.8 mt -71.96 -17.01 62.1 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.568 0.622 . . . . 0.0 111.593 177.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 50.65 39.19 37.7 Favored Glycine 0 C--O 1.219 -0.793 0 C-N-CA 127.336 2.398 . . . . 0.0 114.809 173.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 42.9 mttm -124.4 -28.0 3.69 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.724 1.762 . . . . 0.0 112.032 173.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.419 ' NE2' ' H ' ' A' ' 121' ' ' ASP . 53.4 tp60 -96.53 155.66 16.67 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 172.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.419 ' H ' ' NE2' ' A' ' 120' ' ' GLN . 15.0 m-20 -109.42 150.75 27.61 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 138.59 -154.23 22.97 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 174.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 19.0 t -124.77 114.19 39.46 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -88.6 168.47 12.53 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 173.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -131.6 142.38 49.88 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.561 1.145 . . . . 0.0 108.715 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -143.34 150.44 39.17 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 125.829 1.651 . . . . 0.0 108.194 174.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -129.95 164.64 23.79 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 119.671 1.123 . . . . 0.0 113.285 177.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 57.3 t -131.62 148.56 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 125.613 1.565 . . . . 0.0 108.512 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -155.66 132.96 10.88 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 125.978 1.711 . . . . 0.0 108.078 173.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 36.5 t -137.15 143.46 34.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -174.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.25 163.46 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 173.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.9 t -140.3 137.59 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 CA-C-N 114.185 -1.37 . . . . 0.0 107.337 -173.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.79 174.71 10.33 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 125.957 1.703 . . . . 0.0 107.619 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 45.0 p-10 -89.68 176.01 7.03 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 172.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.8 t -66.1 -3.6 5.82 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 120.098 -1.626 . . . . 0.0 113.484 -177.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -86.69 -17.7 33.09 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 120.613 1.551 . . . . 0.0 110.452 173.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 97.6 1.13 59.02 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.783 1.182 . . . . 0.0 112.251 -173.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 65.4 m-20 -72.29 115.14 11.18 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 119.608 1.704 . . . . 0.0 108.701 174.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.5 m -64.8 143.0 58.24 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.498 1.919 . . . . 0.0 108.624 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -141.29 -36.82 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 124.708 1.203 . . . . 0.0 113.973 -175.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -131.91 144.18 50.67 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -144.13 130.2 19.55 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 35.6 m -68.79 149.07 98.01 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 173.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -89.17 144.92 5.08 Favored 'Trans proline' 0 N--CA 1.444 -1.386 0 CA-C-N 120.84 1.336 . . . . 0.0 109.646 173.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -78.84 112.58 16.13 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 -174.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 172.99 -18.4 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 128.12 2.568 . . . . 0.0 114.331 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.9 79.06 0.12 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.999 0.92 . . . . 0.0 112.08 -173.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 3.3 mm -86.83 148.03 4.92 Favored 'Isoleucine or valine' 0 C--N 1.345 0.38 0 C-N-CA 127.341 2.256 . . . . 0.0 109.361 174.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -125.88 128.41 47.55 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 129.484 3.114 . . . . 0.0 103.12 173.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -102.49 113.26 26.46 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 178.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 56.1 tttt -103.1 121.58 42.9 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 28.9 m -83.38 114.65 21.58 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 174.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 21.8 m -113.09 165.5 12.31 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 119.01 0.823 . . . . 0.0 109.459 174.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.4 pp -141.75 161.61 37.52 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.067 1.347 . . . . 0.0 108.098 174.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.91 130.2 42.24 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.621 1.168 . . . . 0.0 111.843 178.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -144.06 170.34 16.12 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 128.239 2.616 . . . . 0.0 107.606 173.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 . . . . . 0 C--O 1.254 1.314 0 C-N-CA 128.881 2.872 . . . . 0.0 106.075 173.812 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.51 ' H1 ' ' CD2' ' A' ' 3' ' ' HIS . . . . . . . . 0 N--CA 1.471 1.024 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.96 112.79 4.52 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 120.268 2.034 . . . . 0.0 106.731 168.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.51 ' CD2' ' H1 ' ' A' ' 1' ' ' GLY . 8.4 m-70 -161.41 176.8 10.74 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 128.475 2.71 . . . . 0.0 106.603 -173.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 23.3 mmt -63.33 160.33 16.16 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 104.051 -2.574 . . . . 0.0 104.051 172.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.3 mt -43.33 113.5 0.5 Allowed 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -172.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -152.69 176.23 11.97 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 130.483 3.513 . . . . 0.0 108.734 -173.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -145.17 126.29 14.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 102.15 -3.278 . . . . 0.0 102.15 173.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.11 176.56 7.28 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 125.747 1.619 . . . . 0.0 109.846 -173.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 54.9 mp0 -62.15 170.75 2.08 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 122.202 1.001 . . . . 0.0 109.734 173.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -59.01 158.62 8.24 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 122.551 1.167 . . . . 0.0 111.107 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.6 m -176.18 176.96 1.63 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 128.637 2.775 . . . . 0.0 109.467 -174.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.2 tt -42.99 121.91 2.26 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 127.132 2.173 . . . . 0.0 113.469 -173.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -111.76 139.84 46.9 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.265 2.226 . . . . 0.0 108.435 174.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.07 118.28 6.81 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 21.2 p90 -139.42 152.24 46.91 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 119.205 0.912 . . . . 0.0 109.58 177.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.8 mt -83.91 127.86 39.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 102.579 -3.119 . . . . 0.0 102.579 173.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -104.69 136.9 43.35 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 122.9 1.333 . . . . 0.0 111.856 -173.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.2 -22.38 66.88 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.206 -1.361 . . . . 0.0 113.891 -174.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -58.36 -37.9 76.15 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 119.564 1.075 . . . . 0.0 111.422 -173.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -71.19 -51.12 26.57 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 117.816 -1.088 . . . . 0.0 110.151 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.71 -41.73 61.72 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.034 0.834 . . . . 0.0 111.009 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -49.39 -68.27 0.19 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 173.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 98.2 t -51.52 -23.99 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 126.112 1.765 . . . . 0.0 111.825 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.2 mt -82.3 -42.6 18.59 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 124.046 0.939 . . . . 0.0 112.882 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.6 pt -155.26 17.85 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 -172.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.12 18.79 65.28 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.119 1.342 . . . . 0.0 113.012 -174.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -98.51 135.09 40.56 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 126.483 1.913 . . . . 0.0 107.946 -174.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -130.9 113.77 14.44 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -174.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -162.16 126.45 3.21 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.067 2.147 . . . . 0.0 107.506 176.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -96.24 159.08 15.14 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 172.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.2 mp -135.56 113.17 14.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 173.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.67 114.13 18.35 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.8 mt -94.09 -57.06 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.1 t -125.95 141.27 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 C-N-CA 125.003 1.321 . . . . 0.0 108.901 -173.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.0 p -152.43 123.01 7.32 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 102.87 -3.011 . . . . 0.0 102.87 173.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 44.48 33.84 0.97 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.67 1.588 . . . . 0.0 113.818 -174.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.26 -8.82 6.25 Favored Glycine 0 CA--C 1.539 1.566 0 O-C-N 120.814 -1.179 . . . . 0.0 114.694 -177.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.2 ttmt -69.25 37.47 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.461 1 C-N-CA 132.941 4.496 . . . . 0.0 112.812 -177.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 43.0 mtt -38.1 133.04 0.95 Allowed 'General case' 0 C--O 1.233 0.229 0 C-N-CA 126.164 1.786 . . . . 0.0 114.767 -173.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.79 157.64 66.05 Favored Pre-proline 0 N--CA 1.448 -0.559 0 CA-C-N 113.512 -1.676 . . . . 0.0 107.859 173.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -74.27 37.69 0.45 Allowed 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 124.455 3.437 . . . . 0.0 112.192 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -52.61 -26.11 12.58 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 127.266 2.226 . . . . 0.0 113.493 -173.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.8 m -43.52 -51.95 6.46 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.757 2.023 . . . . 0.0 112.388 -174.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.53 ' CE1' ' HZ3' ' A' ' 48' ' ' LYS . 29.9 t-80 -58.28 -62.48 1.8 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.612 0.765 . . . . 0.0 110.569 -174.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.33 52.4 m-20 -76.84 -30.78 56.47 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -173.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.1 -51.7 68.02 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 120.659 -1.276 . . . . 0.0 107.971 173.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.3 ttt180 -67.86 -39.55 83.77 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 118.796 -0.621 . . . . 0.0 109.72 -177.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.53 ' HZ3' ' CE1' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -126.92 113.23 16.25 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-O 115.918 -1.991 . . . . 0.0 112.988 176.777 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -176.31 142.15 0.46 Allowed 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 123.099 2.681 . . . . 0.0 112.166 173.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.6 112.88 24.46 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 101.748 -3.427 . . . . 0.0 101.748 172.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -175.72 -67.36 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.151 1.38 . . . . 0.0 109.62 176.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.7 tpm_? -171.35 -16.91 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 O-C-N 120.933 -1.104 . . . . 0.0 112.467 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.53 -65.99 1.32 Allowed Pre-proline 0 CA--C 1.536 0.438 0 CA-C-O 117.635 -1.174 . . . . 0.0 111.721 -174.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -77.01 -73.92 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.835 0 CA-C-N 120.86 1.343 . . . . 0.0 113.313 -174.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.22 118.11 6.44 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.183 1.393 . . . . 0.0 114.034 -173.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.6 mt -132.09 120.77 17.4 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 127.154 2.181 . . . . 0.0 106.831 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -77.06 156.25 33.9 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.243 1.962 . . . . 0.0 111.124 -178.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.6 p -40.25 -46.84 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 127.834 2.454 . . . . 0.0 113.607 -178.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -63.23 -36.19 82.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 126.066 1.746 . . . . 0.0 113.091 -175.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.5 mm -69.06 113.05 4.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 103.454 -2.795 . . . . 0.0 103.454 174.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -79.57 -32.81 42.08 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.246 176.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.5 m -154.24 162.71 41.0 Favored 'General case' 0 C--N 1.335 -0.031 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -173.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 24.4 mtm -126.55 163.53 23.2 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 172.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -120.17 149.19 42.64 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 118.99 0.814 . . . . 0.0 108.857 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -125.58 156.55 38.95 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 102.898 -3.001 . . . . 0.0 102.898 173.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 m -138.31 135.91 35.9 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -176.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -145.72 159.97 42.4 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 121.593 -0.692 . . . . 0.0 111.053 178.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -165.74 151.99 9.53 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 121.966 0.889 . . . . 0.0 112.688 173.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -82.13 -173.53 4.57 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.504 1.122 . . . . 0.0 108.786 173.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.19 99.73 6.89 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 126.469 1.908 . . . . 0.0 109.368 -174.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 48.14 -60.17 0.0 OUTLIER Glycine 0 CA--C 1.539 1.536 0 C-N-CA 130.646 3.974 . . . . 0.0 119.619 173.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -116.77 -12.99 10.76 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 120.298 2.049 . . . . 0.0 114.354 175.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.7 37.28 0.58 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 130.015 3.326 . . . . 0.0 118.869 -173.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -52.38 113.66 1.12 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 123.058 2.663 . . . . 0.0 109.776 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -84.05 138.46 33.06 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.686 1.595 . . . . 0.0 106.885 174.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -85.61 149.37 25.38 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -133.52 160.1 38.44 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.905 1.23 . . . . 0.0 110.566 174.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -154.58 133.9 12.57 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 173.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -81.97 103.55 11.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.9 tt -64.47 -40.83 96.43 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 173.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 m -154.99 145.99 22.64 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 122.657 1.217 . . . . 0.0 111.739 174.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.54 92.81 2.05 Favored 'General case' 0 N--CA 1.451 -0.389 1 N-CA-C 97.606 -4.961 . . . . 0.0 97.606 173.191 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.01 150.78 27.7 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 120.452 -1.405 . . . . 0.0 114.559 -172.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.1 t -68.74 158.92 33.27 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.762 1.225 . . . . 0.0 111.464 173.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.3 mt -123.38 -26.25 4.29 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.983 1.713 . . . . 0.0 110.925 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.492 ' CG ' ' H ' ' A' ' 87' ' ' LYS . 7.9 t70 -79.09 176.09 9.98 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.791 1.178 . . . . 0.0 109.521 -174.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.492 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 23.4 mmtm -131.62 -50.54 0.98 Allowed 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 127.073 2.149 . . . . 0.0 110.928 -173.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' A' ' 90' ' ' MET . . . -69.48 -65.02 2.72 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 173.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.3 mp -76.63 25.59 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 C-N-CA 129.357 3.063 . . . . 0.0 110.395 -175.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.469 ' H ' ' C ' ' A' ' 88' ' ' GLY . 26.5 ttm -43.33 139.74 1.86 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 129.261 3.025 . . . . 0.0 111.803 -173.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.253 . . -168.14 173.62 7.8 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 130.177 3.391 . . . . 0.0 105.563 -173.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.412 10.4 m-20 -147.51 130.23 7.86 Favored Pre-proline 0 CA--C 1.509 -0.622 0 C-N-CA 127.435 2.294 . . . . 0.0 111.975 172.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.32 156.36 41.59 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 121.953 1.768 . . . . 0.0 109.649 173.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 23.4 p -136.59 158.6 44.07 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 126.524 1.93 . . . . 0.0 108.139 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.6 m -126.34 157.23 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 123.729 0.812 . . . . 0.0 111.222 176.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -79.99 9.77 5.05 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 127.325 2.25 . . . . 0.0 113.68 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.8 m -140.84 163.44 42.72 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 124.527 1.131 . . . . 0.0 109.914 -175.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -66.11 164.56 27.26 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.853 1.702 . . . . 0.0 110.277 173.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -63.16 -14.37 47.98 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 124.503 1.121 . . . . 0.0 112.7 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -143.33 164.78 29.3 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 120.133 1.333 . . . . 0.0 108.65 173.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 164.42 -162.92 35.79 Favored Glycine 0 C--O 1.228 -0.258 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 76.1 p -116.96 149.15 40.68 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 173.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 37.5 t -83.13 113.52 46.57 Favored Pre-proline 0 N--CA 1.448 -0.528 0 N-CA-C 103.635 -2.728 . . . . 0.0 103.635 173.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.414 ' C ' ' H ' ' A' ' 106' ' ' LYS . 45.8 Cg_endo -85.82 156.07 10.2 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.404 2.069 . . . . 0.0 112.176 -173.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -70.55 0.55 6.57 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 120.197 -1.564 . . . . 0.0 113.063 -175.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.414 ' H ' ' C ' ' A' ' 104' ' ' PRO . 0.0 OUTLIER -115.3 114.84 25.71 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 126.598 1.959 . . . . 0.0 106.951 -173.839 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -41.62 106.84 0.06 Allowed 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.693 1.597 . . . . 0.0 109.639 -178.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.4 m -112.21 137.46 50.28 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 178.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.5 t -96.75 114.18 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 114.099 -1.409 . . . . 0.0 108.703 -173.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 98.5 t -94.09 103.33 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 173.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -77.04 140.42 40.33 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 172.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.4 t -115.16 113.62 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 174.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -99.48 149.44 18.93 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 125.927 1.727 . . . . 0.0 109.603 -178.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.415 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 4.4 m-85 -132.3 73.89 76.74 Favored Pre-proline 0 C--O 1.244 0.788 0 CA-C-N 118.965 1.383 . . . . 0.0 112.479 -173.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -66.88 126.83 15.91 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.098 1.865 . . . . 0.0 109.135 173.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 5.7 t -104.82 153.37 21.42 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 124.565 1.146 . . . . 0.0 108.131 174.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.6 mt -74.5 -9.98 59.12 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.369 0.531 . . . . 0.0 111.867 178.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.7 5.93 3.16 Favored Glycine 0 C--O 1.22 -0.723 0 C-N-CA 128.458 2.933 . . . . 0.0 116.408 173.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 27.7 mmtm -93.61 -32.26 14.17 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.737 1.768 . . . . 0.0 113.114 -173.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.431 ' NE2' ' H ' ' A' ' 121' ' ' ASP . 59.4 tp60 -96.63 159.1 15.11 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 173.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.431 ' H ' ' NE2' ' A' ' 120' ' ' GLN . 13.1 m-20 -107.89 148.01 30.18 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.405 1.482 . . . . 0.0 107.197 176.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 140.21 -152.71 22.98 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 174.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.8 t -128.07 113.99 32.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -90.64 167.96 12.14 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 173.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -129.65 156.99 43.35 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 123.719 0.808 . . . . 0.0 109.464 173.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.415 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 3.8 p90 -147.95 151.0 35.07 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 126.801 2.04 . . . . 0.0 105.896 173.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -137.71 173.2 11.9 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 175.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 97.0 t -128.95 147.3 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 124.789 1.236 . . . . 0.0 111.276 -173.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -146.67 120.02 8.99 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 127.666 2.387 . . . . 0.0 106.44 173.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 23.3 t -138.2 124.2 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -177.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.411 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -90.43 164.83 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 106.635 -1.616 . . . . 0.0 106.635 173.695 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.4 t -144.71 132.34 16.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -176.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.73 174.02 11.03 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.475 1.11 . . . . 0.0 108.581 -174.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 32.1 p-10 -88.28 176.06 7.39 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 172.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.1 t -68.09 -6.78 24.69 Favored 'General case' 0 CA--C 1.551 1.015 0 O-C-N 120.659 -1.276 . . . . 0.0 112.286 -175.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -86.32 -14.69 42.87 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 120.59 -1.319 . . . . 0.0 110.606 173.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.42 4.16 62.62 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.736 1.16 . . . . 0.0 112.386 -173.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -75.9 117.55 17.75 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 119.811 1.805 . . . . 0.0 108.952 175.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.4 m -66.98 146.82 53.97 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.96 1.704 . . . . 0.0 110.021 -176.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.84 -35.68 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.868 1.267 . . . . 0.0 113.616 178.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -133.08 148.74 52.17 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -176.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -146.52 150.01 34.72 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 174.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.6 m -102.79 113.81 65.67 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -73.91 154.13 47.96 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.16 1.907 . . . . 0.0 113.105 -173.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -69.49 112.52 6.06 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 102.122 -3.288 . . . . 0.0 102.122 173.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 44.7 m-20 173.35 -30.79 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 130.821 3.649 . . . . 0.0 107.138 -173.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.58 66.6 0.08 Allowed 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 126.842 2.057 . . . . 0.0 109.157 174.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.4 mt -95.62 147.72 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 C-N-CA 126.074 1.75 . . . . 0.0 108.141 176.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.4 ' HB2' ' CE2' ' A' ' 126' ' ' PHE . 20.1 m-85 -130.88 150.61 51.96 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 173.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -127.21 113.36 16.24 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 -173.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 46.5 tttt -101.8 123.22 45.39 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.48 -0.934 . . . . 0.0 108.48 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 39.0 m -83.34 119.93 25.23 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 173.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 11.1 m -114.69 159.66 20.26 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 173.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.2 pp -143.44 160.58 40.32 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 174.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -56.56 114.11 1.9 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 127.999 2.52 . . . . 0.0 111.795 -174.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -133.89 174.83 10.04 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 127.833 2.453 . . . . 0.0 108.6 175.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 . . . . . 0 C--O 1.252 1.191 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 173.458 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.793 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.5 t -157.78 161.8 38.44 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 106.679 -1.601 . . . . 0.0 106.679 169.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -161.57 113.68 1.79 Allowed 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 174.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 36.4 tpp -165.8 170.15 14.23 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.559 1.944 . . . . 0.0 106.709 173.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 86.9 mt -129.74 112.99 14.17 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 173.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -176.62 176.9 1.48 Allowed 'General case' 0 C--O 1.241 0.65 0 C-N-CA 131.439 3.896 . . . . 0.0 103.947 -174.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.53 112.44 4.11 Favored 'General case' 0 N--CA 1.447 -0.619 1 N-CA-C 100.12 -4.03 . . . . 0.0 100.12 173.137 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -103.16 176.18 5.23 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 112.933 -1.939 . . . . 0.0 114.855 -173.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -76.29 176.57 8.0 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.641 1.976 . . . . 0.0 107.527 173.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -56.34 176.64 0.08 Allowed 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 126.749 2.02 . . . . 0.0 108.321 172.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.5 m -140.25 173.32 11.63 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 118.827 -2.421 . . . . 0.0 107.912 172.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.1 tt -47.06 132.71 11.97 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.994 1.27 . . . . 0.0 112.22 -173.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -121.26 129.94 53.41 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.073 1.349 . . . . 0.0 109.58 176.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.4 117.91 8.55 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 5.5 p90 -131.19 175.38 9.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.174 0.99 . . . . 0.0 110.257 174.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.0 mp -115.41 118.28 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 102.997 -2.964 . . . . 0.0 102.997 173.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -89.59 144.6 25.88 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 123.312 1.53 . . . . 0.0 112.487 -173.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.416 ' CB ' ' H ' ' A' ' 29' ' ' GLU . . . -59.53 -6.8 1.19 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 128.341 2.656 . . . . 0.0 115.491 -175.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 62.2 m80 -61.8 -34.06 75.24 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 120.584 1.538 . . . . 0.0 111.638 -177.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -67.35 -41.16 85.62 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.231 176.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.78 -36.32 83.49 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.545 1.138 . . . . 0.0 111.075 173.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.0 ttm-85 -57.17 -58.14 9.53 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 173.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 73.6 t -52.46 -24.05 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 124.978 1.311 . . . . 0.0 111.988 175.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.0 mt -73.77 -49.01 27.48 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 174.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.4 pt -156.11 19.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 -172.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.14 9.36 66.98 Favored Glycine 0 CA--C 1.531 1.094 0 C-N-CA 126.368 1.937 . . . . 0.0 113.564 -173.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -86.56 176.31 7.88 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 127.339 2.256 . . . . 0.0 110.548 -174.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -132.73 120.06 21.17 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 124.838 1.255 . . . . 0.0 108.975 -175.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.416 ' H ' ' CB ' ' A' ' 18' ' ' ALA . 30.9 mt-10 -149.29 112.64 4.97 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.446 0.566 . . . . 0.0 110.017 173.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -97.1 163.11 13.07 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 172.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.3 mp -141.1 113.15 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 103.855 -2.646 . . . . 0.0 103.855 172.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.63 114.11 23.07 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.9 mt -85.45 -58.45 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 118.543 0.61 . . . . 0.0 109.495 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.1 t -123.96 114.1 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 126.757 2.023 . . . . 0.0 106.9 -173.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.6 p -117.48 118.22 31.58 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 173.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.308 1.2 pm0 44.31 52.4 7.24 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.329 1.052 . . . . 0.0 111.121 -173.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.75 -12.95 4.42 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 126.78 2.133 . . . . 0.0 115.935 175.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -67.83 37.79 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.484 1 C-N-CA 132.963 4.505 . . . . 0.0 114.487 -174.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 30.9 mtm -37.83 116.56 0.51 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.876 1.216 . . . . 0.0 112.835 -172.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.67 161.07 22.46 Favored Pre-proline 0 N--CA 1.447 -0.612 0 CA-C-N 113.746 -1.57 . . . . 0.0 109.491 177.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -73.98 27.54 0.33 Allowed 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.699 2.933 . . . . 0.0 111.994 174.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -56.11 -26.68 50.85 Favored 'General case' 0 C--N 1.345 0.409 0 C-N-CA 124.862 1.265 . . . . 0.0 110.616 -174.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 m -45.54 -43.77 12.18 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 129.29 3.036 . . . . 0.0 110.725 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.482 ' CD2' ' HZ1' ' A' ' 48' ' ' LYS . 53.0 t60 -63.65 -55.34 24.31 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.0 0.52 . . . . 0.0 110.707 -177.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.447 ' CG ' ' HZ3' ' A' ' 48' ' ' LYS . 2.8 m-20 -76.1 -26.76 56.75 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -175.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -68.13 -40.36 82.49 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.122 0.969 . . . . 0.0 109.634 173.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.79 -42.81 76.86 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 175.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.482 ' HZ1' ' CD2' ' A' ' 44' ' ' HIS . 1.8 ttmp? -63.79 175.89 1.04 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.241 1.016 . . . . 0.0 108.265 175.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.449 ' H ' ' HG2' ' A' ' 48' ' ' LYS . . . -76.73 112.83 13.72 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 120.3 -1.5 . . . . 0.0 106.969 173.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -96.6 171.8 8.32 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 173.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -48.58 -61.13 2.18 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.282 1.033 . . . . 0.0 111.763 -175.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.74 -16.51 3.76 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 177.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 1.1 mtp -52.59 -52.66 61.78 Favored Pre-proline 0 CA--C 1.534 0.362 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -173.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -75.2 -75.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.021 0 CA-C-N 121.13 1.439 . . . . 0.0 111.366 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.28 113.63 14.05 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.761 0.824 . . . . 0.0 111.829 -173.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 89.4 mt -120.35 130.43 24.85 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 128.464 2.706 . . . . 0.0 105.988 -174.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -83.05 159.32 15.56 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.491 2.127 . . . . 0.0 110.593 174.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.0 p -46.99 -34.61 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 125.715 1.606 . . . . 0.0 112.744 174.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.41 -34.19 72.17 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.509 1.524 . . . . 0.0 111.763 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.6 mm -92.15 112.83 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 102.985 -2.968 . . . . 0.0 102.985 174.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -82.86 -31.26 28.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.354 178.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.3 m -148.05 164.26 34.38 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.339 1.056 . . . . 0.0 110.422 -173.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 36.4 mtm -126.78 149.56 49.59 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 172.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -94.12 149.09 21.55 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 174.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -134.11 158.06 44.57 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 102.567 -3.123 . . . . 0.0 102.567 172.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.3 m -142.82 134.38 26.46 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 -178.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -144.53 169.02 18.76 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.248 0.546 . . . . 0.0 110.092 174.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -166.73 145.75 5.44 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.763 173.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.42 -173.3 1.36 Allowed 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 124.16 1.933 . . . . 0.0 105.864 172.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . 0.264 . . -112.42 121.26 44.34 Favored 'General case' 0 N--CA 1.408 -2.535 1 C-N-CA 131.922 4.089 . . . . 0.0 105.767 -179.084 . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 20.22 -73.65 0.0 OUTLIER Glycine 0 CA--C 1.536 1.358 1 C-N-CA 133.654 5.407 . . . . 0.0 119.079 178.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -116.25 -14.73 11.07 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 120.415 2.108 . . . . 0.0 112.41 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.81 37.48 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 131.339 3.856 . . . . 0.0 116.641 -173.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -38.17 114.16 0.34 Allowed 'General case' 0 C--O 1.237 0.446 0 CA-C-N 121.684 2.038 . . . . 0.0 114.719 -173.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -94.53 116.33 28.65 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 104.682 -2.34 . . . . 0.0 104.682 173.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -79.67 148.68 31.51 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 175.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -129.94 158.27 40.02 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 119.645 1.111 . . . . 0.0 109.861 174.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.49 134.26 12.91 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 173.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -89.16 102.99 15.65 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -175.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.6 tt -68.07 -41.38 82.02 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.518 1.527 . . . . 0.0 107.829 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 m -154.24 135.08 13.71 Favored 'General case' 0 N--CA 1.444 -0.734 0 O-C-N 120.645 -1.285 . . . . 0.0 110.829 179.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.463 ' H ' ' HD3' ' A' ' 83' ' ' ARG . 0.3 OUTLIER -151.99 93.15 1.8 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 101.428 -3.545 . . . . 0.0 101.428 173.508 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.463 ' HD3' ' H ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -156.94 157.17 34.31 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 120.863 1.665 . . . . 0.0 111.352 -178.319 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -78.87 152.99 30.92 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-O 121.549 0.69 . . . . 0.0 109.826 173.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.9 mt -106.91 -17.59 14.15 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.437 1.495 . . . . 0.0 110.721 174.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -90.29 163.23 14.83 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 174.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -139.8 -31.32 0.67 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.164 1.786 . . . . 0.0 112.998 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -64.12 -63.88 4.04 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 106.654 -2.579 . . . . 0.0 106.654 172.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.8 mp -75.78 22.0 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 129.993 3.317 . . . . 0.0 110.23 175.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.4 ttp -43.11 130.79 4.52 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 125.923 2.773 . . . . 0.0 113.26 -173.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -150.55 147.87 27.98 Favored 'General case' 0 N--CA 1.419 -2.014 2 C-N-CA 135.108 5.363 . . . . 0.0 100.86 173.95 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.276 5.4 m-20 -136.74 117.36 10.99 Favored Pre-proline 0 C--N 1.315 -0.931 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 173.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -67.63 158.16 58.43 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 123.033 2.489 . . . . 0.0 114.133 -173.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 32.8 p -136.11 164.52 27.84 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.248 1.819 . . . . 0.0 109.006 177.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.6 m -126.41 159.98 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 123.855 0.862 . . . . 0.0 111.295 175.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -80.1 10.46 4.35 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 127.171 2.188 . . . . 0.0 113.346 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.4 m -140.91 163.76 40.51 Favored Pre-proline 0 C--N 1.328 -0.341 0 C-N-CA 124.168 0.987 . . . . 0.0 110.288 -174.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -65.43 160.12 44.3 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 121.626 1.551 . . . . 0.0 108.836 173.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -67.19 -10.11 47.05 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 123.558 0.743 . . . . 0.0 112.264 -178.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -146.83 163.91 34.54 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 120.543 1.52 . . . . 0.0 108.338 173.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 159.19 -163.15 33.2 Favored Glycine 0 C--O 1.227 -0.298 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 177.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 70.1 p -114.9 146.03 41.56 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 173.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.3 t -77.56 122.42 85.83 Favored Pre-proline 0 CA--C 1.541 0.622 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 177.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.81 148.54 46.4 Favored 'Trans proline' 0 C--O 1.216 -0.577 0 C-N-CA 121.797 1.665 . . . . 0.0 111.749 -175.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 72.9 m-70 -63.82 -24.35 67.72 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 -172.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . 0.515 1.0 OUTLIER -116.71 150.68 37.8 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.781 1.173 . . . . 0.0 111.914 173.141 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -38.49 115.49 0.46 Allowed 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 128.387 2.675 . . . . 0.0 114.404 -172.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 44.6 m -128.69 141.49 51.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 173.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 17.1 t -94.02 122.32 45.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 124.701 1.2 . . . . 0.0 110.196 -173.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.8 t -103.72 103.5 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 173.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -81.03 141.25 34.57 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 173.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.2 t -110.27 113.86 45.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 103.525 -2.768 . . . . 0.0 103.525 174.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -95.67 151.34 19.96 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 125.091 1.329 . . . . 0.0 109.925 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -131.4 72.96 80.47 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.14 125.93 14.31 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.634 1.556 . . . . 0.0 108.471 176.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 5.3 t -105.47 156.99 17.68 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.2 mt -81.16 -8.87 59.84 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.167 0.44 . . . . 0.0 111.713 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.39 28.13 61.6 Favored Glycine 0 C--N 1.339 0.702 0 C-N-CA 126.06 1.791 . . . . 0.0 116.149 173.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 51.4 mttt -122.34 -30.72 3.93 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.938 1.869 . . . . 0.0 114.128 177.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.432 ' NE2' ' H ' ' A' ' 121' ' ' ASP . 57.5 tp60 -96.34 154.88 17.01 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 173.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.432 ' H ' ' NE2' ' A' ' 120' ' ' GLN . 7.3 m-20 -111.17 148.95 31.65 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 138.1 -156.33 23.82 Favored Glycine 0 C--N 1.332 0.361 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 176.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.4 t -122.52 113.7 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -89.45 156.98 18.31 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 173.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -117.62 158.56 24.42 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.805 0.842 . . . . 0.0 110.504 177.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.416 ' CE2' ' HB2' ' A' ' 149' ' ' PHE . 5.7 p90 -150.01 150.78 32.28 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 119.024 0.829 . . . . 0.0 109.2 173.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -123.15 156.4 35.11 Favored 'General case' 0 C--O 1.25 1.116 0 C-N-CA 125.126 1.37 . . . . 0.0 110.678 -174.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 26.6 t -137.79 140.26 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 O-C-N 125.437 1.711 . . . . 0.0 110.862 -177.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -150.61 120.59 7.16 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.931 2.493 . . . . 0.0 105.619 173.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 47.3 t -136.7 119.9 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.467 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -84.55 166.21 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 174.155 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.9 t -141.37 133.33 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 179.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.85 175.98 8.6 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 177.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -96.95 154.16 17.47 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 102.705 -3.072 . . . . 0.0 102.705 172.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.7 t -62.89 -15.86 56.6 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 120.72 -1.238 . . . . 0.0 110.573 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -69.51 -6.36 30.16 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 127.113 2.165 . . . . 0.0 111.914 173.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 99.45 20.25 18.11 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 118.192 2.037 . . . . 0.0 118.192 173.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -124.19 124.46 42.51 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 120.642 2.221 . . . . 0.0 110.071 -173.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.0 m -64.66 142.04 58.56 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 174.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.7 pt -140.51 -37.3 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 124.422 1.089 . . . . 0.0 113.813 -173.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -139.49 154.04 47.63 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 -174.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -154.83 144.52 21.49 Favored 'General case' 0 C--N 1.334 -0.102 0 O-C-N 121.025 -1.047 . . . . 0.0 108.9 174.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 26.8 m -67.77 114.56 20.71 Favored Pre-proline 0 N--CA 1.454 -0.264 0 N-CA-C 104.017 -2.586 . . . . 0.0 104.017 173.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -66.29 146.17 80.17 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 CA-C-N 120.251 1.125 . . . . 0.0 113.167 -173.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -73.45 112.95 10.0 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 173.0 -26.96 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.398 1 C-N-CA 134.792 5.237 . . . . 0.0 109.234 173.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.06 87.12 0.01 OUTLIER 'General case' 0 C--O 1.238 0.475 0 C-N-CA 126.251 1.821 . . . . 0.0 111.384 -174.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.9 mt -123.56 136.75 59.06 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.709 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 173.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.416 ' HB2' ' CE2' ' A' ' 126' ' ' PHE . 0.2 OUTLIER -116.06 164.58 14.25 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 126.263 2.227 . . . . 0.0 107.08 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -140.63 113.56 8.32 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.684 1.194 . . . . 0.0 108.349 -173.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -104.43 128.52 52.33 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 119.427 1.012 . . . . 0.0 108.638 174.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 24.4 m -83.51 114.18 21.32 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 174.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 56.2 m -108.41 165.83 11.22 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 173.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.3 pp -142.9 161.5 37.94 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.054 1.342 . . . . 0.0 108.423 174.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -68.04 122.37 18.1 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.404 1.882 . . . . 0.0 110.289 174.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -153.83 123.08 6.52 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.724 1.21 . . . . 0.0 110.218 174.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 . . . . . 0 C--O 1.255 1.371 0 C-N-CA 128.877 2.871 . . . . 0.0 105.806 173.68 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.098 0 N-CA-C 108.555 -1.818 . . . . 0.0 108.555 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.1 m -56.65 171.26 0.33 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 142.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -65.54 112.62 3.69 Favored 'General case' 0 C--N 1.343 0.3 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 174.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -176.99 176.91 1.34 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 131.025 3.73 . . . . 0.0 103.714 -173.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.92 166.6 11.02 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 172.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -130.18 124.5 32.74 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 173.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.62 141.29 4.21 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 102.549 -3.13 . . . . 0.0 102.549 -174.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.96 113.57 17.18 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 173.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -129.83 148.7 51.73 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -129.9 168.35 16.78 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.431 0.692 . . . . 0.0 110.423 176.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m -176.51 177.22 1.47 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 129.792 3.237 . . . . 0.0 108.841 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.7 tt -43.33 128.21 4.74 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.945 2.098 . . . . 0.0 111.929 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -113.04 137.58 51.2 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.917 1.687 . . . . 0.0 107.94 173.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.67 116.25 7.63 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 9.8 p90 -129.85 175.83 8.53 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.937 0.895 . . . . 0.0 109.429 175.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -114.07 120.11 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 103.006 -2.961 . . . . 0.0 103.006 174.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -83.43 144.81 29.35 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 123.355 1.55 . . . . 0.0 114.746 -173.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.52 -16.48 60.85 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.521 1.928 . . . . 0.0 114.985 -174.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -55.89 -35.02 66.07 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.455 0.57 . . . . 0.0 109.488 174.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -75.74 -44.94 39.22 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.06 -33.94 63.15 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.523 0.729 . . . . 0.0 111.019 174.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 25.8 ttm105 -55.2 -57.26 12.51 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 121.2 -0.938 . . . . 0.0 108.841 173.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.2 t -53.8 -23.81 9.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 119.098 0.863 . . . . 0.0 111.603 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.0 mt -76.2 -44.28 38.55 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 117.116 -1.421 . . . . 0.0 113.893 174.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.0 pt -151.76 17.41 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 -173.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.53 4.56 39.29 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 128.201 2.81 . . . . 0.0 115.368 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -100.75 176.56 5.26 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 128.759 2.824 . . . . 0.0 111.684 -173.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -118.66 117.9 30.19 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.506 1.522 . . . . 0.0 109.105 -178.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.4 ' CD ' HH11 ' A' ' 52' ' ' ARG . 25.2 mt-10 -153.93 113.55 3.81 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.311 1.445 . . . . 0.0 109.585 -178.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -94.74 165.76 12.33 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 173.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.1 mp -141.07 113.39 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 174.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.59 122.54 29.18 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -177.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.2 mt -94.97 -65.3 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 119.027 0.831 . . . . 0.0 109.019 177.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.4 t -113.15 113.6 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 -173.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.5 p -109.22 113.58 26.55 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 103.613 -2.736 . . . . 0.0 103.613 173.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.284 18.1 pm0 44.43 40.87 4.14 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.77 1.628 . . . . 0.0 113.235 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.91 -6.76 8.74 Favored Glycine 0 CA--C 1.543 1.785 0 C-N-CA 124.768 1.175 . . . . 0.0 114.466 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -86.39 37.63 0.74 Allowed 'General case' 0 CA--C 1.539 0.554 1 C-N-CA 134.387 5.075 . . . . 0.0 108.114 -174.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 62.6 mtp -37.66 131.74 0.94 Allowed 'General case' 0 C--O 1.234 0.253 0 C-N-CA 128.427 2.691 . . . . 0.0 115.301 -172.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.6 159.39 85.21 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-N 113.464 -1.698 . . . . 0.0 109.056 173.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -76.46 41.28 0.86 Allowed 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 124.53 3.486 . . . . 0.0 111.783 175.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -54.89 -26.29 34.82 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.443 1.897 . . . . 0.0 112.802 -174.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.5 m -53.14 -33.09 50.9 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 127.201 2.2 . . . . 0.0 112.074 -173.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -62.9 -66.25 0.57 Allowed 'General case' 0 C--N 1.344 0.368 0 CA-C-N 119.201 0.91 . . . . 0.0 109.748 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.9 -35.37 74.72 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -177.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -63.87 -44.56 92.71 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 125.081 1.488 . . . . 0.0 110.092 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 48.7 tpt85 -82.09 -29.42 31.79 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -176.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.06 176.77 1.57 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 128.58 2.752 . . . . 0.0 110.06 179.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.77 176.1 0.16 Allowed 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.058 -1.026 . . . . 0.0 109.916 173.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 5.3 tm0? -43.74 136.64 3.39 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.489 1.516 . . . . 0.0 113.893 -173.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -145.12 -67.18 0.31 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 173.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.4 HH11 ' CD ' ' A' ' 29' ' ' GLU . 4.9 tpm_? -160.06 -16.8 0.06 Allowed 'General case' 0 C--O 1.226 -0.15 0 CA-C-O 118.03 -0.986 . . . . 0.0 112.603 174.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 98.1 mmm -109.35 -48.7 0.08 OUTLIER Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 -173.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -61.33 -71.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.687 0 CA-C-N 121.457 1.556 . . . . 0.0 114.048 -173.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.39 119.81 19.99 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.495 0.718 . . . . 0.0 110.357 -174.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 96.0 mt -123.92 127.92 25.27 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 128.226 2.61 . . . . 0.0 106.134 -175.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -84.59 161.22 12.55 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 122.755 2.304 . . . . 0.0 111.565 174.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.5 p -47.11 -37.0 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 125.281 1.432 . . . . 0.0 112.667 173.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -53.25 -37.7 62.34 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.612 1.565 . . . . 0.0 111.968 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.2 mm -83.23 112.81 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 102.992 -2.966 . . . . 0.0 102.992 173.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -79.39 -40.6 29.7 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 173.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.2 m -141.81 157.89 44.46 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.989 1.716 . . . . 0.0 109.572 -173.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 2.8 mmm -117.75 147.91 42.54 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 173.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -94.49 156.42 16.47 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 173.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -141.23 155.18 46.06 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 129.506 3.122 . . . . 0.0 102.701 172.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.2 m -139.05 133.35 31.51 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -177.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -145.93 162.59 37.43 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.404 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -163.24 146.17 10.37 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 173.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.04 -177.16 5.46 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 173.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -115.09 95.98 5.46 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.989 1.316 . . . . 0.0 109.206 -173.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.67 -89.69 0.03 OUTLIER Glycine 0 CA--C 1.534 1.254 0 C-N-CA 126.128 1.823 . . . . 0.0 115.979 173.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . 0.263 5.5 mm-40 -117.12 26.14 9.99 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.542 1.937 . . . . 0.0 114.462 174.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -94.91 37.25 1.15 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.839 2.456 . . . . 0.0 112.215 177.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -38.9 113.4 0.3 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.802 1.641 . . . . 0.0 112.515 -173.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -106.36 129.98 54.27 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.157 1.783 . . . . 0.0 107.695 175.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -91.53 150.58 21.14 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 176.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -131.93 160.22 36.39 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 119.726 1.148 . . . . 0.0 110.236 174.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -155.37 135.49 13.02 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 173.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -84.14 103.55 13.45 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.9 tt -65.24 -37.55 87.59 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 174.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.7 m -155.01 144.92 21.62 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 120.687 -1.258 . . . . 0.0 111.816 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.441 ' H ' ' HD3' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -156.24 93.52 1.42 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 102.678 -3.082 . . . . 0.0 102.678 173.573 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.441 ' HD3' ' H ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -154.21 158.64 40.6 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 121.206 1.821 . . . . 0.0 111.779 -178.184 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.1 t -71.72 167.65 19.43 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.915 0.886 . . . . 0.0 112.982 173.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.9 mt -126.69 -9.45 6.16 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 126.603 1.961 . . . . 0.0 114.308 174.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.564 ' CG ' ' H ' ' A' ' 87' ' ' LYS 0.309 13.3 t70 -96.43 170.67 9.07 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 122.01 2.186 . . . . 0.0 112.095 -173.721 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.564 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 1.3 mppt? -114.65 -53.01 2.68 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 129.16 2.984 . . . . 0.0 110.223 -173.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.495 ' C ' ' H ' ' A' ' 90' ' ' MET . . . -82.1 -58.62 2.44 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 125.052 1.31 . . . . 0.0 110.643 178.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mp -79.19 25.5 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 126.164 1.786 . . . . 0.0 110.376 -175.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.495 ' H ' ' C ' ' A' ' 88' ' ' GLY . 27.3 ttm -43.4 131.41 4.85 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 130.144 3.377 . . . . 0.0 109.292 -178.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -165.19 160.23 18.34 Favored 'General case' 0 N--CA 1.438 -1.028 1 C-N-CA 131.916 4.086 . . . . 0.0 103.785 -173.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.269 5.7 m-20 -138.16 124.84 13.17 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 118.618 0.644 . . . . 0.0 111.359 173.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -70.08 142.42 46.45 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 122.035 1.824 . . . . 0.0 110.273 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.8 p -131.87 162.09 31.43 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.938 1.695 . . . . 0.0 108.726 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.4 m -126.14 153.37 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 119.176 0.898 . . . . 0.0 112.353 -174.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -79.27 9.67 4.41 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 127.335 2.254 . . . . 0.0 113.337 177.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.5 m -144.24 164.21 30.32 Favored Pre-proline 0 C--N 1.327 -0.376 0 C-N-CA 124.725 1.21 . . . . 0.0 109.603 -174.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -66.9 161.76 40.88 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 121.25 1.3 . . . . 0.0 109.348 173.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -65.57 -7.68 16.0 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.237 1.015 . . . . 0.0 112.192 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -144.47 164.12 31.81 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.372 1.469 . . . . 0.0 108.335 173.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.66 -161.37 34.12 Favored Glycine 0 C--O 1.226 -0.357 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.5 p -125.89 139.17 53.68 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.8 t -74.3 114.34 32.54 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -78.84 150.15 23.62 Favored 'Trans proline' 0 C--O 1.211 -0.845 0 C-N-CA 121.969 1.779 . . . . 0.0 111.583 -174.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.408 ' H ' ' CD2' ' A' ' 105' ' ' HIS . 6.2 m-70 -78.29 4.09 13.76 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 119.726 -1.859 . . . . 0.0 113.98 -173.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.83 127.24 54.11 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 173.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -43.94 110.68 0.22 Allowed 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 126.501 1.921 . . . . 0.0 109.806 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.3 m -119.21 140.45 50.19 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.7 t -94.87 117.52 38.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 C-N-CA 124.953 1.301 . . . . 0.0 108.97 -173.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.6 t -100.09 104.44 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 173.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -82.11 149.01 28.23 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 173.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.5 t -122.49 113.56 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 104.035 -2.579 . . . . 0.0 104.035 175.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -89.37 147.84 19.75 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.506 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 7.0 m-85 -127.73 73.53 78.52 Favored Pre-proline 0 C--O 1.242 0.706 0 CA-C-N 118.156 0.978 . . . . 0.0 109.472 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.28 123.5 10.95 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.681 2.254 . . . . 0.0 107.55 173.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 7.3 t -105.95 152.82 22.83 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.253 1.021 . . . . 0.0 108.717 178.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mt -72.02 -14.95 62.02 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 117.953 0.342 . . . . 0.0 111.409 176.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 54.21 42.91 74.1 Favored Glycine 0 C--O 1.22 -0.77 0 C-N-CA 126.479 1.99 . . . . 0.0 113.827 173.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . 0.282 27.4 mttp -125.39 -34.05 2.75 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.733 1.766 . . . . 0.0 113.551 176.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 50.2 tp60 -96.04 142.06 28.7 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 104.043 -2.576 . . . . 0.0 104.043 172.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -93.97 141.01 29.01 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 142.64 -154.73 25.39 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.7 t -129.2 114.11 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -175.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.73 168.82 12.63 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 173.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -125.6 157.75 36.37 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 123.963 0.905 . . . . 0.0 108.888 173.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.506 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 12.4 p90 -149.89 160.87 43.25 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 173.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -140.42 160.22 40.48 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 124.454 1.102 . . . . 0.0 111.444 -173.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 83.0 t -139.46 146.94 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 126.205 1.802 . . . . 0.0 109.51 -174.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -150.63 122.85 8.33 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 127.892 2.477 . . . . 0.0 105.784 173.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.8 t -135.87 123.74 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.413 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -91.02 165.38 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 173.552 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.8 t -144.99 134.31 18.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 -176.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.77 164.7 29.25 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.605 -174.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.408 ' C ' HD21 ' A' ' 134' ' ' ASN . 0.1 OUTLIER -79.31 166.77 21.76 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 104.104 -2.554 . . . . 0.0 104.104 172.746 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.3 t -60.69 -12.66 11.08 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 120.96 1.709 . . . . 0.0 115.612 -173.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -80.46 -12.08 59.6 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 121.113 1.779 . . . . 0.0 112.303 173.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.23 -3.54 54.85 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.824 1.202 . . . . 0.0 114.117 -174.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -66.91 117.17 8.63 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 120.037 1.919 . . . . 0.0 108.648 177.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -71.81 143.83 49.35 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.681 0.792 . . . . 0.0 108.932 -176.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -138.74 -37.88 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.504 1.122 . . . . 0.0 113.516 -175.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -133.81 147.83 51.27 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 -177.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 10.3 tm0? -147.87 147.03 29.33 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.927 0.891 . . . . 0.0 108.959 174.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 23.5 m -80.67 113.74 42.38 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 176.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.17 147.5 91.31 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 121.202 1.268 . . . . 0.0 110.904 -173.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -79.54 112.24 16.61 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 -174.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.625 37.3 m-80 172.12 -8.13 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.524 1 C-N-CA 134.876 5.271 . . . . 0.0 112.214 172.991 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.74 79.93 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.362 1.465 . . . . 0.0 108.687 174.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.3 mt -117.03 148.72 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 C-N-CA 127.189 2.196 . . . . 0.0 106.316 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -133.88 164.84 26.37 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.015 -1.448 . . . . 0.0 107.182 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -137.4 113.53 9.91 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.017 1.327 . . . . 0.0 107.602 -173.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.12 120.4 41.17 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 119.313 0.96 . . . . 0.0 108.765 -175.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.9 m -84.14 116.59 22.98 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 -177.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 6.9 m -113.09 166.17 11.68 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.832 0.853 . . . . 0.0 109.261 173.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.3 pp -136.88 163.5 30.53 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.845 1.258 . . . . 0.0 108.198 173.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -72.42 121.33 19.38 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 128.258 2.623 . . . . 0.0 110.817 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -146.17 170.35 16.9 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 127.304 2.242 . . . . 0.0 109.387 177.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 . . . . . 0 C--O 1.257 1.489 0 C-N-CA 131.162 3.785 . . . . 0.0 104.339 173.822 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.072 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.4 p -42.99 177.47 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.792 2.037 . . . . 0.0 112.414 120.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.527 ' CG ' ' H ' ' A' ' 4' ' ' MET . 24.8 t-80 -46.3 177.18 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 127.657 2.383 . . . . 0.0 111.307 173.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.527 ' H ' ' CG ' ' A' ' 3' ' ' HIS . 23.4 mmt -47.13 163.21 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.696 0 O-C-N 119.53 -1.981 . . . . 0.0 106.597 172.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -42.88 113.37 0.47 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 122.57 1.176 . . . . 0.0 113.202 -172.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -80.04 172.67 13.46 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 128.2 2.6 . . . . 0.0 110.195 -173.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.36 146.62 17.05 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 104.155 -2.535 . . . . 0.0 104.155 174.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -73.66 168.43 19.36 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 125.473 1.509 . . . . 0.0 108.227 173.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -71.77 160.33 32.79 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 173.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -71.79 156.48 39.27 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 173.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.5 m -174.96 176.03 2.22 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.061 1.344 . . . . 0.0 111.296 -173.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.7 tt -86.39 136.56 33.08 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 128.81 2.844 . . . . 0.0 109.775 178.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -127.72 138.97 52.95 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.857 1.663 . . . . 0.0 108.412 173.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.39 117.6 7.33 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 -176.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 14.1 p90 -130.78 171.18 13.42 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.683 0.793 . . . . 0.0 110.518 177.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.1 mt -108.75 135.18 48.37 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 N-CA-C 103.591 -2.744 . . . . 0.0 103.591 174.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -91.79 159.96 15.55 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 122.577 1.18 . . . . 0.0 113.164 -173.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.423 ' CB ' ' H ' ' A' ' 29' ' ' GLU . . . -76.89 -13.79 59.95 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.119 1.767 . . . . 0.0 113.99 175.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 31.6 m80 -59.4 -38.74 81.34 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 120.615 1.552 . . . . 0.0 109.058 175.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -64.08 -46.02 86.15 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.925 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.46 -31.85 73.15 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 123.244 0.618 . . . . 0.0 112.261 175.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.407 HH21 ' CD ' ' A' ' 28' ' ' GLU . 26.5 ttm180 -58.62 -56.7 18.72 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 174.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 77.3 t -51.98 -24.04 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.363 1.465 . . . . 0.0 112.101 174.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.8 mt -77.72 -46.39 21.94 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 174.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.8 pt -153.99 18.16 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 -172.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.99 15.56 65.13 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.549 1.547 . . . . 0.0 113.433 -174.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -100.77 172.83 6.83 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 126.558 1.943 . . . . 0.0 109.235 -176.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.407 ' CD ' HH21 ' A' ' 22' ' ' ARG . 16.2 tp10 -127.17 127.57 44.75 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -174.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.423 ' H ' ' CB ' ' A' ' 18' ' ' ALA . 80.5 mt-10 -155.14 113.31 3.46 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 118.419 -0.8 . . . . 0.0 112.275 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -96.25 165.12 12.37 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 122.35 2.341 . . . . 0.0 105.765 172.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 79.2 mt -140.26 113.17 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 173.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.81 114.22 24.22 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 -177.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.4 mt -92.44 -53.16 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 118.825 0.738 . . . . 0.0 109.661 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -123.44 113.81 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 -173.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.9 p -112.96 122.66 48.3 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 173.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 44.32 44.39 6.68 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.093 1.357 . . . . 0.0 112.602 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.32 4.72 1.32 Allowed Glycine 0 CA--C 1.536 1.371 0 C-N-CA 127.121 2.296 . . . . 0.0 114.743 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.97 37.28 0.48 Allowed 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 129.875 3.27 . . . . 0.0 111.426 -172.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 34.3 mtt -38.12 116.46 0.52 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 126.339 1.855 . . . . 0.0 114.381 -173.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.34 160.55 75.19 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 173.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.7 65.67 5.77 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 124.134 3.223 . . . . 0.0 109.685 175.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -62.17 -12.33 19.28 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 126.999 2.119 . . . . 0.0 114.77 -173.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 56.8 m -43.69 -48.51 7.88 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 126.049 1.739 . . . . 0.0 113.185 -173.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.482 ' CE1' ' HZ1' ' A' ' 48' ' ' LYS . 21.7 t-80 -59.63 -59.51 5.33 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 118.379 0.536 . . . . 0.0 110.325 -176.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.321 49.0 m-20 -76.04 -23.26 55.13 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -173.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -75.57 -58.04 3.52 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.714 1.143 . . . . 0.0 108.645 173.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -67.75 -25.23 65.53 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.291 -0.88 . . . . 0.0 110.983 -173.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.482 ' HZ1' ' CE1' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -125.87 113.38 17.14 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 173.482 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -166.06 176.96 7.32 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.268 1.027 . . . . 0.0 109.774 -173.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -44.35 148.74 0.43 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.156 1.782 . . . . 0.0 106.995 172.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -44.07 -34.37 1.75 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.052 1.741 . . . . 0.0 113.501 -173.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.03 -16.51 0.77 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.664 1.585 . . . . 0.0 115.002 176.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.52 -65.99 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 120.935 1.698 . . . . 0.0 113.411 -176.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.01 -79.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.875 0 CA-C-N 122.152 1.804 . . . . 0.0 111.462 -174.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.09 113.47 20.64 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.612 0.765 . . . . 0.0 109.062 -174.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.5 mt -110.64 126.22 29.24 Favored Pre-proline 0 C--N 1.323 -0.566 0 C-N-CA 127.158 2.183 . . . . 0.0 105.437 -175.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.3 156.36 37.27 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.562 1.508 . . . . 0.0 110.216 178.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.0 p -42.11 -44.79 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 126.354 1.862 . . . . 0.0 112.194 174.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -61.43 -36.04 79.24 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 126.354 1.861 . . . . 0.0 113.159 -176.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 mm -75.63 112.65 13.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 101.309 -3.589 . . . . 0.0 101.309 173.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -79.25 -36.6 39.65 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.997 178.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.6 m -144.78 170.69 15.62 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 124.125 0.891 . . . . 0.0 111.953 -173.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 62.9 mtp -125.87 156.85 38.98 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 172.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -121.81 113.56 19.84 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -174.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -99.95 162.68 12.84 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 173.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.8 m -141.59 136.34 30.94 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 176.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -143.71 162.93 34.7 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 120.604 -0.439 . . . . 0.0 110.582 174.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -172.8 156.59 3.49 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.265 -0.88 . . . . 0.0 112.04 173.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.44 -173.41 4.7 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 172.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.27 134.15 55.28 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 102.767 -3.049 . . . . 0.0 102.767 173.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 19.28 -60.02 0.0 OUTLIER Glycine 0 CA--C 1.534 1.26 1 C-N-CA 135.634 6.35 . . . . 0.0 120.808 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -116.58 -13.06 10.89 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 121.139 2.47 . . . . 0.0 113.672 -177.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.96 37.4 0.6 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 130.037 3.335 . . . . 0.0 119.503 -173.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -51.39 116.25 1.98 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 123.388 2.813 . . . . 0.0 110.247 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -83.72 150.41 25.85 Favored 'General case' 0 C--N 1.334 -0.089 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 174.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -100.79 146.82 26.78 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 176.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -132.49 160.69 35.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 120.239 1.381 . . . . 0.0 110.983 176.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -152.6 133.74 14.23 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 173.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -81.32 111.22 17.5 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.714 1.206 . . . . 0.0 109.34 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.8 tt -74.28 -48.61 27.43 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.656 1.183 . . . . 0.0 107.857 174.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 m -128.66 148.08 50.78 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.04 1.336 . . . . 0.0 111.839 176.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -175.6 92.62 0.06 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 130.155 3.382 . . . . 0.0 103.913 173.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -162.16 153.46 18.13 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.348 -1.47 . . . . 0.0 111.279 -173.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.8 t -85.74 165.44 16.92 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 121.72 0.771 . . . . 0.0 109.174 173.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 98.8 mt -125.85 0.65 7.36 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 126.035 1.734 . . . . 0.0 112.163 -174.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.543 ' CG ' ' H ' ' A' ' 87' ' ' LYS 0.358 11.3 t70 -98.48 166.14 11.5 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.303 0.956 . . . . 0.0 112.391 178.247 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.543 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 1.4 mppt? -104.67 -46.86 4.22 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 129.401 3.081 . . . . 0.0 112.222 -173.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.403 ' C ' ' H ' ' A' ' 90' ' ' MET . . . -105.0 -44.6 1.48 Allowed Glycine 0 CA--C 1.525 0.711 0 C-N-CA 125.075 1.321 . . . . 0.0 111.792 -178.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mt -84.41 13.93 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 C-N-CA 125.274 1.43 . . . . 0.0 108.614 176.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.403 ' H ' ' C ' ' A' ' 88' ' ' GLY . 23.5 ttp -43.62 148.71 0.33 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 131.175 3.79 . . . . 0.0 110.548 177.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -162.7 176.28 10.48 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 127.724 2.41 . . . . 0.0 107.113 -173.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -137.51 113.92 9.48 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 172.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.91 154.31 75.0 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 N-CA-C 106.602 -2.115 . . . . 0.0 106.602 173.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.0 p -141.55 162.73 34.76 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 125.112 1.365 . . . . 0.0 108.435 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.0 m -126.47 155.43 36.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 123.742 0.817 . . . . 0.0 111.915 175.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -73.24 9.06 1.38 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.712 2.405 . . . . 0.0 113.212 174.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.1 m -140.73 165.52 29.17 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 125.903 1.681 . . . . 0.0 108.594 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -67.37 168.64 17.35 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.621 1.547 . . . . 0.0 111.293 174.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -62.63 -12.53 23.8 Favored 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 124.986 1.315 . . . . 0.0 111.914 174.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -143.17 163.83 31.81 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 120.314 1.416 . . . . 0.0 108.129 173.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.61 -161.7 34.37 Favored Glycine 0 C--O 1.228 -0.277 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 82.3 p -117.81 155.33 30.27 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 117.808 0.804 . . . . 0.0 109.404 173.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.6 t -93.69 113.12 59.54 Favored Pre-proline 0 N--CA 1.448 -0.541 0 N-CA-C 101.77 -3.419 . . . . 0.0 101.77 173.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.408 ' C ' ' H ' ' A' ' 106' ' ' LYS . 11.1 Cg_endo -92.4 161.57 3.02 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.431 2.088 . . . . 0.0 111.998 -173.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -72.62 3.17 5.28 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 120.116 -1.615 . . . . 0.0 112.382 -173.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.408 ' H ' ' C ' ' A' ' 104' ' ' PRO . 2.2 mptt -114.11 116.0 28.42 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 127.654 2.382 . . . . 0.0 107.672 -173.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -44.68 105.87 0.06 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.563 1.145 . . . . 0.0 109.942 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 26.8 m -111.75 135.16 52.72 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.4 t -90.28 114.09 27.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -173.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 70.8 t -94.0 103.21 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 103.536 -2.764 . . . . 0.0 103.536 173.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -84.05 119.08 24.52 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 173.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.5 t -90.56 113.47 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 103.13 -2.915 . . . . 0.0 103.13 173.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -93.9 149.11 19.29 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.435 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 7.8 m-85 -132.3 73.45 77.35 Favored Pre-proline 0 C--O 1.244 0.784 0 CA-C-N 118.258 1.029 . . . . 0.0 110.766 -176.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -68.04 114.27 3.33 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 N-CA-C 106.844 -2.022 . . . . 0.0 106.844 173.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 5.6 t -91.88 143.58 26.36 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 175.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.0 mt -74.26 -11.41 60.27 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 119.32 -0.371 . . . . 0.0 111.5 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 53.17 39.61 58.34 Favored Glycine 0 C--N 1.339 0.744 0 C-N-CA 125.768 1.652 . . . . 0.0 113.69 173.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -93.48 -65.25 1.01 Allowed 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 118.219 1.01 . . . . 0.0 109.299 -177.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 48.6 tp60 -96.07 155.26 16.83 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 174.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -93.44 147.72 22.7 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.383 1.473 . . . . 0.0 107.72 178.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.5 -155.5 26.38 Favored Glycine 0 C--N 1.332 0.34 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.9 t -126.63 114.01 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -88.26 170.58 10.88 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 173.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -124.06 158.19 32.76 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 173.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.435 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 50.1 p90 -148.71 153.55 38.39 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 173.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.55 154.59 37.7 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 126.231 1.813 . . . . 0.0 110.199 -173.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 87.7 t -143.09 144.64 23.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 173.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -157.38 132.53 8.91 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 125.078 1.351 . . . . 0.0 107.894 173.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.3 t -137.26 135.26 47.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -174.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -103.2 164.07 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 173.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.2 t -142.66 138.21 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -173.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.81 175.65 9.42 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 125.565 1.546 . . . . 0.0 107.97 -176.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 39.3 p-10 -90.92 176.22 6.69 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 172.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.1 t -66.17 -7.13 16.14 Favored 'General case' 0 CA--C 1.553 1.059 0 O-C-N 120.552 -1.342 . . . . 0.0 112.549 -176.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -86.13 -14.85 42.93 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.455 -1.403 . . . . 0.0 110.933 173.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.5 1.44 64.15 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.659 1.123 . . . . 0.0 112.465 -173.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 63.2 m-20 -71.75 116.29 11.95 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 119.68 1.74 . . . . 0.0 108.504 174.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -64.76 142.36 58.46 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.063 1.745 . . . . 0.0 108.461 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.3 pt -140.58 -38.69 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.758 1.223 . . . . 0.0 113.841 -174.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -130.91 141.54 50.3 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 -177.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -149.07 124.95 10.57 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -176.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 41.3 m -61.67 143.72 93.57 Favored Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 174.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.49 141.95 23.01 Favored 'Trans proline' 0 N--CA 1.441 -1.613 0 N-CA-C 107.587 -1.736 . . . . 0.0 107.587 173.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -77.0 112.64 13.84 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 102.225 -3.25 . . . . 0.0 102.225 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 4.1 m120 174.45 -30.24 0.0 OUTLIER 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.17 1.788 . . . . 0.0 111.419 -173.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.75 103.91 0.39 Allowed 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.443 1.497 . . . . 0.0 110.219 -174.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 2.0 mt -134.29 148.74 29.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -176.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 126' ' ' PHE . 0.9 OUTLIER -132.19 169.98 15.66 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.198 1.799 . . . . 0.0 107.479 179.078 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -136.4 113.74 10.76 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.281 1.032 . . . . 0.0 109.073 -173.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -103.13 124.95 49.53 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.677 1.126 . . . . 0.0 109.136 179.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 25.7 m -83.67 116.69 22.76 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 174.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 4.5 m -119.27 166.21 13.28 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.494 0.718 . . . . 0.0 109.84 174.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.2 pp -133.27 161.16 35.22 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.459 1.504 . . . . 0.0 107.89 176.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.16 131.95 46.82 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.926 1.29 . . . . 0.0 109.927 177.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -146.91 133.49 19.83 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.814 1.646 . . . . 0.0 107.509 174.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 . . . . . 0 C--O 1.257 1.464 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 177.485 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.83 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.5 m -57.7 164.96 1.83 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.75 0.82 . . . . 0.0 110.747 170.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -62.71 113.62 3.12 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 173.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 57.2 mtm -156.65 176.68 12.4 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 129.002 2.921 . . . . 0.0 105.91 -173.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.9 mp -61.24 162.35 7.69 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 107.985 -1.116 . . . . 0.0 107.985 173.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -51.19 113.8 1.03 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.738 2.015 . . . . 0.0 112.164 -173.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -160.74 174.61 13.68 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 129.021 2.928 . . . . 0.0 103.709 173.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.6 174.14 14.32 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 128.349 2.659 . . . . 0.0 106.497 173.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -135.61 149.77 49.47 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 175.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -82.26 166.59 19.42 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 122.44 1.114 . . . . 0.0 111.606 -177.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.7 m -176.53 177.09 1.48 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 129.822 3.249 . . . . 0.0 107.692 -176.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.1 tt -43.55 138.13 2.62 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.96 2.504 . . . . 0.0 113.075 177.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -122.12 135.57 54.81 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.51 1.924 . . . . 0.0 108.467 173.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.99 121.06 10.08 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 127.231 2.212 . . . . 0.0 107.115 -176.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 12.8 p90 -139.63 175.07 9.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 118.933 0.788 . . . . 0.0 109.946 176.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.2 mp -112.77 113.72 44.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 100.226 -3.99 . . . . 0.0 100.226 173.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -79.58 152.9 29.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 122.861 1.315 . . . . 0.0 111.832 -173.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.2 -19.18 61.32 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -173.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -61.09 -34.06 74.32 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 119.564 1.075 . . . . 0.0 109.396 174.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 48.1 tp60 -69.16 -48.44 62.25 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 118.103 0.41 . . . . 0.0 111.6 177.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.95 -29.58 68.5 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 119.131 -0.461 . . . . 0.0 111.617 174.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 27.0 ttm105 -57.04 -55.57 32.96 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 119.658 1.117 . . . . 0.0 108.038 173.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -54.13 -23.93 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 119.27 0.941 . . . . 0.0 111.499 177.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.8 mt -76.13 -43.32 43.59 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 117.239 -1.362 . . . . 0.0 114.021 174.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.4 pt -151.08 16.6 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 116.919 2.192 . . . . 0.0 116.919 -173.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.33 4.51 30.56 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 128.169 2.795 . . . . 0.0 115.485 -177.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -100.83 176.46 5.28 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 128.674 2.79 . . . . 0.0 111.704 -173.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -115.58 116.37 28.04 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.715 1.606 . . . . 0.0 109.589 -177.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -160.21 114.07 2.18 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.186 1.795 . . . . 0.0 110.569 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -94.55 165.49 12.5 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 172.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.7 mm -137.98 113.35 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 173.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.35 114.63 22.01 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -177.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.2 mt -87.42 -58.41 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -126.04 122.55 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 126.375 1.87 . . . . 0.0 107.683 -173.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 81.0 p -123.56 127.96 49.05 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 101.07 -3.678 . . . . 0.0 101.07 172.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.292 0.4 OUTLIER 44.08 36.66 1.53 Allowed 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 119.893 1.224 . . . . 0.0 114.025 178.55 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.5 -8.4 2.24 Favored Glycine 0 CA--C 1.546 2.024 0 O-C-N 120.461 -1.399 . . . . 0.0 115.443 -175.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.83 37.56 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.573 1 C-N-CA 134.524 5.13 . . . . 0.0 111.987 175.528 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 53.9 mtp -37.6 119.38 0.72 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.262 1.425 . . . . 0.0 112.826 -172.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.407 ' C ' ' H ' ' A' ' 42' ' ' PHE . . . -62.07 163.35 13.81 Favored Pre-proline 0 N--CA 1.447 -0.62 0 CA-C-N 113.442 -1.708 . . . . 0.0 109.696 177.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.97 30.57 0.29 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 123.994 3.129 . . . . 0.0 111.911 173.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.407 ' H ' ' C ' ' A' ' 40' ' ' ALA . 12.9 p90 -55.16 -26.76 40.91 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 126.363 1.865 . . . . 0.0 111.427 -174.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.9 m -56.29 -37.74 70.27 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 127.428 2.291 . . . . 0.0 111.605 -173.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -60.84 -65.51 0.68 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 177.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -65.11 -23.7 67.22 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.637 0.775 . . . . 0.0 112.997 -174.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -70.01 -47.05 63.7 Favored 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 124.002 0.921 . . . . 0.0 109.821 173.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.9 ttp180 -78.72 -22.72 46.17 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.932 1.293 . . . . 0.0 112.468 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -63.03 176.49 0.71 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 128.745 2.818 . . . . 0.0 111.579 -173.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.41 170.71 1.69 Allowed 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.152 -0.968 . . . . 0.0 109.571 173.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -48.39 121.19 4.19 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 124.817 1.247 . . . . 0.0 111.942 -175.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -145.67 -67.09 0.3 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 173.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -141.71 -16.75 0.79 Allowed 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.555 ' H ' ' HD2' ' A' ' 54' ' ' PRO . 90.0 mmm -133.03 -44.84 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 116.278 -1.82 . . . . 0.0 114.635 -173.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.555 ' HD2' ' H ' ' A' ' 53' ' ' MET . 5.6 Cg_endo -59.68 -72.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.791 0 CA-C-N 121.877 1.706 . . . . 0.0 113.252 -173.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.19 125.65 29.66 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -176.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 58.4 mt -124.86 131.18 24.07 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 128.14 2.576 . . . . 0.0 106.207 -173.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -81.07 158.44 20.53 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.11 1.873 . . . . 0.0 111.198 174.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.7 p -46.7 -37.31 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 126.058 1.743 . . . . 0.0 112.313 173.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -53.37 -40.1 64.71 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 126.492 1.917 . . . . 0.0 112.582 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 mm -76.6 112.77 14.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 103.394 -2.817 . . . . 0.0 103.394 174.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -83.09 -35.03 25.99 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 173.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.8 m -147.71 152.86 38.5 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.866 1.266 . . . . 0.0 108.271 -174.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 22.3 mtp -113.36 164.03 14.1 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 172.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -133.88 114.47 13.35 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 -173.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -98.97 168.56 10.03 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 173.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.9 m -141.34 135.24 30.3 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -143.66 164.55 30.11 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 121.856 -0.528 . . . . 0.0 111.046 176.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.51 161.56 18.68 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.525 1.13 . . . . 0.0 111.647 174.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.34 160.15 15.59 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.843 0.857 . . . . 0.0 108.759 173.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.55 84.54 7.2 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.871 1.268 . . . . 0.0 110.924 -174.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 50.88 -46.93 0.01 OUTLIER Glycine 0 CA--C 1.542 1.752 1 C-N-CA 131.51 4.386 . . . . 0.0 121.58 173.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -117.14 2.16 12.59 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 120.471 2.135 . . . . 0.0 116.017 -173.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -126.01 37.24 4.38 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 120.903 3.668 . . . . 0.0 120.903 -172.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -38.29 114.21 0.35 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 123.203 2.728 . . . . 0.0 112.882 -173.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -83.86 123.2 29.68 Favored 'General case' 0 C--N 1.338 0.068 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 -174.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -76.69 148.26 36.92 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 -176.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -132.51 160.27 37.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 119.989 1.268 . . . . 0.0 111.106 176.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -152.76 137.86 17.32 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 173.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -87.27 104.09 16.07 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 125.288 1.435 . . . . 0.0 109.764 -176.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.4 tt -70.7 -39.28 73.56 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.922 1.289 . . . . 0.0 108.449 176.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.7 m -135.56 144.25 46.13 Favored 'General case' 0 C--N 1.34 0.187 0 O-C-N 121.177 -0.952 . . . . 0.0 112.063 178.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 tt -174.13 93.04 0.08 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 128.977 2.911 . . . . 0.0 105.524 173.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -159.97 153.35 22.23 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 119.753 1.16 . . . . 0.0 111.393 -173.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.1 t -78.37 129.02 34.48 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 119.633 1.106 . . . . 0.0 110.798 174.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 68.2 mt -93.16 -27.03 17.15 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 116.874 -1.536 . . . . 0.0 111.164 174.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -77.04 165.72 24.25 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.719 1.6 . . . . 0.0 107.134 175.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.35 -41.98 1.53 Allowed 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.728 1.611 . . . . 0.0 110.855 -173.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.407 ' C ' ' H ' ' A' ' 90' ' ' MET . . . -72.39 -69.57 1.37 Allowed Glycine 0 CA--C 1.533 1.192 0 N-CA-C 108.386 -1.885 . . . . 0.0 108.386 173.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.5 mp -73.44 14.39 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 C-N-CA 128.812 2.845 . . . . 0.0 110.476 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.407 ' H ' ' C ' ' A' ' 88' ' ' GLY . 22.1 ttp -43.2 136.75 2.83 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 128.167 2.587 . . . . 0.0 112.331 -173.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -156.69 113.58 3.1 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 -174.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -97.99 122.53 54.23 Favored Pre-proline 0 CA--C 1.509 -0.629 0 O-C-N 124.364 1.04 . . . . 0.0 109.285 -173.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -65.88 152.37 81.65 Favored 'Trans proline' 0 N--CA 1.443 -1.466 0 C-N-CA 120.83 1.02 . . . . 0.0 109.5 178.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 42.0 p -135.77 161.96 34.11 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.323 1.449 . . . . 0.0 107.137 173.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.9 m -126.47 149.71 31.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 O-C-N 121.241 -0.912 . . . . 0.0 111.679 174.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -86.81 13.77 8.31 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.772 1.629 . . . . 0.0 111.174 173.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.0 m -130.99 163.13 51.21 Favored Pre-proline 0 N--CA 1.454 -0.273 0 C-N-CA 125.829 1.652 . . . . 0.0 106.587 173.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -67.51 163.32 35.32 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 120.72 0.946 . . . . 0.0 109.864 173.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -62.72 -13.36 31.69 Favored 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 124.459 1.104 . . . . 0.0 111.583 175.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -139.53 163.58 32.17 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.205 1.402 . . . . 0.0 107.894 173.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 164.54 -159.67 32.67 Favored Glycine 0 C--O 1.226 -0.349 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -178.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 68.8 p -123.03 151.36 41.99 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 117.548 0.674 . . . . 0.0 109.506 174.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 48.2 t -89.62 113.45 56.78 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 101.925 -3.361 . . . . 0.0 101.925 173.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -91.95 171.68 2.66 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 N-CA-C 117.591 2.112 . . . . 0.0 117.591 -172.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -75.9 -0.59 21.9 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 -173.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.5 138.92 51.01 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 116.319 -1.8 . . . . 0.0 106.724 173.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.54 112.15 0.7 Allowed 'General case' 0 C--O 1.231 0.129 0 O-C-N 125.407 1.692 . . . . 0.0 106.466 173.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.5 m -123.23 136.72 54.85 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -176.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.8 t -85.1 135.89 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 O-C-N 124.737 1.273 . . . . 0.0 108.673 -173.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 74.7 t -112.8 103.66 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 104.355 -2.461 . . . . 0.0 104.355 173.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -83.77 125.63 32.11 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 173.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.5 t -102.94 113.55 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 102.712 -3.07 . . . . 0.0 102.712 173.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -82.86 151.49 29.0 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 174.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.45 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 8.7 m-85 -133.42 73.35 73.57 Favored Pre-proline 0 C--O 1.244 0.784 0 CA-C-N 118.279 1.039 . . . . 0.0 109.994 177.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -67.34 114.08 3.12 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.295 1.997 . . . . 0.0 108.634 173.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 5.9 t -89.45 151.43 22.02 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 173.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.1 mt -71.22 -10.95 60.6 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.102 0.41 . . . . 0.0 111.862 -176.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.77 23.01 49.19 Favored Glycine 0 C--N 1.339 0.713 0 C-N-CA 126.74 2.114 . . . . 0.0 116.786 173.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 50.7 mttt -120.98 -27.38 4.98 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.583 1.691 . . . . 0.0 113.375 177.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -96.62 156.59 16.28 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 173.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -112.03 151.54 29.22 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 175.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 140.41 -155.94 24.92 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 118.673 0.67 . . . . 0.0 111.56 174.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 20.7 t -122.99 114.14 40.91 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 175.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.3 172.89 9.53 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.553 1.141 . . . . 0.0 109.648 173.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -131.64 148.58 52.61 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.154 1.782 . . . . 0.0 107.684 173.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.453 ' CZ ' ' HB2' ' A' ' 149' ' ' PHE . 43.5 p90 -145.69 151.66 38.39 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 173.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -111.22 148.16 33.43 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 125.152 1.381 . . . . 0.0 111.498 -173.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 31.9 t -141.45 145.35 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 173.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -159.9 135.2 8.16 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 125.168 1.387 . . . . 0.0 108.252 174.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 37.4 t -139.74 131.42 33.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -174.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -100.93 165.38 2.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 173.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.2 t -142.06 138.07 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -173.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.8 175.19 9.81 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.667 1.587 . . . . 0.0 108.113 -176.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 36.9 p-10 -89.82 176.13 6.95 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 172.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.2 t -65.91 -3.51 5.31 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 120.24 -1.538 . . . . 0.0 113.678 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -89.62 -15.25 33.15 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 120.655 1.571 . . . . 0.0 110.595 173.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.72 1.12 62.01 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.62 1.105 . . . . 0.0 112.254 -173.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -71.53 115.9 11.25 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 119.606 1.703 . . . . 0.0 108.403 174.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -64.71 142.76 58.32 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 126.203 1.801 . . . . 0.0 108.632 -177.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.7 pt -139.67 -37.97 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 124.773 1.229 . . . . 0.0 113.884 -174.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -132.72 145.12 50.76 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -148.81 126.95 12.06 Favored 'General case' 0 CA--C 1.52 -0.187 0 O-C-N 121.009 -1.057 . . . . 0.0 108.615 -177.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 63.1 m -64.92 143.46 98.85 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 176.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.55 143.36 21.54 Favored 'Trans proline' 0 N--CA 1.445 -1.372 0 N-CA-C 108.989 -1.197 . . . . 0.0 108.989 174.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -80.46 112.68 18.03 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 176.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 173.11 -19.03 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 130.182 3.393 . . . . 0.0 110.434 -174.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.8 78.58 0.86 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.185 1.394 . . . . 0.0 109.879 -175.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 27.9 mm -101.99 130.01 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 105.002 -2.222 . . . . 0.0 105.002 173.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.453 ' HB2' ' CZ ' ' A' ' 126' ' ' PHE . 0.2 OUTLIER -105.0 155.71 18.71 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 173.768 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -130.84 113.47 14.11 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -174.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -110.29 123.9 50.65 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 119.128 0.876 . . . . 0.0 109.617 -174.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 22.5 m -83.48 114.26 21.36 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 175.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 25.5 m -114.6 166.08 12.1 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 123.881 0.872 . . . . 0.0 110.099 174.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.4 pp -141.59 159.08 42.95 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.766 1.627 . . . . 0.0 107.206 173.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.56 128.12 35.25 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.182 0.993 . . . . 0.0 110.318 175.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -157.62 119.44 3.7 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.123 1.369 . . . . 0.0 110.376 176.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 . . . . . 0 C--O 1.256 1.404 0 C-N-CA 129.158 2.983 . . . . 0.0 105.271 173.583 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.785 0 N-CA-C 107.297 -2.321 . . . . 0.0 107.297 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.0 t -60.45 136.18 57.97 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 103.948 -2.612 . . . . 0.0 103.948 130.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . 0.278 28.9 m-70 -90.78 113.56 25.72 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-O 123.094 1.426 . . . . 0.0 111.437 -173.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.4 mmt -156.99 177.07 11.94 Favored 'General case' 0 CA--C 1.543 0.673 1 C-N-CA 138.944 6.898 . . . . 0.0 101.475 175.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 54.6 tp -56.69 113.75 1.77 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 173.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -77.53 114.11 16.04 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 174.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.01 170.58 6.17 Favored 'General case' 0 N--CA 1.425 -1.687 0 C-N-CA 128.083 2.553 . . . . 0.0 104.634 177.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -129.29 113.65 15.27 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 129.88 3.272 . . . . 0.0 103.262 173.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -118.33 171.06 8.4 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.171 1.388 . . . . 0.0 108.331 -173.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -80.85 150.15 29.24 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 173.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m -176.54 176.71 1.54 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 130.49 3.516 . . . . 0.0 108.468 173.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.0 tt -43.91 128.0 5.44 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.776 1.63 . . . . 0.0 111.3 -176.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -115.98 128.48 55.77 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.503 1.521 . . . . 0.0 107.995 174.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.51 120.07 13.24 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 -179.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 14.1 p90 -140.48 174.88 10.08 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.776 0.716 . . . . 0.0 109.878 176.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.7 mp -113.74 113.72 44.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 1 N-CA-C 99.844 -4.132 . . . . 0.0 99.844 173.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -75.95 149.9 37.58 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.971 1.367 . . . . 0.0 111.417 -173.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.19 -26.46 63.9 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 113.75 -1.568 . . . . 0.0 113.304 -173.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -67.16 -44.55 79.48 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -174.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.6 -56.3 23.13 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 118.047 -0.978 . . . . 0.0 108.441 174.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.0 -41.05 61.88 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 117.228 -1.368 . . . . 0.0 111.987 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 51.9 ttm-85 -54.09 -61.55 2.23 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 120.802 1.637 . . . . 0.0 108.925 174.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 85.0 t -50.4 -24.27 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 124.54 1.136 . . . . 0.0 111.377 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.6 mt -86.18 -38.52 17.59 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.6 pt -144.18 14.35 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 -172.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.0 -2.58 0.95 Allowed Glycine 0 CA--C 1.533 1.158 0 C-N-CA 129.185 3.278 . . . . 0.0 115.934 -174.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -101.69 138.59 38.47 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 129.944 3.298 . . . . 0.0 107.217 -178.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -130.5 114.26 15.28 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 124.558 1.143 . . . . 0.0 109.965 -173.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -151.83 141.21 21.52 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 128.687 2.795 . . . . 0.0 104.25 173.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.01 166.47 13.87 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 173.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 82.3 mt -136.86 113.15 12.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 104.44 -2.429 . . . . 0.0 104.44 173.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.42 114.35 23.95 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 -177.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.2 mt -88.47 -61.99 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -116.74 114.34 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 125.648 1.579 . . . . 0.0 107.049 -173.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.9 p -109.92 114.76 28.57 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 173.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.455 ' C ' ' H ' ' A' ' 38' ' ' LYS . 11.5 pt-20 46.41 36.86 3.72 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.491 1.516 . . . . 0.0 112.777 -178.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.19 -22.31 1.28 Allowed Glycine 0 CA--C 1.544 1.891 0 O-C-N 120.15 -1.594 . . . . 0.0 114.191 -175.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.455 ' H ' ' C ' ' A' ' 36' ' ' GLU . 15.9 ttpt -67.39 37.88 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.583 1 C-N-CA 137.471 6.309 . . . . 0.0 110.985 177.024 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . 0.284 34.7 mtt -37.38 136.22 0.49 Allowed 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.882 2.073 . . . . 0.0 114.372 -172.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.31 163.04 56.21 Favored Pre-proline 0 N--CA 1.448 -0.563 0 CA-C-N 112.844 -1.98 . . . . 0.0 107.778 173.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.24 34.37 0.33 Allowed 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 124.04 3.16 . . . . 0.0 112.095 174.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -55.52 -26.75 44.7 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 126.247 1.819 . . . . 0.0 112.257 -173.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.6 m -60.4 -34.68 74.28 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 126.428 1.891 . . . . 0.0 111.585 -173.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -57.92 -65.74 0.59 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.098 0.959 . . . . 0.0 108.676 178.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -61.79 -41.43 97.73 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 117.327 -1.32 . . . . 0.0 113.563 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -55.84 -49.62 72.81 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.301 1.041 . . . . 0.0 111.069 -178.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.9 ttp180 -80.92 -30.18 35.39 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.509 0.595 . . . . 0.0 111.062 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -69.3 171.22 8.87 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 173.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.74 112.99 8.3 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 173.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -96.7 176.03 6.15 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 173.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -44.55 -44.83 9.02 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.215 1.406 . . . . 0.0 112.296 174.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.76 -15.86 0.12 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 175.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.7 mtp -43.86 -63.47 1.05 Allowed Pre-proline 0 N--CA 1.471 0.623 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 -173.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -65.93 -66.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 121.942 1.762 . . . . 0.0 112.401 -174.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.89 114.22 9.75 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.579 1.152 . . . . 0.0 109.863 -174.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 98.0 mt -119.43 119.91 31.26 Favored Pre-proline 0 N--CA 1.449 -0.476 0 C-N-CA 126.5 1.92 . . . . 0.0 106.379 -175.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.42 156.66 41.17 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.064 1.843 . . . . 0.0 110.174 175.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.2 p -40.61 -42.54 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 127.194 2.198 . . . . 0.0 112.91 175.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -57.45 -36.03 70.89 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 126.455 1.902 . . . . 0.0 113.23 -177.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.0 mm -72.12 112.86 8.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 102.649 -3.093 . . . . 0.0 102.649 173.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -82.42 -40.14 21.64 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 173.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.4 m -146.09 165.95 27.56 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.682 0.793 . . . . 0.0 110.141 -173.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 46.4 mtp -126.11 171.87 10.48 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 127.926 2.49 . . . . 0.0 104.889 173.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -140.23 137.48 34.32 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 173.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -111.26 169.15 8.98 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 173.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.4 m -137.37 130.91 31.33 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -144.41 165.52 27.7 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 121.726 -0.609 . . . . 0.0 110.454 174.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -168.31 155.98 8.16 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.081 173.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.99 -174.04 2.54 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 123.536 1.636 . . . . 0.0 107.55 173.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . 0.257 . . -106.37 131.36 53.67 Favored 'General case' 0 N--CA 1.411 -2.389 1 C-N-CA 131.985 4.114 . . . . 0.0 102.99 174.546 . . . . . . . . 3 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -8.63 -55.66 0.01 OUTLIER Glycine 0 CA--C 1.536 1.348 1 C-N-CA 133.883 5.516 . . . . 0.0 119.429 -173.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -116.95 12.03 14.53 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 121.045 2.423 . . . . 0.0 114.664 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.79 37.52 3.42 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 120.251 3.426 . . . . 0.0 120.251 -172.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -45.13 113.71 0.61 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 123.446 2.839 . . . . 0.0 110.448 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -83.83 134.34 34.71 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.412 1.485 . . . . 0.0 106.992 177.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -83.71 146.32 28.27 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -129.8 160.91 32.02 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 120.212 1.369 . . . . 0.0 110.714 175.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -154.48 135.03 13.47 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 173.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -85.69 104.06 15.05 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.951 1.3 . . . . 0.0 108.51 -178.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.9 tt -69.24 -54.54 14.24 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 173.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 m -131.1 141.72 50.18 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 123.342 1.544 . . . . 0.0 111.692 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -163.72 92.61 0.7 Allowed 'General case' 0 N--CA 1.448 -0.536 1 N-CA-C 96.011 -5.552 . . . . 0.0 96.011 172.82 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -158.11 146.54 18.88 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.503 -1.373 . . . . 0.0 112.339 -173.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.1 t -78.5 156.92 29.03 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.956 0.502 . . . . 0.0 110.821 174.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.4 mt -121.04 -26.34 5.16 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 116.908 -1.52 . . . . 0.0 112.461 -176.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -81.32 160.18 24.23 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 121.591 1.996 . . . . 0.0 112.038 -177.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.457 ' HE3' ' HA ' ' A' ' 87' ' ' LYS . 0.5 OUTLIER -105.39 -42.57 5.2 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 131.126 3.77 . . . . 0.0 112.556 176.02 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.465 ' C ' ' H ' ' A' ' 90' ' ' MET . . . -67.75 -74.16 0.6 Allowed Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 174.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.5 mp -77.35 26.03 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 129.996 3.319 . . . . 0.0 110.301 -177.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.465 ' H ' ' C ' ' A' ' 88' ' ' GLY . 10.7 ttm -43.55 140.52 1.72 Allowed 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 128.143 2.577 . . . . 0.0 110.031 -178.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -164.69 175.61 9.58 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 130.017 3.327 . . . . 0.0 105.286 -173.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.273 8.2 m-20 -145.46 115.03 4.86 Favored Pre-proline 0 C--N 1.324 -0.526 0 C-N-CA 124.527 1.131 . . . . 0.0 110.07 173.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -69.58 149.77 68.46 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 N-CA-C 108.322 -1.453 . . . . 0.0 108.322 173.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 21.8 p -137.13 160.63 38.42 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 125.62 1.568 . . . . 0.0 108.072 -175.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.5 m -126.01 153.82 34.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 C-N-CA 124.014 0.925 . . . . 0.0 109.637 174.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -93.2 25.63 3.23 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.613 1.565 . . . . 0.0 111.702 176.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.8 m -134.93 163.3 52.18 Favored Pre-proline 0 C--O 1.235 0.29 0 C-N-CA 124.85 1.26 . . . . 0.0 108.142 174.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -66.66 162.2 38.24 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 121.087 1.191 . . . . 0.0 109.418 173.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.01 -12.72 40.72 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 124.056 0.942 . . . . 0.0 111.902 178.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -143.29 165.71 26.72 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 120.325 1.421 . . . . 0.0 108.641 173.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 164.53 -162.73 35.69 Favored Glycine 0 C--O 1.228 -0.27 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 178.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 82.0 p -117.97 146.66 43.83 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 173.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 28.2 t -82.44 113.74 46.52 Favored Pre-proline 0 N--CA 1.447 -0.594 0 N-CA-C 102.996 -2.964 . . . . 0.0 102.996 173.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.402 ' C ' ' H ' ' A' ' 106' ' ' LYS . 36.5 Cg_endo -84.42 153.63 12.18 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.347 2.031 . . . . 0.0 111.626 -173.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -69.73 1.81 3.91 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 120.113 -1.617 . . . . 0.0 113.369 -173.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 104' ' ' PRO . 1.2 mptt -115.28 119.18 35.44 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 127.086 2.154 . . . . 0.0 107.585 -173.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -43.02 107.84 0.09 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.732 1.213 . . . . 0.0 109.91 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.1 m -118.13 139.18 51.63 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.5 t -96.75 135.25 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 114.301 -1.318 . . . . 0.0 107.834 -173.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 78.5 t -119.86 103.93 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -71.82 143.24 49.54 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 173.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.7 t -124.86 113.91 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 103.707 -2.701 . . . . 0.0 103.707 173.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -100.77 147.91 18.06 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 125.134 1.349 . . . . 0.0 110.145 -178.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.41 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 9.0 m-85 -131.16 73.54 80.47 Favored Pre-proline 0 C--O 1.242 0.706 0 CA-C-N 118.325 1.063 . . . . 0.0 111.596 -174.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -69.18 129.88 19.03 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.326 2.017 . . . . 0.0 108.239 173.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 5.7 t -105.44 154.2 20.65 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 175.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 7.6 mt -70.95 -12.78 61.73 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.559 0.618 . . . . 0.0 111.363 174.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.53 5.01 5.91 Favored Glycine 0 C--O 1.215 -1.037 0 C-N-CA 128.513 2.959 . . . . 0.0 116.169 173.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -94.64 -31.51 13.81 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 120.695 2.247 . . . . 0.0 114.418 -173.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 51.4 tp60 -96.57 146.9 24.41 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 173.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -94.25 143.07 26.71 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 174.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 141.48 -154.44 24.67 Favored Glycine 0 C--N 1.334 0.465 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 178.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.4 t -131.6 114.12 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 C-N-CA 123.288 0.635 . . . . 0.0 109.358 -177.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -89.97 168.34 12.1 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 173.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -124.08 156.87 35.8 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.119 0.968 . . . . 0.0 109.651 174.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.41 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 3.9 p90 -145.14 148.53 33.71 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.334 1.053 . . . . 0.0 108.518 173.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -111.78 157.78 20.14 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 126.456 1.902 . . . . 0.0 110.876 -174.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 89.6 t -141.67 138.32 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.403 1.081 . . . . 0.0 109.311 174.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -150.66 118.53 6.22 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 126.97 2.108 . . . . 0.0 105.889 173.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.434 ' H ' ' HB ' ' A' ' 143' ' ' THR . 31.4 t -127.72 123.96 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 177.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -89.88 164.96 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 173.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.9 t -144.37 135.35 21.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 -176.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.36 173.99 11.08 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.979 1.312 . . . . 0.0 108.832 -176.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -89.06 175.85 7.23 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 172.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 6.7 t -65.02 -15.13 61.98 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 120.11 -1.619 . . . . 0.0 112.175 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -79.86 -3.22 46.97 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.698 1.599 . . . . 0.0 110.913 175.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 80.54 6.54 89.25 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.073 1.32 . . . . 0.0 112.973 178.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -81.72 119.38 23.78 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 178.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -65.98 143.68 57.23 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.359 1.464 . . . . 0.0 109.241 -176.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -140.32 -37.62 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 125.126 1.371 . . . . 0.0 113.576 -174.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -131.01 149.82 52.44 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 178.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.3 tm0? -148.67 150.02 32.49 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.434 ' HB ' ' H ' ' A' ' 130' ' ' VAL . 57.4 m -80.11 113.56 39.52 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 178.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -61.39 140.15 86.4 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 CA-C-N 120.685 1.28 . . . . 0.0 110.59 -173.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -75.57 112.53 12.02 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 -173.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 173.07 -34.49 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 129.874 3.27 . . . . 0.0 108.501 -173.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.44 90.72 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 126.656 1.982 . . . . 0.0 110.521 -174.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.3 mt -126.24 148.58 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 176.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -126.69 164.32 21.57 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 175.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -132.83 113.53 13.02 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.223 1.009 . . . . 0.0 108.309 -173.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -101.03 120.33 40.04 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 28.6 m -83.78 116.33 22.65 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 173.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 9.3 m -111.67 163.44 14.11 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 173.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.2 pp -139.35 159.76 41.41 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 174.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -63.67 114.09 3.76 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 127.813 2.445 . . . . 0.0 111.557 -174.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -153.43 157.7 40.32 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 126.054 1.742 . . . . 0.0 109.549 176.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 . . . . . 0 C--O 1.248 0.985 0 C-N-CA 131.612 3.965 . . . . 0.0 105.557 173.661 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.476 ' H1 ' ' CG ' ' A' ' 6' ' ' ASP . . . . . . . . 0 N--CA 1.472 1.062 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.7 m -43.79 113.82 0.57 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.248 1.819 . . . . 0.0 112.573 -160.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.474 ' CG ' ' H ' ' A' ' 4' ' ' MET . 9.5 t-80 -168.99 177.62 4.85 Favored 'General case' 0 CA--C 1.541 0.634 1 C-N-CA 132.667 4.387 . . . . 0.0 104.459 -172.904 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.474 ' H ' ' CG ' ' A' ' 3' ' ' HIS . 2.9 tmm? -45.22 176.41 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.362 0 CA-C-O 116.807 -1.568 . . . . 0.0 106.924 172.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.5 tt -42.59 112.82 0.39 Allowed 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 121.933 2.151 . . . . 0.0 110.403 -172.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.476 ' CG ' ' H1 ' ' A' ' 1' ' ' GLY . 11.4 t0 -78.55 175.94 9.89 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 131.245 3.818 . . . . 0.0 116.336 -172.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -60.67 112.9 2.19 Favored 'General case' 0 N--CA 1.423 -1.815 0 C-N-CA 128.026 2.53 . . . . 0.0 106.717 174.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.475 ' NE2' ' H ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -78.56 176.65 9.23 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 109.531 -3.486 . . . . 0.0 106.468 173.011 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.475 ' H ' ' NE2' ' A' ' 8' ' ' GLN . 50.6 mt-10 -57.27 158.1 5.73 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 122.137 0.97 . . . . 0.0 109.614 173.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -64.27 176.74 0.97 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.149 1.78 . . . . 0.0 110.435 174.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.2 m -124.96 176.8 6.41 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 120.498 -1.376 . . . . 0.0 112.099 -174.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.8 tt -43.22 123.64 2.99 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.363 2.665 . . . . 0.0 113.458 -173.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -113.75 141.45 47.26 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 128.414 2.686 . . . . 0.0 108.656 173.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.01 121.94 7.07 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.759 1.623 . . . . 0.0 106.996 -178.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 26.9 p90 -137.89 175.43 9.59 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.595 1.089 . . . . 0.0 110.675 176.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -111.84 134.34 54.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 103.228 -2.879 . . . . 0.0 103.228 173.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -78.96 162.49 25.93 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 123.016 1.389 . . . . 0.0 112.846 -173.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.87 -26.41 43.95 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 113.775 -1.557 . . . . 0.0 112.137 -176.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 10.2 m80 -63.98 -41.96 97.37 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.094 0.957 . . . . 0.0 108.73 -175.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -62.26 -43.99 97.56 Favored 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 123.909 0.884 . . . . 0.0 110.616 177.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.75 -35.47 76.48 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 118.401 -0.809 . . . . 0.0 111.005 176.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -54.23 -57.71 10.13 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 173.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.4 t -55.24 -24.03 14.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 123.695 0.798 . . . . 0.0 111.618 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.5 mt -78.04 -39.79 40.82 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 175.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.4 pt -150.0 14.35 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 N-CA-C 117.397 2.369 . . . . 0.0 117.397 -172.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 63.99 0.81 4.51 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 128.296 2.855 . . . . 0.0 114.48 -173.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -101.79 141.24 34.95 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 129.247 3.019 . . . . 0.0 106.289 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -126.86 113.78 17.02 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.232 0.924 . . . . 0.0 111.208 -173.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -155.87 137.53 14.21 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 127.809 2.443 . . . . 0.0 105.942 173.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -72.64 175.77 6.09 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.976 2.11 . . . . 0.0 109.644 173.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 66.9 mt -140.81 113.62 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 173.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.55 127.07 34.33 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -176.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.4 mt -102.39 -56.33 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 119.313 0.961 . . . . 0.0 110.665 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.2 t -125.34 131.7 71.97 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -173.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.8 p -134.49 120.3 19.56 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 174.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.433 1.0 OUTLIER 43.63 47.83 6.43 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 122.72 1.248 . . . . 0.0 112.397 -176.377 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.24 11.68 20.97 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 126.165 1.841 . . . . 0.0 114.959 177.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.469 ' HZ2' ' HB2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -74.23 37.31 0.1 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.633 2.373 . . . . 0.0 113.762 -173.308 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 9.4 mmt -38.22 113.49 0.29 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 122.746 1.26 . . . . 0.0 111.981 -173.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.409 ' C ' ' H ' ' A' ' 42' ' ' PHE . . . -95.78 170.09 8.19 Favored Pre-proline 0 N--CA 1.448 -0.535 0 C-N-CA 127.734 2.413 . . . . 0.0 109.079 -176.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.0 26.19 0.25 Allowed 'Trans proline' 0 CA--C 1.548 1.212 0 C-N-CA 123.678 2.918 . . . . 0.0 112.09 173.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.409 ' H ' ' C ' ' A' ' 40' ' ' ALA . 18.7 p90 -53.57 -26.43 21.47 Favored 'General case' 0 C--N 1.345 0.402 0 C-N-CA 126.437 1.895 . . . . 0.0 111.625 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 m -60.49 -29.81 69.31 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 126.099 1.76 . . . . 0.0 110.696 -173.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -60.76 -63.38 1.32 Allowed 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 174.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.382 1.0 OUTLIER -65.59 -22.89 66.72 Favored 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 124.835 1.254 . . . . 0.0 113.086 -177.775 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -67.95 -52.99 29.71 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.095 -1.628 . . . . 0.0 107.054 173.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.61 -24.53 58.88 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.928 1.291 . . . . 0.0 112.993 -173.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -122.2 113.17 19.09 Favored 'General case' 0 C--O 1.214 -0.784 0 C-N-CA 129.617 3.167 . . . . 0.0 104.897 174.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -166.0 176.12 8.01 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 120.532 1.514 . . . . 0.0 111.148 -174.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.9 165.23 15.8 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 105.812 -1.922 . . . . 0.0 105.812 173.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.65 -19.47 16.44 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 120.347 -1.471 . . . . 0.0 113.413 -174.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 -54.52 -11.09 0.49 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.513 2.325 . . . . 0.0 115.528 174.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 7.2 mtp -135.03 -66.05 0.02 OUTLIER Pre-proline 0 N--CA 1.475 0.793 0 CA-C-N 122.219 2.281 . . . . 0.0 115.865 175.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -61.6 -70.55 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.765 2.31 . . . . 0.0 112.9 -173.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.0 113.56 16.03 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -176.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 94.2 mt -114.31 114.07 45.67 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 126.59 1.956 . . . . 0.0 106.227 -174.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -74.14 158.67 45.21 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 121.86 1.707 . . . . 0.0 110.853 -175.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.6 p -45.45 -38.38 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.428 1.491 . . . . 0.0 112.18 173.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -53.75 -43.1 68.87 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.963 1.705 . . . . 0.0 112.563 176.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.4 mm -81.0 112.93 19.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 103.065 -2.939 . . . . 0.0 103.065 173.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -81.11 -38.45 27.23 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 173.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.3 m -142.74 162.53 35.21 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.891 1.276 . . . . 0.0 111.037 -173.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.9 mmm -116.6 159.22 22.48 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 173.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -109.48 113.16 25.72 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 174.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -100.41 160.21 14.52 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 102.696 -3.075 . . . . 0.0 102.696 172.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.4 m -147.22 136.36 22.45 Favored 'General case' 0 C--N 1.317 -0.84 0 O-C-N 120.086 -1.634 . . . . 0.0 106.976 -177.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -147.62 168.31 22.34 Favored 'General case' 0 C--O 1.246 0.885 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.53 178.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -173.56 149.28 1.64 Allowed 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 113.813 -1.54 . . . . 0.0 114.167 175.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -82.71 -173.9 4.91 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 101.977 -3.342 . . . . 0.0 101.977 172.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -110.78 131.26 55.2 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 103.384 -2.821 . . . . 0.0 103.384 173.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 38.15 -93.79 0.01 OUTLIER Glycine 0 CA--C 1.533 1.204 1 C-N-CA 131.196 4.236 . . . . 0.0 116.008 174.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -116.97 25.08 10.76 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.998 2.119 . . . . 0.0 116.079 174.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.8 37.32 0.53 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 128.855 2.862 . . . . 0.0 114.379 174.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.6 mp0 -38.43 113.56 0.3 Allowed 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 121.5 1.955 . . . . 0.0 116.052 -173.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -103.05 137.36 41.33 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 127.096 2.159 . . . . 0.0 106.446 173.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -99.45 151.31 21.26 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -135.69 159.97 39.98 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 119.918 1.235 . . . . 0.0 110.409 174.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -153.56 134.98 14.24 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 173.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -80.71 103.91 10.88 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.3 tt -64.36 -43.35 94.84 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.058 1.343 . . . . 0.0 107.579 174.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 75.4 m -148.34 149.52 31.94 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.437 1.095 . . . . 0.0 109.335 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.7 tt -169.36 93.21 0.27 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 128.933 2.893 . . . . 0.0 103.289 177.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 44.5 mmm-85 -161.95 162.07 28.9 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.495 1.043 . . . . 0.0 111.669 -174.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.2 t -84.86 161.71 19.79 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 122.271 1.034 . . . . 0.0 111.898 174.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.7 mt -126.43 -0.7 6.92 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 126.108 1.763 . . . . 0.0 113.111 -174.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.585 ' CG ' ' H ' ' A' ' 87' ' ' LYS 0.315 14.6 t70 -98.45 161.82 13.48 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 120.601 1.546 . . . . 0.0 114.591 -175.367 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.585 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER -91.0 -59.24 2.22 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 128.936 2.894 . . . . 0.0 110.2 -177.263 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.49 ' C ' ' H ' ' A' ' 90' ' ' MET . . . -97.09 -45.01 2.69 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 124.977 1.275 . . . . 0.0 112.648 -173.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.7 mp -81.0 24.47 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 CA-C-O 123.323 1.535 . . . . 0.0 109.566 -178.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.49 ' H ' ' C ' ' A' ' 88' ' ' GLY . 24.4 ttm -43.47 133.27 4.4 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 130.808 3.643 . . . . 0.0 109.479 -179.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.261 . . -167.3 176.03 6.96 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 131.382 3.873 . . . . 0.0 105.114 -173.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.283 8.2 m-20 -150.0 136.13 10.52 Favored Pre-proline 0 C--N 1.324 -0.531 0 C-N-CA 124.789 1.236 . . . . 0.0 111.746 172.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -72.99 154.4 52.88 Favored 'Trans proline' 0 N--CA 1.444 -1.394 0 C-N-CA 121.702 1.601 . . . . 0.0 108.476 173.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.2 p -143.88 162.56 35.79 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.626 1.571 . . . . 0.0 108.667 174.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.3 m -126.39 156.25 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 123.73 0.812 . . . . 0.0 112.317 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -74.38 9.23 1.79 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 127.848 2.459 . . . . 0.0 113.584 174.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.4 m -140.68 165.23 31.22 Favored Pre-proline 0 C--N 1.326 -0.421 0 C-N-CA 125.318 1.447 . . . . 0.0 108.84 -178.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -66.57 166.12 23.01 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 121.405 1.403 . . . . 0.0 110.454 173.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.35 -8.99 10.09 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.94 1.296 . . . . 0.0 111.88 175.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -144.56 163.67 33.2 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 120.505 1.502 . . . . 0.0 108.425 173.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.8 -161.28 34.11 Favored Glycine 0 C--O 1.227 -0.342 0 N-CA-C 110.544 -1.023 . . . . 0.0 110.544 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 27.1 p -120.79 148.1 44.45 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.0 t -76.47 113.61 30.61 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -79.86 121.35 4.52 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 121.835 1.69 . . . . 0.0 113.463 -173.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.693 ' H ' ' CD2' ' A' ' 105' ' ' HIS . 1.1 m-70 -63.41 -20.6 65.69 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.329 1.452 . . . . 0.0 111.974 -173.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . 0.274 4.5 mptt -91.88 112.82 24.9 Favored 'General case' 0 N--CA 1.418 -2.046 1 N-CA-C 99.062 -4.422 . . . . 0.0 99.062 176.581 . . . . . . . . 3 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -42.19 117.33 0.96 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.716 1.606 . . . . 0.0 113.003 -173.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 37.4 m -127.33 142.86 51.34 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 123.722 0.639 . . . . 0.0 110.843 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 24.3 t -94.32 116.39 35.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 C-N-CA 125.355 1.462 . . . . 0.0 109.069 -174.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 84.2 t -94.26 103.15 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 103.879 -2.637 . . . . 0.0 103.879 173.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.63 122.59 24.87 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 173.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.5 t -97.63 113.65 32.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 104.307 -2.479 . . . . 0.0 104.307 174.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -100.13 146.37 17.71 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 119.755 1.162 . . . . 0.0 110.377 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.483 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 8.1 m-85 -129.48 73.5 81.54 Favored Pre-proline 0 C--O 1.243 0.74 0 CA-C-N 118.253 1.027 . . . . 0.0 110.097 -174.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.87 127.85 19.53 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.589 2.193 . . . . 0.0 108.802 173.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 6.9 t -105.89 148.47 27.57 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 123.958 0.903 . . . . 0.0 108.908 176.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.6 mt -76.43 -15.7 59.87 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 117.751 0.25 . . . . 0.0 111.31 177.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.1 51.6 57.42 Favored Glycine 0 C--N 1.337 0.605 0 C-N-CA 125.719 1.628 . . . . 0.0 112.092 174.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . 0.297 40.5 mmtm -111.66 -55.44 2.5 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.438 1.119 . . . . 0.0 112.477 -179.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 50.4 tp60 -95.68 149.7 21.18 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 173.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -93.48 139.62 30.52 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 176.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.5 -153.55 25.2 Favored Glycine 0 C--N 1.331 0.278 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -176.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.7 t -130.41 114.14 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -175.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -85.94 170.34 12.42 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 173.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -123.95 151.63 43.4 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 173.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.483 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 32.9 p90 -145.55 156.49 43.73 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 174.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -128.14 160.71 31.18 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 126.281 1.832 . . . . 0.0 111.229 -173.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 67.5 t -141.76 139.28 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 O-C-N 125.307 1.629 . . . . 0.0 108.141 173.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -143.22 121.7 12.43 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 128.043 2.537 . . . . 0.0 106.589 174.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.8 t -133.5 124.2 47.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -177.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.412 ' H ' HD11 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -90.52 164.37 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 173.374 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.0 t -145.15 134.45 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 -175.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.13 174.82 10.2 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 124.821 1.249 . . . . 0.0 107.934 -175.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -89.63 176.06 7.02 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 104.535 -2.394 . . . . 0.0 104.535 172.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.2 t -66.67 -4.14 8.16 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 120.239 -1.538 . . . . 0.0 113.709 -177.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -88.27 -15.38 35.95 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 120.608 1.549 . . . . 0.0 110.513 173.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.75 1.18 61.93 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.705 1.145 . . . . 0.0 112.114 -173.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -70.1 115.96 9.91 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 119.564 1.682 . . . . 0.0 108.403 174.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -67.54 143.79 55.95 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.439 1.496 . . . . 0.0 108.883 -176.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -139.3 -36.58 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 124.486 1.114 . . . . 0.0 113.569 -175.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -136.88 146.97 46.18 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.723 1.609 . . . . 0.0 106.817 -174.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 13.3 tm0? -147.84 150.84 34.92 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 121.105 -0.997 . . . . 0.0 108.671 174.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.4 m -88.05 113.62 55.7 Favored Pre-proline 0 CA--C 1.532 0.253 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -66.72 148.88 83.57 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 121.55 1.5 . . . . 0.0 112.346 -173.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -81.16 112.6 18.66 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.488 -173.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.595 7.1 m-80 172.37 -13.96 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.445 1 C-N-CA 138.022 6.529 . . . . 0.0 111.128 173.279 . . . . . . . . 3 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.69 81.44 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.309 1.844 . . . . 0.0 109.158 174.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.5 mt -133.9 147.78 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 127.606 2.362 . . . . 0.0 106.182 -174.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.427 ' CD1' ' CE1' ' A' ' 126' ' ' PHE . 0.9 OUTLIER -132.18 171.03 14.18 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.363 -1.29 . . . . 0.0 107.718 178.128 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -134.25 113.64 12.2 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 -173.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.57 126.51 53.66 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 -173.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 34.1 m -93.6 115.8 28.29 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 -175.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 4.3 m -115.39 166.43 11.88 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 123.818 0.847 . . . . 0.0 110.294 174.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.1 pp -131.92 161.46 33.0 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.862 1.665 . . . . 0.0 107.129 173.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.37 130.34 42.76 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.19 0.996 . . . . 0.0 109.971 177.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -157.93 163.06 38.24 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.193 1.797 . . . . 0.0 108.739 175.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 . . . . . 0 C--O 1.246 0.885 0 C-N-CA 129.527 3.131 . . . . 0.0 104.28 173.64 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.2 m . . . . . 0 CA--C 1.539 0.537 0 CA-C-O 121.574 0.702 . . . . 0.0 112.066 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.7 tt -45.69 133.38 8.1 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.928 2.891 . . . . 0.0 113.45 -175.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -119.84 138.66 53.25 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.391 1.876 . . . . 0.0 108.618 173.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.27 119.39 6.75 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.921 1.688 . . . . 0.0 106.78 -178.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 17.6 p90 -136.95 157.76 45.99 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 119.607 1.094 . . . . 0.0 110.083 176.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.3 mp -91.83 116.52 33.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 103.119 -2.919 . . . . 0.0 103.119 173.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -79.33 140.07 37.62 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 123.648 1.689 . . . . 0.0 113.762 -173.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.84 -23.85 65.43 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 126.945 2.098 . . . . 0.0 116.006 -173.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 10.9 m80 -56.82 -39.03 73.44 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 43.8 tp60 -66.55 -43.81 84.05 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 123.485 0.714 . . . . 0.0 111.33 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.76 -36.3 71.92 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.704 0.802 . . . . 0.0 111.431 174.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 52.3 ttm-85 . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 173.619 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 . . . . . 0 CA--C 1.536 0.414 0 CA-C-O 118.782 -0.628 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -141.38 113.54 8.01 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.962 1.705 . . . . 0.0 109.458 -175.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -90.3 161.83 15.46 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 173.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.0 mp -140.74 113.53 4.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 173.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.55 119.82 23.05 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.5 mt -91.95 -65.83 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.914 0.886 . . . . 0.0 109.445 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.6 t -115.48 120.37 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 105.809 -1.922 . . . . 0.0 105.809 -173.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.4 p -120.25 120.29 35.66 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 103.844 -2.65 . . . . 0.0 103.844 173.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 45.69 38.95 4.55 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.376 1.471 . . . . 0.0 112.872 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.67 -10.91 1.34 Allowed Glycine 0 CA--C 1.543 1.803 0 O-C-N 120.656 -1.277 . . . . 0.0 114.586 -177.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -80.32 37.53 0.39 Allowed 'General case' 0 C--N 1.324 -0.501 1 C-N-CA 133.915 4.886 . . . . 0.0 110.381 -175.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 45.5 mtm -37.78 129.12 1.16 Allowed 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.426 1.891 . . . . 0.0 113.135 -172.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.35 165.68 16.93 Favored Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 113.92 -1.491 . . . . 0.0 108.456 173.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.52 33.23 0.32 Allowed 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 123.965 3.11 . . . . 0.0 111.259 173.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -54.01 -26.7 27.57 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 127.659 2.383 . . . . 0.0 113.121 -173.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 m -65.38 -32.38 73.98 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.949 1.299 . . . . 0.0 111.565 -173.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -58.81 -60.93 3.06 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -56.88 -40.4 76.14 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 177.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -56.65 -52.07 66.28 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.611 1.165 . . . . 0.0 110.428 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? . . . . . 0 N--CA 1.467 0.387 0 CA-C-N 117.757 0.253 . . . . 0.0 111.652 -175.5 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 78.9 mmm . . . . . 0 N--CA 1.47 0.53 0 N-CA-C 117.601 2.445 . . . . 0.0 117.601 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.9 -69.83 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.754 0 CA-C-N 121.152 1.447 . . . . 0.0 114.039 -173.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.47 114.12 8.28 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.404 1.082 . . . . 0.0 111.74 -173.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 72.5 mt -118.58 133.05 23.59 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 127.731 2.412 . . . . 0.0 106.248 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -83.34 160.22 15.03 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 122.746 2.297 . . . . 0.0 112.076 178.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.5 p -46.47 -41.29 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 125.833 1.653 . . . . 0.0 111.734 173.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -55.87 -36.97 68.18 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 126.224 1.81 . . . . 0.0 112.674 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 mm -78.4 112.86 16.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 103.663 -2.717 . . . . 0.0 103.663 173.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -78.64 -42.08 29.73 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 173.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.1 m -139.71 152.75 46.92 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.198 0.599 . . . . 0.0 111.485 -173.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 15.0 mmm -104.51 171.68 7.2 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 126.43 1.892 . . . . 0.0 106.851 173.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.261 90.2 m-20 -126.51 150.75 48.58 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 173.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -137.02 155.87 49.14 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 102.664 -3.087 . . . . 0.0 102.664 172.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.4 m -140.89 133.97 29.35 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 -175.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -146.99 166.02 28.09 Favored 'General case' 0 C--O 1.24 0.587 0 O-C-N 121.785 -0.572 . . . . 0.0 111.049 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -171.7 161.73 6.11 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 122.223 1.011 . . . . 0.0 112.788 176.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -95.34 -173.74 3.0 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 103.058 -2.942 . . . . 0.0 103.058 172.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.05 144.65 46.45 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 101.476 -3.527 . . . . 0.0 101.476 173.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 12.24 -62.82 0.0 OUTLIER Glycine 0 CA--C 1.542 1.757 1 C-N-CA 134.884 5.992 . . . . 0.0 120.78 -173.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -116.44 -6.69 11.73 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 121.978 2.889 . . . . 0.0 114.22 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.82 37.05 0.41 Allowed 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 119.329 3.085 . . . . 0.0 119.329 -173.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -53.73 114.82 1.69 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 122.826 2.557 . . . . 0.0 110.088 -177.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -83.61 155.52 23.19 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 175.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -104.95 145.45 30.4 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 104.281 -2.489 . . . . 0.0 104.281 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -128.94 162.42 27.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 120.169 1.35 . . . . 0.0 110.675 176.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.448 ' O ' HD13 ' A' ' 131' ' ' ILE . 31.2 tt0 -155.16 134.7 12.6 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 173.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.478 ' CD1' HD23 ' A' ' 82' ' ' LEU . 66.0 m-85 -84.68 103.87 14.16 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.35 1.06 . . . . 0.0 109.762 -175.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.8 tt -69.27 -47.99 63.03 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.132 1.373 . . . . 0.0 109.001 176.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.7 m -130.34 138.22 50.32 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 125.453 1.501 . . . . 0.0 110.837 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.478 HD23 ' CD1' ' A' ' 79' ' ' PHE . 0.1 OUTLIER -170.29 92.75 0.21 Allowed 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 102.354 -3.202 . . . . 0.0 102.354 172.957 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -165.27 154.8 12.75 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 119.998 1.272 . . . . 0.0 110.765 -174.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.3 t -77.39 165.57 24.24 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-O 121.878 0.847 . . . . 0.0 110.201 173.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.5 mt -126.34 -5.16 6.62 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 126.005 1.722 . . . . 0.0 112.158 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.574 ' CG ' ' H ' ' A' ' 87' ' ' LYS 0.396 14.1 t70 -89.85 176.2 6.92 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 120.067 1.303 . . . . 0.0 111.701 -176.43 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.574 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 9.0 mtmm -122.62 -48.81 2.03 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 129.37 3.068 . . . . 0.0 111.699 -173.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 90' ' ' MET . . . -94.16 -54.08 1.66 Allowed Glycine 0 CA--C 1.526 0.729 0 C-N-CA 125.026 1.298 . . . . 0.0 111.562 178.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.3 mp -79.37 15.0 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 C-N-CA 126.225 1.81 . . . . 0.0 109.437 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.401 ' H ' ' C ' ' A' ' 88' ' ' GLY . 19.8 ttp -43.5 141.74 1.33 Allowed 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 130.579 3.552 . . . . 0.0 110.584 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -159.83 175.56 12.95 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 130.293 3.437 . . . . 0.0 105.417 -173.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -139.99 113.89 7.68 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 173.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -70.94 146.82 53.86 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 121.734 1.622 . . . . 0.0 109.691 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 23.4 p -132.45 162.4 31.27 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 125.436 1.494 . . . . 0.0 108.833 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.3 m -125.89 154.34 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 C-N-CA 123.882 0.873 . . . . 0.0 110.446 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -84.17 10.57 9.92 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.812 1.645 . . . . 0.0 112.738 -177.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.9 m -141.33 166.26 23.39 Favored Pre-proline 0 C--N 1.326 -0.446 0 C-N-CA 126.43 1.892 . . . . 0.0 108.396 -173.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -66.41 163.04 33.83 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 121.013 1.142 . . . . 0.0 109.756 173.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -64.01 -10.13 19.96 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.337 1.055 . . . . 0.0 112.466 177.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -142.96 163.27 33.24 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.45 1.5 . . . . 0.0 107.657 173.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 166.83 -161.74 35.53 Favored Glycine 0 N--CA 1.461 0.324 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 82.1 p -119.6 154.39 34.01 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 117.944 0.872 . . . . 0.0 110.307 174.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.0 t -95.01 113.35 61.16 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 104.308 -2.479 . . . . 0.0 104.308 173.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -91.01 157.99 3.92 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.819 2.346 . . . . 0.0 114.355 -173.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.41 ' CD2' ' H ' ' A' ' 105' ' ' HIS . 16.3 m-70 -64.56 -19.76 65.83 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 123.087 1.423 . . . . 0.0 110.469 -176.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -79.55 113.78 17.96 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 129.367 3.067 . . . . 0.0 106.485 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.92 109.26 0.3 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.558 1.072 . . . . 0.0 108.295 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.8 m -124.42 138.19 54.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -174.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.5 t -91.29 141.66 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 88.9 t -125.14 103.83 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 127.423 2.289 . . . . 0.0 105.493 176.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -69.65 151.12 46.27 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 173.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.9 t -129.46 113.51 28.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 173.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -96.49 147.14 18.56 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 119.76 1.164 . . . . 0.0 110.701 -174.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.478 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 10.1 m-85 -131.29 73.37 80.3 Favored Pre-proline 0 C--O 1.245 0.853 0 CA-C-N 118.457 1.129 . . . . 0.0 111.048 -174.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.76 119.74 6.71 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.582 2.188 . . . . 0.0 106.887 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 5.6 t -99.45 145.62 27.23 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.3 mt -77.56 -6.76 54.82 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 118.787 -0.625 . . . . 0.0 111.986 -175.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.19 49.14 78.48 Favored Glycine 0 C--N 1.341 0.821 0 C-N-CA 126.379 1.942 . . . . 0.0 113.529 173.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -112.34 -68.53 0.92 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.17 0.985 . . . . 0.0 111.544 -174.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 46.4 tp60 -95.73 153.11 17.9 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 173.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -93.42 146.97 23.36 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 177.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 141.32 -151.84 22.89 Favored Glycine 0 C--N 1.332 0.31 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.0 t -127.62 114.02 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -177.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -85.31 168.73 14.42 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 173.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -122.99 159.37 28.48 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.826 0.851 . . . . 0.0 109.12 173.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.478 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 10.4 p90 -147.13 146.4 29.91 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 173.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -101.32 149.68 23.78 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 126.707 2.003 . . . . 0.0 110.349 -177.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.478 HG22 HD22 ' A' ' 82' ' ' LEU . 72.2 t -144.63 138.66 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 125.901 1.681 . . . . 0.0 107.31 173.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -160.58 129.69 4.87 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 173.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 41.1 t -134.31 138.77 49.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 -173.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.544 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -105.07 165.27 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.887 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.2 t -143.47 136.93 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -174.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.21 167.16 22.1 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 124.686 1.194 . . . . 0.0 109.195 -177.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 54.6 p30 -83.76 168.79 15.86 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 103.882 -2.636 . . . . 0.0 103.882 172.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.2 t -58.57 -21.19 52.15 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 120.333 1.424 . . . . 0.0 113.876 -174.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -75.01 -9.8 58.88 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.335 -1.478 . . . . 0.0 113.404 174.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 97.72 -2.63 60.47 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.868 1.223 . . . . 0.0 114.576 -175.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -68.8 118.2 11.47 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 120.183 1.991 . . . . 0.0 108.644 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.5 m -67.23 142.14 57.03 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.3 pt -140.64 -38.25 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 124.702 1.201 . . . . 0.0 113.861 -174.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -128.77 143.66 50.98 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 177.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -146.62 130.48 17.14 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 61.8 m -62.73 140.3 97.13 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -81.78 145.23 14.24 Favored 'Trans proline' 0 N--CA 1.443 -1.458 0 CA-C-N 120.258 1.128 . . . . 0.0 109.463 174.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -80.69 112.78 18.38 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -173.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.373 24.0 m-80 172.8 -16.19 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.695 1 C-N-CA 134.006 4.923 . . . . 0.0 112.463 173.663 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.83 97.62 0.08 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 122.166 0.984 . . . . 0.0 110.035 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.1 mm -130.98 138.02 54.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 -176.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.418 ' HB2' ' CE2' ' A' ' 126' ' ' PHE . 0.6 OUTLIER -117.98 170.0 9.19 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 173.859 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -136.21 113.51 10.69 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.29 1.036 . . . . 0.0 108.347 -173.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.36 122.55 48.05 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -174.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 18.6 m -84.02 118.68 24.21 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 7.7 m -119.26 166.37 13.08 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 123.834 0.854 . . . . 0.0 109.735 174.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.7 pp -131.27 161.77 31.52 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 126.408 1.883 . . . . 0.0 106.359 173.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.7 tm0? -63.85 136.66 57.57 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 174.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -165.32 113.08 0.98 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.194 1.398 . . . . 0.0 107.41 173.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 . . . . . 0 C--O 1.247 0.95 0 C-N-CA 130.284 3.434 . . . . 0.0 104.585 173.846 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 CA--C 1.533 0.313 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.4 tt -43.4 124.06 3.27 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 126.136 1.774 . . . . 0.0 112.36 -176.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -112.25 135.38 53.0 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.295 1.438 . . . . 0.0 108.13 173.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.51 120.67 10.15 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.057 1.743 . . . . 0.0 106.638 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 20.4 p90 -135.62 168.49 19.16 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 118.656 0.662 . . . . 0.0 109.884 175.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.3 mt -102.74 113.83 40.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 103.278 -2.86 . . . . 0.0 103.278 174.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -80.42 149.75 30.03 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.947 1.356 . . . . 0.0 110.567 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.99 -11.55 29.87 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -173.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 45.3 m80 -53.42 -44.74 69.02 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.909 1.232 . . . . 0.0 113.63 -173.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 49.7 tp60 -70.28 -39.96 74.59 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 118.867 -1.133 . . . . 0.0 111.159 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.1 -36.72 78.05 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.065 0.546 . . . . 0.0 111.637 176.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 . . . . . 0 N--CA 1.444 -0.768 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 174.077 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 . . . . . 0 CA--C 1.531 0.226 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -157.38 113.95 2.96 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.688 1.195 . . . . 0.0 111.259 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -95.18 167.7 11.2 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 173.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.4 mp -137.08 113.27 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 104.912 -2.255 . . . . 0.0 104.912 173.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.0 113.96 19.56 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 177.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.4 mt -90.09 -54.41 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.9 t -125.61 113.73 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 -173.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.6 p -110.59 113.81 26.71 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 103.399 -2.815 . . . . 0.0 103.399 173.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.346 1.5 pp20? 46.26 34.13 2.08 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -178.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.73 -6.88 76.29 Favored Glycine 0 CA--C 1.536 1.385 0 O-C-N 120.751 -1.218 . . . . 0.0 114.705 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.3 37.23 0.09 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 130.621 3.568 . . . . 0.0 112.64 -174.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 40.9 mtt -38.09 117.66 0.62 Allowed 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 -173.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.94 164.8 58.04 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 113.885 -1.507 . . . . 0.0 107.851 173.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.72 36.59 0.43 Allowed 'Trans proline' 0 CA--C 1.548 1.206 0 C-N-CA 124.236 3.291 . . . . 0.0 112.024 174.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -53.93 -26.51 25.67 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 127.059 2.144 . . . . 0.0 113.756 -173.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 m -60.06 -33.42 72.04 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.922 1.689 . . . . 0.0 112.218 -173.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -60.72 -53.62 55.25 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.279 0.9 OUTLIER -76.13 -29.97 58.03 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -176.609 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -55.37 -47.45 75.77 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.2 -0.938 . . . . 0.0 108.762 173.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 . . . . . 0 CA--C 1.544 0.723 0 CA-C-O 118.562 -0.732 . . . . 0.0 111.762 175.51 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.468 0.438 0 CA-C-O 116.796 -1.573 . . . . 0.0 114.833 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.22 -70.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.729 1.619 . . . . 0.0 112.644 -173.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.26 113.15 20.49 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -174.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 55.7 mt -104.37 119.48 53.79 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 -175.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -74.21 154.22 46.45 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.319 1.346 . . . . 0.0 109.694 -177.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.0 p -41.68 -42.66 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 126.6 1.96 . . . . 0.0 113.008 177.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -59.2 -40.57 86.2 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 126.084 1.754 . . . . 0.0 112.734 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.1 mm -77.54 112.77 15.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 101.762 -3.422 . . . . 0.0 101.762 173.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -84.18 -28.95 27.01 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.568 -177.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.4 m -147.96 170.72 17.1 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.842 1.257 . . . . 0.0 110.941 -173.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.4 mmm -126.69 162.32 26.05 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 126.418 1.887 . . . . 0.0 106.937 172.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -109.34 146.32 34.57 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 173.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -135.84 153.06 51.61 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 103.082 -2.933 . . . . 0.0 103.082 172.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.1 m -140.36 133.65 29.76 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -176.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -146.07 165.05 30.21 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 121.824 -0.547 . . . . 0.0 111.0 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -167.14 144.72 4.73 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 175.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.24 -179.31 6.15 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 172.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -107.42 85.46 2.13 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.396 1.478 . . . . 0.0 111.582 -174.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.04 -59.5 0.01 OUTLIER Glycine 0 CA--C 1.537 1.426 0 C-N-CA 128.462 2.934 . . . . 0.0 119.322 173.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -116.91 -13.02 10.67 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.926 1.863 . . . . 0.0 112.95 173.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.77 37.24 0.09 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 130.755 3.622 . . . . 0.0 118.984 -173.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -44.79 113.77 0.61 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 122.397 2.362 . . . . 0.0 111.511 -174.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -96.2 120.38 36.38 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 174.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -80.01 149.09 30.86 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -134.38 160.78 36.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 119.735 1.152 . . . . 0.0 111.044 176.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.486 ' O ' HD13 ' A' ' 131' ' ' ILE . 29.9 tt0 -151.61 136.8 17.48 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 173.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.4 ' CD2' HG22 ' A' ' 130' ' ' VAL . 49.6 m-85 -80.09 104.0 10.35 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.104 0.961 . . . . 0.0 110.434 -178.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.8 tt -63.14 -46.71 85.97 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.148 1.379 . . . . 0.0 108.658 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.3 m -130.2 138.97 50.85 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.716 1.206 . . . . 0.0 110.768 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.2 tt -170.28 92.66 0.21 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 103.305 -2.85 . . . . 0.0 103.305 173.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -166.82 153.89 9.02 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.485 0.584 . . . . 0.0 111.544 -174.148 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.2 t -72.69 163.27 28.35 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 173.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.4 mt -125.96 -20.18 4.64 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 116.661 -1.638 . . . . 0.0 112.691 174.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.416 ' CG ' ' H ' ' A' ' 87' ' ' LYS . 26.5 t0 -84.26 171.14 13.0 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 121.587 1.994 . . . . 0.0 111.526 174.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.416 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER -109.33 -47.57 3.38 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 129.192 2.997 . . . . 0.0 112.711 174.486 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -70.08 -72.52 0.86 Allowed Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 176.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mp -76.85 19.52 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 128.41 2.684 . . . . 0.0 110.228 -175.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 15.3 ttp -43.75 131.21 5.46 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 127.753 2.421 . . . . 0.0 108.968 -177.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.441 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -158.21 114.01 2.72 Favored 'General case' 0 CA--C 1.508 -0.673 0 C-N-CA 126.54 1.936 . . . . 0.0 106.906 -173.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -97.49 134.39 22.61 Favored Pre-proline 0 C--N 1.323 -0.567 0 O-C-N 124.209 0.943 . . . . 0.0 109.726 -173.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.42 154.25 65.25 Favored 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 121.294 1.329 . . . . 0.0 109.054 173.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 21.5 p -139.28 157.07 46.55 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 126.648 1.979 . . . . 0.0 106.736 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.8 m -126.39 153.84 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-N 119.302 0.955 . . . . 0.0 112.861 178.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -72.54 7.73 1.73 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 127.004 2.122 . . . . 0.0 113.521 174.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.8 m -141.08 165.8 26.82 Favored Pre-proline 0 C--N 1.326 -0.414 0 C-N-CA 126.03 1.732 . . . . 0.0 108.295 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -67.57 168.09 19.13 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.377 1.384 . . . . 0.0 111.082 174.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -64.09 -10.98 25.62 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.733 1.213 . . . . 0.0 112.512 175.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -145.37 164.41 31.58 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.539 1.536 . . . . 0.0 107.355 173.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 160.99 -161.68 33.05 Favored Glycine 0 C--O 1.226 -0.37 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 56.5 p -118.59 151.56 37.68 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 173.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 46.5 t -88.17 113.39 54.84 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 175.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -73.79 158.23 46.94 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.093 2.529 . . . . 0.0 112.881 -173.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -65.27 -19.62 66.05 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 -173.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . 0.266 0.0 OUTLIER -116.81 143.69 45.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 118.563 0.62 . . . . 0.0 112.36 174.159 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -43.04 108.19 0.1 Allowed 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 127.052 2.141 . . . . 0.0 110.951 -174.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.2 m -116.41 143.49 45.49 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 175.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.4 t -97.18 119.39 45.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 C-N-CA 124.403 1.081 . . . . 0.0 111.11 -173.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 72.3 t -95.56 103.58 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 173.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.4 120.55 25.12 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 173.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.5 t -93.23 113.55 28.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 103.872 -2.64 . . . . 0.0 103.872 173.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -92.99 151.12 20.28 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.411 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 11.1 m-85 -132.33 73.81 76.78 Favored Pre-proline 0 C--O 1.244 0.792 0 CA-C-N 118.81 1.305 . . . . 0.0 110.821 -176.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -63.05 114.77 2.59 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.707 2.271 . . . . 0.0 109.679 173.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 9.6 t -91.29 151.15 21.01 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 173.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.1 mt -72.11 -11.19 60.63 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 117.862 0.301 . . . . 0.0 111.545 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 54.44 30.4 49.49 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 127.413 2.435 . . . . 0.0 116.506 173.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 43.1 mttt -120.15 -32.05 4.26 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.388 1.594 . . . . 0.0 113.915 176.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 45.7 tp60 -96.65 146.67 24.64 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 173.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -95.4 148.39 22.5 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 174.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.44 -153.8 23.19 Favored Glycine 0 C--N 1.336 0.537 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 176.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.7 t -131.45 118.45 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.761 0.825 . . . . 0.0 108.864 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -93.54 175.27 6.81 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.67 1.188 . . . . 0.0 109.746 173.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -126.15 155.77 41.17 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.538 1.935 . . . . 0.0 106.997 173.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.411 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 48.9 p90 -150.63 155.49 39.48 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.322 1.049 . . . . 0.0 108.913 174.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -113.93 143.71 44.27 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 125.62 1.568 . . . . 0.0 111.131 -174.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 59.0 t -144.65 119.76 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 173.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -146.42 143.03 28.74 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.209 1.404 . . . . 0.0 108.092 177.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.4 HG22 ' CD2' ' A' ' 79' ' ' PHE . 30.0 t -139.16 141.06 36.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 119.392 0.996 . . . . 0.0 109.939 -173.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.54 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -107.3 163.57 5.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 173.588 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.6 t -141.85 138.3 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -173.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.66 173.37 11.78 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.625 1.57 . . . . 0.0 107.786 -177.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 44.5 p-10 -88.12 176.07 7.44 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 172.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.1 t -67.0 -6.59 17.54 Favored 'General case' 0 CA--C 1.553 1.081 0 O-C-N 120.439 -1.413 . . . . 0.0 112.318 -176.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -84.54 -15.94 44.04 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 120.435 -1.416 . . . . 0.0 110.663 173.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.99 4.62 61.38 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.735 1.159 . . . . 0.0 112.547 -173.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -77.08 117.43 18.64 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.827 1.814 . . . . 0.0 108.937 175.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.7 m -64.32 141.87 58.62 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 126.48 1.912 . . . . 0.0 108.88 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -140.01 -39.03 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 124.931 1.293 . . . . 0.0 113.769 -174.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -130.94 142.35 50.35 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 -177.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -148.59 124.5 10.62 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -176.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 25.1 m -64.1 140.48 97.91 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 174.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.47 141.28 13.97 Favored 'Trans proline' 0 N--CA 1.441 -1.585 0 CA-C-N 119.997 1.035 . . . . 0.0 109.993 177.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 28.2 mp0 -80.4 112.63 17.92 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 -173.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.343 38.5 m-80 172.65 -16.53 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 1 C-N-CA 132.201 4.201 . . . . 0.0 111.311 173.405 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -56.22 98.2 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.024 1.73 . . . . 0.0 110.13 177.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 2.8 mt -135.69 147.22 28.68 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 -174.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -129.08 175.56 8.6 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 173.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -133.23 139.58 47.05 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 -175.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -124.1 122.35 37.61 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 177.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 34.5 m -83.64 118.45 23.85 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 174.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 4.9 m -117.78 166.12 12.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.442 0.639 . . . . 0.0 110.08 173.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.4 pp -138.6 159.7 41.45 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.96 1.704 . . . . 0.0 106.893 173.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.63 127.63 33.45 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.751 0.82 . . . . 0.0 110.302 175.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -147.95 114.32 5.92 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.026 0.93 . . . . 0.0 111.057 176.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 . . . . . 0 C--O 1.256 1.442 0 C-N-CA 129.324 3.049 . . . . 0.0 105.406 173.53 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 CA--C 1.536 0.422 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.423 HD22 HG11 ' A' ' 34' ' ' VAL . 3.1 tt -42.96 129.14 4.41 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 128.066 2.546 . . . . 0.0 113.758 -173.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -117.55 144.6 44.96 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.174 1.79 . . . . 0.0 108.63 173.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.27 123.2 7.51 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.325 1.85 . . . . 0.0 106.615 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 25.7 p90 -141.27 160.93 39.09 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.737 1.153 . . . . 0.0 110.188 178.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -96.13 144.73 9.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 104.509 -2.404 . . . . 0.0 104.509 173.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -97.61 162.74 13.15 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -173.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.9 -18.13 54.39 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 126.114 1.766 . . . . 0.0 114.367 174.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -59.47 -41.13 89.04 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 119.747 1.158 . . . . 0.0 108.978 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 -66.68 -43.49 84.32 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.49 -31.82 73.08 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 121.965 -0.459 . . . . 0.0 111.83 174.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.4 ttm105 . . . . . 0 N--CA 1.445 -0.724 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 173.438 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 . . . . . 0 CA--C 1.533 0.321 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.261 98.7 mt-10 -159.77 112.72 2.16 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.877 1.217 . . . . 0.0 112.994 173.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -97.01 162.6 13.31 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 172.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.9 mp -141.39 113.43 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 173.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.03 119.87 23.43 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.443 HG23 ' CE2' ' A' ' 42' ' ' PHE . 17.8 mt -96.14 -58.44 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 119.024 0.829 . . . . 0.0 109.789 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.423 HG11 HD22 ' A' ' 12' ' ' LEU . 4.0 t -126.48 142.95 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 126.396 1.878 . . . . 0.0 109.069 -173.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.9 p -153.02 135.2 14.89 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 102.318 -3.215 . . . . 0.0 102.318 173.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 44.46 33.91 0.98 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.882 1.273 . . . . 0.0 113.167 -174.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.33 -2.99 8.57 Favored Glycine 0 CA--C 1.541 1.718 0 O-C-N 120.246 -1.534 . . . . 0.0 115.399 -177.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -64.86 37.63 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.512 1 C-N-CA 132.204 4.202 . . . . 0.0 115.076 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.5 mmt -37.82 113.75 0.3 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.376 1.471 . . . . 0.0 110.397 -173.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.32 168.1 15.38 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 125.764 1.626 . . . . 0.0 111.54 -174.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.77 16.73 0.5 Allowed 'Trans proline' 0 CA--C 1.548 1.216 0 C-N-CA 123.474 2.782 . . . . 0.0 111.558 173.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.443 ' CE2' HG23 ' A' ' 33' ' ' ILE . 25.6 p90 -53.43 -26.48 20.16 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 127.031 2.133 . . . . 0.0 112.158 -175.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 m -57.2 -30.95 64.98 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 126.889 2.075 . . . . 0.0 111.293 -173.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 64.8 t60 -63.02 -54.72 33.84 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.294 0.497 . . . . 0.0 110.482 178.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.305 0.9 OUTLIER -76.16 -24.63 54.83 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -178.579 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -61.12 -44.16 97.76 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 173.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 . . . . . 0 C--N 1.343 0.295 0 C-N-CA 123.387 0.675 . . . . 0.0 111.135 174.607 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.47 0 CA-C-O 117.292 -1.337 . . . . 0.0 113.394 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -74.4 -68.31 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 CA-C-N 121.11 1.432 . . . . 0.0 110.732 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.64 119.72 15.2 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.164 0.985 . . . . 0.0 110.187 -174.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.9 mt -124.81 129.93 24.42 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 127.494 2.318 . . . . 0.0 106.312 -177.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -77.76 156.82 31.47 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.124 1.882 . . . . 0.0 111.506 176.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.1 p -41.16 -43.91 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 127.697 2.399 . . . . 0.0 112.932 176.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -59.69 -34.05 72.38 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 126.328 1.851 . . . . 0.0 113.44 -175.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.9 mm -70.02 113.05 5.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 178.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -81.32 -29.07 34.3 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.184 0.594 . . . . 0.0 110.43 178.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.4 m -159.47 165.41 33.12 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.068 0.947 . . . . 0.0 109.08 -175.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 68.8 mtp -125.64 160.27 30.1 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 173.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 -111.21 134.33 52.88 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 124.564 1.145 . . . . 0.0 108.898 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -120.5 165.62 14.72 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 103.189 -2.893 . . . . 0.0 103.189 172.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.1 m -149.17 137.55 20.89 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 120.318 -1.489 . . . . 0.0 108.109 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -148.32 165.6 30.54 Favored 'General case' 0 C--O 1.24 0.597 0 O-C-N 121.801 -0.562 . . . . 0.0 111.167 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' A' ' 104' ' ' PRO . 1.3 pp0? -162.2 145.35 11.66 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 174.019 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -91.8 140.46 29.66 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 173.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.43 78.26 0.17 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 -173.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.87 -73.14 0.12 Allowed Glycine 0 CA--C 1.53 1.025 0 C-N-CA 126.876 2.179 . . . . 0.0 117.517 173.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -116.97 26.34 9.87 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.473 1.636 . . . . 0.0 112.276 173.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -102.38 37.09 1.97 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.41 2.284 . . . . 0.0 111.168 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -38.81 113.36 0.3 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.98 1.312 . . . . 0.0 112.203 -173.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -114.22 119.97 38.86 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 175.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -84.38 152.5 24.02 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -134.56 160.71 37.22 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.809 1.186 . . . . 0.0 110.675 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.44 ' O ' HD13 ' A' ' 131' ' ' ILE . 30.1 tt0 -154.11 135.07 13.83 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 173.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.425 ' CD2' HG22 ' A' ' 130' ' ' VAL . 69.2 m-85 -80.6 103.63 10.58 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.3 tt -61.43 -40.85 95.96 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 173.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 m -155.89 145.44 21.01 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 120.896 -1.128 . . . . 0.0 112.502 177.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.465 ' H ' ' HD3' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -153.25 93.53 1.72 Allowed 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 173.339 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.465 ' HD3' ' H ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -156.41 161.57 40.09 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 121.081 1.764 . . . . 0.0 111.52 -177.99 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 27.4 t -81.57 162.9 22.96 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.419 0.628 . . . . 0.0 109.375 173.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 74.7 mt -116.38 -14.96 10.99 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.054 1.741 . . . . 0.0 110.864 174.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -96.32 164.27 12.72 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 175.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.9 mmtm -138.55 -32.38 0.7 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.259 1.824 . . . . 0.0 113.263 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -64.36 -63.67 4.15 Favored Glycine 0 CA--C 1.54 1.648 0 N-CA-C 106.787 -2.525 . . . . 0.0 106.787 172.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.444 ' H ' HD12 ' A' ' 89' ' ' ILE . 4.8 mp -76.81 21.77 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 129.473 3.109 . . . . 0.0 110.219 175.089 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 3.5 ttp -43.2 132.85 4.16 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 125.579 2.609 . . . . 0.0 113.56 -173.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -149.01 150.87 33.55 Favored 'General case' 0 N--CA 1.421 -1.91 2 C-N-CA 135.317 5.447 . . . . 0.0 100.939 173.583 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -139.74 113.85 7.85 Favored Pre-proline 0 C--N 1.315 -0.899 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 173.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -67.68 157.4 61.94 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.962 2.441 . . . . 0.0 113.096 -173.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 39.1 p -136.94 170.11 16.65 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.464 1.506 . . . . 0.0 109.395 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.2 m -126.26 155.65 36.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 124.612 1.165 . . . . 0.0 108.322 173.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -101.6 35.32 2.34 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.024 1.329 . . . . 0.0 110.24 174.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.9 m -139.91 162.11 52.37 Favored Pre-proline 0 C--O 1.236 0.39 0 C-N-CA 127.057 2.143 . . . . 0.0 106.14 173.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -68.74 159.0 55.52 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 N-CA-C 109.213 -1.11 . . . . 0.0 109.213 173.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.38 -11.09 29.22 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 124.194 0.998 . . . . 0.0 112.014 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -141.64 163.68 32.26 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.376 1.47 . . . . 0.0 107.79 173.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 166.61 -161.74 35.47 Favored Glycine 0 C--O 1.226 -0.385 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -177.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.2 p -125.28 144.67 50.36 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.5 t -74.25 117.3 60.59 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 105.0 -2.222 . . . . 0.0 105.0 175.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.411 ' O ' ' HA ' ' A' ' 68' ' ' GLN . 89.3 Cg_endo -74.51 160.53 41.41 Favored 'Trans proline' 0 C--O 1.213 -0.751 0 C-N-CA 121.974 1.782 . . . . 0.0 115.231 -173.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . 0.304 93.0 m-70 -75.05 -14.65 60.62 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 118.114 2.635 . . . . 0.0 118.114 -172.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.96 151.68 36.18 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 173.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -49.05 108.7 0.2 Allowed 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 125.438 1.495 . . . . 0.0 109.025 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 21.1 m -123.89 138.89 54.41 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.8 t -80.05 152.34 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -174.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 86.8 t -129.9 109.85 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 174.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -82.16 135.26 35.31 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 174.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.5 t -116.41 116.58 52.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 173.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -94.43 149.78 19.52 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 125.665 1.603 . . . . 0.0 111.236 -178.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.466 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 4.8 m-85 -133.79 73.8 70.92 Favored Pre-proline 0 C--O 1.242 0.672 0 CA-C-N 118.037 0.919 . . . . 0.0 110.785 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.29 123.06 9.57 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.747 1.631 . . . . 0.0 108.068 173.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 5.7 t -105.27 152.53 22.77 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 173.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.7 mt -79.25 -10.48 59.82 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.558 0.617 . . . . 0.0 112.118 -174.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.03 32.47 66.85 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 125.534 1.54 . . . . 0.0 115.499 173.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.6 mttt -122.92 -29.38 3.95 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.546 1.673 . . . . 0.0 113.857 176.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -96.71 160.08 14.57 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 173.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -114.56 148.03 38.59 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 176.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 141.19 -155.97 25.37 Favored Glycine 0 C--N 1.333 0.404 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 176.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.3 t -125.33 113.68 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.75 164.43 15.97 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 173.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -121.93 158.13 29.72 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 121.422 -0.799 . . . . 0.0 110.459 174.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.466 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 24.0 p90 -153.2 161.47 42.39 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 124.21 1.004 . . . . 0.0 109.274 173.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -140.35 159.81 41.37 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 124.543 1.137 . . . . 0.0 111.839 -173.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 77.6 t -133.05 136.35 55.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 127.702 2.401 . . . . 0.0 107.575 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -145.18 122.54 11.61 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 173.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.425 HG22 ' CD2' ' A' ' 79' ' ' PHE . 21.4 t -135.52 131.56 51.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 -176.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.609 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -97.83 164.86 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 173.462 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.8 t -144.03 134.49 21.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 -175.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.48 173.9 11.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.282 -1.326 . . . . 0.0 108.55 -175.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -86.32 176.11 8.08 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 105.142 -2.169 . . . . 0.0 105.142 172.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.2 t -58.75 -31.38 68.29 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.846 -1.158 . . . . 0.0 112.216 -173.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -81.22 -4.15 54.59 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.39 -0.819 . . . . 0.0 112.581 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.81 7.0 57.92 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.218 0.914 . . . . 0.0 113.976 175.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -70.32 114.97 8.97 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.762 1.781 . . . . 0.0 108.688 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -69.52 141.89 53.78 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.641 0.776 . . . . 0.0 108.953 -176.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.08 -38.39 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 124.687 1.195 . . . . 0.0 113.475 -174.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -134.02 146.86 50.78 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 16.2 tm0? -148.42 153.98 39.27 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.278 1.031 . . . . 0.0 108.758 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 36.3 m -83.52 114.18 51.76 Favored Pre-proline 0 CA--C 1.529 0.162 0 C-N-CA 125.044 1.338 . . . . 0.0 108.535 -176.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -61.95 143.53 95.48 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 CA-C-N 120.294 1.141 . . . . 0.0 110.08 -173.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -81.49 112.52 18.81 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.913 -173.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.624 30.0 m-80 172.4 -11.48 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 1 C-N-CA 135.992 5.717 . . . . 0.0 112.694 173.169 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.38 75.08 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.021 2.128 . . . . 0.0 110.7 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -118.8 145.47 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 128.061 2.545 . . . . 0.0 105.434 178.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -126.91 169.34 13.38 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 174.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -136.93 113.42 10.09 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.524 1.13 . . . . 0.0 108.197 -173.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 49.0 tttt -99.29 123.3 43.45 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 31.1 m -83.47 116.7 22.65 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 173.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 25.5 m -114.49 164.99 13.22 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.5 pp -142.82 160.05 41.06 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.975 1.31 . . . . 0.0 108.191 174.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.12 127.32 32.42 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.528 1.131 . . . . 0.0 110.433 175.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -155.55 116.44 3.88 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.673 1.189 . . . . 0.0 110.807 175.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 . . . . . 0 C--O 1.247 0.974 0 C-N-CA 128.963 2.905 . . . . 0.0 105.445 173.55 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 CA--C 1.541 0.617 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.7 tt -42.85 129.32 4.31 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 128.328 2.651 . . . . 0.0 113.876 -173.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -117.17 142.14 47.4 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.187 2.195 . . . . 0.0 109.243 173.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.75 117.59 5.85 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.424 1.89 . . . . 0.0 106.652 -177.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 18.4 p90 -138.13 143.31 40.28 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.734 1.152 . . . . 0.0 109.337 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.9 mp -83.91 113.7 23.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 104.856 -2.276 . . . . 0.0 104.856 176.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -78.66 151.23 32.35 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 122.707 1.241 . . . . 0.0 111.118 -176.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.15 -9.76 49.07 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 127.216 2.206 . . . . 0.0 115.619 -173.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -54.48 -38.62 66.62 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 119.7 1.136 . . . . 0.0 112.952 -173.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -73.84 -40.3 63.39 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.809 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.35 -39.08 78.56 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.516 1.126 . . . . 0.0 110.885 173.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 . . . . . 0 N--CA 1.448 -0.575 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 175.852 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -148.9 113.22 5.25 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 174.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -95.43 154.89 16.98 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 102.706 -3.072 . . . . 0.0 102.706 172.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.3 mm -135.31 113.31 15.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 104.535 -2.394 . . . . 0.0 104.535 173.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.03 114.28 19.79 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 -176.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.435 HG23 ' CD1' ' A' ' 42' ' ' PHE . 10.9 mt -87.49 -61.53 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.1 t -125.72 142.11 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 125.533 1.533 . . . . 0.0 108.974 -173.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.0 p -149.81 124.29 9.66 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 102.921 -2.992 . . . . 0.0 102.921 173.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 44.34 33.95 0.96 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.697 1.599 . . . . 0.0 113.582 -174.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.96 -5.95 4.26 Favored Glycine 0 CA--C 1.544 1.852 0 O-C-N 120.663 -1.273 . . . . 0.0 114.932 -176.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -75.73 37.61 0.15 Allowed 'General case' 0 N--CA 1.468 0.442 1 C-N-CA 133.248 4.619 . . . . 0.0 111.114 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 30.7 mtp -37.84 131.92 0.98 Allowed 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.886 1.674 . . . . 0.0 114.531 -172.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.03 162.26 69.94 Favored Pre-proline 0 N--CA 1.448 -0.552 0 CA-C-N 113.746 -1.57 . . . . 0.0 107.945 173.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.79 39.6 0.58 Allowed 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 124.172 3.248 . . . . 0.0 111.421 174.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.435 ' CD1' HG23 ' A' ' 33' ' ' ILE . 11.8 p90 -55.07 -26.55 38.49 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.695 1.998 . . . . 0.0 112.142 -173.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.6 m -60.73 -27.92 68.29 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.89 1.676 . . . . 0.0 110.786 -174.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -57.23 -65.74 0.57 Allowed 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.663 1.185 . . . . 0.0 109.713 174.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.91 -24.36 62.45 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -178.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -65.82 -50.12 65.75 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.611 0.641 . . . . 0.0 110.338 174.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? . . . . . 0 CA--C 1.541 0.601 0 O-C-N 121.453 -0.78 . . . . 0.0 109.393 -176.332 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.537 0 CA-C-O 116.98 -1.486 . . . . 0.0 115.008 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -83.68 -65.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.805 0 CA-C-N 122.0 1.75 . . . . 0.0 112.023 -174.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.26 120.5 16.03 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.094 1.358 . . . . 0.0 110.593 -173.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.3 mt -129.4 129.6 23.26 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 126.461 1.904 . . . . 0.0 106.215 -175.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -78.89 158.5 27.54 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.271 1.981 . . . . 0.0 111.393 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.4 p -41.64 -49.1 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 126.408 1.883 . . . . 0.0 112.068 174.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -59.17 -40.26 85.09 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 126.638 1.975 . . . . 0.0 113.024 -176.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.4 mm -73.18 112.76 9.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 102.256 -3.239 . . . . 0.0 102.256 174.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -81.22 -36.78 29.62 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 114.664 -1.153 . . . . 0.0 108.922 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.8 m -141.84 168.62 19.33 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 123.883 0.739 . . . . 0.0 111.968 -173.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 70.8 mtp -126.81 155.57 42.65 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 172.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 46.6 m-20 -107.22 149.29 27.89 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 174.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -135.15 155.07 51.32 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 129.788 3.235 . . . . 0.0 103.015 172.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.5 m -140.71 134.2 29.99 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 -177.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -146.82 165.03 30.94 Favored 'General case' 0 C--O 1.239 0.528 0 O-C-N 121.803 -0.561 . . . . 0.0 110.952 176.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.22 163.43 5.81 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.736 1.215 . . . . 0.0 111.169 174.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.1 170.63 7.8 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 173.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.08 101.84 13.43 Favored 'General case' 0 N--CA 1.445 -0.708 0 O-C-N 119.966 -1.709 . . . . 0.0 109.099 -174.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 44.58 -48.73 0.0 OUTLIER Glycine 0 CA--C 1.54 1.637 1 C-N-CA 133.14 5.162 . . . . 0.0 121.032 174.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -116.92 -18.99 10.01 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 121.85 2.825 . . . . 0.0 115.78 174.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.48 37.1 0.56 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 128.185 2.594 . . . . 0.0 117.908 -173.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -48.99 114.11 0.93 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 122.53 2.423 . . . . 0.0 110.283 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -83.65 153.14 24.41 Favored 'General case' 0 C--N 1.335 -0.029 0 C-N-CA 125.376 1.47 . . . . 0.0 107.857 174.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -97.46 151.02 20.41 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -133.98 159.88 39.42 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.905 1.229 . . . . 0.0 110.616 174.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.418 ' O ' HD13 ' A' ' 131' ' ' ILE . 28.0 tt0 -156.16 141.55 17.6 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 173.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -91.75 103.66 16.2 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.309 1.043 . . . . 0.0 108.899 -174.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.7 tt -73.26 -44.09 59.94 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.154 1.382 . . . . 0.0 108.104 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.2 m -136.83 137.35 39.65 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.237 1.415 . . . . 0.0 110.218 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -170.3 92.94 0.21 Allowed 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 102.022 -3.325 . . . . 0.0 102.022 173.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -162.29 152.44 16.66 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 118.647 -0.692 . . . . 0.0 111.41 -174.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.5 t -69.85 167.71 16.72 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 122.326 1.06 . . . . 0.0 112.511 173.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.9 mt -126.51 -9.61 6.27 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 126.593 1.957 . . . . 0.0 113.37 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.519 ' CG ' ' H ' ' A' ' 87' ' ' LYS 0.348 14.4 t70 -101.53 162.22 13.06 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 121.625 2.011 . . . . 0.0 113.665 -175.489 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.519 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 0.7 OUTLIER -106.32 -48.76 3.5 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 129.476 3.11 . . . . 0.0 112.293 -173.286 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.411 ' C ' ' H ' ' A' ' 90' ' ' MET . . . -94.05 -49.7 2.4 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 124.865 1.222 . . . . 0.0 111.754 -177.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 mt -81.31 17.56 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 126.052 1.741 . . . . 0.0 109.179 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.411 ' H ' ' C ' ' A' ' 88' ' ' GLY . 14.4 ttp -43.49 130.64 5.12 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 130.215 3.406 . . . . 0.0 109.77 -177.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.255 . . -162.47 166.67 24.63 Favored 'General case' 0 N--CA 1.441 -0.908 1 C-N-CA 133.179 4.591 . . . . 0.0 104.351 -173.578 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -141.88 145.54 36.98 Favored Pre-proline 0 N--CA 1.473 0.678 0 CA-C-N 118.923 0.783 . . . . 0.0 110.453 173.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -77.61 145.74 23.51 Favored 'Trans proline' 0 N--CA 1.443 -1.454 0 C-N-CA 121.532 1.488 . . . . 0.0 109.352 173.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 23.8 p -129.14 153.93 47.21 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 126.047 1.739 . . . . 0.0 107.353 176.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.2 m -126.06 150.37 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 119.382 0.992 . . . . 0.0 111.579 -174.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -80.52 9.08 6.46 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.432 1.893 . . . . 0.0 113.552 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.6 m -143.38 163.45 36.93 Favored Pre-proline 0 C--N 1.327 -0.381 0 C-N-CA 124.97 1.308 . . . . 0.0 109.06 -177.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -66.2 162.16 37.1 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.334 1.356 . . . . 0.0 109.339 173.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -66.44 -12.0 54.91 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.119 0.968 . . . . 0.0 112.035 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -140.81 163.49 32.78 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.155 1.382 . . . . 0.0 107.796 173.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.24 -160.83 33.46 Favored Glycine 0 C--O 1.227 -0.341 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 72.1 p -119.14 147.93 43.64 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 174.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.1 t -81.31 113.4 41.23 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 100.983 -3.71 . . . . 0.0 100.983 173.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -92.29 167.4 2.91 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.28 1.986 . . . . 0.0 116.837 -172.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -75.94 10.46 1.86 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.688 1.195 . . . . 0.0 114.167 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.93 122.49 45.46 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 176.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.26 105.25 0.14 Allowed 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 174.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.0 m -114.27 136.56 52.83 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -174.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 26.6 t -95.13 114.97 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -174.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 78.7 t -93.69 103.36 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 N-CA-C 103.514 -2.772 . . . . 0.0 103.514 173.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -85.19 140.85 30.58 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 173.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.5 t -115.61 113.83 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 104.108 -2.553 . . . . 0.0 104.108 174.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -95.76 150.4 19.64 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 125.525 1.536 . . . . 0.0 109.919 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.468 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 7.9 m-85 -130.0 73.5 81.34 Favored Pre-proline 0 C--O 1.243 0.721 0 CA-C-N 118.478 1.139 . . . . 0.0 110.366 -173.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.16 121.96 9.78 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.351 2.034 . . . . 0.0 107.898 173.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 8.7 t -103.67 149.85 24.57 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 175.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.1 mt -81.58 -8.02 59.66 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 118.752 -0.642 . . . . 0.0 111.332 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.2 49.19 78.04 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 126.312 1.91 . . . . 0.0 113.323 173.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -112.47 -75.69 0.6 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.116 0.958 . . . . 0.0 111.152 -173.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 51.2 tp60 -83.08 152.19 25.45 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 173.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -93.47 142.6 27.15 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 178.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.52 -154.68 25.94 Favored Glycine 0 C--N 1.331 0.294 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -177.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.3 t -128.14 113.78 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -86.63 169.57 12.61 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 173.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -132.19 162.22 31.46 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.14 0.576 . . . . 0.0 109.818 175.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.468 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 20.2 p90 -144.91 147.15 32.42 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 173.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -104.21 144.75 31.18 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 127.437 2.295 . . . . 0.0 109.474 -174.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 43.7 t -137.43 143.43 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 123.605 0.762 . . . . 0.0 110.02 173.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -157.5 119.4 3.74 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 128.454 2.702 . . . . 0.0 105.616 174.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.439 ' H ' ' HB ' ' A' ' 143' ' ' THR . 61.6 t -130.33 121.81 52.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.625 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -85.77 167.18 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-O 123.018 1.389 . . . . 0.0 107.501 173.95 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.1 t -143.24 132.64 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 C-N-CA 127.448 2.299 . . . . 0.0 105.829 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.15 174.84 10.1 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.448 1.099 . . . . 0.0 108.596 -176.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -88.98 176.09 7.15 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 172.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.7 t -67.55 -3.57 9.15 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 120.499 -1.376 . . . . 0.0 113.58 -176.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -91.36 -12.76 33.97 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 120.364 1.438 . . . . 0.0 110.581 173.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 93.26 -0.77 69.02 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.557 1.075 . . . . 0.0 111.926 -173.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 59.9 m-20 -67.73 115.42 7.27 Favored 'General case' 0 C--N 1.343 0.306 0 CA-C-N 119.427 1.613 . . . . 0.0 108.005 174.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -71.5 147.3 47.89 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.415 1.486 . . . . 0.0 109.386 -174.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.48 -33.87 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.453 HD13 ' N ' ' A' ' 142' ' ' GLN . 1.5 tm? -136.83 147.45 46.56 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -173.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.453 ' N ' HD13 ' A' ' 141' ' ' LEU . 6.2 tm0? -148.81 150.12 32.5 Favored 'General case' 0 N--CA 1.462 0.129 0 O-C-N 121.378 -0.826 . . . . 0.0 109.309 177.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.439 ' HB ' ' H ' ' A' ' 130' ' ' VAL . 24.1 m -82.29 113.75 46.23 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 175.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -64.86 146.43 88.03 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 121.62 1.547 . . . . 0.0 112.21 -173.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -77.72 112.55 14.68 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.303 19.5 m-80 172.71 -17.2 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 1 C-N-CA 137.773 6.429 . . . . 0.0 109.553 173.936 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.6 82.57 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.062 1.745 . . . . 0.0 109.627 174.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.2 mm -121.72 136.03 59.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 176.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.417 ' HB2' ' CE2' ' A' ' 126' ' ' PHE . 6.5 m-85 -112.85 163.51 14.53 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 174.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -138.32 113.4 9.28 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.022 1.329 . . . . 0.0 108.395 -173.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.33 121.43 44.37 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -174.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 23.1 m -84.53 115.59 22.67 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 126.042 1.737 . . . . 0.0 106.726 -175.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 4.2 m -113.98 166.35 11.69 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.185 0.902 . . . . 0.0 109.425 173.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.9 pp -134.22 162.31 32.5 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.626 1.57 . . . . 0.0 106.914 173.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.5 120.34 11.51 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 123.982 0.913 . . . . 0.0 109.907 175.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -163.93 114.17 1.28 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.063 1.345 . . . . 0.0 109.841 176.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 . . . . . 0 C--O 1.256 1.431 0 C-N-CA 128.936 2.894 . . . . 0.0 105.546 173.786 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . 0.295 4.5 m . . . . . 0 CA--C 1.541 0.606 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.9 tt -65.26 137.69 57.73 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 130.302 3.441 . . . . 0.0 112.018 -176.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.41 ' CD2' ' HA ' ' A' ' 35' ' ' SER . 88.3 m-85 -126.91 138.38 53.29 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.257 2.223 . . . . 0.0 108.342 173.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.11 118.72 6.53 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 -175.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 14.2 p90 -135.6 175.45 9.58 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.707 1.203 . . . . 0.0 110.574 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.421 HD11 HD11 ' A' ' 33' ' ' ILE . 1.6 mp -114.22 141.19 31.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 103.52 -2.77 . . . . 0.0 103.52 173.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -93.11 158.73 15.62 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -173.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.34 -15.13 59.03 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 113.122 -1.854 . . . . 0.0 113.497 177.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -61.02 -43.31 99.08 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 119.795 1.18 . . . . 0.0 108.428 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -66.55 -49.56 66.04 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 122.83 0.452 . . . . 0.0 111.143 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.17 -35.31 67.07 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.468 0.707 . . . . 0.0 111.785 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.403 HH21 ' CD ' ' A' ' 28' ' ' GLU . 26.9 ttm105 . . . . . 0 N--CA 1.443 -0.819 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 175.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.403 ' CD ' HH21 ' A' ' 22' ' ' ARG . 16.6 tp10 . . . . . 0 CA--C 1.532 0.263 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -155.91 113.49 3.29 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.737 0.815 . . . . 0.0 112.344 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -96.04 159.34 15.01 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 103.002 -2.962 . . . . 0.0 103.002 172.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 84.2 mt -134.39 113.4 17.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 174.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.05 114.25 23.5 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -174.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.421 HD11 HD11 ' A' ' 16' ' ' ILE . 13.6 mt -89.05 -62.84 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.614 0.766 . . . . 0.0 109.355 -179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.515 HG22 ' HG2' ' A' ' 39' ' ' MET . 19.7 t -116.0 128.87 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 126.147 1.779 . . . . 0.0 107.725 -173.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.41 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 54.5 p -132.02 124.51 29.43 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 102.643 -3.095 . . . . 0.0 102.643 173.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.265 1.7 pm0 44.07 40.77 3.64 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.417 1.487 . . . . 0.0 112.863 -175.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.01 -31.76 1.08 Allowed Glycine 0 CA--C 1.542 1.724 0 C-N-CA 126.268 1.89 . . . . 0.0 114.916 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . 0.462 8.8 tmtt? -54.31 37.66 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.835 1 C-N-CA 137.85 6.46 . . . . 0.0 116.126 174.966 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.515 ' HG2' HG22 ' A' ' 34' ' ' VAL . 42.5 mtt -38.01 142.73 0.15 Allowed 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.215 1.806 . . . . 0.0 115.418 -173.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.84 160.29 83.06 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 173.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -74.81 37.69 0.48 Allowed 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 124.217 3.278 . . . . 0.0 111.994 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -55.76 -26.66 46.84 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 126.6 1.96 . . . . 0.0 113.196 -173.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.7 m -54.77 -39.32 68.26 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.451 2.3 . . . . 0.0 112.672 -173.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 -58.0 -65.94 0.56 Allowed 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.811 1.644 . . . . 0.0 109.724 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -70.91 -27.19 63.6 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-O 118.076 -0.964 . . . . 0.0 111.689 -173.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -69.79 -49.17 55.45 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.812 1.245 . . . . 0.0 111.557 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 . . . . . 0 N--CA 1.469 0.505 0 CA-C-N 119.31 0.959 . . . . 0.0 109.566 178.2 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 91.0 mmm . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 118.164 2.654 . . . . 0.0 118.164 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -68.76 -70.0 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.697 0 CA-C-N 121.67 1.632 . . . . 0.0 113.698 -173.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.59 114.08 8.33 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.721 0.808 . . . . 0.0 110.504 -173.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 62.4 mt -119.45 127.26 26.54 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 127.097 2.159 . . . . 0.0 106.335 -177.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -77.31 156.58 33.08 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.125 1.883 . . . . 0.0 110.752 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.7 p -42.58 -43.77 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 127.136 2.174 . . . . 0.0 113.1 177.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -62.21 -41.35 98.29 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 126.181 1.792 . . . . 0.0 112.831 -174.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.6 mm -67.64 112.93 3.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 102.912 -2.995 . . . . 0.0 102.912 174.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -81.65 -27.11 34.26 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 118.716 -0.659 . . . . 0.0 109.512 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.4 m -155.27 168.96 25.34 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.383 1.073 . . . . 0.0 110.59 -173.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.1 mtm -126.26 151.02 48.01 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 172.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -104.92 113.29 26.79 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 122.882 0.473 . . . . 0.0 110.422 -176.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -100.76 153.02 19.8 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 103.06 -2.941 . . . . 0.0 103.06 172.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.3 m -138.17 133.71 33.64 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 -177.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -143.81 163.56 33.02 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.42 175.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -172.74 157.03 3.65 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.173 173.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.55 -173.6 4.59 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 172.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -123.49 134.51 53.88 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 101.478 -3.527 . . . . 0.0 101.478 173.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 16.49 -55.86 0.0 OUTLIER Glycine 0 CA--C 1.534 1.227 1 C-N-CA 135.274 6.178 . . . . 0.0 120.671 -176.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -116.61 -14.97 10.85 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 120.721 2.261 . . . . 0.0 113.999 -177.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.84 37.16 0.35 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 129.303 3.041 . . . . 0.0 118.859 -173.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -56.95 113.81 1.84 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 123.239 2.745 . . . . 0.0 110.307 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -85.81 155.72 20.88 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 125.38 1.472 . . . . 0.0 108.288 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -102.82 150.09 23.84 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 177.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -136.21 160.88 37.34 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.949 1.25 . . . . 0.0 110.905 176.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.45 ' O ' HD13 ' A' ' 131' ' ' ILE . 27.4 tt0 -153.53 140.13 18.86 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 172.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.402 ' CD2' HG22 ' A' ' 130' ' ' VAL . 70.8 m-85 -87.1 103.44 15.39 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.9 tt -74.27 -40.79 62.09 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 175.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.4 m -138.34 135.97 35.9 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.328 1.051 . . . . 0.0 111.591 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.495 HD22 HG22 ' A' ' 128' ' ' VAL . 0.1 OUTLIER -165.63 93.18 0.56 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 102.188 -3.264 . . . . 0.0 102.188 173.254 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.411 ' HD3' ' H ' ' A' ' 82' ' ' LEU . 0.1 OUTLIER -160.12 154.42 23.56 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 121.001 -1.062 . . . . 0.0 110.053 -174.221 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.412 ' HB2' ' HA ' ' A' ' 92' ' ' ASP . 5.4 t -73.89 169.05 18.22 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.716 0.77 . . . . 0.0 110.477 173.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.0 mt -122.34 -21.54 5.79 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 116.179 -1.867 . . . . 0.0 110.849 174.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -106.11 152.29 23.61 Favored 'General case' 0 C--N 1.353 0.741 0 CA-C-N 121.528 1.967 . . . . 0.0 110.773 173.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.44 ' HE3' ' HA ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -120.33 -23.85 6.07 Favored 'General case' 0 N--CA 1.445 -0.718 1 C-N-CA 135.67 5.588 . . . . 0.0 113.982 179.879 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -72.92 -71.57 1.07 Allowed Glycine 0 CA--C 1.533 1.214 0 N-CA-C 107.118 -2.393 . . . . 0.0 107.118 173.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 mp -77.12 26.52 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 130.052 3.341 . . . . 0.0 110.358 174.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.43 ' SD ' ' HE3' ' A' ' 87' ' ' LYS . 4.7 ttp -42.95 127.76 4.17 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 129.04 2.936 . . . . 0.0 113.487 -173.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -146.99 152.17 38.18 Favored 'General case' 0 N--CA 1.431 -1.42 1 C-N-CA 133.556 4.742 . . . . 0.0 102.216 173.639 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.412 ' HA ' ' HB2' ' A' ' 84' ' ' SER . 5.9 m-20 -139.81 114.19 7.85 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 173.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -70.0 160.76 48.48 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.114 2.543 . . . . 0.0 114.919 -173.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.1 p -137.03 167.11 22.15 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.532 1.933 . . . . 0.0 109.76 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.9 m -126.54 154.76 36.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.038 0.935 . . . . 0.0 111.432 173.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -78.94 9.58 4.16 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.592 2.357 . . . . 0.0 113.574 178.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.7 m -140.84 164.19 37.86 Favored Pre-proline 0 C--N 1.327 -0.4 0 C-N-CA 124.593 1.157 . . . . 0.0 109.557 -175.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -65.58 163.09 31.38 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.418 1.412 . . . . 0.0 109.699 173.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -62.9 -12.98 28.74 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 124.151 0.981 . . . . 0.0 112.423 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -143.66 164.85 29.27 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 120.334 1.425 . . . . 0.0 108.308 173.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.59 -161.96 35.39 Favored Glycine 0 C--O 1.228 -0.231 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 73.6 p -120.76 159.05 26.2 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 117.485 0.642 . . . . 0.0 109.784 174.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.9 t -94.05 113.18 59.96 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 173.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -93.32 163.75 2.45 Favored 'Trans proline' 0 C--O 1.218 -0.485 0 C-N-CA 122.861 2.374 . . . . 0.0 114.114 -173.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -73.26 2.11 8.07 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 120.303 -1.498 . . . . 0.0 113.887 -173.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.41 126.95 55.0 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-O 115.525 -2.179 . . . . 0.0 107.864 177.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -42.29 111.95 0.29 Allowed 'General case' 0 N--CA 1.462 0.155 0 O-C-N 125.299 1.624 . . . . 0.0 109.023 173.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.5 m -117.82 138.25 52.21 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 176.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.4 t -97.5 114.98 36.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 123.796 0.838 . . . . 0.0 110.035 -173.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 77.1 t -93.9 103.21 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 102.689 -3.078 . . . . 0.0 102.689 173.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -85.53 121.44 28.23 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 173.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.5 t -90.02 113.57 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 103.535 -2.765 . . . . 0.0 103.535 173.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -85.77 149.79 23.65 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.488 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 5.4 m-85 -135.62 73.56 61.38 Favored Pre-proline 0 C--O 1.244 0.779 0 CA-C-N 117.772 0.786 . . . . 0.0 109.229 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.3 114.42 3.44 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 N-CA-C 107.575 -1.741 . . . . 0.0 107.575 173.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 5.6 t -95.85 141.55 29.16 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 173.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.9 mt -81.92 -11.02 59.1 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 123.276 0.36 . . . . 0.0 110.716 -178.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 56.99 57.91 17.3 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 126.517 2.008 . . . . 0.0 111.871 173.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.407 ' HD3' ' HA ' ' A' ' 119' ' ' LYS 0.321 41.6 mmtm -113.05 -75.72 0.6 Allowed 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 117.589 -1.196 . . . . 0.0 111.065 179.992 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 49.0 tp60 -77.51 150.58 34.84 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 173.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -93.66 143.31 26.43 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 177.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.86 -152.93 24.88 Favored Glycine 0 C--N 1.334 0.442 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 19.3 t -128.34 113.71 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.96 167.41 13.75 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 173.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -127.97 163.26 24.89 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.431 0.692 . . . . 0.0 109.981 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.488 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 16.0 p90 -146.09 154.44 41.83 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.024 0.93 . . . . 0.0 108.899 173.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -114.39 149.24 36.46 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 127.55 2.34 . . . . 0.0 110.32 -174.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.495 HG22 HD22 ' A' ' 82' ' ' LEU . 63.2 t -140.16 143.49 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 125.043 1.337 . . . . 0.0 109.958 175.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -156.97 116.78 3.47 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 128.1 2.56 . . . . 0.0 105.488 173.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.468 ' H ' ' HB ' ' A' ' 143' ' ' THR . 46.3 t -126.41 121.76 59.65 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.826 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 176.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.461 HG22 ' HG3' ' A' ' 142' ' ' GLN . 0.1 OUTLIER -91.13 162.62 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 O-C-N 124.543 1.152 . . . . 0.0 107.942 174.534 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.3 t -136.91 134.86 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 C-N-CA 125.442 1.497 . . . . 0.0 107.041 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.22 174.41 10.58 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.593 1.157 . . . . 0.0 108.854 -175.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -90.2 176.31 6.8 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 104.694 -2.335 . . . . 0.0 104.694 172.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.9 t -65.47 -4.24 5.53 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 120.4 -1.437 . . . . 0.0 113.871 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -90.3 -14.55 32.98 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 120.725 1.602 . . . . 0.0 110.833 173.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.16 1.08 65.11 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.402 1.001 . . . . 0.0 111.915 -173.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 -69.93 116.03 9.84 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 119.524 1.662 . . . . 0.0 108.209 174.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -69.74 143.63 52.98 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 125.702 1.601 . . . . 0.0 108.776 -175.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -141.4 -37.68 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 124.667 1.187 . . . . 0.0 113.915 -173.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -130.19 150.84 51.26 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.461 ' HG3' HG22 ' A' ' 131' ' ' ILE . 5.5 tm0? -150.0 148.25 28.83 Favored 'General case' 0 CA--C 1.517 -0.307 0 O-C-N 121.054 -1.029 . . . . 0.0 109.469 176.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.468 ' HB ' ' H ' ' A' ' 130' ' ' VAL . 28.7 m -79.17 113.51 36.82 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 103.541 -2.763 . . . . 0.0 103.541 173.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.56 144.74 80.1 Favored 'Trans proline' 0 N--CA 1.445 -1.37 0 CA-C-N 120.369 1.167 . . . . 0.0 110.072 -173.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -75.81 112.39 12.15 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 -174.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 172.91 -31.93 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 129.38 3.072 . . . . 0.0 109.484 -173.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.14 92.9 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.125 1.77 . . . . 0.0 109.381 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.1 mm -125.65 141.19 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.428 ' HB2' ' CE2' ' A' ' 126' ' ' PHE . 0.2 OUTLIER -124.32 166.45 15.9 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 174.151 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -133.7 113.45 12.36 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.359 1.064 . . . . 0.0 108.392 -173.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.4 tttt -100.85 122.65 43.81 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 32.7 m -83.45 117.82 23.33 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 174.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 10.0 m -118.74 166.09 13.2 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.852 0.751 . . . . 0.0 109.431 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.3 pp -138.61 161.81 36.18 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.2 1.4 . . . . 0.0 108.022 176.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.1 126.84 28.7 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.649 1.18 . . . . 0.0 110.345 176.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -158.34 166.96 31.02 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.314 1.846 . . . . 0.0 108.36 174.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 . . . . . 0 C--O 1.258 1.527 0 C-N-CA 128.591 2.757 . . . . 0.0 104.258 173.621 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.9 m . . . . . 0 CA--C 1.549 0.932 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.405 HD12 HG11 ' A' ' 132' ' ' VAL . 3.6 tt -47.17 124.67 6.82 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 120.903 1.683 . . . . 0.0 111.955 -174.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -116.32 145.02 43.51 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.914 0.885 . . . . 0.0 110.137 174.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.98 118.56 4.52 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 9.9 p90 -130.78 176.34 8.29 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.446 1.499 . . . . 0.0 110.534 176.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.433 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 5.9 mt -112.62 113.97 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 102.714 -3.069 . . . . 0.0 102.714 173.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -73.59 149.69 41.92 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 122.795 1.283 . . . . 0.0 109.85 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.21 -18.4 3.83 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -173.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -56.61 -34.45 67.23 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 119.515 1.052 . . . . 0.0 111.038 175.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 21.5 tp60 -61.2 -56.14 24.07 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 119.338 0.972 . . . . 0.0 110.633 174.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.85 -39.13 62.31 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.66 0.784 . . . . 0.0 111.799 174.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.9 ttm-85 . . . . . 0 N--CA 1.443 -0.788 0 O-C-N 121.019 -1.051 . . . . 0.0 108.86 175.493 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.534 0.346 0 CA-C-O 119.261 -0.399 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -157.63 113.97 2.89 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.209 1.803 . . . . 0.0 109.827 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -82.89 168.06 17.44 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 173.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.3 mp -137.56 113.09 10.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 173.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.73 114.15 22.47 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 -178.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.4 mt -88.75 -55.76 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -175.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.4 t -125.57 113.62 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 -174.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 94.6 p -111.89 126.88 55.59 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 102.432 -3.174 . . . . 0.0 102.432 173.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.263 0.7 OUTLIER 46.39 34.06 2.15 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.81 1.244 . . . . 0.0 114.251 175.352 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.26 -4.29 26.39 Favored Glycine 0 CA--C 1.544 1.861 0 C-N-CA 126.545 2.022 . . . . 0.0 115.561 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -76.97 37.16 0.18 Allowed 'General case' 0 N--CA 1.474 0.739 1 C-N-CA 133.98 4.912 . . . . 0.0 111.037 -173.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 35.0 mtt -38.04 118.6 0.7 Allowed 'General case' 0 C--O 1.232 0.183 0 C-N-CA 126.864 2.066 . . . . 0.0 114.568 -173.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.16 164.29 43.73 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 113.835 -1.529 . . . . 0.0 108.722 173.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -73.39 26.85 0.31 Allowed 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 123.931 3.087 . . . . 0.0 112.779 174.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -55.26 -26.61 40.99 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 125.891 1.676 . . . . 0.0 112.876 -174.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 m -65.05 -30.16 71.1 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.248 1.019 . . . . 0.0 110.77 -173.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.455 ' CE1' HH22 ' A' ' 47' ' ' ARG . 3.0 t60 -69.78 -57.31 5.25 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -58.95 -23.75 61.84 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.9 -64.96 0.8 Allowed 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 173.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.455 HH22 ' CE1' ' A' ' 44' ' ' HIS . 2.8 tmm_? . . . . . 0 CA--C 1.546 0.81 0 C-N-CA 127.132 2.173 . . . . 0.0 114.561 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 85.1 mtp . . . . . 0 CA--C 1.538 0.514 0 N-CA-C 116.819 2.155 . . . . 0.0 116.819 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -72.5 -80.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.74 0 CA-C-N 123.035 2.12 . . . . 0.0 110.073 -173.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.27 113.99 7.97 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 96.3 mt -115.14 117.08 41.8 Favored Pre-proline 0 C--N 1.326 -0.435 0 C-N-CA 128.097 2.559 . . . . 0.0 105.32 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -73.61 157.85 48.11 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.537 1.491 . . . . 0.0 110.519 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.468 HG21 HD12 ' A' ' 154' ' ' LEU . 12.3 p -41.05 -42.58 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 126.225 1.81 . . . . 0.0 112.403 173.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -46.88 -42.45 17.47 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 127.338 2.255 . . . . 0.0 113.047 177.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.1 mm -75.64 112.97 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 177.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -79.95 -34.13 39.05 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 173.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.5 m -160.0 155.94 26.22 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.346 0.658 . . . . 0.0 111.135 -173.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 33.1 mtt -101.76 158.36 16.17 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 103.781 -2.674 . . . . 0.0 103.781 172.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -118.59 113.73 21.71 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 173.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.433 ' HA ' ' HA ' ' A' ' 16' ' ' ILE . 29.6 m-85 -101.49 157.3 16.91 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 173.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.2 m -137.07 135.48 37.53 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 177.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -143.75 166.24 25.42 Favored 'General case' 0 CA--C 1.511 -0.538 0 O-C-N 121.729 -0.607 . . . . 0.0 110.058 177.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -163.61 148.42 10.82 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.965 174.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.45 -173.84 3.52 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 122.916 1.341 . . . . 0.0 107.785 172.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -115.18 95.74 5.34 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 127.934 2.494 . . . . 0.0 110.13 -173.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 37.06 -56.6 0.0 OUTLIER Glycine 0 CA--C 1.543 1.835 1 C-N-CA 132.713 4.959 . . . . 0.0 120.795 -176.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -116.89 -16.88 10.54 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 121.643 2.722 . . . . 0.0 114.458 173.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.27 37.28 0.1 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 129.255 3.022 . . . . 0.0 115.673 -174.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -38.75 113.59 0.31 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 121.552 1.978 . . . . 0.0 110.367 -174.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -89.24 114.11 25.42 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -74.97 147.11 41.12 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 104.897 -2.261 . . . . 0.0 104.897 174.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -133.17 160.24 37.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 119.585 1.084 . . . . 0.0 110.078 176.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.475 ' O ' HD13 ' A' ' 131' ' ' ILE . 29.7 tt0 -152.38 135.07 15.39 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 173.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -82.92 103.7 12.58 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.062 0.945 . . . . 0.0 108.838 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.7 tt -67.04 -42.25 85.14 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.191 1.397 . . . . 0.0 108.19 174.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.3 m -135.06 139.71 44.98 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.488 1.115 . . . . 0.0 110.966 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.1 tt -170.36 92.96 0.21 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 173.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -161.72 156.3 22.75 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 118.721 0.691 . . . . 0.0 111.269 -174.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.4 t -72.0 163.78 27.26 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.1 mt -125.85 -17.02 5.5 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 116.734 -1.603 . . . . 0.0 112.379 174.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.527 ' CG ' ' H ' ' A' ' 87' ' ' LYS . 20.8 t0 -87.21 175.61 7.97 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 121.66 2.027 . . . . 0.0 112.248 177.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.527 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -115.27 -49.0 2.78 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 129.702 3.201 . . . . 0.0 112.841 177.304 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -78.88 -66.44 1.71 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 178.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.417 ' H ' HD12 ' A' ' 89' ' ' ILE . 3.5 mp -76.78 16.41 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 128.285 2.634 . . . . 0.0 109.81 -176.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 13.1 ttp -43.54 133.07 4.58 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 128.643 2.777 . . . . 0.0 109.838 -173.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -157.6 115.62 3.11 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 125.962 1.705 . . . . 0.0 107.908 -173.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -98.27 135.23 21.35 Favored Pre-proline 0 C--N 1.324 -0.522 0 O-C-N 123.973 0.795 . . . . 0.0 109.547 -174.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.46 154.71 55.58 Favored 'Trans proline' 0 N--CA 1.447 -1.26 0 C-N-CA 121.548 1.499 . . . . 0.0 109.25 173.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 17.9 p -140.4 157.8 44.97 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.556 1.543 . . . . 0.0 108.09 174.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.9 m -126.53 153.72 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 119.143 0.883 . . . . 0.0 113.011 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -74.94 7.11 3.42 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.498 2.319 . . . . 0.0 113.584 174.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.2 m -141.34 165.16 30.65 Favored Pre-proline 0 C--N 1.326 -0.443 0 C-N-CA 125.311 1.444 . . . . 0.0 108.632 -176.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -66.63 166.72 21.13 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 121.077 1.185 . . . . 0.0 110.398 173.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.97 -9.08 18.72 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.61 1.164 . . . . 0.0 112.03 176.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -145.63 164.35 32.01 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.446 1.498 . . . . 0.0 107.84 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 160.24 -161.25 32.38 Favored Glycine 0 C--O 1.227 -0.295 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 27.2 p -120.69 151.46 39.48 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 173.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.1 t -88.64 113.6 56.3 Favored Pre-proline 0 N--CA 1.447 -0.583 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 174.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.4 158.67 47.87 Favored 'Trans proline' 0 CA--C 1.512 -0.613 0 C-N-CA 122.245 1.963 . . . . 0.0 112.736 -174.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -64.39 -26.25 68.38 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 116.692 2.108 . . . . 0.0 116.692 -172.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . 0.566 1.0 OUTLIER -116.94 151.54 36.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 119.406 1.003 . . . . 0.0 113.102 173.134 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -38.61 110.96 0.15 Allowed 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 128.175 2.59 . . . . 0.0 113.292 -173.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.9 m -124.89 143.28 50.93 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 173.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.8 t -93.57 128.73 44.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 124.739 1.216 . . . . 0.0 112.022 -173.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 70.3 t -111.49 103.21 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 173.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -80.38 127.7 32.71 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 173.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.6 t -101.26 113.36 37.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 N-CA-C 103.549 -2.76 . . . . 0.0 103.549 173.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -92.45 148.68 19.24 Favored Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -129.54 73.75 81.34 Favored Pre-proline 0 C--O 1.243 0.762 0 CA-C-N 118.238 1.019 . . . . 0.0 110.66 -175.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.32 114.64 2.76 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.789 2.326 . . . . 0.0 109.553 173.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 8.0 t -91.15 145.29 24.8 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 173.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.3 mt -72.43 -16.39 61.83 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 117.793 0.269 . . . . 0.0 110.613 176.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 59.26 22.15 55.21 Favored Glycine 0 C--O 1.221 -0.679 0 C-N-CA 126.785 2.136 . . . . 0.0 115.456 173.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt -93.86 -46.75 7.05 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 120.2 2.0 . . . . 0.0 111.405 -174.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -96.52 151.3 19.71 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -93.69 151.59 19.54 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 174.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.79 -152.6 22.7 Favored Glycine 0 C--N 1.333 0.387 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 176.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.8 t -128.2 114.29 33.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -86.8 175.21 8.33 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.468 1.107 . . . . 0.0 108.907 173.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -128.32 156.49 42.97 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.776 1.63 . . . . 0.0 107.835 173.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.447 ' CE1' ' CD1' ' A' ' 149' ' ' PHE . 42.3 p90 -150.13 152.91 35.46 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.89 1.276 . . . . 0.0 107.904 173.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -116.28 145.9 42.81 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.736 1.615 . . . . 0.0 112.322 -173.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 92.8 t -141.63 138.28 32.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 173.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -154.3 130.21 10.18 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.854 1.661 . . . . 0.0 106.962 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.0 t -136.23 130.88 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 -174.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.629 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -98.35 163.65 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 173.699 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.405 HG11 HD12 ' A' ' 12' ' ' LEU . 7.1 t -141.91 134.06 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 -174.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.82 175.78 9.15 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 126.178 1.791 . . . . 0.0 107.067 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -93.17 176.01 6.56 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 103.76 -2.681 . . . . 0.0 103.76 172.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.4 t -65.37 -4.23 5.26 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 120.077 -1.639 . . . . 0.0 113.539 -178.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -85.54 -15.47 42.6 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 120.826 1.648 . . . . 0.0 110.374 173.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.4 0.1 65.39 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.837 1.208 . . . . 0.0 112.03 -173.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -70.8 115.63 10.17 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 119.494 1.647 . . . . 0.0 108.42 175.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -64.79 142.23 58.5 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.896 1.678 . . . . 0.0 108.253 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -140.28 -36.38 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 124.517 1.127 . . . . 0.0 113.559 -174.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -135.35 149.05 49.62 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.601 1.16 . . . . 0.0 107.929 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -142.63 138.89 31.02 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 85.8 m -65.97 131.3 94.52 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 174.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.8 143.61 41.85 Favored 'Trans proline' 0 N--CA 1.443 -1.486 0 N-CA-C 108.796 -1.271 . . . . 0.0 108.796 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -85.3 112.83 21.15 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -173.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.408 ' H ' ' H ' ' A' ' 147' ' ' ALA 0.297 0.9 OUTLIER 173.06 -10.44 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.725 1 C-N-CA 136.395 5.878 . . . . 0.0 110.457 174.015 . . . . . . . . 5 4 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.408 ' H ' ' H ' ' A' ' 146' ' ' ASN . . . -63.74 83.55 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.575 1.95 . . . . 0.0 112.069 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 3.9 mm -125.04 122.97 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 -178.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.447 ' CD1' ' CE1' ' A' ' 126' ' ' PHE . 1.0 OUTLIER -103.89 164.4 11.72 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 173.62 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -134.11 113.51 12.15 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -173.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 60.4 tttt -103.9 123.94 48.06 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.815 1.189 . . . . 0.0 109.453 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 25.0 m -83.55 114.57 21.6 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 174.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 5.5 m -116.96 166.63 11.96 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 124.487 1.115 . . . . 0.0 110.301 174.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.468 HD12 HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -137.2 159.44 41.91 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 126.61 1.964 . . . . 0.0 107.881 -177.762 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -69.99 117.6 11.76 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.272 1.429 . . . . 0.0 111.283 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -140.38 165.77 26.52 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.881 2.073 . . . . 0.0 108.495 174.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 . . . . . 0 C--O 1.25 1.099 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 173.67 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.6 m . . . . . 0 CA--C 1.537 0.455 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.0 tt -43.14 130.89 4.56 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.849 2.46 . . . . 0.0 112.99 -176.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -115.77 140.83 48.84 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.679 2.391 . . . . 0.0 108.235 173.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.22 118.03 6.65 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -136.63 176.11 9.0 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.759 0.79 . . . . 0.0 109.264 177.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 12.6 mt -114.47 113.53 44.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 1 N-CA-C 99.573 -4.232 . . . . 0.0 99.573 173.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -78.59 144.88 35.11 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 122.674 1.226 . . . . 0.0 110.999 -173.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.45 ' HB1' ' HG3' ' A' ' 28' ' ' GLU . . . -62.7 -26.49 68.69 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.193 -1.367 . . . . 0.0 112.898 -173.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -67.14 -38.99 86.47 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -174.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -57.54 11.09 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 117.649 -1.167 . . . . 0.0 108.49 173.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.14 -41.42 48.82 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 119.567 1.076 . . . . 0.0 111.751 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 173.629 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.45 ' HG3' ' HB1' ' A' ' 18' ' ' ALA . 31.3 tt0 . . . . . 0 CA--C 1.533 0.307 0 CA-C-O 119.548 -0.263 . . . . 0.0 110.549 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -153.19 139.24 18.24 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 128.313 2.645 . . . . 0.0 106.014 173.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -87.03 166.2 15.23 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 173.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.98 113.2 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 104.434 -2.432 . . . . 0.0 104.434 173.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.79 113.93 23.92 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -177.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.3 mt -93.09 -56.25 5.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -176.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.429 HG22 ' HG2' ' A' ' 39' ' ' MET . 6.3 t -126.27 133.72 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 125.904 1.682 . . . . 0.0 106.767 -174.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.9 p -140.13 126.84 20.48 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 102.164 -3.272 . . . . 0.0 102.164 173.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.269 6.2 pt-20 46.05 34.0 1.88 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.177 1.391 . . . . 0.0 113.514 -177.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 64.46 -3.53 1.81 Allowed Glycine 0 CA--C 1.544 1.865 0 O-C-N 120.273 -1.517 . . . . 0.0 114.173 -174.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.5 ttpt -79.72 37.12 0.34 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 131.055 3.742 . . . . 0.0 111.436 -173.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.429 ' HG2' HG22 ' A' ' 34' ' ' VAL . 38.0 mtt -37.82 122.88 1.02 Allowed 'General case' 0 C--O 1.24 0.585 0 C-N-CA 125.478 1.511 . . . . 0.0 112.825 -173.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.1 167.83 7.29 Favored Pre-proline 0 N--CA 1.449 -0.495 0 O-C-N 125.798 1.936 . . . . 0.0 108.052 173.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.57 29.26 0.24 Allowed 'Trans proline' 0 CA--C 1.548 1.19 0 C-N-CA 123.939 3.093 . . . . 0.0 112.365 174.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -53.86 -26.61 25.43 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 126.784 2.033 . . . . 0.0 113.022 -173.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 m -62.17 -29.88 70.66 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.243 1.417 . . . . 0.0 111.46 -173.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -55.3 -65.83 0.52 Allowed 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.098 1.359 . . . . 0.0 109.362 175.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.253 44.1 m-20 -76.44 -23.75 53.93 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.055 0.455 . . . . 0.0 111.571 -175.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -60.31 -44.64 95.24 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 120.099 -1.626 . . . . 0.0 108.331 173.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.4 0 O-C-N 121.639 -0.663 . . . . 0.0 109.277 176.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.393 0 CA-C-O 117.379 -1.295 . . . . 0.0 114.097 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -78.84 -64.41 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 CA-C-N 121.443 1.551 . . . . 0.0 110.646 -176.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.47 118.06 13.81 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.743 1.217 . . . . 0.0 110.842 -173.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.9 mt -126.14 116.25 23.76 Favored Pre-proline 0 N--CA 1.448 -0.543 0 C-N-CA 126.555 1.942 . . . . 0.0 106.612 -174.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -72.23 155.9 55.77 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.018 1.812 . . . . 0.0 110.353 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.9 p -40.32 -43.66 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 127.715 2.406 . . . . 0.0 112.854 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -59.89 -33.97 72.55 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 126.954 2.101 . . . . 0.0 114.076 -177.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.3 mm -68.47 112.93 3.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 104.098 -2.556 . . . . 0.0 104.098 175.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -81.86 -33.48 30.6 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.669 174.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.3 m -158.39 157.88 33.15 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.32 0.648 . . . . 0.0 109.301 -174.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 33.7 mtm -126.28 166.78 16.48 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 173.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -134.63 130.92 37.16 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -107.95 162.24 14.2 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 173.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.4 m -135.86 133.43 37.76 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -175.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -144.56 165.56 27.65 Favored 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 121.332 -0.855 . . . . 0.0 111.312 179.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.09 158.37 4.6 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 124.238 1.015 . . . . 0.0 110.898 174.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.27 177.42 6.05 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 173.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.15 101.79 12.93 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 120.212 -1.555 . . . . 0.0 108.996 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 44.36 -53.82 0.0 OUTLIER Glycine 0 CA--C 1.541 1.669 1 C-N-CA 132.814 5.007 . . . . 0.0 120.363 175.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -116.9 -19.83 9.67 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 121.628 2.714 . . . . 0.0 115.396 174.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.71 37.17 0.14 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 128.56 2.744 . . . . 0.0 116.082 -173.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.532 ' HG2' ' HE2' ' A' ' 105' ' ' HIS . 3.4 mm-40 -44.36 113.49 0.54 Allowed 'General case' 0 CA--C 1.557 1.224 0 CA-C-N 121.891 2.132 . . . . 0.0 109.147 -174.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -84.35 162.55 20.0 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.346 1.459 . . . . 0.0 111.595 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -111.77 149.53 31.57 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -135.52 161.82 34.41 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 120.226 1.375 . . . . 0.0 111.142 175.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.411 ' O ' HD13 ' A' ' 131' ' ' ILE . 31.1 tt0 -155.49 139.11 16.01 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 173.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -88.78 103.84 16.35 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.959 1.303 . . . . 0.0 109.71 -175.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.9 tt -72.34 -47.66 47.95 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.289 1.435 . . . . 0.0 108.981 175.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 38.1 m -131.61 138.2 48.71 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.493 1.517 . . . . 0.0 111.161 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.438 HD22 HG22 ' A' ' 128' ' ' VAL . 0.3 OUTLIER -168.83 92.69 0.29 Allowed 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 101.936 -3.357 . . . . 0.0 101.936 173.124 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -165.0 154.44 12.94 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 120.037 1.289 . . . . 0.0 112.486 -174.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.1 t -67.96 161.43 26.57 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 119.6 1.091 . . . . 0.0 110.243 173.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.9 mt -126.43 -2.61 6.83 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 125.772 1.629 . . . . 0.0 112.385 174.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.495 ' CG ' ' H ' ' A' ' 87' ' ' LYS 0.337 11.2 t70 -99.07 169.11 9.64 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.819 1.645 . . . . 0.0 112.169 -175.514 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.495 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 1.4 mppt? -109.2 -49.02 3.17 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 129.557 3.143 . . . . 0.0 111.631 -173.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -105.95 -47.66 1.07 Allowed Glycine 0 CA--C 1.524 0.636 0 C-N-CA 125.247 1.403 . . . . 0.0 112.095 -177.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.2 mp -80.73 14.97 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 125.571 1.548 . . . . 0.0 108.884 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 12.9 ttm -43.27 130.72 4.78 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 129.453 3.101 . . . . 0.0 109.199 -173.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -156.94 114.62 3.17 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 126.09 1.756 . . . . 0.0 106.62 -173.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.288 3.9 m-20 -96.36 129.14 34.21 Favored Pre-proline 0 CA--C 1.51 -0.58 0 O-C-N 124.493 1.121 . . . . 0.0 110.995 -174.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -75.64 149.68 34.5 Favored 'Trans proline' 0 N--CA 1.441 -1.561 0 C-N-CA 121.91 1.74 . . . . 0.0 109.685 175.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 20.8 p -131.88 155.44 47.86 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 125.109 1.364 . . . . 0.0 107.912 174.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.6 m -125.23 153.06 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 C-N-CA 124.193 0.997 . . . . 0.0 109.977 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -86.12 11.41 11.88 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.345 1.458 . . . . 0.0 113.367 -177.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.3 m -137.53 164.1 43.86 Favored Pre-proline 0 C--N 1.326 -0.432 0 C-N-CA 124.414 1.086 . . . . 0.0 109.798 -173.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -65.78 162.2 35.74 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.375 1.383 . . . . 0.0 109.803 173.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -65.69 -11.39 44.76 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 124.213 1.005 . . . . 0.0 112.251 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -143.02 164.37 30.28 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.138 1.375 . . . . 0.0 107.807 173.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.64 -160.67 34.13 Favored Glycine 0 C--O 1.226 -0.352 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.0 p -123.48 152.16 42.0 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.261 0.531 . . . . 0.0 109.958 176.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.5 t -94.93 113.09 60.5 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 102.736 -3.061 . . . . 0.0 102.736 173.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -97.17 161.53 1.0 Allowed 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.825 2.35 . . . . 0.0 112.514 -173.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.532 ' HE2' ' HG2' ' A' ' 74' ' ' GLU . 80.8 m-70 -66.72 -19.65 65.8 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 119.971 -1.706 . . . . 0.0 114.88 -174.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.05 114.08 24.32 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 -174.016 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -47.3 111.43 0.41 Allowed 'General case' 0 N--CA 1.463 0.219 0 O-C-N 124.438 1.086 . . . . 0.0 109.249 -175.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 66.3 m -116.84 143.97 45.05 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -174.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.4 t -105.79 139.0 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -173.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.5 t -121.9 103.7 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -73.73 147.0 43.97 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 173.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.4 t -130.96 113.91 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 104.443 -2.429 . . . . 0.0 104.443 177.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -100.61 146.61 17.65 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 125.249 1.404 . . . . 0.0 110.517 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -129.99 73.6 81.26 Favored Pre-proline 0 CA--C 1.546 0.813 0 CA-C-N 118.88 1.34 . . . . 0.0 111.704 -174.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -64.54 117.14 4.23 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.443 2.095 . . . . 0.0 109.056 173.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 8.5 t -94.01 144.29 25.6 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 173.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.6 mt -79.59 -10.87 59.87 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 122.966 0.506 . . . . 0.0 111.15 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 55.19 33.57 57.99 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 125.817 1.675 . . . . 0.0 114.22 173.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -93.74 -63.42 1.2 Allowed 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 118.471 1.136 . . . . 0.0 110.271 -177.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -96.05 154.66 17.12 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 174.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -93.51 152.28 19.16 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.46 1.504 . . . . 0.0 107.407 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.15 -152.07 22.12 Favored Glycine 0 C--N 1.331 0.305 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.8 t -127.47 113.86 33.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -84.35 173.34 11.01 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 173.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -133.85 159.78 39.62 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.533 1.133 . . . . 0.0 109.554 174.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -146.15 140.73 26.87 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 173.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -94.43 148.0 22.67 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 125.242 1.417 . . . . 0.0 111.25 -175.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.5 HG21 ' CE1' ' A' ' 149' ' ' PHE . 24.8 t -139.19 135.65 41.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 125.396 1.479 . . . . 0.0 108.997 173.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -155.8 120.46 4.68 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 173.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.411 ' H ' ' HB ' ' A' ' 143' ' ' THR . 43.8 t -130.44 123.83 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.618 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -88.76 166.58 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 173.81 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.6 t -146.1 134.59 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 -174.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.34 174.9 10.06 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.977 -175.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -86.83 175.96 7.94 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 172.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.3 t -65.65 -13.93 60.17 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 120.756 -1.215 . . . . 0.0 113.754 -173.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -94.78 -4.19 47.72 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.433 1.093 . . . . 0.0 111.423 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.86 9.44 57.35 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 118.958 -0.912 . . . . 0.0 113.703 176.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -74.28 116.49 15.01 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 119.786 1.793 . . . . 0.0 108.592 175.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.8 m -70.19 143.83 52.12 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 123.815 0.846 . . . . 0.0 109.186 -177.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.57 -36.0 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 124.523 1.129 . . . . 0.0 113.394 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -131.68 145.4 51.63 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -175.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -146.13 147.32 31.41 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.411 ' HB ' ' H ' ' A' ' 130' ' ' VAL . 58.5 m -78.48 113.49 34.84 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.26 144.28 85.87 Favored 'Trans proline' 0 N--CA 1.446 -1.31 0 CA-C-N 119.944 1.016 . . . . 0.0 110.796 -173.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -80.56 112.53 18.0 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 -173.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.444 14.0 m-80 172.55 -13.83 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 1 C-N-CA 138.555 6.742 . . . . 0.0 110.252 173.722 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.55 77.31 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.81 2.044 . . . . 0.0 109.861 173.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 37.0 mm -115.64 125.5 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.5 ' CE1' HG21 ' A' ' 128' ' ' VAL . 0.7 OUTLIER -93.97 154.75 17.5 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 173.946 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -131.05 113.51 14.04 Favored 'General case' 0 CA--C 1.521 -0.156 0 O-C-N 121.366 -0.834 . . . . 0.0 108.755 -173.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -106.71 122.23 45.93 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 118.838 0.745 . . . . 0.0 109.204 -177.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 27.7 m -83.37 117.09 22.79 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 105.68 -1.971 . . . . 0.0 105.68 174.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 6.7 m -118.14 166.41 12.61 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.488 0.715 . . . . 0.0 109.615 173.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.4 pp -131.62 160.44 35.36 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.362 1.465 . . . . 0.0 107.627 175.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -68.41 125.22 25.77 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.457 1.503 . . . . 0.0 109.701 176.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -146.7 127.9 14.75 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.851 1.26 . . . . 0.0 107.809 174.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 . . . . . 0 C--O 1.255 1.361 0 C-N-CA 127.505 2.322 . . . . 0.0 105.42 174.162 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.9 m . . . . . 0 C--O 1.222 -0.375 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tt -43.04 126.14 3.81 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 129.011 2.925 . . . . 0.0 112.934 -173.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.401 ' CD1' ' HA ' ' A' ' 35' ' ' SER . 98.1 m-85 -114.3 141.44 47.59 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 128.281 2.632 . . . . 0.0 108.17 174.039 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.86 120.76 8.17 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 18.0 p90 -135.94 168.76 18.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 119.159 0.89 . . . . 0.0 109.842 175.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.9 mt -99.78 114.36 37.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 102.073 -3.306 . . . . 0.0 102.073 173.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -79.32 136.08 36.91 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 123.903 1.811 . . . . 0.0 113.068 -173.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.62 -20.37 46.9 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 127.375 2.27 . . . . 0.0 116.213 -173.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -56.47 -40.83 75.54 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 118.886 0.766 . . . . 0.0 109.55 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 42.6 tp60 -65.38 -44.24 88.18 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.681 178.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.66 -32.03 73.38 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 118.854 -0.593 . . . . 0.0 112.235 176.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 173.149 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 . . . . . 0 CA--C 1.536 0.434 0 CA-C-O 118.621 -0.704 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -137.13 113.47 10.02 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.967 1.707 . . . . 0.0 109.251 -174.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -92.14 163.31 13.99 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.144 1.338 . . . . 0.0 107.492 173.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.3 mp -136.71 113.17 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 173.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.86 116.58 23.39 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -176.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 27.4 mt -95.05 -63.76 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.034 0.934 . . . . 0.0 109.335 -177.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.9 t -118.41 133.97 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -173.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.401 ' HA ' ' CD1' ' A' ' 13' ' ' TYR . 2.9 p -137.59 124.55 21.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 104.216 -2.513 . . . . 0.0 104.216 173.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 43.95 33.26 0.73 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.19 2.196 . . . . 0.0 114.091 -174.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.38 -6.87 5.32 Favored Glycine 0 CA--C 1.544 1.873 0 O-C-N 120.713 -1.242 . . . . 0.0 114.73 -174.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -79.19 37.29 0.31 Allowed 'General case' 0 CA--C 1.537 0.466 1 C-N-CA 131.706 4.002 . . . . 0.0 111.215 -178.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 42.6 mtm -38.22 134.73 0.8 Allowed 'General case' 0 C--O 1.233 0.195 0 C-N-CA 126.207 1.803 . . . . 0.0 114.362 -173.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.1 165.38 48.36 Favored Pre-proline 0 N--CA 1.45 -0.446 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 173.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.28 38.2 0.53 Allowed 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 123.911 3.074 . . . . 0.0 110.6 173.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -53.72 -26.7 24.35 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 127.25 2.22 . . . . 0.0 114.095 -173.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.5 m -60.27 -32.08 70.83 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.624 1.169 . . . . 0.0 111.621 -173.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -58.36 -64.13 1.03 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.252 1.021 . . . . 0.0 109.852 176.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -76.37 -29.35 57.14 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -174.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -57.1 -55.99 27.63 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.18 0.992 . . . . 0.0 108.584 173.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.287 0 CA-C-O 118.537 -0.744 . . . . 0.0 111.102 -174.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 69.2 mmm . . . . . 0 N--CA 1.468 0.467 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -69.35 -77.39 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.042 0 CA-C-N 120.837 1.335 . . . . 0.0 110.361 173.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.21 113.32 20.59 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.39 0.614 . . . . 0.0 111.055 -173.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.89 131.5 21.92 Favored Pre-proline 0 C--N 1.327 -0.373 0 C-N-CA 128.489 2.716 . . . . 0.0 106.228 -177.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -79.31 157.6 26.0 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.731 1.621 . . . . 0.0 110.743 177.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.4 p -41.95 -41.17 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 126.97 2.108 . . . . 0.0 112.088 173.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.51 -39.47 83.97 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 127.519 2.328 . . . . 0.0 112.825 -176.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 mm -74.28 112.85 11.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 101.548 -3.501 . . . . 0.0 101.548 173.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -78.14 -38.25 44.16 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.0 m -149.83 161.3 42.53 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.362 1.065 . . . . 0.0 109.585 -173.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 24.3 mtm -126.33 152.38 46.3 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 172.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -94.59 150.29 20.39 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -136.51 152.48 50.57 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 102.376 -3.194 . . . . 0.0 102.376 172.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.0 m -139.95 135.53 32.89 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -176.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -145.84 165.69 28.13 Favored 'General case' 0 C--O 1.24 0.566 0 O-C-N 121.916 -0.49 . . . . 0.0 110.635 177.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.83 157.55 3.06 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.927 0.87 . . . . 0.0 112.438 177.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.6 -174.02 4.17 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 173.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.87 111.83 18.9 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 126.047 1.739 . . . . 0.0 107.101 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 43.4 -57.9 0.0 OUTLIER Glycine 0 CA--C 1.537 1.418 1 C-N-CA 132.74 4.971 . . . . 0.0 119.372 173.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -116.57 -25.79 7.28 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.724 1.762 . . . . 0.0 113.548 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.73 37.1 0.08 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 130.993 3.717 . . . . 0.0 119.068 -173.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -54.37 113.96 1.47 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 123.234 2.743 . . . . 0.0 111.013 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -84.1 142.93 30.04 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 125.322 1.449 . . . . 0.0 107.348 173.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -90.35 149.27 22.37 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -131.95 161.0 34.16 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 120.302 1.41 . . . . 0.0 110.905 175.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.419 ' O ' HD13 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -154.11 134.95 13.73 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 173.276 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -87.28 103.13 15.16 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.098 0.559 . . . . 0.0 110.03 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.0 tt -73.38 -42.07 62.6 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.3 m -138.58 132.72 31.52 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.356 1.062 . . . . 0.0 111.486 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.545 HD22 HG22 ' A' ' 128' ' ' VAL . 0.1 OUTLIER -162.76 93.01 0.8 Allowed 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 101.309 -3.589 . . . . 0.0 101.309 173.2 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.433 ' HD3' ' H ' ' A' ' 82' ' ' LEU . 0.1 OUTLIER -161.4 155.55 22.51 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 119.75 1.159 . . . . 0.0 111.284 -173.753 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.0 t -82.85 153.79 24.97 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 173.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 70.8 mt -107.31 -9.27 16.1 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.253 1.421 . . . . 0.0 111.679 176.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -104.97 162.76 13.07 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 173.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.7 mmtm -138.16 -33.24 0.7 Allowed 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.412 1.885 . . . . 0.0 112.297 -177.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -62.1 -54.26 36.21 Favored Glycine 0 CA--C 1.545 1.912 0 N-CA-C 106.808 -2.517 . . . . 0.0 106.808 172.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.7 mt -90.45 25.28 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 129.281 3.032 . . . . 0.0 110.518 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 4.1 ttp -43.17 133.82 3.82 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 125.458 2.551 . . . . 0.0 112.712 -173.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -149.68 155.38 40.11 Favored 'General case' 0 N--CA 1.422 -1.842 2 C-N-CA 135.994 5.718 . . . . 0.0 101.302 173.785 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -144.86 114.22 5.03 Favored Pre-proline 0 C--N 1.316 -0.855 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 173.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -67.44 157.93 59.44 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 122.816 2.344 . . . . 0.0 113.652 -173.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.3 p -133.17 165.65 24.28 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.513 1.525 . . . . 0.0 109.773 176.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.4 m -126.34 155.58 36.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.174 0.989 . . . . 0.0 110.677 173.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -78.21 9.47 3.77 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.209 2.204 . . . . 0.0 113.485 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.5 m -139.3 163.71 43.82 Favored Pre-proline 0 C--N 1.327 -0.372 0 C-N-CA 124.443 1.097 . . . . 0.0 109.976 -176.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -65.41 162.07 35.31 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.705 1.603 . . . . 0.0 110.071 173.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -64.34 -10.59 25.35 Favored 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 124.634 1.174 . . . . 0.0 112.586 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -145.77 164.06 33.04 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 120.151 1.341 . . . . 0.0 107.857 173.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.37 -161.65 34.22 Favored Glycine 0 C--O 1.227 -0.335 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 77.8 p -117.25 150.94 37.94 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 173.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.2 t -87.16 113.23 52.72 Favored Pre-proline 0 N--CA 1.448 -0.547 0 N-CA-C 102.276 -3.231 . . . . 0.0 102.276 173.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -92.34 155.51 3.09 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.414 2.076 . . . . 0.0 111.98 -173.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.406 ' CD2' ' H ' ' A' ' 105' ' ' HIS . 18.0 m-70 -65.51 -16.88 64.11 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 120.164 -1.585 . . . . 0.0 112.179 -174.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.474 ' H ' ' HD2' ' A' ' 106' ' ' LYS . 3.8 mptt -85.88 113.77 22.27 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 -174.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.65 110.58 0.48 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 119.098 0.863 . . . . 0.0 109.37 -176.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 45.3 m -117.04 139.86 50.18 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -175.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.6 t -98.37 114.16 35.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 C-N-CA 124.402 1.081 . . . . 0.0 109.425 -173.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 85.1 t -93.98 103.41 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 N-CA-C 103.875 -2.639 . . . . 0.0 103.875 173.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -84.49 126.09 32.97 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 104.921 -2.251 . . . . 0.0 104.921 173.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.7 t -94.14 113.84 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 104.462 -2.422 . . . . 0.0 104.462 174.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -87.71 148.32 21.01 Favored Glycine 0 N--CA 1.44 -1.057 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 176.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.454 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 3.8 m-85 -132.19 73.45 77.67 Favored Pre-proline 0 C--O 1.242 0.68 0 C-N-CA 124.125 0.97 . . . . 0.0 108.924 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.98 121.76 8.16 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 121.652 1.568 . . . . 0.0 108.082 174.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 5.9 t -101.99 149.69 23.98 Favored 'General case' 0 C--N 1.34 0.191 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 173.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mt -79.42 -18.0 53.14 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 118.068 0.394 . . . . 0.0 110.697 176.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.54 17.52 53.74 Favored Glycine 0 C--O 1.215 -1.082 0 C-N-CA 127.632 2.539 . . . . 0.0 115.719 173.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 24.6 mttt -93.19 -29.38 15.75 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 121.576 2.688 . . . . 0.0 111.449 -173.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -96.66 154.88 17.03 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 172.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -102.24 144.58 30.59 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 174.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 151.21 -157.71 27.34 Favored Glycine 0 C--N 1.332 0.319 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 175.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 18.8 t -127.18 113.57 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 175.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -89.32 164.16 15.03 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 173.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -122.96 163.84 19.65 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 121.227 -0.92 . . . . 0.0 110.104 176.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.454 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 9.1 p90 -149.61 150.53 32.34 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 118.4 0.545 . . . . 0.0 109.65 173.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -111.53 150.58 29.77 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 127.638 2.375 . . . . 0.0 110.33 -174.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.545 HG22 HD22 ' A' ' 82' ' ' LEU . 85.6 t -138.83 137.47 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 125.698 1.599 . . . . 0.0 109.083 174.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -156.32 124.47 5.69 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 126.809 2.043 . . . . 0.0 106.357 173.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 42.7 t -135.01 128.39 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.628 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -95.22 164.57 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 174.383 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.1 t -143.27 135.26 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -173.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.52 175.46 9.58 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.866 1.266 . . . . 0.0 108.642 -174.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 37.9 p-10 -89.99 176.32 6.84 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 172.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.6 t -65.49 -4.81 6.4 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 120.28 -1.512 . . . . 0.0 113.949 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -88.63 -16.73 31.7 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 120.714 1.597 . . . . 0.0 110.696 173.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.57 1.16 60.54 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.555 1.074 . . . . 0.0 111.808 -173.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 60.6 m-20 -70.84 116.56 11.29 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 119.535 1.668 . . . . 0.0 108.384 174.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.5 m -68.03 143.87 55.35 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.842 1.657 . . . . 0.0 109.024 -174.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -140.99 -36.34 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.628 1.171 . . . . 0.0 113.999 -174.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -130.55 144.11 51.2 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 178.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -144.79 131.37 19.91 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 177.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 77.5 m -63.57 131.35 94.82 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 174.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -72.17 144.5 42.09 Favored 'Trans proline' 0 N--CA 1.444 -1.408 0 N-CA-C 108.401 -1.423 . . . . 0.0 108.401 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -82.76 112.52 19.68 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 -175.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.599 38.9 m-80 172.31 -13.19 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 1 C-N-CA 132.739 4.415 . . . . 0.0 114.295 173.28 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.86 96.6 0.09 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.056 1.342 . . . . 0.0 108.612 177.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.1 mt -133.58 148.8 30.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.416 ' CD1' ' CZ ' ' A' ' 126' ' ' PHE . 0.4 OUTLIER -130.87 170.08 14.89 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.274 1.429 . . . . 0.0 107.624 175.648 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -135.3 113.48 11.31 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.865 1.266 . . . . 0.0 108.023 -173.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -101.31 123.55 45.58 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 23.9 m -83.48 117.81 23.34 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 175.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 30.9 m -112.25 158.17 20.05 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 174.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.8 pp -146.24 159.59 43.12 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 176.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.44 121.25 2.89 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.73 2.412 . . . . 0.0 115.223 -173.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -139.74 164.14 30.73 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 130.131 3.372 . . . . 0.0 106.646 173.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 . . . . . 0 C--O 1.252 1.188 0 C-N-CA 127.515 2.326 . . . . 0.0 105.957 175.708 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.472 0.632 0 CA-C-O 119.085 -0.484 . . . . 0.0 109.978 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.2 tt -43.41 129.23 5.05 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 127.15 2.18 . . . . 0.0 112.236 -174.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.412 ' CD1' ' HA ' ' A' ' 35' ' ' SER . 74.5 m-85 -116.18 132.88 56.54 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.041 1.736 . . . . 0.0 109.062 174.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.07 120.56 11.02 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -178.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.5 p90 -134.25 175.32 9.61 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.71 0.804 . . . . 0.0 110.088 176.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.3 mt -111.81 116.17 51.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 102.213 -3.254 . . . . 0.0 102.213 174.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -83.18 148.56 27.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 123.501 1.619 . . . . 0.0 114.639 -173.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.81 -14.33 32.15 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 126.863 2.065 . . . . 0.0 114.666 -174.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -58.26 -35.1 71.25 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 119.185 0.902 . . . . 0.0 109.876 174.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 47.2 tp60 -67.37 -43.05 82.39 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 118.376 0.535 . . . . 0.0 111.104 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.71 -37.8 82.89 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.881 0.872 . . . . 0.0 111.044 173.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 . . . . . 0 N--CA 1.445 -0.72 0 O-C-N 121.002 -1.061 . . . . 0.0 108.198 173.762 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 . . . . . 0 CA--C 1.531 0.229 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -160.0 115.46 2.37 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.449 0.7 . . . . 0.0 110.598 -178.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -89.55 175.73 7.17 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.369 1.468 . . . . 0.0 109.633 173.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 21.6 mt -143.91 113.27 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 172.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.72 114.23 24.14 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -177.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.2 mt -91.3 -61.54 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 118.944 0.793 . . . . 0.0 109.198 -177.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.6 t -116.6 122.89 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 -173.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.412 ' HA ' ' CD1' ' A' ' 13' ' ' TYR . 2.9 p -126.11 119.36 27.36 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 102.966 -2.976 . . . . 0.0 102.966 173.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.32 17.6 pm0 45.91 42.16 8.8 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.914 1.686 . . . . 0.0 112.884 -176.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.99 -24.22 1.3 Allowed Glycine 0 CA--C 1.543 1.829 0 C-N-CA 125.965 1.745 . . . . 0.0 115.136 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . 0.437 7.0 tmtt? -53.94 37.32 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.686 1 C-N-CA 137.609 6.364 . . . . 0.0 117.085 174.373 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 42.6 mtt -38.17 130.03 1.24 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.11 167.63 32.52 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 173.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.48 34.17 0.34 Allowed 'Trans proline' 0 CA--C 1.55 1.313 0 C-N-CA 124.069 3.179 . . . . 0.0 111.728 173.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -54.7 -26.57 34.5 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 127.899 2.48 . . . . 0.0 114.4 -173.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 m -62.9 -32.38 73.64 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.5 1.12 . . . . 0.0 112.185 -172.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 61.3 t60 -59.96 -51.42 69.74 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.328 0.9 OUTLIER -76.09 -28.69 57.65 Favored 'General case' 0 C--O 1.224 -0.237 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.294 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -55.88 -46.53 78.29 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.066 -1.021 . . . . 0.0 108.274 173.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.9 ttt85 . . . . . 0 CA--C 1.54 0.586 0 CA-C-O 118.506 -0.759 . . . . 0.0 112.302 178.775 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.535 0 CA-C-O 116.497 -1.716 . . . . 0.0 114.564 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -75.83 -71.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.593 0 CA-C-N 122.586 1.959 . . . . 0.0 113.14 -173.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.01 113.62 14.91 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.622 0.769 . . . . 0.0 110.04 -173.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 94.3 mt -109.4 119.37 48.45 Favored Pre-proline 0 C--N 1.325 -0.498 0 C-N-CA 127.122 2.169 . . . . 0.0 105.903 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -74.33 155.91 46.15 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 121.782 1.655 . . . . 0.0 109.486 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.3 p -41.54 -41.77 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 126.66 1.984 . . . . 0.0 112.598 174.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -56.25 -42.4 77.32 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 126.896 2.078 . . . . 0.0 113.099 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.2 mm -74.53 112.86 12.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 101.642 -3.466 . . . . 0.0 101.642 173.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -76.55 -36.11 57.83 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . 0.253 4.2 m -148.99 161.83 41.12 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.195 1.398 . . . . 0.0 109.933 -173.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -117.7 145.65 44.27 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 172.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 44.9 m-20 -94.12 146.82 23.7 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 174.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -136.09 153.77 51.21 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 102.528 -3.138 . . . . 0.0 102.528 172.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.1 m -139.5 133.66 31.18 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -177.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -145.02 166.76 24.41 Favored 'General case' 0 C--O 1.238 0.496 0 O-C-N 122.056 -0.403 . . . . 0.0 111.158 177.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.24 158.22 13.94 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 124.866 1.266 . . . . 0.0 110.349 174.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -97.73 168.44 10.33 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 173.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.21 96.15 10.53 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 120.157 -1.589 . . . . 0.0 110.526 -174.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 48.74 -58.54 0.0 OUTLIER Glycine 0 CA--C 1.536 1.363 1 C-N-CA 131.783 4.516 . . . . 0.0 119.544 173.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -117.08 -15.66 10.52 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.446 2.123 . . . . 0.0 115.783 173.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.33 37.18 0.2 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 129.231 3.012 . . . . 0.0 115.998 -173.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -39.02 113.43 0.31 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 121.621 2.009 . . . . 0.0 110.031 -173.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -89.91 130.16 36.17 Favored 'General case' 0 CA--C 1.522 -0.106 0 C-N-CA 125.147 1.379 . . . . 0.0 107.62 175.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -84.6 150.95 24.84 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -137.76 160.87 38.05 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 119.913 1.233 . . . . 0.0 110.815 174.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.484 ' O ' HD13 ' A' ' 131' ' ' ILE . 28.5 tt0 -153.56 138.75 17.43 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 173.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.417 ' CD2' HD23 ' A' ' 82' ' ' LEU . 68.8 m-85 -86.12 103.45 14.79 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tt -70.81 -41.99 70.84 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.627 1.171 . . . . 0.0 108.123 174.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.2 m -138.61 135.7 35.21 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.634 1.174 . . . . 0.0 111.397 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.541 HD22 HG22 ' A' ' 128' ' ' VAL . 0.1 OUTLIER -164.97 93.13 0.61 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 102.169 -3.271 . . . . 0.0 102.169 173.194 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.412 ' HD3' ' H ' ' A' ' 82' ' ' LEU . 0.1 OUTLIER -161.43 154.14 20.52 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 120.821 -1.175 . . . . 0.0 110.76 -174.037 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.3 t -73.14 165.31 25.29 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.36 0.6 . . . . 0.0 109.628 173.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.5 mt -120.49 -21.87 6.65 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 116.505 -1.712 . . . . 0.0 110.764 173.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -99.35 164.89 11.93 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-O 123.935 1.826 . . . . 0.0 108.407 173.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.4 mmtm -136.71 -27.24 1.03 Allowed 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 129.255 3.022 . . . . 0.0 112.315 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.31 -63.85 3.86 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 106.67 -2.572 . . . . 0.0 106.67 172.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.417 HG22 ' O ' ' A' ' 89' ' ' ILE . 3.7 mp -81.87 26.7 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 128.934 2.894 . . . . 0.0 110.855 174.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 2.8 ttp -43.06 128.24 4.39 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 125.107 2.385 . . . . 0.0 112.734 -173.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.557 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -150.65 146.98 26.84 Favored 'General case' 0 N--CA 1.427 -1.606 1 C-N-CA 135.435 5.494 . . . . 0.0 101.263 174.091 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -136.73 117.0 10.87 Favored Pre-proline 0 C--N 1.318 -0.802 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 177.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -68.31 159.81 51.68 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.977 2.451 . . . . 0.0 113.932 -173.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 21.7 p -138.58 161.86 36.02 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.89 2.076 . . . . 0.0 109.031 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.5 m -126.37 154.73 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.195 0.998 . . . . 0.0 111.784 174.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -80.17 10.11 4.82 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 127.522 2.329 . . . . 0.0 113.468 177.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.9 m -140.49 163.18 45.12 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 124.54 1.136 . . . . 0.0 109.72 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -66.67 161.91 39.55 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 121.454 1.436 . . . . 0.0 109.567 173.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -64.58 -12.25 43.22 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 124.232 1.013 . . . . 0.0 112.644 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -145.16 165.1 29.29 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.974 1.31 . . . . 0.0 108.023 173.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 161.08 -161.12 32.68 Favored Glycine 0 C--O 1.227 -0.286 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 68.5 p -119.06 148.21 43.28 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 173.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.0 t -80.12 113.41 38.29 Favored Pre-proline 0 N--CA 1.447 -0.608 0 N-CA-C 102.15 -3.278 . . . . 0.0 102.15 173.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -84.33 165.64 12.61 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.585 1.523 . . . . 0.0 114.647 -173.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -77.43 3.68 12.75 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 120.687 -1.258 . . . . 0.0 114.341 -173.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.67 134.09 55.23 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 173.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.86 110.84 0.46 Allowed 'General case' 0 C--O 1.231 0.13 0 C-N-CA 124.785 1.234 . . . . 0.0 108.664 176.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.2 m -118.78 140.29 50.19 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.3 t -94.98 114.81 32.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 124.156 0.983 . . . . 0.0 109.941 -173.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 77.7 t -93.84 103.48 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 103.342 -2.836 . . . . 0.0 103.342 173.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -89.26 125.37 35.07 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 173.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.5 t -95.39 113.68 30.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 103.939 -2.615 . . . . 0.0 103.939 173.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -94.17 144.77 17.32 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.477 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 6.2 m-85 -129.22 73.89 81.39 Favored Pre-proline 0 C--O 1.243 0.724 0 CA-C-N 117.903 0.851 . . . . 0.0 110.495 -174.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.09 122.47 9.78 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 N-CA-C 107.928 -1.605 . . . . 0.0 107.928 173.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.557 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 5.9 t -105.75 153.13 22.3 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 124.703 1.201 . . . . 0.0 107.97 173.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.7 mt -81.42 -10.27 59.55 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.371 0.532 . . . . 0.0 112.011 -175.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 54.21 42.73 73.63 Favored Glycine 0 C--O 1.222 -0.643 0 C-N-CA 126.78 2.133 . . . . 0.0 114.759 173.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -126.89 -29.99 2.78 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.592 1.696 . . . . 0.0 113.307 173.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -96.31 153.55 17.75 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 104.764 -2.31 . . . . 0.0 104.764 172.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -108.73 143.44 37.85 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 177.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 141.83 -154.86 25.1 Favored Glycine 0 C--N 1.334 0.435 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.0 t -130.38 113.91 27.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 123.398 0.679 . . . . 0.0 109.36 -177.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -88.88 168.82 12.1 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 173.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -127.22 160.53 31.01 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.729 0.812 . . . . 0.0 109.827 173.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.477 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 12.7 p90 -146.93 152.31 38.46 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.792 0.837 . . . . 0.0 109.51 173.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -112.23 150.23 31.18 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 127.102 2.161 . . . . 0.0 112.144 -173.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.541 HG22 HD22 ' A' ' 82' ' ' LEU . 95.3 t -139.17 141.33 36.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 124.815 1.246 . . . . 0.0 109.619 173.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -155.78 119.25 4.38 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 127.654 2.382 . . . . 0.0 105.436 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.406 ' H ' ' HB ' ' A' ' 143' ' ' THR . 45.1 t -129.45 125.28 61.45 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 179.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.484 HD13 ' O ' ' A' ' 78' ' ' GLU . 0.1 OUTLIER -92.56 161.52 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 173.86 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.9 t -137.52 135.12 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 -177.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.81 174.44 10.57 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 124.821 1.249 . . . . 0.0 108.355 -176.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -89.97 176.18 6.9 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 172.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.3 t -66.04 -3.68 5.85 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 120.233 -1.542 . . . . 0.0 113.765 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -89.71 -14.61 34.34 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 120.625 1.557 . . . . 0.0 110.612 173.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.62 0.46 64.59 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.581 1.086 . . . . 0.0 112.107 -173.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -69.74 115.77 9.36 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.507 1.653 . . . . 0.0 108.302 174.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -68.9 143.69 54.41 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.684 1.594 . . . . 0.0 108.821 -175.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -140.02 -37.73 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.667 1.187 . . . . 0.0 113.761 -174.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -132.78 149.14 52.31 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 10.0 tm0? -147.85 148.69 31.14 Favored 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 120.99 -1.069 . . . . 0.0 108.649 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.406 ' HB ' ' H ' ' A' ' 130' ' ' VAL . 27.1 m -80.2 113.29 37.58 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 175.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.33 146.09 79.67 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 CA-C-N 120.071 1.061 . . . . 0.0 110.856 -173.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -78.61 112.63 15.88 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 -173.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.488 28.2 m-80 172.49 -21.07 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 1 C-N-CA 136.276 5.831 . . . . 0.0 111.376 173.543 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -56.66 91.85 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.346 2.258 . . . . 0.0 110.355 176.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.6 mt -136.4 149.79 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.415 ' CD1' ' CZ ' ' A' ' 126' ' ' PHE . 0.8 OUTLIER -128.22 169.48 14.11 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 174.195 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -133.9 113.76 12.56 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.177 1.391 . . . . 0.0 107.523 -173.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 51.6 tttt -101.05 122.4 43.49 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 120.097 1.317 . . . . 0.0 109.173 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.6 m -83.52 118.39 23.75 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 173.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 20.3 m -114.55 165.22 12.99 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 173.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.4 pp -141.14 161.67 37.3 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.525 1.13 . . . . 0.0 108.666 174.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -74.67 126.82 31.66 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 128.447 2.699 . . . . 0.0 111.307 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -139.77 168.45 19.79 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 126.517 1.927 . . . . 0.0 108.989 173.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 . . . . . 0 C--O 1.247 0.921 0 C-N-CA 131.035 3.734 . . . . 0.0 104.629 174.116 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.467 0.412 0 N-CA-C 110.822 -0.066 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.0 tt -43.52 128.6 5.11 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 127.816 2.446 . . . . 0.0 112.435 -174.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -115.28 133.83 55.68 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.739 1.615 . . . . 0.0 108.822 173.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.56 120.85 10.22 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.2 p90 -135.15 170.88 15.24 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 119.201 0.91 . . . . 0.0 109.32 175.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mt -106.39 113.79 43.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 101.798 -3.408 . . . . 0.0 101.798 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -76.28 148.29 37.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 123.299 1.523 . . . . 0.0 113.373 -173.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.37 -22.4 66.09 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 113.388 -1.733 . . . . 0.0 114.84 -173.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -57.62 -38.67 75.35 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 119.448 1.022 . . . . 0.0 109.859 -177.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -69.3 -44.93 70.77 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 122.36 -0.212 . . . . 0.0 111.156 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.08 -31.28 69.87 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 119.118 -0.468 . . . . 0.0 112.006 173.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 38.2 ttm-85 . . . . . 0 N--CA 1.442 -0.865 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 173.55 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.534 0.337 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -161.17 124.85 3.34 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.183 1.793 . . . . 0.0 109.787 175.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -92.7 174.38 7.29 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.777 1.631 . . . . 0.0 106.964 173.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.2 mt -140.77 113.49 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 172.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.66 117.53 20.66 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -177.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.46 HG23 ' CD1' ' A' ' 42' ' ' PHE . 21.6 mt -89.96 -66.32 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 119.178 0.899 . . . . 0.0 108.825 177.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -111.92 116.47 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.541 1.536 . . . . 0.0 107.447 -173.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.5 p -112.47 116.08 29.7 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 173.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.287 2.8 pm0 45.29 40.2 4.99 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.813 1.645 . . . . 0.0 112.813 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.44 -30.7 1.42 Allowed Glycine 0 CA--C 1.544 1.906 0 C-N-CA 125.652 1.596 . . . . 0.0 114.101 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . 0.434 7.3 tmtt? -61.94 38.02 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.768 1 C-N-CA 138.838 6.855 . . . . 0.0 112.708 173.761 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 33.0 mtm -37.51 139.23 0.29 Allowed 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 126.69 1.996 . . . . 0.0 115.527 -172.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.42 164.49 43.52 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 112.673 -2.058 . . . . 0.0 108.964 173.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.27 32.69 0.31 Allowed 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 124.039 3.16 . . . . 0.0 112.395 174.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.46 ' CD1' HG23 ' A' ' 33' ' ' ILE . 12.5 p90 -52.91 -26.15 14.01 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.816 2.047 . . . . 0.0 111.843 -174.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.6 m -57.65 -30.31 65.31 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.038 1.735 . . . . 0.0 109.974 -174.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -56.44 -62.83 1.45 Allowed 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.501 1.121 . . . . 0.0 108.968 173.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -68.31 -25.41 65.11 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.397 1.079 . . . . 0.0 111.989 -174.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -72.37 -49.12 36.37 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.036 0.534 . . . . 0.0 110.026 174.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.518 ' CZ ' ' HA ' ' A' ' 47' ' ' ARG . 0.2 OUTLIER . . . . . 0 CA--C 1.553 1.068 0 C-N-CA 124.811 1.244 . . . . 0.0 111.883 -174.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.401 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 63.7 mmm . . . . . 0 CA--C 1.536 0.412 0 CA-C-O 117.355 -1.307 . . . . 0.0 113.688 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 53' ' ' MET . 79.0 Cg_endo -78.12 -98.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.881 1.721 . . . . 0.0 110.118 -173.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.24 124.79 24.09 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.213 -0.93 . . . . 0.0 109.748 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.5 mt -130.94 138.03 32.08 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 128.81 2.844 . . . . 0.0 106.842 -174.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -81.34 157.43 19.63 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.702 2.268 . . . . 0.0 111.655 174.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.3 p -42.94 -41.47 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 127.257 2.223 . . . . 0.0 112.908 174.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -58.25 -34.36 70.38 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 126.65 1.98 . . . . 0.0 113.077 -175.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.7 mm -71.62 112.89 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 102.863 -3.014 . . . . 0.0 102.863 174.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -95.48 -23.42 17.12 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 -177.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.6 m -149.8 166.03 30.69 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 125.118 1.367 . . . . 0.0 107.548 173.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 13.9 mmm -123.13 163.29 20.86 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 173.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -117.96 150.5 39.15 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 173.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -139.52 153.5 47.48 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 102.101 -3.296 . . . . 0.0 102.101 172.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.3 m -138.63 132.91 31.69 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -176.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -145.1 161.56 39.17 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.184 177.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -165.89 145.14 6.18 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 123.937 0.895 . . . . 0.0 110.689 173.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.71 177.2 7.76 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 173.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.19 99.81 10.55 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 125.281 1.432 . . . . 0.0 110.136 -173.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 47.3 -56.27 0.0 OUTLIER Glycine 0 CA--C 1.536 1.386 1 C-N-CA 132.613 4.911 . . . . 0.0 119.396 174.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -117.01 -16.53 10.5 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.518 2.159 . . . . 0.0 115.706 173.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.31 37.11 0.38 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 128.56 2.744 . . . . 0.0 116.92 -173.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -46.36 113.87 0.71 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 122.01 2.187 . . . . 0.0 110.549 -177.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -83.83 145.95 28.38 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 125.341 1.456 . . . . 0.0 107.51 174.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -94.05 150.89 19.93 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -133.8 160.18 38.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 119.869 1.213 . . . . 0.0 111.165 175.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.469 ' O ' HD13 ' A' ' 131' ' ' ILE . 29.5 tt0 -154.13 138.4 16.62 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 173.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -86.43 103.68 15.21 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.896 1.279 . . . . 0.0 109.025 -177.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.9 tt -68.3 -41.78 80.44 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.792 1.237 . . . . 0.0 107.862 175.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.4 m -136.88 141.34 42.76 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.096 0.958 . . . . 0.0 111.847 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.4 tt -171.27 92.99 0.16 Allowed 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 128.755 2.822 . . . . 0.0 104.579 173.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -162.32 149.86 14.03 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 118.501 -0.761 . . . . 0.0 109.994 -174.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.432 ' HB2' ' HA ' ' A' ' 92' ' ' ASP . 5.8 t -91.98 134.12 35.09 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 119.593 1.088 . . . . 0.0 109.843 173.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 71.2 mt -82.26 -26.32 33.29 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 116.314 -1.803 . . . . 0.0 110.788 177.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.405 ' OD2' HD12 ' A' ' 89' ' ' ILE . 28.3 t0 -93.94 144.96 24.98 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 121.155 1.798 . . . . 0.0 109.485 174.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.46 ' HE3' ' SD ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -113.94 -24.53 9.03 Favored 'General case' 0 N--CA 1.443 -0.796 1 C-N-CA 133.653 4.781 . . . . 0.0 113.822 178.35 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -71.14 -69.93 1.3 Allowed Glycine 0 CA--C 1.533 1.211 0 N-CA-C 107.12 -2.392 . . . . 0.0 107.12 173.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.407 HG22 ' O ' ' A' ' 89' ' ' ILE . 3.3 mp -78.48 26.3 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 128.579 2.752 . . . . 0.0 110.994 175.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.46 ' SD ' ' HE3' ' A' ' 87' ' ' LYS . 6.7 ttp -43.16 125.18 3.57 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.79 2.436 . . . . 0.0 111.247 -173.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -161.35 113.48 1.83 Allowed 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 101.272 -3.603 . . . . 0.0 101.272 -175.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.432 ' HA ' ' HB2' ' A' ' 84' ' ' SER 0.313 1.6 m-20 -112.97 127.45 26.82 Favored Pre-proline 0 C--N 1.319 -0.721 0 O-C-N 124.372 1.045 . . . . 0.0 110.913 -173.372 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.09 154.02 71.05 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 121.733 1.622 . . . . 0.0 110.318 -174.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 18.4 p -139.16 162.93 33.75 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.453 1.501 . . . . 0.0 108.482 174.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.0 m -126.5 150.39 32.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 123.829 0.852 . . . . 0.0 110.696 173.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -86.03 17.85 3.33 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.501 1.52 . . . . 0.0 111.463 173.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.6 m -132.49 163.03 53.45 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 125.651 1.58 . . . . 0.0 107.011 173.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -67.33 162.41 38.84 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 120.754 0.969 . . . . 0.0 109.767 173.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -64.38 -12.89 47.35 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.361 1.065 . . . . 0.0 111.774 176.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -140.78 164.39 30.34 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.239 1.415 . . . . 0.0 107.89 173.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.17 -161.26 33.82 Favored Glycine 0 C--O 1.227 -0.332 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 75.4 p -119.0 155.1 31.98 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 173.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 24.5 t -90.43 113.27 56.96 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 103.414 -2.809 . . . . 0.0 103.414 173.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -88.95 171.76 4.66 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.541 2.16 . . . . 0.0 114.491 -173.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -81.98 3.04 28.03 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 -173.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.5 133.84 55.55 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 114.869 -2.491 . . . . 0.0 106.834 173.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -44.95 111.06 0.28 Allowed 'General case' 0 C--O 1.232 0.171 0 O-C-N 125.808 1.942 . . . . 0.0 107.757 173.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.3 m -116.72 137.41 52.21 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.4 t -93.87 120.88 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 O-C-N 124.692 1.245 . . . . 0.0 108.794 -173.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.3 t -93.91 103.72 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 N-CA-C 103.094 -2.928 . . . . 0.0 103.094 173.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -84.2 119.24 24.79 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 173.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.4 t -95.0 113.5 29.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 104.249 -2.5 . . . . 0.0 104.249 174.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -86.34 143.14 19.26 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.407 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 14.6 m-85 -128.34 73.5 80.07 Favored Pre-proline 0 C--O 1.245 0.844 0 CA-C-N 118.333 1.066 . . . . 0.0 110.814 -178.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.55 120.33 7.28 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.332 2.021 . . . . 0.0 109.282 173.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 12.8 t -98.95 148.66 23.75 Favored 'General case' 0 C--N 1.342 0.276 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 173.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.3 mt -76.77 -13.52 60.01 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 117.88 0.309 . . . . 0.0 111.043 178.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 51.31 40.56 45.79 Favored Glycine 0 C--O 1.22 -0.765 0 C-N-CA 127.868 2.651 . . . . 0.0 115.137 173.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . 0.262 42.1 mttm -123.09 -29.67 3.86 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.847 1.824 . . . . 0.0 112.71 173.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -96.46 149.41 21.76 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 172.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -102.12 149.45 24.26 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 176.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.4 -154.56 23.59 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.7 t -128.78 113.83 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.01 166.04 15.37 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 173.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -123.81 145.02 49.36 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.715 1.206 . . . . 0.0 108.538 174.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.407 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 37.5 p90 -140.66 142.78 34.92 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 119.321 0.964 . . . . 0.0 110.317 174.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -104.07 144.79 31.09 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 126.768 2.027 . . . . 0.0 111.36 -173.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.0 t -140.05 139.12 37.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 173.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -155.15 130.6 9.75 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.906 1.682 . . . . 0.0 106.987 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.4 t -135.94 129.5 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -175.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.609 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -97.9 165.75 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 173.737 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.7 t -143.31 134.7 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 -174.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.01 174.35 10.66 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.876 1.27 . . . . 0.0 108.286 -175.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -89.95 176.13 6.92 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 104.667 -2.346 . . . . 0.0 104.667 172.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.1 t -66.2 -4.02 6.84 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 120.356 -1.465 . . . . 0.0 113.685 -177.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -89.34 -14.88 34.66 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 120.572 1.533 . . . . 0.0 110.657 173.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.04 0.42 63.67 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.591 1.091 . . . . 0.0 112.039 -173.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -69.57 115.51 8.9 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 119.494 1.647 . . . . 0.0 108.357 174.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -69.09 143.51 54.18 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.786 1.634 . . . . 0.0 108.81 -175.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -140.61 -37.29 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.62 1.168 . . . . 0.0 113.598 -174.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -130.5 145.43 51.85 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -143.98 136.06 26.49 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 91.7 m -66.87 128.03 93.71 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 174.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.41 143.4 43.02 Favored 'Trans proline' 0 N--CA 1.444 -1.436 0 CA-C-N 120.606 1.252 . . . . 0.0 109.122 -177.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -81.75 112.97 19.39 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 -174.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 173.17 -19.59 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.572 1 C-N-CA 135.116 5.366 . . . . 0.0 110.942 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.39 83.95 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.837 1.655 . . . . 0.0 111.4 -175.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.4 mt -125.21 135.57 63.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 175.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.401 ' HB2' ' CZ ' ' A' ' 126' ' ' PHE . 6.3 m-85 -106.32 161.94 14.11 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 125.911 1.684 . . . . 0.0 106.722 177.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -136.41 113.3 10.35 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 55.0 tttt -99.3 122.43 42.44 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 21.4 m -83.61 115.13 21.99 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 105.299 -2.112 . . . . 0.0 105.299 173.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 36.9 m -111.21 165.92 11.52 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 119.196 0.907 . . . . 0.0 109.192 173.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.5 pp -141.35 160.14 40.75 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.178 1.391 . . . . 0.0 107.694 173.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.99 131.11 43.87 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.795 1.238 . . . . 0.0 111.669 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -144.33 169.92 16.99 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 128.008 2.523 . . . . 0.0 107.693 173.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 . . . . . 0 C--O 1.255 1.385 0 C-N-CA 128.925 2.89 . . . . 0.0 106.057 173.857 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.6 m . . . . . 0 CA--C 1.538 0.488 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.9 tt -43.32 129.85 4.89 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 129.335 3.054 . . . . 0.0 113.285 -175.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -115.1 139.6 49.75 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.18 2.192 . . . . 0.0 108.441 173.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.25 117.97 6.19 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 126.05 1.74 . . . . 0.0 106.693 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 13.7 p90 -131.02 176.06 8.57 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.296 1.039 . . . . 0.0 110.083 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.5 mt -113.06 113.91 45.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 102.418 -3.179 . . . . 0.0 102.418 174.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -76.89 139.21 40.15 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 123.069 1.414 . . . . 0.0 111.967 -173.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.19 -25.54 61.7 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.276 1.83 . . . . 0.0 114.367 -173.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 13.6 m80 -56.53 -37.3 70.29 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 118.978 0.808 . . . . 0.0 110.018 -174.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 49.1 tp60 -66.83 -41.31 87.66 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 121.992 -0.443 . . . . 0.0 111.067 178.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.4 -35.4 80.77 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 121.683 -0.636 . . . . 0.0 110.904 173.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.512 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 173.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 . . . . . 0 CA--C 1.537 0.462 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -165.85 136.49 3.62 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 130.681 3.592 . . . . 0.0 107.507 174.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -86.45 176.21 7.98 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.093 1.757 . . . . 0.0 107.823 173.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.0 mp -137.54 113.1 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 173.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.52 115.23 26.79 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -176.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.5 mt -94.66 -53.94 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 118.635 0.652 . . . . 0.0 110.065 -176.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.464 HG22 ' HG2' ' A' ' 39' ' ' MET . 6.2 t -126.15 129.99 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 125.68 1.592 . . . . 0.0 107.703 -173.436 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.0 p -138.4 132.94 32.22 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 103.165 -2.902 . . . . 0.0 103.165 173.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.31 18.0 pm0 44.33 33.73 0.91 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.151 1.38 . . . . 0.0 113.796 -174.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.54 -4.17 14.87 Favored Glycine 0 CA--C 1.543 1.813 0 O-C-N 120.652 -1.28 . . . . 0.0 115.135 -176.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.469 ' HZ3' ' HB3' ' A' ' 38' ' ' LYS . 4.3 ttpm? -66.4 37.41 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.596 1 C-N-CA 132.467 4.307 . . . . 0.0 114.222 -176.74 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.464 ' HG2' HG22 ' A' ' 34' ' ' VAL . 31.4 mtt -38.07 114.33 0.35 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 120.183 1.356 . . . . 0.0 113.742 -173.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.56 164.79 29.19 Favored Pre-proline 0 N--CA 1.447 -0.599 0 CA-C-N 113.777 -1.556 . . . . 0.0 107.977 173.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.84 40.9 0.59 Allowed 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 124.215 3.276 . . . . 0.0 111.002 173.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -52.27 -26.26 11.46 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 127.913 2.485 . . . . 0.0 112.603 -173.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.9 m -44.01 -43.72 6.87 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.152 1.781 . . . . 0.0 111.619 177.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -60.81 -66.05 0.59 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.427 0.691 . . . . 0.0 110.191 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -73.98 -23.01 59.4 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.155 1.782 . . . . 0.0 114.062 -173.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -77.89 -56.81 4.19 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 124.669 1.187 . . . . 0.0 110.229 173.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 18.5 ttp180 . . . . . 0 C--N 1.345 0.386 0 O-C-N 121.657 -0.652 . . . . 0.0 109.873 -173.461 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 61.1 mmm . . . . . 0 N--CA 1.468 0.467 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.24 -74.21 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.195 1.93 . . . . 0.0 111.82 -173.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.73 113.42 14.36 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -174.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 62.9 mt -113.16 126.75 27.74 Favored Pre-proline 0 C--N 1.324 -0.536 0 C-N-CA 127.734 2.413 . . . . 0.0 105.803 -174.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -78.46 157.29 28.94 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 121.691 1.594 . . . . 0.0 110.356 176.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.4 p -45.7 -38.74 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 125.849 1.66 . . . . 0.0 111.975 173.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -55.91 -40.08 72.56 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 126.677 1.991 . . . . 0.0 112.832 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mm -77.11 112.73 15.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 101.914 -3.365 . . . . 0.0 101.914 173.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -79.92 -40.67 27.7 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 174.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.8 m -141.51 161.75 37.16 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.609 1.164 . . . . 0.0 110.053 -173.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 52.8 mtp -123.68 167.47 13.94 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.426 1.49 . . . . 0.0 107.092 173.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -114.03 155.85 25.17 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 174.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -140.75 151.54 44.54 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 130.489 3.516 . . . . 0.0 102.268 172.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.3 m -137.97 133.85 34.19 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -145.42 162.38 37.44 Favored 'General case' 0 C--O 1.238 0.473 0 O-C-N 121.857 -0.527 . . . . 0.0 111.198 178.225 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -167.36 153.36 7.78 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.969 0.89 . . . . 0.0 112.484 173.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.3 -173.65 4.83 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.333 1.453 . . . . 0.0 109.174 173.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.85 100.11 7.04 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.789 1.635 . . . . 0.0 108.324 -174.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.07 -63.29 0.0 OUTLIER Glycine 0 CA--C 1.538 1.522 0 C-N-CA 130.184 3.754 . . . . 0.0 119.016 173.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -116.88 -13.78 10.69 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 120.583 2.191 . . . . 0.0 114.113 173.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.59 37.1 0.17 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 129.136 2.975 . . . . 0.0 118.021 -173.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -53.58 113.68 1.26 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 122.873 2.579 . . . . 0.0 109.672 -177.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -84.06 129.95 34.89 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 126.187 1.795 . . . . 0.0 107.935 174.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -79.85 147.67 31.65 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -132.56 161.26 34.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 120.127 1.33 . . . . 0.0 111.182 176.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.503 ' O ' HD13 ' A' ' 131' ' ' ILE . 31.7 tt0 -152.71 137.24 16.8 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 173.094 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -81.68 104.08 11.83 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.635 1.174 . . . . 0.0 109.91 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.7 tt -67.36 -41.72 84.65 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.43 1.092 . . . . 0.0 108.114 174.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.8 m -133.87 141.29 47.33 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.881 0.872 . . . . 0.0 111.202 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.3 tt -171.95 93.07 0.14 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 104.15 -2.537 . . . . 0.0 104.15 173.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -162.18 156.73 22.17 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.024 0.829 . . . . 0.0 111.416 -173.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.6 t -75.99 161.95 28.48 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 173.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.6 mt -122.1 -26.33 4.75 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 116.99 -1.481 . . . . 0.0 112.045 174.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.422 ' CG ' ' H ' ' A' ' 87' ' ' LYS . 23.2 t0 -83.3 168.11 16.98 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 121.34 1.882 . . . . 0.0 111.604 177.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.422 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -111.3 -49.32 3.02 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 128.533 2.733 . . . . 0.0 112.501 179.099 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.84 -70.19 1.16 Allowed Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 174.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mp -79.75 18.63 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 128.786 2.834 . . . . 0.0 110.048 -174.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -43.93 134.11 4.68 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 127.061 2.144 . . . . 0.0 110.239 -175.086 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -157.51 113.76 2.89 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 126.118 1.767 . . . . 0.0 106.916 -173.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -97.34 132.43 25.46 Favored Pre-proline 0 C--N 1.324 -0.541 0 O-C-N 124.142 0.901 . . . . 0.0 109.876 -173.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.01 153.81 67.42 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 C-N-CA 121.409 1.406 . . . . 0.0 109.347 174.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 21.1 p -140.11 157.09 46.17 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 126.682 1.993 . . . . 0.0 107.439 174.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.9 m -126.33 153.66 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 119.648 1.113 . . . . 0.0 113.145 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -73.83 7.94 2.26 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 127.567 2.347 . . . . 0.0 113.647 174.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.6 m -140.75 164.89 33.44 Favored Pre-proline 0 C--N 1.326 -0.452 0 C-N-CA 125.648 1.579 . . . . 0.0 108.286 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -67.18 167.61 19.71 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 121.347 1.365 . . . . 0.0 110.937 174.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -63.22 -11.37 20.63 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.786 1.235 . . . . 0.0 112.119 175.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -145.07 164.3 31.64 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.22 1.408 . . . . 0.0 107.884 173.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.33 -161.74 34.28 Favored Glycine 0 C--O 1.227 -0.342 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 71.4 p -117.86 151.19 37.86 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.5 t -88.69 113.37 55.44 Favored Pre-proline 0 N--CA 1.448 -0.542 0 N-CA-C 102.84 -3.022 . . . . 0.0 102.84 173.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -90.09 160.02 4.83 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.803 2.336 . . . . 0.0 111.424 -173.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -74.18 4.44 5.65 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 119.753 -1.842 . . . . 0.0 113.3 -173.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -115.54 116.85 28.87 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 126.259 1.824 . . . . 0.0 106.736 -173.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -43.06 105.37 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 125.039 1.336 . . . . 0.0 109.755 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.3 m -112.02 136.0 51.94 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.0 t -95.68 116.09 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.05 -173.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 82.5 t -93.76 103.27 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 N-CA-C 103.476 -2.787 . . . . 0.0 103.476 173.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.58 120.11 25.11 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 103.324 -2.843 . . . . 0.0 103.324 173.287 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.4 t -94.7 113.64 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 104.23 -2.507 . . . . 0.0 104.23 173.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -92.36 149.42 19.62 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 175.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.458 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 9.8 m-85 -131.13 73.64 80.42 Favored Pre-proline 0 C--O 1.242 0.7 0 CA-C-N 118.544 1.172 . . . . 0.0 110.422 -176.065 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -62.94 116.14 3.38 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.479 2.119 . . . . 0.0 109.309 173.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 9.2 t -93.67 147.67 22.81 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 173.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.4 mt -74.16 -13.48 60.81 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.134 0.425 . . . . 0.0 111.822 -176.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.8 34.3 89.57 Favored Glycine 0 C--N 1.34 0.804 0 C-N-CA 125.757 1.646 . . . . 0.0 114.352 173.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.7 mttm -114.9 -50.64 2.76 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.349 1.575 . . . . 0.0 112.442 -173.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 48.6 tp60 -96.06 147.49 23.66 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 173.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -93.93 142.12 27.74 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 175.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.72 -154.83 26.09 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-N 118.781 0.719 . . . . 0.0 111.649 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.6 t -129.96 116.73 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 123.846 0.858 . . . . 0.0 108.789 -179.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -92.42 175.3 6.89 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.15 1.38 . . . . 0.0 109.297 173.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -128.6 155.03 45.59 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.767 1.627 . . . . 0.0 107.386 173.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.458 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 40.3 p90 -147.05 157.84 43.74 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.576 1.15 . . . . 0.0 108.035 173.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -123.36 150.52 43.57 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.542 1.537 . . . . 0.0 111.909 -173.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 62.5 t -141.45 143.2 27.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 173.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -160.81 136.13 7.85 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.023 1.329 . . . . 0.0 107.687 174.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.7 t -136.79 139.26 45.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-N 119.51 1.05 . . . . 0.0 109.265 -173.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.542 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -106.9 163.64 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 173.743 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.6 t -141.74 137.81 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -173.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.31 174.12 10.89 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.542 1.537 . . . . 0.0 108.416 -176.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -88.84 175.8 7.32 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 172.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 6.1 t -65.1 -14.86 61.55 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 120.212 -1.555 . . . . 0.0 112.112 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -80.12 -3.3 48.25 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.73 1.612 . . . . 0.0 110.65 176.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.22 5.66 89.9 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 125.123 1.345 . . . . 0.0 112.996 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -80.92 118.19 22.2 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.5 m -64.71 143.07 58.19 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.434 1.493 . . . . 0.0 108.748 -178.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -140.07 -37.26 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.774 1.23 . . . . 0.0 113.626 -175.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -130.56 141.08 50.47 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -146.6 126.35 13.46 Favored 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 121.422 -0.799 . . . . 0.0 109.081 -176.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 30.3 m -67.52 142.68 96.47 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 173.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -83.59 147.55 12.4 Favored 'Trans proline' 0 N--CA 1.443 -1.477 0 N-CA-C 108.731 -1.296 . . . . 0.0 108.731 174.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -75.46 112.63 11.99 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 103.505 -2.776 . . . . 0.0 103.505 -178.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 173.73 -23.81 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 128.17 2.588 . . . . 0.0 112.17 -173.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.89 87.34 0.14 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 122.208 1.004 . . . . 0.0 108.428 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.9 mt -127.84 147.91 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -174.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 126' ' ' PHE . 0.5 OUTLIER -134.28 167.89 19.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 113.971 -1.468 . . . . 0.0 107.298 -176.783 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -135.33 113.5 11.3 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.175 0.99 . . . . 0.0 109.456 -173.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -104.22 122.43 45.36 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 119.435 1.016 . . . . 0.0 109.431 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 25.6 m -83.68 115.44 22.17 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 174.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 5.0 m -116.78 166.3 12.3 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.496 0.665 . . . . 0.0 110.163 174.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.3 pp -134.12 162.45 32.07 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.109 1.364 . . . . 0.0 107.539 173.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -73.57 114.72 12.13 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 127.738 2.415 . . . . 0.0 109.463 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -163.5 118.54 1.64 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.335 1.454 . . . . 0.0 109.79 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 . . . . . 0 C--O 1.256 1.416 0 C-N-CA 128.667 2.787 . . . . 0.0 105.914 173.743 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 m . . . . . 0 CA--C 1.545 0.755 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.52 HD23 ' N ' ' A' ' 13' ' ' TYR . 5.5 tt -46.57 136.8 7.32 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.165 1.786 . . . . 0.0 112.788 -174.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.52 ' N ' HD23 ' A' ' 12' ' ' LEU . 54.6 m-85 -122.07 137.03 54.96 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.317 1.447 . . . . 0.0 110.249 175.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.79 119.12 6.38 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.57 1.548 . . . . 0.0 107.803 -178.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.462 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 30.9 p90 -142.84 148.08 36.47 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.641 1.109 . . . . 0.0 109.541 -178.332 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.0 mp -84.12 118.53 31.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 102.893 -3.003 . . . . 0.0 102.893 173.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.03 143.81 29.51 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 123.691 1.71 . . . . 0.0 114.313 -173.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.459 ' HB1' ' HG3' ' A' ' 28' ' ' GLU . . . -72.75 -26.11 61.44 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 112.774 -2.012 . . . . 0.0 113.636 -173.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.9 m80 -62.63 -38.25 89.52 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 122.926 0.49 . . . . 0.0 110.519 -173.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -71.54 -49.3 42.14 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.149 174.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.61 -43.06 56.74 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-O 118.404 -0.807 . . . . 0.0 111.218 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.0 ttp-105 . . . . . 0 C--O 1.225 -0.217 0 CA-C-N 119.797 1.181 . . . . 0.0 108.452 173.526 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.459 ' HG3' ' HB1' ' A' ' 18' ' ' ALA . 36.5 tt0 . . . . . 0 CA--C 1.535 0.368 0 CA-C-O 119.904 -0.093 . . . . 0.0 111.039 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -150.7 144.98 25.52 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.437 2.695 . . . . 0.0 106.383 173.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -96.03 164.83 12.54 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 173.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.2 mp -135.27 113.38 15.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 103.858 -2.645 . . . . 0.0 103.858 173.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.462 ' HG ' ' HB3' ' A' ' 15' ' ' TRP . 4.4 tt -94.62 114.07 25.97 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -173.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.6 mt -83.86 -61.75 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 124.349 1.06 . . . . 0.0 108.281 -174.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.455 HG11 HD22 ' A' ' 12' ' ' LEU . 25.1 t -117.1 113.66 43.46 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -173.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.4 p -111.92 125.93 54.58 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 102.616 -3.105 . . . . 0.0 102.616 173.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 46.08 38.2 4.56 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.148 1.379 . . . . 0.0 112.508 174.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 54.98 19.84 16.96 Favored Glycine 0 CA--C 1.539 1.58 0 C-N-CA 124.992 1.282 . . . . 0.0 113.824 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -122.97 37.97 4.29 Favored 'General case' 0 CA--C 1.536 0.434 1 C-N-CA 131.861 4.064 . . . . 0.0 108.051 -172.978 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.42 ' HG2' HG22 ' A' ' 34' ' ' VAL 0.272 20.2 mtp -37.29 146.71 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 130.762 3.625 . . . . 0.0 115.696 -172.508 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.72 162.07 75.12 Favored Pre-proline 0 N--CA 1.452 -0.368 0 CA-C-N 113.141 -1.845 . . . . 0.0 109.314 173.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.09 42.36 0.98 Allowed 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 124.552 3.501 . . . . 0.0 111.609 174.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -53.86 -26.58 25.32 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.647 1.979 . . . . 0.0 113.197 -174.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.5 m -58.25 -29.35 65.69 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 126.501 1.92 . . . . 0.0 111.434 -173.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 62.8 t60 -62.86 -66.48 0.54 Allowed 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 118.64 0.655 . . . . 0.0 109.346 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.63 -23.82 65.4 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -175.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -67.96 -47.62 68.14 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.68 1.192 . . . . 0.0 111.223 174.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.517 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -173.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 88.2 mtp . . . . . 0 CA--C 1.539 0.532 0 CA-C-O 115.587 -2.149 . . . . 0.0 115.661 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -51.34 -68.45 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.949 0 CA-C-N 123.08 2.136 . . . . 0.0 114.641 -173.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.27 113.9 22.65 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 177.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.9 mt -103.85 118.84 56.27 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 127.008 2.123 . . . . 0.0 105.761 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -74.48 153.95 44.88 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 121.355 1.37 . . . . 0.0 110.164 176.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.3 p -39.93 -44.28 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 127.483 2.313 . . . . 0.0 113.321 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -58.71 -34.43 71.3 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 126.706 2.002 . . . . 0.0 113.567 -176.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.0 mm -71.36 113.08 7.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 104.362 -2.458 . . . . 0.0 104.362 175.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -79.85 -39.34 30.86 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 173.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.2 m -153.06 162.29 41.49 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -173.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 54.5 mtm -126.69 162.4 25.87 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 172.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 39.1 m-20 -120.47 114.09 21.28 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 118.509 0.595 . . . . 0.0 109.725 -175.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -94.32 150.69 20.05 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 102.3 -3.222 . . . . 0.0 102.3 172.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.9 m -139.5 135.68 33.75 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 -175.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -148.96 165.81 30.48 Favored 'General case' 0 CA--C 1.509 -0.611 0 O-C-N 121.572 -0.705 . . . . 0.0 110.525 -178.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -165.37 149.7 8.66 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.587 173.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.02 177.52 4.29 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 172.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.551 ' O ' ' HD2' ' A' ' 105' ' ' HIS . . . -88.91 143.57 26.78 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 100.998 -3.705 . . . . 0.0 100.998 173.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -1.25 -73.99 0.0 OUTLIER Glycine 0 C--N 1.302 -1.324 1 C-N-CA 133.88 5.514 . . . . 0.0 117.721 -173.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . 0.273 21.4 mm100 -117.35 23.95 11.46 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 173.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -108.99 37.47 2.55 Favored 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 130.859 3.664 . . . . 0.0 120.693 -173.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -39.61 116.2 0.6 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 122.34 2.337 . . . . 0.0 113.785 -173.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -84.4 132.68 34.56 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 174.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -83.82 149.08 26.63 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 175.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -134.05 159.76 39.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 119.473 1.033 . . . . 0.0 111.133 175.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.5 ' O ' HD13 ' A' ' 131' ' ' ILE . 30.6 tt0 -152.83 137.93 17.33 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 173.03 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -85.86 104.02 15.14 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.592 1.157 . . . . 0.0 110.041 -176.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.2 tt -61.34 -43.88 98.12 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.69 1.596 . . . . 0.0 108.687 173.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.6 m -134.25 143.73 47.97 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.558 1.143 . . . . 0.0 111.723 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.2 tt -172.36 92.79 0.12 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 103.477 -2.786 . . . . 0.0 103.477 173.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -168.89 152.79 5.45 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 118.833 0.742 . . . . 0.0 111.025 -174.006 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.7 t -79.43 127.75 32.5 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.0 mt -87.01 -26.57 23.69 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 116.67 -1.633 . . . . 0.0 110.857 174.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -86.79 152.42 22.51 Favored 'General case' 0 C--N 1.348 0.508 0 CA-C-N 120.9 1.682 . . . . 0.0 109.377 173.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.26 -36.54 6.25 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 128.892 2.877 . . . . 0.0 112.678 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -68.71 -75.95 0.48 Allowed Glycine 0 CA--C 1.53 1.025 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 173.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.1 mp -74.21 20.03 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 129.951 3.3 . . . . 0.0 110.441 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 14.0 ttp -43.42 130.81 5.01 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 127.402 2.281 . . . . 0.0 111.255 -173.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -153.65 113.37 3.85 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 -175.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -99.58 132.81 22.5 Favored Pre-proline 0 C--N 1.322 -0.615 0 O-C-N 124.286 0.991 . . . . 0.0 109.239 -173.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.9 153.67 72.28 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 C-N-CA 121.084 1.19 . . . . 0.0 109.338 174.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 17.1 p -137.57 152.57 49.56 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 126.244 1.817 . . . . 0.0 106.436 173.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.8 m -126.37 153.98 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 CA-C-N 118.966 0.803 . . . . 0.0 112.268 177.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -75.94 8.46 3.12 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.38 1.872 . . . . 0.0 113.822 174.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.67 165.1 32.13 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 124.777 1.231 . . . . 0.0 109.481 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -66.87 166.01 24.03 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.536 1.49 . . . . 0.0 110.478 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -66.97 -10.32 48.11 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.579 1.152 . . . . 0.0 112.256 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -144.28 164.1 31.76 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.564 1.545 . . . . 0.0 107.398 173.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 160.3 -161.42 32.54 Favored Glycine 0 C--O 1.228 -0.24 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 73.1 p -118.0 151.44 37.47 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.5 t -88.92 113.59 56.62 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 175.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.4 154.85 40.93 Favored 'Trans proline' 0 CA--C 1.512 -0.598 0 C-N-CA 121.839 1.692 . . . . 0.0 111.161 -176.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.551 ' HD2' ' O ' ' A' ' 70' ' ' ALA . 7.5 m80 -74.4 -7.07 51.67 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 120.353 -1.467 . . . . 0.0 113.687 -172.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.6 mptt -116.51 122.69 45.45 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 -174.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -38.73 111.39 0.17 Allowed 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 127.123 2.169 . . . . 0.0 111.76 -173.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 57.6 m -118.62 144.54 46.07 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 176.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.0 t -100.63 117.42 45.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 124.835 1.254 . . . . 0.0 111.303 -173.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.2 t -98.47 103.06 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 104.501 -2.407 . . . . 0.0 104.501 173.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -78.55 131.12 36.66 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 104.859 -2.275 . . . . 0.0 104.859 173.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.4 t -103.11 113.45 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 101.634 -3.469 . . . . 0.0 101.634 173.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -97.06 150.26 19.51 Favored Glycine 0 N--CA 1.439 -1.123 0 N-CA-C 108.621 -1.791 . . . . 0.0 108.621 176.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -133.3 73.54 73.83 Favored Pre-proline 0 C--O 1.242 0.7 0 CA-C-N 118.199 1.0 . . . . 0.0 109.402 -174.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -63.8 116.97 3.99 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.649 2.233 . . . . 0.0 109.885 173.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 7.1 t -90.75 146.43 23.99 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 173.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.9 mt -74.27 -12.34 60.52 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 117.856 0.298 . . . . 0.0 111.371 -177.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.61 21.76 43.75 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 127.123 2.297 . . . . 0.0 116.527 173.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . 0.339 4.6 mptp? -102.16 -40.9 6.59 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.984 1.892 . . . . 0.0 114.451 174.329 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 38.8 tp60 -96.49 146.1 25.09 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.469 1.032 . . . . 0.0 108.467 173.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -94.38 152.06 18.91 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.446 1.498 . . . . 0.0 107.869 174.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 138.06 -152.77 21.97 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.9 t -127.67 114.12 34.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.16 173.36 9.28 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.59 1.156 . . . . 0.0 109.307 173.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -128.24 150.27 50.11 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.338 1.855 . . . . 0.0 106.58 173.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -147.74 154.35 40.42 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 173.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -113.54 141.26 47.36 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.776 1.63 . . . . 0.0 110.291 -173.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 61.1 t -146.71 113.53 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 N-CA-C 104.258 -2.497 . . . . 0.0 104.258 173.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -144.19 137.77 27.62 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -174.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.0 t -136.62 148.9 26.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 121.794 0.807 . . . . 0.0 110.071 -173.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.5 HD13 ' O ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -115.74 162.64 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 173.714 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.7 t -139.08 136.08 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 -173.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.33 175.53 9.5 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 125.495 1.518 . . . . 0.0 107.371 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -92.95 176.12 6.54 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 172.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.2 t -65.89 -3.92 5.98 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 120.03 -1.669 . . . . 0.0 113.442 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -86.02 -15.24 42.05 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 120.697 1.59 . . . . 0.0 110.41 173.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.08 -0.63 66.81 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.73 1.157 . . . . 0.0 111.964 -173.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -70.15 116.04 10.05 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 119.456 1.628 . . . . 0.0 108.346 174.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -64.66 141.95 58.59 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.915 1.686 . . . . 0.0 107.951 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.8 pt -140.07 -37.25 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 124.481 1.113 . . . . 0.0 113.71 -174.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -133.97 145.42 49.51 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -147.45 136.99 22.73 Favored 'General case' 0 CA--C 1.516 -0.354 0 O-C-N 121.339 -0.851 . . . . 0.0 109.269 -176.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 35.5 m -72.33 129.84 86.9 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 173.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.4 143.94 35.72 Favored 'Trans proline' 0 N--CA 1.444 -1.415 0 N-CA-C 108.302 -1.461 . . . . 0.0 108.302 175.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 28.3 mp0 -79.37 112.38 16.55 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -173.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.547 25.6 m-80 172.48 -4.52 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.513 1 C-N-CA 136.115 5.766 . . . . 0.0 112.121 173.472 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.66 86.45 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 123.428 1.585 . . . . 0.0 108.836 174.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.9 mm -133.98 139.39 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 127.747 2.419 . . . . 0.0 105.522 -173.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -122.98 167.13 13.99 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 173.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -129.85 113.55 14.79 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 -173.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 57.7 tttt -102.16 121.74 42.8 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 119.748 1.158 . . . . 0.0 108.715 -176.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 30.1 m -83.61 116.86 22.81 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 104.84 -2.281 . . . . 0.0 104.84 173.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 13.2 m -117.85 166.12 12.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.304 0.573 . . . . 0.0 110.315 174.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.5 pp -137.12 159.27 42.39 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.636 1.574 . . . . 0.0 107.359 173.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.61 132.59 45.69 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.236 1.014 . . . . 0.0 110.463 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -153.35 161.75 42.01 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.177 1.791 . . . . 0.0 108.68 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 . . . . . 0 C--O 1.255 1.357 0 C-N-CA 129.898 3.279 . . . . 0.0 105.109 173.723 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.6 m . . . . . 0 CA--C 1.544 0.728 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.1 tt -44.71 127.32 6.14 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.764 2.026 . . . . 0.0 113.487 -176.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -115.64 128.35 55.86 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.261 1.825 . . . . 0.0 109.185 174.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.93 118.07 11.27 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 127.135 2.174 . . . . 0.0 107.388 -178.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 9.0 p90 -133.81 170.89 14.92 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.184 0.994 . . . . 0.0 110.229 176.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.0 mp -108.02 115.15 48.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 102.187 -3.264 . . . . 0.0 102.187 173.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -82.2 142.52 32.11 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 123.32 1.533 . . . . 0.0 112.967 -173.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.62 -16.83 51.88 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.884 1.674 . . . . 0.0 115.32 -173.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 27.7 m80 -58.03 -35.34 71.16 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.51 1.05 . . . . 0.0 110.458 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -70.52 -46.64 63.26 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 122.313 -0.242 . . . . 0.0 111.052 177.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.97 -31.57 65.17 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 118.907 -0.568 . . . . 0.0 112.136 174.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.7 tpp85 . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 173.379 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 . . . . . 0 CA--C 1.528 0.132 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -153.02 113.28 3.99 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.693 1.197 . . . . 0.0 109.752 174.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -96.4 161.19 14.03 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 172.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.1 mm -138.65 113.39 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 173.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.31 113.89 20.41 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.4 mt -86.04 -65.6 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 32.0 t -114.73 114.23 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 -173.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.8 p -113.05 115.17 27.92 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 103.8 -2.667 . . . . 0.0 103.8 173.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.258 6.4 pt-20 44.43 45.97 7.74 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.689 1.195 . . . . 0.0 113.013 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 67.53 -7.28 2.09 Favored Glycine 0 CA--C 1.541 1.672 0 C-N-CA 125.804 1.669 . . . . 0.0 114.817 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -83.22 37.43 0.55 Allowed 'General case' 0 CA--C 1.539 0.533 1 C-N-CA 133.323 4.649 . . . . 0.0 109.022 -173.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 52.1 mtm -37.98 132.09 1.01 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 127.166 2.186 . . . . 0.0 114.54 -172.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.48 160.62 78.56 Favored Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.347 173.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.36 35.33 0.43 Allowed 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 124.215 3.277 . . . . 0.0 112.039 175.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -54.71 -26.59 34.82 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.481 1.913 . . . . 0.0 112.793 -173.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.7 m -48.82 -47.05 42.68 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 129.219 3.007 . . . . 0.0 112.861 -173.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -59.17 -59.08 6.04 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.258 1.023 . . . . 0.0 109.944 -175.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.298 47.0 m-20 -76.74 -27.93 55.58 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.289 -175.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -61.21 -50.52 72.78 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 120.91 -1.119 . . . . 0.0 108.767 173.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 . . . . . 0 C--N 1.346 0.426 0 CA-C-O 118.576 -0.726 . . . . 0.0 110.651 178.275 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 78.6 mmm . . . . . 0 CA--C 1.533 0.31 0 CA-C-O 117.549 -1.215 . . . . 0.0 113.936 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.52 -66.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 121.93 1.753 . . . . 0.0 113.482 -173.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.7 113.82 8.18 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.461 0.704 . . . . 0.0 110.238 -174.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 38.6 mt -124.35 132.15 24.27 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 126.421 1.888 . . . . 0.0 108.187 -173.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -80.04 157.83 23.68 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.854 2.369 . . . . 0.0 111.559 174.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.6 p -42.77 -43.49 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 127.058 2.143 . . . . 0.0 112.791 175.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -60.09 -34.19 73.13 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 126.29 1.836 . . . . 0.0 113.106 -174.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 mm -71.8 112.95 7.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 103.107 -2.923 . . . . 0.0 103.107 174.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 -94.75 -23.46 17.53 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.2 m -152.12 161.42 42.66 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.308 1.043 . . . . 0.0 108.59 173.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 16.8 mtm -126.19 156.96 39.37 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 173.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.252 59.8 m-20 -96.46 150.42 20.63 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 174.236 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -138.09 151.34 47.72 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 130.985 3.714 . . . . 0.0 101.799 172.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.4 m -137.35 130.65 31.0 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 -177.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -144.1 165.05 28.9 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.72 175.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -167.01 154.87 9.42 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.493 173.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.24 -174.51 2.37 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 123.403 1.573 . . . . 0.0 107.031 172.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.11 135.56 45.38 Favored 'General case' 0 N--CA 1.411 -2.375 0 C-N-CA 130.812 3.645 . . . . 0.0 101.873 173.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -7.45 -56.42 0.01 OUTLIER Glycine 0 CA--C 1.54 1.615 1 C-N-CA 133.801 5.477 . . . . 0.0 120.022 -173.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -116.93 9.89 13.9 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 121.207 2.504 . . . . 0.0 114.862 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -107.43 37.44 2.4 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 120.759 3.615 . . . . 0.0 120.759 -172.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -44.81 113.63 0.59 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 123.559 2.89 . . . . 0.0 110.601 -175.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -84.99 121.32 27.6 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -174.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -73.98 144.51 45.18 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 178.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -130.28 161.02 32.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 119.358 0.981 . . . . 0.0 110.781 176.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.433 ' O ' HD13 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -152.57 133.94 14.4 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 173.263 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -84.01 103.23 13.09 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -176.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.5 tt -64.72 -40.46 95.38 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 125.566 1.546 . . . . 0.0 108.32 176.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.0 m -148.83 142.86 25.88 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 120.499 -1.376 . . . . 0.0 110.358 177.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.9 tt -164.94 93.02 0.61 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 101.658 -3.46 . . . . 0.0 101.658 173.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 42.1 mmm-85 -166.01 163.32 18.31 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.09 0.956 . . . . 0.0 110.646 -177.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 126' ' ' PHE . 8.8 t -91.47 158.25 16.59 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.99 1.316 . . . . 0.0 113.792 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.0 mt -110.13 -26.46 9.66 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.256 -1.338 . . . . 0.0 111.261 177.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -76.74 169.73 17.75 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 120.495 1.498 . . . . 0.0 109.349 -174.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.7 mmtm -131.1 -46.3 1.01 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.602 1.961 . . . . 0.0 111.307 -173.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -70.38 -71.29 1.03 Allowed Glycine 0 CA--C 1.533 1.208 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 173.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.644 ' H ' HD12 ' A' ' 89' ' ' ILE . 3.7 mp -70.04 12.19 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 129.805 3.242 . . . . 0.0 111.07 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 28.5 ttp -43.69 142.31 1.28 Allowed 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 128.304 2.642 . . . . 0.0 112.193 -174.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.252 . . -161.95 174.98 12.32 Favored 'General case' 0 N--CA 1.439 -0.976 1 C-N-CA 131.851 4.06 . . . . 0.0 104.492 -173.572 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -151.32 137.4 11.19 Favored Pre-proline 0 C--N 1.321 -0.661 0 C-N-CA 124.359 1.064 . . . . 0.0 110.014 172.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -71.7 157.86 54.65 Favored 'Trans proline' 0 N--CA 1.443 -1.496 0 C-N-CA 121.396 1.397 . . . . 0.0 109.081 173.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 20.2 p -142.75 161.94 36.76 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 126.916 2.087 . . . . 0.0 107.28 174.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.9 m -126.44 150.97 32.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 123.532 0.733 . . . . 0.0 110.738 174.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -82.86 15.73 2.57 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.441 1.497 . . . . 0.0 111.482 173.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.2 m -129.6 163.24 48.09 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 173.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -67.47 162.75 37.59 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 CA-C-N 119.659 0.914 . . . . 0.0 109.91 173.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.52 -6.73 8.03 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.811 1.244 . . . . 0.0 111.693 175.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -145.9 163.22 35.78 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.621 1.569 . . . . 0.0 107.249 173.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 162.13 -160.2 32.3 Favored Glycine 0 C--O 1.227 -0.294 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 80.7 p -120.82 146.41 46.57 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 173.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.0 t -87.45 113.68 55.23 Favored Pre-proline 0 N--CA 1.448 -0.549 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 173.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -84.41 156.35 12.51 Favored 'Trans proline' 0 C--O 1.213 -0.736 0 C-N-CA 122.546 2.164 . . . . 0.0 112.402 -174.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -71.11 1.13 6.24 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 120.248 -1.532 . . . . 0.0 111.714 -174.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -114.03 115.6 27.86 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 128.102 2.561 . . . . 0.0 108.125 -173.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -41.56 108.74 0.1 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.096 1.358 . . . . 0.0 110.056 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.7 m -119.25 139.34 52.05 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.61 118.9 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 114.447 -1.252 . . . . 0.0 108.621 -173.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 75.9 t -93.88 104.21 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 173.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -82.34 115.04 21.21 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 104.532 -2.396 . . . . 0.0 104.532 173.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.3 t -93.33 113.82 28.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 104.111 -2.551 . . . . 0.0 104.111 174.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -89.19 144.86 18.21 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 124.891 1.234 . . . . 0.0 110.33 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -129.63 73.6 81.41 Favored Pre-proline 0 C--O 1.244 0.769 0 CA-C-N 118.754 1.277 . . . . 0.0 111.052 -175.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.3 129.06 19.53 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.397 2.064 . . . . 0.0 109.117 173.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 5.7 t -105.82 154.61 20.28 Favored 'General case' 0 C--N 1.338 0.1 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 174.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.8 mt -71.96 -17.01 62.1 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.568 0.622 . . . . 0.0 111.593 177.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 50.65 39.19 37.7 Favored Glycine 0 C--O 1.219 -0.793 0 C-N-CA 127.336 2.398 . . . . 0.0 114.809 173.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 42.9 mttm -124.4 -28.0 3.69 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.724 1.762 . . . . 0.0 112.032 173.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -96.53 155.66 16.67 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 172.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -109.42 150.75 27.61 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 138.59 -154.23 22.97 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 174.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 19.0 t -124.77 114.19 39.46 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -88.6 168.47 12.53 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 173.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -131.6 142.38 49.88 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.561 1.145 . . . . 0.0 108.715 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 33.6 p90 -143.34 150.44 39.17 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 125.829 1.651 . . . . 0.0 108.194 174.017 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -129.95 164.64 23.79 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 119.671 1.123 . . . . 0.0 113.285 177.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 57.3 t -131.62 148.56 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 125.613 1.565 . . . . 0.0 108.512 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -155.66 132.96 10.88 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 125.978 1.711 . . . . 0.0 108.078 173.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 36.5 t -137.15 143.46 34.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -174.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.532 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -110.25 163.46 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 173.939 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.9 t -140.3 137.59 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 CA-C-N 114.185 -1.37 . . . . 0.0 107.337 -173.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.79 174.71 10.33 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 125.957 1.703 . . . . 0.0 107.619 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 45.0 p-10 -89.68 176.01 7.03 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 172.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.8 t -66.1 -3.6 5.82 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 120.098 -1.626 . . . . 0.0 113.484 -177.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -86.69 -17.7 33.09 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 120.613 1.551 . . . . 0.0 110.452 173.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 97.6 1.13 59.02 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.783 1.182 . . . . 0.0 112.251 -173.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 65.4 m-20 -72.29 115.14 11.18 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 119.608 1.704 . . . . 0.0 108.701 174.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.5 m -64.8 143.0 58.24 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.498 1.919 . . . . 0.0 108.624 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -141.29 -36.82 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 124.708 1.203 . . . . 0.0 113.973 -175.257 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -131.91 144.18 50.67 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.13 130.2 19.55 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 35.6 m -68.79 149.07 98.01 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 173.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -89.17 144.92 5.08 Favored 'Trans proline' 0 N--CA 1.444 -1.386 0 CA-C-N 120.84 1.336 . . . . 0.0 109.646 173.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -78.84 112.58 16.13 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 -174.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 172.99 -18.4 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 128.12 2.568 . . . . 0.0 114.331 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.9 79.06 0.12 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.999 0.92 . . . . 0.0 112.08 -173.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.425 HG21 ' CZ ' ' A' ' 150' ' ' PHE . 3.3 mm -86.83 148.03 4.92 Favored 'Isoleucine or valine' 0 C--N 1.345 0.38 0 C-N-CA 127.341 2.256 . . . . 0.0 109.361 174.049 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -125.88 128.41 47.55 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 129.484 3.114 . . . . 0.0 103.12 173.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.425 ' CZ ' HG21 ' A' ' 148' ' ' ILE . 66.0 m-85 -102.49 113.26 26.46 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 178.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 56.1 tttt -103.1 121.58 42.9 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 28.9 m -83.38 114.65 21.58 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 174.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 21.8 m -113.09 165.5 12.31 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 119.01 0.823 . . . . 0.0 109.459 174.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.4 pp -141.75 161.61 37.52 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.067 1.347 . . . . 0.0 108.098 174.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.91 130.2 42.24 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.621 1.168 . . . . 0.0 111.843 178.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -144.06 170.34 16.12 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 128.239 2.616 . . . . 0.0 107.606 173.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 . . . . . 0 C--O 1.254 1.314 0 C-N-CA 128.881 2.872 . . . . 0.0 106.075 173.812 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.6 m . . . . . 0 CA--C 1.537 0.443 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.2 tt -42.99 121.91 2.26 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 127.132 2.173 . . . . 0.0 113.469 -173.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -111.76 139.84 46.9 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.265 2.226 . . . . 0.0 108.435 174.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.07 118.28 6.81 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 21.2 p90 -139.42 152.24 46.91 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 119.205 0.912 . . . . 0.0 109.58 177.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.8 mt -83.91 127.86 39.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 102.579 -3.119 . . . . 0.0 102.579 173.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -104.69 136.9 43.35 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 122.9 1.333 . . . . 0.0 111.856 -173.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.2 -22.38 66.88 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.206 -1.361 . . . . 0.0 113.891 -174.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -58.36 -37.9 76.15 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 119.564 1.075 . . . . 0.0 111.422 -173.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -71.19 -51.12 26.57 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 117.816 -1.088 . . . . 0.0 110.151 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.71 -41.73 61.72 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.034 0.834 . . . . 0.0 111.009 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 173.943 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.456 -0.168 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -162.16 126.45 3.21 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.067 2.147 . . . . 0.0 107.506 176.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -96.24 159.08 15.14 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 172.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.2 mp -135.56 113.17 14.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 173.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.67 114.13 18.35 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.8 mt -94.09 -57.06 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.402 HG22 ' HG2' ' A' ' 39' ' ' MET . 4.1 t -125.95 141.27 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 C-N-CA 125.003 1.321 . . . . 0.0 108.901 -173.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.0 p -152.43 123.01 7.32 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 102.87 -3.011 . . . . 0.0 102.87 173.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 44.48 33.84 0.97 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.67 1.588 . . . . 0.0 113.818 -174.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.26 -8.82 6.25 Favored Glycine 0 CA--C 1.539 1.566 0 O-C-N 120.814 -1.179 . . . . 0.0 114.694 -177.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.2 ttmt -69.25 37.47 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.461 1 C-N-CA 132.941 4.496 . . . . 0.0 112.812 -177.042 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.402 ' HG2' HG22 ' A' ' 34' ' ' VAL . 43.0 mtt -38.1 133.04 0.95 Allowed 'General case' 0 C--O 1.233 0.229 0 C-N-CA 126.164 1.786 . . . . 0.0 114.767 -173.242 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.79 157.64 66.05 Favored Pre-proline 0 N--CA 1.448 -0.559 0 CA-C-N 113.512 -1.676 . . . . 0.0 107.859 173.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -74.27 37.69 0.45 Allowed 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 124.455 3.437 . . . . 0.0 112.192 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -52.61 -26.11 12.58 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 127.266 2.226 . . . . 0.0 113.493 -173.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.404 HG23 ' CG ' ' A' ' 146' ' ' ASN . 1.8 m -43.52 -51.95 6.46 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.757 2.023 . . . . 0.0 112.388 -174.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -58.28 -62.48 1.8 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.612 0.765 . . . . 0.0 110.569 -174.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.33 52.4 m-20 -76.84 -30.78 56.47 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -173.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.1 -51.7 68.02 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 120.659 -1.276 . . . . 0.0 107.971 173.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.471 HH21 HD11 ' A' ' 148' ' ' ILE . 6.3 ttt180 . . . . . 0 CA--C 1.537 0.468 0 CA-C-O 118.796 -0.621 . . . . 0.0 109.72 -177.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.438 0 CA-C-O 117.635 -1.174 . . . . 0.0 111.721 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -77.01 -73.92 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.835 0 CA-C-N 120.86 1.343 . . . . 0.0 113.313 -174.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.22 118.11 6.44 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.183 1.393 . . . . 0.0 114.034 -173.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.6 mt -132.09 120.77 17.4 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 127.154 2.181 . . . . 0.0 106.831 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -77.06 156.25 33.9 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.243 1.962 . . . . 0.0 111.124 -178.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.6 p -40.25 -46.84 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 127.834 2.454 . . . . 0.0 113.607 -178.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -63.23 -36.19 82.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 126.066 1.746 . . . . 0.0 113.091 -175.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.5 mm -69.06 113.05 4.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 103.454 -2.795 . . . . 0.0 103.454 174.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -79.57 -32.81 42.08 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.246 176.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.5 m -154.24 162.71 41.0 Favored 'General case' 0 C--N 1.335 -0.031 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -173.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 24.4 mtm -126.55 163.53 23.2 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 172.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -120.17 149.19 42.64 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 118.99 0.814 . . . . 0.0 108.857 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -125.58 156.55 38.95 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 102.898 -3.001 . . . . 0.0 102.898 173.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 m -138.31 135.91 35.9 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -176.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -145.72 159.97 42.4 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 121.593 -0.692 . . . . 0.0 111.053 178.258 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -165.74 151.99 9.53 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 121.966 0.889 . . . . 0.0 112.688 173.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -82.13 -173.53 4.57 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.504 1.122 . . . . 0.0 108.786 173.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.19 99.73 6.89 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 126.469 1.908 . . . . 0.0 109.368 -174.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 48.14 -60.17 0.0 OUTLIER Glycine 0 CA--C 1.539 1.536 0 C-N-CA 130.646 3.974 . . . . 0.0 119.619 173.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -116.77 -12.99 10.76 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 120.298 2.049 . . . . 0.0 114.354 175.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.7 37.28 0.58 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 130.015 3.326 . . . . 0.0 118.869 -173.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -52.38 113.66 1.12 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 123.058 2.663 . . . . 0.0 109.776 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -84.05 138.46 33.06 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.686 1.595 . . . . 0.0 106.885 174.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -85.61 149.37 25.38 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -133.52 160.1 38.44 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.905 1.23 . . . . 0.0 110.566 174.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.436 ' O ' HD13 ' A' ' 131' ' ' ILE . 31.3 tt0 -154.58 133.9 12.57 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 173.178 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.487 ' CD2' HD23 ' A' ' 82' ' ' LEU . 80.6 m-85 -81.97 103.55 11.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.9 tt -64.47 -40.83 96.43 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 173.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 m -154.99 145.99 22.64 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 122.657 1.217 . . . . 0.0 111.739 174.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.634 HD22 HG22 ' A' ' 128' ' ' VAL . 0.2 OUTLIER -148.54 92.81 2.05 Favored 'General case' 0 N--CA 1.451 -0.389 1 N-CA-C 97.606 -4.961 . . . . 0.0 97.606 173.191 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.01 150.78 27.7 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 120.452 -1.405 . . . . 0.0 114.559 -172.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.1 t -68.74 158.92 33.27 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.762 1.225 . . . . 0.0 111.464 173.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.3 mt -123.38 -26.25 4.29 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.983 1.713 . . . . 0.0 110.925 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.434 ' CG ' ' H ' ' A' ' 87' ' ' LYS . 7.9 t70 -79.09 176.09 9.98 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.791 1.178 . . . . 0.0 109.521 -174.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.434 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 23.4 mmtm -131.62 -50.54 0.98 Allowed 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 127.073 2.149 . . . . 0.0 110.928 -173.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -69.48 -65.02 2.72 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 173.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.492 ' H ' HD12 ' A' ' 89' ' ' ILE . 4.3 mp -76.63 25.59 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 C-N-CA 129.357 3.063 . . . . 0.0 110.395 -175.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 26.5 ttm -43.33 139.74 1.86 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 129.261 3.025 . . . . 0.0 111.803 -173.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.253 . . -168.14 173.62 7.8 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 130.177 3.391 . . . . 0.0 105.563 -173.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.412 10.4 m-20 -147.51 130.23 7.86 Favored Pre-proline 0 CA--C 1.509 -0.622 0 C-N-CA 127.435 2.294 . . . . 0.0 111.975 172.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.32 156.36 41.59 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 121.953 1.768 . . . . 0.0 109.649 173.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 23.4 p -136.59 158.6 44.07 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 126.524 1.93 . . . . 0.0 108.139 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.6 m -126.34 157.23 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 123.729 0.812 . . . . 0.0 111.222 176.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -79.99 9.77 5.05 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 127.325 2.25 . . . . 0.0 113.68 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.8 m -140.84 163.44 42.72 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 124.527 1.131 . . . . 0.0 109.914 -175.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -66.11 164.56 27.26 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.853 1.702 . . . . 0.0 110.277 173.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -63.16 -14.37 47.98 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 124.503 1.121 . . . . 0.0 112.7 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -143.33 164.78 29.3 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 120.133 1.333 . . . . 0.0 108.65 173.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 164.42 -162.92 35.79 Favored Glycine 0 C--O 1.228 -0.258 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 76.1 p -116.96 149.15 40.68 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 173.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 37.5 t -83.13 113.52 46.57 Favored Pre-proline 0 N--CA 1.448 -0.528 0 N-CA-C 103.635 -2.728 . . . . 0.0 103.635 173.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.42 ' HB2' ' HE3' ' A' ' 106' ' ' LYS . 45.8 Cg_endo -85.82 156.07 10.2 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.404 2.069 . . . . 0.0 112.176 -173.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -70.55 0.55 6.57 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 120.197 -1.564 . . . . 0.0 113.063 -175.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.42 ' HE3' ' HB2' ' A' ' 104' ' ' PRO . 0.0 OUTLIER -115.3 114.84 25.71 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 126.598 1.959 . . . . 0.0 106.951 -173.839 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -41.62 106.84 0.06 Allowed 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.693 1.597 . . . . 0.0 109.639 -178.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.4 m -112.21 137.46 50.28 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 178.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.5 t -96.75 114.18 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 114.099 -1.409 . . . . 0.0 108.703 -173.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 98.5 t -94.09 103.33 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 173.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -77.04 140.42 40.33 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 172.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.4 t -115.16 113.62 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 174.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -99.48 149.44 18.93 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 125.927 1.727 . . . . 0.0 109.603 -178.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.415 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 4.4 m-85 -132.3 73.89 76.74 Favored Pre-proline 0 C--O 1.244 0.788 0 CA-C-N 118.965 1.383 . . . . 0.0 112.479 -173.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -66.88 126.83 15.91 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.098 1.865 . . . . 0.0 109.135 173.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 5.7 t -104.82 153.37 21.42 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 124.565 1.146 . . . . 0.0 108.131 174.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.6 mt -74.5 -9.98 59.12 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.369 0.531 . . . . 0.0 111.867 178.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.7 5.93 3.16 Favored Glycine 0 C--O 1.22 -0.723 0 C-N-CA 128.458 2.933 . . . . 0.0 116.408 173.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 27.7 mmtm -93.61 -32.26 14.17 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.737 1.768 . . . . 0.0 113.114 -173.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -96.63 159.1 15.11 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 173.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -107.89 148.01 30.18 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.405 1.482 . . . . 0.0 107.197 176.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 140.21 -152.71 22.98 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 174.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.8 t -128.07 113.99 32.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.428 ' HB2' ' HB ' ' A' ' 89' ' ' ILE . . . -90.64 167.96 12.14 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 173.312 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -129.65 156.99 43.35 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 123.719 0.808 . . . . 0.0 109.464 173.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 149' ' ' PHE . 3.8 p90 -147.95 151.0 35.07 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 126.801 2.04 . . . . 0.0 105.896 173.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -137.71 173.2 11.9 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 175.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.634 HG22 HD22 ' A' ' 82' ' ' LEU . 97.0 t -128.95 147.3 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 124.789 1.236 . . . . 0.0 111.276 -173.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -146.67 120.02 8.99 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 127.666 2.387 . . . . 0.0 106.44 173.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.406 HG22 ' CD2' ' A' ' 79' ' ' PHE . 23.3 t -138.2 124.2 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -177.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.687 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -90.43 164.83 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 106.635 -1.616 . . . . 0.0 106.635 173.695 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.4 t -144.71 132.34 16.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -176.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.73 174.02 11.03 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.475 1.11 . . . . 0.0 108.581 -174.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 32.1 p-10 -88.28 176.06 7.39 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 172.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.1 t -68.09 -6.78 24.69 Favored 'General case' 0 CA--C 1.551 1.015 0 O-C-N 120.659 -1.276 . . . . 0.0 112.286 -175.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -86.32 -14.69 42.87 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 120.59 -1.319 . . . . 0.0 110.606 173.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.42 4.16 62.62 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.736 1.16 . . . . 0.0 112.386 -173.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -75.9 117.55 17.75 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 119.811 1.805 . . . . 0.0 108.952 175.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.4 m -66.98 146.82 53.97 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.96 1.704 . . . . 0.0 110.021 -176.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.84 -35.68 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.868 1.267 . . . . 0.0 113.616 178.125 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -133.08 148.74 52.17 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -176.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -146.52 150.01 34.72 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 174.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.6 m -102.79 113.81 65.67 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -73.91 154.13 47.96 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.16 1.907 . . . . 0.0 113.105 -173.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -69.49 112.52 6.06 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 102.122 -3.288 . . . . 0.0 102.122 173.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.404 ' CG ' HG23 ' A' ' 43' ' ' THR . 44.7 m-20 173.35 -30.79 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 130.821 3.649 . . . . 0.0 107.138 -173.277 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.58 66.6 0.08 Allowed 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 126.842 2.057 . . . . 0.0 109.157 174.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.471 HD11 HH21 ' A' ' 47' ' ' ARG . 1.4 mt -95.62 147.72 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 C-N-CA 126.074 1.75 . . . . 0.0 108.141 176.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.417 ' HB2' ' CE2' ' A' ' 126' ' ' PHE . 20.1 m-85 -130.88 150.61 51.96 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 173.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -127.21 113.36 16.24 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 -173.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 46.5 tttt -101.8 123.22 45.39 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.48 -0.934 . . . . 0.0 108.48 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 39.0 m -83.34 119.93 25.23 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 173.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 11.1 m -114.69 159.66 20.26 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 173.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.2 pp -143.44 160.58 40.32 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 174.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -56.56 114.11 1.9 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 127.999 2.52 . . . . 0.0 111.795 -174.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -133.89 174.83 10.04 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 127.833 2.453 . . . . 0.0 108.6 175.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 . . . . . 0 C--O 1.252 1.191 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 173.458 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.5 m . . . . . 0 CA--C 1.542 0.667 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.51 HD23 ' N ' ' A' ' 13' ' ' TYR . 6.1 tt -47.06 132.71 11.97 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.994 1.27 . . . . 0.0 112.22 -173.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.51 ' N ' HD23 ' A' ' 12' ' ' LEU . 81.7 m-85 -121.26 129.94 53.41 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.073 1.349 . . . . 0.0 109.58 176.181 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.4 117.91 8.55 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 5.5 p90 -131.19 175.38 9.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.174 0.99 . . . . 0.0 110.257 174.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.505 HD11 HD11 ' A' ' 33' ' ' ILE . 2.0 mp -115.41 118.28 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 102.997 -2.964 . . . . 0.0 102.997 173.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -89.59 144.6 25.88 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 123.312 1.53 . . . . 0.0 112.487 -173.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.53 -6.8 1.19 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 128.341 2.656 . . . . 0.0 115.491 -175.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 62.2 m80 -61.8 -34.06 75.24 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 120.584 1.538 . . . . 0.0 111.638 -177.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -67.35 -41.16 85.62 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.231 176.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.78 -36.32 83.49 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.545 1.138 . . . . 0.0 111.075 173.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.0 ttm-85 . . . . . 0 N--CA 1.447 -0.615 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 173.865 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -149.29 112.64 4.97 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.446 0.566 . . . . 0.0 110.017 173.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -97.1 163.11 13.07 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 172.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.3 mp -141.1 113.15 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 103.855 -2.646 . . . . 0.0 103.855 172.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.63 114.11 23.07 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.505 HD11 HD11 ' A' ' 16' ' ' ILE . 10.9 mt -85.45 -58.45 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 118.543 0.61 . . . . 0.0 109.495 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.415 HG11 HD22 ' A' ' 12' ' ' LEU . 22.1 t -123.96 114.1 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 126.757 2.023 . . . . 0.0 106.9 -173.218 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.6 p -117.48 118.22 31.58 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 173.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.308 1.2 pm0 44.31 52.4 7.24 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.329 1.052 . . . . 0.0 111.121 -173.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.75 -12.95 4.42 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 126.78 2.133 . . . . 0.0 115.935 175.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -67.83 37.79 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.484 1 C-N-CA 132.963 4.505 . . . . 0.0 114.487 -174.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 30.9 mtm -37.83 116.56 0.51 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.876 1.216 . . . . 0.0 112.835 -172.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.67 161.07 22.46 Favored Pre-proline 0 N--CA 1.447 -0.612 0 CA-C-N 113.746 -1.57 . . . . 0.0 109.491 177.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -73.98 27.54 0.33 Allowed 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.699 2.933 . . . . 0.0 111.994 174.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -56.11 -26.68 50.85 Favored 'General case' 0 C--N 1.345 0.409 0 C-N-CA 124.862 1.265 . . . . 0.0 110.616 -174.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 m -45.54 -43.77 12.18 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 129.29 3.036 . . . . 0.0 110.725 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 53.0 t60 -63.65 -55.34 24.31 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.0 0.52 . . . . 0.0 110.707 -177.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -76.1 -26.76 56.75 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -175.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -68.13 -40.36 82.49 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.122 0.969 . . . . 0.0 109.634 173.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.548 0.894 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 175.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.428 ' SD ' HD13 ' A' ' 16' ' ' ILE . 1.1 mtp . . . . . 0 CA--C 1.534 0.362 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -75.2 -75.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.021 0 CA-C-N 121.13 1.439 . . . . 0.0 111.366 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.28 113.63 14.05 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.761 0.824 . . . . 0.0 111.829 -173.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 89.4 mt -120.35 130.43 24.85 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 128.464 2.706 . . . . 0.0 105.988 -174.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -83.05 159.32 15.56 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.491 2.127 . . . . 0.0 110.593 174.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.0 p -46.99 -34.61 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 125.715 1.606 . . . . 0.0 112.744 174.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.41 -34.19 72.17 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.509 1.524 . . . . 0.0 111.763 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.6 mm -92.15 112.83 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 102.985 -2.968 . . . . 0.0 102.985 174.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -82.86 -31.26 28.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.354 178.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.3 m -148.05 164.26 34.38 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.339 1.056 . . . . 0.0 110.422 -173.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 36.4 mtm -126.78 149.56 49.59 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 172.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -94.12 149.09 21.55 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 174.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -134.11 158.06 44.57 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 102.567 -3.123 . . . . 0.0 102.567 172.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.3 m -142.82 134.38 26.46 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 -178.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -144.53 169.02 18.76 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.248 0.546 . . . . 0.0 110.092 174.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -166.73 145.75 5.44 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.763 173.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.42 -173.3 1.36 Allowed 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 124.16 1.933 . . . . 0.0 105.864 172.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . 0.264 . . -112.42 121.26 44.34 Favored 'General case' 0 N--CA 1.408 -2.535 1 C-N-CA 131.922 4.089 . . . . 0.0 105.767 -179.084 . . . . . . . . 3 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 20.22 -73.65 0.0 OUTLIER Glycine 0 CA--C 1.536 1.358 1 C-N-CA 133.654 5.407 . . . . 0.0 119.079 178.333 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -116.25 -14.73 11.07 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 120.415 2.108 . . . . 0.0 112.41 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.81 37.48 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 131.339 3.856 . . . . 0.0 116.641 -173.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -38.17 114.16 0.34 Allowed 'General case' 0 C--O 1.237 0.446 0 CA-C-N 121.684 2.038 . . . . 0.0 114.719 -173.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -94.53 116.33 28.65 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 104.682 -2.34 . . . . 0.0 104.682 173.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -79.67 148.68 31.51 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 175.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -129.94 158.27 40.02 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 119.645 1.111 . . . . 0.0 109.861 174.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.49 134.26 12.91 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 173.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -89.16 102.99 15.65 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -175.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.6 tt -68.07 -41.38 82.02 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.518 1.527 . . . . 0.0 107.829 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 m -154.24 135.08 13.71 Favored 'General case' 0 N--CA 1.444 -0.734 0 O-C-N 120.645 -1.285 . . . . 0.0 110.829 179.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.483 ' H ' ' HD3' ' A' ' 83' ' ' ARG . 0.3 OUTLIER -151.99 93.15 1.8 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 101.428 -3.545 . . . . 0.0 101.428 173.508 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.483 ' HD3' ' H ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -156.94 157.17 34.31 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 120.863 1.665 . . . . 0.0 111.352 -178.319 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -78.87 152.99 30.92 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-O 121.549 0.69 . . . . 0.0 109.826 173.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.9 mt -106.91 -17.59 14.15 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.437 1.495 . . . . 0.0 110.721 174.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -90.29 163.23 14.83 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 174.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -139.8 -31.32 0.67 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.164 1.786 . . . . 0.0 112.998 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -64.12 -63.88 4.04 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 106.654 -2.579 . . . . 0.0 106.654 172.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.455 ' H ' HD12 ' A' ' 89' ' ' ILE . 4.8 mp -75.78 22.0 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 129.993 3.317 . . . . 0.0 110.23 175.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.4 ttp -43.11 130.79 4.52 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 125.923 2.773 . . . . 0.0 113.26 -173.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.536 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -150.55 147.87 27.98 Favored 'General case' 0 N--CA 1.419 -2.014 2 C-N-CA 135.108 5.363 . . . . 0.0 100.86 173.95 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.276 5.4 m-20 -136.74 117.36 10.99 Favored Pre-proline 0 C--N 1.315 -0.931 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 173.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -67.63 158.16 58.43 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 123.033 2.489 . . . . 0.0 114.133 -173.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 32.8 p -136.11 164.52 27.84 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.248 1.819 . . . . 0.0 109.006 177.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.6 m -126.41 159.98 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 123.855 0.862 . . . . 0.0 111.295 175.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -80.1 10.46 4.35 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 127.171 2.188 . . . . 0.0 113.346 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.4 m -140.91 163.76 40.51 Favored Pre-proline 0 C--N 1.328 -0.341 0 C-N-CA 124.168 0.987 . . . . 0.0 110.288 -174.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -65.43 160.12 44.3 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 121.626 1.551 . . . . 0.0 108.836 173.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -67.19 -10.11 47.05 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 123.558 0.743 . . . . 0.0 112.264 -178.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -146.83 163.91 34.54 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 120.543 1.52 . . . . 0.0 108.338 173.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 159.19 -163.15 33.2 Favored Glycine 0 C--O 1.227 -0.298 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 177.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 70.1 p -114.9 146.03 41.56 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 173.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.3 t -77.56 122.42 85.83 Favored Pre-proline 0 CA--C 1.541 0.622 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 177.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.81 148.54 46.4 Favored 'Trans proline' 0 C--O 1.216 -0.577 0 C-N-CA 121.797 1.665 . . . . 0.0 111.749 -175.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 72.9 m-70 -63.82 -24.35 67.72 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 -172.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . 0.515 1.0 OUTLIER -116.71 150.68 37.8 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.781 1.173 . . . . 0.0 111.914 173.141 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -38.49 115.49 0.46 Allowed 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 128.387 2.675 . . . . 0.0 114.404 -172.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 44.6 m -128.69 141.49 51.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 173.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 17.1 t -94.02 122.32 45.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 124.701 1.2 . . . . 0.0 110.196 -173.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.8 t -103.72 103.5 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 173.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -81.03 141.25 34.57 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 173.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.2 t -110.27 113.86 45.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 103.525 -2.768 . . . . 0.0 103.525 174.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -95.67 151.34 19.96 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 125.091 1.329 . . . . 0.0 109.925 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -131.4 72.96 80.47 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.14 125.93 14.31 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.634 1.556 . . . . 0.0 108.471 176.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.536 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 5.3 t -105.47 156.99 17.68 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.2 mt -81.16 -8.87 59.84 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.167 0.44 . . . . 0.0 111.713 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.39 28.13 61.6 Favored Glycine 0 C--N 1.339 0.702 0 C-N-CA 126.06 1.791 . . . . 0.0 116.149 173.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 51.4 mttt -122.34 -30.72 3.93 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.938 1.869 . . . . 0.0 114.128 177.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 -96.34 154.88 17.01 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 173.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -111.17 148.95 31.65 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 138.1 -156.33 23.82 Favored Glycine 0 C--N 1.332 0.361 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 176.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.4 t -122.52 113.7 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -89.45 156.98 18.31 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 173.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -117.62 158.56 24.42 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.805 0.842 . . . . 0.0 110.504 177.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.405 ' CE2' ' HB2' ' A' ' 149' ' ' PHE . 5.7 p90 -150.01 150.78 32.28 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 119.024 0.829 . . . . 0.0 109.2 173.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.415 ' CG ' HH12 ' A' ' 83' ' ' ARG . 24.7 pt-20 -123.15 156.4 35.11 Favored 'General case' 0 C--O 1.25 1.116 0 C-N-CA 125.126 1.37 . . . . 0.0 110.678 -174.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.465 HG22 HD22 ' A' ' 82' ' ' LEU . 26.6 t -137.79 140.26 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 O-C-N 125.437 1.711 . . . . 0.0 110.862 -177.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -150.61 120.59 7.16 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.931 2.493 . . . . 0.0 105.619 173.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 47.3 t -136.7 119.9 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.716 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -84.55 166.21 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 174.155 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.9 t -141.37 133.33 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 179.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.85 175.98 8.6 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 177.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -96.95 154.16 17.47 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 102.705 -3.072 . . . . 0.0 102.705 172.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.7 t -62.89 -15.86 56.6 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 120.72 -1.238 . . . . 0.0 110.573 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -69.51 -6.36 30.16 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 127.113 2.165 . . . . 0.0 111.914 173.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 99.45 20.25 18.11 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 118.192 2.037 . . . . 0.0 118.192 173.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -124.19 124.46 42.51 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 120.642 2.221 . . . . 0.0 110.071 -173.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.0 m -64.66 142.04 58.56 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 174.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.7 pt -140.51 -37.3 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 124.422 1.089 . . . . 0.0 113.813 -173.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.42 HD13 ' N ' ' A' ' 142' ' ' GLN . 2.9 tm? -139.49 154.04 47.63 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 -174.046 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.427 ' HG3' HG22 ' A' ' 131' ' ' ILE . 1.9 tm0? -154.83 144.52 21.49 Favored 'General case' 0 C--N 1.334 -0.102 0 O-C-N 121.025 -1.047 . . . . 0.0 108.9 174.066 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 26.8 m -67.77 114.56 20.71 Favored Pre-proline 0 N--CA 1.454 -0.264 0 N-CA-C 104.017 -2.586 . . . . 0.0 104.017 173.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -66.29 146.17 80.17 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 CA-C-N 120.251 1.125 . . . . 0.0 113.167 -173.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -73.45 112.95 10.0 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 173.0 -26.96 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.398 1 C-N-CA 134.792 5.237 . . . . 0.0 109.234 173.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.06 87.12 0.01 OUTLIER 'General case' 0 C--O 1.238 0.475 0 C-N-CA 126.251 1.821 . . . . 0.0 111.384 -174.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.9 mt -123.56 136.75 59.06 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.709 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 173.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.405 ' HB2' ' CE2' ' A' ' 126' ' ' PHE . 0.2 OUTLIER -116.06 164.58 14.25 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 126.263 2.227 . . . . 0.0 107.08 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -140.63 113.56 8.32 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.684 1.194 . . . . 0.0 108.349 -173.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -104.43 128.52 52.33 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 119.427 1.012 . . . . 0.0 108.638 174.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 24.4 m -83.51 114.18 21.32 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 174.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 56.2 m -108.41 165.83 11.22 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 173.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.3 pp -142.9 161.5 37.94 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.054 1.342 . . . . 0.0 108.423 174.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -68.04 122.37 18.1 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.404 1.882 . . . . 0.0 110.289 174.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -153.83 123.08 6.52 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.724 1.21 . . . . 0.0 110.218 174.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 . . . . . 0 C--O 1.255 1.371 0 C-N-CA 128.877 2.871 . . . . 0.0 105.806 173.68 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 CA--C 1.533 0.309 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.7 tt -43.33 128.21 4.74 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.945 2.098 . . . . 0.0 111.929 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -113.04 137.58 51.2 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.917 1.687 . . . . 0.0 107.94 173.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.67 116.25 7.63 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 9.8 p90 -129.85 175.83 8.53 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.937 0.895 . . . . 0.0 109.429 175.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.428 HD11 HD11 ' A' ' 33' ' ' ILE . 1.8 mp -114.07 120.11 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 103.006 -2.961 . . . . 0.0 103.006 174.04 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -83.43 144.81 29.35 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 123.355 1.55 . . . . 0.0 114.746 -173.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.52 -16.48 60.85 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.521 1.928 . . . . 0.0 114.985 -174.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -55.89 -35.02 66.07 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.455 0.57 . . . . 0.0 109.488 174.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -75.74 -44.94 39.22 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.06 -33.94 63.15 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.523 0.729 . . . . 0.0 111.019 174.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 25.8 ttm105 . . . . . 0 N--CA 1.447 -0.587 0 O-C-N 121.2 -0.938 . . . . 0.0 108.841 173.544 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 . . . . . 0 CA--C 1.534 0.361 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -153.93 113.55 3.81 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.311 1.445 . . . . 0.0 109.585 -178.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -94.74 165.76 12.33 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 173.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.1 mp -141.07 113.39 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 174.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.59 122.54 29.18 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -177.326 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.428 HD11 HD11 ' A' ' 16' ' ' ILE . 17.2 mt -94.97 -65.3 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 119.027 0.831 . . . . 0.0 109.019 177.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.4 t -113.15 113.6 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 -173.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.5 p -109.22 113.58 26.55 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 103.613 -2.736 . . . . 0.0 103.613 173.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.284 18.1 pm0 44.43 40.87 4.14 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.77 1.628 . . . . 0.0 113.235 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.91 -6.76 8.74 Favored Glycine 0 CA--C 1.543 1.785 0 C-N-CA 124.768 1.175 . . . . 0.0 114.466 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -86.39 37.63 0.74 Allowed 'General case' 0 CA--C 1.539 0.554 1 C-N-CA 134.387 5.075 . . . . 0.0 108.114 -174.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 62.6 mtp -37.66 131.74 0.94 Allowed 'General case' 0 C--O 1.234 0.253 0 C-N-CA 128.427 2.691 . . . . 0.0 115.301 -172.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.6 159.39 85.21 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-N 113.464 -1.698 . . . . 0.0 109.056 173.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -76.46 41.28 0.86 Allowed 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 124.53 3.486 . . . . 0.0 111.783 175.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -54.89 -26.29 34.82 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.443 1.897 . . . . 0.0 112.802 -174.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.5 m -53.14 -33.09 50.9 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 127.201 2.2 . . . . 0.0 112.074 -173.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -62.9 -66.25 0.57 Allowed 'General case' 0 C--N 1.344 0.368 0 CA-C-N 119.201 0.91 . . . . 0.0 109.748 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.9 -35.37 74.72 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -177.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -63.87 -44.56 92.71 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 125.081 1.488 . . . . 0.0 110.092 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 48.7 tpt85 . . . . . 0 C--O 1.238 0.452 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -176.003 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 98.1 mmm . . . . . 0 CA--C 1.534 0.365 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -61.33 -71.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.687 0 CA-C-N 121.457 1.556 . . . . 0.0 114.048 -173.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.39 119.81 19.99 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.495 0.718 . . . . 0.0 110.357 -174.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 96.0 mt -123.92 127.92 25.27 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 128.226 2.61 . . . . 0.0 106.134 -175.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -84.59 161.22 12.55 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 122.755 2.304 . . . . 0.0 111.565 174.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.5 p -47.11 -37.0 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 125.281 1.432 . . . . 0.0 112.667 173.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -53.25 -37.7 62.34 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.612 1.565 . . . . 0.0 111.968 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.2 mm -83.23 112.81 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 102.992 -2.966 . . . . 0.0 102.992 173.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -79.39 -40.6 29.7 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 173.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.2 m -141.81 157.89 44.46 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.989 1.716 . . . . 0.0 109.572 -173.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 2.8 mmm -117.75 147.91 42.54 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 173.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -94.49 156.42 16.47 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 173.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -141.23 155.18 46.06 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 129.506 3.122 . . . . 0.0 102.701 172.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.2 m -139.05 133.35 31.51 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -177.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -145.93 162.59 37.43 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.404 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -163.24 146.17 10.37 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 173.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.04 -177.16 5.46 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 173.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -115.09 95.98 5.46 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.989 1.316 . . . . 0.0 109.206 -173.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.67 -89.69 0.03 OUTLIER Glycine 0 CA--C 1.534 1.254 0 C-N-CA 126.128 1.823 . . . . 0.0 115.979 173.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . 0.263 16.0 mm100 -117.12 26.14 9.99 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.542 1.937 . . . . 0.0 114.462 174.15 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -94.91 37.25 1.15 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.839 2.456 . . . . 0.0 112.215 177.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -38.9 113.4 0.3 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.802 1.641 . . . . 0.0 112.515 -173.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -106.36 129.98 54.27 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.157 1.783 . . . . 0.0 107.695 175.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -91.53 150.58 21.14 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 176.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -131.93 160.22 36.39 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 119.726 1.148 . . . . 0.0 110.236 174.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.444 ' O ' HD13 ' A' ' 131' ' ' ILE . 29.0 tt0 -155.37 135.49 13.02 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 173.288 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.478 ' CD2' HD23 ' A' ' 82' ' ' LEU . 77.6 m-85 -84.14 103.55 13.45 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.9 tt -65.24 -37.55 87.59 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 174.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.7 m -155.01 144.92 21.62 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 120.687 -1.258 . . . . 0.0 111.816 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.485 HD22 HG22 ' A' ' 128' ' ' VAL . 0.1 OUTLIER -156.24 93.52 1.42 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 102.678 -3.082 . . . . 0.0 102.678 173.573 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.461 ' HD3' ' H ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -154.21 158.64 40.6 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 121.206 1.821 . . . . 0.0 111.779 -178.184 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.1 t -71.72 167.65 19.43 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.915 0.886 . . . . 0.0 112.982 173.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.9 mt -126.69 -9.45 6.16 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 126.603 1.961 . . . . 0.0 114.308 174.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.524 ' CG ' ' H ' ' A' ' 87' ' ' LYS 0.309 13.3 t70 -96.43 170.67 9.07 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 122.01 2.186 . . . . 0.0 112.095 -173.721 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.524 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 1.3 mppt? -114.65 -53.01 2.68 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 129.16 2.984 . . . . 0.0 110.223 -173.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.433 ' C ' ' H ' ' A' ' 90' ' ' MET . . . -82.1 -58.62 2.44 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 125.052 1.31 . . . . 0.0 110.643 178.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mp -79.19 25.5 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 126.164 1.786 . . . . 0.0 110.376 -175.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.433 ' H ' ' C ' ' A' ' 88' ' ' GLY . 27.3 ttm -43.4 131.41 4.85 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 130.144 3.377 . . . . 0.0 109.292 -178.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -165.19 160.23 18.34 Favored 'General case' 0 N--CA 1.438 -1.028 1 C-N-CA 131.916 4.086 . . . . 0.0 103.785 -173.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.269 5.7 m-20 -138.16 124.84 13.17 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 118.618 0.644 . . . . 0.0 111.359 173.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.421 ' HG2' HD12 ' A' ' 82' ' ' LEU . 75.7 Cg_endo -70.08 142.42 46.45 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 122.035 1.824 . . . . 0.0 110.273 179.144 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.8 p -131.87 162.09 31.43 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.938 1.695 . . . . 0.0 108.726 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.4 m -126.14 153.37 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 119.176 0.898 . . . . 0.0 112.353 -174.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -79.27 9.67 4.41 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 127.335 2.254 . . . . 0.0 113.337 177.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.5 m -144.24 164.21 30.32 Favored Pre-proline 0 C--N 1.327 -0.376 0 C-N-CA 124.725 1.21 . . . . 0.0 109.603 -174.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -66.9 161.76 40.88 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 121.25 1.3 . . . . 0.0 109.348 173.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -65.57 -7.68 16.0 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.237 1.015 . . . . 0.0 112.192 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -144.47 164.12 31.81 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.372 1.469 . . . . 0.0 108.335 173.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.66 -161.37 34.12 Favored Glycine 0 C--O 1.226 -0.357 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.5 p -125.89 139.17 53.68 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.8 t -74.3 114.34 32.54 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -78.84 150.15 23.62 Favored 'Trans proline' 0 C--O 1.211 -0.845 0 C-N-CA 121.969 1.779 . . . . 0.0 111.583 -174.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.415 ' H ' ' CD2' ' A' ' 105' ' ' HIS . 6.2 m-70 -78.29 4.09 13.76 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 119.726 -1.859 . . . . 0.0 113.98 -173.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.83 127.24 54.11 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 173.303 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -43.94 110.68 0.22 Allowed 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 126.501 1.921 . . . . 0.0 109.806 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.3 m -119.21 140.45 50.19 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.7 t -94.87 117.52 38.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 C-N-CA 124.953 1.301 . . . . 0.0 108.97 -173.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.6 t -100.09 104.44 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 173.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -82.11 149.01 28.23 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 173.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.5 t -122.49 113.56 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 104.035 -2.579 . . . . 0.0 104.035 175.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -89.37 147.84 19.75 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.506 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 7.0 m-85 -127.73 73.53 78.52 Favored Pre-proline 0 C--O 1.242 0.706 0 CA-C-N 118.156 0.978 . . . . 0.0 109.472 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.28 123.5 10.95 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.681 2.254 . . . . 0.0 107.55 173.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 7.3 t -105.95 152.82 22.83 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.253 1.021 . . . . 0.0 108.717 178.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mt -72.02 -14.95 62.02 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 117.953 0.342 . . . . 0.0 111.409 176.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 54.21 42.91 74.1 Favored Glycine 0 C--O 1.22 -0.77 0 C-N-CA 126.479 1.99 . . . . 0.0 113.827 173.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . 0.282 27.4 mttp -125.39 -34.05 2.75 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.733 1.766 . . . . 0.0 113.551 176.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 50.2 tp60 -96.04 142.06 28.7 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 104.043 -2.576 . . . . 0.0 104.043 172.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -93.97 141.01 29.01 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 142.64 -154.73 25.39 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.7 t -129.2 114.11 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -175.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.73 168.82 12.63 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 173.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -125.6 157.75 36.37 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 123.963 0.905 . . . . 0.0 108.888 173.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.506 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 12.4 p90 -149.89 160.87 43.25 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 173.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.442 ' HG3' HH12 ' A' ' 83' ' ' ARG . 5.1 pt-20 -140.42 160.22 40.48 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 124.454 1.102 . . . . 0.0 111.444 -173.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.485 HG22 HD22 ' A' ' 82' ' ' LEU . 83.0 t -139.46 146.94 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 126.205 1.802 . . . . 0.0 109.51 -174.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -150.63 122.85 8.33 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 127.892 2.477 . . . . 0.0 105.784 173.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.422 HG22 ' CD2' ' A' ' 79' ' ' PHE . 21.8 t -135.87 123.74 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.674 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -91.02 165.38 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 173.552 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.8 t -144.99 134.31 18.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 -176.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.77 164.7 29.25 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.605 -174.059 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 45.2 p30 -79.31 166.77 21.76 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 104.104 -2.554 . . . . 0.0 104.104 172.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.3 t -60.69 -12.66 11.08 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 120.96 1.709 . . . . 0.0 115.612 -173.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -80.46 -12.08 59.6 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 121.113 1.779 . . . . 0.0 112.303 173.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.23 -3.54 54.85 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.824 1.202 . . . . 0.0 114.117 -174.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -66.91 117.17 8.63 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 120.037 1.919 . . . . 0.0 108.648 177.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -71.81 143.83 49.35 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.681 0.792 . . . . 0.0 108.932 -176.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -138.74 -37.88 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.504 1.122 . . . . 0.0 113.516 -175.021 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.46 HD13 ' N ' ' A' ' 142' ' ' GLN . 1.9 tm? -133.81 147.83 51.27 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 -177.278 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.46 ' N ' HD13 ' A' ' 141' ' ' LEU . 10.3 tm0? -147.87 147.03 29.33 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.927 0.891 . . . . 0.0 108.959 174.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 23.5 m -80.67 113.74 42.38 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 176.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.17 147.5 91.31 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 121.202 1.268 . . . . 0.0 110.904 -173.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -79.54 112.24 16.61 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 -174.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.625 37.3 m-80 172.12 -8.13 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.524 1 C-N-CA 134.876 5.271 . . . . 0.0 112.214 172.991 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.74 79.93 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.362 1.465 . . . . 0.0 108.687 174.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.3 mt -117.03 148.72 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 C-N-CA 127.189 2.196 . . . . 0.0 106.316 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -133.88 164.84 26.37 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.015 -1.448 . . . . 0.0 107.182 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -137.4 113.53 9.91 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.017 1.327 . . . . 0.0 107.602 -173.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.12 120.4 41.17 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 119.313 0.96 . . . . 0.0 108.765 -175.081 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.9 m -84.14 116.59 22.98 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 -177.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 6.9 m -113.09 166.17 11.68 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.832 0.853 . . . . 0.0 109.261 173.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.3 pp -136.88 163.5 30.53 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.845 1.258 . . . . 0.0 108.198 173.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -72.42 121.33 19.38 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 128.258 2.623 . . . . 0.0 110.817 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -146.17 170.35 16.9 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 127.304 2.242 . . . . 0.0 109.387 177.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 . . . . . 0 C--O 1.257 1.489 0 C-N-CA 131.162 3.785 . . . . 0.0 104.339 173.822 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.5 m . . . . . 0 CA--C 1.537 0.448 0 CA-C-O 121.624 0.726 . . . . 0.0 111.296 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.7 tt -86.39 136.56 33.08 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 128.81 2.844 . . . . 0.0 109.775 178.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -127.72 138.97 52.95 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.857 1.663 . . . . 0.0 108.412 173.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.39 117.6 7.33 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 -176.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 14.1 p90 -130.78 171.18 13.42 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.683 0.793 . . . . 0.0 110.518 177.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.1 mt -108.75 135.18 48.37 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 N-CA-C 103.591 -2.744 . . . . 0.0 103.591 174.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -91.79 159.96 15.55 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 122.577 1.18 . . . . 0.0 113.164 -173.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.89 -13.79 59.95 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.119 1.767 . . . . 0.0 113.99 175.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 31.6 m80 -59.4 -38.74 81.34 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 120.615 1.552 . . . . 0.0 109.058 175.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -64.08 -46.02 86.15 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.925 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.46 -31.85 73.15 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 123.244 0.618 . . . . 0.0 112.261 175.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 . . . . . 0 N--CA 1.447 -0.619 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 174.272 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 . . . . . 0 N--CA 1.454 -0.225 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -155.14 113.31 3.46 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 118.419 -0.8 . . . . 0.0 112.275 -179.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -96.25 165.12 12.37 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 122.35 2.341 . . . . 0.0 105.765 172.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 79.2 mt -140.26 113.17 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 173.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.81 114.22 24.22 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 -177.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.4 mt -92.44 -53.16 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 118.825 0.738 . . . . 0.0 109.661 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -123.44 113.81 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 -173.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.9 p -112.96 122.66 48.3 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 173.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 44.32 44.39 6.68 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.093 1.357 . . . . 0.0 112.602 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.32 4.72 1.32 Allowed Glycine 0 CA--C 1.536 1.371 0 C-N-CA 127.121 2.296 . . . . 0.0 114.743 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.97 37.28 0.48 Allowed 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 129.875 3.27 . . . . 0.0 111.426 -172.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 34.3 mtt -38.12 116.46 0.52 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 126.339 1.855 . . . . 0.0 114.381 -173.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.34 160.55 75.19 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 173.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.7 65.67 5.77 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 124.134 3.223 . . . . 0.0 109.685 175.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -62.17 -12.33 19.28 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 126.999 2.119 . . . . 0.0 114.77 -173.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 56.8 m -43.69 -48.51 7.88 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 126.049 1.739 . . . . 0.0 113.185 -173.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -59.63 -59.51 5.33 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 118.379 0.536 . . . . 0.0 110.325 -176.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.321 49.0 m-20 -76.04 -23.26 55.13 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -173.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -75.57 -58.04 3.52 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.714 1.143 . . . . 0.0 108.645 173.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 . . . . . 0 CA--C 1.539 0.522 0 O-C-N 121.291 -0.88 . . . . 0.0 110.983 -173.65 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.37 0 CA-C-O 116.85 -1.548 . . . . 0.0 113.411 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.01 -79.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.875 0 CA-C-N 122.152 1.804 . . . . 0.0 111.462 -174.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.09 113.47 20.64 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.612 0.765 . . . . 0.0 109.062 -174.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.5 mt -110.64 126.22 29.24 Favored Pre-proline 0 C--N 1.323 -0.566 0 C-N-CA 127.158 2.183 . . . . 0.0 105.437 -175.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.3 156.36 37.27 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.562 1.508 . . . . 0.0 110.216 178.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.0 p -42.11 -44.79 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 126.354 1.862 . . . . 0.0 112.194 174.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -61.43 -36.04 79.24 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 126.354 1.861 . . . . 0.0 113.159 -176.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 mm -75.63 112.65 13.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 101.309 -3.589 . . . . 0.0 101.309 173.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -79.25 -36.6 39.65 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.997 178.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.6 m -144.78 170.69 15.62 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 124.125 0.891 . . . . 0.0 111.953 -173.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 62.9 mtp -125.87 156.85 38.98 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 172.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -121.81 113.56 19.84 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -174.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -99.95 162.68 12.84 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 173.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.8 m -141.59 136.34 30.94 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 176.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -143.71 162.93 34.7 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 120.604 -0.439 . . . . 0.0 110.582 174.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -172.8 156.59 3.49 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.265 -0.88 . . . . 0.0 112.04 173.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.44 -173.41 4.7 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 172.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.27 134.15 55.28 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 102.767 -3.049 . . . . 0.0 102.767 173.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 19.28 -60.02 0.0 OUTLIER Glycine 0 CA--C 1.534 1.26 1 C-N-CA 135.634 6.35 . . . . 0.0 120.808 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -116.58 -13.06 10.89 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 121.139 2.47 . . . . 0.0 113.672 -177.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.96 37.4 0.6 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 130.037 3.335 . . . . 0.0 119.503 -173.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -51.39 116.25 1.98 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 123.388 2.813 . . . . 0.0 110.247 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -83.72 150.41 25.85 Favored 'General case' 0 C--N 1.334 -0.089 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 174.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -100.79 146.82 26.78 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 176.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -132.49 160.69 35.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 120.239 1.381 . . . . 0.0 110.983 176.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.457 ' O ' HD13 ' A' ' 131' ' ' ILE . 28.2 tt0 -152.6 133.74 14.23 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 173.12 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -81.32 111.22 17.5 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.714 1.206 . . . . 0.0 109.34 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.8 tt -74.28 -48.61 27.43 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.656 1.183 . . . . 0.0 107.857 174.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 m -128.66 148.08 50.78 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.04 1.336 . . . . 0.0 111.839 176.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -175.6 92.62 0.06 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 130.155 3.382 . . . . 0.0 103.913 173.085 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -162.16 153.46 18.13 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.348 -1.47 . . . . 0.0 111.279 -173.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.8 t -85.74 165.44 16.92 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 121.72 0.771 . . . . 0.0 109.174 173.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 98.8 mt -125.85 0.65 7.36 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 126.035 1.734 . . . . 0.0 112.163 -174.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.471 ' CG ' ' H ' ' A' ' 87' ' ' LYS 0.358 11.3 t70 -98.48 166.14 11.5 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.303 0.956 . . . . 0.0 112.391 178.247 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.471 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 1.4 mppt? -104.67 -46.86 4.22 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 129.401 3.081 . . . . 0.0 112.222 -173.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -105.0 -44.6 1.48 Allowed Glycine 0 CA--C 1.525 0.711 0 C-N-CA 125.075 1.321 . . . . 0.0 111.792 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mt -84.41 13.93 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 C-N-CA 125.274 1.43 . . . . 0.0 108.614 176.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 23.5 ttp -43.62 148.71 0.33 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 131.175 3.79 . . . . 0.0 110.548 177.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -162.7 176.28 10.48 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 127.724 2.41 . . . . 0.0 107.113 -173.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -137.51 113.92 9.48 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 172.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.91 154.31 75.0 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 N-CA-C 106.602 -2.115 . . . . 0.0 106.602 173.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.0 p -141.55 162.73 34.76 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 125.112 1.365 . . . . 0.0 108.435 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.0 m -126.47 155.43 36.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 123.742 0.817 . . . . 0.0 111.915 175.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -73.24 9.06 1.38 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.712 2.405 . . . . 0.0 113.212 174.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.1 m -140.73 165.52 29.17 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 125.903 1.681 . . . . 0.0 108.594 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -67.37 168.64 17.35 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.621 1.547 . . . . 0.0 111.293 174.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -62.63 -12.53 23.8 Favored 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 124.986 1.315 . . . . 0.0 111.914 174.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -143.17 163.83 31.81 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 120.314 1.416 . . . . 0.0 108.129 173.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.61 -161.7 34.37 Favored Glycine 0 C--O 1.228 -0.277 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 82.3 p -117.81 155.33 30.27 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 117.808 0.804 . . . . 0.0 109.404 173.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.6 t -93.69 113.12 59.54 Favored Pre-proline 0 N--CA 1.448 -0.541 0 N-CA-C 101.77 -3.419 . . . . 0.0 101.77 173.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -92.4 161.57 3.02 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.431 2.088 . . . . 0.0 111.998 -173.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -72.62 3.17 5.28 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 120.116 -1.615 . . . . 0.0 112.382 -173.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -114.11 116.0 28.42 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 127.654 2.382 . . . . 0.0 107.672 -173.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -44.68 105.87 0.06 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.563 1.145 . . . . 0.0 109.942 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 26.8 m -111.75 135.16 52.72 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.4 t -90.28 114.09 27.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -173.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 70.8 t -94.0 103.21 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 103.536 -2.764 . . . . 0.0 103.536 173.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -84.05 119.08 24.52 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 173.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.5 t -90.56 113.47 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 103.13 -2.915 . . . . 0.0 103.13 173.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -93.9 149.11 19.29 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.435 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 7.8 m-85 -132.3 73.45 77.35 Favored Pre-proline 0 C--O 1.244 0.784 0 CA-C-N 118.258 1.029 . . . . 0.0 110.766 -176.134 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -68.04 114.27 3.33 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 N-CA-C 106.844 -2.022 . . . . 0.0 106.844 173.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 5.6 t -91.88 143.58 26.36 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 175.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.0 mt -74.26 -11.41 60.27 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 119.32 -0.371 . . . . 0.0 111.5 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 53.17 39.61 58.34 Favored Glycine 0 C--N 1.339 0.744 0 C-N-CA 125.768 1.652 . . . . 0.0 113.69 173.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -93.48 -65.25 1.01 Allowed 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 118.219 1.01 . . . . 0.0 109.299 -177.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -96.07 155.26 16.83 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 174.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -93.44 147.72 22.7 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.383 1.473 . . . . 0.0 107.72 178.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.5 -155.5 26.38 Favored Glycine 0 C--N 1.332 0.34 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.9 t -126.63 114.01 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -88.26 170.58 10.88 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 173.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -124.06 158.19 32.76 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 173.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.435 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 50.1 p90 -148.71 153.55 38.39 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 173.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.55 154.59 37.7 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 126.231 1.813 . . . . 0.0 110.199 -173.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 87.7 t -143.09 144.64 23.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 173.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -157.38 132.53 8.91 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 125.078 1.351 . . . . 0.0 107.894 173.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.3 t -137.26 135.26 47.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -174.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.585 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -103.2 164.07 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 173.838 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.2 t -142.66 138.21 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -173.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.81 175.65 9.42 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 125.565 1.546 . . . . 0.0 107.97 -176.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 39.3 p-10 -90.92 176.22 6.69 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 172.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.1 t -66.17 -7.13 16.14 Favored 'General case' 0 CA--C 1.553 1.059 0 O-C-N 120.552 -1.342 . . . . 0.0 112.549 -176.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -86.13 -14.85 42.93 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.455 -1.403 . . . . 0.0 110.933 173.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.5 1.44 64.15 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.659 1.123 . . . . 0.0 112.465 -173.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 63.2 m-20 -71.75 116.29 11.95 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 119.68 1.74 . . . . 0.0 108.504 174.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -64.76 142.36 58.46 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.063 1.745 . . . . 0.0 108.461 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.3 pt -140.58 -38.69 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.758 1.223 . . . . 0.0 113.841 -174.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -130.91 141.54 50.3 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 -177.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -149.07 124.95 10.57 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -176.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 41.3 m -61.67 143.72 93.57 Favored Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 174.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.49 141.95 23.01 Favored 'Trans proline' 0 N--CA 1.441 -1.613 0 N-CA-C 107.587 -1.736 . . . . 0.0 107.587 173.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -77.0 112.64 13.84 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 102.225 -3.25 . . . . 0.0 102.225 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 4.1 m120 174.45 -30.24 0.0 OUTLIER 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.17 1.788 . . . . 0.0 111.419 -173.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.75 103.91 0.39 Allowed 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.443 1.497 . . . . 0.0 110.219 -174.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 2.0 mt -134.29 148.74 29.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -176.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 126' ' ' PHE . 0.9 OUTLIER -132.19 169.98 15.66 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.198 1.799 . . . . 0.0 107.479 179.078 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -136.4 113.74 10.76 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.281 1.032 . . . . 0.0 109.073 -173.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -103.13 124.95 49.53 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.677 1.126 . . . . 0.0 109.136 179.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 25.7 m -83.67 116.69 22.76 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 174.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 4.5 m -119.27 166.21 13.28 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.494 0.718 . . . . 0.0 109.84 174.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.2 pp -133.27 161.16 35.22 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.459 1.504 . . . . 0.0 107.89 176.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.16 131.95 46.82 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.926 1.29 . . . . 0.0 109.927 177.037 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -146.91 133.49 19.83 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.814 1.646 . . . . 0.0 107.509 174.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 . . . . . 0 C--O 1.257 1.464 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 177.485 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 CA--C 1.537 0.462 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 13' ' ' TYR . 3.1 tt -43.55 138.13 2.62 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.96 2.504 . . . . 0.0 113.075 177.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.469 ' N ' HD23 ' A' ' 12' ' ' LEU . 86.9 m-85 -122.12 135.57 54.81 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.51 1.924 . . . . 0.0 108.467 173.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.99 121.06 10.08 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 127.231 2.212 . . . . 0.0 107.115 -176.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 12.8 p90 -139.63 175.07 9.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 118.933 0.788 . . . . 0.0 109.946 176.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.434 HD11 HD11 ' A' ' 33' ' ' ILE . 2.2 mp -112.77 113.72 44.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 100.226 -3.99 . . . . 0.0 100.226 173.051 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -79.58 152.9 29.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 122.861 1.315 . . . . 0.0 111.832 -173.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.2 -19.18 61.32 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -173.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -61.09 -34.06 74.32 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 119.564 1.075 . . . . 0.0 109.396 174.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 48.1 tp60 -69.16 -48.44 62.25 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 118.103 0.41 . . . . 0.0 111.6 177.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.95 -29.58 68.5 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 119.131 -0.461 . . . . 0.0 111.617 174.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 27.0 ttm105 . . . . . 0 N--CA 1.447 -0.592 0 CA-C-N 119.658 1.117 . . . . 0.0 108.038 173.435 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 . . . . . 0 CA--C 1.536 0.427 0 CA-C-O 118.987 -0.53 . . . . 0.0 109.589 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -160.21 114.07 2.18 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.186 1.795 . . . . 0.0 110.569 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -94.55 165.49 12.5 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 172.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.7 mm -137.98 113.35 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 173.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.35 114.63 22.01 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -177.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.434 HD11 HD11 ' A' ' 16' ' ' ILE . 17.2 mt -87.42 -58.41 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -126.04 122.55 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 126.375 1.87 . . . . 0.0 107.683 -173.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 81.0 p -123.56 127.96 49.05 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 101.07 -3.678 . . . . 0.0 101.07 172.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.292 0.4 OUTLIER 44.08 36.66 1.53 Allowed 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 119.893 1.224 . . . . 0.0 114.025 178.55 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.5 -8.4 2.24 Favored Glycine 0 CA--C 1.546 2.024 0 O-C-N 120.461 -1.399 . . . . 0.0 115.443 -175.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.83 37.56 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.573 1 C-N-CA 134.524 5.13 . . . . 0.0 111.987 175.528 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 53.9 mtp -37.6 119.38 0.72 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.262 1.425 . . . . 0.0 112.826 -172.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.07 163.35 13.81 Favored Pre-proline 0 N--CA 1.447 -0.62 0 CA-C-N 113.442 -1.708 . . . . 0.0 109.696 177.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.97 30.57 0.29 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 123.994 3.129 . . . . 0.0 111.911 173.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -55.16 -26.76 40.91 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 126.363 1.865 . . . . 0.0 111.427 -174.204 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.9 m -56.29 -37.74 70.27 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 127.428 2.291 . . . . 0.0 111.605 -173.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -60.84 -65.51 0.68 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 177.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -65.11 -23.7 67.22 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.637 0.775 . . . . 0.0 112.997 -174.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -70.01 -47.05 63.7 Favored 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 124.002 0.921 . . . . 0.0 109.821 173.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.9 ttp180 . . . . . 0 CA--C 1.545 0.781 0 C-N-CA 124.932 1.293 . . . . 0.0 112.468 -177.026 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 90.0 mmm . . . . . 0 CA--C 1.535 0.387 0 CA-C-O 116.278 -1.82 . . . . 0.0 114.635 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -59.68 -72.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.791 0 CA-C-N 121.877 1.706 . . . . 0.0 113.252 -173.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.19 125.65 29.66 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -176.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 58.4 mt -124.86 131.18 24.07 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 128.14 2.576 . . . . 0.0 106.207 -173.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -81.07 158.44 20.53 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.11 1.873 . . . . 0.0 111.198 174.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.7 p -46.7 -37.31 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 126.058 1.743 . . . . 0.0 112.313 173.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -53.37 -40.1 64.71 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 126.492 1.917 . . . . 0.0 112.582 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 mm -76.6 112.77 14.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 103.394 -2.817 . . . . 0.0 103.394 174.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -83.09 -35.03 25.99 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 173.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.8 m -147.71 152.86 38.5 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.866 1.266 . . . . 0.0 108.271 -174.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 22.3 mtp -113.36 164.03 14.1 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 172.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -133.88 114.47 13.35 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 -173.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -98.97 168.56 10.03 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 173.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.9 m -141.34 135.24 30.3 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -143.66 164.55 30.11 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 121.856 -0.528 . . . . 0.0 111.046 176.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.51 161.56 18.68 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.525 1.13 . . . . 0.0 111.647 174.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.34 160.15 15.59 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.843 0.857 . . . . 0.0 108.759 173.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.55 84.54 7.2 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.871 1.268 . . . . 0.0 110.924 -174.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 50.88 -46.93 0.01 OUTLIER Glycine 0 CA--C 1.542 1.752 1 C-N-CA 131.51 4.386 . . . . 0.0 121.58 173.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -117.14 2.16 12.59 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 120.471 2.135 . . . . 0.0 116.017 -173.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.435 ' H ' ' CE1' ' A' ' 105' ' ' HIS . . . -126.01 37.24 4.38 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 120.903 3.668 . . . . 0.0 120.903 -172.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -38.29 114.21 0.35 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 123.203 2.728 . . . . 0.0 112.882 -173.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -83.86 123.2 29.68 Favored 'General case' 0 C--N 1.338 0.068 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 -174.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -76.69 148.26 36.92 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 -176.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -132.51 160.27 37.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 119.989 1.268 . . . . 0.0 111.106 176.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.482 ' O ' HD13 ' A' ' 131' ' ' ILE . 29.0 tt0 -152.76 137.86 17.32 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 173.008 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -87.27 104.09 16.07 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 125.288 1.435 . . . . 0.0 109.764 -176.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.4 tt -70.7 -39.28 73.56 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.922 1.289 . . . . 0.0 108.449 176.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.7 m -135.56 144.25 46.13 Favored 'General case' 0 C--N 1.34 0.187 0 O-C-N 121.177 -0.952 . . . . 0.0 112.063 178.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.403 ' H ' ' HD3' ' A' ' 83' ' ' ARG . 1.6 tt -174.13 93.04 0.08 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 128.977 2.911 . . . . 0.0 105.524 173.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.403 ' HD3' ' H ' ' A' ' 82' ' ' LEU . 0.2 OUTLIER -159.97 153.35 22.23 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 119.753 1.16 . . . . 0.0 111.393 -173.993 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.1 t -78.37 129.02 34.48 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 119.633 1.106 . . . . 0.0 110.798 174.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 68.2 mt -93.16 -27.03 17.15 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 116.874 -1.536 . . . . 0.0 111.164 174.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -77.04 165.72 24.25 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.719 1.6 . . . . 0.0 107.134 175.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.35 -41.98 1.53 Allowed 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.728 1.611 . . . . 0.0 110.855 -173.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -72.39 -69.57 1.37 Allowed Glycine 0 CA--C 1.533 1.192 0 N-CA-C 108.386 -1.885 . . . . 0.0 108.386 173.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.574 ' H ' HD12 ' A' ' 89' ' ' ILE . 3.5 mp -73.44 14.39 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 C-N-CA 128.812 2.845 . . . . 0.0 110.476 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 22.1 ttp -43.2 136.75 2.83 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 128.167 2.587 . . . . 0.0 112.331 -173.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -156.69 113.58 3.1 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 -174.2 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -97.99 122.53 54.23 Favored Pre-proline 0 CA--C 1.509 -0.629 0 O-C-N 124.364 1.04 . . . . 0.0 109.285 -173.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -65.88 152.37 81.65 Favored 'Trans proline' 0 N--CA 1.443 -1.466 0 C-N-CA 120.83 1.02 . . . . 0.0 109.5 178.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 42.0 p -135.77 161.96 34.11 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.323 1.449 . . . . 0.0 107.137 173.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.9 m -126.47 149.71 31.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 O-C-N 121.241 -0.912 . . . . 0.0 111.679 174.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -86.81 13.77 8.31 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.772 1.629 . . . . 0.0 111.174 173.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.0 m -130.99 163.13 51.21 Favored Pre-proline 0 N--CA 1.454 -0.273 0 C-N-CA 125.829 1.652 . . . . 0.0 106.587 173.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -67.51 163.32 35.32 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 120.72 0.946 . . . . 0.0 109.864 173.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -62.72 -13.36 31.69 Favored 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 124.459 1.104 . . . . 0.0 111.583 175.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -139.53 163.58 32.17 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.205 1.402 . . . . 0.0 107.894 173.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 164.54 -159.67 32.67 Favored Glycine 0 C--O 1.226 -0.349 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -178.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 68.8 p -123.03 151.36 41.99 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 117.548 0.674 . . . . 0.0 109.506 174.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 48.2 t -89.62 113.45 56.78 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 101.925 -3.361 . . . . 0.0 101.925 173.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -91.95 171.68 2.66 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 N-CA-C 117.591 2.112 . . . . 0.0 117.591 -172.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.435 ' CE1' ' H ' ' A' ' 73' ' ' ALA . 76.1 m-70 -75.9 -0.59 21.9 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 -173.219 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.5 138.92 51.01 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 116.319 -1.8 . . . . 0.0 106.724 173.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.54 112.15 0.7 Allowed 'General case' 0 C--O 1.231 0.129 0 O-C-N 125.407 1.692 . . . . 0.0 106.466 173.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.5 m -123.23 136.72 54.85 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -176.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.8 t -85.1 135.89 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 O-C-N 124.737 1.273 . . . . 0.0 108.673 -173.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 74.7 t -112.8 103.66 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 104.355 -2.461 . . . . 0.0 104.355 173.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -83.77 125.63 32.11 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 173.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.5 t -102.94 113.55 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 102.712 -3.07 . . . . 0.0 102.712 173.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -82.86 151.49 29.0 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 174.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.45 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 8.7 m-85 -133.42 73.35 73.57 Favored Pre-proline 0 C--O 1.244 0.784 0 CA-C-N 118.279 1.039 . . . . 0.0 109.994 177.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -67.34 114.08 3.12 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.295 1.997 . . . . 0.0 108.634 173.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 5.9 t -89.45 151.43 22.02 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 173.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.1 mt -71.22 -10.95 60.6 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.102 0.41 . . . . 0.0 111.862 -176.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.77 23.01 49.19 Favored Glycine 0 C--N 1.339 0.713 0 C-N-CA 126.74 2.114 . . . . 0.0 116.786 173.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 50.7 mttt -120.98 -27.38 4.98 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.583 1.691 . . . . 0.0 113.375 177.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -96.62 156.59 16.28 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 173.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -112.03 151.54 29.22 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 175.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 140.41 -155.94 24.92 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 118.673 0.67 . . . . 0.0 111.56 174.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 20.7 t -122.99 114.14 40.91 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 175.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.3 172.89 9.53 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.553 1.141 . . . . 0.0 109.648 173.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -131.64 148.58 52.61 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.154 1.782 . . . . 0.0 107.684 173.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.46 ' CZ ' ' HB2' ' A' ' 149' ' ' PHE . 43.5 p90 -145.69 151.66 38.39 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 173.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -111.22 148.16 33.43 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 125.152 1.381 . . . . 0.0 111.498 -173.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 31.9 t -141.45 145.35 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 173.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -159.9 135.2 8.16 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 125.168 1.387 . . . . 0.0 108.252 174.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 37.4 t -139.74 131.42 33.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -174.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.616 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -100.93 165.38 2.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 173.829 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.2 t -142.06 138.07 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -173.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.8 175.19 9.81 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.667 1.587 . . . . 0.0 108.113 -176.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 36.9 p-10 -89.82 176.13 6.95 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 172.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.2 t -65.91 -3.51 5.31 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 120.24 -1.538 . . . . 0.0 113.678 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -89.62 -15.25 33.15 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 120.655 1.571 . . . . 0.0 110.595 173.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.72 1.12 62.01 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.62 1.105 . . . . 0.0 112.254 -173.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -71.53 115.9 11.25 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 119.606 1.703 . . . . 0.0 108.403 174.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -64.71 142.76 58.32 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 126.203 1.801 . . . . 0.0 108.632 -177.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.7 pt -139.67 -37.97 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 124.773 1.229 . . . . 0.0 113.884 -174.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -132.72 145.12 50.76 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -148.81 126.95 12.06 Favored 'General case' 0 CA--C 1.52 -0.187 0 O-C-N 121.009 -1.057 . . . . 0.0 108.615 -177.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 63.1 m -64.92 143.46 98.85 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 176.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.55 143.36 21.54 Favored 'Trans proline' 0 N--CA 1.445 -1.372 0 N-CA-C 108.989 -1.197 . . . . 0.0 108.989 174.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -80.46 112.68 18.03 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 176.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 173.11 -19.03 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 130.182 3.393 . . . . 0.0 110.434 -174.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.8 78.58 0.86 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.185 1.394 . . . . 0.0 109.879 -175.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 27.9 mm -101.99 130.01 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 105.002 -2.222 . . . . 0.0 105.002 173.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 126' ' ' PHE . 0.2 OUTLIER -105.0 155.71 18.71 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 173.768 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -130.84 113.47 14.11 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -174.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -110.29 123.9 50.65 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 119.128 0.876 . . . . 0.0 109.617 -174.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 22.5 m -83.48 114.26 21.36 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 175.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 25.5 m -114.6 166.08 12.1 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 123.881 0.872 . . . . 0.0 110.099 174.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.4 pp -141.59 159.08 42.95 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.766 1.627 . . . . 0.0 107.206 173.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.56 128.12 35.25 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.182 0.993 . . . . 0.0 110.318 175.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -157.62 119.44 3.7 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.123 1.369 . . . . 0.0 110.376 176.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 . . . . . 0 C--O 1.256 1.404 0 C-N-CA 129.158 2.983 . . . . 0.0 105.271 173.583 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 CA--C 1.534 0.331 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.0 tt -43.91 128.0 5.44 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.776 1.63 . . . . 0.0 111.3 -176.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -115.98 128.48 55.77 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.503 1.521 . . . . 0.0 107.995 174.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.51 120.07 13.24 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 -179.336 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 14.1 p90 -140.48 174.88 10.08 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.776 0.716 . . . . 0.0 109.878 176.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.7 mp -113.74 113.72 44.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 1 N-CA-C 99.844 -4.132 . . . . 0.0 99.844 173.098 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -75.95 149.9 37.58 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.971 1.367 . . . . 0.0 111.417 -173.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.19 -26.46 63.9 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 113.75 -1.568 . . . . 0.0 113.304 -173.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -67.16 -44.55 79.48 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -174.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.6 -56.3 23.13 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 118.047 -0.978 . . . . 0.0 108.441 174.116 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.0 -41.05 61.88 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 117.228 -1.368 . . . . 0.0 111.987 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 51.9 ttm-85 . . . . . 0 N--CA 1.454 -0.228 0 CA-C-N 120.802 1.637 . . . . 0.0 108.925 174.168 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 . . . . . 0 C--O 1.225 -0.185 0 CA-C-O 118.607 -0.711 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -151.83 141.21 21.52 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 128.687 2.795 . . . . 0.0 104.25 173.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.01 166.47 13.87 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 173.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 82.3 mt -136.86 113.15 12.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 104.44 -2.429 . . . . 0.0 104.44 173.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.42 114.35 23.95 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 -177.098 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.2 mt -88.47 -61.99 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.455 HG22 ' HG2' ' A' ' 39' ' ' MET . 21.2 t -116.74 114.34 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 125.648 1.579 . . . . 0.0 107.049 -173.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.9 p -109.92 114.76 28.57 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 173.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.434 ' C ' ' H ' ' A' ' 38' ' ' LYS . 11.5 pt-20 46.41 36.86 3.72 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.491 1.516 . . . . 0.0 112.777 -178.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.19 -22.31 1.28 Allowed Glycine 0 CA--C 1.544 1.891 0 O-C-N 120.15 -1.594 . . . . 0.0 114.191 -175.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.434 ' H ' ' C ' ' A' ' 36' ' ' GLU . 15.9 ttpt -67.39 37.88 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.583 1 C-N-CA 137.471 6.309 . . . . 0.0 110.985 177.024 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.455 ' HG2' HG22 ' A' ' 34' ' ' VAL 0.284 34.7 mtt -37.38 136.22 0.49 Allowed 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.882 2.073 . . . . 0.0 114.372 -172.86 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.31 163.04 56.21 Favored Pre-proline 0 N--CA 1.448 -0.563 0 CA-C-N 112.844 -1.98 . . . . 0.0 107.778 173.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.24 34.37 0.33 Allowed 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 124.04 3.16 . . . . 0.0 112.095 174.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -55.52 -26.75 44.7 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 126.247 1.819 . . . . 0.0 112.257 -173.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.6 m -60.4 -34.68 74.28 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 126.428 1.891 . . . . 0.0 111.585 -173.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -57.92 -65.74 0.59 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.098 0.959 . . . . 0.0 108.676 178.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -61.79 -41.43 97.73 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 117.327 -1.32 . . . . 0.0 113.563 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -55.84 -49.62 72.81 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.301 1.041 . . . . 0.0 111.069 -178.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.9 ttp180 . . . . . 0 CA--C 1.537 0.477 0 CA-C-N 118.509 0.595 . . . . 0.0 111.062 -178.768 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.7 mtp . . . . . 0 N--CA 1.471 0.623 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -65.93 -66.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 121.942 1.762 . . . . 0.0 112.401 -174.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.89 114.22 9.75 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.579 1.152 . . . . 0.0 109.863 -174.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 98.0 mt -119.43 119.91 31.26 Favored Pre-proline 0 N--CA 1.449 -0.476 0 C-N-CA 126.5 1.92 . . . . 0.0 106.379 -175.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.42 156.66 41.17 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.064 1.843 . . . . 0.0 110.174 175.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.2 p -40.61 -42.54 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 127.194 2.198 . . . . 0.0 112.91 175.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -57.45 -36.03 70.89 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 126.455 1.902 . . . . 0.0 113.23 -177.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.0 mm -72.12 112.86 8.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 102.649 -3.093 . . . . 0.0 102.649 173.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -82.42 -40.14 21.64 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 173.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.4 m -146.09 165.95 27.56 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.682 0.793 . . . . 0.0 110.141 -173.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 46.4 mtp -126.11 171.87 10.48 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 127.926 2.49 . . . . 0.0 104.889 173.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -140.23 137.48 34.32 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 173.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -111.26 169.15 8.98 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 173.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.4 m -137.37 130.91 31.33 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -144.41 165.52 27.7 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 121.726 -0.609 . . . . 0.0 110.454 174.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -168.31 155.98 8.16 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.081 173.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.99 -174.04 2.54 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 123.536 1.636 . . . . 0.0 107.55 173.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . 0.257 . . -106.37 131.36 53.67 Favored 'General case' 0 N--CA 1.411 -2.389 1 C-N-CA 131.985 4.114 . . . . 0.0 102.99 174.546 . . . . . . . . 3 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -8.63 -55.66 0.01 OUTLIER Glycine 0 CA--C 1.536 1.348 1 C-N-CA 133.883 5.516 . . . . 0.0 119.429 -173.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -116.95 12.03 14.53 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 121.045 2.423 . . . . 0.0 114.664 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.79 37.52 3.42 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 120.251 3.426 . . . . 0.0 120.251 -172.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -45.13 113.71 0.61 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 123.446 2.839 . . . . 0.0 110.448 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -83.83 134.34 34.71 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.412 1.485 . . . . 0.0 106.992 177.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -83.71 146.32 28.27 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -129.8 160.91 32.02 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 120.212 1.369 . . . . 0.0 110.714 175.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.43 ' O ' HD13 ' A' ' 131' ' ' ILE . 30.6 tt0 -154.48 135.03 13.47 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 173.272 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -85.69 104.06 15.05 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.951 1.3 . . . . 0.0 108.51 -178.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.9 tt -69.24 -54.54 14.24 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 173.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 m -131.1 141.72 50.18 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 123.342 1.544 . . . . 0.0 111.692 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.486 HD22 HG22 ' A' ' 128' ' ' VAL . 0.1 OUTLIER -163.72 92.61 0.7 Allowed 'General case' 0 N--CA 1.448 -0.536 1 N-CA-C 96.011 -5.552 . . . . 0.0 96.011 172.82 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -158.11 146.54 18.88 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.503 -1.373 . . . . 0.0 112.339 -173.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.1 t -78.5 156.92 29.03 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.956 0.502 . . . . 0.0 110.821 174.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.4 mt -121.04 -26.34 5.16 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 116.908 -1.52 . . . . 0.0 112.461 -176.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -81.32 160.18 24.23 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 121.591 1.996 . . . . 0.0 112.038 -177.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.456 ' HE3' ' HA ' ' A' ' 87' ' ' LYS . 0.5 OUTLIER -105.39 -42.57 5.2 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 131.126 3.77 . . . . 0.0 112.556 176.02 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -67.75 -74.16 0.6 Allowed Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 174.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.405 ' HB ' ' HB2' ' A' ' 124' ' ' ALA . 3.5 mp -77.35 26.03 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 129.996 3.319 . . . . 0.0 110.301 -177.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 10.7 ttm -43.55 140.52 1.72 Allowed 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 128.143 2.577 . . . . 0.0 110.031 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -164.69 175.61 9.58 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 130.017 3.327 . . . . 0.0 105.286 -173.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.273 8.2 m-20 -145.46 115.03 4.86 Favored Pre-proline 0 C--N 1.324 -0.526 0 C-N-CA 124.527 1.131 . . . . 0.0 110.07 173.002 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -69.58 149.77 68.46 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 N-CA-C 108.322 -1.453 . . . . 0.0 108.322 173.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 21.8 p -137.13 160.63 38.42 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 125.62 1.568 . . . . 0.0 108.072 -175.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.5 m -126.01 153.82 34.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 C-N-CA 124.014 0.925 . . . . 0.0 109.637 174.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -93.2 25.63 3.23 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.613 1.565 . . . . 0.0 111.702 176.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.8 m -134.93 163.3 52.18 Favored Pre-proline 0 C--O 1.235 0.29 0 C-N-CA 124.85 1.26 . . . . 0.0 108.142 174.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -66.66 162.2 38.24 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 121.087 1.191 . . . . 0.0 109.418 173.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.01 -12.72 40.72 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 124.056 0.942 . . . . 0.0 111.902 178.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -143.29 165.71 26.72 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 120.325 1.421 . . . . 0.0 108.641 173.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 164.53 -162.73 35.69 Favored Glycine 0 C--O 1.228 -0.27 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 178.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 82.0 p -117.97 146.66 43.83 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 173.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 28.2 t -82.44 113.74 46.52 Favored Pre-proline 0 N--CA 1.447 -0.594 0 N-CA-C 102.996 -2.964 . . . . 0.0 102.996 173.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -84.42 153.63 12.18 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.347 2.031 . . . . 0.0 111.626 -173.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -69.73 1.81 3.91 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 120.113 -1.617 . . . . 0.0 113.369 -173.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -115.28 119.18 35.44 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 127.086 2.154 . . . . 0.0 107.585 -173.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -43.02 107.84 0.09 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.732 1.213 . . . . 0.0 109.91 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.1 m -118.13 139.18 51.63 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.5 t -96.75 135.25 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 114.301 -1.318 . . . . 0.0 107.834 -173.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 78.5 t -119.86 103.93 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -71.82 143.24 49.54 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 173.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.7 t -124.86 113.91 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 103.707 -2.701 . . . . 0.0 103.707 173.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -100.77 147.91 18.06 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 125.134 1.349 . . . . 0.0 110.145 -178.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.41 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 9.0 m-85 -131.16 73.54 80.47 Favored Pre-proline 0 C--O 1.242 0.706 0 CA-C-N 118.325 1.063 . . . . 0.0 111.596 -174.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -69.18 129.88 19.03 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.326 2.017 . . . . 0.0 108.239 173.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 5.7 t -105.44 154.2 20.65 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 175.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 7.6 mt -70.95 -12.78 61.73 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.559 0.618 . . . . 0.0 111.363 174.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.53 5.01 5.91 Favored Glycine 0 C--O 1.215 -1.037 0 C-N-CA 128.513 2.959 . . . . 0.0 116.169 173.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -94.64 -31.51 13.81 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 120.695 2.247 . . . . 0.0 114.418 -173.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 51.4 tp60 -96.57 146.9 24.41 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 173.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -94.25 143.07 26.71 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 174.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 141.48 -154.44 24.67 Favored Glycine 0 C--N 1.334 0.465 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 178.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.4 t -131.6 114.12 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 C-N-CA 123.288 0.635 . . . . 0.0 109.358 -177.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.405 ' HB2' ' HB ' ' A' ' 89' ' ' ILE . . . -89.97 168.34 12.1 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 173.302 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -124.08 156.87 35.8 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.119 0.968 . . . . 0.0 109.651 174.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.41 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 3.9 p90 -145.14 148.53 33.71 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.334 1.053 . . . . 0.0 108.518 173.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -111.78 157.78 20.14 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 126.456 1.902 . . . . 0.0 110.876 -174.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.486 HG22 HD22 ' A' ' 82' ' ' LEU . 89.6 t -141.67 138.32 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.403 1.081 . . . . 0.0 109.311 174.009 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -150.66 118.53 6.22 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 126.97 2.108 . . . . 0.0 105.889 173.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 31.4 t -127.72 123.96 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.65 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -89.88 164.96 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 173.717 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.9 t -144.37 135.35 21.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 -176.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.36 173.99 11.08 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.979 1.312 . . . . 0.0 108.832 -176.536 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -89.06 175.85 7.23 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 172.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 6.7 t -65.02 -15.13 61.98 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 120.11 -1.619 . . . . 0.0 112.175 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -79.86 -3.22 46.97 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.698 1.599 . . . . 0.0 110.913 175.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 80.54 6.54 89.25 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.073 1.32 . . . . 0.0 112.973 178.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -81.72 119.38 23.78 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 178.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -65.98 143.68 57.23 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.359 1.464 . . . . 0.0 109.241 -176.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -140.32 -37.62 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 125.126 1.371 . . . . 0.0 113.576 -174.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -131.01 149.82 52.44 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 178.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.3 tm0? -148.67 150.02 32.49 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 57.4 m -80.11 113.56 39.52 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 178.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -61.39 140.15 86.4 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 CA-C-N 120.685 1.28 . . . . 0.0 110.59 -173.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -75.57 112.53 12.02 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 -173.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 173.07 -34.49 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 129.874 3.27 . . . . 0.0 108.501 -173.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.44 90.72 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 126.656 1.982 . . . . 0.0 110.521 -174.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.3 mt -126.24 148.58 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 176.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -126.69 164.32 21.57 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 175.166 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -132.83 113.53 13.02 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.223 1.009 . . . . 0.0 108.309 -173.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -101.03 120.33 40.04 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 28.6 m -83.78 116.33 22.65 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 173.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 9.3 m -111.67 163.44 14.11 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 173.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.2 pp -139.35 159.76 41.41 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 174.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -63.67 114.09 3.76 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 127.813 2.445 . . . . 0.0 111.557 -174.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -153.43 157.7 40.32 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 126.054 1.742 . . . . 0.0 109.549 176.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 . . . . . 0 C--O 1.248 0.985 0 C-N-CA 131.612 3.965 . . . . 0.0 105.557 173.661 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.2 m . . . . . 0 C--O 1.224 -0.28 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.8 tt -43.22 123.64 2.99 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.363 2.665 . . . . 0.0 113.458 -173.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.432 ' CD1' ' HA ' ' A' ' 35' ' ' SER . 94.5 m-85 -113.75 141.45 47.26 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 128.414 2.686 . . . . 0.0 108.656 173.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.01 121.94 7.07 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.759 1.623 . . . . 0.0 106.996 -178.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 26.9 p90 -137.89 175.43 9.59 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.595 1.089 . . . . 0.0 110.675 176.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -111.84 134.34 54.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 103.228 -2.879 . . . . 0.0 103.228 173.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -78.96 162.49 25.93 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 123.016 1.389 . . . . 0.0 112.846 -173.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.4 ' HB1' ' HG3' ' A' ' 28' ' ' GLU . . . -78.87 -26.41 43.95 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 113.775 -1.557 . . . . 0.0 112.137 -176.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 10.2 m80 -63.98 -41.96 97.37 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.094 0.957 . . . . 0.0 108.73 -175.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -62.26 -43.99 97.56 Favored 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 123.909 0.884 . . . . 0.0 110.616 177.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.75 -35.47 76.48 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 118.401 -0.809 . . . . 0.0 111.005 176.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 173.507 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.4 ' HG3' ' HB1' ' A' ' 18' ' ' ALA . 19.9 tt0 . . . . . 0 CA--C 1.533 0.306 0 CA-C-O 119.754 -0.165 . . . . 0.0 111.208 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -155.87 137.53 14.21 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 127.809 2.443 . . . . 0.0 105.942 173.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -72.64 175.77 6.09 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.976 2.11 . . . . 0.0 109.644 173.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 66.9 mt -140.81 113.62 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 173.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.55 127.07 34.33 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -176.553 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.4 mt -102.39 -56.33 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 119.313 0.961 . . . . 0.0 110.665 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.2 t -125.34 131.7 71.97 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -173.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.432 ' HA ' ' CD1' ' A' ' 13' ' ' TYR . 18.8 p -134.49 120.3 19.56 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 174.086 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.433 1.0 OUTLIER 43.63 47.83 6.43 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 122.72 1.248 . . . . 0.0 112.397 -176.377 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.24 11.68 20.97 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 126.165 1.841 . . . . 0.0 114.959 177.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.489 ' HB2' ' HZ3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -74.23 37.31 0.1 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.633 2.373 . . . . 0.0 113.762 -173.308 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 9.4 mmt -38.22 113.49 0.29 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 122.746 1.26 . . . . 0.0 111.981 -173.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.78 170.09 8.19 Favored Pre-proline 0 N--CA 1.448 -0.535 0 C-N-CA 127.734 2.413 . . . . 0.0 109.079 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.0 26.19 0.25 Allowed 'Trans proline' 0 CA--C 1.548 1.212 0 C-N-CA 123.678 2.918 . . . . 0.0 112.09 173.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -53.57 -26.43 21.47 Favored 'General case' 0 C--N 1.345 0.402 0 C-N-CA 126.437 1.895 . . . . 0.0 111.625 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 m -60.49 -29.81 69.31 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 126.099 1.76 . . . . 0.0 110.696 -173.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -60.76 -63.38 1.32 Allowed 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 174.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.382 1.0 OUTLIER -65.59 -22.89 66.72 Favored 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 124.835 1.254 . . . . 0.0 113.086 -177.775 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -67.95 -52.99 29.71 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.095 -1.628 . . . . 0.0 107.054 173.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.468 0 C-N-CA 124.928 1.291 . . . . 0.0 112.993 -173.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 7.2 mtp . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -61.6 -70.55 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.765 2.31 . . . . 0.0 112.9 -173.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.0 113.56 16.03 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -176.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 94.2 mt -114.31 114.07 45.67 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 126.59 1.956 . . . . 0.0 106.227 -174.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -74.14 158.67 45.21 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 121.86 1.707 . . . . 0.0 110.853 -175.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.6 p -45.45 -38.38 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.428 1.491 . . . . 0.0 112.18 173.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -53.75 -43.1 68.87 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.963 1.705 . . . . 0.0 112.563 176.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.4 mm -81.0 112.93 19.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 103.065 -2.939 . . . . 0.0 103.065 173.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -81.11 -38.45 27.23 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 173.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.3 m -142.74 162.53 35.21 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.891 1.276 . . . . 0.0 111.037 -173.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.9 mmm -116.6 159.22 22.48 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 173.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -109.48 113.16 25.72 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 174.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -100.41 160.21 14.52 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 102.696 -3.075 . . . . 0.0 102.696 172.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.4 m -147.22 136.36 22.45 Favored 'General case' 0 C--N 1.317 -0.84 0 O-C-N 120.086 -1.634 . . . . 0.0 106.976 -177.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -147.62 168.31 22.34 Favored 'General case' 0 C--O 1.246 0.885 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.53 178.151 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -173.56 149.28 1.64 Allowed 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 113.813 -1.54 . . . . 0.0 114.167 175.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -82.71 -173.9 4.91 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 101.977 -3.342 . . . . 0.0 101.977 172.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -110.78 131.26 55.2 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 103.384 -2.821 . . . . 0.0 103.384 173.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 38.15 -93.79 0.01 OUTLIER Glycine 0 CA--C 1.533 1.204 1 C-N-CA 131.196 4.236 . . . . 0.0 116.008 174.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -116.97 25.08 10.76 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.998 2.119 . . . . 0.0 116.079 174.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.8 37.32 0.53 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 128.855 2.862 . . . . 0.0 114.379 174.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.6 mp0 -38.43 113.56 0.3 Allowed 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 121.5 1.955 . . . . 0.0 116.052 -173.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -103.05 137.36 41.33 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 127.096 2.159 . . . . 0.0 106.446 173.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -99.45 151.31 21.26 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -135.69 159.97 39.98 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 119.918 1.235 . . . . 0.0 110.409 174.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.452 ' O ' HD13 ' A' ' 131' ' ' ILE . 28.8 tt0 -153.56 134.98 14.24 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 173.19 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -80.71 103.91 10.88 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.3 tt -64.36 -43.35 94.84 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.058 1.343 . . . . 0.0 107.579 174.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 75.4 m -148.34 149.52 31.94 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.437 1.095 . . . . 0.0 109.335 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.7 tt -169.36 93.21 0.27 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 128.933 2.893 . . . . 0.0 103.289 177.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 44.5 mmm-85 -161.95 162.07 28.9 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.495 1.043 . . . . 0.0 111.669 -174.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.2 t -84.86 161.71 19.79 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 122.271 1.034 . . . . 0.0 111.898 174.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.7 mt -126.43 -0.7 6.92 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 126.108 1.763 . . . . 0.0 113.111 -174.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.469 ' CG ' ' H ' ' A' ' 87' ' ' LYS 0.315 14.6 t70 -98.45 161.82 13.48 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 120.601 1.546 . . . . 0.0 114.591 -175.367 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.469 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER -91.0 -59.24 2.22 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 128.936 2.894 . . . . 0.0 110.2 -177.263 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' A' ' 90' ' ' MET . . . -97.09 -45.01 2.69 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 124.977 1.275 . . . . 0.0 112.648 -173.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.7 mp -81.0 24.47 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 CA-C-O 123.323 1.535 . . . . 0.0 109.566 -178.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.454 ' H ' ' C ' ' A' ' 88' ' ' GLY . 24.4 ttm -43.47 133.27 4.4 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 130.808 3.643 . . . . 0.0 109.479 -179.015 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.261 . . -167.3 176.03 6.96 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 131.382 3.873 . . . . 0.0 105.114 -173.366 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.283 8.2 m-20 -150.0 136.13 10.52 Favored Pre-proline 0 C--N 1.324 -0.531 0 C-N-CA 124.789 1.236 . . . . 0.0 111.746 172.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -72.99 154.4 52.88 Favored 'Trans proline' 0 N--CA 1.444 -1.394 0 C-N-CA 121.702 1.601 . . . . 0.0 108.476 173.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.2 p -143.88 162.56 35.79 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.626 1.571 . . . . 0.0 108.667 174.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.3 m -126.39 156.25 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 123.73 0.812 . . . . 0.0 112.317 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -74.38 9.23 1.79 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 127.848 2.459 . . . . 0.0 113.584 174.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.4 m -140.68 165.23 31.22 Favored Pre-proline 0 C--N 1.326 -0.421 0 C-N-CA 125.318 1.447 . . . . 0.0 108.84 -178.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -66.57 166.12 23.01 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 121.405 1.403 . . . . 0.0 110.454 173.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.35 -8.99 10.09 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.94 1.296 . . . . 0.0 111.88 175.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -144.56 163.67 33.2 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 120.505 1.502 . . . . 0.0 108.425 173.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.8 -161.28 34.11 Favored Glycine 0 C--O 1.227 -0.342 0 N-CA-C 110.544 -1.023 . . . . 0.0 110.544 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 27.1 p -120.79 148.1 44.45 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.0 t -76.47 113.61 30.61 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -79.86 121.35 4.52 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 121.835 1.69 . . . . 0.0 113.463 -173.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.72 ' H ' ' CD2' ' A' ' 105' ' ' HIS . 1.1 m-70 -63.41 -20.6 65.69 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.329 1.452 . . . . 0.0 111.974 -173.435 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . 0.274 4.5 mptt -91.88 112.82 24.9 Favored 'General case' 0 N--CA 1.418 -2.046 1 N-CA-C 99.062 -4.422 . . . . 0.0 99.062 176.581 . . . . . . . . 3 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -42.19 117.33 0.96 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.716 1.606 . . . . 0.0 113.003 -173.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 37.4 m -127.33 142.86 51.34 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 123.722 0.639 . . . . 0.0 110.843 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 24.3 t -94.32 116.39 35.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 C-N-CA 125.355 1.462 . . . . 0.0 109.069 -174.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 84.2 t -94.26 103.15 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 103.879 -2.637 . . . . 0.0 103.879 173.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.63 122.59 24.87 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 173.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.5 t -97.63 113.65 32.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 104.307 -2.479 . . . . 0.0 104.307 174.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -100.13 146.37 17.71 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 119.755 1.162 . . . . 0.0 110.377 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.483 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 8.1 m-85 -129.48 73.5 81.54 Favored Pre-proline 0 C--O 1.243 0.74 0 CA-C-N 118.253 1.027 . . . . 0.0 110.097 -174.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.87 127.85 19.53 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.589 2.193 . . . . 0.0 108.802 173.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 6.9 t -105.89 148.47 27.57 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 123.958 0.903 . . . . 0.0 108.908 176.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.6 mt -76.43 -15.7 59.87 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 117.751 0.25 . . . . 0.0 111.31 177.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.1 51.6 57.42 Favored Glycine 0 C--N 1.337 0.605 0 C-N-CA 125.719 1.628 . . . . 0.0 112.092 174.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.418 ' HE3' ' OE2' ' A' ' 157' ' ' GLU 0.297 40.5 mmtm -111.66 -55.44 2.5 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.438 1.119 . . . . 0.0 112.477 -179.061 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 50.4 tp60 -95.68 149.7 21.18 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 173.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -93.48 139.62 30.52 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 176.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.5 -153.55 25.2 Favored Glycine 0 C--N 1.331 0.278 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -176.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.7 t -130.41 114.14 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -175.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -85.94 170.34 12.42 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 173.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -123.95 151.63 43.4 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 173.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.483 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 32.9 p90 -145.55 156.49 43.73 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 174.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -128.14 160.71 31.18 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 126.281 1.832 . . . . 0.0 111.229 -173.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 67.5 t -141.76 139.28 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 O-C-N 125.307 1.629 . . . . 0.0 108.141 173.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -143.22 121.7 12.43 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 128.043 2.537 . . . . 0.0 106.589 174.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.8 t -133.5 124.2 47.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -177.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.661 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -90.52 164.37 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 173.374 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.0 t -145.15 134.45 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 -175.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.13 174.82 10.2 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 124.821 1.249 . . . . 0.0 107.934 -175.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -89.63 176.06 7.02 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 104.535 -2.394 . . . . 0.0 104.535 172.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.2 t -66.67 -4.14 8.16 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 120.239 -1.538 . . . . 0.0 113.709 -177.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -88.27 -15.38 35.95 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 120.608 1.549 . . . . 0.0 110.513 173.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.75 1.18 61.93 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.705 1.145 . . . . 0.0 112.114 -173.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -70.1 115.96 9.91 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 119.564 1.682 . . . . 0.0 108.403 174.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -67.54 143.79 55.95 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.439 1.496 . . . . 0.0 108.883 -176.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -139.3 -36.58 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 124.486 1.114 . . . . 0.0 113.569 -175.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.428 HD13 ' N ' ' A' ' 142' ' ' GLN . 1.6 tm? -136.88 146.97 46.18 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.723 1.609 . . . . 0.0 106.817 -174.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.428 ' N ' HD13 ' A' ' 141' ' ' LEU . 13.3 tm0? -147.84 150.84 34.92 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 121.105 -0.997 . . . . 0.0 108.671 174.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.4 m -88.05 113.62 55.7 Favored Pre-proline 0 CA--C 1.532 0.253 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -66.72 148.88 83.57 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 121.55 1.5 . . . . 0.0 112.346 -173.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -81.16 112.6 18.66 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.488 -173.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.595 7.1 m-80 172.37 -13.96 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.445 1 C-N-CA 138.022 6.529 . . . . 0.0 111.128 173.279 . . . . . . . . 3 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.69 81.44 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.309 1.844 . . . . 0.0 109.158 174.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.5 mt -133.9 147.78 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 127.606 2.362 . . . . 0.0 106.182 -174.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.427 ' CD1' ' CE1' ' A' ' 126' ' ' PHE . 0.9 OUTLIER -132.18 171.03 14.18 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.363 -1.29 . . . . 0.0 107.718 178.128 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -134.25 113.64 12.2 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 -173.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.57 126.51 53.66 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 -173.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 34.1 m -93.6 115.8 28.29 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 -175.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 4.3 m -115.39 166.43 11.88 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 123.818 0.847 . . . . 0.0 110.294 174.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.1 pp -131.92 161.46 33.0 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.862 1.665 . . . . 0.0 107.129 173.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.37 130.34 42.76 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.19 0.996 . . . . 0.0 109.971 177.025 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -157.93 163.06 38.24 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.193 1.797 . . . . 0.0 108.739 175.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.418 ' OE2' ' HE3' ' A' ' 119' ' ' LYS . 2.9 tp10 . . . . . 0 C--O 1.246 0.885 0 C-N-CA 129.527 3.131 . . . . 0.0 104.28 173.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.26 0 N-CA-C 107.078 -2.409 . . . . 0.0 107.078 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.9 m -164.27 176.84 8.79 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 118.694 -1.202 . . . . 0.0 113.281 -125.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.11 177.66 2.15 Favored 'General case' 0 CA--C 1.545 0.757 1 C-N-CA 133.262 4.625 . . . . 0.0 104.975 172.546 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 65.2 mtt -44.47 164.53 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.988 0 O-C-N 120.015 -1.678 . . . . 0.0 108.371 172.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 11.1 mp -42.87 114.8 0.64 Allowed 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -172.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -66.67 176.1 2.1 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 129.125 2.97 . . . . 0.0 110.28 -178.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -126.41 114.15 17.81 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -133.86 176.65 8.37 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 129.561 3.144 . . . . 0.0 107.29 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -53.6 160.56 1.26 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.462 1.505 . . . . 0.0 112.256 -175.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -72.97 176.03 6.1 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 123.321 1.534 . . . . 0.0 113.099 -173.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.2 m -92.76 175.93 6.63 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.066 177.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.7 tt -45.69 133.38 8.1 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.928 2.891 . . . . 0.0 113.45 -175.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -119.84 138.66 53.25 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.391 1.876 . . . . 0.0 108.618 173.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.27 119.39 6.75 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.921 1.688 . . . . 0.0 106.78 -178.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 17.6 p90 -136.95 157.76 45.99 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 119.607 1.094 . . . . 0.0 110.083 176.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.3 mp -91.83 116.52 33.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 103.119 -2.919 . . . . 0.0 103.119 173.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -79.33 140.07 37.62 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 123.648 1.689 . . . . 0.0 113.762 -173.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.84 -23.85 65.43 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 126.945 2.098 . . . . 0.0 116.006 -173.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 10.9 m80 -56.82 -39.03 73.44 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 43.8 tp60 -66.55 -43.81 84.05 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 123.485 0.714 . . . . 0.0 111.33 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.76 -36.3 71.92 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.704 0.802 . . . . 0.0 111.431 174.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 52.3 ttm-85 -54.62 -54.61 39.24 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 173.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.4 t -54.4 -26.32 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 119.334 0.97 . . . . 0.0 111.618 178.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mt -70.67 -44.69 66.5 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 173.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.4 pt -150.88 15.73 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 116.253 1.946 . . . . 0.0 116.253 -173.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.98 -1.2 8.65 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 128.363 2.887 . . . . 0.0 114.881 -174.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -101.8 149.0 24.63 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 129.777 3.231 . . . . 0.0 107.549 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -112.22 123.11 49.57 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.402 1.001 . . . . 0.0 109.328 -173.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -141.38 113.54 8.01 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.962 1.705 . . . . 0.0 109.458 -175.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -90.3 161.83 15.46 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 173.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.0 mp -140.74 113.53 4.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 173.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.55 119.82 23.05 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.5 mt -91.95 -65.83 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.914 0.886 . . . . 0.0 109.445 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.6 t -115.48 120.37 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 105.809 -1.922 . . . . 0.0 105.809 -173.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.4 p -120.25 120.29 35.66 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 103.844 -2.65 . . . . 0.0 103.844 173.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 45.69 38.95 4.55 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.376 1.471 . . . . 0.0 112.872 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.67 -10.91 1.34 Allowed Glycine 0 CA--C 1.543 1.803 0 O-C-N 120.656 -1.277 . . . . 0.0 114.586 -177.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -80.32 37.53 0.39 Allowed 'General case' 0 C--N 1.324 -0.501 1 C-N-CA 133.915 4.886 . . . . 0.0 110.381 -175.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 45.5 mtm -37.78 129.12 1.16 Allowed 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.426 1.891 . . . . 0.0 113.135 -172.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.35 165.68 16.93 Favored Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 113.92 -1.491 . . . . 0.0 108.456 173.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.52 33.23 0.32 Allowed 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 123.965 3.11 . . . . 0.0 111.259 173.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -54.01 -26.7 27.57 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 127.659 2.383 . . . . 0.0 113.121 -173.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 m -65.38 -32.38 73.98 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.949 1.299 . . . . 0.0 111.565 -173.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -58.81 -60.93 3.06 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -56.88 -40.4 76.14 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 177.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -56.65 -52.07 66.28 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.611 1.165 . . . . 0.0 110.428 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -85.67 -23.86 27.27 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 117.757 0.253 . . . . 0.0 111.652 -175.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -67.48 162.54 22.97 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 173.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.05 112.71 7.42 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 173.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -97.07 166.56 11.53 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.986 1.314 . . . . 0.0 108.48 173.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.6 tp60 -61.81 -28.7 69.65 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 117.756 -1.116 . . . . 0.0 110.87 173.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.42 -16.8 1.03 Allowed 'General case' 0 C--N 1.351 0.639 0 N-CA-C 120.479 3.511 . . . . 0.0 120.479 -173.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 78.9 mmm -84.51 -53.41 0.5 Allowed Pre-proline 0 N--CA 1.47 0.53 0 N-CA-C 117.601 2.445 . . . . 0.0 117.601 -173.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.9 -69.83 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.754 0 CA-C-N 121.152 1.447 . . . . 0.0 114.039 -173.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.47 114.12 8.28 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.404 1.082 . . . . 0.0 111.74 -173.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 72.5 mt -118.58 133.05 23.59 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 127.731 2.412 . . . . 0.0 106.248 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -83.34 160.22 15.03 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 122.746 2.297 . . . . 0.0 112.076 178.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.5 p -46.47 -41.29 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 125.833 1.653 . . . . 0.0 111.734 173.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -55.87 -36.97 68.18 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 126.224 1.81 . . . . 0.0 112.674 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 mm -78.4 112.86 16.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 103.663 -2.717 . . . . 0.0 103.663 173.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -78.64 -42.08 29.73 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 173.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.1 m -139.71 152.75 46.92 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.198 0.599 . . . . 0.0 111.485 -173.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 15.0 mmm -104.51 171.68 7.2 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 126.43 1.892 . . . . 0.0 106.851 173.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.261 90.2 m-20 -126.51 150.75 48.58 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 173.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -137.02 155.87 49.14 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 102.664 -3.087 . . . . 0.0 102.664 172.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.4 m -140.89 133.97 29.35 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 -175.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -146.99 166.02 28.09 Favored 'General case' 0 C--O 1.24 0.587 0 O-C-N 121.785 -0.572 . . . . 0.0 111.049 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -171.7 161.73 6.11 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 122.223 1.011 . . . . 0.0 112.788 176.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -95.34 -173.74 3.0 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 103.058 -2.942 . . . . 0.0 103.058 172.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.05 144.65 46.45 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 101.476 -3.527 . . . . 0.0 101.476 173.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 12.24 -62.82 0.0 OUTLIER Glycine 0 CA--C 1.542 1.757 1 C-N-CA 134.884 5.992 . . . . 0.0 120.78 -173.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -116.44 -6.69 11.73 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 121.978 2.889 . . . . 0.0 114.22 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.82 37.05 0.41 Allowed 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 119.329 3.085 . . . . 0.0 119.329 -173.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -53.73 114.82 1.69 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 122.826 2.557 . . . . 0.0 110.088 -177.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -83.61 155.52 23.19 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 175.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -104.95 145.45 30.4 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 104.281 -2.489 . . . . 0.0 104.281 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -128.94 162.42 27.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 120.169 1.35 . . . . 0.0 110.675 176.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.448 ' O ' HD13 ' A' ' 131' ' ' ILE . 31.2 tt0 -155.16 134.7 12.6 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 173.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.478 ' CD1' HD23 ' A' ' 82' ' ' LEU . 66.0 m-85 -84.68 103.87 14.16 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.35 1.06 . . . . 0.0 109.762 -175.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.8 tt -69.27 -47.99 63.03 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.132 1.373 . . . . 0.0 109.001 176.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.7 m -130.34 138.22 50.32 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 125.453 1.501 . . . . 0.0 110.837 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.478 HD23 ' CD1' ' A' ' 79' ' ' PHE . 0.1 OUTLIER -170.29 92.75 0.21 Allowed 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 102.354 -3.202 . . . . 0.0 102.354 172.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -165.27 154.8 12.75 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 119.998 1.272 . . . . 0.0 110.765 -174.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.3 t -77.39 165.57 24.24 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-O 121.878 0.847 . . . . 0.0 110.201 173.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.5 mt -126.34 -5.16 6.62 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 126.005 1.722 . . . . 0.0 112.158 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.574 ' CG ' ' H ' ' A' ' 87' ' ' LYS 0.396 14.1 t70 -89.85 176.2 6.92 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 120.067 1.303 . . . . 0.0 111.701 -176.43 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.574 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 9.0 mtmm -122.62 -48.81 2.03 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 129.37 3.068 . . . . 0.0 111.699 -173.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 90' ' ' MET . . . -94.16 -54.08 1.66 Allowed Glycine 0 CA--C 1.526 0.729 0 C-N-CA 125.026 1.298 . . . . 0.0 111.562 178.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.3 mp -79.37 15.0 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 C-N-CA 126.225 1.81 . . . . 0.0 109.437 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.401 ' H ' ' C ' ' A' ' 88' ' ' GLY . 19.8 ttp -43.5 141.74 1.33 Allowed 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 130.579 3.552 . . . . 0.0 110.584 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -159.83 175.56 12.95 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 130.293 3.437 . . . . 0.0 105.417 -173.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -139.99 113.89 7.68 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 173.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -70.94 146.82 53.86 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 121.734 1.622 . . . . 0.0 109.691 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 23.4 p -132.45 162.4 31.27 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 125.436 1.494 . . . . 0.0 108.833 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.3 m -125.89 154.34 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 C-N-CA 123.882 0.873 . . . . 0.0 110.446 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -84.17 10.57 9.92 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.812 1.645 . . . . 0.0 112.738 -177.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.9 m -141.33 166.26 23.39 Favored Pre-proline 0 C--N 1.326 -0.446 0 C-N-CA 126.43 1.892 . . . . 0.0 108.396 -173.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -66.41 163.04 33.83 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 121.013 1.142 . . . . 0.0 109.756 173.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -64.01 -10.13 19.96 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.337 1.055 . . . . 0.0 112.466 177.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -142.96 163.27 33.24 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.45 1.5 . . . . 0.0 107.657 173.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 166.83 -161.74 35.53 Favored Glycine 0 N--CA 1.461 0.324 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 82.1 p -119.6 154.39 34.01 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 117.944 0.872 . . . . 0.0 110.307 174.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.0 t -95.01 113.35 61.16 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 104.308 -2.479 . . . . 0.0 104.308 173.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -91.01 157.99 3.92 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.819 2.346 . . . . 0.0 114.355 -173.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.41 ' CD2' ' H ' ' A' ' 105' ' ' HIS . 16.3 m-70 -64.56 -19.76 65.83 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 123.087 1.423 . . . . 0.0 110.469 -176.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -79.55 113.78 17.96 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 129.367 3.067 . . . . 0.0 106.485 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.92 109.26 0.3 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.558 1.072 . . . . 0.0 108.295 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.8 m -124.42 138.19 54.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -174.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.5 t -91.29 141.66 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 88.9 t -125.14 103.83 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 127.423 2.289 . . . . 0.0 105.493 176.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -69.65 151.12 46.27 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 173.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.9 t -129.46 113.51 28.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 173.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -96.49 147.14 18.56 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 119.76 1.164 . . . . 0.0 110.701 -174.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.478 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 10.1 m-85 -131.29 73.37 80.3 Favored Pre-proline 0 C--O 1.245 0.853 0 CA-C-N 118.457 1.129 . . . . 0.0 111.048 -174.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.76 119.74 6.71 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.582 2.188 . . . . 0.0 106.887 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 5.6 t -99.45 145.62 27.23 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.3 mt -77.56 -6.76 54.82 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 118.787 -0.625 . . . . 0.0 111.986 -175.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.19 49.14 78.48 Favored Glycine 0 C--N 1.341 0.821 0 C-N-CA 126.379 1.942 . . . . 0.0 113.529 173.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -112.34 -68.53 0.92 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.17 0.985 . . . . 0.0 111.544 -174.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 46.4 tp60 -95.73 153.11 17.9 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 173.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -93.42 146.97 23.36 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 177.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 141.32 -151.84 22.89 Favored Glycine 0 C--N 1.332 0.31 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.0 t -127.62 114.02 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -177.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -85.31 168.73 14.42 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 173.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -122.99 159.37 28.48 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.826 0.851 . . . . 0.0 109.12 173.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.478 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 10.4 p90 -147.13 146.4 29.91 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 173.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -101.32 149.68 23.78 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 126.707 2.003 . . . . 0.0 110.349 -177.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.478 HG22 HD22 ' A' ' 82' ' ' LEU . 72.2 t -144.63 138.66 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 125.901 1.681 . . . . 0.0 107.31 173.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -160.58 129.69 4.87 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 173.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 41.1 t -134.31 138.77 49.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 -173.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.544 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -105.07 165.27 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.887 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.2 t -143.47 136.93 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -174.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.21 167.16 22.1 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 124.686 1.194 . . . . 0.0 109.195 -177.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 54.6 p30 -83.76 168.79 15.86 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 103.882 -2.636 . . . . 0.0 103.882 172.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.2 t -58.57 -21.19 52.15 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 120.333 1.424 . . . . 0.0 113.876 -174.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -75.01 -9.8 58.88 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.335 -1.478 . . . . 0.0 113.404 174.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 97.72 -2.63 60.47 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.868 1.223 . . . . 0.0 114.576 -175.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -68.8 118.2 11.47 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 120.183 1.991 . . . . 0.0 108.644 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.5 m -67.23 142.14 57.03 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.3 pt -140.64 -38.25 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 124.702 1.201 . . . . 0.0 113.861 -174.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -128.77 143.66 50.98 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 177.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -146.62 130.48 17.14 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 61.8 m -62.73 140.3 97.13 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -81.78 145.23 14.24 Favored 'Trans proline' 0 N--CA 1.443 -1.458 0 CA-C-N 120.258 1.128 . . . . 0.0 109.463 174.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -80.69 112.78 18.38 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -173.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.373 24.0 m-80 172.8 -16.19 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.695 1 C-N-CA 134.006 4.923 . . . . 0.0 112.463 173.663 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.83 97.62 0.08 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 122.166 0.984 . . . . 0.0 110.035 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.1 mm -130.98 138.02 54.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 -176.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.418 ' HB2' ' CE2' ' A' ' 126' ' ' PHE . 0.6 OUTLIER -117.98 170.0 9.19 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 173.859 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -136.21 113.51 10.69 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.29 1.036 . . . . 0.0 108.347 -173.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.36 122.55 48.05 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -174.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 18.6 m -84.02 118.68 24.21 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 7.7 m -119.26 166.37 13.08 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 123.834 0.854 . . . . 0.0 109.735 174.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.7 pp -131.27 161.77 31.52 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 126.408 1.883 . . . . 0.0 106.359 173.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.7 tm0? -63.85 136.66 57.57 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 174.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -165.32 113.08 0.98 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.194 1.398 . . . . 0.0 107.41 173.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 . . . . . 0 C--O 1.247 0.95 0 C-N-CA 130.284 3.434 . . . . 0.0 104.585 173.846 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.795 0 N-CA-C 107.553 -2.219 . . . . 0.0 107.553 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.3 m -60.88 176.06 0.44 Allowed 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 143.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -63.16 113.21 3.02 Favored 'General case' 0 C--N 1.343 0.323 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 173.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 75.9 mtp -161.86 176.54 10.74 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 129.676 3.19 . . . . 0.0 105.09 -173.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -104.8 113.56 27.23 Favored 'General case' 0 N--CA 1.451 -0.412 1 N-CA-C 99.209 -4.367 . . . . 0.0 99.209 172.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -83.66 154.59 23.61 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -174.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -150.54 151.26 32.37 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 102.946 -2.983 . . . . 0.0 102.946 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -73.37 175.62 6.76 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.075 -1.421 . . . . 0.0 109.907 173.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -55.99 158.02 4.14 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 129.185 2.994 . . . . 0.0 112.331 -174.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -139.83 167.97 20.88 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.21 1.404 . . . . 0.0 107.546 173.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m -176.35 177.11 1.54 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 130.427 3.491 . . . . 0.0 108.501 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.4 tt -43.4 124.06 3.27 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 126.136 1.774 . . . . 0.0 112.36 -176.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -112.25 135.38 53.0 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.295 1.438 . . . . 0.0 108.13 173.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.51 120.67 10.15 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.057 1.743 . . . . 0.0 106.638 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 20.4 p90 -135.62 168.49 19.16 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 118.656 0.662 . . . . 0.0 109.884 175.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.3 mt -102.74 113.83 40.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 103.278 -2.86 . . . . 0.0 103.278 174.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -80.42 149.75 30.03 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.947 1.356 . . . . 0.0 110.567 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.99 -11.55 29.87 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -173.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 45.3 m80 -53.42 -44.74 69.02 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.909 1.232 . . . . 0.0 113.63 -173.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 49.7 tp60 -70.28 -39.96 74.59 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 118.867 -1.133 . . . . 0.0 111.159 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.1 -36.72 78.05 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.065 0.546 . . . . 0.0 111.637 176.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -55.16 -56.93 14.32 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 174.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 60.3 t -54.18 -24.28 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 124.183 0.993 . . . . 0.0 111.835 177.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.8 mt -77.83 -41.55 36.67 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 173.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.1 pt -146.85 14.9 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 117.212 2.301 . . . . 0.0 117.212 -172.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.4 10.3 21.84 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 127.503 2.477 . . . . 0.0 114.724 -174.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -101.25 174.03 6.18 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.32 2.248 . . . . 0.0 109.86 -174.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -125.82 124.1 40.18 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.673 0.789 . . . . 0.0 109.253 -177.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -157.38 113.95 2.96 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.688 1.195 . . . . 0.0 111.259 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -95.18 167.7 11.2 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 173.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.4 mp -137.08 113.27 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 104.912 -2.255 . . . . 0.0 104.912 173.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.0 113.96 19.56 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 177.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.4 mt -90.09 -54.41 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.9 t -125.61 113.73 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 -173.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.6 p -110.59 113.81 26.71 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 103.399 -2.815 . . . . 0.0 103.399 173.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.346 1.5 pp20? 46.26 34.13 2.08 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -178.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.73 -6.88 76.29 Favored Glycine 0 CA--C 1.536 1.385 0 O-C-N 120.751 -1.218 . . . . 0.0 114.705 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.3 37.23 0.09 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 130.621 3.568 . . . . 0.0 112.64 -174.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 40.9 mtt -38.09 117.66 0.62 Allowed 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 -173.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.94 164.8 58.04 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 113.885 -1.507 . . . . 0.0 107.851 173.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.72 36.59 0.43 Allowed 'Trans proline' 0 CA--C 1.548 1.206 0 C-N-CA 124.236 3.291 . . . . 0.0 112.024 174.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -53.93 -26.51 25.67 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 127.059 2.144 . . . . 0.0 113.756 -173.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 m -60.06 -33.42 72.04 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.922 1.689 . . . . 0.0 112.218 -173.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -60.72 -53.62 55.25 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.279 0.9 OUTLIER -76.13 -29.97 58.03 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -176.609 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -55.37 -47.45 75.77 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.2 -0.938 . . . . 0.0 108.762 173.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -73.08 -37.4 66.77 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 118.562 -0.732 . . . . 0.0 111.762 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.33 112.99 16.33 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 120.324 1.42 . . . . 0.0 109.54 -176.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -172.73 176.86 3.05 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 120.008 1.276 . . . . 0.0 108.407 -178.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -44.29 140.72 2.1 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 173.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? -43.62 -33.78 1.27 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.085 1.754 . . . . 0.0 113.649 -173.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.44 -11.07 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 129.307 3.043 . . . . 0.0 115.601 173.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -117.54 -66.03 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.438 0 C-N-CA 126.534 1.934 . . . . 0.0 114.833 173.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.22 -70.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.729 1.619 . . . . 0.0 112.644 -173.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.26 113.15 20.49 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -174.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 55.7 mt -104.37 119.48 53.79 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 -175.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -74.21 154.22 46.45 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.319 1.346 . . . . 0.0 109.694 -177.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.0 p -41.68 -42.66 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 126.6 1.96 . . . . 0.0 113.008 177.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -59.2 -40.57 86.2 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 126.084 1.754 . . . . 0.0 112.734 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.1 mm -77.54 112.77 15.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 101.762 -3.422 . . . . 0.0 101.762 173.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -84.18 -28.95 27.01 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.568 -177.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.4 m -147.96 170.72 17.1 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.842 1.257 . . . . 0.0 110.941 -173.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.4 mmm -126.69 162.32 26.05 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 126.418 1.887 . . . . 0.0 106.937 172.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -109.34 146.32 34.57 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 173.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -135.84 153.06 51.61 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 103.082 -2.933 . . . . 0.0 103.082 172.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.1 m -140.36 133.65 29.76 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -176.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -146.07 165.05 30.21 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 121.824 -0.547 . . . . 0.0 111.0 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -167.14 144.72 4.73 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 175.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.24 -179.31 6.15 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 172.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -107.42 85.46 2.13 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.396 1.478 . . . . 0.0 111.582 -174.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.04 -59.5 0.01 OUTLIER Glycine 0 CA--C 1.537 1.426 0 C-N-CA 128.462 2.934 . . . . 0.0 119.322 173.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -116.91 -13.02 10.67 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.926 1.863 . . . . 0.0 112.95 173.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.77 37.24 0.09 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 130.755 3.622 . . . . 0.0 118.984 -173.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -44.79 113.77 0.61 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 122.397 2.362 . . . . 0.0 111.511 -174.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -96.2 120.38 36.38 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 174.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -80.01 149.09 30.86 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -134.38 160.78 36.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 119.735 1.152 . . . . 0.0 111.044 176.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.486 ' O ' HD13 ' A' ' 131' ' ' ILE . 29.9 tt0 -151.61 136.8 17.48 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 173.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.4 ' CD2' HG22 ' A' ' 130' ' ' VAL . 49.6 m-85 -80.09 104.0 10.35 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.104 0.961 . . . . 0.0 110.434 -178.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.8 tt -63.14 -46.71 85.97 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.148 1.379 . . . . 0.0 108.658 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.3 m -130.2 138.97 50.85 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.716 1.206 . . . . 0.0 110.768 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.2 tt -170.28 92.66 0.21 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 103.305 -2.85 . . . . 0.0 103.305 173.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -166.82 153.89 9.02 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.485 0.584 . . . . 0.0 111.544 -174.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.2 t -72.69 163.27 28.35 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 173.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.4 mt -125.96 -20.18 4.64 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 116.661 -1.638 . . . . 0.0 112.691 174.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.416 ' CG ' ' H ' ' A' ' 87' ' ' LYS . 26.5 t0 -84.26 171.14 13.0 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 121.587 1.994 . . . . 0.0 111.526 174.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.416 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER -109.33 -47.57 3.38 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 129.192 2.997 . . . . 0.0 112.711 174.486 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -70.08 -72.52 0.86 Allowed Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 176.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mp -76.85 19.52 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 128.41 2.684 . . . . 0.0 110.228 -175.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 15.3 ttp -43.75 131.21 5.46 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 127.753 2.421 . . . . 0.0 108.968 -177.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.441 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -158.21 114.01 2.72 Favored 'General case' 0 CA--C 1.508 -0.673 0 C-N-CA 126.54 1.936 . . . . 0.0 106.906 -173.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -97.49 134.39 22.61 Favored Pre-proline 0 C--N 1.323 -0.567 0 O-C-N 124.209 0.943 . . . . 0.0 109.726 -173.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.42 154.25 65.25 Favored 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 121.294 1.329 . . . . 0.0 109.054 173.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 21.5 p -139.28 157.07 46.55 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 126.648 1.979 . . . . 0.0 106.736 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.8 m -126.39 153.84 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-N 119.302 0.955 . . . . 0.0 112.861 178.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -72.54 7.73 1.73 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 127.004 2.122 . . . . 0.0 113.521 174.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.8 m -141.08 165.8 26.82 Favored Pre-proline 0 C--N 1.326 -0.414 0 C-N-CA 126.03 1.732 . . . . 0.0 108.295 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -67.57 168.09 19.13 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.377 1.384 . . . . 0.0 111.082 174.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -64.09 -10.98 25.62 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.733 1.213 . . . . 0.0 112.512 175.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -145.37 164.41 31.58 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.539 1.536 . . . . 0.0 107.355 173.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 160.99 -161.68 33.05 Favored Glycine 0 C--O 1.226 -0.37 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 56.5 p -118.59 151.56 37.68 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 173.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 46.5 t -88.17 113.39 54.84 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 175.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -73.79 158.23 46.94 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.093 2.529 . . . . 0.0 112.881 -173.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -65.27 -19.62 66.05 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 -173.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . 0.266 0.0 OUTLIER -116.81 143.69 45.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 118.563 0.62 . . . . 0.0 112.36 174.159 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -43.04 108.19 0.1 Allowed 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 127.052 2.141 . . . . 0.0 110.951 -174.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.2 m -116.41 143.49 45.49 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 175.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.4 t -97.18 119.39 45.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 C-N-CA 124.403 1.081 . . . . 0.0 111.11 -173.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 72.3 t -95.56 103.58 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 173.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.4 120.55 25.12 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 173.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.5 t -93.23 113.55 28.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 103.872 -2.64 . . . . 0.0 103.872 173.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -92.99 151.12 20.28 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.411 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 11.1 m-85 -132.33 73.81 76.78 Favored Pre-proline 0 C--O 1.244 0.792 0 CA-C-N 118.81 1.305 . . . . 0.0 110.821 -176.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -63.05 114.77 2.59 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.707 2.271 . . . . 0.0 109.679 173.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 9.6 t -91.29 151.15 21.01 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 173.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.1 mt -72.11 -11.19 60.63 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 117.862 0.301 . . . . 0.0 111.545 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 54.44 30.4 49.49 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 127.413 2.435 . . . . 0.0 116.506 173.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 43.1 mttt -120.15 -32.05 4.26 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.388 1.594 . . . . 0.0 113.915 176.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 45.7 tp60 -96.65 146.67 24.64 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 173.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -95.4 148.39 22.5 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 174.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.44 -153.8 23.19 Favored Glycine 0 C--N 1.336 0.537 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 176.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.7 t -131.45 118.45 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.761 0.825 . . . . 0.0 108.864 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -93.54 175.27 6.81 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.67 1.188 . . . . 0.0 109.746 173.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -126.15 155.77 41.17 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.538 1.935 . . . . 0.0 106.997 173.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.411 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 48.9 p90 -150.63 155.49 39.48 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.322 1.049 . . . . 0.0 108.913 174.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -113.93 143.71 44.27 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 125.62 1.568 . . . . 0.0 111.131 -174.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 59.0 t -144.65 119.76 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 173.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -146.42 143.03 28.74 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.209 1.404 . . . . 0.0 108.092 177.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.4 HG22 ' CD2' ' A' ' 79' ' ' PHE . 30.0 t -139.16 141.06 36.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 119.392 0.996 . . . . 0.0 109.939 -173.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.54 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -107.3 163.57 5.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 173.588 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.6 t -141.85 138.3 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -173.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.66 173.37 11.78 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.625 1.57 . . . . 0.0 107.786 -177.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 44.5 p-10 -88.12 176.07 7.44 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 172.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.1 t -67.0 -6.59 17.54 Favored 'General case' 0 CA--C 1.553 1.081 0 O-C-N 120.439 -1.413 . . . . 0.0 112.318 -176.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -84.54 -15.94 44.04 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 120.435 -1.416 . . . . 0.0 110.663 173.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.99 4.62 61.38 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.735 1.159 . . . . 0.0 112.547 -173.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -77.08 117.43 18.64 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.827 1.814 . . . . 0.0 108.937 175.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.7 m -64.32 141.87 58.62 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 126.48 1.912 . . . . 0.0 108.88 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -140.01 -39.03 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 124.931 1.293 . . . . 0.0 113.769 -174.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -130.94 142.35 50.35 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 -177.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -148.59 124.5 10.62 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -176.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 25.1 m -64.1 140.48 97.91 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 174.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.47 141.28 13.97 Favored 'Trans proline' 0 N--CA 1.441 -1.585 0 CA-C-N 119.997 1.035 . . . . 0.0 109.993 177.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 28.2 mp0 -80.4 112.63 17.92 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 -173.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.343 38.5 m-80 172.65 -16.53 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 1 C-N-CA 132.201 4.201 . . . . 0.0 111.311 173.405 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -56.22 98.2 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.024 1.73 . . . . 0.0 110.13 177.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 2.8 mt -135.69 147.22 28.68 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 -174.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -129.08 175.56 8.6 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 173.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -133.23 139.58 47.05 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 -175.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -124.1 122.35 37.61 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 177.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 34.5 m -83.64 118.45 23.85 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 174.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 4.9 m -117.78 166.12 12.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.442 0.639 . . . . 0.0 110.08 173.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.4 pp -138.6 159.7 41.45 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.96 1.704 . . . . 0.0 106.893 173.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.63 127.63 33.45 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.751 0.82 . . . . 0.0 110.302 175.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -147.95 114.32 5.92 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.026 0.93 . . . . 0.0 111.057 176.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 . . . . . 0 C--O 1.256 1.442 0 C-N-CA 129.324 3.049 . . . . 0.0 105.406 173.53 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.617 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.3 p -80.51 112.53 17.95 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 120.549 2.175 . . . . 0.0 106.274 167.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -177.23 176.47 1.35 Allowed 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 130.963 3.705 . . . . 0.0 104.562 173.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.07 112.54 18.83 Favored 'General case' 0 N--CA 1.45 -0.444 1 N-CA-C 99.403 -4.295 . . . . 0.0 99.403 172.44 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 28.4 tp -177.0 113.37 0.09 Allowed 'General case' 0 CA--C 1.513 -0.465 1 N-CA-C 99.978 -4.082 . . . . 0.0 99.978 173.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -140.95 114.0 8.49 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 -173.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.6 113.83 0.44 Allowed 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 127.216 2.206 . . . . 0.0 105.46 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.9 tp60 -158.44 176.37 12.52 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 176.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.2 160.0 11.12 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.822 1.249 . . . . 0.0 108.98 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -68.11 168.38 12.22 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 122.88 1.324 . . . . 0.0 111.569 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m -171.75 176.97 3.5 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 129.117 2.967 . . . . 0.0 108.895 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.423 HD22 HG11 ' A' ' 34' ' ' VAL . 3.1 tt -42.96 129.14 4.41 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 128.066 2.546 . . . . 0.0 113.758 -173.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -117.55 144.6 44.96 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.174 1.79 . . . . 0.0 108.63 173.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.27 123.2 7.51 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.325 1.85 . . . . 0.0 106.615 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 25.7 p90 -141.27 160.93 39.09 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.737 1.153 . . . . 0.0 110.188 178.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -96.13 144.73 9.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 104.509 -2.404 . . . . 0.0 104.509 173.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -97.61 162.74 13.15 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -173.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.9 -18.13 54.39 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 126.114 1.766 . . . . 0.0 114.367 174.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -59.47 -41.13 89.04 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 119.747 1.158 . . . . 0.0 108.978 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 -66.68 -43.49 84.32 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.631 ' HA ' HD12 ' A' ' 24' ' ' LEU . . . -63.49 -31.82 73.08 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 121.965 -0.459 . . . . 0.0 111.83 174.184 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.4 ttm105 -57.71 -55.61 32.58 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 173.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 89.4 t -52.67 -23.85 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.632 1.173 . . . . 0.0 111.766 175.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.631 HD12 ' HA ' ' A' ' 21' ' ' ALA . 7.3 mt -75.12 -48.31 24.35 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 117.676 -1.154 . . . . 0.0 113.685 173.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.1 pt -155.71 20.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 -172.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.08 -1.65 54.64 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 126.55 2.024 . . . . 0.0 114.811 -176.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -79.92 176.47 9.71 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 129.2 3.0 . . . . 0.0 111.154 -173.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -125.47 126.97 45.75 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.516 1.526 . . . . 0.0 107.416 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.261 98.7 mt-10 -159.77 112.72 2.16 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.877 1.217 . . . . 0.0 112.994 173.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -97.01 162.6 13.31 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 172.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.9 mp -141.39 113.43 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 173.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.03 119.87 23.43 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.443 HG23 ' CE2' ' A' ' 42' ' ' PHE . 17.8 mt -96.14 -58.44 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 119.024 0.829 . . . . 0.0 109.789 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.423 HG11 HD22 ' A' ' 12' ' ' LEU . 4.0 t -126.48 142.95 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 126.396 1.878 . . . . 0.0 109.069 -173.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.9 p -153.02 135.2 14.89 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 102.318 -3.215 . . . . 0.0 102.318 173.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 44.46 33.91 0.98 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.882 1.273 . . . . 0.0 113.167 -174.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.33 -2.99 8.57 Favored Glycine 0 CA--C 1.541 1.718 0 O-C-N 120.246 -1.534 . . . . 0.0 115.399 -177.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -64.86 37.63 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.512 1 C-N-CA 132.204 4.202 . . . . 0.0 115.076 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.5 mmt -37.82 113.75 0.3 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.376 1.471 . . . . 0.0 110.397 -173.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.32 168.1 15.38 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 125.764 1.626 . . . . 0.0 111.54 -174.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.77 16.73 0.5 Allowed 'Trans proline' 0 CA--C 1.548 1.216 0 C-N-CA 123.474 2.782 . . . . 0.0 111.558 173.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.443 ' CE2' HG23 ' A' ' 33' ' ' ILE . 25.6 p90 -53.43 -26.48 20.16 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 127.031 2.133 . . . . 0.0 112.158 -175.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 m -57.2 -30.95 64.98 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 126.889 2.075 . . . . 0.0 111.293 -173.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 64.8 t60 -63.02 -54.72 33.84 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.294 0.497 . . . . 0.0 110.482 178.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.305 0.9 OUTLIER -76.16 -24.63 54.83 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -178.579 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -61.12 -44.16 97.76 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 173.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -68.7 -45.19 72.29 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.387 0.675 . . . . 0.0 111.135 174.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.42 112.79 16.03 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.019 -176.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -176.62 113.88 0.1 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 173.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.48 112.61 20.54 Favored 'General case' 0 CA--C 1.527 0.07 0 N-CA-C 103.556 -2.757 . . . . 0.0 103.556 173.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -176.48 -66.62 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.944 1.698 . . . . 0.0 108.205 173.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.42 -16.49 0.07 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -173.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.0 -66.36 0.23 Allowed Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 120.675 1.58 . . . . 0.0 113.394 -173.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -74.4 -68.31 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 CA-C-N 121.11 1.432 . . . . 0.0 110.732 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.64 119.72 15.2 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.164 0.985 . . . . 0.0 110.187 -174.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.9 mt -124.81 129.93 24.42 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 127.494 2.318 . . . . 0.0 106.312 -177.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -77.76 156.82 31.47 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.124 1.882 . . . . 0.0 111.506 176.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.1 p -41.16 -43.91 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 127.697 2.399 . . . . 0.0 112.932 176.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -59.69 -34.05 72.38 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 126.328 1.851 . . . . 0.0 113.44 -175.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.465 HD11 ' HG ' ' A' ' 24' ' ' LEU . 5.9 mm -70.02 113.05 5.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 178.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -81.32 -29.07 34.3 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.184 0.594 . . . . 0.0 110.43 178.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.4 m -159.47 165.41 33.12 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.068 0.947 . . . . 0.0 109.08 -175.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 68.8 mtp -125.64 160.27 30.1 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 173.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 -111.21 134.33 52.88 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 124.564 1.145 . . . . 0.0 108.898 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -120.5 165.62 14.72 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 103.189 -2.893 . . . . 0.0 103.189 172.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.1 m -149.17 137.55 20.89 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 120.318 -1.489 . . . . 0.0 108.109 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -148.32 165.6 30.54 Favored 'General case' 0 C--O 1.24 0.597 0 O-C-N 121.801 -0.562 . . . . 0.0 111.167 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' A' ' 104' ' ' PRO . 1.3 pp0? -162.2 145.35 11.66 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 174.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -91.8 140.46 29.66 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 173.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.43 78.26 0.17 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 -173.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.87 -73.14 0.12 Allowed Glycine 0 CA--C 1.53 1.025 0 C-N-CA 126.876 2.179 . . . . 0.0 117.517 173.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -116.97 26.34 9.87 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.473 1.636 . . . . 0.0 112.276 173.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -102.38 37.09 1.97 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.41 2.284 . . . . 0.0 111.168 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -38.81 113.36 0.3 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.98 1.312 . . . . 0.0 112.203 -173.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -114.22 119.97 38.86 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 175.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -84.38 152.5 24.02 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -134.56 160.71 37.22 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.809 1.186 . . . . 0.0 110.675 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.44 ' O ' HD13 ' A' ' 131' ' ' ILE . 30.1 tt0 -154.11 135.07 13.83 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 173.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.425 ' CD2' HG22 ' A' ' 130' ' ' VAL . 69.2 m-85 -80.6 103.63 10.58 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.3 tt -61.43 -40.85 95.96 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 173.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 m -155.89 145.44 21.01 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 120.896 -1.128 . . . . 0.0 112.502 177.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.465 ' H ' ' HD3' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -153.25 93.53 1.72 Allowed 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 173.339 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.465 ' HD3' ' H ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -156.41 161.57 40.09 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 121.081 1.764 . . . . 0.0 111.52 -177.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 27.4 t -81.57 162.9 22.96 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.419 0.628 . . . . 0.0 109.375 173.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 74.7 mt -116.38 -14.96 10.99 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.054 1.741 . . . . 0.0 110.864 174.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -96.32 164.27 12.72 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 175.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.9 mmtm -138.55 -32.38 0.7 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.259 1.824 . . . . 0.0 113.263 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -64.36 -63.67 4.15 Favored Glycine 0 CA--C 1.54 1.648 0 N-CA-C 106.787 -2.525 . . . . 0.0 106.787 172.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.444 ' H ' HD12 ' A' ' 89' ' ' ILE . 4.8 mp -76.81 21.77 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 129.473 3.109 . . . . 0.0 110.219 175.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 3.5 ttp -43.2 132.85 4.16 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 125.579 2.609 . . . . 0.0 113.56 -173.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -149.01 150.87 33.55 Favored 'General case' 0 N--CA 1.421 -1.91 2 C-N-CA 135.317 5.447 . . . . 0.0 100.939 173.583 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -139.74 113.85 7.85 Favored Pre-proline 0 C--N 1.315 -0.899 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 173.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -67.68 157.4 61.94 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.962 2.441 . . . . 0.0 113.096 -173.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 39.1 p -136.94 170.11 16.65 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.464 1.506 . . . . 0.0 109.395 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.2 m -126.26 155.65 36.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 124.612 1.165 . . . . 0.0 108.322 173.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -101.6 35.32 2.34 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.024 1.329 . . . . 0.0 110.24 174.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.9 m -139.91 162.11 52.37 Favored Pre-proline 0 C--O 1.236 0.39 0 C-N-CA 127.057 2.143 . . . . 0.0 106.14 173.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -68.74 159.0 55.52 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 N-CA-C 109.213 -1.11 . . . . 0.0 109.213 173.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.38 -11.09 29.22 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 124.194 0.998 . . . . 0.0 112.014 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -141.64 163.68 32.26 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.376 1.47 . . . . 0.0 107.79 173.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 166.61 -161.74 35.47 Favored Glycine 0 C--O 1.226 -0.385 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -177.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.2 p -125.28 144.67 50.36 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.5 t -74.25 117.3 60.59 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 105.0 -2.222 . . . . 0.0 105.0 175.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.411 ' O ' ' HA ' ' A' ' 68' ' ' GLN . 89.3 Cg_endo -74.51 160.53 41.41 Favored 'Trans proline' 0 C--O 1.213 -0.751 0 C-N-CA 121.974 1.782 . . . . 0.0 115.231 -173.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . 0.304 93.0 m-70 -75.05 -14.65 60.62 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 118.114 2.635 . . . . 0.0 118.114 -172.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.96 151.68 36.18 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 173.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -49.05 108.7 0.2 Allowed 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 125.438 1.495 . . . . 0.0 109.025 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 21.1 m -123.89 138.89 54.41 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.8 t -80.05 152.34 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -174.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 86.8 t -129.9 109.85 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 174.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -82.16 135.26 35.31 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 174.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.5 t -116.41 116.58 52.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 173.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -94.43 149.78 19.52 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 125.665 1.603 . . . . 0.0 111.236 -178.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.466 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 4.8 m-85 -133.79 73.8 70.92 Favored Pre-proline 0 C--O 1.242 0.672 0 CA-C-N 118.037 0.919 . . . . 0.0 110.785 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.29 123.06 9.57 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.747 1.631 . . . . 0.0 108.068 173.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 5.7 t -105.27 152.53 22.77 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 173.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.7 mt -79.25 -10.48 59.82 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.558 0.617 . . . . 0.0 112.118 -174.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.03 32.47 66.85 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 125.534 1.54 . . . . 0.0 115.499 173.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.6 mttt -122.92 -29.38 3.95 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.546 1.673 . . . . 0.0 113.857 176.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -96.71 160.08 14.57 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 173.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -114.56 148.03 38.59 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 176.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 141.19 -155.97 25.37 Favored Glycine 0 C--N 1.333 0.404 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 176.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.3 t -125.33 113.68 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.75 164.43 15.97 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 173.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -121.93 158.13 29.72 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 121.422 -0.799 . . . . 0.0 110.459 174.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.466 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 24.0 p90 -153.2 161.47 42.39 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 124.21 1.004 . . . . 0.0 109.274 173.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -140.35 159.81 41.37 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 124.543 1.137 . . . . 0.0 111.839 -173.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 77.6 t -133.05 136.35 55.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 127.702 2.401 . . . . 0.0 107.575 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -145.18 122.54 11.61 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 173.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.425 HG22 ' CD2' ' A' ' 79' ' ' PHE . 21.4 t -135.52 131.56 51.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 -176.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.609 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -97.83 164.86 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 173.462 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.8 t -144.03 134.49 21.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 -175.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.48 173.9 11.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.282 -1.326 . . . . 0.0 108.55 -175.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -86.32 176.11 8.08 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 105.142 -2.169 . . . . 0.0 105.142 172.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.2 t -58.75 -31.38 68.29 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.846 -1.158 . . . . 0.0 112.216 -173.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -81.22 -4.15 54.59 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.39 -0.819 . . . . 0.0 112.581 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.81 7.0 57.92 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.218 0.914 . . . . 0.0 113.976 175.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -70.32 114.97 8.97 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.762 1.781 . . . . 0.0 108.688 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -69.52 141.89 53.78 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.641 0.776 . . . . 0.0 108.953 -176.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.08 -38.39 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 124.687 1.195 . . . . 0.0 113.475 -174.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -134.02 146.86 50.78 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 16.2 tm0? -148.42 153.98 39.27 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.278 1.031 . . . . 0.0 108.758 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 36.3 m -83.52 114.18 51.76 Favored Pre-proline 0 CA--C 1.529 0.162 0 C-N-CA 125.044 1.338 . . . . 0.0 108.535 -176.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -61.95 143.53 95.48 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 CA-C-N 120.294 1.141 . . . . 0.0 110.08 -173.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -81.49 112.52 18.81 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.913 -173.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.624 30.0 m-80 172.4 -11.48 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 1 C-N-CA 135.992 5.717 . . . . 0.0 112.694 173.169 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.38 75.08 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.021 2.128 . . . . 0.0 110.7 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -118.8 145.47 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 128.061 2.545 . . . . 0.0 105.434 178.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -126.91 169.34 13.38 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 174.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -136.93 113.42 10.09 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.524 1.13 . . . . 0.0 108.197 -173.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 49.0 tttt -99.29 123.3 43.45 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 31.1 m -83.47 116.7 22.65 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 173.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 25.5 m -114.49 164.99 13.22 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.5 pp -142.82 160.05 41.06 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.975 1.31 . . . . 0.0 108.191 174.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.12 127.32 32.42 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.528 1.131 . . . . 0.0 110.433 175.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -155.55 116.44 3.88 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.673 1.189 . . . . 0.0 110.807 175.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 . . . . . 0 C--O 1.247 0.974 0 C-N-CA 128.963 2.905 . . . . 0.0 105.445 173.55 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.829 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.9 m -92.18 112.9 25.01 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 165.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -176.89 176.12 1.5 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.737 2.415 . . . . 0.0 106.766 -178.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 52.8 ttm -136.63 112.69 9.7 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 102.074 -3.306 . . . . 0.0 102.074 172.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -177.01 176.08 1.47 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 129.453 3.101 . . . . 0.0 105.91 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -114.3 113.24 24.32 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 103.552 -2.759 . . . . 0.0 103.552 173.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -162.72 176.49 10.24 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 130.826 3.65 . . . . 0.0 103.361 -177.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -125.06 173.34 8.77 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 129.354 3.062 . . . . 0.0 106.329 173.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -132.31 163.78 27.9 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 176.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -93.31 176.1 6.52 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.7 1.2 . . . . 0.0 113.932 -173.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.7 m -168.17 177.07 5.68 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 129.003 2.921 . . . . 0.0 109.531 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.7 tt -42.85 129.32 4.31 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 128.328 2.651 . . . . 0.0 113.876 -173.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -117.17 142.14 47.4 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.187 2.195 . . . . 0.0 109.243 173.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.75 117.59 5.85 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.424 1.89 . . . . 0.0 106.652 -177.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 18.4 p90 -138.13 143.31 40.28 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.734 1.152 . . . . 0.0 109.337 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.9 mp -83.91 113.7 23.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 104.856 -2.276 . . . . 0.0 104.856 176.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -78.66 151.23 32.35 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 122.707 1.241 . . . . 0.0 111.118 -176.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.15 -9.76 49.07 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 127.216 2.206 . . . . 0.0 115.619 -173.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -54.48 -38.62 66.62 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 119.7 1.136 . . . . 0.0 112.952 -173.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -73.84 -40.3 63.39 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.809 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.511 ' HA ' HD12 ' A' ' 24' ' ' LEU . . . -58.35 -39.08 78.56 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.516 1.126 . . . . 0.0 110.885 173.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -55.46 -58.69 6.72 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 88.5 t -54.1 -24.35 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.664 1.186 . . . . 0.0 112.08 177.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.511 HD12 ' HA ' ' A' ' 21' ' ' ALA . 7.5 mt -73.12 -46.01 53.69 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 174.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.8 pt -154.51 18.39 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 -172.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.75 14.56 63.08 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.7 1.619 . . . . 0.0 113.218 -174.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -100.67 159.83 14.85 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 126.239 1.815 . . . . 0.0 109.236 -175.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -118.83 128.83 54.82 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -174.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -148.9 113.22 5.25 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 174.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -95.43 154.89 16.98 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 102.706 -3.072 . . . . 0.0 102.706 172.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.3 mm -135.31 113.31 15.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 104.535 -2.394 . . . . 0.0 104.535 173.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.03 114.28 19.79 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 -176.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.435 HG23 ' CD1' ' A' ' 42' ' ' PHE . 10.9 mt -87.49 -61.53 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.1 t -125.72 142.11 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 125.533 1.533 . . . . 0.0 108.974 -173.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.0 p -149.81 124.29 9.66 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 102.921 -2.992 . . . . 0.0 102.921 173.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 44.34 33.95 0.96 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.697 1.599 . . . . 0.0 113.582 -174.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.96 -5.95 4.26 Favored Glycine 0 CA--C 1.544 1.852 0 O-C-N 120.663 -1.273 . . . . 0.0 114.932 -176.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -75.73 37.61 0.15 Allowed 'General case' 0 N--CA 1.468 0.442 1 C-N-CA 133.248 4.619 . . . . 0.0 111.114 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 30.7 mtp -37.84 131.92 0.98 Allowed 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.886 1.674 . . . . 0.0 114.531 -172.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.03 162.26 69.94 Favored Pre-proline 0 N--CA 1.448 -0.552 0 CA-C-N 113.746 -1.57 . . . . 0.0 107.945 173.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.79 39.6 0.58 Allowed 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 124.172 3.248 . . . . 0.0 111.421 174.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.435 ' CD1' HG23 ' A' ' 33' ' ' ILE . 11.8 p90 -55.07 -26.55 38.49 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.695 1.998 . . . . 0.0 112.142 -173.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.6 m -60.73 -27.92 68.29 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.89 1.676 . . . . 0.0 110.786 -174.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -57.23 -65.74 0.57 Allowed 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.663 1.185 . . . . 0.0 109.713 174.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.91 -24.36 62.45 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -178.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -65.82 -50.12 65.75 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.611 0.641 . . . . 0.0 110.338 174.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -77.11 -40.66 45.02 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.453 -0.78 . . . . 0.0 109.393 -176.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.4 ttmt -63.97 160.91 16.79 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 175.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -79.04 112.67 16.48 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 117.947 -1.501 . . . . 0.0 110.154 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.425 ' HB3' ' H ' ' A' ' 53' ' ' MET . 40.8 tt0 -97.24 172.02 8.07 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 172.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -65.95 -26.29 67.51 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.287 -0.883 . . . . 0.0 110.96 173.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.77 -16.18 2.98 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 -173.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.425 ' H ' ' HB3' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -74.99 -66.52 0.43 Allowed Pre-proline 0 N--CA 1.47 0.537 0 CA-C-N 121.473 1.942 . . . . 0.0 115.008 -173.291 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -83.68 -65.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.805 0 CA-C-N 122.0 1.75 . . . . 0.0 112.023 -174.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.26 120.5 16.03 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.094 1.358 . . . . 0.0 110.593 -173.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.3 mt -129.4 129.6 23.26 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 126.461 1.904 . . . . 0.0 106.215 -175.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -78.89 158.5 27.54 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.271 1.981 . . . . 0.0 111.393 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.4 p -41.64 -49.1 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 126.408 1.883 . . . . 0.0 112.068 174.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -59.17 -40.26 85.09 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 126.638 1.975 . . . . 0.0 113.024 -176.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.4 mm -73.18 112.76 9.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 102.256 -3.239 . . . . 0.0 102.256 174.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -81.22 -36.78 29.62 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 114.664 -1.153 . . . . 0.0 108.922 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.8 m -141.84 168.62 19.33 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 123.883 0.739 . . . . 0.0 111.968 -173.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 70.8 mtp -126.81 155.57 42.65 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 172.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 46.6 m-20 -107.22 149.29 27.89 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 174.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -135.15 155.07 51.32 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 129.788 3.235 . . . . 0.0 103.015 172.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.5 m -140.71 134.2 29.99 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 -177.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -146.82 165.03 30.94 Favored 'General case' 0 C--O 1.239 0.528 0 O-C-N 121.803 -0.561 . . . . 0.0 110.952 176.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.22 163.43 5.81 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.736 1.215 . . . . 0.0 111.169 174.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.1 170.63 7.8 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 173.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.08 101.84 13.43 Favored 'General case' 0 N--CA 1.445 -0.708 0 O-C-N 119.966 -1.709 . . . . 0.0 109.099 -174.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 44.58 -48.73 0.0 OUTLIER Glycine 0 CA--C 1.54 1.637 1 C-N-CA 133.14 5.162 . . . . 0.0 121.032 174.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -116.92 -18.99 10.01 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 121.85 2.825 . . . . 0.0 115.78 174.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.48 37.1 0.56 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 128.185 2.594 . . . . 0.0 117.908 -173.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -48.99 114.11 0.93 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 122.53 2.423 . . . . 0.0 110.283 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -83.65 153.14 24.41 Favored 'General case' 0 C--N 1.335 -0.029 0 C-N-CA 125.376 1.47 . . . . 0.0 107.857 174.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -97.46 151.02 20.41 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -133.98 159.88 39.42 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.905 1.229 . . . . 0.0 110.616 174.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.418 ' O ' HD13 ' A' ' 131' ' ' ILE . 28.0 tt0 -156.16 141.55 17.6 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 173.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -91.75 103.66 16.2 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.309 1.043 . . . . 0.0 108.899 -174.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.7 tt -73.26 -44.09 59.94 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.154 1.382 . . . . 0.0 108.104 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.2 m -136.83 137.35 39.65 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.237 1.415 . . . . 0.0 110.218 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -170.3 92.94 0.21 Allowed 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 102.022 -3.325 . . . . 0.0 102.022 173.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -162.29 152.44 16.66 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 118.647 -0.692 . . . . 0.0 111.41 -174.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.5 t -69.85 167.71 16.72 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 122.326 1.06 . . . . 0.0 112.511 173.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.9 mt -126.51 -9.61 6.27 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 126.593 1.957 . . . . 0.0 113.37 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.519 ' CG ' ' H ' ' A' ' 87' ' ' LYS 0.348 14.4 t70 -101.53 162.22 13.06 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 121.625 2.011 . . . . 0.0 113.665 -175.489 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.519 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 0.7 OUTLIER -106.32 -48.76 3.5 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 129.476 3.11 . . . . 0.0 112.293 -173.286 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.411 ' C ' ' H ' ' A' ' 90' ' ' MET . . . -94.05 -49.7 2.4 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 124.865 1.222 . . . . 0.0 111.754 -177.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 mt -81.31 17.56 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 126.052 1.741 . . . . 0.0 109.179 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.411 ' H ' ' C ' ' A' ' 88' ' ' GLY . 14.4 ttp -43.49 130.64 5.12 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 130.215 3.406 . . . . 0.0 109.77 -177.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.255 . . -162.47 166.67 24.63 Favored 'General case' 0 N--CA 1.441 -0.908 1 C-N-CA 133.179 4.591 . . . . 0.0 104.351 -173.578 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -141.88 145.54 36.98 Favored Pre-proline 0 N--CA 1.473 0.678 0 CA-C-N 118.923 0.783 . . . . 0.0 110.453 173.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -77.61 145.74 23.51 Favored 'Trans proline' 0 N--CA 1.443 -1.454 0 C-N-CA 121.532 1.488 . . . . 0.0 109.352 173.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 23.8 p -129.14 153.93 47.21 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 126.047 1.739 . . . . 0.0 107.353 176.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.2 m -126.06 150.37 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 119.382 0.992 . . . . 0.0 111.579 -174.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -80.52 9.08 6.46 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.432 1.893 . . . . 0.0 113.552 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.6 m -143.38 163.45 36.93 Favored Pre-proline 0 C--N 1.327 -0.381 0 C-N-CA 124.97 1.308 . . . . 0.0 109.06 -177.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -66.2 162.16 37.1 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.334 1.356 . . . . 0.0 109.339 173.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -66.44 -12.0 54.91 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.119 0.968 . . . . 0.0 112.035 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -140.81 163.49 32.78 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.155 1.382 . . . . 0.0 107.796 173.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.24 -160.83 33.46 Favored Glycine 0 C--O 1.227 -0.341 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 72.1 p -119.14 147.93 43.64 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 174.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.1 t -81.31 113.4 41.23 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 100.983 -3.71 . . . . 0.0 100.983 173.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -92.29 167.4 2.91 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.28 1.986 . . . . 0.0 116.837 -172.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -75.94 10.46 1.86 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.688 1.195 . . . . 0.0 114.167 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.93 122.49 45.46 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 176.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.26 105.25 0.14 Allowed 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 174.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.0 m -114.27 136.56 52.83 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -174.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 26.6 t -95.13 114.97 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -174.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 78.7 t -93.69 103.36 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 N-CA-C 103.514 -2.772 . . . . 0.0 103.514 173.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -85.19 140.85 30.58 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 173.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.5 t -115.61 113.83 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 104.108 -2.553 . . . . 0.0 104.108 174.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -95.76 150.4 19.64 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 125.525 1.536 . . . . 0.0 109.919 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.468 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 7.9 m-85 -130.0 73.5 81.34 Favored Pre-proline 0 C--O 1.243 0.721 0 CA-C-N 118.478 1.139 . . . . 0.0 110.366 -173.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.16 121.96 9.78 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.351 2.034 . . . . 0.0 107.898 173.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 8.7 t -103.67 149.85 24.57 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 175.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.1 mt -81.58 -8.02 59.66 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 118.752 -0.642 . . . . 0.0 111.332 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.2 49.19 78.04 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 126.312 1.91 . . . . 0.0 113.323 173.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -112.47 -75.69 0.6 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.116 0.958 . . . . 0.0 111.152 -173.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 51.2 tp60 -83.08 152.19 25.45 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 173.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -93.47 142.6 27.15 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 178.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.52 -154.68 25.94 Favored Glycine 0 C--N 1.331 0.294 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -177.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.3 t -128.14 113.78 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -86.63 169.57 12.61 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 173.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -132.19 162.22 31.46 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.14 0.576 . . . . 0.0 109.818 175.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.468 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 20.2 p90 -144.91 147.15 32.42 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 173.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -104.21 144.75 31.18 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 127.437 2.295 . . . . 0.0 109.474 -174.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 43.7 t -137.43 143.43 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 123.605 0.762 . . . . 0.0 110.02 173.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -157.5 119.4 3.74 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 128.454 2.702 . . . . 0.0 105.616 174.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.439 ' H ' ' HB ' ' A' ' 143' ' ' THR . 61.6 t -130.33 121.81 52.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.625 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -85.77 167.18 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-O 123.018 1.389 . . . . 0.0 107.501 173.95 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.1 t -143.24 132.64 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 C-N-CA 127.448 2.299 . . . . 0.0 105.829 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.15 174.84 10.1 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.448 1.099 . . . . 0.0 108.596 -176.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -88.98 176.09 7.15 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 172.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.7 t -67.55 -3.57 9.15 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 120.499 -1.376 . . . . 0.0 113.58 -176.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -91.36 -12.76 33.97 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 120.364 1.438 . . . . 0.0 110.581 173.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 93.26 -0.77 69.02 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.557 1.075 . . . . 0.0 111.926 -173.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 59.9 m-20 -67.73 115.42 7.27 Favored 'General case' 0 C--N 1.343 0.306 0 CA-C-N 119.427 1.613 . . . . 0.0 108.005 174.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -71.5 147.3 47.89 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.415 1.486 . . . . 0.0 109.386 -174.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.48 -33.87 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.453 HD13 ' N ' ' A' ' 142' ' ' GLN . 1.5 tm? -136.83 147.45 46.56 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -173.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.453 ' N ' HD13 ' A' ' 141' ' ' LEU . 6.2 tm0? -148.81 150.12 32.5 Favored 'General case' 0 N--CA 1.462 0.129 0 O-C-N 121.378 -0.826 . . . . 0.0 109.309 177.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.439 ' HB ' ' H ' ' A' ' 130' ' ' VAL . 24.1 m -82.29 113.75 46.23 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 175.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -64.86 146.43 88.03 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 121.62 1.547 . . . . 0.0 112.21 -173.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -77.72 112.55 14.68 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.303 19.5 m-80 172.71 -17.2 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 1 C-N-CA 137.773 6.429 . . . . 0.0 109.553 173.936 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.6 82.57 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.062 1.745 . . . . 0.0 109.627 174.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.2 mm -121.72 136.03 59.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 176.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.417 ' HB2' ' CE2' ' A' ' 126' ' ' PHE . 6.5 m-85 -112.85 163.51 14.53 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 174.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -138.32 113.4 9.28 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.022 1.329 . . . . 0.0 108.395 -173.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.33 121.43 44.37 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -174.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 23.1 m -84.53 115.59 22.67 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 126.042 1.737 . . . . 0.0 106.726 -175.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 4.2 m -113.98 166.35 11.69 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.185 0.902 . . . . 0.0 109.425 173.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.9 pp -134.22 162.31 32.5 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.626 1.57 . . . . 0.0 106.914 173.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.5 120.34 11.51 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 123.982 0.913 . . . . 0.0 109.907 175.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -163.93 114.17 1.28 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.063 1.345 . . . . 0.0 109.841 176.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 . . . . . 0 C--O 1.256 1.431 0 C-N-CA 128.936 2.894 . . . . 0.0 105.546 173.786 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.557 ' H3 ' ' CG ' ' A' ' 6' ' ' ASP . . . . . . . . 0 N--CA 1.471 0.977 0 N-CA-C 108.407 -1.877 . . . . 0.0 108.407 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.2 t -61.16 177.05 0.38 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 144.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.1 m80 -44.72 131.51 6.84 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 102.717 -3.068 . . . . 0.0 102.717 172.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.0 ptm -43.62 112.46 0.39 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 116.586 2.069 . . . . 0.0 116.586 -172.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.4 mt -177.0 113.34 0.09 Allowed 'General case' 0 N--CA 1.45 -0.432 2 C-N-CA 137.999 6.52 . . . . 0.0 95.855 173.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.557 ' CG ' ' H3 ' ' A' ' 1' ' ' GLY . 7.6 m-20 -148.81 176.04 10.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 120.252 1.387 . . . . 0.0 110.152 -173.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -136.19 172.99 12.21 Favored 'General case' 0 N--CA 1.428 -1.551 0 C-N-CA 130.018 3.327 . . . . 0.0 102.191 173.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -140.25 175.18 9.81 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 128.822 2.849 . . . . 0.0 109.43 -175.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.4 mp0 -69.1 165.01 21.22 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.035 1.734 . . . . 0.0 110.531 174.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.548 ' HB3' ' HB3' ' A' ' 70' ' ' ALA . 52.4 mt-10 -96.99 173.8 7.09 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.152 1.781 . . . . 0.0 110.458 -177.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . 0.295 4.5 m -175.87 176.57 1.8 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.49 2.316 . . . . 0.0 114.811 173.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.9 tt -65.26 137.69 57.73 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 130.302 3.441 . . . . 0.0 112.018 -176.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.41 ' CD2' ' HA ' ' A' ' 35' ' ' SER . 88.3 m-85 -126.91 138.38 53.29 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.257 2.223 . . . . 0.0 108.342 173.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.11 118.72 6.53 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 -175.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 14.2 p90 -135.6 175.45 9.58 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.707 1.203 . . . . 0.0 110.574 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.421 HD11 HD11 ' A' ' 33' ' ' ILE . 1.6 mp -114.22 141.19 31.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 103.52 -2.77 . . . . 0.0 103.52 173.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -93.11 158.73 15.62 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -173.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.34 -15.13 59.03 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 113.122 -1.854 . . . . 0.0 113.497 177.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -61.02 -43.31 99.08 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 119.795 1.18 . . . . 0.0 108.428 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -66.55 -49.56 66.04 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 122.83 0.452 . . . . 0.0 111.143 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.17 -35.31 67.07 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.468 0.707 . . . . 0.0 111.785 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.403 HH21 ' CD ' ' A' ' 28' ' ' GLU . 26.9 ttm105 -56.23 -56.73 17.34 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 175.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.4 t -53.78 -25.58 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 118.738 0.699 . . . . 0.0 111.513 177.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.8 mt -72.45 -43.8 63.26 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 173.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.0 pt -149.93 16.01 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 116.555 2.058 . . . . 0.0 116.555 -173.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.24 9.78 44.1 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 127.398 2.428 . . . . 0.0 114.683 -175.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -101.43 175.9 5.42 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 127.273 2.229 . . . . 0.0 109.709 -174.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.403 ' CD ' HH21 ' A' ' 22' ' ' ARG . 16.6 tp10 -120.68 122.18 39.91 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -155.91 113.49 3.29 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.737 0.815 . . . . 0.0 112.344 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -96.04 159.34 15.01 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 103.002 -2.962 . . . . 0.0 103.002 172.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 84.2 mt -134.39 113.4 17.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 174.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.05 114.25 23.5 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -174.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.421 HD11 HD11 ' A' ' 16' ' ' ILE . 13.6 mt -89.05 -62.84 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.614 0.766 . . . . 0.0 109.355 -179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.515 HG22 ' HG2' ' A' ' 39' ' ' MET . 19.7 t -116.0 128.87 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 126.147 1.779 . . . . 0.0 107.725 -173.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.41 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 54.5 p -132.02 124.51 29.43 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 102.643 -3.095 . . . . 0.0 102.643 173.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.265 1.7 pm0 44.07 40.77 3.64 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.417 1.487 . . . . 0.0 112.863 -175.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.01 -31.76 1.08 Allowed Glycine 0 CA--C 1.542 1.724 0 C-N-CA 126.268 1.89 . . . . 0.0 114.916 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . 0.462 8.8 tmtt? -54.31 37.66 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.835 1 C-N-CA 137.85 6.46 . . . . 0.0 116.126 174.966 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.515 ' HG2' HG22 ' A' ' 34' ' ' VAL . 42.5 mtt -38.01 142.73 0.15 Allowed 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.215 1.806 . . . . 0.0 115.418 -173.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.84 160.29 83.06 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 173.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -74.81 37.69 0.48 Allowed 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 124.217 3.278 . . . . 0.0 111.994 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -55.76 -26.66 46.84 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 126.6 1.96 . . . . 0.0 113.196 -173.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.7 m -54.77 -39.32 68.26 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.451 2.3 . . . . 0.0 112.672 -173.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 -58.0 -65.94 0.56 Allowed 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.811 1.644 . . . . 0.0 109.724 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -70.91 -27.19 63.6 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-O 118.076 -0.964 . . . . 0.0 111.689 -173.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -69.79 -49.17 55.45 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.812 1.245 . . . . 0.0 111.557 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -71.94 -32.1 66.98 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.31 0.959 . . . . 0.0 109.566 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -65.2 165.7 10.99 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 172.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.88 112.96 5.22 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 173.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.418 ' H ' ' HG3' ' A' ' 54' ' ' PRO . 4.7 tt0 -96.56 172.41 7.94 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.53 -30.49 63.12 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 117.51 -1.233 . . . . 0.0 112.651 177.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.79 -16.76 2.55 Favored 'General case' 0 C--N 1.348 0.503 0 N-CA-C 118.027 2.603 . . . . 0.0 118.027 -173.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 91.0 mmm -92.13 -52.83 0.27 Allowed Pre-proline 0 N--CA 1.469 0.524 0 N-CA-C 118.164 2.654 . . . . 0.0 118.164 -173.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.418 ' HG3' ' H ' ' A' ' 50' ' ' GLN . 36.6 Cg_endo -68.76 -70.0 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.697 0 CA-C-N 121.67 1.632 . . . . 0.0 113.698 -173.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.59 114.08 8.33 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.721 0.808 . . . . 0.0 110.504 -173.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 62.4 mt -119.45 127.26 26.54 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 127.097 2.159 . . . . 0.0 106.335 -177.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -77.31 156.58 33.08 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.125 1.883 . . . . 0.0 110.752 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.7 p -42.58 -43.77 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 127.136 2.174 . . . . 0.0 113.1 177.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -62.21 -41.35 98.29 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 126.181 1.792 . . . . 0.0 112.831 -174.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.6 mm -67.64 112.93 3.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 102.912 -2.995 . . . . 0.0 102.912 174.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -81.65 -27.11 34.26 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 118.716 -0.659 . . . . 0.0 109.512 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.4 m -155.27 168.96 25.34 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.383 1.073 . . . . 0.0 110.59 -173.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.1 mtm -126.26 151.02 48.01 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 172.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -104.92 113.29 26.79 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 122.882 0.473 . . . . 0.0 110.422 -176.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -100.76 153.02 19.8 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 103.06 -2.941 . . . . 0.0 103.06 172.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.3 m -138.17 133.71 33.64 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 -177.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -143.81 163.56 33.02 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.42 175.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -172.74 157.03 3.65 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.173 173.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.55 -173.6 4.59 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 172.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.548 ' HB3' ' HB3' ' A' ' 10' ' ' GLU . . . -123.49 134.51 53.88 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 101.478 -3.527 . . . . 0.0 101.478 173.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 16.49 -55.86 0.0 OUTLIER Glycine 0 CA--C 1.534 1.227 1 C-N-CA 135.274 6.178 . . . . 0.0 120.671 -176.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -116.61 -14.97 10.85 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 120.721 2.261 . . . . 0.0 113.999 -177.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.84 37.16 0.35 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 129.303 3.041 . . . . 0.0 118.859 -173.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -56.95 113.81 1.84 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 123.239 2.745 . . . . 0.0 110.307 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -85.81 155.72 20.88 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 125.38 1.472 . . . . 0.0 108.288 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -102.82 150.09 23.84 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 177.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -136.21 160.88 37.34 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.949 1.25 . . . . 0.0 110.905 176.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.45 ' O ' HD13 ' A' ' 131' ' ' ILE . 27.4 tt0 -153.53 140.13 18.86 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 172.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.402 ' CD2' HG22 ' A' ' 130' ' ' VAL . 70.8 m-85 -87.1 103.44 15.39 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.9 tt -74.27 -40.79 62.09 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 175.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.4 m -138.34 135.97 35.9 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.328 1.051 . . . . 0.0 111.591 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.495 HD22 HG22 ' A' ' 128' ' ' VAL . 0.1 OUTLIER -165.63 93.18 0.56 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 102.188 -3.264 . . . . 0.0 102.188 173.254 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.411 ' HD3' ' H ' ' A' ' 82' ' ' LEU . 0.1 OUTLIER -160.12 154.42 23.56 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 121.001 -1.062 . . . . 0.0 110.053 -174.221 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.412 ' HB2' ' HA ' ' A' ' 92' ' ' ASP . 5.4 t -73.89 169.05 18.22 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.716 0.77 . . . . 0.0 110.477 173.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.0 mt -122.34 -21.54 5.79 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 116.179 -1.867 . . . . 0.0 110.849 174.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -106.11 152.29 23.61 Favored 'General case' 0 C--N 1.353 0.741 0 CA-C-N 121.528 1.967 . . . . 0.0 110.773 173.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.44 ' HA ' ' HE3' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -120.33 -23.85 6.07 Favored 'General case' 0 N--CA 1.445 -0.718 1 C-N-CA 135.67 5.588 . . . . 0.0 113.982 179.879 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -72.92 -71.57 1.07 Allowed Glycine 0 CA--C 1.533 1.214 0 N-CA-C 107.118 -2.393 . . . . 0.0 107.118 173.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 mp -77.12 26.52 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 130.052 3.341 . . . . 0.0 110.358 174.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.43 ' SD ' ' HE3' ' A' ' 87' ' ' LYS . 4.7 ttp -42.95 127.76 4.17 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 129.04 2.936 . . . . 0.0 113.487 -173.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -146.99 152.17 38.18 Favored 'General case' 0 N--CA 1.431 -1.42 1 C-N-CA 133.556 4.742 . . . . 0.0 102.216 173.639 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.412 ' HA ' ' HB2' ' A' ' 84' ' ' SER . 5.9 m-20 -139.81 114.19 7.85 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 173.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -70.0 160.76 48.48 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.114 2.543 . . . . 0.0 114.919 -173.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.1 p -137.03 167.11 22.15 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.532 1.933 . . . . 0.0 109.76 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.9 m -126.54 154.76 36.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.038 0.935 . . . . 0.0 111.432 173.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -78.94 9.58 4.16 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.592 2.357 . . . . 0.0 113.574 178.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.7 m -140.84 164.19 37.86 Favored Pre-proline 0 C--N 1.327 -0.4 0 C-N-CA 124.593 1.157 . . . . 0.0 109.557 -175.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -65.58 163.09 31.38 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.418 1.412 . . . . 0.0 109.699 173.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -62.9 -12.98 28.74 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 124.151 0.981 . . . . 0.0 112.423 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -143.66 164.85 29.27 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 120.334 1.425 . . . . 0.0 108.308 173.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.59 -161.96 35.39 Favored Glycine 0 C--O 1.228 -0.231 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 73.6 p -120.76 159.05 26.2 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 117.485 0.642 . . . . 0.0 109.784 174.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.9 t -94.05 113.18 59.96 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 173.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -93.32 163.75 2.45 Favored 'Trans proline' 0 C--O 1.218 -0.485 0 C-N-CA 122.861 2.374 . . . . 0.0 114.114 -173.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -73.26 2.11 8.07 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 120.303 -1.498 . . . . 0.0 113.887 -173.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.41 126.95 55.0 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-O 115.525 -2.179 . . . . 0.0 107.864 177.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -42.29 111.95 0.29 Allowed 'General case' 0 N--CA 1.462 0.155 0 O-C-N 125.299 1.624 . . . . 0.0 109.023 173.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.5 m -117.82 138.25 52.21 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 176.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.4 t -97.5 114.98 36.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 123.796 0.838 . . . . 0.0 110.035 -173.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 77.1 t -93.9 103.21 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 102.689 -3.078 . . . . 0.0 102.689 173.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -85.53 121.44 28.23 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 173.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.5 t -90.02 113.57 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 103.535 -2.765 . . . . 0.0 103.535 173.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -85.77 149.79 23.65 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.488 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 5.4 m-85 -135.62 73.56 61.38 Favored Pre-proline 0 C--O 1.244 0.779 0 CA-C-N 117.772 0.786 . . . . 0.0 109.229 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.3 114.42 3.44 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 N-CA-C 107.575 -1.741 . . . . 0.0 107.575 173.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 5.6 t -95.85 141.55 29.16 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 173.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.9 mt -81.92 -11.02 59.1 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 123.276 0.36 . . . . 0.0 110.716 -178.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 56.99 57.91 17.3 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 126.517 2.008 . . . . 0.0 111.871 173.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.407 ' HD3' ' HA ' ' A' ' 119' ' ' LYS 0.321 41.6 mmtm -113.05 -75.72 0.6 Allowed 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 117.589 -1.196 . . . . 0.0 111.065 179.992 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 49.0 tp60 -77.51 150.58 34.84 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 173.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -93.66 143.31 26.43 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 177.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.86 -152.93 24.88 Favored Glycine 0 C--N 1.334 0.442 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 19.3 t -128.34 113.71 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.96 167.41 13.75 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 173.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -127.97 163.26 24.89 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.431 0.692 . . . . 0.0 109.981 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.488 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 16.0 p90 -146.09 154.44 41.83 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.024 0.93 . . . . 0.0 108.899 173.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -114.39 149.24 36.46 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 127.55 2.34 . . . . 0.0 110.32 -174.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.495 HG22 HD22 ' A' ' 82' ' ' LEU . 63.2 t -140.16 143.49 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 125.043 1.337 . . . . 0.0 109.958 175.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -156.97 116.78 3.47 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 128.1 2.56 . . . . 0.0 105.488 173.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.468 ' H ' ' HB ' ' A' ' 143' ' ' THR . 46.3 t -126.41 121.76 59.65 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.826 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 176.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.461 HG22 ' HG3' ' A' ' 142' ' ' GLN . 0.1 OUTLIER -91.13 162.62 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 O-C-N 124.543 1.152 . . . . 0.0 107.942 174.534 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.3 t -136.91 134.86 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 C-N-CA 125.442 1.497 . . . . 0.0 107.041 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.22 174.41 10.58 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.593 1.157 . . . . 0.0 108.854 -175.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -90.2 176.31 6.8 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 104.694 -2.335 . . . . 0.0 104.694 172.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.9 t -65.47 -4.24 5.53 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 120.4 -1.437 . . . . 0.0 113.871 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -90.3 -14.55 32.98 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 120.725 1.602 . . . . 0.0 110.833 173.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.16 1.08 65.11 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.402 1.001 . . . . 0.0 111.915 -173.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 -69.93 116.03 9.84 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 119.524 1.662 . . . . 0.0 108.209 174.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -69.74 143.63 52.98 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 125.702 1.601 . . . . 0.0 108.776 -175.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -141.4 -37.68 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 124.667 1.187 . . . . 0.0 113.915 -173.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -130.19 150.84 51.26 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.461 ' HG3' HG22 ' A' ' 131' ' ' ILE . 5.5 tm0? -150.0 148.25 28.83 Favored 'General case' 0 CA--C 1.517 -0.307 0 O-C-N 121.054 -1.029 . . . . 0.0 109.469 176.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.468 ' HB ' ' H ' ' A' ' 130' ' ' VAL . 28.7 m -79.17 113.51 36.82 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 103.541 -2.763 . . . . 0.0 103.541 173.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.56 144.74 80.1 Favored 'Trans proline' 0 N--CA 1.445 -1.37 0 CA-C-N 120.369 1.167 . . . . 0.0 110.072 -173.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -75.81 112.39 12.15 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 -174.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 172.91 -31.93 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 129.38 3.072 . . . . 0.0 109.484 -173.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.14 92.9 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.125 1.77 . . . . 0.0 109.381 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.1 mm -125.65 141.19 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.428 ' HB2' ' CE2' ' A' ' 126' ' ' PHE . 0.2 OUTLIER -124.32 166.45 15.9 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 174.151 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -133.7 113.45 12.36 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.359 1.064 . . . . 0.0 108.392 -173.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.4 tttt -100.85 122.65 43.81 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 32.7 m -83.45 117.82 23.33 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 174.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 10.0 m -118.74 166.09 13.2 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.852 0.751 . . . . 0.0 109.431 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.3 pp -138.61 161.81 36.18 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.2 1.4 . . . . 0.0 108.022 176.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.1 126.84 28.7 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.649 1.18 . . . . 0.0 110.345 176.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -158.34 166.96 31.02 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.314 1.846 . . . . 0.0 108.36 174.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 . . . . . 0 C--O 1.258 1.527 0 C-N-CA 128.591 2.757 . . . . 0.0 104.258 173.621 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.502 ' H1 ' ' CG ' ' A' ' 6' ' ' ASP . . . . . . . . 0 N--CA 1.467 0.715 0 N-CA-C 106.577 -2.609 . . . . 0.0 106.577 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.3 m -58.69 169.56 0.94 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 140.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -70.43 112.85 7.03 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 173.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 33.8 tpp -176.41 174.56 1.92 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 127.663 2.385 . . . . 0.0 106.171 -175.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -87.65 114.0 23.86 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 101.991 -3.337 . . . . 0.0 101.991 173.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.502 ' CG ' ' H1 ' ' A' ' 1' ' ' GLY . 34.0 m-20 -75.61 157.27 34.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.313 0.577 . . . . 0.0 110.549 -174.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.23 147.19 6.5 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 130.76 3.624 . . . . 0.0 101.413 173.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -150.86 152.46 33.73 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 123.876 0.87 . . . . 0.0 108.727 173.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -111.77 176.15 5.14 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 126.078 1.751 . . . . 0.0 108.465 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.468 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 14.5 mt-10 -67.55 166.91 13.91 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-O 121.842 0.83 . . . . 0.0 109.807 173.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.9 m -166.77 176.13 7.34 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 130.291 3.436 . . . . 0.0 106.453 173.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.405 HD12 HG11 ' A' ' 132' ' ' VAL . 3.6 tt -47.17 124.67 6.82 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 120.903 1.683 . . . . 0.0 111.955 -174.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -116.32 145.02 43.51 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.914 0.885 . . . . 0.0 110.137 174.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.98 118.56 4.52 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 9.9 p90 -130.78 176.34 8.29 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.446 1.499 . . . . 0.0 110.534 176.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.433 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 5.9 mt -112.62 113.97 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 102.714 -3.069 . . . . 0.0 102.714 173.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -73.59 149.69 41.92 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 122.795 1.283 . . . . 0.0 109.85 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.21 -18.4 3.83 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -173.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -56.61 -34.45 67.23 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 119.515 1.052 . . . . 0.0 111.038 175.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 21.5 tp60 -61.2 -56.14 24.07 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 119.338 0.972 . . . . 0.0 110.633 174.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.451 ' HA ' HD12 ' A' ' 24' ' ' LEU . . . -52.85 -39.13 62.31 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.66 0.784 . . . . 0.0 111.799 174.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.9 ttm-85 -56.24 -59.25 5.21 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 121.019 -1.051 . . . . 0.0 108.86 175.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.487 HG12 HD13 ' A' ' 60' ' ' ILE . 33.5 t -52.94 -23.81 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 CA-C-N 119.322 0.965 . . . . 0.0 111.49 176.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.496 ' HG ' HD11 ' A' ' 60' ' ' ILE . 17.4 mt -78.59 -42.56 28.71 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 117.845 -1.074 . . . . 0.0 113.55 176.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.1 pt -150.42 16.79 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 116.826 2.158 . . . . 0.0 116.826 -172.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.84 7.1 27.58 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 127.952 2.691 . . . . 0.0 115.166 -176.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -100.96 176.31 5.31 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 128.953 2.901 . . . . 0.0 110.148 -173.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -123.18 115.44 21.78 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.882 0.873 . . . . 0.0 110.149 -175.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -157.63 113.97 2.89 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.209 1.803 . . . . 0.0 109.827 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -82.89 168.06 17.44 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 173.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.3 mp -137.56 113.09 10.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 173.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.73 114.15 22.47 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 -178.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.4 mt -88.75 -55.76 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -175.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.4 t -125.57 113.62 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 -174.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 94.6 p -111.89 126.88 55.59 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 102.432 -3.174 . . . . 0.0 102.432 173.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.263 0.7 OUTLIER 46.39 34.06 2.15 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.81 1.244 . . . . 0.0 114.251 175.352 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.26 -4.29 26.39 Favored Glycine 0 CA--C 1.544 1.861 0 C-N-CA 126.545 2.022 . . . . 0.0 115.561 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -76.97 37.16 0.18 Allowed 'General case' 0 N--CA 1.474 0.739 1 C-N-CA 133.98 4.912 . . . . 0.0 111.037 -173.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 35.0 mtt -38.04 118.6 0.7 Allowed 'General case' 0 C--O 1.232 0.183 0 C-N-CA 126.864 2.066 . . . . 0.0 114.568 -173.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.16 164.29 43.73 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 113.835 -1.529 . . . . 0.0 108.722 173.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -73.39 26.85 0.31 Allowed 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 123.931 3.087 . . . . 0.0 112.779 174.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -55.26 -26.61 40.99 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 125.891 1.676 . . . . 0.0 112.876 -174.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 m -65.05 -30.16 71.1 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.248 1.019 . . . . 0.0 110.77 -173.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.455 ' CE1' HH22 ' A' ' 47' ' ' ARG . 3.0 t60 -69.78 -57.31 5.25 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -58.95 -23.75 61.84 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.9 -64.96 0.8 Allowed 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 173.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.455 HH22 ' CE1' ' A' ' 44' ' ' HIS . 2.8 tmm_? -56.59 -22.88 36.75 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 127.132 2.173 . . . . 0.0 114.561 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -63.1 176.96 0.66 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 129.595 3.158 . . . . 0.0 110.675 -176.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.43 172.15 0.93 Allowed 'General case' 0 CA--C 1.544 0.713 0 O-C-N 120.425 -1.422 . . . . 0.0 109.874 173.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 5.1 tm0? -44.42 114.34 0.67 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.675 1.59 . . . . 0.0 111.517 -174.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -142.61 -66.29 0.39 Allowed 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.339 0.655 . . . . 0.0 109.366 174.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.7 tpp180 -145.38 -16.19 0.49 Allowed 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.592 ' H ' ' CD ' ' A' ' 54' ' ' PRO . 85.1 mtp -138.43 -24.08 0.01 OUTLIER Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 116.819 2.155 . . . . 0.0 116.819 -176.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.592 ' CD ' ' H ' ' A' ' 53' ' ' MET . 37.8 Cg_endo -72.5 -80.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.74 0 CA-C-N 123.035 2.12 . . . . 0.0 110.073 -173.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.27 113.99 7.97 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 96.3 mt -115.14 117.08 41.8 Favored Pre-proline 0 C--N 1.326 -0.435 0 C-N-CA 128.097 2.559 . . . . 0.0 105.32 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -73.61 157.85 48.11 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.537 1.491 . . . . 0.0 110.519 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.468 HG21 HD12 ' A' ' 154' ' ' LEU . 12.3 p -41.05 -42.58 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 126.225 1.81 . . . . 0.0 112.403 173.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -46.88 -42.45 17.47 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 127.338 2.255 . . . . 0.0 113.047 177.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.496 HD11 ' HG ' ' A' ' 24' ' ' LEU . 9.1 mm -75.64 112.97 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 177.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -79.95 -34.13 39.05 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 173.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.5 m -160.0 155.94 26.22 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.346 0.658 . . . . 0.0 111.135 -173.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 33.1 mtt -101.76 158.36 16.17 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 103.781 -2.674 . . . . 0.0 103.781 172.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -118.59 113.73 21.71 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 173.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.433 ' HA ' ' HA ' ' A' ' 16' ' ' ILE . 29.6 m-85 -101.49 157.3 16.91 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 173.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.2 m -137.07 135.48 37.53 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 177.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -143.75 166.24 25.42 Favored 'General case' 0 CA--C 1.511 -0.538 0 O-C-N 121.729 -0.607 . . . . 0.0 110.058 177.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -163.61 148.42 10.82 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.965 174.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.45 -173.84 3.52 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 122.916 1.341 . . . . 0.0 107.785 172.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.468 ' HB1' ' HB2' ' A' ' 10' ' ' GLU . . . -115.18 95.74 5.34 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 127.934 2.494 . . . . 0.0 110.13 -173.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 37.06 -56.6 0.0 OUTLIER Glycine 0 CA--C 1.543 1.835 1 C-N-CA 132.713 4.959 . . . . 0.0 120.795 -176.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -116.89 -16.88 10.54 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 121.643 2.722 . . . . 0.0 114.458 173.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.27 37.28 0.1 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 129.255 3.022 . . . . 0.0 115.673 -174.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -38.75 113.59 0.31 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 121.552 1.978 . . . . 0.0 110.367 -174.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -89.24 114.11 25.42 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -74.97 147.11 41.12 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 104.897 -2.261 . . . . 0.0 104.897 174.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -133.17 160.24 37.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 119.585 1.084 . . . . 0.0 110.078 176.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.475 ' O ' HD13 ' A' ' 131' ' ' ILE . 29.7 tt0 -152.38 135.07 15.39 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 173.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -82.92 103.7 12.58 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.062 0.945 . . . . 0.0 108.838 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.7 tt -67.04 -42.25 85.14 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.191 1.397 . . . . 0.0 108.19 174.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.3 m -135.06 139.71 44.98 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.488 1.115 . . . . 0.0 110.966 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.1 tt -170.36 92.96 0.21 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 173.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -161.72 156.3 22.75 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 118.721 0.691 . . . . 0.0 111.269 -174.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.4 t -72.0 163.78 27.26 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.1 mt -125.85 -17.02 5.5 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 116.734 -1.603 . . . . 0.0 112.379 174.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.527 ' CG ' ' H ' ' A' ' 87' ' ' LYS . 20.8 t0 -87.21 175.61 7.97 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 121.66 2.027 . . . . 0.0 112.248 177.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.527 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -115.27 -49.0 2.78 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 129.702 3.201 . . . . 0.0 112.841 177.304 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -78.88 -66.44 1.71 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 178.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.417 ' H ' HD12 ' A' ' 89' ' ' ILE . 3.5 mp -76.78 16.41 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 128.285 2.634 . . . . 0.0 109.81 -176.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 13.1 ttp -43.54 133.07 4.58 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 128.643 2.777 . . . . 0.0 109.838 -173.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -157.6 115.62 3.11 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 125.962 1.705 . . . . 0.0 107.908 -173.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -98.27 135.23 21.35 Favored Pre-proline 0 C--N 1.324 -0.522 0 O-C-N 123.973 0.795 . . . . 0.0 109.547 -174.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.46 154.71 55.58 Favored 'Trans proline' 0 N--CA 1.447 -1.26 0 C-N-CA 121.548 1.499 . . . . 0.0 109.25 173.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 17.9 p -140.4 157.8 44.97 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.556 1.543 . . . . 0.0 108.09 174.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.9 m -126.53 153.72 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 119.143 0.883 . . . . 0.0 113.011 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -74.94 7.11 3.42 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.498 2.319 . . . . 0.0 113.584 174.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.2 m -141.34 165.16 30.65 Favored Pre-proline 0 C--N 1.326 -0.443 0 C-N-CA 125.311 1.444 . . . . 0.0 108.632 -176.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -66.63 166.72 21.13 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 121.077 1.185 . . . . 0.0 110.398 173.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.97 -9.08 18.72 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.61 1.164 . . . . 0.0 112.03 176.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -145.63 164.35 32.01 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.446 1.498 . . . . 0.0 107.84 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 160.24 -161.25 32.38 Favored Glycine 0 C--O 1.227 -0.295 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 27.2 p -120.69 151.46 39.48 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 173.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.1 t -88.64 113.6 56.3 Favored Pre-proline 0 N--CA 1.447 -0.583 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 174.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.4 158.67 47.87 Favored 'Trans proline' 0 CA--C 1.512 -0.613 0 C-N-CA 122.245 1.963 . . . . 0.0 112.736 -174.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -64.39 -26.25 68.38 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 116.692 2.108 . . . . 0.0 116.692 -172.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . 0.566 1.0 OUTLIER -116.94 151.54 36.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 119.406 1.003 . . . . 0.0 113.102 173.134 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -38.61 110.96 0.15 Allowed 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 128.175 2.59 . . . . 0.0 113.292 -173.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.9 m -124.89 143.28 50.93 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 173.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.8 t -93.57 128.73 44.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 124.739 1.216 . . . . 0.0 112.022 -173.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 70.3 t -111.49 103.21 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 173.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -80.38 127.7 32.71 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 173.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.6 t -101.26 113.36 37.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 N-CA-C 103.549 -2.76 . . . . 0.0 103.549 173.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -92.45 148.68 19.24 Favored Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -129.54 73.75 81.34 Favored Pre-proline 0 C--O 1.243 0.762 0 CA-C-N 118.238 1.019 . . . . 0.0 110.66 -175.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.32 114.64 2.76 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.789 2.326 . . . . 0.0 109.553 173.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 8.0 t -91.15 145.29 24.8 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 173.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.3 mt -72.43 -16.39 61.83 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 117.793 0.269 . . . . 0.0 110.613 176.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 59.26 22.15 55.21 Favored Glycine 0 C--O 1.221 -0.679 0 C-N-CA 126.785 2.136 . . . . 0.0 115.456 173.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt -93.86 -46.75 7.05 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 120.2 2.0 . . . . 0.0 111.405 -174.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -96.52 151.3 19.71 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -93.69 151.59 19.54 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 174.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.79 -152.6 22.7 Favored Glycine 0 C--N 1.333 0.387 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 176.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.8 t -128.2 114.29 33.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -86.8 175.21 8.33 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.468 1.107 . . . . 0.0 108.907 173.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -128.32 156.49 42.97 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.776 1.63 . . . . 0.0 107.835 173.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.447 ' CE1' ' CD1' ' A' ' 149' ' ' PHE . 42.3 p90 -150.13 152.91 35.46 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.89 1.276 . . . . 0.0 107.904 173.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -116.28 145.9 42.81 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.736 1.615 . . . . 0.0 112.322 -173.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 92.8 t -141.63 138.28 32.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 173.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -154.3 130.21 10.18 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.854 1.661 . . . . 0.0 106.962 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.0 t -136.23 130.88 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 -174.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.629 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -98.35 163.65 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 173.699 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.405 HG11 HD12 ' A' ' 12' ' ' LEU . 7.1 t -141.91 134.06 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 -174.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.82 175.78 9.15 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 126.178 1.791 . . . . 0.0 107.067 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -93.17 176.01 6.56 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 103.76 -2.681 . . . . 0.0 103.76 172.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.4 t -65.37 -4.23 5.26 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 120.077 -1.639 . . . . 0.0 113.539 -178.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -85.54 -15.47 42.6 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 120.826 1.648 . . . . 0.0 110.374 173.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.4 0.1 65.39 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.837 1.208 . . . . 0.0 112.03 -173.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -70.8 115.63 10.17 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 119.494 1.647 . . . . 0.0 108.42 175.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -64.79 142.23 58.5 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.896 1.678 . . . . 0.0 108.253 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -140.28 -36.38 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 124.517 1.127 . . . . 0.0 113.559 -174.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -135.35 149.05 49.62 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.601 1.16 . . . . 0.0 107.929 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -142.63 138.89 31.02 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 85.8 m -65.97 131.3 94.52 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 174.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.8 143.61 41.85 Favored 'Trans proline' 0 N--CA 1.443 -1.486 0 N-CA-C 108.796 -1.271 . . . . 0.0 108.796 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -85.3 112.83 21.15 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -173.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.408 ' H ' ' H ' ' A' ' 147' ' ' ALA 0.297 0.9 OUTLIER 173.06 -10.44 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.725 1 C-N-CA 136.395 5.878 . . . . 0.0 110.457 174.015 . . . . . . . . 5 4 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.408 ' H ' ' H ' ' A' ' 146' ' ' ASN . . . -63.74 83.55 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.575 1.95 . . . . 0.0 112.069 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 3.9 mm -125.04 122.97 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 -178.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.447 ' CD1' ' CE1' ' A' ' 126' ' ' PHE . 1.0 OUTLIER -103.89 164.4 11.72 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 173.62 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -134.11 113.51 12.15 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -173.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 60.4 tttt -103.9 123.94 48.06 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.815 1.189 . . . . 0.0 109.453 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 25.0 m -83.55 114.57 21.6 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 174.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 5.5 m -116.96 166.63 11.96 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 124.487 1.115 . . . . 0.0 110.301 174.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.468 HD12 HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -137.2 159.44 41.91 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 126.61 1.964 . . . . 0.0 107.881 -177.762 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -69.99 117.6 11.76 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.272 1.429 . . . . 0.0 111.283 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -140.38 165.77 26.52 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.881 2.073 . . . . 0.0 108.495 174.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 . . . . . 0 C--O 1.25 1.099 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 173.67 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.081 0 N-CA-C 108.412 -1.875 . . . . 0.0 108.412 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.0 m -143.03 176.06 9.37 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.691 1.597 . . . . 0.0 106.73 165.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 30.5 t-80 -119.99 139.8 51.94 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -175.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -76.81 175.53 9.36 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.007 1.723 . . . . 0.0 108.263 173.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -74.09 121.31 20.92 Favored 'General case' 0 C--N 1.335 -0.045 0 N-CA-C 102.01 -3.33 . . . . 0.0 102.01 173.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -44.12 113.15 0.49 Allowed 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.519 1.127 . . . . 0.0 112.159 -173.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 -164.69 176.48 8.81 Favored 'General case' 0 N--CA 1.437 -1.093 1 C-N-CA 133.388 4.675 . . . . 0.0 102.77 -174.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.99 113.75 25.81 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 125.234 1.414 . . . . 0.0 107.582 173.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -141.36 167.53 21.94 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 126.849 2.06 . . . . 0.0 106.817 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -142.47 169.72 17.04 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.165 0.986 . . . . 0.0 109.105 173.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.6 m -176.31 177.24 1.54 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 128.862 2.865 . . . . 0.0 109.405 -175.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.0 tt -43.14 130.89 4.56 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.849 2.46 . . . . 0.0 112.99 -176.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -115.77 140.83 48.84 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.679 2.391 . . . . 0.0 108.235 173.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.22 118.03 6.65 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -136.63 176.11 9.0 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.759 0.79 . . . . 0.0 109.264 177.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 12.6 mt -114.47 113.53 44.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 1 N-CA-C 99.573 -4.232 . . . . 0.0 99.573 173.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -78.59 144.88 35.11 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 122.674 1.226 . . . . 0.0 110.999 -173.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.45 ' HB1' ' HG3' ' A' ' 28' ' ' GLU . . . -62.7 -26.49 68.69 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.193 -1.367 . . . . 0.0 112.898 -173.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -67.14 -38.99 86.47 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -174.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -57.54 11.09 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 117.649 -1.167 . . . . 0.0 108.49 173.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.14 -41.42 48.82 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 119.567 1.076 . . . . 0.0 111.751 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -51.59 -65.07 0.62 Allowed 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 173.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 84.5 t -50.46 -24.1 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 125.089 1.355 . . . . 0.0 111.659 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.1 mt -84.35 -38.28 20.53 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.2 pt -145.33 14.06 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 117.275 2.324 . . . . 0.0 117.275 -173.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.83 0.24 2.03 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 128.826 3.107 . . . . 0.0 114.913 -174.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -101.94 134.53 45.0 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 129.36 3.064 . . . . 0.0 106.416 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.45 ' HG3' ' HB1' ' A' ' 18' ' ' ALA . 31.3 tt0 -124.08 113.46 18.41 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.505 1.048 . . . . 0.0 110.549 -173.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -153.19 139.24 18.24 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 128.313 2.645 . . . . 0.0 106.014 173.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -87.03 166.2 15.23 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 173.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.98 113.2 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 104.434 -2.432 . . . . 0.0 104.434 173.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.79 113.93 23.92 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -177.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.3 mt -93.09 -56.25 5.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -176.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.429 HG22 ' HG2' ' A' ' 39' ' ' MET . 6.3 t -126.27 133.72 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 125.904 1.682 . . . . 0.0 106.767 -174.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.9 p -140.13 126.84 20.48 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 102.164 -3.272 . . . . 0.0 102.164 173.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.269 6.2 pt-20 46.05 34.0 1.88 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.177 1.391 . . . . 0.0 113.514 -177.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 64.46 -3.53 1.81 Allowed Glycine 0 CA--C 1.544 1.865 0 O-C-N 120.273 -1.517 . . . . 0.0 114.173 -174.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.5 ttpt -79.72 37.12 0.34 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 131.055 3.742 . . . . 0.0 111.436 -173.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.429 ' HG2' HG22 ' A' ' 34' ' ' VAL . 38.0 mtt -37.82 122.88 1.02 Allowed 'General case' 0 C--O 1.24 0.585 0 C-N-CA 125.478 1.511 . . . . 0.0 112.825 -173.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.1 167.83 7.29 Favored Pre-proline 0 N--CA 1.449 -0.495 0 O-C-N 125.798 1.936 . . . . 0.0 108.052 173.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.57 29.26 0.24 Allowed 'Trans proline' 0 CA--C 1.548 1.19 0 C-N-CA 123.939 3.093 . . . . 0.0 112.365 174.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -53.86 -26.61 25.43 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 126.784 2.033 . . . . 0.0 113.022 -173.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 m -62.17 -29.88 70.66 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.243 1.417 . . . . 0.0 111.46 -173.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.533 ' CE1' ' HZ1' ' A' ' 48' ' ' LYS . 9.7 t-80 -55.3 -65.83 0.52 Allowed 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.098 1.359 . . . . 0.0 109.362 175.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.253 44.1 m-20 -76.44 -23.75 53.93 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.055 0.455 . . . . 0.0 111.571 -175.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -60.31 -44.64 95.24 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 120.099 -1.626 . . . . 0.0 108.331 173.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -40.22 74.6 Favored 'General case' 0 C--O 1.237 0.4 0 O-C-N 121.639 -0.663 . . . . 0.0 109.277 176.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.533 ' HZ1' ' CE1' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -125.68 112.56 16.25 Favored 'General case' 0 C--O 1.215 -0.722 0 O-C-N 120.562 -1.336 . . . . 0.0 110.517 -175.917 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -177.01 113.85 0.09 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-O 116.915 -1.517 . . . . 0.0 107.245 173.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -87.35 112.43 22.09 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 100.554 -3.869 . . . . 0.0 100.554 172.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -176.76 -67.01 0.01 OUTLIER 'General case' 0 C--O 1.232 0.159 0 C-N-CA 125.784 1.634 . . . . 0.0 107.101 174.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.488 ' CZ ' ' HA ' ' A' ' 52' ' ' ARG . 0.1 OUTLIER -155.72 -16.54 0.11 Allowed 'General case' 0 C--N 1.347 0.496 0 N-CA-C 117.049 2.241 . . . . 0.0 117.049 178.569 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.92 -66.74 0.29 Allowed Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 121.173 1.806 . . . . 0.0 114.097 -174.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -78.84 -64.41 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 CA-C-N 121.443 1.551 . . . . 0.0 110.646 -176.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.47 118.06 13.81 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.743 1.217 . . . . 0.0 110.842 -173.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.9 mt -126.14 116.25 23.76 Favored Pre-proline 0 N--CA 1.448 -0.543 0 C-N-CA 126.555 1.942 . . . . 0.0 106.612 -174.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -72.23 155.9 55.77 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.018 1.812 . . . . 0.0 110.353 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.9 p -40.32 -43.66 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 127.715 2.406 . . . . 0.0 112.854 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -59.89 -33.97 72.55 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 126.954 2.101 . . . . 0.0 114.076 -177.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.3 mm -68.47 112.93 3.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 104.098 -2.556 . . . . 0.0 104.098 175.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -81.86 -33.48 30.6 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.669 174.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.3 m -158.39 157.88 33.15 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.32 0.648 . . . . 0.0 109.301 -174.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 33.7 mtm -126.28 166.78 16.48 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 173.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -134.63 130.92 37.16 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -107.95 162.24 14.2 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 173.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.4 m -135.86 133.43 37.76 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -175.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -144.56 165.56 27.65 Favored 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 121.332 -0.855 . . . . 0.0 111.312 179.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.09 158.37 4.6 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 124.238 1.015 . . . . 0.0 110.898 174.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.27 177.42 6.05 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 173.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.15 101.79 12.93 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 120.212 -1.555 . . . . 0.0 108.996 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 44.36 -53.82 0.0 OUTLIER Glycine 0 CA--C 1.541 1.669 1 C-N-CA 132.814 5.007 . . . . 0.0 120.363 175.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -116.9 -19.83 9.67 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 121.628 2.714 . . . . 0.0 115.396 174.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.71 37.17 0.14 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 128.56 2.744 . . . . 0.0 116.082 -173.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.532 ' HG2' ' HE2' ' A' ' 105' ' ' HIS . 3.4 mm-40 -44.36 113.49 0.54 Allowed 'General case' 0 CA--C 1.557 1.224 0 CA-C-N 121.891 2.132 . . . . 0.0 109.147 -174.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -84.35 162.55 20.0 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.346 1.459 . . . . 0.0 111.595 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -111.77 149.53 31.57 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -135.52 161.82 34.41 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 120.226 1.375 . . . . 0.0 111.142 175.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.411 ' O ' HD13 ' A' ' 131' ' ' ILE . 31.1 tt0 -155.49 139.11 16.01 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 173.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -88.78 103.84 16.35 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.959 1.303 . . . . 0.0 109.71 -175.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.9 tt -72.34 -47.66 47.95 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.289 1.435 . . . . 0.0 108.981 175.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 38.1 m -131.61 138.2 48.71 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.493 1.517 . . . . 0.0 111.161 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.438 HD22 HG22 ' A' ' 128' ' ' VAL . 0.3 OUTLIER -168.83 92.69 0.29 Allowed 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 101.936 -3.357 . . . . 0.0 101.936 173.124 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -165.0 154.44 12.94 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 120.037 1.289 . . . . 0.0 112.486 -174.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.1 t -67.96 161.43 26.57 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 119.6 1.091 . . . . 0.0 110.243 173.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.9 mt -126.43 -2.61 6.83 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 125.772 1.629 . . . . 0.0 112.385 174.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.495 ' CG ' ' H ' ' A' ' 87' ' ' LYS 0.337 11.2 t70 -99.07 169.11 9.64 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.819 1.645 . . . . 0.0 112.169 -175.514 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.495 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 1.4 mppt? -109.2 -49.02 3.17 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 129.557 3.143 . . . . 0.0 111.631 -173.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -105.95 -47.66 1.07 Allowed Glycine 0 CA--C 1.524 0.636 0 C-N-CA 125.247 1.403 . . . . 0.0 112.095 -177.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.2 mp -80.73 14.97 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 125.571 1.548 . . . . 0.0 108.884 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 12.9 ttm -43.27 130.72 4.78 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 129.453 3.101 . . . . 0.0 109.199 -173.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -156.94 114.62 3.17 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 126.09 1.756 . . . . 0.0 106.62 -173.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.288 3.9 m-20 -96.36 129.14 34.21 Favored Pre-proline 0 CA--C 1.51 -0.58 0 O-C-N 124.493 1.121 . . . . 0.0 110.995 -174.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -75.64 149.68 34.5 Favored 'Trans proline' 0 N--CA 1.441 -1.561 0 C-N-CA 121.91 1.74 . . . . 0.0 109.685 175.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 20.8 p -131.88 155.44 47.86 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 125.109 1.364 . . . . 0.0 107.912 174.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.6 m -125.23 153.06 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 C-N-CA 124.193 0.997 . . . . 0.0 109.977 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -86.12 11.41 11.88 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.345 1.458 . . . . 0.0 113.367 -177.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.3 m -137.53 164.1 43.86 Favored Pre-proline 0 C--N 1.326 -0.432 0 C-N-CA 124.414 1.086 . . . . 0.0 109.798 -173.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -65.78 162.2 35.74 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.375 1.383 . . . . 0.0 109.803 173.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -65.69 -11.39 44.76 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 124.213 1.005 . . . . 0.0 112.251 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -143.02 164.37 30.28 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.138 1.375 . . . . 0.0 107.807 173.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.64 -160.67 34.13 Favored Glycine 0 C--O 1.226 -0.352 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.0 p -123.48 152.16 42.0 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.261 0.531 . . . . 0.0 109.958 176.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.5 t -94.93 113.09 60.5 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 102.736 -3.061 . . . . 0.0 102.736 173.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -97.17 161.53 1.0 Allowed 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.825 2.35 . . . . 0.0 112.514 -173.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.532 ' HE2' ' HG2' ' A' ' 74' ' ' GLU . 80.8 m-70 -66.72 -19.65 65.8 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 119.971 -1.706 . . . . 0.0 114.88 -174.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.05 114.08 24.32 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 -174.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -47.3 111.43 0.41 Allowed 'General case' 0 N--CA 1.463 0.219 0 O-C-N 124.438 1.086 . . . . 0.0 109.249 -175.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 66.3 m -116.84 143.97 45.05 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -174.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.4 t -105.79 139.0 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -173.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.5 t -121.9 103.7 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -73.73 147.0 43.97 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 173.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.4 t -130.96 113.91 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 104.443 -2.429 . . . . 0.0 104.443 177.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -100.61 146.61 17.65 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 125.249 1.404 . . . . 0.0 110.517 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -129.99 73.6 81.26 Favored Pre-proline 0 CA--C 1.546 0.813 0 CA-C-N 118.88 1.34 . . . . 0.0 111.704 -174.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -64.54 117.14 4.23 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.443 2.095 . . . . 0.0 109.056 173.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 8.5 t -94.01 144.29 25.6 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 173.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.6 mt -79.59 -10.87 59.87 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 122.966 0.506 . . . . 0.0 111.15 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 55.19 33.57 57.99 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 125.817 1.675 . . . . 0.0 114.22 173.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -93.74 -63.42 1.2 Allowed 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 118.471 1.136 . . . . 0.0 110.271 -177.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -96.05 154.66 17.12 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 174.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -93.51 152.28 19.16 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.46 1.504 . . . . 0.0 107.407 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.15 -152.07 22.12 Favored Glycine 0 C--N 1.331 0.305 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.8 t -127.47 113.86 33.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -84.35 173.34 11.01 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 173.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -133.85 159.78 39.62 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.533 1.133 . . . . 0.0 109.554 174.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -146.15 140.73 26.87 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 173.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -94.43 148.0 22.67 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 125.242 1.417 . . . . 0.0 111.25 -175.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.5 HG21 ' CE1' ' A' ' 149' ' ' PHE . 24.8 t -139.19 135.65 41.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 125.396 1.479 . . . . 0.0 108.997 173.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -155.8 120.46 4.68 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 173.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.411 ' H ' ' HB ' ' A' ' 143' ' ' THR . 43.8 t -130.44 123.83 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.618 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -88.76 166.58 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 173.81 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.6 t -146.1 134.59 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 -174.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.34 174.9 10.06 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.977 -175.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -86.83 175.96 7.94 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 172.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.3 t -65.65 -13.93 60.17 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 120.756 -1.215 . . . . 0.0 113.754 -173.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -94.78 -4.19 47.72 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.433 1.093 . . . . 0.0 111.423 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.86 9.44 57.35 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 118.958 -0.912 . . . . 0.0 113.703 176.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -74.28 116.49 15.01 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 119.786 1.793 . . . . 0.0 108.592 175.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.8 m -70.19 143.83 52.12 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 123.815 0.846 . . . . 0.0 109.186 -177.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.57 -36.0 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 124.523 1.129 . . . . 0.0 113.394 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -131.68 145.4 51.63 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -175.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -146.13 147.32 31.41 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.411 ' HB ' ' H ' ' A' ' 130' ' ' VAL . 58.5 m -78.48 113.49 34.84 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.26 144.28 85.87 Favored 'Trans proline' 0 N--CA 1.446 -1.31 0 CA-C-N 119.944 1.016 . . . . 0.0 110.796 -173.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -80.56 112.53 18.0 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 -173.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.444 14.0 m-80 172.55 -13.83 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 1 C-N-CA 138.555 6.742 . . . . 0.0 110.252 173.722 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.55 77.31 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.81 2.044 . . . . 0.0 109.861 173.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 37.0 mm -115.64 125.5 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.5 ' CE1' HG21 ' A' ' 128' ' ' VAL . 0.7 OUTLIER -93.97 154.75 17.5 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 173.946 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -131.05 113.51 14.04 Favored 'General case' 0 CA--C 1.521 -0.156 0 O-C-N 121.366 -0.834 . . . . 0.0 108.755 -173.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -106.71 122.23 45.93 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 118.838 0.745 . . . . 0.0 109.204 -177.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 27.7 m -83.37 117.09 22.79 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 105.68 -1.971 . . . . 0.0 105.68 174.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 6.7 m -118.14 166.41 12.61 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.488 0.715 . . . . 0.0 109.615 173.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.4 pp -131.62 160.44 35.36 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.362 1.465 . . . . 0.0 107.627 175.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -68.41 125.22 25.77 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.457 1.503 . . . . 0.0 109.701 176.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -146.7 127.9 14.75 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.851 1.26 . . . . 0.0 107.809 174.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 . . . . . 0 C--O 1.255 1.361 0 C-N-CA 127.505 2.322 . . . . 0.0 105.42 174.162 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.442 ' H3 ' ' CD2' ' A' ' 3' ' ' HIS . . . . . . . . 0 N--CA 1.467 0.71 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.2 m -63.78 127.56 31.9 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 163.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.442 ' CD2' ' H3 ' ' A' ' 1' ' ' GLY . 88.6 m-70 -144.41 175.23 10.27 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 122.028 0.918 . . . . 0.0 110.307 -175.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 8.8 tpt -142.87 176.28 9.19 Favored 'General case' 0 CA--C 1.544 0.734 1 C-N-CA 133.351 4.661 . . . . 0.0 103.174 173.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.7 tt -69.72 112.7 6.36 Favored 'General case' 0 C--N 1.344 0.341 1 N-CA-C 100.018 -4.067 . . . . 0.0 100.018 173.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -176.29 176.96 1.59 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.55 2.34 . . . . 0.0 106.306 -172.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -128.04 113.75 16.2 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 120.462 1.483 . . . . 0.0 110.302 176.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -123.59 175.9 6.53 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 128.601 2.761 . . . . 0.0 107.985 173.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -67.95 163.56 21.85 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.852 1.261 . . . . 0.0 109.391 173.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -67.46 176.69 2.23 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 123.462 1.601 . . . . 0.0 109.642 173.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.9 m -146.3 177.1 9.27 Favored 'General case' 0 C--O 1.222 -0.375 0 O-C-N 119.036 -2.29 . . . . 0.0 112.613 -173.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tt -43.04 126.14 3.81 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 129.011 2.925 . . . . 0.0 112.934 -173.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.401 ' CD1' ' HA ' ' A' ' 35' ' ' SER . 98.1 m-85 -114.3 141.44 47.59 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 128.281 2.632 . . . . 0.0 108.17 174.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.86 120.76 8.17 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 18.0 p90 -135.94 168.76 18.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 119.159 0.89 . . . . 0.0 109.842 175.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.9 mt -99.78 114.36 37.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 102.073 -3.306 . . . . 0.0 102.073 173.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -79.32 136.08 36.91 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 123.903 1.811 . . . . 0.0 113.068 -173.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.62 -20.37 46.9 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 127.375 2.27 . . . . 0.0 116.213 -173.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -56.47 -40.83 75.54 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 118.886 0.766 . . . . 0.0 109.55 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 42.6 tp60 -65.38 -44.24 88.18 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.681 178.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.581 ' HA ' HD12 ' A' ' 24' ' ' LEU . . . -63.66 -32.03 73.38 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 118.854 -0.593 . . . . 0.0 112.235 176.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -58.48 -54.32 48.31 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 173.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 80.0 t -53.66 -23.96 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 O-C-N 121.39 -0.819 . . . . 0.0 111.927 175.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.581 HD12 ' HA ' ' A' ' 21' ' ' ALA . 13.8 mt -76.61 -40.61 48.87 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 174.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.7 pt -148.83 14.08 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 116.808 2.151 . . . . 0.0 116.808 -172.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.27 -4.4 1.91 Allowed Glycine 0 CA--C 1.533 1.189 0 C-N-CA 128.988 3.185 . . . . 0.0 114.506 -173.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -101.99 139.8 37.13 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 130.674 3.59 . . . . 0.0 105.725 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -101.59 124.05 46.61 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.092 0.957 . . . . 0.0 109.407 -173.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -137.13 113.47 10.02 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.967 1.707 . . . . 0.0 109.251 -174.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -92.14 163.31 13.99 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.144 1.338 . . . . 0.0 107.492 173.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.3 mp -136.71 113.17 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 173.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.86 116.58 23.39 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -176.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 27.4 mt -95.05 -63.76 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.034 0.934 . . . . 0.0 109.335 -177.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.9 t -118.41 133.97 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -173.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.401 ' HA ' ' CD1' ' A' ' 13' ' ' TYR . 2.9 p -137.59 124.55 21.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 104.216 -2.513 . . . . 0.0 104.216 173.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 43.95 33.26 0.73 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.19 2.196 . . . . 0.0 114.091 -174.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.38 -6.87 5.32 Favored Glycine 0 CA--C 1.544 1.873 0 O-C-N 120.713 -1.242 . . . . 0.0 114.73 -174.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -79.19 37.29 0.31 Allowed 'General case' 0 CA--C 1.537 0.466 1 C-N-CA 131.706 4.002 . . . . 0.0 111.215 -178.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 42.6 mtm -38.22 134.73 0.8 Allowed 'General case' 0 C--O 1.233 0.195 0 C-N-CA 126.207 1.803 . . . . 0.0 114.362 -173.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.1 165.38 48.36 Favored Pre-proline 0 N--CA 1.45 -0.446 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 173.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.28 38.2 0.53 Allowed 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 123.911 3.074 . . . . 0.0 110.6 173.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -53.72 -26.7 24.35 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 127.25 2.22 . . . . 0.0 114.095 -173.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.5 m -60.27 -32.08 70.83 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.624 1.169 . . . . 0.0 111.621 -173.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -58.36 -64.13 1.03 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.252 1.021 . . . . 0.0 109.852 176.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -76.37 -29.35 57.14 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -174.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -57.1 -55.99 27.63 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.18 0.992 . . . . 0.0 108.584 173.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.6 -24.46 42.0 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 118.537 -0.744 . . . . 0.0 111.102 -174.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.71 112.92 15.99 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 120.259 1.39 . . . . 0.0 109.689 173.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -172.68 151.11 2.27 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 120.379 1.445 . . . . 0.0 108.507 173.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.48 112.9 24.48 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 173.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -175.73 -67.35 0.01 OUTLIER 'General case' 0 C--O 1.235 0.342 0 N-CA-C 102.752 -3.055 . . . . 0.0 102.752 173.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.09 -17.03 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 117.819 -1.086 . . . . 0.0 110.843 172.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 69.2 mmm -44.8 -52.22 19.4 Favored Pre-proline 0 N--CA 1.468 0.467 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -173.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -69.35 -77.39 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.042 0 CA-C-N 120.837 1.335 . . . . 0.0 110.361 173.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.21 113.32 20.59 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.39 0.614 . . . . 0.0 111.055 -173.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.89 131.5 21.92 Favored Pre-proline 0 C--N 1.327 -0.373 0 C-N-CA 128.489 2.716 . . . . 0.0 106.228 -177.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -79.31 157.6 26.0 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.731 1.621 . . . . 0.0 110.743 177.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.4 p -41.95 -41.17 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 126.97 2.108 . . . . 0.0 112.088 173.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.51 -39.47 83.97 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 127.519 2.328 . . . . 0.0 112.825 -176.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 mm -74.28 112.85 11.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 101.548 -3.501 . . . . 0.0 101.548 173.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -78.14 -38.25 44.16 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.0 m -149.83 161.3 42.53 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.362 1.065 . . . . 0.0 109.585 -173.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 24.3 mtm -126.33 152.38 46.3 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 172.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -94.59 150.29 20.39 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -136.51 152.48 50.57 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 102.376 -3.194 . . . . 0.0 102.376 172.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.0 m -139.95 135.53 32.89 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -176.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -145.84 165.69 28.13 Favored 'General case' 0 C--O 1.24 0.566 0 O-C-N 121.916 -0.49 . . . . 0.0 110.635 177.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.83 157.55 3.06 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.927 0.87 . . . . 0.0 112.438 177.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.6 -174.02 4.17 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 173.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.87 111.83 18.9 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 126.047 1.739 . . . . 0.0 107.101 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 43.4 -57.9 0.0 OUTLIER Glycine 0 CA--C 1.537 1.418 1 C-N-CA 132.74 4.971 . . . . 0.0 119.372 173.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -116.57 -25.79 7.28 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.724 1.762 . . . . 0.0 113.548 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.73 37.1 0.08 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 130.993 3.717 . . . . 0.0 119.068 -173.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -54.37 113.96 1.47 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 123.234 2.743 . . . . 0.0 111.013 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -84.1 142.93 30.04 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 125.322 1.449 . . . . 0.0 107.348 173.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -90.35 149.27 22.37 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -131.95 161.0 34.16 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 120.302 1.41 . . . . 0.0 110.905 175.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.419 ' O ' HD13 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -154.11 134.95 13.73 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 173.276 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -87.28 103.13 15.16 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.098 0.559 . . . . 0.0 110.03 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.0 tt -73.38 -42.07 62.6 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.3 m -138.58 132.72 31.52 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.356 1.062 . . . . 0.0 111.486 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.545 HD22 HG22 ' A' ' 128' ' ' VAL . 0.1 OUTLIER -162.76 93.01 0.8 Allowed 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 101.309 -3.589 . . . . 0.0 101.309 173.2 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.433 ' HD3' ' H ' ' A' ' 82' ' ' LEU . 0.1 OUTLIER -161.4 155.55 22.51 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 119.75 1.159 . . . . 0.0 111.284 -173.753 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.0 t -82.85 153.79 24.97 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 173.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 70.8 mt -107.31 -9.27 16.1 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.253 1.421 . . . . 0.0 111.679 176.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -104.97 162.76 13.07 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 173.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.7 mmtm -138.16 -33.24 0.7 Allowed 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.412 1.885 . . . . 0.0 112.297 -177.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -62.1 -54.26 36.21 Favored Glycine 0 CA--C 1.545 1.912 0 N-CA-C 106.808 -2.517 . . . . 0.0 106.808 172.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.7 mt -90.45 25.28 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 129.281 3.032 . . . . 0.0 110.518 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 4.1 ttp -43.17 133.82 3.82 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 125.458 2.551 . . . . 0.0 112.712 -173.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -149.68 155.38 40.11 Favored 'General case' 0 N--CA 1.422 -1.842 2 C-N-CA 135.994 5.718 . . . . 0.0 101.302 173.785 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -144.86 114.22 5.03 Favored Pre-proline 0 C--N 1.316 -0.855 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 173.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -67.44 157.93 59.44 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 122.816 2.344 . . . . 0.0 113.652 -173.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.3 p -133.17 165.65 24.28 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.513 1.525 . . . . 0.0 109.773 176.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.4 m -126.34 155.58 36.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.174 0.989 . . . . 0.0 110.677 173.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -78.21 9.47 3.77 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.209 2.204 . . . . 0.0 113.485 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.5 m -139.3 163.71 43.82 Favored Pre-proline 0 C--N 1.327 -0.372 0 C-N-CA 124.443 1.097 . . . . 0.0 109.976 -176.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -65.41 162.07 35.31 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.705 1.603 . . . . 0.0 110.071 173.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -64.34 -10.59 25.35 Favored 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 124.634 1.174 . . . . 0.0 112.586 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -145.77 164.06 33.04 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 120.151 1.341 . . . . 0.0 107.857 173.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.37 -161.65 34.22 Favored Glycine 0 C--O 1.227 -0.335 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 77.8 p -117.25 150.94 37.94 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 173.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.2 t -87.16 113.23 52.72 Favored Pre-proline 0 N--CA 1.448 -0.547 0 N-CA-C 102.276 -3.231 . . . . 0.0 102.276 173.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -92.34 155.51 3.09 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.414 2.076 . . . . 0.0 111.98 -173.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.406 ' CD2' ' H ' ' A' ' 105' ' ' HIS . 18.0 m-70 -65.51 -16.88 64.11 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 120.164 -1.585 . . . . 0.0 112.179 -174.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.474 ' H ' ' HD2' ' A' ' 106' ' ' LYS . 3.8 mptt -85.88 113.77 22.27 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 -174.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.65 110.58 0.48 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 119.098 0.863 . . . . 0.0 109.37 -176.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 45.3 m -117.04 139.86 50.18 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -175.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.6 t -98.37 114.16 35.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 C-N-CA 124.402 1.081 . . . . 0.0 109.425 -173.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 85.1 t -93.98 103.41 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 N-CA-C 103.875 -2.639 . . . . 0.0 103.875 173.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -84.49 126.09 32.97 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 104.921 -2.251 . . . . 0.0 104.921 173.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.7 t -94.14 113.84 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 104.462 -2.422 . . . . 0.0 104.462 174.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -87.71 148.32 21.01 Favored Glycine 0 N--CA 1.44 -1.057 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 176.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.454 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 3.8 m-85 -132.19 73.45 77.67 Favored Pre-proline 0 C--O 1.242 0.68 0 C-N-CA 124.125 0.97 . . . . 0.0 108.924 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.98 121.76 8.16 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 121.652 1.568 . . . . 0.0 108.082 174.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 5.9 t -101.99 149.69 23.98 Favored 'General case' 0 C--N 1.34 0.191 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 173.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mt -79.42 -18.0 53.14 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 118.068 0.394 . . . . 0.0 110.697 176.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.54 17.52 53.74 Favored Glycine 0 C--O 1.215 -1.082 0 C-N-CA 127.632 2.539 . . . . 0.0 115.719 173.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 24.6 mttt -93.19 -29.38 15.75 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 121.576 2.688 . . . . 0.0 111.449 -173.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -96.66 154.88 17.03 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 172.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -102.24 144.58 30.59 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 174.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 151.21 -157.71 27.34 Favored Glycine 0 C--N 1.332 0.319 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 175.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 18.8 t -127.18 113.57 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 175.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -89.32 164.16 15.03 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 173.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -122.96 163.84 19.65 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 121.227 -0.92 . . . . 0.0 110.104 176.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.454 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 9.1 p90 -149.61 150.53 32.34 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 118.4 0.545 . . . . 0.0 109.65 173.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -111.53 150.58 29.77 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 127.638 2.375 . . . . 0.0 110.33 -174.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.545 HG22 HD22 ' A' ' 82' ' ' LEU . 85.6 t -138.83 137.47 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 125.698 1.599 . . . . 0.0 109.083 174.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -156.32 124.47 5.69 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 126.809 2.043 . . . . 0.0 106.357 173.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 42.7 t -135.01 128.39 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.628 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -95.22 164.57 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 174.383 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.1 t -143.27 135.26 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -173.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.52 175.46 9.58 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.866 1.266 . . . . 0.0 108.642 -174.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 37.9 p-10 -89.99 176.32 6.84 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 172.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.6 t -65.49 -4.81 6.4 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 120.28 -1.512 . . . . 0.0 113.949 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -88.63 -16.73 31.7 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 120.714 1.597 . . . . 0.0 110.696 173.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.57 1.16 60.54 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.555 1.074 . . . . 0.0 111.808 -173.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 60.6 m-20 -70.84 116.56 11.29 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 119.535 1.668 . . . . 0.0 108.384 174.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.5 m -68.03 143.87 55.35 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.842 1.657 . . . . 0.0 109.024 -174.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -140.99 -36.34 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.628 1.171 . . . . 0.0 113.999 -174.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -130.55 144.11 51.2 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 178.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -144.79 131.37 19.91 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 177.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 77.5 m -63.57 131.35 94.82 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 174.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -72.17 144.5 42.09 Favored 'Trans proline' 0 N--CA 1.444 -1.408 0 N-CA-C 108.401 -1.423 . . . . 0.0 108.401 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -82.76 112.52 19.68 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 -175.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.599 38.9 m-80 172.31 -13.19 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 1 C-N-CA 132.739 4.415 . . . . 0.0 114.295 173.28 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.86 96.6 0.09 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.056 1.342 . . . . 0.0 108.612 177.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.1 mt -133.58 148.8 30.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.416 ' CD1' ' CZ ' ' A' ' 126' ' ' PHE . 0.4 OUTLIER -130.87 170.08 14.89 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.274 1.429 . . . . 0.0 107.624 175.648 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -135.3 113.48 11.31 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.865 1.266 . . . . 0.0 108.023 -173.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -101.31 123.55 45.58 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 23.9 m -83.48 117.81 23.34 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 175.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 30.9 m -112.25 158.17 20.05 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 174.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.8 pp -146.24 159.59 43.12 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 176.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.44 121.25 2.89 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.73 2.412 . . . . 0.0 115.223 -173.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -139.74 164.14 30.73 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 130.131 3.372 . . . . 0.0 106.646 173.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 . . . . . 0 C--O 1.252 1.188 0 C-N-CA 127.515 2.326 . . . . 0.0 105.957 175.708 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.04 0 N-CA-C 107.263 -2.335 . . . . 0.0 107.263 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 p -53.04 176.56 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.415 0.686 . . . . 0.0 110.597 136.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -58.21 170.29 0.71 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 173.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -61.9 155.71 22.73 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 122.699 0.4 . . . . 0.0 109.967 175.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.7 mp -131.8 164.28 26.36 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 128.272 2.629 . . . . 0.0 104.161 173.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -80.25 148.45 30.78 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.222 1.409 . . . . 0.0 110.333 174.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.409 ' HG2' ' H ' ' A' ' 8' ' ' GLN . 4.2 tt0 -169.36 176.2 5.22 Favored 'General case' 0 N--CA 1.439 -1.009 1 C-N-CA 131.711 4.004 . . . . 0.0 102.5 173.771 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.409 ' H ' ' HG2' ' A' ' 7' ' ' GLN . 27.2 tp60 -127.62 166.03 18.84 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 128.476 2.711 . . . . 0.0 106.266 173.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 58.2 mp0 -65.47 167.29 8.95 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.529 1.532 . . . . 0.0 110.823 175.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -137.7 172.54 12.8 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.504 1.522 . . . . 0.0 109.037 -174.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m -175.79 176.99 1.76 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 129.237 3.015 . . . . 0.0 109.978 178.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.2 tt -43.41 129.23 5.05 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 127.15 2.18 . . . . 0.0 112.236 -174.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.412 ' CD1' ' HA ' ' A' ' 35' ' ' SER . 74.5 m-85 -116.18 132.88 56.54 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.041 1.736 . . . . 0.0 109.062 174.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.07 120.56 11.02 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -178.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.5 p90 -134.25 175.32 9.61 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.71 0.804 . . . . 0.0 110.088 176.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.3 mt -111.81 116.17 51.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 102.213 -3.254 . . . . 0.0 102.213 174.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -83.18 148.56 27.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 123.501 1.619 . . . . 0.0 114.639 -173.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.81 -14.33 32.15 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 126.863 2.065 . . . . 0.0 114.666 -174.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -58.26 -35.1 71.25 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 119.185 0.902 . . . . 0.0 109.876 174.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 47.2 tp60 -67.37 -43.05 82.39 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 118.376 0.535 . . . . 0.0 111.104 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.583 ' HA ' HD12 ' A' ' 24' ' ' LEU . . . -60.71 -37.8 82.89 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.881 0.872 . . . . 0.0 111.044 173.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -56.21 -58.22 8.89 Favored 'General case' 0 N--CA 1.445 -0.72 0 O-C-N 121.002 -1.061 . . . . 0.0 108.198 173.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 72.6 t -52.24 -23.64 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 124.563 1.145 . . . . 0.0 111.822 175.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.583 HD12 ' HA ' ' A' ' 21' ' ' ALA . 14.2 mt -73.87 -51.17 17.1 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 117.93 -1.034 . . . . 0.0 112.456 175.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.6 pt -156.13 21.53 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -172.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.63 -0.64 60.48 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 126.694 2.092 . . . . 0.0 114.656 -174.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -80.02 176.39 9.79 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 128.285 2.634 . . . . 0.0 110.035 -173.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -138.04 113.4 9.43 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -173.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -160.0 115.46 2.37 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.449 0.7 . . . . 0.0 110.598 -178.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -89.55 175.73 7.17 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.369 1.468 . . . . 0.0 109.633 173.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 21.6 mt -143.91 113.27 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 172.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.72 114.23 24.14 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -177.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.2 mt -91.3 -61.54 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 118.944 0.793 . . . . 0.0 109.198 -177.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.6 t -116.6 122.89 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 -173.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.412 ' HA ' ' CD1' ' A' ' 13' ' ' TYR . 2.9 p -126.11 119.36 27.36 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 102.966 -2.976 . . . . 0.0 102.966 173.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.32 17.6 pm0 45.91 42.16 8.8 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.914 1.686 . . . . 0.0 112.884 -176.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.99 -24.22 1.3 Allowed Glycine 0 CA--C 1.543 1.829 0 C-N-CA 125.965 1.745 . . . . 0.0 115.136 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . 0.437 7.0 tmtt? -53.94 37.32 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.686 1 C-N-CA 137.609 6.364 . . . . 0.0 117.085 174.373 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 42.6 mtt -38.17 130.03 1.24 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.11 167.63 32.52 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 173.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.48 34.17 0.34 Allowed 'Trans proline' 0 CA--C 1.55 1.313 0 C-N-CA 124.069 3.179 . . . . 0.0 111.728 173.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -54.7 -26.57 34.5 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 127.899 2.48 . . . . 0.0 114.4 -173.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 m -62.9 -32.38 73.64 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.5 1.12 . . . . 0.0 112.185 -172.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 61.3 t60 -59.96 -51.42 69.74 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.411 ' HA ' ' O ' ' A' ' 48' ' ' LYS 0.328 0.9 OUTLIER -76.09 -28.69 57.65 Favored 'General case' 0 C--O 1.224 -0.237 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.294 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -55.88 -46.53 78.29 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.066 -1.021 . . . . 0.0 108.274 173.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.9 ttt85 -76.8 -35.46 57.61 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 118.506 -0.759 . . . . 0.0 112.302 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -126.56 113.0 16.19 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 116.897 -1.525 . . . . 0.0 109.171 178.391 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -176.03 176.91 1.69 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 121.375 1.898 . . . . 0.0 109.117 178.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -50.99 158.36 0.71 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.957 1.303 . . . . 0.0 107.668 173.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -43.73 -32.93 1.12 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.722 2.409 . . . . 0.0 113.735 -173.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 47.8 ttp85 -57.98 -11.23 2.26 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 116.754 -1.593 . . . . 0.0 115.274 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.67 -66.85 0.02 OUTLIER Pre-proline 0 N--CA 1.47 0.535 0 CA-C-N 121.732 2.06 . . . . 0.0 114.564 174.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -75.83 -71.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.593 0 CA-C-N 122.586 1.959 . . . . 0.0 113.14 -173.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.01 113.62 14.91 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.622 0.769 . . . . 0.0 110.04 -173.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 94.3 mt -109.4 119.37 48.45 Favored Pre-proline 0 C--N 1.325 -0.498 0 C-N-CA 127.122 2.169 . . . . 0.0 105.903 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -74.33 155.91 46.15 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 121.782 1.655 . . . . 0.0 109.486 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.3 p -41.54 -41.77 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 126.66 1.984 . . . . 0.0 112.598 174.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -56.25 -42.4 77.32 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 126.896 2.078 . . . . 0.0 113.099 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.2 mm -74.53 112.86 12.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 101.642 -3.466 . . . . 0.0 101.642 173.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -76.55 -36.11 57.83 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . 0.253 4.2 m -148.99 161.83 41.12 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.195 1.398 . . . . 0.0 109.933 -173.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -117.7 145.65 44.27 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 172.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 44.9 m-20 -94.12 146.82 23.7 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 174.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -136.09 153.77 51.21 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 102.528 -3.138 . . . . 0.0 102.528 172.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.1 m -139.5 133.66 31.18 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -177.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -145.02 166.76 24.41 Favored 'General case' 0 C--O 1.238 0.496 0 O-C-N 122.056 -0.403 . . . . 0.0 111.158 177.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.24 158.22 13.94 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 124.866 1.266 . . . . 0.0 110.349 174.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -97.73 168.44 10.33 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 173.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.21 96.15 10.53 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 120.157 -1.589 . . . . 0.0 110.526 -174.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 48.74 -58.54 0.0 OUTLIER Glycine 0 CA--C 1.536 1.363 1 C-N-CA 131.783 4.516 . . . . 0.0 119.544 173.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -117.08 -15.66 10.52 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.446 2.123 . . . . 0.0 115.783 173.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.33 37.18 0.2 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 129.231 3.012 . . . . 0.0 115.998 -173.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -39.02 113.43 0.31 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 121.621 2.009 . . . . 0.0 110.031 -173.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -89.91 130.16 36.17 Favored 'General case' 0 CA--C 1.522 -0.106 0 C-N-CA 125.147 1.379 . . . . 0.0 107.62 175.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -84.6 150.95 24.84 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -137.76 160.87 38.05 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 119.913 1.233 . . . . 0.0 110.815 174.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.484 ' O ' HD13 ' A' ' 131' ' ' ILE . 28.5 tt0 -153.56 138.75 17.43 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 173.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.417 ' CD2' HD23 ' A' ' 82' ' ' LEU . 68.8 m-85 -86.12 103.45 14.79 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tt -70.81 -41.99 70.84 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.627 1.171 . . . . 0.0 108.123 174.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.2 m -138.61 135.7 35.21 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.634 1.174 . . . . 0.0 111.397 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.541 HD22 HG22 ' A' ' 128' ' ' VAL . 0.1 OUTLIER -164.97 93.13 0.61 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 102.169 -3.271 . . . . 0.0 102.169 173.194 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.412 ' HD3' ' H ' ' A' ' 82' ' ' LEU . 0.1 OUTLIER -161.43 154.14 20.52 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 120.821 -1.175 . . . . 0.0 110.76 -174.037 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.3 t -73.14 165.31 25.29 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.36 0.6 . . . . 0.0 109.628 173.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.5 mt -120.49 -21.87 6.65 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 116.505 -1.712 . . . . 0.0 110.764 173.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -99.35 164.89 11.93 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-O 123.935 1.826 . . . . 0.0 108.407 173.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.4 mmtm -136.71 -27.24 1.03 Allowed 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 129.255 3.022 . . . . 0.0 112.315 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.31 -63.85 3.86 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 106.67 -2.572 . . . . 0.0 106.67 172.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.417 HG22 ' O ' ' A' ' 89' ' ' ILE . 3.7 mp -81.87 26.7 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 128.934 2.894 . . . . 0.0 110.855 174.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 2.8 ttp -43.06 128.24 4.39 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 125.107 2.385 . . . . 0.0 112.734 -173.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.557 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -150.65 146.98 26.84 Favored 'General case' 0 N--CA 1.427 -1.606 1 C-N-CA 135.435 5.494 . . . . 0.0 101.263 174.091 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -136.73 117.0 10.87 Favored Pre-proline 0 C--N 1.318 -0.802 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 177.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -68.31 159.81 51.68 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.977 2.451 . . . . 0.0 113.932 -173.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 21.7 p -138.58 161.86 36.02 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.89 2.076 . . . . 0.0 109.031 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.5 m -126.37 154.73 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.195 0.998 . . . . 0.0 111.784 174.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -80.17 10.11 4.82 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 127.522 2.329 . . . . 0.0 113.468 177.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.9 m -140.49 163.18 45.12 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 124.54 1.136 . . . . 0.0 109.72 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -66.67 161.91 39.55 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 121.454 1.436 . . . . 0.0 109.567 173.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -64.58 -12.25 43.22 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 124.232 1.013 . . . . 0.0 112.644 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -145.16 165.1 29.29 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.974 1.31 . . . . 0.0 108.023 173.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 161.08 -161.12 32.68 Favored Glycine 0 C--O 1.227 -0.286 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 68.5 p -119.06 148.21 43.28 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 173.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.0 t -80.12 113.41 38.29 Favored Pre-proline 0 N--CA 1.447 -0.608 0 N-CA-C 102.15 -3.278 . . . . 0.0 102.15 173.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -84.33 165.64 12.61 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.585 1.523 . . . . 0.0 114.647 -173.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -77.43 3.68 12.75 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 120.687 -1.258 . . . . 0.0 114.341 -173.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.67 134.09 55.23 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 173.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.86 110.84 0.46 Allowed 'General case' 0 C--O 1.231 0.13 0 C-N-CA 124.785 1.234 . . . . 0.0 108.664 176.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.2 m -118.78 140.29 50.19 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.3 t -94.98 114.81 32.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 124.156 0.983 . . . . 0.0 109.941 -173.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 77.7 t -93.84 103.48 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 103.342 -2.836 . . . . 0.0 103.342 173.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -89.26 125.37 35.07 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 173.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.5 t -95.39 113.68 30.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 103.939 -2.615 . . . . 0.0 103.939 173.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -94.17 144.77 17.32 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.477 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 6.2 m-85 -129.22 73.89 81.39 Favored Pre-proline 0 C--O 1.243 0.724 0 CA-C-N 117.903 0.851 . . . . 0.0 110.495 -174.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.09 122.47 9.78 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 N-CA-C 107.928 -1.605 . . . . 0.0 107.928 173.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.557 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 5.9 t -105.75 153.13 22.3 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 124.703 1.201 . . . . 0.0 107.97 173.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.7 mt -81.42 -10.27 59.55 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.371 0.532 . . . . 0.0 112.011 -175.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 54.21 42.73 73.63 Favored Glycine 0 C--O 1.222 -0.643 0 C-N-CA 126.78 2.133 . . . . 0.0 114.759 173.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -126.89 -29.99 2.78 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.592 1.696 . . . . 0.0 113.307 173.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -96.31 153.55 17.75 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 104.764 -2.31 . . . . 0.0 104.764 172.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -108.73 143.44 37.85 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 177.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 141.83 -154.86 25.1 Favored Glycine 0 C--N 1.334 0.435 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.0 t -130.38 113.91 27.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 123.398 0.679 . . . . 0.0 109.36 -177.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -88.88 168.82 12.1 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 173.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -127.22 160.53 31.01 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.729 0.812 . . . . 0.0 109.827 173.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.477 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 12.7 p90 -146.93 152.31 38.46 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.792 0.837 . . . . 0.0 109.51 173.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -112.23 150.23 31.18 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 127.102 2.161 . . . . 0.0 112.144 -173.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.541 HG22 HD22 ' A' ' 82' ' ' LEU . 95.3 t -139.17 141.33 36.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 124.815 1.246 . . . . 0.0 109.619 173.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -155.78 119.25 4.38 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 127.654 2.382 . . . . 0.0 105.436 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.406 ' H ' ' HB ' ' A' ' 143' ' ' THR . 45.1 t -129.45 125.28 61.45 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 179.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.484 HD13 ' O ' ' A' ' 78' ' ' GLU . 0.1 OUTLIER -92.56 161.52 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 173.86 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.9 t -137.52 135.12 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 -177.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.81 174.44 10.57 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 124.821 1.249 . . . . 0.0 108.355 -176.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -89.97 176.18 6.9 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 172.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.3 t -66.04 -3.68 5.85 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 120.233 -1.542 . . . . 0.0 113.765 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -89.71 -14.61 34.34 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 120.625 1.557 . . . . 0.0 110.612 173.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.62 0.46 64.59 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.581 1.086 . . . . 0.0 112.107 -173.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -69.74 115.77 9.36 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.507 1.653 . . . . 0.0 108.302 174.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -68.9 143.69 54.41 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.684 1.594 . . . . 0.0 108.821 -175.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -140.02 -37.73 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.667 1.187 . . . . 0.0 113.761 -174.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -132.78 149.14 52.31 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 10.0 tm0? -147.85 148.69 31.14 Favored 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 120.99 -1.069 . . . . 0.0 108.649 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.406 ' HB ' ' H ' ' A' ' 130' ' ' VAL . 27.1 m -80.2 113.29 37.58 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 175.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.33 146.09 79.67 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 CA-C-N 120.071 1.061 . . . . 0.0 110.856 -173.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -78.61 112.63 15.88 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 -173.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.488 28.2 m-80 172.49 -21.07 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 1 C-N-CA 136.276 5.831 . . . . 0.0 111.376 173.543 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -56.66 91.85 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.346 2.258 . . . . 0.0 110.355 176.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.6 mt -136.4 149.79 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.415 ' CD1' ' CZ ' ' A' ' 126' ' ' PHE . 0.8 OUTLIER -128.22 169.48 14.11 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 174.195 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -133.9 113.76 12.56 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.177 1.391 . . . . 0.0 107.523 -173.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 51.6 tttt -101.05 122.4 43.49 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 120.097 1.317 . . . . 0.0 109.173 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.6 m -83.52 118.39 23.75 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 173.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 20.3 m -114.55 165.22 12.99 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 173.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.4 pp -141.14 161.67 37.3 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.525 1.13 . . . . 0.0 108.666 174.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -74.67 126.82 31.66 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 128.447 2.699 . . . . 0.0 111.307 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -139.77 168.45 19.79 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 126.517 1.927 . . . . 0.0 108.989 173.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 . . . . . 0 C--O 1.247 0.921 0 C-N-CA 131.035 3.734 . . . . 0.0 104.629 174.116 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.137 0 N-CA-C 106.823 -2.511 . . . . 0.0 106.823 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 m -52.86 176.69 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 122.813 0.445 . . . . 0.0 110.42 136.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -55.75 171.06 0.24 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.534 0.734 . . . . 0.0 109.512 173.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 8.6 ttm -58.68 152.52 18.53 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 174.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.11 176.58 8.58 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 129.569 3.147 . . . . 0.0 105.992 176.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -44.15 113.49 0.54 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.976 2.11 . . . . 0.0 110.376 -173.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -164.26 145.76 8.57 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 129.375 3.07 . . . . 0.0 103.363 -174.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -147.24 175.8 10.47 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 127.57 2.348 . . . . 0.0 108.755 173.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 27.7 mp0 -74.82 168.35 20.05 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 129.223 3.009 . . . . 0.0 112.509 -173.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -82.14 175.49 10.27 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.053 1.341 . . . . 0.0 109.725 173.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m -170.73 177.02 4.02 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 127.604 2.361 . . . . 0.0 110.822 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.0 tt -43.52 128.6 5.11 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 127.816 2.446 . . . . 0.0 112.435 -174.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -115.28 133.83 55.68 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.739 1.615 . . . . 0.0 108.822 173.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.56 120.85 10.22 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.2 p90 -135.15 170.88 15.24 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 119.201 0.91 . . . . 0.0 109.32 175.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mt -106.39 113.79 43.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 101.798 -3.408 . . . . 0.0 101.798 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -76.28 148.29 37.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 123.299 1.523 . . . . 0.0 113.373 -173.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.37 -22.4 66.09 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 113.388 -1.733 . . . . 0.0 114.84 -173.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -57.62 -38.67 75.35 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 119.448 1.022 . . . . 0.0 109.859 -177.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -69.3 -44.93 70.77 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 122.36 -0.212 . . . . 0.0 111.156 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.598 ' HA ' HD12 ' A' ' 24' ' ' LEU . . . -60.08 -31.28 69.87 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 119.118 -0.468 . . . . 0.0 112.006 173.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 38.2 ttm-85 -58.39 -54.96 41.13 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 173.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.6 t -52.99 -23.79 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.095 0.958 . . . . 0.0 111.914 175.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.598 HD12 ' HA ' ' A' ' 21' ' ' ALA . 10.5 mt -78.46 -42.21 30.52 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 174.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.7 pt -146.81 16.07 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 117.247 2.314 . . . . 0.0 117.247 -172.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.22 6.29 10.0 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 128.522 2.963 . . . . 0.0 115.339 -175.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -101.25 176.25 5.31 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 128.532 2.733 . . . . 0.0 109.594 -173.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -125.56 116.51 21.86 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 123.166 0.586 . . . . 0.0 109.452 -178.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -161.17 124.85 3.34 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.183 1.793 . . . . 0.0 109.787 175.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -92.7 174.38 7.29 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.777 1.631 . . . . 0.0 106.964 173.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.2 mt -140.77 113.49 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 172.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.66 117.53 20.66 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -177.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.46 HG23 ' CD1' ' A' ' 42' ' ' PHE . 21.6 mt -89.96 -66.32 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 119.178 0.899 . . . . 0.0 108.825 177.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -111.92 116.47 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.541 1.536 . . . . 0.0 107.447 -173.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.5 p -112.47 116.08 29.7 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 173.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.287 2.8 pm0 45.29 40.2 4.99 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.813 1.645 . . . . 0.0 112.813 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.44 -30.7 1.42 Allowed Glycine 0 CA--C 1.544 1.906 0 C-N-CA 125.652 1.596 . . . . 0.0 114.101 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . 0.434 7.3 tmtt? -61.94 38.02 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.768 1 C-N-CA 138.838 6.855 . . . . 0.0 112.708 173.761 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 33.0 mtm -37.51 139.23 0.29 Allowed 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 126.69 1.996 . . . . 0.0 115.527 -172.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.42 164.49 43.52 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 112.673 -2.058 . . . . 0.0 108.964 173.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.27 32.69 0.31 Allowed 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 124.039 3.16 . . . . 0.0 112.395 174.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.46 ' CD1' HG23 ' A' ' 33' ' ' ILE . 12.5 p90 -52.91 -26.15 14.01 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.816 2.047 . . . . 0.0 111.843 -174.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.6 m -57.65 -30.31 65.31 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.038 1.735 . . . . 0.0 109.974 -174.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -56.44 -62.83 1.45 Allowed 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.501 1.121 . . . . 0.0 108.968 173.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -68.31 -25.41 65.11 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.397 1.079 . . . . 0.0 111.989 -174.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -72.37 -49.12 36.37 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.036 0.534 . . . . 0.0 110.026 174.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.518 ' CZ ' ' HA ' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -76.77 -23.21 52.93 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 124.811 1.244 . . . . 0.0 111.883 -174.06 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.7 ttpm? -63.45 177.14 0.71 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.032 1.733 . . . . 0.0 111.806 -174.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.03 176.66 0.3 Allowed 'General case' 0 CA--C 1.546 0.806 0 O-C-N 120.119 -1.613 . . . . 0.0 109.635 173.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -43.61 121.51 2.34 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.645 1.578 . . . . 0.0 109.767 -174.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -152.87 -66.69 0.16 Allowed 'General case' 0 CA--C 1.533 0.292 0 O-C-N 123.797 0.686 . . . . 0.0 109.353 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -154.4 -16.87 0.13 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.573 ' H ' ' CD ' ' A' ' 54' ' ' PRO . 63.7 mmm -123.31 -35.82 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 125.402 1.481 . . . . 0.0 113.688 -177.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.573 ' CD ' ' H ' ' A' ' 53' ' ' MET . 79.0 Cg_endo -78.12 -98.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.881 1.721 . . . . 0.0 110.118 -173.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.24 124.79 24.09 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.213 -0.93 . . . . 0.0 109.748 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.5 mt -130.94 138.03 32.08 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 128.81 2.844 . . . . 0.0 106.842 -174.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -81.34 157.43 19.63 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.702 2.268 . . . . 0.0 111.655 174.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.3 p -42.94 -41.47 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 127.257 2.223 . . . . 0.0 112.908 174.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -58.25 -34.36 70.38 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 126.65 1.98 . . . . 0.0 113.077 -175.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.7 mm -71.62 112.89 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 102.863 -3.014 . . . . 0.0 102.863 174.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -95.48 -23.42 17.12 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 -177.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.6 m -149.8 166.03 30.69 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 125.118 1.367 . . . . 0.0 107.548 173.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 13.9 mmm -123.13 163.29 20.86 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 173.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -117.96 150.5 39.15 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 173.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -139.52 153.5 47.48 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 102.101 -3.296 . . . . 0.0 102.101 172.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.3 m -138.63 132.91 31.69 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -176.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -145.1 161.56 39.17 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.184 177.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -165.89 145.14 6.18 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 123.937 0.895 . . . . 0.0 110.689 173.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.71 177.2 7.76 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 173.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.19 99.81 10.55 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 125.281 1.432 . . . . 0.0 110.136 -173.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 47.3 -56.27 0.0 OUTLIER Glycine 0 CA--C 1.536 1.386 1 C-N-CA 132.613 4.911 . . . . 0.0 119.396 174.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -117.01 -16.53 10.5 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.518 2.159 . . . . 0.0 115.706 173.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.31 37.11 0.38 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 128.56 2.744 . . . . 0.0 116.92 -173.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -46.36 113.87 0.71 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 122.01 2.187 . . . . 0.0 110.549 -177.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -83.83 145.95 28.38 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 125.341 1.456 . . . . 0.0 107.51 174.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -94.05 150.89 19.93 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -133.8 160.18 38.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 119.869 1.213 . . . . 0.0 111.165 175.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.469 ' O ' HD13 ' A' ' 131' ' ' ILE . 29.5 tt0 -154.13 138.4 16.62 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 173.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -86.43 103.68 15.21 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.896 1.279 . . . . 0.0 109.025 -177.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.9 tt -68.3 -41.78 80.44 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.792 1.237 . . . . 0.0 107.862 175.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.4 m -136.88 141.34 42.76 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.096 0.958 . . . . 0.0 111.847 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.4 tt -171.27 92.99 0.16 Allowed 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 128.755 2.822 . . . . 0.0 104.579 173.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -162.32 149.86 14.03 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 118.501 -0.761 . . . . 0.0 109.994 -174.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.432 ' HB2' ' HA ' ' A' ' 92' ' ' ASP . 5.8 t -91.98 134.12 35.09 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 119.593 1.088 . . . . 0.0 109.843 173.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 71.2 mt -82.26 -26.32 33.29 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 116.314 -1.803 . . . . 0.0 110.788 177.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.405 ' OD2' HD12 ' A' ' 89' ' ' ILE . 28.3 t0 -93.94 144.96 24.98 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 121.155 1.798 . . . . 0.0 109.485 174.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.46 ' HE3' ' SD ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -113.94 -24.53 9.03 Favored 'General case' 0 N--CA 1.443 -0.796 1 C-N-CA 133.653 4.781 . . . . 0.0 113.822 178.35 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -71.14 -69.93 1.3 Allowed Glycine 0 CA--C 1.533 1.211 0 N-CA-C 107.12 -2.392 . . . . 0.0 107.12 173.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.407 HG22 ' O ' ' A' ' 89' ' ' ILE . 3.3 mp -78.48 26.3 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 128.579 2.752 . . . . 0.0 110.994 175.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.46 ' SD ' ' HE3' ' A' ' 87' ' ' LYS . 6.7 ttp -43.16 125.18 3.57 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.79 2.436 . . . . 0.0 111.247 -173.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -161.35 113.48 1.83 Allowed 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 101.272 -3.603 . . . . 0.0 101.272 -175.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.432 ' HA ' ' HB2' ' A' ' 84' ' ' SER 0.313 1.6 m-20 -112.97 127.45 26.82 Favored Pre-proline 0 C--N 1.319 -0.721 0 O-C-N 124.372 1.045 . . . . 0.0 110.913 -173.372 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.09 154.02 71.05 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 121.733 1.622 . . . . 0.0 110.318 -174.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 18.4 p -139.16 162.93 33.75 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.453 1.501 . . . . 0.0 108.482 174.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.0 m -126.5 150.39 32.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 123.829 0.852 . . . . 0.0 110.696 173.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -86.03 17.85 3.33 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.501 1.52 . . . . 0.0 111.463 173.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.6 m -132.49 163.03 53.45 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 125.651 1.58 . . . . 0.0 107.011 173.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -67.33 162.41 38.84 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 120.754 0.969 . . . . 0.0 109.767 173.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -64.38 -12.89 47.35 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.361 1.065 . . . . 0.0 111.774 176.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -140.78 164.39 30.34 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.239 1.415 . . . . 0.0 107.89 173.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.17 -161.26 33.82 Favored Glycine 0 C--O 1.227 -0.332 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 75.4 p -119.0 155.1 31.98 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 173.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 24.5 t -90.43 113.27 56.96 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 103.414 -2.809 . . . . 0.0 103.414 173.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -88.95 171.76 4.66 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.541 2.16 . . . . 0.0 114.491 -173.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -81.98 3.04 28.03 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 -173.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.5 133.84 55.55 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 114.869 -2.491 . . . . 0.0 106.834 173.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -44.95 111.06 0.28 Allowed 'General case' 0 C--O 1.232 0.171 0 O-C-N 125.808 1.942 . . . . 0.0 107.757 173.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.3 m -116.72 137.41 52.21 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.4 t -93.87 120.88 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 O-C-N 124.692 1.245 . . . . 0.0 108.794 -173.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.3 t -93.91 103.72 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 N-CA-C 103.094 -2.928 . . . . 0.0 103.094 173.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -84.2 119.24 24.79 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 173.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.4 t -95.0 113.5 29.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 104.249 -2.5 . . . . 0.0 104.249 174.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -86.34 143.14 19.26 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.407 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 14.6 m-85 -128.34 73.5 80.07 Favored Pre-proline 0 C--O 1.245 0.844 0 CA-C-N 118.333 1.066 . . . . 0.0 110.814 -178.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.55 120.33 7.28 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.332 2.021 . . . . 0.0 109.282 173.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 12.8 t -98.95 148.66 23.75 Favored 'General case' 0 C--N 1.342 0.276 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 173.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.3 mt -76.77 -13.52 60.01 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 117.88 0.309 . . . . 0.0 111.043 178.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 51.31 40.56 45.79 Favored Glycine 0 C--O 1.22 -0.765 0 C-N-CA 127.868 2.651 . . . . 0.0 115.137 173.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . 0.262 42.1 mttm -123.09 -29.67 3.86 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.847 1.824 . . . . 0.0 112.71 173.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -96.46 149.41 21.76 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 172.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -102.12 149.45 24.26 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 176.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.4 -154.56 23.59 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.7 t -128.78 113.83 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.01 166.04 15.37 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 173.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -123.81 145.02 49.36 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.715 1.206 . . . . 0.0 108.538 174.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.407 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 37.5 p90 -140.66 142.78 34.92 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 119.321 0.964 . . . . 0.0 110.317 174.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -104.07 144.79 31.09 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 126.768 2.027 . . . . 0.0 111.36 -173.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.0 t -140.05 139.12 37.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 173.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -155.15 130.6 9.75 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.906 1.682 . . . . 0.0 106.987 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.4 t -135.94 129.5 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -175.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.609 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -97.9 165.75 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 173.737 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.7 t -143.31 134.7 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 -174.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.01 174.35 10.66 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.876 1.27 . . . . 0.0 108.286 -175.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -89.95 176.13 6.92 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 104.667 -2.346 . . . . 0.0 104.667 172.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.1 t -66.2 -4.02 6.84 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 120.356 -1.465 . . . . 0.0 113.685 -177.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -89.34 -14.88 34.66 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 120.572 1.533 . . . . 0.0 110.657 173.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.04 0.42 63.67 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.591 1.091 . . . . 0.0 112.039 -173.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -69.57 115.51 8.9 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 119.494 1.647 . . . . 0.0 108.357 174.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -69.09 143.51 54.18 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.786 1.634 . . . . 0.0 108.81 -175.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -140.61 -37.29 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.62 1.168 . . . . 0.0 113.598 -174.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -130.5 145.43 51.85 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -143.98 136.06 26.49 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 91.7 m -66.87 128.03 93.71 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 174.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.41 143.4 43.02 Favored 'Trans proline' 0 N--CA 1.444 -1.436 0 CA-C-N 120.606 1.252 . . . . 0.0 109.122 -177.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -81.75 112.97 19.39 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 -174.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 173.17 -19.59 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.572 1 C-N-CA 135.116 5.366 . . . . 0.0 110.942 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.39 83.95 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.837 1.655 . . . . 0.0 111.4 -175.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.4 mt -125.21 135.57 63.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 175.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.401 ' HB2' ' CZ ' ' A' ' 126' ' ' PHE . 6.3 m-85 -106.32 161.94 14.11 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 125.911 1.684 . . . . 0.0 106.722 177.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -136.41 113.3 10.35 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 55.0 tttt -99.3 122.43 42.44 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 21.4 m -83.61 115.13 21.99 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 105.299 -2.112 . . . . 0.0 105.299 173.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 36.9 m -111.21 165.92 11.52 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 119.196 0.907 . . . . 0.0 109.192 173.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.5 pp -141.35 160.14 40.75 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.178 1.391 . . . . 0.0 107.694 173.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.99 131.11 43.87 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.795 1.238 . . . . 0.0 111.669 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -144.33 169.92 16.99 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 128.008 2.523 . . . . 0.0 107.693 173.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 . . . . . 0 C--O 1.255 1.385 0 C-N-CA 128.925 2.89 . . . . 0.0 106.057 173.857 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.628 0 N-CA-C 106.088 -2.805 . . . . 0.0 106.088 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.5 m -65.69 166.89 10.04 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 150.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -80.28 114.1 18.94 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 173.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -99.45 176.69 5.42 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.176 0.99 . . . . 0.0 111.282 -174.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.427 ' H ' HD23 ' A' ' 5' ' ' LEU . 1.8 pt? -129.56 176.42 8.0 Favored 'General case' 0 CA--C 1.545 0.784 1 C-N-CA 134.889 5.275 . . . . 0.0 101.805 172.917 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -59.39 112.55 1.79 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 121.296 1.862 . . . . 0.0 108.467 -173.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.14 176.27 1.4 Allowed 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 131.153 3.781 . . . . 0.0 102.689 -174.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -114.81 176.07 5.22 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 127.054 2.141 . . . . 0.0 109.391 173.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -134.28 175.17 9.74 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 127.106 2.162 . . . . 0.0 105.944 173.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -141.74 174.39 10.62 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.882 1.673 . . . . 0.0 108.105 173.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.6 m -175.86 177.0 1.74 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.508 2.723 . . . . 0.0 109.863 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.9 tt -43.32 129.85 4.89 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 129.335 3.054 . . . . 0.0 113.285 -175.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -115.1 139.6 49.75 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.18 2.192 . . . . 0.0 108.441 173.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.25 117.97 6.19 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 126.05 1.74 . . . . 0.0 106.693 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 13.7 p90 -131.02 176.06 8.57 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.296 1.039 . . . . 0.0 110.083 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.5 mt -113.06 113.91 45.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 102.418 -3.179 . . . . 0.0 102.418 174.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -76.89 139.21 40.15 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 123.069 1.414 . . . . 0.0 111.967 -173.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.19 -25.54 61.7 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.276 1.83 . . . . 0.0 114.367 -173.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 13.6 m80 -56.53 -37.3 70.29 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 118.978 0.808 . . . . 0.0 110.018 -174.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 49.1 tp60 -66.83 -41.31 87.66 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 121.992 -0.443 . . . . 0.0 111.067 178.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.672 ' HA ' HD12 ' A' ' 24' ' ' LEU . . . -64.4 -35.4 80.77 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 121.683 -0.636 . . . . 0.0 110.904 173.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.3 -57.26 13.02 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 173.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.0 t -51.51 -27.72 7.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.712 1.205 . . . . 0.0 111.424 177.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.672 HD12 ' HA ' ' A' ' 21' ' ' ALA . 6.2 mt -71.16 -47.6 56.75 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 117.729 -1.129 . . . . 0.0 113.404 175.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.4 pt -154.56 14.66 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 -172.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.95 13.25 75.68 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 125.338 1.447 . . . . 0.0 113.314 -174.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -101.37 143.27 31.61 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 126.822 2.049 . . . . 0.0 106.849 -176.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -128.64 117.6 21.49 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.696 1.134 . . . . 0.0 109.673 -173.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -165.85 136.49 3.62 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 130.681 3.592 . . . . 0.0 107.507 174.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -86.45 176.21 7.98 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.093 1.757 . . . . 0.0 107.823 173.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.0 mp -137.54 113.1 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 173.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.52 115.23 26.79 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -176.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.5 mt -94.66 -53.94 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 118.635 0.652 . . . . 0.0 110.065 -176.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.464 HG22 ' HG2' ' A' ' 39' ' ' MET . 6.2 t -126.15 129.99 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 125.68 1.592 . . . . 0.0 107.703 -173.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.0 p -138.4 132.94 32.22 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 103.165 -2.902 . . . . 0.0 103.165 173.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.31 18.0 pm0 44.33 33.73 0.91 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.151 1.38 . . . . 0.0 113.796 -174.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.54 -4.17 14.87 Favored Glycine 0 CA--C 1.543 1.813 0 O-C-N 120.652 -1.28 . . . . 0.0 115.135 -176.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.469 ' HZ3' ' HB3' ' A' ' 38' ' ' LYS . 4.3 ttpm? -66.4 37.41 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.596 1 C-N-CA 132.467 4.307 . . . . 0.0 114.222 -176.74 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.464 ' HG2' HG22 ' A' ' 34' ' ' VAL . 31.4 mtt -38.07 114.33 0.35 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 120.183 1.356 . . . . 0.0 113.742 -173.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.56 164.79 29.19 Favored Pre-proline 0 N--CA 1.447 -0.599 0 CA-C-N 113.777 -1.556 . . . . 0.0 107.977 173.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.84 40.9 0.59 Allowed 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 124.215 3.276 . . . . 0.0 111.002 173.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -52.27 -26.26 11.46 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 127.913 2.485 . . . . 0.0 112.603 -173.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.9 m -44.01 -43.72 6.87 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.152 1.781 . . . . 0.0 111.619 177.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -60.81 -66.05 0.59 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.427 0.691 . . . . 0.0 110.191 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.598 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 49.3 m-20 -73.98 -23.01 59.4 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.155 1.782 . . . . 0.0 114.062 -173.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -77.89 -56.81 4.19 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 124.669 1.187 . . . . 0.0 110.229 173.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 18.5 ttp180 -69.71 -32.57 71.23 Favored 'General case' 0 C--N 1.345 0.386 0 O-C-N 121.657 -0.652 . . . . 0.0 109.873 -173.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.02 113.53 24.9 Favored 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 103.101 -2.926 . . . . 0.0 103.101 173.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.598 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -158.83 176.07 12.8 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 120.015 1.279 . . . . 0.0 111.286 -174.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -66.93 164.37 17.7 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 172.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.3 tm0? -48.4 -25.46 1.64 Allowed 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -174.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.406 ' HA ' HD13 ' A' ' 24' ' ' LEU . 23.8 ttm180 -52.19 -16.31 0.78 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.068 1.747 . . . . 0.0 114.97 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 61.1 mmm -130.69 -66.12 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.467 0 CA-C-N 121.132 1.787 . . . . 0.0 115.079 -175.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.492 ' HD3' ' HB3' ' A' ' 49' ' ' ALA . 37.1 Cg_endo -68.24 -74.21 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.195 1.93 . . . . 0.0 111.82 -173.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.73 113.42 14.36 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -174.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 62.9 mt -113.16 126.75 27.74 Favored Pre-proline 0 C--N 1.324 -0.536 0 C-N-CA 127.734 2.413 . . . . 0.0 105.803 -174.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -78.46 157.29 28.94 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 121.691 1.594 . . . . 0.0 110.356 176.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.4 p -45.7 -38.74 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 125.849 1.66 . . . . 0.0 111.975 173.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -55.91 -40.08 72.56 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 126.677 1.991 . . . . 0.0 112.832 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mm -77.11 112.73 15.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 101.914 -3.365 . . . . 0.0 101.914 173.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -79.92 -40.67 27.7 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 174.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.8 m -141.51 161.75 37.16 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.609 1.164 . . . . 0.0 110.053 -173.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 52.8 mtp -123.68 167.47 13.94 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.426 1.49 . . . . 0.0 107.092 173.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -114.03 155.85 25.17 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 174.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -140.75 151.54 44.54 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 130.489 3.516 . . . . 0.0 102.268 172.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.3 m -137.97 133.85 34.19 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -145.42 162.38 37.44 Favored 'General case' 0 C--O 1.238 0.473 0 O-C-N 121.857 -0.527 . . . . 0.0 111.198 178.225 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -167.36 153.36 7.78 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.969 0.89 . . . . 0.0 112.484 173.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.3 -173.65 4.83 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.333 1.453 . . . . 0.0 109.174 173.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.85 100.11 7.04 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.789 1.635 . . . . 0.0 108.324 -174.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.07 -63.29 0.0 OUTLIER Glycine 0 CA--C 1.538 1.522 0 C-N-CA 130.184 3.754 . . . . 0.0 119.016 173.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -116.88 -13.78 10.69 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 120.583 2.191 . . . . 0.0 114.113 173.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.59 37.1 0.17 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 129.136 2.975 . . . . 0.0 118.021 -173.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -53.58 113.68 1.26 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 122.873 2.579 . . . . 0.0 109.672 -177.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -84.06 129.95 34.89 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 126.187 1.795 . . . . 0.0 107.935 174.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -79.85 147.67 31.65 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -132.56 161.26 34.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 120.127 1.33 . . . . 0.0 111.182 176.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.503 ' O ' HD13 ' A' ' 131' ' ' ILE . 31.7 tt0 -152.71 137.24 16.8 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 173.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -81.68 104.08 11.83 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.635 1.174 . . . . 0.0 109.91 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.7 tt -67.36 -41.72 84.65 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.43 1.092 . . . . 0.0 108.114 174.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.8 m -133.87 141.29 47.33 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.881 0.872 . . . . 0.0 111.202 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.3 tt -171.95 93.07 0.14 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 104.15 -2.537 . . . . 0.0 104.15 173.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -162.18 156.73 22.17 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.024 0.829 . . . . 0.0 111.416 -173.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.6 t -75.99 161.95 28.48 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 173.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.6 mt -122.1 -26.33 4.75 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 116.99 -1.481 . . . . 0.0 112.045 174.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.422 ' CG ' ' H ' ' A' ' 87' ' ' LYS . 23.2 t0 -83.3 168.11 16.98 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 121.34 1.882 . . . . 0.0 111.604 177.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.422 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -111.3 -49.32 3.02 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 128.533 2.733 . . . . 0.0 112.501 179.099 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.84 -70.19 1.16 Allowed Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 174.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mp -79.75 18.63 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 128.786 2.834 . . . . 0.0 110.048 -174.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -43.93 134.11 4.68 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 127.061 2.144 . . . . 0.0 110.239 -175.086 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -157.51 113.76 2.89 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 126.118 1.767 . . . . 0.0 106.916 -173.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -97.34 132.43 25.46 Favored Pre-proline 0 C--N 1.324 -0.541 0 O-C-N 124.142 0.901 . . . . 0.0 109.876 -173.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.01 153.81 67.42 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 C-N-CA 121.409 1.406 . . . . 0.0 109.347 174.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 21.1 p -140.11 157.09 46.17 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 126.682 1.993 . . . . 0.0 107.439 174.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.9 m -126.33 153.66 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 119.648 1.113 . . . . 0.0 113.145 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -73.83 7.94 2.26 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 127.567 2.347 . . . . 0.0 113.647 174.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.6 m -140.75 164.89 33.44 Favored Pre-proline 0 C--N 1.326 -0.452 0 C-N-CA 125.648 1.579 . . . . 0.0 108.286 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -67.18 167.61 19.71 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 121.347 1.365 . . . . 0.0 110.937 174.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -63.22 -11.37 20.63 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.786 1.235 . . . . 0.0 112.119 175.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -145.07 164.3 31.64 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.22 1.408 . . . . 0.0 107.884 173.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.33 -161.74 34.28 Favored Glycine 0 C--O 1.227 -0.342 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 71.4 p -117.86 151.19 37.86 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.5 t -88.69 113.37 55.44 Favored Pre-proline 0 N--CA 1.448 -0.542 0 N-CA-C 102.84 -3.022 . . . . 0.0 102.84 173.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -90.09 160.02 4.83 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.803 2.336 . . . . 0.0 111.424 -173.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -74.18 4.44 5.65 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 119.753 -1.842 . . . . 0.0 113.3 -173.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -115.54 116.85 28.87 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 126.259 1.824 . . . . 0.0 106.736 -173.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -43.06 105.37 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 125.039 1.336 . . . . 0.0 109.755 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.3 m -112.02 136.0 51.94 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.0 t -95.68 116.09 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.05 -173.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 82.5 t -93.76 103.27 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 N-CA-C 103.476 -2.787 . . . . 0.0 103.476 173.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.58 120.11 25.11 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 103.324 -2.843 . . . . 0.0 103.324 173.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.4 t -94.7 113.64 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 104.23 -2.507 . . . . 0.0 104.23 173.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -92.36 149.42 19.62 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 175.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.458 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 9.8 m-85 -131.13 73.64 80.42 Favored Pre-proline 0 C--O 1.242 0.7 0 CA-C-N 118.544 1.172 . . . . 0.0 110.422 -176.065 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -62.94 116.14 3.38 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.479 2.119 . . . . 0.0 109.309 173.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 9.2 t -93.67 147.67 22.81 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 173.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.4 mt -74.16 -13.48 60.81 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.134 0.425 . . . . 0.0 111.822 -176.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.8 34.3 89.57 Favored Glycine 0 C--N 1.34 0.804 0 C-N-CA 125.757 1.646 . . . . 0.0 114.352 173.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.7 mttm -114.9 -50.64 2.76 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.349 1.575 . . . . 0.0 112.442 -173.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 48.6 tp60 -96.06 147.49 23.66 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 173.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -93.93 142.12 27.74 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 175.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.72 -154.83 26.09 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-N 118.781 0.719 . . . . 0.0 111.649 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.6 t -129.96 116.73 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 123.846 0.858 . . . . 0.0 108.789 -179.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -92.42 175.3 6.89 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.15 1.38 . . . . 0.0 109.297 173.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -128.6 155.03 45.59 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.767 1.627 . . . . 0.0 107.386 173.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.458 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 40.3 p90 -147.05 157.84 43.74 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.576 1.15 . . . . 0.0 108.035 173.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -123.36 150.52 43.57 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.542 1.537 . . . . 0.0 111.909 -173.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 62.5 t -141.45 143.2 27.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 173.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -160.81 136.13 7.85 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.023 1.329 . . . . 0.0 107.687 174.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.7 t -136.79 139.26 45.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-N 119.51 1.05 . . . . 0.0 109.265 -173.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.542 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -106.9 163.64 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 173.743 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.6 t -141.74 137.81 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -173.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.31 174.12 10.89 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.542 1.537 . . . . 0.0 108.416 -176.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -88.84 175.8 7.32 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 172.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 6.1 t -65.1 -14.86 61.55 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 120.212 -1.555 . . . . 0.0 112.112 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -80.12 -3.3 48.25 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.73 1.612 . . . . 0.0 110.65 176.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.22 5.66 89.9 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 125.123 1.345 . . . . 0.0 112.996 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -80.92 118.19 22.2 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.5 m -64.71 143.07 58.19 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.434 1.493 . . . . 0.0 108.748 -178.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -140.07 -37.26 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.774 1.23 . . . . 0.0 113.626 -175.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -130.56 141.08 50.47 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -146.6 126.35 13.46 Favored 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 121.422 -0.799 . . . . 0.0 109.081 -176.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 30.3 m -67.52 142.68 96.47 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 173.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -83.59 147.55 12.4 Favored 'Trans proline' 0 N--CA 1.443 -1.477 0 N-CA-C 108.731 -1.296 . . . . 0.0 108.731 174.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -75.46 112.63 11.99 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 103.505 -2.776 . . . . 0.0 103.505 -178.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 173.73 -23.81 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 128.17 2.588 . . . . 0.0 112.17 -173.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.89 87.34 0.14 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 122.208 1.004 . . . . 0.0 108.428 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.9 mt -127.84 147.91 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -174.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 126' ' ' PHE . 0.5 OUTLIER -134.28 167.89 19.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 113.971 -1.468 . . . . 0.0 107.298 -176.783 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -135.33 113.5 11.3 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.175 0.99 . . . . 0.0 109.456 -173.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -104.22 122.43 45.36 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 119.435 1.016 . . . . 0.0 109.431 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 25.6 m -83.68 115.44 22.17 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 174.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 5.0 m -116.78 166.3 12.3 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.496 0.665 . . . . 0.0 110.163 174.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.3 pp -134.12 162.45 32.07 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.109 1.364 . . . . 0.0 107.539 173.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -73.57 114.72 12.13 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 127.738 2.415 . . . . 0.0 109.463 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -163.5 118.54 1.64 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.335 1.454 . . . . 0.0 109.79 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 . . . . . 0 C--O 1.256 1.416 0 C-N-CA 128.667 2.787 . . . . 0.0 105.914 173.743 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.131 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.7 t -60.85 176.16 0.42 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 117.985 0.892 . . . . 0.0 110.302 162.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -50.63 127.3 17.66 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.823 1.249 . . . . 0.0 111.296 -174.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 45.5 mtp -145.98 176.64 9.55 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 128.122 2.569 . . . . 0.0 107.651 -174.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.8 mt -113.24 127.48 56.18 Favored 'General case' 0 C--N 1.328 -0.343 1 N-CA-C 97.386 -5.042 . . . . 0.0 97.386 172.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -44.19 113.22 0.5 Allowed 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 -172.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.52 113.26 0.1 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 131.234 3.813 . . . . 0.0 101.373 173.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -120.55 114.09 21.23 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -173.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -126.44 159.52 33.08 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 126.796 2.038 . . . . 0.0 106.097 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -75.07 170.72 15.46 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 122.1 0.952 . . . . 0.0 111.396 176.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 m -175.53 175.72 2.07 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 129.925 3.29 . . . . 0.0 106.937 173.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.52 HD23 ' N ' ' A' ' 13' ' ' TYR . 5.5 tt -46.57 136.8 7.32 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.165 1.786 . . . . 0.0 112.788 -174.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.52 ' N ' HD23 ' A' ' 12' ' ' LEU . 54.6 m-85 -122.07 137.03 54.96 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.317 1.447 . . . . 0.0 110.249 175.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.79 119.12 6.38 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.57 1.548 . . . . 0.0 107.803 -178.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.462 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 30.9 p90 -142.84 148.08 36.47 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.641 1.109 . . . . 0.0 109.541 -178.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.0 mp -84.12 118.53 31.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 102.893 -3.003 . . . . 0.0 102.893 173.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.03 143.81 29.51 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 123.691 1.71 . . . . 0.0 114.313 -173.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.459 ' HB1' ' HG3' ' A' ' 28' ' ' GLU . . . -72.75 -26.11 61.44 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 112.774 -2.012 . . . . 0.0 113.636 -173.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.9 m80 -62.63 -38.25 89.52 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 122.926 0.49 . . . . 0.0 110.519 -173.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -71.54 -49.3 42.14 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.149 174.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.61 -43.06 56.74 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-O 118.404 -0.807 . . . . 0.0 111.218 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.0 ttp-105 -50.51 -64.91 0.66 Allowed 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 119.797 1.181 . . . . 0.0 108.452 173.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.2 t -51.27 -23.72 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.727 1.211 . . . . 0.0 111.679 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 75.6 mt -85.15 -37.49 20.13 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.3 pt -143.57 14.05 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 117.001 2.223 . . . . 0.0 117.001 -173.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.41 -1.75 0.62 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 129.761 3.553 . . . . 0.0 115.55 -174.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -101.97 143.04 32.33 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 129.192 2.997 . . . . 0.0 108.043 -177.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.459 ' HG3' ' HB1' ' A' ' 18' ' ' ALA . 36.5 tt0 -132.88 114.49 14.11 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.706 1.139 . . . . 0.0 111.039 -173.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -150.7 144.98 25.52 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.437 2.695 . . . . 0.0 106.383 173.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -96.03 164.83 12.54 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 173.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.2 mp -135.27 113.38 15.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 103.858 -2.645 . . . . 0.0 103.858 173.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.462 ' HG ' ' HB3' ' A' ' 15' ' ' TRP . 4.4 tt -94.62 114.07 25.97 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -173.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.6 mt -83.86 -61.75 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 124.349 1.06 . . . . 0.0 108.281 -174.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.455 HG11 HD22 ' A' ' 12' ' ' LEU . 25.1 t -117.1 113.66 43.46 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -173.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.4 p -111.92 125.93 54.58 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 102.616 -3.105 . . . . 0.0 102.616 173.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 46.08 38.2 4.56 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.148 1.379 . . . . 0.0 112.508 174.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 54.98 19.84 16.96 Favored Glycine 0 CA--C 1.539 1.58 0 C-N-CA 124.992 1.282 . . . . 0.0 113.824 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -122.97 37.97 4.29 Favored 'General case' 0 CA--C 1.536 0.434 1 C-N-CA 131.861 4.064 . . . . 0.0 108.051 -172.978 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.42 ' HG2' HG22 ' A' ' 34' ' ' VAL 0.272 20.2 mtp -37.29 146.71 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 130.762 3.625 . . . . 0.0 115.696 -172.508 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.72 162.07 75.12 Favored Pre-proline 0 N--CA 1.452 -0.368 0 CA-C-N 113.141 -1.845 . . . . 0.0 109.314 173.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.09 42.36 0.98 Allowed 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 124.552 3.501 . . . . 0.0 111.609 174.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -53.86 -26.58 25.32 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.647 1.979 . . . . 0.0 113.197 -174.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.5 m -58.25 -29.35 65.69 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 126.501 1.92 . . . . 0.0 111.434 -173.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 62.8 t60 -62.86 -66.48 0.54 Allowed 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 118.64 0.655 . . . . 0.0 109.346 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.63 -23.82 65.4 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -175.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -67.96 -47.62 68.14 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.68 1.192 . . . . 0.0 111.223 174.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.23 -25.59 15.75 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -173.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.6 176.55 1.89 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.129 1.771 . . . . 0.0 109.285 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -51.33 160.97 0.49 Allowed 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.561 -0.712 . . . . 0.0 109.508 173.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 5.3 tm0? -43.53 134.4 4.07 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.82 1.648 . . . . 0.0 113.706 -173.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -136.31 -66.85 0.53 Allowed 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 173.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -146.94 -16.23 0.41 Allowed 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 120.546 -0.461 . . . . 0.0 111.97 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.564 ' H ' ' CD ' ' A' ' 54' ' ' PRO . 88.2 mtp -135.05 -28.66 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.532 0 CA-C-O 115.587 -2.149 . . . . 0.0 115.661 -174.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.564 ' CD ' ' H ' ' A' ' 53' ' ' MET . 54.2 Cg_exo -51.34 -68.45 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.949 0 CA-C-N 123.08 2.136 . . . . 0.0 114.641 -173.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.27 113.9 22.65 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 177.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.9 mt -103.85 118.84 56.27 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 127.008 2.123 . . . . 0.0 105.761 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -74.48 153.95 44.88 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 121.355 1.37 . . . . 0.0 110.164 176.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.3 p -39.93 -44.28 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 127.483 2.313 . . . . 0.0 113.321 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -58.71 -34.43 71.3 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 126.706 2.002 . . . . 0.0 113.567 -176.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.0 mm -71.36 113.08 7.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 104.362 -2.458 . . . . 0.0 104.362 175.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -79.85 -39.34 30.86 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 173.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.2 m -153.06 162.29 41.49 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -173.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 54.5 mtm -126.69 162.4 25.87 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 172.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 39.1 m-20 -120.47 114.09 21.28 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 118.509 0.595 . . . . 0.0 109.725 -175.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -94.32 150.69 20.05 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 102.3 -3.222 . . . . 0.0 102.3 172.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.9 m -139.5 135.68 33.75 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 -175.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -148.96 165.81 30.48 Favored 'General case' 0 CA--C 1.509 -0.611 0 O-C-N 121.572 -0.705 . . . . 0.0 110.525 -178.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -165.37 149.7 8.66 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.587 173.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.02 177.52 4.29 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 172.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.551 ' O ' ' HD2' ' A' ' 105' ' ' HIS . . . -88.91 143.57 26.78 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 100.998 -3.705 . . . . 0.0 100.998 173.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -1.25 -73.99 0.0 OUTLIER Glycine 0 C--N 1.302 -1.324 1 C-N-CA 133.88 5.514 . . . . 0.0 117.721 -173.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . 0.273 21.4 mm100 -117.35 23.95 11.46 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 173.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -108.99 37.47 2.55 Favored 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 130.859 3.664 . . . . 0.0 120.693 -173.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -39.61 116.2 0.6 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 122.34 2.337 . . . . 0.0 113.785 -173.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -84.4 132.68 34.56 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 174.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -83.82 149.08 26.63 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 175.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -134.05 159.76 39.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 119.473 1.033 . . . . 0.0 111.133 175.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.5 ' O ' HD13 ' A' ' 131' ' ' ILE . 30.6 tt0 -152.83 137.93 17.33 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 173.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -85.86 104.02 15.14 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.592 1.157 . . . . 0.0 110.041 -176.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.2 tt -61.34 -43.88 98.12 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.69 1.596 . . . . 0.0 108.687 173.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.6 m -134.25 143.73 47.97 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.558 1.143 . . . . 0.0 111.723 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.2 tt -172.36 92.79 0.12 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 103.477 -2.786 . . . . 0.0 103.477 173.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -168.89 152.79 5.45 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 118.833 0.742 . . . . 0.0 111.025 -174.006 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.7 t -79.43 127.75 32.5 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.0 mt -87.01 -26.57 23.69 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 116.67 -1.633 . . . . 0.0 110.857 174.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -86.79 152.42 22.51 Favored 'General case' 0 C--N 1.348 0.508 0 CA-C-N 120.9 1.682 . . . . 0.0 109.377 173.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.26 -36.54 6.25 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 128.892 2.877 . . . . 0.0 112.678 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -68.71 -75.95 0.48 Allowed Glycine 0 CA--C 1.53 1.025 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 173.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.1 mp -74.21 20.03 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 129.951 3.3 . . . . 0.0 110.441 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 14.0 ttp -43.42 130.81 5.01 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 127.402 2.281 . . . . 0.0 111.255 -173.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -153.65 113.37 3.85 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 -175.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -99.58 132.81 22.5 Favored Pre-proline 0 C--N 1.322 -0.615 0 O-C-N 124.286 0.991 . . . . 0.0 109.239 -173.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.9 153.67 72.28 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 C-N-CA 121.084 1.19 . . . . 0.0 109.338 174.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 17.1 p -137.57 152.57 49.56 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 126.244 1.817 . . . . 0.0 106.436 173.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.8 m -126.37 153.98 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 CA-C-N 118.966 0.803 . . . . 0.0 112.268 177.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -75.94 8.46 3.12 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.38 1.872 . . . . 0.0 113.822 174.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.67 165.1 32.13 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 124.777 1.231 . . . . 0.0 109.481 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -66.87 166.01 24.03 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.536 1.49 . . . . 0.0 110.478 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -66.97 -10.32 48.11 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.579 1.152 . . . . 0.0 112.256 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -144.28 164.1 31.76 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.564 1.545 . . . . 0.0 107.398 173.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 160.3 -161.42 32.54 Favored Glycine 0 C--O 1.228 -0.24 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 73.1 p -118.0 151.44 37.47 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.5 t -88.92 113.59 56.62 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 175.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.4 154.85 40.93 Favored 'Trans proline' 0 CA--C 1.512 -0.598 0 C-N-CA 121.839 1.692 . . . . 0.0 111.161 -176.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.551 ' HD2' ' O ' ' A' ' 70' ' ' ALA . 7.5 m80 -74.4 -7.07 51.67 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 120.353 -1.467 . . . . 0.0 113.687 -172.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.6 mptt -116.51 122.69 45.45 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 -174.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -38.73 111.39 0.17 Allowed 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 127.123 2.169 . . . . 0.0 111.76 -173.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 57.6 m -118.62 144.54 46.07 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 176.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.0 t -100.63 117.42 45.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 124.835 1.254 . . . . 0.0 111.303 -173.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.2 t -98.47 103.06 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 104.501 -2.407 . . . . 0.0 104.501 173.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -78.55 131.12 36.66 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 104.859 -2.275 . . . . 0.0 104.859 173.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.4 t -103.11 113.45 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 101.634 -3.469 . . . . 0.0 101.634 173.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -97.06 150.26 19.51 Favored Glycine 0 N--CA 1.439 -1.123 0 N-CA-C 108.621 -1.791 . . . . 0.0 108.621 176.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -133.3 73.54 73.83 Favored Pre-proline 0 C--O 1.242 0.7 0 CA-C-N 118.199 1.0 . . . . 0.0 109.402 -174.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -63.8 116.97 3.99 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.649 2.233 . . . . 0.0 109.885 173.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 7.1 t -90.75 146.43 23.99 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 173.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.9 mt -74.27 -12.34 60.52 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 117.856 0.298 . . . . 0.0 111.371 -177.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.61 21.76 43.75 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 127.123 2.297 . . . . 0.0 116.527 173.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . 0.339 4.6 mptp? -102.16 -40.9 6.59 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.984 1.892 . . . . 0.0 114.451 174.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 38.8 tp60 -96.49 146.1 25.09 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.469 1.032 . . . . 0.0 108.467 173.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -94.38 152.06 18.91 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.446 1.498 . . . . 0.0 107.869 174.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 138.06 -152.77 21.97 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.9 t -127.67 114.12 34.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.16 173.36 9.28 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.59 1.156 . . . . 0.0 109.307 173.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -128.24 150.27 50.11 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.338 1.855 . . . . 0.0 106.58 173.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -147.74 154.35 40.42 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 173.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -113.54 141.26 47.36 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.776 1.63 . . . . 0.0 110.291 -173.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 61.1 t -146.71 113.53 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 N-CA-C 104.258 -2.497 . . . . 0.0 104.258 173.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -144.19 137.77 27.62 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -174.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.0 t -136.62 148.9 26.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 121.794 0.807 . . . . 0.0 110.071 -173.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.5 HD13 ' O ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -115.74 162.64 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 173.714 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.7 t -139.08 136.08 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 -173.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.33 175.53 9.5 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 125.495 1.518 . . . . 0.0 107.371 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -92.95 176.12 6.54 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 172.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.2 t -65.89 -3.92 5.98 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 120.03 -1.669 . . . . 0.0 113.442 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -86.02 -15.24 42.05 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 120.697 1.59 . . . . 0.0 110.41 173.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.08 -0.63 66.81 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.73 1.157 . . . . 0.0 111.964 -173.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -70.15 116.04 10.05 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 119.456 1.628 . . . . 0.0 108.346 174.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -64.66 141.95 58.59 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.915 1.686 . . . . 0.0 107.951 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.8 pt -140.07 -37.25 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 124.481 1.113 . . . . 0.0 113.71 -174.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -133.97 145.42 49.51 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -147.45 136.99 22.73 Favored 'General case' 0 CA--C 1.516 -0.354 0 O-C-N 121.339 -0.851 . . . . 0.0 109.269 -176.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 35.5 m -72.33 129.84 86.9 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 173.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.4 143.94 35.72 Favored 'Trans proline' 0 N--CA 1.444 -1.415 0 N-CA-C 108.302 -1.461 . . . . 0.0 108.302 175.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 28.3 mp0 -79.37 112.38 16.55 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -173.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.547 25.6 m-80 172.48 -4.52 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.513 1 C-N-CA 136.115 5.766 . . . . 0.0 112.121 173.472 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.66 86.45 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 123.428 1.585 . . . . 0.0 108.836 174.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.9 mm -133.98 139.39 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 127.747 2.419 . . . . 0.0 105.522 -173.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -122.98 167.13 13.99 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 173.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -129.85 113.55 14.79 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 -173.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 57.7 tttt -102.16 121.74 42.8 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 119.748 1.158 . . . . 0.0 108.715 -176.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 30.1 m -83.61 116.86 22.81 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 104.84 -2.281 . . . . 0.0 104.84 173.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 13.2 m -117.85 166.12 12.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.304 0.573 . . . . 0.0 110.315 174.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.5 pp -137.12 159.27 42.39 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.636 1.574 . . . . 0.0 107.359 173.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.61 132.59 45.69 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.236 1.014 . . . . 0.0 110.463 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -153.35 161.75 42.01 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.177 1.791 . . . . 0.0 108.68 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 . . . . . 0 C--O 1.255 1.357 0 C-N-CA 129.898 3.279 . . . . 0.0 105.109 173.723 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.14 0 N-CA-C 106.507 -2.637 . . . . 0.0 106.507 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.4 t -63.3 176.24 0.83 Allowed 'General case' 0 C--O 1.242 0.687 0 C-N-CA 118.892 -1.123 . . . . 0.0 108.166 135.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -112.82 172.14 7.11 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 173.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 28.0 ptm -144.0 176.2 9.47 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 127.217 2.207 . . . . 0.0 106.782 174.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.402 HD23 ' H ' ' A' ' 6' ' ' ASP . 0.5 OUTLIER -145.57 169.85 17.58 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 173.914 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.402 ' H ' HD23 ' A' ' 5' ' ' LEU . 4.3 m-20 -63.22 120.87 12.37 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 173.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.06 158.5 16.87 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 103.899 -2.63 . . . . 0.0 103.899 -173.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -123.15 113.36 18.86 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 173.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -75.0 176.28 7.35 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.082 0.953 . . . . 0.0 109.045 174.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.67 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 74.6 mt-10 -58.25 169.93 0.77 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.549 1.14 . . . . 0.0 110.298 173.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.6 m -159.23 176.32 12.34 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.235 1.814 . . . . 0.0 109.166 173.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.1 tt -44.71 127.32 6.14 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.764 2.026 . . . . 0.0 113.487 -176.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -115.64 128.35 55.86 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.261 1.825 . . . . 0.0 109.185 174.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.93 118.07 11.27 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 127.135 2.174 . . . . 0.0 107.388 -178.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 9.0 p90 -133.81 170.89 14.92 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.184 0.994 . . . . 0.0 110.229 176.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.0 mp -108.02 115.15 48.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 102.187 -3.264 . . . . 0.0 102.187 173.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -82.2 142.52 32.11 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 123.32 1.533 . . . . 0.0 112.967 -173.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.62 -16.83 51.88 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.884 1.674 . . . . 0.0 115.32 -173.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 27.7 m80 -58.03 -35.34 71.16 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.51 1.05 . . . . 0.0 110.458 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -70.52 -46.64 63.26 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 122.313 -0.242 . . . . 0.0 111.052 177.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.481 ' HA ' HD12 ' A' ' 24' ' ' LEU . . . -56.97 -31.57 65.17 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 118.907 -0.568 . . . . 0.0 112.136 174.129 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.7 tpp85 -55.72 -59.64 4.57 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 173.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 60.8 t -53.78 -23.81 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 124.796 1.238 . . . . 0.0 111.71 177.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.481 HD12 ' HA ' ' A' ' 21' ' ' ALA . 9.0 mt -73.05 -46.06 53.96 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 117.504 -1.236 . . . . 0.0 113.622 174.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.5 pt -152.46 17.97 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 116.247 1.944 . . . . 0.0 116.247 -173.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.76 10.17 54.3 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 127.817 2.627 . . . . 0.0 114.547 -174.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -101.39 175.71 5.48 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 126.864 2.066 . . . . 0.0 111.034 -173.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -122.39 121.34 36.43 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.159 0.984 . . . . 0.0 109.129 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -153.02 113.28 3.99 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.693 1.197 . . . . 0.0 109.752 174.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -96.4 161.19 14.03 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 172.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.1 mm -138.65 113.39 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 173.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.31 113.89 20.41 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.4 mt -86.04 -65.6 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 32.0 t -114.73 114.23 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 -173.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.8 p -113.05 115.17 27.92 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 103.8 -2.667 . . . . 0.0 103.8 173.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.258 6.4 pt-20 44.43 45.97 7.74 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.689 1.195 . . . . 0.0 113.013 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 67.53 -7.28 2.09 Favored Glycine 0 CA--C 1.541 1.672 0 C-N-CA 125.804 1.669 . . . . 0.0 114.817 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -83.22 37.43 0.55 Allowed 'General case' 0 CA--C 1.539 0.533 1 C-N-CA 133.323 4.649 . . . . 0.0 109.022 -173.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 52.1 mtm -37.98 132.09 1.01 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 127.166 2.186 . . . . 0.0 114.54 -172.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.48 160.62 78.56 Favored Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.347 173.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.36 35.33 0.43 Allowed 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 124.215 3.277 . . . . 0.0 112.039 175.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -54.71 -26.59 34.82 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.481 1.913 . . . . 0.0 112.793 -173.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.7 m -48.82 -47.05 42.68 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 129.219 3.007 . . . . 0.0 112.861 -173.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -59.17 -59.08 6.04 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.258 1.023 . . . . 0.0 109.944 -175.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.298 47.0 m-20 -76.74 -27.93 55.58 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.289 -175.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -61.21 -50.52 72.78 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 120.91 -1.119 . . . . 0.0 108.767 173.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -65.84 -42.16 90.85 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-O 118.576 -0.726 . . . . 0.0 110.651 178.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.69 112.79 15.85 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-O 116.832 -1.556 . . . . 0.0 111.801 178.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -176.77 142.43 0.4 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 121.39 1.905 . . . . 0.0 110.463 172.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -96.74 112.91 24.47 Favored 'General case' 0 N--CA 1.452 -0.353 1 N-CA-C 100.114 -4.032 . . . . 0.0 100.114 172.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -163.87 -67.33 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 120.426 1.466 . . . . 0.0 111.046 174.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.76 -17.11 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.895 1.225 . . . . 0.0 113.075 -174.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 78.6 mmm -93.87 -65.48 0.12 Allowed Pre-proline 0 CA--C 1.533 0.31 0 CA-C-O 117.549 -1.215 . . . . 0.0 113.936 -173.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.52 -66.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 121.93 1.753 . . . . 0.0 113.482 -173.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.7 113.82 8.18 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.461 0.704 . . . . 0.0 110.238 -174.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 38.6 mt -124.35 132.15 24.27 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 126.421 1.888 . . . . 0.0 108.187 -173.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -80.04 157.83 23.68 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.854 2.369 . . . . 0.0 111.559 174.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.6 p -42.77 -43.49 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 127.058 2.143 . . . . 0.0 112.791 175.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -60.09 -34.19 73.13 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 126.29 1.836 . . . . 0.0 113.106 -174.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 mm -71.8 112.95 7.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 103.107 -2.923 . . . . 0.0 103.107 174.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 -94.75 -23.46 17.53 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.2 m -152.12 161.42 42.66 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.308 1.043 . . . . 0.0 108.59 173.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 16.8 mtm -126.19 156.96 39.37 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 173.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.252 59.8 m-20 -96.46 150.42 20.63 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 174.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -138.09 151.34 47.72 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 130.985 3.714 . . . . 0.0 101.799 172.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.4 m -137.35 130.65 31.0 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 -177.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -144.1 165.05 28.9 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.72 175.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -167.01 154.87 9.42 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.493 173.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.24 -174.51 2.37 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 123.403 1.573 . . . . 0.0 107.031 172.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.67 ' HB1' ' HB2' ' A' ' 10' ' ' GLU . . . -104.11 135.56 45.38 Favored 'General case' 0 N--CA 1.411 -2.375 0 C-N-CA 130.812 3.645 . . . . 0.0 101.873 173.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -7.45 -56.42 0.01 OUTLIER Glycine 0 CA--C 1.54 1.615 1 C-N-CA 133.801 5.477 . . . . 0.0 120.022 -173.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -116.93 9.89 13.9 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 121.207 2.504 . . . . 0.0 114.862 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -107.43 37.44 2.4 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 120.759 3.615 . . . . 0.0 120.759 -172.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -44.81 113.63 0.59 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 123.559 2.89 . . . . 0.0 110.601 -175.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -84.99 121.32 27.6 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -174.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -73.98 144.51 45.18 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 178.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -130.28 161.02 32.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 119.358 0.981 . . . . 0.0 110.781 176.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.433 ' O ' HD13 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -152.57 133.94 14.4 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 173.263 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -84.01 103.23 13.09 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -176.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.5 tt -64.72 -40.46 95.38 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 125.566 1.546 . . . . 0.0 108.32 176.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.0 m -148.83 142.86 25.88 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 120.499 -1.376 . . . . 0.0 110.358 177.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.9 tt -164.94 93.02 0.61 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 101.658 -3.46 . . . . 0.0 101.658 173.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 42.1 mmm-85 -166.01 163.32 18.31 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.09 0.956 . . . . 0.0 110.646 -177.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 126' ' ' PHE . 8.8 t -91.47 158.25 16.59 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.99 1.316 . . . . 0.0 113.792 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.0 mt -110.13 -26.46 9.66 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.256 -1.338 . . . . 0.0 111.261 177.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -76.74 169.73 17.75 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 120.495 1.498 . . . . 0.0 109.349 -174.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.7 mmtm -131.1 -46.3 1.01 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.602 1.961 . . . . 0.0 111.307 -173.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -70.38 -71.29 1.03 Allowed Glycine 0 CA--C 1.533 1.208 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 173.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.644 ' H ' HD12 ' A' ' 89' ' ' ILE . 3.7 mp -70.04 12.19 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 129.805 3.242 . . . . 0.0 111.07 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 28.5 ttp -43.69 142.31 1.28 Allowed 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 128.304 2.642 . . . . 0.0 112.193 -174.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.252 . . -161.95 174.98 12.32 Favored 'General case' 0 N--CA 1.439 -0.976 1 C-N-CA 131.851 4.06 . . . . 0.0 104.492 -173.572 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -151.32 137.4 11.19 Favored Pre-proline 0 C--N 1.321 -0.661 0 C-N-CA 124.359 1.064 . . . . 0.0 110.014 172.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -71.7 157.86 54.65 Favored 'Trans proline' 0 N--CA 1.443 -1.496 0 C-N-CA 121.396 1.397 . . . . 0.0 109.081 173.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 20.2 p -142.75 161.94 36.76 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 126.916 2.087 . . . . 0.0 107.28 174.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.9 m -126.44 150.97 32.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 123.532 0.733 . . . . 0.0 110.738 174.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -82.86 15.73 2.57 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.441 1.497 . . . . 0.0 111.482 173.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.2 m -129.6 163.24 48.09 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 173.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -67.47 162.75 37.59 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 CA-C-N 119.659 0.914 . . . . 0.0 109.91 173.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.52 -6.73 8.03 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.811 1.244 . . . . 0.0 111.693 175.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -145.9 163.22 35.78 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.621 1.569 . . . . 0.0 107.249 173.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 162.13 -160.2 32.3 Favored Glycine 0 C--O 1.227 -0.294 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 80.7 p -120.82 146.41 46.57 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 173.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.0 t -87.45 113.68 55.23 Favored Pre-proline 0 N--CA 1.448 -0.549 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 173.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -84.41 156.35 12.51 Favored 'Trans proline' 0 C--O 1.213 -0.736 0 C-N-CA 122.546 2.164 . . . . 0.0 112.402 -174.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -71.11 1.13 6.24 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 120.248 -1.532 . . . . 0.0 111.714 -174.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -114.03 115.6 27.86 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 128.102 2.561 . . . . 0.0 108.125 -173.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -41.56 108.74 0.1 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.096 1.358 . . . . 0.0 110.056 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.7 m -119.25 139.34 52.05 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.61 118.9 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 114.447 -1.252 . . . . 0.0 108.621 -173.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 75.9 t -93.88 104.21 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 173.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -82.34 115.04 21.21 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 104.532 -2.396 . . . . 0.0 104.532 173.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.3 t -93.33 113.82 28.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 104.111 -2.551 . . . . 0.0 104.111 174.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -89.19 144.86 18.21 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 124.891 1.234 . . . . 0.0 110.33 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -129.63 73.6 81.41 Favored Pre-proline 0 C--O 1.244 0.769 0 CA-C-N 118.754 1.277 . . . . 0.0 111.052 -175.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.3 129.06 19.53 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.397 2.064 . . . . 0.0 109.117 173.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 5.7 t -105.82 154.61 20.28 Favored 'General case' 0 C--N 1.338 0.1 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 174.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.8 mt -71.96 -17.01 62.1 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.568 0.622 . . . . 0.0 111.593 177.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 50.65 39.19 37.7 Favored Glycine 0 C--O 1.219 -0.793 0 C-N-CA 127.336 2.398 . . . . 0.0 114.809 173.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 42.9 mttm -124.4 -28.0 3.69 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.724 1.762 . . . . 0.0 112.032 173.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -96.53 155.66 16.67 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 172.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -109.42 150.75 27.61 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 138.59 -154.23 22.97 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 174.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 19.0 t -124.77 114.19 39.46 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -88.6 168.47 12.53 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 173.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -131.6 142.38 49.88 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.561 1.145 . . . . 0.0 108.715 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 33.6 p90 -143.34 150.44 39.17 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 125.829 1.651 . . . . 0.0 108.194 174.017 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -129.95 164.64 23.79 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 119.671 1.123 . . . . 0.0 113.285 177.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 57.3 t -131.62 148.56 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 125.613 1.565 . . . . 0.0 108.512 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -155.66 132.96 10.88 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 125.978 1.711 . . . . 0.0 108.078 173.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 36.5 t -137.15 143.46 34.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -174.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.532 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -110.25 163.46 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 173.939 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.9 t -140.3 137.59 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 CA-C-N 114.185 -1.37 . . . . 0.0 107.337 -173.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.79 174.71 10.33 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 125.957 1.703 . . . . 0.0 107.619 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 45.0 p-10 -89.68 176.01 7.03 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 172.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.8 t -66.1 -3.6 5.82 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 120.098 -1.626 . . . . 0.0 113.484 -177.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -86.69 -17.7 33.09 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 120.613 1.551 . . . . 0.0 110.452 173.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 97.6 1.13 59.02 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.783 1.182 . . . . 0.0 112.251 -173.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 65.4 m-20 -72.29 115.14 11.18 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 119.608 1.704 . . . . 0.0 108.701 174.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.5 m -64.8 143.0 58.24 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.498 1.919 . . . . 0.0 108.624 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -141.29 -36.82 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 124.708 1.203 . . . . 0.0 113.973 -175.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -131.91 144.18 50.67 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.13 130.2 19.55 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 35.6 m -68.79 149.07 98.01 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 173.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -89.17 144.92 5.08 Favored 'Trans proline' 0 N--CA 1.444 -1.386 0 CA-C-N 120.84 1.336 . . . . 0.0 109.646 173.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -78.84 112.58 16.13 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 -174.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 172.99 -18.4 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 128.12 2.568 . . . . 0.0 114.331 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.9 79.06 0.12 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.999 0.92 . . . . 0.0 112.08 -173.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.425 HG21 ' CZ ' ' A' ' 150' ' ' PHE . 3.3 mm -86.83 148.03 4.92 Favored 'Isoleucine or valine' 0 C--N 1.345 0.38 0 C-N-CA 127.341 2.256 . . . . 0.0 109.361 174.049 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -125.88 128.41 47.55 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 129.484 3.114 . . . . 0.0 103.12 173.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.425 ' CZ ' HG21 ' A' ' 148' ' ' ILE . 66.0 m-85 -102.49 113.26 26.46 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 178.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 56.1 tttt -103.1 121.58 42.9 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 28.9 m -83.38 114.65 21.58 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 174.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 21.8 m -113.09 165.5 12.31 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 119.01 0.823 . . . . 0.0 109.459 174.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.4 pp -141.75 161.61 37.52 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.067 1.347 . . . . 0.0 108.098 174.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.91 130.2 42.24 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.621 1.168 . . . . 0.0 111.843 178.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -144.06 170.34 16.12 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 128.239 2.616 . . . . 0.0 107.606 173.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 . . . . . 0 C--O 1.254 1.314 0 C-N-CA 128.881 2.872 . . . . 0.0 106.075 173.812 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.024 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.96 112.79 4.52 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 120.268 2.034 . . . . 0.0 106.731 168.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -161.41 176.8 10.74 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 128.475 2.71 . . . . 0.0 106.603 -173.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 23.3 mmt -63.33 160.33 16.16 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 104.051 -2.574 . . . . 0.0 104.051 172.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.3 mt -43.33 113.5 0.5 Allowed 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -172.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -152.69 176.23 11.97 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 130.483 3.513 . . . . 0.0 108.734 -173.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -145.17 126.29 14.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 102.15 -3.278 . . . . 0.0 102.15 173.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.11 176.56 7.28 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 125.747 1.619 . . . . 0.0 109.846 -173.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 54.9 mp0 -62.15 170.75 2.08 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 122.202 1.001 . . . . 0.0 109.734 173.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -59.01 158.62 8.24 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 122.551 1.167 . . . . 0.0 111.107 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.6 m -176.18 176.96 1.63 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 128.637 2.775 . . . . 0.0 109.467 -174.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.2 tt -42.99 121.91 2.26 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 127.132 2.173 . . . . 0.0 113.469 -173.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -111.76 139.84 46.9 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.265 2.226 . . . . 0.0 108.435 174.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.07 118.28 6.81 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 21.2 p90 -139.42 152.24 46.91 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 119.205 0.912 . . . . 0.0 109.58 177.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.8 mt -83.91 127.86 39.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 102.579 -3.119 . . . . 0.0 102.579 173.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -104.69 136.9 43.35 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 122.9 1.333 . . . . 0.0 111.856 -173.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.2 -22.38 66.88 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.206 -1.361 . . . . 0.0 113.891 -174.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -58.36 -37.9 76.15 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 119.564 1.075 . . . . 0.0 111.422 -173.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -71.19 -51.12 26.57 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 117.816 -1.088 . . . . 0.0 110.151 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.71 -41.73 61.72 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.034 0.834 . . . . 0.0 111.009 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -49.39 -68.27 0.19 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 173.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 98.2 t -51.52 -23.99 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 126.112 1.765 . . . . 0.0 111.825 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.2 mt -82.3 -42.6 18.59 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 124.046 0.939 . . . . 0.0 112.882 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.6 pt -155.26 17.85 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 -172.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.12 18.79 65.28 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.119 1.342 . . . . 0.0 113.012 -174.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -98.51 135.09 40.56 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 126.483 1.913 . . . . 0.0 107.946 -174.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -130.9 113.77 14.44 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -174.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -162.16 126.45 3.21 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.067 2.147 . . . . 0.0 107.506 176.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -96.24 159.08 15.14 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 172.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.2 mp -135.56 113.17 14.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 173.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.67 114.13 18.35 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.8 mt -94.09 -57.06 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.402 HG22 ' HG2' ' A' ' 39' ' ' MET . 4.1 t -125.95 141.27 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 C-N-CA 125.003 1.321 . . . . 0.0 108.901 -173.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.0 p -152.43 123.01 7.32 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 102.87 -3.011 . . . . 0.0 102.87 173.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 44.48 33.84 0.97 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.67 1.588 . . . . 0.0 113.818 -174.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.26 -8.82 6.25 Favored Glycine 0 CA--C 1.539 1.566 0 O-C-N 120.814 -1.179 . . . . 0.0 114.694 -177.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.2 ttmt -69.25 37.47 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.461 1 C-N-CA 132.941 4.496 . . . . 0.0 112.812 -177.042 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.402 ' HG2' HG22 ' A' ' 34' ' ' VAL . 43.0 mtt -38.1 133.04 0.95 Allowed 'General case' 0 C--O 1.233 0.229 0 C-N-CA 126.164 1.786 . . . . 0.0 114.767 -173.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.79 157.64 66.05 Favored Pre-proline 0 N--CA 1.448 -0.559 0 CA-C-N 113.512 -1.676 . . . . 0.0 107.859 173.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -74.27 37.69 0.45 Allowed 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 124.455 3.437 . . . . 0.0 112.192 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -52.61 -26.11 12.58 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 127.266 2.226 . . . . 0.0 113.493 -173.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.404 HG23 ' CG ' ' A' ' 146' ' ' ASN . 1.8 m -43.52 -51.95 6.46 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.757 2.023 . . . . 0.0 112.388 -174.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -58.28 -62.48 1.8 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.612 0.765 . . . . 0.0 110.569 -174.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.33 52.4 m-20 -76.84 -30.78 56.47 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -173.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.1 -51.7 68.02 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 120.659 -1.276 . . . . 0.0 107.971 173.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.471 HH21 HD11 ' A' ' 148' ' ' ILE . 6.3 ttt180 -67.86 -39.55 83.77 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 118.796 -0.621 . . . . 0.0 109.72 -177.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.92 113.23 16.25 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-O 115.918 -1.991 . . . . 0.0 112.988 176.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -176.31 142.15 0.46 Allowed 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 123.099 2.681 . . . . 0.0 112.166 173.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.6 112.88 24.46 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 101.748 -3.427 . . . . 0.0 101.748 172.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -175.72 -67.36 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.151 1.38 . . . . 0.0 109.62 176.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.4 ' HA ' ' CZ ' ' A' ' 52' ' ' ARG . 2.7 tpm_? -171.35 -16.91 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 O-C-N 120.933 -1.104 . . . . 0.0 112.467 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.53 -65.99 1.32 Allowed Pre-proline 0 CA--C 1.536 0.438 0 CA-C-O 117.635 -1.174 . . . . 0.0 111.721 -174.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -77.01 -73.92 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.835 0 CA-C-N 120.86 1.343 . . . . 0.0 113.313 -174.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.22 118.11 6.44 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.183 1.393 . . . . 0.0 114.034 -173.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.6 mt -132.09 120.77 17.4 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 127.154 2.181 . . . . 0.0 106.831 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -77.06 156.25 33.9 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.243 1.962 . . . . 0.0 111.124 -178.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.6 p -40.25 -46.84 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 127.834 2.454 . . . . 0.0 113.607 -178.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -63.23 -36.19 82.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 126.066 1.746 . . . . 0.0 113.091 -175.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.5 mm -69.06 113.05 4.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 103.454 -2.795 . . . . 0.0 103.454 174.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -79.57 -32.81 42.08 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.246 176.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.5 m -154.24 162.71 41.0 Favored 'General case' 0 C--N 1.335 -0.031 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -173.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 24.4 mtm -126.55 163.53 23.2 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 172.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -120.17 149.19 42.64 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 118.99 0.814 . . . . 0.0 108.857 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -125.58 156.55 38.95 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 102.898 -3.001 . . . . 0.0 102.898 173.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 m -138.31 135.91 35.9 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -176.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -145.72 159.97 42.4 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 121.593 -0.692 . . . . 0.0 111.053 178.258 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -165.74 151.99 9.53 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 121.966 0.889 . . . . 0.0 112.688 173.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -82.13 -173.53 4.57 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.504 1.122 . . . . 0.0 108.786 173.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.19 99.73 6.89 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 126.469 1.908 . . . . 0.0 109.368 -174.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 48.14 -60.17 0.0 OUTLIER Glycine 0 CA--C 1.539 1.536 0 C-N-CA 130.646 3.974 . . . . 0.0 119.619 173.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -116.77 -12.99 10.76 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 120.298 2.049 . . . . 0.0 114.354 175.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.7 37.28 0.58 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 130.015 3.326 . . . . 0.0 118.869 -173.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -52.38 113.66 1.12 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 123.058 2.663 . . . . 0.0 109.776 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -84.05 138.46 33.06 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.686 1.595 . . . . 0.0 106.885 174.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -85.61 149.37 25.38 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -133.52 160.1 38.44 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.905 1.23 . . . . 0.0 110.566 174.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.436 ' O ' HD13 ' A' ' 131' ' ' ILE . 31.3 tt0 -154.58 133.9 12.57 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 173.178 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.487 ' CD2' HD23 ' A' ' 82' ' ' LEU . 80.6 m-85 -81.97 103.55 11.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.9 tt -64.47 -40.83 96.43 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 173.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 m -154.99 145.99 22.64 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 122.657 1.217 . . . . 0.0 111.739 174.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.634 HD22 HG22 ' A' ' 128' ' ' VAL . 0.2 OUTLIER -148.54 92.81 2.05 Favored 'General case' 0 N--CA 1.451 -0.389 1 N-CA-C 97.606 -4.961 . . . . 0.0 97.606 173.191 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.01 150.78 27.7 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 120.452 -1.405 . . . . 0.0 114.559 -172.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.1 t -68.74 158.92 33.27 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.762 1.225 . . . . 0.0 111.464 173.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.3 mt -123.38 -26.25 4.29 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.983 1.713 . . . . 0.0 110.925 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.434 ' CG ' ' H ' ' A' ' 87' ' ' LYS . 7.9 t70 -79.09 176.09 9.98 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.791 1.178 . . . . 0.0 109.521 -174.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.434 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 23.4 mmtm -131.62 -50.54 0.98 Allowed 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 127.073 2.149 . . . . 0.0 110.928 -173.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -69.48 -65.02 2.72 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 173.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.492 ' H ' HD12 ' A' ' 89' ' ' ILE . 4.3 mp -76.63 25.59 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 C-N-CA 129.357 3.063 . . . . 0.0 110.395 -175.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 26.5 ttm -43.33 139.74 1.86 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 129.261 3.025 . . . . 0.0 111.803 -173.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.253 . . -168.14 173.62 7.8 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 130.177 3.391 . . . . 0.0 105.563 -173.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.412 10.4 m-20 -147.51 130.23 7.86 Favored Pre-proline 0 CA--C 1.509 -0.622 0 C-N-CA 127.435 2.294 . . . . 0.0 111.975 172.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.32 156.36 41.59 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 121.953 1.768 . . . . 0.0 109.649 173.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 23.4 p -136.59 158.6 44.07 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 126.524 1.93 . . . . 0.0 108.139 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.6 m -126.34 157.23 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 123.729 0.812 . . . . 0.0 111.222 176.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -79.99 9.77 5.05 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 127.325 2.25 . . . . 0.0 113.68 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.8 m -140.84 163.44 42.72 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 124.527 1.131 . . . . 0.0 109.914 -175.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -66.11 164.56 27.26 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.853 1.702 . . . . 0.0 110.277 173.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -63.16 -14.37 47.98 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 124.503 1.121 . . . . 0.0 112.7 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -143.33 164.78 29.3 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 120.133 1.333 . . . . 0.0 108.65 173.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 164.42 -162.92 35.79 Favored Glycine 0 C--O 1.228 -0.258 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 76.1 p -116.96 149.15 40.68 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 173.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 37.5 t -83.13 113.52 46.57 Favored Pre-proline 0 N--CA 1.448 -0.528 0 N-CA-C 103.635 -2.728 . . . . 0.0 103.635 173.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.42 ' HB2' ' HE3' ' A' ' 106' ' ' LYS . 45.8 Cg_endo -85.82 156.07 10.2 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.404 2.069 . . . . 0.0 112.176 -173.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -70.55 0.55 6.57 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 120.197 -1.564 . . . . 0.0 113.063 -175.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.42 ' HE3' ' HB2' ' A' ' 104' ' ' PRO . 0.0 OUTLIER -115.3 114.84 25.71 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 126.598 1.959 . . . . 0.0 106.951 -173.839 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -41.62 106.84 0.06 Allowed 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.693 1.597 . . . . 0.0 109.639 -178.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.4 m -112.21 137.46 50.28 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 178.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.5 t -96.75 114.18 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 114.099 -1.409 . . . . 0.0 108.703 -173.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 98.5 t -94.09 103.33 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 173.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -77.04 140.42 40.33 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 172.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.4 t -115.16 113.62 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 174.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -99.48 149.44 18.93 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 125.927 1.727 . . . . 0.0 109.603 -178.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.415 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 4.4 m-85 -132.3 73.89 76.74 Favored Pre-proline 0 C--O 1.244 0.788 0 CA-C-N 118.965 1.383 . . . . 0.0 112.479 -173.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -66.88 126.83 15.91 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.098 1.865 . . . . 0.0 109.135 173.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 5.7 t -104.82 153.37 21.42 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 124.565 1.146 . . . . 0.0 108.131 174.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.6 mt -74.5 -9.98 59.12 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.369 0.531 . . . . 0.0 111.867 178.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.7 5.93 3.16 Favored Glycine 0 C--O 1.22 -0.723 0 C-N-CA 128.458 2.933 . . . . 0.0 116.408 173.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 27.7 mmtm -93.61 -32.26 14.17 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.737 1.768 . . . . 0.0 113.114 -173.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -96.63 159.1 15.11 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 173.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -107.89 148.01 30.18 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.405 1.482 . . . . 0.0 107.197 176.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 140.21 -152.71 22.98 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 174.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.8 t -128.07 113.99 32.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.428 ' HB2' ' HB ' ' A' ' 89' ' ' ILE . . . -90.64 167.96 12.14 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 173.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -129.65 156.99 43.35 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 123.719 0.808 . . . . 0.0 109.464 173.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 149' ' ' PHE . 3.8 p90 -147.95 151.0 35.07 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 126.801 2.04 . . . . 0.0 105.896 173.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -137.71 173.2 11.9 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 175.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.634 HG22 HD22 ' A' ' 82' ' ' LEU . 97.0 t -128.95 147.3 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 124.789 1.236 . . . . 0.0 111.276 -173.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -146.67 120.02 8.99 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 127.666 2.387 . . . . 0.0 106.44 173.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.406 HG22 ' CD2' ' A' ' 79' ' ' PHE . 23.3 t -138.2 124.2 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -177.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.687 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -90.43 164.83 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 106.635 -1.616 . . . . 0.0 106.635 173.695 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.4 t -144.71 132.34 16.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -176.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.73 174.02 11.03 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.475 1.11 . . . . 0.0 108.581 -174.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 32.1 p-10 -88.28 176.06 7.39 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 172.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.1 t -68.09 -6.78 24.69 Favored 'General case' 0 CA--C 1.551 1.015 0 O-C-N 120.659 -1.276 . . . . 0.0 112.286 -175.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -86.32 -14.69 42.87 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 120.59 -1.319 . . . . 0.0 110.606 173.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.42 4.16 62.62 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.736 1.16 . . . . 0.0 112.386 -173.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -75.9 117.55 17.75 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 119.811 1.805 . . . . 0.0 108.952 175.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.4 m -66.98 146.82 53.97 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.96 1.704 . . . . 0.0 110.021 -176.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.84 -35.68 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.868 1.267 . . . . 0.0 113.616 178.125 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -133.08 148.74 52.17 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -176.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -146.52 150.01 34.72 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 174.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.6 m -102.79 113.81 65.67 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -73.91 154.13 47.96 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.16 1.907 . . . . 0.0 113.105 -173.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -69.49 112.52 6.06 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 102.122 -3.288 . . . . 0.0 102.122 173.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.404 ' CG ' HG23 ' A' ' 43' ' ' THR . 44.7 m-20 173.35 -30.79 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 130.821 3.649 . . . . 0.0 107.138 -173.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.58 66.6 0.08 Allowed 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 126.842 2.057 . . . . 0.0 109.157 174.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.471 HD11 HH21 ' A' ' 47' ' ' ARG . 1.4 mt -95.62 147.72 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 C-N-CA 126.074 1.75 . . . . 0.0 108.141 176.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.417 ' HB2' ' CE2' ' A' ' 126' ' ' PHE . 20.1 m-85 -130.88 150.61 51.96 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 173.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -127.21 113.36 16.24 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 -173.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 46.5 tttt -101.8 123.22 45.39 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.48 -0.934 . . . . 0.0 108.48 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 39.0 m -83.34 119.93 25.23 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 173.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 11.1 m -114.69 159.66 20.26 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 173.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.2 pp -143.44 160.58 40.32 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 174.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -56.56 114.11 1.9 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 127.999 2.52 . . . . 0.0 111.795 -174.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -133.89 174.83 10.04 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 127.833 2.453 . . . . 0.0 108.6 175.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 . . . . . 0 C--O 1.252 1.191 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 173.458 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.793 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.5 t -157.78 161.8 38.44 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 106.679 -1.601 . . . . 0.0 106.679 169.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -161.57 113.68 1.79 Allowed 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 174.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 36.4 tpp -165.8 170.15 14.23 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.559 1.944 . . . . 0.0 106.709 173.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 86.9 mt -129.74 112.99 14.17 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 173.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -176.62 176.9 1.48 Allowed 'General case' 0 C--O 1.241 0.65 0 C-N-CA 131.439 3.896 . . . . 0.0 103.947 -174.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.53 112.44 4.11 Favored 'General case' 0 N--CA 1.447 -0.619 1 N-CA-C 100.12 -4.03 . . . . 0.0 100.12 173.137 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -103.16 176.18 5.23 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 112.933 -1.939 . . . . 0.0 114.855 -173.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -76.29 176.57 8.0 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.641 1.976 . . . . 0.0 107.527 173.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.593 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 49.4 mt-10 -56.34 176.64 0.08 Allowed 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 126.749 2.02 . . . . 0.0 108.321 172.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.5 m -140.25 173.32 11.63 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 118.827 -2.421 . . . . 0.0 107.912 172.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.51 HD23 ' N ' ' A' ' 13' ' ' TYR . 6.1 tt -47.06 132.71 11.97 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.994 1.27 . . . . 0.0 112.22 -173.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.51 ' N ' HD23 ' A' ' 12' ' ' LEU . 81.7 m-85 -121.26 129.94 53.41 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.073 1.349 . . . . 0.0 109.58 176.181 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.4 117.91 8.55 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 5.5 p90 -131.19 175.38 9.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.174 0.99 . . . . 0.0 110.257 174.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.505 HD11 HD11 ' A' ' 33' ' ' ILE . 2.0 mp -115.41 118.28 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 102.997 -2.964 . . . . 0.0 102.997 173.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -89.59 144.6 25.88 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 123.312 1.53 . . . . 0.0 112.487 -173.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.53 -6.8 1.19 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 128.341 2.656 . . . . 0.0 115.491 -175.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 62.2 m80 -61.8 -34.06 75.24 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 120.584 1.538 . . . . 0.0 111.638 -177.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -67.35 -41.16 85.62 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.231 176.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.518 ' HA ' HD12 ' A' ' 24' ' ' LEU . . . -63.78 -36.32 83.49 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.545 1.138 . . . . 0.0 111.075 173.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.0 ttm-85 -57.17 -58.14 9.53 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 173.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 73.6 t -52.46 -24.05 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 124.978 1.311 . . . . 0.0 111.988 175.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.518 HD12 ' HA ' ' A' ' 21' ' ' ALA . 6.0 mt -73.77 -49.01 27.48 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 174.069 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.4 pt -156.11 19.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 -172.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.14 9.36 66.98 Favored Glycine 0 CA--C 1.531 1.094 0 C-N-CA 126.368 1.937 . . . . 0.0 113.564 -173.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -86.56 176.31 7.88 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 127.339 2.256 . . . . 0.0 110.548 -174.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -132.73 120.06 21.17 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 124.838 1.255 . . . . 0.0 108.975 -175.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -149.29 112.64 4.97 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.446 0.566 . . . . 0.0 110.017 173.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -97.1 163.11 13.07 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 172.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.3 mp -141.1 113.15 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 103.855 -2.646 . . . . 0.0 103.855 172.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.63 114.11 23.07 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.505 HD11 HD11 ' A' ' 16' ' ' ILE . 10.9 mt -85.45 -58.45 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 118.543 0.61 . . . . 0.0 109.495 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.415 HG11 HD22 ' A' ' 12' ' ' LEU . 22.1 t -123.96 114.1 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 126.757 2.023 . . . . 0.0 106.9 -173.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.6 p -117.48 118.22 31.58 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 173.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.308 1.2 pm0 44.31 52.4 7.24 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.329 1.052 . . . . 0.0 111.121 -173.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.75 -12.95 4.42 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 126.78 2.133 . . . . 0.0 115.935 175.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -67.83 37.79 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.484 1 C-N-CA 132.963 4.505 . . . . 0.0 114.487 -174.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 30.9 mtm -37.83 116.56 0.51 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.876 1.216 . . . . 0.0 112.835 -172.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.67 161.07 22.46 Favored Pre-proline 0 N--CA 1.447 -0.612 0 CA-C-N 113.746 -1.57 . . . . 0.0 109.491 177.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -73.98 27.54 0.33 Allowed 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.699 2.933 . . . . 0.0 111.994 174.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -56.11 -26.68 50.85 Favored 'General case' 0 C--N 1.345 0.409 0 C-N-CA 124.862 1.265 . . . . 0.0 110.616 -174.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 m -45.54 -43.77 12.18 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 129.29 3.036 . . . . 0.0 110.725 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.513 ' CD2' ' HZ1' ' A' ' 48' ' ' LYS . 53.0 t60 -63.65 -55.34 24.31 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.0 0.52 . . . . 0.0 110.707 -177.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -76.1 -26.76 56.75 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -175.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -68.13 -40.36 82.49 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.122 0.969 . . . . 0.0 109.634 173.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.79 -42.81 76.86 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 175.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.513 ' HZ1' ' CD2' ' A' ' 44' ' ' HIS . 1.8 ttmp? -63.79 175.89 1.04 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.241 1.016 . . . . 0.0 108.265 175.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.73 112.83 13.72 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 120.3 -1.5 . . . . 0.0 106.969 173.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -96.6 171.8 8.32 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 173.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -48.58 -61.13 2.18 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.282 1.033 . . . . 0.0 111.763 -175.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.74 -16.51 3.76 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 177.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.428 ' SD ' HD13 ' A' ' 16' ' ' ILE . 1.1 mtp -52.59 -52.66 61.78 Favored Pre-proline 0 CA--C 1.534 0.362 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -173.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -75.2 -75.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.021 0 CA-C-N 121.13 1.439 . . . . 0.0 111.366 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.28 113.63 14.05 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.761 0.824 . . . . 0.0 111.829 -173.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 89.4 mt -120.35 130.43 24.85 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 128.464 2.706 . . . . 0.0 105.988 -174.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -83.05 159.32 15.56 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.491 2.127 . . . . 0.0 110.593 174.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.0 p -46.99 -34.61 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 125.715 1.606 . . . . 0.0 112.744 174.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.41 -34.19 72.17 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.509 1.524 . . . . 0.0 111.763 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.514 HD11 ' HG ' ' A' ' 24' ' ' LEU . 10.6 mm -92.15 112.83 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 102.985 -2.968 . . . . 0.0 102.985 174.188 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -82.86 -31.26 28.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.354 178.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.3 m -148.05 164.26 34.38 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.339 1.056 . . . . 0.0 110.422 -173.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 36.4 mtm -126.78 149.56 49.59 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 172.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -94.12 149.09 21.55 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 174.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -134.11 158.06 44.57 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 102.567 -3.123 . . . . 0.0 102.567 172.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.3 m -142.82 134.38 26.46 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 -178.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -144.53 169.02 18.76 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.248 0.546 . . . . 0.0 110.092 174.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -166.73 145.75 5.44 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.763 173.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.42 -173.3 1.36 Allowed 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 124.16 1.933 . . . . 0.0 105.864 172.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.593 ' HB1' ' HB2' ' A' ' 10' ' ' GLU 0.264 . . -112.42 121.26 44.34 Favored 'General case' 0 N--CA 1.408 -2.535 1 C-N-CA 131.922 4.089 . . . . 0.0 105.767 -179.084 . . . . . . . . 4 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 20.22 -73.65 0.0 OUTLIER Glycine 0 CA--C 1.536 1.358 1 C-N-CA 133.654 5.407 . . . . 0.0 119.079 178.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -116.25 -14.73 11.07 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 120.415 2.108 . . . . 0.0 112.41 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.81 37.48 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 131.339 3.856 . . . . 0.0 116.641 -173.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -38.17 114.16 0.34 Allowed 'General case' 0 C--O 1.237 0.446 0 CA-C-N 121.684 2.038 . . . . 0.0 114.719 -173.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -94.53 116.33 28.65 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 104.682 -2.34 . . . . 0.0 104.682 173.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -79.67 148.68 31.51 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 175.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -129.94 158.27 40.02 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 119.645 1.111 . . . . 0.0 109.861 174.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.49 134.26 12.91 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 173.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -89.16 102.99 15.65 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -175.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.6 tt -68.07 -41.38 82.02 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.518 1.527 . . . . 0.0 107.829 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 m -154.24 135.08 13.71 Favored 'General case' 0 N--CA 1.444 -0.734 0 O-C-N 120.645 -1.285 . . . . 0.0 110.829 179.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.483 ' H ' ' HD3' ' A' ' 83' ' ' ARG . 0.3 OUTLIER -151.99 93.15 1.8 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 101.428 -3.545 . . . . 0.0 101.428 173.508 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.483 ' HD3' ' H ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -156.94 157.17 34.31 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 120.863 1.665 . . . . 0.0 111.352 -178.319 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -78.87 152.99 30.92 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-O 121.549 0.69 . . . . 0.0 109.826 173.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.9 mt -106.91 -17.59 14.15 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.437 1.495 . . . . 0.0 110.721 174.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -90.29 163.23 14.83 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 174.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -139.8 -31.32 0.67 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.164 1.786 . . . . 0.0 112.998 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -64.12 -63.88 4.04 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 106.654 -2.579 . . . . 0.0 106.654 172.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.455 ' H ' HD12 ' A' ' 89' ' ' ILE . 4.8 mp -75.78 22.0 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 129.993 3.317 . . . . 0.0 110.23 175.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.4 ttp -43.11 130.79 4.52 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 125.923 2.773 . . . . 0.0 113.26 -173.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.536 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -150.55 147.87 27.98 Favored 'General case' 0 N--CA 1.419 -2.014 2 C-N-CA 135.108 5.363 . . . . 0.0 100.86 173.95 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.276 5.4 m-20 -136.74 117.36 10.99 Favored Pre-proline 0 C--N 1.315 -0.931 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 173.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -67.63 158.16 58.43 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 123.033 2.489 . . . . 0.0 114.133 -173.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 32.8 p -136.11 164.52 27.84 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.248 1.819 . . . . 0.0 109.006 177.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.6 m -126.41 159.98 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 123.855 0.862 . . . . 0.0 111.295 175.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -80.1 10.46 4.35 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 127.171 2.188 . . . . 0.0 113.346 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.4 m -140.91 163.76 40.51 Favored Pre-proline 0 C--N 1.328 -0.341 0 C-N-CA 124.168 0.987 . . . . 0.0 110.288 -174.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -65.43 160.12 44.3 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 121.626 1.551 . . . . 0.0 108.836 173.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -67.19 -10.11 47.05 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 123.558 0.743 . . . . 0.0 112.264 -178.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -146.83 163.91 34.54 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 120.543 1.52 . . . . 0.0 108.338 173.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 159.19 -163.15 33.2 Favored Glycine 0 C--O 1.227 -0.298 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 177.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 70.1 p -114.9 146.03 41.56 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 173.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.3 t -77.56 122.42 85.83 Favored Pre-proline 0 CA--C 1.541 0.622 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 177.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.81 148.54 46.4 Favored 'Trans proline' 0 C--O 1.216 -0.577 0 C-N-CA 121.797 1.665 . . . . 0.0 111.749 -175.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 72.9 m-70 -63.82 -24.35 67.72 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 -172.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . 0.515 1.0 OUTLIER -116.71 150.68 37.8 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.781 1.173 . . . . 0.0 111.914 173.141 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -38.49 115.49 0.46 Allowed 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 128.387 2.675 . . . . 0.0 114.404 -172.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 44.6 m -128.69 141.49 51.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 173.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 17.1 t -94.02 122.32 45.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 124.701 1.2 . . . . 0.0 110.196 -173.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.8 t -103.72 103.5 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 173.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -81.03 141.25 34.57 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 173.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.2 t -110.27 113.86 45.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 103.525 -2.768 . . . . 0.0 103.525 174.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -95.67 151.34 19.96 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 125.091 1.329 . . . . 0.0 109.925 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -131.4 72.96 80.47 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.14 125.93 14.31 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.634 1.556 . . . . 0.0 108.471 176.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.536 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 5.3 t -105.47 156.99 17.68 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.2 mt -81.16 -8.87 59.84 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.167 0.44 . . . . 0.0 111.713 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.39 28.13 61.6 Favored Glycine 0 C--N 1.339 0.702 0 C-N-CA 126.06 1.791 . . . . 0.0 116.149 173.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 51.4 mttt -122.34 -30.72 3.93 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.938 1.869 . . . . 0.0 114.128 177.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 -96.34 154.88 17.01 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 173.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -111.17 148.95 31.65 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 138.1 -156.33 23.82 Favored Glycine 0 C--N 1.332 0.361 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 176.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.4 t -122.52 113.7 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -89.45 156.98 18.31 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 173.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -117.62 158.56 24.42 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.805 0.842 . . . . 0.0 110.504 177.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.405 ' CE2' ' HB2' ' A' ' 149' ' ' PHE . 5.7 p90 -150.01 150.78 32.28 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 119.024 0.829 . . . . 0.0 109.2 173.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.415 ' CG ' HH12 ' A' ' 83' ' ' ARG . 24.7 pt-20 -123.15 156.4 35.11 Favored 'General case' 0 C--O 1.25 1.116 0 C-N-CA 125.126 1.37 . . . . 0.0 110.678 -174.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.465 HG22 HD22 ' A' ' 82' ' ' LEU . 26.6 t -137.79 140.26 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 O-C-N 125.437 1.711 . . . . 0.0 110.862 -177.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -150.61 120.59 7.16 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.931 2.493 . . . . 0.0 105.619 173.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 47.3 t -136.7 119.9 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.716 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -84.55 166.21 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 174.155 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.9 t -141.37 133.33 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 179.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.85 175.98 8.6 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 177.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -96.95 154.16 17.47 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 102.705 -3.072 . . . . 0.0 102.705 172.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.7 t -62.89 -15.86 56.6 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 120.72 -1.238 . . . . 0.0 110.573 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -69.51 -6.36 30.16 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 127.113 2.165 . . . . 0.0 111.914 173.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 99.45 20.25 18.11 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 118.192 2.037 . . . . 0.0 118.192 173.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -124.19 124.46 42.51 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 120.642 2.221 . . . . 0.0 110.071 -173.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.0 m -64.66 142.04 58.56 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 174.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.7 pt -140.51 -37.3 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 124.422 1.089 . . . . 0.0 113.813 -173.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.42 HD13 ' N ' ' A' ' 142' ' ' GLN . 2.9 tm? -139.49 154.04 47.63 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 -174.046 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.427 ' HG3' HG22 ' A' ' 131' ' ' ILE . 1.9 tm0? -154.83 144.52 21.49 Favored 'General case' 0 C--N 1.334 -0.102 0 O-C-N 121.025 -1.047 . . . . 0.0 108.9 174.066 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 26.8 m -67.77 114.56 20.71 Favored Pre-proline 0 N--CA 1.454 -0.264 0 N-CA-C 104.017 -2.586 . . . . 0.0 104.017 173.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -66.29 146.17 80.17 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 CA-C-N 120.251 1.125 . . . . 0.0 113.167 -173.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -73.45 112.95 10.0 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 173.0 -26.96 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.398 1 C-N-CA 134.792 5.237 . . . . 0.0 109.234 173.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.06 87.12 0.01 OUTLIER 'General case' 0 C--O 1.238 0.475 0 C-N-CA 126.251 1.821 . . . . 0.0 111.384 -174.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.9 mt -123.56 136.75 59.06 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.709 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 173.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.405 ' HB2' ' CE2' ' A' ' 126' ' ' PHE . 0.2 OUTLIER -116.06 164.58 14.25 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 126.263 2.227 . . . . 0.0 107.08 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -140.63 113.56 8.32 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.684 1.194 . . . . 0.0 108.349 -173.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -104.43 128.52 52.33 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 119.427 1.012 . . . . 0.0 108.638 174.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 24.4 m -83.51 114.18 21.32 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 174.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 56.2 m -108.41 165.83 11.22 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 173.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.3 pp -142.9 161.5 37.94 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.054 1.342 . . . . 0.0 108.423 174.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -68.04 122.37 18.1 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.404 1.882 . . . . 0.0 110.289 174.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -153.83 123.08 6.52 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.724 1.21 . . . . 0.0 110.218 174.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 . . . . . 0 C--O 1.255 1.371 0 C-N-CA 128.877 2.871 . . . . 0.0 105.806 173.68 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.098 0 N-CA-C 108.555 -1.818 . . . . 0.0 108.555 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.1 m -56.65 171.26 0.33 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 142.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -65.54 112.62 3.69 Favored 'General case' 0 C--N 1.343 0.3 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 174.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -176.99 176.91 1.34 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 131.025 3.73 . . . . 0.0 103.714 -173.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.92 166.6 11.02 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 172.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -130.18 124.5 32.74 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 173.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.62 141.29 4.21 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 102.549 -3.13 . . . . 0.0 102.549 -174.29 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.96 113.57 17.18 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 173.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -129.83 148.7 51.73 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -129.9 168.35 16.78 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.431 0.692 . . . . 0.0 110.423 176.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m -176.51 177.22 1.47 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 129.792 3.237 . . . . 0.0 108.841 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.7 tt -43.33 128.21 4.74 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.945 2.098 . . . . 0.0 111.929 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -113.04 137.58 51.2 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.917 1.687 . . . . 0.0 107.94 173.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.67 116.25 7.63 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 9.8 p90 -129.85 175.83 8.53 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.937 0.895 . . . . 0.0 109.429 175.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.428 HD11 HD11 ' A' ' 33' ' ' ILE . 1.8 mp -114.07 120.11 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 103.006 -2.961 . . . . 0.0 103.006 174.04 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -83.43 144.81 29.35 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 123.355 1.55 . . . . 0.0 114.746 -173.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.52 -16.48 60.85 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.521 1.928 . . . . 0.0 114.985 -174.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -55.89 -35.02 66.07 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.455 0.57 . . . . 0.0 109.488 174.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -75.74 -44.94 39.22 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.429 ' HA ' HD12 ' A' ' 24' ' ' LEU . . . -55.06 -33.94 63.15 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.523 0.729 . . . . 0.0 111.019 174.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 25.8 ttm105 -55.2 -57.26 12.51 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 121.2 -0.938 . . . . 0.0 108.841 173.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.2 t -53.8 -23.81 9.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 119.098 0.863 . . . . 0.0 111.603 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 21' ' ' ALA . 5.0 mt -76.2 -44.28 38.55 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 117.116 -1.421 . . . . 0.0 113.893 174.15 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.0 pt -151.76 17.41 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 -173.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.53 4.56 39.29 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 128.201 2.81 . . . . 0.0 115.368 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -100.75 176.56 5.26 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 128.759 2.824 . . . . 0.0 111.684 -173.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -118.66 117.9 30.19 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.506 1.522 . . . . 0.0 109.105 -178.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -153.93 113.55 3.81 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.311 1.445 . . . . 0.0 109.585 -178.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -94.74 165.76 12.33 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 173.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.1 mp -141.07 113.39 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 174.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.59 122.54 29.18 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -177.326 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.428 HD11 HD11 ' A' ' 16' ' ' ILE . 17.2 mt -94.97 -65.3 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 119.027 0.831 . . . . 0.0 109.019 177.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.4 t -113.15 113.6 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 -173.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.5 p -109.22 113.58 26.55 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 103.613 -2.736 . . . . 0.0 103.613 173.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.284 18.1 pm0 44.43 40.87 4.14 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.77 1.628 . . . . 0.0 113.235 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.91 -6.76 8.74 Favored Glycine 0 CA--C 1.543 1.785 0 C-N-CA 124.768 1.175 . . . . 0.0 114.466 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -86.39 37.63 0.74 Allowed 'General case' 0 CA--C 1.539 0.554 1 C-N-CA 134.387 5.075 . . . . 0.0 108.114 -174.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 62.6 mtp -37.66 131.74 0.94 Allowed 'General case' 0 C--O 1.234 0.253 0 C-N-CA 128.427 2.691 . . . . 0.0 115.301 -172.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.6 159.39 85.21 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-N 113.464 -1.698 . . . . 0.0 109.056 173.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -76.46 41.28 0.86 Allowed 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 124.53 3.486 . . . . 0.0 111.783 175.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -54.89 -26.29 34.82 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.443 1.897 . . . . 0.0 112.802 -174.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.5 m -53.14 -33.09 50.9 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 127.201 2.2 . . . . 0.0 112.074 -173.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -62.9 -66.25 0.57 Allowed 'General case' 0 C--N 1.344 0.368 0 CA-C-N 119.201 0.91 . . . . 0.0 109.748 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.9 -35.37 74.72 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -177.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -63.87 -44.56 92.71 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 125.081 1.488 . . . . 0.0 110.092 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 48.7 tpt85 -82.09 -29.42 31.79 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -176.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.06 176.77 1.57 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 128.58 2.752 . . . . 0.0 110.06 179.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.77 176.1 0.16 Allowed 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.058 -1.026 . . . . 0.0 109.916 173.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 5.3 tm0? -43.74 136.64 3.39 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.489 1.516 . . . . 0.0 113.893 -173.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -145.12 -67.18 0.31 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 173.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.9 tpm_? -160.06 -16.8 0.06 Allowed 'General case' 0 C--O 1.226 -0.15 0 CA-C-O 118.03 -0.986 . . . . 0.0 112.603 174.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.498 ' H ' ' HD2' ' A' ' 54' ' ' PRO . 98.1 mmm -109.35 -48.7 0.08 OUTLIER Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 -173.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.498 ' HD2' ' H ' ' A' ' 53' ' ' MET . 9.2 Cg_endo -61.33 -71.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.687 0 CA-C-N 121.457 1.556 . . . . 0.0 114.048 -173.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.39 119.81 19.99 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.495 0.718 . . . . 0.0 110.357 -174.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 96.0 mt -123.92 127.92 25.27 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 128.226 2.61 . . . . 0.0 106.134 -175.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -84.59 161.22 12.55 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 122.755 2.304 . . . . 0.0 111.565 174.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.5 p -47.11 -37.0 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 125.281 1.432 . . . . 0.0 112.667 173.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -53.25 -37.7 62.34 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.612 1.565 . . . . 0.0 111.968 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.2 mm -83.23 112.81 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 102.992 -2.966 . . . . 0.0 102.992 173.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -79.39 -40.6 29.7 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 173.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.2 m -141.81 157.89 44.46 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.989 1.716 . . . . 0.0 109.572 -173.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 2.8 mmm -117.75 147.91 42.54 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 173.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -94.49 156.42 16.47 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 173.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -141.23 155.18 46.06 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 129.506 3.122 . . . . 0.0 102.701 172.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.2 m -139.05 133.35 31.51 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -177.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -145.93 162.59 37.43 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.404 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -163.24 146.17 10.37 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 173.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.04 -177.16 5.46 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 173.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -115.09 95.98 5.46 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.989 1.316 . . . . 0.0 109.206 -173.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.67 -89.69 0.03 OUTLIER Glycine 0 CA--C 1.534 1.254 0 C-N-CA 126.128 1.823 . . . . 0.0 115.979 173.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . 0.263 16.0 mm100 -117.12 26.14 9.99 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.542 1.937 . . . . 0.0 114.462 174.15 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -94.91 37.25 1.15 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.839 2.456 . . . . 0.0 112.215 177.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -38.9 113.4 0.3 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.802 1.641 . . . . 0.0 112.515 -173.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -106.36 129.98 54.27 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.157 1.783 . . . . 0.0 107.695 175.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -91.53 150.58 21.14 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 176.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -131.93 160.22 36.39 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 119.726 1.148 . . . . 0.0 110.236 174.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.444 ' O ' HD13 ' A' ' 131' ' ' ILE . 29.0 tt0 -155.37 135.49 13.02 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 173.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.478 ' CD2' HD23 ' A' ' 82' ' ' LEU . 77.6 m-85 -84.14 103.55 13.45 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.9 tt -65.24 -37.55 87.59 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 174.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.7 m -155.01 144.92 21.62 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 120.687 -1.258 . . . . 0.0 111.816 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.485 HD22 HG22 ' A' ' 128' ' ' VAL . 0.1 OUTLIER -156.24 93.52 1.42 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 102.678 -3.082 . . . . 0.0 102.678 173.573 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.461 ' HD3' ' H ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -154.21 158.64 40.6 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 121.206 1.821 . . . . 0.0 111.779 -178.184 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.1 t -71.72 167.65 19.43 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.915 0.886 . . . . 0.0 112.982 173.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.9 mt -126.69 -9.45 6.16 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 126.603 1.961 . . . . 0.0 114.308 174.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.524 ' CG ' ' H ' ' A' ' 87' ' ' LYS 0.309 13.3 t70 -96.43 170.67 9.07 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 122.01 2.186 . . . . 0.0 112.095 -173.721 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.524 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 1.3 mppt? -114.65 -53.01 2.68 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 129.16 2.984 . . . . 0.0 110.223 -173.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.433 ' C ' ' H ' ' A' ' 90' ' ' MET . . . -82.1 -58.62 2.44 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 125.052 1.31 . . . . 0.0 110.643 178.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mp -79.19 25.5 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 126.164 1.786 . . . . 0.0 110.376 -175.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.433 ' H ' ' C ' ' A' ' 88' ' ' GLY . 27.3 ttm -43.4 131.41 4.85 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 130.144 3.377 . . . . 0.0 109.292 -178.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -165.19 160.23 18.34 Favored 'General case' 0 N--CA 1.438 -1.028 1 C-N-CA 131.916 4.086 . . . . 0.0 103.785 -173.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.269 5.7 m-20 -138.16 124.84 13.17 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 118.618 0.644 . . . . 0.0 111.359 173.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.421 ' HG2' HD12 ' A' ' 82' ' ' LEU . 75.7 Cg_endo -70.08 142.42 46.45 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 122.035 1.824 . . . . 0.0 110.273 179.144 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.8 p -131.87 162.09 31.43 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.938 1.695 . . . . 0.0 108.726 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.4 m -126.14 153.37 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 119.176 0.898 . . . . 0.0 112.353 -174.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -79.27 9.67 4.41 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 127.335 2.254 . . . . 0.0 113.337 177.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.5 m -144.24 164.21 30.32 Favored Pre-proline 0 C--N 1.327 -0.376 0 C-N-CA 124.725 1.21 . . . . 0.0 109.603 -174.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -66.9 161.76 40.88 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 121.25 1.3 . . . . 0.0 109.348 173.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -65.57 -7.68 16.0 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.237 1.015 . . . . 0.0 112.192 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -144.47 164.12 31.81 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.372 1.469 . . . . 0.0 108.335 173.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.66 -161.37 34.12 Favored Glycine 0 C--O 1.226 -0.357 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.5 p -125.89 139.17 53.68 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.8 t -74.3 114.34 32.54 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -78.84 150.15 23.62 Favored 'Trans proline' 0 C--O 1.211 -0.845 0 C-N-CA 121.969 1.779 . . . . 0.0 111.583 -174.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.415 ' H ' ' CD2' ' A' ' 105' ' ' HIS . 6.2 m-70 -78.29 4.09 13.76 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 119.726 -1.859 . . . . 0.0 113.98 -173.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.83 127.24 54.11 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 173.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -43.94 110.68 0.22 Allowed 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 126.501 1.921 . . . . 0.0 109.806 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.3 m -119.21 140.45 50.19 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.7 t -94.87 117.52 38.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 C-N-CA 124.953 1.301 . . . . 0.0 108.97 -173.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.6 t -100.09 104.44 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 173.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -82.11 149.01 28.23 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 173.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.5 t -122.49 113.56 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 104.035 -2.579 . . . . 0.0 104.035 175.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -89.37 147.84 19.75 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.506 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 7.0 m-85 -127.73 73.53 78.52 Favored Pre-proline 0 C--O 1.242 0.706 0 CA-C-N 118.156 0.978 . . . . 0.0 109.472 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.28 123.5 10.95 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.681 2.254 . . . . 0.0 107.55 173.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 7.3 t -105.95 152.82 22.83 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.253 1.021 . . . . 0.0 108.717 178.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mt -72.02 -14.95 62.02 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 117.953 0.342 . . . . 0.0 111.409 176.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 54.21 42.91 74.1 Favored Glycine 0 C--O 1.22 -0.77 0 C-N-CA 126.479 1.99 . . . . 0.0 113.827 173.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . 0.282 27.4 mttp -125.39 -34.05 2.75 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.733 1.766 . . . . 0.0 113.551 176.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 50.2 tp60 -96.04 142.06 28.7 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 104.043 -2.576 . . . . 0.0 104.043 172.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -93.97 141.01 29.01 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 142.64 -154.73 25.39 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.7 t -129.2 114.11 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -175.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.73 168.82 12.63 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 173.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -125.6 157.75 36.37 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 123.963 0.905 . . . . 0.0 108.888 173.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.506 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 12.4 p90 -149.89 160.87 43.25 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 173.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.442 ' HG3' HH12 ' A' ' 83' ' ' ARG . 5.1 pt-20 -140.42 160.22 40.48 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 124.454 1.102 . . . . 0.0 111.444 -173.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.485 HG22 HD22 ' A' ' 82' ' ' LEU . 83.0 t -139.46 146.94 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 126.205 1.802 . . . . 0.0 109.51 -174.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -150.63 122.85 8.33 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 127.892 2.477 . . . . 0.0 105.784 173.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.422 HG22 ' CD2' ' A' ' 79' ' ' PHE . 21.8 t -135.87 123.74 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.674 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -91.02 165.38 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 173.552 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.8 t -144.99 134.31 18.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 -176.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.77 164.7 29.25 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.605 -174.059 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 45.2 p30 -79.31 166.77 21.76 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 104.104 -2.554 . . . . 0.0 104.104 172.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.3 t -60.69 -12.66 11.08 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 120.96 1.709 . . . . 0.0 115.612 -173.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -80.46 -12.08 59.6 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 121.113 1.779 . . . . 0.0 112.303 173.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.23 -3.54 54.85 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.824 1.202 . . . . 0.0 114.117 -174.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -66.91 117.17 8.63 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 120.037 1.919 . . . . 0.0 108.648 177.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -71.81 143.83 49.35 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.681 0.792 . . . . 0.0 108.932 -176.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -138.74 -37.88 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.504 1.122 . . . . 0.0 113.516 -175.021 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.46 HD13 ' N ' ' A' ' 142' ' ' GLN . 1.9 tm? -133.81 147.83 51.27 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 -177.278 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.46 ' N ' HD13 ' A' ' 141' ' ' LEU . 10.3 tm0? -147.87 147.03 29.33 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.927 0.891 . . . . 0.0 108.959 174.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 23.5 m -80.67 113.74 42.38 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 176.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.17 147.5 91.31 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 121.202 1.268 . . . . 0.0 110.904 -173.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -79.54 112.24 16.61 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 -174.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.625 37.3 m-80 172.12 -8.13 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.524 1 C-N-CA 134.876 5.271 . . . . 0.0 112.214 172.991 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.74 79.93 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.362 1.465 . . . . 0.0 108.687 174.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.3 mt -117.03 148.72 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 C-N-CA 127.189 2.196 . . . . 0.0 106.316 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -133.88 164.84 26.37 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.015 -1.448 . . . . 0.0 107.182 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -137.4 113.53 9.91 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.017 1.327 . . . . 0.0 107.602 -173.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.12 120.4 41.17 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 119.313 0.96 . . . . 0.0 108.765 -175.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.9 m -84.14 116.59 22.98 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 -177.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 6.9 m -113.09 166.17 11.68 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.832 0.853 . . . . 0.0 109.261 173.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.3 pp -136.88 163.5 30.53 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.845 1.258 . . . . 0.0 108.198 173.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -72.42 121.33 19.38 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 128.258 2.623 . . . . 0.0 110.817 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -146.17 170.35 16.9 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 127.304 2.242 . . . . 0.0 109.387 177.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 . . . . . 0 C--O 1.257 1.489 0 C-N-CA 131.162 3.785 . . . . 0.0 104.339 173.822 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.072 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.4 p -42.99 177.47 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.792 2.037 . . . . 0.0 112.414 120.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -46.3 177.18 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 127.657 2.383 . . . . 0.0 111.307 173.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 23.4 mmt -47.13 163.21 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.696 0 O-C-N 119.53 -1.981 . . . . 0.0 106.597 172.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -42.88 113.37 0.47 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 122.57 1.176 . . . . 0.0 113.202 -172.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -80.04 172.67 13.46 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 128.2 2.6 . . . . 0.0 110.195 -173.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.36 146.62 17.05 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 104.155 -2.535 . . . . 0.0 104.155 174.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -73.66 168.43 19.36 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 125.473 1.509 . . . . 0.0 108.227 173.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -71.77 160.33 32.79 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 173.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -71.79 156.48 39.27 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 173.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.5 m -174.96 176.03 2.22 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.061 1.344 . . . . 0.0 111.296 -173.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.7 tt -86.39 136.56 33.08 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 128.81 2.844 . . . . 0.0 109.775 178.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -127.72 138.97 52.95 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.857 1.663 . . . . 0.0 108.412 173.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.39 117.6 7.33 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 -176.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 14.1 p90 -130.78 171.18 13.42 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.683 0.793 . . . . 0.0 110.518 177.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.1 mt -108.75 135.18 48.37 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 N-CA-C 103.591 -2.744 . . . . 0.0 103.591 174.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -91.79 159.96 15.55 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 122.577 1.18 . . . . 0.0 113.164 -173.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.89 -13.79 59.95 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.119 1.767 . . . . 0.0 113.99 175.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 31.6 m80 -59.4 -38.74 81.34 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 120.615 1.552 . . . . 0.0 109.058 175.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -64.08 -46.02 86.15 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.925 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.591 ' HA ' HD12 ' A' ' 24' ' ' LEU . . . -65.46 -31.85 73.15 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 123.244 0.618 . . . . 0.0 112.261 175.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -58.62 -56.7 18.72 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 174.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 77.3 t -51.98 -24.04 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.363 1.465 . . . . 0.0 112.101 174.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.591 HD12 ' HA ' ' A' ' 21' ' ' ALA . 7.8 mt -77.72 -46.39 21.94 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 174.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.8 pt -153.99 18.16 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 -172.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.99 15.56 65.13 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.549 1.547 . . . . 0.0 113.433 -174.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -100.77 172.83 6.83 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 126.558 1.943 . . . . 0.0 109.235 -176.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -127.17 127.57 44.75 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -174.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -155.14 113.31 3.46 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 118.419 -0.8 . . . . 0.0 112.275 -179.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -96.25 165.12 12.37 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 122.35 2.341 . . . . 0.0 105.765 172.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 79.2 mt -140.26 113.17 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 173.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.81 114.22 24.22 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 -177.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.4 mt -92.44 -53.16 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 118.825 0.738 . . . . 0.0 109.661 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -123.44 113.81 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 -173.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.9 p -112.96 122.66 48.3 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 173.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 44.32 44.39 6.68 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.093 1.357 . . . . 0.0 112.602 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.32 4.72 1.32 Allowed Glycine 0 CA--C 1.536 1.371 0 C-N-CA 127.121 2.296 . . . . 0.0 114.743 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.97 37.28 0.48 Allowed 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 129.875 3.27 . . . . 0.0 111.426 -172.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 34.3 mtt -38.12 116.46 0.52 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 126.339 1.855 . . . . 0.0 114.381 -173.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.34 160.55 75.19 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 173.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.7 65.67 5.77 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 124.134 3.223 . . . . 0.0 109.685 175.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -62.17 -12.33 19.28 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 126.999 2.119 . . . . 0.0 114.77 -173.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 56.8 m -43.69 -48.51 7.88 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 126.049 1.739 . . . . 0.0 113.185 -173.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -59.63 -59.51 5.33 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 118.379 0.536 . . . . 0.0 110.325 -176.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.734 ' O ' ' HB2' ' A' ' 49' ' ' ALA 0.321 49.0 m-20 -76.04 -23.26 55.13 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -173.626 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -75.57 -58.04 3.52 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.714 1.143 . . . . 0.0 108.645 173.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -67.75 -25.23 65.53 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.291 -0.88 . . . . 0.0 110.983 -173.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.87 113.38 17.14 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 173.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.734 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -166.06 176.96 7.32 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.268 1.027 . . . . 0.0 109.774 -173.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -44.35 148.74 0.43 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.156 1.782 . . . . 0.0 106.995 172.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -44.07 -34.37 1.75 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.052 1.741 . . . . 0.0 113.501 -173.395 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.03 -16.51 0.77 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.664 1.585 . . . . 0.0 115.002 176.204 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.508 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -111.52 -65.99 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 120.935 1.698 . . . . 0.0 113.411 -176.004 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.01 -79.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.875 0 CA-C-N 122.152 1.804 . . . . 0.0 111.462 -174.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.09 113.47 20.64 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.612 0.765 . . . . 0.0 109.062 -174.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.5 mt -110.64 126.22 29.24 Favored Pre-proline 0 C--N 1.323 -0.566 0 C-N-CA 127.158 2.183 . . . . 0.0 105.437 -175.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.3 156.36 37.27 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.562 1.508 . . . . 0.0 110.216 178.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.0 p -42.11 -44.79 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 126.354 1.862 . . . . 0.0 112.194 174.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -61.43 -36.04 79.24 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 126.354 1.861 . . . . 0.0 113.159 -176.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 mm -75.63 112.65 13.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 101.309 -3.589 . . . . 0.0 101.309 173.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -79.25 -36.6 39.65 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.997 178.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.6 m -144.78 170.69 15.62 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 124.125 0.891 . . . . 0.0 111.953 -173.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 62.9 mtp -125.87 156.85 38.98 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 172.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -121.81 113.56 19.84 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -174.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -99.95 162.68 12.84 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 173.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.8 m -141.59 136.34 30.94 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 176.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -143.71 162.93 34.7 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 120.604 -0.439 . . . . 0.0 110.582 174.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -172.8 156.59 3.49 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.265 -0.88 . . . . 0.0 112.04 173.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.44 -173.41 4.7 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 172.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.27 134.15 55.28 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 102.767 -3.049 . . . . 0.0 102.767 173.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 19.28 -60.02 0.0 OUTLIER Glycine 0 CA--C 1.534 1.26 1 C-N-CA 135.634 6.35 . . . . 0.0 120.808 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -116.58 -13.06 10.89 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 121.139 2.47 . . . . 0.0 113.672 -177.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.96 37.4 0.6 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 130.037 3.335 . . . . 0.0 119.503 -173.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -51.39 116.25 1.98 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 123.388 2.813 . . . . 0.0 110.247 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -83.72 150.41 25.85 Favored 'General case' 0 C--N 1.334 -0.089 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 174.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -100.79 146.82 26.78 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 176.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -132.49 160.69 35.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 120.239 1.381 . . . . 0.0 110.983 176.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.457 ' O ' HD13 ' A' ' 131' ' ' ILE . 28.2 tt0 -152.6 133.74 14.23 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 173.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -81.32 111.22 17.5 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.714 1.206 . . . . 0.0 109.34 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.8 tt -74.28 -48.61 27.43 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.656 1.183 . . . . 0.0 107.857 174.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 m -128.66 148.08 50.78 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.04 1.336 . . . . 0.0 111.839 176.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -175.6 92.62 0.06 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 130.155 3.382 . . . . 0.0 103.913 173.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -162.16 153.46 18.13 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.348 -1.47 . . . . 0.0 111.279 -173.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.8 t -85.74 165.44 16.92 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 121.72 0.771 . . . . 0.0 109.174 173.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 98.8 mt -125.85 0.65 7.36 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 126.035 1.734 . . . . 0.0 112.163 -174.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.471 ' CG ' ' H ' ' A' ' 87' ' ' LYS 0.358 11.3 t70 -98.48 166.14 11.5 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.303 0.956 . . . . 0.0 112.391 178.247 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.471 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 1.4 mppt? -104.67 -46.86 4.22 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 129.401 3.081 . . . . 0.0 112.222 -173.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -105.0 -44.6 1.48 Allowed Glycine 0 CA--C 1.525 0.711 0 C-N-CA 125.075 1.321 . . . . 0.0 111.792 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mt -84.41 13.93 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 C-N-CA 125.274 1.43 . . . . 0.0 108.614 176.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 23.5 ttp -43.62 148.71 0.33 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 131.175 3.79 . . . . 0.0 110.548 177.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -162.7 176.28 10.48 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 127.724 2.41 . . . . 0.0 107.113 -173.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -137.51 113.92 9.48 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 172.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.91 154.31 75.0 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 N-CA-C 106.602 -2.115 . . . . 0.0 106.602 173.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.0 p -141.55 162.73 34.76 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 125.112 1.365 . . . . 0.0 108.435 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.0 m -126.47 155.43 36.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 123.742 0.817 . . . . 0.0 111.915 175.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -73.24 9.06 1.38 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.712 2.405 . . . . 0.0 113.212 174.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.1 m -140.73 165.52 29.17 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 125.903 1.681 . . . . 0.0 108.594 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -67.37 168.64 17.35 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.621 1.547 . . . . 0.0 111.293 174.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -62.63 -12.53 23.8 Favored 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 124.986 1.315 . . . . 0.0 111.914 174.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -143.17 163.83 31.81 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 120.314 1.416 . . . . 0.0 108.129 173.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.61 -161.7 34.37 Favored Glycine 0 C--O 1.228 -0.277 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 82.3 p -117.81 155.33 30.27 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 117.808 0.804 . . . . 0.0 109.404 173.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.6 t -93.69 113.12 59.54 Favored Pre-proline 0 N--CA 1.448 -0.541 0 N-CA-C 101.77 -3.419 . . . . 0.0 101.77 173.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -92.4 161.57 3.02 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.431 2.088 . . . . 0.0 111.998 -173.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -72.62 3.17 5.28 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 120.116 -1.615 . . . . 0.0 112.382 -173.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -114.11 116.0 28.42 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 127.654 2.382 . . . . 0.0 107.672 -173.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -44.68 105.87 0.06 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.563 1.145 . . . . 0.0 109.942 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 26.8 m -111.75 135.16 52.72 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.4 t -90.28 114.09 27.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -173.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 70.8 t -94.0 103.21 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 103.536 -2.764 . . . . 0.0 103.536 173.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -84.05 119.08 24.52 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 173.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.5 t -90.56 113.47 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 103.13 -2.915 . . . . 0.0 103.13 173.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -93.9 149.11 19.29 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.435 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 7.8 m-85 -132.3 73.45 77.35 Favored Pre-proline 0 C--O 1.244 0.784 0 CA-C-N 118.258 1.029 . . . . 0.0 110.766 -176.134 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -68.04 114.27 3.33 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 N-CA-C 106.844 -2.022 . . . . 0.0 106.844 173.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 5.6 t -91.88 143.58 26.36 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 175.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.0 mt -74.26 -11.41 60.27 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 119.32 -0.371 . . . . 0.0 111.5 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 53.17 39.61 58.34 Favored Glycine 0 C--N 1.339 0.744 0 C-N-CA 125.768 1.652 . . . . 0.0 113.69 173.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -93.48 -65.25 1.01 Allowed 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 118.219 1.01 . . . . 0.0 109.299 -177.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -96.07 155.26 16.83 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 174.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -93.44 147.72 22.7 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.383 1.473 . . . . 0.0 107.72 178.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.5 -155.5 26.38 Favored Glycine 0 C--N 1.332 0.34 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.9 t -126.63 114.01 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -88.26 170.58 10.88 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 173.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -124.06 158.19 32.76 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 173.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.435 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 50.1 p90 -148.71 153.55 38.39 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 173.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.55 154.59 37.7 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 126.231 1.813 . . . . 0.0 110.199 -173.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 87.7 t -143.09 144.64 23.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 173.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -157.38 132.53 8.91 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 125.078 1.351 . . . . 0.0 107.894 173.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.3 t -137.26 135.26 47.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -174.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.585 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -103.2 164.07 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 173.838 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.2 t -142.66 138.21 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -173.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.81 175.65 9.42 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 125.565 1.546 . . . . 0.0 107.97 -176.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 39.3 p-10 -90.92 176.22 6.69 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 172.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.1 t -66.17 -7.13 16.14 Favored 'General case' 0 CA--C 1.553 1.059 0 O-C-N 120.552 -1.342 . . . . 0.0 112.549 -176.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -86.13 -14.85 42.93 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.455 -1.403 . . . . 0.0 110.933 173.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.5 1.44 64.15 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.659 1.123 . . . . 0.0 112.465 -173.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 63.2 m-20 -71.75 116.29 11.95 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 119.68 1.74 . . . . 0.0 108.504 174.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -64.76 142.36 58.46 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.063 1.745 . . . . 0.0 108.461 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.3 pt -140.58 -38.69 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.758 1.223 . . . . 0.0 113.841 -174.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -130.91 141.54 50.3 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 -177.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -149.07 124.95 10.57 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -176.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 41.3 m -61.67 143.72 93.57 Favored Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 174.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.49 141.95 23.01 Favored 'Trans proline' 0 N--CA 1.441 -1.613 0 N-CA-C 107.587 -1.736 . . . . 0.0 107.587 173.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -77.0 112.64 13.84 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 102.225 -3.25 . . . . 0.0 102.225 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 4.1 m120 174.45 -30.24 0.0 OUTLIER 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.17 1.788 . . . . 0.0 111.419 -173.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.75 103.91 0.39 Allowed 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.443 1.497 . . . . 0.0 110.219 -174.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 2.0 mt -134.29 148.74 29.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -176.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 126' ' ' PHE . 0.9 OUTLIER -132.19 169.98 15.66 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.198 1.799 . . . . 0.0 107.479 179.078 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -136.4 113.74 10.76 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.281 1.032 . . . . 0.0 109.073 -173.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -103.13 124.95 49.53 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.677 1.126 . . . . 0.0 109.136 179.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 25.7 m -83.67 116.69 22.76 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 174.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 4.5 m -119.27 166.21 13.28 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.494 0.718 . . . . 0.0 109.84 174.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.2 pp -133.27 161.16 35.22 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.459 1.504 . . . . 0.0 107.89 176.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.16 131.95 46.82 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.926 1.29 . . . . 0.0 109.927 177.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -146.91 133.49 19.83 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.814 1.646 . . . . 0.0 107.509 174.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 . . . . . 0 C--O 1.257 1.464 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 177.485 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.83 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.5 m -57.7 164.96 1.83 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.75 0.82 . . . . 0.0 110.747 170.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -62.71 113.62 3.12 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 173.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 57.2 mtm -156.65 176.68 12.4 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 129.002 2.921 . . . . 0.0 105.91 -173.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.9 mp -61.24 162.35 7.69 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 107.985 -1.116 . . . . 0.0 107.985 173.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -51.19 113.8 1.03 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.738 2.015 . . . . 0.0 112.164 -173.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -160.74 174.61 13.68 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 129.021 2.928 . . . . 0.0 103.709 173.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.6 174.14 14.32 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 128.349 2.659 . . . . 0.0 106.497 173.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -135.61 149.77 49.47 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 175.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -82.26 166.59 19.42 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 122.44 1.114 . . . . 0.0 111.606 -177.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.7 m -176.53 177.09 1.48 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 129.822 3.249 . . . . 0.0 107.692 -176.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 13' ' ' TYR . 3.1 tt -43.55 138.13 2.62 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.96 2.504 . . . . 0.0 113.075 177.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.469 ' N ' HD23 ' A' ' 12' ' ' LEU . 86.9 m-85 -122.12 135.57 54.81 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.51 1.924 . . . . 0.0 108.467 173.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.99 121.06 10.08 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 127.231 2.212 . . . . 0.0 107.115 -176.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 12.8 p90 -139.63 175.07 9.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 118.933 0.788 . . . . 0.0 109.946 176.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.434 HD11 HD11 ' A' ' 33' ' ' ILE . 2.2 mp -112.77 113.72 44.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 100.226 -3.99 . . . . 0.0 100.226 173.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -79.58 152.9 29.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 122.861 1.315 . . . . 0.0 111.832 -173.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.2 -19.18 61.32 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -173.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -61.09 -34.06 74.32 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 119.564 1.075 . . . . 0.0 109.396 174.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 48.1 tp60 -69.16 -48.44 62.25 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 118.103 0.41 . . . . 0.0 111.6 177.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.541 ' HA ' HD12 ' A' ' 24' ' ' LEU . . . -59.95 -29.58 68.5 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 119.131 -0.461 . . . . 0.0 111.617 174.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 27.0 ttm105 -57.04 -55.57 32.96 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 119.658 1.117 . . . . 0.0 108.038 173.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -54.13 -23.93 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 119.27 0.941 . . . . 0.0 111.499 177.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.541 HD12 ' HA ' ' A' ' 21' ' ' ALA . 4.8 mt -76.13 -43.32 43.59 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 117.239 -1.362 . . . . 0.0 114.021 174.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.4 pt -151.08 16.6 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 116.919 2.192 . . . . 0.0 116.919 -173.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.33 4.51 30.56 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 128.169 2.795 . . . . 0.0 115.485 -177.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -100.83 176.46 5.28 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 128.674 2.79 . . . . 0.0 111.704 -173.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -115.58 116.37 28.04 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.715 1.606 . . . . 0.0 109.589 -177.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -160.21 114.07 2.18 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.186 1.795 . . . . 0.0 110.569 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -94.55 165.49 12.5 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 172.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.7 mm -137.98 113.35 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 173.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.35 114.63 22.01 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -177.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.434 HD11 HD11 ' A' ' 16' ' ' ILE . 17.2 mt -87.42 -58.41 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -126.04 122.55 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 126.375 1.87 . . . . 0.0 107.683 -173.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 81.0 p -123.56 127.96 49.05 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 101.07 -3.678 . . . . 0.0 101.07 172.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.292 0.4 OUTLIER 44.08 36.66 1.53 Allowed 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 119.893 1.224 . . . . 0.0 114.025 178.55 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.5 -8.4 2.24 Favored Glycine 0 CA--C 1.546 2.024 0 O-C-N 120.461 -1.399 . . . . 0.0 115.443 -175.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.83 37.56 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.573 1 C-N-CA 134.524 5.13 . . . . 0.0 111.987 175.528 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 53.9 mtp -37.6 119.38 0.72 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.262 1.425 . . . . 0.0 112.826 -172.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.07 163.35 13.81 Favored Pre-proline 0 N--CA 1.447 -0.62 0 CA-C-N 113.442 -1.708 . . . . 0.0 109.696 177.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.97 30.57 0.29 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 123.994 3.129 . . . . 0.0 111.911 173.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -55.16 -26.76 40.91 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 126.363 1.865 . . . . 0.0 111.427 -174.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.9 m -56.29 -37.74 70.27 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 127.428 2.291 . . . . 0.0 111.605 -173.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -60.84 -65.51 0.68 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 177.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -65.11 -23.7 67.22 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.637 0.775 . . . . 0.0 112.997 -174.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -70.01 -47.05 63.7 Favored 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 124.002 0.921 . . . . 0.0 109.821 173.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.9 ttp180 -78.72 -22.72 46.17 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.932 1.293 . . . . 0.0 112.468 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -63.03 176.49 0.71 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 128.745 2.818 . . . . 0.0 111.579 -173.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.41 170.71 1.69 Allowed 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.152 -0.968 . . . . 0.0 109.571 173.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -48.39 121.19 4.19 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 124.817 1.247 . . . . 0.0 111.942 -175.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -145.67 -67.09 0.3 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 173.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -141.71 -16.75 0.79 Allowed 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.687 ' H ' ' HD2' ' A' ' 54' ' ' PRO . 90.0 mmm -133.03 -44.84 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 116.278 -1.82 . . . . 0.0 114.635 -173.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.687 ' HD2' ' H ' ' A' ' 53' ' ' MET . 5.6 Cg_endo -59.68 -72.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.791 0 CA-C-N 121.877 1.706 . . . . 0.0 113.252 -173.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.19 125.65 29.66 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -176.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 58.4 mt -124.86 131.18 24.07 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 128.14 2.576 . . . . 0.0 106.207 -173.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -81.07 158.44 20.53 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.11 1.873 . . . . 0.0 111.198 174.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.7 p -46.7 -37.31 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 126.058 1.743 . . . . 0.0 112.313 173.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -53.37 -40.1 64.71 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 126.492 1.917 . . . . 0.0 112.582 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 mm -76.6 112.77 14.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 103.394 -2.817 . . . . 0.0 103.394 174.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -83.09 -35.03 25.99 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 173.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.8 m -147.71 152.86 38.5 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.866 1.266 . . . . 0.0 108.271 -174.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 22.3 mtp -113.36 164.03 14.1 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 172.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -133.88 114.47 13.35 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 -173.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -98.97 168.56 10.03 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 173.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.9 m -141.34 135.24 30.3 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -143.66 164.55 30.11 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 121.856 -0.528 . . . . 0.0 111.046 176.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.51 161.56 18.68 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.525 1.13 . . . . 0.0 111.647 174.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.34 160.15 15.59 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.843 0.857 . . . . 0.0 108.759 173.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.55 84.54 7.2 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.871 1.268 . . . . 0.0 110.924 -174.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 50.88 -46.93 0.01 OUTLIER Glycine 0 CA--C 1.542 1.752 1 C-N-CA 131.51 4.386 . . . . 0.0 121.58 173.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -117.14 2.16 12.59 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 120.471 2.135 . . . . 0.0 116.017 -173.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.435 ' H ' ' CE1' ' A' ' 105' ' ' HIS . . . -126.01 37.24 4.38 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 120.903 3.668 . . . . 0.0 120.903 -172.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -38.29 114.21 0.35 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 123.203 2.728 . . . . 0.0 112.882 -173.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -83.86 123.2 29.68 Favored 'General case' 0 C--N 1.338 0.068 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 -174.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -76.69 148.26 36.92 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 -176.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -132.51 160.27 37.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 119.989 1.268 . . . . 0.0 111.106 176.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.482 ' O ' HD13 ' A' ' 131' ' ' ILE . 29.0 tt0 -152.76 137.86 17.32 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 173.008 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -87.27 104.09 16.07 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 125.288 1.435 . . . . 0.0 109.764 -176.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.4 tt -70.7 -39.28 73.56 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.922 1.289 . . . . 0.0 108.449 176.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.7 m -135.56 144.25 46.13 Favored 'General case' 0 C--N 1.34 0.187 0 O-C-N 121.177 -0.952 . . . . 0.0 112.063 178.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.403 ' H ' ' HD3' ' A' ' 83' ' ' ARG . 1.6 tt -174.13 93.04 0.08 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 128.977 2.911 . . . . 0.0 105.524 173.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.403 ' HD3' ' H ' ' A' ' 82' ' ' LEU . 0.2 OUTLIER -159.97 153.35 22.23 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 119.753 1.16 . . . . 0.0 111.393 -173.993 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.1 t -78.37 129.02 34.48 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 119.633 1.106 . . . . 0.0 110.798 174.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 68.2 mt -93.16 -27.03 17.15 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 116.874 -1.536 . . . . 0.0 111.164 174.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -77.04 165.72 24.25 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.719 1.6 . . . . 0.0 107.134 175.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.35 -41.98 1.53 Allowed 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.728 1.611 . . . . 0.0 110.855 -173.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -72.39 -69.57 1.37 Allowed Glycine 0 CA--C 1.533 1.192 0 N-CA-C 108.386 -1.885 . . . . 0.0 108.386 173.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.574 ' H ' HD12 ' A' ' 89' ' ' ILE . 3.5 mp -73.44 14.39 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 C-N-CA 128.812 2.845 . . . . 0.0 110.476 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 22.1 ttp -43.2 136.75 2.83 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 128.167 2.587 . . . . 0.0 112.331 -173.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -156.69 113.58 3.1 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 -174.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -97.99 122.53 54.23 Favored Pre-proline 0 CA--C 1.509 -0.629 0 O-C-N 124.364 1.04 . . . . 0.0 109.285 -173.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -65.88 152.37 81.65 Favored 'Trans proline' 0 N--CA 1.443 -1.466 0 C-N-CA 120.83 1.02 . . . . 0.0 109.5 178.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 42.0 p -135.77 161.96 34.11 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.323 1.449 . . . . 0.0 107.137 173.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.9 m -126.47 149.71 31.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 O-C-N 121.241 -0.912 . . . . 0.0 111.679 174.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -86.81 13.77 8.31 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.772 1.629 . . . . 0.0 111.174 173.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.0 m -130.99 163.13 51.21 Favored Pre-proline 0 N--CA 1.454 -0.273 0 C-N-CA 125.829 1.652 . . . . 0.0 106.587 173.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -67.51 163.32 35.32 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 120.72 0.946 . . . . 0.0 109.864 173.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -62.72 -13.36 31.69 Favored 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 124.459 1.104 . . . . 0.0 111.583 175.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -139.53 163.58 32.17 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.205 1.402 . . . . 0.0 107.894 173.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 164.54 -159.67 32.67 Favored Glycine 0 C--O 1.226 -0.349 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -178.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 68.8 p -123.03 151.36 41.99 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 117.548 0.674 . . . . 0.0 109.506 174.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 48.2 t -89.62 113.45 56.78 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 101.925 -3.361 . . . . 0.0 101.925 173.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -91.95 171.68 2.66 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 N-CA-C 117.591 2.112 . . . . 0.0 117.591 -172.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.435 ' CE1' ' H ' ' A' ' 73' ' ' ALA . 76.1 m-70 -75.9 -0.59 21.9 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 -173.219 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.5 138.92 51.01 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 116.319 -1.8 . . . . 0.0 106.724 173.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.54 112.15 0.7 Allowed 'General case' 0 C--O 1.231 0.129 0 O-C-N 125.407 1.692 . . . . 0.0 106.466 173.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.5 m -123.23 136.72 54.85 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -176.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.8 t -85.1 135.89 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 O-C-N 124.737 1.273 . . . . 0.0 108.673 -173.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 74.7 t -112.8 103.66 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 104.355 -2.461 . . . . 0.0 104.355 173.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -83.77 125.63 32.11 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 173.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.5 t -102.94 113.55 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 102.712 -3.07 . . . . 0.0 102.712 173.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -82.86 151.49 29.0 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 174.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.45 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 8.7 m-85 -133.42 73.35 73.57 Favored Pre-proline 0 C--O 1.244 0.784 0 CA-C-N 118.279 1.039 . . . . 0.0 109.994 177.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -67.34 114.08 3.12 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.295 1.997 . . . . 0.0 108.634 173.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 5.9 t -89.45 151.43 22.02 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 173.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.1 mt -71.22 -10.95 60.6 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.102 0.41 . . . . 0.0 111.862 -176.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.77 23.01 49.19 Favored Glycine 0 C--N 1.339 0.713 0 C-N-CA 126.74 2.114 . . . . 0.0 116.786 173.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 50.7 mttt -120.98 -27.38 4.98 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.583 1.691 . . . . 0.0 113.375 177.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -96.62 156.59 16.28 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 173.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -112.03 151.54 29.22 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 175.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 140.41 -155.94 24.92 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 118.673 0.67 . . . . 0.0 111.56 174.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 20.7 t -122.99 114.14 40.91 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 175.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.3 172.89 9.53 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.553 1.141 . . . . 0.0 109.648 173.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -131.64 148.58 52.61 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.154 1.782 . . . . 0.0 107.684 173.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.46 ' CZ ' ' HB2' ' A' ' 149' ' ' PHE . 43.5 p90 -145.69 151.66 38.39 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 173.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -111.22 148.16 33.43 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 125.152 1.381 . . . . 0.0 111.498 -173.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 31.9 t -141.45 145.35 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 173.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -159.9 135.2 8.16 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 125.168 1.387 . . . . 0.0 108.252 174.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 37.4 t -139.74 131.42 33.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -174.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.616 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -100.93 165.38 2.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 173.829 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.2 t -142.06 138.07 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -173.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.8 175.19 9.81 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.667 1.587 . . . . 0.0 108.113 -176.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 36.9 p-10 -89.82 176.13 6.95 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 172.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.2 t -65.91 -3.51 5.31 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 120.24 -1.538 . . . . 0.0 113.678 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -89.62 -15.25 33.15 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 120.655 1.571 . . . . 0.0 110.595 173.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.72 1.12 62.01 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.62 1.105 . . . . 0.0 112.254 -173.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -71.53 115.9 11.25 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 119.606 1.703 . . . . 0.0 108.403 174.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -64.71 142.76 58.32 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 126.203 1.801 . . . . 0.0 108.632 -177.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.7 pt -139.67 -37.97 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 124.773 1.229 . . . . 0.0 113.884 -174.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -132.72 145.12 50.76 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -148.81 126.95 12.06 Favored 'General case' 0 CA--C 1.52 -0.187 0 O-C-N 121.009 -1.057 . . . . 0.0 108.615 -177.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 63.1 m -64.92 143.46 98.85 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 176.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.55 143.36 21.54 Favored 'Trans proline' 0 N--CA 1.445 -1.372 0 N-CA-C 108.989 -1.197 . . . . 0.0 108.989 174.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -80.46 112.68 18.03 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 176.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 173.11 -19.03 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 130.182 3.393 . . . . 0.0 110.434 -174.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.8 78.58 0.86 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.185 1.394 . . . . 0.0 109.879 -175.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 27.9 mm -101.99 130.01 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 105.002 -2.222 . . . . 0.0 105.002 173.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 126' ' ' PHE . 0.2 OUTLIER -105.0 155.71 18.71 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 173.768 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -130.84 113.47 14.11 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -174.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -110.29 123.9 50.65 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 119.128 0.876 . . . . 0.0 109.617 -174.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 22.5 m -83.48 114.26 21.36 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 175.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 25.5 m -114.6 166.08 12.1 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 123.881 0.872 . . . . 0.0 110.099 174.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.4 pp -141.59 159.08 42.95 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.766 1.627 . . . . 0.0 107.206 173.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.56 128.12 35.25 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.182 0.993 . . . . 0.0 110.318 175.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -157.62 119.44 3.7 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.123 1.369 . . . . 0.0 110.376 176.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 . . . . . 0 C--O 1.256 1.404 0 C-N-CA 129.158 2.983 . . . . 0.0 105.271 173.583 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.431 ' H1 ' ' CG ' ' A' ' 6' ' ' ASP . . . . . . . . 0 N--CA 1.468 0.785 0 N-CA-C 107.297 -2.321 . . . . 0.0 107.297 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.0 t -60.45 136.18 57.97 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 103.948 -2.612 . . . . 0.0 103.948 130.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . 0.278 28.9 m-70 -90.78 113.56 25.72 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-O 123.094 1.426 . . . . 0.0 111.437 -173.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.4 mmt -156.99 177.07 11.94 Favored 'General case' 0 CA--C 1.543 0.673 1 C-N-CA 138.944 6.898 . . . . 0.0 101.475 175.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 54.6 tp -56.69 113.75 1.77 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 173.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.431 ' CG ' ' H1 ' ' A' ' 1' ' ' GLY . 7.7 m-20 -77.53 114.11 16.04 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 174.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.01 170.58 6.17 Favored 'General case' 0 N--CA 1.425 -1.687 0 C-N-CA 128.083 2.553 . . . . 0.0 104.634 177.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -129.29 113.65 15.27 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 129.88 3.272 . . . . 0.0 103.262 173.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -118.33 171.06 8.4 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.171 1.388 . . . . 0.0 108.331 -173.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.645 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . 25.3 mt-10 -80.85 150.15 29.24 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 173.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m -176.54 176.71 1.54 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 130.49 3.516 . . . . 0.0 108.468 173.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.0 tt -43.91 128.0 5.44 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.776 1.63 . . . . 0.0 111.3 -176.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -115.98 128.48 55.77 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.503 1.521 . . . . 0.0 107.995 174.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.51 120.07 13.24 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 -179.336 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 14.1 p90 -140.48 174.88 10.08 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.776 0.716 . . . . 0.0 109.878 176.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.7 mp -113.74 113.72 44.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 1 N-CA-C 99.844 -4.132 . . . . 0.0 99.844 173.098 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -75.95 149.9 37.58 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.971 1.367 . . . . 0.0 111.417 -173.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.19 -26.46 63.9 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 113.75 -1.568 . . . . 0.0 113.304 -173.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -67.16 -44.55 79.48 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -174.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.6 -56.3 23.13 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 118.047 -0.978 . . . . 0.0 108.441 174.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.0 -41.05 61.88 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 117.228 -1.368 . . . . 0.0 111.987 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 51.9 ttm-85 -54.09 -61.55 2.23 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 120.802 1.637 . . . . 0.0 108.925 174.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 85.0 t -50.4 -24.27 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 124.54 1.136 . . . . 0.0 111.377 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.6 mt -86.18 -38.52 17.59 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.6 pt -144.18 14.35 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 -172.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.0 -2.58 0.95 Allowed Glycine 0 CA--C 1.533 1.158 0 C-N-CA 129.185 3.278 . . . . 0.0 115.934 -174.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -101.69 138.59 38.47 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 129.944 3.298 . . . . 0.0 107.217 -178.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -130.5 114.26 15.28 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 124.558 1.143 . . . . 0.0 109.965 -173.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -151.83 141.21 21.52 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 128.687 2.795 . . . . 0.0 104.25 173.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.01 166.47 13.87 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 173.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 82.3 mt -136.86 113.15 12.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 104.44 -2.429 . . . . 0.0 104.44 173.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.42 114.35 23.95 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 -177.098 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.2 mt -88.47 -61.99 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.455 HG22 ' HG2' ' A' ' 39' ' ' MET . 21.2 t -116.74 114.34 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 125.648 1.579 . . . . 0.0 107.049 -173.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.9 p -109.92 114.76 28.57 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 173.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.434 ' C ' ' H ' ' A' ' 38' ' ' LYS . 11.5 pt-20 46.41 36.86 3.72 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.491 1.516 . . . . 0.0 112.777 -178.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.19 -22.31 1.28 Allowed Glycine 0 CA--C 1.544 1.891 0 O-C-N 120.15 -1.594 . . . . 0.0 114.191 -175.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.434 ' H ' ' C ' ' A' ' 36' ' ' GLU . 15.9 ttpt -67.39 37.88 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.583 1 C-N-CA 137.471 6.309 . . . . 0.0 110.985 177.024 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.455 ' HG2' HG22 ' A' ' 34' ' ' VAL 0.284 34.7 mtt -37.38 136.22 0.49 Allowed 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.882 2.073 . . . . 0.0 114.372 -172.86 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.31 163.04 56.21 Favored Pre-proline 0 N--CA 1.448 -0.563 0 CA-C-N 112.844 -1.98 . . . . 0.0 107.778 173.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.24 34.37 0.33 Allowed 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 124.04 3.16 . . . . 0.0 112.095 174.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -55.52 -26.75 44.7 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 126.247 1.819 . . . . 0.0 112.257 -173.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.6 m -60.4 -34.68 74.28 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 126.428 1.891 . . . . 0.0 111.585 -173.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -57.92 -65.74 0.59 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.098 0.959 . . . . 0.0 108.676 178.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -61.79 -41.43 97.73 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 117.327 -1.32 . . . . 0.0 113.563 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -55.84 -49.62 72.81 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.301 1.041 . . . . 0.0 111.069 -178.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.9 ttp180 -80.92 -30.18 35.39 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.509 0.595 . . . . 0.0 111.062 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -69.3 171.22 8.87 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 173.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.74 112.99 8.3 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 173.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -96.7 176.03 6.15 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 173.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -44.55 -44.83 9.02 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.215 1.406 . . . . 0.0 112.296 174.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.76 -15.86 0.12 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 175.143 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.7 mtp -43.86 -63.47 1.05 Allowed Pre-proline 0 N--CA 1.471 0.623 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 -173.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -65.93 -66.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 121.942 1.762 . . . . 0.0 112.401 -174.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.89 114.22 9.75 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.579 1.152 . . . . 0.0 109.863 -174.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 98.0 mt -119.43 119.91 31.26 Favored Pre-proline 0 N--CA 1.449 -0.476 0 C-N-CA 126.5 1.92 . . . . 0.0 106.379 -175.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.42 156.66 41.17 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.064 1.843 . . . . 0.0 110.174 175.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.2 p -40.61 -42.54 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 127.194 2.198 . . . . 0.0 112.91 175.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -57.45 -36.03 70.89 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 126.455 1.902 . . . . 0.0 113.23 -177.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.0 mm -72.12 112.86 8.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 102.649 -3.093 . . . . 0.0 102.649 173.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -82.42 -40.14 21.64 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 173.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.4 m -146.09 165.95 27.56 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.682 0.793 . . . . 0.0 110.141 -173.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 46.4 mtp -126.11 171.87 10.48 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 127.926 2.49 . . . . 0.0 104.889 173.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -140.23 137.48 34.32 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 173.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -111.26 169.15 8.98 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 173.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.4 m -137.37 130.91 31.33 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -144.41 165.52 27.7 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 121.726 -0.609 . . . . 0.0 110.454 174.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -168.31 155.98 8.16 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.081 173.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.99 -174.04 2.54 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 123.536 1.636 . . . . 0.0 107.55 173.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.645 ' HB1' ' HB3' ' A' ' 10' ' ' GLU 0.257 . . -106.37 131.36 53.67 Favored 'General case' 0 N--CA 1.411 -2.389 1 C-N-CA 131.985 4.114 . . . . 0.0 102.99 174.546 . . . . . . . . 4 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -8.63 -55.66 0.01 OUTLIER Glycine 0 CA--C 1.536 1.348 1 C-N-CA 133.883 5.516 . . . . 0.0 119.429 -173.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -116.95 12.03 14.53 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 121.045 2.423 . . . . 0.0 114.664 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.79 37.52 3.42 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 120.251 3.426 . . . . 0.0 120.251 -172.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -45.13 113.71 0.61 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 123.446 2.839 . . . . 0.0 110.448 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -83.83 134.34 34.71 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.412 1.485 . . . . 0.0 106.992 177.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -83.71 146.32 28.27 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -129.8 160.91 32.02 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 120.212 1.369 . . . . 0.0 110.714 175.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.43 ' O ' HD13 ' A' ' 131' ' ' ILE . 30.6 tt0 -154.48 135.03 13.47 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 173.272 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -85.69 104.06 15.05 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.951 1.3 . . . . 0.0 108.51 -178.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.9 tt -69.24 -54.54 14.24 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 173.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 m -131.1 141.72 50.18 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 123.342 1.544 . . . . 0.0 111.692 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.486 HD22 HG22 ' A' ' 128' ' ' VAL . 0.1 OUTLIER -163.72 92.61 0.7 Allowed 'General case' 0 N--CA 1.448 -0.536 1 N-CA-C 96.011 -5.552 . . . . 0.0 96.011 172.82 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -158.11 146.54 18.88 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.503 -1.373 . . . . 0.0 112.339 -173.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.1 t -78.5 156.92 29.03 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.956 0.502 . . . . 0.0 110.821 174.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.4 mt -121.04 -26.34 5.16 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 116.908 -1.52 . . . . 0.0 112.461 -176.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -81.32 160.18 24.23 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 121.591 1.996 . . . . 0.0 112.038 -177.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.456 ' HE3' ' HA ' ' A' ' 87' ' ' LYS . 0.5 OUTLIER -105.39 -42.57 5.2 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 131.126 3.77 . . . . 0.0 112.556 176.02 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -67.75 -74.16 0.6 Allowed Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 174.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.405 ' HB ' ' HB2' ' A' ' 124' ' ' ALA . 3.5 mp -77.35 26.03 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 129.996 3.319 . . . . 0.0 110.301 -177.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 10.7 ttm -43.55 140.52 1.72 Allowed 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 128.143 2.577 . . . . 0.0 110.031 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -164.69 175.61 9.58 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 130.017 3.327 . . . . 0.0 105.286 -173.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.273 8.2 m-20 -145.46 115.03 4.86 Favored Pre-proline 0 C--N 1.324 -0.526 0 C-N-CA 124.527 1.131 . . . . 0.0 110.07 173.002 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -69.58 149.77 68.46 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 N-CA-C 108.322 -1.453 . . . . 0.0 108.322 173.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 21.8 p -137.13 160.63 38.42 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 125.62 1.568 . . . . 0.0 108.072 -175.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.5 m -126.01 153.82 34.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 C-N-CA 124.014 0.925 . . . . 0.0 109.637 174.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -93.2 25.63 3.23 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.613 1.565 . . . . 0.0 111.702 176.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.8 m -134.93 163.3 52.18 Favored Pre-proline 0 C--O 1.235 0.29 0 C-N-CA 124.85 1.26 . . . . 0.0 108.142 174.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -66.66 162.2 38.24 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 121.087 1.191 . . . . 0.0 109.418 173.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.01 -12.72 40.72 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 124.056 0.942 . . . . 0.0 111.902 178.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -143.29 165.71 26.72 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 120.325 1.421 . . . . 0.0 108.641 173.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 164.53 -162.73 35.69 Favored Glycine 0 C--O 1.228 -0.27 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 178.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 82.0 p -117.97 146.66 43.83 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 173.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 28.2 t -82.44 113.74 46.52 Favored Pre-proline 0 N--CA 1.447 -0.594 0 N-CA-C 102.996 -2.964 . . . . 0.0 102.996 173.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -84.42 153.63 12.18 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.347 2.031 . . . . 0.0 111.626 -173.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -69.73 1.81 3.91 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 120.113 -1.617 . . . . 0.0 113.369 -173.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -115.28 119.18 35.44 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 127.086 2.154 . . . . 0.0 107.585 -173.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -43.02 107.84 0.09 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.732 1.213 . . . . 0.0 109.91 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.1 m -118.13 139.18 51.63 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.5 t -96.75 135.25 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 114.301 -1.318 . . . . 0.0 107.834 -173.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 78.5 t -119.86 103.93 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -71.82 143.24 49.54 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 173.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.7 t -124.86 113.91 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 103.707 -2.701 . . . . 0.0 103.707 173.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -100.77 147.91 18.06 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 125.134 1.349 . . . . 0.0 110.145 -178.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.41 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 9.0 m-85 -131.16 73.54 80.47 Favored Pre-proline 0 C--O 1.242 0.706 0 CA-C-N 118.325 1.063 . . . . 0.0 111.596 -174.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -69.18 129.88 19.03 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.326 2.017 . . . . 0.0 108.239 173.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 5.7 t -105.44 154.2 20.65 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 175.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 7.6 mt -70.95 -12.78 61.73 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.559 0.618 . . . . 0.0 111.363 174.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.53 5.01 5.91 Favored Glycine 0 C--O 1.215 -1.037 0 C-N-CA 128.513 2.959 . . . . 0.0 116.169 173.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -94.64 -31.51 13.81 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 120.695 2.247 . . . . 0.0 114.418 -173.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 51.4 tp60 -96.57 146.9 24.41 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 173.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -94.25 143.07 26.71 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 174.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 141.48 -154.44 24.67 Favored Glycine 0 C--N 1.334 0.465 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 178.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.4 t -131.6 114.12 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 C-N-CA 123.288 0.635 . . . . 0.0 109.358 -177.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.405 ' HB2' ' HB ' ' A' ' 89' ' ' ILE . . . -89.97 168.34 12.1 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 173.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -124.08 156.87 35.8 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.119 0.968 . . . . 0.0 109.651 174.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.41 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 3.9 p90 -145.14 148.53 33.71 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.334 1.053 . . . . 0.0 108.518 173.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -111.78 157.78 20.14 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 126.456 1.902 . . . . 0.0 110.876 -174.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.486 HG22 HD22 ' A' ' 82' ' ' LEU . 89.6 t -141.67 138.32 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.403 1.081 . . . . 0.0 109.311 174.009 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -150.66 118.53 6.22 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 126.97 2.108 . . . . 0.0 105.889 173.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 31.4 t -127.72 123.96 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.65 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -89.88 164.96 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 173.717 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.9 t -144.37 135.35 21.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 -176.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.36 173.99 11.08 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.979 1.312 . . . . 0.0 108.832 -176.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -89.06 175.85 7.23 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 172.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 6.7 t -65.02 -15.13 61.98 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 120.11 -1.619 . . . . 0.0 112.175 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -79.86 -3.22 46.97 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.698 1.599 . . . . 0.0 110.913 175.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 80.54 6.54 89.25 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.073 1.32 . . . . 0.0 112.973 178.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -81.72 119.38 23.78 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 178.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -65.98 143.68 57.23 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.359 1.464 . . . . 0.0 109.241 -176.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -140.32 -37.62 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 125.126 1.371 . . . . 0.0 113.576 -174.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -131.01 149.82 52.44 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 178.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.3 tm0? -148.67 150.02 32.49 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 57.4 m -80.11 113.56 39.52 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 178.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -61.39 140.15 86.4 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 CA-C-N 120.685 1.28 . . . . 0.0 110.59 -173.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -75.57 112.53 12.02 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 -173.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 173.07 -34.49 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 129.874 3.27 . . . . 0.0 108.501 -173.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.44 90.72 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 126.656 1.982 . . . . 0.0 110.521 -174.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.3 mt -126.24 148.58 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 176.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -126.69 164.32 21.57 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 175.166 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -132.83 113.53 13.02 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.223 1.009 . . . . 0.0 108.309 -173.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -101.03 120.33 40.04 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 28.6 m -83.78 116.33 22.65 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 173.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 9.3 m -111.67 163.44 14.11 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 173.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.2 pp -139.35 159.76 41.41 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 174.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -63.67 114.09 3.76 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 127.813 2.445 . . . . 0.0 111.557 -174.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -153.43 157.7 40.32 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 126.054 1.742 . . . . 0.0 109.549 176.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 . . . . . 0 C--O 1.248 0.985 0 C-N-CA 131.612 3.965 . . . . 0.0 105.557 173.661 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.49 ' H2 ' ' CG ' ' A' ' 6' ' ' ASP . . . . . . . . 0 N--CA 1.472 1.062 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.7 m -43.79 113.82 0.57 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.248 1.819 . . . . 0.0 112.573 -160.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -168.99 177.62 4.85 Favored 'General case' 0 CA--C 1.541 0.634 1 C-N-CA 132.667 4.387 . . . . 0.0 104.459 -172.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.9 tmm? -45.22 176.41 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.362 0 CA-C-O 116.807 -1.568 . . . . 0.0 106.924 172.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.5 tt -42.59 112.82 0.39 Allowed 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 121.933 2.151 . . . . 0.0 110.403 -172.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.49 ' CG ' ' H2 ' ' A' ' 1' ' ' GLY . 11.4 t0 -78.55 175.94 9.89 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 131.245 3.818 . . . . 0.0 116.336 -172.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -60.67 112.9 2.19 Favored 'General case' 0 N--CA 1.423 -1.815 0 C-N-CA 128.026 2.53 . . . . 0.0 106.717 174.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.56 176.65 9.23 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 109.531 -3.486 . . . . 0.0 106.468 173.011 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -57.27 158.1 5.73 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 122.137 0.97 . . . . 0.0 109.614 173.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -64.27 176.74 0.97 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.149 1.78 . . . . 0.0 110.435 174.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.2 m -124.96 176.8 6.41 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 120.498 -1.376 . . . . 0.0 112.099 -174.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.8 tt -43.22 123.64 2.99 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.363 2.665 . . . . 0.0 113.458 -173.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.432 ' CD1' ' HA ' ' A' ' 35' ' ' SER . 94.5 m-85 -113.75 141.45 47.26 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 128.414 2.686 . . . . 0.0 108.656 173.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.01 121.94 7.07 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.759 1.623 . . . . 0.0 106.996 -178.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 26.9 p90 -137.89 175.43 9.59 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.595 1.089 . . . . 0.0 110.675 176.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -111.84 134.34 54.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 103.228 -2.879 . . . . 0.0 103.228 173.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -78.96 162.49 25.93 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 123.016 1.389 . . . . 0.0 112.846 -173.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.4 ' HB1' ' HG3' ' A' ' 28' ' ' GLU . . . -78.87 -26.41 43.95 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 113.775 -1.557 . . . . 0.0 112.137 -176.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 10.2 m80 -63.98 -41.96 97.37 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.094 0.957 . . . . 0.0 108.73 -175.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -62.26 -43.99 97.56 Favored 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 123.909 0.884 . . . . 0.0 110.616 177.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.534 ' HA ' HD12 ' A' ' 24' ' ' LEU . . . -60.75 -35.47 76.48 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 118.401 -0.809 . . . . 0.0 111.005 176.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -54.23 -57.71 10.13 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 173.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.4 t -55.24 -24.03 14.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 123.695 0.798 . . . . 0.0 111.618 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.534 HD12 ' HA ' ' A' ' 21' ' ' ALA . 6.5 mt -78.04 -39.79 40.82 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 175.12 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.4 pt -150.0 14.35 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 N-CA-C 117.397 2.369 . . . . 0.0 117.397 -172.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 63.99 0.81 4.51 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 128.296 2.855 . . . . 0.0 114.48 -173.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -101.79 141.24 34.95 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 129.247 3.019 . . . . 0.0 106.289 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.4 ' HG3' ' HB1' ' A' ' 18' ' ' ALA . 19.9 tt0 -126.86 113.78 17.02 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.232 0.924 . . . . 0.0 111.208 -173.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -155.87 137.53 14.21 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 127.809 2.443 . . . . 0.0 105.942 173.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -72.64 175.77 6.09 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.976 2.11 . . . . 0.0 109.644 173.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 66.9 mt -140.81 113.62 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 173.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.55 127.07 34.33 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -176.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.4 mt -102.39 -56.33 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 119.313 0.961 . . . . 0.0 110.665 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.2 t -125.34 131.7 71.97 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -173.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.432 ' HA ' ' CD1' ' A' ' 13' ' ' TYR . 18.8 p -134.49 120.3 19.56 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 174.086 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.433 1.0 OUTLIER 43.63 47.83 6.43 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 122.72 1.248 . . . . 0.0 112.397 -176.377 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.24 11.68 20.97 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 126.165 1.841 . . . . 0.0 114.959 177.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.489 ' HB2' ' HZ3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -74.23 37.31 0.1 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.633 2.373 . . . . 0.0 113.762 -173.308 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 9.4 mmt -38.22 113.49 0.29 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 122.746 1.26 . . . . 0.0 111.981 -173.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.78 170.09 8.19 Favored Pre-proline 0 N--CA 1.448 -0.535 0 C-N-CA 127.734 2.413 . . . . 0.0 109.079 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.0 26.19 0.25 Allowed 'Trans proline' 0 CA--C 1.548 1.212 0 C-N-CA 123.678 2.918 . . . . 0.0 112.09 173.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -53.57 -26.43 21.47 Favored 'General case' 0 C--N 1.345 0.402 0 C-N-CA 126.437 1.895 . . . . 0.0 111.625 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 m -60.49 -29.81 69.31 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 126.099 1.76 . . . . 0.0 110.696 -173.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -60.76 -63.38 1.32 Allowed 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 174.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.672 ' O ' ' HB2' ' A' ' 49' ' ' ALA 0.382 1.0 OUTLIER -65.59 -22.89 66.72 Favored 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 124.835 1.254 . . . . 0.0 113.086 -177.775 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -67.95 -52.99 29.71 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.095 -1.628 . . . . 0.0 107.054 173.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.61 -24.53 58.88 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.928 1.291 . . . . 0.0 112.993 -173.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -122.2 113.17 19.09 Favored 'General case' 0 C--O 1.214 -0.784 0 C-N-CA 129.617 3.167 . . . . 0.0 104.897 174.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.672 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -166.0 176.12 8.01 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 120.532 1.514 . . . . 0.0 111.148 -174.236 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.9 165.23 15.8 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 105.812 -1.922 . . . . 0.0 105.812 173.003 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.65 -19.47 16.44 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 120.347 -1.471 . . . . 0.0 113.413 -174.014 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 -54.52 -11.09 0.49 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.513 2.325 . . . . 0.0 115.528 174.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 7.2 mtp -135.03 -66.05 0.02 OUTLIER Pre-proline 0 N--CA 1.475 0.793 0 CA-C-N 122.219 2.281 . . . . 0.0 115.865 175.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.537 ' CD ' ' HB3' ' A' ' 49' ' ' ALA . 19.9 Cg_endo -61.6 -70.55 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.765 2.31 . . . . 0.0 112.9 -173.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.0 113.56 16.03 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -176.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 94.2 mt -114.31 114.07 45.67 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 126.59 1.956 . . . . 0.0 106.227 -174.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -74.14 158.67 45.21 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 121.86 1.707 . . . . 0.0 110.853 -175.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.6 p -45.45 -38.38 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.428 1.491 . . . . 0.0 112.18 173.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -53.75 -43.1 68.87 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.963 1.705 . . . . 0.0 112.563 176.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.4 mm -81.0 112.93 19.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 103.065 -2.939 . . . . 0.0 103.065 173.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -81.11 -38.45 27.23 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 173.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.3 m -142.74 162.53 35.21 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.891 1.276 . . . . 0.0 111.037 -173.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.9 mmm -116.6 159.22 22.48 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 173.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -109.48 113.16 25.72 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 174.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -100.41 160.21 14.52 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 102.696 -3.075 . . . . 0.0 102.696 172.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.4 m -147.22 136.36 22.45 Favored 'General case' 0 C--N 1.317 -0.84 0 O-C-N 120.086 -1.634 . . . . 0.0 106.976 -177.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -147.62 168.31 22.34 Favored 'General case' 0 C--O 1.246 0.885 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.53 178.151 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -173.56 149.28 1.64 Allowed 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 113.813 -1.54 . . . . 0.0 114.167 175.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -82.71 -173.9 4.91 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 101.977 -3.342 . . . . 0.0 101.977 172.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -110.78 131.26 55.2 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 103.384 -2.821 . . . . 0.0 103.384 173.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 38.15 -93.79 0.01 OUTLIER Glycine 0 CA--C 1.533 1.204 1 C-N-CA 131.196 4.236 . . . . 0.0 116.008 174.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -116.97 25.08 10.76 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.998 2.119 . . . . 0.0 116.079 174.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.8 37.32 0.53 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 128.855 2.862 . . . . 0.0 114.379 174.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.6 mp0 -38.43 113.56 0.3 Allowed 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 121.5 1.955 . . . . 0.0 116.052 -173.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -103.05 137.36 41.33 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 127.096 2.159 . . . . 0.0 106.446 173.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -99.45 151.31 21.26 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -135.69 159.97 39.98 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 119.918 1.235 . . . . 0.0 110.409 174.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.452 ' O ' HD13 ' A' ' 131' ' ' ILE . 28.8 tt0 -153.56 134.98 14.24 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 173.19 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -80.71 103.91 10.88 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.3 tt -64.36 -43.35 94.84 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.058 1.343 . . . . 0.0 107.579 174.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 75.4 m -148.34 149.52 31.94 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.437 1.095 . . . . 0.0 109.335 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.7 tt -169.36 93.21 0.27 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 128.933 2.893 . . . . 0.0 103.289 177.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 44.5 mmm-85 -161.95 162.07 28.9 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.495 1.043 . . . . 0.0 111.669 -174.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.2 t -84.86 161.71 19.79 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 122.271 1.034 . . . . 0.0 111.898 174.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.7 mt -126.43 -0.7 6.92 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 126.108 1.763 . . . . 0.0 113.111 -174.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.469 ' CG ' ' H ' ' A' ' 87' ' ' LYS 0.315 14.6 t70 -98.45 161.82 13.48 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 120.601 1.546 . . . . 0.0 114.591 -175.367 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.469 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER -91.0 -59.24 2.22 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 128.936 2.894 . . . . 0.0 110.2 -177.263 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' A' ' 90' ' ' MET . . . -97.09 -45.01 2.69 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 124.977 1.275 . . . . 0.0 112.648 -173.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.7 mp -81.0 24.47 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 CA-C-O 123.323 1.535 . . . . 0.0 109.566 -178.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.454 ' H ' ' C ' ' A' ' 88' ' ' GLY . 24.4 ttm -43.47 133.27 4.4 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 130.808 3.643 . . . . 0.0 109.479 -179.015 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.261 . . -167.3 176.03 6.96 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 131.382 3.873 . . . . 0.0 105.114 -173.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.283 8.2 m-20 -150.0 136.13 10.52 Favored Pre-proline 0 C--N 1.324 -0.531 0 C-N-CA 124.789 1.236 . . . . 0.0 111.746 172.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -72.99 154.4 52.88 Favored 'Trans proline' 0 N--CA 1.444 -1.394 0 C-N-CA 121.702 1.601 . . . . 0.0 108.476 173.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.2 p -143.88 162.56 35.79 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.626 1.571 . . . . 0.0 108.667 174.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.3 m -126.39 156.25 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 123.73 0.812 . . . . 0.0 112.317 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -74.38 9.23 1.79 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 127.848 2.459 . . . . 0.0 113.584 174.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.4 m -140.68 165.23 31.22 Favored Pre-proline 0 C--N 1.326 -0.421 0 C-N-CA 125.318 1.447 . . . . 0.0 108.84 -178.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -66.57 166.12 23.01 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 121.405 1.403 . . . . 0.0 110.454 173.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.35 -8.99 10.09 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.94 1.296 . . . . 0.0 111.88 175.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -144.56 163.67 33.2 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 120.505 1.502 . . . . 0.0 108.425 173.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.8 -161.28 34.11 Favored Glycine 0 C--O 1.227 -0.342 0 N-CA-C 110.544 -1.023 . . . . 0.0 110.544 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 27.1 p -120.79 148.1 44.45 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.0 t -76.47 113.61 30.61 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -79.86 121.35 4.52 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 121.835 1.69 . . . . 0.0 113.463 -173.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.72 ' H ' ' CD2' ' A' ' 105' ' ' HIS . 1.1 m-70 -63.41 -20.6 65.69 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.329 1.452 . . . . 0.0 111.974 -173.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . 0.274 4.5 mptt -91.88 112.82 24.9 Favored 'General case' 0 N--CA 1.418 -2.046 1 N-CA-C 99.062 -4.422 . . . . 0.0 99.062 176.581 . . . . . . . . 3 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -42.19 117.33 0.96 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.716 1.606 . . . . 0.0 113.003 -173.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 37.4 m -127.33 142.86 51.34 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 123.722 0.639 . . . . 0.0 110.843 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 24.3 t -94.32 116.39 35.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 C-N-CA 125.355 1.462 . . . . 0.0 109.069 -174.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 84.2 t -94.26 103.15 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 103.879 -2.637 . . . . 0.0 103.879 173.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.63 122.59 24.87 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 173.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.5 t -97.63 113.65 32.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 104.307 -2.479 . . . . 0.0 104.307 174.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -100.13 146.37 17.71 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 119.755 1.162 . . . . 0.0 110.377 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.483 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 8.1 m-85 -129.48 73.5 81.54 Favored Pre-proline 0 C--O 1.243 0.74 0 CA-C-N 118.253 1.027 . . . . 0.0 110.097 -174.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.87 127.85 19.53 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.589 2.193 . . . . 0.0 108.802 173.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 6.9 t -105.89 148.47 27.57 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 123.958 0.903 . . . . 0.0 108.908 176.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.6 mt -76.43 -15.7 59.87 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 117.751 0.25 . . . . 0.0 111.31 177.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.1 51.6 57.42 Favored Glycine 0 C--N 1.337 0.605 0 C-N-CA 125.719 1.628 . . . . 0.0 112.092 174.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.418 ' HE3' ' OE2' ' A' ' 157' ' ' GLU 0.297 40.5 mmtm -111.66 -55.44 2.5 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.438 1.119 . . . . 0.0 112.477 -179.061 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 50.4 tp60 -95.68 149.7 21.18 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 173.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -93.48 139.62 30.52 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 176.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.5 -153.55 25.2 Favored Glycine 0 C--N 1.331 0.278 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -176.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.7 t -130.41 114.14 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -175.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -85.94 170.34 12.42 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 173.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -123.95 151.63 43.4 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 173.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.483 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 32.9 p90 -145.55 156.49 43.73 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 174.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -128.14 160.71 31.18 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 126.281 1.832 . . . . 0.0 111.229 -173.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 67.5 t -141.76 139.28 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 O-C-N 125.307 1.629 . . . . 0.0 108.141 173.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -143.22 121.7 12.43 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 128.043 2.537 . . . . 0.0 106.589 174.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.8 t -133.5 124.2 47.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -177.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.661 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -90.52 164.37 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 173.374 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.0 t -145.15 134.45 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 -175.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.13 174.82 10.2 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 124.821 1.249 . . . . 0.0 107.934 -175.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -89.63 176.06 7.02 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 104.535 -2.394 . . . . 0.0 104.535 172.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.2 t -66.67 -4.14 8.16 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 120.239 -1.538 . . . . 0.0 113.709 -177.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -88.27 -15.38 35.95 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 120.608 1.549 . . . . 0.0 110.513 173.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.75 1.18 61.93 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.705 1.145 . . . . 0.0 112.114 -173.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -70.1 115.96 9.91 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 119.564 1.682 . . . . 0.0 108.403 174.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -67.54 143.79 55.95 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.439 1.496 . . . . 0.0 108.883 -176.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -139.3 -36.58 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 124.486 1.114 . . . . 0.0 113.569 -175.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.428 HD13 ' N ' ' A' ' 142' ' ' GLN . 1.6 tm? -136.88 146.97 46.18 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.723 1.609 . . . . 0.0 106.817 -174.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.428 ' N ' HD13 ' A' ' 141' ' ' LEU . 13.3 tm0? -147.84 150.84 34.92 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 121.105 -0.997 . . . . 0.0 108.671 174.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.4 m -88.05 113.62 55.7 Favored Pre-proline 0 CA--C 1.532 0.253 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -66.72 148.88 83.57 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 121.55 1.5 . . . . 0.0 112.346 -173.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -81.16 112.6 18.66 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.488 -173.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.595 7.1 m-80 172.37 -13.96 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.445 1 C-N-CA 138.022 6.529 . . . . 0.0 111.128 173.279 . . . . . . . . 3 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.69 81.44 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.309 1.844 . . . . 0.0 109.158 174.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.5 mt -133.9 147.78 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 127.606 2.362 . . . . 0.0 106.182 -174.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.427 ' CD1' ' CE1' ' A' ' 126' ' ' PHE . 0.9 OUTLIER -132.18 171.03 14.18 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.363 -1.29 . . . . 0.0 107.718 178.128 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -134.25 113.64 12.2 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 -173.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.57 126.51 53.66 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 -173.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 34.1 m -93.6 115.8 28.29 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 -175.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 4.3 m -115.39 166.43 11.88 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 123.818 0.847 . . . . 0.0 110.294 174.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.1 pp -131.92 161.46 33.0 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.862 1.665 . . . . 0.0 107.129 173.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.37 130.34 42.76 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.19 0.996 . . . . 0.0 109.971 177.025 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -157.93 163.06 38.24 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.193 1.797 . . . . 0.0 108.739 175.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.418 ' OE2' ' HE3' ' A' ' 119' ' ' LYS . 2.9 tp10 . . . . . 0 C--O 1.246 0.885 0 C-N-CA 129.527 3.131 . . . . 0.0 104.28 173.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.2 m . . . . . 0 CA--C 1.539 0.537 0 CA-C-O 121.574 0.702 . . . . 0.0 112.066 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.7 tt -45.69 133.38 8.1 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.928 2.891 . . . . 0.0 113.45 -175.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -119.84 138.66 53.25 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.391 1.876 . . . . 0.0 108.618 173.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.27 119.39 6.75 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.921 1.688 . . . . 0.0 106.78 -178.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 17.6 p90 -136.95 157.76 45.99 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 119.607 1.094 . . . . 0.0 110.083 176.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.3 mp -91.83 116.52 33.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 103.119 -2.919 . . . . 0.0 103.119 173.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -79.33 140.07 37.62 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 123.648 1.689 . . . . 0.0 113.762 -173.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.84 -23.85 65.43 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 126.945 2.098 . . . . 0.0 116.006 -173.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 10.9 m80 -56.82 -39.03 73.44 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 43.8 tp60 -66.55 -43.81 84.05 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 123.485 0.714 . . . . 0.0 111.33 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.76 -36.3 71.92 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.704 0.802 . . . . 0.0 111.431 174.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 52.3 ttm-85 . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 173.619 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 . . . . . 0 CA--C 1.536 0.414 0 CA-C-O 118.782 -0.628 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -141.38 113.54 8.01 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.962 1.705 . . . . 0.0 109.458 -175.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -90.3 161.83 15.46 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 173.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.0 mp -140.74 113.53 4.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 173.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.55 119.82 23.05 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.5 mt -91.95 -65.83 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.914 0.886 . . . . 0.0 109.445 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.6 t -115.48 120.37 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 105.809 -1.922 . . . . 0.0 105.809 -173.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.4 p -120.25 120.29 35.66 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 103.844 -2.65 . . . . 0.0 103.844 173.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 45.69 38.95 4.55 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.376 1.471 . . . . 0.0 112.872 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.67 -10.91 1.34 Allowed Glycine 0 CA--C 1.543 1.803 0 O-C-N 120.656 -1.277 . . . . 0.0 114.586 -177.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -80.32 37.53 0.39 Allowed 'General case' 0 C--N 1.324 -0.501 1 C-N-CA 133.915 4.886 . . . . 0.0 110.381 -175.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 45.5 mtm -37.78 129.12 1.16 Allowed 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.426 1.891 . . . . 0.0 113.135 -172.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.35 165.68 16.93 Favored Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 113.92 -1.491 . . . . 0.0 108.456 173.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.52 33.23 0.32 Allowed 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 123.965 3.11 . . . . 0.0 111.259 173.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -54.01 -26.7 27.57 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 127.659 2.383 . . . . 0.0 113.121 -173.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 m -65.38 -32.38 73.98 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.949 1.299 . . . . 0.0 111.565 -173.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -58.81 -60.93 3.06 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -56.88 -40.4 76.14 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 177.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -56.65 -52.07 66.28 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.611 1.165 . . . . 0.0 110.428 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? . . . . . 0 N--CA 1.467 0.387 0 CA-C-N 117.757 0.253 . . . . 0.0 111.652 -175.5 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 78.9 mmm . . . . . 0 N--CA 1.47 0.53 0 N-CA-C 117.601 2.445 . . . . 0.0 117.601 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.9 -69.83 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.754 0 CA-C-N 121.152 1.447 . . . . 0.0 114.039 -173.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.47 114.12 8.28 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.404 1.082 . . . . 0.0 111.74 -173.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 72.5 mt -118.58 133.05 23.59 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 127.731 2.412 . . . . 0.0 106.248 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -83.34 160.22 15.03 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 122.746 2.297 . . . . 0.0 112.076 178.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.5 p -46.47 -41.29 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 125.833 1.653 . . . . 0.0 111.734 173.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -55.87 -36.97 68.18 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 126.224 1.81 . . . . 0.0 112.674 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 mm -78.4 112.86 16.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 103.663 -2.717 . . . . 0.0 103.663 173.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -78.64 -42.08 29.73 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 173.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.1 m -139.71 152.75 46.92 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.198 0.599 . . . . 0.0 111.485 -173.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 15.0 mmm -104.51 171.68 7.2 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 126.43 1.892 . . . . 0.0 106.851 173.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.261 90.2 m-20 -126.51 150.75 48.58 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 173.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -137.02 155.87 49.14 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 102.664 -3.087 . . . . 0.0 102.664 172.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.4 m -140.89 133.97 29.35 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 -175.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -146.99 166.02 28.09 Favored 'General case' 0 C--O 1.24 0.587 0 O-C-N 121.785 -0.572 . . . . 0.0 111.049 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -171.7 161.73 6.11 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 122.223 1.011 . . . . 0.0 112.788 176.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -95.34 -173.74 3.0 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 103.058 -2.942 . . . . 0.0 103.058 172.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.05 144.65 46.45 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 101.476 -3.527 . . . . 0.0 101.476 173.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 12.24 -62.82 0.0 OUTLIER Glycine 0 CA--C 1.542 1.757 1 C-N-CA 134.884 5.992 . . . . 0.0 120.78 -173.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -116.44 -6.69 11.73 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 121.978 2.889 . . . . 0.0 114.22 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.82 37.05 0.41 Allowed 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 119.329 3.085 . . . . 0.0 119.329 -173.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -53.73 114.82 1.69 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 122.826 2.557 . . . . 0.0 110.088 -177.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -83.61 155.52 23.19 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 175.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -104.95 145.45 30.4 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 104.281 -2.489 . . . . 0.0 104.281 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -128.94 162.42 27.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 120.169 1.35 . . . . 0.0 110.675 176.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.448 ' O ' HD13 ' A' ' 131' ' ' ILE . 31.2 tt0 -155.16 134.7 12.6 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 173.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.478 ' CD1' HD23 ' A' ' 82' ' ' LEU . 66.0 m-85 -84.68 103.87 14.16 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.35 1.06 . . . . 0.0 109.762 -175.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.8 tt -69.27 -47.99 63.03 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.132 1.373 . . . . 0.0 109.001 176.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.7 m -130.34 138.22 50.32 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 125.453 1.501 . . . . 0.0 110.837 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.478 HD22 HG22 ' A' ' 128' ' ' VAL . 0.1 OUTLIER -170.29 92.75 0.21 Allowed 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 102.354 -3.202 . . . . 0.0 102.354 172.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -165.27 154.8 12.75 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 119.998 1.272 . . . . 0.0 110.765 -174.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.3 t -77.39 165.57 24.24 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-O 121.878 0.847 . . . . 0.0 110.201 173.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.5 mt -126.34 -5.16 6.62 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 126.005 1.722 . . . . 0.0 112.158 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.574 ' CG ' ' H ' ' A' ' 87' ' ' LYS 0.396 14.1 t70 -89.85 176.2 6.92 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 120.067 1.303 . . . . 0.0 111.701 -176.43 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.574 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 9.0 mtmm -122.62 -48.81 2.03 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 129.37 3.068 . . . . 0.0 111.699 -173.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 90' ' ' MET . . . -94.16 -54.08 1.66 Allowed Glycine 0 CA--C 1.526 0.729 0 C-N-CA 125.026 1.298 . . . . 0.0 111.562 178.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.3 mp -79.37 15.0 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 C-N-CA 126.225 1.81 . . . . 0.0 109.437 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.401 ' H ' ' C ' ' A' ' 88' ' ' GLY . 19.8 ttp -43.5 141.74 1.33 Allowed 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 130.579 3.552 . . . . 0.0 110.584 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -159.83 175.56 12.95 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 130.293 3.437 . . . . 0.0 105.417 -173.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -139.99 113.89 7.68 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 173.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -70.94 146.82 53.86 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 121.734 1.622 . . . . 0.0 109.691 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 23.4 p -132.45 162.4 31.27 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 125.436 1.494 . . . . 0.0 108.833 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.3 m -125.89 154.34 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 C-N-CA 123.882 0.873 . . . . 0.0 110.446 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -84.17 10.57 9.92 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.812 1.645 . . . . 0.0 112.738 -177.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.9 m -141.33 166.26 23.39 Favored Pre-proline 0 C--N 1.326 -0.446 0 C-N-CA 126.43 1.892 . . . . 0.0 108.396 -173.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -66.41 163.04 33.83 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 121.013 1.142 . . . . 0.0 109.756 173.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -64.01 -10.13 19.96 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.337 1.055 . . . . 0.0 112.466 177.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -142.96 163.27 33.24 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.45 1.5 . . . . 0.0 107.657 173.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 166.83 -161.74 35.53 Favored Glycine 0 N--CA 1.461 0.324 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 82.1 p -119.6 154.39 34.01 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 117.944 0.872 . . . . 0.0 110.307 174.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.0 t -95.01 113.35 61.16 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 104.308 -2.479 . . . . 0.0 104.308 173.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -91.01 157.99 3.92 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.819 2.346 . . . . 0.0 114.355 -173.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.41 ' CD2' ' H ' ' A' ' 105' ' ' HIS . 16.3 m-70 -64.56 -19.76 65.83 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 123.087 1.423 . . . . 0.0 110.469 -176.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -79.55 113.78 17.96 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 129.367 3.067 . . . . 0.0 106.485 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.92 109.26 0.3 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.558 1.072 . . . . 0.0 108.295 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.8 m -124.42 138.19 54.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -174.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.5 t -91.29 141.66 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 88.9 t -125.14 103.83 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 127.423 2.289 . . . . 0.0 105.493 176.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -69.65 151.12 46.27 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 173.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.9 t -129.46 113.51 28.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 173.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -96.49 147.14 18.56 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 119.76 1.164 . . . . 0.0 110.701 -174.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.478 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 10.1 m-85 -131.29 73.37 80.3 Favored Pre-proline 0 C--O 1.245 0.853 0 CA-C-N 118.457 1.129 . . . . 0.0 111.048 -174.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.76 119.74 6.71 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.582 2.188 . . . . 0.0 106.887 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 5.6 t -99.45 145.62 27.23 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.3 mt -77.56 -6.76 54.82 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 118.787 -0.625 . . . . 0.0 111.986 -175.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.19 49.14 78.48 Favored Glycine 0 C--N 1.341 0.821 0 C-N-CA 126.379 1.942 . . . . 0.0 113.529 173.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -112.34 -68.53 0.92 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.17 0.985 . . . . 0.0 111.544 -174.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 46.4 tp60 -95.73 153.11 17.9 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 173.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -93.42 146.97 23.36 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 177.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 141.32 -151.84 22.89 Favored Glycine 0 C--N 1.332 0.31 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.0 t -127.62 114.02 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -177.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -85.31 168.73 14.42 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 173.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -122.99 159.37 28.48 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.826 0.851 . . . . 0.0 109.12 173.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.478 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 10.4 p90 -147.13 146.4 29.91 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 173.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -101.32 149.68 23.78 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 126.707 2.003 . . . . 0.0 110.349 -177.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.478 HG22 HD22 ' A' ' 82' ' ' LEU . 72.2 t -144.63 138.66 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 125.901 1.681 . . . . 0.0 107.31 173.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -160.58 129.69 4.87 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 173.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 41.1 t -134.31 138.77 49.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 -173.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.544 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -105.07 165.27 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.2 t -143.47 136.93 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -174.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.21 167.16 22.1 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 124.686 1.194 . . . . 0.0 109.195 -177.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.47 ' C ' HD22 ' A' ' 134' ' ' ASN . 0.1 OUTLIER -83.76 168.79 15.86 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 103.882 -2.636 . . . . 0.0 103.882 172.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.2 t -58.57 -21.19 52.15 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 120.333 1.424 . . . . 0.0 113.876 -174.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -75.01 -9.8 58.88 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.335 -1.478 . . . . 0.0 113.404 174.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 97.72 -2.63 60.47 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.868 1.223 . . . . 0.0 114.576 -175.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -68.8 118.2 11.47 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 120.183 1.991 . . . . 0.0 108.644 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.5 m -67.23 142.14 57.03 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.3 pt -140.64 -38.25 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 124.702 1.201 . . . . 0.0 113.861 -174.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -128.77 143.66 50.98 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 177.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -146.62 130.48 17.14 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 61.8 m -62.73 140.3 97.13 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -81.78 145.23 14.24 Favored 'Trans proline' 0 N--CA 1.443 -1.458 0 CA-C-N 120.258 1.128 . . . . 0.0 109.463 174.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -80.69 112.78 18.38 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -173.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.373 24.0 m-80 172.8 -16.19 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.695 1 C-N-CA 134.006 4.923 . . . . 0.0 112.463 173.663 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.83 97.62 0.08 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 122.166 0.984 . . . . 0.0 110.035 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.1 mm -130.98 138.02 54.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 -176.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.418 ' HB2' ' CE2' ' A' ' 126' ' ' PHE . 0.6 OUTLIER -117.98 170.0 9.19 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 173.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -136.21 113.51 10.69 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.29 1.036 . . . . 0.0 108.347 -173.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.36 122.55 48.05 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -174.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 18.6 m -84.02 118.68 24.21 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 7.7 m -119.26 166.37 13.08 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 123.834 0.854 . . . . 0.0 109.735 174.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.7 pp -131.27 161.77 31.52 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 126.408 1.883 . . . . 0.0 106.359 173.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.7 tm0? -63.85 136.66 57.57 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 174.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -165.32 113.08 0.98 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.194 1.398 . . . . 0.0 107.41 173.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 . . . . . 0 C--O 1.247 0.95 0 C-N-CA 130.284 3.434 . . . . 0.0 104.585 173.846 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 CA--C 1.533 0.313 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.4 tt -43.4 124.06 3.27 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 126.136 1.774 . . . . 0.0 112.36 -176.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -112.25 135.38 53.0 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.295 1.438 . . . . 0.0 108.13 173.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.51 120.67 10.15 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.057 1.743 . . . . 0.0 106.638 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 20.4 p90 -135.62 168.49 19.16 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 118.656 0.662 . . . . 0.0 109.884 175.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.3 mt -102.74 113.83 40.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 103.278 -2.86 . . . . 0.0 103.278 174.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -80.42 149.75 30.03 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.947 1.356 . . . . 0.0 110.567 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.99 -11.55 29.87 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -173.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 45.3 m80 -53.42 -44.74 69.02 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.909 1.232 . . . . 0.0 113.63 -173.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 49.7 tp60 -70.28 -39.96 74.59 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 118.867 -1.133 . . . . 0.0 111.159 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.1 -36.72 78.05 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.065 0.546 . . . . 0.0 111.637 176.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 . . . . . 0 N--CA 1.444 -0.768 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 174.077 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 . . . . . 0 CA--C 1.531 0.226 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -157.38 113.95 2.96 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.688 1.195 . . . . 0.0 111.259 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -95.18 167.7 11.2 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 173.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.4 mp -137.08 113.27 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 104.912 -2.255 . . . . 0.0 104.912 173.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.0 113.96 19.56 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 177.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.4 mt -90.09 -54.41 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.9 t -125.61 113.73 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 -173.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.6 p -110.59 113.81 26.71 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 103.399 -2.815 . . . . 0.0 103.399 173.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.346 1.5 pp20? 46.26 34.13 2.08 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -178.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.73 -6.88 76.29 Favored Glycine 0 CA--C 1.536 1.385 0 O-C-N 120.751 -1.218 . . . . 0.0 114.705 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.3 37.23 0.09 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 130.621 3.568 . . . . 0.0 112.64 -174.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 40.9 mtt -38.09 117.66 0.62 Allowed 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 -173.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.94 164.8 58.04 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 113.885 -1.507 . . . . 0.0 107.851 173.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.72 36.59 0.43 Allowed 'Trans proline' 0 CA--C 1.548 1.206 0 C-N-CA 124.236 3.291 . . . . 0.0 112.024 174.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -53.93 -26.51 25.67 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 127.059 2.144 . . . . 0.0 113.756 -173.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 m -60.06 -33.42 72.04 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.922 1.689 . . . . 0.0 112.218 -173.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -60.72 -53.62 55.25 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.279 0.9 OUTLIER -76.13 -29.97 58.03 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -176.609 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -55.37 -47.45 75.77 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.2 -0.938 . . . . 0.0 108.762 173.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 . . . . . 0 CA--C 1.544 0.723 0 CA-C-O 118.562 -0.732 . . . . 0.0 111.762 175.51 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.468 0.438 0 CA-C-O 116.796 -1.573 . . . . 0.0 114.833 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.22 -70.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.729 1.619 . . . . 0.0 112.644 -173.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.26 113.15 20.49 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -174.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 55.7 mt -104.37 119.48 53.79 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 -175.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -74.21 154.22 46.45 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.319 1.346 . . . . 0.0 109.694 -177.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.0 p -41.68 -42.66 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 126.6 1.96 . . . . 0.0 113.008 177.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -59.2 -40.57 86.2 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 126.084 1.754 . . . . 0.0 112.734 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.1 mm -77.54 112.77 15.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 101.762 -3.422 . . . . 0.0 101.762 173.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -84.18 -28.95 27.01 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.568 -177.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.4 m -147.96 170.72 17.1 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.842 1.257 . . . . 0.0 110.941 -173.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.4 mmm -126.69 162.32 26.05 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 126.418 1.887 . . . . 0.0 106.937 172.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -109.34 146.32 34.57 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 173.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -135.84 153.06 51.61 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 103.082 -2.933 . . . . 0.0 103.082 172.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.1 m -140.36 133.65 29.76 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -176.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -146.07 165.05 30.21 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 121.824 -0.547 . . . . 0.0 111.0 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -167.14 144.72 4.73 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 175.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.24 -179.31 6.15 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 172.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -107.42 85.46 2.13 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.396 1.478 . . . . 0.0 111.582 -174.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.04 -59.5 0.01 OUTLIER Glycine 0 CA--C 1.537 1.426 0 C-N-CA 128.462 2.934 . . . . 0.0 119.322 173.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -116.91 -13.02 10.67 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.926 1.863 . . . . 0.0 112.95 173.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.77 37.24 0.09 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 130.755 3.622 . . . . 0.0 118.984 -173.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -44.79 113.77 0.61 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 122.397 2.362 . . . . 0.0 111.511 -174.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -96.2 120.38 36.38 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 174.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -80.01 149.09 30.86 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -134.38 160.78 36.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 119.735 1.152 . . . . 0.0 111.044 176.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.486 ' O ' HD13 ' A' ' 131' ' ' ILE . 29.9 tt0 -151.61 136.8 17.48 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 173.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.4 ' CD2' HG22 ' A' ' 130' ' ' VAL . 49.6 m-85 -80.09 104.0 10.35 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.104 0.961 . . . . 0.0 110.434 -178.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.8 tt -63.14 -46.71 85.97 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.148 1.379 . . . . 0.0 108.658 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.3 m -130.2 138.97 50.85 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.716 1.206 . . . . 0.0 110.768 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.2 tt -170.28 92.66 0.21 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 103.305 -2.85 . . . . 0.0 103.305 173.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -166.82 153.89 9.02 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.485 0.584 . . . . 0.0 111.544 -174.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.2 t -72.69 163.27 28.35 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 173.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.4 mt -125.96 -20.18 4.64 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 116.661 -1.638 . . . . 0.0 112.691 174.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.416 ' CG ' ' H ' ' A' ' 87' ' ' LYS . 26.5 t0 -84.26 171.14 13.0 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 121.587 1.994 . . . . 0.0 111.526 174.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.416 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER -109.33 -47.57 3.38 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 129.192 2.997 . . . . 0.0 112.711 174.486 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -70.08 -72.52 0.86 Allowed Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 176.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mp -76.85 19.52 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 128.41 2.684 . . . . 0.0 110.228 -175.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 15.3 ttp -43.75 131.21 5.46 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 127.753 2.421 . . . . 0.0 108.968 -177.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.441 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -158.21 114.01 2.72 Favored 'General case' 0 CA--C 1.508 -0.673 0 C-N-CA 126.54 1.936 . . . . 0.0 106.906 -173.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -97.49 134.39 22.61 Favored Pre-proline 0 C--N 1.323 -0.567 0 O-C-N 124.209 0.943 . . . . 0.0 109.726 -173.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.42 154.25 65.25 Favored 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 121.294 1.329 . . . . 0.0 109.054 173.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 21.5 p -139.28 157.07 46.55 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 126.648 1.979 . . . . 0.0 106.736 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.8 m -126.39 153.84 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-N 119.302 0.955 . . . . 0.0 112.861 178.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -72.54 7.73 1.73 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 127.004 2.122 . . . . 0.0 113.521 174.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.8 m -141.08 165.8 26.82 Favored Pre-proline 0 C--N 1.326 -0.414 0 C-N-CA 126.03 1.732 . . . . 0.0 108.295 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -67.57 168.09 19.13 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.377 1.384 . . . . 0.0 111.082 174.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -64.09 -10.98 25.62 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.733 1.213 . . . . 0.0 112.512 175.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -145.37 164.41 31.58 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.539 1.536 . . . . 0.0 107.355 173.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 160.99 -161.68 33.05 Favored Glycine 0 C--O 1.226 -0.37 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 56.5 p -118.59 151.56 37.68 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 173.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 46.5 t -88.17 113.39 54.84 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 175.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -73.79 158.23 46.94 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.093 2.529 . . . . 0.0 112.881 -173.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -65.27 -19.62 66.05 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 -173.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . 0.266 0.0 OUTLIER -116.81 143.69 45.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 118.563 0.62 . . . . 0.0 112.36 174.159 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -43.04 108.19 0.1 Allowed 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 127.052 2.141 . . . . 0.0 110.951 -174.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.2 m -116.41 143.49 45.49 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 175.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.4 t -97.18 119.39 45.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 C-N-CA 124.403 1.081 . . . . 0.0 111.11 -173.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 72.3 t -95.56 103.58 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 173.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.4 120.55 25.12 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 173.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.5 t -93.23 113.55 28.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 103.872 -2.64 . . . . 0.0 103.872 173.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -92.99 151.12 20.28 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.411 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 11.1 m-85 -132.33 73.81 76.78 Favored Pre-proline 0 C--O 1.244 0.792 0 CA-C-N 118.81 1.305 . . . . 0.0 110.821 -176.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -63.05 114.77 2.59 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.707 2.271 . . . . 0.0 109.679 173.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 9.6 t -91.29 151.15 21.01 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 173.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.1 mt -72.11 -11.19 60.63 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 117.862 0.301 . . . . 0.0 111.545 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 54.44 30.4 49.49 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 127.413 2.435 . . . . 0.0 116.506 173.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 43.1 mttt -120.15 -32.05 4.26 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.388 1.594 . . . . 0.0 113.915 176.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 45.7 tp60 -96.65 146.67 24.64 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 173.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -95.4 148.39 22.5 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 174.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.44 -153.8 23.19 Favored Glycine 0 C--N 1.336 0.537 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 176.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.7 t -131.45 118.45 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.761 0.825 . . . . 0.0 108.864 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -93.54 175.27 6.81 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.67 1.188 . . . . 0.0 109.746 173.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -126.15 155.77 41.17 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.538 1.935 . . . . 0.0 106.997 173.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.411 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 48.9 p90 -150.63 155.49 39.48 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.322 1.049 . . . . 0.0 108.913 174.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -113.93 143.71 44.27 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 125.62 1.568 . . . . 0.0 111.131 -174.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 59.0 t -144.65 119.76 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 173.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -146.42 143.03 28.74 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.209 1.404 . . . . 0.0 108.092 177.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.4 HG22 ' CD2' ' A' ' 79' ' ' PHE . 30.0 t -139.16 141.06 36.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 119.392 0.996 . . . . 0.0 109.939 -173.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.54 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -107.3 163.57 5.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 173.588 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.6 t -141.85 138.3 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -173.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.66 173.37 11.78 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.625 1.57 . . . . 0.0 107.786 -177.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 44.5 p-10 -88.12 176.07 7.44 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 172.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.1 t -67.0 -6.59 17.54 Favored 'General case' 0 CA--C 1.553 1.081 0 O-C-N 120.439 -1.413 . . . . 0.0 112.318 -176.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -84.54 -15.94 44.04 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 120.435 -1.416 . . . . 0.0 110.663 173.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.99 4.62 61.38 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.735 1.159 . . . . 0.0 112.547 -173.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -77.08 117.43 18.64 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.827 1.814 . . . . 0.0 108.937 175.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.7 m -64.32 141.87 58.62 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 126.48 1.912 . . . . 0.0 108.88 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -140.01 -39.03 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 124.931 1.293 . . . . 0.0 113.769 -174.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -130.94 142.35 50.35 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 -177.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -148.59 124.5 10.62 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -176.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 25.1 m -64.1 140.48 97.91 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 174.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.47 141.28 13.97 Favored 'Trans proline' 0 N--CA 1.441 -1.585 0 CA-C-N 119.997 1.035 . . . . 0.0 109.993 177.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 28.2 mp0 -80.4 112.63 17.92 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 -173.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.343 38.5 m-80 172.65 -16.53 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 1 C-N-CA 132.201 4.201 . . . . 0.0 111.311 173.405 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -56.22 98.2 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.024 1.73 . . . . 0.0 110.13 177.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 2.8 mt -135.69 147.22 28.68 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 -174.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -129.08 175.56 8.6 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 173.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -133.23 139.58 47.05 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 -175.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -124.1 122.35 37.61 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 177.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 34.5 m -83.64 118.45 23.85 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 174.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 4.9 m -117.78 166.12 12.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.442 0.639 . . . . 0.0 110.08 173.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.4 pp -138.6 159.7 41.45 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.96 1.704 . . . . 0.0 106.893 173.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.63 127.63 33.45 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.751 0.82 . . . . 0.0 110.302 175.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -147.95 114.32 5.92 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.026 0.93 . . . . 0.0 111.057 176.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 . . . . . 0 C--O 1.256 1.442 0 C-N-CA 129.324 3.049 . . . . 0.0 105.406 173.53 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 CA--C 1.536 0.422 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.423 HD22 HG11 ' A' ' 34' ' ' VAL . 3.1 tt -42.96 129.14 4.41 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 128.066 2.546 . . . . 0.0 113.758 -173.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -117.55 144.6 44.96 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.174 1.79 . . . . 0.0 108.63 173.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.27 123.2 7.51 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.325 1.85 . . . . 0.0 106.615 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 25.7 p90 -141.27 160.93 39.09 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.737 1.153 . . . . 0.0 110.188 178.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -96.13 144.73 9.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 104.509 -2.404 . . . . 0.0 104.509 173.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -97.61 162.74 13.15 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -173.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.9 -18.13 54.39 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 126.114 1.766 . . . . 0.0 114.367 174.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -59.47 -41.13 89.04 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 119.747 1.158 . . . . 0.0 108.978 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 -66.68 -43.49 84.32 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.49 -31.82 73.08 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 121.965 -0.459 . . . . 0.0 111.83 174.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.4 ttm105 . . . . . 0 N--CA 1.445 -0.724 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 173.438 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 . . . . . 0 CA--C 1.533 0.321 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.261 98.7 mt-10 -159.77 112.72 2.16 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.877 1.217 . . . . 0.0 112.994 173.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -97.01 162.6 13.31 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 172.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.9 mp -141.39 113.43 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 173.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.03 119.87 23.43 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.443 HG23 ' CE2' ' A' ' 42' ' ' PHE . 17.8 mt -96.14 -58.44 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 119.024 0.829 . . . . 0.0 109.789 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.423 HG11 HD22 ' A' ' 12' ' ' LEU . 4.0 t -126.48 142.95 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 126.396 1.878 . . . . 0.0 109.069 -173.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.9 p -153.02 135.2 14.89 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 102.318 -3.215 . . . . 0.0 102.318 173.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 44.46 33.91 0.98 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.882 1.273 . . . . 0.0 113.167 -174.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.33 -2.99 8.57 Favored Glycine 0 CA--C 1.541 1.718 0 O-C-N 120.246 -1.534 . . . . 0.0 115.399 -177.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -64.86 37.63 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.512 1 C-N-CA 132.204 4.202 . . . . 0.0 115.076 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.5 mmt -37.82 113.75 0.3 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.376 1.471 . . . . 0.0 110.397 -173.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.32 168.1 15.38 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 125.764 1.626 . . . . 0.0 111.54 -174.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.77 16.73 0.5 Allowed 'Trans proline' 0 CA--C 1.548 1.216 0 C-N-CA 123.474 2.782 . . . . 0.0 111.558 173.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.443 ' CE2' HG23 ' A' ' 33' ' ' ILE . 25.6 p90 -53.43 -26.48 20.16 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 127.031 2.133 . . . . 0.0 112.158 -175.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 m -57.2 -30.95 64.98 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 126.889 2.075 . . . . 0.0 111.293 -173.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 64.8 t60 -63.02 -54.72 33.84 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.294 0.497 . . . . 0.0 110.482 178.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.305 0.9 OUTLIER -76.16 -24.63 54.83 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -178.579 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -61.12 -44.16 97.76 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 173.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 . . . . . 0 C--N 1.343 0.295 0 C-N-CA 123.387 0.675 . . . . 0.0 111.135 174.607 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.47 0 CA-C-O 117.292 -1.337 . . . . 0.0 113.394 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -74.4 -68.31 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 CA-C-N 121.11 1.432 . . . . 0.0 110.732 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.64 119.72 15.2 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.164 0.985 . . . . 0.0 110.187 -174.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.9 mt -124.81 129.93 24.42 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 127.494 2.318 . . . . 0.0 106.312 -177.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -77.76 156.82 31.47 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.124 1.882 . . . . 0.0 111.506 176.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.1 p -41.16 -43.91 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 127.697 2.399 . . . . 0.0 112.932 176.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -59.69 -34.05 72.38 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 126.328 1.851 . . . . 0.0 113.44 -175.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.9 mm -70.02 113.05 5.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 178.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -81.32 -29.07 34.3 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.184 0.594 . . . . 0.0 110.43 178.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.4 m -159.47 165.41 33.12 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.068 0.947 . . . . 0.0 109.08 -175.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 68.8 mtp -125.64 160.27 30.1 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 173.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 -111.21 134.33 52.88 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 124.564 1.145 . . . . 0.0 108.898 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -120.5 165.62 14.72 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 103.189 -2.893 . . . . 0.0 103.189 172.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.1 m -149.17 137.55 20.89 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 120.318 -1.489 . . . . 0.0 108.109 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -148.32 165.6 30.54 Favored 'General case' 0 C--O 1.24 0.597 0 O-C-N 121.801 -0.562 . . . . 0.0 111.167 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' A' ' 104' ' ' PRO . 1.3 pp0? -162.2 145.35 11.66 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 174.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -91.8 140.46 29.66 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 173.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.43 78.26 0.17 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 -173.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.87 -73.14 0.12 Allowed Glycine 0 CA--C 1.53 1.025 0 C-N-CA 126.876 2.179 . . . . 0.0 117.517 173.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.489 ' HA ' HE21 ' A' ' 72' ' ' GLN . 0.0 OUTLIER -116.97 26.34 9.87 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.473 1.636 . . . . 0.0 112.276 173.835 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -102.38 37.09 1.97 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.41 2.284 . . . . 0.0 111.168 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -38.81 113.36 0.3 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.98 1.312 . . . . 0.0 112.203 -173.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -114.22 119.97 38.86 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 175.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -84.38 152.5 24.02 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -134.56 160.71 37.22 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.809 1.186 . . . . 0.0 110.675 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.44 ' O ' HD13 ' A' ' 131' ' ' ILE . 30.1 tt0 -154.11 135.07 13.83 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 173.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.425 ' CD2' HG22 ' A' ' 130' ' ' VAL . 69.2 m-85 -80.6 103.63 10.58 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.3 tt -61.43 -40.85 95.96 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 173.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 m -155.89 145.44 21.01 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 120.896 -1.128 . . . . 0.0 112.502 177.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.465 ' H ' ' HD3' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -153.25 93.53 1.72 Allowed 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 173.339 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.465 ' HD3' ' H ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -156.41 161.57 40.09 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 121.081 1.764 . . . . 0.0 111.52 -177.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 27.4 t -81.57 162.9 22.96 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.419 0.628 . . . . 0.0 109.375 173.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 74.7 mt -116.38 -14.96 10.99 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.054 1.741 . . . . 0.0 110.864 174.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -96.32 164.27 12.72 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 175.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.9 mmtm -138.55 -32.38 0.7 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.259 1.824 . . . . 0.0 113.263 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -64.36 -63.67 4.15 Favored Glycine 0 CA--C 1.54 1.648 0 N-CA-C 106.787 -2.525 . . . . 0.0 106.787 172.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.444 HD12 ' H ' ' A' ' 89' ' ' ILE . 4.8 mp -76.81 21.77 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 129.473 3.109 . . . . 0.0 110.219 175.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 3.5 ttp -43.2 132.85 4.16 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 125.579 2.609 . . . . 0.0 113.56 -173.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -149.01 150.87 33.55 Favored 'General case' 0 N--CA 1.421 -1.91 2 C-N-CA 135.317 5.447 . . . . 0.0 100.939 173.583 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -139.74 113.85 7.85 Favored Pre-proline 0 C--N 1.315 -0.899 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 173.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -67.68 157.4 61.94 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.962 2.441 . . . . 0.0 113.096 -173.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 39.1 p -136.94 170.11 16.65 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.464 1.506 . . . . 0.0 109.395 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.2 m -126.26 155.65 36.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 124.612 1.165 . . . . 0.0 108.322 173.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -101.6 35.32 2.34 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.024 1.329 . . . . 0.0 110.24 174.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.9 m -139.91 162.11 52.37 Favored Pre-proline 0 C--O 1.236 0.39 0 C-N-CA 127.057 2.143 . . . . 0.0 106.14 173.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -68.74 159.0 55.52 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 N-CA-C 109.213 -1.11 . . . . 0.0 109.213 173.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.38 -11.09 29.22 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 124.194 0.998 . . . . 0.0 112.014 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -141.64 163.68 32.26 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.376 1.47 . . . . 0.0 107.79 173.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 166.61 -161.74 35.47 Favored Glycine 0 C--O 1.226 -0.385 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -177.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.2 p -125.28 144.67 50.36 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.5 t -74.25 117.3 60.59 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 105.0 -2.222 . . . . 0.0 105.0 175.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.411 ' O ' ' HA ' ' A' ' 68' ' ' GLN . 89.3 Cg_endo -74.51 160.53 41.41 Favored 'Trans proline' 0 C--O 1.213 -0.751 0 C-N-CA 121.974 1.782 . . . . 0.0 115.231 -173.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . 0.304 93.0 m-70 -75.05 -14.65 60.62 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 118.114 2.635 . . . . 0.0 118.114 -172.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.96 151.68 36.18 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 173.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -49.05 108.7 0.2 Allowed 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 125.438 1.495 . . . . 0.0 109.025 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 21.1 m -123.89 138.89 54.41 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.8 t -80.05 152.34 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -174.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 86.8 t -129.9 109.85 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 174.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -82.16 135.26 35.31 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 174.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.5 t -116.41 116.58 52.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 173.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -94.43 149.78 19.52 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 125.665 1.603 . . . . 0.0 111.236 -178.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.466 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 4.8 m-85 -133.79 73.8 70.92 Favored Pre-proline 0 C--O 1.242 0.672 0 CA-C-N 118.037 0.919 . . . . 0.0 110.785 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.29 123.06 9.57 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.747 1.631 . . . . 0.0 108.068 173.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 5.7 t -105.27 152.53 22.77 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 173.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.7 mt -79.25 -10.48 59.82 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.558 0.617 . . . . 0.0 112.118 -174.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.03 32.47 66.85 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 125.534 1.54 . . . . 0.0 115.499 173.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.6 mttt -122.92 -29.38 3.95 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.546 1.673 . . . . 0.0 113.857 176.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -96.71 160.08 14.57 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 173.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -114.56 148.03 38.59 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 176.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 141.19 -155.97 25.37 Favored Glycine 0 C--N 1.333 0.404 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 176.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.3 t -125.33 113.68 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.75 164.43 15.97 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 173.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -121.93 158.13 29.72 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 121.422 -0.799 . . . . 0.0 110.459 174.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.466 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 24.0 p90 -153.2 161.47 42.39 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 124.21 1.004 . . . . 0.0 109.274 173.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -140.35 159.81 41.37 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 124.543 1.137 . . . . 0.0 111.839 -173.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 77.6 t -133.05 136.35 55.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 127.702 2.401 . . . . 0.0 107.575 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -145.18 122.54 11.61 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 173.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.425 HG22 ' CD2' ' A' ' 79' ' ' PHE . 21.4 t -135.52 131.56 51.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 -176.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.609 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -97.83 164.86 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 173.462 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.8 t -144.03 134.49 21.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 -175.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.48 173.9 11.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.282 -1.326 . . . . 0.0 108.55 -175.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -86.32 176.11 8.08 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 105.142 -2.169 . . . . 0.0 105.142 172.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.2 t -58.75 -31.38 68.29 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.846 -1.158 . . . . 0.0 112.216 -173.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -81.22 -4.15 54.59 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.39 -0.819 . . . . 0.0 112.581 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.81 7.0 57.92 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.218 0.914 . . . . 0.0 113.976 175.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -70.32 114.97 8.97 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.762 1.781 . . . . 0.0 108.688 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -69.52 141.89 53.78 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.641 0.776 . . . . 0.0 108.953 -176.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.08 -38.39 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 124.687 1.195 . . . . 0.0 113.475 -174.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -134.02 146.86 50.78 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 16.2 tm0? -148.42 153.98 39.27 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.278 1.031 . . . . 0.0 108.758 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 36.3 m -83.52 114.18 51.76 Favored Pre-proline 0 CA--C 1.529 0.162 0 C-N-CA 125.044 1.338 . . . . 0.0 108.535 -176.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -61.95 143.53 95.48 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 CA-C-N 120.294 1.141 . . . . 0.0 110.08 -173.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -81.49 112.52 18.81 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.913 -173.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.624 30.0 m-80 172.4 -11.48 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 1 C-N-CA 135.992 5.717 . . . . 0.0 112.694 173.169 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.38 75.08 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.021 2.128 . . . . 0.0 110.7 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -118.8 145.47 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 128.061 2.545 . . . . 0.0 105.434 178.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -126.91 169.34 13.38 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 174.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -136.93 113.42 10.09 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.524 1.13 . . . . 0.0 108.197 -173.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 49.0 tttt -99.29 123.3 43.45 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 31.1 m -83.47 116.7 22.65 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 173.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 25.5 m -114.49 164.99 13.22 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.5 pp -142.82 160.05 41.06 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.975 1.31 . . . . 0.0 108.191 174.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.12 127.32 32.42 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.528 1.131 . . . . 0.0 110.433 175.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -155.55 116.44 3.88 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.673 1.189 . . . . 0.0 110.807 175.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 . . . . . 0 C--O 1.247 0.974 0 C-N-CA 128.963 2.905 . . . . 0.0 105.445 173.55 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 CA--C 1.541 0.617 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.7 tt -42.85 129.32 4.31 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 128.328 2.651 . . . . 0.0 113.876 -173.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -117.17 142.14 47.4 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.187 2.195 . . . . 0.0 109.243 173.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.75 117.59 5.85 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.424 1.89 . . . . 0.0 106.652 -177.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 18.4 p90 -138.13 143.31 40.28 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.734 1.152 . . . . 0.0 109.337 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.9 mp -83.91 113.7 23.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 104.856 -2.276 . . . . 0.0 104.856 176.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -78.66 151.23 32.35 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 122.707 1.241 . . . . 0.0 111.118 -176.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.15 -9.76 49.07 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 127.216 2.206 . . . . 0.0 115.619 -173.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -54.48 -38.62 66.62 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 119.7 1.136 . . . . 0.0 112.952 -173.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 49.5 tp60 -73.84 -40.3 63.39 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.809 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.35 -39.08 78.56 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.516 1.126 . . . . 0.0 110.885 173.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 . . . . . 0 N--CA 1.448 -0.575 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 175.852 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -148.9 113.22 5.25 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 174.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -95.43 154.89 16.98 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 102.706 -3.072 . . . . 0.0 102.706 172.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.3 mm -135.31 113.31 15.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 104.535 -2.394 . . . . 0.0 104.535 173.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.03 114.28 19.79 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 -176.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.435 HG23 ' CD1' ' A' ' 42' ' ' PHE . 10.9 mt -87.49 -61.53 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.1 t -125.72 142.11 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 125.533 1.533 . . . . 0.0 108.974 -173.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.0 p -149.81 124.29 9.66 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 102.921 -2.992 . . . . 0.0 102.921 173.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 44.34 33.95 0.96 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.697 1.599 . . . . 0.0 113.582 -174.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.96 -5.95 4.26 Favored Glycine 0 CA--C 1.544 1.852 0 O-C-N 120.663 -1.273 . . . . 0.0 114.932 -176.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -75.73 37.61 0.15 Allowed 'General case' 0 N--CA 1.468 0.442 1 C-N-CA 133.248 4.619 . . . . 0.0 111.114 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 30.7 mtp -37.84 131.92 0.98 Allowed 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.886 1.674 . . . . 0.0 114.531 -172.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.03 162.26 69.94 Favored Pre-proline 0 N--CA 1.448 -0.552 0 CA-C-N 113.746 -1.57 . . . . 0.0 107.945 173.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.79 39.6 0.58 Allowed 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 124.172 3.248 . . . . 0.0 111.421 174.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.435 ' CD1' HG23 ' A' ' 33' ' ' ILE . 11.8 p90 -55.07 -26.55 38.49 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.695 1.998 . . . . 0.0 112.142 -173.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.6 m -60.73 -27.92 68.29 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.89 1.676 . . . . 0.0 110.786 -174.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -57.23 -65.74 0.57 Allowed 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.663 1.185 . . . . 0.0 109.713 174.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.91 -24.36 62.45 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -178.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -65.82 -50.12 65.75 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.611 0.641 . . . . 0.0 110.338 174.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? . . . . . 0 CA--C 1.541 0.601 0 O-C-N 121.453 -0.78 . . . . 0.0 109.393 -176.332 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.537 0 CA-C-O 116.98 -1.486 . . . . 0.0 115.008 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -83.68 -65.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.805 0 CA-C-N 122.0 1.75 . . . . 0.0 112.023 -174.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.26 120.5 16.03 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.094 1.358 . . . . 0.0 110.593 -173.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.3 mt -129.4 129.6 23.26 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 126.461 1.904 . . . . 0.0 106.215 -175.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -78.89 158.5 27.54 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.271 1.981 . . . . 0.0 111.393 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.4 p -41.64 -49.1 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 126.408 1.883 . . . . 0.0 112.068 174.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -59.17 -40.26 85.09 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 126.638 1.975 . . . . 0.0 113.024 -176.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.4 mm -73.18 112.76 9.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 102.256 -3.239 . . . . 0.0 102.256 174.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -81.22 -36.78 29.62 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 114.664 -1.153 . . . . 0.0 108.922 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.8 m -141.84 168.62 19.33 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 123.883 0.739 . . . . 0.0 111.968 -173.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 70.8 mtp -126.81 155.57 42.65 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 172.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 46.6 m-20 -107.22 149.29 27.89 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 174.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -135.15 155.07 51.32 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 129.788 3.235 . . . . 0.0 103.015 172.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.5 m -140.71 134.2 29.99 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 -177.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -146.82 165.03 30.94 Favored 'General case' 0 C--O 1.239 0.528 0 O-C-N 121.803 -0.561 . . . . 0.0 110.952 176.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.22 163.43 5.81 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.736 1.215 . . . . 0.0 111.169 174.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.1 170.63 7.8 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 173.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.08 101.84 13.43 Favored 'General case' 0 N--CA 1.445 -0.708 0 O-C-N 119.966 -1.709 . . . . 0.0 109.099 -174.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 44.58 -48.73 0.0 OUTLIER Glycine 0 CA--C 1.54 1.637 1 C-N-CA 133.14 5.162 . . . . 0.0 121.032 174.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -116.92 -18.99 10.01 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 121.85 2.825 . . . . 0.0 115.78 174.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.48 37.1 0.56 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 128.185 2.594 . . . . 0.0 117.908 -173.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -48.99 114.11 0.93 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 122.53 2.423 . . . . 0.0 110.283 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -83.65 153.14 24.41 Favored 'General case' 0 C--N 1.335 -0.029 0 C-N-CA 125.376 1.47 . . . . 0.0 107.857 174.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -97.46 151.02 20.41 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -133.98 159.88 39.42 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.905 1.229 . . . . 0.0 110.616 174.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.418 ' O ' HD13 ' A' ' 131' ' ' ILE . 28.0 tt0 -156.16 141.55 17.6 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 173.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -91.75 103.66 16.2 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.309 1.043 . . . . 0.0 108.899 -174.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.7 tt -73.26 -44.09 59.94 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.154 1.382 . . . . 0.0 108.104 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.2 m -136.83 137.35 39.65 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.237 1.415 . . . . 0.0 110.218 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -170.3 92.94 0.21 Allowed 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 102.022 -3.325 . . . . 0.0 102.022 173.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -162.29 152.44 16.66 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 118.647 -0.692 . . . . 0.0 111.41 -174.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.5 t -69.85 167.71 16.72 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 122.326 1.06 . . . . 0.0 112.511 173.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.9 mt -126.51 -9.61 6.27 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 126.593 1.957 . . . . 0.0 113.37 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.519 ' CG ' ' H ' ' A' ' 87' ' ' LYS 0.348 14.4 t70 -101.53 162.22 13.06 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 121.625 2.011 . . . . 0.0 113.665 -175.489 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.519 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 0.7 OUTLIER -106.32 -48.76 3.5 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 129.476 3.11 . . . . 0.0 112.293 -173.286 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.411 ' C ' ' H ' ' A' ' 90' ' ' MET . . . -94.05 -49.7 2.4 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 124.865 1.222 . . . . 0.0 111.754 -177.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 mt -81.31 17.56 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 126.052 1.741 . . . . 0.0 109.179 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.411 ' H ' ' C ' ' A' ' 88' ' ' GLY . 14.4 ttp -43.49 130.64 5.12 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 130.215 3.406 . . . . 0.0 109.77 -177.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.255 . . -162.47 166.67 24.63 Favored 'General case' 0 N--CA 1.441 -0.908 1 C-N-CA 133.179 4.591 . . . . 0.0 104.351 -173.578 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -141.88 145.54 36.98 Favored Pre-proline 0 N--CA 1.473 0.678 0 CA-C-N 118.923 0.783 . . . . 0.0 110.453 173.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -77.61 145.74 23.51 Favored 'Trans proline' 0 N--CA 1.443 -1.454 0 C-N-CA 121.532 1.488 . . . . 0.0 109.352 173.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 23.8 p -129.14 153.93 47.21 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 126.047 1.739 . . . . 0.0 107.353 176.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.2 m -126.06 150.37 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 119.382 0.992 . . . . 0.0 111.579 -174.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -80.52 9.08 6.46 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.432 1.893 . . . . 0.0 113.552 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.6 m -143.38 163.45 36.93 Favored Pre-proline 0 C--N 1.327 -0.381 0 C-N-CA 124.97 1.308 . . . . 0.0 109.06 -177.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -66.2 162.16 37.1 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.334 1.356 . . . . 0.0 109.339 173.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -66.44 -12.0 54.91 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.119 0.968 . . . . 0.0 112.035 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -140.81 163.49 32.78 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.155 1.382 . . . . 0.0 107.796 173.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.24 -160.83 33.46 Favored Glycine 0 C--O 1.227 -0.341 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 72.1 p -119.14 147.93 43.64 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 174.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.1 t -81.31 113.4 41.23 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 100.983 -3.71 . . . . 0.0 100.983 173.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -92.29 167.4 2.91 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.28 1.986 . . . . 0.0 116.837 -172.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -75.94 10.46 1.86 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.688 1.195 . . . . 0.0 114.167 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.93 122.49 45.46 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 176.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.26 105.25 0.14 Allowed 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 174.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.0 m -114.27 136.56 52.83 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -174.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 26.6 t -95.13 114.97 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -174.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 78.7 t -93.69 103.36 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 N-CA-C 103.514 -2.772 . . . . 0.0 103.514 173.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -85.19 140.85 30.58 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 173.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.5 t -115.61 113.83 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 104.108 -2.553 . . . . 0.0 104.108 174.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -95.76 150.4 19.64 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 125.525 1.536 . . . . 0.0 109.919 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.468 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 7.9 m-85 -130.0 73.5 81.34 Favored Pre-proline 0 C--O 1.243 0.721 0 CA-C-N 118.478 1.139 . . . . 0.0 110.366 -173.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.16 121.96 9.78 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.351 2.034 . . . . 0.0 107.898 173.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 8.7 t -103.67 149.85 24.57 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 175.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.1 mt -81.58 -8.02 59.66 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 118.752 -0.642 . . . . 0.0 111.332 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.2 49.19 78.04 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 126.312 1.91 . . . . 0.0 113.323 173.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -112.47 -75.69 0.6 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.116 0.958 . . . . 0.0 111.152 -173.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 51.2 tp60 -83.08 152.19 25.45 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 173.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -93.47 142.6 27.15 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 178.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.52 -154.68 25.94 Favored Glycine 0 C--N 1.331 0.294 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -177.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.3 t -128.14 113.78 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -86.63 169.57 12.61 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 173.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -132.19 162.22 31.46 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.14 0.576 . . . . 0.0 109.818 175.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.468 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 20.2 p90 -144.91 147.15 32.42 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 173.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -104.21 144.75 31.18 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 127.437 2.295 . . . . 0.0 109.474 -174.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 43.7 t -137.43 143.43 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 123.605 0.762 . . . . 0.0 110.02 173.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -157.5 119.4 3.74 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 128.454 2.702 . . . . 0.0 105.616 174.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.439 ' H ' ' HB ' ' A' ' 143' ' ' THR . 61.6 t -130.33 121.81 52.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.625 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -85.77 167.18 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-O 123.018 1.389 . . . . 0.0 107.501 173.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.1 t -143.24 132.64 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 C-N-CA 127.448 2.299 . . . . 0.0 105.829 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.15 174.84 10.1 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.448 1.099 . . . . 0.0 108.596 -176.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -88.98 176.09 7.15 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 172.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.7 t -67.55 -3.57 9.15 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 120.499 -1.376 . . . . 0.0 113.58 -176.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -91.36 -12.76 33.97 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 120.364 1.438 . . . . 0.0 110.581 173.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 93.26 -0.77 69.02 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.557 1.075 . . . . 0.0 111.926 -173.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 59.9 m-20 -67.73 115.42 7.27 Favored 'General case' 0 C--N 1.343 0.306 0 CA-C-N 119.427 1.613 . . . . 0.0 108.005 174.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -71.5 147.3 47.89 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.415 1.486 . . . . 0.0 109.386 -174.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.48 -33.87 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.453 HD13 ' N ' ' A' ' 142' ' ' GLN . 1.5 tm? -136.83 147.45 46.56 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -173.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.453 ' N ' HD13 ' A' ' 141' ' ' LEU . 6.2 tm0? -148.81 150.12 32.5 Favored 'General case' 0 N--CA 1.462 0.129 0 O-C-N 121.378 -0.826 . . . . 0.0 109.309 177.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.439 ' HB ' ' H ' ' A' ' 130' ' ' VAL . 24.1 m -82.29 113.75 46.23 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 175.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -64.86 146.43 88.03 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 121.62 1.547 . . . . 0.0 112.21 -173.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -77.72 112.55 14.68 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.303 19.5 m-80 172.71 -17.2 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 1 C-N-CA 137.773 6.429 . . . . 0.0 109.553 173.936 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.6 82.57 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.062 1.745 . . . . 0.0 109.627 174.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.2 mm -121.72 136.03 59.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 176.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.417 ' HB2' ' CE2' ' A' ' 126' ' ' PHE . 6.5 m-85 -112.85 163.51 14.53 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 174.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -138.32 113.4 9.28 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.022 1.329 . . . . 0.0 108.395 -173.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.33 121.43 44.37 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -174.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 23.1 m -84.53 115.59 22.67 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 126.042 1.737 . . . . 0.0 106.726 -175.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 4.2 m -113.98 166.35 11.69 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.185 0.902 . . . . 0.0 109.425 173.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.9 pp -134.22 162.31 32.5 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.626 1.57 . . . . 0.0 106.914 173.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.5 120.34 11.51 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 123.982 0.913 . . . . 0.0 109.907 175.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -163.93 114.17 1.28 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.063 1.345 . . . . 0.0 109.841 176.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 . . . . . 0 C--O 1.256 1.431 0 C-N-CA 128.936 2.894 . . . . 0.0 105.546 173.786 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . 0.295 4.5 m . . . . . 0 CA--C 1.541 0.606 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.9 tt -65.26 137.69 57.73 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 130.302 3.441 . . . . 0.0 112.018 -176.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.41 ' CD2' ' HA ' ' A' ' 35' ' ' SER . 88.3 m-85 -126.91 138.38 53.29 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.257 2.223 . . . . 0.0 108.342 173.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.11 118.72 6.53 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 -175.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 14.2 p90 -135.6 175.45 9.58 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.707 1.203 . . . . 0.0 110.574 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.421 HD11 HD11 ' A' ' 33' ' ' ILE . 1.6 mp -114.22 141.19 31.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 103.52 -2.77 . . . . 0.0 103.52 173.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -93.11 158.73 15.62 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -173.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.34 -15.13 59.03 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 113.122 -1.854 . . . . 0.0 113.497 177.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -61.02 -43.31 99.08 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 119.795 1.18 . . . . 0.0 108.428 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -66.55 -49.56 66.04 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 122.83 0.452 . . . . 0.0 111.143 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.17 -35.31 67.07 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.468 0.707 . . . . 0.0 111.785 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.403 HH21 ' CD ' ' A' ' 28' ' ' GLU . 26.9 ttm105 . . . . . 0 N--CA 1.443 -0.819 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 175.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.403 ' CD ' HH21 ' A' ' 22' ' ' ARG . 16.6 tp10 . . . . . 0 CA--C 1.532 0.263 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -155.91 113.49 3.29 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.737 0.815 . . . . 0.0 112.344 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -96.04 159.34 15.01 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 103.002 -2.962 . . . . 0.0 103.002 172.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 84.2 mt -134.39 113.4 17.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 174.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.05 114.25 23.5 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -174.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.421 HD11 HD11 ' A' ' 16' ' ' ILE . 13.6 mt -89.05 -62.84 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.614 0.766 . . . . 0.0 109.355 -179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.515 HG22 ' HG2' ' A' ' 39' ' ' MET . 19.7 t -116.0 128.87 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 126.147 1.779 . . . . 0.0 107.725 -173.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.41 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 54.5 p -132.02 124.51 29.43 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 102.643 -3.095 . . . . 0.0 102.643 173.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.265 1.7 pm0 44.07 40.77 3.64 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.417 1.487 . . . . 0.0 112.863 -175.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.01 -31.76 1.08 Allowed Glycine 0 CA--C 1.542 1.724 0 C-N-CA 126.268 1.89 . . . . 0.0 114.916 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . 0.462 8.8 tmtt? -54.31 37.66 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.835 1 C-N-CA 137.85 6.46 . . . . 0.0 116.126 174.966 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.515 ' HG2' HG22 ' A' ' 34' ' ' VAL . 42.5 mtt -38.01 142.73 0.15 Allowed 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.215 1.806 . . . . 0.0 115.418 -173.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.84 160.29 83.06 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 173.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -74.81 37.69 0.48 Allowed 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 124.217 3.278 . . . . 0.0 111.994 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -55.76 -26.66 46.84 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 126.6 1.96 . . . . 0.0 113.196 -173.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.7 m -54.77 -39.32 68.26 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.451 2.3 . . . . 0.0 112.672 -173.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 -58.0 -65.94 0.56 Allowed 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.811 1.644 . . . . 0.0 109.724 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -70.91 -27.19 63.6 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-O 118.076 -0.964 . . . . 0.0 111.689 -173.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -69.79 -49.17 55.45 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.812 1.245 . . . . 0.0 111.557 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 . . . . . 0 N--CA 1.469 0.505 0 CA-C-N 119.31 0.959 . . . . 0.0 109.566 178.2 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 91.0 mmm . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 118.164 2.654 . . . . 0.0 118.164 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -68.76 -70.0 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.697 0 CA-C-N 121.67 1.632 . . . . 0.0 113.698 -173.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.59 114.08 8.33 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.721 0.808 . . . . 0.0 110.504 -173.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 62.4 mt -119.45 127.26 26.54 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 127.097 2.159 . . . . 0.0 106.335 -177.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -77.31 156.58 33.08 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.125 1.883 . . . . 0.0 110.752 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.7 p -42.58 -43.77 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 127.136 2.174 . . . . 0.0 113.1 177.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -62.21 -41.35 98.29 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 126.181 1.792 . . . . 0.0 112.831 -174.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.6 mm -67.64 112.93 3.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 102.912 -2.995 . . . . 0.0 102.912 174.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -81.65 -27.11 34.26 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 118.716 -0.659 . . . . 0.0 109.512 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.4 m -155.27 168.96 25.34 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.383 1.073 . . . . 0.0 110.59 -173.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.1 mtm -126.26 151.02 48.01 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 172.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -104.92 113.29 26.79 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 122.882 0.473 . . . . 0.0 110.422 -176.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -100.76 153.02 19.8 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 103.06 -2.941 . . . . 0.0 103.06 172.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.3 m -138.17 133.71 33.64 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 -177.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -143.81 163.56 33.02 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.42 175.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -172.74 157.03 3.65 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.173 173.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.55 -173.6 4.59 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 172.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -123.49 134.51 53.88 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 101.478 -3.527 . . . . 0.0 101.478 173.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 16.49 -55.86 0.0 OUTLIER Glycine 0 CA--C 1.534 1.227 1 C-N-CA 135.274 6.178 . . . . 0.0 120.671 -176.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -116.61 -14.97 10.85 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 120.721 2.261 . . . . 0.0 113.999 -177.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.84 37.16 0.35 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 129.303 3.041 . . . . 0.0 118.859 -173.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -56.95 113.81 1.84 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 123.239 2.745 . . . . 0.0 110.307 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -85.81 155.72 20.88 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 125.38 1.472 . . . . 0.0 108.288 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -102.82 150.09 23.84 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 177.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -136.21 160.88 37.34 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.949 1.25 . . . . 0.0 110.905 176.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.45 ' O ' HD13 ' A' ' 131' ' ' ILE . 27.4 tt0 -153.53 140.13 18.86 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 172.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.402 ' CD2' HG22 ' A' ' 130' ' ' VAL . 70.8 m-85 -87.1 103.44 15.39 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.9 tt -74.27 -40.79 62.09 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 175.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.4 m -138.34 135.97 35.9 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.328 1.051 . . . . 0.0 111.591 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.495 HD22 HG22 ' A' ' 128' ' ' VAL . 0.1 OUTLIER -165.63 93.18 0.56 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 102.188 -3.264 . . . . 0.0 102.188 173.254 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.411 ' HD3' ' H ' ' A' ' 82' ' ' LEU . 0.1 OUTLIER -160.12 154.42 23.56 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 121.001 -1.062 . . . . 0.0 110.053 -174.221 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.412 ' HB2' ' HA ' ' A' ' 92' ' ' ASP . 5.4 t -73.89 169.05 18.22 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.716 0.77 . . . . 0.0 110.477 173.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.0 mt -122.34 -21.54 5.79 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 116.179 -1.867 . . . . 0.0 110.849 174.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -106.11 152.29 23.61 Favored 'General case' 0 C--N 1.353 0.741 0 CA-C-N 121.528 1.967 . . . . 0.0 110.773 173.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.44 ' HE3' ' HA ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -120.33 -23.85 6.07 Favored 'General case' 0 N--CA 1.445 -0.718 1 C-N-CA 135.67 5.588 . . . . 0.0 113.982 179.879 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -72.92 -71.57 1.07 Allowed Glycine 0 CA--C 1.533 1.214 0 N-CA-C 107.118 -2.393 . . . . 0.0 107.118 173.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 mp -77.12 26.52 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 130.052 3.341 . . . . 0.0 110.358 174.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.43 ' SD ' ' HE3' ' A' ' 87' ' ' LYS . 4.7 ttp -42.95 127.76 4.17 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 129.04 2.936 . . . . 0.0 113.487 -173.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -146.99 152.17 38.18 Favored 'General case' 0 N--CA 1.431 -1.42 1 C-N-CA 133.556 4.742 . . . . 0.0 102.216 173.639 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.412 ' HA ' ' HB2' ' A' ' 84' ' ' SER . 5.9 m-20 -139.81 114.19 7.85 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 173.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -70.0 160.76 48.48 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.114 2.543 . . . . 0.0 114.919 -173.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.1 p -137.03 167.11 22.15 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.532 1.933 . . . . 0.0 109.76 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.9 m -126.54 154.76 36.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.038 0.935 . . . . 0.0 111.432 173.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -78.94 9.58 4.16 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.592 2.357 . . . . 0.0 113.574 178.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.7 m -140.84 164.19 37.86 Favored Pre-proline 0 C--N 1.327 -0.4 0 C-N-CA 124.593 1.157 . . . . 0.0 109.557 -175.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -65.58 163.09 31.38 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.418 1.412 . . . . 0.0 109.699 173.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -62.9 -12.98 28.74 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 124.151 0.981 . . . . 0.0 112.423 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -143.66 164.85 29.27 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 120.334 1.425 . . . . 0.0 108.308 173.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.59 -161.96 35.39 Favored Glycine 0 C--O 1.228 -0.231 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 73.6 p -120.76 159.05 26.2 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 117.485 0.642 . . . . 0.0 109.784 174.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.9 t -94.05 113.18 59.96 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 173.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -93.32 163.75 2.45 Favored 'Trans proline' 0 C--O 1.218 -0.485 0 C-N-CA 122.861 2.374 . . . . 0.0 114.114 -173.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -73.26 2.11 8.07 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 120.303 -1.498 . . . . 0.0 113.887 -173.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.41 126.95 55.0 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-O 115.525 -2.179 . . . . 0.0 107.864 177.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -42.29 111.95 0.29 Allowed 'General case' 0 N--CA 1.462 0.155 0 O-C-N 125.299 1.624 . . . . 0.0 109.023 173.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.5 m -117.82 138.25 52.21 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 176.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.4 t -97.5 114.98 36.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 123.796 0.838 . . . . 0.0 110.035 -173.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 77.1 t -93.9 103.21 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 102.689 -3.078 . . . . 0.0 102.689 173.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -85.53 121.44 28.23 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 173.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.5 t -90.02 113.57 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 103.535 -2.765 . . . . 0.0 103.535 173.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -85.77 149.79 23.65 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.488 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 5.4 m-85 -135.62 73.56 61.38 Favored Pre-proline 0 C--O 1.244 0.779 0 CA-C-N 117.772 0.786 . . . . 0.0 109.229 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.3 114.42 3.44 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 N-CA-C 107.575 -1.741 . . . . 0.0 107.575 173.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 5.6 t -95.85 141.55 29.16 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 173.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.9 mt -81.92 -11.02 59.1 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 123.276 0.36 . . . . 0.0 110.716 -178.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 56.99 57.91 17.3 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 126.517 2.008 . . . . 0.0 111.871 173.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.407 ' HD3' ' HA ' ' A' ' 119' ' ' LYS 0.321 41.6 mmtm -113.05 -75.72 0.6 Allowed 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 117.589 -1.196 . . . . 0.0 111.065 179.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 49.0 tp60 -77.51 150.58 34.84 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 173.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -93.66 143.31 26.43 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 177.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.86 -152.93 24.88 Favored Glycine 0 C--N 1.334 0.442 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 19.3 t -128.34 113.71 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.96 167.41 13.75 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 173.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -127.97 163.26 24.89 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.431 0.692 . . . . 0.0 109.981 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.488 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 16.0 p90 -146.09 154.44 41.83 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.024 0.93 . . . . 0.0 108.899 173.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -114.39 149.24 36.46 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 127.55 2.34 . . . . 0.0 110.32 -174.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.495 HG22 HD22 ' A' ' 82' ' ' LEU . 63.2 t -140.16 143.49 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 125.043 1.337 . . . . 0.0 109.958 175.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -156.97 116.78 3.47 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 128.1 2.56 . . . . 0.0 105.488 173.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.468 ' H ' ' HB ' ' A' ' 143' ' ' THR . 46.3 t -126.41 121.76 59.65 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.826 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 176.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.461 HG22 ' HG3' ' A' ' 142' ' ' GLN . 0.1 OUTLIER -91.13 162.62 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 O-C-N 124.543 1.152 . . . . 0.0 107.942 174.534 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.3 t -136.91 134.86 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 C-N-CA 125.442 1.497 . . . . 0.0 107.041 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.22 174.41 10.58 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.593 1.157 . . . . 0.0 108.854 -175.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -90.2 176.31 6.8 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 104.694 -2.335 . . . . 0.0 104.694 172.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.9 t -65.47 -4.24 5.53 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 120.4 -1.437 . . . . 0.0 113.871 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -90.3 -14.55 32.98 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 120.725 1.602 . . . . 0.0 110.833 173.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.16 1.08 65.11 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.402 1.001 . . . . 0.0 111.915 -173.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 -69.93 116.03 9.84 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 119.524 1.662 . . . . 0.0 108.209 174.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -69.74 143.63 52.98 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 125.702 1.601 . . . . 0.0 108.776 -175.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -141.4 -37.68 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 124.667 1.187 . . . . 0.0 113.915 -173.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -130.19 150.84 51.26 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.461 ' HG3' HG22 ' A' ' 131' ' ' ILE . 5.5 tm0? -150.0 148.25 28.83 Favored 'General case' 0 CA--C 1.517 -0.307 0 O-C-N 121.054 -1.029 . . . . 0.0 109.469 176.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.468 ' HB ' ' H ' ' A' ' 130' ' ' VAL . 28.7 m -79.17 113.51 36.82 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 103.541 -2.763 . . . . 0.0 103.541 173.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.56 144.74 80.1 Favored 'Trans proline' 0 N--CA 1.445 -1.37 0 CA-C-N 120.369 1.167 . . . . 0.0 110.072 -173.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -75.81 112.39 12.15 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 -174.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 172.91 -31.93 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 129.38 3.072 . . . . 0.0 109.484 -173.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.14 92.9 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.125 1.77 . . . . 0.0 109.381 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.1 mm -125.65 141.19 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.428 ' HB2' ' CE2' ' A' ' 126' ' ' PHE . 0.2 OUTLIER -124.32 166.45 15.9 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 174.151 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -133.7 113.45 12.36 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.359 1.064 . . . . 0.0 108.392 -173.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.4 tttt -100.85 122.65 43.81 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 32.7 m -83.45 117.82 23.33 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 174.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 10.0 m -118.74 166.09 13.2 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.852 0.751 . . . . 0.0 109.431 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.3 pp -138.61 161.81 36.18 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.2 1.4 . . . . 0.0 108.022 176.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.1 126.84 28.7 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.649 1.18 . . . . 0.0 110.345 176.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -158.34 166.96 31.02 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.314 1.846 . . . . 0.0 108.36 174.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 . . . . . 0 C--O 1.258 1.527 0 C-N-CA 128.591 2.757 . . . . 0.0 104.258 173.621 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.9 m . . . . . 0 CA--C 1.549 0.932 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.405 HD12 HG11 ' A' ' 132' ' ' VAL . 3.6 tt -47.17 124.67 6.82 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 120.903 1.683 . . . . 0.0 111.955 -174.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -116.32 145.02 43.51 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.914 0.885 . . . . 0.0 110.137 174.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.98 118.56 4.52 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 9.9 p90 -130.78 176.34 8.29 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.446 1.499 . . . . 0.0 110.534 176.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.433 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 5.9 mt -112.62 113.97 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 102.714 -3.069 . . . . 0.0 102.714 173.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -73.59 149.69 41.92 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 122.795 1.283 . . . . 0.0 109.85 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.21 -18.4 3.83 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -173.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -56.61 -34.45 67.23 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 119.515 1.052 . . . . 0.0 111.038 175.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.488 ' HA ' HE21 ' A' ' 20' ' ' GLN . 0.9 OUTLIER -61.2 -56.14 24.07 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 119.338 0.972 . . . . 0.0 110.633 174.525 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.85 -39.13 62.31 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.66 0.784 . . . . 0.0 111.799 174.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.9 ttm-85 . . . . . 0 N--CA 1.443 -0.788 0 O-C-N 121.019 -1.051 . . . . 0.0 108.86 175.493 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.534 0.346 0 CA-C-O 119.261 -0.399 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -157.63 113.97 2.89 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.209 1.803 . . . . 0.0 109.827 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -82.89 168.06 17.44 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 173.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.3 mp -137.56 113.09 10.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 173.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.73 114.15 22.47 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 -178.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.4 mt -88.75 -55.76 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -175.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.4 t -125.57 113.62 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 -174.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 94.6 p -111.89 126.88 55.59 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 102.432 -3.174 . . . . 0.0 102.432 173.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.263 0.7 OUTLIER 46.39 34.06 2.15 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.81 1.244 . . . . 0.0 114.251 175.352 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.26 -4.29 26.39 Favored Glycine 0 CA--C 1.544 1.861 0 C-N-CA 126.545 2.022 . . . . 0.0 115.561 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -76.97 37.16 0.18 Allowed 'General case' 0 N--CA 1.474 0.739 1 C-N-CA 133.98 4.912 . . . . 0.0 111.037 -173.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 35.0 mtt -38.04 118.6 0.7 Allowed 'General case' 0 C--O 1.232 0.183 0 C-N-CA 126.864 2.066 . . . . 0.0 114.568 -173.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.16 164.29 43.73 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 113.835 -1.529 . . . . 0.0 108.722 173.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -73.39 26.85 0.31 Allowed 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 123.931 3.087 . . . . 0.0 112.779 174.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -55.26 -26.61 40.99 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 125.891 1.676 . . . . 0.0 112.876 -174.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 m -65.05 -30.16 71.1 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.248 1.019 . . . . 0.0 110.77 -173.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.455 ' CE1' HH22 ' A' ' 47' ' ' ARG . 3.0 t60 -69.78 -57.31 5.25 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -58.95 -23.75 61.84 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.9 -64.96 0.8 Allowed 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 173.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.455 HH22 ' CE1' ' A' ' 44' ' ' HIS . 2.8 tmm_? . . . . . 0 CA--C 1.546 0.81 0 C-N-CA 127.132 2.173 . . . . 0.0 114.561 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 85.1 mtp . . . . . 0 CA--C 1.538 0.514 0 N-CA-C 116.819 2.155 . . . . 0.0 116.819 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -72.5 -80.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.74 0 CA-C-N 123.035 2.12 . . . . 0.0 110.073 -173.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.27 113.99 7.97 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 96.3 mt -115.14 117.08 41.8 Favored Pre-proline 0 C--N 1.326 -0.435 0 C-N-CA 128.097 2.559 . . . . 0.0 105.32 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -73.61 157.85 48.11 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.537 1.491 . . . . 0.0 110.519 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.468 HG21 HD12 ' A' ' 154' ' ' LEU . 12.3 p -41.05 -42.58 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 126.225 1.81 . . . . 0.0 112.403 173.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -46.88 -42.45 17.47 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 127.338 2.255 . . . . 0.0 113.047 177.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.1 mm -75.64 112.97 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 177.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -79.95 -34.13 39.05 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 173.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.5 m -160.0 155.94 26.22 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.346 0.658 . . . . 0.0 111.135 -173.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 33.1 mtt -101.76 158.36 16.17 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 103.781 -2.674 . . . . 0.0 103.781 172.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -118.59 113.73 21.71 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 173.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.433 ' HA ' ' HA ' ' A' ' 16' ' ' ILE . 29.6 m-85 -101.49 157.3 16.91 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 173.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.2 m -137.07 135.48 37.53 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 177.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -143.75 166.24 25.42 Favored 'General case' 0 CA--C 1.511 -0.538 0 O-C-N 121.729 -0.607 . . . . 0.0 110.058 177.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -163.61 148.42 10.82 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.965 174.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.45 -173.84 3.52 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 122.916 1.341 . . . . 0.0 107.785 172.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -115.18 95.74 5.34 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 127.934 2.494 . . . . 0.0 110.13 -173.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 37.06 -56.6 0.0 OUTLIER Glycine 0 CA--C 1.543 1.835 1 C-N-CA 132.713 4.959 . . . . 0.0 120.795 -176.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -116.89 -16.88 10.54 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 121.643 2.722 . . . . 0.0 114.458 173.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.27 37.28 0.1 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 129.255 3.022 . . . . 0.0 115.673 -174.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -38.75 113.59 0.31 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 121.552 1.978 . . . . 0.0 110.367 -174.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -89.24 114.11 25.42 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -74.97 147.11 41.12 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 104.897 -2.261 . . . . 0.0 104.897 174.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -133.17 160.24 37.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 119.585 1.084 . . . . 0.0 110.078 176.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.475 ' O ' HD13 ' A' ' 131' ' ' ILE . 29.7 tt0 -152.38 135.07 15.39 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 173.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -82.92 103.7 12.58 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.062 0.945 . . . . 0.0 108.838 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.7 tt -67.04 -42.25 85.14 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.191 1.397 . . . . 0.0 108.19 174.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.3 m -135.06 139.71 44.98 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.488 1.115 . . . . 0.0 110.966 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.1 tt -170.36 92.96 0.21 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 173.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -161.72 156.3 22.75 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 118.721 0.691 . . . . 0.0 111.269 -174.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.4 t -72.0 163.78 27.26 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.1 mt -125.85 -17.02 5.5 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 116.734 -1.603 . . . . 0.0 112.379 174.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.527 ' CG ' ' H ' ' A' ' 87' ' ' LYS . 20.8 t0 -87.21 175.61 7.97 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 121.66 2.027 . . . . 0.0 112.248 177.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.527 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -115.27 -49.0 2.78 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 129.702 3.201 . . . . 0.0 112.841 177.304 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -78.88 -66.44 1.71 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 178.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.417 HD12 ' H ' ' A' ' 89' ' ' ILE . 3.5 mp -76.78 16.41 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 128.285 2.634 . . . . 0.0 109.81 -176.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 13.1 ttp -43.54 133.07 4.58 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 128.643 2.777 . . . . 0.0 109.838 -173.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -157.6 115.62 3.11 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 125.962 1.705 . . . . 0.0 107.908 -173.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -98.27 135.23 21.35 Favored Pre-proline 0 C--N 1.324 -0.522 0 O-C-N 123.973 0.795 . . . . 0.0 109.547 -174.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.46 154.71 55.58 Favored 'Trans proline' 0 N--CA 1.447 -1.26 0 C-N-CA 121.548 1.499 . . . . 0.0 109.25 173.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 17.9 p -140.4 157.8 44.97 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.556 1.543 . . . . 0.0 108.09 174.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.9 m -126.53 153.72 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 119.143 0.883 . . . . 0.0 113.011 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -74.94 7.11 3.42 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.498 2.319 . . . . 0.0 113.584 174.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.2 m -141.34 165.16 30.65 Favored Pre-proline 0 C--N 1.326 -0.443 0 C-N-CA 125.311 1.444 . . . . 0.0 108.632 -176.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -66.63 166.72 21.13 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 121.077 1.185 . . . . 0.0 110.398 173.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.97 -9.08 18.72 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.61 1.164 . . . . 0.0 112.03 176.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -145.63 164.35 32.01 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.446 1.498 . . . . 0.0 107.84 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 160.24 -161.25 32.38 Favored Glycine 0 C--O 1.227 -0.295 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 27.2 p -120.69 151.46 39.48 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 173.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.1 t -88.64 113.6 56.3 Favored Pre-proline 0 N--CA 1.447 -0.583 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 174.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.4 158.67 47.87 Favored 'Trans proline' 0 CA--C 1.512 -0.613 0 C-N-CA 122.245 1.963 . . . . 0.0 112.736 -174.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -64.39 -26.25 68.38 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 116.692 2.108 . . . . 0.0 116.692 -172.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . 0.566 1.0 OUTLIER -116.94 151.54 36.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 119.406 1.003 . . . . 0.0 113.102 173.134 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -38.61 110.96 0.15 Allowed 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 128.175 2.59 . . . . 0.0 113.292 -173.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.9 m -124.89 143.28 50.93 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 173.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.8 t -93.57 128.73 44.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 124.739 1.216 . . . . 0.0 112.022 -173.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 70.3 t -111.49 103.21 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 173.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -80.38 127.7 32.71 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 173.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.6 t -101.26 113.36 37.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 N-CA-C 103.549 -2.76 . . . . 0.0 103.549 173.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -92.45 148.68 19.24 Favored Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -129.54 73.75 81.34 Favored Pre-proline 0 C--O 1.243 0.762 0 CA-C-N 118.238 1.019 . . . . 0.0 110.66 -175.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.32 114.64 2.76 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.789 2.326 . . . . 0.0 109.553 173.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 8.0 t -91.15 145.29 24.8 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 173.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.3 mt -72.43 -16.39 61.83 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 117.793 0.269 . . . . 0.0 110.613 176.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 59.26 22.15 55.21 Favored Glycine 0 C--O 1.221 -0.679 0 C-N-CA 126.785 2.136 . . . . 0.0 115.456 173.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt -93.86 -46.75 7.05 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 120.2 2.0 . . . . 0.0 111.405 -174.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -96.52 151.3 19.71 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -93.69 151.59 19.54 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 174.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.79 -152.6 22.7 Favored Glycine 0 C--N 1.333 0.387 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 176.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.8 t -128.2 114.29 33.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -86.8 175.21 8.33 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.468 1.107 . . . . 0.0 108.907 173.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -128.32 156.49 42.97 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.776 1.63 . . . . 0.0 107.835 173.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.447 ' CE1' ' CD1' ' A' ' 149' ' ' PHE . 42.3 p90 -150.13 152.91 35.46 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.89 1.276 . . . . 0.0 107.904 173.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -116.28 145.9 42.81 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.736 1.615 . . . . 0.0 112.322 -173.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 92.8 t -141.63 138.28 32.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 173.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -154.3 130.21 10.18 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.854 1.661 . . . . 0.0 106.962 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.0 t -136.23 130.88 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 -174.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.629 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -98.35 163.65 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 173.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.405 HG11 HD12 ' A' ' 12' ' ' LEU . 7.1 t -141.91 134.06 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 -174.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.82 175.78 9.15 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 126.178 1.791 . . . . 0.0 107.067 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -93.17 176.01 6.56 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 103.76 -2.681 . . . . 0.0 103.76 172.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.4 t -65.37 -4.23 5.26 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 120.077 -1.639 . . . . 0.0 113.539 -178.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -85.54 -15.47 42.6 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 120.826 1.648 . . . . 0.0 110.374 173.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.4 0.1 65.39 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.837 1.208 . . . . 0.0 112.03 -173.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -70.8 115.63 10.17 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 119.494 1.647 . . . . 0.0 108.42 175.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -64.79 142.23 58.5 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.896 1.678 . . . . 0.0 108.253 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -140.28 -36.38 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 124.517 1.127 . . . . 0.0 113.559 -174.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -135.35 149.05 49.62 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.601 1.16 . . . . 0.0 107.929 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -142.63 138.89 31.02 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 85.8 m -65.97 131.3 94.52 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 174.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.8 143.61 41.85 Favored 'Trans proline' 0 N--CA 1.443 -1.486 0 N-CA-C 108.796 -1.271 . . . . 0.0 108.796 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -85.3 112.83 21.15 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -173.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.408 ' H ' ' H ' ' A' ' 147' ' ' ALA 0.297 0.9 OUTLIER 173.06 -10.44 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.725 1 C-N-CA 136.395 5.878 . . . . 0.0 110.457 174.015 . . . . . . . . 5 4 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.408 ' H ' ' H ' ' A' ' 146' ' ' ASN . . . -63.74 83.55 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.575 1.95 . . . . 0.0 112.069 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 3.9 mm -125.04 122.97 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 -178.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.447 ' CD1' ' CE1' ' A' ' 126' ' ' PHE . 1.0 OUTLIER -103.89 164.4 11.72 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 173.62 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -134.11 113.51 12.15 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -173.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 60.4 tttt -103.9 123.94 48.06 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.815 1.189 . . . . 0.0 109.453 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 25.0 m -83.55 114.57 21.6 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 174.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 5.5 m -116.96 166.63 11.96 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 124.487 1.115 . . . . 0.0 110.301 174.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.468 HD12 HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -137.2 159.44 41.91 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 126.61 1.964 . . . . 0.0 107.881 -177.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -69.99 117.6 11.76 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.272 1.429 . . . . 0.0 111.283 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -140.38 165.77 26.52 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.881 2.073 . . . . 0.0 108.495 174.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 . . . . . 0 C--O 1.25 1.099 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 173.67 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.6 m . . . . . 0 CA--C 1.537 0.455 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.0 tt -43.14 130.89 4.56 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.849 2.46 . . . . 0.0 112.99 -176.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -115.77 140.83 48.84 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.679 2.391 . . . . 0.0 108.235 173.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.22 118.03 6.65 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -136.63 176.11 9.0 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.759 0.79 . . . . 0.0 109.264 177.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 12.6 mt -114.47 113.53 44.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 1 N-CA-C 99.573 -4.232 . . . . 0.0 99.573 173.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -78.59 144.88 35.11 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 122.674 1.226 . . . . 0.0 110.999 -173.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.45 ' HB1' ' HG3' ' A' ' 28' ' ' GLU . . . -62.7 -26.49 68.69 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.193 -1.367 . . . . 0.0 112.898 -173.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -67.14 -38.99 86.47 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -174.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -57.54 11.09 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 117.649 -1.167 . . . . 0.0 108.49 173.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.14 -41.42 48.82 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 119.567 1.076 . . . . 0.0 111.751 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 173.629 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.45 ' HG3' ' HB1' ' A' ' 18' ' ' ALA . 31.3 tt0 . . . . . 0 CA--C 1.533 0.307 0 CA-C-O 119.548 -0.263 . . . . 0.0 110.549 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -153.19 139.24 18.24 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 128.313 2.645 . . . . 0.0 106.014 173.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -87.03 166.2 15.23 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 173.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.98 113.2 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 104.434 -2.432 . . . . 0.0 104.434 173.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.79 113.93 23.92 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -177.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.3 mt -93.09 -56.25 5.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -176.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.429 HG22 ' HG2' ' A' ' 39' ' ' MET . 6.3 t -126.27 133.72 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 125.904 1.682 . . . . 0.0 106.767 -174.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.9 p -140.13 126.84 20.48 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 102.164 -3.272 . . . . 0.0 102.164 173.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.269 6.2 pt-20 46.05 34.0 1.88 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.177 1.391 . . . . 0.0 113.514 -177.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 64.46 -3.53 1.81 Allowed Glycine 0 CA--C 1.544 1.865 0 O-C-N 120.273 -1.517 . . . . 0.0 114.173 -174.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.5 ttpt -79.72 37.12 0.34 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 131.055 3.742 . . . . 0.0 111.436 -173.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.429 ' HG2' HG22 ' A' ' 34' ' ' VAL . 38.0 mtt -37.82 122.88 1.02 Allowed 'General case' 0 C--O 1.24 0.585 0 C-N-CA 125.478 1.511 . . . . 0.0 112.825 -173.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.1 167.83 7.29 Favored Pre-proline 0 N--CA 1.449 -0.495 0 O-C-N 125.798 1.936 . . . . 0.0 108.052 173.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.57 29.26 0.24 Allowed 'Trans proline' 0 CA--C 1.548 1.19 0 C-N-CA 123.939 3.093 . . . . 0.0 112.365 174.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -53.86 -26.61 25.43 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 126.784 2.033 . . . . 0.0 113.022 -173.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 m -62.17 -29.88 70.66 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.243 1.417 . . . . 0.0 111.46 -173.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -55.3 -65.83 0.52 Allowed 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.098 1.359 . . . . 0.0 109.362 175.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.253 44.1 m-20 -76.44 -23.75 53.93 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.055 0.455 . . . . 0.0 111.571 -175.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -60.31 -44.64 95.24 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 120.099 -1.626 . . . . 0.0 108.331 173.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.4 0 O-C-N 121.639 -0.663 . . . . 0.0 109.277 176.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.393 0 CA-C-O 117.379 -1.295 . . . . 0.0 114.097 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -78.84 -64.41 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 CA-C-N 121.443 1.551 . . . . 0.0 110.646 -176.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.47 118.06 13.81 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.743 1.217 . . . . 0.0 110.842 -173.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.9 mt -126.14 116.25 23.76 Favored Pre-proline 0 N--CA 1.448 -0.543 0 C-N-CA 126.555 1.942 . . . . 0.0 106.612 -174.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -72.23 155.9 55.77 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.018 1.812 . . . . 0.0 110.353 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.9 p -40.32 -43.66 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 127.715 2.406 . . . . 0.0 112.854 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -59.89 -33.97 72.55 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 126.954 2.101 . . . . 0.0 114.076 -177.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.3 mm -68.47 112.93 3.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 104.098 -2.556 . . . . 0.0 104.098 175.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -81.86 -33.48 30.6 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.669 174.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.3 m -158.39 157.88 33.15 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.32 0.648 . . . . 0.0 109.301 -174.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 33.7 mtm -126.28 166.78 16.48 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 173.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -134.63 130.92 37.16 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -107.95 162.24 14.2 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 173.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.4 m -135.86 133.43 37.76 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -175.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -144.56 165.56 27.65 Favored 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 121.332 -0.855 . . . . 0.0 111.312 179.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.09 158.37 4.6 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 124.238 1.015 . . . . 0.0 110.898 174.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.27 177.42 6.05 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 173.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.15 101.79 12.93 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 120.212 -1.555 . . . . 0.0 108.996 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 44.36 -53.82 0.0 OUTLIER Glycine 0 CA--C 1.541 1.669 1 C-N-CA 132.814 5.007 . . . . 0.0 120.363 175.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -116.9 -19.83 9.67 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 121.628 2.714 . . . . 0.0 115.396 174.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.71 37.17 0.14 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 128.56 2.744 . . . . 0.0 116.082 -173.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.532 ' HG2' ' HE2' ' A' ' 105' ' ' HIS . 3.4 mm-40 -44.36 113.49 0.54 Allowed 'General case' 0 CA--C 1.557 1.224 0 CA-C-N 121.891 2.132 . . . . 0.0 109.147 -174.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -84.35 162.55 20.0 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.346 1.459 . . . . 0.0 111.595 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -111.77 149.53 31.57 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -135.52 161.82 34.41 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 120.226 1.375 . . . . 0.0 111.142 175.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.411 ' O ' HD13 ' A' ' 131' ' ' ILE . 31.1 tt0 -155.49 139.11 16.01 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 173.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -88.78 103.84 16.35 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.959 1.303 . . . . 0.0 109.71 -175.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.9 tt -72.34 -47.66 47.95 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.289 1.435 . . . . 0.0 108.981 175.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 38.1 m -131.61 138.2 48.71 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.493 1.517 . . . . 0.0 111.161 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.438 HD22 HG22 ' A' ' 128' ' ' VAL . 0.3 OUTLIER -168.83 92.69 0.29 Allowed 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 101.936 -3.357 . . . . 0.0 101.936 173.124 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -165.0 154.44 12.94 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 120.037 1.289 . . . . 0.0 112.486 -174.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.1 t -67.96 161.43 26.57 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 119.6 1.091 . . . . 0.0 110.243 173.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.9 mt -126.43 -2.61 6.83 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 125.772 1.629 . . . . 0.0 112.385 174.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.495 ' CG ' ' H ' ' A' ' 87' ' ' LYS 0.337 11.2 t70 -99.07 169.11 9.64 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.819 1.645 . . . . 0.0 112.169 -175.514 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.495 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 1.4 mppt? -109.2 -49.02 3.17 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 129.557 3.143 . . . . 0.0 111.631 -173.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -105.95 -47.66 1.07 Allowed Glycine 0 CA--C 1.524 0.636 0 C-N-CA 125.247 1.403 . . . . 0.0 112.095 -177.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.2 mp -80.73 14.97 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 125.571 1.548 . . . . 0.0 108.884 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 12.9 ttm -43.27 130.72 4.78 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 129.453 3.101 . . . . 0.0 109.199 -173.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -156.94 114.62 3.17 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 126.09 1.756 . . . . 0.0 106.62 -173.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.288 3.9 m-20 -96.36 129.14 34.21 Favored Pre-proline 0 CA--C 1.51 -0.58 0 O-C-N 124.493 1.121 . . . . 0.0 110.995 -174.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -75.64 149.68 34.5 Favored 'Trans proline' 0 N--CA 1.441 -1.561 0 C-N-CA 121.91 1.74 . . . . 0.0 109.685 175.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 20.8 p -131.88 155.44 47.86 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 125.109 1.364 . . . . 0.0 107.912 174.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.6 m -125.23 153.06 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 C-N-CA 124.193 0.997 . . . . 0.0 109.977 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -86.12 11.41 11.88 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.345 1.458 . . . . 0.0 113.367 -177.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.3 m -137.53 164.1 43.86 Favored Pre-proline 0 C--N 1.326 -0.432 0 C-N-CA 124.414 1.086 . . . . 0.0 109.798 -173.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -65.78 162.2 35.74 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.375 1.383 . . . . 0.0 109.803 173.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -65.69 -11.39 44.76 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 124.213 1.005 . . . . 0.0 112.251 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -143.02 164.37 30.28 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.138 1.375 . . . . 0.0 107.807 173.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.64 -160.67 34.13 Favored Glycine 0 C--O 1.226 -0.352 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.0 p -123.48 152.16 42.0 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.261 0.531 . . . . 0.0 109.958 176.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.5 t -94.93 113.09 60.5 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 102.736 -3.061 . . . . 0.0 102.736 173.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -97.17 161.53 1.0 Allowed 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.825 2.35 . . . . 0.0 112.514 -173.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.532 ' HE2' ' HG2' ' A' ' 74' ' ' GLU . 80.8 m-70 -66.72 -19.65 65.8 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 119.971 -1.706 . . . . 0.0 114.88 -174.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.05 114.08 24.32 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 -174.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -47.3 111.43 0.41 Allowed 'General case' 0 N--CA 1.463 0.219 0 O-C-N 124.438 1.086 . . . . 0.0 109.249 -175.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 66.3 m -116.84 143.97 45.05 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -174.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.4 t -105.79 139.0 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -173.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.5 t -121.9 103.7 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -73.73 147.0 43.97 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 173.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.4 t -130.96 113.91 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 104.443 -2.429 . . . . 0.0 104.443 177.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -100.61 146.61 17.65 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 125.249 1.404 . . . . 0.0 110.517 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -129.99 73.6 81.26 Favored Pre-proline 0 CA--C 1.546 0.813 0 CA-C-N 118.88 1.34 . . . . 0.0 111.704 -174.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -64.54 117.14 4.23 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.443 2.095 . . . . 0.0 109.056 173.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 8.5 t -94.01 144.29 25.6 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 173.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.6 mt -79.59 -10.87 59.87 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 122.966 0.506 . . . . 0.0 111.15 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 55.19 33.57 57.99 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 125.817 1.675 . . . . 0.0 114.22 173.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -93.74 -63.42 1.2 Allowed 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 118.471 1.136 . . . . 0.0 110.271 -177.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.411 ' NE2' ' H ' ' A' ' 121' ' ' ASP . 38.6 tp60 -96.05 154.66 17.12 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 174.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.411 ' H ' ' NE2' ' A' ' 120' ' ' GLN . 4.0 m-20 -93.51 152.28 19.16 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.46 1.504 . . . . 0.0 107.407 175.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.15 -152.07 22.12 Favored Glycine 0 C--N 1.331 0.305 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.8 t -127.47 113.86 33.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -84.35 173.34 11.01 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 173.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -133.85 159.78 39.62 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.533 1.133 . . . . 0.0 109.554 174.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -146.15 140.73 26.87 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 173.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -94.43 148.0 22.67 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 125.242 1.417 . . . . 0.0 111.25 -175.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.5 HG21 ' CE1' ' A' ' 149' ' ' PHE . 24.8 t -139.19 135.65 41.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 125.396 1.479 . . . . 0.0 108.997 173.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -155.8 120.46 4.68 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 173.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.411 ' H ' ' HB ' ' A' ' 143' ' ' THR . 43.8 t -130.44 123.83 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.618 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -88.76 166.58 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 173.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.6 t -146.1 134.59 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 -174.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.34 174.9 10.06 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.977 -175.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -86.83 175.96 7.94 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 172.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.3 t -65.65 -13.93 60.17 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 120.756 -1.215 . . . . 0.0 113.754 -173.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -94.78 -4.19 47.72 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.433 1.093 . . . . 0.0 111.423 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.86 9.44 57.35 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 118.958 -0.912 . . . . 0.0 113.703 176.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -74.28 116.49 15.01 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 119.786 1.793 . . . . 0.0 108.592 175.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.8 m -70.19 143.83 52.12 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 123.815 0.846 . . . . 0.0 109.186 -177.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.57 -36.0 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 124.523 1.129 . . . . 0.0 113.394 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -131.68 145.4 51.63 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -175.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -146.13 147.32 31.41 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.411 ' HB ' ' H ' ' A' ' 130' ' ' VAL . 58.5 m -78.48 113.49 34.84 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.26 144.28 85.87 Favored 'Trans proline' 0 N--CA 1.446 -1.31 0 CA-C-N 119.944 1.016 . . . . 0.0 110.796 -173.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -80.56 112.53 18.0 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 -173.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.444 14.0 m-80 172.55 -13.83 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 1 C-N-CA 138.555 6.742 . . . . 0.0 110.252 173.722 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.55 77.31 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.81 2.044 . . . . 0.0 109.861 173.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 37.0 mm -115.64 125.5 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.5 ' CE1' HG21 ' A' ' 128' ' ' VAL . 0.7 OUTLIER -93.97 154.75 17.5 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 173.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -131.05 113.51 14.04 Favored 'General case' 0 CA--C 1.521 -0.156 0 O-C-N 121.366 -0.834 . . . . 0.0 108.755 -173.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -106.71 122.23 45.93 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 118.838 0.745 . . . . 0.0 109.204 -177.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 27.7 m -83.37 117.09 22.79 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 105.68 -1.971 . . . . 0.0 105.68 174.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 6.7 m -118.14 166.41 12.61 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.488 0.715 . . . . 0.0 109.615 173.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.4 pp -131.62 160.44 35.36 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.362 1.465 . . . . 0.0 107.627 175.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -68.41 125.22 25.77 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.457 1.503 . . . . 0.0 109.701 176.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -146.7 127.9 14.75 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.851 1.26 . . . . 0.0 107.809 174.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 . . . . . 0 C--O 1.255 1.361 0 C-N-CA 127.505 2.322 . . . . 0.0 105.42 174.162 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.9 m . . . . . 0 C--O 1.222 -0.375 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tt -43.04 126.14 3.81 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 129.011 2.925 . . . . 0.0 112.934 -173.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.401 ' CD1' ' HA ' ' A' ' 35' ' ' SER . 98.1 m-85 -114.3 141.44 47.59 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 128.281 2.632 . . . . 0.0 108.17 174.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.86 120.76 8.17 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 18.0 p90 -135.94 168.76 18.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 119.159 0.89 . . . . 0.0 109.842 175.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.9 mt -99.78 114.36 37.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 102.073 -3.306 . . . . 0.0 102.073 173.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -79.32 136.08 36.91 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 123.903 1.811 . . . . 0.0 113.068 -173.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.62 -20.37 46.9 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 127.375 2.27 . . . . 0.0 116.213 -173.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -56.47 -40.83 75.54 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 118.886 0.766 . . . . 0.0 109.55 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 42.6 tp60 -65.38 -44.24 88.18 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.681 178.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.66 -32.03 73.38 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 118.854 -0.593 . . . . 0.0 112.235 176.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 173.149 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 . . . . . 0 CA--C 1.536 0.434 0 CA-C-O 118.621 -0.704 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -137.13 113.47 10.02 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.967 1.707 . . . . 0.0 109.251 -174.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -92.14 163.31 13.99 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.144 1.338 . . . . 0.0 107.492 173.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.3 mp -136.71 113.17 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 173.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.86 116.58 23.39 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -176.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 27.4 mt -95.05 -63.76 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.034 0.934 . . . . 0.0 109.335 -177.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.9 t -118.41 133.97 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -173.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.401 ' HA ' ' CD1' ' A' ' 13' ' ' TYR . 2.9 p -137.59 124.55 21.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 104.216 -2.513 . . . . 0.0 104.216 173.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 43.95 33.26 0.73 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.19 2.196 . . . . 0.0 114.091 -174.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.38 -6.87 5.32 Favored Glycine 0 CA--C 1.544 1.873 0 O-C-N 120.713 -1.242 . . . . 0.0 114.73 -174.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -79.19 37.29 0.31 Allowed 'General case' 0 CA--C 1.537 0.466 1 C-N-CA 131.706 4.002 . . . . 0.0 111.215 -178.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 42.6 mtm -38.22 134.73 0.8 Allowed 'General case' 0 C--O 1.233 0.195 0 C-N-CA 126.207 1.803 . . . . 0.0 114.362 -173.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.1 165.38 48.36 Favored Pre-proline 0 N--CA 1.45 -0.446 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 173.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.28 38.2 0.53 Allowed 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 123.911 3.074 . . . . 0.0 110.6 173.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -53.72 -26.7 24.35 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 127.25 2.22 . . . . 0.0 114.095 -173.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.5 m -60.27 -32.08 70.83 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.624 1.169 . . . . 0.0 111.621 -173.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -58.36 -64.13 1.03 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.252 1.021 . . . . 0.0 109.852 176.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -76.37 -29.35 57.14 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -174.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -57.1 -55.99 27.63 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.18 0.992 . . . . 0.0 108.584 173.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.287 0 CA-C-O 118.537 -0.744 . . . . 0.0 111.102 -174.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 69.2 mmm . . . . . 0 N--CA 1.468 0.467 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -69.35 -77.39 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.042 0 CA-C-N 120.837 1.335 . . . . 0.0 110.361 173.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.21 113.32 20.59 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.39 0.614 . . . . 0.0 111.055 -173.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.89 131.5 21.92 Favored Pre-proline 0 C--N 1.327 -0.373 0 C-N-CA 128.489 2.716 . . . . 0.0 106.228 -177.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -79.31 157.6 26.0 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.731 1.621 . . . . 0.0 110.743 177.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.4 p -41.95 -41.17 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 126.97 2.108 . . . . 0.0 112.088 173.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.51 -39.47 83.97 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 127.519 2.328 . . . . 0.0 112.825 -176.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 mm -74.28 112.85 11.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 101.548 -3.501 . . . . 0.0 101.548 173.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -78.14 -38.25 44.16 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.0 m -149.83 161.3 42.53 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.362 1.065 . . . . 0.0 109.585 -173.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 24.3 mtm -126.33 152.38 46.3 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 172.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -94.59 150.29 20.39 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -136.51 152.48 50.57 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 102.376 -3.194 . . . . 0.0 102.376 172.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.0 m -139.95 135.53 32.89 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -176.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -145.84 165.69 28.13 Favored 'General case' 0 C--O 1.24 0.566 0 O-C-N 121.916 -0.49 . . . . 0.0 110.635 177.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.83 157.55 3.06 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.927 0.87 . . . . 0.0 112.438 177.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.6 -174.02 4.17 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 173.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.87 111.83 18.9 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 126.047 1.739 . . . . 0.0 107.101 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 43.4 -57.9 0.0 OUTLIER Glycine 0 CA--C 1.537 1.418 1 C-N-CA 132.74 4.971 . . . . 0.0 119.372 173.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -116.57 -25.79 7.28 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.724 1.762 . . . . 0.0 113.548 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.73 37.1 0.08 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 130.993 3.717 . . . . 0.0 119.068 -173.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -54.37 113.96 1.47 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 123.234 2.743 . . . . 0.0 111.013 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -84.1 142.93 30.04 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 125.322 1.449 . . . . 0.0 107.348 173.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -90.35 149.27 22.37 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -131.95 161.0 34.16 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 120.302 1.41 . . . . 0.0 110.905 175.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.419 ' O ' HD13 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -154.11 134.95 13.73 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 173.276 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -87.28 103.13 15.16 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.098 0.559 . . . . 0.0 110.03 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.0 tt -73.38 -42.07 62.6 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.3 m -138.58 132.72 31.52 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.356 1.062 . . . . 0.0 111.486 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.545 HD22 HG22 ' A' ' 128' ' ' VAL . 0.1 OUTLIER -162.76 93.01 0.8 Allowed 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 101.309 -3.589 . . . . 0.0 101.309 173.2 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.433 ' HD3' ' H ' ' A' ' 82' ' ' LEU . 0.1 OUTLIER -161.4 155.55 22.51 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 119.75 1.159 . . . . 0.0 111.284 -173.753 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.0 t -82.85 153.79 24.97 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 173.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 70.8 mt -107.31 -9.27 16.1 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.253 1.421 . . . . 0.0 111.679 176.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -104.97 162.76 13.07 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 173.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.7 mmtm -138.16 -33.24 0.7 Allowed 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.412 1.885 . . . . 0.0 112.297 -177.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -62.1 -54.26 36.21 Favored Glycine 0 CA--C 1.545 1.912 0 N-CA-C 106.808 -2.517 . . . . 0.0 106.808 172.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.7 mt -90.45 25.28 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 129.281 3.032 . . . . 0.0 110.518 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 4.1 ttp -43.17 133.82 3.82 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 125.458 2.551 . . . . 0.0 112.712 -173.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -149.68 155.38 40.11 Favored 'General case' 0 N--CA 1.422 -1.842 2 C-N-CA 135.994 5.718 . . . . 0.0 101.302 173.785 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -144.86 114.22 5.03 Favored Pre-proline 0 C--N 1.316 -0.855 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 173.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -67.44 157.93 59.44 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 122.816 2.344 . . . . 0.0 113.652 -173.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.3 p -133.17 165.65 24.28 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.513 1.525 . . . . 0.0 109.773 176.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.4 m -126.34 155.58 36.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.174 0.989 . . . . 0.0 110.677 173.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -78.21 9.47 3.77 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.209 2.204 . . . . 0.0 113.485 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.5 m -139.3 163.71 43.82 Favored Pre-proline 0 C--N 1.327 -0.372 0 C-N-CA 124.443 1.097 . . . . 0.0 109.976 -176.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -65.41 162.07 35.31 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.705 1.603 . . . . 0.0 110.071 173.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -64.34 -10.59 25.35 Favored 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 124.634 1.174 . . . . 0.0 112.586 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -145.77 164.06 33.04 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 120.151 1.341 . . . . 0.0 107.857 173.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.37 -161.65 34.22 Favored Glycine 0 C--O 1.227 -0.335 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 77.8 p -117.25 150.94 37.94 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 173.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.2 t -87.16 113.23 52.72 Favored Pre-proline 0 N--CA 1.448 -0.547 0 N-CA-C 102.276 -3.231 . . . . 0.0 102.276 173.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -92.34 155.51 3.09 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.414 2.076 . . . . 0.0 111.98 -173.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.406 ' CD2' ' H ' ' A' ' 105' ' ' HIS . 18.0 m-70 -65.51 -16.88 64.11 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 120.164 -1.585 . . . . 0.0 112.179 -174.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.474 ' H ' ' HD2' ' A' ' 106' ' ' LYS . 3.8 mptt -85.88 113.77 22.27 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 -174.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.65 110.58 0.48 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 119.098 0.863 . . . . 0.0 109.37 -176.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 45.3 m -117.04 139.86 50.18 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -175.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.6 t -98.37 114.16 35.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 C-N-CA 124.402 1.081 . . . . 0.0 109.425 -173.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 85.1 t -93.98 103.41 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 N-CA-C 103.875 -2.639 . . . . 0.0 103.875 173.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -84.49 126.09 32.97 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 104.921 -2.251 . . . . 0.0 104.921 173.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.7 t -94.14 113.84 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 104.462 -2.422 . . . . 0.0 104.462 174.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -87.71 148.32 21.01 Favored Glycine 0 N--CA 1.44 -1.057 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 176.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.454 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 3.8 m-85 -132.19 73.45 77.67 Favored Pre-proline 0 C--O 1.242 0.68 0 C-N-CA 124.125 0.97 . . . . 0.0 108.924 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.98 121.76 8.16 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 121.652 1.568 . . . . 0.0 108.082 174.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 5.9 t -101.99 149.69 23.98 Favored 'General case' 0 C--N 1.34 0.191 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 173.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mt -79.42 -18.0 53.14 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 118.068 0.394 . . . . 0.0 110.697 176.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.54 17.52 53.74 Favored Glycine 0 C--O 1.215 -1.082 0 C-N-CA 127.632 2.539 . . . . 0.0 115.719 173.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 24.6 mttt -93.19 -29.38 15.75 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 121.576 2.688 . . . . 0.0 111.449 -173.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -96.66 154.88 17.03 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 172.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -102.24 144.58 30.59 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 174.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 151.21 -157.71 27.34 Favored Glycine 0 C--N 1.332 0.319 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 175.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 18.8 t -127.18 113.57 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 175.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -89.32 164.16 15.03 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 173.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -122.96 163.84 19.65 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 121.227 -0.92 . . . . 0.0 110.104 176.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.454 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 9.1 p90 -149.61 150.53 32.34 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 118.4 0.545 . . . . 0.0 109.65 173.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -111.53 150.58 29.77 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 127.638 2.375 . . . . 0.0 110.33 -174.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.545 HG22 HD22 ' A' ' 82' ' ' LEU . 85.6 t -138.83 137.47 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 125.698 1.599 . . . . 0.0 109.083 174.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -156.32 124.47 5.69 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 126.809 2.043 . . . . 0.0 106.357 173.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 42.7 t -135.01 128.39 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.628 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -95.22 164.57 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 174.383 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.1 t -143.27 135.26 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -173.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.52 175.46 9.58 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.866 1.266 . . . . 0.0 108.642 -174.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 37.9 p-10 -89.99 176.32 6.84 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 172.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.6 t -65.49 -4.81 6.4 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 120.28 -1.512 . . . . 0.0 113.949 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -88.63 -16.73 31.7 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 120.714 1.597 . . . . 0.0 110.696 173.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.57 1.16 60.54 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.555 1.074 . . . . 0.0 111.808 -173.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 60.6 m-20 -70.84 116.56 11.29 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 119.535 1.668 . . . . 0.0 108.384 174.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.5 m -68.03 143.87 55.35 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.842 1.657 . . . . 0.0 109.024 -174.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -140.99 -36.34 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.628 1.171 . . . . 0.0 113.999 -174.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -130.55 144.11 51.2 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 178.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -144.79 131.37 19.91 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 177.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 77.5 m -63.57 131.35 94.82 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 174.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -72.17 144.5 42.09 Favored 'Trans proline' 0 N--CA 1.444 -1.408 0 N-CA-C 108.401 -1.423 . . . . 0.0 108.401 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -82.76 112.52 19.68 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 -175.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.599 38.9 m-80 172.31 -13.19 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 1 C-N-CA 132.739 4.415 . . . . 0.0 114.295 173.28 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.86 96.6 0.09 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.056 1.342 . . . . 0.0 108.612 177.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.1 mt -133.58 148.8 30.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.416 ' CD1' ' CZ ' ' A' ' 126' ' ' PHE . 0.4 OUTLIER -130.87 170.08 14.89 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.274 1.429 . . . . 0.0 107.624 175.648 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -135.3 113.48 11.31 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.865 1.266 . . . . 0.0 108.023 -173.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -101.31 123.55 45.58 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 23.9 m -83.48 117.81 23.34 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 175.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 30.9 m -112.25 158.17 20.05 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 174.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.8 pp -146.24 159.59 43.12 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 176.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.44 121.25 2.89 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.73 2.412 . . . . 0.0 115.223 -173.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -139.74 164.14 30.73 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 130.131 3.372 . . . . 0.0 106.646 173.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 . . . . . 0 C--O 1.252 1.188 0 C-N-CA 127.515 2.326 . . . . 0.0 105.957 175.708 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.472 0.632 0 CA-C-O 119.085 -0.484 . . . . 0.0 109.978 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.2 tt -43.41 129.23 5.05 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 127.15 2.18 . . . . 0.0 112.236 -174.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.412 ' CD1' ' HA ' ' A' ' 35' ' ' SER . 74.5 m-85 -116.18 132.88 56.54 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.041 1.736 . . . . 0.0 109.062 174.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.07 120.56 11.02 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -178.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.5 p90 -134.25 175.32 9.61 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.71 0.804 . . . . 0.0 110.088 176.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.3 mt -111.81 116.17 51.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 102.213 -3.254 . . . . 0.0 102.213 174.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -83.18 148.56 27.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 123.501 1.619 . . . . 0.0 114.639 -173.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.81 -14.33 32.15 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 126.863 2.065 . . . . 0.0 114.666 -174.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -58.26 -35.1 71.25 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 119.185 0.902 . . . . 0.0 109.876 174.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 47.2 tp60 -67.37 -43.05 82.39 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 118.376 0.535 . . . . 0.0 111.104 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.71 -37.8 82.89 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.881 0.872 . . . . 0.0 111.044 173.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 . . . . . 0 N--CA 1.445 -0.72 0 O-C-N 121.002 -1.061 . . . . 0.0 108.198 173.762 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 . . . . . 0 CA--C 1.531 0.229 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -160.0 115.46 2.37 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.449 0.7 . . . . 0.0 110.598 -178.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -89.55 175.73 7.17 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.369 1.468 . . . . 0.0 109.633 173.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 21.6 mt -143.91 113.27 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 172.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.72 114.23 24.14 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -177.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.2 mt -91.3 -61.54 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 118.944 0.793 . . . . 0.0 109.198 -177.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.6 t -116.6 122.89 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 -173.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.412 ' HA ' ' CD1' ' A' ' 13' ' ' TYR . 2.9 p -126.11 119.36 27.36 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 102.966 -2.976 . . . . 0.0 102.966 173.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.32 17.6 pm0 45.91 42.16 8.8 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.914 1.686 . . . . 0.0 112.884 -176.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.99 -24.22 1.3 Allowed Glycine 0 CA--C 1.543 1.829 0 C-N-CA 125.965 1.745 . . . . 0.0 115.136 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . 0.437 7.0 tmtt? -53.94 37.32 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.686 1 C-N-CA 137.609 6.364 . . . . 0.0 117.085 174.373 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 42.6 mtt -38.17 130.03 1.24 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.11 167.63 32.52 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 173.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.48 34.17 0.34 Allowed 'Trans proline' 0 CA--C 1.55 1.313 0 C-N-CA 124.069 3.179 . . . . 0.0 111.728 173.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -54.7 -26.57 34.5 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 127.899 2.48 . . . . 0.0 114.4 -173.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 m -62.9 -32.38 73.64 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.5 1.12 . . . . 0.0 112.185 -172.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 61.3 t60 -59.96 -51.42 69.74 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.328 0.9 OUTLIER -76.09 -28.69 57.65 Favored 'General case' 0 C--O 1.224 -0.237 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.294 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -55.88 -46.53 78.29 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.066 -1.021 . . . . 0.0 108.274 173.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.9 ttt85 . . . . . 0 CA--C 1.54 0.586 0 CA-C-O 118.506 -0.759 . . . . 0.0 112.302 178.775 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.535 0 CA-C-O 116.497 -1.716 . . . . 0.0 114.564 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -75.83 -71.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.593 0 CA-C-N 122.586 1.959 . . . . 0.0 113.14 -173.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.01 113.62 14.91 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.622 0.769 . . . . 0.0 110.04 -173.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 94.3 mt -109.4 119.37 48.45 Favored Pre-proline 0 C--N 1.325 -0.498 0 C-N-CA 127.122 2.169 . . . . 0.0 105.903 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -74.33 155.91 46.15 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 121.782 1.655 . . . . 0.0 109.486 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.3 p -41.54 -41.77 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 126.66 1.984 . . . . 0.0 112.598 174.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -56.25 -42.4 77.32 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 126.896 2.078 . . . . 0.0 113.099 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.2 mm -74.53 112.86 12.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 101.642 -3.466 . . . . 0.0 101.642 173.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -76.55 -36.11 57.83 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . 0.253 4.2 m -148.99 161.83 41.12 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.195 1.398 . . . . 0.0 109.933 -173.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -117.7 145.65 44.27 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 172.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 44.9 m-20 -94.12 146.82 23.7 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 174.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -136.09 153.77 51.21 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 102.528 -3.138 . . . . 0.0 102.528 172.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.1 m -139.5 133.66 31.18 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -177.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -145.02 166.76 24.41 Favored 'General case' 0 C--O 1.238 0.496 0 O-C-N 122.056 -0.403 . . . . 0.0 111.158 177.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.24 158.22 13.94 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 124.866 1.266 . . . . 0.0 110.349 174.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -97.73 168.44 10.33 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 173.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.21 96.15 10.53 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 120.157 -1.589 . . . . 0.0 110.526 -174.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 48.74 -58.54 0.0 OUTLIER Glycine 0 CA--C 1.536 1.363 1 C-N-CA 131.783 4.516 . . . . 0.0 119.544 173.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -117.08 -15.66 10.52 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.446 2.123 . . . . 0.0 115.783 173.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.33 37.18 0.2 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 129.231 3.012 . . . . 0.0 115.998 -173.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -39.02 113.43 0.31 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 121.621 2.009 . . . . 0.0 110.031 -173.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -89.91 130.16 36.17 Favored 'General case' 0 CA--C 1.522 -0.106 0 C-N-CA 125.147 1.379 . . . . 0.0 107.62 175.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -84.6 150.95 24.84 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -137.76 160.87 38.05 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 119.913 1.233 . . . . 0.0 110.815 174.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.484 ' O ' HD13 ' A' ' 131' ' ' ILE . 28.5 tt0 -153.56 138.75 17.43 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 173.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.417 ' CD2' HD23 ' A' ' 82' ' ' LEU . 68.8 m-85 -86.12 103.45 14.79 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tt -70.81 -41.99 70.84 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.627 1.171 . . . . 0.0 108.123 174.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.2 m -138.61 135.7 35.21 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.634 1.174 . . . . 0.0 111.397 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.541 HD22 HG22 ' A' ' 128' ' ' VAL . 0.1 OUTLIER -164.97 93.13 0.61 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 102.169 -3.271 . . . . 0.0 102.169 173.194 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.412 ' HD3' ' H ' ' A' ' 82' ' ' LEU . 0.1 OUTLIER -161.43 154.14 20.52 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 120.821 -1.175 . . . . 0.0 110.76 -174.037 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.3 t -73.14 165.31 25.29 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.36 0.6 . . . . 0.0 109.628 173.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.5 mt -120.49 -21.87 6.65 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 116.505 -1.712 . . . . 0.0 110.764 173.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -99.35 164.89 11.93 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-O 123.935 1.826 . . . . 0.0 108.407 173.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.4 mmtm -136.71 -27.24 1.03 Allowed 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 129.255 3.022 . . . . 0.0 112.315 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.31 -63.85 3.86 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 106.67 -2.572 . . . . 0.0 106.67 172.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.417 ' O ' HG22 ' A' ' 89' ' ' ILE . 3.7 mp -81.87 26.7 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 128.934 2.894 . . . . 0.0 110.855 174.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 2.8 ttp -43.06 128.24 4.39 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 125.107 2.385 . . . . 0.0 112.734 -173.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.557 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -150.65 146.98 26.84 Favored 'General case' 0 N--CA 1.427 -1.606 1 C-N-CA 135.435 5.494 . . . . 0.0 101.263 174.091 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -136.73 117.0 10.87 Favored Pre-proline 0 C--N 1.318 -0.802 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 177.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -68.31 159.81 51.68 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.977 2.451 . . . . 0.0 113.932 -173.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 21.7 p -138.58 161.86 36.02 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.89 2.076 . . . . 0.0 109.031 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.5 m -126.37 154.73 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.195 0.998 . . . . 0.0 111.784 174.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -80.17 10.11 4.82 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 127.522 2.329 . . . . 0.0 113.468 177.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.9 m -140.49 163.18 45.12 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 124.54 1.136 . . . . 0.0 109.72 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -66.67 161.91 39.55 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 121.454 1.436 . . . . 0.0 109.567 173.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -64.58 -12.25 43.22 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 124.232 1.013 . . . . 0.0 112.644 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -145.16 165.1 29.29 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.974 1.31 . . . . 0.0 108.023 173.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 161.08 -161.12 32.68 Favored Glycine 0 C--O 1.227 -0.286 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 68.5 p -119.06 148.21 43.28 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 173.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.0 t -80.12 113.41 38.29 Favored Pre-proline 0 N--CA 1.447 -0.608 0 N-CA-C 102.15 -3.278 . . . . 0.0 102.15 173.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -84.33 165.64 12.61 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.585 1.523 . . . . 0.0 114.647 -173.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -77.43 3.68 12.75 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 120.687 -1.258 . . . . 0.0 114.341 -173.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.67 134.09 55.23 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 173.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.86 110.84 0.46 Allowed 'General case' 0 C--O 1.231 0.13 0 C-N-CA 124.785 1.234 . . . . 0.0 108.664 176.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.2 m -118.78 140.29 50.19 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.3 t -94.98 114.81 32.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 124.156 0.983 . . . . 0.0 109.941 -173.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 77.7 t -93.84 103.48 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 103.342 -2.836 . . . . 0.0 103.342 173.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -89.26 125.37 35.07 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 173.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.5 t -95.39 113.68 30.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 103.939 -2.615 . . . . 0.0 103.939 173.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -94.17 144.77 17.32 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.477 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 6.2 m-85 -129.22 73.89 81.39 Favored Pre-proline 0 C--O 1.243 0.724 0 CA-C-N 117.903 0.851 . . . . 0.0 110.495 -174.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.09 122.47 9.78 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 N-CA-C 107.928 -1.605 . . . . 0.0 107.928 173.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.557 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 5.9 t -105.75 153.13 22.3 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 124.703 1.201 . . . . 0.0 107.97 173.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.7 mt -81.42 -10.27 59.55 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.371 0.532 . . . . 0.0 112.011 -175.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 54.21 42.73 73.63 Favored Glycine 0 C--O 1.222 -0.643 0 C-N-CA 126.78 2.133 . . . . 0.0 114.759 173.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -126.89 -29.99 2.78 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.592 1.696 . . . . 0.0 113.307 173.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -96.31 153.55 17.75 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 104.764 -2.31 . . . . 0.0 104.764 172.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -108.73 143.44 37.85 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 177.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 141.83 -154.86 25.1 Favored Glycine 0 C--N 1.334 0.435 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.0 t -130.38 113.91 27.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 123.398 0.679 . . . . 0.0 109.36 -177.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -88.88 168.82 12.1 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 173.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -127.22 160.53 31.01 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.729 0.812 . . . . 0.0 109.827 173.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.477 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 12.7 p90 -146.93 152.31 38.46 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.792 0.837 . . . . 0.0 109.51 173.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -112.23 150.23 31.18 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 127.102 2.161 . . . . 0.0 112.144 -173.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.541 HG22 HD22 ' A' ' 82' ' ' LEU . 95.3 t -139.17 141.33 36.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 124.815 1.246 . . . . 0.0 109.619 173.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -155.78 119.25 4.38 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 127.654 2.382 . . . . 0.0 105.436 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.406 ' H ' ' HB ' ' A' ' 143' ' ' THR . 45.1 t -129.45 125.28 61.45 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 179.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.484 HD13 ' O ' ' A' ' 78' ' ' GLU . 0.1 OUTLIER -92.56 161.52 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 173.86 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.9 t -137.52 135.12 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 -177.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.81 174.44 10.57 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 124.821 1.249 . . . . 0.0 108.355 -176.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -89.97 176.18 6.9 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 172.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.3 t -66.04 -3.68 5.85 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 120.233 -1.542 . . . . 0.0 113.765 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -89.71 -14.61 34.34 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 120.625 1.557 . . . . 0.0 110.612 173.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.62 0.46 64.59 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.581 1.086 . . . . 0.0 112.107 -173.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -69.74 115.77 9.36 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.507 1.653 . . . . 0.0 108.302 174.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -68.9 143.69 54.41 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.684 1.594 . . . . 0.0 108.821 -175.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -140.02 -37.73 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.667 1.187 . . . . 0.0 113.761 -174.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -132.78 149.14 52.31 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 10.0 tm0? -147.85 148.69 31.14 Favored 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 120.99 -1.069 . . . . 0.0 108.649 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.406 ' HB ' ' H ' ' A' ' 130' ' ' VAL . 27.1 m -80.2 113.29 37.58 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 175.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.33 146.09 79.67 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 CA-C-N 120.071 1.061 . . . . 0.0 110.856 -173.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -78.61 112.63 15.88 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 -173.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.488 28.2 m-80 172.49 -21.07 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 1 C-N-CA 136.276 5.831 . . . . 0.0 111.376 173.543 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -56.66 91.85 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.346 2.258 . . . . 0.0 110.355 176.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.6 mt -136.4 149.79 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.415 ' CD1' ' CZ ' ' A' ' 126' ' ' PHE . 0.8 OUTLIER -128.22 169.48 14.11 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 174.195 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -133.9 113.76 12.56 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.177 1.391 . . . . 0.0 107.523 -173.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 51.6 tttt -101.05 122.4 43.49 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 120.097 1.317 . . . . 0.0 109.173 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.6 m -83.52 118.39 23.75 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 173.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 20.3 m -114.55 165.22 12.99 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 173.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.4 pp -141.14 161.67 37.3 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.525 1.13 . . . . 0.0 108.666 174.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -74.67 126.82 31.66 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 128.447 2.699 . . . . 0.0 111.307 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -139.77 168.45 19.79 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 126.517 1.927 . . . . 0.0 108.989 173.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 . . . . . 0 C--O 1.247 0.921 0 C-N-CA 131.035 3.734 . . . . 0.0 104.629 174.116 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.467 0.412 0 N-CA-C 110.822 -0.066 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.0 tt -43.52 128.6 5.11 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 127.816 2.446 . . . . 0.0 112.435 -174.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -115.28 133.83 55.68 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.739 1.615 . . . . 0.0 108.822 173.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.56 120.85 10.22 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.2 p90 -135.15 170.88 15.24 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 119.201 0.91 . . . . 0.0 109.32 175.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mt -106.39 113.79 43.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 101.798 -3.408 . . . . 0.0 101.798 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -76.28 148.29 37.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 123.299 1.523 . . . . 0.0 113.373 -173.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.37 -22.4 66.09 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 113.388 -1.733 . . . . 0.0 114.84 -173.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -57.62 -38.67 75.35 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 119.448 1.022 . . . . 0.0 109.859 -177.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -69.3 -44.93 70.77 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 122.36 -0.212 . . . . 0.0 111.156 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.08 -31.28 69.87 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 119.118 -0.468 . . . . 0.0 112.006 173.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 38.2 ttm-85 . . . . . 0 N--CA 1.442 -0.865 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 173.55 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.534 0.337 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -161.17 124.85 3.34 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.183 1.793 . . . . 0.0 109.787 175.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -92.7 174.38 7.29 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.777 1.631 . . . . 0.0 106.964 173.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.2 mt -140.77 113.49 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 172.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.66 117.53 20.66 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -177.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.46 HG23 ' CD1' ' A' ' 42' ' ' PHE . 21.6 mt -89.96 -66.32 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 119.178 0.899 . . . . 0.0 108.825 177.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -111.92 116.47 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.541 1.536 . . . . 0.0 107.447 -173.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.5 p -112.47 116.08 29.7 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 173.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.287 2.8 pm0 45.29 40.2 4.99 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.813 1.645 . . . . 0.0 112.813 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.44 -30.7 1.42 Allowed Glycine 0 CA--C 1.544 1.906 0 C-N-CA 125.652 1.596 . . . . 0.0 114.101 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . 0.434 7.3 tmtt? -61.94 38.02 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.768 1 C-N-CA 138.838 6.855 . . . . 0.0 112.708 173.761 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 33.0 mtm -37.51 139.23 0.29 Allowed 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 126.69 1.996 . . . . 0.0 115.527 -172.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.42 164.49 43.52 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 112.673 -2.058 . . . . 0.0 108.964 173.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.27 32.69 0.31 Allowed 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 124.039 3.16 . . . . 0.0 112.395 174.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.46 ' CD1' HG23 ' A' ' 33' ' ' ILE . 12.5 p90 -52.91 -26.15 14.01 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.816 2.047 . . . . 0.0 111.843 -174.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.6 m -57.65 -30.31 65.31 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.038 1.735 . . . . 0.0 109.974 -174.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -56.44 -62.83 1.45 Allowed 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.501 1.121 . . . . 0.0 108.968 173.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -68.31 -25.41 65.11 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.397 1.079 . . . . 0.0 111.989 -174.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -72.37 -49.12 36.37 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.036 0.534 . . . . 0.0 110.026 174.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.518 ' CZ ' ' HA ' ' A' ' 47' ' ' ARG . 0.2 OUTLIER . . . . . 0 CA--C 1.553 1.068 0 C-N-CA 124.811 1.244 . . . . 0.0 111.883 -174.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.401 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 63.7 mmm . . . . . 0 CA--C 1.536 0.412 0 CA-C-O 117.355 -1.307 . . . . 0.0 113.688 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 53' ' ' MET . 79.0 Cg_endo -78.12 -98.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.881 1.721 . . . . 0.0 110.118 -173.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.24 124.79 24.09 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.213 -0.93 . . . . 0.0 109.748 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.5 mt -130.94 138.03 32.08 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 128.81 2.844 . . . . 0.0 106.842 -174.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -81.34 157.43 19.63 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.702 2.268 . . . . 0.0 111.655 174.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.3 p -42.94 -41.47 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 127.257 2.223 . . . . 0.0 112.908 174.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -58.25 -34.36 70.38 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 126.65 1.98 . . . . 0.0 113.077 -175.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.7 mm -71.62 112.89 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 102.863 -3.014 . . . . 0.0 102.863 174.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -95.48 -23.42 17.12 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 -177.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.6 m -149.8 166.03 30.69 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 125.118 1.367 . . . . 0.0 107.548 173.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 13.9 mmm -123.13 163.29 20.86 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 173.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -117.96 150.5 39.15 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 173.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -139.52 153.5 47.48 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 102.101 -3.296 . . . . 0.0 102.101 172.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.3 m -138.63 132.91 31.69 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -176.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -145.1 161.56 39.17 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.184 177.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -165.89 145.14 6.18 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 123.937 0.895 . . . . 0.0 110.689 173.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.71 177.2 7.76 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 173.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.19 99.81 10.55 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 125.281 1.432 . . . . 0.0 110.136 -173.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 47.3 -56.27 0.0 OUTLIER Glycine 0 CA--C 1.536 1.386 1 C-N-CA 132.613 4.911 . . . . 0.0 119.396 174.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -117.01 -16.53 10.5 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.518 2.159 . . . . 0.0 115.706 173.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.31 37.11 0.38 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 128.56 2.744 . . . . 0.0 116.92 -173.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -46.36 113.87 0.71 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 122.01 2.187 . . . . 0.0 110.549 -177.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -83.83 145.95 28.38 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 125.341 1.456 . . . . 0.0 107.51 174.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -94.05 150.89 19.93 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -133.8 160.18 38.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 119.869 1.213 . . . . 0.0 111.165 175.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.469 ' O ' HD13 ' A' ' 131' ' ' ILE . 29.5 tt0 -154.13 138.4 16.62 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 173.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -86.43 103.68 15.21 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.896 1.279 . . . . 0.0 109.025 -177.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.9 tt -68.3 -41.78 80.44 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.792 1.237 . . . . 0.0 107.862 175.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.4 m -136.88 141.34 42.76 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.096 0.958 . . . . 0.0 111.847 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.4 tt -171.27 92.99 0.16 Allowed 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 128.755 2.822 . . . . 0.0 104.579 173.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -162.32 149.86 14.03 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 118.501 -0.761 . . . . 0.0 109.994 -174.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.432 ' HB2' ' HA ' ' A' ' 92' ' ' ASP . 5.8 t -91.98 134.12 35.09 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 119.593 1.088 . . . . 0.0 109.843 173.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 71.2 mt -82.26 -26.32 33.29 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 116.314 -1.803 . . . . 0.0 110.788 177.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.405 ' OD2' HD12 ' A' ' 89' ' ' ILE . 28.3 t0 -93.94 144.96 24.98 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 121.155 1.798 . . . . 0.0 109.485 174.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.46 ' HE3' ' SD ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -113.94 -24.53 9.03 Favored 'General case' 0 N--CA 1.443 -0.796 1 C-N-CA 133.653 4.781 . . . . 0.0 113.822 178.35 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -71.14 -69.93 1.3 Allowed Glycine 0 CA--C 1.533 1.211 0 N-CA-C 107.12 -2.392 . . . . 0.0 107.12 173.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.407 HG22 ' O ' ' A' ' 89' ' ' ILE . 3.3 mp -78.48 26.3 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 128.579 2.752 . . . . 0.0 110.994 175.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.46 ' SD ' ' HE3' ' A' ' 87' ' ' LYS . 6.7 ttp -43.16 125.18 3.57 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.79 2.436 . . . . 0.0 111.247 -173.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -161.35 113.48 1.83 Allowed 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 101.272 -3.603 . . . . 0.0 101.272 -175.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.432 ' HA ' ' HB2' ' A' ' 84' ' ' SER 0.313 1.6 m-20 -112.97 127.45 26.82 Favored Pre-proline 0 C--N 1.319 -0.721 0 O-C-N 124.372 1.045 . . . . 0.0 110.913 -173.372 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.09 154.02 71.05 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 121.733 1.622 . . . . 0.0 110.318 -174.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 18.4 p -139.16 162.93 33.75 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.453 1.501 . . . . 0.0 108.482 174.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.0 m -126.5 150.39 32.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 123.829 0.852 . . . . 0.0 110.696 173.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -86.03 17.85 3.33 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.501 1.52 . . . . 0.0 111.463 173.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.6 m -132.49 163.03 53.45 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 125.651 1.58 . . . . 0.0 107.011 173.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -67.33 162.41 38.84 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 120.754 0.969 . . . . 0.0 109.767 173.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -64.38 -12.89 47.35 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.361 1.065 . . . . 0.0 111.774 176.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -140.78 164.39 30.34 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.239 1.415 . . . . 0.0 107.89 173.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.17 -161.26 33.82 Favored Glycine 0 C--O 1.227 -0.332 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 75.4 p -119.0 155.1 31.98 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 173.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 24.5 t -90.43 113.27 56.96 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 103.414 -2.809 . . . . 0.0 103.414 173.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -88.95 171.76 4.66 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.541 2.16 . . . . 0.0 114.491 -173.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -81.98 3.04 28.03 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 -173.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.5 133.84 55.55 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 114.869 -2.491 . . . . 0.0 106.834 173.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -44.95 111.06 0.28 Allowed 'General case' 0 C--O 1.232 0.171 0 O-C-N 125.808 1.942 . . . . 0.0 107.757 173.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.3 m -116.72 137.41 52.21 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.4 t -93.87 120.88 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 O-C-N 124.692 1.245 . . . . 0.0 108.794 -173.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.3 t -93.91 103.72 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 N-CA-C 103.094 -2.928 . . . . 0.0 103.094 173.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -84.2 119.24 24.79 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 173.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.4 t -95.0 113.5 29.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 104.249 -2.5 . . . . 0.0 104.249 174.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -86.34 143.14 19.26 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.407 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 14.6 m-85 -128.34 73.5 80.07 Favored Pre-proline 0 C--O 1.245 0.844 0 CA-C-N 118.333 1.066 . . . . 0.0 110.814 -178.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.55 120.33 7.28 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.332 2.021 . . . . 0.0 109.282 173.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 12.8 t -98.95 148.66 23.75 Favored 'General case' 0 C--N 1.342 0.276 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 173.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.3 mt -76.77 -13.52 60.01 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 117.88 0.309 . . . . 0.0 111.043 178.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 51.31 40.56 45.79 Favored Glycine 0 C--O 1.22 -0.765 0 C-N-CA 127.868 2.651 . . . . 0.0 115.137 173.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . 0.262 42.1 mttm -123.09 -29.67 3.86 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.847 1.824 . . . . 0.0 112.71 173.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -96.46 149.41 21.76 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 172.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -102.12 149.45 24.26 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 176.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.4 -154.56 23.59 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.7 t -128.78 113.83 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.01 166.04 15.37 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 173.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -123.81 145.02 49.36 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.715 1.206 . . . . 0.0 108.538 174.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.407 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 37.5 p90 -140.66 142.78 34.92 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 119.321 0.964 . . . . 0.0 110.317 174.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -104.07 144.79 31.09 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 126.768 2.027 . . . . 0.0 111.36 -173.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.0 t -140.05 139.12 37.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 173.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -155.15 130.6 9.75 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.906 1.682 . . . . 0.0 106.987 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.4 t -135.94 129.5 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -175.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.609 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -97.9 165.75 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 173.737 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.7 t -143.31 134.7 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 -174.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.01 174.35 10.66 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.876 1.27 . . . . 0.0 108.286 -175.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -89.95 176.13 6.92 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 104.667 -2.346 . . . . 0.0 104.667 172.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.1 t -66.2 -4.02 6.84 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 120.356 -1.465 . . . . 0.0 113.685 -177.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -89.34 -14.88 34.66 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 120.572 1.533 . . . . 0.0 110.657 173.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.04 0.42 63.67 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.591 1.091 . . . . 0.0 112.039 -173.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -69.57 115.51 8.9 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 119.494 1.647 . . . . 0.0 108.357 174.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -69.09 143.51 54.18 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.786 1.634 . . . . 0.0 108.81 -175.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -140.61 -37.29 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.62 1.168 . . . . 0.0 113.598 -174.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -130.5 145.43 51.85 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -143.98 136.06 26.49 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 91.7 m -66.87 128.03 93.71 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 174.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.41 143.4 43.02 Favored 'Trans proline' 0 N--CA 1.444 -1.436 0 CA-C-N 120.606 1.252 . . . . 0.0 109.122 -177.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -81.75 112.97 19.39 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 -174.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 173.17 -19.59 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.572 1 C-N-CA 135.116 5.366 . . . . 0.0 110.942 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.39 83.95 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.837 1.655 . . . . 0.0 111.4 -175.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.4 mt -125.21 135.57 63.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 175.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.401 ' HB2' ' CZ ' ' A' ' 126' ' ' PHE . 6.3 m-85 -106.32 161.94 14.11 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 125.911 1.684 . . . . 0.0 106.722 177.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -136.41 113.3 10.35 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 55.0 tttt -99.3 122.43 42.44 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 21.4 m -83.61 115.13 21.99 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 105.299 -2.112 . . . . 0.0 105.299 173.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 36.9 m -111.21 165.92 11.52 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 119.196 0.907 . . . . 0.0 109.192 173.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.5 pp -141.35 160.14 40.75 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.178 1.391 . . . . 0.0 107.694 173.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.99 131.11 43.87 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.795 1.238 . . . . 0.0 111.669 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -144.33 169.92 16.99 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 128.008 2.523 . . . . 0.0 107.693 173.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 . . . . . 0 C--O 1.255 1.385 0 C-N-CA 128.925 2.89 . . . . 0.0 106.057 173.857 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.6 m . . . . . 0 CA--C 1.538 0.488 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.9 tt -43.32 129.85 4.89 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 129.335 3.054 . . . . 0.0 113.285 -175.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -115.1 139.6 49.75 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.18 2.192 . . . . 0.0 108.441 173.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.25 117.97 6.19 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 126.05 1.74 . . . . 0.0 106.693 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 13.7 p90 -131.02 176.06 8.57 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.296 1.039 . . . . 0.0 110.083 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.5 mt -113.06 113.91 45.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 102.418 -3.179 . . . . 0.0 102.418 174.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -76.89 139.21 40.15 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 123.069 1.414 . . . . 0.0 111.967 -173.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.19 -25.54 61.7 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.276 1.83 . . . . 0.0 114.367 -173.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 13.6 m80 -56.53 -37.3 70.29 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 118.978 0.808 . . . . 0.0 110.018 -174.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 49.1 tp60 -66.83 -41.31 87.66 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 121.992 -0.443 . . . . 0.0 111.067 178.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.4 -35.4 80.77 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 121.683 -0.636 . . . . 0.0 110.904 173.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.512 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 173.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 . . . . . 0 CA--C 1.537 0.462 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -165.85 136.49 3.62 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 130.681 3.592 . . . . 0.0 107.507 174.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -86.45 176.21 7.98 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.093 1.757 . . . . 0.0 107.823 173.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.0 mp -137.54 113.1 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 173.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.52 115.23 26.79 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -176.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.5 mt -94.66 -53.94 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 118.635 0.652 . . . . 0.0 110.065 -176.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.464 HG22 ' HG2' ' A' ' 39' ' ' MET . 6.2 t -126.15 129.99 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 125.68 1.592 . . . . 0.0 107.703 -173.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.0 p -138.4 132.94 32.22 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 103.165 -2.902 . . . . 0.0 103.165 173.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.31 18.0 pm0 44.33 33.73 0.91 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.151 1.38 . . . . 0.0 113.796 -174.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.54 -4.17 14.87 Favored Glycine 0 CA--C 1.543 1.813 0 O-C-N 120.652 -1.28 . . . . 0.0 115.135 -176.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.469 ' HZ3' ' HB3' ' A' ' 38' ' ' LYS . 4.3 ttpm? -66.4 37.41 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.596 1 C-N-CA 132.467 4.307 . . . . 0.0 114.222 -176.74 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.464 ' HG2' HG22 ' A' ' 34' ' ' VAL . 31.4 mtt -38.07 114.33 0.35 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 120.183 1.356 . . . . 0.0 113.742 -173.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.56 164.79 29.19 Favored Pre-proline 0 N--CA 1.447 -0.599 0 CA-C-N 113.777 -1.556 . . . . 0.0 107.977 173.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.84 40.9 0.59 Allowed 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 124.215 3.276 . . . . 0.0 111.002 173.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -52.27 -26.26 11.46 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 127.913 2.485 . . . . 0.0 112.603 -173.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.9 m -44.01 -43.72 6.87 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.152 1.781 . . . . 0.0 111.619 177.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -60.81 -66.05 0.59 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.427 0.691 . . . . 0.0 110.191 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -73.98 -23.01 59.4 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.155 1.782 . . . . 0.0 114.062 -173.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -77.89 -56.81 4.19 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 124.669 1.187 . . . . 0.0 110.229 173.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 18.5 ttp180 . . . . . 0 C--N 1.345 0.386 0 O-C-N 121.657 -0.652 . . . . 0.0 109.873 -173.461 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 61.1 mmm . . . . . 0 N--CA 1.468 0.467 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.24 -74.21 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.195 1.93 . . . . 0.0 111.82 -173.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.73 113.42 14.36 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -174.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 62.9 mt -113.16 126.75 27.74 Favored Pre-proline 0 C--N 1.324 -0.536 0 C-N-CA 127.734 2.413 . . . . 0.0 105.803 -174.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -78.46 157.29 28.94 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 121.691 1.594 . . . . 0.0 110.356 176.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.4 p -45.7 -38.74 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 125.849 1.66 . . . . 0.0 111.975 173.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -55.91 -40.08 72.56 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 126.677 1.991 . . . . 0.0 112.832 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mm -77.11 112.73 15.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 101.914 -3.365 . . . . 0.0 101.914 173.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -79.92 -40.67 27.7 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 174.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.8 m -141.51 161.75 37.16 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.609 1.164 . . . . 0.0 110.053 -173.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 52.8 mtp -123.68 167.47 13.94 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.426 1.49 . . . . 0.0 107.092 173.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -114.03 155.85 25.17 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 174.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -140.75 151.54 44.54 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 130.489 3.516 . . . . 0.0 102.268 172.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.3 m -137.97 133.85 34.19 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -145.42 162.38 37.44 Favored 'General case' 0 C--O 1.238 0.473 0 O-C-N 121.857 -0.527 . . . . 0.0 111.198 178.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -167.36 153.36 7.78 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.969 0.89 . . . . 0.0 112.484 173.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.3 -173.65 4.83 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.333 1.453 . . . . 0.0 109.174 173.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.85 100.11 7.04 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.789 1.635 . . . . 0.0 108.324 -174.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.07 -63.29 0.0 OUTLIER Glycine 0 CA--C 1.538 1.522 0 C-N-CA 130.184 3.754 . . . . 0.0 119.016 173.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -116.88 -13.78 10.69 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 120.583 2.191 . . . . 0.0 114.113 173.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.59 37.1 0.17 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 129.136 2.975 . . . . 0.0 118.021 -173.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -53.58 113.68 1.26 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 122.873 2.579 . . . . 0.0 109.672 -177.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -84.06 129.95 34.89 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 126.187 1.795 . . . . 0.0 107.935 174.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -79.85 147.67 31.65 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -132.56 161.26 34.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 120.127 1.33 . . . . 0.0 111.182 176.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.503 ' O ' HD13 ' A' ' 131' ' ' ILE . 31.7 tt0 -152.71 137.24 16.8 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 173.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -81.68 104.08 11.83 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.635 1.174 . . . . 0.0 109.91 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.7 tt -67.36 -41.72 84.65 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.43 1.092 . . . . 0.0 108.114 174.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.8 m -133.87 141.29 47.33 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.881 0.872 . . . . 0.0 111.202 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.3 tt -171.95 93.07 0.14 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 104.15 -2.537 . . . . 0.0 104.15 173.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -162.18 156.73 22.17 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.024 0.829 . . . . 0.0 111.416 -173.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.6 t -75.99 161.95 28.48 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 173.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.6 mt -122.1 -26.33 4.75 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 116.99 -1.481 . . . . 0.0 112.045 174.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.422 ' CG ' ' H ' ' A' ' 87' ' ' LYS . 23.2 t0 -83.3 168.11 16.98 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 121.34 1.882 . . . . 0.0 111.604 177.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.422 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -111.3 -49.32 3.02 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 128.533 2.733 . . . . 0.0 112.501 179.099 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.84 -70.19 1.16 Allowed Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 174.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mp -79.75 18.63 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 128.786 2.834 . . . . 0.0 110.048 -174.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -43.93 134.11 4.68 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 127.061 2.144 . . . . 0.0 110.239 -175.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -157.51 113.76 2.89 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 126.118 1.767 . . . . 0.0 106.916 -173.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -97.34 132.43 25.46 Favored Pre-proline 0 C--N 1.324 -0.541 0 O-C-N 124.142 0.901 . . . . 0.0 109.876 -173.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.01 153.81 67.42 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 C-N-CA 121.409 1.406 . . . . 0.0 109.347 174.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 21.1 p -140.11 157.09 46.17 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 126.682 1.993 . . . . 0.0 107.439 174.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.9 m -126.33 153.66 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 119.648 1.113 . . . . 0.0 113.145 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -73.83 7.94 2.26 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 127.567 2.347 . . . . 0.0 113.647 174.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.6 m -140.75 164.89 33.44 Favored Pre-proline 0 C--N 1.326 -0.452 0 C-N-CA 125.648 1.579 . . . . 0.0 108.286 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -67.18 167.61 19.71 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 121.347 1.365 . . . . 0.0 110.937 174.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -63.22 -11.37 20.63 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.786 1.235 . . . . 0.0 112.119 175.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -145.07 164.3 31.64 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.22 1.408 . . . . 0.0 107.884 173.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.33 -161.74 34.28 Favored Glycine 0 C--O 1.227 -0.342 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 71.4 p -117.86 151.19 37.86 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.5 t -88.69 113.37 55.44 Favored Pre-proline 0 N--CA 1.448 -0.542 0 N-CA-C 102.84 -3.022 . . . . 0.0 102.84 173.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -90.09 160.02 4.83 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.803 2.336 . . . . 0.0 111.424 -173.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -74.18 4.44 5.65 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 119.753 -1.842 . . . . 0.0 113.3 -173.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -115.54 116.85 28.87 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 126.259 1.824 . . . . 0.0 106.736 -173.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -43.06 105.37 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 125.039 1.336 . . . . 0.0 109.755 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.3 m -112.02 136.0 51.94 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.0 t -95.68 116.09 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.05 -173.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 82.5 t -93.76 103.27 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 N-CA-C 103.476 -2.787 . . . . 0.0 103.476 173.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.58 120.11 25.11 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 103.324 -2.843 . . . . 0.0 103.324 173.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.4 t -94.7 113.64 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 104.23 -2.507 . . . . 0.0 104.23 173.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -92.36 149.42 19.62 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 175.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.458 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 9.8 m-85 -131.13 73.64 80.42 Favored Pre-proline 0 C--O 1.242 0.7 0 CA-C-N 118.544 1.172 . . . . 0.0 110.422 -176.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -62.94 116.14 3.38 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.479 2.119 . . . . 0.0 109.309 173.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 9.2 t -93.67 147.67 22.81 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 173.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.4 mt -74.16 -13.48 60.81 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.134 0.425 . . . . 0.0 111.822 -176.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.8 34.3 89.57 Favored Glycine 0 C--N 1.34 0.804 0 C-N-CA 125.757 1.646 . . . . 0.0 114.352 173.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.7 mttm -114.9 -50.64 2.76 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.349 1.575 . . . . 0.0 112.442 -173.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 48.6 tp60 -96.06 147.49 23.66 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 173.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -93.93 142.12 27.74 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 175.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.72 -154.83 26.09 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-N 118.781 0.719 . . . . 0.0 111.649 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.6 t -129.96 116.73 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 123.846 0.858 . . . . 0.0 108.789 -179.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -92.42 175.3 6.89 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.15 1.38 . . . . 0.0 109.297 173.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -128.6 155.03 45.59 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.767 1.627 . . . . 0.0 107.386 173.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.458 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 40.3 p90 -147.05 157.84 43.74 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.576 1.15 . . . . 0.0 108.035 173.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -123.36 150.52 43.57 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.542 1.537 . . . . 0.0 111.909 -173.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 62.5 t -141.45 143.2 27.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 173.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -160.81 136.13 7.85 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.023 1.329 . . . . 0.0 107.687 174.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.7 t -136.79 139.26 45.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-N 119.51 1.05 . . . . 0.0 109.265 -173.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.542 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -106.9 163.64 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 173.743 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.6 t -141.74 137.81 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -173.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.31 174.12 10.89 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.542 1.537 . . . . 0.0 108.416 -176.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -88.84 175.8 7.32 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 172.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 6.1 t -65.1 -14.86 61.55 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 120.212 -1.555 . . . . 0.0 112.112 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -80.12 -3.3 48.25 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.73 1.612 . . . . 0.0 110.65 176.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.22 5.66 89.9 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 125.123 1.345 . . . . 0.0 112.996 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -80.92 118.19 22.2 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.5 m -64.71 143.07 58.19 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.434 1.493 . . . . 0.0 108.748 -178.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -140.07 -37.26 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.774 1.23 . . . . 0.0 113.626 -175.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -130.56 141.08 50.47 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -146.6 126.35 13.46 Favored 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 121.422 -0.799 . . . . 0.0 109.081 -176.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 30.3 m -67.52 142.68 96.47 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 173.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -83.59 147.55 12.4 Favored 'Trans proline' 0 N--CA 1.443 -1.477 0 N-CA-C 108.731 -1.296 . . . . 0.0 108.731 174.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -75.46 112.63 11.99 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 103.505 -2.776 . . . . 0.0 103.505 -178.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 173.73 -23.81 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 128.17 2.588 . . . . 0.0 112.17 -173.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.89 87.34 0.14 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 122.208 1.004 . . . . 0.0 108.428 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.9 mt -127.84 147.91 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -174.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 126' ' ' PHE . 0.5 OUTLIER -134.28 167.89 19.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 113.971 -1.468 . . . . 0.0 107.298 -176.783 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -135.33 113.5 11.3 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.175 0.99 . . . . 0.0 109.456 -173.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -104.22 122.43 45.36 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 119.435 1.016 . . . . 0.0 109.431 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 25.6 m -83.68 115.44 22.17 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 174.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 5.0 m -116.78 166.3 12.3 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.496 0.665 . . . . 0.0 110.163 174.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.3 pp -134.12 162.45 32.07 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.109 1.364 . . . . 0.0 107.539 173.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -73.57 114.72 12.13 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 127.738 2.415 . . . . 0.0 109.463 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -163.5 118.54 1.64 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.335 1.454 . . . . 0.0 109.79 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 . . . . . 0 C--O 1.256 1.416 0 C-N-CA 128.667 2.787 . . . . 0.0 105.914 173.743 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 m . . . . . 0 CA--C 1.545 0.755 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.52 HD23 ' N ' ' A' ' 13' ' ' TYR . 5.5 tt -46.57 136.8 7.32 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.165 1.786 . . . . 0.0 112.788 -174.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.52 ' N ' HD23 ' A' ' 12' ' ' LEU . 54.6 m-85 -122.07 137.03 54.96 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.317 1.447 . . . . 0.0 110.249 175.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.79 119.12 6.38 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.57 1.548 . . . . 0.0 107.803 -178.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.462 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 30.9 p90 -142.84 148.08 36.47 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.641 1.109 . . . . 0.0 109.541 -178.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.0 mp -84.12 118.53 31.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 102.893 -3.003 . . . . 0.0 102.893 173.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.03 143.81 29.51 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 123.691 1.71 . . . . 0.0 114.313 -173.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.459 ' HB1' ' HG3' ' A' ' 28' ' ' GLU . . . -72.75 -26.11 61.44 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 112.774 -2.012 . . . . 0.0 113.636 -173.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.9 m80 -62.63 -38.25 89.52 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 122.926 0.49 . . . . 0.0 110.519 -173.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -71.54 -49.3 42.14 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.149 174.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.61 -43.06 56.74 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-O 118.404 -0.807 . . . . 0.0 111.218 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.0 ttp-105 . . . . . 0 C--O 1.225 -0.217 0 CA-C-N 119.797 1.181 . . . . 0.0 108.452 173.526 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.459 ' HG3' ' HB1' ' A' ' 18' ' ' ALA . 36.5 tt0 . . . . . 0 CA--C 1.535 0.368 0 CA-C-O 119.904 -0.093 . . . . 0.0 111.039 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -150.7 144.98 25.52 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.437 2.695 . . . . 0.0 106.383 173.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -96.03 164.83 12.54 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 173.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.2 mp -135.27 113.38 15.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 103.858 -2.645 . . . . 0.0 103.858 173.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.462 ' HG ' ' HB3' ' A' ' 15' ' ' TRP . 4.4 tt -94.62 114.07 25.97 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -173.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.6 mt -83.86 -61.75 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 124.349 1.06 . . . . 0.0 108.281 -174.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.455 HG11 HD22 ' A' ' 12' ' ' LEU . 25.1 t -117.1 113.66 43.46 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -173.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.4 p -111.92 125.93 54.58 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 102.616 -3.105 . . . . 0.0 102.616 173.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 46.08 38.2 4.56 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.148 1.379 . . . . 0.0 112.508 174.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 54.98 19.84 16.96 Favored Glycine 0 CA--C 1.539 1.58 0 C-N-CA 124.992 1.282 . . . . 0.0 113.824 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -122.97 37.97 4.29 Favored 'General case' 0 CA--C 1.536 0.434 1 C-N-CA 131.861 4.064 . . . . 0.0 108.051 -172.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.42 ' HG2' HG22 ' A' ' 34' ' ' VAL 0.272 20.2 mtp -37.29 146.71 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 130.762 3.625 . . . . 0.0 115.696 -172.508 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.72 162.07 75.12 Favored Pre-proline 0 N--CA 1.452 -0.368 0 CA-C-N 113.141 -1.845 . . . . 0.0 109.314 173.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.09 42.36 0.98 Allowed 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 124.552 3.501 . . . . 0.0 111.609 174.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -53.86 -26.58 25.32 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.647 1.979 . . . . 0.0 113.197 -174.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.5 m -58.25 -29.35 65.69 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 126.501 1.92 . . . . 0.0 111.434 -173.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 62.8 t60 -62.86 -66.48 0.54 Allowed 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 118.64 0.655 . . . . 0.0 109.346 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.63 -23.82 65.4 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -175.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -67.96 -47.62 68.14 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.68 1.192 . . . . 0.0 111.223 174.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.517 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -173.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 88.2 mtp . . . . . 0 CA--C 1.539 0.532 0 CA-C-O 115.587 -2.149 . . . . 0.0 115.661 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -51.34 -68.45 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.949 0 CA-C-N 123.08 2.136 . . . . 0.0 114.641 -173.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.27 113.9 22.65 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 177.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.9 mt -103.85 118.84 56.27 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 127.008 2.123 . . . . 0.0 105.761 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -74.48 153.95 44.88 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 121.355 1.37 . . . . 0.0 110.164 176.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.3 p -39.93 -44.28 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 127.483 2.313 . . . . 0.0 113.321 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -58.71 -34.43 71.3 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 126.706 2.002 . . . . 0.0 113.567 -176.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.0 mm -71.36 113.08 7.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 104.362 -2.458 . . . . 0.0 104.362 175.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -79.85 -39.34 30.86 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 173.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.2 m -153.06 162.29 41.49 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -173.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 54.5 mtm -126.69 162.4 25.87 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 172.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 39.1 m-20 -120.47 114.09 21.28 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 118.509 0.595 . . . . 0.0 109.725 -175.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -94.32 150.69 20.05 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 102.3 -3.222 . . . . 0.0 102.3 172.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.9 m -139.5 135.68 33.75 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 -175.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -148.96 165.81 30.48 Favored 'General case' 0 CA--C 1.509 -0.611 0 O-C-N 121.572 -0.705 . . . . 0.0 110.525 -178.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -165.37 149.7 8.66 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.587 173.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.02 177.52 4.29 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 172.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.91 143.57 26.78 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 100.998 -3.705 . . . . 0.0 100.998 173.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -1.25 -73.99 0.0 OUTLIER Glycine 0 C--N 1.302 -1.324 1 C-N-CA 133.88 5.514 . . . . 0.0 117.721 -173.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.401 ' HA ' ' CE1' ' A' ' 105' ' ' HIS 0.273 21.4 mm100 -117.35 23.95 11.46 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 173.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -108.99 37.47 2.55 Favored 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 130.859 3.664 . . . . 0.0 120.693 -173.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.497 ' H ' ' HE1' ' A' ' 105' ' ' HIS . 13.8 mt-10 -39.61 116.2 0.6 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 122.34 2.337 . . . . 0.0 113.785 -173.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -84.4 132.68 34.56 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 174.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -83.82 149.08 26.63 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 175.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -134.05 159.76 39.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 119.473 1.033 . . . . 0.0 111.133 175.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.5 ' O ' HD13 ' A' ' 131' ' ' ILE . 30.6 tt0 -152.83 137.93 17.33 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 173.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -85.86 104.02 15.14 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.592 1.157 . . . . 0.0 110.041 -176.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.2 tt -61.34 -43.88 98.12 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.69 1.596 . . . . 0.0 108.687 173.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.6 m -134.25 143.73 47.97 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.558 1.143 . . . . 0.0 111.723 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.2 tt -172.36 92.79 0.12 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 103.477 -2.786 . . . . 0.0 103.477 173.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -168.89 152.79 5.45 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 118.833 0.742 . . . . 0.0 111.025 -174.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.7 t -79.43 127.75 32.5 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.0 mt -87.01 -26.57 23.69 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 116.67 -1.633 . . . . 0.0 110.857 174.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -86.79 152.42 22.51 Favored 'General case' 0 C--N 1.348 0.508 0 CA-C-N 120.9 1.682 . . . . 0.0 109.377 173.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.26 -36.54 6.25 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 128.892 2.877 . . . . 0.0 112.678 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -68.71 -75.95 0.48 Allowed Glycine 0 CA--C 1.53 1.025 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 173.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.1 mp -74.21 20.03 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 129.951 3.3 . . . . 0.0 110.441 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 14.0 ttp -43.42 130.81 5.01 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 127.402 2.281 . . . . 0.0 111.255 -173.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -153.65 113.37 3.85 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 -175.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -99.58 132.81 22.5 Favored Pre-proline 0 C--N 1.322 -0.615 0 O-C-N 124.286 0.991 . . . . 0.0 109.239 -173.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.9 153.67 72.28 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 C-N-CA 121.084 1.19 . . . . 0.0 109.338 174.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 17.1 p -137.57 152.57 49.56 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 126.244 1.817 . . . . 0.0 106.436 173.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.8 m -126.37 153.98 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 CA-C-N 118.966 0.803 . . . . 0.0 112.268 177.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -75.94 8.46 3.12 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.38 1.872 . . . . 0.0 113.822 174.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.67 165.1 32.13 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 124.777 1.231 . . . . 0.0 109.481 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -66.87 166.01 24.03 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.536 1.49 . . . . 0.0 110.478 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -66.97 -10.32 48.11 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.579 1.152 . . . . 0.0 112.256 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -144.28 164.1 31.76 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.564 1.545 . . . . 0.0 107.398 173.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 160.3 -161.42 32.54 Favored Glycine 0 C--O 1.228 -0.24 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 73.1 p -118.0 151.44 37.47 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.5 t -88.92 113.59 56.62 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 175.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.4 154.85 40.93 Favored 'Trans proline' 0 CA--C 1.512 -0.598 0 C-N-CA 121.839 1.692 . . . . 0.0 111.161 -176.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.497 ' HE1' ' H ' ' A' ' 74' ' ' GLU . 12.8 m-70 -74.4 -7.07 51.67 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 120.353 -1.467 . . . . 0.0 113.687 -172.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.6 mptt -116.51 122.69 45.45 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 -174.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -38.73 111.39 0.17 Allowed 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 127.123 2.169 . . . . 0.0 111.76 -173.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 57.6 m -118.62 144.54 46.07 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 176.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.0 t -100.63 117.42 45.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 124.835 1.254 . . . . 0.0 111.303 -173.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.2 t -98.47 103.06 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 104.501 -2.407 . . . . 0.0 104.501 173.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -78.55 131.12 36.66 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 104.859 -2.275 . . . . 0.0 104.859 173.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.4 t -103.11 113.45 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 101.634 -3.469 . . . . 0.0 101.634 173.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -97.06 150.26 19.51 Favored Glycine 0 N--CA 1.439 -1.123 0 N-CA-C 108.621 -1.791 . . . . 0.0 108.621 176.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -133.3 73.54 73.83 Favored Pre-proline 0 C--O 1.242 0.7 0 CA-C-N 118.199 1.0 . . . . 0.0 109.402 -174.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -63.8 116.97 3.99 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.649 2.233 . . . . 0.0 109.885 173.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 7.1 t -90.75 146.43 23.99 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 173.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.9 mt -74.27 -12.34 60.52 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 117.856 0.298 . . . . 0.0 111.371 -177.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.61 21.76 43.75 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 127.123 2.297 . . . . 0.0 116.527 173.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . 0.339 4.6 mptp? -102.16 -40.9 6.59 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.984 1.892 . . . . 0.0 114.451 174.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 38.8 tp60 -96.49 146.1 25.09 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.469 1.032 . . . . 0.0 108.467 173.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -94.38 152.06 18.91 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.446 1.498 . . . . 0.0 107.869 174.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 138.06 -152.77 21.97 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.9 t -127.67 114.12 34.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.16 173.36 9.28 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.59 1.156 . . . . 0.0 109.307 173.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -128.24 150.27 50.11 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.338 1.855 . . . . 0.0 106.58 173.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -147.74 154.35 40.42 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 173.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -113.54 141.26 47.36 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.776 1.63 . . . . 0.0 110.291 -173.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 61.1 t -146.71 113.53 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 N-CA-C 104.258 -2.497 . . . . 0.0 104.258 173.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -144.19 137.77 27.62 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -174.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.0 t -136.62 148.9 26.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 121.794 0.807 . . . . 0.0 110.071 -173.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.5 HD13 ' O ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -115.74 162.64 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 173.714 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.7 t -139.08 136.08 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 -173.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.33 175.53 9.5 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 125.495 1.518 . . . . 0.0 107.371 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -92.95 176.12 6.54 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 172.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.2 t -65.89 -3.92 5.98 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 120.03 -1.669 . . . . 0.0 113.442 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -86.02 -15.24 42.05 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 120.697 1.59 . . . . 0.0 110.41 173.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.08 -0.63 66.81 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.73 1.157 . . . . 0.0 111.964 -173.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -70.15 116.04 10.05 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 119.456 1.628 . . . . 0.0 108.346 174.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -64.66 141.95 58.59 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.915 1.686 . . . . 0.0 107.951 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.8 pt -140.07 -37.25 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 124.481 1.113 . . . . 0.0 113.71 -174.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -133.97 145.42 49.51 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -147.45 136.99 22.73 Favored 'General case' 0 CA--C 1.516 -0.354 0 O-C-N 121.339 -0.851 . . . . 0.0 109.269 -176.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 35.5 m -72.33 129.84 86.9 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 173.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.4 143.94 35.72 Favored 'Trans proline' 0 N--CA 1.444 -1.415 0 N-CA-C 108.302 -1.461 . . . . 0.0 108.302 175.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 28.3 mp0 -79.37 112.38 16.55 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -173.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.547 25.6 m-80 172.48 -4.52 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.513 1 C-N-CA 136.115 5.766 . . . . 0.0 112.121 173.472 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.66 86.45 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 123.428 1.585 . . . . 0.0 108.836 174.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.9 mm -133.98 139.39 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 127.747 2.419 . . . . 0.0 105.522 -173.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -122.98 167.13 13.99 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 173.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -129.85 113.55 14.79 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 -173.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 57.7 tttt -102.16 121.74 42.8 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 119.748 1.158 . . . . 0.0 108.715 -176.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 30.1 m -83.61 116.86 22.81 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 104.84 -2.281 . . . . 0.0 104.84 173.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 13.2 m -117.85 166.12 12.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.304 0.573 . . . . 0.0 110.315 174.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.5 pp -137.12 159.27 42.39 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.636 1.574 . . . . 0.0 107.359 173.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.61 132.59 45.69 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.236 1.014 . . . . 0.0 110.463 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -153.35 161.75 42.01 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.177 1.791 . . . . 0.0 108.68 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 . . . . . 0 C--O 1.255 1.357 0 C-N-CA 129.898 3.279 . . . . 0.0 105.109 173.723 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.6 m . . . . . 0 CA--C 1.544 0.728 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.1 tt -44.71 127.32 6.14 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.764 2.026 . . . . 0.0 113.487 -176.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -115.64 128.35 55.86 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.261 1.825 . . . . 0.0 109.185 174.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.93 118.07 11.27 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 127.135 2.174 . . . . 0.0 107.388 -178.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 9.0 p90 -133.81 170.89 14.92 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.184 0.994 . . . . 0.0 110.229 176.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.0 mp -108.02 115.15 48.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 102.187 -3.264 . . . . 0.0 102.187 173.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -82.2 142.52 32.11 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 123.32 1.533 . . . . 0.0 112.967 -173.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.62 -16.83 51.88 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.884 1.674 . . . . 0.0 115.32 -173.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 27.7 m80 -58.03 -35.34 71.16 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.51 1.05 . . . . 0.0 110.458 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -70.52 -46.64 63.26 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 122.313 -0.242 . . . . 0.0 111.052 177.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.97 -31.57 65.17 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 118.907 -0.568 . . . . 0.0 112.136 174.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.7 tpp85 . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 173.379 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 . . . . . 0 CA--C 1.528 0.132 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -153.02 113.28 3.99 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.693 1.197 . . . . 0.0 109.752 174.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -96.4 161.19 14.03 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 172.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.1 mm -138.65 113.39 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 173.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.31 113.89 20.41 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.4 mt -86.04 -65.6 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 32.0 t -114.73 114.23 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 -173.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.8 p -113.05 115.17 27.92 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 103.8 -2.667 . . . . 0.0 103.8 173.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.258 6.4 pt-20 44.43 45.97 7.74 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.689 1.195 . . . . 0.0 113.013 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 67.53 -7.28 2.09 Favored Glycine 0 CA--C 1.541 1.672 0 C-N-CA 125.804 1.669 . . . . 0.0 114.817 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -83.22 37.43 0.55 Allowed 'General case' 0 CA--C 1.539 0.533 1 C-N-CA 133.323 4.649 . . . . 0.0 109.022 -173.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 52.1 mtm -37.98 132.09 1.01 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 127.166 2.186 . . . . 0.0 114.54 -172.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.48 160.62 78.56 Favored Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.347 173.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.36 35.33 0.43 Allowed 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 124.215 3.277 . . . . 0.0 112.039 175.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -54.71 -26.59 34.82 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.481 1.913 . . . . 0.0 112.793 -173.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.7 m -48.82 -47.05 42.68 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 129.219 3.007 . . . . 0.0 112.861 -173.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -59.17 -59.08 6.04 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.258 1.023 . . . . 0.0 109.944 -175.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.298 47.0 m-20 -76.74 -27.93 55.58 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.289 -175.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -61.21 -50.52 72.78 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 120.91 -1.119 . . . . 0.0 108.767 173.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 . . . . . 0 C--N 1.346 0.426 0 CA-C-O 118.576 -0.726 . . . . 0.0 110.651 178.275 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 78.6 mmm . . . . . 0 CA--C 1.533 0.31 0 CA-C-O 117.549 -1.215 . . . . 0.0 113.936 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.52 -66.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 121.93 1.753 . . . . 0.0 113.482 -173.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.7 113.82 8.18 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.461 0.704 . . . . 0.0 110.238 -174.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 38.6 mt -124.35 132.15 24.27 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 126.421 1.888 . . . . 0.0 108.187 -173.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -80.04 157.83 23.68 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.854 2.369 . . . . 0.0 111.559 174.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.6 p -42.77 -43.49 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 127.058 2.143 . . . . 0.0 112.791 175.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -60.09 -34.19 73.13 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 126.29 1.836 . . . . 0.0 113.106 -174.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 mm -71.8 112.95 7.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 103.107 -2.923 . . . . 0.0 103.107 174.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 -94.75 -23.46 17.53 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.2 m -152.12 161.42 42.66 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.308 1.043 . . . . 0.0 108.59 173.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 16.8 mtm -126.19 156.96 39.37 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 173.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.252 59.8 m-20 -96.46 150.42 20.63 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 174.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -138.09 151.34 47.72 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 130.985 3.714 . . . . 0.0 101.799 172.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.4 m -137.35 130.65 31.0 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 -177.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -144.1 165.05 28.9 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.72 175.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -167.01 154.87 9.42 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.493 173.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.24 -174.51 2.37 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 123.403 1.573 . . . . 0.0 107.031 172.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.11 135.56 45.38 Favored 'General case' 0 N--CA 1.411 -2.375 0 C-N-CA 130.812 3.645 . . . . 0.0 101.873 173.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -7.45 -56.42 0.01 OUTLIER Glycine 0 CA--C 1.54 1.615 1 C-N-CA 133.801 5.477 . . . . 0.0 120.022 -173.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -116.93 9.89 13.9 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 121.207 2.504 . . . . 0.0 114.862 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -107.43 37.44 2.4 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 120.759 3.615 . . . . 0.0 120.759 -172.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -44.81 113.63 0.59 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 123.559 2.89 . . . . 0.0 110.601 -175.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -84.99 121.32 27.6 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -174.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -73.98 144.51 45.18 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 178.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -130.28 161.02 32.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 119.358 0.981 . . . . 0.0 110.781 176.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.433 ' O ' HD13 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -152.57 133.94 14.4 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 173.263 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -84.01 103.23 13.09 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -176.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.5 tt -64.72 -40.46 95.38 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 125.566 1.546 . . . . 0.0 108.32 176.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.0 m -148.83 142.86 25.88 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 120.499 -1.376 . . . . 0.0 110.358 177.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.9 tt -164.94 93.02 0.61 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 101.658 -3.46 . . . . 0.0 101.658 173.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 42.1 mmm-85 -166.01 163.32 18.31 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.09 0.956 . . . . 0.0 110.646 -177.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 126' ' ' PHE . 8.8 t -91.47 158.25 16.59 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.99 1.316 . . . . 0.0 113.792 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.0 mt -110.13 -26.46 9.66 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.256 -1.338 . . . . 0.0 111.261 177.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -76.74 169.73 17.75 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 120.495 1.498 . . . . 0.0 109.349 -174.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.7 mmtm -131.1 -46.3 1.01 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.602 1.961 . . . . 0.0 111.307 -173.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -70.38 -71.29 1.03 Allowed Glycine 0 CA--C 1.533 1.208 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 173.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.644 HD12 ' H ' ' A' ' 89' ' ' ILE . 3.7 mp -70.04 12.19 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 129.805 3.242 . . . . 0.0 111.07 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 28.5 ttp -43.69 142.31 1.28 Allowed 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 128.304 2.642 . . . . 0.0 112.193 -174.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.252 . . -161.95 174.98 12.32 Favored 'General case' 0 N--CA 1.439 -0.976 1 C-N-CA 131.851 4.06 . . . . 0.0 104.492 -173.572 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -151.32 137.4 11.19 Favored Pre-proline 0 C--N 1.321 -0.661 0 C-N-CA 124.359 1.064 . . . . 0.0 110.014 172.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -71.7 157.86 54.65 Favored 'Trans proline' 0 N--CA 1.443 -1.496 0 C-N-CA 121.396 1.397 . . . . 0.0 109.081 173.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 20.2 p -142.75 161.94 36.76 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 126.916 2.087 . . . . 0.0 107.28 174.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.9 m -126.44 150.97 32.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 123.532 0.733 . . . . 0.0 110.738 174.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -82.86 15.73 2.57 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.441 1.497 . . . . 0.0 111.482 173.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.2 m -129.6 163.24 48.09 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 173.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -67.47 162.75 37.59 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 CA-C-N 119.659 0.914 . . . . 0.0 109.91 173.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.52 -6.73 8.03 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.811 1.244 . . . . 0.0 111.693 175.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -145.9 163.22 35.78 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.621 1.569 . . . . 0.0 107.249 173.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 162.13 -160.2 32.3 Favored Glycine 0 C--O 1.227 -0.294 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 80.7 p -120.82 146.41 46.57 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 173.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.0 t -87.45 113.68 55.23 Favored Pre-proline 0 N--CA 1.448 -0.549 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 173.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -84.41 156.35 12.51 Favored 'Trans proline' 0 C--O 1.213 -0.736 0 C-N-CA 122.546 2.164 . . . . 0.0 112.402 -174.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -71.11 1.13 6.24 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 120.248 -1.532 . . . . 0.0 111.714 -174.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -114.03 115.6 27.86 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 128.102 2.561 . . . . 0.0 108.125 -173.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -41.56 108.74 0.1 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.096 1.358 . . . . 0.0 110.056 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.7 m -119.25 139.34 52.05 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.61 118.9 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 114.447 -1.252 . . . . 0.0 108.621 -173.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 75.9 t -93.88 104.21 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 173.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -82.34 115.04 21.21 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 104.532 -2.396 . . . . 0.0 104.532 173.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.3 t -93.33 113.82 28.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 104.111 -2.551 . . . . 0.0 104.111 174.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -89.19 144.86 18.21 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 124.891 1.234 . . . . 0.0 110.33 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -129.63 73.6 81.41 Favored Pre-proline 0 C--O 1.244 0.769 0 CA-C-N 118.754 1.277 . . . . 0.0 111.052 -175.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.3 129.06 19.53 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.397 2.064 . . . . 0.0 109.117 173.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 5.7 t -105.82 154.61 20.28 Favored 'General case' 0 C--N 1.338 0.1 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 174.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.8 mt -71.96 -17.01 62.1 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.568 0.622 . . . . 0.0 111.593 177.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 50.65 39.19 37.7 Favored Glycine 0 C--O 1.219 -0.793 0 C-N-CA 127.336 2.398 . . . . 0.0 114.809 173.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 42.9 mttm -124.4 -28.0 3.69 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.724 1.762 . . . . 0.0 112.032 173.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -96.53 155.66 16.67 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 172.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -109.42 150.75 27.61 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 138.59 -154.23 22.97 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 174.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 19.0 t -124.77 114.19 39.46 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -88.6 168.47 12.53 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 173.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -131.6 142.38 49.88 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.561 1.145 . . . . 0.0 108.715 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 33.6 p90 -143.34 150.44 39.17 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 125.829 1.651 . . . . 0.0 108.194 174.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -129.95 164.64 23.79 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 119.671 1.123 . . . . 0.0 113.285 177.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 57.3 t -131.62 148.56 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 125.613 1.565 . . . . 0.0 108.512 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -155.66 132.96 10.88 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 125.978 1.711 . . . . 0.0 108.078 173.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 36.5 t -137.15 143.46 34.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -174.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.532 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -110.25 163.46 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 173.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.9 t -140.3 137.59 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 CA-C-N 114.185 -1.37 . . . . 0.0 107.337 -173.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.79 174.71 10.33 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 125.957 1.703 . . . . 0.0 107.619 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 45.0 p-10 -89.68 176.01 7.03 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 172.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.8 t -66.1 -3.6 5.82 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 120.098 -1.626 . . . . 0.0 113.484 -177.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -86.69 -17.7 33.09 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 120.613 1.551 . . . . 0.0 110.452 173.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 97.6 1.13 59.02 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.783 1.182 . . . . 0.0 112.251 -173.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 65.4 m-20 -72.29 115.14 11.18 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 119.608 1.704 . . . . 0.0 108.701 174.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.5 m -64.8 143.0 58.24 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.498 1.919 . . . . 0.0 108.624 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -141.29 -36.82 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 124.708 1.203 . . . . 0.0 113.973 -175.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -131.91 144.18 50.67 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -144.13 130.2 19.55 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 35.6 m -68.79 149.07 98.01 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 173.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -89.17 144.92 5.08 Favored 'Trans proline' 0 N--CA 1.444 -1.386 0 CA-C-N 120.84 1.336 . . . . 0.0 109.646 173.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -78.84 112.58 16.13 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 -174.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 172.99 -18.4 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 128.12 2.568 . . . . 0.0 114.331 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.9 79.06 0.12 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.999 0.92 . . . . 0.0 112.08 -173.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.425 HG21 ' CZ ' ' A' ' 150' ' ' PHE . 3.3 mm -86.83 148.03 4.92 Favored 'Isoleucine or valine' 0 C--N 1.345 0.38 0 C-N-CA 127.341 2.256 . . . . 0.0 109.361 174.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -125.88 128.41 47.55 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 129.484 3.114 . . . . 0.0 103.12 173.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.425 ' CZ ' HG21 ' A' ' 148' ' ' ILE . 66.0 m-85 -102.49 113.26 26.46 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 178.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 56.1 tttt -103.1 121.58 42.9 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 28.9 m -83.38 114.65 21.58 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 174.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 21.8 m -113.09 165.5 12.31 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 119.01 0.823 . . . . 0.0 109.459 174.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.4 pp -141.75 161.61 37.52 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.067 1.347 . . . . 0.0 108.098 174.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.91 130.2 42.24 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.621 1.168 . . . . 0.0 111.843 178.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -144.06 170.34 16.12 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 128.239 2.616 . . . . 0.0 107.606 173.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 . . . . . 0 C--O 1.254 1.314 0 C-N-CA 128.881 2.872 . . . . 0.0 106.075 173.812 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.6 m . . . . . 0 CA--C 1.537 0.443 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.2 tt -42.99 121.91 2.26 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 127.132 2.173 . . . . 0.0 113.469 -173.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -111.76 139.84 46.9 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.265 2.226 . . . . 0.0 108.435 174.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.07 118.28 6.81 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 21.2 p90 -139.42 152.24 46.91 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 119.205 0.912 . . . . 0.0 109.58 177.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.8 mt -83.91 127.86 39.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 102.579 -3.119 . . . . 0.0 102.579 173.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -104.69 136.9 43.35 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 122.9 1.333 . . . . 0.0 111.856 -173.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.2 -22.38 66.88 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.206 -1.361 . . . . 0.0 113.891 -174.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -58.36 -37.9 76.15 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 119.564 1.075 . . . . 0.0 111.422 -173.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -71.19 -51.12 26.57 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 117.816 -1.088 . . . . 0.0 110.151 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.71 -41.73 61.72 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.034 0.834 . . . . 0.0 111.009 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 173.943 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.456 -0.168 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -162.16 126.45 3.21 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.067 2.147 . . . . 0.0 107.506 176.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -96.24 159.08 15.14 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 172.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.2 mp -135.56 113.17 14.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 173.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.67 114.13 18.35 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.8 mt -94.09 -57.06 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.402 HG22 ' HG2' ' A' ' 39' ' ' MET . 4.1 t -125.95 141.27 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 C-N-CA 125.003 1.321 . . . . 0.0 108.901 -173.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.0 p -152.43 123.01 7.32 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 102.87 -3.011 . . . . 0.0 102.87 173.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 44.48 33.84 0.97 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.67 1.588 . . . . 0.0 113.818 -174.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.26 -8.82 6.25 Favored Glycine 0 CA--C 1.539 1.566 0 O-C-N 120.814 -1.179 . . . . 0.0 114.694 -177.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.2 ttmt -69.25 37.47 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.461 1 C-N-CA 132.941 4.496 . . . . 0.0 112.812 -177.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.402 ' HG2' HG22 ' A' ' 34' ' ' VAL . 43.0 mtt -38.1 133.04 0.95 Allowed 'General case' 0 C--O 1.233 0.229 0 C-N-CA 126.164 1.786 . . . . 0.0 114.767 -173.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.79 157.64 66.05 Favored Pre-proline 0 N--CA 1.448 -0.559 0 CA-C-N 113.512 -1.676 . . . . 0.0 107.859 173.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -74.27 37.69 0.45 Allowed 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 124.455 3.437 . . . . 0.0 112.192 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -52.61 -26.11 12.58 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 127.266 2.226 . . . . 0.0 113.493 -173.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.404 HG23 ' CG ' ' A' ' 146' ' ' ASN . 1.8 m -43.52 -51.95 6.46 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.757 2.023 . . . . 0.0 112.388 -174.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -58.28 -62.48 1.8 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.612 0.765 . . . . 0.0 110.569 -174.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.33 52.4 m-20 -76.84 -30.78 56.47 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -173.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.1 -51.7 68.02 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 120.659 -1.276 . . . . 0.0 107.971 173.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.471 HH21 HD11 ' A' ' 148' ' ' ILE . 6.3 ttt180 . . . . . 0 CA--C 1.537 0.468 0 CA-C-O 118.796 -0.621 . . . . 0.0 109.72 -177.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.438 0 CA-C-O 117.635 -1.174 . . . . 0.0 111.721 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -77.01 -73.92 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.835 0 CA-C-N 120.86 1.343 . . . . 0.0 113.313 -174.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.22 118.11 6.44 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.183 1.393 . . . . 0.0 114.034 -173.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.6 mt -132.09 120.77 17.4 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 127.154 2.181 . . . . 0.0 106.831 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -77.06 156.25 33.9 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.243 1.962 . . . . 0.0 111.124 -178.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.6 p -40.25 -46.84 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 127.834 2.454 . . . . 0.0 113.607 -178.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -63.23 -36.19 82.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 126.066 1.746 . . . . 0.0 113.091 -175.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.5 mm -69.06 113.05 4.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 103.454 -2.795 . . . . 0.0 103.454 174.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -79.57 -32.81 42.08 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.246 176.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.5 m -154.24 162.71 41.0 Favored 'General case' 0 C--N 1.335 -0.031 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -173.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 24.4 mtm -126.55 163.53 23.2 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 172.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -120.17 149.19 42.64 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 118.99 0.814 . . . . 0.0 108.857 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -125.58 156.55 38.95 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 102.898 -3.001 . . . . 0.0 102.898 173.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 m -138.31 135.91 35.9 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -176.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -145.72 159.97 42.4 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 121.593 -0.692 . . . . 0.0 111.053 178.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -165.74 151.99 9.53 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 121.966 0.889 . . . . 0.0 112.688 173.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -82.13 -173.53 4.57 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.504 1.122 . . . . 0.0 108.786 173.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.19 99.73 6.89 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 126.469 1.908 . . . . 0.0 109.368 -174.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 48.14 -60.17 0.0 OUTLIER Glycine 0 CA--C 1.539 1.536 0 C-N-CA 130.646 3.974 . . . . 0.0 119.619 173.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -116.77 -12.99 10.76 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 120.298 2.049 . . . . 0.0 114.354 175.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.7 37.28 0.58 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 130.015 3.326 . . . . 0.0 118.869 -173.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -52.38 113.66 1.12 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 123.058 2.663 . . . . 0.0 109.776 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -84.05 138.46 33.06 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.686 1.595 . . . . 0.0 106.885 174.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -85.61 149.37 25.38 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -133.52 160.1 38.44 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.905 1.23 . . . . 0.0 110.566 174.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.436 ' O ' HD13 ' A' ' 131' ' ' ILE . 31.3 tt0 -154.58 133.9 12.57 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 173.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.487 ' CD2' HD23 ' A' ' 82' ' ' LEU . 80.6 m-85 -81.97 103.55 11.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.9 tt -64.47 -40.83 96.43 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 173.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 m -154.99 145.99 22.64 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 122.657 1.217 . . . . 0.0 111.739 174.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.634 HD22 HG22 ' A' ' 128' ' ' VAL . 0.2 OUTLIER -148.54 92.81 2.05 Favored 'General case' 0 N--CA 1.451 -0.389 1 N-CA-C 97.606 -4.961 . . . . 0.0 97.606 173.191 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.01 150.78 27.7 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 120.452 -1.405 . . . . 0.0 114.559 -172.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.1 t -68.74 158.92 33.27 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.762 1.225 . . . . 0.0 111.464 173.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.3 mt -123.38 -26.25 4.29 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.983 1.713 . . . . 0.0 110.925 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.434 ' CG ' ' H ' ' A' ' 87' ' ' LYS . 7.9 t70 -79.09 176.09 9.98 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.791 1.178 . . . . 0.0 109.521 -174.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.434 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 23.4 mmtm -131.62 -50.54 0.98 Allowed 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 127.073 2.149 . . . . 0.0 110.928 -173.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -69.48 -65.02 2.72 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 173.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.492 HD12 ' H ' ' A' ' 89' ' ' ILE . 4.3 mp -76.63 25.59 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 C-N-CA 129.357 3.063 . . . . 0.0 110.395 -175.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 26.5 ttm -43.33 139.74 1.86 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 129.261 3.025 . . . . 0.0 111.803 -173.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.253 . . -168.14 173.62 7.8 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 130.177 3.391 . . . . 0.0 105.563 -173.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.412 10.4 m-20 -147.51 130.23 7.86 Favored Pre-proline 0 CA--C 1.509 -0.622 0 C-N-CA 127.435 2.294 . . . . 0.0 111.975 172.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.32 156.36 41.59 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 121.953 1.768 . . . . 0.0 109.649 173.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 23.4 p -136.59 158.6 44.07 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 126.524 1.93 . . . . 0.0 108.139 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.6 m -126.34 157.23 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 123.729 0.812 . . . . 0.0 111.222 176.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -79.99 9.77 5.05 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 127.325 2.25 . . . . 0.0 113.68 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.8 m -140.84 163.44 42.72 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 124.527 1.131 . . . . 0.0 109.914 -175.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -66.11 164.56 27.26 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.853 1.702 . . . . 0.0 110.277 173.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -63.16 -14.37 47.98 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 124.503 1.121 . . . . 0.0 112.7 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -143.33 164.78 29.3 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 120.133 1.333 . . . . 0.0 108.65 173.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 164.42 -162.92 35.79 Favored Glycine 0 C--O 1.228 -0.258 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 76.1 p -116.96 149.15 40.68 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 173.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 37.5 t -83.13 113.52 46.57 Favored Pre-proline 0 N--CA 1.448 -0.528 0 N-CA-C 103.635 -2.728 . . . . 0.0 103.635 173.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.42 ' HB2' ' HE3' ' A' ' 106' ' ' LYS . 45.8 Cg_endo -85.82 156.07 10.2 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.404 2.069 . . . . 0.0 112.176 -173.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -70.55 0.55 6.57 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 120.197 -1.564 . . . . 0.0 113.063 -175.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.42 ' HE3' ' HB2' ' A' ' 104' ' ' PRO . 0.0 OUTLIER -115.3 114.84 25.71 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 126.598 1.959 . . . . 0.0 106.951 -173.839 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -41.62 106.84 0.06 Allowed 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.693 1.597 . . . . 0.0 109.639 -178.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.4 m -112.21 137.46 50.28 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 178.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.5 t -96.75 114.18 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 114.099 -1.409 . . . . 0.0 108.703 -173.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 98.5 t -94.09 103.33 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 173.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -77.04 140.42 40.33 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 172.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.4 t -115.16 113.62 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 174.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -99.48 149.44 18.93 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 125.927 1.727 . . . . 0.0 109.603 -178.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.415 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 4.4 m-85 -132.3 73.89 76.74 Favored Pre-proline 0 C--O 1.244 0.788 0 CA-C-N 118.965 1.383 . . . . 0.0 112.479 -173.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -66.88 126.83 15.91 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.098 1.865 . . . . 0.0 109.135 173.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 5.7 t -104.82 153.37 21.42 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 124.565 1.146 . . . . 0.0 108.131 174.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.6 mt -74.5 -9.98 59.12 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.369 0.531 . . . . 0.0 111.867 178.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.7 5.93 3.16 Favored Glycine 0 C--O 1.22 -0.723 0 C-N-CA 128.458 2.933 . . . . 0.0 116.408 173.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 27.7 mmtm -93.61 -32.26 14.17 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.737 1.768 . . . . 0.0 113.114 -173.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -96.63 159.1 15.11 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 173.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -107.89 148.01 30.18 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.405 1.482 . . . . 0.0 107.197 176.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 140.21 -152.71 22.98 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 174.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.8 t -128.07 113.99 32.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.428 ' HB2' ' HB ' ' A' ' 89' ' ' ILE . . . -90.64 167.96 12.14 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 173.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -129.65 156.99 43.35 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 123.719 0.808 . . . . 0.0 109.464 173.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 149' ' ' PHE . 3.8 p90 -147.95 151.0 35.07 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 126.801 2.04 . . . . 0.0 105.896 173.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -137.71 173.2 11.9 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 175.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.634 HG22 HD22 ' A' ' 82' ' ' LEU . 97.0 t -128.95 147.3 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 124.789 1.236 . . . . 0.0 111.276 -173.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -146.67 120.02 8.99 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 127.666 2.387 . . . . 0.0 106.44 173.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.406 HG22 ' CD2' ' A' ' 79' ' ' PHE . 23.3 t -138.2 124.2 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -177.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.687 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -90.43 164.83 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 106.635 -1.616 . . . . 0.0 106.635 173.695 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.4 t -144.71 132.34 16.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -176.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.73 174.02 11.03 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.475 1.11 . . . . 0.0 108.581 -174.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 32.1 p-10 -88.28 176.06 7.39 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 172.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.1 t -68.09 -6.78 24.69 Favored 'General case' 0 CA--C 1.551 1.015 0 O-C-N 120.659 -1.276 . . . . 0.0 112.286 -175.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -86.32 -14.69 42.87 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 120.59 -1.319 . . . . 0.0 110.606 173.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.42 4.16 62.62 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.736 1.16 . . . . 0.0 112.386 -173.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -75.9 117.55 17.75 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 119.811 1.805 . . . . 0.0 108.952 175.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.4 m -66.98 146.82 53.97 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.96 1.704 . . . . 0.0 110.021 -176.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.84 -35.68 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.868 1.267 . . . . 0.0 113.616 178.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -133.08 148.74 52.17 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -176.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -146.52 150.01 34.72 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 174.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.6 m -102.79 113.81 65.67 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -73.91 154.13 47.96 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.16 1.907 . . . . 0.0 113.105 -173.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -69.49 112.52 6.06 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 102.122 -3.288 . . . . 0.0 102.122 173.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.404 ' CG ' HG23 ' A' ' 43' ' ' THR . 44.7 m-20 173.35 -30.79 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 130.821 3.649 . . . . 0.0 107.138 -173.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.58 66.6 0.08 Allowed 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 126.842 2.057 . . . . 0.0 109.157 174.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.471 HD11 HH21 ' A' ' 47' ' ' ARG . 1.4 mt -95.62 147.72 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 C-N-CA 126.074 1.75 . . . . 0.0 108.141 176.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.417 ' HB2' ' CE2' ' A' ' 126' ' ' PHE . 20.1 m-85 -130.88 150.61 51.96 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 173.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -127.21 113.36 16.24 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 -173.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 46.5 tttt -101.8 123.22 45.39 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.48 -0.934 . . . . 0.0 108.48 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 39.0 m -83.34 119.93 25.23 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 173.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 11.1 m -114.69 159.66 20.26 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 173.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.2 pp -143.44 160.58 40.32 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 174.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -56.56 114.11 1.9 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 127.999 2.52 . . . . 0.0 111.795 -174.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -133.89 174.83 10.04 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 127.833 2.453 . . . . 0.0 108.6 175.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 . . . . . 0 C--O 1.252 1.191 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 173.458 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.5 m . . . . . 0 CA--C 1.542 0.667 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.51 HD23 ' N ' ' A' ' 13' ' ' TYR . 6.1 tt -47.06 132.71 11.97 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.994 1.27 . . . . 0.0 112.22 -173.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.51 ' N ' HD23 ' A' ' 12' ' ' LEU . 81.7 m-85 -121.26 129.94 53.41 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.073 1.349 . . . . 0.0 109.58 176.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.4 117.91 8.55 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 5.5 p90 -131.19 175.38 9.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.174 0.99 . . . . 0.0 110.257 174.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.505 HD11 HD11 ' A' ' 33' ' ' ILE . 2.0 mp -115.41 118.28 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 102.997 -2.964 . . . . 0.0 102.997 173.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -89.59 144.6 25.88 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 123.312 1.53 . . . . 0.0 112.487 -173.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.53 -6.8 1.19 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 128.341 2.656 . . . . 0.0 115.491 -175.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 62.2 m80 -61.8 -34.06 75.24 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 120.584 1.538 . . . . 0.0 111.638 -177.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -67.35 -41.16 85.62 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.231 176.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.78 -36.32 83.49 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.545 1.138 . . . . 0.0 111.075 173.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.0 ttm-85 . . . . . 0 N--CA 1.447 -0.615 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 173.865 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -149.29 112.64 4.97 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.446 0.566 . . . . 0.0 110.017 173.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -97.1 163.11 13.07 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 172.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.3 mp -141.1 113.15 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 103.855 -2.646 . . . . 0.0 103.855 172.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.63 114.11 23.07 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.505 HD11 HD11 ' A' ' 16' ' ' ILE . 10.9 mt -85.45 -58.45 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 118.543 0.61 . . . . 0.0 109.495 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.415 HG11 HD22 ' A' ' 12' ' ' LEU . 22.1 t -123.96 114.1 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 126.757 2.023 . . . . 0.0 106.9 -173.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.6 p -117.48 118.22 31.58 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 173.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.308 1.2 pm0 44.31 52.4 7.24 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.329 1.052 . . . . 0.0 111.121 -173.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.75 -12.95 4.42 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 126.78 2.133 . . . . 0.0 115.935 175.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -67.83 37.79 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.484 1 C-N-CA 132.963 4.505 . . . . 0.0 114.487 -174.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 30.9 mtm -37.83 116.56 0.51 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.876 1.216 . . . . 0.0 112.835 -172.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.67 161.07 22.46 Favored Pre-proline 0 N--CA 1.447 -0.612 0 CA-C-N 113.746 -1.57 . . . . 0.0 109.491 177.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -73.98 27.54 0.33 Allowed 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.699 2.933 . . . . 0.0 111.994 174.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -56.11 -26.68 50.85 Favored 'General case' 0 C--N 1.345 0.409 0 C-N-CA 124.862 1.265 . . . . 0.0 110.616 -174.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 m -45.54 -43.77 12.18 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 129.29 3.036 . . . . 0.0 110.725 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 53.0 t60 -63.65 -55.34 24.31 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.0 0.52 . . . . 0.0 110.707 -177.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -76.1 -26.76 56.75 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -175.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -68.13 -40.36 82.49 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.122 0.969 . . . . 0.0 109.634 173.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.548 0.894 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 175.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.428 ' SD ' HD13 ' A' ' 16' ' ' ILE . 1.1 mtp . . . . . 0 CA--C 1.534 0.362 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -75.2 -75.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.021 0 CA-C-N 121.13 1.439 . . . . 0.0 111.366 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.28 113.63 14.05 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.761 0.824 . . . . 0.0 111.829 -173.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 89.4 mt -120.35 130.43 24.85 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 128.464 2.706 . . . . 0.0 105.988 -174.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -83.05 159.32 15.56 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.491 2.127 . . . . 0.0 110.593 174.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.0 p -46.99 -34.61 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 125.715 1.606 . . . . 0.0 112.744 174.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.41 -34.19 72.17 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.509 1.524 . . . . 0.0 111.763 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.6 mm -92.15 112.83 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 102.985 -2.968 . . . . 0.0 102.985 174.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -82.86 -31.26 28.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.354 178.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.3 m -148.05 164.26 34.38 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.339 1.056 . . . . 0.0 110.422 -173.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 36.4 mtm -126.78 149.56 49.59 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 172.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -94.12 149.09 21.55 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 174.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -134.11 158.06 44.57 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 102.567 -3.123 . . . . 0.0 102.567 172.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.3 m -142.82 134.38 26.46 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 -178.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -144.53 169.02 18.76 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.248 0.546 . . . . 0.0 110.092 174.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -166.73 145.75 5.44 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.763 173.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.42 -173.3 1.36 Allowed 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 124.16 1.933 . . . . 0.0 105.864 172.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . 0.264 . . -112.42 121.26 44.34 Favored 'General case' 0 N--CA 1.408 -2.535 1 C-N-CA 131.922 4.089 . . . . 0.0 105.767 -179.084 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 20.22 -73.65 0.0 OUTLIER Glycine 0 CA--C 1.536 1.358 1 C-N-CA 133.654 5.407 . . . . 0.0 119.079 178.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -116.25 -14.73 11.07 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 120.415 2.108 . . . . 0.0 112.41 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.81 37.48 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 131.339 3.856 . . . . 0.0 116.641 -173.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -38.17 114.16 0.34 Allowed 'General case' 0 C--O 1.237 0.446 0 CA-C-N 121.684 2.038 . . . . 0.0 114.719 -173.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -94.53 116.33 28.65 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 104.682 -2.34 . . . . 0.0 104.682 173.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -79.67 148.68 31.51 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 175.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -129.94 158.27 40.02 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 119.645 1.111 . . . . 0.0 109.861 174.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.49 134.26 12.91 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 173.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -89.16 102.99 15.65 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -175.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.6 tt -68.07 -41.38 82.02 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.518 1.527 . . . . 0.0 107.829 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 m -154.24 135.08 13.71 Favored 'General case' 0 N--CA 1.444 -0.734 0 O-C-N 120.645 -1.285 . . . . 0.0 110.829 179.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.483 ' H ' ' HD3' ' A' ' 83' ' ' ARG . 0.3 OUTLIER -151.99 93.15 1.8 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 101.428 -3.545 . . . . 0.0 101.428 173.508 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.483 ' HD3' ' H ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -156.94 157.17 34.31 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 120.863 1.665 . . . . 0.0 111.352 -178.319 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -78.87 152.99 30.92 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-O 121.549 0.69 . . . . 0.0 109.826 173.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.9 mt -106.91 -17.59 14.15 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.437 1.495 . . . . 0.0 110.721 174.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -90.29 163.23 14.83 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 174.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -139.8 -31.32 0.67 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.164 1.786 . . . . 0.0 112.998 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -64.12 -63.88 4.04 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 106.654 -2.579 . . . . 0.0 106.654 172.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.455 HD12 ' H ' ' A' ' 89' ' ' ILE . 4.8 mp -75.78 22.0 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 129.993 3.317 . . . . 0.0 110.23 175.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.4 ttp -43.11 130.79 4.52 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 125.923 2.773 . . . . 0.0 113.26 -173.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.536 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -150.55 147.87 27.98 Favored 'General case' 0 N--CA 1.419 -2.014 2 C-N-CA 135.108 5.363 . . . . 0.0 100.86 173.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.276 5.4 m-20 -136.74 117.36 10.99 Favored Pre-proline 0 C--N 1.315 -0.931 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 173.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -67.63 158.16 58.43 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 123.033 2.489 . . . . 0.0 114.133 -173.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 32.8 p -136.11 164.52 27.84 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.248 1.819 . . . . 0.0 109.006 177.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.6 m -126.41 159.98 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 123.855 0.862 . . . . 0.0 111.295 175.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -80.1 10.46 4.35 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 127.171 2.188 . . . . 0.0 113.346 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.4 m -140.91 163.76 40.51 Favored Pre-proline 0 C--N 1.328 -0.341 0 C-N-CA 124.168 0.987 . . . . 0.0 110.288 -174.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -65.43 160.12 44.3 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 121.626 1.551 . . . . 0.0 108.836 173.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -67.19 -10.11 47.05 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 123.558 0.743 . . . . 0.0 112.264 -178.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -146.83 163.91 34.54 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 120.543 1.52 . . . . 0.0 108.338 173.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 159.19 -163.15 33.2 Favored Glycine 0 C--O 1.227 -0.298 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 177.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 70.1 p -114.9 146.03 41.56 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 173.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.3 t -77.56 122.42 85.83 Favored Pre-proline 0 CA--C 1.541 0.622 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 177.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.81 148.54 46.4 Favored 'Trans proline' 0 C--O 1.216 -0.577 0 C-N-CA 121.797 1.665 . . . . 0.0 111.749 -175.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 72.9 m-70 -63.82 -24.35 67.72 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 -172.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . 0.515 1.0 OUTLIER -116.71 150.68 37.8 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.781 1.173 . . . . 0.0 111.914 173.141 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -38.49 115.49 0.46 Allowed 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 128.387 2.675 . . . . 0.0 114.404 -172.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 44.6 m -128.69 141.49 51.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 173.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 17.1 t -94.02 122.32 45.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 124.701 1.2 . . . . 0.0 110.196 -173.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.8 t -103.72 103.5 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 173.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -81.03 141.25 34.57 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 173.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.2 t -110.27 113.86 45.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 103.525 -2.768 . . . . 0.0 103.525 174.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -95.67 151.34 19.96 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 125.091 1.329 . . . . 0.0 109.925 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -131.4 72.96 80.47 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.14 125.93 14.31 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.634 1.556 . . . . 0.0 108.471 176.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.536 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 5.3 t -105.47 156.99 17.68 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.2 mt -81.16 -8.87 59.84 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.167 0.44 . . . . 0.0 111.713 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.39 28.13 61.6 Favored Glycine 0 C--N 1.339 0.702 0 C-N-CA 126.06 1.791 . . . . 0.0 116.149 173.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 51.4 mttt -122.34 -30.72 3.93 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.938 1.869 . . . . 0.0 114.128 177.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.406 ' NE2' ' H ' ' A' ' 121' ' ' ASP . 57.5 tp60 -96.34 154.88 17.01 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 173.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.406 ' H ' ' NE2' ' A' ' 120' ' ' GLN . 7.3 m-20 -111.17 148.95 31.65 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 138.1 -156.33 23.82 Favored Glycine 0 C--N 1.332 0.361 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 176.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.4 t -122.52 113.7 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -89.45 156.98 18.31 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 173.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -117.62 158.56 24.42 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.805 0.842 . . . . 0.0 110.504 177.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.405 ' CE2' ' HB2' ' A' ' 149' ' ' PHE . 5.7 p90 -150.01 150.78 32.28 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 119.024 0.829 . . . . 0.0 109.2 173.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.415 ' CG ' HH12 ' A' ' 83' ' ' ARG . 24.7 pt-20 -123.15 156.4 35.11 Favored 'General case' 0 C--O 1.25 1.116 0 C-N-CA 125.126 1.37 . . . . 0.0 110.678 -174.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.465 HG22 HD22 ' A' ' 82' ' ' LEU . 26.6 t -137.79 140.26 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 O-C-N 125.437 1.711 . . . . 0.0 110.862 -177.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -150.61 120.59 7.16 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.931 2.493 . . . . 0.0 105.619 173.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 47.3 t -136.7 119.9 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.716 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -84.55 166.21 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 174.155 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.9 t -141.37 133.33 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 179.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.85 175.98 8.6 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 177.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -96.95 154.16 17.47 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 102.705 -3.072 . . . . 0.0 102.705 172.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.7 t -62.89 -15.86 56.6 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 120.72 -1.238 . . . . 0.0 110.573 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -69.51 -6.36 30.16 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 127.113 2.165 . . . . 0.0 111.914 173.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 99.45 20.25 18.11 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 118.192 2.037 . . . . 0.0 118.192 173.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -124.19 124.46 42.51 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 120.642 2.221 . . . . 0.0 110.071 -173.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.0 m -64.66 142.04 58.56 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 174.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.7 pt -140.51 -37.3 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 124.422 1.089 . . . . 0.0 113.813 -173.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.42 HD13 ' N ' ' A' ' 142' ' ' GLN . 2.9 tm? -139.49 154.04 47.63 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 -174.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.427 ' HG3' HG22 ' A' ' 131' ' ' ILE . 1.9 tm0? -154.83 144.52 21.49 Favored 'General case' 0 C--N 1.334 -0.102 0 O-C-N 121.025 -1.047 . . . . 0.0 108.9 174.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 26.8 m -67.77 114.56 20.71 Favored Pre-proline 0 N--CA 1.454 -0.264 0 N-CA-C 104.017 -2.586 . . . . 0.0 104.017 173.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -66.29 146.17 80.17 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 CA-C-N 120.251 1.125 . . . . 0.0 113.167 -173.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -73.45 112.95 10.0 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 173.0 -26.96 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.398 1 C-N-CA 134.792 5.237 . . . . 0.0 109.234 173.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.06 87.12 0.01 OUTLIER 'General case' 0 C--O 1.238 0.475 0 C-N-CA 126.251 1.821 . . . . 0.0 111.384 -174.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.9 mt -123.56 136.75 59.06 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.709 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 173.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.405 ' HB2' ' CE2' ' A' ' 126' ' ' PHE . 0.2 OUTLIER -116.06 164.58 14.25 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 126.263 2.227 . . . . 0.0 107.08 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -140.63 113.56 8.32 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.684 1.194 . . . . 0.0 108.349 -173.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -104.43 128.52 52.33 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 119.427 1.012 . . . . 0.0 108.638 174.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 24.4 m -83.51 114.18 21.32 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 174.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 56.2 m -108.41 165.83 11.22 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 173.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.3 pp -142.9 161.5 37.94 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.054 1.342 . . . . 0.0 108.423 174.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -68.04 122.37 18.1 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.404 1.882 . . . . 0.0 110.289 174.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -153.83 123.08 6.52 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.724 1.21 . . . . 0.0 110.218 174.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 . . . . . 0 C--O 1.255 1.371 0 C-N-CA 128.877 2.871 . . . . 0.0 105.806 173.68 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 CA--C 1.533 0.309 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.7 tt -43.33 128.21 4.74 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.945 2.098 . . . . 0.0 111.929 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -113.04 137.58 51.2 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.917 1.687 . . . . 0.0 107.94 173.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.67 116.25 7.63 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 9.8 p90 -129.85 175.83 8.53 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.937 0.895 . . . . 0.0 109.429 175.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.428 HD11 HD11 ' A' ' 33' ' ' ILE . 1.8 mp -114.07 120.11 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 103.006 -2.961 . . . . 0.0 103.006 174.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -83.43 144.81 29.35 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 123.355 1.55 . . . . 0.0 114.746 -173.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.52 -16.48 60.85 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.521 1.928 . . . . 0.0 114.985 -174.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -55.89 -35.02 66.07 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.455 0.57 . . . . 0.0 109.488 174.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -75.74 -44.94 39.22 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.06 -33.94 63.15 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.523 0.729 . . . . 0.0 111.019 174.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 25.8 ttm105 . . . . . 0 N--CA 1.447 -0.587 0 O-C-N 121.2 -0.938 . . . . 0.0 108.841 173.544 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 . . . . . 0 CA--C 1.534 0.361 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -153.93 113.55 3.81 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.311 1.445 . . . . 0.0 109.585 -178.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -94.74 165.76 12.33 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 173.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.1 mp -141.07 113.39 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 174.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.59 122.54 29.18 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -177.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.428 HD11 HD11 ' A' ' 16' ' ' ILE . 17.2 mt -94.97 -65.3 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 119.027 0.831 . . . . 0.0 109.019 177.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.4 t -113.15 113.6 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 -173.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.5 p -109.22 113.58 26.55 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 103.613 -2.736 . . . . 0.0 103.613 173.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.284 18.1 pm0 44.43 40.87 4.14 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.77 1.628 . . . . 0.0 113.235 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.91 -6.76 8.74 Favored Glycine 0 CA--C 1.543 1.785 0 C-N-CA 124.768 1.175 . . . . 0.0 114.466 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -86.39 37.63 0.74 Allowed 'General case' 0 CA--C 1.539 0.554 1 C-N-CA 134.387 5.075 . . . . 0.0 108.114 -174.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 62.6 mtp -37.66 131.74 0.94 Allowed 'General case' 0 C--O 1.234 0.253 0 C-N-CA 128.427 2.691 . . . . 0.0 115.301 -172.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.6 159.39 85.21 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-N 113.464 -1.698 . . . . 0.0 109.056 173.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -76.46 41.28 0.86 Allowed 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 124.53 3.486 . . . . 0.0 111.783 175.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -54.89 -26.29 34.82 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.443 1.897 . . . . 0.0 112.802 -174.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.5 m -53.14 -33.09 50.9 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 127.201 2.2 . . . . 0.0 112.074 -173.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -62.9 -66.25 0.57 Allowed 'General case' 0 C--N 1.344 0.368 0 CA-C-N 119.201 0.91 . . . . 0.0 109.748 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.9 -35.37 74.72 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -177.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -63.87 -44.56 92.71 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 125.081 1.488 . . . . 0.0 110.092 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 48.7 tpt85 . . . . . 0 C--O 1.238 0.452 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -176.003 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 98.1 mmm . . . . . 0 CA--C 1.534 0.365 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -61.33 -71.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.687 0 CA-C-N 121.457 1.556 . . . . 0.0 114.048 -173.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.39 119.81 19.99 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.495 0.718 . . . . 0.0 110.357 -174.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 96.0 mt -123.92 127.92 25.27 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 128.226 2.61 . . . . 0.0 106.134 -175.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -84.59 161.22 12.55 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 122.755 2.304 . . . . 0.0 111.565 174.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.5 p -47.11 -37.0 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 125.281 1.432 . . . . 0.0 112.667 173.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -53.25 -37.7 62.34 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.612 1.565 . . . . 0.0 111.968 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.2 mm -83.23 112.81 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 102.992 -2.966 . . . . 0.0 102.992 173.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -79.39 -40.6 29.7 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 173.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.2 m -141.81 157.89 44.46 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.989 1.716 . . . . 0.0 109.572 -173.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 2.8 mmm -117.75 147.91 42.54 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 173.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -94.49 156.42 16.47 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 173.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -141.23 155.18 46.06 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 129.506 3.122 . . . . 0.0 102.701 172.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.2 m -139.05 133.35 31.51 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -177.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -145.93 162.59 37.43 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.404 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -163.24 146.17 10.37 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 173.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.04 -177.16 5.46 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 173.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -115.09 95.98 5.46 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.989 1.316 . . . . 0.0 109.206 -173.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.67 -89.69 0.03 OUTLIER Glycine 0 CA--C 1.534 1.254 0 C-N-CA 126.128 1.823 . . . . 0.0 115.979 173.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . 0.263 5.5 mm-40 -117.12 26.14 9.99 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.542 1.937 . . . . 0.0 114.462 174.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -94.91 37.25 1.15 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.839 2.456 . . . . 0.0 112.215 177.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -38.9 113.4 0.3 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.802 1.641 . . . . 0.0 112.515 -173.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -106.36 129.98 54.27 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.157 1.783 . . . . 0.0 107.695 175.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -91.53 150.58 21.14 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 176.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -131.93 160.22 36.39 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 119.726 1.148 . . . . 0.0 110.236 174.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.444 ' O ' HD13 ' A' ' 131' ' ' ILE . 29.0 tt0 -155.37 135.49 13.02 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 173.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.478 ' CD2' HD23 ' A' ' 82' ' ' LEU . 77.6 m-85 -84.14 103.55 13.45 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.9 tt -65.24 -37.55 87.59 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 174.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.7 m -155.01 144.92 21.62 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 120.687 -1.258 . . . . 0.0 111.816 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.485 HD22 HG22 ' A' ' 128' ' ' VAL . 0.1 OUTLIER -156.24 93.52 1.42 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 102.678 -3.082 . . . . 0.0 102.678 173.573 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.461 ' HD3' ' H ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -154.21 158.64 40.6 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 121.206 1.821 . . . . 0.0 111.779 -178.184 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.1 t -71.72 167.65 19.43 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.915 0.886 . . . . 0.0 112.982 173.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.9 mt -126.69 -9.45 6.16 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 126.603 1.961 . . . . 0.0 114.308 174.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.524 ' CG ' ' H ' ' A' ' 87' ' ' LYS 0.309 13.3 t70 -96.43 170.67 9.07 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 122.01 2.186 . . . . 0.0 112.095 -173.721 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.524 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 1.3 mppt? -114.65 -53.01 2.68 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 129.16 2.984 . . . . 0.0 110.223 -173.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.433 ' C ' ' H ' ' A' ' 90' ' ' MET . . . -82.1 -58.62 2.44 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 125.052 1.31 . . . . 0.0 110.643 178.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mp -79.19 25.5 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 126.164 1.786 . . . . 0.0 110.376 -175.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.433 ' H ' ' C ' ' A' ' 88' ' ' GLY . 27.3 ttm -43.4 131.41 4.85 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 130.144 3.377 . . . . 0.0 109.292 -178.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -165.19 160.23 18.34 Favored 'General case' 0 N--CA 1.438 -1.028 1 C-N-CA 131.916 4.086 . . . . 0.0 103.785 -173.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.269 5.7 m-20 -138.16 124.84 13.17 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 118.618 0.644 . . . . 0.0 111.359 173.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.421 ' HG2' HD12 ' A' ' 82' ' ' LEU . 75.7 Cg_endo -70.08 142.42 46.45 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 122.035 1.824 . . . . 0.0 110.273 179.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.8 p -131.87 162.09 31.43 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.938 1.695 . . . . 0.0 108.726 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.4 m -126.14 153.37 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 119.176 0.898 . . . . 0.0 112.353 -174.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -79.27 9.67 4.41 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 127.335 2.254 . . . . 0.0 113.337 177.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.5 m -144.24 164.21 30.32 Favored Pre-proline 0 C--N 1.327 -0.376 0 C-N-CA 124.725 1.21 . . . . 0.0 109.603 -174.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -66.9 161.76 40.88 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 121.25 1.3 . . . . 0.0 109.348 173.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -65.57 -7.68 16.0 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.237 1.015 . . . . 0.0 112.192 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -144.47 164.12 31.81 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.372 1.469 . . . . 0.0 108.335 173.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.66 -161.37 34.12 Favored Glycine 0 C--O 1.226 -0.357 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.5 p -125.89 139.17 53.68 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.8 t -74.3 114.34 32.54 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -78.84 150.15 23.62 Favored 'Trans proline' 0 C--O 1.211 -0.845 0 C-N-CA 121.969 1.779 . . . . 0.0 111.583 -174.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.415 ' H ' ' CD2' ' A' ' 105' ' ' HIS . 6.2 m-70 -78.29 4.09 13.76 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 119.726 -1.859 . . . . 0.0 113.98 -173.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.83 127.24 54.11 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 173.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -43.94 110.68 0.22 Allowed 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 126.501 1.921 . . . . 0.0 109.806 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.3 m -119.21 140.45 50.19 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.7 t -94.87 117.52 38.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 C-N-CA 124.953 1.301 . . . . 0.0 108.97 -173.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.6 t -100.09 104.44 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 173.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -82.11 149.01 28.23 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 173.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.5 t -122.49 113.56 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 104.035 -2.579 . . . . 0.0 104.035 175.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -89.37 147.84 19.75 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.506 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 7.0 m-85 -127.73 73.53 78.52 Favored Pre-proline 0 C--O 1.242 0.706 0 CA-C-N 118.156 0.978 . . . . 0.0 109.472 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.28 123.5 10.95 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.681 2.254 . . . . 0.0 107.55 173.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 7.3 t -105.95 152.82 22.83 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.253 1.021 . . . . 0.0 108.717 178.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mt -72.02 -14.95 62.02 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 117.953 0.342 . . . . 0.0 111.409 176.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 54.21 42.91 74.1 Favored Glycine 0 C--O 1.22 -0.77 0 C-N-CA 126.479 1.99 . . . . 0.0 113.827 173.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . 0.282 27.4 mttp -125.39 -34.05 2.75 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.733 1.766 . . . . 0.0 113.551 176.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 50.2 tp60 -96.04 142.06 28.7 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 104.043 -2.576 . . . . 0.0 104.043 172.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -93.97 141.01 29.01 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 142.64 -154.73 25.39 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.7 t -129.2 114.11 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -175.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.73 168.82 12.63 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 173.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -125.6 157.75 36.37 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 123.963 0.905 . . . . 0.0 108.888 173.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.506 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 12.4 p90 -149.89 160.87 43.25 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 173.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.442 ' HG3' HH12 ' A' ' 83' ' ' ARG . 5.1 pt-20 -140.42 160.22 40.48 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 124.454 1.102 . . . . 0.0 111.444 -173.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.485 HG22 HD22 ' A' ' 82' ' ' LEU . 83.0 t -139.46 146.94 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 126.205 1.802 . . . . 0.0 109.51 -174.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -150.63 122.85 8.33 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 127.892 2.477 . . . . 0.0 105.784 173.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.422 HG22 ' CD2' ' A' ' 79' ' ' PHE . 21.8 t -135.87 123.74 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.674 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -91.02 165.38 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 173.552 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.8 t -144.99 134.31 18.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 -176.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.77 164.7 29.25 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.605 -174.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.482 ' C ' HD22 ' A' ' 134' ' ' ASN . 0.1 OUTLIER -79.31 166.77 21.76 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 104.104 -2.554 . . . . 0.0 104.104 172.746 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.3 t -60.69 -12.66 11.08 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 120.96 1.709 . . . . 0.0 115.612 -173.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -80.46 -12.08 59.6 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 121.113 1.779 . . . . 0.0 112.303 173.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.23 -3.54 54.85 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.824 1.202 . . . . 0.0 114.117 -174.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -66.91 117.17 8.63 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 120.037 1.919 . . . . 0.0 108.648 177.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -71.81 143.83 49.35 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.681 0.792 . . . . 0.0 108.932 -176.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -138.74 -37.88 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.504 1.122 . . . . 0.0 113.516 -175.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.46 HD13 ' N ' ' A' ' 142' ' ' GLN . 1.9 tm? -133.81 147.83 51.27 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 -177.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.46 ' N ' HD13 ' A' ' 141' ' ' LEU . 10.3 tm0? -147.87 147.03 29.33 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.927 0.891 . . . . 0.0 108.959 174.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 23.5 m -80.67 113.74 42.38 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 176.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.17 147.5 91.31 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 121.202 1.268 . . . . 0.0 110.904 -173.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -79.54 112.24 16.61 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 -174.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.625 37.3 m-80 172.12 -8.13 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.524 1 C-N-CA 134.876 5.271 . . . . 0.0 112.214 172.991 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.74 79.93 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.362 1.465 . . . . 0.0 108.687 174.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.3 mt -117.03 148.72 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 C-N-CA 127.189 2.196 . . . . 0.0 106.316 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -133.88 164.84 26.37 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.015 -1.448 . . . . 0.0 107.182 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -137.4 113.53 9.91 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.017 1.327 . . . . 0.0 107.602 -173.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.12 120.4 41.17 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 119.313 0.96 . . . . 0.0 108.765 -175.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.9 m -84.14 116.59 22.98 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 -177.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 6.9 m -113.09 166.17 11.68 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.832 0.853 . . . . 0.0 109.261 173.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.3 pp -136.88 163.5 30.53 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.845 1.258 . . . . 0.0 108.198 173.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -72.42 121.33 19.38 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 128.258 2.623 . . . . 0.0 110.817 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -146.17 170.35 16.9 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 127.304 2.242 . . . . 0.0 109.387 177.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 . . . . . 0 C--O 1.257 1.489 0 C-N-CA 131.162 3.785 . . . . 0.0 104.339 173.822 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.5 m . . . . . 0 CA--C 1.537 0.448 0 CA-C-O 121.624 0.726 . . . . 0.0 111.296 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.7 tt -86.39 136.56 33.08 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 128.81 2.844 . . . . 0.0 109.775 178.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -127.72 138.97 52.95 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.857 1.663 . . . . 0.0 108.412 173.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.39 117.6 7.33 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 -176.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 14.1 p90 -130.78 171.18 13.42 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.683 0.793 . . . . 0.0 110.518 177.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.1 mt -108.75 135.18 48.37 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 N-CA-C 103.591 -2.744 . . . . 0.0 103.591 174.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -91.79 159.96 15.55 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 122.577 1.18 . . . . 0.0 113.164 -173.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.89 -13.79 59.95 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.119 1.767 . . . . 0.0 113.99 175.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 31.6 m80 -59.4 -38.74 81.34 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 120.615 1.552 . . . . 0.0 109.058 175.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -64.08 -46.02 86.15 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.925 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.46 -31.85 73.15 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 123.244 0.618 . . . . 0.0 112.261 175.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 . . . . . 0 N--CA 1.447 -0.619 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 174.272 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 . . . . . 0 N--CA 1.454 -0.225 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -155.14 113.31 3.46 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 118.419 -0.8 . . . . 0.0 112.275 -179.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -96.25 165.12 12.37 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 122.35 2.341 . . . . 0.0 105.765 172.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 79.2 mt -140.26 113.17 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 173.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.81 114.22 24.22 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 -177.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.4 mt -92.44 -53.16 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 118.825 0.738 . . . . 0.0 109.661 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -123.44 113.81 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 -173.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.9 p -112.96 122.66 48.3 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 173.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 44.32 44.39 6.68 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.093 1.357 . . . . 0.0 112.602 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.32 4.72 1.32 Allowed Glycine 0 CA--C 1.536 1.371 0 C-N-CA 127.121 2.296 . . . . 0.0 114.743 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.97 37.28 0.48 Allowed 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 129.875 3.27 . . . . 0.0 111.426 -172.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 34.3 mtt -38.12 116.46 0.52 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 126.339 1.855 . . . . 0.0 114.381 -173.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.34 160.55 75.19 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 173.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.7 65.67 5.77 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 124.134 3.223 . . . . 0.0 109.685 175.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -62.17 -12.33 19.28 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 126.999 2.119 . . . . 0.0 114.77 -173.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 56.8 m -43.69 -48.51 7.88 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 126.049 1.739 . . . . 0.0 113.185 -173.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -59.63 -59.51 5.33 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 118.379 0.536 . . . . 0.0 110.325 -176.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.321 49.0 m-20 -76.04 -23.26 55.13 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -173.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -75.57 -58.04 3.52 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.714 1.143 . . . . 0.0 108.645 173.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 . . . . . 0 CA--C 1.539 0.522 0 O-C-N 121.291 -0.88 . . . . 0.0 110.983 -173.65 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.37 0 CA-C-O 116.85 -1.548 . . . . 0.0 113.411 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.01 -79.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.875 0 CA-C-N 122.152 1.804 . . . . 0.0 111.462 -174.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.09 113.47 20.64 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.612 0.765 . . . . 0.0 109.062 -174.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.5 mt -110.64 126.22 29.24 Favored Pre-proline 0 C--N 1.323 -0.566 0 C-N-CA 127.158 2.183 . . . . 0.0 105.437 -175.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.3 156.36 37.27 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.562 1.508 . . . . 0.0 110.216 178.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.0 p -42.11 -44.79 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 126.354 1.862 . . . . 0.0 112.194 174.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -61.43 -36.04 79.24 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 126.354 1.861 . . . . 0.0 113.159 -176.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 mm -75.63 112.65 13.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 101.309 -3.589 . . . . 0.0 101.309 173.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -79.25 -36.6 39.65 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.997 178.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.6 m -144.78 170.69 15.62 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 124.125 0.891 . . . . 0.0 111.953 -173.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 62.9 mtp -125.87 156.85 38.98 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 172.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -121.81 113.56 19.84 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -174.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -99.95 162.68 12.84 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 173.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.8 m -141.59 136.34 30.94 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 176.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -143.71 162.93 34.7 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 120.604 -0.439 . . . . 0.0 110.582 174.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -172.8 156.59 3.49 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.265 -0.88 . . . . 0.0 112.04 173.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.44 -173.41 4.7 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 172.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.27 134.15 55.28 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 102.767 -3.049 . . . . 0.0 102.767 173.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 19.28 -60.02 0.0 OUTLIER Glycine 0 CA--C 1.534 1.26 1 C-N-CA 135.634 6.35 . . . . 0.0 120.808 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -116.58 -13.06 10.89 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 121.139 2.47 . . . . 0.0 113.672 -177.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.96 37.4 0.6 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 130.037 3.335 . . . . 0.0 119.503 -173.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -51.39 116.25 1.98 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 123.388 2.813 . . . . 0.0 110.247 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -83.72 150.41 25.85 Favored 'General case' 0 C--N 1.334 -0.089 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 174.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -100.79 146.82 26.78 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 176.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -132.49 160.69 35.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 120.239 1.381 . . . . 0.0 110.983 176.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.457 ' O ' HD13 ' A' ' 131' ' ' ILE . 28.2 tt0 -152.6 133.74 14.23 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 173.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -81.32 111.22 17.5 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.714 1.206 . . . . 0.0 109.34 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.8 tt -74.28 -48.61 27.43 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.656 1.183 . . . . 0.0 107.857 174.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 m -128.66 148.08 50.78 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.04 1.336 . . . . 0.0 111.839 176.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -175.6 92.62 0.06 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 130.155 3.382 . . . . 0.0 103.913 173.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -162.16 153.46 18.13 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.348 -1.47 . . . . 0.0 111.279 -173.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.8 t -85.74 165.44 16.92 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 121.72 0.771 . . . . 0.0 109.174 173.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 98.8 mt -125.85 0.65 7.36 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 126.035 1.734 . . . . 0.0 112.163 -174.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.471 ' CG ' ' H ' ' A' ' 87' ' ' LYS 0.358 11.3 t70 -98.48 166.14 11.5 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.303 0.956 . . . . 0.0 112.391 178.247 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.471 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 1.4 mppt? -104.67 -46.86 4.22 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 129.401 3.081 . . . . 0.0 112.222 -173.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -105.0 -44.6 1.48 Allowed Glycine 0 CA--C 1.525 0.711 0 C-N-CA 125.075 1.321 . . . . 0.0 111.792 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mt -84.41 13.93 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 C-N-CA 125.274 1.43 . . . . 0.0 108.614 176.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 23.5 ttp -43.62 148.71 0.33 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 131.175 3.79 . . . . 0.0 110.548 177.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -162.7 176.28 10.48 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 127.724 2.41 . . . . 0.0 107.113 -173.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -137.51 113.92 9.48 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 172.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.91 154.31 75.0 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 N-CA-C 106.602 -2.115 . . . . 0.0 106.602 173.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.0 p -141.55 162.73 34.76 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 125.112 1.365 . . . . 0.0 108.435 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.0 m -126.47 155.43 36.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 123.742 0.817 . . . . 0.0 111.915 175.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -73.24 9.06 1.38 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.712 2.405 . . . . 0.0 113.212 174.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.1 m -140.73 165.52 29.17 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 125.903 1.681 . . . . 0.0 108.594 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -67.37 168.64 17.35 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.621 1.547 . . . . 0.0 111.293 174.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -62.63 -12.53 23.8 Favored 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 124.986 1.315 . . . . 0.0 111.914 174.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -143.17 163.83 31.81 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 120.314 1.416 . . . . 0.0 108.129 173.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.61 -161.7 34.37 Favored Glycine 0 C--O 1.228 -0.277 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 82.3 p -117.81 155.33 30.27 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 117.808 0.804 . . . . 0.0 109.404 173.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.6 t -93.69 113.12 59.54 Favored Pre-proline 0 N--CA 1.448 -0.541 0 N-CA-C 101.77 -3.419 . . . . 0.0 101.77 173.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -92.4 161.57 3.02 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.431 2.088 . . . . 0.0 111.998 -173.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -72.62 3.17 5.28 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 120.116 -1.615 . . . . 0.0 112.382 -173.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -114.11 116.0 28.42 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 127.654 2.382 . . . . 0.0 107.672 -173.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -44.68 105.87 0.06 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.563 1.145 . . . . 0.0 109.942 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 26.8 m -111.75 135.16 52.72 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.4 t -90.28 114.09 27.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -173.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 70.8 t -94.0 103.21 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 103.536 -2.764 . . . . 0.0 103.536 173.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -84.05 119.08 24.52 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 173.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.5 t -90.56 113.47 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 103.13 -2.915 . . . . 0.0 103.13 173.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -93.9 149.11 19.29 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.435 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 7.8 m-85 -132.3 73.45 77.35 Favored Pre-proline 0 C--O 1.244 0.784 0 CA-C-N 118.258 1.029 . . . . 0.0 110.766 -176.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -68.04 114.27 3.33 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 N-CA-C 106.844 -2.022 . . . . 0.0 106.844 173.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 5.6 t -91.88 143.58 26.36 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 175.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.0 mt -74.26 -11.41 60.27 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 119.32 -0.371 . . . . 0.0 111.5 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 53.17 39.61 58.34 Favored Glycine 0 C--N 1.339 0.744 0 C-N-CA 125.768 1.652 . . . . 0.0 113.69 173.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -93.48 -65.25 1.01 Allowed 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 118.219 1.01 . . . . 0.0 109.299 -177.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 48.6 tp60 -96.07 155.26 16.83 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 174.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -93.44 147.72 22.7 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.383 1.473 . . . . 0.0 107.72 178.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.5 -155.5 26.38 Favored Glycine 0 C--N 1.332 0.34 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.9 t -126.63 114.01 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -88.26 170.58 10.88 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 173.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -124.06 158.19 32.76 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 173.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.435 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 50.1 p90 -148.71 153.55 38.39 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 173.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.55 154.59 37.7 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 126.231 1.813 . . . . 0.0 110.199 -173.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 87.7 t -143.09 144.64 23.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 173.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -157.38 132.53 8.91 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 125.078 1.351 . . . . 0.0 107.894 173.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.3 t -137.26 135.26 47.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -174.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.585 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -103.2 164.07 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 173.838 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.2 t -142.66 138.21 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -173.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.81 175.65 9.42 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 125.565 1.546 . . . . 0.0 107.97 -176.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 39.3 p-10 -90.92 176.22 6.69 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 172.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.1 t -66.17 -7.13 16.14 Favored 'General case' 0 CA--C 1.553 1.059 0 O-C-N 120.552 -1.342 . . . . 0.0 112.549 -176.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -86.13 -14.85 42.93 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.455 -1.403 . . . . 0.0 110.933 173.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.5 1.44 64.15 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.659 1.123 . . . . 0.0 112.465 -173.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 63.2 m-20 -71.75 116.29 11.95 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 119.68 1.74 . . . . 0.0 108.504 174.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -64.76 142.36 58.46 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.063 1.745 . . . . 0.0 108.461 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.3 pt -140.58 -38.69 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.758 1.223 . . . . 0.0 113.841 -174.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -130.91 141.54 50.3 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 -177.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -149.07 124.95 10.57 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -176.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 41.3 m -61.67 143.72 93.57 Favored Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 174.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.49 141.95 23.01 Favored 'Trans proline' 0 N--CA 1.441 -1.613 0 N-CA-C 107.587 -1.736 . . . . 0.0 107.587 173.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -77.0 112.64 13.84 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 102.225 -3.25 . . . . 0.0 102.225 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 4.1 m120 174.45 -30.24 0.0 OUTLIER 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.17 1.788 . . . . 0.0 111.419 -173.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.75 103.91 0.39 Allowed 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.443 1.497 . . . . 0.0 110.219 -174.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 2.0 mt -134.29 148.74 29.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -176.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 126' ' ' PHE . 0.9 OUTLIER -132.19 169.98 15.66 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.198 1.799 . . . . 0.0 107.479 179.078 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -136.4 113.74 10.76 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.281 1.032 . . . . 0.0 109.073 -173.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -103.13 124.95 49.53 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.677 1.126 . . . . 0.0 109.136 179.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 25.7 m -83.67 116.69 22.76 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 174.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 4.5 m -119.27 166.21 13.28 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.494 0.718 . . . . 0.0 109.84 174.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.2 pp -133.27 161.16 35.22 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.459 1.504 . . . . 0.0 107.89 176.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.16 131.95 46.82 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.926 1.29 . . . . 0.0 109.927 177.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -146.91 133.49 19.83 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.814 1.646 . . . . 0.0 107.509 174.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 . . . . . 0 C--O 1.257 1.464 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 177.485 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 CA--C 1.537 0.462 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 13' ' ' TYR . 3.1 tt -43.55 138.13 2.62 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.96 2.504 . . . . 0.0 113.075 177.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.469 ' N ' HD23 ' A' ' 12' ' ' LEU . 86.9 m-85 -122.12 135.57 54.81 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.51 1.924 . . . . 0.0 108.467 173.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.99 121.06 10.08 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 127.231 2.212 . . . . 0.0 107.115 -176.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 12.8 p90 -139.63 175.07 9.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 118.933 0.788 . . . . 0.0 109.946 176.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.434 HD11 HD11 ' A' ' 33' ' ' ILE . 2.2 mp -112.77 113.72 44.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 100.226 -3.99 . . . . 0.0 100.226 173.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -79.58 152.9 29.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 122.861 1.315 . . . . 0.0 111.832 -173.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.2 -19.18 61.32 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -173.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -61.09 -34.06 74.32 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 119.564 1.075 . . . . 0.0 109.396 174.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 48.1 tp60 -69.16 -48.44 62.25 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 118.103 0.41 . . . . 0.0 111.6 177.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.95 -29.58 68.5 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 119.131 -0.461 . . . . 0.0 111.617 174.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 27.0 ttm105 . . . . . 0 N--CA 1.447 -0.592 0 CA-C-N 119.658 1.117 . . . . 0.0 108.038 173.435 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 . . . . . 0 CA--C 1.536 0.427 0 CA-C-O 118.987 -0.53 . . . . 0.0 109.589 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -160.21 114.07 2.18 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.186 1.795 . . . . 0.0 110.569 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -94.55 165.49 12.5 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 172.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.7 mm -137.98 113.35 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 173.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.35 114.63 22.01 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -177.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.434 HD11 HD11 ' A' ' 16' ' ' ILE . 17.2 mt -87.42 -58.41 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -126.04 122.55 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 126.375 1.87 . . . . 0.0 107.683 -173.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 81.0 p -123.56 127.96 49.05 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 101.07 -3.678 . . . . 0.0 101.07 172.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.292 0.4 OUTLIER 44.08 36.66 1.53 Allowed 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 119.893 1.224 . . . . 0.0 114.025 178.55 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.5 -8.4 2.24 Favored Glycine 0 CA--C 1.546 2.024 0 O-C-N 120.461 -1.399 . . . . 0.0 115.443 -175.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.83 37.56 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.573 1 C-N-CA 134.524 5.13 . . . . 0.0 111.987 175.528 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 53.9 mtp -37.6 119.38 0.72 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.262 1.425 . . . . 0.0 112.826 -172.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.07 163.35 13.81 Favored Pre-proline 0 N--CA 1.447 -0.62 0 CA-C-N 113.442 -1.708 . . . . 0.0 109.696 177.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.97 30.57 0.29 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 123.994 3.129 . . . . 0.0 111.911 173.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -55.16 -26.76 40.91 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 126.363 1.865 . . . . 0.0 111.427 -174.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.9 m -56.29 -37.74 70.27 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 127.428 2.291 . . . . 0.0 111.605 -173.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -60.84 -65.51 0.68 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 177.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -65.11 -23.7 67.22 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.637 0.775 . . . . 0.0 112.997 -174.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -70.01 -47.05 63.7 Favored 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 124.002 0.921 . . . . 0.0 109.821 173.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.9 ttp180 . . . . . 0 CA--C 1.545 0.781 0 C-N-CA 124.932 1.293 . . . . 0.0 112.468 -177.026 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 90.0 mmm . . . . . 0 CA--C 1.535 0.387 0 CA-C-O 116.278 -1.82 . . . . 0.0 114.635 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -59.68 -72.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.791 0 CA-C-N 121.877 1.706 . . . . 0.0 113.252 -173.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.19 125.65 29.66 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -176.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 58.4 mt -124.86 131.18 24.07 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 128.14 2.576 . . . . 0.0 106.207 -173.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -81.07 158.44 20.53 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.11 1.873 . . . . 0.0 111.198 174.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.7 p -46.7 -37.31 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 126.058 1.743 . . . . 0.0 112.313 173.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -53.37 -40.1 64.71 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 126.492 1.917 . . . . 0.0 112.582 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 mm -76.6 112.77 14.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 103.394 -2.817 . . . . 0.0 103.394 174.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -83.09 -35.03 25.99 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 173.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.8 m -147.71 152.86 38.5 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.866 1.266 . . . . 0.0 108.271 -174.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 22.3 mtp -113.36 164.03 14.1 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 172.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -133.88 114.47 13.35 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 -173.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -98.97 168.56 10.03 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 173.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.9 m -141.34 135.24 30.3 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -143.66 164.55 30.11 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 121.856 -0.528 . . . . 0.0 111.046 176.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.51 161.56 18.68 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.525 1.13 . . . . 0.0 111.647 174.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.34 160.15 15.59 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.843 0.857 . . . . 0.0 108.759 173.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.55 84.54 7.2 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.871 1.268 . . . . 0.0 110.924 -174.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 50.88 -46.93 0.01 OUTLIER Glycine 0 CA--C 1.542 1.752 1 C-N-CA 131.51 4.386 . . . . 0.0 121.58 173.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -117.14 2.16 12.59 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 120.471 2.135 . . . . 0.0 116.017 -173.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.435 ' H ' ' CE1' ' A' ' 105' ' ' HIS . . . -126.01 37.24 4.38 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 120.903 3.668 . . . . 0.0 120.903 -172.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -38.29 114.21 0.35 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 123.203 2.728 . . . . 0.0 112.882 -173.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -83.86 123.2 29.68 Favored 'General case' 0 C--N 1.338 0.068 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 -174.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -76.69 148.26 36.92 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 -176.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -132.51 160.27 37.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 119.989 1.268 . . . . 0.0 111.106 176.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.482 ' O ' HD13 ' A' ' 131' ' ' ILE . 29.0 tt0 -152.76 137.86 17.32 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 173.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -87.27 104.09 16.07 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 125.288 1.435 . . . . 0.0 109.764 -176.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.4 tt -70.7 -39.28 73.56 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.922 1.289 . . . . 0.0 108.449 176.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.7 m -135.56 144.25 46.13 Favored 'General case' 0 C--N 1.34 0.187 0 O-C-N 121.177 -0.952 . . . . 0.0 112.063 178.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.403 ' H ' ' HD3' ' A' ' 83' ' ' ARG . 1.6 tt -174.13 93.04 0.08 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 128.977 2.911 . . . . 0.0 105.524 173.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.403 ' HD3' ' H ' ' A' ' 82' ' ' LEU . 0.2 OUTLIER -159.97 153.35 22.23 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 119.753 1.16 . . . . 0.0 111.393 -173.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.1 t -78.37 129.02 34.48 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 119.633 1.106 . . . . 0.0 110.798 174.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 68.2 mt -93.16 -27.03 17.15 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 116.874 -1.536 . . . . 0.0 111.164 174.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -77.04 165.72 24.25 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.719 1.6 . . . . 0.0 107.134 175.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.35 -41.98 1.53 Allowed 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.728 1.611 . . . . 0.0 110.855 -173.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -72.39 -69.57 1.37 Allowed Glycine 0 CA--C 1.533 1.192 0 N-CA-C 108.386 -1.885 . . . . 0.0 108.386 173.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.574 HD12 ' H ' ' A' ' 89' ' ' ILE . 3.5 mp -73.44 14.39 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 C-N-CA 128.812 2.845 . . . . 0.0 110.476 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 22.1 ttp -43.2 136.75 2.83 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 128.167 2.587 . . . . 0.0 112.331 -173.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -156.69 113.58 3.1 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 -174.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -97.99 122.53 54.23 Favored Pre-proline 0 CA--C 1.509 -0.629 0 O-C-N 124.364 1.04 . . . . 0.0 109.285 -173.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -65.88 152.37 81.65 Favored 'Trans proline' 0 N--CA 1.443 -1.466 0 C-N-CA 120.83 1.02 . . . . 0.0 109.5 178.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 42.0 p -135.77 161.96 34.11 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.323 1.449 . . . . 0.0 107.137 173.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.9 m -126.47 149.71 31.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 O-C-N 121.241 -0.912 . . . . 0.0 111.679 174.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -86.81 13.77 8.31 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.772 1.629 . . . . 0.0 111.174 173.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.0 m -130.99 163.13 51.21 Favored Pre-proline 0 N--CA 1.454 -0.273 0 C-N-CA 125.829 1.652 . . . . 0.0 106.587 173.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -67.51 163.32 35.32 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 120.72 0.946 . . . . 0.0 109.864 173.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -62.72 -13.36 31.69 Favored 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 124.459 1.104 . . . . 0.0 111.583 175.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -139.53 163.58 32.17 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.205 1.402 . . . . 0.0 107.894 173.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 164.54 -159.67 32.67 Favored Glycine 0 C--O 1.226 -0.349 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -178.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 68.8 p -123.03 151.36 41.99 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 117.548 0.674 . . . . 0.0 109.506 174.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 48.2 t -89.62 113.45 56.78 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 101.925 -3.361 . . . . 0.0 101.925 173.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -91.95 171.68 2.66 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 N-CA-C 117.591 2.112 . . . . 0.0 117.591 -172.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.435 ' CE1' ' H ' ' A' ' 73' ' ' ALA . 76.1 m-70 -75.9 -0.59 21.9 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 -173.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.5 138.92 51.01 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 116.319 -1.8 . . . . 0.0 106.724 173.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.54 112.15 0.7 Allowed 'General case' 0 C--O 1.231 0.129 0 O-C-N 125.407 1.692 . . . . 0.0 106.466 173.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.5 m -123.23 136.72 54.85 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -176.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.8 t -85.1 135.89 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 O-C-N 124.737 1.273 . . . . 0.0 108.673 -173.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 74.7 t -112.8 103.66 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 104.355 -2.461 . . . . 0.0 104.355 173.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -83.77 125.63 32.11 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 173.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.5 t -102.94 113.55 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 102.712 -3.07 . . . . 0.0 102.712 173.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -82.86 151.49 29.0 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 174.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.45 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 8.7 m-85 -133.42 73.35 73.57 Favored Pre-proline 0 C--O 1.244 0.784 0 CA-C-N 118.279 1.039 . . . . 0.0 109.994 177.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -67.34 114.08 3.12 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.295 1.997 . . . . 0.0 108.634 173.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 5.9 t -89.45 151.43 22.02 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 173.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.1 mt -71.22 -10.95 60.6 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.102 0.41 . . . . 0.0 111.862 -176.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.77 23.01 49.19 Favored Glycine 0 C--N 1.339 0.713 0 C-N-CA 126.74 2.114 . . . . 0.0 116.786 173.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 50.7 mttt -120.98 -27.38 4.98 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.583 1.691 . . . . 0.0 113.375 177.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -96.62 156.59 16.28 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 173.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -112.03 151.54 29.22 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 175.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 140.41 -155.94 24.92 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 118.673 0.67 . . . . 0.0 111.56 174.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 20.7 t -122.99 114.14 40.91 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 175.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.3 172.89 9.53 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.553 1.141 . . . . 0.0 109.648 173.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -131.64 148.58 52.61 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.154 1.782 . . . . 0.0 107.684 173.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.46 ' CZ ' ' HB2' ' A' ' 149' ' ' PHE . 43.5 p90 -145.69 151.66 38.39 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 173.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -111.22 148.16 33.43 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 125.152 1.381 . . . . 0.0 111.498 -173.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 31.9 t -141.45 145.35 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 173.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -159.9 135.2 8.16 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 125.168 1.387 . . . . 0.0 108.252 174.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 37.4 t -139.74 131.42 33.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -174.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.616 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -100.93 165.38 2.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 173.829 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.2 t -142.06 138.07 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -173.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.8 175.19 9.81 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.667 1.587 . . . . 0.0 108.113 -176.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 36.9 p-10 -89.82 176.13 6.95 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 172.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.2 t -65.91 -3.51 5.31 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 120.24 -1.538 . . . . 0.0 113.678 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -89.62 -15.25 33.15 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 120.655 1.571 . . . . 0.0 110.595 173.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.72 1.12 62.01 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.62 1.105 . . . . 0.0 112.254 -173.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -71.53 115.9 11.25 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 119.606 1.703 . . . . 0.0 108.403 174.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -64.71 142.76 58.32 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 126.203 1.801 . . . . 0.0 108.632 -177.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.7 pt -139.67 -37.97 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 124.773 1.229 . . . . 0.0 113.884 -174.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -132.72 145.12 50.76 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -148.81 126.95 12.06 Favored 'General case' 0 CA--C 1.52 -0.187 0 O-C-N 121.009 -1.057 . . . . 0.0 108.615 -177.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 63.1 m -64.92 143.46 98.85 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 176.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.55 143.36 21.54 Favored 'Trans proline' 0 N--CA 1.445 -1.372 0 N-CA-C 108.989 -1.197 . . . . 0.0 108.989 174.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -80.46 112.68 18.03 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 176.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 173.11 -19.03 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 130.182 3.393 . . . . 0.0 110.434 -174.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.8 78.58 0.86 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.185 1.394 . . . . 0.0 109.879 -175.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 27.9 mm -101.99 130.01 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 105.002 -2.222 . . . . 0.0 105.002 173.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 126' ' ' PHE . 0.2 OUTLIER -105.0 155.71 18.71 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 173.768 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -130.84 113.47 14.11 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -174.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -110.29 123.9 50.65 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 119.128 0.876 . . . . 0.0 109.617 -174.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 22.5 m -83.48 114.26 21.36 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 175.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 25.5 m -114.6 166.08 12.1 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 123.881 0.872 . . . . 0.0 110.099 174.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.4 pp -141.59 159.08 42.95 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.766 1.627 . . . . 0.0 107.206 173.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.56 128.12 35.25 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.182 0.993 . . . . 0.0 110.318 175.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -157.62 119.44 3.7 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.123 1.369 . . . . 0.0 110.376 176.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 . . . . . 0 C--O 1.256 1.404 0 C-N-CA 129.158 2.983 . . . . 0.0 105.271 173.583 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 CA--C 1.534 0.331 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.0 tt -43.91 128.0 5.44 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.776 1.63 . . . . 0.0 111.3 -176.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -115.98 128.48 55.77 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.503 1.521 . . . . 0.0 107.995 174.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.51 120.07 13.24 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 -179.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 14.1 p90 -140.48 174.88 10.08 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.776 0.716 . . . . 0.0 109.878 176.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.7 mp -113.74 113.72 44.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 1 N-CA-C 99.844 -4.132 . . . . 0.0 99.844 173.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -75.95 149.9 37.58 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.971 1.367 . . . . 0.0 111.417 -173.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.19 -26.46 63.9 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 113.75 -1.568 . . . . 0.0 113.304 -173.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -67.16 -44.55 79.48 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -174.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.6 -56.3 23.13 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 118.047 -0.978 . . . . 0.0 108.441 174.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.0 -41.05 61.88 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 117.228 -1.368 . . . . 0.0 111.987 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 51.9 ttm-85 . . . . . 0 N--CA 1.454 -0.228 0 CA-C-N 120.802 1.637 . . . . 0.0 108.925 174.168 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 . . . . . 0 C--O 1.225 -0.185 0 CA-C-O 118.607 -0.711 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -151.83 141.21 21.52 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 128.687 2.795 . . . . 0.0 104.25 173.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.01 166.47 13.87 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 173.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 82.3 mt -136.86 113.15 12.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 104.44 -2.429 . . . . 0.0 104.44 173.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.42 114.35 23.95 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 -177.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.2 mt -88.47 -61.99 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.455 HG22 ' HG2' ' A' ' 39' ' ' MET . 21.2 t -116.74 114.34 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 125.648 1.579 . . . . 0.0 107.049 -173.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.9 p -109.92 114.76 28.57 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 173.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.434 ' C ' ' H ' ' A' ' 38' ' ' LYS . 11.5 pt-20 46.41 36.86 3.72 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.491 1.516 . . . . 0.0 112.777 -178.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.19 -22.31 1.28 Allowed Glycine 0 CA--C 1.544 1.891 0 O-C-N 120.15 -1.594 . . . . 0.0 114.191 -175.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.434 ' H ' ' C ' ' A' ' 36' ' ' GLU . 15.9 ttpt -67.39 37.88 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.583 1 C-N-CA 137.471 6.309 . . . . 0.0 110.985 177.024 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.455 ' HG2' HG22 ' A' ' 34' ' ' VAL 0.284 34.7 mtt -37.38 136.22 0.49 Allowed 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.882 2.073 . . . . 0.0 114.372 -172.86 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.31 163.04 56.21 Favored Pre-proline 0 N--CA 1.448 -0.563 0 CA-C-N 112.844 -1.98 . . . . 0.0 107.778 173.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.24 34.37 0.33 Allowed 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 124.04 3.16 . . . . 0.0 112.095 174.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -55.52 -26.75 44.7 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 126.247 1.819 . . . . 0.0 112.257 -173.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.6 m -60.4 -34.68 74.28 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 126.428 1.891 . . . . 0.0 111.585 -173.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -57.92 -65.74 0.59 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.098 0.959 . . . . 0.0 108.676 178.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -61.79 -41.43 97.73 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 117.327 -1.32 . . . . 0.0 113.563 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -55.84 -49.62 72.81 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.301 1.041 . . . . 0.0 111.069 -178.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.9 ttp180 . . . . . 0 CA--C 1.537 0.477 0 CA-C-N 118.509 0.595 . . . . 0.0 111.062 -178.768 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.7 mtp . . . . . 0 N--CA 1.471 0.623 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -65.93 -66.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 121.942 1.762 . . . . 0.0 112.401 -174.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.89 114.22 9.75 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.579 1.152 . . . . 0.0 109.863 -174.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 98.0 mt -119.43 119.91 31.26 Favored Pre-proline 0 N--CA 1.449 -0.476 0 C-N-CA 126.5 1.92 . . . . 0.0 106.379 -175.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.42 156.66 41.17 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.064 1.843 . . . . 0.0 110.174 175.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.2 p -40.61 -42.54 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 127.194 2.198 . . . . 0.0 112.91 175.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -57.45 -36.03 70.89 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 126.455 1.902 . . . . 0.0 113.23 -177.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.0 mm -72.12 112.86 8.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 102.649 -3.093 . . . . 0.0 102.649 173.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -82.42 -40.14 21.64 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 173.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.4 m -146.09 165.95 27.56 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.682 0.793 . . . . 0.0 110.141 -173.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 46.4 mtp -126.11 171.87 10.48 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 127.926 2.49 . . . . 0.0 104.889 173.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -140.23 137.48 34.32 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 173.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -111.26 169.15 8.98 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 173.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.4 m -137.37 130.91 31.33 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -144.41 165.52 27.7 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 121.726 -0.609 . . . . 0.0 110.454 174.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -168.31 155.98 8.16 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.081 173.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.99 -174.04 2.54 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 123.536 1.636 . . . . 0.0 107.55 173.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . 0.257 . . -106.37 131.36 53.67 Favored 'General case' 0 N--CA 1.411 -2.389 1 C-N-CA 131.985 4.114 . . . . 0.0 102.99 174.546 . . . . . . . . 3 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -8.63 -55.66 0.01 OUTLIER Glycine 0 CA--C 1.536 1.348 1 C-N-CA 133.883 5.516 . . . . 0.0 119.429 -173.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -116.95 12.03 14.53 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 121.045 2.423 . . . . 0.0 114.664 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.79 37.52 3.42 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 120.251 3.426 . . . . 0.0 120.251 -172.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -45.13 113.71 0.61 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 123.446 2.839 . . . . 0.0 110.448 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -83.83 134.34 34.71 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.412 1.485 . . . . 0.0 106.992 177.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -83.71 146.32 28.27 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -129.8 160.91 32.02 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 120.212 1.369 . . . . 0.0 110.714 175.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.43 ' O ' HD13 ' A' ' 131' ' ' ILE . 30.6 tt0 -154.48 135.03 13.47 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 173.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -85.69 104.06 15.05 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.951 1.3 . . . . 0.0 108.51 -178.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.9 tt -69.24 -54.54 14.24 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 173.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 m -131.1 141.72 50.18 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 123.342 1.544 . . . . 0.0 111.692 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.486 HD22 HG22 ' A' ' 128' ' ' VAL . 0.1 OUTLIER -163.72 92.61 0.7 Allowed 'General case' 0 N--CA 1.448 -0.536 1 N-CA-C 96.011 -5.552 . . . . 0.0 96.011 172.82 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -158.11 146.54 18.88 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.503 -1.373 . . . . 0.0 112.339 -173.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.1 t -78.5 156.92 29.03 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.956 0.502 . . . . 0.0 110.821 174.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.4 mt -121.04 -26.34 5.16 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 116.908 -1.52 . . . . 0.0 112.461 -176.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -81.32 160.18 24.23 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 121.591 1.996 . . . . 0.0 112.038 -177.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.456 ' HE3' ' HA ' ' A' ' 87' ' ' LYS . 0.5 OUTLIER -105.39 -42.57 5.2 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 131.126 3.77 . . . . 0.0 112.556 176.02 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -67.75 -74.16 0.6 Allowed Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 174.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.405 ' HB ' ' HB2' ' A' ' 124' ' ' ALA . 3.5 mp -77.35 26.03 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 129.996 3.319 . . . . 0.0 110.301 -177.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 10.7 ttm -43.55 140.52 1.72 Allowed 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 128.143 2.577 . . . . 0.0 110.031 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -164.69 175.61 9.58 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 130.017 3.327 . . . . 0.0 105.286 -173.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.273 8.2 m-20 -145.46 115.03 4.86 Favored Pre-proline 0 C--N 1.324 -0.526 0 C-N-CA 124.527 1.131 . . . . 0.0 110.07 173.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -69.58 149.77 68.46 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 N-CA-C 108.322 -1.453 . . . . 0.0 108.322 173.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 21.8 p -137.13 160.63 38.42 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 125.62 1.568 . . . . 0.0 108.072 -175.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.5 m -126.01 153.82 34.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 C-N-CA 124.014 0.925 . . . . 0.0 109.637 174.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -93.2 25.63 3.23 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.613 1.565 . . . . 0.0 111.702 176.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.8 m -134.93 163.3 52.18 Favored Pre-proline 0 C--O 1.235 0.29 0 C-N-CA 124.85 1.26 . . . . 0.0 108.142 174.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -66.66 162.2 38.24 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 121.087 1.191 . . . . 0.0 109.418 173.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.01 -12.72 40.72 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 124.056 0.942 . . . . 0.0 111.902 178.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -143.29 165.71 26.72 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 120.325 1.421 . . . . 0.0 108.641 173.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 164.53 -162.73 35.69 Favored Glycine 0 C--O 1.228 -0.27 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 178.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 82.0 p -117.97 146.66 43.83 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 173.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 28.2 t -82.44 113.74 46.52 Favored Pre-proline 0 N--CA 1.447 -0.594 0 N-CA-C 102.996 -2.964 . . . . 0.0 102.996 173.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -84.42 153.63 12.18 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.347 2.031 . . . . 0.0 111.626 -173.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -69.73 1.81 3.91 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 120.113 -1.617 . . . . 0.0 113.369 -173.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -115.28 119.18 35.44 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 127.086 2.154 . . . . 0.0 107.585 -173.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -43.02 107.84 0.09 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.732 1.213 . . . . 0.0 109.91 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.1 m -118.13 139.18 51.63 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.5 t -96.75 135.25 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 114.301 -1.318 . . . . 0.0 107.834 -173.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 78.5 t -119.86 103.93 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -71.82 143.24 49.54 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 173.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.7 t -124.86 113.91 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 103.707 -2.701 . . . . 0.0 103.707 173.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -100.77 147.91 18.06 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 125.134 1.349 . . . . 0.0 110.145 -178.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.41 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 9.0 m-85 -131.16 73.54 80.47 Favored Pre-proline 0 C--O 1.242 0.706 0 CA-C-N 118.325 1.063 . . . . 0.0 111.596 -174.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -69.18 129.88 19.03 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.326 2.017 . . . . 0.0 108.239 173.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 5.7 t -105.44 154.2 20.65 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 175.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 7.6 mt -70.95 -12.78 61.73 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.559 0.618 . . . . 0.0 111.363 174.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.53 5.01 5.91 Favored Glycine 0 C--O 1.215 -1.037 0 C-N-CA 128.513 2.959 . . . . 0.0 116.169 173.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -94.64 -31.51 13.81 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 120.695 2.247 . . . . 0.0 114.418 -173.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 51.4 tp60 -96.57 146.9 24.41 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 173.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -94.25 143.07 26.71 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 174.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 141.48 -154.44 24.67 Favored Glycine 0 C--N 1.334 0.465 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 178.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.4 t -131.6 114.12 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 C-N-CA 123.288 0.635 . . . . 0.0 109.358 -177.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.405 ' HB2' ' HB ' ' A' ' 89' ' ' ILE . . . -89.97 168.34 12.1 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 173.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -124.08 156.87 35.8 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.119 0.968 . . . . 0.0 109.651 174.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.41 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 3.9 p90 -145.14 148.53 33.71 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.334 1.053 . . . . 0.0 108.518 173.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -111.78 157.78 20.14 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 126.456 1.902 . . . . 0.0 110.876 -174.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.486 HG22 HD22 ' A' ' 82' ' ' LEU . 89.6 t -141.67 138.32 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.403 1.081 . . . . 0.0 109.311 174.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -150.66 118.53 6.22 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 126.97 2.108 . . . . 0.0 105.889 173.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 31.4 t -127.72 123.96 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.65 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -89.88 164.96 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 173.717 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.9 t -144.37 135.35 21.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 -176.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.36 173.99 11.08 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.979 1.312 . . . . 0.0 108.832 -176.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -89.06 175.85 7.23 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 172.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 6.7 t -65.02 -15.13 61.98 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 120.11 -1.619 . . . . 0.0 112.175 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -79.86 -3.22 46.97 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.698 1.599 . . . . 0.0 110.913 175.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 80.54 6.54 89.25 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.073 1.32 . . . . 0.0 112.973 178.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -81.72 119.38 23.78 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 178.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -65.98 143.68 57.23 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.359 1.464 . . . . 0.0 109.241 -176.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -140.32 -37.62 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 125.126 1.371 . . . . 0.0 113.576 -174.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -131.01 149.82 52.44 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 178.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.3 tm0? -148.67 150.02 32.49 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 57.4 m -80.11 113.56 39.52 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 178.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -61.39 140.15 86.4 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 CA-C-N 120.685 1.28 . . . . 0.0 110.59 -173.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -75.57 112.53 12.02 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 -173.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 173.07 -34.49 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 129.874 3.27 . . . . 0.0 108.501 -173.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.44 90.72 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 126.656 1.982 . . . . 0.0 110.521 -174.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.3 mt -126.24 148.58 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 176.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -126.69 164.32 21.57 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 175.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -132.83 113.53 13.02 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.223 1.009 . . . . 0.0 108.309 -173.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -101.03 120.33 40.04 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 28.6 m -83.78 116.33 22.65 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 173.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 9.3 m -111.67 163.44 14.11 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 173.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.2 pp -139.35 159.76 41.41 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 174.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -63.67 114.09 3.76 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 127.813 2.445 . . . . 0.0 111.557 -174.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -153.43 157.7 40.32 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 126.054 1.742 . . . . 0.0 109.549 176.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 . . . . . 0 C--O 1.248 0.985 0 C-N-CA 131.612 3.965 . . . . 0.0 105.557 173.661 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.2 m . . . . . 0 C--O 1.224 -0.28 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.8 tt -43.22 123.64 2.99 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.363 2.665 . . . . 0.0 113.458 -173.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.432 ' CD1' ' HA ' ' A' ' 35' ' ' SER . 94.5 m-85 -113.75 141.45 47.26 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 128.414 2.686 . . . . 0.0 108.656 173.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.01 121.94 7.07 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.759 1.623 . . . . 0.0 106.996 -178.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 26.9 p90 -137.89 175.43 9.59 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.595 1.089 . . . . 0.0 110.675 176.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -111.84 134.34 54.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 103.228 -2.879 . . . . 0.0 103.228 173.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -78.96 162.49 25.93 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 123.016 1.389 . . . . 0.0 112.846 -173.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.4 ' HB1' ' HG3' ' A' ' 28' ' ' GLU . . . -78.87 -26.41 43.95 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 113.775 -1.557 . . . . 0.0 112.137 -176.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 10.2 m80 -63.98 -41.96 97.37 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.094 0.957 . . . . 0.0 108.73 -175.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -62.26 -43.99 97.56 Favored 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 123.909 0.884 . . . . 0.0 110.616 177.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.75 -35.47 76.48 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 118.401 -0.809 . . . . 0.0 111.005 176.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 173.507 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.4 ' HG3' ' HB1' ' A' ' 18' ' ' ALA . 19.9 tt0 . . . . . 0 CA--C 1.533 0.306 0 CA-C-O 119.754 -0.165 . . . . 0.0 111.208 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -155.87 137.53 14.21 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 127.809 2.443 . . . . 0.0 105.942 173.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -72.64 175.77 6.09 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.976 2.11 . . . . 0.0 109.644 173.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 66.9 mt -140.81 113.62 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 173.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.55 127.07 34.33 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -176.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.4 mt -102.39 -56.33 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 119.313 0.961 . . . . 0.0 110.665 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.2 t -125.34 131.7 71.97 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -173.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.432 ' HA ' ' CD1' ' A' ' 13' ' ' TYR . 18.8 p -134.49 120.3 19.56 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 174.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.433 1.0 OUTLIER 43.63 47.83 6.43 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 122.72 1.248 . . . . 0.0 112.397 -176.377 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.24 11.68 20.97 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 126.165 1.841 . . . . 0.0 114.959 177.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.489 ' HB2' ' HZ3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -74.23 37.31 0.1 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.633 2.373 . . . . 0.0 113.762 -173.308 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 9.4 mmt -38.22 113.49 0.29 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 122.746 1.26 . . . . 0.0 111.981 -173.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.78 170.09 8.19 Favored Pre-proline 0 N--CA 1.448 -0.535 0 C-N-CA 127.734 2.413 . . . . 0.0 109.079 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.0 26.19 0.25 Allowed 'Trans proline' 0 CA--C 1.548 1.212 0 C-N-CA 123.678 2.918 . . . . 0.0 112.09 173.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -53.57 -26.43 21.47 Favored 'General case' 0 C--N 1.345 0.402 0 C-N-CA 126.437 1.895 . . . . 0.0 111.625 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 m -60.49 -29.81 69.31 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 126.099 1.76 . . . . 0.0 110.696 -173.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -60.76 -63.38 1.32 Allowed 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 174.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.382 1.0 OUTLIER -65.59 -22.89 66.72 Favored 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 124.835 1.254 . . . . 0.0 113.086 -177.775 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -67.95 -52.99 29.71 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.095 -1.628 . . . . 0.0 107.054 173.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.468 0 C-N-CA 124.928 1.291 . . . . 0.0 112.993 -173.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 7.2 mtp . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -61.6 -70.55 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.765 2.31 . . . . 0.0 112.9 -173.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.0 113.56 16.03 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -176.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 94.2 mt -114.31 114.07 45.67 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 126.59 1.956 . . . . 0.0 106.227 -174.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -74.14 158.67 45.21 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 121.86 1.707 . . . . 0.0 110.853 -175.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.6 p -45.45 -38.38 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.428 1.491 . . . . 0.0 112.18 173.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -53.75 -43.1 68.87 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.963 1.705 . . . . 0.0 112.563 176.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.4 mm -81.0 112.93 19.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 103.065 -2.939 . . . . 0.0 103.065 173.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -81.11 -38.45 27.23 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 173.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.3 m -142.74 162.53 35.21 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.891 1.276 . . . . 0.0 111.037 -173.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.9 mmm -116.6 159.22 22.48 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 173.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -109.48 113.16 25.72 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 174.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -100.41 160.21 14.52 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 102.696 -3.075 . . . . 0.0 102.696 172.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.4 m -147.22 136.36 22.45 Favored 'General case' 0 C--N 1.317 -0.84 0 O-C-N 120.086 -1.634 . . . . 0.0 106.976 -177.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -147.62 168.31 22.34 Favored 'General case' 0 C--O 1.246 0.885 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.53 178.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -173.56 149.28 1.64 Allowed 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 113.813 -1.54 . . . . 0.0 114.167 175.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -82.71 -173.9 4.91 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 101.977 -3.342 . . . . 0.0 101.977 172.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -110.78 131.26 55.2 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 103.384 -2.821 . . . . 0.0 103.384 173.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 38.15 -93.79 0.01 OUTLIER Glycine 0 CA--C 1.533 1.204 1 C-N-CA 131.196 4.236 . . . . 0.0 116.008 174.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -116.97 25.08 10.76 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.998 2.119 . . . . 0.0 116.079 174.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.8 37.32 0.53 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 128.855 2.862 . . . . 0.0 114.379 174.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.6 mp0 -38.43 113.56 0.3 Allowed 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 121.5 1.955 . . . . 0.0 116.052 -173.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -103.05 137.36 41.33 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 127.096 2.159 . . . . 0.0 106.446 173.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -99.45 151.31 21.26 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -135.69 159.97 39.98 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 119.918 1.235 . . . . 0.0 110.409 174.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.452 ' O ' HD13 ' A' ' 131' ' ' ILE . 28.8 tt0 -153.56 134.98 14.24 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 173.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -80.71 103.91 10.88 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.3 tt -64.36 -43.35 94.84 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.058 1.343 . . . . 0.0 107.579 174.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 75.4 m -148.34 149.52 31.94 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.437 1.095 . . . . 0.0 109.335 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.7 tt -169.36 93.21 0.27 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 128.933 2.893 . . . . 0.0 103.289 177.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 44.5 mmm-85 -161.95 162.07 28.9 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.495 1.043 . . . . 0.0 111.669 -174.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.2 t -84.86 161.71 19.79 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 122.271 1.034 . . . . 0.0 111.898 174.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.7 mt -126.43 -0.7 6.92 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 126.108 1.763 . . . . 0.0 113.111 -174.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.469 ' CG ' ' H ' ' A' ' 87' ' ' LYS 0.315 14.6 t70 -98.45 161.82 13.48 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 120.601 1.546 . . . . 0.0 114.591 -175.367 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.469 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER -91.0 -59.24 2.22 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 128.936 2.894 . . . . 0.0 110.2 -177.263 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' A' ' 90' ' ' MET . . . -97.09 -45.01 2.69 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 124.977 1.275 . . . . 0.0 112.648 -173.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.7 mp -81.0 24.47 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 CA-C-O 123.323 1.535 . . . . 0.0 109.566 -178.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.454 ' H ' ' C ' ' A' ' 88' ' ' GLY . 24.4 ttm -43.47 133.27 4.4 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 130.808 3.643 . . . . 0.0 109.479 -179.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.261 . . -167.3 176.03 6.96 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 131.382 3.873 . . . . 0.0 105.114 -173.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.283 8.2 m-20 -150.0 136.13 10.52 Favored Pre-proline 0 C--N 1.324 -0.531 0 C-N-CA 124.789 1.236 . . . . 0.0 111.746 172.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -72.99 154.4 52.88 Favored 'Trans proline' 0 N--CA 1.444 -1.394 0 C-N-CA 121.702 1.601 . . . . 0.0 108.476 173.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.2 p -143.88 162.56 35.79 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.626 1.571 . . . . 0.0 108.667 174.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.3 m -126.39 156.25 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 123.73 0.812 . . . . 0.0 112.317 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -74.38 9.23 1.79 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 127.848 2.459 . . . . 0.0 113.584 174.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.4 m -140.68 165.23 31.22 Favored Pre-proline 0 C--N 1.326 -0.421 0 C-N-CA 125.318 1.447 . . . . 0.0 108.84 -178.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -66.57 166.12 23.01 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 121.405 1.403 . . . . 0.0 110.454 173.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.35 -8.99 10.09 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.94 1.296 . . . . 0.0 111.88 175.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -144.56 163.67 33.2 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 120.505 1.502 . . . . 0.0 108.425 173.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.8 -161.28 34.11 Favored Glycine 0 C--O 1.227 -0.342 0 N-CA-C 110.544 -1.023 . . . . 0.0 110.544 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 27.1 p -120.79 148.1 44.45 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.0 t -76.47 113.61 30.61 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -79.86 121.35 4.52 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 121.835 1.69 . . . . 0.0 113.463 -173.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.72 ' H ' ' CD2' ' A' ' 105' ' ' HIS . 1.1 m-70 -63.41 -20.6 65.69 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.329 1.452 . . . . 0.0 111.974 -173.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . 0.274 4.5 mptt -91.88 112.82 24.9 Favored 'General case' 0 N--CA 1.418 -2.046 1 N-CA-C 99.062 -4.422 . . . . 0.0 99.062 176.581 . . . . . . . . 3 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -42.19 117.33 0.96 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.716 1.606 . . . . 0.0 113.003 -173.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 37.4 m -127.33 142.86 51.34 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 123.722 0.639 . . . . 0.0 110.843 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 24.3 t -94.32 116.39 35.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 C-N-CA 125.355 1.462 . . . . 0.0 109.069 -174.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 84.2 t -94.26 103.15 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 103.879 -2.637 . . . . 0.0 103.879 173.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.63 122.59 24.87 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 173.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.5 t -97.63 113.65 32.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 104.307 -2.479 . . . . 0.0 104.307 174.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -100.13 146.37 17.71 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 119.755 1.162 . . . . 0.0 110.377 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.483 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 8.1 m-85 -129.48 73.5 81.54 Favored Pre-proline 0 C--O 1.243 0.74 0 CA-C-N 118.253 1.027 . . . . 0.0 110.097 -174.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.87 127.85 19.53 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.589 2.193 . . . . 0.0 108.802 173.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 6.9 t -105.89 148.47 27.57 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 123.958 0.903 . . . . 0.0 108.908 176.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.6 mt -76.43 -15.7 59.87 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 117.751 0.25 . . . . 0.0 111.31 177.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.1 51.6 57.42 Favored Glycine 0 C--N 1.337 0.605 0 C-N-CA 125.719 1.628 . . . . 0.0 112.092 174.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.418 ' HE3' ' OE2' ' A' ' 157' ' ' GLU 0.297 40.5 mmtm -111.66 -55.44 2.5 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.438 1.119 . . . . 0.0 112.477 -179.061 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 50.4 tp60 -95.68 149.7 21.18 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 173.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -93.48 139.62 30.52 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 176.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.5 -153.55 25.2 Favored Glycine 0 C--N 1.331 0.278 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -176.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.7 t -130.41 114.14 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -175.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -85.94 170.34 12.42 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 173.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -123.95 151.63 43.4 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 173.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.483 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 32.9 p90 -145.55 156.49 43.73 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 174.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -128.14 160.71 31.18 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 126.281 1.832 . . . . 0.0 111.229 -173.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 67.5 t -141.76 139.28 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 O-C-N 125.307 1.629 . . . . 0.0 108.141 173.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -143.22 121.7 12.43 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 128.043 2.537 . . . . 0.0 106.589 174.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.8 t -133.5 124.2 47.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -177.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.661 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -90.52 164.37 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 173.374 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.0 t -145.15 134.45 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 -175.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.13 174.82 10.2 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 124.821 1.249 . . . . 0.0 107.934 -175.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -89.63 176.06 7.02 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 104.535 -2.394 . . . . 0.0 104.535 172.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.2 t -66.67 -4.14 8.16 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 120.239 -1.538 . . . . 0.0 113.709 -177.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -88.27 -15.38 35.95 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 120.608 1.549 . . . . 0.0 110.513 173.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.75 1.18 61.93 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.705 1.145 . . . . 0.0 112.114 -173.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -70.1 115.96 9.91 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 119.564 1.682 . . . . 0.0 108.403 174.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -67.54 143.79 55.95 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.439 1.496 . . . . 0.0 108.883 -176.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -139.3 -36.58 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 124.486 1.114 . . . . 0.0 113.569 -175.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.428 HD13 ' N ' ' A' ' 142' ' ' GLN . 1.6 tm? -136.88 146.97 46.18 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.723 1.609 . . . . 0.0 106.817 -174.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.428 ' N ' HD13 ' A' ' 141' ' ' LEU . 13.3 tm0? -147.84 150.84 34.92 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 121.105 -0.997 . . . . 0.0 108.671 174.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.4 m -88.05 113.62 55.7 Favored Pre-proline 0 CA--C 1.532 0.253 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -66.72 148.88 83.57 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 121.55 1.5 . . . . 0.0 112.346 -173.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -81.16 112.6 18.66 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.488 -173.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.595 7.1 m-80 172.37 -13.96 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.445 1 C-N-CA 138.022 6.529 . . . . 0.0 111.128 173.279 . . . . . . . . 3 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.69 81.44 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.309 1.844 . . . . 0.0 109.158 174.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.5 mt -133.9 147.78 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 127.606 2.362 . . . . 0.0 106.182 -174.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.427 ' CD1' ' CE1' ' A' ' 126' ' ' PHE . 0.9 OUTLIER -132.18 171.03 14.18 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.363 -1.29 . . . . 0.0 107.718 178.128 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -134.25 113.64 12.2 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 -173.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.57 126.51 53.66 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 -173.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 34.1 m -93.6 115.8 28.29 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 -175.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 4.3 m -115.39 166.43 11.88 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 123.818 0.847 . . . . 0.0 110.294 174.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.1 pp -131.92 161.46 33.0 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.862 1.665 . . . . 0.0 107.129 173.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.37 130.34 42.76 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.19 0.996 . . . . 0.0 109.971 177.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -157.93 163.06 38.24 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.193 1.797 . . . . 0.0 108.739 175.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.418 ' OE2' ' HE3' ' A' ' 119' ' ' LYS . 2.9 tp10 . . . . . 0 C--O 1.246 0.885 0 C-N-CA 129.527 3.131 . . . . 0.0 104.28 173.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.26 0 N-CA-C 107.078 -2.409 . . . . 0.0 107.078 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.9 m -164.27 176.84 8.79 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 118.694 -1.202 . . . . 0.0 113.281 -125.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.11 177.66 2.15 Favored 'General case' 0 CA--C 1.545 0.757 1 C-N-CA 133.262 4.625 . . . . 0.0 104.975 172.546 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 65.2 mtt -44.47 164.53 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.988 0 O-C-N 120.015 -1.678 . . . . 0.0 108.371 172.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 11.1 mp -42.87 114.8 0.64 Allowed 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -172.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -66.67 176.1 2.1 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 129.125 2.97 . . . . 0.0 110.28 -178.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -126.41 114.15 17.81 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -133.86 176.65 8.37 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 129.561 3.144 . . . . 0.0 107.29 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -53.6 160.56 1.26 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.462 1.505 . . . . 0.0 112.256 -175.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -72.97 176.03 6.1 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 123.321 1.534 . . . . 0.0 113.099 -173.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.2 m -92.76 175.93 6.63 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.066 177.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.7 tt -45.69 133.38 8.1 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.928 2.891 . . . . 0.0 113.45 -175.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -119.84 138.66 53.25 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.391 1.876 . . . . 0.0 108.618 173.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.27 119.39 6.75 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.921 1.688 . . . . 0.0 106.78 -178.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 17.6 p90 -136.95 157.76 45.99 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 119.607 1.094 . . . . 0.0 110.083 176.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.3 mp -91.83 116.52 33.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 103.119 -2.919 . . . . 0.0 103.119 173.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -79.33 140.07 37.62 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 123.648 1.689 . . . . 0.0 113.762 -173.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.84 -23.85 65.43 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 126.945 2.098 . . . . 0.0 116.006 -173.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 10.9 m80 -56.82 -39.03 73.44 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 43.8 tp60 -66.55 -43.81 84.05 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 123.485 0.714 . . . . 0.0 111.33 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.76 -36.3 71.92 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.704 0.802 . . . . 0.0 111.431 174.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 52.3 ttm-85 -54.62 -54.61 39.24 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 173.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.4 t -54.4 -26.32 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 119.334 0.97 . . . . 0.0 111.618 178.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mt -70.67 -44.69 66.5 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 173.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.4 pt -150.88 15.73 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 116.253 1.946 . . . . 0.0 116.253 -173.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.98 -1.2 8.65 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 128.363 2.887 . . . . 0.0 114.881 -174.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -101.8 149.0 24.63 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 129.777 3.231 . . . . 0.0 107.549 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -112.22 123.11 49.57 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.402 1.001 . . . . 0.0 109.328 -173.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -141.38 113.54 8.01 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.962 1.705 . . . . 0.0 109.458 -175.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -90.3 161.83 15.46 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 173.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.0 mp -140.74 113.53 4.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 173.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.55 119.82 23.05 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.5 mt -91.95 -65.83 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.914 0.886 . . . . 0.0 109.445 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.6 t -115.48 120.37 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 105.809 -1.922 . . . . 0.0 105.809 -173.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.4 p -120.25 120.29 35.66 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 103.844 -2.65 . . . . 0.0 103.844 173.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 45.69 38.95 4.55 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.376 1.471 . . . . 0.0 112.872 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.67 -10.91 1.34 Allowed Glycine 0 CA--C 1.543 1.803 0 O-C-N 120.656 -1.277 . . . . 0.0 114.586 -177.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -80.32 37.53 0.39 Allowed 'General case' 0 C--N 1.324 -0.501 1 C-N-CA 133.915 4.886 . . . . 0.0 110.381 -175.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 45.5 mtm -37.78 129.12 1.16 Allowed 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.426 1.891 . . . . 0.0 113.135 -172.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.35 165.68 16.93 Favored Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 113.92 -1.491 . . . . 0.0 108.456 173.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.52 33.23 0.32 Allowed 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 123.965 3.11 . . . . 0.0 111.259 173.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -54.01 -26.7 27.57 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 127.659 2.383 . . . . 0.0 113.121 -173.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 m -65.38 -32.38 73.98 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.949 1.299 . . . . 0.0 111.565 -173.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -58.81 -60.93 3.06 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -56.88 -40.4 76.14 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 177.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -56.65 -52.07 66.28 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.611 1.165 . . . . 0.0 110.428 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -85.67 -23.86 27.27 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 117.757 0.253 . . . . 0.0 111.652 -175.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -67.48 162.54 22.97 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 173.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.05 112.71 7.42 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 173.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -97.07 166.56 11.53 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.986 1.314 . . . . 0.0 108.48 173.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.6 tp60 -61.81 -28.7 69.65 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 117.756 -1.116 . . . . 0.0 110.87 173.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.42 -16.8 1.03 Allowed 'General case' 0 C--N 1.351 0.639 0 N-CA-C 120.479 3.511 . . . . 0.0 120.479 -173.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 78.9 mmm -84.51 -53.41 0.5 Allowed Pre-proline 0 N--CA 1.47 0.53 0 N-CA-C 117.601 2.445 . . . . 0.0 117.601 -173.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.9 -69.83 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.754 0 CA-C-N 121.152 1.447 . . . . 0.0 114.039 -173.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.47 114.12 8.28 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.404 1.082 . . . . 0.0 111.74 -173.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 72.5 mt -118.58 133.05 23.59 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 127.731 2.412 . . . . 0.0 106.248 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -83.34 160.22 15.03 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 122.746 2.297 . . . . 0.0 112.076 178.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.5 p -46.47 -41.29 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 125.833 1.653 . . . . 0.0 111.734 173.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -55.87 -36.97 68.18 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 126.224 1.81 . . . . 0.0 112.674 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 mm -78.4 112.86 16.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 103.663 -2.717 . . . . 0.0 103.663 173.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -78.64 -42.08 29.73 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 173.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.1 m -139.71 152.75 46.92 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.198 0.599 . . . . 0.0 111.485 -173.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 15.0 mmm -104.51 171.68 7.2 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 126.43 1.892 . . . . 0.0 106.851 173.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.261 90.2 m-20 -126.51 150.75 48.58 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 173.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -137.02 155.87 49.14 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 102.664 -3.087 . . . . 0.0 102.664 172.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.4 m -140.89 133.97 29.35 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 -175.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -146.99 166.02 28.09 Favored 'General case' 0 C--O 1.24 0.587 0 O-C-N 121.785 -0.572 . . . . 0.0 111.049 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -171.7 161.73 6.11 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 122.223 1.011 . . . . 0.0 112.788 176.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -95.34 -173.74 3.0 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 103.058 -2.942 . . . . 0.0 103.058 172.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.05 144.65 46.45 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 101.476 -3.527 . . . . 0.0 101.476 173.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 12.24 -62.82 0.0 OUTLIER Glycine 0 CA--C 1.542 1.757 1 C-N-CA 134.884 5.992 . . . . 0.0 120.78 -173.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -116.44 -6.69 11.73 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 121.978 2.889 . . . . 0.0 114.22 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.82 37.05 0.41 Allowed 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 119.329 3.085 . . . . 0.0 119.329 -173.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -53.73 114.82 1.69 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 122.826 2.557 . . . . 0.0 110.088 -177.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -83.61 155.52 23.19 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 175.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -104.95 145.45 30.4 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 104.281 -2.489 . . . . 0.0 104.281 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -128.94 162.42 27.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 120.169 1.35 . . . . 0.0 110.675 176.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.448 ' O ' HD13 ' A' ' 131' ' ' ILE . 31.2 tt0 -155.16 134.7 12.6 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 173.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.478 ' CD1' HD23 ' A' ' 82' ' ' LEU . 66.0 m-85 -84.68 103.87 14.16 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.35 1.06 . . . . 0.0 109.762 -175.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.8 tt -69.27 -47.99 63.03 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.132 1.373 . . . . 0.0 109.001 176.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.7 m -130.34 138.22 50.32 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 125.453 1.501 . . . . 0.0 110.837 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.478 HD22 HG22 ' A' ' 128' ' ' VAL . 0.1 OUTLIER -170.29 92.75 0.21 Allowed 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 102.354 -3.202 . . . . 0.0 102.354 172.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -165.27 154.8 12.75 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 119.998 1.272 . . . . 0.0 110.765 -174.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.3 t -77.39 165.57 24.24 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-O 121.878 0.847 . . . . 0.0 110.201 173.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.5 mt -126.34 -5.16 6.62 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 126.005 1.722 . . . . 0.0 112.158 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.574 ' CG ' ' H ' ' A' ' 87' ' ' LYS 0.396 14.1 t70 -89.85 176.2 6.92 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 120.067 1.303 . . . . 0.0 111.701 -176.43 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.574 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 9.0 mtmm -122.62 -48.81 2.03 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 129.37 3.068 . . . . 0.0 111.699 -173.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 90' ' ' MET . . . -94.16 -54.08 1.66 Allowed Glycine 0 CA--C 1.526 0.729 0 C-N-CA 125.026 1.298 . . . . 0.0 111.562 178.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.3 mp -79.37 15.0 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 C-N-CA 126.225 1.81 . . . . 0.0 109.437 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.401 ' H ' ' C ' ' A' ' 88' ' ' GLY . 19.8 ttp -43.5 141.74 1.33 Allowed 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 130.579 3.552 . . . . 0.0 110.584 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -159.83 175.56 12.95 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 130.293 3.437 . . . . 0.0 105.417 -173.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -139.99 113.89 7.68 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 173.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -70.94 146.82 53.86 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 121.734 1.622 . . . . 0.0 109.691 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 23.4 p -132.45 162.4 31.27 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 125.436 1.494 . . . . 0.0 108.833 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.3 m -125.89 154.34 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 C-N-CA 123.882 0.873 . . . . 0.0 110.446 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -84.17 10.57 9.92 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.812 1.645 . . . . 0.0 112.738 -177.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.9 m -141.33 166.26 23.39 Favored Pre-proline 0 C--N 1.326 -0.446 0 C-N-CA 126.43 1.892 . . . . 0.0 108.396 -173.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -66.41 163.04 33.83 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 121.013 1.142 . . . . 0.0 109.756 173.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -64.01 -10.13 19.96 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.337 1.055 . . . . 0.0 112.466 177.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -142.96 163.27 33.24 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.45 1.5 . . . . 0.0 107.657 173.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 166.83 -161.74 35.53 Favored Glycine 0 N--CA 1.461 0.324 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 82.1 p -119.6 154.39 34.01 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 117.944 0.872 . . . . 0.0 110.307 174.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.0 t -95.01 113.35 61.16 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 104.308 -2.479 . . . . 0.0 104.308 173.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -91.01 157.99 3.92 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.819 2.346 . . . . 0.0 114.355 -173.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.41 ' CD2' ' H ' ' A' ' 105' ' ' HIS . 16.3 m-70 -64.56 -19.76 65.83 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 123.087 1.423 . . . . 0.0 110.469 -176.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -79.55 113.78 17.96 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 129.367 3.067 . . . . 0.0 106.485 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.92 109.26 0.3 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.558 1.072 . . . . 0.0 108.295 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.8 m -124.42 138.19 54.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -174.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.5 t -91.29 141.66 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 88.9 t -125.14 103.83 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 127.423 2.289 . . . . 0.0 105.493 176.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -69.65 151.12 46.27 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 173.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.9 t -129.46 113.51 28.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 173.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -96.49 147.14 18.56 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 119.76 1.164 . . . . 0.0 110.701 -174.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.478 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 10.1 m-85 -131.29 73.37 80.3 Favored Pre-proline 0 C--O 1.245 0.853 0 CA-C-N 118.457 1.129 . . . . 0.0 111.048 -174.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.76 119.74 6.71 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.582 2.188 . . . . 0.0 106.887 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 5.6 t -99.45 145.62 27.23 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.3 mt -77.56 -6.76 54.82 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 118.787 -0.625 . . . . 0.0 111.986 -175.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.19 49.14 78.48 Favored Glycine 0 C--N 1.341 0.821 0 C-N-CA 126.379 1.942 . . . . 0.0 113.529 173.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -112.34 -68.53 0.92 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.17 0.985 . . . . 0.0 111.544 -174.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 46.4 tp60 -95.73 153.11 17.9 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 173.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -93.42 146.97 23.36 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 177.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 141.32 -151.84 22.89 Favored Glycine 0 C--N 1.332 0.31 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.0 t -127.62 114.02 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -177.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -85.31 168.73 14.42 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 173.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -122.99 159.37 28.48 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.826 0.851 . . . . 0.0 109.12 173.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.478 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 10.4 p90 -147.13 146.4 29.91 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 173.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -101.32 149.68 23.78 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 126.707 2.003 . . . . 0.0 110.349 -177.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.478 HG22 HD22 ' A' ' 82' ' ' LEU . 72.2 t -144.63 138.66 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 125.901 1.681 . . . . 0.0 107.31 173.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -160.58 129.69 4.87 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 173.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 41.1 t -134.31 138.77 49.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 -173.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.544 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -105.07 165.27 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.2 t -143.47 136.93 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -174.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.21 167.16 22.1 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 124.686 1.194 . . . . 0.0 109.195 -177.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.47 ' C ' HD22 ' A' ' 134' ' ' ASN . 0.1 OUTLIER -83.76 168.79 15.86 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 103.882 -2.636 . . . . 0.0 103.882 172.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.2 t -58.57 -21.19 52.15 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 120.333 1.424 . . . . 0.0 113.876 -174.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -75.01 -9.8 58.88 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.335 -1.478 . . . . 0.0 113.404 174.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 97.72 -2.63 60.47 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.868 1.223 . . . . 0.0 114.576 -175.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -68.8 118.2 11.47 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 120.183 1.991 . . . . 0.0 108.644 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.5 m -67.23 142.14 57.03 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.3 pt -140.64 -38.25 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 124.702 1.201 . . . . 0.0 113.861 -174.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -128.77 143.66 50.98 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 177.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -146.62 130.48 17.14 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 61.8 m -62.73 140.3 97.13 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -81.78 145.23 14.24 Favored 'Trans proline' 0 N--CA 1.443 -1.458 0 CA-C-N 120.258 1.128 . . . . 0.0 109.463 174.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -80.69 112.78 18.38 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -173.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.373 24.0 m-80 172.8 -16.19 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.695 1 C-N-CA 134.006 4.923 . . . . 0.0 112.463 173.663 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.83 97.62 0.08 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 122.166 0.984 . . . . 0.0 110.035 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.1 mm -130.98 138.02 54.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 -176.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.418 ' HB2' ' CE2' ' A' ' 126' ' ' PHE . 0.6 OUTLIER -117.98 170.0 9.19 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 173.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -136.21 113.51 10.69 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.29 1.036 . . . . 0.0 108.347 -173.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.36 122.55 48.05 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -174.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 18.6 m -84.02 118.68 24.21 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 7.7 m -119.26 166.37 13.08 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 123.834 0.854 . . . . 0.0 109.735 174.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.7 pp -131.27 161.77 31.52 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 126.408 1.883 . . . . 0.0 106.359 173.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 9.7 tm0? -63.85 136.66 57.57 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 174.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -165.32 113.08 0.98 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.194 1.398 . . . . 0.0 107.41 173.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 . . . . . 0 C--O 1.247 0.95 0 C-N-CA 130.284 3.434 . . . . 0.0 104.585 173.846 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.795 0 N-CA-C 107.553 -2.219 . . . . 0.0 107.553 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.3 m -60.88 176.06 0.44 Allowed 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 143.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -63.16 113.21 3.02 Favored 'General case' 0 C--N 1.343 0.323 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 173.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 75.9 mtp -161.86 176.54 10.74 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 129.676 3.19 . . . . 0.0 105.09 -173.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -104.8 113.56 27.23 Favored 'General case' 0 N--CA 1.451 -0.412 1 N-CA-C 99.209 -4.367 . . . . 0.0 99.209 172.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -83.66 154.59 23.61 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -174.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -150.54 151.26 32.37 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 102.946 -2.983 . . . . 0.0 102.946 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -73.37 175.62 6.76 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.075 -1.421 . . . . 0.0 109.907 173.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -55.99 158.02 4.14 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 129.185 2.994 . . . . 0.0 112.331 -174.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -139.83 167.97 20.88 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.21 1.404 . . . . 0.0 107.546 173.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m -176.35 177.11 1.54 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 130.427 3.491 . . . . 0.0 108.501 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.4 tt -43.4 124.06 3.27 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 126.136 1.774 . . . . 0.0 112.36 -176.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -112.25 135.38 53.0 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.295 1.438 . . . . 0.0 108.13 173.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.51 120.67 10.15 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.057 1.743 . . . . 0.0 106.638 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 20.4 p90 -135.62 168.49 19.16 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 118.656 0.662 . . . . 0.0 109.884 175.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.3 mt -102.74 113.83 40.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 103.278 -2.86 . . . . 0.0 103.278 174.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -80.42 149.75 30.03 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.947 1.356 . . . . 0.0 110.567 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.99 -11.55 29.87 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -173.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 45.3 m80 -53.42 -44.74 69.02 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.909 1.232 . . . . 0.0 113.63 -173.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 49.7 tp60 -70.28 -39.96 74.59 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 118.867 -1.133 . . . . 0.0 111.159 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.1 -36.72 78.05 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.065 0.546 . . . . 0.0 111.637 176.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -55.16 -56.93 14.32 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 174.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 60.3 t -54.18 -24.28 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 124.183 0.993 . . . . 0.0 111.835 177.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.8 mt -77.83 -41.55 36.67 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 173.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.1 pt -146.85 14.9 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 117.212 2.301 . . . . 0.0 117.212 -172.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.4 10.3 21.84 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 127.503 2.477 . . . . 0.0 114.724 -174.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -101.25 174.03 6.18 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.32 2.248 . . . . 0.0 109.86 -174.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -125.82 124.1 40.18 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.673 0.789 . . . . 0.0 109.253 -177.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -157.38 113.95 2.96 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.688 1.195 . . . . 0.0 111.259 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -95.18 167.7 11.2 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 173.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.4 mp -137.08 113.27 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 104.912 -2.255 . . . . 0.0 104.912 173.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.0 113.96 19.56 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 177.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.4 mt -90.09 -54.41 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.9 t -125.61 113.73 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 -173.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.6 p -110.59 113.81 26.71 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 103.399 -2.815 . . . . 0.0 103.399 173.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.346 1.5 pp20? 46.26 34.13 2.08 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -178.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.73 -6.88 76.29 Favored Glycine 0 CA--C 1.536 1.385 0 O-C-N 120.751 -1.218 . . . . 0.0 114.705 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.3 37.23 0.09 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 130.621 3.568 . . . . 0.0 112.64 -174.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 40.9 mtt -38.09 117.66 0.62 Allowed 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 -173.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.94 164.8 58.04 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 113.885 -1.507 . . . . 0.0 107.851 173.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.72 36.59 0.43 Allowed 'Trans proline' 0 CA--C 1.548 1.206 0 C-N-CA 124.236 3.291 . . . . 0.0 112.024 174.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -53.93 -26.51 25.67 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 127.059 2.144 . . . . 0.0 113.756 -173.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 m -60.06 -33.42 72.04 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.922 1.689 . . . . 0.0 112.218 -173.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -60.72 -53.62 55.25 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.279 0.9 OUTLIER -76.13 -29.97 58.03 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -176.609 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -55.37 -47.45 75.77 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.2 -0.938 . . . . 0.0 108.762 173.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -73.08 -37.4 66.77 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 118.562 -0.732 . . . . 0.0 111.762 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.33 112.99 16.33 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 120.324 1.42 . . . . 0.0 109.54 -176.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -172.73 176.86 3.05 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 120.008 1.276 . . . . 0.0 108.407 -178.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -44.29 140.72 2.1 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 173.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? -43.62 -33.78 1.27 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.085 1.754 . . . . 0.0 113.649 -173.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.44 -11.07 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 129.307 3.043 . . . . 0.0 115.601 173.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -117.54 -66.03 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.438 0 C-N-CA 126.534 1.934 . . . . 0.0 114.833 173.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.22 -70.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.729 1.619 . . . . 0.0 112.644 -173.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.26 113.15 20.49 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -174.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 55.7 mt -104.37 119.48 53.79 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 -175.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -74.21 154.22 46.45 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.319 1.346 . . . . 0.0 109.694 -177.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.0 p -41.68 -42.66 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 126.6 1.96 . . . . 0.0 113.008 177.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -59.2 -40.57 86.2 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 126.084 1.754 . . . . 0.0 112.734 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.1 mm -77.54 112.77 15.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 101.762 -3.422 . . . . 0.0 101.762 173.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -84.18 -28.95 27.01 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.568 -177.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.4 m -147.96 170.72 17.1 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.842 1.257 . . . . 0.0 110.941 -173.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.4 mmm -126.69 162.32 26.05 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 126.418 1.887 . . . . 0.0 106.937 172.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -109.34 146.32 34.57 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 173.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -135.84 153.06 51.61 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 103.082 -2.933 . . . . 0.0 103.082 172.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.1 m -140.36 133.65 29.76 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -176.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -146.07 165.05 30.21 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 121.824 -0.547 . . . . 0.0 111.0 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -167.14 144.72 4.73 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 175.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.24 -179.31 6.15 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 172.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -107.42 85.46 2.13 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.396 1.478 . . . . 0.0 111.582 -174.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.04 -59.5 0.01 OUTLIER Glycine 0 CA--C 1.537 1.426 0 C-N-CA 128.462 2.934 . . . . 0.0 119.322 173.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -116.91 -13.02 10.67 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.926 1.863 . . . . 0.0 112.95 173.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.77 37.24 0.09 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 130.755 3.622 . . . . 0.0 118.984 -173.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -44.79 113.77 0.61 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 122.397 2.362 . . . . 0.0 111.511 -174.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -96.2 120.38 36.38 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 174.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -80.01 149.09 30.86 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -134.38 160.78 36.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 119.735 1.152 . . . . 0.0 111.044 176.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.486 ' O ' HD13 ' A' ' 131' ' ' ILE . 29.9 tt0 -151.61 136.8 17.48 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 173.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.4 ' CD2' HG22 ' A' ' 130' ' ' VAL . 49.6 m-85 -80.09 104.0 10.35 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.104 0.961 . . . . 0.0 110.434 -178.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.8 tt -63.14 -46.71 85.97 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.148 1.379 . . . . 0.0 108.658 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.3 m -130.2 138.97 50.85 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.716 1.206 . . . . 0.0 110.768 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.2 tt -170.28 92.66 0.21 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 103.305 -2.85 . . . . 0.0 103.305 173.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -166.82 153.89 9.02 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.485 0.584 . . . . 0.0 111.544 -174.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.2 t -72.69 163.27 28.35 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 173.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.4 mt -125.96 -20.18 4.64 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 116.661 -1.638 . . . . 0.0 112.691 174.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.416 ' CG ' ' H ' ' A' ' 87' ' ' LYS . 26.5 t0 -84.26 171.14 13.0 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 121.587 1.994 . . . . 0.0 111.526 174.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.416 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER -109.33 -47.57 3.38 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 129.192 2.997 . . . . 0.0 112.711 174.486 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -70.08 -72.52 0.86 Allowed Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 176.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mp -76.85 19.52 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 128.41 2.684 . . . . 0.0 110.228 -175.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 15.3 ttp -43.75 131.21 5.46 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 127.753 2.421 . . . . 0.0 108.968 -177.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.441 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -158.21 114.01 2.72 Favored 'General case' 0 CA--C 1.508 -0.673 0 C-N-CA 126.54 1.936 . . . . 0.0 106.906 -173.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -97.49 134.39 22.61 Favored Pre-proline 0 C--N 1.323 -0.567 0 O-C-N 124.209 0.943 . . . . 0.0 109.726 -173.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.42 154.25 65.25 Favored 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 121.294 1.329 . . . . 0.0 109.054 173.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 21.5 p -139.28 157.07 46.55 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 126.648 1.979 . . . . 0.0 106.736 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.8 m -126.39 153.84 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-N 119.302 0.955 . . . . 0.0 112.861 178.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -72.54 7.73 1.73 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 127.004 2.122 . . . . 0.0 113.521 174.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.8 m -141.08 165.8 26.82 Favored Pre-proline 0 C--N 1.326 -0.414 0 C-N-CA 126.03 1.732 . . . . 0.0 108.295 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -67.57 168.09 19.13 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.377 1.384 . . . . 0.0 111.082 174.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -64.09 -10.98 25.62 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.733 1.213 . . . . 0.0 112.512 175.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -145.37 164.41 31.58 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.539 1.536 . . . . 0.0 107.355 173.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 160.99 -161.68 33.05 Favored Glycine 0 C--O 1.226 -0.37 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 56.5 p -118.59 151.56 37.68 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 173.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 46.5 t -88.17 113.39 54.84 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 175.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -73.79 158.23 46.94 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.093 2.529 . . . . 0.0 112.881 -173.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -65.27 -19.62 66.05 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 -173.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . 0.266 0.0 OUTLIER -116.81 143.69 45.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 118.563 0.62 . . . . 0.0 112.36 174.159 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -43.04 108.19 0.1 Allowed 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 127.052 2.141 . . . . 0.0 110.951 -174.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.2 m -116.41 143.49 45.49 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 175.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.4 t -97.18 119.39 45.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 C-N-CA 124.403 1.081 . . . . 0.0 111.11 -173.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 72.3 t -95.56 103.58 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 173.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.4 120.55 25.12 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 173.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.5 t -93.23 113.55 28.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 103.872 -2.64 . . . . 0.0 103.872 173.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -92.99 151.12 20.28 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.411 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 11.1 m-85 -132.33 73.81 76.78 Favored Pre-proline 0 C--O 1.244 0.792 0 CA-C-N 118.81 1.305 . . . . 0.0 110.821 -176.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -63.05 114.77 2.59 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.707 2.271 . . . . 0.0 109.679 173.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 9.6 t -91.29 151.15 21.01 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 173.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.1 mt -72.11 -11.19 60.63 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 117.862 0.301 . . . . 0.0 111.545 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 54.44 30.4 49.49 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 127.413 2.435 . . . . 0.0 116.506 173.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 43.1 mttt -120.15 -32.05 4.26 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.388 1.594 . . . . 0.0 113.915 176.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 45.7 tp60 -96.65 146.67 24.64 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 173.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -95.4 148.39 22.5 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 174.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.44 -153.8 23.19 Favored Glycine 0 C--N 1.336 0.537 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 176.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.7 t -131.45 118.45 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.761 0.825 . . . . 0.0 108.864 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -93.54 175.27 6.81 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.67 1.188 . . . . 0.0 109.746 173.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -126.15 155.77 41.17 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.538 1.935 . . . . 0.0 106.997 173.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.411 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 48.9 p90 -150.63 155.49 39.48 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.322 1.049 . . . . 0.0 108.913 174.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -113.93 143.71 44.27 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 125.62 1.568 . . . . 0.0 111.131 -174.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 59.0 t -144.65 119.76 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 173.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -146.42 143.03 28.74 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.209 1.404 . . . . 0.0 108.092 177.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.4 HG22 ' CD2' ' A' ' 79' ' ' PHE . 30.0 t -139.16 141.06 36.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 119.392 0.996 . . . . 0.0 109.939 -173.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.54 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -107.3 163.57 5.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 173.588 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.6 t -141.85 138.3 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -173.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.66 173.37 11.78 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.625 1.57 . . . . 0.0 107.786 -177.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 44.5 p-10 -88.12 176.07 7.44 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 172.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.1 t -67.0 -6.59 17.54 Favored 'General case' 0 CA--C 1.553 1.081 0 O-C-N 120.439 -1.413 . . . . 0.0 112.318 -176.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -84.54 -15.94 44.04 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 120.435 -1.416 . . . . 0.0 110.663 173.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.99 4.62 61.38 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.735 1.159 . . . . 0.0 112.547 -173.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -77.08 117.43 18.64 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.827 1.814 . . . . 0.0 108.937 175.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.7 m -64.32 141.87 58.62 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 126.48 1.912 . . . . 0.0 108.88 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -140.01 -39.03 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 124.931 1.293 . . . . 0.0 113.769 -174.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -130.94 142.35 50.35 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 -177.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -148.59 124.5 10.62 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -176.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 25.1 m -64.1 140.48 97.91 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 174.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.47 141.28 13.97 Favored 'Trans proline' 0 N--CA 1.441 -1.585 0 CA-C-N 119.997 1.035 . . . . 0.0 109.993 177.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 28.2 mp0 -80.4 112.63 17.92 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 -173.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.343 38.5 m-80 172.65 -16.53 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 1 C-N-CA 132.201 4.201 . . . . 0.0 111.311 173.405 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -56.22 98.2 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.024 1.73 . . . . 0.0 110.13 177.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 2.8 mt -135.69 147.22 28.68 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 -174.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -129.08 175.56 8.6 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 173.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -133.23 139.58 47.05 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 -175.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -124.1 122.35 37.61 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 177.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 34.5 m -83.64 118.45 23.85 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 174.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 4.9 m -117.78 166.12 12.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.442 0.639 . . . . 0.0 110.08 173.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.4 pp -138.6 159.7 41.45 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.96 1.704 . . . . 0.0 106.893 173.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.63 127.63 33.45 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.751 0.82 . . . . 0.0 110.302 175.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -147.95 114.32 5.92 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.026 0.93 . . . . 0.0 111.057 176.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 . . . . . 0 C--O 1.256 1.442 0 C-N-CA 129.324 3.049 . . . . 0.0 105.406 173.53 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.617 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.3 p -80.51 112.53 17.95 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 120.549 2.175 . . . . 0.0 106.274 167.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -177.23 176.47 1.35 Allowed 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 130.963 3.705 . . . . 0.0 104.562 173.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.07 112.54 18.83 Favored 'General case' 0 N--CA 1.45 -0.444 1 N-CA-C 99.403 -4.295 . . . . 0.0 99.403 172.44 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 28.4 tp -177.0 113.37 0.09 Allowed 'General case' 0 CA--C 1.513 -0.465 1 N-CA-C 99.978 -4.082 . . . . 0.0 99.978 173.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -140.95 114.0 8.49 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 -173.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.6 113.83 0.44 Allowed 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 127.216 2.206 . . . . 0.0 105.46 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.9 tp60 -158.44 176.37 12.52 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 176.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.2 160.0 11.12 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.822 1.249 . . . . 0.0 108.98 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -68.11 168.38 12.22 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 122.88 1.324 . . . . 0.0 111.569 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m -171.75 176.97 3.5 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 129.117 2.967 . . . . 0.0 108.895 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.423 HD22 HG11 ' A' ' 34' ' ' VAL . 3.1 tt -42.96 129.14 4.41 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 128.066 2.546 . . . . 0.0 113.758 -173.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -117.55 144.6 44.96 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.174 1.79 . . . . 0.0 108.63 173.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.27 123.2 7.51 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.325 1.85 . . . . 0.0 106.615 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 25.7 p90 -141.27 160.93 39.09 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.737 1.153 . . . . 0.0 110.188 178.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -96.13 144.73 9.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 104.509 -2.404 . . . . 0.0 104.509 173.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -97.61 162.74 13.15 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -173.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.9 -18.13 54.39 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 126.114 1.766 . . . . 0.0 114.367 174.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -59.47 -41.13 89.04 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 119.747 1.158 . . . . 0.0 108.978 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 -66.68 -43.49 84.32 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.631 ' HA ' HD12 ' A' ' 24' ' ' LEU . . . -63.49 -31.82 73.08 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 121.965 -0.459 . . . . 0.0 111.83 174.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.4 ttm105 -57.71 -55.61 32.58 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 173.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 89.4 t -52.67 -23.85 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.632 1.173 . . . . 0.0 111.766 175.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.631 HD12 ' HA ' ' A' ' 21' ' ' ALA . 7.3 mt -75.12 -48.31 24.35 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 117.676 -1.154 . . . . 0.0 113.685 173.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.1 pt -155.71 20.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 -172.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.08 -1.65 54.64 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 126.55 2.024 . . . . 0.0 114.811 -176.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -79.92 176.47 9.71 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 129.2 3.0 . . . . 0.0 111.154 -173.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -125.47 126.97 45.75 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.516 1.526 . . . . 0.0 107.416 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.261 98.7 mt-10 -159.77 112.72 2.16 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.877 1.217 . . . . 0.0 112.994 173.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -97.01 162.6 13.31 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 172.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.9 mp -141.39 113.43 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 173.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.03 119.87 23.43 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.443 HG23 ' CE2' ' A' ' 42' ' ' PHE . 17.8 mt -96.14 -58.44 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 119.024 0.829 . . . . 0.0 109.789 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.423 HG11 HD22 ' A' ' 12' ' ' LEU . 4.0 t -126.48 142.95 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 126.396 1.878 . . . . 0.0 109.069 -173.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.9 p -153.02 135.2 14.89 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 102.318 -3.215 . . . . 0.0 102.318 173.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 44.46 33.91 0.98 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.882 1.273 . . . . 0.0 113.167 -174.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.33 -2.99 8.57 Favored Glycine 0 CA--C 1.541 1.718 0 O-C-N 120.246 -1.534 . . . . 0.0 115.399 -177.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -64.86 37.63 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.512 1 C-N-CA 132.204 4.202 . . . . 0.0 115.076 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.5 mmt -37.82 113.75 0.3 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.376 1.471 . . . . 0.0 110.397 -173.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.32 168.1 15.38 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 125.764 1.626 . . . . 0.0 111.54 -174.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.77 16.73 0.5 Allowed 'Trans proline' 0 CA--C 1.548 1.216 0 C-N-CA 123.474 2.782 . . . . 0.0 111.558 173.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.443 ' CE2' HG23 ' A' ' 33' ' ' ILE . 25.6 p90 -53.43 -26.48 20.16 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 127.031 2.133 . . . . 0.0 112.158 -175.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 m -57.2 -30.95 64.98 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 126.889 2.075 . . . . 0.0 111.293 -173.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 64.8 t60 -63.02 -54.72 33.84 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.294 0.497 . . . . 0.0 110.482 178.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.305 0.9 OUTLIER -76.16 -24.63 54.83 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -178.579 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -61.12 -44.16 97.76 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 173.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -68.7 -45.19 72.29 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.387 0.675 . . . . 0.0 111.135 174.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.42 112.79 16.03 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.019 -176.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -176.62 113.88 0.1 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 173.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.48 112.61 20.54 Favored 'General case' 0 CA--C 1.527 0.07 0 N-CA-C 103.556 -2.757 . . . . 0.0 103.556 173.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -176.48 -66.62 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.944 1.698 . . . . 0.0 108.205 173.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.42 -16.49 0.07 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -173.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.0 -66.36 0.23 Allowed Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 120.675 1.58 . . . . 0.0 113.394 -173.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -74.4 -68.31 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 CA-C-N 121.11 1.432 . . . . 0.0 110.732 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.64 119.72 15.2 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.164 0.985 . . . . 0.0 110.187 -174.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.9 mt -124.81 129.93 24.42 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 127.494 2.318 . . . . 0.0 106.312 -177.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -77.76 156.82 31.47 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.124 1.882 . . . . 0.0 111.506 176.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.1 p -41.16 -43.91 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 127.697 2.399 . . . . 0.0 112.932 176.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -59.69 -34.05 72.38 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 126.328 1.851 . . . . 0.0 113.44 -175.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.465 HD11 ' HG ' ' A' ' 24' ' ' LEU . 5.9 mm -70.02 113.05 5.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 178.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -81.32 -29.07 34.3 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.184 0.594 . . . . 0.0 110.43 178.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.4 m -159.47 165.41 33.12 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.068 0.947 . . . . 0.0 109.08 -175.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 68.8 mtp -125.64 160.27 30.1 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 173.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 -111.21 134.33 52.88 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 124.564 1.145 . . . . 0.0 108.898 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -120.5 165.62 14.72 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 103.189 -2.893 . . . . 0.0 103.189 172.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.1 m -149.17 137.55 20.89 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 120.318 -1.489 . . . . 0.0 108.109 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -148.32 165.6 30.54 Favored 'General case' 0 C--O 1.24 0.597 0 O-C-N 121.801 -0.562 . . . . 0.0 111.167 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' A' ' 104' ' ' PRO . 1.3 pp0? -162.2 145.35 11.66 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 174.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -91.8 140.46 29.66 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 173.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.43 78.26 0.17 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 -173.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.87 -73.14 0.12 Allowed Glycine 0 CA--C 1.53 1.025 0 C-N-CA 126.876 2.179 . . . . 0.0 117.517 173.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.489 ' HA ' HE21 ' A' ' 72' ' ' GLN . 0.0 OUTLIER -116.97 26.34 9.87 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.473 1.636 . . . . 0.0 112.276 173.835 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -102.38 37.09 1.97 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.41 2.284 . . . . 0.0 111.168 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -38.81 113.36 0.3 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.98 1.312 . . . . 0.0 112.203 -173.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -114.22 119.97 38.86 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 175.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -84.38 152.5 24.02 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -134.56 160.71 37.22 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.809 1.186 . . . . 0.0 110.675 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.44 ' O ' HD13 ' A' ' 131' ' ' ILE . 30.1 tt0 -154.11 135.07 13.83 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 173.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.425 ' CD2' HG22 ' A' ' 130' ' ' VAL . 69.2 m-85 -80.6 103.63 10.58 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.3 tt -61.43 -40.85 95.96 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 173.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 m -155.89 145.44 21.01 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 120.896 -1.128 . . . . 0.0 112.502 177.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.465 ' H ' ' HD3' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -153.25 93.53 1.72 Allowed 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 173.339 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.465 ' HD3' ' H ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -156.41 161.57 40.09 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 121.081 1.764 . . . . 0.0 111.52 -177.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 27.4 t -81.57 162.9 22.96 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.419 0.628 . . . . 0.0 109.375 173.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 74.7 mt -116.38 -14.96 10.99 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.054 1.741 . . . . 0.0 110.864 174.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -96.32 164.27 12.72 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 175.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.9 mmtm -138.55 -32.38 0.7 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.259 1.824 . . . . 0.0 113.263 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -64.36 -63.67 4.15 Favored Glycine 0 CA--C 1.54 1.648 0 N-CA-C 106.787 -2.525 . . . . 0.0 106.787 172.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.444 HD12 ' H ' ' A' ' 89' ' ' ILE . 4.8 mp -76.81 21.77 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 129.473 3.109 . . . . 0.0 110.219 175.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 3.5 ttp -43.2 132.85 4.16 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 125.579 2.609 . . . . 0.0 113.56 -173.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -149.01 150.87 33.55 Favored 'General case' 0 N--CA 1.421 -1.91 2 C-N-CA 135.317 5.447 . . . . 0.0 100.939 173.583 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -139.74 113.85 7.85 Favored Pre-proline 0 C--N 1.315 -0.899 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 173.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -67.68 157.4 61.94 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.962 2.441 . . . . 0.0 113.096 -173.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 39.1 p -136.94 170.11 16.65 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.464 1.506 . . . . 0.0 109.395 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.2 m -126.26 155.65 36.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 124.612 1.165 . . . . 0.0 108.322 173.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -101.6 35.32 2.34 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.024 1.329 . . . . 0.0 110.24 174.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.9 m -139.91 162.11 52.37 Favored Pre-proline 0 C--O 1.236 0.39 0 C-N-CA 127.057 2.143 . . . . 0.0 106.14 173.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -68.74 159.0 55.52 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 N-CA-C 109.213 -1.11 . . . . 0.0 109.213 173.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.38 -11.09 29.22 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 124.194 0.998 . . . . 0.0 112.014 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -141.64 163.68 32.26 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.376 1.47 . . . . 0.0 107.79 173.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 166.61 -161.74 35.47 Favored Glycine 0 C--O 1.226 -0.385 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -177.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.2 p -125.28 144.67 50.36 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.5 t -74.25 117.3 60.59 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 105.0 -2.222 . . . . 0.0 105.0 175.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.411 ' O ' ' HA ' ' A' ' 68' ' ' GLN . 89.3 Cg_endo -74.51 160.53 41.41 Favored 'Trans proline' 0 C--O 1.213 -0.751 0 C-N-CA 121.974 1.782 . . . . 0.0 115.231 -173.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . 0.304 93.0 m-70 -75.05 -14.65 60.62 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 118.114 2.635 . . . . 0.0 118.114 -172.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.96 151.68 36.18 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 173.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -49.05 108.7 0.2 Allowed 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 125.438 1.495 . . . . 0.0 109.025 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 21.1 m -123.89 138.89 54.41 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.8 t -80.05 152.34 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -174.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 86.8 t -129.9 109.85 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 174.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -82.16 135.26 35.31 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 174.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.5 t -116.41 116.58 52.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 173.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -94.43 149.78 19.52 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 125.665 1.603 . . . . 0.0 111.236 -178.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.466 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 4.8 m-85 -133.79 73.8 70.92 Favored Pre-proline 0 C--O 1.242 0.672 0 CA-C-N 118.037 0.919 . . . . 0.0 110.785 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.29 123.06 9.57 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.747 1.631 . . . . 0.0 108.068 173.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 5.7 t -105.27 152.53 22.77 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 173.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.7 mt -79.25 -10.48 59.82 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.558 0.617 . . . . 0.0 112.118 -174.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.03 32.47 66.85 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 125.534 1.54 . . . . 0.0 115.499 173.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.6 mttt -122.92 -29.38 3.95 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.546 1.673 . . . . 0.0 113.857 176.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -96.71 160.08 14.57 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 173.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -114.56 148.03 38.59 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 176.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 141.19 -155.97 25.37 Favored Glycine 0 C--N 1.333 0.404 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 176.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.3 t -125.33 113.68 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.75 164.43 15.97 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 173.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -121.93 158.13 29.72 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 121.422 -0.799 . . . . 0.0 110.459 174.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.466 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 24.0 p90 -153.2 161.47 42.39 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 124.21 1.004 . . . . 0.0 109.274 173.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -140.35 159.81 41.37 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 124.543 1.137 . . . . 0.0 111.839 -173.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 77.6 t -133.05 136.35 55.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 127.702 2.401 . . . . 0.0 107.575 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -145.18 122.54 11.61 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 173.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.425 HG22 ' CD2' ' A' ' 79' ' ' PHE . 21.4 t -135.52 131.56 51.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 -176.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.609 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -97.83 164.86 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 173.462 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.8 t -144.03 134.49 21.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 -175.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.48 173.9 11.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.282 -1.326 . . . . 0.0 108.55 -175.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -86.32 176.11 8.08 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 105.142 -2.169 . . . . 0.0 105.142 172.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.2 t -58.75 -31.38 68.29 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.846 -1.158 . . . . 0.0 112.216 -173.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -81.22 -4.15 54.59 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.39 -0.819 . . . . 0.0 112.581 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.81 7.0 57.92 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.218 0.914 . . . . 0.0 113.976 175.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -70.32 114.97 8.97 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.762 1.781 . . . . 0.0 108.688 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -69.52 141.89 53.78 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.641 0.776 . . . . 0.0 108.953 -176.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.08 -38.39 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 124.687 1.195 . . . . 0.0 113.475 -174.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -134.02 146.86 50.78 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 16.2 tm0? -148.42 153.98 39.27 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.278 1.031 . . . . 0.0 108.758 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 36.3 m -83.52 114.18 51.76 Favored Pre-proline 0 CA--C 1.529 0.162 0 C-N-CA 125.044 1.338 . . . . 0.0 108.535 -176.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -61.95 143.53 95.48 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 CA-C-N 120.294 1.141 . . . . 0.0 110.08 -173.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -81.49 112.52 18.81 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.913 -173.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.624 30.0 m-80 172.4 -11.48 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 1 C-N-CA 135.992 5.717 . . . . 0.0 112.694 173.169 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.38 75.08 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.021 2.128 . . . . 0.0 110.7 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -118.8 145.47 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 128.061 2.545 . . . . 0.0 105.434 178.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -126.91 169.34 13.38 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 174.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -136.93 113.42 10.09 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.524 1.13 . . . . 0.0 108.197 -173.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 49.0 tttt -99.29 123.3 43.45 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 31.1 m -83.47 116.7 22.65 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 173.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 25.5 m -114.49 164.99 13.22 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.5 pp -142.82 160.05 41.06 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.975 1.31 . . . . 0.0 108.191 174.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.12 127.32 32.42 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.528 1.131 . . . . 0.0 110.433 175.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -155.55 116.44 3.88 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.673 1.189 . . . . 0.0 110.807 175.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 . . . . . 0 C--O 1.247 0.974 0 C-N-CA 128.963 2.905 . . . . 0.0 105.445 173.55 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.829 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.9 m -92.18 112.9 25.01 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 165.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -176.89 176.12 1.5 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.737 2.415 . . . . 0.0 106.766 -178.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 52.8 ttm -136.63 112.69 9.7 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 102.074 -3.306 . . . . 0.0 102.074 172.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -177.01 176.08 1.47 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 129.453 3.101 . . . . 0.0 105.91 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -114.3 113.24 24.32 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 103.552 -2.759 . . . . 0.0 103.552 173.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -162.72 176.49 10.24 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 130.826 3.65 . . . . 0.0 103.361 -177.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -125.06 173.34 8.77 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 129.354 3.062 . . . . 0.0 106.329 173.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -132.31 163.78 27.9 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 176.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -93.31 176.1 6.52 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.7 1.2 . . . . 0.0 113.932 -173.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.7 m -168.17 177.07 5.68 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 129.003 2.921 . . . . 0.0 109.531 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.7 tt -42.85 129.32 4.31 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 128.328 2.651 . . . . 0.0 113.876 -173.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -117.17 142.14 47.4 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.187 2.195 . . . . 0.0 109.243 173.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.75 117.59 5.85 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.424 1.89 . . . . 0.0 106.652 -177.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 18.4 p90 -138.13 143.31 40.28 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.734 1.152 . . . . 0.0 109.337 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.9 mp -83.91 113.7 23.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 104.856 -2.276 . . . . 0.0 104.856 176.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -78.66 151.23 32.35 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 122.707 1.241 . . . . 0.0 111.118 -176.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.15 -9.76 49.07 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 127.216 2.206 . . . . 0.0 115.619 -173.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -54.48 -38.62 66.62 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 119.7 1.136 . . . . 0.0 112.952 -173.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 49.5 tp60 -73.84 -40.3 63.39 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.809 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.511 ' HA ' HD12 ' A' ' 24' ' ' LEU . . . -58.35 -39.08 78.56 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.516 1.126 . . . . 0.0 110.885 173.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -55.46 -58.69 6.72 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 88.5 t -54.1 -24.35 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.664 1.186 . . . . 0.0 112.08 177.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.511 HD12 ' HA ' ' A' ' 21' ' ' ALA . 7.5 mt -73.12 -46.01 53.69 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 174.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.8 pt -154.51 18.39 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 -172.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.75 14.56 63.08 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.7 1.619 . . . . 0.0 113.218 -174.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -100.67 159.83 14.85 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 126.239 1.815 . . . . 0.0 109.236 -175.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -118.83 128.83 54.82 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -174.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -148.9 113.22 5.25 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 174.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -95.43 154.89 16.98 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 102.706 -3.072 . . . . 0.0 102.706 172.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.3 mm -135.31 113.31 15.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 104.535 -2.394 . . . . 0.0 104.535 173.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.03 114.28 19.79 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 -176.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.435 HG23 ' CD1' ' A' ' 42' ' ' PHE . 10.9 mt -87.49 -61.53 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.1 t -125.72 142.11 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 125.533 1.533 . . . . 0.0 108.974 -173.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.0 p -149.81 124.29 9.66 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 102.921 -2.992 . . . . 0.0 102.921 173.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 44.34 33.95 0.96 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.697 1.599 . . . . 0.0 113.582 -174.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.96 -5.95 4.26 Favored Glycine 0 CA--C 1.544 1.852 0 O-C-N 120.663 -1.273 . . . . 0.0 114.932 -176.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -75.73 37.61 0.15 Allowed 'General case' 0 N--CA 1.468 0.442 1 C-N-CA 133.248 4.619 . . . . 0.0 111.114 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 30.7 mtp -37.84 131.92 0.98 Allowed 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.886 1.674 . . . . 0.0 114.531 -172.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.03 162.26 69.94 Favored Pre-proline 0 N--CA 1.448 -0.552 0 CA-C-N 113.746 -1.57 . . . . 0.0 107.945 173.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.79 39.6 0.58 Allowed 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 124.172 3.248 . . . . 0.0 111.421 174.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.435 ' CD1' HG23 ' A' ' 33' ' ' ILE . 11.8 p90 -55.07 -26.55 38.49 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.695 1.998 . . . . 0.0 112.142 -173.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.6 m -60.73 -27.92 68.29 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.89 1.676 . . . . 0.0 110.786 -174.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -57.23 -65.74 0.57 Allowed 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.663 1.185 . . . . 0.0 109.713 174.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.91 -24.36 62.45 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -178.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -65.82 -50.12 65.75 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.611 0.641 . . . . 0.0 110.338 174.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -77.11 -40.66 45.02 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.453 -0.78 . . . . 0.0 109.393 -176.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.4 ttmt -63.97 160.91 16.79 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 175.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -79.04 112.67 16.48 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 117.947 -1.501 . . . . 0.0 110.154 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.425 ' HB3' ' H ' ' A' ' 53' ' ' MET . 40.8 tt0 -97.24 172.02 8.07 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 172.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -65.95 -26.29 67.51 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.287 -0.883 . . . . 0.0 110.96 173.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.77 -16.18 2.98 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 -173.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.425 ' H ' ' HB3' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -74.99 -66.52 0.43 Allowed Pre-proline 0 N--CA 1.47 0.537 0 CA-C-N 121.473 1.942 . . . . 0.0 115.008 -173.291 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -83.68 -65.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.805 0 CA-C-N 122.0 1.75 . . . . 0.0 112.023 -174.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.26 120.5 16.03 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.094 1.358 . . . . 0.0 110.593 -173.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.3 mt -129.4 129.6 23.26 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 126.461 1.904 . . . . 0.0 106.215 -175.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -78.89 158.5 27.54 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.271 1.981 . . . . 0.0 111.393 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.4 p -41.64 -49.1 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 126.408 1.883 . . . . 0.0 112.068 174.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -59.17 -40.26 85.09 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 126.638 1.975 . . . . 0.0 113.024 -176.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.4 mm -73.18 112.76 9.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 102.256 -3.239 . . . . 0.0 102.256 174.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -81.22 -36.78 29.62 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 114.664 -1.153 . . . . 0.0 108.922 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.8 m -141.84 168.62 19.33 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 123.883 0.739 . . . . 0.0 111.968 -173.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 70.8 mtp -126.81 155.57 42.65 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 172.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 46.6 m-20 -107.22 149.29 27.89 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 174.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -135.15 155.07 51.32 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 129.788 3.235 . . . . 0.0 103.015 172.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.5 m -140.71 134.2 29.99 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 -177.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -146.82 165.03 30.94 Favored 'General case' 0 C--O 1.239 0.528 0 O-C-N 121.803 -0.561 . . . . 0.0 110.952 176.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.22 163.43 5.81 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.736 1.215 . . . . 0.0 111.169 174.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.1 170.63 7.8 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 173.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.08 101.84 13.43 Favored 'General case' 0 N--CA 1.445 -0.708 0 O-C-N 119.966 -1.709 . . . . 0.0 109.099 -174.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 44.58 -48.73 0.0 OUTLIER Glycine 0 CA--C 1.54 1.637 1 C-N-CA 133.14 5.162 . . . . 0.0 121.032 174.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -116.92 -18.99 10.01 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 121.85 2.825 . . . . 0.0 115.78 174.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.48 37.1 0.56 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 128.185 2.594 . . . . 0.0 117.908 -173.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -48.99 114.11 0.93 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 122.53 2.423 . . . . 0.0 110.283 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -83.65 153.14 24.41 Favored 'General case' 0 C--N 1.335 -0.029 0 C-N-CA 125.376 1.47 . . . . 0.0 107.857 174.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -97.46 151.02 20.41 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -133.98 159.88 39.42 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.905 1.229 . . . . 0.0 110.616 174.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.418 ' O ' HD13 ' A' ' 131' ' ' ILE . 28.0 tt0 -156.16 141.55 17.6 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 173.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -91.75 103.66 16.2 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.309 1.043 . . . . 0.0 108.899 -174.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.7 tt -73.26 -44.09 59.94 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.154 1.382 . . . . 0.0 108.104 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.2 m -136.83 137.35 39.65 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.237 1.415 . . . . 0.0 110.218 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -170.3 92.94 0.21 Allowed 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 102.022 -3.325 . . . . 0.0 102.022 173.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -162.29 152.44 16.66 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 118.647 -0.692 . . . . 0.0 111.41 -174.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.5 t -69.85 167.71 16.72 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 122.326 1.06 . . . . 0.0 112.511 173.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.9 mt -126.51 -9.61 6.27 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 126.593 1.957 . . . . 0.0 113.37 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.519 ' CG ' ' H ' ' A' ' 87' ' ' LYS 0.348 14.4 t70 -101.53 162.22 13.06 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 121.625 2.011 . . . . 0.0 113.665 -175.489 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.519 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 0.7 OUTLIER -106.32 -48.76 3.5 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 129.476 3.11 . . . . 0.0 112.293 -173.286 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.411 ' C ' ' H ' ' A' ' 90' ' ' MET . . . -94.05 -49.7 2.4 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 124.865 1.222 . . . . 0.0 111.754 -177.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 mt -81.31 17.56 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 126.052 1.741 . . . . 0.0 109.179 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.411 ' H ' ' C ' ' A' ' 88' ' ' GLY . 14.4 ttp -43.49 130.64 5.12 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 130.215 3.406 . . . . 0.0 109.77 -177.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.255 . . -162.47 166.67 24.63 Favored 'General case' 0 N--CA 1.441 -0.908 1 C-N-CA 133.179 4.591 . . . . 0.0 104.351 -173.578 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -141.88 145.54 36.98 Favored Pre-proline 0 N--CA 1.473 0.678 0 CA-C-N 118.923 0.783 . . . . 0.0 110.453 173.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -77.61 145.74 23.51 Favored 'Trans proline' 0 N--CA 1.443 -1.454 0 C-N-CA 121.532 1.488 . . . . 0.0 109.352 173.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 23.8 p -129.14 153.93 47.21 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 126.047 1.739 . . . . 0.0 107.353 176.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.2 m -126.06 150.37 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 119.382 0.992 . . . . 0.0 111.579 -174.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -80.52 9.08 6.46 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.432 1.893 . . . . 0.0 113.552 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.6 m -143.38 163.45 36.93 Favored Pre-proline 0 C--N 1.327 -0.381 0 C-N-CA 124.97 1.308 . . . . 0.0 109.06 -177.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -66.2 162.16 37.1 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.334 1.356 . . . . 0.0 109.339 173.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -66.44 -12.0 54.91 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.119 0.968 . . . . 0.0 112.035 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -140.81 163.49 32.78 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.155 1.382 . . . . 0.0 107.796 173.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.24 -160.83 33.46 Favored Glycine 0 C--O 1.227 -0.341 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 72.1 p -119.14 147.93 43.64 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 174.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.1 t -81.31 113.4 41.23 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 100.983 -3.71 . . . . 0.0 100.983 173.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -92.29 167.4 2.91 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.28 1.986 . . . . 0.0 116.837 -172.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -75.94 10.46 1.86 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.688 1.195 . . . . 0.0 114.167 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.93 122.49 45.46 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 176.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.26 105.25 0.14 Allowed 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 174.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.0 m -114.27 136.56 52.83 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -174.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 26.6 t -95.13 114.97 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -174.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 78.7 t -93.69 103.36 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 N-CA-C 103.514 -2.772 . . . . 0.0 103.514 173.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -85.19 140.85 30.58 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 173.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.5 t -115.61 113.83 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 104.108 -2.553 . . . . 0.0 104.108 174.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -95.76 150.4 19.64 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 125.525 1.536 . . . . 0.0 109.919 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.468 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 7.9 m-85 -130.0 73.5 81.34 Favored Pre-proline 0 C--O 1.243 0.721 0 CA-C-N 118.478 1.139 . . . . 0.0 110.366 -173.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.16 121.96 9.78 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.351 2.034 . . . . 0.0 107.898 173.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 8.7 t -103.67 149.85 24.57 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 175.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.1 mt -81.58 -8.02 59.66 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 118.752 -0.642 . . . . 0.0 111.332 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.2 49.19 78.04 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 126.312 1.91 . . . . 0.0 113.323 173.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -112.47 -75.69 0.6 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.116 0.958 . . . . 0.0 111.152 -173.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 51.2 tp60 -83.08 152.19 25.45 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 173.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -93.47 142.6 27.15 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 178.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.52 -154.68 25.94 Favored Glycine 0 C--N 1.331 0.294 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -177.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.3 t -128.14 113.78 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -86.63 169.57 12.61 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 173.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -132.19 162.22 31.46 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.14 0.576 . . . . 0.0 109.818 175.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.468 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 20.2 p90 -144.91 147.15 32.42 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 173.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -104.21 144.75 31.18 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 127.437 2.295 . . . . 0.0 109.474 -174.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 43.7 t -137.43 143.43 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 123.605 0.762 . . . . 0.0 110.02 173.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -157.5 119.4 3.74 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 128.454 2.702 . . . . 0.0 105.616 174.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.439 ' H ' ' HB ' ' A' ' 143' ' ' THR . 61.6 t -130.33 121.81 52.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.625 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -85.77 167.18 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-O 123.018 1.389 . . . . 0.0 107.501 173.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.1 t -143.24 132.64 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 C-N-CA 127.448 2.299 . . . . 0.0 105.829 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.15 174.84 10.1 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.448 1.099 . . . . 0.0 108.596 -176.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -88.98 176.09 7.15 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 172.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.7 t -67.55 -3.57 9.15 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 120.499 -1.376 . . . . 0.0 113.58 -176.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -91.36 -12.76 33.97 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 120.364 1.438 . . . . 0.0 110.581 173.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 93.26 -0.77 69.02 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.557 1.075 . . . . 0.0 111.926 -173.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 59.9 m-20 -67.73 115.42 7.27 Favored 'General case' 0 C--N 1.343 0.306 0 CA-C-N 119.427 1.613 . . . . 0.0 108.005 174.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -71.5 147.3 47.89 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.415 1.486 . . . . 0.0 109.386 -174.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.48 -33.87 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.453 HD13 ' N ' ' A' ' 142' ' ' GLN . 1.5 tm? -136.83 147.45 46.56 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -173.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.453 ' N ' HD13 ' A' ' 141' ' ' LEU . 6.2 tm0? -148.81 150.12 32.5 Favored 'General case' 0 N--CA 1.462 0.129 0 O-C-N 121.378 -0.826 . . . . 0.0 109.309 177.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.439 ' HB ' ' H ' ' A' ' 130' ' ' VAL . 24.1 m -82.29 113.75 46.23 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 175.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -64.86 146.43 88.03 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 121.62 1.547 . . . . 0.0 112.21 -173.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -77.72 112.55 14.68 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.303 19.5 m-80 172.71 -17.2 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 1 C-N-CA 137.773 6.429 . . . . 0.0 109.553 173.936 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.6 82.57 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.062 1.745 . . . . 0.0 109.627 174.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.2 mm -121.72 136.03 59.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 176.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.417 ' HB2' ' CE2' ' A' ' 126' ' ' PHE . 6.5 m-85 -112.85 163.51 14.53 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 174.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -138.32 113.4 9.28 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.022 1.329 . . . . 0.0 108.395 -173.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.33 121.43 44.37 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -174.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 23.1 m -84.53 115.59 22.67 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 126.042 1.737 . . . . 0.0 106.726 -175.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 4.2 m -113.98 166.35 11.69 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.185 0.902 . . . . 0.0 109.425 173.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.9 pp -134.22 162.31 32.5 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.626 1.57 . . . . 0.0 106.914 173.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.5 120.34 11.51 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 123.982 0.913 . . . . 0.0 109.907 175.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -163.93 114.17 1.28 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.063 1.345 . . . . 0.0 109.841 176.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 . . . . . 0 C--O 1.256 1.431 0 C-N-CA 128.936 2.894 . . . . 0.0 105.546 173.786 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.557 ' H3 ' ' CG ' ' A' ' 6' ' ' ASP . . . . . . . . 0 N--CA 1.471 0.977 0 N-CA-C 108.407 -1.877 . . . . 0.0 108.407 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.2 t -61.16 177.05 0.38 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 144.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.1 m80 -44.72 131.51 6.84 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 102.717 -3.068 . . . . 0.0 102.717 172.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.0 ptm -43.62 112.46 0.39 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 116.586 2.069 . . . . 0.0 116.586 -172.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.4 mt -177.0 113.34 0.09 Allowed 'General case' 0 N--CA 1.45 -0.432 2 C-N-CA 137.999 6.52 . . . . 0.0 95.855 173.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.557 ' CG ' ' H3 ' ' A' ' 1' ' ' GLY . 7.6 m-20 -148.81 176.04 10.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 120.252 1.387 . . . . 0.0 110.152 -173.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -136.19 172.99 12.21 Favored 'General case' 0 N--CA 1.428 -1.551 0 C-N-CA 130.018 3.327 . . . . 0.0 102.191 173.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -140.25 175.18 9.81 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 128.822 2.849 . . . . 0.0 109.43 -175.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.4 mp0 -69.1 165.01 21.22 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.035 1.734 . . . . 0.0 110.531 174.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.548 ' HB3' ' HB3' ' A' ' 70' ' ' ALA . 52.4 mt-10 -96.99 173.8 7.09 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.152 1.781 . . . . 0.0 110.458 -177.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . 0.295 4.5 m -175.87 176.57 1.8 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.49 2.316 . . . . 0.0 114.811 173.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.9 tt -65.26 137.69 57.73 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 130.302 3.441 . . . . 0.0 112.018 -176.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.41 ' CD2' ' HA ' ' A' ' 35' ' ' SER . 88.3 m-85 -126.91 138.38 53.29 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.257 2.223 . . . . 0.0 108.342 173.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.11 118.72 6.53 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 -175.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 14.2 p90 -135.6 175.45 9.58 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.707 1.203 . . . . 0.0 110.574 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.421 HD11 HD11 ' A' ' 33' ' ' ILE . 1.6 mp -114.22 141.19 31.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 103.52 -2.77 . . . . 0.0 103.52 173.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -93.11 158.73 15.62 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -173.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.34 -15.13 59.03 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 113.122 -1.854 . . . . 0.0 113.497 177.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -61.02 -43.31 99.08 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 119.795 1.18 . . . . 0.0 108.428 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -66.55 -49.56 66.04 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 122.83 0.452 . . . . 0.0 111.143 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.17 -35.31 67.07 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.468 0.707 . . . . 0.0 111.785 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.403 HH21 ' CD ' ' A' ' 28' ' ' GLU . 26.9 ttm105 -56.23 -56.73 17.34 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 175.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.4 t -53.78 -25.58 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 118.738 0.699 . . . . 0.0 111.513 177.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.8 mt -72.45 -43.8 63.26 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 173.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.0 pt -149.93 16.01 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 116.555 2.058 . . . . 0.0 116.555 -173.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.24 9.78 44.1 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 127.398 2.428 . . . . 0.0 114.683 -175.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -101.43 175.9 5.42 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 127.273 2.229 . . . . 0.0 109.709 -174.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.403 ' CD ' HH21 ' A' ' 22' ' ' ARG . 16.6 tp10 -120.68 122.18 39.91 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -155.91 113.49 3.29 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.737 0.815 . . . . 0.0 112.344 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -96.04 159.34 15.01 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 103.002 -2.962 . . . . 0.0 103.002 172.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 84.2 mt -134.39 113.4 17.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 174.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.05 114.25 23.5 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -174.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.421 HD11 HD11 ' A' ' 16' ' ' ILE . 13.6 mt -89.05 -62.84 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.614 0.766 . . . . 0.0 109.355 -179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.515 HG22 ' HG2' ' A' ' 39' ' ' MET . 19.7 t -116.0 128.87 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 126.147 1.779 . . . . 0.0 107.725 -173.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.41 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 54.5 p -132.02 124.51 29.43 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 102.643 -3.095 . . . . 0.0 102.643 173.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.265 1.7 pm0 44.07 40.77 3.64 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.417 1.487 . . . . 0.0 112.863 -175.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.01 -31.76 1.08 Allowed Glycine 0 CA--C 1.542 1.724 0 C-N-CA 126.268 1.89 . . . . 0.0 114.916 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . 0.462 8.8 tmtt? -54.31 37.66 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.835 1 C-N-CA 137.85 6.46 . . . . 0.0 116.126 174.966 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.515 ' HG2' HG22 ' A' ' 34' ' ' VAL . 42.5 mtt -38.01 142.73 0.15 Allowed 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.215 1.806 . . . . 0.0 115.418 -173.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.84 160.29 83.06 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 173.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -74.81 37.69 0.48 Allowed 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 124.217 3.278 . . . . 0.0 111.994 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -55.76 -26.66 46.84 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 126.6 1.96 . . . . 0.0 113.196 -173.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.7 m -54.77 -39.32 68.26 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.451 2.3 . . . . 0.0 112.672 -173.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 -58.0 -65.94 0.56 Allowed 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.811 1.644 . . . . 0.0 109.724 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -70.91 -27.19 63.6 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-O 118.076 -0.964 . . . . 0.0 111.689 -173.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -69.79 -49.17 55.45 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.812 1.245 . . . . 0.0 111.557 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -71.94 -32.1 66.98 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.31 0.959 . . . . 0.0 109.566 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -65.2 165.7 10.99 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 172.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.88 112.96 5.22 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 173.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.418 ' H ' ' HG3' ' A' ' 54' ' ' PRO . 4.7 tt0 -96.56 172.41 7.94 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.53 -30.49 63.12 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 117.51 -1.233 . . . . 0.0 112.651 177.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.79 -16.76 2.55 Favored 'General case' 0 C--N 1.348 0.503 0 N-CA-C 118.027 2.603 . . . . 0.0 118.027 -173.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 91.0 mmm -92.13 -52.83 0.27 Allowed Pre-proline 0 N--CA 1.469 0.524 0 N-CA-C 118.164 2.654 . . . . 0.0 118.164 -173.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.418 ' HG3' ' H ' ' A' ' 50' ' ' GLN . 36.6 Cg_endo -68.76 -70.0 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.697 0 CA-C-N 121.67 1.632 . . . . 0.0 113.698 -173.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.59 114.08 8.33 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.721 0.808 . . . . 0.0 110.504 -173.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 62.4 mt -119.45 127.26 26.54 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 127.097 2.159 . . . . 0.0 106.335 -177.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -77.31 156.58 33.08 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.125 1.883 . . . . 0.0 110.752 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.7 p -42.58 -43.77 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 127.136 2.174 . . . . 0.0 113.1 177.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -62.21 -41.35 98.29 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 126.181 1.792 . . . . 0.0 112.831 -174.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.6 mm -67.64 112.93 3.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 102.912 -2.995 . . . . 0.0 102.912 174.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -81.65 -27.11 34.26 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 118.716 -0.659 . . . . 0.0 109.512 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.4 m -155.27 168.96 25.34 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.383 1.073 . . . . 0.0 110.59 -173.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.1 mtm -126.26 151.02 48.01 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 172.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -104.92 113.29 26.79 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 122.882 0.473 . . . . 0.0 110.422 -176.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -100.76 153.02 19.8 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 103.06 -2.941 . . . . 0.0 103.06 172.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.3 m -138.17 133.71 33.64 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 -177.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -143.81 163.56 33.02 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.42 175.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -172.74 157.03 3.65 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.173 173.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.55 -173.6 4.59 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 172.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.548 ' HB3' ' HB3' ' A' ' 10' ' ' GLU . . . -123.49 134.51 53.88 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 101.478 -3.527 . . . . 0.0 101.478 173.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 16.49 -55.86 0.0 OUTLIER Glycine 0 CA--C 1.534 1.227 1 C-N-CA 135.274 6.178 . . . . 0.0 120.671 -176.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -116.61 -14.97 10.85 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 120.721 2.261 . . . . 0.0 113.999 -177.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.84 37.16 0.35 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 129.303 3.041 . . . . 0.0 118.859 -173.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -56.95 113.81 1.84 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 123.239 2.745 . . . . 0.0 110.307 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -85.81 155.72 20.88 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 125.38 1.472 . . . . 0.0 108.288 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -102.82 150.09 23.84 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 177.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -136.21 160.88 37.34 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.949 1.25 . . . . 0.0 110.905 176.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.45 ' O ' HD13 ' A' ' 131' ' ' ILE . 27.4 tt0 -153.53 140.13 18.86 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 172.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.402 ' CD2' HG22 ' A' ' 130' ' ' VAL . 70.8 m-85 -87.1 103.44 15.39 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.9 tt -74.27 -40.79 62.09 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 175.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.4 m -138.34 135.97 35.9 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.328 1.051 . . . . 0.0 111.591 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.495 HD22 HG22 ' A' ' 128' ' ' VAL . 0.1 OUTLIER -165.63 93.18 0.56 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 102.188 -3.264 . . . . 0.0 102.188 173.254 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.411 ' HD3' ' H ' ' A' ' 82' ' ' LEU . 0.1 OUTLIER -160.12 154.42 23.56 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 121.001 -1.062 . . . . 0.0 110.053 -174.221 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.412 ' HB2' ' HA ' ' A' ' 92' ' ' ASP . 5.4 t -73.89 169.05 18.22 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.716 0.77 . . . . 0.0 110.477 173.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.0 mt -122.34 -21.54 5.79 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 116.179 -1.867 . . . . 0.0 110.849 174.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -106.11 152.29 23.61 Favored 'General case' 0 C--N 1.353 0.741 0 CA-C-N 121.528 1.967 . . . . 0.0 110.773 173.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.44 ' HA ' ' HE3' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -120.33 -23.85 6.07 Favored 'General case' 0 N--CA 1.445 -0.718 1 C-N-CA 135.67 5.588 . . . . 0.0 113.982 179.879 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -72.92 -71.57 1.07 Allowed Glycine 0 CA--C 1.533 1.214 0 N-CA-C 107.118 -2.393 . . . . 0.0 107.118 173.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 mp -77.12 26.52 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 130.052 3.341 . . . . 0.0 110.358 174.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.43 ' SD ' ' HE3' ' A' ' 87' ' ' LYS . 4.7 ttp -42.95 127.76 4.17 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 129.04 2.936 . . . . 0.0 113.487 -173.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -146.99 152.17 38.18 Favored 'General case' 0 N--CA 1.431 -1.42 1 C-N-CA 133.556 4.742 . . . . 0.0 102.216 173.639 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.412 ' HA ' ' HB2' ' A' ' 84' ' ' SER . 5.9 m-20 -139.81 114.19 7.85 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 173.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -70.0 160.76 48.48 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.114 2.543 . . . . 0.0 114.919 -173.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.1 p -137.03 167.11 22.15 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.532 1.933 . . . . 0.0 109.76 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.9 m -126.54 154.76 36.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.038 0.935 . . . . 0.0 111.432 173.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -78.94 9.58 4.16 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.592 2.357 . . . . 0.0 113.574 178.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.7 m -140.84 164.19 37.86 Favored Pre-proline 0 C--N 1.327 -0.4 0 C-N-CA 124.593 1.157 . . . . 0.0 109.557 -175.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -65.58 163.09 31.38 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.418 1.412 . . . . 0.0 109.699 173.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -62.9 -12.98 28.74 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 124.151 0.981 . . . . 0.0 112.423 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -143.66 164.85 29.27 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 120.334 1.425 . . . . 0.0 108.308 173.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.59 -161.96 35.39 Favored Glycine 0 C--O 1.228 -0.231 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 73.6 p -120.76 159.05 26.2 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 117.485 0.642 . . . . 0.0 109.784 174.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.9 t -94.05 113.18 59.96 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 173.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -93.32 163.75 2.45 Favored 'Trans proline' 0 C--O 1.218 -0.485 0 C-N-CA 122.861 2.374 . . . . 0.0 114.114 -173.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -73.26 2.11 8.07 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 120.303 -1.498 . . . . 0.0 113.887 -173.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.41 126.95 55.0 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-O 115.525 -2.179 . . . . 0.0 107.864 177.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -42.29 111.95 0.29 Allowed 'General case' 0 N--CA 1.462 0.155 0 O-C-N 125.299 1.624 . . . . 0.0 109.023 173.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.5 m -117.82 138.25 52.21 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 176.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.4 t -97.5 114.98 36.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 123.796 0.838 . . . . 0.0 110.035 -173.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 77.1 t -93.9 103.21 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 102.689 -3.078 . . . . 0.0 102.689 173.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -85.53 121.44 28.23 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 173.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.5 t -90.02 113.57 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 103.535 -2.765 . . . . 0.0 103.535 173.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -85.77 149.79 23.65 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.488 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 5.4 m-85 -135.62 73.56 61.38 Favored Pre-proline 0 C--O 1.244 0.779 0 CA-C-N 117.772 0.786 . . . . 0.0 109.229 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.3 114.42 3.44 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 N-CA-C 107.575 -1.741 . . . . 0.0 107.575 173.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 5.6 t -95.85 141.55 29.16 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 173.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.9 mt -81.92 -11.02 59.1 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 123.276 0.36 . . . . 0.0 110.716 -178.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 56.99 57.91 17.3 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 126.517 2.008 . . . . 0.0 111.871 173.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.407 ' HD3' ' HA ' ' A' ' 119' ' ' LYS 0.321 41.6 mmtm -113.05 -75.72 0.6 Allowed 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 117.589 -1.196 . . . . 0.0 111.065 179.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 49.0 tp60 -77.51 150.58 34.84 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 173.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -93.66 143.31 26.43 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 177.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.86 -152.93 24.88 Favored Glycine 0 C--N 1.334 0.442 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 19.3 t -128.34 113.71 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.96 167.41 13.75 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 173.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -127.97 163.26 24.89 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.431 0.692 . . . . 0.0 109.981 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.488 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 16.0 p90 -146.09 154.44 41.83 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.024 0.93 . . . . 0.0 108.899 173.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -114.39 149.24 36.46 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 127.55 2.34 . . . . 0.0 110.32 -174.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.495 HG22 HD22 ' A' ' 82' ' ' LEU . 63.2 t -140.16 143.49 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 125.043 1.337 . . . . 0.0 109.958 175.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -156.97 116.78 3.47 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 128.1 2.56 . . . . 0.0 105.488 173.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.468 ' H ' ' HB ' ' A' ' 143' ' ' THR . 46.3 t -126.41 121.76 59.65 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.826 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 176.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.461 HG22 ' HG3' ' A' ' 142' ' ' GLN . 0.1 OUTLIER -91.13 162.62 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 O-C-N 124.543 1.152 . . . . 0.0 107.942 174.534 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.3 t -136.91 134.86 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 C-N-CA 125.442 1.497 . . . . 0.0 107.041 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.22 174.41 10.58 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.593 1.157 . . . . 0.0 108.854 -175.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -90.2 176.31 6.8 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 104.694 -2.335 . . . . 0.0 104.694 172.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.9 t -65.47 -4.24 5.53 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 120.4 -1.437 . . . . 0.0 113.871 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -90.3 -14.55 32.98 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 120.725 1.602 . . . . 0.0 110.833 173.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.16 1.08 65.11 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.402 1.001 . . . . 0.0 111.915 -173.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 -69.93 116.03 9.84 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 119.524 1.662 . . . . 0.0 108.209 174.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -69.74 143.63 52.98 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 125.702 1.601 . . . . 0.0 108.776 -175.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -141.4 -37.68 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 124.667 1.187 . . . . 0.0 113.915 -173.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -130.19 150.84 51.26 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.461 ' HG3' HG22 ' A' ' 131' ' ' ILE . 5.5 tm0? -150.0 148.25 28.83 Favored 'General case' 0 CA--C 1.517 -0.307 0 O-C-N 121.054 -1.029 . . . . 0.0 109.469 176.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.468 ' HB ' ' H ' ' A' ' 130' ' ' VAL . 28.7 m -79.17 113.51 36.82 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 103.541 -2.763 . . . . 0.0 103.541 173.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.56 144.74 80.1 Favored 'Trans proline' 0 N--CA 1.445 -1.37 0 CA-C-N 120.369 1.167 . . . . 0.0 110.072 -173.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -75.81 112.39 12.15 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 -174.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 172.91 -31.93 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 129.38 3.072 . . . . 0.0 109.484 -173.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.14 92.9 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.125 1.77 . . . . 0.0 109.381 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.1 mm -125.65 141.19 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.428 ' HB2' ' CE2' ' A' ' 126' ' ' PHE . 0.2 OUTLIER -124.32 166.45 15.9 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 174.151 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -133.7 113.45 12.36 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.359 1.064 . . . . 0.0 108.392 -173.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.4 tttt -100.85 122.65 43.81 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 32.7 m -83.45 117.82 23.33 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 174.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 10.0 m -118.74 166.09 13.2 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.852 0.751 . . . . 0.0 109.431 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.3 pp -138.61 161.81 36.18 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.2 1.4 . . . . 0.0 108.022 176.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.1 126.84 28.7 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.649 1.18 . . . . 0.0 110.345 176.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -158.34 166.96 31.02 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.314 1.846 . . . . 0.0 108.36 174.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 . . . . . 0 C--O 1.258 1.527 0 C-N-CA 128.591 2.757 . . . . 0.0 104.258 173.621 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.502 ' H1 ' ' CG ' ' A' ' 6' ' ' ASP . . . . . . . . 0 N--CA 1.467 0.715 0 N-CA-C 106.577 -2.609 . . . . 0.0 106.577 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.3 m -58.69 169.56 0.94 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 140.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -70.43 112.85 7.03 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 173.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 33.8 tpp -176.41 174.56 1.92 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 127.663 2.385 . . . . 0.0 106.171 -175.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -87.65 114.0 23.86 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 101.991 -3.337 . . . . 0.0 101.991 173.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.502 ' CG ' ' H1 ' ' A' ' 1' ' ' GLY . 34.0 m-20 -75.61 157.27 34.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.313 0.577 . . . . 0.0 110.549 -174.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.23 147.19 6.5 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 130.76 3.624 . . . . 0.0 101.413 173.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -150.86 152.46 33.73 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 123.876 0.87 . . . . 0.0 108.727 173.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -111.77 176.15 5.14 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 126.078 1.751 . . . . 0.0 108.465 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.468 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 14.5 mt-10 -67.55 166.91 13.91 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-O 121.842 0.83 . . . . 0.0 109.807 173.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.9 m -166.77 176.13 7.34 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 130.291 3.436 . . . . 0.0 106.453 173.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.405 HD12 HG11 ' A' ' 132' ' ' VAL . 3.6 tt -47.17 124.67 6.82 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 120.903 1.683 . . . . 0.0 111.955 -174.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -116.32 145.02 43.51 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.914 0.885 . . . . 0.0 110.137 174.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.98 118.56 4.52 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 9.9 p90 -130.78 176.34 8.29 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.446 1.499 . . . . 0.0 110.534 176.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.433 ' HA ' ' HA ' ' A' ' 65' ' ' PHE . 5.9 mt -112.62 113.97 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 102.714 -3.069 . . . . 0.0 102.714 173.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -73.59 149.69 41.92 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 122.795 1.283 . . . . 0.0 109.85 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.21 -18.4 3.83 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -173.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -56.61 -34.45 67.23 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 119.515 1.052 . . . . 0.0 111.038 175.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.488 ' HA ' HE21 ' A' ' 20' ' ' GLN . 0.9 OUTLIER -61.2 -56.14 24.07 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 119.338 0.972 . . . . 0.0 110.633 174.525 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.451 ' HA ' HD12 ' A' ' 24' ' ' LEU . . . -52.85 -39.13 62.31 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.66 0.784 . . . . 0.0 111.799 174.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.9 ttm-85 -56.24 -59.25 5.21 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 121.019 -1.051 . . . . 0.0 108.86 175.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.487 HG12 HD13 ' A' ' 60' ' ' ILE . 33.5 t -52.94 -23.81 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 CA-C-N 119.322 0.965 . . . . 0.0 111.49 176.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.496 ' HG ' HD11 ' A' ' 60' ' ' ILE . 17.4 mt -78.59 -42.56 28.71 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 117.845 -1.074 . . . . 0.0 113.55 176.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.1 pt -150.42 16.79 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 116.826 2.158 . . . . 0.0 116.826 -172.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.84 7.1 27.58 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 127.952 2.691 . . . . 0.0 115.166 -176.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -100.96 176.31 5.31 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 128.953 2.901 . . . . 0.0 110.148 -173.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -123.18 115.44 21.78 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.882 0.873 . . . . 0.0 110.149 -175.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -157.63 113.97 2.89 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.209 1.803 . . . . 0.0 109.827 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -82.89 168.06 17.44 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 173.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.3 mp -137.56 113.09 10.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 173.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.73 114.15 22.47 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 -178.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.4 mt -88.75 -55.76 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -175.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.4 t -125.57 113.62 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 -174.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 94.6 p -111.89 126.88 55.59 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 102.432 -3.174 . . . . 0.0 102.432 173.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.263 0.7 OUTLIER 46.39 34.06 2.15 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.81 1.244 . . . . 0.0 114.251 175.352 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.26 -4.29 26.39 Favored Glycine 0 CA--C 1.544 1.861 0 C-N-CA 126.545 2.022 . . . . 0.0 115.561 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -76.97 37.16 0.18 Allowed 'General case' 0 N--CA 1.474 0.739 1 C-N-CA 133.98 4.912 . . . . 0.0 111.037 -173.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 35.0 mtt -38.04 118.6 0.7 Allowed 'General case' 0 C--O 1.232 0.183 0 C-N-CA 126.864 2.066 . . . . 0.0 114.568 -173.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.16 164.29 43.73 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 113.835 -1.529 . . . . 0.0 108.722 173.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -73.39 26.85 0.31 Allowed 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 123.931 3.087 . . . . 0.0 112.779 174.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -55.26 -26.61 40.99 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 125.891 1.676 . . . . 0.0 112.876 -174.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 m -65.05 -30.16 71.1 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.248 1.019 . . . . 0.0 110.77 -173.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.455 ' CE1' HH22 ' A' ' 47' ' ' ARG . 3.0 t60 -69.78 -57.31 5.25 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -58.95 -23.75 61.84 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.9 -64.96 0.8 Allowed 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 173.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.455 HH22 ' CE1' ' A' ' 44' ' ' HIS . 2.8 tmm_? -56.59 -22.88 36.75 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 127.132 2.173 . . . . 0.0 114.561 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -63.1 176.96 0.66 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 129.595 3.158 . . . . 0.0 110.675 -176.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.43 172.15 0.93 Allowed 'General case' 0 CA--C 1.544 0.713 0 O-C-N 120.425 -1.422 . . . . 0.0 109.874 173.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 5.1 tm0? -44.42 114.34 0.67 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.675 1.59 . . . . 0.0 111.517 -174.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -142.61 -66.29 0.39 Allowed 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.339 0.655 . . . . 0.0 109.366 174.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.7 tpp180 -145.38 -16.19 0.49 Allowed 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.592 ' H ' ' CD ' ' A' ' 54' ' ' PRO . 85.1 mtp -138.43 -24.08 0.01 OUTLIER Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 116.819 2.155 . . . . 0.0 116.819 -176.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.592 ' CD ' ' H ' ' A' ' 53' ' ' MET . 37.8 Cg_endo -72.5 -80.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.74 0 CA-C-N 123.035 2.12 . . . . 0.0 110.073 -173.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.27 113.99 7.97 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 96.3 mt -115.14 117.08 41.8 Favored Pre-proline 0 C--N 1.326 -0.435 0 C-N-CA 128.097 2.559 . . . . 0.0 105.32 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -73.61 157.85 48.11 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.537 1.491 . . . . 0.0 110.519 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.468 HG21 HD12 ' A' ' 154' ' ' LEU . 12.3 p -41.05 -42.58 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 126.225 1.81 . . . . 0.0 112.403 173.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -46.88 -42.45 17.47 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 127.338 2.255 . . . . 0.0 113.047 177.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.496 HD11 ' HG ' ' A' ' 24' ' ' LEU . 9.1 mm -75.64 112.97 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 177.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -79.95 -34.13 39.05 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 173.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.5 m -160.0 155.94 26.22 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.346 0.658 . . . . 0.0 111.135 -173.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 33.1 mtt -101.76 158.36 16.17 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 103.781 -2.674 . . . . 0.0 103.781 172.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -118.59 113.73 21.71 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 173.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.433 ' HA ' ' HA ' ' A' ' 16' ' ' ILE . 29.6 m-85 -101.49 157.3 16.91 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 173.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.2 m -137.07 135.48 37.53 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 177.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -143.75 166.24 25.42 Favored 'General case' 0 CA--C 1.511 -0.538 0 O-C-N 121.729 -0.607 . . . . 0.0 110.058 177.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -163.61 148.42 10.82 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.965 174.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.45 -173.84 3.52 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 122.916 1.341 . . . . 0.0 107.785 172.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.468 ' HB1' ' HB2' ' A' ' 10' ' ' GLU . . . -115.18 95.74 5.34 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 127.934 2.494 . . . . 0.0 110.13 -173.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 37.06 -56.6 0.0 OUTLIER Glycine 0 CA--C 1.543 1.835 1 C-N-CA 132.713 4.959 . . . . 0.0 120.795 -176.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -116.89 -16.88 10.54 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 121.643 2.722 . . . . 0.0 114.458 173.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.27 37.28 0.1 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 129.255 3.022 . . . . 0.0 115.673 -174.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -38.75 113.59 0.31 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 121.552 1.978 . . . . 0.0 110.367 -174.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -89.24 114.11 25.42 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -74.97 147.11 41.12 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 104.897 -2.261 . . . . 0.0 104.897 174.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -133.17 160.24 37.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 119.585 1.084 . . . . 0.0 110.078 176.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.475 ' O ' HD13 ' A' ' 131' ' ' ILE . 29.7 tt0 -152.38 135.07 15.39 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 173.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -82.92 103.7 12.58 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.062 0.945 . . . . 0.0 108.838 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.7 tt -67.04 -42.25 85.14 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.191 1.397 . . . . 0.0 108.19 174.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.3 m -135.06 139.71 44.98 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.488 1.115 . . . . 0.0 110.966 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.1 tt -170.36 92.96 0.21 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 173.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -161.72 156.3 22.75 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 118.721 0.691 . . . . 0.0 111.269 -174.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.4 t -72.0 163.78 27.26 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.1 mt -125.85 -17.02 5.5 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 116.734 -1.603 . . . . 0.0 112.379 174.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.527 ' CG ' ' H ' ' A' ' 87' ' ' LYS . 20.8 t0 -87.21 175.61 7.97 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 121.66 2.027 . . . . 0.0 112.248 177.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.527 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -115.27 -49.0 2.78 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 129.702 3.201 . . . . 0.0 112.841 177.304 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -78.88 -66.44 1.71 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 178.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.417 HD12 ' H ' ' A' ' 89' ' ' ILE . 3.5 mp -76.78 16.41 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 128.285 2.634 . . . . 0.0 109.81 -176.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 13.1 ttp -43.54 133.07 4.58 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 128.643 2.777 . . . . 0.0 109.838 -173.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -157.6 115.62 3.11 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 125.962 1.705 . . . . 0.0 107.908 -173.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -98.27 135.23 21.35 Favored Pre-proline 0 C--N 1.324 -0.522 0 O-C-N 123.973 0.795 . . . . 0.0 109.547 -174.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.46 154.71 55.58 Favored 'Trans proline' 0 N--CA 1.447 -1.26 0 C-N-CA 121.548 1.499 . . . . 0.0 109.25 173.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 17.9 p -140.4 157.8 44.97 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.556 1.543 . . . . 0.0 108.09 174.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.9 m -126.53 153.72 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 119.143 0.883 . . . . 0.0 113.011 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -74.94 7.11 3.42 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.498 2.319 . . . . 0.0 113.584 174.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.2 m -141.34 165.16 30.65 Favored Pre-proline 0 C--N 1.326 -0.443 0 C-N-CA 125.311 1.444 . . . . 0.0 108.632 -176.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -66.63 166.72 21.13 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 121.077 1.185 . . . . 0.0 110.398 173.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.97 -9.08 18.72 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.61 1.164 . . . . 0.0 112.03 176.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -145.63 164.35 32.01 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.446 1.498 . . . . 0.0 107.84 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 160.24 -161.25 32.38 Favored Glycine 0 C--O 1.227 -0.295 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 27.2 p -120.69 151.46 39.48 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 173.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.1 t -88.64 113.6 56.3 Favored Pre-proline 0 N--CA 1.447 -0.583 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 174.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.4 158.67 47.87 Favored 'Trans proline' 0 CA--C 1.512 -0.613 0 C-N-CA 122.245 1.963 . . . . 0.0 112.736 -174.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -64.39 -26.25 68.38 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 116.692 2.108 . . . . 0.0 116.692 -172.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . 0.566 1.0 OUTLIER -116.94 151.54 36.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 119.406 1.003 . . . . 0.0 113.102 173.134 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -38.61 110.96 0.15 Allowed 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 128.175 2.59 . . . . 0.0 113.292 -173.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.9 m -124.89 143.28 50.93 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 173.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.8 t -93.57 128.73 44.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 124.739 1.216 . . . . 0.0 112.022 -173.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 70.3 t -111.49 103.21 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 173.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -80.38 127.7 32.71 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 173.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.6 t -101.26 113.36 37.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 N-CA-C 103.549 -2.76 . . . . 0.0 103.549 173.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -92.45 148.68 19.24 Favored Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -129.54 73.75 81.34 Favored Pre-proline 0 C--O 1.243 0.762 0 CA-C-N 118.238 1.019 . . . . 0.0 110.66 -175.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.32 114.64 2.76 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.789 2.326 . . . . 0.0 109.553 173.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 8.0 t -91.15 145.29 24.8 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 173.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.3 mt -72.43 -16.39 61.83 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 117.793 0.269 . . . . 0.0 110.613 176.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 59.26 22.15 55.21 Favored Glycine 0 C--O 1.221 -0.679 0 C-N-CA 126.785 2.136 . . . . 0.0 115.456 173.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt -93.86 -46.75 7.05 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 120.2 2.0 . . . . 0.0 111.405 -174.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -96.52 151.3 19.71 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -93.69 151.59 19.54 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 174.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.79 -152.6 22.7 Favored Glycine 0 C--N 1.333 0.387 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 176.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.8 t -128.2 114.29 33.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -86.8 175.21 8.33 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.468 1.107 . . . . 0.0 108.907 173.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -128.32 156.49 42.97 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.776 1.63 . . . . 0.0 107.835 173.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.447 ' CE1' ' CD1' ' A' ' 149' ' ' PHE . 42.3 p90 -150.13 152.91 35.46 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.89 1.276 . . . . 0.0 107.904 173.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -116.28 145.9 42.81 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.736 1.615 . . . . 0.0 112.322 -173.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 92.8 t -141.63 138.28 32.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 173.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -154.3 130.21 10.18 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.854 1.661 . . . . 0.0 106.962 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.0 t -136.23 130.88 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 -174.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.629 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -98.35 163.65 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 173.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.405 HG11 HD12 ' A' ' 12' ' ' LEU . 7.1 t -141.91 134.06 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 -174.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.82 175.78 9.15 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 126.178 1.791 . . . . 0.0 107.067 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -93.17 176.01 6.56 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 103.76 -2.681 . . . . 0.0 103.76 172.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.4 t -65.37 -4.23 5.26 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 120.077 -1.639 . . . . 0.0 113.539 -178.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -85.54 -15.47 42.6 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 120.826 1.648 . . . . 0.0 110.374 173.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.4 0.1 65.39 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.837 1.208 . . . . 0.0 112.03 -173.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -70.8 115.63 10.17 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 119.494 1.647 . . . . 0.0 108.42 175.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -64.79 142.23 58.5 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.896 1.678 . . . . 0.0 108.253 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -140.28 -36.38 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 124.517 1.127 . . . . 0.0 113.559 -174.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -135.35 149.05 49.62 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.601 1.16 . . . . 0.0 107.929 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -142.63 138.89 31.02 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 85.8 m -65.97 131.3 94.52 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 174.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.8 143.61 41.85 Favored 'Trans proline' 0 N--CA 1.443 -1.486 0 N-CA-C 108.796 -1.271 . . . . 0.0 108.796 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -85.3 112.83 21.15 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -173.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.408 ' H ' ' H ' ' A' ' 147' ' ' ALA 0.297 0.9 OUTLIER 173.06 -10.44 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.725 1 C-N-CA 136.395 5.878 . . . . 0.0 110.457 174.015 . . . . . . . . 5 4 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.408 ' H ' ' H ' ' A' ' 146' ' ' ASN . . . -63.74 83.55 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.575 1.95 . . . . 0.0 112.069 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 3.9 mm -125.04 122.97 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 -178.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.447 ' CD1' ' CE1' ' A' ' 126' ' ' PHE . 1.0 OUTLIER -103.89 164.4 11.72 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 173.62 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -134.11 113.51 12.15 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -173.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 60.4 tttt -103.9 123.94 48.06 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.815 1.189 . . . . 0.0 109.453 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 25.0 m -83.55 114.57 21.6 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 174.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 5.5 m -116.96 166.63 11.96 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 124.487 1.115 . . . . 0.0 110.301 174.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.468 HD12 HG21 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -137.2 159.44 41.91 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 126.61 1.964 . . . . 0.0 107.881 -177.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -69.99 117.6 11.76 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.272 1.429 . . . . 0.0 111.283 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -140.38 165.77 26.52 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.881 2.073 . . . . 0.0 108.495 174.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 . . . . . 0 C--O 1.25 1.099 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 173.67 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.081 0 N-CA-C 108.412 -1.875 . . . . 0.0 108.412 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.0 m -143.03 176.06 9.37 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.691 1.597 . . . . 0.0 106.73 165.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 30.5 t-80 -119.99 139.8 51.94 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -175.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -76.81 175.53 9.36 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.007 1.723 . . . . 0.0 108.263 173.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -74.09 121.31 20.92 Favored 'General case' 0 C--N 1.335 -0.045 0 N-CA-C 102.01 -3.33 . . . . 0.0 102.01 173.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -44.12 113.15 0.49 Allowed 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.519 1.127 . . . . 0.0 112.159 -173.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 -164.69 176.48 8.81 Favored 'General case' 0 N--CA 1.437 -1.093 1 C-N-CA 133.388 4.675 . . . . 0.0 102.77 -174.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.99 113.75 25.81 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 125.234 1.414 . . . . 0.0 107.582 173.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -141.36 167.53 21.94 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 126.849 2.06 . . . . 0.0 106.817 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -142.47 169.72 17.04 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.165 0.986 . . . . 0.0 109.105 173.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.6 m -176.31 177.24 1.54 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 128.862 2.865 . . . . 0.0 109.405 -175.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.0 tt -43.14 130.89 4.56 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.849 2.46 . . . . 0.0 112.99 -176.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -115.77 140.83 48.84 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.679 2.391 . . . . 0.0 108.235 173.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.22 118.03 6.65 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -136.63 176.11 9.0 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.759 0.79 . . . . 0.0 109.264 177.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 12.6 mt -114.47 113.53 44.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 1 N-CA-C 99.573 -4.232 . . . . 0.0 99.573 173.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -78.59 144.88 35.11 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 122.674 1.226 . . . . 0.0 110.999 -173.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.45 ' HB1' ' HG3' ' A' ' 28' ' ' GLU . . . -62.7 -26.49 68.69 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.193 -1.367 . . . . 0.0 112.898 -173.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -67.14 -38.99 86.47 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -174.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -57.54 11.09 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 117.649 -1.167 . . . . 0.0 108.49 173.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.14 -41.42 48.82 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 119.567 1.076 . . . . 0.0 111.751 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -51.59 -65.07 0.62 Allowed 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 173.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 84.5 t -50.46 -24.1 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 125.089 1.355 . . . . 0.0 111.659 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.1 mt -84.35 -38.28 20.53 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.2 pt -145.33 14.06 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 117.275 2.324 . . . . 0.0 117.275 -173.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.83 0.24 2.03 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 128.826 3.107 . . . . 0.0 114.913 -174.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -101.94 134.53 45.0 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 129.36 3.064 . . . . 0.0 106.416 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.45 ' HG3' ' HB1' ' A' ' 18' ' ' ALA . 31.3 tt0 -124.08 113.46 18.41 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.505 1.048 . . . . 0.0 110.549 -173.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -153.19 139.24 18.24 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 128.313 2.645 . . . . 0.0 106.014 173.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -87.03 166.2 15.23 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 173.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.4 mp -134.98 113.2 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 104.434 -2.432 . . . . 0.0 104.434 173.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.79 113.93 23.92 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -177.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.3 mt -93.09 -56.25 5.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -176.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.429 HG22 ' HG2' ' A' ' 39' ' ' MET . 6.3 t -126.27 133.72 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 125.904 1.682 . . . . 0.0 106.767 -174.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.9 p -140.13 126.84 20.48 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 102.164 -3.272 . . . . 0.0 102.164 173.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.269 6.2 pt-20 46.05 34.0 1.88 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.177 1.391 . . . . 0.0 113.514 -177.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 64.46 -3.53 1.81 Allowed Glycine 0 CA--C 1.544 1.865 0 O-C-N 120.273 -1.517 . . . . 0.0 114.173 -174.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.5 ttpt -79.72 37.12 0.34 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 131.055 3.742 . . . . 0.0 111.436 -173.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.429 ' HG2' HG22 ' A' ' 34' ' ' VAL . 38.0 mtt -37.82 122.88 1.02 Allowed 'General case' 0 C--O 1.24 0.585 0 C-N-CA 125.478 1.511 . . . . 0.0 112.825 -173.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.1 167.83 7.29 Favored Pre-proline 0 N--CA 1.449 -0.495 0 O-C-N 125.798 1.936 . . . . 0.0 108.052 173.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.57 29.26 0.24 Allowed 'Trans proline' 0 CA--C 1.548 1.19 0 C-N-CA 123.939 3.093 . . . . 0.0 112.365 174.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -53.86 -26.61 25.43 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 126.784 2.033 . . . . 0.0 113.022 -173.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 m -62.17 -29.88 70.66 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.243 1.417 . . . . 0.0 111.46 -173.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.533 ' CE1' ' HZ1' ' A' ' 48' ' ' LYS . 9.7 t-80 -55.3 -65.83 0.52 Allowed 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.098 1.359 . . . . 0.0 109.362 175.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.253 44.1 m-20 -76.44 -23.75 53.93 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.055 0.455 . . . . 0.0 111.571 -175.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -60.31 -44.64 95.24 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 120.099 -1.626 . . . . 0.0 108.331 173.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -40.22 74.6 Favored 'General case' 0 C--O 1.237 0.4 0 O-C-N 121.639 -0.663 . . . . 0.0 109.277 176.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.533 ' HZ1' ' CE1' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -125.68 112.56 16.25 Favored 'General case' 0 C--O 1.215 -0.722 0 O-C-N 120.562 -1.336 . . . . 0.0 110.517 -175.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -177.01 113.85 0.09 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-O 116.915 -1.517 . . . . 0.0 107.245 173.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -87.35 112.43 22.09 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 100.554 -3.869 . . . . 0.0 100.554 172.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -176.76 -67.01 0.01 OUTLIER 'General case' 0 C--O 1.232 0.159 0 C-N-CA 125.784 1.634 . . . . 0.0 107.101 174.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.488 ' CZ ' ' HA ' ' A' ' 52' ' ' ARG . 0.1 OUTLIER -155.72 -16.54 0.11 Allowed 'General case' 0 C--N 1.347 0.496 0 N-CA-C 117.049 2.241 . . . . 0.0 117.049 178.569 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.92 -66.74 0.29 Allowed Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 121.173 1.806 . . . . 0.0 114.097 -174.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -78.84 -64.41 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 CA-C-N 121.443 1.551 . . . . 0.0 110.646 -176.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.47 118.06 13.81 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.743 1.217 . . . . 0.0 110.842 -173.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.9 mt -126.14 116.25 23.76 Favored Pre-proline 0 N--CA 1.448 -0.543 0 C-N-CA 126.555 1.942 . . . . 0.0 106.612 -174.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -72.23 155.9 55.77 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.018 1.812 . . . . 0.0 110.353 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.9 p -40.32 -43.66 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 127.715 2.406 . . . . 0.0 112.854 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -59.89 -33.97 72.55 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 126.954 2.101 . . . . 0.0 114.076 -177.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.3 mm -68.47 112.93 3.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 104.098 -2.556 . . . . 0.0 104.098 175.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -81.86 -33.48 30.6 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.669 174.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.3 m -158.39 157.88 33.15 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.32 0.648 . . . . 0.0 109.301 -174.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 33.7 mtm -126.28 166.78 16.48 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 173.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -134.63 130.92 37.16 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -107.95 162.24 14.2 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 173.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.4 m -135.86 133.43 37.76 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -175.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -144.56 165.56 27.65 Favored 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 121.332 -0.855 . . . . 0.0 111.312 179.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.09 158.37 4.6 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 124.238 1.015 . . . . 0.0 110.898 174.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.27 177.42 6.05 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 173.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.15 101.79 12.93 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 120.212 -1.555 . . . . 0.0 108.996 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 44.36 -53.82 0.0 OUTLIER Glycine 0 CA--C 1.541 1.669 1 C-N-CA 132.814 5.007 . . . . 0.0 120.363 175.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -116.9 -19.83 9.67 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 121.628 2.714 . . . . 0.0 115.396 174.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.71 37.17 0.14 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 128.56 2.744 . . . . 0.0 116.082 -173.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.532 ' HG2' ' HE2' ' A' ' 105' ' ' HIS . 3.4 mm-40 -44.36 113.49 0.54 Allowed 'General case' 0 CA--C 1.557 1.224 0 CA-C-N 121.891 2.132 . . . . 0.0 109.147 -174.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -84.35 162.55 20.0 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.346 1.459 . . . . 0.0 111.595 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -111.77 149.53 31.57 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -135.52 161.82 34.41 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 120.226 1.375 . . . . 0.0 111.142 175.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.411 ' O ' HD13 ' A' ' 131' ' ' ILE . 31.1 tt0 -155.49 139.11 16.01 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 173.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -88.78 103.84 16.35 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.959 1.303 . . . . 0.0 109.71 -175.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.9 tt -72.34 -47.66 47.95 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.289 1.435 . . . . 0.0 108.981 175.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 38.1 m -131.61 138.2 48.71 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.493 1.517 . . . . 0.0 111.161 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.438 HD22 HG22 ' A' ' 128' ' ' VAL . 0.3 OUTLIER -168.83 92.69 0.29 Allowed 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 101.936 -3.357 . . . . 0.0 101.936 173.124 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -165.0 154.44 12.94 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 120.037 1.289 . . . . 0.0 112.486 -174.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.1 t -67.96 161.43 26.57 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 119.6 1.091 . . . . 0.0 110.243 173.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.9 mt -126.43 -2.61 6.83 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 125.772 1.629 . . . . 0.0 112.385 174.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.495 ' CG ' ' H ' ' A' ' 87' ' ' LYS 0.337 11.2 t70 -99.07 169.11 9.64 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.819 1.645 . . . . 0.0 112.169 -175.514 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.495 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 1.4 mppt? -109.2 -49.02 3.17 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 129.557 3.143 . . . . 0.0 111.631 -173.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -105.95 -47.66 1.07 Allowed Glycine 0 CA--C 1.524 0.636 0 C-N-CA 125.247 1.403 . . . . 0.0 112.095 -177.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.2 mp -80.73 14.97 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 125.571 1.548 . . . . 0.0 108.884 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 12.9 ttm -43.27 130.72 4.78 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 129.453 3.101 . . . . 0.0 109.199 -173.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -156.94 114.62 3.17 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 126.09 1.756 . . . . 0.0 106.62 -173.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.288 3.9 m-20 -96.36 129.14 34.21 Favored Pre-proline 0 CA--C 1.51 -0.58 0 O-C-N 124.493 1.121 . . . . 0.0 110.995 -174.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -75.64 149.68 34.5 Favored 'Trans proline' 0 N--CA 1.441 -1.561 0 C-N-CA 121.91 1.74 . . . . 0.0 109.685 175.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 20.8 p -131.88 155.44 47.86 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 125.109 1.364 . . . . 0.0 107.912 174.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.6 m -125.23 153.06 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 C-N-CA 124.193 0.997 . . . . 0.0 109.977 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -86.12 11.41 11.88 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.345 1.458 . . . . 0.0 113.367 -177.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.3 m -137.53 164.1 43.86 Favored Pre-proline 0 C--N 1.326 -0.432 0 C-N-CA 124.414 1.086 . . . . 0.0 109.798 -173.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -65.78 162.2 35.74 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.375 1.383 . . . . 0.0 109.803 173.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -65.69 -11.39 44.76 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 124.213 1.005 . . . . 0.0 112.251 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -143.02 164.37 30.28 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.138 1.375 . . . . 0.0 107.807 173.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.64 -160.67 34.13 Favored Glycine 0 C--O 1.226 -0.352 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.0 p -123.48 152.16 42.0 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.261 0.531 . . . . 0.0 109.958 176.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.5 t -94.93 113.09 60.5 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 102.736 -3.061 . . . . 0.0 102.736 173.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -97.17 161.53 1.0 Allowed 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.825 2.35 . . . . 0.0 112.514 -173.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.532 ' HE2' ' HG2' ' A' ' 74' ' ' GLU . 80.8 m-70 -66.72 -19.65 65.8 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 119.971 -1.706 . . . . 0.0 114.88 -174.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.05 114.08 24.32 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 -174.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -47.3 111.43 0.41 Allowed 'General case' 0 N--CA 1.463 0.219 0 O-C-N 124.438 1.086 . . . . 0.0 109.249 -175.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 66.3 m -116.84 143.97 45.05 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -174.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.4 t -105.79 139.0 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -173.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.5 t -121.9 103.7 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -73.73 147.0 43.97 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 173.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.4 t -130.96 113.91 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 104.443 -2.429 . . . . 0.0 104.443 177.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -100.61 146.61 17.65 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 125.249 1.404 . . . . 0.0 110.517 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -129.99 73.6 81.26 Favored Pre-proline 0 CA--C 1.546 0.813 0 CA-C-N 118.88 1.34 . . . . 0.0 111.704 -174.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -64.54 117.14 4.23 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.443 2.095 . . . . 0.0 109.056 173.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 8.5 t -94.01 144.29 25.6 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 173.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.6 mt -79.59 -10.87 59.87 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 122.966 0.506 . . . . 0.0 111.15 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 55.19 33.57 57.99 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 125.817 1.675 . . . . 0.0 114.22 173.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -93.74 -63.42 1.2 Allowed 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 118.471 1.136 . . . . 0.0 110.271 -177.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.411 ' NE2' ' H ' ' A' ' 121' ' ' ASP . 38.6 tp60 -96.05 154.66 17.12 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 174.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.411 ' H ' ' NE2' ' A' ' 120' ' ' GLN . 4.0 m-20 -93.51 152.28 19.16 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.46 1.504 . . . . 0.0 107.407 175.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.15 -152.07 22.12 Favored Glycine 0 C--N 1.331 0.305 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.8 t -127.47 113.86 33.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -84.35 173.34 11.01 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 173.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -133.85 159.78 39.62 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.533 1.133 . . . . 0.0 109.554 174.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -146.15 140.73 26.87 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 173.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -94.43 148.0 22.67 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 125.242 1.417 . . . . 0.0 111.25 -175.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.5 HG21 ' CE1' ' A' ' 149' ' ' PHE . 24.8 t -139.19 135.65 41.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 125.396 1.479 . . . . 0.0 108.997 173.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -155.8 120.46 4.68 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 173.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.411 ' H ' ' HB ' ' A' ' 143' ' ' THR . 43.8 t -130.44 123.83 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.618 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -88.76 166.58 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 173.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.6 t -146.1 134.59 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 -174.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.34 174.9 10.06 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.977 -175.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -86.83 175.96 7.94 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 172.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.3 t -65.65 -13.93 60.17 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 120.756 -1.215 . . . . 0.0 113.754 -173.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -94.78 -4.19 47.72 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.433 1.093 . . . . 0.0 111.423 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.86 9.44 57.35 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 118.958 -0.912 . . . . 0.0 113.703 176.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -74.28 116.49 15.01 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 119.786 1.793 . . . . 0.0 108.592 175.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.8 m -70.19 143.83 52.12 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 123.815 0.846 . . . . 0.0 109.186 -177.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.57 -36.0 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 124.523 1.129 . . . . 0.0 113.394 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -131.68 145.4 51.63 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -175.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -146.13 147.32 31.41 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.411 ' HB ' ' H ' ' A' ' 130' ' ' VAL . 58.5 m -78.48 113.49 34.84 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.26 144.28 85.87 Favored 'Trans proline' 0 N--CA 1.446 -1.31 0 CA-C-N 119.944 1.016 . . . . 0.0 110.796 -173.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -80.56 112.53 18.0 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 -173.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.444 14.0 m-80 172.55 -13.83 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 1 C-N-CA 138.555 6.742 . . . . 0.0 110.252 173.722 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.55 77.31 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.81 2.044 . . . . 0.0 109.861 173.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 37.0 mm -115.64 125.5 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.5 ' CE1' HG21 ' A' ' 128' ' ' VAL . 0.7 OUTLIER -93.97 154.75 17.5 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 173.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -131.05 113.51 14.04 Favored 'General case' 0 CA--C 1.521 -0.156 0 O-C-N 121.366 -0.834 . . . . 0.0 108.755 -173.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -106.71 122.23 45.93 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 118.838 0.745 . . . . 0.0 109.204 -177.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 27.7 m -83.37 117.09 22.79 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 105.68 -1.971 . . . . 0.0 105.68 174.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 6.7 m -118.14 166.41 12.61 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.488 0.715 . . . . 0.0 109.615 173.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.4 pp -131.62 160.44 35.36 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.362 1.465 . . . . 0.0 107.627 175.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -68.41 125.22 25.77 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.457 1.503 . . . . 0.0 109.701 176.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -146.7 127.9 14.75 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.851 1.26 . . . . 0.0 107.809 174.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 . . . . . 0 C--O 1.255 1.361 0 C-N-CA 127.505 2.322 . . . . 0.0 105.42 174.162 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.442 ' H3 ' ' CD2' ' A' ' 3' ' ' HIS . . . . . . . . 0 N--CA 1.467 0.71 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.2 m -63.78 127.56 31.9 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 163.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.442 ' CD2' ' H3 ' ' A' ' 1' ' ' GLY . 88.6 m-70 -144.41 175.23 10.27 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 122.028 0.918 . . . . 0.0 110.307 -175.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 8.8 tpt -142.87 176.28 9.19 Favored 'General case' 0 CA--C 1.544 0.734 1 C-N-CA 133.351 4.661 . . . . 0.0 103.174 173.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.7 tt -69.72 112.7 6.36 Favored 'General case' 0 C--N 1.344 0.341 1 N-CA-C 100.018 -4.067 . . . . 0.0 100.018 173.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -176.29 176.96 1.59 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.55 2.34 . . . . 0.0 106.306 -172.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -128.04 113.75 16.2 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 120.462 1.483 . . . . 0.0 110.302 176.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -123.59 175.9 6.53 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 128.601 2.761 . . . . 0.0 107.985 173.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -67.95 163.56 21.85 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.852 1.261 . . . . 0.0 109.391 173.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -67.46 176.69 2.23 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 123.462 1.601 . . . . 0.0 109.642 173.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.9 m -146.3 177.1 9.27 Favored 'General case' 0 C--O 1.222 -0.375 0 O-C-N 119.036 -2.29 . . . . 0.0 112.613 -173.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tt -43.04 126.14 3.81 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 129.011 2.925 . . . . 0.0 112.934 -173.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.401 ' CD1' ' HA ' ' A' ' 35' ' ' SER . 98.1 m-85 -114.3 141.44 47.59 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 128.281 2.632 . . . . 0.0 108.17 174.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.86 120.76 8.17 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 18.0 p90 -135.94 168.76 18.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 119.159 0.89 . . . . 0.0 109.842 175.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.9 mt -99.78 114.36 37.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 102.073 -3.306 . . . . 0.0 102.073 173.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -79.32 136.08 36.91 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 123.903 1.811 . . . . 0.0 113.068 -173.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.62 -20.37 46.9 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 127.375 2.27 . . . . 0.0 116.213 -173.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -56.47 -40.83 75.54 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 118.886 0.766 . . . . 0.0 109.55 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 42.6 tp60 -65.38 -44.24 88.18 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.681 178.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.581 ' HA ' HD12 ' A' ' 24' ' ' LEU . . . -63.66 -32.03 73.38 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 118.854 -0.593 . . . . 0.0 112.235 176.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -58.48 -54.32 48.31 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 173.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 80.0 t -53.66 -23.96 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 O-C-N 121.39 -0.819 . . . . 0.0 111.927 175.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.581 HD12 ' HA ' ' A' ' 21' ' ' ALA . 13.8 mt -76.61 -40.61 48.87 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 174.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.7 pt -148.83 14.08 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 116.808 2.151 . . . . 0.0 116.808 -172.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.27 -4.4 1.91 Allowed Glycine 0 CA--C 1.533 1.189 0 C-N-CA 128.988 3.185 . . . . 0.0 114.506 -173.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -101.99 139.8 37.13 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 130.674 3.59 . . . . 0.0 105.725 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -101.59 124.05 46.61 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.092 0.957 . . . . 0.0 109.407 -173.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -137.13 113.47 10.02 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.967 1.707 . . . . 0.0 109.251 -174.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -92.14 163.31 13.99 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.144 1.338 . . . . 0.0 107.492 173.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.3 mp -136.71 113.17 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 173.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.86 116.58 23.39 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -176.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 27.4 mt -95.05 -63.76 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.034 0.934 . . . . 0.0 109.335 -177.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.9 t -118.41 133.97 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -173.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.401 ' HA ' ' CD1' ' A' ' 13' ' ' TYR . 2.9 p -137.59 124.55 21.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 104.216 -2.513 . . . . 0.0 104.216 173.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 43.95 33.26 0.73 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.19 2.196 . . . . 0.0 114.091 -174.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.38 -6.87 5.32 Favored Glycine 0 CA--C 1.544 1.873 0 O-C-N 120.713 -1.242 . . . . 0.0 114.73 -174.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -79.19 37.29 0.31 Allowed 'General case' 0 CA--C 1.537 0.466 1 C-N-CA 131.706 4.002 . . . . 0.0 111.215 -178.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 42.6 mtm -38.22 134.73 0.8 Allowed 'General case' 0 C--O 1.233 0.195 0 C-N-CA 126.207 1.803 . . . . 0.0 114.362 -173.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.1 165.38 48.36 Favored Pre-proline 0 N--CA 1.45 -0.446 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 173.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.28 38.2 0.53 Allowed 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 123.911 3.074 . . . . 0.0 110.6 173.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -53.72 -26.7 24.35 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 127.25 2.22 . . . . 0.0 114.095 -173.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.5 m -60.27 -32.08 70.83 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.624 1.169 . . . . 0.0 111.621 -173.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -58.36 -64.13 1.03 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.252 1.021 . . . . 0.0 109.852 176.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -76.37 -29.35 57.14 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -174.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -57.1 -55.99 27.63 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.18 0.992 . . . . 0.0 108.584 173.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.6 -24.46 42.0 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 118.537 -0.744 . . . . 0.0 111.102 -174.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.71 112.92 15.99 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 120.259 1.39 . . . . 0.0 109.689 173.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -172.68 151.11 2.27 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 120.379 1.445 . . . . 0.0 108.507 173.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.48 112.9 24.48 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 173.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -175.73 -67.35 0.01 OUTLIER 'General case' 0 C--O 1.235 0.342 0 N-CA-C 102.752 -3.055 . . . . 0.0 102.752 173.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.09 -17.03 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 117.819 -1.086 . . . . 0.0 110.843 172.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 69.2 mmm -44.8 -52.22 19.4 Favored Pre-proline 0 N--CA 1.468 0.467 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -173.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -69.35 -77.39 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.042 0 CA-C-N 120.837 1.335 . . . . 0.0 110.361 173.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.21 113.32 20.59 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.39 0.614 . . . . 0.0 111.055 -173.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.89 131.5 21.92 Favored Pre-proline 0 C--N 1.327 -0.373 0 C-N-CA 128.489 2.716 . . . . 0.0 106.228 -177.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -79.31 157.6 26.0 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.731 1.621 . . . . 0.0 110.743 177.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.4 p -41.95 -41.17 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 126.97 2.108 . . . . 0.0 112.088 173.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.51 -39.47 83.97 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 127.519 2.328 . . . . 0.0 112.825 -176.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 mm -74.28 112.85 11.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 101.548 -3.501 . . . . 0.0 101.548 173.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -78.14 -38.25 44.16 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.0 m -149.83 161.3 42.53 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.362 1.065 . . . . 0.0 109.585 -173.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 24.3 mtm -126.33 152.38 46.3 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 172.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -94.59 150.29 20.39 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -136.51 152.48 50.57 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 102.376 -3.194 . . . . 0.0 102.376 172.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.0 m -139.95 135.53 32.89 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -176.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -145.84 165.69 28.13 Favored 'General case' 0 C--O 1.24 0.566 0 O-C-N 121.916 -0.49 . . . . 0.0 110.635 177.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.83 157.55 3.06 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.927 0.87 . . . . 0.0 112.438 177.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.6 -174.02 4.17 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 173.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.87 111.83 18.9 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 126.047 1.739 . . . . 0.0 107.101 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 43.4 -57.9 0.0 OUTLIER Glycine 0 CA--C 1.537 1.418 1 C-N-CA 132.74 4.971 . . . . 0.0 119.372 173.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -116.57 -25.79 7.28 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.724 1.762 . . . . 0.0 113.548 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.73 37.1 0.08 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 130.993 3.717 . . . . 0.0 119.068 -173.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -54.37 113.96 1.47 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 123.234 2.743 . . . . 0.0 111.013 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -84.1 142.93 30.04 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 125.322 1.449 . . . . 0.0 107.348 173.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -90.35 149.27 22.37 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -131.95 161.0 34.16 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 120.302 1.41 . . . . 0.0 110.905 175.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.419 ' O ' HD13 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -154.11 134.95 13.73 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 173.276 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -87.28 103.13 15.16 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.098 0.559 . . . . 0.0 110.03 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.0 tt -73.38 -42.07 62.6 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.3 m -138.58 132.72 31.52 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.356 1.062 . . . . 0.0 111.486 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.545 HD22 HG22 ' A' ' 128' ' ' VAL . 0.1 OUTLIER -162.76 93.01 0.8 Allowed 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 101.309 -3.589 . . . . 0.0 101.309 173.2 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.433 ' HD3' ' H ' ' A' ' 82' ' ' LEU . 0.1 OUTLIER -161.4 155.55 22.51 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 119.75 1.159 . . . . 0.0 111.284 -173.753 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.0 t -82.85 153.79 24.97 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 173.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 70.8 mt -107.31 -9.27 16.1 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.253 1.421 . . . . 0.0 111.679 176.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -104.97 162.76 13.07 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 173.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.7 mmtm -138.16 -33.24 0.7 Allowed 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.412 1.885 . . . . 0.0 112.297 -177.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -62.1 -54.26 36.21 Favored Glycine 0 CA--C 1.545 1.912 0 N-CA-C 106.808 -2.517 . . . . 0.0 106.808 172.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.7 mt -90.45 25.28 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 129.281 3.032 . . . . 0.0 110.518 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 4.1 ttp -43.17 133.82 3.82 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 125.458 2.551 . . . . 0.0 112.712 -173.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -149.68 155.38 40.11 Favored 'General case' 0 N--CA 1.422 -1.842 2 C-N-CA 135.994 5.718 . . . . 0.0 101.302 173.785 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -144.86 114.22 5.03 Favored Pre-proline 0 C--N 1.316 -0.855 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 173.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -67.44 157.93 59.44 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 122.816 2.344 . . . . 0.0 113.652 -173.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.3 p -133.17 165.65 24.28 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.513 1.525 . . . . 0.0 109.773 176.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.4 m -126.34 155.58 36.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.174 0.989 . . . . 0.0 110.677 173.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -78.21 9.47 3.77 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.209 2.204 . . . . 0.0 113.485 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.5 m -139.3 163.71 43.82 Favored Pre-proline 0 C--N 1.327 -0.372 0 C-N-CA 124.443 1.097 . . . . 0.0 109.976 -176.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -65.41 162.07 35.31 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.705 1.603 . . . . 0.0 110.071 173.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -64.34 -10.59 25.35 Favored 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 124.634 1.174 . . . . 0.0 112.586 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -145.77 164.06 33.04 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 120.151 1.341 . . . . 0.0 107.857 173.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.37 -161.65 34.22 Favored Glycine 0 C--O 1.227 -0.335 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 77.8 p -117.25 150.94 37.94 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 173.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.2 t -87.16 113.23 52.72 Favored Pre-proline 0 N--CA 1.448 -0.547 0 N-CA-C 102.276 -3.231 . . . . 0.0 102.276 173.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -92.34 155.51 3.09 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.414 2.076 . . . . 0.0 111.98 -173.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.406 ' CD2' ' H ' ' A' ' 105' ' ' HIS . 18.0 m-70 -65.51 -16.88 64.11 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 120.164 -1.585 . . . . 0.0 112.179 -174.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.474 ' H ' ' HD2' ' A' ' 106' ' ' LYS . 3.8 mptt -85.88 113.77 22.27 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 -174.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.65 110.58 0.48 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 119.098 0.863 . . . . 0.0 109.37 -176.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 45.3 m -117.04 139.86 50.18 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -175.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.6 t -98.37 114.16 35.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 C-N-CA 124.402 1.081 . . . . 0.0 109.425 -173.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 85.1 t -93.98 103.41 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 N-CA-C 103.875 -2.639 . . . . 0.0 103.875 173.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -84.49 126.09 32.97 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 104.921 -2.251 . . . . 0.0 104.921 173.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.7 t -94.14 113.84 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 104.462 -2.422 . . . . 0.0 104.462 174.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -87.71 148.32 21.01 Favored Glycine 0 N--CA 1.44 -1.057 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 176.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.454 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 3.8 m-85 -132.19 73.45 77.67 Favored Pre-proline 0 C--O 1.242 0.68 0 C-N-CA 124.125 0.97 . . . . 0.0 108.924 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.98 121.76 8.16 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 121.652 1.568 . . . . 0.0 108.082 174.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 5.9 t -101.99 149.69 23.98 Favored 'General case' 0 C--N 1.34 0.191 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 173.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mt -79.42 -18.0 53.14 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 118.068 0.394 . . . . 0.0 110.697 176.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.54 17.52 53.74 Favored Glycine 0 C--O 1.215 -1.082 0 C-N-CA 127.632 2.539 . . . . 0.0 115.719 173.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 24.6 mttt -93.19 -29.38 15.75 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 121.576 2.688 . . . . 0.0 111.449 -173.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -96.66 154.88 17.03 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 172.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -102.24 144.58 30.59 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 174.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 151.21 -157.71 27.34 Favored Glycine 0 C--N 1.332 0.319 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 175.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 18.8 t -127.18 113.57 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 175.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -89.32 164.16 15.03 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 173.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -122.96 163.84 19.65 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 121.227 -0.92 . . . . 0.0 110.104 176.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.454 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 9.1 p90 -149.61 150.53 32.34 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 118.4 0.545 . . . . 0.0 109.65 173.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -111.53 150.58 29.77 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 127.638 2.375 . . . . 0.0 110.33 -174.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.545 HG22 HD22 ' A' ' 82' ' ' LEU . 85.6 t -138.83 137.47 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 125.698 1.599 . . . . 0.0 109.083 174.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -156.32 124.47 5.69 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 126.809 2.043 . . . . 0.0 106.357 173.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 42.7 t -135.01 128.39 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.628 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -95.22 164.57 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 174.383 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.1 t -143.27 135.26 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -173.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.52 175.46 9.58 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.866 1.266 . . . . 0.0 108.642 -174.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 37.9 p-10 -89.99 176.32 6.84 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 172.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.6 t -65.49 -4.81 6.4 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 120.28 -1.512 . . . . 0.0 113.949 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -88.63 -16.73 31.7 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 120.714 1.597 . . . . 0.0 110.696 173.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.57 1.16 60.54 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.555 1.074 . . . . 0.0 111.808 -173.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 60.6 m-20 -70.84 116.56 11.29 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 119.535 1.668 . . . . 0.0 108.384 174.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.5 m -68.03 143.87 55.35 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.842 1.657 . . . . 0.0 109.024 -174.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -140.99 -36.34 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.628 1.171 . . . . 0.0 113.999 -174.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -130.55 144.11 51.2 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 178.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -144.79 131.37 19.91 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 177.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 77.5 m -63.57 131.35 94.82 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 174.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -72.17 144.5 42.09 Favored 'Trans proline' 0 N--CA 1.444 -1.408 0 N-CA-C 108.401 -1.423 . . . . 0.0 108.401 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -82.76 112.52 19.68 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 -175.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.599 38.9 m-80 172.31 -13.19 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 1 C-N-CA 132.739 4.415 . . . . 0.0 114.295 173.28 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.86 96.6 0.09 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.056 1.342 . . . . 0.0 108.612 177.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.1 mt -133.58 148.8 30.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.416 ' CD1' ' CZ ' ' A' ' 126' ' ' PHE . 0.4 OUTLIER -130.87 170.08 14.89 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.274 1.429 . . . . 0.0 107.624 175.648 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -135.3 113.48 11.31 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.865 1.266 . . . . 0.0 108.023 -173.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -101.31 123.55 45.58 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 23.9 m -83.48 117.81 23.34 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 175.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 30.9 m -112.25 158.17 20.05 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 174.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.8 pp -146.24 159.59 43.12 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 176.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.44 121.25 2.89 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.73 2.412 . . . . 0.0 115.223 -173.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -139.74 164.14 30.73 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 130.131 3.372 . . . . 0.0 106.646 173.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 . . . . . 0 C--O 1.252 1.188 0 C-N-CA 127.515 2.326 . . . . 0.0 105.957 175.708 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.04 0 N-CA-C 107.263 -2.335 . . . . 0.0 107.263 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 p -53.04 176.56 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.415 0.686 . . . . 0.0 110.597 136.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -58.21 170.29 0.71 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 173.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -61.9 155.71 22.73 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 122.699 0.4 . . . . 0.0 109.967 175.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.7 mp -131.8 164.28 26.36 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 128.272 2.629 . . . . 0.0 104.161 173.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -80.25 148.45 30.78 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.222 1.409 . . . . 0.0 110.333 174.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.409 ' HG2' ' H ' ' A' ' 8' ' ' GLN . 4.2 tt0 -169.36 176.2 5.22 Favored 'General case' 0 N--CA 1.439 -1.009 1 C-N-CA 131.711 4.004 . . . . 0.0 102.5 173.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.409 ' H ' ' HG2' ' A' ' 7' ' ' GLN . 27.2 tp60 -127.62 166.03 18.84 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 128.476 2.711 . . . . 0.0 106.266 173.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 58.2 mp0 -65.47 167.29 8.95 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.529 1.532 . . . . 0.0 110.823 175.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -137.7 172.54 12.8 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.504 1.522 . . . . 0.0 109.037 -174.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m -175.79 176.99 1.76 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 129.237 3.015 . . . . 0.0 109.978 178.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.2 tt -43.41 129.23 5.05 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 127.15 2.18 . . . . 0.0 112.236 -174.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.412 ' CD1' ' HA ' ' A' ' 35' ' ' SER . 74.5 m-85 -116.18 132.88 56.54 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.041 1.736 . . . . 0.0 109.062 174.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.07 120.56 11.02 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -178.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.5 p90 -134.25 175.32 9.61 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.71 0.804 . . . . 0.0 110.088 176.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.3 mt -111.81 116.17 51.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 102.213 -3.254 . . . . 0.0 102.213 174.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -83.18 148.56 27.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 123.501 1.619 . . . . 0.0 114.639 -173.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.81 -14.33 32.15 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 126.863 2.065 . . . . 0.0 114.666 -174.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -58.26 -35.1 71.25 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 119.185 0.902 . . . . 0.0 109.876 174.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 47.2 tp60 -67.37 -43.05 82.39 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 118.376 0.535 . . . . 0.0 111.104 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.583 ' HA ' HD12 ' A' ' 24' ' ' LEU . . . -60.71 -37.8 82.89 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.881 0.872 . . . . 0.0 111.044 173.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -56.21 -58.22 8.89 Favored 'General case' 0 N--CA 1.445 -0.72 0 O-C-N 121.002 -1.061 . . . . 0.0 108.198 173.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 72.6 t -52.24 -23.64 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 124.563 1.145 . . . . 0.0 111.822 175.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.583 HD12 ' HA ' ' A' ' 21' ' ' ALA . 14.2 mt -73.87 -51.17 17.1 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 117.93 -1.034 . . . . 0.0 112.456 175.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.6 pt -156.13 21.53 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -172.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.63 -0.64 60.48 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 126.694 2.092 . . . . 0.0 114.656 -174.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -80.02 176.39 9.79 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 128.285 2.634 . . . . 0.0 110.035 -173.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -138.04 113.4 9.43 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -173.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -160.0 115.46 2.37 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.449 0.7 . . . . 0.0 110.598 -178.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -89.55 175.73 7.17 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.369 1.468 . . . . 0.0 109.633 173.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 21.6 mt -143.91 113.27 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 172.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.72 114.23 24.14 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -177.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.2 mt -91.3 -61.54 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 118.944 0.793 . . . . 0.0 109.198 -177.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.6 t -116.6 122.89 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 -173.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.412 ' HA ' ' CD1' ' A' ' 13' ' ' TYR . 2.9 p -126.11 119.36 27.36 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 102.966 -2.976 . . . . 0.0 102.966 173.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.32 17.6 pm0 45.91 42.16 8.8 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.914 1.686 . . . . 0.0 112.884 -176.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.99 -24.22 1.3 Allowed Glycine 0 CA--C 1.543 1.829 0 C-N-CA 125.965 1.745 . . . . 0.0 115.136 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . 0.437 7.0 tmtt? -53.94 37.32 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.686 1 C-N-CA 137.609 6.364 . . . . 0.0 117.085 174.373 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 42.6 mtt -38.17 130.03 1.24 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.11 167.63 32.52 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 173.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.48 34.17 0.34 Allowed 'Trans proline' 0 CA--C 1.55 1.313 0 C-N-CA 124.069 3.179 . . . . 0.0 111.728 173.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -54.7 -26.57 34.5 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 127.899 2.48 . . . . 0.0 114.4 -173.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 m -62.9 -32.38 73.64 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.5 1.12 . . . . 0.0 112.185 -172.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 61.3 t60 -59.96 -51.42 69.74 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.411 ' HA ' ' O ' ' A' ' 48' ' ' LYS 0.328 0.9 OUTLIER -76.09 -28.69 57.65 Favored 'General case' 0 C--O 1.224 -0.237 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.294 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -55.88 -46.53 78.29 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.066 -1.021 . . . . 0.0 108.274 173.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.9 ttt85 -76.8 -35.46 57.61 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 118.506 -0.759 . . . . 0.0 112.302 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -126.56 113.0 16.19 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 116.897 -1.525 . . . . 0.0 109.171 178.391 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -176.03 176.91 1.69 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 121.375 1.898 . . . . 0.0 109.117 178.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -50.99 158.36 0.71 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.957 1.303 . . . . 0.0 107.668 173.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -43.73 -32.93 1.12 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.722 2.409 . . . . 0.0 113.735 -173.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 47.8 ttp85 -57.98 -11.23 2.26 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 116.754 -1.593 . . . . 0.0 115.274 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.67 -66.85 0.02 OUTLIER Pre-proline 0 N--CA 1.47 0.535 0 CA-C-N 121.732 2.06 . . . . 0.0 114.564 174.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -75.83 -71.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.593 0 CA-C-N 122.586 1.959 . . . . 0.0 113.14 -173.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.01 113.62 14.91 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.622 0.769 . . . . 0.0 110.04 -173.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 94.3 mt -109.4 119.37 48.45 Favored Pre-proline 0 C--N 1.325 -0.498 0 C-N-CA 127.122 2.169 . . . . 0.0 105.903 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -74.33 155.91 46.15 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 121.782 1.655 . . . . 0.0 109.486 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.3 p -41.54 -41.77 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 126.66 1.984 . . . . 0.0 112.598 174.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -56.25 -42.4 77.32 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 126.896 2.078 . . . . 0.0 113.099 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.2 mm -74.53 112.86 12.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 101.642 -3.466 . . . . 0.0 101.642 173.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -76.55 -36.11 57.83 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . 0.253 4.2 m -148.99 161.83 41.12 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.195 1.398 . . . . 0.0 109.933 -173.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -117.7 145.65 44.27 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 172.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 44.9 m-20 -94.12 146.82 23.7 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 174.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -136.09 153.77 51.21 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 102.528 -3.138 . . . . 0.0 102.528 172.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.1 m -139.5 133.66 31.18 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -177.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -145.02 166.76 24.41 Favored 'General case' 0 C--O 1.238 0.496 0 O-C-N 122.056 -0.403 . . . . 0.0 111.158 177.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.24 158.22 13.94 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 124.866 1.266 . . . . 0.0 110.349 174.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -97.73 168.44 10.33 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 173.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.21 96.15 10.53 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 120.157 -1.589 . . . . 0.0 110.526 -174.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 48.74 -58.54 0.0 OUTLIER Glycine 0 CA--C 1.536 1.363 1 C-N-CA 131.783 4.516 . . . . 0.0 119.544 173.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -117.08 -15.66 10.52 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.446 2.123 . . . . 0.0 115.783 173.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.33 37.18 0.2 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 129.231 3.012 . . . . 0.0 115.998 -173.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -39.02 113.43 0.31 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 121.621 2.009 . . . . 0.0 110.031 -173.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -89.91 130.16 36.17 Favored 'General case' 0 CA--C 1.522 -0.106 0 C-N-CA 125.147 1.379 . . . . 0.0 107.62 175.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -84.6 150.95 24.84 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -137.76 160.87 38.05 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 119.913 1.233 . . . . 0.0 110.815 174.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.484 ' O ' HD13 ' A' ' 131' ' ' ILE . 28.5 tt0 -153.56 138.75 17.43 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 173.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.417 ' CD2' HD23 ' A' ' 82' ' ' LEU . 68.8 m-85 -86.12 103.45 14.79 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tt -70.81 -41.99 70.84 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.627 1.171 . . . . 0.0 108.123 174.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.2 m -138.61 135.7 35.21 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.634 1.174 . . . . 0.0 111.397 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.541 HD22 HG22 ' A' ' 128' ' ' VAL . 0.1 OUTLIER -164.97 93.13 0.61 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 102.169 -3.271 . . . . 0.0 102.169 173.194 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.412 ' HD3' ' H ' ' A' ' 82' ' ' LEU . 0.1 OUTLIER -161.43 154.14 20.52 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 120.821 -1.175 . . . . 0.0 110.76 -174.037 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.3 t -73.14 165.31 25.29 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.36 0.6 . . . . 0.0 109.628 173.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.5 mt -120.49 -21.87 6.65 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 116.505 -1.712 . . . . 0.0 110.764 173.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -99.35 164.89 11.93 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-O 123.935 1.826 . . . . 0.0 108.407 173.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.4 mmtm -136.71 -27.24 1.03 Allowed 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 129.255 3.022 . . . . 0.0 112.315 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.31 -63.85 3.86 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 106.67 -2.572 . . . . 0.0 106.67 172.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.417 ' O ' HG22 ' A' ' 89' ' ' ILE . 3.7 mp -81.87 26.7 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 128.934 2.894 . . . . 0.0 110.855 174.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 2.8 ttp -43.06 128.24 4.39 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 125.107 2.385 . . . . 0.0 112.734 -173.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.557 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -150.65 146.98 26.84 Favored 'General case' 0 N--CA 1.427 -1.606 1 C-N-CA 135.435 5.494 . . . . 0.0 101.263 174.091 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -136.73 117.0 10.87 Favored Pre-proline 0 C--N 1.318 -0.802 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 177.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -68.31 159.81 51.68 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.977 2.451 . . . . 0.0 113.932 -173.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 21.7 p -138.58 161.86 36.02 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.89 2.076 . . . . 0.0 109.031 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.5 m -126.37 154.73 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.195 0.998 . . . . 0.0 111.784 174.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -80.17 10.11 4.82 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 127.522 2.329 . . . . 0.0 113.468 177.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.9 m -140.49 163.18 45.12 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 124.54 1.136 . . . . 0.0 109.72 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -66.67 161.91 39.55 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 121.454 1.436 . . . . 0.0 109.567 173.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -64.58 -12.25 43.22 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 124.232 1.013 . . . . 0.0 112.644 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -145.16 165.1 29.29 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.974 1.31 . . . . 0.0 108.023 173.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 161.08 -161.12 32.68 Favored Glycine 0 C--O 1.227 -0.286 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 68.5 p -119.06 148.21 43.28 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 173.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.0 t -80.12 113.41 38.29 Favored Pre-proline 0 N--CA 1.447 -0.608 0 N-CA-C 102.15 -3.278 . . . . 0.0 102.15 173.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -84.33 165.64 12.61 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.585 1.523 . . . . 0.0 114.647 -173.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -77.43 3.68 12.75 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 120.687 -1.258 . . . . 0.0 114.341 -173.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.67 134.09 55.23 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 173.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.86 110.84 0.46 Allowed 'General case' 0 C--O 1.231 0.13 0 C-N-CA 124.785 1.234 . . . . 0.0 108.664 176.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.2 m -118.78 140.29 50.19 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.3 t -94.98 114.81 32.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 124.156 0.983 . . . . 0.0 109.941 -173.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 77.7 t -93.84 103.48 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 103.342 -2.836 . . . . 0.0 103.342 173.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -89.26 125.37 35.07 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 173.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.5 t -95.39 113.68 30.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 103.939 -2.615 . . . . 0.0 103.939 173.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -94.17 144.77 17.32 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.477 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 6.2 m-85 -129.22 73.89 81.39 Favored Pre-proline 0 C--O 1.243 0.724 0 CA-C-N 117.903 0.851 . . . . 0.0 110.495 -174.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.09 122.47 9.78 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 N-CA-C 107.928 -1.605 . . . . 0.0 107.928 173.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.557 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 5.9 t -105.75 153.13 22.3 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 124.703 1.201 . . . . 0.0 107.97 173.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.7 mt -81.42 -10.27 59.55 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.371 0.532 . . . . 0.0 112.011 -175.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 54.21 42.73 73.63 Favored Glycine 0 C--O 1.222 -0.643 0 C-N-CA 126.78 2.133 . . . . 0.0 114.759 173.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -126.89 -29.99 2.78 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.592 1.696 . . . . 0.0 113.307 173.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -96.31 153.55 17.75 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 104.764 -2.31 . . . . 0.0 104.764 172.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -108.73 143.44 37.85 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 177.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 141.83 -154.86 25.1 Favored Glycine 0 C--N 1.334 0.435 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.0 t -130.38 113.91 27.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 123.398 0.679 . . . . 0.0 109.36 -177.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -88.88 168.82 12.1 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 173.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -127.22 160.53 31.01 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.729 0.812 . . . . 0.0 109.827 173.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.477 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 12.7 p90 -146.93 152.31 38.46 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.792 0.837 . . . . 0.0 109.51 173.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -112.23 150.23 31.18 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 127.102 2.161 . . . . 0.0 112.144 -173.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.541 HG22 HD22 ' A' ' 82' ' ' LEU . 95.3 t -139.17 141.33 36.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 124.815 1.246 . . . . 0.0 109.619 173.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -155.78 119.25 4.38 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 127.654 2.382 . . . . 0.0 105.436 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.406 ' H ' ' HB ' ' A' ' 143' ' ' THR . 45.1 t -129.45 125.28 61.45 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 179.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.484 HD13 ' O ' ' A' ' 78' ' ' GLU . 0.1 OUTLIER -92.56 161.52 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 173.86 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.9 t -137.52 135.12 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 -177.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.81 174.44 10.57 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 124.821 1.249 . . . . 0.0 108.355 -176.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -89.97 176.18 6.9 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 172.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.3 t -66.04 -3.68 5.85 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 120.233 -1.542 . . . . 0.0 113.765 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -89.71 -14.61 34.34 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 120.625 1.557 . . . . 0.0 110.612 173.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.62 0.46 64.59 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.581 1.086 . . . . 0.0 112.107 -173.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -69.74 115.77 9.36 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.507 1.653 . . . . 0.0 108.302 174.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -68.9 143.69 54.41 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.684 1.594 . . . . 0.0 108.821 -175.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -140.02 -37.73 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.667 1.187 . . . . 0.0 113.761 -174.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -132.78 149.14 52.31 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 10.0 tm0? -147.85 148.69 31.14 Favored 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 120.99 -1.069 . . . . 0.0 108.649 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.406 ' HB ' ' H ' ' A' ' 130' ' ' VAL . 27.1 m -80.2 113.29 37.58 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 175.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.33 146.09 79.67 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 CA-C-N 120.071 1.061 . . . . 0.0 110.856 -173.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -78.61 112.63 15.88 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 -173.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.488 28.2 m-80 172.49 -21.07 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 1 C-N-CA 136.276 5.831 . . . . 0.0 111.376 173.543 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -56.66 91.85 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.346 2.258 . . . . 0.0 110.355 176.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.6 mt -136.4 149.79 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.415 ' CD1' ' CZ ' ' A' ' 126' ' ' PHE . 0.8 OUTLIER -128.22 169.48 14.11 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 174.195 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -133.9 113.76 12.56 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.177 1.391 . . . . 0.0 107.523 -173.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 51.6 tttt -101.05 122.4 43.49 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 120.097 1.317 . . . . 0.0 109.173 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.6 m -83.52 118.39 23.75 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 173.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 20.3 m -114.55 165.22 12.99 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 173.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.4 pp -141.14 161.67 37.3 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.525 1.13 . . . . 0.0 108.666 174.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -74.67 126.82 31.66 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 128.447 2.699 . . . . 0.0 111.307 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -139.77 168.45 19.79 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 126.517 1.927 . . . . 0.0 108.989 173.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 . . . . . 0 C--O 1.247 0.921 0 C-N-CA 131.035 3.734 . . . . 0.0 104.629 174.116 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.137 0 N-CA-C 106.823 -2.511 . . . . 0.0 106.823 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 m -52.86 176.69 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 122.813 0.445 . . . . 0.0 110.42 136.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -55.75 171.06 0.24 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.534 0.734 . . . . 0.0 109.512 173.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 8.6 ttm -58.68 152.52 18.53 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 174.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.11 176.58 8.58 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 129.569 3.147 . . . . 0.0 105.992 176.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -44.15 113.49 0.54 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.976 2.11 . . . . 0.0 110.376 -173.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -164.26 145.76 8.57 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 129.375 3.07 . . . . 0.0 103.363 -174.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -147.24 175.8 10.47 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 127.57 2.348 . . . . 0.0 108.755 173.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 27.7 mp0 -74.82 168.35 20.05 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 129.223 3.009 . . . . 0.0 112.509 -173.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -82.14 175.49 10.27 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.053 1.341 . . . . 0.0 109.725 173.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m -170.73 177.02 4.02 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 127.604 2.361 . . . . 0.0 110.822 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.0 tt -43.52 128.6 5.11 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 127.816 2.446 . . . . 0.0 112.435 -174.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -115.28 133.83 55.68 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.739 1.615 . . . . 0.0 108.822 173.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.56 120.85 10.22 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.2 p90 -135.15 170.88 15.24 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 119.201 0.91 . . . . 0.0 109.32 175.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mt -106.39 113.79 43.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 101.798 -3.408 . . . . 0.0 101.798 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -76.28 148.29 37.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 123.299 1.523 . . . . 0.0 113.373 -173.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.37 -22.4 66.09 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 113.388 -1.733 . . . . 0.0 114.84 -173.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -57.62 -38.67 75.35 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 119.448 1.022 . . . . 0.0 109.859 -177.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -69.3 -44.93 70.77 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 122.36 -0.212 . . . . 0.0 111.156 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.598 ' HA ' HD12 ' A' ' 24' ' ' LEU . . . -60.08 -31.28 69.87 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 119.118 -0.468 . . . . 0.0 112.006 173.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 38.2 ttm-85 -58.39 -54.96 41.13 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 173.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.6 t -52.99 -23.79 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.095 0.958 . . . . 0.0 111.914 175.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.598 HD12 ' HA ' ' A' ' 21' ' ' ALA . 10.5 mt -78.46 -42.21 30.52 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 174.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.7 pt -146.81 16.07 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 117.247 2.314 . . . . 0.0 117.247 -172.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.22 6.29 10.0 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 128.522 2.963 . . . . 0.0 115.339 -175.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -101.25 176.25 5.31 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 128.532 2.733 . . . . 0.0 109.594 -173.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -125.56 116.51 21.86 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 123.166 0.586 . . . . 0.0 109.452 -178.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -161.17 124.85 3.34 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.183 1.793 . . . . 0.0 109.787 175.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -92.7 174.38 7.29 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.777 1.631 . . . . 0.0 106.964 173.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.2 mt -140.77 113.49 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 172.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.66 117.53 20.66 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -177.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.46 HG23 ' CD1' ' A' ' 42' ' ' PHE . 21.6 mt -89.96 -66.32 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 119.178 0.899 . . . . 0.0 108.825 177.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -111.92 116.47 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.541 1.536 . . . . 0.0 107.447 -173.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.5 p -112.47 116.08 29.7 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 173.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.287 2.8 pm0 45.29 40.2 4.99 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.813 1.645 . . . . 0.0 112.813 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.44 -30.7 1.42 Allowed Glycine 0 CA--C 1.544 1.906 0 C-N-CA 125.652 1.596 . . . . 0.0 114.101 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . 0.434 7.3 tmtt? -61.94 38.02 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.768 1 C-N-CA 138.838 6.855 . . . . 0.0 112.708 173.761 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 33.0 mtm -37.51 139.23 0.29 Allowed 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 126.69 1.996 . . . . 0.0 115.527 -172.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.42 164.49 43.52 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 112.673 -2.058 . . . . 0.0 108.964 173.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.27 32.69 0.31 Allowed 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 124.039 3.16 . . . . 0.0 112.395 174.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.46 ' CD1' HG23 ' A' ' 33' ' ' ILE . 12.5 p90 -52.91 -26.15 14.01 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.816 2.047 . . . . 0.0 111.843 -174.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.6 m -57.65 -30.31 65.31 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.038 1.735 . . . . 0.0 109.974 -174.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -56.44 -62.83 1.45 Allowed 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.501 1.121 . . . . 0.0 108.968 173.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -68.31 -25.41 65.11 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.397 1.079 . . . . 0.0 111.989 -174.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -72.37 -49.12 36.37 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.036 0.534 . . . . 0.0 110.026 174.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.518 ' CZ ' ' HA ' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -76.77 -23.21 52.93 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 124.811 1.244 . . . . 0.0 111.883 -174.06 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.7 ttpm? -63.45 177.14 0.71 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.032 1.733 . . . . 0.0 111.806 -174.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.03 176.66 0.3 Allowed 'General case' 0 CA--C 1.546 0.806 0 O-C-N 120.119 -1.613 . . . . 0.0 109.635 173.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -43.61 121.51 2.34 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.645 1.578 . . . . 0.0 109.767 -174.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -152.87 -66.69 0.16 Allowed 'General case' 0 CA--C 1.533 0.292 0 O-C-N 123.797 0.686 . . . . 0.0 109.353 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -154.4 -16.87 0.13 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.573 ' H ' ' CD ' ' A' ' 54' ' ' PRO . 63.7 mmm -123.31 -35.82 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 125.402 1.481 . . . . 0.0 113.688 -177.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.573 ' CD ' ' H ' ' A' ' 53' ' ' MET . 79.0 Cg_endo -78.12 -98.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.881 1.721 . . . . 0.0 110.118 -173.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.24 124.79 24.09 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.213 -0.93 . . . . 0.0 109.748 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.5 mt -130.94 138.03 32.08 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 128.81 2.844 . . . . 0.0 106.842 -174.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -81.34 157.43 19.63 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.702 2.268 . . . . 0.0 111.655 174.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.3 p -42.94 -41.47 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 127.257 2.223 . . . . 0.0 112.908 174.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -58.25 -34.36 70.38 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 126.65 1.98 . . . . 0.0 113.077 -175.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.7 mm -71.62 112.89 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 102.863 -3.014 . . . . 0.0 102.863 174.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -95.48 -23.42 17.12 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 -177.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.6 m -149.8 166.03 30.69 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 125.118 1.367 . . . . 0.0 107.548 173.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 13.9 mmm -123.13 163.29 20.86 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 173.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -117.96 150.5 39.15 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 173.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -139.52 153.5 47.48 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 102.101 -3.296 . . . . 0.0 102.101 172.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.3 m -138.63 132.91 31.69 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -176.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -145.1 161.56 39.17 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.184 177.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -165.89 145.14 6.18 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 123.937 0.895 . . . . 0.0 110.689 173.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.71 177.2 7.76 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 173.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.19 99.81 10.55 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 125.281 1.432 . . . . 0.0 110.136 -173.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 47.3 -56.27 0.0 OUTLIER Glycine 0 CA--C 1.536 1.386 1 C-N-CA 132.613 4.911 . . . . 0.0 119.396 174.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -117.01 -16.53 10.5 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.518 2.159 . . . . 0.0 115.706 173.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.31 37.11 0.38 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 128.56 2.744 . . . . 0.0 116.92 -173.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -46.36 113.87 0.71 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 122.01 2.187 . . . . 0.0 110.549 -177.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -83.83 145.95 28.38 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 125.341 1.456 . . . . 0.0 107.51 174.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -94.05 150.89 19.93 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -133.8 160.18 38.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 119.869 1.213 . . . . 0.0 111.165 175.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.469 ' O ' HD13 ' A' ' 131' ' ' ILE . 29.5 tt0 -154.13 138.4 16.62 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 173.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -86.43 103.68 15.21 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.896 1.279 . . . . 0.0 109.025 -177.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.9 tt -68.3 -41.78 80.44 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.792 1.237 . . . . 0.0 107.862 175.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.4 m -136.88 141.34 42.76 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.096 0.958 . . . . 0.0 111.847 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.4 tt -171.27 92.99 0.16 Allowed 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 128.755 2.822 . . . . 0.0 104.579 173.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -162.32 149.86 14.03 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 118.501 -0.761 . . . . 0.0 109.994 -174.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.432 ' HB2' ' HA ' ' A' ' 92' ' ' ASP . 5.8 t -91.98 134.12 35.09 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 119.593 1.088 . . . . 0.0 109.843 173.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 71.2 mt -82.26 -26.32 33.29 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 116.314 -1.803 . . . . 0.0 110.788 177.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.405 ' OD2' HD12 ' A' ' 89' ' ' ILE . 28.3 t0 -93.94 144.96 24.98 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 121.155 1.798 . . . . 0.0 109.485 174.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.46 ' HE3' ' SD ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -113.94 -24.53 9.03 Favored 'General case' 0 N--CA 1.443 -0.796 1 C-N-CA 133.653 4.781 . . . . 0.0 113.822 178.35 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -71.14 -69.93 1.3 Allowed Glycine 0 CA--C 1.533 1.211 0 N-CA-C 107.12 -2.392 . . . . 0.0 107.12 173.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.407 HG22 ' O ' ' A' ' 89' ' ' ILE . 3.3 mp -78.48 26.3 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 128.579 2.752 . . . . 0.0 110.994 175.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.46 ' SD ' ' HE3' ' A' ' 87' ' ' LYS . 6.7 ttp -43.16 125.18 3.57 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.79 2.436 . . . . 0.0 111.247 -173.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -161.35 113.48 1.83 Allowed 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 101.272 -3.603 . . . . 0.0 101.272 -175.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.432 ' HA ' ' HB2' ' A' ' 84' ' ' SER 0.313 1.6 m-20 -112.97 127.45 26.82 Favored Pre-proline 0 C--N 1.319 -0.721 0 O-C-N 124.372 1.045 . . . . 0.0 110.913 -173.372 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.09 154.02 71.05 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 121.733 1.622 . . . . 0.0 110.318 -174.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 18.4 p -139.16 162.93 33.75 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.453 1.501 . . . . 0.0 108.482 174.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.0 m -126.5 150.39 32.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 123.829 0.852 . . . . 0.0 110.696 173.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -86.03 17.85 3.33 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.501 1.52 . . . . 0.0 111.463 173.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.6 m -132.49 163.03 53.45 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 125.651 1.58 . . . . 0.0 107.011 173.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -67.33 162.41 38.84 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 120.754 0.969 . . . . 0.0 109.767 173.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -64.38 -12.89 47.35 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.361 1.065 . . . . 0.0 111.774 176.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -140.78 164.39 30.34 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.239 1.415 . . . . 0.0 107.89 173.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.17 -161.26 33.82 Favored Glycine 0 C--O 1.227 -0.332 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 75.4 p -119.0 155.1 31.98 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 173.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 24.5 t -90.43 113.27 56.96 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 103.414 -2.809 . . . . 0.0 103.414 173.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -88.95 171.76 4.66 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.541 2.16 . . . . 0.0 114.491 -173.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -81.98 3.04 28.03 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 -173.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.5 133.84 55.55 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 114.869 -2.491 . . . . 0.0 106.834 173.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -44.95 111.06 0.28 Allowed 'General case' 0 C--O 1.232 0.171 0 O-C-N 125.808 1.942 . . . . 0.0 107.757 173.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.3 m -116.72 137.41 52.21 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.4 t -93.87 120.88 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 O-C-N 124.692 1.245 . . . . 0.0 108.794 -173.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.3 t -93.91 103.72 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 N-CA-C 103.094 -2.928 . . . . 0.0 103.094 173.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -84.2 119.24 24.79 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 173.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.4 t -95.0 113.5 29.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 104.249 -2.5 . . . . 0.0 104.249 174.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -86.34 143.14 19.26 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.407 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 14.6 m-85 -128.34 73.5 80.07 Favored Pre-proline 0 C--O 1.245 0.844 0 CA-C-N 118.333 1.066 . . . . 0.0 110.814 -178.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.55 120.33 7.28 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.332 2.021 . . . . 0.0 109.282 173.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 12.8 t -98.95 148.66 23.75 Favored 'General case' 0 C--N 1.342 0.276 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 173.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.3 mt -76.77 -13.52 60.01 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 117.88 0.309 . . . . 0.0 111.043 178.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 51.31 40.56 45.79 Favored Glycine 0 C--O 1.22 -0.765 0 C-N-CA 127.868 2.651 . . . . 0.0 115.137 173.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . 0.262 42.1 mttm -123.09 -29.67 3.86 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.847 1.824 . . . . 0.0 112.71 173.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -96.46 149.41 21.76 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 172.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -102.12 149.45 24.26 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 176.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.4 -154.56 23.59 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.7 t -128.78 113.83 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.01 166.04 15.37 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 173.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -123.81 145.02 49.36 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.715 1.206 . . . . 0.0 108.538 174.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.407 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 37.5 p90 -140.66 142.78 34.92 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 119.321 0.964 . . . . 0.0 110.317 174.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -104.07 144.79 31.09 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 126.768 2.027 . . . . 0.0 111.36 -173.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.0 t -140.05 139.12 37.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 173.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -155.15 130.6 9.75 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.906 1.682 . . . . 0.0 106.987 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.4 t -135.94 129.5 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -175.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.609 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -97.9 165.75 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 173.737 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.7 t -143.31 134.7 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 -174.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.01 174.35 10.66 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.876 1.27 . . . . 0.0 108.286 -175.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -89.95 176.13 6.92 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 104.667 -2.346 . . . . 0.0 104.667 172.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.1 t -66.2 -4.02 6.84 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 120.356 -1.465 . . . . 0.0 113.685 -177.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -89.34 -14.88 34.66 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 120.572 1.533 . . . . 0.0 110.657 173.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.04 0.42 63.67 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.591 1.091 . . . . 0.0 112.039 -173.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -69.57 115.51 8.9 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 119.494 1.647 . . . . 0.0 108.357 174.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -69.09 143.51 54.18 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.786 1.634 . . . . 0.0 108.81 -175.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -140.61 -37.29 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.62 1.168 . . . . 0.0 113.598 -174.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -130.5 145.43 51.85 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -143.98 136.06 26.49 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 91.7 m -66.87 128.03 93.71 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 174.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.41 143.4 43.02 Favored 'Trans proline' 0 N--CA 1.444 -1.436 0 CA-C-N 120.606 1.252 . . . . 0.0 109.122 -177.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -81.75 112.97 19.39 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 -174.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 173.17 -19.59 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.572 1 C-N-CA 135.116 5.366 . . . . 0.0 110.942 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.39 83.95 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.837 1.655 . . . . 0.0 111.4 -175.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.4 mt -125.21 135.57 63.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 175.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.401 ' HB2' ' CZ ' ' A' ' 126' ' ' PHE . 6.3 m-85 -106.32 161.94 14.11 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 125.911 1.684 . . . . 0.0 106.722 177.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -136.41 113.3 10.35 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 55.0 tttt -99.3 122.43 42.44 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 21.4 m -83.61 115.13 21.99 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 105.299 -2.112 . . . . 0.0 105.299 173.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 36.9 m -111.21 165.92 11.52 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 119.196 0.907 . . . . 0.0 109.192 173.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.5 pp -141.35 160.14 40.75 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.178 1.391 . . . . 0.0 107.694 173.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.99 131.11 43.87 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.795 1.238 . . . . 0.0 111.669 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -144.33 169.92 16.99 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 128.008 2.523 . . . . 0.0 107.693 173.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 . . . . . 0 C--O 1.255 1.385 0 C-N-CA 128.925 2.89 . . . . 0.0 106.057 173.857 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.628 0 N-CA-C 106.088 -2.805 . . . . 0.0 106.088 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.5 m -65.69 166.89 10.04 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 150.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -80.28 114.1 18.94 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 173.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -99.45 176.69 5.42 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.176 0.99 . . . . 0.0 111.282 -174.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.427 HD23 ' H ' ' A' ' 5' ' ' LEU . 1.8 pt? -129.56 176.42 8.0 Favored 'General case' 0 CA--C 1.545 0.784 1 C-N-CA 134.889 5.275 . . . . 0.0 101.805 172.917 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -59.39 112.55 1.79 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 121.296 1.862 . . . . 0.0 108.467 -173.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.14 176.27 1.4 Allowed 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 131.153 3.781 . . . . 0.0 102.689 -174.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -114.81 176.07 5.22 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 127.054 2.141 . . . . 0.0 109.391 173.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -134.28 175.17 9.74 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 127.106 2.162 . . . . 0.0 105.944 173.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -141.74 174.39 10.62 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.882 1.673 . . . . 0.0 108.105 173.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.6 m -175.86 177.0 1.74 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.508 2.723 . . . . 0.0 109.863 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.9 tt -43.32 129.85 4.89 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 129.335 3.054 . . . . 0.0 113.285 -175.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -115.1 139.6 49.75 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.18 2.192 . . . . 0.0 108.441 173.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.25 117.97 6.19 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 126.05 1.74 . . . . 0.0 106.693 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 13.7 p90 -131.02 176.06 8.57 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.296 1.039 . . . . 0.0 110.083 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.5 mt -113.06 113.91 45.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 102.418 -3.179 . . . . 0.0 102.418 174.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -76.89 139.21 40.15 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 123.069 1.414 . . . . 0.0 111.967 -173.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.19 -25.54 61.7 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.276 1.83 . . . . 0.0 114.367 -173.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 13.6 m80 -56.53 -37.3 70.29 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 118.978 0.808 . . . . 0.0 110.018 -174.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 49.1 tp60 -66.83 -41.31 87.66 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 121.992 -0.443 . . . . 0.0 111.067 178.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.672 ' HA ' HD12 ' A' ' 24' ' ' LEU . . . -64.4 -35.4 80.77 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 121.683 -0.636 . . . . 0.0 110.904 173.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.3 -57.26 13.02 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 173.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.0 t -51.51 -27.72 7.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.712 1.205 . . . . 0.0 111.424 177.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.672 HD12 ' HA ' ' A' ' 21' ' ' ALA . 6.2 mt -71.16 -47.6 56.75 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 117.729 -1.129 . . . . 0.0 113.404 175.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.4 pt -154.56 14.66 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 -172.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.95 13.25 75.68 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 125.338 1.447 . . . . 0.0 113.314 -174.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -101.37 143.27 31.61 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 126.822 2.049 . . . . 0.0 106.849 -176.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -128.64 117.6 21.49 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.696 1.134 . . . . 0.0 109.673 -173.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -165.85 136.49 3.62 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 130.681 3.592 . . . . 0.0 107.507 174.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -86.45 176.21 7.98 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.093 1.757 . . . . 0.0 107.823 173.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.0 mp -137.54 113.1 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 173.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.52 115.23 26.79 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -176.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.5 mt -94.66 -53.94 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 118.635 0.652 . . . . 0.0 110.065 -176.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.464 HG22 ' HG2' ' A' ' 39' ' ' MET . 6.2 t -126.15 129.99 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 125.68 1.592 . . . . 0.0 107.703 -173.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.0 p -138.4 132.94 32.22 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 103.165 -2.902 . . . . 0.0 103.165 173.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.31 18.0 pm0 44.33 33.73 0.91 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.151 1.38 . . . . 0.0 113.796 -174.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.54 -4.17 14.87 Favored Glycine 0 CA--C 1.543 1.813 0 O-C-N 120.652 -1.28 . . . . 0.0 115.135 -176.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.469 ' HZ3' ' HB3' ' A' ' 38' ' ' LYS . 4.3 ttpm? -66.4 37.41 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.596 1 C-N-CA 132.467 4.307 . . . . 0.0 114.222 -176.74 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.464 ' HG2' HG22 ' A' ' 34' ' ' VAL . 31.4 mtt -38.07 114.33 0.35 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 120.183 1.356 . . . . 0.0 113.742 -173.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.56 164.79 29.19 Favored Pre-proline 0 N--CA 1.447 -0.599 0 CA-C-N 113.777 -1.556 . . . . 0.0 107.977 173.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.84 40.9 0.59 Allowed 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 124.215 3.276 . . . . 0.0 111.002 173.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -52.27 -26.26 11.46 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 127.913 2.485 . . . . 0.0 112.603 -173.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.9 m -44.01 -43.72 6.87 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.152 1.781 . . . . 0.0 111.619 177.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -60.81 -66.05 0.59 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.427 0.691 . . . . 0.0 110.191 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.598 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 49.3 m-20 -73.98 -23.01 59.4 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.155 1.782 . . . . 0.0 114.062 -173.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -77.89 -56.81 4.19 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 124.669 1.187 . . . . 0.0 110.229 173.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 18.5 ttp180 -69.71 -32.57 71.23 Favored 'General case' 0 C--N 1.345 0.386 0 O-C-N 121.657 -0.652 . . . . 0.0 109.873 -173.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.02 113.53 24.9 Favored 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 103.101 -2.926 . . . . 0.0 103.101 173.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.598 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -158.83 176.07 12.8 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 120.015 1.279 . . . . 0.0 111.286 -174.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -66.93 164.37 17.7 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 172.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.3 tm0? -48.4 -25.46 1.64 Allowed 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -174.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.406 ' HA ' HD13 ' A' ' 24' ' ' LEU . 23.8 ttm180 -52.19 -16.31 0.78 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.068 1.747 . . . . 0.0 114.97 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 61.1 mmm -130.69 -66.12 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.467 0 CA-C-N 121.132 1.787 . . . . 0.0 115.079 -175.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.492 ' HD3' ' HB3' ' A' ' 49' ' ' ALA . 37.1 Cg_endo -68.24 -74.21 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.195 1.93 . . . . 0.0 111.82 -173.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.73 113.42 14.36 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -174.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 62.9 mt -113.16 126.75 27.74 Favored Pre-proline 0 C--N 1.324 -0.536 0 C-N-CA 127.734 2.413 . . . . 0.0 105.803 -174.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -78.46 157.29 28.94 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 121.691 1.594 . . . . 0.0 110.356 176.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.4 p -45.7 -38.74 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 125.849 1.66 . . . . 0.0 111.975 173.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -55.91 -40.08 72.56 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 126.677 1.991 . . . . 0.0 112.832 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mm -77.11 112.73 15.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 101.914 -3.365 . . . . 0.0 101.914 173.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -79.92 -40.67 27.7 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 174.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.8 m -141.51 161.75 37.16 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.609 1.164 . . . . 0.0 110.053 -173.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 52.8 mtp -123.68 167.47 13.94 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.426 1.49 . . . . 0.0 107.092 173.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -114.03 155.85 25.17 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 174.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -140.75 151.54 44.54 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 130.489 3.516 . . . . 0.0 102.268 172.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.3 m -137.97 133.85 34.19 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -145.42 162.38 37.44 Favored 'General case' 0 C--O 1.238 0.473 0 O-C-N 121.857 -0.527 . . . . 0.0 111.198 178.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -167.36 153.36 7.78 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.969 0.89 . . . . 0.0 112.484 173.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.3 -173.65 4.83 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.333 1.453 . . . . 0.0 109.174 173.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.85 100.11 7.04 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.789 1.635 . . . . 0.0 108.324 -174.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.07 -63.29 0.0 OUTLIER Glycine 0 CA--C 1.538 1.522 0 C-N-CA 130.184 3.754 . . . . 0.0 119.016 173.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -116.88 -13.78 10.69 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 120.583 2.191 . . . . 0.0 114.113 173.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.59 37.1 0.17 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 129.136 2.975 . . . . 0.0 118.021 -173.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -53.58 113.68 1.26 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 122.873 2.579 . . . . 0.0 109.672 -177.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -84.06 129.95 34.89 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 126.187 1.795 . . . . 0.0 107.935 174.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -79.85 147.67 31.65 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -132.56 161.26 34.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 120.127 1.33 . . . . 0.0 111.182 176.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.503 ' O ' HD13 ' A' ' 131' ' ' ILE . 31.7 tt0 -152.71 137.24 16.8 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 173.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -81.68 104.08 11.83 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.635 1.174 . . . . 0.0 109.91 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.7 tt -67.36 -41.72 84.65 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.43 1.092 . . . . 0.0 108.114 174.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.8 m -133.87 141.29 47.33 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.881 0.872 . . . . 0.0 111.202 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.3 tt -171.95 93.07 0.14 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 104.15 -2.537 . . . . 0.0 104.15 173.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -162.18 156.73 22.17 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.024 0.829 . . . . 0.0 111.416 -173.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.6 t -75.99 161.95 28.48 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 173.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.6 mt -122.1 -26.33 4.75 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 116.99 -1.481 . . . . 0.0 112.045 174.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.422 ' CG ' ' H ' ' A' ' 87' ' ' LYS . 23.2 t0 -83.3 168.11 16.98 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 121.34 1.882 . . . . 0.0 111.604 177.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.422 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -111.3 -49.32 3.02 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 128.533 2.733 . . . . 0.0 112.501 179.099 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.84 -70.19 1.16 Allowed Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 174.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mp -79.75 18.63 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 128.786 2.834 . . . . 0.0 110.048 -174.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -43.93 134.11 4.68 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 127.061 2.144 . . . . 0.0 110.239 -175.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -157.51 113.76 2.89 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 126.118 1.767 . . . . 0.0 106.916 -173.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -97.34 132.43 25.46 Favored Pre-proline 0 C--N 1.324 -0.541 0 O-C-N 124.142 0.901 . . . . 0.0 109.876 -173.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.01 153.81 67.42 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 C-N-CA 121.409 1.406 . . . . 0.0 109.347 174.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 21.1 p -140.11 157.09 46.17 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 126.682 1.993 . . . . 0.0 107.439 174.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.9 m -126.33 153.66 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 119.648 1.113 . . . . 0.0 113.145 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -73.83 7.94 2.26 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 127.567 2.347 . . . . 0.0 113.647 174.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.6 m -140.75 164.89 33.44 Favored Pre-proline 0 C--N 1.326 -0.452 0 C-N-CA 125.648 1.579 . . . . 0.0 108.286 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -67.18 167.61 19.71 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 121.347 1.365 . . . . 0.0 110.937 174.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -63.22 -11.37 20.63 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.786 1.235 . . . . 0.0 112.119 175.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -145.07 164.3 31.64 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.22 1.408 . . . . 0.0 107.884 173.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.33 -161.74 34.28 Favored Glycine 0 C--O 1.227 -0.342 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 71.4 p -117.86 151.19 37.86 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.5 t -88.69 113.37 55.44 Favored Pre-proline 0 N--CA 1.448 -0.542 0 N-CA-C 102.84 -3.022 . . . . 0.0 102.84 173.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -90.09 160.02 4.83 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.803 2.336 . . . . 0.0 111.424 -173.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -74.18 4.44 5.65 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 119.753 -1.842 . . . . 0.0 113.3 -173.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -115.54 116.85 28.87 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 126.259 1.824 . . . . 0.0 106.736 -173.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -43.06 105.37 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 125.039 1.336 . . . . 0.0 109.755 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.3 m -112.02 136.0 51.94 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.0 t -95.68 116.09 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.05 -173.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 82.5 t -93.76 103.27 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 N-CA-C 103.476 -2.787 . . . . 0.0 103.476 173.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.58 120.11 25.11 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 103.324 -2.843 . . . . 0.0 103.324 173.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.4 t -94.7 113.64 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 104.23 -2.507 . . . . 0.0 104.23 173.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -92.36 149.42 19.62 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 175.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.458 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 9.8 m-85 -131.13 73.64 80.42 Favored Pre-proline 0 C--O 1.242 0.7 0 CA-C-N 118.544 1.172 . . . . 0.0 110.422 -176.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -62.94 116.14 3.38 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.479 2.119 . . . . 0.0 109.309 173.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 9.2 t -93.67 147.67 22.81 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 173.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.4 mt -74.16 -13.48 60.81 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.134 0.425 . . . . 0.0 111.822 -176.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.8 34.3 89.57 Favored Glycine 0 C--N 1.34 0.804 0 C-N-CA 125.757 1.646 . . . . 0.0 114.352 173.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.7 mttm -114.9 -50.64 2.76 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.349 1.575 . . . . 0.0 112.442 -173.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 48.6 tp60 -96.06 147.49 23.66 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 173.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -93.93 142.12 27.74 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 175.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.72 -154.83 26.09 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-N 118.781 0.719 . . . . 0.0 111.649 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.6 t -129.96 116.73 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 123.846 0.858 . . . . 0.0 108.789 -179.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -92.42 175.3 6.89 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.15 1.38 . . . . 0.0 109.297 173.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -128.6 155.03 45.59 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.767 1.627 . . . . 0.0 107.386 173.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.458 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 40.3 p90 -147.05 157.84 43.74 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.576 1.15 . . . . 0.0 108.035 173.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -123.36 150.52 43.57 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.542 1.537 . . . . 0.0 111.909 -173.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 62.5 t -141.45 143.2 27.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 173.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -160.81 136.13 7.85 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.023 1.329 . . . . 0.0 107.687 174.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.7 t -136.79 139.26 45.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-N 119.51 1.05 . . . . 0.0 109.265 -173.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.542 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -106.9 163.64 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 173.743 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.6 t -141.74 137.81 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -173.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.31 174.12 10.89 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.542 1.537 . . . . 0.0 108.416 -176.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -88.84 175.8 7.32 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 172.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 6.1 t -65.1 -14.86 61.55 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 120.212 -1.555 . . . . 0.0 112.112 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -80.12 -3.3 48.25 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.73 1.612 . . . . 0.0 110.65 176.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.22 5.66 89.9 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 125.123 1.345 . . . . 0.0 112.996 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -80.92 118.19 22.2 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.5 m -64.71 143.07 58.19 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.434 1.493 . . . . 0.0 108.748 -178.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -140.07 -37.26 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.774 1.23 . . . . 0.0 113.626 -175.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -130.56 141.08 50.47 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -146.6 126.35 13.46 Favored 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 121.422 -0.799 . . . . 0.0 109.081 -176.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 30.3 m -67.52 142.68 96.47 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 173.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -83.59 147.55 12.4 Favored 'Trans proline' 0 N--CA 1.443 -1.477 0 N-CA-C 108.731 -1.296 . . . . 0.0 108.731 174.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -75.46 112.63 11.99 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 103.505 -2.776 . . . . 0.0 103.505 -178.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 173.73 -23.81 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 128.17 2.588 . . . . 0.0 112.17 -173.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.89 87.34 0.14 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 122.208 1.004 . . . . 0.0 108.428 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.9 mt -127.84 147.91 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -174.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 126' ' ' PHE . 0.5 OUTLIER -134.28 167.89 19.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 113.971 -1.468 . . . . 0.0 107.298 -176.783 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -135.33 113.5 11.3 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.175 0.99 . . . . 0.0 109.456 -173.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -104.22 122.43 45.36 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 119.435 1.016 . . . . 0.0 109.431 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 25.6 m -83.68 115.44 22.17 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 174.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 5.0 m -116.78 166.3 12.3 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.496 0.665 . . . . 0.0 110.163 174.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.3 pp -134.12 162.45 32.07 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.109 1.364 . . . . 0.0 107.539 173.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -73.57 114.72 12.13 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 127.738 2.415 . . . . 0.0 109.463 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -163.5 118.54 1.64 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.335 1.454 . . . . 0.0 109.79 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 . . . . . 0 C--O 1.256 1.416 0 C-N-CA 128.667 2.787 . . . . 0.0 105.914 173.743 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.131 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.7 t -60.85 176.16 0.42 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 117.985 0.892 . . . . 0.0 110.302 162.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -50.63 127.3 17.66 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.823 1.249 . . . . 0.0 111.296 -174.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 45.5 mtp -145.98 176.64 9.55 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 128.122 2.569 . . . . 0.0 107.651 -174.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.8 mt -113.24 127.48 56.18 Favored 'General case' 0 C--N 1.328 -0.343 1 N-CA-C 97.386 -5.042 . . . . 0.0 97.386 172.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -44.19 113.22 0.5 Allowed 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 -172.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.52 113.26 0.1 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 131.234 3.813 . . . . 0.0 101.373 173.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -120.55 114.09 21.23 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -173.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -126.44 159.52 33.08 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 126.796 2.038 . . . . 0.0 106.097 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -75.07 170.72 15.46 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 122.1 0.952 . . . . 0.0 111.396 176.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 m -175.53 175.72 2.07 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 129.925 3.29 . . . . 0.0 106.937 173.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.52 HD23 ' N ' ' A' ' 13' ' ' TYR . 5.5 tt -46.57 136.8 7.32 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.165 1.786 . . . . 0.0 112.788 -174.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.52 ' N ' HD23 ' A' ' 12' ' ' LEU . 54.6 m-85 -122.07 137.03 54.96 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.317 1.447 . . . . 0.0 110.249 175.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.79 119.12 6.38 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.57 1.548 . . . . 0.0 107.803 -178.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.462 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 30.9 p90 -142.84 148.08 36.47 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.641 1.109 . . . . 0.0 109.541 -178.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.0 mp -84.12 118.53 31.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 102.893 -3.003 . . . . 0.0 102.893 173.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.03 143.81 29.51 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 123.691 1.71 . . . . 0.0 114.313 -173.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.459 ' HB1' ' HG3' ' A' ' 28' ' ' GLU . . . -72.75 -26.11 61.44 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 112.774 -2.012 . . . . 0.0 113.636 -173.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.9 m80 -62.63 -38.25 89.52 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 122.926 0.49 . . . . 0.0 110.519 -173.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -71.54 -49.3 42.14 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.149 174.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.61 -43.06 56.74 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-O 118.404 -0.807 . . . . 0.0 111.218 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.0 ttp-105 -50.51 -64.91 0.66 Allowed 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 119.797 1.181 . . . . 0.0 108.452 173.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.2 t -51.27 -23.72 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.727 1.211 . . . . 0.0 111.679 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 75.6 mt -85.15 -37.49 20.13 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.3 pt -143.57 14.05 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 117.001 2.223 . . . . 0.0 117.001 -173.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.41 -1.75 0.62 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 129.761 3.553 . . . . 0.0 115.55 -174.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -101.97 143.04 32.33 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 129.192 2.997 . . . . 0.0 108.043 -177.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.459 ' HG3' ' HB1' ' A' ' 18' ' ' ALA . 36.5 tt0 -132.88 114.49 14.11 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.706 1.139 . . . . 0.0 111.039 -173.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -150.7 144.98 25.52 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.437 2.695 . . . . 0.0 106.383 173.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -96.03 164.83 12.54 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 173.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.2 mp -135.27 113.38 15.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 103.858 -2.645 . . . . 0.0 103.858 173.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.462 ' HG ' ' HB3' ' A' ' 15' ' ' TRP . 4.4 tt -94.62 114.07 25.97 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -173.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.6 mt -83.86 -61.75 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 124.349 1.06 . . . . 0.0 108.281 -174.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.455 HG11 HD22 ' A' ' 12' ' ' LEU . 25.1 t -117.1 113.66 43.46 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -173.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.4 p -111.92 125.93 54.58 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 102.616 -3.105 . . . . 0.0 102.616 173.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 46.08 38.2 4.56 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.148 1.379 . . . . 0.0 112.508 174.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 54.98 19.84 16.96 Favored Glycine 0 CA--C 1.539 1.58 0 C-N-CA 124.992 1.282 . . . . 0.0 113.824 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -122.97 37.97 4.29 Favored 'General case' 0 CA--C 1.536 0.434 1 C-N-CA 131.861 4.064 . . . . 0.0 108.051 -172.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.42 ' HG2' HG22 ' A' ' 34' ' ' VAL 0.272 20.2 mtp -37.29 146.71 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 130.762 3.625 . . . . 0.0 115.696 -172.508 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.72 162.07 75.12 Favored Pre-proline 0 N--CA 1.452 -0.368 0 CA-C-N 113.141 -1.845 . . . . 0.0 109.314 173.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.09 42.36 0.98 Allowed 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 124.552 3.501 . . . . 0.0 111.609 174.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -53.86 -26.58 25.32 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.647 1.979 . . . . 0.0 113.197 -174.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.5 m -58.25 -29.35 65.69 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 126.501 1.92 . . . . 0.0 111.434 -173.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 62.8 t60 -62.86 -66.48 0.54 Allowed 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 118.64 0.655 . . . . 0.0 109.346 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.63 -23.82 65.4 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -175.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -67.96 -47.62 68.14 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.68 1.192 . . . . 0.0 111.223 174.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.23 -25.59 15.75 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -173.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.6 176.55 1.89 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.129 1.771 . . . . 0.0 109.285 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -51.33 160.97 0.49 Allowed 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.561 -0.712 . . . . 0.0 109.508 173.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 5.3 tm0? -43.53 134.4 4.07 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.82 1.648 . . . . 0.0 113.706 -173.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -136.31 -66.85 0.53 Allowed 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 173.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -146.94 -16.23 0.41 Allowed 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 120.546 -0.461 . . . . 0.0 111.97 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.564 ' H ' ' CD ' ' A' ' 54' ' ' PRO . 88.2 mtp -135.05 -28.66 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.532 0 CA-C-O 115.587 -2.149 . . . . 0.0 115.661 -174.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.564 ' CD ' ' H ' ' A' ' 53' ' ' MET . 54.2 Cg_exo -51.34 -68.45 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.949 0 CA-C-N 123.08 2.136 . . . . 0.0 114.641 -173.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.27 113.9 22.65 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 177.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.9 mt -103.85 118.84 56.27 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 127.008 2.123 . . . . 0.0 105.761 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -74.48 153.95 44.88 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 121.355 1.37 . . . . 0.0 110.164 176.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.3 p -39.93 -44.28 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 127.483 2.313 . . . . 0.0 113.321 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -58.71 -34.43 71.3 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 126.706 2.002 . . . . 0.0 113.567 -176.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.0 mm -71.36 113.08 7.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 104.362 -2.458 . . . . 0.0 104.362 175.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -79.85 -39.34 30.86 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 173.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.2 m -153.06 162.29 41.49 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -173.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 54.5 mtm -126.69 162.4 25.87 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 172.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 39.1 m-20 -120.47 114.09 21.28 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 118.509 0.595 . . . . 0.0 109.725 -175.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -94.32 150.69 20.05 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 102.3 -3.222 . . . . 0.0 102.3 172.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.9 m -139.5 135.68 33.75 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 -175.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -148.96 165.81 30.48 Favored 'General case' 0 CA--C 1.509 -0.611 0 O-C-N 121.572 -0.705 . . . . 0.0 110.525 -178.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -165.37 149.7 8.66 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.587 173.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.02 177.52 4.29 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 172.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.91 143.57 26.78 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 100.998 -3.705 . . . . 0.0 100.998 173.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -1.25 -73.99 0.0 OUTLIER Glycine 0 C--N 1.302 -1.324 1 C-N-CA 133.88 5.514 . . . . 0.0 117.721 -173.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.401 ' HA ' ' CE1' ' A' ' 105' ' ' HIS 0.273 21.4 mm100 -117.35 23.95 11.46 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 173.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -108.99 37.47 2.55 Favored 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 130.859 3.664 . . . . 0.0 120.693 -173.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.497 ' H ' ' HE1' ' A' ' 105' ' ' HIS . 13.8 mt-10 -39.61 116.2 0.6 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 122.34 2.337 . . . . 0.0 113.785 -173.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -84.4 132.68 34.56 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 174.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -83.82 149.08 26.63 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 175.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -134.05 159.76 39.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 119.473 1.033 . . . . 0.0 111.133 175.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.5 ' O ' HD13 ' A' ' 131' ' ' ILE . 30.6 tt0 -152.83 137.93 17.33 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 173.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -85.86 104.02 15.14 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.592 1.157 . . . . 0.0 110.041 -176.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.2 tt -61.34 -43.88 98.12 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.69 1.596 . . . . 0.0 108.687 173.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.6 m -134.25 143.73 47.97 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.558 1.143 . . . . 0.0 111.723 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.2 tt -172.36 92.79 0.12 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 103.477 -2.786 . . . . 0.0 103.477 173.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -168.89 152.79 5.45 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 118.833 0.742 . . . . 0.0 111.025 -174.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.7 t -79.43 127.75 32.5 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.0 mt -87.01 -26.57 23.69 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 116.67 -1.633 . . . . 0.0 110.857 174.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -86.79 152.42 22.51 Favored 'General case' 0 C--N 1.348 0.508 0 CA-C-N 120.9 1.682 . . . . 0.0 109.377 173.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.26 -36.54 6.25 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 128.892 2.877 . . . . 0.0 112.678 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -68.71 -75.95 0.48 Allowed Glycine 0 CA--C 1.53 1.025 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 173.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.1 mp -74.21 20.03 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 129.951 3.3 . . . . 0.0 110.441 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 14.0 ttp -43.42 130.81 5.01 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 127.402 2.281 . . . . 0.0 111.255 -173.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -153.65 113.37 3.85 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 -175.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -99.58 132.81 22.5 Favored Pre-proline 0 C--N 1.322 -0.615 0 O-C-N 124.286 0.991 . . . . 0.0 109.239 -173.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.9 153.67 72.28 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 C-N-CA 121.084 1.19 . . . . 0.0 109.338 174.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 17.1 p -137.57 152.57 49.56 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 126.244 1.817 . . . . 0.0 106.436 173.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.8 m -126.37 153.98 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 CA-C-N 118.966 0.803 . . . . 0.0 112.268 177.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -75.94 8.46 3.12 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.38 1.872 . . . . 0.0 113.822 174.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.67 165.1 32.13 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 124.777 1.231 . . . . 0.0 109.481 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -66.87 166.01 24.03 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.536 1.49 . . . . 0.0 110.478 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -66.97 -10.32 48.11 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.579 1.152 . . . . 0.0 112.256 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -144.28 164.1 31.76 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.564 1.545 . . . . 0.0 107.398 173.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 160.3 -161.42 32.54 Favored Glycine 0 C--O 1.228 -0.24 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 73.1 p -118.0 151.44 37.47 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.5 t -88.92 113.59 56.62 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 175.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.4 154.85 40.93 Favored 'Trans proline' 0 CA--C 1.512 -0.598 0 C-N-CA 121.839 1.692 . . . . 0.0 111.161 -176.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.497 ' HE1' ' H ' ' A' ' 74' ' ' GLU . 12.8 m-70 -74.4 -7.07 51.67 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 120.353 -1.467 . . . . 0.0 113.687 -172.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.6 mptt -116.51 122.69 45.45 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 -174.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -38.73 111.39 0.17 Allowed 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 127.123 2.169 . . . . 0.0 111.76 -173.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 57.6 m -118.62 144.54 46.07 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 176.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.0 t -100.63 117.42 45.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 124.835 1.254 . . . . 0.0 111.303 -173.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.2 t -98.47 103.06 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 104.501 -2.407 . . . . 0.0 104.501 173.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -78.55 131.12 36.66 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 104.859 -2.275 . . . . 0.0 104.859 173.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.4 t -103.11 113.45 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 101.634 -3.469 . . . . 0.0 101.634 173.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -97.06 150.26 19.51 Favored Glycine 0 N--CA 1.439 -1.123 0 N-CA-C 108.621 -1.791 . . . . 0.0 108.621 176.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -133.3 73.54 73.83 Favored Pre-proline 0 C--O 1.242 0.7 0 CA-C-N 118.199 1.0 . . . . 0.0 109.402 -174.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -63.8 116.97 3.99 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.649 2.233 . . . . 0.0 109.885 173.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 7.1 t -90.75 146.43 23.99 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 173.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.9 mt -74.27 -12.34 60.52 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 117.856 0.298 . . . . 0.0 111.371 -177.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.61 21.76 43.75 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 127.123 2.297 . . . . 0.0 116.527 173.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . 0.339 4.6 mptp? -102.16 -40.9 6.59 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.984 1.892 . . . . 0.0 114.451 174.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 38.8 tp60 -96.49 146.1 25.09 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.469 1.032 . . . . 0.0 108.467 173.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -94.38 152.06 18.91 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.446 1.498 . . . . 0.0 107.869 174.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 138.06 -152.77 21.97 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.9 t -127.67 114.12 34.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.16 173.36 9.28 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.59 1.156 . . . . 0.0 109.307 173.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -128.24 150.27 50.11 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.338 1.855 . . . . 0.0 106.58 173.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -147.74 154.35 40.42 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 173.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -113.54 141.26 47.36 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.776 1.63 . . . . 0.0 110.291 -173.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 61.1 t -146.71 113.53 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 N-CA-C 104.258 -2.497 . . . . 0.0 104.258 173.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -144.19 137.77 27.62 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -174.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.0 t -136.62 148.9 26.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 121.794 0.807 . . . . 0.0 110.071 -173.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.5 HD13 ' O ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -115.74 162.64 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 173.714 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.7 t -139.08 136.08 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 -173.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.33 175.53 9.5 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 125.495 1.518 . . . . 0.0 107.371 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -92.95 176.12 6.54 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 172.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.2 t -65.89 -3.92 5.98 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 120.03 -1.669 . . . . 0.0 113.442 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -86.02 -15.24 42.05 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 120.697 1.59 . . . . 0.0 110.41 173.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.08 -0.63 66.81 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.73 1.157 . . . . 0.0 111.964 -173.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -70.15 116.04 10.05 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 119.456 1.628 . . . . 0.0 108.346 174.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -64.66 141.95 58.59 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.915 1.686 . . . . 0.0 107.951 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.8 pt -140.07 -37.25 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 124.481 1.113 . . . . 0.0 113.71 -174.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -133.97 145.42 49.51 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -147.45 136.99 22.73 Favored 'General case' 0 CA--C 1.516 -0.354 0 O-C-N 121.339 -0.851 . . . . 0.0 109.269 -176.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 35.5 m -72.33 129.84 86.9 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 173.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.4 143.94 35.72 Favored 'Trans proline' 0 N--CA 1.444 -1.415 0 N-CA-C 108.302 -1.461 . . . . 0.0 108.302 175.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 28.3 mp0 -79.37 112.38 16.55 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -173.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.547 25.6 m-80 172.48 -4.52 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.513 1 C-N-CA 136.115 5.766 . . . . 0.0 112.121 173.472 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.66 86.45 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 123.428 1.585 . . . . 0.0 108.836 174.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.9 mm -133.98 139.39 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 127.747 2.419 . . . . 0.0 105.522 -173.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -122.98 167.13 13.99 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 173.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -129.85 113.55 14.79 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 -173.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 57.7 tttt -102.16 121.74 42.8 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 119.748 1.158 . . . . 0.0 108.715 -176.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 30.1 m -83.61 116.86 22.81 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 104.84 -2.281 . . . . 0.0 104.84 173.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 13.2 m -117.85 166.12 12.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.304 0.573 . . . . 0.0 110.315 174.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.5 pp -137.12 159.27 42.39 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.636 1.574 . . . . 0.0 107.359 173.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.61 132.59 45.69 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.236 1.014 . . . . 0.0 110.463 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -153.35 161.75 42.01 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.177 1.791 . . . . 0.0 108.68 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 . . . . . 0 C--O 1.255 1.357 0 C-N-CA 129.898 3.279 . . . . 0.0 105.109 173.723 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.14 0 N-CA-C 106.507 -2.637 . . . . 0.0 106.507 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.4 t -63.3 176.24 0.83 Allowed 'General case' 0 C--O 1.242 0.687 0 C-N-CA 118.892 -1.123 . . . . 0.0 108.166 135.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -112.82 172.14 7.11 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 173.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 28.0 ptm -144.0 176.2 9.47 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 127.217 2.207 . . . . 0.0 106.782 174.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.402 HD23 ' H ' ' A' ' 6' ' ' ASP . 0.5 OUTLIER -145.57 169.85 17.58 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 173.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.402 ' H ' HD23 ' A' ' 5' ' ' LEU . 4.3 m-20 -63.22 120.87 12.37 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 173.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.06 158.5 16.87 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 103.899 -2.63 . . . . 0.0 103.899 -173.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -123.15 113.36 18.86 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 173.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -75.0 176.28 7.35 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.082 0.953 . . . . 0.0 109.045 174.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.67 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 74.6 mt-10 -58.25 169.93 0.77 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.549 1.14 . . . . 0.0 110.298 173.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.6 m -159.23 176.32 12.34 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.235 1.814 . . . . 0.0 109.166 173.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.1 tt -44.71 127.32 6.14 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.764 2.026 . . . . 0.0 113.487 -176.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -115.64 128.35 55.86 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.261 1.825 . . . . 0.0 109.185 174.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.93 118.07 11.27 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 127.135 2.174 . . . . 0.0 107.388 -178.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 9.0 p90 -133.81 170.89 14.92 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.184 0.994 . . . . 0.0 110.229 176.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.0 mp -108.02 115.15 48.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 102.187 -3.264 . . . . 0.0 102.187 173.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -82.2 142.52 32.11 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 123.32 1.533 . . . . 0.0 112.967 -173.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.62 -16.83 51.88 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.884 1.674 . . . . 0.0 115.32 -173.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 27.7 m80 -58.03 -35.34 71.16 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.51 1.05 . . . . 0.0 110.458 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -70.52 -46.64 63.26 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 122.313 -0.242 . . . . 0.0 111.052 177.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.481 ' HA ' HD12 ' A' ' 24' ' ' LEU . . . -56.97 -31.57 65.17 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 118.907 -0.568 . . . . 0.0 112.136 174.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.7 tpp85 -55.72 -59.64 4.57 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 173.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 60.8 t -53.78 -23.81 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 124.796 1.238 . . . . 0.0 111.71 177.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.481 HD12 ' HA ' ' A' ' 21' ' ' ALA . 9.0 mt -73.05 -46.06 53.96 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 117.504 -1.236 . . . . 0.0 113.622 174.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.5 pt -152.46 17.97 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 116.247 1.944 . . . . 0.0 116.247 -173.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.76 10.17 54.3 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 127.817 2.627 . . . . 0.0 114.547 -174.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -101.39 175.71 5.48 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 126.864 2.066 . . . . 0.0 111.034 -173.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -122.39 121.34 36.43 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.159 0.984 . . . . 0.0 109.129 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -153.02 113.28 3.99 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.693 1.197 . . . . 0.0 109.752 174.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -96.4 161.19 14.03 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 172.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.1 mm -138.65 113.39 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 173.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.31 113.89 20.41 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.4 mt -86.04 -65.6 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 32.0 t -114.73 114.23 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 -173.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.8 p -113.05 115.17 27.92 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 103.8 -2.667 . . . . 0.0 103.8 173.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.258 6.4 pt-20 44.43 45.97 7.74 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.689 1.195 . . . . 0.0 113.013 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 67.53 -7.28 2.09 Favored Glycine 0 CA--C 1.541 1.672 0 C-N-CA 125.804 1.669 . . . . 0.0 114.817 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -83.22 37.43 0.55 Allowed 'General case' 0 CA--C 1.539 0.533 1 C-N-CA 133.323 4.649 . . . . 0.0 109.022 -173.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 52.1 mtm -37.98 132.09 1.01 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 127.166 2.186 . . . . 0.0 114.54 -172.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.48 160.62 78.56 Favored Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.347 173.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.36 35.33 0.43 Allowed 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 124.215 3.277 . . . . 0.0 112.039 175.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -54.71 -26.59 34.82 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.481 1.913 . . . . 0.0 112.793 -173.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.7 m -48.82 -47.05 42.68 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 129.219 3.007 . . . . 0.0 112.861 -173.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -59.17 -59.08 6.04 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.258 1.023 . . . . 0.0 109.944 -175.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.298 47.0 m-20 -76.74 -27.93 55.58 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.289 -175.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -61.21 -50.52 72.78 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 120.91 -1.119 . . . . 0.0 108.767 173.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -65.84 -42.16 90.85 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-O 118.576 -0.726 . . . . 0.0 110.651 178.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.69 112.79 15.85 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-O 116.832 -1.556 . . . . 0.0 111.801 178.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -176.77 142.43 0.4 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 121.39 1.905 . . . . 0.0 110.463 172.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -96.74 112.91 24.47 Favored 'General case' 0 N--CA 1.452 -0.353 1 N-CA-C 100.114 -4.032 . . . . 0.0 100.114 172.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -163.87 -67.33 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 120.426 1.466 . . . . 0.0 111.046 174.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.76 -17.11 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.895 1.225 . . . . 0.0 113.075 -174.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 78.6 mmm -93.87 -65.48 0.12 Allowed Pre-proline 0 CA--C 1.533 0.31 0 CA-C-O 117.549 -1.215 . . . . 0.0 113.936 -173.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.52 -66.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 121.93 1.753 . . . . 0.0 113.482 -173.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.7 113.82 8.18 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.461 0.704 . . . . 0.0 110.238 -174.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 38.6 mt -124.35 132.15 24.27 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 126.421 1.888 . . . . 0.0 108.187 -173.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -80.04 157.83 23.68 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.854 2.369 . . . . 0.0 111.559 174.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.6 p -42.77 -43.49 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 127.058 2.143 . . . . 0.0 112.791 175.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -60.09 -34.19 73.13 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 126.29 1.836 . . . . 0.0 113.106 -174.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 mm -71.8 112.95 7.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 103.107 -2.923 . . . . 0.0 103.107 174.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 -94.75 -23.46 17.53 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.2 m -152.12 161.42 42.66 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.308 1.043 . . . . 0.0 108.59 173.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 16.8 mtm -126.19 156.96 39.37 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 173.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.252 59.8 m-20 -96.46 150.42 20.63 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 174.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -138.09 151.34 47.72 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 130.985 3.714 . . . . 0.0 101.799 172.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.4 m -137.35 130.65 31.0 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 -177.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -144.1 165.05 28.9 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.72 175.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -167.01 154.87 9.42 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.493 173.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.24 -174.51 2.37 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 123.403 1.573 . . . . 0.0 107.031 172.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.67 ' HB1' ' HB2' ' A' ' 10' ' ' GLU . . . -104.11 135.56 45.38 Favored 'General case' 0 N--CA 1.411 -2.375 0 C-N-CA 130.812 3.645 . . . . 0.0 101.873 173.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -7.45 -56.42 0.01 OUTLIER Glycine 0 CA--C 1.54 1.615 1 C-N-CA 133.801 5.477 . . . . 0.0 120.022 -173.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -116.93 9.89 13.9 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 121.207 2.504 . . . . 0.0 114.862 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -107.43 37.44 2.4 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 120.759 3.615 . . . . 0.0 120.759 -172.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -44.81 113.63 0.59 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 123.559 2.89 . . . . 0.0 110.601 -175.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -84.99 121.32 27.6 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -174.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -73.98 144.51 45.18 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 178.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -130.28 161.02 32.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 119.358 0.981 . . . . 0.0 110.781 176.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.433 ' O ' HD13 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -152.57 133.94 14.4 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 173.263 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -84.01 103.23 13.09 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -176.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.5 tt -64.72 -40.46 95.38 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 125.566 1.546 . . . . 0.0 108.32 176.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.0 m -148.83 142.86 25.88 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 120.499 -1.376 . . . . 0.0 110.358 177.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.9 tt -164.94 93.02 0.61 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 101.658 -3.46 . . . . 0.0 101.658 173.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 42.1 mmm-85 -166.01 163.32 18.31 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.09 0.956 . . . . 0.0 110.646 -177.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 126' ' ' PHE . 8.8 t -91.47 158.25 16.59 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.99 1.316 . . . . 0.0 113.792 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.0 mt -110.13 -26.46 9.66 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.256 -1.338 . . . . 0.0 111.261 177.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -76.74 169.73 17.75 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 120.495 1.498 . . . . 0.0 109.349 -174.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.7 mmtm -131.1 -46.3 1.01 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.602 1.961 . . . . 0.0 111.307 -173.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -70.38 -71.29 1.03 Allowed Glycine 0 CA--C 1.533 1.208 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 173.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.644 HD12 ' H ' ' A' ' 89' ' ' ILE . 3.7 mp -70.04 12.19 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 129.805 3.242 . . . . 0.0 111.07 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 28.5 ttp -43.69 142.31 1.28 Allowed 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 128.304 2.642 . . . . 0.0 112.193 -174.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.252 . . -161.95 174.98 12.32 Favored 'General case' 0 N--CA 1.439 -0.976 1 C-N-CA 131.851 4.06 . . . . 0.0 104.492 -173.572 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -151.32 137.4 11.19 Favored Pre-proline 0 C--N 1.321 -0.661 0 C-N-CA 124.359 1.064 . . . . 0.0 110.014 172.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -71.7 157.86 54.65 Favored 'Trans proline' 0 N--CA 1.443 -1.496 0 C-N-CA 121.396 1.397 . . . . 0.0 109.081 173.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 20.2 p -142.75 161.94 36.76 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 126.916 2.087 . . . . 0.0 107.28 174.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.9 m -126.44 150.97 32.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 123.532 0.733 . . . . 0.0 110.738 174.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -82.86 15.73 2.57 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.441 1.497 . . . . 0.0 111.482 173.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.2 m -129.6 163.24 48.09 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 173.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -67.47 162.75 37.59 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 CA-C-N 119.659 0.914 . . . . 0.0 109.91 173.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.52 -6.73 8.03 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.811 1.244 . . . . 0.0 111.693 175.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -145.9 163.22 35.78 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.621 1.569 . . . . 0.0 107.249 173.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 162.13 -160.2 32.3 Favored Glycine 0 C--O 1.227 -0.294 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 80.7 p -120.82 146.41 46.57 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 173.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.0 t -87.45 113.68 55.23 Favored Pre-proline 0 N--CA 1.448 -0.549 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 173.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -84.41 156.35 12.51 Favored 'Trans proline' 0 C--O 1.213 -0.736 0 C-N-CA 122.546 2.164 . . . . 0.0 112.402 -174.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -71.11 1.13 6.24 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 120.248 -1.532 . . . . 0.0 111.714 -174.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -114.03 115.6 27.86 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 128.102 2.561 . . . . 0.0 108.125 -173.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -41.56 108.74 0.1 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.096 1.358 . . . . 0.0 110.056 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.7 m -119.25 139.34 52.05 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.61 118.9 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 114.447 -1.252 . . . . 0.0 108.621 -173.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 75.9 t -93.88 104.21 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 173.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -82.34 115.04 21.21 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 104.532 -2.396 . . . . 0.0 104.532 173.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.3 t -93.33 113.82 28.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 104.111 -2.551 . . . . 0.0 104.111 174.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -89.19 144.86 18.21 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 124.891 1.234 . . . . 0.0 110.33 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -129.63 73.6 81.41 Favored Pre-proline 0 C--O 1.244 0.769 0 CA-C-N 118.754 1.277 . . . . 0.0 111.052 -175.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.3 129.06 19.53 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.397 2.064 . . . . 0.0 109.117 173.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 5.7 t -105.82 154.61 20.28 Favored 'General case' 0 C--N 1.338 0.1 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 174.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.8 mt -71.96 -17.01 62.1 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.568 0.622 . . . . 0.0 111.593 177.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 50.65 39.19 37.7 Favored Glycine 0 C--O 1.219 -0.793 0 C-N-CA 127.336 2.398 . . . . 0.0 114.809 173.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 42.9 mttm -124.4 -28.0 3.69 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.724 1.762 . . . . 0.0 112.032 173.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -96.53 155.66 16.67 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 172.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -109.42 150.75 27.61 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 138.59 -154.23 22.97 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 174.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 19.0 t -124.77 114.19 39.46 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -88.6 168.47 12.53 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 173.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -131.6 142.38 49.88 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.561 1.145 . . . . 0.0 108.715 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 33.6 p90 -143.34 150.44 39.17 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 125.829 1.651 . . . . 0.0 108.194 174.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -129.95 164.64 23.79 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 119.671 1.123 . . . . 0.0 113.285 177.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 57.3 t -131.62 148.56 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 125.613 1.565 . . . . 0.0 108.512 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -155.66 132.96 10.88 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 125.978 1.711 . . . . 0.0 108.078 173.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 36.5 t -137.15 143.46 34.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -174.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.532 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -110.25 163.46 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 173.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.9 t -140.3 137.59 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 CA-C-N 114.185 -1.37 . . . . 0.0 107.337 -173.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.79 174.71 10.33 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 125.957 1.703 . . . . 0.0 107.619 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 45.0 p-10 -89.68 176.01 7.03 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 172.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.8 t -66.1 -3.6 5.82 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 120.098 -1.626 . . . . 0.0 113.484 -177.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -86.69 -17.7 33.09 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 120.613 1.551 . . . . 0.0 110.452 173.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 97.6 1.13 59.02 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.783 1.182 . . . . 0.0 112.251 -173.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 65.4 m-20 -72.29 115.14 11.18 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 119.608 1.704 . . . . 0.0 108.701 174.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.5 m -64.8 143.0 58.24 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.498 1.919 . . . . 0.0 108.624 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -141.29 -36.82 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 124.708 1.203 . . . . 0.0 113.973 -175.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -131.91 144.18 50.67 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -144.13 130.2 19.55 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 35.6 m -68.79 149.07 98.01 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 173.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -89.17 144.92 5.08 Favored 'Trans proline' 0 N--CA 1.444 -1.386 0 CA-C-N 120.84 1.336 . . . . 0.0 109.646 173.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -78.84 112.58 16.13 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 -174.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 172.99 -18.4 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 128.12 2.568 . . . . 0.0 114.331 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.9 79.06 0.12 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.999 0.92 . . . . 0.0 112.08 -173.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.425 HG21 ' CZ ' ' A' ' 150' ' ' PHE . 3.3 mm -86.83 148.03 4.92 Favored 'Isoleucine or valine' 0 C--N 1.345 0.38 0 C-N-CA 127.341 2.256 . . . . 0.0 109.361 174.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -125.88 128.41 47.55 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 129.484 3.114 . . . . 0.0 103.12 173.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.425 ' CZ ' HG21 ' A' ' 148' ' ' ILE . 66.0 m-85 -102.49 113.26 26.46 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 178.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 56.1 tttt -103.1 121.58 42.9 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 28.9 m -83.38 114.65 21.58 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 174.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 21.8 m -113.09 165.5 12.31 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 119.01 0.823 . . . . 0.0 109.459 174.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.4 pp -141.75 161.61 37.52 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.067 1.347 . . . . 0.0 108.098 174.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.91 130.2 42.24 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.621 1.168 . . . . 0.0 111.843 178.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -144.06 170.34 16.12 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 128.239 2.616 . . . . 0.0 107.606 173.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 . . . . . 0 C--O 1.254 1.314 0 C-N-CA 128.881 2.872 . . . . 0.0 106.075 173.812 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.024 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.96 112.79 4.52 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 120.268 2.034 . . . . 0.0 106.731 168.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -161.41 176.8 10.74 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 128.475 2.71 . . . . 0.0 106.603 -173.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 23.3 mmt -63.33 160.33 16.16 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 104.051 -2.574 . . . . 0.0 104.051 172.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.3 mt -43.33 113.5 0.5 Allowed 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -172.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -152.69 176.23 11.97 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 130.483 3.513 . . . . 0.0 108.734 -173.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -145.17 126.29 14.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 102.15 -3.278 . . . . 0.0 102.15 173.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.11 176.56 7.28 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 125.747 1.619 . . . . 0.0 109.846 -173.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 54.9 mp0 -62.15 170.75 2.08 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 122.202 1.001 . . . . 0.0 109.734 173.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -59.01 158.62 8.24 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 122.551 1.167 . . . . 0.0 111.107 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.6 m -176.18 176.96 1.63 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 128.637 2.775 . . . . 0.0 109.467 -174.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.2 tt -42.99 121.91 2.26 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 127.132 2.173 . . . . 0.0 113.469 -173.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -111.76 139.84 46.9 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.265 2.226 . . . . 0.0 108.435 174.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.07 118.28 6.81 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 21.2 p90 -139.42 152.24 46.91 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 119.205 0.912 . . . . 0.0 109.58 177.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.8 mt -83.91 127.86 39.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 102.579 -3.119 . . . . 0.0 102.579 173.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -104.69 136.9 43.35 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 122.9 1.333 . . . . 0.0 111.856 -173.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.2 -22.38 66.88 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.206 -1.361 . . . . 0.0 113.891 -174.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -58.36 -37.9 76.15 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 119.564 1.075 . . . . 0.0 111.422 -173.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -71.19 -51.12 26.57 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 117.816 -1.088 . . . . 0.0 110.151 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.71 -41.73 61.72 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.034 0.834 . . . . 0.0 111.009 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -49.39 -68.27 0.19 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 173.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 98.2 t -51.52 -23.99 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 126.112 1.765 . . . . 0.0 111.825 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.2 mt -82.3 -42.6 18.59 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 124.046 0.939 . . . . 0.0 112.882 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.6 pt -155.26 17.85 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 -172.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.12 18.79 65.28 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.119 1.342 . . . . 0.0 113.012 -174.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -98.51 135.09 40.56 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 126.483 1.913 . . . . 0.0 107.946 -174.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -130.9 113.77 14.44 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -174.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -162.16 126.45 3.21 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.067 2.147 . . . . 0.0 107.506 176.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -96.24 159.08 15.14 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 172.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.2 mp -135.56 113.17 14.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 173.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.67 114.13 18.35 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.8 mt -94.09 -57.06 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.402 HG22 ' HG2' ' A' ' 39' ' ' MET . 4.1 t -125.95 141.27 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 C-N-CA 125.003 1.321 . . . . 0.0 108.901 -173.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.0 p -152.43 123.01 7.32 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 102.87 -3.011 . . . . 0.0 102.87 173.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 44.48 33.84 0.97 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.67 1.588 . . . . 0.0 113.818 -174.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.26 -8.82 6.25 Favored Glycine 0 CA--C 1.539 1.566 0 O-C-N 120.814 -1.179 . . . . 0.0 114.694 -177.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.2 ttmt -69.25 37.47 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.461 1 C-N-CA 132.941 4.496 . . . . 0.0 112.812 -177.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.402 ' HG2' HG22 ' A' ' 34' ' ' VAL . 43.0 mtt -38.1 133.04 0.95 Allowed 'General case' 0 C--O 1.233 0.229 0 C-N-CA 126.164 1.786 . . . . 0.0 114.767 -173.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.79 157.64 66.05 Favored Pre-proline 0 N--CA 1.448 -0.559 0 CA-C-N 113.512 -1.676 . . . . 0.0 107.859 173.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -74.27 37.69 0.45 Allowed 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 124.455 3.437 . . . . 0.0 112.192 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -52.61 -26.11 12.58 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 127.266 2.226 . . . . 0.0 113.493 -173.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.404 HG23 ' CG ' ' A' ' 146' ' ' ASN . 1.8 m -43.52 -51.95 6.46 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.757 2.023 . . . . 0.0 112.388 -174.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -58.28 -62.48 1.8 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.612 0.765 . . . . 0.0 110.569 -174.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . 0.33 52.4 m-20 -76.84 -30.78 56.47 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -173.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.1 -51.7 68.02 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 120.659 -1.276 . . . . 0.0 107.971 173.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.471 HH21 HD11 ' A' ' 148' ' ' ILE . 6.3 ttt180 -67.86 -39.55 83.77 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 118.796 -0.621 . . . . 0.0 109.72 -177.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.92 113.23 16.25 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-O 115.918 -1.991 . . . . 0.0 112.988 176.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -176.31 142.15 0.46 Allowed 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 123.099 2.681 . . . . 0.0 112.166 173.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.6 112.88 24.46 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 101.748 -3.427 . . . . 0.0 101.748 172.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -175.72 -67.36 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.151 1.38 . . . . 0.0 109.62 176.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.4 ' HA ' ' CZ ' ' A' ' 52' ' ' ARG . 2.7 tpm_? -171.35 -16.91 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 O-C-N 120.933 -1.104 . . . . 0.0 112.467 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.53 -65.99 1.32 Allowed Pre-proline 0 CA--C 1.536 0.438 0 CA-C-O 117.635 -1.174 . . . . 0.0 111.721 -174.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -77.01 -73.92 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.835 0 CA-C-N 120.86 1.343 . . . . 0.0 113.313 -174.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.22 118.11 6.44 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.183 1.393 . . . . 0.0 114.034 -173.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.6 mt -132.09 120.77 17.4 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 127.154 2.181 . . . . 0.0 106.831 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -77.06 156.25 33.9 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.243 1.962 . . . . 0.0 111.124 -178.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.6 p -40.25 -46.84 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 127.834 2.454 . . . . 0.0 113.607 -178.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -63.23 -36.19 82.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 126.066 1.746 . . . . 0.0 113.091 -175.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.5 mm -69.06 113.05 4.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 103.454 -2.795 . . . . 0.0 103.454 174.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -79.57 -32.81 42.08 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.246 176.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.5 m -154.24 162.71 41.0 Favored 'General case' 0 C--N 1.335 -0.031 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -173.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 24.4 mtm -126.55 163.53 23.2 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 172.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -120.17 149.19 42.64 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 118.99 0.814 . . . . 0.0 108.857 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -125.58 156.55 38.95 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 102.898 -3.001 . . . . 0.0 102.898 173.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 m -138.31 135.91 35.9 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -176.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -145.72 159.97 42.4 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 121.593 -0.692 . . . . 0.0 111.053 178.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -165.74 151.99 9.53 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 121.966 0.889 . . . . 0.0 112.688 173.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -82.13 -173.53 4.57 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.504 1.122 . . . . 0.0 108.786 173.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.19 99.73 6.89 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 126.469 1.908 . . . . 0.0 109.368 -174.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 48.14 -60.17 0.0 OUTLIER Glycine 0 CA--C 1.539 1.536 0 C-N-CA 130.646 3.974 . . . . 0.0 119.619 173.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -116.77 -12.99 10.76 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 120.298 2.049 . . . . 0.0 114.354 175.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.7 37.28 0.58 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 130.015 3.326 . . . . 0.0 118.869 -173.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -52.38 113.66 1.12 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 123.058 2.663 . . . . 0.0 109.776 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -84.05 138.46 33.06 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.686 1.595 . . . . 0.0 106.885 174.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -85.61 149.37 25.38 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -133.52 160.1 38.44 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.905 1.23 . . . . 0.0 110.566 174.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.436 ' O ' HD13 ' A' ' 131' ' ' ILE . 31.3 tt0 -154.58 133.9 12.57 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 173.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.487 ' CD2' HD23 ' A' ' 82' ' ' LEU . 80.6 m-85 -81.97 103.55 11.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.9 tt -64.47 -40.83 96.43 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 173.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 m -154.99 145.99 22.64 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 122.657 1.217 . . . . 0.0 111.739 174.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.634 HD22 HG22 ' A' ' 128' ' ' VAL . 0.2 OUTLIER -148.54 92.81 2.05 Favored 'General case' 0 N--CA 1.451 -0.389 1 N-CA-C 97.606 -4.961 . . . . 0.0 97.606 173.191 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.01 150.78 27.7 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 120.452 -1.405 . . . . 0.0 114.559 -172.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.1 t -68.74 158.92 33.27 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.762 1.225 . . . . 0.0 111.464 173.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.3 mt -123.38 -26.25 4.29 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.983 1.713 . . . . 0.0 110.925 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.434 ' CG ' ' H ' ' A' ' 87' ' ' LYS . 7.9 t70 -79.09 176.09 9.98 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.791 1.178 . . . . 0.0 109.521 -174.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.434 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 23.4 mmtm -131.62 -50.54 0.98 Allowed 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 127.073 2.149 . . . . 0.0 110.928 -173.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -69.48 -65.02 2.72 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 173.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.492 HD12 ' H ' ' A' ' 89' ' ' ILE . 4.3 mp -76.63 25.59 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 C-N-CA 129.357 3.063 . . . . 0.0 110.395 -175.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 26.5 ttm -43.33 139.74 1.86 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 129.261 3.025 . . . . 0.0 111.803 -173.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.253 . . -168.14 173.62 7.8 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 130.177 3.391 . . . . 0.0 105.563 -173.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.412 10.4 m-20 -147.51 130.23 7.86 Favored Pre-proline 0 CA--C 1.509 -0.622 0 C-N-CA 127.435 2.294 . . . . 0.0 111.975 172.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.32 156.36 41.59 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 121.953 1.768 . . . . 0.0 109.649 173.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 23.4 p -136.59 158.6 44.07 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 126.524 1.93 . . . . 0.0 108.139 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.6 m -126.34 157.23 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 123.729 0.812 . . . . 0.0 111.222 176.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -79.99 9.77 5.05 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 127.325 2.25 . . . . 0.0 113.68 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.8 m -140.84 163.44 42.72 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 124.527 1.131 . . . . 0.0 109.914 -175.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -66.11 164.56 27.26 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.853 1.702 . . . . 0.0 110.277 173.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -63.16 -14.37 47.98 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 124.503 1.121 . . . . 0.0 112.7 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -143.33 164.78 29.3 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 120.133 1.333 . . . . 0.0 108.65 173.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 164.42 -162.92 35.79 Favored Glycine 0 C--O 1.228 -0.258 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 76.1 p -116.96 149.15 40.68 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 173.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 37.5 t -83.13 113.52 46.57 Favored Pre-proline 0 N--CA 1.448 -0.528 0 N-CA-C 103.635 -2.728 . . . . 0.0 103.635 173.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.42 ' HB2' ' HE3' ' A' ' 106' ' ' LYS . 45.8 Cg_endo -85.82 156.07 10.2 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.404 2.069 . . . . 0.0 112.176 -173.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -70.55 0.55 6.57 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 120.197 -1.564 . . . . 0.0 113.063 -175.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.42 ' HE3' ' HB2' ' A' ' 104' ' ' PRO . 0.0 OUTLIER -115.3 114.84 25.71 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 126.598 1.959 . . . . 0.0 106.951 -173.839 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -41.62 106.84 0.06 Allowed 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.693 1.597 . . . . 0.0 109.639 -178.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.4 m -112.21 137.46 50.28 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 178.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.5 t -96.75 114.18 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 114.099 -1.409 . . . . 0.0 108.703 -173.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 98.5 t -94.09 103.33 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 173.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -77.04 140.42 40.33 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 172.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.4 t -115.16 113.62 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 174.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -99.48 149.44 18.93 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 125.927 1.727 . . . . 0.0 109.603 -178.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.415 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 4.4 m-85 -132.3 73.89 76.74 Favored Pre-proline 0 C--O 1.244 0.788 0 CA-C-N 118.965 1.383 . . . . 0.0 112.479 -173.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -66.88 126.83 15.91 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.098 1.865 . . . . 0.0 109.135 173.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 5.7 t -104.82 153.37 21.42 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 124.565 1.146 . . . . 0.0 108.131 174.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.6 mt -74.5 -9.98 59.12 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.369 0.531 . . . . 0.0 111.867 178.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.7 5.93 3.16 Favored Glycine 0 C--O 1.22 -0.723 0 C-N-CA 128.458 2.933 . . . . 0.0 116.408 173.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 27.7 mmtm -93.61 -32.26 14.17 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.737 1.768 . . . . 0.0 113.114 -173.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -96.63 159.1 15.11 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 173.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -107.89 148.01 30.18 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.405 1.482 . . . . 0.0 107.197 176.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 140.21 -152.71 22.98 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 174.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.8 t -128.07 113.99 32.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.428 ' HB2' ' HB ' ' A' ' 89' ' ' ILE . . . -90.64 167.96 12.14 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 173.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -129.65 156.99 43.35 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 123.719 0.808 . . . . 0.0 109.464 173.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 149' ' ' PHE . 3.8 p90 -147.95 151.0 35.07 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 126.801 2.04 . . . . 0.0 105.896 173.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -137.71 173.2 11.9 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 175.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.634 HG22 HD22 ' A' ' 82' ' ' LEU . 97.0 t -128.95 147.3 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 124.789 1.236 . . . . 0.0 111.276 -173.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -146.67 120.02 8.99 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 127.666 2.387 . . . . 0.0 106.44 173.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.406 HG22 ' CD2' ' A' ' 79' ' ' PHE . 23.3 t -138.2 124.2 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -177.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.687 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -90.43 164.83 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 106.635 -1.616 . . . . 0.0 106.635 173.695 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.4 t -144.71 132.34 16.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -176.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.73 174.02 11.03 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.475 1.11 . . . . 0.0 108.581 -174.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 32.1 p-10 -88.28 176.06 7.39 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 172.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.1 t -68.09 -6.78 24.69 Favored 'General case' 0 CA--C 1.551 1.015 0 O-C-N 120.659 -1.276 . . . . 0.0 112.286 -175.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -86.32 -14.69 42.87 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 120.59 -1.319 . . . . 0.0 110.606 173.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.42 4.16 62.62 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.736 1.16 . . . . 0.0 112.386 -173.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -75.9 117.55 17.75 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 119.811 1.805 . . . . 0.0 108.952 175.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.4 m -66.98 146.82 53.97 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.96 1.704 . . . . 0.0 110.021 -176.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.84 -35.68 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.868 1.267 . . . . 0.0 113.616 178.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -133.08 148.74 52.17 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -176.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -146.52 150.01 34.72 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 174.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.6 m -102.79 113.81 65.67 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -73.91 154.13 47.96 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.16 1.907 . . . . 0.0 113.105 -173.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -69.49 112.52 6.06 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 102.122 -3.288 . . . . 0.0 102.122 173.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.404 ' CG ' HG23 ' A' ' 43' ' ' THR . 44.7 m-20 173.35 -30.79 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 130.821 3.649 . . . . 0.0 107.138 -173.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.58 66.6 0.08 Allowed 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 126.842 2.057 . . . . 0.0 109.157 174.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.471 HD11 HH21 ' A' ' 47' ' ' ARG . 1.4 mt -95.62 147.72 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 C-N-CA 126.074 1.75 . . . . 0.0 108.141 176.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.417 ' HB2' ' CE2' ' A' ' 126' ' ' PHE . 20.1 m-85 -130.88 150.61 51.96 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 173.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -127.21 113.36 16.24 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 -173.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 46.5 tttt -101.8 123.22 45.39 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.48 -0.934 . . . . 0.0 108.48 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 39.0 m -83.34 119.93 25.23 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 173.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 11.1 m -114.69 159.66 20.26 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 173.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.2 pp -143.44 160.58 40.32 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 174.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -56.56 114.11 1.9 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 127.999 2.52 . . . . 0.0 111.795 -174.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -133.89 174.83 10.04 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 127.833 2.453 . . . . 0.0 108.6 175.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 . . . . . 0 C--O 1.252 1.191 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 173.458 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.793 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.5 t -157.78 161.8 38.44 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 106.679 -1.601 . . . . 0.0 106.679 169.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -161.57 113.68 1.79 Allowed 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 174.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 36.4 tpp -165.8 170.15 14.23 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.559 1.944 . . . . 0.0 106.709 173.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 86.9 mt -129.74 112.99 14.17 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 173.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -176.62 176.9 1.48 Allowed 'General case' 0 C--O 1.241 0.65 0 C-N-CA 131.439 3.896 . . . . 0.0 103.947 -174.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.53 112.44 4.11 Favored 'General case' 0 N--CA 1.447 -0.619 1 N-CA-C 100.12 -4.03 . . . . 0.0 100.12 173.137 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -103.16 176.18 5.23 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 112.933 -1.939 . . . . 0.0 114.855 -173.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -76.29 176.57 8.0 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.641 1.976 . . . . 0.0 107.527 173.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.593 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 49.4 mt-10 -56.34 176.64 0.08 Allowed 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 126.749 2.02 . . . . 0.0 108.321 172.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.5 m -140.25 173.32 11.63 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 118.827 -2.421 . . . . 0.0 107.912 172.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.51 HD23 ' N ' ' A' ' 13' ' ' TYR . 6.1 tt -47.06 132.71 11.97 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.994 1.27 . . . . 0.0 112.22 -173.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.51 ' N ' HD23 ' A' ' 12' ' ' LEU . 81.7 m-85 -121.26 129.94 53.41 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.073 1.349 . . . . 0.0 109.58 176.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.4 117.91 8.55 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 5.5 p90 -131.19 175.38 9.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.174 0.99 . . . . 0.0 110.257 174.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.505 HD11 HD11 ' A' ' 33' ' ' ILE . 2.0 mp -115.41 118.28 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 102.997 -2.964 . . . . 0.0 102.997 173.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -89.59 144.6 25.88 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 123.312 1.53 . . . . 0.0 112.487 -173.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.53 -6.8 1.19 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 128.341 2.656 . . . . 0.0 115.491 -175.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 62.2 m80 -61.8 -34.06 75.24 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 120.584 1.538 . . . . 0.0 111.638 -177.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -67.35 -41.16 85.62 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.231 176.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.518 ' HA ' HD12 ' A' ' 24' ' ' LEU . . . -63.78 -36.32 83.49 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.545 1.138 . . . . 0.0 111.075 173.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.0 ttm-85 -57.17 -58.14 9.53 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 173.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 73.6 t -52.46 -24.05 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 124.978 1.311 . . . . 0.0 111.988 175.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.518 HD12 ' HA ' ' A' ' 21' ' ' ALA . 6.0 mt -73.77 -49.01 27.48 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 174.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.4 pt -156.11 19.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 -172.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.14 9.36 66.98 Favored Glycine 0 CA--C 1.531 1.094 0 C-N-CA 126.368 1.937 . . . . 0.0 113.564 -173.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -86.56 176.31 7.88 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 127.339 2.256 . . . . 0.0 110.548 -174.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -132.73 120.06 21.17 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 124.838 1.255 . . . . 0.0 108.975 -175.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -149.29 112.64 4.97 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.446 0.566 . . . . 0.0 110.017 173.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -97.1 163.11 13.07 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 172.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.3 mp -141.1 113.15 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 103.855 -2.646 . . . . 0.0 103.855 172.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.63 114.11 23.07 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.505 HD11 HD11 ' A' ' 16' ' ' ILE . 10.9 mt -85.45 -58.45 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 118.543 0.61 . . . . 0.0 109.495 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.415 HG11 HD22 ' A' ' 12' ' ' LEU . 22.1 t -123.96 114.1 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 126.757 2.023 . . . . 0.0 106.9 -173.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.6 p -117.48 118.22 31.58 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 173.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.308 1.2 pm0 44.31 52.4 7.24 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.329 1.052 . . . . 0.0 111.121 -173.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.75 -12.95 4.42 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 126.78 2.133 . . . . 0.0 115.935 175.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -67.83 37.79 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.484 1 C-N-CA 132.963 4.505 . . . . 0.0 114.487 -174.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 30.9 mtm -37.83 116.56 0.51 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.876 1.216 . . . . 0.0 112.835 -172.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.67 161.07 22.46 Favored Pre-proline 0 N--CA 1.447 -0.612 0 CA-C-N 113.746 -1.57 . . . . 0.0 109.491 177.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -73.98 27.54 0.33 Allowed 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.699 2.933 . . . . 0.0 111.994 174.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -56.11 -26.68 50.85 Favored 'General case' 0 C--N 1.345 0.409 0 C-N-CA 124.862 1.265 . . . . 0.0 110.616 -174.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 m -45.54 -43.77 12.18 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 129.29 3.036 . . . . 0.0 110.725 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.513 ' CD2' ' HZ1' ' A' ' 48' ' ' LYS . 53.0 t60 -63.65 -55.34 24.31 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.0 0.52 . . . . 0.0 110.707 -177.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -76.1 -26.76 56.75 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -175.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -68.13 -40.36 82.49 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.122 0.969 . . . . 0.0 109.634 173.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.79 -42.81 76.86 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 175.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.513 ' HZ1' ' CD2' ' A' ' 44' ' ' HIS . 1.8 ttmp? -63.79 175.89 1.04 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.241 1.016 . . . . 0.0 108.265 175.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.73 112.83 13.72 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 120.3 -1.5 . . . . 0.0 106.969 173.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -96.6 171.8 8.32 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 173.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -48.58 -61.13 2.18 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.282 1.033 . . . . 0.0 111.763 -175.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.74 -16.51 3.76 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 177.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.428 ' SD ' HD13 ' A' ' 16' ' ' ILE . 1.1 mtp -52.59 -52.66 61.78 Favored Pre-proline 0 CA--C 1.534 0.362 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -173.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -75.2 -75.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.021 0 CA-C-N 121.13 1.439 . . . . 0.0 111.366 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.28 113.63 14.05 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.761 0.824 . . . . 0.0 111.829 -173.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 89.4 mt -120.35 130.43 24.85 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 128.464 2.706 . . . . 0.0 105.988 -174.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -83.05 159.32 15.56 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.491 2.127 . . . . 0.0 110.593 174.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.0 p -46.99 -34.61 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 125.715 1.606 . . . . 0.0 112.744 174.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.41 -34.19 72.17 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.509 1.524 . . . . 0.0 111.763 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.514 HD11 ' HG ' ' A' ' 24' ' ' LEU . 10.6 mm -92.15 112.83 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 102.985 -2.968 . . . . 0.0 102.985 174.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -82.86 -31.26 28.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.354 178.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.3 m -148.05 164.26 34.38 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.339 1.056 . . . . 0.0 110.422 -173.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 36.4 mtm -126.78 149.56 49.59 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 172.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -94.12 149.09 21.55 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 174.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -134.11 158.06 44.57 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 102.567 -3.123 . . . . 0.0 102.567 172.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.3 m -142.82 134.38 26.46 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 -178.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -144.53 169.02 18.76 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.248 0.546 . . . . 0.0 110.092 174.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -166.73 145.75 5.44 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.763 173.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.42 -173.3 1.36 Allowed 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 124.16 1.933 . . . . 0.0 105.864 172.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.593 ' HB1' ' HB2' ' A' ' 10' ' ' GLU 0.264 . . -112.42 121.26 44.34 Favored 'General case' 0 N--CA 1.408 -2.535 1 C-N-CA 131.922 4.089 . . . . 0.0 105.767 -179.084 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 20.22 -73.65 0.0 OUTLIER Glycine 0 CA--C 1.536 1.358 1 C-N-CA 133.654 5.407 . . . . 0.0 119.079 178.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -116.25 -14.73 11.07 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 120.415 2.108 . . . . 0.0 112.41 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.81 37.48 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 131.339 3.856 . . . . 0.0 116.641 -173.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -38.17 114.16 0.34 Allowed 'General case' 0 C--O 1.237 0.446 0 CA-C-N 121.684 2.038 . . . . 0.0 114.719 -173.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -94.53 116.33 28.65 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 104.682 -2.34 . . . . 0.0 104.682 173.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -79.67 148.68 31.51 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 175.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -129.94 158.27 40.02 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 119.645 1.111 . . . . 0.0 109.861 174.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.49 134.26 12.91 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 173.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -89.16 102.99 15.65 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -175.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.6 tt -68.07 -41.38 82.02 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.518 1.527 . . . . 0.0 107.829 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 m -154.24 135.08 13.71 Favored 'General case' 0 N--CA 1.444 -0.734 0 O-C-N 120.645 -1.285 . . . . 0.0 110.829 179.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.483 ' H ' ' HD3' ' A' ' 83' ' ' ARG . 0.3 OUTLIER -151.99 93.15 1.8 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 101.428 -3.545 . . . . 0.0 101.428 173.508 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.483 ' HD3' ' H ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -156.94 157.17 34.31 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 120.863 1.665 . . . . 0.0 111.352 -178.319 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -78.87 152.99 30.92 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-O 121.549 0.69 . . . . 0.0 109.826 173.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.9 mt -106.91 -17.59 14.15 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.437 1.495 . . . . 0.0 110.721 174.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -90.29 163.23 14.83 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 174.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -139.8 -31.32 0.67 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.164 1.786 . . . . 0.0 112.998 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -64.12 -63.88 4.04 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 106.654 -2.579 . . . . 0.0 106.654 172.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.455 HD12 ' H ' ' A' ' 89' ' ' ILE . 4.8 mp -75.78 22.0 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 129.993 3.317 . . . . 0.0 110.23 175.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.4 ttp -43.11 130.79 4.52 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 125.923 2.773 . . . . 0.0 113.26 -173.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.536 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -150.55 147.87 27.98 Favored 'General case' 0 N--CA 1.419 -2.014 2 C-N-CA 135.108 5.363 . . . . 0.0 100.86 173.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.276 5.4 m-20 -136.74 117.36 10.99 Favored Pre-proline 0 C--N 1.315 -0.931 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 173.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -67.63 158.16 58.43 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 123.033 2.489 . . . . 0.0 114.133 -173.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 32.8 p -136.11 164.52 27.84 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.248 1.819 . . . . 0.0 109.006 177.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.6 m -126.41 159.98 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 123.855 0.862 . . . . 0.0 111.295 175.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -80.1 10.46 4.35 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 127.171 2.188 . . . . 0.0 113.346 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.4 m -140.91 163.76 40.51 Favored Pre-proline 0 C--N 1.328 -0.341 0 C-N-CA 124.168 0.987 . . . . 0.0 110.288 -174.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -65.43 160.12 44.3 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 121.626 1.551 . . . . 0.0 108.836 173.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -67.19 -10.11 47.05 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 123.558 0.743 . . . . 0.0 112.264 -178.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -146.83 163.91 34.54 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 120.543 1.52 . . . . 0.0 108.338 173.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 159.19 -163.15 33.2 Favored Glycine 0 C--O 1.227 -0.298 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 177.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 70.1 p -114.9 146.03 41.56 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 173.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.3 t -77.56 122.42 85.83 Favored Pre-proline 0 CA--C 1.541 0.622 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 177.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.81 148.54 46.4 Favored 'Trans proline' 0 C--O 1.216 -0.577 0 C-N-CA 121.797 1.665 . . . . 0.0 111.749 -175.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 72.9 m-70 -63.82 -24.35 67.72 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 -172.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . 0.515 1.0 OUTLIER -116.71 150.68 37.8 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.781 1.173 . . . . 0.0 111.914 173.141 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -38.49 115.49 0.46 Allowed 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 128.387 2.675 . . . . 0.0 114.404 -172.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 44.6 m -128.69 141.49 51.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 173.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 17.1 t -94.02 122.32 45.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 124.701 1.2 . . . . 0.0 110.196 -173.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.8 t -103.72 103.5 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 173.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -81.03 141.25 34.57 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 173.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.2 t -110.27 113.86 45.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 103.525 -2.768 . . . . 0.0 103.525 174.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -95.67 151.34 19.96 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 125.091 1.329 . . . . 0.0 109.925 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -131.4 72.96 80.47 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.14 125.93 14.31 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.634 1.556 . . . . 0.0 108.471 176.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.536 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 5.3 t -105.47 156.99 17.68 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.2 mt -81.16 -8.87 59.84 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.167 0.44 . . . . 0.0 111.713 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.39 28.13 61.6 Favored Glycine 0 C--N 1.339 0.702 0 C-N-CA 126.06 1.791 . . . . 0.0 116.149 173.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 51.4 mttt -122.34 -30.72 3.93 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.938 1.869 . . . . 0.0 114.128 177.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.406 ' NE2' ' H ' ' A' ' 121' ' ' ASP . 57.5 tp60 -96.34 154.88 17.01 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 173.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.406 ' H ' ' NE2' ' A' ' 120' ' ' GLN . 7.3 m-20 -111.17 148.95 31.65 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 138.1 -156.33 23.82 Favored Glycine 0 C--N 1.332 0.361 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 176.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.4 t -122.52 113.7 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -89.45 156.98 18.31 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 173.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -117.62 158.56 24.42 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.805 0.842 . . . . 0.0 110.504 177.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.405 ' CE2' ' HB2' ' A' ' 149' ' ' PHE . 5.7 p90 -150.01 150.78 32.28 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 119.024 0.829 . . . . 0.0 109.2 173.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.415 ' CG ' HH12 ' A' ' 83' ' ' ARG . 24.7 pt-20 -123.15 156.4 35.11 Favored 'General case' 0 C--O 1.25 1.116 0 C-N-CA 125.126 1.37 . . . . 0.0 110.678 -174.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.465 HG22 HD22 ' A' ' 82' ' ' LEU . 26.6 t -137.79 140.26 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 O-C-N 125.437 1.711 . . . . 0.0 110.862 -177.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -150.61 120.59 7.16 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.931 2.493 . . . . 0.0 105.619 173.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 47.3 t -136.7 119.9 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.716 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -84.55 166.21 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 174.155 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.9 t -141.37 133.33 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 179.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.85 175.98 8.6 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 177.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -96.95 154.16 17.47 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 102.705 -3.072 . . . . 0.0 102.705 172.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.7 t -62.89 -15.86 56.6 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 120.72 -1.238 . . . . 0.0 110.573 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -69.51 -6.36 30.16 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 127.113 2.165 . . . . 0.0 111.914 173.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 99.45 20.25 18.11 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 118.192 2.037 . . . . 0.0 118.192 173.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -124.19 124.46 42.51 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 120.642 2.221 . . . . 0.0 110.071 -173.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.0 m -64.66 142.04 58.56 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 174.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.7 pt -140.51 -37.3 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 124.422 1.089 . . . . 0.0 113.813 -173.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.42 HD13 ' N ' ' A' ' 142' ' ' GLN . 2.9 tm? -139.49 154.04 47.63 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 -174.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.427 ' HG3' HG22 ' A' ' 131' ' ' ILE . 1.9 tm0? -154.83 144.52 21.49 Favored 'General case' 0 C--N 1.334 -0.102 0 O-C-N 121.025 -1.047 . . . . 0.0 108.9 174.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 26.8 m -67.77 114.56 20.71 Favored Pre-proline 0 N--CA 1.454 -0.264 0 N-CA-C 104.017 -2.586 . . . . 0.0 104.017 173.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -66.29 146.17 80.17 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 CA-C-N 120.251 1.125 . . . . 0.0 113.167 -173.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -73.45 112.95 10.0 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 173.0 -26.96 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.398 1 C-N-CA 134.792 5.237 . . . . 0.0 109.234 173.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.06 87.12 0.01 OUTLIER 'General case' 0 C--O 1.238 0.475 0 C-N-CA 126.251 1.821 . . . . 0.0 111.384 -174.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.9 mt -123.56 136.75 59.06 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.709 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 173.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.405 ' HB2' ' CE2' ' A' ' 126' ' ' PHE . 0.2 OUTLIER -116.06 164.58 14.25 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 126.263 2.227 . . . . 0.0 107.08 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -140.63 113.56 8.32 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.684 1.194 . . . . 0.0 108.349 -173.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -104.43 128.52 52.33 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 119.427 1.012 . . . . 0.0 108.638 174.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 24.4 m -83.51 114.18 21.32 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 174.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 56.2 m -108.41 165.83 11.22 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 173.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.3 pp -142.9 161.5 37.94 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.054 1.342 . . . . 0.0 108.423 174.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -68.04 122.37 18.1 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.404 1.882 . . . . 0.0 110.289 174.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -153.83 123.08 6.52 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.724 1.21 . . . . 0.0 110.218 174.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 . . . . . 0 C--O 1.255 1.371 0 C-N-CA 128.877 2.871 . . . . 0.0 105.806 173.68 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.098 0 N-CA-C 108.555 -1.818 . . . . 0.0 108.555 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.1 m -56.65 171.26 0.33 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 142.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -65.54 112.62 3.69 Favored 'General case' 0 C--N 1.343 0.3 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 174.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -176.99 176.91 1.34 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 131.025 3.73 . . . . 0.0 103.714 -173.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.92 166.6 11.02 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 172.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -130.18 124.5 32.74 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 173.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.62 141.29 4.21 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 102.549 -3.13 . . . . 0.0 102.549 -174.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.96 113.57 17.18 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 173.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -129.83 148.7 51.73 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -129.9 168.35 16.78 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.431 0.692 . . . . 0.0 110.423 176.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m -176.51 177.22 1.47 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 129.792 3.237 . . . . 0.0 108.841 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.7 tt -43.33 128.21 4.74 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.945 2.098 . . . . 0.0 111.929 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -113.04 137.58 51.2 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.917 1.687 . . . . 0.0 107.94 173.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.67 116.25 7.63 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 9.8 p90 -129.85 175.83 8.53 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.937 0.895 . . . . 0.0 109.429 175.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.428 HD11 HD11 ' A' ' 33' ' ' ILE . 1.8 mp -114.07 120.11 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 103.006 -2.961 . . . . 0.0 103.006 174.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -83.43 144.81 29.35 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 123.355 1.55 . . . . 0.0 114.746 -173.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.52 -16.48 60.85 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.521 1.928 . . . . 0.0 114.985 -174.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -55.89 -35.02 66.07 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.455 0.57 . . . . 0.0 109.488 174.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -75.74 -44.94 39.22 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.429 ' HA ' HD12 ' A' ' 24' ' ' LEU . . . -55.06 -33.94 63.15 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.523 0.729 . . . . 0.0 111.019 174.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 25.8 ttm105 -55.2 -57.26 12.51 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 121.2 -0.938 . . . . 0.0 108.841 173.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.2 t -53.8 -23.81 9.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 119.098 0.863 . . . . 0.0 111.603 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 21' ' ' ALA . 5.0 mt -76.2 -44.28 38.55 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 117.116 -1.421 . . . . 0.0 113.893 174.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.0 pt -151.76 17.41 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 -173.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.53 4.56 39.29 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 128.201 2.81 . . . . 0.0 115.368 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -100.75 176.56 5.26 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 128.759 2.824 . . . . 0.0 111.684 -173.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -118.66 117.9 30.19 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.506 1.522 . . . . 0.0 109.105 -178.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -153.93 113.55 3.81 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.311 1.445 . . . . 0.0 109.585 -178.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -94.74 165.76 12.33 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 173.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.1 mp -141.07 113.39 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 174.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.59 122.54 29.18 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -177.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.428 HD11 HD11 ' A' ' 16' ' ' ILE . 17.2 mt -94.97 -65.3 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 119.027 0.831 . . . . 0.0 109.019 177.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.4 t -113.15 113.6 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 -173.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.5 p -109.22 113.58 26.55 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 103.613 -2.736 . . . . 0.0 103.613 173.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.284 18.1 pm0 44.43 40.87 4.14 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.77 1.628 . . . . 0.0 113.235 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.91 -6.76 8.74 Favored Glycine 0 CA--C 1.543 1.785 0 C-N-CA 124.768 1.175 . . . . 0.0 114.466 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -86.39 37.63 0.74 Allowed 'General case' 0 CA--C 1.539 0.554 1 C-N-CA 134.387 5.075 . . . . 0.0 108.114 -174.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 62.6 mtp -37.66 131.74 0.94 Allowed 'General case' 0 C--O 1.234 0.253 0 C-N-CA 128.427 2.691 . . . . 0.0 115.301 -172.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.6 159.39 85.21 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-N 113.464 -1.698 . . . . 0.0 109.056 173.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -76.46 41.28 0.86 Allowed 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 124.53 3.486 . . . . 0.0 111.783 175.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -54.89 -26.29 34.82 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.443 1.897 . . . . 0.0 112.802 -174.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.5 m -53.14 -33.09 50.9 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 127.201 2.2 . . . . 0.0 112.074 -173.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -62.9 -66.25 0.57 Allowed 'General case' 0 C--N 1.344 0.368 0 CA-C-N 119.201 0.91 . . . . 0.0 109.748 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.9 -35.37 74.72 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -177.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -63.87 -44.56 92.71 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 125.081 1.488 . . . . 0.0 110.092 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 48.7 tpt85 -82.09 -29.42 31.79 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -176.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.06 176.77 1.57 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 128.58 2.752 . . . . 0.0 110.06 179.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.77 176.1 0.16 Allowed 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.058 -1.026 . . . . 0.0 109.916 173.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 5.3 tm0? -43.74 136.64 3.39 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.489 1.516 . . . . 0.0 113.893 -173.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -145.12 -67.18 0.31 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 173.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.9 tpm_? -160.06 -16.8 0.06 Allowed 'General case' 0 C--O 1.226 -0.15 0 CA-C-O 118.03 -0.986 . . . . 0.0 112.603 174.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.498 ' H ' ' HD2' ' A' ' 54' ' ' PRO . 98.1 mmm -109.35 -48.7 0.08 OUTLIER Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 -173.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.498 ' HD2' ' H ' ' A' ' 53' ' ' MET . 9.2 Cg_endo -61.33 -71.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.687 0 CA-C-N 121.457 1.556 . . . . 0.0 114.048 -173.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.39 119.81 19.99 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.495 0.718 . . . . 0.0 110.357 -174.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 96.0 mt -123.92 127.92 25.27 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 128.226 2.61 . . . . 0.0 106.134 -175.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -84.59 161.22 12.55 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 122.755 2.304 . . . . 0.0 111.565 174.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.5 p -47.11 -37.0 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 125.281 1.432 . . . . 0.0 112.667 173.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -53.25 -37.7 62.34 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.612 1.565 . . . . 0.0 111.968 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.2 mm -83.23 112.81 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 102.992 -2.966 . . . . 0.0 102.992 173.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -79.39 -40.6 29.7 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 173.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.2 m -141.81 157.89 44.46 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.989 1.716 . . . . 0.0 109.572 -173.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 2.8 mmm -117.75 147.91 42.54 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 173.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -94.49 156.42 16.47 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 173.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -141.23 155.18 46.06 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 129.506 3.122 . . . . 0.0 102.701 172.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.2 m -139.05 133.35 31.51 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -177.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -145.93 162.59 37.43 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.404 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -163.24 146.17 10.37 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 173.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.04 -177.16 5.46 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 173.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -115.09 95.98 5.46 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.989 1.316 . . . . 0.0 109.206 -173.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.67 -89.69 0.03 OUTLIER Glycine 0 CA--C 1.534 1.254 0 C-N-CA 126.128 1.823 . . . . 0.0 115.979 173.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . 0.263 5.5 mm-40 -117.12 26.14 9.99 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.542 1.937 . . . . 0.0 114.462 174.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -94.91 37.25 1.15 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.839 2.456 . . . . 0.0 112.215 177.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -38.9 113.4 0.3 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.802 1.641 . . . . 0.0 112.515 -173.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -106.36 129.98 54.27 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.157 1.783 . . . . 0.0 107.695 175.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -91.53 150.58 21.14 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 176.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -131.93 160.22 36.39 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 119.726 1.148 . . . . 0.0 110.236 174.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.444 ' O ' HD13 ' A' ' 131' ' ' ILE . 29.0 tt0 -155.37 135.49 13.02 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 173.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.478 ' CD2' HD23 ' A' ' 82' ' ' LEU . 77.6 m-85 -84.14 103.55 13.45 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.9 tt -65.24 -37.55 87.59 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 174.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.7 m -155.01 144.92 21.62 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 120.687 -1.258 . . . . 0.0 111.816 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.485 HD22 HG22 ' A' ' 128' ' ' VAL . 0.1 OUTLIER -156.24 93.52 1.42 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 102.678 -3.082 . . . . 0.0 102.678 173.573 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.461 ' HD3' ' H ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -154.21 158.64 40.6 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 121.206 1.821 . . . . 0.0 111.779 -178.184 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.1 t -71.72 167.65 19.43 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.915 0.886 . . . . 0.0 112.982 173.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.9 mt -126.69 -9.45 6.16 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 126.603 1.961 . . . . 0.0 114.308 174.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.524 ' CG ' ' H ' ' A' ' 87' ' ' LYS 0.309 13.3 t70 -96.43 170.67 9.07 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 122.01 2.186 . . . . 0.0 112.095 -173.721 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.524 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 1.3 mppt? -114.65 -53.01 2.68 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 129.16 2.984 . . . . 0.0 110.223 -173.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.433 ' C ' ' H ' ' A' ' 90' ' ' MET . . . -82.1 -58.62 2.44 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 125.052 1.31 . . . . 0.0 110.643 178.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mp -79.19 25.5 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 126.164 1.786 . . . . 0.0 110.376 -175.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.433 ' H ' ' C ' ' A' ' 88' ' ' GLY . 27.3 ttm -43.4 131.41 4.85 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 130.144 3.377 . . . . 0.0 109.292 -178.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -165.19 160.23 18.34 Favored 'General case' 0 N--CA 1.438 -1.028 1 C-N-CA 131.916 4.086 . . . . 0.0 103.785 -173.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.269 5.7 m-20 -138.16 124.84 13.17 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 118.618 0.644 . . . . 0.0 111.359 173.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.421 ' HG2' HD12 ' A' ' 82' ' ' LEU . 75.7 Cg_endo -70.08 142.42 46.45 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 122.035 1.824 . . . . 0.0 110.273 179.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.8 p -131.87 162.09 31.43 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.938 1.695 . . . . 0.0 108.726 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.4 m -126.14 153.37 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 119.176 0.898 . . . . 0.0 112.353 -174.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -79.27 9.67 4.41 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 127.335 2.254 . . . . 0.0 113.337 177.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.5 m -144.24 164.21 30.32 Favored Pre-proline 0 C--N 1.327 -0.376 0 C-N-CA 124.725 1.21 . . . . 0.0 109.603 -174.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -66.9 161.76 40.88 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 121.25 1.3 . . . . 0.0 109.348 173.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -65.57 -7.68 16.0 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.237 1.015 . . . . 0.0 112.192 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -144.47 164.12 31.81 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.372 1.469 . . . . 0.0 108.335 173.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.66 -161.37 34.12 Favored Glycine 0 C--O 1.226 -0.357 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.5 p -125.89 139.17 53.68 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.8 t -74.3 114.34 32.54 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -78.84 150.15 23.62 Favored 'Trans proline' 0 C--O 1.211 -0.845 0 C-N-CA 121.969 1.779 . . . . 0.0 111.583 -174.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.415 ' H ' ' CD2' ' A' ' 105' ' ' HIS . 6.2 m-70 -78.29 4.09 13.76 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 119.726 -1.859 . . . . 0.0 113.98 -173.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.83 127.24 54.11 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 173.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -43.94 110.68 0.22 Allowed 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 126.501 1.921 . . . . 0.0 109.806 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.3 m -119.21 140.45 50.19 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.7 t -94.87 117.52 38.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 C-N-CA 124.953 1.301 . . . . 0.0 108.97 -173.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.6 t -100.09 104.44 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 173.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -82.11 149.01 28.23 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 173.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.5 t -122.49 113.56 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 104.035 -2.579 . . . . 0.0 104.035 175.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -89.37 147.84 19.75 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.506 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 7.0 m-85 -127.73 73.53 78.52 Favored Pre-proline 0 C--O 1.242 0.706 0 CA-C-N 118.156 0.978 . . . . 0.0 109.472 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.28 123.5 10.95 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.681 2.254 . . . . 0.0 107.55 173.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 7.3 t -105.95 152.82 22.83 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.253 1.021 . . . . 0.0 108.717 178.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mt -72.02 -14.95 62.02 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 117.953 0.342 . . . . 0.0 111.409 176.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 54.21 42.91 74.1 Favored Glycine 0 C--O 1.22 -0.77 0 C-N-CA 126.479 1.99 . . . . 0.0 113.827 173.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . 0.282 27.4 mttp -125.39 -34.05 2.75 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.733 1.766 . . . . 0.0 113.551 176.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 50.2 tp60 -96.04 142.06 28.7 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 104.043 -2.576 . . . . 0.0 104.043 172.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -93.97 141.01 29.01 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 142.64 -154.73 25.39 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.7 t -129.2 114.11 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -175.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.73 168.82 12.63 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 173.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -125.6 157.75 36.37 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 123.963 0.905 . . . . 0.0 108.888 173.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.506 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 12.4 p90 -149.89 160.87 43.25 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 173.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.442 ' HG3' HH12 ' A' ' 83' ' ' ARG . 5.1 pt-20 -140.42 160.22 40.48 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 124.454 1.102 . . . . 0.0 111.444 -173.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.485 HG22 HD22 ' A' ' 82' ' ' LEU . 83.0 t -139.46 146.94 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 126.205 1.802 . . . . 0.0 109.51 -174.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -150.63 122.85 8.33 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 127.892 2.477 . . . . 0.0 105.784 173.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.422 HG22 ' CD2' ' A' ' 79' ' ' PHE . 21.8 t -135.87 123.74 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.674 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -91.02 165.38 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 173.552 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.8 t -144.99 134.31 18.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 -176.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.77 164.7 29.25 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.605 -174.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.482 ' C ' HD22 ' A' ' 134' ' ' ASN . 0.1 OUTLIER -79.31 166.77 21.76 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 104.104 -2.554 . . . . 0.0 104.104 172.746 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.3 t -60.69 -12.66 11.08 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 120.96 1.709 . . . . 0.0 115.612 -173.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -80.46 -12.08 59.6 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 121.113 1.779 . . . . 0.0 112.303 173.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.23 -3.54 54.85 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.824 1.202 . . . . 0.0 114.117 -174.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -66.91 117.17 8.63 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 120.037 1.919 . . . . 0.0 108.648 177.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -71.81 143.83 49.35 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.681 0.792 . . . . 0.0 108.932 -176.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -138.74 -37.88 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.504 1.122 . . . . 0.0 113.516 -175.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.46 HD13 ' N ' ' A' ' 142' ' ' GLN . 1.9 tm? -133.81 147.83 51.27 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 -177.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.46 ' N ' HD13 ' A' ' 141' ' ' LEU . 10.3 tm0? -147.87 147.03 29.33 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.927 0.891 . . . . 0.0 108.959 174.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 23.5 m -80.67 113.74 42.38 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 176.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.17 147.5 91.31 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 121.202 1.268 . . . . 0.0 110.904 -173.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -79.54 112.24 16.61 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 -174.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.625 37.3 m-80 172.12 -8.13 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.524 1 C-N-CA 134.876 5.271 . . . . 0.0 112.214 172.991 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.74 79.93 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.362 1.465 . . . . 0.0 108.687 174.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.3 mt -117.03 148.72 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 C-N-CA 127.189 2.196 . . . . 0.0 106.316 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -133.88 164.84 26.37 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.015 -1.448 . . . . 0.0 107.182 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -137.4 113.53 9.91 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.017 1.327 . . . . 0.0 107.602 -173.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.12 120.4 41.17 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 119.313 0.96 . . . . 0.0 108.765 -175.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.9 m -84.14 116.59 22.98 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 -177.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 6.9 m -113.09 166.17 11.68 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.832 0.853 . . . . 0.0 109.261 173.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.3 pp -136.88 163.5 30.53 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.845 1.258 . . . . 0.0 108.198 173.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -72.42 121.33 19.38 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 128.258 2.623 . . . . 0.0 110.817 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -146.17 170.35 16.9 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 127.304 2.242 . . . . 0.0 109.387 177.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 . . . . . 0 C--O 1.257 1.489 0 C-N-CA 131.162 3.785 . . . . 0.0 104.339 173.822 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.072 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.4 p -42.99 177.47 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.792 2.037 . . . . 0.0 112.414 120.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -46.3 177.18 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 127.657 2.383 . . . . 0.0 111.307 173.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 23.4 mmt -47.13 163.21 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.696 0 O-C-N 119.53 -1.981 . . . . 0.0 106.597 172.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -42.88 113.37 0.47 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 122.57 1.176 . . . . 0.0 113.202 -172.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -80.04 172.67 13.46 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 128.2 2.6 . . . . 0.0 110.195 -173.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.36 146.62 17.05 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 104.155 -2.535 . . . . 0.0 104.155 174.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -73.66 168.43 19.36 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 125.473 1.509 . . . . 0.0 108.227 173.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -71.77 160.33 32.79 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 173.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -71.79 156.48 39.27 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 173.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.5 m -174.96 176.03 2.22 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.061 1.344 . . . . 0.0 111.296 -173.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.7 tt -86.39 136.56 33.08 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 128.81 2.844 . . . . 0.0 109.775 178.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -127.72 138.97 52.95 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.857 1.663 . . . . 0.0 108.412 173.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.39 117.6 7.33 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 -176.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 14.1 p90 -130.78 171.18 13.42 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.683 0.793 . . . . 0.0 110.518 177.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.1 mt -108.75 135.18 48.37 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 N-CA-C 103.591 -2.744 . . . . 0.0 103.591 174.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -91.79 159.96 15.55 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 122.577 1.18 . . . . 0.0 113.164 -173.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.89 -13.79 59.95 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.119 1.767 . . . . 0.0 113.99 175.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 31.6 m80 -59.4 -38.74 81.34 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 120.615 1.552 . . . . 0.0 109.058 175.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -64.08 -46.02 86.15 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.925 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.591 ' HA ' HD12 ' A' ' 24' ' ' LEU . . . -65.46 -31.85 73.15 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 123.244 0.618 . . . . 0.0 112.261 175.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -58.62 -56.7 18.72 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 174.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 77.3 t -51.98 -24.04 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.363 1.465 . . . . 0.0 112.101 174.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.591 HD12 ' HA ' ' A' ' 21' ' ' ALA . 7.8 mt -77.72 -46.39 21.94 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 174.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.8 pt -153.99 18.16 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 -172.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.99 15.56 65.13 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.549 1.547 . . . . 0.0 113.433 -174.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -100.77 172.83 6.83 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 126.558 1.943 . . . . 0.0 109.235 -176.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -127.17 127.57 44.75 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -174.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -155.14 113.31 3.46 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 118.419 -0.8 . . . . 0.0 112.275 -179.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -96.25 165.12 12.37 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 122.35 2.341 . . . . 0.0 105.765 172.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 79.2 mt -140.26 113.17 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 173.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.81 114.22 24.22 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 -177.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.4 mt -92.44 -53.16 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 118.825 0.738 . . . . 0.0 109.661 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -123.44 113.81 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 -173.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.9 p -112.96 122.66 48.3 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 173.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 44.32 44.39 6.68 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.093 1.357 . . . . 0.0 112.602 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.32 4.72 1.32 Allowed Glycine 0 CA--C 1.536 1.371 0 C-N-CA 127.121 2.296 . . . . 0.0 114.743 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.97 37.28 0.48 Allowed 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 129.875 3.27 . . . . 0.0 111.426 -172.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 34.3 mtt -38.12 116.46 0.52 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 126.339 1.855 . . . . 0.0 114.381 -173.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.34 160.55 75.19 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 173.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.7 65.67 5.77 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 124.134 3.223 . . . . 0.0 109.685 175.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -62.17 -12.33 19.28 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 126.999 2.119 . . . . 0.0 114.77 -173.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 56.8 m -43.69 -48.51 7.88 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 126.049 1.739 . . . . 0.0 113.185 -173.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -59.63 -59.51 5.33 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 118.379 0.536 . . . . 0.0 110.325 -176.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.734 ' O ' ' HB2' ' A' ' 49' ' ' ALA 0.321 49.0 m-20 -76.04 -23.26 55.13 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -173.626 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -75.57 -58.04 3.52 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.714 1.143 . . . . 0.0 108.645 173.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -67.75 -25.23 65.53 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.291 -0.88 . . . . 0.0 110.983 -173.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.87 113.38 17.14 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 173.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.734 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -166.06 176.96 7.32 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.268 1.027 . . . . 0.0 109.774 -173.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -44.35 148.74 0.43 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.156 1.782 . . . . 0.0 106.995 172.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -44.07 -34.37 1.75 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.052 1.741 . . . . 0.0 113.501 -173.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.03 -16.51 0.77 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.664 1.585 . . . . 0.0 115.002 176.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.508 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -111.52 -65.99 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 120.935 1.698 . . . . 0.0 113.411 -176.004 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.01 -79.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.875 0 CA-C-N 122.152 1.804 . . . . 0.0 111.462 -174.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.09 113.47 20.64 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.612 0.765 . . . . 0.0 109.062 -174.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.5 mt -110.64 126.22 29.24 Favored Pre-proline 0 C--N 1.323 -0.566 0 C-N-CA 127.158 2.183 . . . . 0.0 105.437 -175.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.3 156.36 37.27 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.562 1.508 . . . . 0.0 110.216 178.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.0 p -42.11 -44.79 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 126.354 1.862 . . . . 0.0 112.194 174.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -61.43 -36.04 79.24 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 126.354 1.861 . . . . 0.0 113.159 -176.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 mm -75.63 112.65 13.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 101.309 -3.589 . . . . 0.0 101.309 173.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -79.25 -36.6 39.65 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.997 178.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.6 m -144.78 170.69 15.62 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 124.125 0.891 . . . . 0.0 111.953 -173.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 62.9 mtp -125.87 156.85 38.98 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 172.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -121.81 113.56 19.84 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -174.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -99.95 162.68 12.84 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 173.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.8 m -141.59 136.34 30.94 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 176.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -143.71 162.93 34.7 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 120.604 -0.439 . . . . 0.0 110.582 174.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -172.8 156.59 3.49 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.265 -0.88 . . . . 0.0 112.04 173.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.44 -173.41 4.7 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 172.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.27 134.15 55.28 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 102.767 -3.049 . . . . 0.0 102.767 173.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 19.28 -60.02 0.0 OUTLIER Glycine 0 CA--C 1.534 1.26 1 C-N-CA 135.634 6.35 . . . . 0.0 120.808 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -116.58 -13.06 10.89 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 121.139 2.47 . . . . 0.0 113.672 -177.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.96 37.4 0.6 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 130.037 3.335 . . . . 0.0 119.503 -173.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -51.39 116.25 1.98 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 123.388 2.813 . . . . 0.0 110.247 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -83.72 150.41 25.85 Favored 'General case' 0 C--N 1.334 -0.089 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 174.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -100.79 146.82 26.78 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 176.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -132.49 160.69 35.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 120.239 1.381 . . . . 0.0 110.983 176.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.457 ' O ' HD13 ' A' ' 131' ' ' ILE . 28.2 tt0 -152.6 133.74 14.23 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 173.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -81.32 111.22 17.5 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.714 1.206 . . . . 0.0 109.34 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.8 tt -74.28 -48.61 27.43 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.656 1.183 . . . . 0.0 107.857 174.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 m -128.66 148.08 50.78 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.04 1.336 . . . . 0.0 111.839 176.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -175.6 92.62 0.06 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 130.155 3.382 . . . . 0.0 103.913 173.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -162.16 153.46 18.13 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.348 -1.47 . . . . 0.0 111.279 -173.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.8 t -85.74 165.44 16.92 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 121.72 0.771 . . . . 0.0 109.174 173.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 98.8 mt -125.85 0.65 7.36 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 126.035 1.734 . . . . 0.0 112.163 -174.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.471 ' CG ' ' H ' ' A' ' 87' ' ' LYS 0.358 11.3 t70 -98.48 166.14 11.5 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.303 0.956 . . . . 0.0 112.391 178.247 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.471 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 1.4 mppt? -104.67 -46.86 4.22 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 129.401 3.081 . . . . 0.0 112.222 -173.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -105.0 -44.6 1.48 Allowed Glycine 0 CA--C 1.525 0.711 0 C-N-CA 125.075 1.321 . . . . 0.0 111.792 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mt -84.41 13.93 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 C-N-CA 125.274 1.43 . . . . 0.0 108.614 176.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 23.5 ttp -43.62 148.71 0.33 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 131.175 3.79 . . . . 0.0 110.548 177.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -162.7 176.28 10.48 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 127.724 2.41 . . . . 0.0 107.113 -173.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -137.51 113.92 9.48 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 172.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.91 154.31 75.0 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 N-CA-C 106.602 -2.115 . . . . 0.0 106.602 173.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.0 p -141.55 162.73 34.76 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 125.112 1.365 . . . . 0.0 108.435 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.0 m -126.47 155.43 36.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 123.742 0.817 . . . . 0.0 111.915 175.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -73.24 9.06 1.38 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.712 2.405 . . . . 0.0 113.212 174.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.1 m -140.73 165.52 29.17 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 125.903 1.681 . . . . 0.0 108.594 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -67.37 168.64 17.35 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.621 1.547 . . . . 0.0 111.293 174.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -62.63 -12.53 23.8 Favored 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 124.986 1.315 . . . . 0.0 111.914 174.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -143.17 163.83 31.81 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 120.314 1.416 . . . . 0.0 108.129 173.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.61 -161.7 34.37 Favored Glycine 0 C--O 1.228 -0.277 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 82.3 p -117.81 155.33 30.27 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 117.808 0.804 . . . . 0.0 109.404 173.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.6 t -93.69 113.12 59.54 Favored Pre-proline 0 N--CA 1.448 -0.541 0 N-CA-C 101.77 -3.419 . . . . 0.0 101.77 173.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -92.4 161.57 3.02 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.431 2.088 . . . . 0.0 111.998 -173.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -72.62 3.17 5.28 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 120.116 -1.615 . . . . 0.0 112.382 -173.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -114.11 116.0 28.42 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 127.654 2.382 . . . . 0.0 107.672 -173.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -44.68 105.87 0.06 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.563 1.145 . . . . 0.0 109.942 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 26.8 m -111.75 135.16 52.72 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.4 t -90.28 114.09 27.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -173.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 70.8 t -94.0 103.21 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 103.536 -2.764 . . . . 0.0 103.536 173.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -84.05 119.08 24.52 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 173.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.5 t -90.56 113.47 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 103.13 -2.915 . . . . 0.0 103.13 173.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -93.9 149.11 19.29 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.435 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 7.8 m-85 -132.3 73.45 77.35 Favored Pre-proline 0 C--O 1.244 0.784 0 CA-C-N 118.258 1.029 . . . . 0.0 110.766 -176.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -68.04 114.27 3.33 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 N-CA-C 106.844 -2.022 . . . . 0.0 106.844 173.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 5.6 t -91.88 143.58 26.36 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 175.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.0 mt -74.26 -11.41 60.27 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 119.32 -0.371 . . . . 0.0 111.5 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 53.17 39.61 58.34 Favored Glycine 0 C--N 1.339 0.744 0 C-N-CA 125.768 1.652 . . . . 0.0 113.69 173.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -93.48 -65.25 1.01 Allowed 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 118.219 1.01 . . . . 0.0 109.299 -177.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 48.6 tp60 -96.07 155.26 16.83 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 174.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -93.44 147.72 22.7 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.383 1.473 . . . . 0.0 107.72 178.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.5 -155.5 26.38 Favored Glycine 0 C--N 1.332 0.34 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.9 t -126.63 114.01 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -88.26 170.58 10.88 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 173.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -124.06 158.19 32.76 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 173.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.435 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 50.1 p90 -148.71 153.55 38.39 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 173.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.55 154.59 37.7 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 126.231 1.813 . . . . 0.0 110.199 -173.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 87.7 t -143.09 144.64 23.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 173.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -157.38 132.53 8.91 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 125.078 1.351 . . . . 0.0 107.894 173.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.3 t -137.26 135.26 47.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -174.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.585 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -103.2 164.07 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 173.838 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.2 t -142.66 138.21 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -173.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.81 175.65 9.42 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 125.565 1.546 . . . . 0.0 107.97 -176.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 39.3 p-10 -90.92 176.22 6.69 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 172.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.1 t -66.17 -7.13 16.14 Favored 'General case' 0 CA--C 1.553 1.059 0 O-C-N 120.552 -1.342 . . . . 0.0 112.549 -176.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -86.13 -14.85 42.93 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.455 -1.403 . . . . 0.0 110.933 173.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.5 1.44 64.15 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.659 1.123 . . . . 0.0 112.465 -173.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 63.2 m-20 -71.75 116.29 11.95 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 119.68 1.74 . . . . 0.0 108.504 174.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -64.76 142.36 58.46 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.063 1.745 . . . . 0.0 108.461 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.3 pt -140.58 -38.69 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.758 1.223 . . . . 0.0 113.841 -174.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -130.91 141.54 50.3 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 -177.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -149.07 124.95 10.57 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -176.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 41.3 m -61.67 143.72 93.57 Favored Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 174.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.49 141.95 23.01 Favored 'Trans proline' 0 N--CA 1.441 -1.613 0 N-CA-C 107.587 -1.736 . . . . 0.0 107.587 173.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -77.0 112.64 13.84 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 102.225 -3.25 . . . . 0.0 102.225 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 4.1 m120 174.45 -30.24 0.0 OUTLIER 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.17 1.788 . . . . 0.0 111.419 -173.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.75 103.91 0.39 Allowed 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.443 1.497 . . . . 0.0 110.219 -174.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 2.0 mt -134.29 148.74 29.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -176.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 126' ' ' PHE . 0.9 OUTLIER -132.19 169.98 15.66 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.198 1.799 . . . . 0.0 107.479 179.078 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -136.4 113.74 10.76 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.281 1.032 . . . . 0.0 109.073 -173.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -103.13 124.95 49.53 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.677 1.126 . . . . 0.0 109.136 179.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 25.7 m -83.67 116.69 22.76 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 174.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 4.5 m -119.27 166.21 13.28 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.494 0.718 . . . . 0.0 109.84 174.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.2 pp -133.27 161.16 35.22 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.459 1.504 . . . . 0.0 107.89 176.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.16 131.95 46.82 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.926 1.29 . . . . 0.0 109.927 177.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -146.91 133.49 19.83 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.814 1.646 . . . . 0.0 107.509 174.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 . . . . . 0 C--O 1.257 1.464 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 177.485 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.83 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.5 m -57.7 164.96 1.83 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.75 0.82 . . . . 0.0 110.747 170.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -62.71 113.62 3.12 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 173.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 57.2 mtm -156.65 176.68 12.4 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 129.002 2.921 . . . . 0.0 105.91 -173.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.9 mp -61.24 162.35 7.69 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 107.985 -1.116 . . . . 0.0 107.985 173.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -51.19 113.8 1.03 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.738 2.015 . . . . 0.0 112.164 -173.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -160.74 174.61 13.68 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 129.021 2.928 . . . . 0.0 103.709 173.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.6 174.14 14.32 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 128.349 2.659 . . . . 0.0 106.497 173.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -135.61 149.77 49.47 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 175.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -82.26 166.59 19.42 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 122.44 1.114 . . . . 0.0 111.606 -177.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.7 m -176.53 177.09 1.48 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 129.822 3.249 . . . . 0.0 107.692 -176.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 13' ' ' TYR . 3.1 tt -43.55 138.13 2.62 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.96 2.504 . . . . 0.0 113.075 177.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.469 ' N ' HD23 ' A' ' 12' ' ' LEU . 86.9 m-85 -122.12 135.57 54.81 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.51 1.924 . . . . 0.0 108.467 173.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.99 121.06 10.08 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 127.231 2.212 . . . . 0.0 107.115 -176.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 12.8 p90 -139.63 175.07 9.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 118.933 0.788 . . . . 0.0 109.946 176.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.434 HD11 HD11 ' A' ' 33' ' ' ILE . 2.2 mp -112.77 113.72 44.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 100.226 -3.99 . . . . 0.0 100.226 173.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -79.58 152.9 29.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 122.861 1.315 . . . . 0.0 111.832 -173.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.2 -19.18 61.32 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -173.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -61.09 -34.06 74.32 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 119.564 1.075 . . . . 0.0 109.396 174.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 48.1 tp60 -69.16 -48.44 62.25 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 118.103 0.41 . . . . 0.0 111.6 177.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.541 ' HA ' HD12 ' A' ' 24' ' ' LEU . . . -59.95 -29.58 68.5 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 119.131 -0.461 . . . . 0.0 111.617 174.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 27.0 ttm105 -57.04 -55.57 32.96 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 119.658 1.117 . . . . 0.0 108.038 173.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -54.13 -23.93 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 119.27 0.941 . . . . 0.0 111.499 177.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.541 HD12 ' HA ' ' A' ' 21' ' ' ALA . 4.8 mt -76.13 -43.32 43.59 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 117.239 -1.362 . . . . 0.0 114.021 174.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.4 pt -151.08 16.6 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 116.919 2.192 . . . . 0.0 116.919 -173.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.33 4.51 30.56 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 128.169 2.795 . . . . 0.0 115.485 -177.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -100.83 176.46 5.28 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 128.674 2.79 . . . . 0.0 111.704 -173.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -115.58 116.37 28.04 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.715 1.606 . . . . 0.0 109.589 -177.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -160.21 114.07 2.18 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.186 1.795 . . . . 0.0 110.569 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -94.55 165.49 12.5 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 172.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.7 mm -137.98 113.35 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 173.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.35 114.63 22.01 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -177.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.434 HD11 HD11 ' A' ' 16' ' ' ILE . 17.2 mt -87.42 -58.41 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -126.04 122.55 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 126.375 1.87 . . . . 0.0 107.683 -173.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 81.0 p -123.56 127.96 49.05 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 101.07 -3.678 . . . . 0.0 101.07 172.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.292 0.4 OUTLIER 44.08 36.66 1.53 Allowed 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 119.893 1.224 . . . . 0.0 114.025 178.55 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.5 -8.4 2.24 Favored Glycine 0 CA--C 1.546 2.024 0 O-C-N 120.461 -1.399 . . . . 0.0 115.443 -175.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.83 37.56 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.573 1 C-N-CA 134.524 5.13 . . . . 0.0 111.987 175.528 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 53.9 mtp -37.6 119.38 0.72 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.262 1.425 . . . . 0.0 112.826 -172.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.07 163.35 13.81 Favored Pre-proline 0 N--CA 1.447 -0.62 0 CA-C-N 113.442 -1.708 . . . . 0.0 109.696 177.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.97 30.57 0.29 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 123.994 3.129 . . . . 0.0 111.911 173.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -55.16 -26.76 40.91 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 126.363 1.865 . . . . 0.0 111.427 -174.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.9 m -56.29 -37.74 70.27 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 127.428 2.291 . . . . 0.0 111.605 -173.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -60.84 -65.51 0.68 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 177.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -65.11 -23.7 67.22 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.637 0.775 . . . . 0.0 112.997 -174.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -70.01 -47.05 63.7 Favored 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 124.002 0.921 . . . . 0.0 109.821 173.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.9 ttp180 -78.72 -22.72 46.17 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.932 1.293 . . . . 0.0 112.468 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -63.03 176.49 0.71 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 128.745 2.818 . . . . 0.0 111.579 -173.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.41 170.71 1.69 Allowed 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.152 -0.968 . . . . 0.0 109.571 173.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -48.39 121.19 4.19 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 124.817 1.247 . . . . 0.0 111.942 -175.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -145.67 -67.09 0.3 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 173.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -141.71 -16.75 0.79 Allowed 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.687 ' H ' ' HD2' ' A' ' 54' ' ' PRO . 90.0 mmm -133.03 -44.84 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 116.278 -1.82 . . . . 0.0 114.635 -173.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.687 ' HD2' ' H ' ' A' ' 53' ' ' MET . 5.6 Cg_endo -59.68 -72.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.791 0 CA-C-N 121.877 1.706 . . . . 0.0 113.252 -173.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.19 125.65 29.66 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -176.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 58.4 mt -124.86 131.18 24.07 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 128.14 2.576 . . . . 0.0 106.207 -173.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -81.07 158.44 20.53 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.11 1.873 . . . . 0.0 111.198 174.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.7 p -46.7 -37.31 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 126.058 1.743 . . . . 0.0 112.313 173.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -53.37 -40.1 64.71 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 126.492 1.917 . . . . 0.0 112.582 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 mm -76.6 112.77 14.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 103.394 -2.817 . . . . 0.0 103.394 174.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -83.09 -35.03 25.99 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 173.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.8 m -147.71 152.86 38.5 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.866 1.266 . . . . 0.0 108.271 -174.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 22.3 mtp -113.36 164.03 14.1 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 172.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -133.88 114.47 13.35 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 -173.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -98.97 168.56 10.03 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 173.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.9 m -141.34 135.24 30.3 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -143.66 164.55 30.11 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 121.856 -0.528 . . . . 0.0 111.046 176.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.51 161.56 18.68 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.525 1.13 . . . . 0.0 111.647 174.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.34 160.15 15.59 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.843 0.857 . . . . 0.0 108.759 173.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.55 84.54 7.2 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.871 1.268 . . . . 0.0 110.924 -174.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 50.88 -46.93 0.01 OUTLIER Glycine 0 CA--C 1.542 1.752 1 C-N-CA 131.51 4.386 . . . . 0.0 121.58 173.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -117.14 2.16 12.59 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 120.471 2.135 . . . . 0.0 116.017 -173.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.435 ' H ' ' CE1' ' A' ' 105' ' ' HIS . . . -126.01 37.24 4.38 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 120.903 3.668 . . . . 0.0 120.903 -172.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -38.29 114.21 0.35 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 123.203 2.728 . . . . 0.0 112.882 -173.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -83.86 123.2 29.68 Favored 'General case' 0 C--N 1.338 0.068 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 -174.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -76.69 148.26 36.92 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 -176.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -132.51 160.27 37.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 119.989 1.268 . . . . 0.0 111.106 176.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.482 ' O ' HD13 ' A' ' 131' ' ' ILE . 29.0 tt0 -152.76 137.86 17.32 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 173.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -87.27 104.09 16.07 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 125.288 1.435 . . . . 0.0 109.764 -176.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.4 tt -70.7 -39.28 73.56 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.922 1.289 . . . . 0.0 108.449 176.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.7 m -135.56 144.25 46.13 Favored 'General case' 0 C--N 1.34 0.187 0 O-C-N 121.177 -0.952 . . . . 0.0 112.063 178.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.403 ' H ' ' HD3' ' A' ' 83' ' ' ARG . 1.6 tt -174.13 93.04 0.08 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 128.977 2.911 . . . . 0.0 105.524 173.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.403 ' HD3' ' H ' ' A' ' 82' ' ' LEU . 0.2 OUTLIER -159.97 153.35 22.23 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 119.753 1.16 . . . . 0.0 111.393 -173.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.1 t -78.37 129.02 34.48 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 119.633 1.106 . . . . 0.0 110.798 174.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 68.2 mt -93.16 -27.03 17.15 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 116.874 -1.536 . . . . 0.0 111.164 174.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -77.04 165.72 24.25 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.719 1.6 . . . . 0.0 107.134 175.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.35 -41.98 1.53 Allowed 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.728 1.611 . . . . 0.0 110.855 -173.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -72.39 -69.57 1.37 Allowed Glycine 0 CA--C 1.533 1.192 0 N-CA-C 108.386 -1.885 . . . . 0.0 108.386 173.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.574 HD12 ' H ' ' A' ' 89' ' ' ILE . 3.5 mp -73.44 14.39 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 C-N-CA 128.812 2.845 . . . . 0.0 110.476 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 22.1 ttp -43.2 136.75 2.83 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 128.167 2.587 . . . . 0.0 112.331 -173.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 116' ' ' CYS . . . -156.69 113.58 3.1 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 -174.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -97.99 122.53 54.23 Favored Pre-proline 0 CA--C 1.509 -0.629 0 O-C-N 124.364 1.04 . . . . 0.0 109.285 -173.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -65.88 152.37 81.65 Favored 'Trans proline' 0 N--CA 1.443 -1.466 0 C-N-CA 120.83 1.02 . . . . 0.0 109.5 178.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 42.0 p -135.77 161.96 34.11 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.323 1.449 . . . . 0.0 107.137 173.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.9 m -126.47 149.71 31.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 O-C-N 121.241 -0.912 . . . . 0.0 111.679 174.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -86.81 13.77 8.31 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.772 1.629 . . . . 0.0 111.174 173.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.0 m -130.99 163.13 51.21 Favored Pre-proline 0 N--CA 1.454 -0.273 0 C-N-CA 125.829 1.652 . . . . 0.0 106.587 173.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -67.51 163.32 35.32 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 120.72 0.946 . . . . 0.0 109.864 173.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -62.72 -13.36 31.69 Favored 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 124.459 1.104 . . . . 0.0 111.583 175.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -139.53 163.58 32.17 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.205 1.402 . . . . 0.0 107.894 173.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 164.54 -159.67 32.67 Favored Glycine 0 C--O 1.226 -0.349 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -178.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 68.8 p -123.03 151.36 41.99 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 117.548 0.674 . . . . 0.0 109.506 174.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 48.2 t -89.62 113.45 56.78 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 101.925 -3.361 . . . . 0.0 101.925 173.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -91.95 171.68 2.66 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 N-CA-C 117.591 2.112 . . . . 0.0 117.591 -172.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.435 ' CE1' ' H ' ' A' ' 73' ' ' ALA . 76.1 m-70 -75.9 -0.59 21.9 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 -173.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.5 138.92 51.01 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 116.319 -1.8 . . . . 0.0 106.724 173.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.54 112.15 0.7 Allowed 'General case' 0 C--O 1.231 0.129 0 O-C-N 125.407 1.692 . . . . 0.0 106.466 173.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.5 m -123.23 136.72 54.85 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -176.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.8 t -85.1 135.89 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 O-C-N 124.737 1.273 . . . . 0.0 108.673 -173.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 74.7 t -112.8 103.66 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 104.355 -2.461 . . . . 0.0 104.355 173.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -83.77 125.63 32.11 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 173.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.5 t -102.94 113.55 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 102.712 -3.07 . . . . 0.0 102.712 173.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -82.86 151.49 29.0 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 174.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.45 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 8.7 m-85 -133.42 73.35 73.57 Favored Pre-proline 0 C--O 1.244 0.784 0 CA-C-N 118.279 1.039 . . . . 0.0 109.994 177.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -67.34 114.08 3.12 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.295 1.997 . . . . 0.0 108.634 173.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 5.9 t -89.45 151.43 22.02 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 173.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.1 mt -71.22 -10.95 60.6 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.102 0.41 . . . . 0.0 111.862 -176.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.77 23.01 49.19 Favored Glycine 0 C--N 1.339 0.713 0 C-N-CA 126.74 2.114 . . . . 0.0 116.786 173.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 50.7 mttt -120.98 -27.38 4.98 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.583 1.691 . . . . 0.0 113.375 177.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -96.62 156.59 16.28 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 173.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -112.03 151.54 29.22 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 175.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 140.41 -155.94 24.92 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 118.673 0.67 . . . . 0.0 111.56 174.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 20.7 t -122.99 114.14 40.91 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 175.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.3 172.89 9.53 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.553 1.141 . . . . 0.0 109.648 173.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -131.64 148.58 52.61 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.154 1.782 . . . . 0.0 107.684 173.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.46 ' CZ ' ' HB2' ' A' ' 149' ' ' PHE . 43.5 p90 -145.69 151.66 38.39 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 173.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -111.22 148.16 33.43 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 125.152 1.381 . . . . 0.0 111.498 -173.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 31.9 t -141.45 145.35 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 173.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -159.9 135.2 8.16 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 125.168 1.387 . . . . 0.0 108.252 174.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 37.4 t -139.74 131.42 33.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -174.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.616 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -100.93 165.38 2.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 173.829 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.2 t -142.06 138.07 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -173.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.8 175.19 9.81 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.667 1.587 . . . . 0.0 108.113 -176.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 36.9 p-10 -89.82 176.13 6.95 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 172.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.2 t -65.91 -3.51 5.31 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 120.24 -1.538 . . . . 0.0 113.678 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -89.62 -15.25 33.15 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 120.655 1.571 . . . . 0.0 110.595 173.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.72 1.12 62.01 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.62 1.105 . . . . 0.0 112.254 -173.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -71.53 115.9 11.25 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 119.606 1.703 . . . . 0.0 108.403 174.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -64.71 142.76 58.32 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 126.203 1.801 . . . . 0.0 108.632 -177.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.7 pt -139.67 -37.97 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 124.773 1.229 . . . . 0.0 113.884 -174.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -132.72 145.12 50.76 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -148.81 126.95 12.06 Favored 'General case' 0 CA--C 1.52 -0.187 0 O-C-N 121.009 -1.057 . . . . 0.0 108.615 -177.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 63.1 m -64.92 143.46 98.85 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 176.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.55 143.36 21.54 Favored 'Trans proline' 0 N--CA 1.445 -1.372 0 N-CA-C 108.989 -1.197 . . . . 0.0 108.989 174.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -80.46 112.68 18.03 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 176.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 173.11 -19.03 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 130.182 3.393 . . . . 0.0 110.434 -174.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.8 78.58 0.86 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.185 1.394 . . . . 0.0 109.879 -175.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 27.9 mm -101.99 130.01 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 105.002 -2.222 . . . . 0.0 105.002 173.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 126' ' ' PHE . 0.2 OUTLIER -105.0 155.71 18.71 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 173.768 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -130.84 113.47 14.11 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -174.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -110.29 123.9 50.65 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 119.128 0.876 . . . . 0.0 109.617 -174.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 22.5 m -83.48 114.26 21.36 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 175.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 25.5 m -114.6 166.08 12.1 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 123.881 0.872 . . . . 0.0 110.099 174.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.4 pp -141.59 159.08 42.95 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.766 1.627 . . . . 0.0 107.206 173.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.56 128.12 35.25 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.182 0.993 . . . . 0.0 110.318 175.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -157.62 119.44 3.7 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.123 1.369 . . . . 0.0 110.376 176.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 . . . . . 0 C--O 1.256 1.404 0 C-N-CA 129.158 2.983 . . . . 0.0 105.271 173.583 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.431 ' H1 ' ' CG ' ' A' ' 6' ' ' ASP . . . . . . . . 0 N--CA 1.468 0.785 0 N-CA-C 107.297 -2.321 . . . . 0.0 107.297 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.0 t -60.45 136.18 57.97 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 103.948 -2.612 . . . . 0.0 103.948 130.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . 0.278 28.9 m-70 -90.78 113.56 25.72 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-O 123.094 1.426 . . . . 0.0 111.437 -173.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.4 mmt -156.99 177.07 11.94 Favored 'General case' 0 CA--C 1.543 0.673 1 C-N-CA 138.944 6.898 . . . . 0.0 101.475 175.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 54.6 tp -56.69 113.75 1.77 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 173.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.431 ' CG ' ' H1 ' ' A' ' 1' ' ' GLY . 7.7 m-20 -77.53 114.11 16.04 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 174.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.01 170.58 6.17 Favored 'General case' 0 N--CA 1.425 -1.687 0 C-N-CA 128.083 2.553 . . . . 0.0 104.634 177.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -129.29 113.65 15.27 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 129.88 3.272 . . . . 0.0 103.262 173.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -118.33 171.06 8.4 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.171 1.388 . . . . 0.0 108.331 -173.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.645 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . 25.3 mt-10 -80.85 150.15 29.24 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 173.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m -176.54 176.71 1.54 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 130.49 3.516 . . . . 0.0 108.468 173.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.0 tt -43.91 128.0 5.44 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.776 1.63 . . . . 0.0 111.3 -176.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -115.98 128.48 55.77 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.503 1.521 . . . . 0.0 107.995 174.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.51 120.07 13.24 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 -179.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 14.1 p90 -140.48 174.88 10.08 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.776 0.716 . . . . 0.0 109.878 176.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.7 mp -113.74 113.72 44.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 1 N-CA-C 99.844 -4.132 . . . . 0.0 99.844 173.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -75.95 149.9 37.58 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.971 1.367 . . . . 0.0 111.417 -173.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.19 -26.46 63.9 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 113.75 -1.568 . . . . 0.0 113.304 -173.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -67.16 -44.55 79.48 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -174.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.6 -56.3 23.13 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 118.047 -0.978 . . . . 0.0 108.441 174.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.0 -41.05 61.88 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 117.228 -1.368 . . . . 0.0 111.987 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 51.9 ttm-85 -54.09 -61.55 2.23 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 120.802 1.637 . . . . 0.0 108.925 174.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 85.0 t -50.4 -24.27 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 124.54 1.136 . . . . 0.0 111.377 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.6 mt -86.18 -38.52 17.59 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.6 pt -144.18 14.35 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 -172.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.0 -2.58 0.95 Allowed Glycine 0 CA--C 1.533 1.158 0 C-N-CA 129.185 3.278 . . . . 0.0 115.934 -174.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -101.69 138.59 38.47 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 129.944 3.298 . . . . 0.0 107.217 -178.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -130.5 114.26 15.28 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 124.558 1.143 . . . . 0.0 109.965 -173.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -151.83 141.21 21.52 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 128.687 2.795 . . . . 0.0 104.25 173.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.01 166.47 13.87 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 173.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 82.3 mt -136.86 113.15 12.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 104.44 -2.429 . . . . 0.0 104.44 173.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.42 114.35 23.95 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 -177.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.2 mt -88.47 -61.99 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.455 HG22 ' HG2' ' A' ' 39' ' ' MET . 21.2 t -116.74 114.34 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 125.648 1.579 . . . . 0.0 107.049 -173.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.9 p -109.92 114.76 28.57 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 173.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.434 ' C ' ' H ' ' A' ' 38' ' ' LYS . 11.5 pt-20 46.41 36.86 3.72 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.491 1.516 . . . . 0.0 112.777 -178.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.19 -22.31 1.28 Allowed Glycine 0 CA--C 1.544 1.891 0 O-C-N 120.15 -1.594 . . . . 0.0 114.191 -175.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.434 ' H ' ' C ' ' A' ' 36' ' ' GLU . 15.9 ttpt -67.39 37.88 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.583 1 C-N-CA 137.471 6.309 . . . . 0.0 110.985 177.024 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.455 ' HG2' HG22 ' A' ' 34' ' ' VAL 0.284 34.7 mtt -37.38 136.22 0.49 Allowed 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.882 2.073 . . . . 0.0 114.372 -172.86 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.31 163.04 56.21 Favored Pre-proline 0 N--CA 1.448 -0.563 0 CA-C-N 112.844 -1.98 . . . . 0.0 107.778 173.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.24 34.37 0.33 Allowed 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 124.04 3.16 . . . . 0.0 112.095 174.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -55.52 -26.75 44.7 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 126.247 1.819 . . . . 0.0 112.257 -173.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.6 m -60.4 -34.68 74.28 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 126.428 1.891 . . . . 0.0 111.585 -173.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -57.92 -65.74 0.59 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.098 0.959 . . . . 0.0 108.676 178.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -61.79 -41.43 97.73 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 117.327 -1.32 . . . . 0.0 113.563 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -55.84 -49.62 72.81 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.301 1.041 . . . . 0.0 111.069 -178.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.9 ttp180 -80.92 -30.18 35.39 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.509 0.595 . . . . 0.0 111.062 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -69.3 171.22 8.87 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 173.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.74 112.99 8.3 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 173.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -96.7 176.03 6.15 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 173.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -44.55 -44.83 9.02 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.215 1.406 . . . . 0.0 112.296 174.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.76 -15.86 0.12 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 175.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.7 mtp -43.86 -63.47 1.05 Allowed Pre-proline 0 N--CA 1.471 0.623 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 -173.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -65.93 -66.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 121.942 1.762 . . . . 0.0 112.401 -174.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.89 114.22 9.75 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.579 1.152 . . . . 0.0 109.863 -174.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 98.0 mt -119.43 119.91 31.26 Favored Pre-proline 0 N--CA 1.449 -0.476 0 C-N-CA 126.5 1.92 . . . . 0.0 106.379 -175.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.42 156.66 41.17 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.064 1.843 . . . . 0.0 110.174 175.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.2 p -40.61 -42.54 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 127.194 2.198 . . . . 0.0 112.91 175.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -57.45 -36.03 70.89 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 126.455 1.902 . . . . 0.0 113.23 -177.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.0 mm -72.12 112.86 8.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 102.649 -3.093 . . . . 0.0 102.649 173.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -82.42 -40.14 21.64 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 173.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.4 m -146.09 165.95 27.56 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.682 0.793 . . . . 0.0 110.141 -173.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 46.4 mtp -126.11 171.87 10.48 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 127.926 2.49 . . . . 0.0 104.889 173.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -140.23 137.48 34.32 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 173.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -111.26 169.15 8.98 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 173.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.4 m -137.37 130.91 31.33 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -144.41 165.52 27.7 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 121.726 -0.609 . . . . 0.0 110.454 174.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -168.31 155.98 8.16 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.081 173.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.99 -174.04 2.54 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 123.536 1.636 . . . . 0.0 107.55 173.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.645 ' HB1' ' HB3' ' A' ' 10' ' ' GLU 0.257 . . -106.37 131.36 53.67 Favored 'General case' 0 N--CA 1.411 -2.389 1 C-N-CA 131.985 4.114 . . . . 0.0 102.99 174.546 . . . . . . . . 4 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -8.63 -55.66 0.01 OUTLIER Glycine 0 CA--C 1.536 1.348 1 C-N-CA 133.883 5.516 . . . . 0.0 119.429 -173.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -116.95 12.03 14.53 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 121.045 2.423 . . . . 0.0 114.664 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.79 37.52 3.42 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 120.251 3.426 . . . . 0.0 120.251 -172.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -45.13 113.71 0.61 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 123.446 2.839 . . . . 0.0 110.448 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -83.83 134.34 34.71 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.412 1.485 . . . . 0.0 106.992 177.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -83.71 146.32 28.27 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -129.8 160.91 32.02 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 120.212 1.369 . . . . 0.0 110.714 175.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.43 ' O ' HD13 ' A' ' 131' ' ' ILE . 30.6 tt0 -154.48 135.03 13.47 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 173.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -85.69 104.06 15.05 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.951 1.3 . . . . 0.0 108.51 -178.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.9 tt -69.24 -54.54 14.24 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 173.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 m -131.1 141.72 50.18 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 123.342 1.544 . . . . 0.0 111.692 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.486 HD22 HG22 ' A' ' 128' ' ' VAL . 0.1 OUTLIER -163.72 92.61 0.7 Allowed 'General case' 0 N--CA 1.448 -0.536 1 N-CA-C 96.011 -5.552 . . . . 0.0 96.011 172.82 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -158.11 146.54 18.88 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.503 -1.373 . . . . 0.0 112.339 -173.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.1 t -78.5 156.92 29.03 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.956 0.502 . . . . 0.0 110.821 174.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.4 mt -121.04 -26.34 5.16 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 116.908 -1.52 . . . . 0.0 112.461 -176.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -81.32 160.18 24.23 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 121.591 1.996 . . . . 0.0 112.038 -177.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.456 ' HE3' ' HA ' ' A' ' 87' ' ' LYS . 0.5 OUTLIER -105.39 -42.57 5.2 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 131.126 3.77 . . . . 0.0 112.556 176.02 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -67.75 -74.16 0.6 Allowed Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 174.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.405 ' HB ' ' HB2' ' A' ' 124' ' ' ALA . 3.5 mp -77.35 26.03 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 129.996 3.319 . . . . 0.0 110.301 -177.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 10.7 ttm -43.55 140.52 1.72 Allowed 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 128.143 2.577 . . . . 0.0 110.031 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -164.69 175.61 9.58 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 130.017 3.327 . . . . 0.0 105.286 -173.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.273 8.2 m-20 -145.46 115.03 4.86 Favored Pre-proline 0 C--N 1.324 -0.526 0 C-N-CA 124.527 1.131 . . . . 0.0 110.07 173.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -69.58 149.77 68.46 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 N-CA-C 108.322 -1.453 . . . . 0.0 108.322 173.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 21.8 p -137.13 160.63 38.42 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 125.62 1.568 . . . . 0.0 108.072 -175.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.5 m -126.01 153.82 34.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 C-N-CA 124.014 0.925 . . . . 0.0 109.637 174.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -93.2 25.63 3.23 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.613 1.565 . . . . 0.0 111.702 176.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.8 m -134.93 163.3 52.18 Favored Pre-proline 0 C--O 1.235 0.29 0 C-N-CA 124.85 1.26 . . . . 0.0 108.142 174.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -66.66 162.2 38.24 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 121.087 1.191 . . . . 0.0 109.418 173.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.01 -12.72 40.72 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 124.056 0.942 . . . . 0.0 111.902 178.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -143.29 165.71 26.72 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 120.325 1.421 . . . . 0.0 108.641 173.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 164.53 -162.73 35.69 Favored Glycine 0 C--O 1.228 -0.27 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 178.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 82.0 p -117.97 146.66 43.83 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 173.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 28.2 t -82.44 113.74 46.52 Favored Pre-proline 0 N--CA 1.447 -0.594 0 N-CA-C 102.996 -2.964 . . . . 0.0 102.996 173.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -84.42 153.63 12.18 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.347 2.031 . . . . 0.0 111.626 -173.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -69.73 1.81 3.91 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 120.113 -1.617 . . . . 0.0 113.369 -173.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -115.28 119.18 35.44 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 127.086 2.154 . . . . 0.0 107.585 -173.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -43.02 107.84 0.09 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.732 1.213 . . . . 0.0 109.91 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.1 m -118.13 139.18 51.63 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.5 t -96.75 135.25 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 114.301 -1.318 . . . . 0.0 107.834 -173.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 78.5 t -119.86 103.93 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -71.82 143.24 49.54 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 173.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.7 t -124.86 113.91 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 103.707 -2.701 . . . . 0.0 103.707 173.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -100.77 147.91 18.06 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 125.134 1.349 . . . . 0.0 110.145 -178.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.41 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 9.0 m-85 -131.16 73.54 80.47 Favored Pre-proline 0 C--O 1.242 0.706 0 CA-C-N 118.325 1.063 . . . . 0.0 111.596 -174.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -69.18 129.88 19.03 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.326 2.017 . . . . 0.0 108.239 173.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 5.7 t -105.44 154.2 20.65 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 175.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 7.6 mt -70.95 -12.78 61.73 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.559 0.618 . . . . 0.0 111.363 174.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.53 5.01 5.91 Favored Glycine 0 C--O 1.215 -1.037 0 C-N-CA 128.513 2.959 . . . . 0.0 116.169 173.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -94.64 -31.51 13.81 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 120.695 2.247 . . . . 0.0 114.418 -173.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 51.4 tp60 -96.57 146.9 24.41 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 173.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -94.25 143.07 26.71 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 174.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 141.48 -154.44 24.67 Favored Glycine 0 C--N 1.334 0.465 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 178.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.4 t -131.6 114.12 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 C-N-CA 123.288 0.635 . . . . 0.0 109.358 -177.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.405 ' HB2' ' HB ' ' A' ' 89' ' ' ILE . . . -89.97 168.34 12.1 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 173.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -124.08 156.87 35.8 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.119 0.968 . . . . 0.0 109.651 174.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.41 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 3.9 p90 -145.14 148.53 33.71 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.334 1.053 . . . . 0.0 108.518 173.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -111.78 157.78 20.14 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 126.456 1.902 . . . . 0.0 110.876 -174.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.486 HG22 HD22 ' A' ' 82' ' ' LEU . 89.6 t -141.67 138.32 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.403 1.081 . . . . 0.0 109.311 174.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -150.66 118.53 6.22 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 126.97 2.108 . . . . 0.0 105.889 173.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 31.4 t -127.72 123.96 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.65 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -89.88 164.96 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 173.717 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.9 t -144.37 135.35 21.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 -176.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.36 173.99 11.08 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.979 1.312 . . . . 0.0 108.832 -176.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -89.06 175.85 7.23 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 172.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 6.7 t -65.02 -15.13 61.98 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 120.11 -1.619 . . . . 0.0 112.175 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -79.86 -3.22 46.97 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.698 1.599 . . . . 0.0 110.913 175.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 80.54 6.54 89.25 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.073 1.32 . . . . 0.0 112.973 178.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -81.72 119.38 23.78 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 178.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -65.98 143.68 57.23 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.359 1.464 . . . . 0.0 109.241 -176.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -140.32 -37.62 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 125.126 1.371 . . . . 0.0 113.576 -174.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -131.01 149.82 52.44 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 178.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.3 tm0? -148.67 150.02 32.49 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 57.4 m -80.11 113.56 39.52 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 178.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -61.39 140.15 86.4 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 CA-C-N 120.685 1.28 . . . . 0.0 110.59 -173.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -75.57 112.53 12.02 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 -173.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 173.07 -34.49 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 129.874 3.27 . . . . 0.0 108.501 -173.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.44 90.72 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 126.656 1.982 . . . . 0.0 110.521 -174.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.3 mt -126.24 148.58 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 176.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -126.69 164.32 21.57 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 175.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -132.83 113.53 13.02 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.223 1.009 . . . . 0.0 108.309 -173.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -101.03 120.33 40.04 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 28.6 m -83.78 116.33 22.65 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 173.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 9.3 m -111.67 163.44 14.11 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 173.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.2 pp -139.35 159.76 41.41 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 174.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -63.67 114.09 3.76 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 127.813 2.445 . . . . 0.0 111.557 -174.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -153.43 157.7 40.32 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 126.054 1.742 . . . . 0.0 109.549 176.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 . . . . . 0 C--O 1.248 0.985 0 C-N-CA 131.612 3.965 . . . . 0.0 105.557 173.661 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.49 ' H2 ' ' CG ' ' A' ' 6' ' ' ASP . . . . . . . . 0 N--CA 1.472 1.062 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.7 m -43.79 113.82 0.57 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.248 1.819 . . . . 0.0 112.573 -160.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -168.99 177.62 4.85 Favored 'General case' 0 CA--C 1.541 0.634 1 C-N-CA 132.667 4.387 . . . . 0.0 104.459 -172.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.9 tmm? -45.22 176.41 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.362 0 CA-C-O 116.807 -1.568 . . . . 0.0 106.924 172.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.5 tt -42.59 112.82 0.39 Allowed 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 121.933 2.151 . . . . 0.0 110.403 -172.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.49 ' CG ' ' H2 ' ' A' ' 1' ' ' GLY . 11.4 t0 -78.55 175.94 9.89 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 131.245 3.818 . . . . 0.0 116.336 -172.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -60.67 112.9 2.19 Favored 'General case' 0 N--CA 1.423 -1.815 0 C-N-CA 128.026 2.53 . . . . 0.0 106.717 174.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.421 ' NE2' ' H ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -78.56 176.65 9.23 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 109.531 -3.486 . . . . 0.0 106.468 173.011 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.421 ' H ' ' NE2' ' A' ' 8' ' ' GLN . 50.6 mt-10 -57.27 158.1 5.73 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 122.137 0.97 . . . . 0.0 109.614 173.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -64.27 176.74 0.97 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.149 1.78 . . . . 0.0 110.435 174.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.2 m -124.96 176.8 6.41 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 120.498 -1.376 . . . . 0.0 112.099 -174.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.8 tt -43.22 123.64 2.99 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.363 2.665 . . . . 0.0 113.458 -173.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.432 ' CD1' ' HA ' ' A' ' 35' ' ' SER . 94.5 m-85 -113.75 141.45 47.26 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 128.414 2.686 . . . . 0.0 108.656 173.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.01 121.94 7.07 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.759 1.623 . . . . 0.0 106.996 -178.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 26.9 p90 -137.89 175.43 9.59 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.595 1.089 . . . . 0.0 110.675 176.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -111.84 134.34 54.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 103.228 -2.879 . . . . 0.0 103.228 173.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -78.96 162.49 25.93 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 123.016 1.389 . . . . 0.0 112.846 -173.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.4 ' HB1' ' HG3' ' A' ' 28' ' ' GLU . . . -78.87 -26.41 43.95 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 113.775 -1.557 . . . . 0.0 112.137 -176.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 10.2 m80 -63.98 -41.96 97.37 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.094 0.957 . . . . 0.0 108.73 -175.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -62.26 -43.99 97.56 Favored 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 123.909 0.884 . . . . 0.0 110.616 177.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.534 ' HA ' HD12 ' A' ' 24' ' ' LEU . . . -60.75 -35.47 76.48 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 118.401 -0.809 . . . . 0.0 111.005 176.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -54.23 -57.71 10.13 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 173.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.4 t -55.24 -24.03 14.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 123.695 0.798 . . . . 0.0 111.618 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.534 HD12 ' HA ' ' A' ' 21' ' ' ALA . 6.5 mt -78.04 -39.79 40.82 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 175.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.4 pt -150.0 14.35 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 N-CA-C 117.397 2.369 . . . . 0.0 117.397 -172.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 63.99 0.81 4.51 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 128.296 2.855 . . . . 0.0 114.48 -173.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -101.79 141.24 34.95 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 129.247 3.019 . . . . 0.0 106.289 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.4 ' HG3' ' HB1' ' A' ' 18' ' ' ALA . 19.9 tt0 -126.86 113.78 17.02 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.232 0.924 . . . . 0.0 111.208 -173.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -155.87 137.53 14.21 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 127.809 2.443 . . . . 0.0 105.942 173.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -72.64 175.77 6.09 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.976 2.11 . . . . 0.0 109.644 173.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 66.9 mt -140.81 113.62 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 173.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.55 127.07 34.33 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -176.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.4 mt -102.39 -56.33 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 119.313 0.961 . . . . 0.0 110.665 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.2 t -125.34 131.7 71.97 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -173.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.432 ' HA ' ' CD1' ' A' ' 13' ' ' TYR . 18.8 p -134.49 120.3 19.56 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 174.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.433 1.0 OUTLIER 43.63 47.83 6.43 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 122.72 1.248 . . . . 0.0 112.397 -176.377 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.24 11.68 20.97 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 126.165 1.841 . . . . 0.0 114.959 177.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.489 ' HB2' ' HZ3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -74.23 37.31 0.1 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.633 2.373 . . . . 0.0 113.762 -173.308 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 9.4 mmt -38.22 113.49 0.29 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 122.746 1.26 . . . . 0.0 111.981 -173.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.78 170.09 8.19 Favored Pre-proline 0 N--CA 1.448 -0.535 0 C-N-CA 127.734 2.413 . . . . 0.0 109.079 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.0 26.19 0.25 Allowed 'Trans proline' 0 CA--C 1.548 1.212 0 C-N-CA 123.678 2.918 . . . . 0.0 112.09 173.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -53.57 -26.43 21.47 Favored 'General case' 0 C--N 1.345 0.402 0 C-N-CA 126.437 1.895 . . . . 0.0 111.625 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 m -60.49 -29.81 69.31 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 126.099 1.76 . . . . 0.0 110.696 -173.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -60.76 -63.38 1.32 Allowed 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 174.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.672 ' O ' ' HB2' ' A' ' 49' ' ' ALA 0.382 1.0 OUTLIER -65.59 -22.89 66.72 Favored 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 124.835 1.254 . . . . 0.0 113.086 -177.775 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -67.95 -52.99 29.71 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.095 -1.628 . . . . 0.0 107.054 173.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.61 -24.53 58.88 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.928 1.291 . . . . 0.0 112.993 -173.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -122.2 113.17 19.09 Favored 'General case' 0 C--O 1.214 -0.784 0 C-N-CA 129.617 3.167 . . . . 0.0 104.897 174.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.672 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -166.0 176.12 8.01 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 120.532 1.514 . . . . 0.0 111.148 -174.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.9 165.23 15.8 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 105.812 -1.922 . . . . 0.0 105.812 173.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.65 -19.47 16.44 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 120.347 -1.471 . . . . 0.0 113.413 -174.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 -54.52 -11.09 0.49 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.513 2.325 . . . . 0.0 115.528 174.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 7.2 mtp -135.03 -66.05 0.02 OUTLIER Pre-proline 0 N--CA 1.475 0.793 0 CA-C-N 122.219 2.281 . . . . 0.0 115.865 175.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.537 ' CD ' ' HB3' ' A' ' 49' ' ' ALA . 19.9 Cg_endo -61.6 -70.55 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.765 2.31 . . . . 0.0 112.9 -173.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.0 113.56 16.03 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -176.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 94.2 mt -114.31 114.07 45.67 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 126.59 1.956 . . . . 0.0 106.227 -174.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -74.14 158.67 45.21 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 121.86 1.707 . . . . 0.0 110.853 -175.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.6 p -45.45 -38.38 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.428 1.491 . . . . 0.0 112.18 173.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -53.75 -43.1 68.87 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.963 1.705 . . . . 0.0 112.563 176.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.4 mm -81.0 112.93 19.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 103.065 -2.939 . . . . 0.0 103.065 173.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -81.11 -38.45 27.23 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 173.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.3 m -142.74 162.53 35.21 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.891 1.276 . . . . 0.0 111.037 -173.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.9 mmm -116.6 159.22 22.48 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 173.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -109.48 113.16 25.72 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 174.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -100.41 160.21 14.52 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 102.696 -3.075 . . . . 0.0 102.696 172.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.4 m -147.22 136.36 22.45 Favored 'General case' 0 C--N 1.317 -0.84 0 O-C-N 120.086 -1.634 . . . . 0.0 106.976 -177.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -147.62 168.31 22.34 Favored 'General case' 0 C--O 1.246 0.885 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.53 178.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -173.56 149.28 1.64 Allowed 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 113.813 -1.54 . . . . 0.0 114.167 175.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -82.71 -173.9 4.91 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 101.977 -3.342 . . . . 0.0 101.977 172.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -110.78 131.26 55.2 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 103.384 -2.821 . . . . 0.0 103.384 173.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 38.15 -93.79 0.01 OUTLIER Glycine 0 CA--C 1.533 1.204 1 C-N-CA 131.196 4.236 . . . . 0.0 116.008 174.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -116.97 25.08 10.76 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.998 2.119 . . . . 0.0 116.079 174.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.8 37.32 0.53 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 128.855 2.862 . . . . 0.0 114.379 174.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.6 mp0 -38.43 113.56 0.3 Allowed 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 121.5 1.955 . . . . 0.0 116.052 -173.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -103.05 137.36 41.33 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 127.096 2.159 . . . . 0.0 106.446 173.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -99.45 151.31 21.26 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -135.69 159.97 39.98 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 119.918 1.235 . . . . 0.0 110.409 174.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.452 ' O ' HD13 ' A' ' 131' ' ' ILE . 28.8 tt0 -153.56 134.98 14.24 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 173.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -80.71 103.91 10.88 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.3 tt -64.36 -43.35 94.84 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.058 1.343 . . . . 0.0 107.579 174.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 75.4 m -148.34 149.52 31.94 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.437 1.095 . . . . 0.0 109.335 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.7 tt -169.36 93.21 0.27 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 128.933 2.893 . . . . 0.0 103.289 177.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 44.5 mmm-85 -161.95 162.07 28.9 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.495 1.043 . . . . 0.0 111.669 -174.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.2 t -84.86 161.71 19.79 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 122.271 1.034 . . . . 0.0 111.898 174.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.7 mt -126.43 -0.7 6.92 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 126.108 1.763 . . . . 0.0 113.111 -174.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.469 ' CG ' ' H ' ' A' ' 87' ' ' LYS 0.315 14.6 t70 -98.45 161.82 13.48 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 120.601 1.546 . . . . 0.0 114.591 -175.367 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.469 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER -91.0 -59.24 2.22 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 128.936 2.894 . . . . 0.0 110.2 -177.263 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' A' ' 90' ' ' MET . . . -97.09 -45.01 2.69 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 124.977 1.275 . . . . 0.0 112.648 -173.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.7 mp -81.0 24.47 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 CA-C-O 123.323 1.535 . . . . 0.0 109.566 -178.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.454 ' H ' ' C ' ' A' ' 88' ' ' GLY . 24.4 ttm -43.47 133.27 4.4 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 130.808 3.643 . . . . 0.0 109.479 -179.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.261 . . -167.3 176.03 6.96 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 131.382 3.873 . . . . 0.0 105.114 -173.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.283 8.2 m-20 -150.0 136.13 10.52 Favored Pre-proline 0 C--N 1.324 -0.531 0 C-N-CA 124.789 1.236 . . . . 0.0 111.746 172.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -72.99 154.4 52.88 Favored 'Trans proline' 0 N--CA 1.444 -1.394 0 C-N-CA 121.702 1.601 . . . . 0.0 108.476 173.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.2 p -143.88 162.56 35.79 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.626 1.571 . . . . 0.0 108.667 174.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.3 m -126.39 156.25 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 123.73 0.812 . . . . 0.0 112.317 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -74.38 9.23 1.79 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 127.848 2.459 . . . . 0.0 113.584 174.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.4 m -140.68 165.23 31.22 Favored Pre-proline 0 C--N 1.326 -0.421 0 C-N-CA 125.318 1.447 . . . . 0.0 108.84 -178.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -66.57 166.12 23.01 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 121.405 1.403 . . . . 0.0 110.454 173.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.35 -8.99 10.09 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.94 1.296 . . . . 0.0 111.88 175.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -144.56 163.67 33.2 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 120.505 1.502 . . . . 0.0 108.425 173.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 163.8 -161.28 34.11 Favored Glycine 0 C--O 1.227 -0.342 0 N-CA-C 110.544 -1.023 . . . . 0.0 110.544 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 27.1 p -120.79 148.1 44.45 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.0 t -76.47 113.61 30.61 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -79.86 121.35 4.52 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 121.835 1.69 . . . . 0.0 113.463 -173.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.72 ' H ' ' CD2' ' A' ' 105' ' ' HIS . 1.1 m-70 -63.41 -20.6 65.69 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.329 1.452 . . . . 0.0 111.974 -173.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . 0.274 4.5 mptt -91.88 112.82 24.9 Favored 'General case' 0 N--CA 1.418 -2.046 1 N-CA-C 99.062 -4.422 . . . . 0.0 99.062 176.581 . . . . . . . . 3 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -42.19 117.33 0.96 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.716 1.606 . . . . 0.0 113.003 -173.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 37.4 m -127.33 142.86 51.34 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 123.722 0.639 . . . . 0.0 110.843 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 24.3 t -94.32 116.39 35.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 C-N-CA 125.355 1.462 . . . . 0.0 109.069 -174.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 84.2 t -94.26 103.15 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 103.879 -2.637 . . . . 0.0 103.879 173.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.63 122.59 24.87 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 173.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.5 t -97.63 113.65 32.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 104.307 -2.479 . . . . 0.0 104.307 174.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -100.13 146.37 17.71 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 119.755 1.162 . . . . 0.0 110.377 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.483 ' CE1' ' CZ ' ' A' ' 126' ' ' PHE . 8.1 m-85 -129.48 73.5 81.54 Favored Pre-proline 0 C--O 1.243 0.74 0 CA-C-N 118.253 1.027 . . . . 0.0 110.097 -174.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.87 127.85 19.53 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.589 2.193 . . . . 0.0 108.802 173.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 6.9 t -105.89 148.47 27.57 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 123.958 0.903 . . . . 0.0 108.908 176.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.6 mt -76.43 -15.7 59.87 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 117.751 0.25 . . . . 0.0 111.31 177.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.1 51.6 57.42 Favored Glycine 0 C--N 1.337 0.605 0 C-N-CA 125.719 1.628 . . . . 0.0 112.092 174.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.418 ' HE3' ' OE2' ' A' ' 157' ' ' GLU 0.297 40.5 mmtm -111.66 -55.44 2.5 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.438 1.119 . . . . 0.0 112.477 -179.061 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 50.4 tp60 -95.68 149.7 21.18 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 173.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -93.48 139.62 30.52 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 176.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.5 -153.55 25.2 Favored Glycine 0 C--N 1.331 0.278 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -176.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.7 t -130.41 114.14 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -175.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -85.94 170.34 12.42 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 173.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -123.95 151.63 43.4 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 173.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.483 ' CZ ' ' CE1' ' A' ' 114' ' ' PHE . 32.9 p90 -145.55 156.49 43.73 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 174.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -128.14 160.71 31.18 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 126.281 1.832 . . . . 0.0 111.229 -173.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 67.5 t -141.76 139.28 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 O-C-N 125.307 1.629 . . . . 0.0 108.141 173.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -143.22 121.7 12.43 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 128.043 2.537 . . . . 0.0 106.589 174.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.8 t -133.5 124.2 47.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -177.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.661 HD13 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -90.52 164.37 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 173.374 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.0 t -145.15 134.45 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 -175.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.13 174.82 10.2 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 124.821 1.249 . . . . 0.0 107.934 -175.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -89.63 176.06 7.02 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 104.535 -2.394 . . . . 0.0 104.535 172.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.2 t -66.67 -4.14 8.16 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 120.239 -1.538 . . . . 0.0 113.709 -177.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -88.27 -15.38 35.95 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 120.608 1.549 . . . . 0.0 110.513 173.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.75 1.18 61.93 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.705 1.145 . . . . 0.0 112.114 -173.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -70.1 115.96 9.91 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 119.564 1.682 . . . . 0.0 108.403 174.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -67.54 143.79 55.95 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.439 1.496 . . . . 0.0 108.883 -176.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -139.3 -36.58 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 124.486 1.114 . . . . 0.0 113.569 -175.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.428 HD13 ' N ' ' A' ' 142' ' ' GLN . 1.6 tm? -136.88 146.97 46.18 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.723 1.609 . . . . 0.0 106.817 -174.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.428 ' N ' HD13 ' A' ' 141' ' ' LEU . 13.3 tm0? -147.84 150.84 34.92 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 121.105 -0.997 . . . . 0.0 108.671 174.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.4 m -88.05 113.62 55.7 Favored Pre-proline 0 CA--C 1.532 0.253 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -66.72 148.88 83.57 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 121.55 1.5 . . . . 0.0 112.346 -173.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -81.16 112.6 18.66 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.488 -173.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . 0.595 7.1 m-80 172.37 -13.96 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.445 1 C-N-CA 138.022 6.529 . . . . 0.0 111.128 173.279 . . . . . . . . 3 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.69 81.44 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.309 1.844 . . . . 0.0 109.158 174.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.5 mt -133.9 147.78 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 127.606 2.362 . . . . 0.0 106.182 -174.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.427 ' CD1' ' CE1' ' A' ' 126' ' ' PHE . 0.9 OUTLIER -132.18 171.03 14.18 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.363 -1.29 . . . . 0.0 107.718 178.128 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -134.25 113.64 12.2 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 -173.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.57 126.51 53.66 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 -173.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 34.1 m -93.6 115.8 28.29 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 -175.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 4.3 m -115.39 166.43 11.88 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 123.818 0.847 . . . . 0.0 110.294 174.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.1 pp -131.92 161.46 33.0 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.862 1.665 . . . . 0.0 107.129 173.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.37 130.34 42.76 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.19 0.996 . . . . 0.0 109.971 177.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -157.93 163.06 38.24 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.193 1.797 . . . . 0.0 108.739 175.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.418 ' OE2' ' HE3' ' A' ' 119' ' ' LYS . 2.9 tp10 . . . . . 0 C--O 1.246 0.885 0 C-N-CA 129.527 3.131 . . . . 0.0 104.28 173.64 . . . . . . . . 1 1 . 1 stop_ save_